PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Poidevin, L; Andreeva, K; Khachatoorian, C; Judelson, HS				Poidevin, Laetitia; Andreeva, Kalina; Khachatoorian, Careen; Judelson, Howard S.			Comparisons of Ribosomal Protein Gene Promoters Indicate Superiority of Heterologous Regulatory Sequences for Expressing Transgenes in Phytophthora infestans	PLOS ONE			English	Article							FUNCTIONAL GENOMICS; BREMIA-LACTUCAE; PLANT PATHOGEN; DNA; ARABIDOPSIS; DISCOVERY; VECTORS; RNAS; PARASITICA; EVOLUTION	Molecular genetics approaches in Phytophthora research can be hampered by the limited number of known constitutive promoters for expressing transgenes and the instability of transgene activity. We have therefore characterized genes encoding the cytoplasmic ribosomal proteins of Phytophthora and studied their suitability for expressing transgenes in P. infestans. Phytophthora spp. encode a standard complement of 79 cytoplasmic ribosomal proteins. Several genes are duplicated, and two appear to be pseudogenes. Half of the genes are expressed at similar levels during all stages of asexual development, and we discovered that the majority share a novel promoter motif named the PhRiboBox. This sequence is enriched in genes associated with transcription, translation, and DNA replication, including tRNA and rRNA biogenesis. Promoters from the three P. infestans genes encoding ribosomal proteins S9, L10, and L23 and their orthologs from P. capsici were tested for their ability to drive transgenes in stable transformants of P. infestans. Five of the six promoters yielded strong expression of a GUS reporter, but the stability of expression was higher using the P. capsici promoters. With the RPS9 and RPL10 promoters of P. infestans, about half of transformants stopped making GUS over two years of culture, while their P. capsici orthologs conferred stable expression. Since cross-talk between native and transgene loci may trigger gene silencing, we encourage the use of heterologous promoters in transformation studies.	[Poidevin, Laetitia; Andreeva, Kalina; Khachatoorian, Careen; Judelson, Howard S.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Judelson, HS (corresponding author), Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.	howard.judelson@ucr.edu	Poidevin, Laetitia/AAJ-9009-2020	Poidevin, Laetitia/0000-0002-0348-4405	National Science Foundation of the United States [1004793, 1120225]	National Science Foundation of the United States(National Science Foundation (NSF))	This work was supported by grants 1004793 and 1120225 to HSJ from the National Science Foundation of the United States. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapito-Tenfen SZ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0346-8; Ah-Fong AMV, 2008, FUNGAL GENET BIOL, V45, P1197, DOI 10.1016/j.fgb.2008.05.009; Ah-Fong AMV, 2007, EUKARYOT CELL, V6, P2222, DOI 10.1128/EC.00328-07; Ah-Fong AMV, 2011, FUNGAL BIOL-UK, V115, P882, DOI 10.1016/j.funbio.2011.07.001; Amaldi F, 1995, BIOCHEM CELL BIOL, V73, P969, DOI 10.1139/o95-104; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barakat A, 2001, PLANT PHYSIOL, V127, P398, DOI 10.1104/pp.010265; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bhullar S, 2003, PLANT PHYSIOL, V132, P988, DOI 10.1104/pp.103.020602; Bottin A, 1999, FEMS MICROBIOL LETT, V176, P51, DOI 10.1111/j.1574-6968.1999.tb13641.x; Daxinger L, 2008, TRENDS PLANT SCI, V13, P4, DOI 10.1016/j.tplants.2007.10.007; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Feng BZ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-126; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hodges BL, 2004, MOL THER, V10, P269, DOI 10.1016/j.ymthe.2004.04.018; Horstick EJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv035; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Judelson HS, 2008, MOL PLANT MICROBE IN, V21, P433, DOI 10.1094/MPMI-21-4-0433; JUDELSON HS, 1995, CURR GENET, V28, P571, DOI 10.1007/BF00518171; JUDELSON HS, 1990, MOL PLANT MICROBE IN, V3, P225, DOI 10.1094/MPMI-3-225; JUDELSON HS, 1993, GENE, V133, P63, DOI 10.1016/0378-1119(93)90225-R; JUDELSON HS, 1992, MOL GEN GENET, V234, P138, DOI 10.1007/BF00272355; JUDELSON HS, 1989, GENE, V79, P207, DOI 10.1016/0378-1119(89)90203-5; JUDELSON HS, 1993, MOL GEN GENET, V239, P241, DOI 10.1007/BF00281624; Judelson HS, PLANT PATHOL, V16, P83; Jupe J, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r63; Kamoun S, 2015, MOL PLANT PATHOL, V16, P413, DOI 10.1111/mpp.12190; Kim JH, 2009, GENOME RES, V19, P533, DOI 10.1101/gr.086496.108; Kishimoto N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054670; Koia J, 2013, PLANT MOL BIOL, V81, P327, DOI 10.1007/s11103-012-0002-3; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; Matzke AJM, 1998, CURR OPIN PLANT BIOL, V1, P142, DOI 10.1016/S1369-5266(98)80016-2; Nakao A, 2004, NUCLEIC ACIDS RES, V32, pD168, DOI 10.1093/nar/gkh004; Natesan S, 1997, NATURE, V390, P349, DOI 10.1038/37019; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Panabieres F, 1998, MICROBIOL-UK, V144, P3343, DOI 10.1099/00221287-144-12-3343; Qutob D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2354; Rach EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001274; Randall E, 2014, MOL PLANT PATHOL, V15, P664, DOI 10.1111/mpp.12124; Roy S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003182; Roy S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-106; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Scrable H, 1999, MUTAT RES-FUND MOL M, V429, P225, DOI 10.1016/S0027-5107(99)00114-1; Stajich JE, 2012, NUCLEIC ACIDS RES, V40, pD675, DOI 10.1093/nar/gkr918; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Thines M, 2014, EUR J PLANT PATHOL, V138, P431, DOI 10.1007/s10658-013-0366-5; van West P, 1999, MOL CELL, V3, P339, DOI 10.1016/S1097-2765(00)80461-X; van West P, 1999, FEMS MICROBIOL LETT, V178, P71, DOI 10.1111/j.1574-6968.1999.tb13761.x; Vetukuri RR, 2011, MOL PLANT PATHOL, V12, P772, DOI [10.1111/J.1364-3703.2011.00710.X, 10.1111/j.1364-3703.2011.00710.x]; Xiang QJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092086; Yan HZ, 2006, FUNGAL GENET BIOL, V43, P430, DOI 10.1016/j.fgb.2006.01.010; Zhou J, 2009, CURR GENET, V55, P485, DOI 10.1007/s00294-009-0261-y	55	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145612	10.1371/journal.pone.0145612	http://dx.doi.org/10.1371/journal.pone.0145612			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716454	gold, Green Published, Green Submitted			2022-12-27	WOS:000367510500047
J	van Zon, SKR; Bultmann, U; de Leon, CFM; Reijneveld, SA				van Zon, Sander K. R.; Bultmann, Ute; de Leon, Carlos F. Mendes; Reijneveld, Sijmen A.			Absolute and Relative Socioeconomic Health Inequalities across Age Groups	PLOS ONE			English	Article							LIFE-COURSE; SOCIAL-STRATIFICATION; OLD-AGE; EDUCATION; POSITION; COHORT; DETERMINANTS; RETIREMENT; CURVE	Background The magnitude of socioeconomic health inequalities differs across age groups. It is less clear whether socioeconomic health inequalities differ across age groups by other factors that are known to affect the relation between socioeconomic position and health, like the indicator of socioeconomic position, the health outcome, gender, and as to whether socioeconomic health inequalities are measured in absolute or in relative terms. The aim is to investigate whether absolute and relative socioeconomic health inequalities differ across age groups by indicator of socioeconomic position, health outcome and gender. Methods The study sample was derived from the baseline measurement of the LifeLines Cohort Study and consisted of 95,432 participants. Socioeconomic position was measured as educational level and household income. Physical and mental health were measured with the RAND-36. Age concerned eleven 5-years age groups. Absolute inequalities were examined by comparing means. Relative inequalities were examined by comparing Gini-coefficients. Analyses were performed for both health outcomes by both educational level and household income. Analyses were performed for all age groups, and stratified by gender. Results Absolute and relative socioeconomic health inequalities differed across age groups by indicator of socioeconomic position, health outcome, and gender. Absolute inequalities were most pronounced for mental health by household income. They were larger in younger than older age groups. Relative inequalities were most pronounced for physical health by educational level. Gini-coefficients were largest in young age groups and smallest in older age groups. Conclusions Absolute and relative socioeconomic health inequalities differed cross-sectionally across age groups by indicator of socioeconomic position, health outcome and gender. Researchers should critically consider the implications of choosing a specific age group, in addition to the indicator of socioeconomic position and health outcome, as findings on socioeconomic health inequalities may differ between them.	[van Zon, Sander K. R.; Bultmann, Ute; Reijneveld, Sijmen A.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, NL-9700 AD Groningen, Netherlands; [de Leon, Carlos F. Mendes] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	University of Groningen; University of Michigan System; University of Michigan	van Zon, SKR (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, Antonius Deusinglaan 1, NL-9700 AD Groningen, Netherlands.	s.k.r.van.zon@umcg.nl		Bultmann, Ute/0000-0001-9589-9220; Reijneveld, Sijmen/0000-0002-1206-7523				Addo J, 2012, STROKE, V43, P1186, DOI 10.1161/STROKEAHA.111.639732; Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Alessie R, 2008, NETSPAR PANEL PAPERS; Barros AJD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001390; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Chandola T, 2007, BRIT MED J, V334, P990, DOI 10.1136/bmj.39167.439792.55; European Commission Eurostat, 2012, SCH TO WORK TRANS ST; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001; Geyer S, 2006, J EPIDEMIOL COMMUN H, V60, P804, DOI 10.1136/jech.2005.041319; Gini C, 1912, CONTRIBUTO STUDIO DI; Grundy E, 2001, J EPIDEMIOL COMMUN H, V55, P895, DOI 10.1136/jech.55.12.895; Guilley E, 2010, ARCH GERONTOL GERIAT, V51, pE37, DOI 10.1016/j.archger.2009.12.009; Gunning-Schepers LJ, 1995, EUR J PUBLIC HEALTH, V5, P187; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; Harper S, 2005, METHODS MEASURING CA; Hays R.D., 1998, RAND 36 HLTH STATUS; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Herd P, 2006, RES AGING, V28, P375, DOI 10.1177/0164027505285845; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; HOUSE JS, 1994, J HEALTH SOC BEHAV, V35, P213, DOI 10.2307/2137277; House JS, 2005, J GERONTOL B-PSYCHOL, V60, P15; HOUSE JS, 1990, MILBANK Q, V68, P383, DOI 10.2307/3350111; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Lynch SM, 2006, J HEALTH SOC BEHAV, V47, P324, DOI 10.1177/002214650604700402; Lynch SM, 2003, DEMOGRAPHY, V40, P309, DOI 10.2307/3180803; Macintyre S, 2003, J PUBLIC HEALTH MED, V25, P288, DOI 10.1093/pubmed/fdg089; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 2015, EUR J PUBLIC HEALTH, V25, P185, DOI 10.1093/eurpub/cku217; Mackenbach JP, 2002, BRIT MED J, V325, P1029, DOI 10.1136/bmj.325.7371.1029; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Mein G, 2003, J EPIDEMIOL COMMUN H, V57, P46, DOI 10.1136/jech.57.1.46; Moser K, 2007, INT J EPIDEMIOL, V36, P1285, DOI 10.1093/ije/dym176; OECD, 2012, ED GLANCE 2012 OECD; Porta M., 2014, DICT EPIDEMIOLOGY, V6th ed; Regidor E, 2004, J EPIDEMIOL COMMUN H, V58, P858, DOI 10.1136/jech.2003.015347; Reijneveld SA, 2003, J EPIDEMIOL COMMUN H, V57, P397, DOI 10.1136/jech.57.6.397; Reijneveld SA, 1998, J EPIDEMIOL COMMUN H, V52, P2, DOI 10.1136/jech.52.1.2; Ross CE, 1996, J HEALTH SOC BEHAV, V37, P104, DOI 10.2307/2137234; Sacker A, 2005, J EPIDEMIOL COMMUN H, V59, P495, DOI 10.1136/jech.2004.026278; Sacker A, 2009, PSYCHOSOM MED, V71, P763, DOI 10.1097/PSY.0b013e3181b1e45e; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P153; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; van der Zee KI, 1996, INT J BEHAV MED, V3, P104, DOI 10.1207/s15327558ijbm0302_2; Veldman K., 2014, PLOS ONE, V9, P3, DOI DOI 10.1371/J0URNAL.P0NE.0101751; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Westerlund H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6149; Westerlund H, 2009, LANCET, V374, P1889, DOI 10.1016/S0140-6736(09)61570-1	51	13	13	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145947	10.1371/journal.pone.0145947	http://dx.doi.org/10.1371/journal.pone.0145947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26717482	gold, Green Submitted, Green Published			2022-12-27	WOS:000367510500101
J	Flores-Pliego, A; Espejel-Nunez, A; Castillo-Castrejon, M; Meraz-Cruz, N; Beltran-Montoya, J; Zaga-Clavellina, V; Nava-Salazar, S; Sanchez-Martinez, M; Vadillo-Ortega, F; Estrada-Gutierrez, G				Flores-Pliego, Arturo; Espejel-Nunez, Aurora; Castillo-Castrejon, Marisol; Meraz-Cruz, Noemi; Beltran-Montoya, Jorge; Zaga-Clavellina, Veronica; Nava-Salazar, Sonia; Sanchez-Martinez, Maribel; Vadillo-Ortega, Felipe; Estrada-Gutierrez, Guadalupe			Matrix Metalloproteinase-3 (MMP-3) Is an Endogenous Activator of the MMP-9 Secreted by Placental Leukocytes: Implication in Human Labor	PLOS ONE			English	Article							HUMAN FETAL MEMBRANES; PREMATURE RUPTURE; MATRIX-METALLOPROTEINASE-9 MMP-9; PRETERM LABOR; GELATINASE-B; EXPRESSION; TERM; DECIDUA; BIOLOGY; CELLS	Background The activity of matrix degrading enzymes plays a leading role in the rupture of the fetal membranes under normal and pathological human labor, and matrix metalloproteinase-9 (MMP-9) it is considered a biomarker of this event. To gain further insight into local MMP-9 origin and activation, in this study we analyzed the contribution of human placental leukocytes to MMP-9 secretion and explored the local mechanisms of the pro-enzyme activation. Methods Placental blood leukocytes were obtained from women at term gestation without labor and maintained in culture up to 72 h. MMP-9 activity in the culture supernatants was determined by zymography and using a specific substrate. The presence of a potential pro-MMP-9 activator in the culture supernatants was monitored using a recombinant biotin-labeled human pro-MMP-9. To characterize the endogenous pro-MMP-9 activator, MMP-1, -3, -7 and -9 were measured by multiplex assay in the supernatants, and an inhibition assay of MMP-9 activation was performed using an anti-human MMP-3 and a specific MMP-3 inhibitor. Finally, production of MMP-9 and MMP-3 in placental leukocytes obtained from term pregnancies with and without labor was assessed by immunofluorescence. Results Placental leukocytes spontaneously secreted pro-MMP-9 after 24 h of culture, increasing significantly at 48 h (P <= 0.05), when the active form of MMP-9 was detected. Culture supernatants activated the recombinant pro-MMP-9 showing that placental leukocytes secrete the activator. A significant increase in MMP-3 secretion by placental leukocytes was observed since 48 h in culture (P <= 0.05) and up to 72 h (P <= 0.001), when concentration reached its maximum value. Specific activity of MMP-9 decreased significantly (P <= 0.005) when an anti-MMP-3 antibody or a specific MMP-3 inhibitor were added to the culture media. Placental leukocytes from term labor produced more MMP-9 and MMP-3 compared to term non-labor cells. Conclusions In this work we confirm that placental leukocytes from human term pregnancies are able to secrete large amounts of MMP-9, and that the production of the enzyme it is enhanced by labor. We also demonstrate for the first time that endogenous MMP-3 plays a major role in MMP-9 activation process. These findings support the contribution of placental leukocytes to create the collagenolytic microenvironment that induces the rupture of the fetal membranes during human labor.	[Flores-Pliego, Arturo; Espejel-Nunez, Aurora; Beltran-Montoya, Jorge; Zaga-Clavellina, Veronica; Nava-Salazar, Sonia; Sanchez-Martinez, Maribel; Estrada-Gutierrez, Guadalupe] Inst Nacl Perinatol Isidro Espinosa Reyes, Mexico City, DF, Mexico; [Castillo-Castrejon, Marisol; Meraz-Cruz, Noemi; Vadillo-Ortega, Felipe] Univ Nacl Autonoma Mexico, Fac Med, Unidad Vinculac, Inst Nacl Med Genom, Mexico City, DF, Mexico	Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico	Estrada-Gutierrez, G (corresponding author), Inst Nacl Perinatol Isidro Espinosa Reyes, Mexico City, DF, Mexico.	gpestrad@gmail.com	Estrada-Gutierrez, Guadalupe/AAM-4642-2021; Flores-Pliego, Arturo/GPK-6349-2022; Castillo-Castrejon, Marisol/GMX-4189-2022; Espejel, Aurora/AAO-6510-2021; Zaga-Clavellina, Veronica/ABB-9954-2020; Vadillo-Ortega, Felipe/I-5273-2017; Estrada, Guadalupe/AAT-3970-2021	Estrada-Gutierrez, Guadalupe/0000-0001-9551-9021; Flores-Pliego, Arturo/0000-0001-7876-6098; Zaga-Clavellina, Veronica/0000-0002-3365-2932; Vadillo-Ortega, Felipe/0000-0001-7137-4200; ESPEJEL NUNEZ, AURORA/0000-0001-9087-8017	Instituto Nacional de Perinatologia [212250-02081]	Instituto Nacional de Perinatologia	GEG was funded by the Instituto Nacional de Perinatologia, grant 212250-02081. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arechavaleta-Velasco F, 2004, AM J OBSTET GYNECOL, V190, P843, DOI 10.1016/j.ajog.2003.09.032; Caldeyro-Barcia R, 1974, ADVERSE PERINATAL EF, P431; Castillo-Castrejon M, 2014, AM J REPROD IMMUNOL, V71, P86, DOI 10.1111/aji.12179; Estrada-Gutierrez G, 2005, MATRIX BIOL, V24, P306, DOI 10.1016/j.matbio.2005.05.001; Fortunato SJ, 2003, AM J REPROD IMMUNOL, V49, P120, DOI 10.1034/j.1600-0897.2003.00012.x; Goldman S, 2003, MOL HUM REPROD, V9, P367, DOI 10.1093/molehr/gag040; Gomez-Lopez N, 2009, J REPROD IMMUNOL, V80, P122, DOI 10.1016/j.jri.2009.01.002; Hahn-Dantona E, 1999, ANN NY ACAD SCI, V878, P372, DOI 10.1111/j.1749-6632.1999.tb07696.x; IMAI K, 1995, J BIOL CHEM, V270, P6691, DOI 10.1074/jbc.270.12.6691; KLEINER DE, 1994, ANAL BIOCHEM, V218, P325, DOI 10.1006/abio.1994.1186; Meraz-Cruz N, 2006, MOL HUM REPROD, V12, P633, DOI 10.1093/molehr/gal072; Moore RM, 2006, PLACENTA, V27, P1037, DOI 10.1016/j.placenta.2006.01.002; MORODOMI T, 1992, BIOCHEM J, V285, P603, DOI 10.1042/bj2850603; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nishihara S, 2008, REPROD SCI, V15, P156, DOI 10.1177/1933719107310308; O'Brien M, 2007, MOL HUM REPROD, V13, P655, DOI 10.1093/molehr/gam047; OGATA Y, 1992, J BIOL CHEM, V267, P3581; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Osman I, 2006, J SOC GYNECOL INVEST, V13, P97, DOI 10.1016/j.jsgi.2005.12.002; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Owen CA, 1999, J LEUKOCYTE BIOL, V65, P137, DOI 10.1002/jlb.65.2.137; Park KH, 2003, J PERINAT MED, V31, P12, DOI 10.1515/JPM.2003.002; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; SANG QX, 1995, BBA-PROTEIN STRUCT M, V1251, P99, DOI 10.1016/0167-4838(95)00086-A; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Toth Marta, 2012, Methods Mol Biol, V878, P121, DOI 10.1007/978-1-61779-854-2_8; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vadillo-Ortega F, 2005, BJOG-INT J OBSTET GY, V112, P19, DOI 10.1111/j.1471-0528.2005.00579.x; VADILLOORTEGA F, 1995, AM J PATHOL, V146, P148; VADILLOORTEGA F, 1990, OBSTET GYNECOL, V75, P84; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vega-Sanchez R, 2010, J REPROD IMMUNOL, V84, P100, DOI 10.1016/j.jri.2009.08.002; Vu TD, 2008, REPROD SCI, V15, P420, DOI 10.1177/1933719108314625; WEINGARTEN H, 1985, ANAL BIOCHEM, V147, P437, DOI 10.1016/0003-2697(85)90294-5; Weiss A, 2007, FRONT BIOSCI-LANDMRK, V12, P649, DOI 10.2741/2089; Xu P, 2002, J CLIN ENDOCR METAB, V87, P1353, DOI 10.1210/jc.87.3.1353; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yonemoto H, 2006, PLACENTA, V27, P669, DOI 10.1016/j.placenta.2005.05.014	41	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145366	10.1371/journal.pone.0145366	http://dx.doi.org/10.1371/journal.pone.0145366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713439	gold, Green Submitted, Green Published			2022-12-27	WOS:000367481900037
J	France, B; Bell, W; Chang, E; Scholten, T				France, Brian; Bell, William; Chang, Emily; Scholten, Trudy			Composite Sampling Approaches for Bacillus anthracis Surrogate Extracted from Soil	PLOS ONE			English	Article								Any release of anthrax spores in the U.S. would require action to decontaminate the site and restore its use and operations as rapidly as possible. The remediation activity would require environmental sampling, both initially to determine the extent of contamination (hazard mapping) and post-decon to determine that the site is free of contamination (clearance sampling). Whether the spore contamination is within a building or outdoors, collecting and analyzing what could be thousands of samples can become the factor that limits the pace of restoring operations. To address this sampling and analysis bottleneck and decrease the time needed to recover from an anthrax contamination event, this study investigates the use of composite sampling. Pooling or compositing of samples is an established technique to reduce the number of analyses required, and its use for anthrax spore sampling has recently been investigated. However, use of composite sampling in an anthrax spore remediation event will require well-documented and accepted methods. In particular, previous composite sampling studies have focused on sampling from hard surfaces; data on soil sampling are required to extend the procedure to outdoor use. Further, we must consider whether combining liquid samples, thus increasing the volume, lowers the sensitivity of detection and produces false negatives. In this study, methods to composite bacterial spore samples from soil are demonstrated. B. subtilis spore suspensions were used as a surrogate for anthrax spores. Two soils (Arizona Test Dust and sterilized potting soil) were contaminated and spore recovery with composites was shown to match individual sample performance. Results show that dilution can be overcome by concentrating bacterial spores using standard filtration methods. This study shows that composite sampling can be a viable method of pooling samples to reduce the number of analysis that must be performed during anthrax spore remediation.	[France, Brian; Bell, William; Chang, Emily; Scholten, Trudy] TDA Res Inc, Wheat Ridge, CO 80033 USA		France, B (corresponding author), TDA Res Inc, Wheat Ridge, CO 80033 USA.	bfrance@tda.com			Defense Threat Reduction Agency (DTRA) [HDTRA1-12-C-0071]	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	The funder provided support in the form of salaries for all the authors [BF, WB, EC, TS]. The specific roles of these authors are articulated in the 'author contributions' section. This work was also supported by the Defense Threat Reduction Agency (DTRA) under contract HDTRA1-12-C-0071. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Defense Threat Reduction Agency (DTRA) under contract HDTRA1-12-C-0071.	Buhr TL, 2011, J APPL MICROBIOL, V111, P1057, DOI 10.1111/j.1365-2672.2011.05122.x; CAHOONYOUNG B, 1989, J CLIN MICROBIOL, V27, P1893, DOI 10.1128/JCM.27.8.1893-1895.1989; Dorfman R, 1943, ANN MATH STAT, V14, P436, DOI 10.1214/aoms/1177731363; Drielak S., 2004, HOT ZONE FORENSICS C; Emanuel P, 2008, SAMPLING BIOL AGENTS; EPA, 2013, EPA600R13168; EPA, 1995, EPA230R95005; Lancaster VA, 1998, J AM STAT ASSOC, V93, P1216, DOI 10.2307/2669863; Patil GP, 2010, COMPOSITE SAMPLING N; Piepel GF, 2009, PNNL18187; PNNL, 2011, VIS SAMPL PLAN; Rose L, 2004, EMERG INFECT DIS, V10, P1023, DOI 10.3201/eid1006.030716; Shah, 2012, EPA TECHNICAL BRIEF; Tufts JAM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114082	14	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145799	10.1371/journal.pone.0145799	http://dx.doi.org/10.1371/journal.pone.0145799			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714315	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900084
J	Kim, D; Hwang, G; Liu, Y; Wang, YF; Singh, AP; Vorsa, N; Koo, H				Kim, Dongyeop; Hwang, Geelsu; Liu, Yuan; Wang, Yifei; Singh, Ajay P.; Vorsa, Nicholi; Koo, Hyun			Cranberry Flavonoids Modulate Cariogenic Properties of Mixed-Species Biofilm through Exopolysaccharides-Matrix Disruption	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS BIOFILMS; AMERICAN CRANBERRY; NATURAL-PRODUCTS; GLUCAN SYNTHESIS; CARIES; SURFACE; PROANTHOCYANIDINS; MODEL; GLUCOSYLTRANSFERASES; ACIDOGENICITY	The exopolysaccharides (EPS) produced by Streptococcus mutans-derived glucosyltransferases (Gtfs) are essential virulence factors associated with the initiation of cariogenic biofilms. EPS forms the core of the biofilm matrix-scaffold, providing mechanical stability while facilitating the creation of localized acidic microenvironments. Cranberry flavonoids, such as A-type proanthocyanidins (PACs) and myricetin, have been shown to inhibit the activity of Gtfs and EPS-mediated bacterial adhesion without killing the organisms. Here, we investigated whether a combination of cranberry flavonoids disrupts EPS accumulation and S. mutans survival using a mixed-species biofilm model under cariogenic conditions. We also assessed the impact of cranberry flavonoids on mechanical stability and the in situ pH at the biofilm-apatite interface. Topical application of an optimized combination of PACs oligomers (100-300 mu M) with myricetin (2 mM) twice daily was used to simulate treatment regimen experienced clinically. Treatments with cranberry flavonoids effectively reduced the insoluble EPS content (>80% reduction vs. vehicle-control; p<0.001), while hindering S. mutans outgrowth within mixed-species biofilms. As a result, the 3D architecture of cranberry-treated biofilms was severely compromised, showing a defective EPS-matrix and failure to develop microcolonies on the saliva-coated hydroxyapatite (sHA) surface. Furthermore, topical applications of cranberry flavonoids significantly weaken the mechanical stability of the biofilms; nearly 90% of the biofilm was removed from sHA surface after exposure to a shear stress of 0.449 N/m(2) (vs. 36% removal in vehicle-treated biofilms). Importantly, in situ pH measurements in cranberry-treated biofilms showed significantly higher pH values (5.2 +/- 0.1) at the biofilm-apatite interface vs. vehicle-treated biofilms (4.6 +/- 0.1). Altogether, the data provide important insights on how cranberry flavonoids treatments modulate virulence properties by disrupting the biochemical and ecological changes associated with cariogenic biofilm development, which could lead to new alternative or adjunctive antibiofilm/anticaries chemotherapeutic formulations.	[Kim, Dongyeop; Hwang, Geelsu; Liu, Yuan; Koo, Hyun] Univ Penn, Biofilm Res Labs, Dept Orthodont, Philadelphia, PA 19104 USA; [Kim, Dongyeop; Hwang, Geelsu; Liu, Yuan; Koo, Hyun] Univ Penn, Div Pediat Dent, Philadelphia, PA 19104 USA; [Kim, Dongyeop; Hwang, Geelsu; Liu, Yuan; Koo, Hyun] Univ Penn, Div Community Oral Hlth, Philadelphia, PA 19104 USA; [Wang, Yifei; Singh, Ajay P.; Vorsa, Nicholi] Rutgers State Univ, Dept Plant Biol & Plant Pathol, New Brunswick, NJ 08903 USA; [Vorsa, Nicholi] Rutgers State Univ, Philip E Marucci Ctr Blueberry & Cranberry Res &, Chatsworth, NJ USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Koo, H (corresponding author), Univ Penn, Biofilm Res Labs, Dept Orthodont, Philadelphia, PA 19104 USA.	koohy@dental.upenn.edu	Hwang, Geelsu/F-9484-2011; Liu, Yuan/M-2801-2017; Singh, Ajay/AAF-4414-2020	Hwang, Geelsu/0000-0001-7277-5639; Liu, Yuan/0000-0003-0213-606X	NIH [5R01DE016139, S10RR027128]; School of Veterinary Medicine, the University of Pennsylvania; Commonwealth of Pennsylvania; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016139] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); School of Veterinary Medicine, the University of Pennsylvania; Commonwealth of Pennsylvania; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH grant 5R01DE016139. Imaging experiments were performed in the PennVet Imaging Core Facility on instrumentation supported by NIH S10RR027128, the School of Veterinary Medicine, the University of Pennsylvania, and the Commonwealth of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH grant 5R01DE016139. Imaging experiments were performed in the PennVet Imaging Core Facility on instrumentation supported by NIH S10RR027128, the School of Veterinary Medicine, the University of Pennsylvania, and the Commonwealth of Pennsylvania. APS and NV are thankful to Susan Butterworth for their help in isolation of PACs	Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Bowen WH, 2013, ODONTOLOGY, V101, P2, DOI 10.1007/s10266-012-0092-z; Cross SE, 2007, MICROBIOL-SGM, V153, P3124, DOI 10.1099/mic.0.2007/007625-0; Dawes Colin, 2003, J Can Dent Assoc, V69, P722; Duarte S, 2006, FEMS MICROBIOL LETT, V257, P50, DOI 10.1111/j.1574-6968.2006.00147.x; Fajardo D, 2013, PLANT MOL BIOL REP, V31, P264, DOI 10.1007/s11105-012-0497-4; Fears KP, 2015, LANGMUIR, V31, P4654, DOI 10.1021/la504461h; Feng GP, 2013, BIOFOULING, V29, P629, DOI 10.1080/08927014.2013.794456; Gregoire S, 2007, J APPL MICROBIOL, V103, P1960, DOI 10.1111/j.1365-2672.2007.03441.x; Guo LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057182; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Harvey A, 2000, DRUG DISCOV TODAY, V5, P294, DOI 10.1016/S1359-6446(00)01511-7; Hope CK, 2004, ANTIMICROB AGENTS CH, V48, P1461, DOI 10.1128/AAC.48.5.1461-1468.2004; Hwang G, 2014, BIOFOULING, V30, P1079, DOI 10.1080/08927014.2014.969249; Jeon JG, 2011, CARIES RES, V45, P243, DOI 10.1159/000327250; Jobstl E, 2004, BIOMACROMOLECULES, V5, P942, DOI 10.1021/bm0345110; Kassebaum NJ, 2015, J DENT RES, V94, P650, DOI 10.1177/0022034515573272; Kim D, 2012, INNOV FOOD SCI EMERG, V16, P191, DOI 10.1016/j.ifset.2012.05.014; Klein MI, 2011, JOVE-J VIS EXP, V47, pe2512, DOI DOI 10.3791/2512; Koo H, 2002, ANTIMICROB AGENTS CH, V46, P1302, DOI 10.1128/AAC.46.5.1302-1309.2002; Koo H, 2010, CARIES RES, V44, P116, DOI 10.1159/000296306; Kreth J, 2008, ORAL MICROBIOL IMMUN, V23, P213, DOI 10.1111/j.1399-302X.2007.00413.x; La VD, 2010, ANTIMICROB AGENTS CH, V54, P1778, DOI 10.1128/AAC.01432-09; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Lemos JA, 2008, MICROBIOL-SGM, V154, P3247, DOI 10.1099/mic.0.2008/023770-0; Lynch DJ, 2007, FEMS MICROBIOL LETT, V268, P158, DOI 10.1111/j.1574-6968.2006.00576.x; Marsh PD, 2011, PERIODONTOL 2000, V55, P16, DOI 10.1111/j.1600-0757.2009.00339.x; Mattos-Graner RO, 2000, J DENT RES, V79, P1371, DOI 10.1177/00220345000790060401; Sato Y, 1997, INFECT IMMUN, V65, P668, DOI 10.1128/IAI.65.2.668-675.1997; Schlafer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025299; Singh AP, 2009, PHYTOTHER RES, V23, P1066, DOI 10.1002/ptr.2667; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Vinogradov A., 2004, BIOFILMS, V1, P49, DOI DOI 10.1017/S1479050503001078; Vroom JM, 1999, APPL ENVIRON MICROB, V65, P3502; Vvedenskaya IO, 2004, PLANT SCI, V167, P1043, DOI 10.1016/j.plantsci.2004.06.001; Vvedenskaya IO, 2004, J AGR FOOD CHEM, V52, P188, DOI 10.1021/jf034970s; Waters MS, 2014, ACS APPL MATER INTER, V6, P327, DOI 10.1021/am404344h; Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623; YAMASHITA Y, 1993, INFECT IMMUN, V61, P3811, DOI 10.1128/IAI.61.9.3811-3817.1993; Yanagida A, 2000, J AGR FOOD CHEM, V48, P5666, DOI 10.1021/jf000363i	40	29	29	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145844	10.1371/journal.pone.0145844	http://dx.doi.org/10.1371/journal.pone.0145844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713438	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900093
J	Huang, W; Xu, F; Qu, T; Zhang, R; Li, L; Que, HY; Zhang, GF				Huang, Wen; Xu, Fei; Qu, Tao; Zhang, Rui; Li, Li; Que, Huayong; Zhang, Guofan			Identification of Thyroid Hormones and Functional Characterization of Thyroid Hormone Receptor in the Pacific Oyster Crassostrea gigas Provide Insight into Evolution of the Thyroid Hormone System	PLOS ONE			English	Article							GENE-EXPRESSION; METAMORPHOSIS; REVEALS; BETA; METABOLISM; HOMOLOGS; GROWTH; MODEL; T-3	Thyroid hormones (THs) play important roles in development, metamorphosis, and metabolism in vertebrates. During the past century, TH functions were regarded as a synapomorphy of vertebrates. More recently, accumulating evidence has gradually convinced us that TH functions also occur in invertebrate chordates. To date, however, TH-related studies in non-chordate invertebrates have been limited. In this study, THs were qualitatively detected by two reliable methods (HPLC and LC/MS) in a well-studied molluscan species, the Pacific oyster Crassostrea gigas. Quantitative measurement of THs during the development of C. gigas showed high TH contents during embryogenesis and that oyster embryos may synthesize THs endogenously. As a first step in elucidating the TH signaling cascade, an ortholog of vertebrate TH receptor (TR), the most critical gene mediating TH effects, was cloned in C. gigas. The sequence of CgTR has conserved DNA-binding and ligand-binding domains that normally characterize these receptors. Experimental results demonstrated that CgTR can repress gene expression through binding to promoters of target genes and can interact with oyster retinoid X receptor. Moreover, CgTR mRNA expression was activated by T4 and the transcriptional activity of CgTR promoter was repressed by unliganded CgTR protein. An atypical thyroid hormone response element (CgDR5) was found in the promoter of CgTR, which was verified by electrophoretic mobility shift assay (EMSA). These results indicated that some of the CgTR function is conserved. However, the EMSA assay showed that DNA binding specificity of CgTR was different from that of the vertebrate TR and experiments with two dual-luciferase reporter systems indicated that L-thyroxine, 3,30,5-triiodothyronine, and triiodothyroacetic acid failed to activate the transcriptional activity of CgTR. This is the first study to functionally characterize TR in mollusks. The presence of THs and the functions of CgTR in mollusks contribute to better understanding of the evolution of the TH system.	[Huang, Wen; Xu, Fei; Qu, Tao; Zhang, Rui; Li, Li; Que, Huayong; Zhang, Guofan] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Huang, Wen; Zhang, Rui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Huang, Wen; Xu, Fei; Qu, Tao; Zhang, Rui; Li, Li; Que, Huayong; Zhang, Guofan] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Huang, Wen; Xu, Fei; Qu, Tao; Zhang, Rui; Li, Li; Que, Huayong; Zhang, Guofan] Chinese Acad Sci, Inst Oceanol, Natl & Local Joint Engn Lab Ecol Mariculture, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS	Que, HY (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	hque@qdio.ac.cn; gfzhang@qdio.ac.cn	Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022; Xu, Fei/A-1736-2012; li, li/GPX-3938-2022; li, li/HII-4157-2022; huang, wen/GXW-0661-2022	Xu, Fei/0000-0002-0981-8429; 	National Natural Science Foundation of China [31372515, 31402285]; National Basic Research Program of China (973 Program) [2010CB126401]; National High Technology Research and Development Program (863 program) [2012AA10A405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program (863 program)(National High Technology Research and Development Program of China)	This research was financially supported by the National Natural Science Foundation of China (No.31372515 and 31402285), the National Basic Research Program of China (973 Program, 2010CB126401), and the National High Technology Research and Development Program (863 program, 2012AA10A405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antheunisse LJ, 1956, KONINKLYKE NEDERLAND, V59, P562; AYSON FG, 1993, AQUACULTURE, V109, P83, DOI 10.1016/0044-8486(93)90488-K; Barucchi VC, 2013, CYTOGENET GENOME RES, V141, P80, DOI 10.1159/000354098; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Campinho MA, 2014, MOL ENDOCRINOL, V28, P1136, DOI 10.1210/me.2014-1032; Crane HM, 2004, GEN COMP ENDOCR, V139, P55, DOI 10.1016/j.ygcen.2004.07.004; Das B, 2009, J BIOL CHEM, V284, P34167, DOI 10.1074/jbc.M109.066084; Du YS, 2013, FISH SHELLFISH IMMUN, V34, P939, DOI 10.1016/j.fsi.2012.12.007; Escriva H, 2002, MOL BIOL EVOL, V19, P1440, DOI 10.1093/oxfordjournals.molbev.a004207; Fukazawa H, 2001, FISHERIES SCI, V67, P985, DOI 10.1046/j.1444-2906.2001.00351.x; Heyland A, 2005, J EXP BIOL, V208, P4355, DOI 10.1242/jeb.01877; Heyland A, 2006, J EXP ZOOL PART B, V306B, P551, DOI 10.1002/jez.b.21113; Huang W, 2015, CHIN J OCEANOL LIMN; Keay J, 2006, ENDOCRINOLOGY, V147, P3861, DOI 10.1210/en.2006-0363; Klootwijk W, 2011, ENDOCRINOLOGY, V152, P3259, DOI 10.1210/en.2010-1408; Kuraku S, 2008, ZOOL SCI, V25, P960, DOI 10.2108/zsj.25.960; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laudet V, 2011, CURR BIOL, V21, pR726, DOI 10.1016/j.cub.2011.07.030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morvan-Dubois G, 2008, MOL CELL ENDOCRINOL, V293, P71, DOI 10.1016/j.mce.2008.06.012; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Nakajima K, 2012, GENES CELLS, V17, P645, DOI 10.1111/j.1365-2443.2012.01614.x; Novac Natalia, 2004, Current Drug Targets - Inflammation and Allergy, V3, P335; Ogasawara M, 1999, J EXP ZOOL, V285, P158, DOI 10.1002/(SICI)1097-010X(19990815)285:2<158::AID-JEZ8>3.0.CO;2-0; Ogasawara M, 2000, DEV GENES EVOL, V210, P231, DOI 10.1007/s004270050309; Paris M, 2008, CURR BIOL, V18, P825, DOI 10.1016/j.cub.2008.04.078; Paris M, 2010, INTEGR COMP BIOL, V50, P63, DOI 10.1093/icb/icq052; Paris M, 2008, DEV GENES EVOL, V218, P667, DOI 10.1007/s00427-008-0255-7; Qiu CH, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-172; Qu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089040; RANJAN M, 1994, J BIOL CHEM, V269, P24699; Samanidou VF, 2000, J LIQ CHROMATOGR R T, V23, P681, DOI 10.1081/JLC-100101481; Shepherdley CA, 2004, ENDOCRINOLOGY, V145, P1255, DOI 10.1210/en.2003-1248; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tata JR, 2006, MOL CELL ENDOCRINOL, V246, P10, DOI 10.1016/j.mce.2005.11.024; TATA JR, 1993, J STEROID BIOCHEM, V46, P105, DOI 10.1016/0960-0760(93)90286-6; TONG W, 1961, BIOCHIM BIOPHYS ACTA, V48, P347, DOI 10.1016/0006-3002(61)90485-1; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Vogeler S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-369; Wagner RL, 2001, MOL ENDOCRINOL, V15, P398, DOI 10.1210/me.15.3.398; Wang L, 2010, J BONE MINER RES, V25, P1138, DOI 10.1002/jbmr.5; Wang SH, 2009, MOL CELL ENDOCRINOL, V313, P57, DOI 10.1016/j.mce.2009.08.024; Wu TT, 2012, FISH SHELLFISH IMMUN, V33, P286, DOI 10.1016/j.fsi.2012.05.011; Wu W, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-150; Wu WJ, 2007, FEBS J, V274, P390, DOI 10.1111/j.1742-4658.2006.05587.x; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	47	31	32	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144991	10.1371/journal.pone.0144991	http://dx.doi.org/10.1371/journal.pone.0144991			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710071	Green Published, Green Submitted, gold			2022-12-27	WOS:000367451400017
J	Rajpal, DK; Klein, JL; Mayhew, D; Boucheron, J; Spivak, AT; Kumar, V; Ingraham, K; Paulik, M; Chen, LH; Van Horn, S; Thomas, E; Sathe, G; Livi, GP; Holmes, DJ; Brown, JR				Rajpal, Deepak K.; Klein, Jean-Louis; Mayhew, David; Boucheron, Joyce; Spivak, Aaron T.; Kumar, Vinod; Ingraham, Karen; Paulik, Mark; Chen, Lihong; Van Horn, Stephanie; Thomas, Elizabeth; Sathe, Ganesh; Livi, George P.; Holmes, David J.; Brown, James R.			Selective Spectrum Antibiotic Modulation of the Gut Microbiome in Obesity and Diabetes Rodent Models	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; INCREASES; DIET; CONSEQUENCES; NORFLOXACIN; VANCOMYCIN; METAGENOME; PREBIOTICS; TOLERANCE; INULIN	The gastrointestinal tract microbiome has been suggested as a potential therapeutic target for metabolic diseases such as obesity and Type 2 diabetes mellitus (T2DM). However, the relationship between changes in microbial communities and metabolic disease-phenotypes are still poorly understood. In this study, we used antibiotics with markedly different antibacterial spectra to modulate the gut microbiome in a diet-induced obesity mouse model and then measured relevant biochemical, hormonal and phenotypic biomarkers of obesity and T2DM. Mice fed a high-fat diet were treated with either ceftazidime (a primarily anti-Gram negative bacteria antibiotic) or vancomycin (mainly anti-Gram positive bacteria activity) in an escalating three-dose regimen. We also dosed animals with a well-known prebiotic weight-loss supplement, 10% oligofructose saccharide (10% OFS). Vancomycin treated mice showed little weight change and no improvement in glycemic control while ceftazidime and 10% OFS treatments induced significant weight loss. However, only ceftazidime showed significant, dose dependent improvement in key metabolic variables including glucose, insulin, protein tyrosine tyrosine (PYY) and glucagon-like peptide-1 (GLP-1). Subsequently, we confirmed the positive hyperglycemic control effects of ceftazidime in the Zucker diabetic fatty (ZDF) rat model. Metagenomic DNA sequencing of bacterial 16S rRNA gene regions V1-V3 showed that the microbiomes of ceftazidime dosed mice and rats were enriched for the phylum Firmicutes while 10% OFS treated mice had a greater abundance of Bacteroidetes. We show that specific changes in microbial community composition are associated with obesity and glycemic control phenotypes. More broadly, our study suggests that in vivo modulation of the microbiome warrants further investigation as a potential therapeutic strategy for metabolic diseases.	[Rajpal, Deepak K.; Mayhew, David; Spivak, Aaron T.; Kumar, Vinod; Brown, James R.] GlaxoSmithKline, Res & Dev, Target Sci, Computat Biol, Collegeville, PA USA; [Klein, Jean-Louis; Van Horn, Stephanie; Thomas, Elizabeth; Sathe, Ganesh; Livi, George P.] GlaxoSmithKline, Res & Dev, Target & Pathway Validat, Target Sci, Collegeville, PA USA; [Boucheron, Joyce; Paulik, Mark; Chen, Lihong] GlaxoSmithKline, Enteroendocrine Discovery Performance Unit, Res & Dev, Res Triangle Pk, NC USA; [Ingraham, Karen; Holmes, David J.] GlaxoSmithKline, Antibacterial Discovery Performance Unit, Res & Dev, Collegeville, PA USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Brown, JR (corresponding author), GlaxoSmithKline, Res & Dev, Target Sci, Computat Biol, Collegeville, PA USA.	James.R.Brown@gsk.com		Brown, James/0000-0002-9368-627X	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The study was funded by GlaxoSmithKline. The funder provided support in the form of salaries for authors [DR, JLK, DM, JB, AS, VK, KI, MP, LC, SVH, ET, GS, GPL, DJH, JRB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaser M, 2011, NATURE, V476, P393, DOI 10.1038/476393a; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; Caporaso J Gregory, 2010, NAT METHODS, V7, P335, DOI [10.1038/nmeth.f.303, DOI 10.1038/NMETH.F.303]; Chou CJ, 2008, NESTLE NUTR WORKS SE, V62, P127, DOI 10.1159/000146256; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Cox A. J., 2014, LANCET DIABETES ENDO; Dallinga-Thie GM, 2015, ARTERIOSCL THROM VAS, V35, P1048, DOI 10.1161/ATVBAHA.115.305479; Delzenne NM, 2007, J NUTR, V137, p2547S, DOI 10.1093/jn/137.11.2547S; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Derrien M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00166; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HAYES MV, 1983, J ANTIMICROB CHEMOTH, V12, P119, DOI 10.1093/jac/12.2.119; Holmes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004244; Holzer P, 2014, ADV EXP MED BIOL, V817, P195, DOI 10.1007/978-1-4939-0897-4_9; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Loh K, 2015, TRENDS ENDOCRIN MET, V26, P125, DOI 10.1016/j.tem.2015.01.003; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Meyer D, 2009, EUR J CLIN NUTR, V63, P1277, DOI 10.1038/ejcn.2009.64; Moellering RC, 2006, CLIN INFECT DIS, V42, pS3, DOI 10.1086/491708; Murphy EF, 2013, GUT, V62, P220, DOI 10.1136/gutjnl-2011-300705; Napolitano A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100778; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; R Core Team, 2021, R LANGUAGE ENV STAT; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sweeney TE, 2013, JAMA SURG, V148, P563, DOI 10.1001/jamasurg.2013.5; Tarini J, 2010, APPL PHYSIOL NUTR ME, V35, P9, DOI 10.1139/H09-119; Thuny F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009074; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ueda Y, 2010, INT IMMUNOL, V22, P953, DOI 10.1093/intimm/dxq449; van Passel MWJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016876; Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012	46	32	37	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145499	10.1371/journal.pone.0145499	http://dx.doi.org/10.1371/journal.pone.0145499			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709835	gold, Green Published, Green Submitted			2022-12-27	WOS:000367451400055
J	Fortin, E; Quach, C; Fontela, PS; Buckeridge, DL; Platt, RW				Fortin, Elise; Quach, Caroline; Fontela, Patricia S.; Buckeridge, David L.; Platt, Robert W.			A Simulation Study to Assess Indicators of Antimicrobial Use as Predictors of Resistance: Does It Matter Which Indicator Is Used?	PLOS ONE			English	Article							ANTIBIOTIC USE; HOSPITALS; TRENDS	Objective Indicators of antimicrobial use have been described previously, but few studies have compared their accuracy in prediction of antimicrobial resistance in hospital settings. This study aimed to identify conditions under which significant differences would be observed in the predictive accuracy of indicators in the context of surveillance of intensive care units (ICUs). Methods Ten resistance / antimicrobial use combinations were studied. We used simulation to determine if Quebec's network of 81 ICUs or the National Healthcare Safety Network (NHSN) of 2952 ICUs are large enough to allow the detection of predetermined differences between the most accurate and 1) the second most accurate indicator, and 2) the least accurate indicator, in more than 80% of simulations. For each indicator, we simulated absolute errors in prediction for each ICU and each 4-week period, for surveillance lasting up to 5 years. Absolute errors were generated following a binomial distribution, using mean absolute errors (MAEs) observed in 9 ICUs as the average proportion; simulated MAEs were compared using t-tests. This was repeated 1000 times per scenario. Results When comparing the two most accurate indicators, 80% power was reached less often with the Quebec network versus the NHSN (0/20 versus 2/20 scenarios, with 5 years of surveillance data), a finding reinforced when comparing the most and least accurate indicators (3/20 versus 20/20 scenarios). When simulating 1 year of data, scenarios reaching an 80% power dropped to 0/20, comparing the two most accurate indicators with the larger network, and to 1/20, comparing the most and least accurate indicators with the smaller network. Conclusion Most of the time (72%), identifying an indicator of antimicrobial use predicting antimicrobial resistance with a better accuracy was not possible. The choice of an indicator for an eventual surveillance system should rely on criteria other that predictive accuracy.	[Fortin, Elise; Quach, Caroline; Fontela, Patricia S.; Buckeridge, David L.; Platt, Robert W.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Fortin, Elise; Quach, Caroline] Inst Natl Sante Publ Quebec, Direct Risques Biol & Sante Travail, Quebec City, PQ, Canada; [Fortin, Elise; Quach, Caroline] Inst Natl Sante Publ Quebec, Direct Risques Biol & Sante Travail, Montreal, PQ, Canada; [Quach, Caroline; Fontela, Patricia S.] McGill Univ, Montreal Childrens Hosp, Dept Pediat, Montreal, PQ H3H 1P3, Canada	McGill University; Institut national de sante publique du Quebec (INSPQ); Institut national de sante publique du Quebec (INSPQ); McGill University	Platt, RW (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	robert.platt@mcgill.ca	Quach, Caroline/AAT-6987-2021; Fontela, Patricia/S-6455-2019	Quach, Caroline/0000-0002-1170-9475; 	Fonds de recherche du Quebec - Sante [22282]	Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec)	This project was funded by the Fonds de recherche du Quebec - Sante (record number 22282; http://www.frqs.gouv.qc.ca/fr/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antachopoulos C, 2004, 14 EUR C CLIN MICR I; Berrington A, 2010, J ANTIMICROB CHEMOTH, V65, P163, DOI 10.1093/jac/dkp399; de With K, 2006, INFECTION, V34, P91, DOI 10.1007/s15010-006-5085-9; Di Pentima M, 2011, IDSA 49 ANN M 2011 B; Dudeck MA, 2011, AM J INFECT CONTROL, V39, P349, DOI 10.1016/j.ajic.2011.04.011; Filius PMG, 2005, J ANTIMICROB CHEMOTH, V55, P805, DOI 10.1093/jac/dki093; Fortin E, 2014, J ANTIMICROB CHEMOTH, V69, P1447, DOI 10.1093/jac/dku003; Fortin E, PLOS ONE IN PRESS; Fortin E, 2012, INFECT CONT HOSP EP, V33, P456, DOI 10.1086/665323; Haug JB, 2013, J ANTIMICROB CHEMOTH, V68, P2940, DOI 10.1093/jac/dkt268; Hyndman R.J., 2006, FORESIGHT INT J APPL, V4, P43; Ibrahim OM, 2012, EXPERT REV ANTI-INFE, V10, P445, DOI 10.1586/eri.12.18; ISAACS D, 1987, ARCH DIS CHILD, V62, P204, DOI 10.1136/adc.62.2.204; Lagace-Wiens PRS, 2013, J ANTIMICROB CHEMOTH, V68, pi23, DOI 10.1093/jac/dkt023; Liem TBY, 2010, ACTA PAEDIATR, V99, P1900, DOI 10.1111/j.1651-2227.2010.01957.x; Mataseje LF, 2012, J ANTIMICROB CHEMOTH, V67, P1359, DOI 10.1093/jac/dks046; Monnet DL, 2007, CLIN INFECT DIS, V44, P671, DOI 10.1086/511649; MSSS, 2011, MIS OEUVR PROGR SURV; National Healthcare Safety Network (NHSN), 2014, ANT US RES AUR MOD; Raz R, 1998, J INFECTION, V37, P224, DOI 10.1016/S0163-4453(98)91890-4; Ruef C, 2006, INFECTION, V34, P53, DOI 10.1007/s15010-006-7206-x; Schechner V, 2013, CLIN MICROBIOL REV, V26, P289, DOI 10.1128/CMR.00001-13; SPIN, 2014, SURV PROV INF NOS SP; World Health Organisation Collaborating Center for Drug Statistics Methodology, 2011, GUID ATC CLASS DDD A; Zarb P, 2011, J ANTIMICROB CHEMOTH, V66, P443, DOI 10.1093/jac/dkq430	25	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145761	10.1371/journal.pone.0145761	http://dx.doi.org/10.1371/journal.pone.0145761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700185	Green Published, gold			2022-12-27	WOS:000367092600131
J	Prudden, HJ; Beattie, TS; Bobrova, N; Panovska-Griffiths, J; Mukandavire, Z; Gorgens, M; Wilson, D; Watts, CH				Prudden, Holly J.; Beattie, Tara S.; Bobrova, Natalia; Panovska-Griffiths, Jasmina; Mukandavire, Zindoga; Gorgens, Marelize; Wilson, David; Watts, Charlotte H.			Factors Associated with Variations in Population HIV Prevalence across West Africa: Findings from an Ecological Analysis	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; FEMALE SEX WORKERS; MALE CLIENTS; RISK; TRANSMISSION; INFECTION; DYNAMICS; COUNTRIES; BEHAVIOR; BENIN	Background Population HIV prevalence across West Africa varies substantially. We assess the national epidemiological and behavioural factors associated with this. Methods National, urban and rural data on HIV prevalence, the percentage of younger (15-24) and older (25-49) women and men reporting multiple (2+) partners in the past year, HIV prevalence among female sex workers (FSWs), men who have bought sex in the past year (clients), and ART coverage, were compiled for 13 countries. An Ecological analysis using linear regression assessed which factors are associated with national variations in population female and male HIV prevalence, and with each other. Findings National population HIV prevalence varies between 0 4-2 9% for men and 0 4-5.6% for women. ART coverage ranges from 6-23%. National variations in HIV prevalence are not shown to be associated with variations in HIV prevalence among FSWs or clients. Instead they are associated with variations in the percentage of younger and older males and females reporting multiple partners. HIV prevalence is weakly negatively associated with ART coverage, implying it is not increased survival that is the cause of variations in HIV prevalence. FSWs and younger female HIV prevalence are associated with client population sizes, especially older men. Younger female HIV prevalence is strongly associated with older male and female HIV prevalence. Interpretation In West Africa, population HIV prevalence is not significantly higher in countries with high FSW HIV prevalence. Our analysis suggests, higher prevalence occurs where more men buy sex, and where a higher percentage of younger women, and older men and women have multiple partnerships. If a sexual network between clients and young females exists, clients may potentially bridge infection to younger females. HIV prevention should focus both on commercial sex and transmission between clients and younger females with multiple partners. have multiple partnerships. If a sexual network between clients and young females exists, clients may potentially bridge infection to younger females. HIV prevention should focus both on commercial sex and transmission between clients and younger females with multiple partners.	[Prudden, Holly J.; Beattie, Tara S.; Bobrova, Natalia; Panovska-Griffiths, Jasmina; Mukandavire, Zindoga; Watts, Charlotte H.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Gorgens, Marelize; Wilson, David] World Bank, Washington, DC 20433 USA	University of London; London School of Hygiene & Tropical Medicine; The World Bank	Prudden, HJ (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England.	Holly.Prudden@lshtm.ac.uk		Panovska-Griffiths, Jasmina/0000-0002-7720-1121; Beattie, Tara/0000-0001-9156-7341; Mukandavire, Zindoga/0000-0002-8108-1441	STRIVE research programme consortium - UKaid from the Department for International Development; World Bank; Department for International Development (DFID) [201447] Funding Source: researchfish	STRIVE research programme consortium - UKaid from the Department for International Development; World Bank(The World Bank India); Department for International Development (DFID)	The authors wish to acknowledge funders for this work, The World Bank. This study was also supported by the STRIVE research programme consortium funded by UKaid from the Department for International Development. However, the views expressed do not necessarily reflect the views of the funders.; We wish to acknowledge our funders for this work, The World Bank. This study was also supported by the STRIVE research programme consortium funded by UKaid from the Department for International Development. However, the views expressed do not necessarily reflect the views of the funders.	Alary M, 2004, AIDS, V18, P945, DOI 10.1097/00002030-200404090-00013; Alary M, 2003, SEX TRANSM INFECT, V79, P388, DOI 10.1136/sti.79.5.388; Avert, 2012, HIV AIDS SUBS AFR; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Beattie T, 2011, SEX WORK TYPOLOGIES; Boily MC, 2015, JAIDS-J ACQ IMM DEF, V68, pS74, DOI 10.1097/QAI.0000000000000437; Comite National de Lutte contre le SIDA, 2012, RAPP UNGASS 2012 GUI; Dupas P, 2011, AM ECON J-APPL ECON, V3, P1, DOI 10.1257/app.3.1.1; Fenton KA, 2001, SEX TRANSM INFECT, V77, P84, DOI 10.1136/sti.77.2.84; Garnett GP, 1998, AIDS PATIENT CARE ST, V12, P435, DOI 10.1089/apc.1998.12.435; Godin G, 2008, AIDS BEHAV, V12, P441, DOI 10.1007/s10461-007-9296-6; Harcourt C, 2005, SEX TRANSM INFECT, V81, P201, DOI 10.1136/sti.2004.012468; Harling G, 2014, JAIDS-J ACQ IMM DEF, V66, P443, DOI 10.1097/QAI.0000000000000198; Jewkes R, 2012, AIDS CLIN RES, V3; Kim J, 2009, B WORLD HEALTH ORGAN, V87, P824, DOI 10.2471/BLT.08.056580; Laga M, 2010, SEX TRANSM INFECT, V86, pI6, DOI 10.1136/sti.2009.039255; Lowndes CM, 2002, SEX TRANSM INFECT, V78, pI69, DOI 10.1136/sti.78.suppl_1.i69; Mishra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050691; Moore Ann M, 2007, Afr J Reprod Health, V11, P44, DOI 10.2307/25549731; Morison L, 2001, AIDS, V15; Odeyemi Kofoworola, 2009, Int J Adolesc Med Health, V21, P101, DOI 10.1515/IJAMH.2009.21.1.101; Owoaje E T, 2009, East Afr J Public Health, V6, P274; Peltzer K, 2013, ANN GEN PSYCHIATR, V12, DOI 10.1186/1744-859X-12-18; Roianapithayakorn W, 2006, REPROD HEALTH MATTER, V14, P41; Santo MEGD, 2005, SEX TRANSM INFECT, V81, P342, DOI 10.1136/sti.2004.011940; Sobela F, 2009, JAIDS-J ACQ IMM DEF, V51, P216, DOI 10.1097/QAI.0b013e31819c170f; The World Bank, 2008, W AFR HIV AIDS EP RE; The World Bank, 2012, DAT STAT; The World Bank, 2015, PREV HIV TOT POP AG; UNAIDS, 2013, UNAIDS SPEC REP AFR; Vinod M, 2009, CHANGES HIV RELATED; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; YORKE JA, 1978, SEX TRANSM DIS, V5, P51, DOI 10.1097/00007435-197804000-00003	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0142601	10.1371/journal.pone.0142601	http://dx.doi.org/10.1371/journal.pone.0142601			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698854	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000367092600004
J	Cui, HX; Yang, MY; Wang, LP; Xian, CJ				Cui, Hongxia; Yang, Muyang; Wang, Liping; Xian, Cory J.			Identification of a New Marine Bacterial Strain SD8 and Optimization of Its Culture Conditions for Producing Alkaline Protease	PLOS ONE			English	Article							PURIFICATION; ISOLATE; BRAN; SP.	While much attention has been given to marine microorganisms for production of enzymes, which in general are relatively more stable and active compared to those from plants and animals, studies on alkaline protease production from marine microorganisms have been very limited. In the present study, the alkaline protease producing marine bacterial strain SD8 isolated from sea muds in the Geziwo Qinhuangdao sea area of China was characterized and its optimal culture conditions were investigated. Strain SD8 was initially classified to belong to genus Pseudomonas by morphological, physiological and biochemical characterizations, and then through 16S rDNA sequence it was identified to be likely Pseudomonas hibiscicola. In addition, the culture mediums, carbon sources and culture conditions of strain SD8 were optimized for maximum production of alkaline protease. Optimum enzyme production (236U/mL when cultured bacteria being at 0.75 mg dry weight/mL fermentation broth) was obtained when the isolate at a 3% inoculum size was grown in LB medium at 20 mL medium/100mL Erlenmeyer flask for 48h culture at 30 degrees C with an initial of pH 7.5. This was the first report of strain Pseudomonas hibiscicola secreting alkaline protease, and the data for its optimal cultural conditions for alkaline protease production has laid a foundation for future exploration for the potential use of SD8 strain for alkaline protease production.	[Cui, Hongxia; Yang, Muyang] Yanshan Univ, Coll Environm & Chem Engn, Qinhuangdao 066004, Peoples R China; [Cui, Hongxia] Hebei Prov Key Lab Appl Chem, Qinhuangdao 066004, Peoples R China; [Wang, Liping; Xian, Cory J.] Univ S Australia, Sansom Inst Hlth Res, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia	Yanshan University; University of South Australia	Cui, HX (corresponding author), Yanshan Univ, Coll Environm & Chem Engn, Qinhuangdao 066004, Peoples R China.	hxcui@ysu.edu.cn; cory.xian@unisa.edu.au	Xian, Cory/D-2646-2009	Xian, Cory/0000-0002-8467-2845; /0000-0001-9355-1167	Natural Science Foundation of Hebei Province [D2014203102]; Ministry of Education Specialized Research Fund for the Doctoral Program of Higher Education [20131333120010]; Australian National Health and Medical Research Council (NHMRC)	Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Ministry of Education Specialized Research Fund for the Doctoral Program of Higher Education; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study is financially supported by Natural Science Foundation of Hebei Province (D2014203102 to HC) and Ministry of Education Specialized Research Fund for the Doctoral Program of Higher Education (20131333120010 to HC). LW is supported by Australian National Health and Medical Research Council (NHMRC) Postgraduate Research Scholarship, and CJX is supported by NHMRC Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal D, 2005, PROCESS BIOCHEM, V40, P1131, DOI 10.1016/j.procbio.2004.03.006; Annamalai N, 2014, PROCESS BIOCHEM, V49, P1012, DOI 10.1016/j.procbio.2014.03.007; Annamalai N, 2013, BIOPROC BIOSYST ENG, V36, P873, DOI 10.1007/s00449-012-0820-3; Badoei-Dalfard A, 2013, J MOL CATAL B-ENZYM, V89, P15, DOI 10.1016/j.molcatb.2012.11.016; Chatterjee J, 2015, BIOTECHNOL APPL BIOC, V62, P709, DOI 10.1002/bab.1309; Chi Z, 2007, BIORESOURCE TECHNOL, V98, P534, DOI 10.1016/j.biortech.2006.02.006; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Gupta R, 2002, APPL MICROBIOL BIOT, V60, P381, DOI 10.1007/s00253-002-1142-1; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; Hameed A, 1999, J CHEM TECHNOL BIOT, V74, P5, DOI 10.1002/(SICI)1097-4660(199901)74:1<5::AID-JCTB979>3.0.CO;2-T; Holt GL, 1984, BERGEYS MANUAL SYSTE; Kalaiarasi K, 2009, AFR J BIOTECHNOL, V8, P7035; Kandasamy N, 2012, J CLEAN PROD, V25, P27, DOI 10.1016/j.jclepro.2011.12.007; Kumar RS, 2014, BIOCATAL AGR BIOTECH, V3, P191, DOI 10.1010/j.bcab.2013.11.005; KUNITZ M, 1947, J GEN PHYSIOL, V30, P291, DOI 10.1085/jgp.30.4.291; Lee BH, 2010, ENZYME MICROB TECH, V46, P38, DOI 10.1016/j.enzmictec.2009.07.009; Liu ZQ, 2005, COLL PAP NAT C HIGH, V3, P243; Meena P, 2013, BIOCATAL AGRIC BIOTE, V2, P210, DOI 10.1016/j.bcab.2013.05.003; Miyaji T, 2006, LETT APPL MICROBIOL, V42, P242, DOI 10.1111/j.1472-765X.2005.01851.x; Olofsson TC, 2007, INT J FOOD MICROBIOL, V118, P233, DOI 10.1016/j.ijfoodmicro.2007.07.017; Pant G, 2015, J TAIBAH UNIV SCI, V9, P50, DOI 10.1016/j.jtusci.2014.04.010; Patel R, 2005, PROCESS BIOCHEM, V40, P3569, DOI 10.1016/j.procbio.2005.03.049; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Rasmussen RS, 2007, ADV FOOD NUTR RES, V52, P237, DOI 10.1016/S1043-4526(06)52005-4; Raval VH, 2014, PROCESS BIOCHEM, V49, P955, DOI 10.1016/j.procbio.2014.03.014; REDBURN AC, 1993, FEMS MICROBIOL LETT, V113, P81, DOI 10.1111/j.1574-6968.1993.tb06492.x; Saba I, 2012, WORLD J MICROB BIOT, V28, P1071, DOI 10.1007/s11274-011-0905-1; Singh SK, 2011, PROCESS BIOCHEM, V46, P1430, DOI 10.1016/j.procbio.2011.03.012; Smibert Robert M., 1994, P607; Wang L, 2014, J CHEM PHARM RES, V6, P1236	30	6	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146067	10.1371/journal.pone.0146067	http://dx.doi.org/10.1371/journal.pone.0146067			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716833	Green Published, gold, Green Accepted			2022-12-27	WOS:000367510500129
J	Fan, YG; Weng, ZY; Gao, HG; Hu, JH; Wang, HY; Li, LH; Liu, H				Fan, Yonggang; Weng, Zhiyong; Gao, Hongguo; Hu, Jiehua; Wang, Hongyan; Li, Lihua; Liu, Hua			Isoalantolactone Enhances the Radiosensitivity of UMSCC-10A Cells via Specific Inhibition of Erk1/2 Phosphorylation	PLOS ONE			English	Article								Background Although radiotherapy is one of the mainstream approaches for the treatment of head and neck squamous cell carcinoma (HNSCC), this cancer is always associated with resistance to radiation. In this study, the mechanism of action of isoalantolactone as well as its radio-sensitizing effect was investigated in UMSCC-10A cells. Methods The radiosensitization of UMSCC-10A cells treated with isoalantolactone was analyzed by colony formation assay. The radiosensitization effects of isoalantolactone on cell proliferation, cell cycle and apoptosis regulation were examined by BrdU incorporation assay, DNA content assay and flow cytometry, respectively. Western blotting was performed to determine the effects of isoalantolactone combined with radiation on the protein expression of Mek, extracellular signal-regulated kinase (Erk1/2) as well as phosphorylated Mek and Erk1/2. Erk1/2 knockdown by siRNA was used to confirm that isoalantolactone specifically inhibited the activation of Erk1/2 signaling pathway in UMSCC-10A cells. Results Isoalantolactone enhanced the radiosensitivity of UMSCC-10A cells; the sensitivity enhanced ratios (SERs) were 1.44 and 1.63, respectively, for 2.5 and 5 mu M. Moreover, isoalantolactone enhanced radiation-induced cell proliferation and apoptosis and cell cycle arrested at G2/M phase. Furthermore, no marked changes were observed in the expression of total Erk1/2 and Mek protein after radiation treatment. However, isoalantolactone was significantly reduced radiation-induced the phosphorylation of Erk1/2, whereas it altered the phosphorylation of Mek to a lesser extent. In addition, the radiosensitivity of UMSCC-10A cells with Erk1/2 knockdown was increased. Isoalantolactone cannot further prevent the proliferation of UMSCC-10A cells with Erk1/2 knockdown which other mechanism regulated cell proliferation. Conclusion Our results suggested that isoalantolactone enhanced radiation-induced apoptosis, cell cycle arrested and reduced the cell proliferation of UMSCC-10A cells via specifically inhibited the phosphorylation of Erk1/2. Thus a low concentration of isoalantolactone may be used to overcome the resistance of UMSCC-10A cells to radiation and may be a promising radiosensitizer in cancer therapy.	[Fan, Yonggang; Weng, Zhiyong; Li, Lihua; Liu, Hua] Liaoning Med Univ, Dept Cell Biol, Jinzhou, Liaoning, Peoples R China; [Gao, Hongguo; Wang, Hongyan] Daqing Oilfield Gen Hosp, Dept Clin Lab, Daqing, Heilongjiang, Peoples R China; [Hu, Jiehua] Naval Univ Engn, Logist Coll, Informat Ctr, Tianjin, Peoples R China	Jinzhou Medical University; Wuhan Naval University of Engineering	Li, LH (corresponding author), Liaoning Med Univ, Dept Cell Biol, Jinzhou, Liaoning, Peoples R China.	lilihua1018@sina.com; lh509515@163.com	shi, zhensheng/GXN-3967-2022		National Natural Science Foundation of China [31571184]; Aohongboze Graduate Sci-tech Innovation Foundation; Liaoning Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Aohongboze Graduate Sci-tech Innovation Foundation; Liaoning Medical University	This study was supported by grants from the National Natural Science Foundation of China (31571184, recipient: Lihua Li) and Aohongboze Graduate Sci-tech Innovation Foundation, the President Fund of Liaoning Medical University (recipient: Yonggan Fan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger B, 2010, STRAHLENTHER ONKOL, V186, P255, DOI 10.1007/s00066-010-2082-9; Bieri S, 2003, STRAHLENTHER ONKOL, V179, P390, DOI 10.1007/s00066-003-1077-1; Bozec A, 2013, ANTICANCER AGENTS ME, V13; Caron RW, 2005, CELL CYCLE, V4, P456, DOI 10.4161/cc.4.3.1249; Curado MP, 2009, CURR OPIN ONCOL, V21, P194, DOI 10.1097/CCO.0b013e32832a68ca; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Drigotas M, 2013, J ORAL PATHOL MED, V42, P612, DOI 10.1111/jop.12056; Du Y, 2014, PHARM THER, V142; Eder-Czembirek C, 2010, STRAHLENTHER ONKOL, V186, P143, DOI 10.1007/s00066-010-2069-6; Farahabadi SS, 2015, NEUROSCIENCE; Gallo O, 1999, INT J CANC, V84; Garg AK, 2005, ANTIOXID REDOX SIGN, V7, P1630, DOI 10.1089/ars.2005.7.1630; Ghantous A, 2010, DRUG DISCOV TODAY, V15, P668, DOI 10.1016/j.drudis.2010.06.002; Han S, 2014, BR J CANC, V111; HONG JJ, 2013, PLOS ONE, V8; Jeggo PA, 2007, NAT REV CANC, V7; Khan M, 2012, INT J BIOL SCI, V8, P533, DOI 10.7150/ijbs.3753; Kotowski U, 2011, STRAHLENTHER ONKOL, V187, P575, DOI 10.1007/s00066-011-2218-6; Li Y, 2012, Z NATURFORSCH C, V67, P375; Liu Y, 2013, ADV MATH PHYS, V2013, DOI 10.1155/2013/787891; Oh YT, 2015, ONCOGENE; Pal HC, 2010, TOXICOL IN VITRO, V24, P1599, DOI 10.1016/j.tiv.2010.06.007; Qian Y, 2015, CELL PHYSL BIOCH, V35; Rasul A, 2013, ARCH PHARM RES, V36, P1262, DOI 10.1007/s12272-013-0217-0; Saki M, 2013, RADIOTHER ONCOL, V108, P473, DOI 10.1016/j.radonc.2013.06.023; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Schultz DR, 2003, SEMIN ARTHRITIS RHEU, V32, P345, DOI 10.1053/sarh.2003.50005; Tan TH, 2005, CELL BIOCH BIOPHYS, V43; Wolff HA, 2010, STRAHLENTHER ONKOL, V186; Wu MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080668, 10.1371/journal.pone.0083412]; Yang J, 2011, MOL CANC THER, V10; Yin X, 2011, HEAD NECK, V33; Zheng M, 2008, CANC RES, V68	33	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145790	10.1371/journal.pone.0145790	http://dx.doi.org/10.1371/journal.pone.0145790			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716456	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500071
J	Maffei, A; Vencato, V; Angrilli, A				Maffei, Antonio; Vencato, Valentina; Angrilli, Alessandro			Sex Differences in Emotional Evaluation of Film Clips: Interaction with Five High Arousal Emotional Categories	PLOS ONE			English	Article							GENDER-DIFFERENCES; PICTURES; STIMULI; PERCEPTION; REACTIVITY; EXPERIENCE; RESPONSES; VALIDITY; FEAR	The present study aimed to investigate gender differences in the emotional evaluation of 18 film clips divided into six categories: Erotic, Scenery, Neutral, Sadness, Compassion, and Fear. 41 female and 40 male students rated all clips for valence-pleasantness, arousal, level of elicited distress, anxiety, jittery feelings, excitation, and embarrassment. Analysis of positive films revealed higher levels of arousal, pleasantness, and excitation to the Scenery clips in both genders, but lower pleasantness and greater embarrassment in women compared to men to Erotic clips. Concerning unpleasant stimuli, unlike men, women reported more unpleasantness to the Compassion, Sadness, and Fear compared to the Neutral clips and rated them also as more arousing than did men. They further differentiated the films by perceiving greater arousal to Fear than to Compassion clips. Women rated the Sadness and Fear clips with greater Distress and Jittery feelings than men did. Correlation analysis between arousal and the other emotional scales revealed that, although men looked less aroused than women to all unpleasant clips, they also showed a larger variance in their emotional responses as indicated by the high number of correlations and their relatively greater extent, an outcome pointing to a masked larger sensitivity of part of male sample to emotional clips. We propose a new perspective in which gender difference in emotional responses can be better evidenced by means of film clips selected and clustered in more homogeneous categories, controlled for arousal levels, as well as evaluated through a number of emotion focused adjectives.	[Maffei, Antonio; Vencato, Valentina; Angrilli, Alessandro] Univ Padua, Dept Gen Psychol, Padua, Italy; [Angrilli, Alessandro] IN CNR Inst Neurosci, Padova Sect, Padua, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Angrilli, A (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	alessandro.angrilli@unipd.it	Maffei, Antonio/AAB-5793-2021	Maffei, Antonio/0000-0003-4470-6243; Angrilli, Alessandro/0000-0002-5571-7637				Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Bianchin M, 2012, PHYSIOL BEHAV, V105, P925, DOI 10.1016/j.physbeh.2011.10.031; Bos MGN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062661; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Carvalho S, 2012, APPL PSYCHOPHYS BIOF, V37, P279, DOI 10.1007/s10484-012-9201-6; Caseras X, 2007, BIOL PSYCHIAT, V62, P464, DOI 10.1016/j.biopsych.2006.10.030; Codispoti M, 2008, INT J PSYCHOPHYSIOL, V69, P90, DOI 10.1016/j.ijpsycho.2008.03.004; Costa M, 2003, BIOL PSYCHOL, V63, P129, DOI 10.1016/S0301-0511(03)00054-1; Costa M, 2001, J NONVERBAL BEHAV, V25, P225, DOI 10.1023/A:1012544204986; Gard MG, 2007, EMOTION, V7, P429, DOI 10.1037/1528-3542.7.2.429; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; GRAY JA, 1971, ACTA PSYCHOL, V35, P29, DOI 10.1016/0001-6918(71)90029-1; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; GROSSMAN M, 1993, J PERS SOC PSYCHOL, V65, P1010, DOI 10.1037/0022-3514.65.5.1010; Hagemann D, 1999, PERS INDIV DIFFER, V26, P627, DOI 10.1016/S0191-8869(98)00159-7; Hendriks MCP, 2008, J SOC PSYCHOL, V148, P22, DOI 10.3200/SOCP.148.1.22-42; Hendriks MCP, 2006, COGNITION EMOTION, V20, P878, DOI 10.1080/02699930500450218; JANSEN DM, 1994, PSYCHOPHYSIOLOGY, V31, P565, DOI 10.1111/j.1469-8986.1994.tb02349.x; Janssen E, 2003, ARCH SEX BEHAV, V32, P243, DOI 10.1023/A:1023413617648; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Kring AM, 1998, J PERS SOC PSYCHOL, V74, P686, DOI 10.1037/0022-3514.74.3.686; Kunzmann U, 2005, PSYCHOL AGING, V20, P47, DOI 10.1037/0882-7974.20.1.47; Lithari C, 2010, BRAIN TOPOGR, V23, P27, DOI 10.1007/s10548-009-0130-5; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; PHILIPPOT P, 1993, COGNITION EMOTION, V7, P171, DOI 10.1080/02699939308409183; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Poli E, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00010; Rupp HA, 2008, ARCH SEX BEHAV, V37, P206, DOI 10.1007/s10508-007-9217-9; Sabatinelli D, 2004, NEUROREPORT, V15, P1109, DOI 10.1097/00001756-200405190-00005; Sarlo M, 2005, NEUROSCI LETT, V382, P291, DOI 10.1016/j.neulet.2005.03.037; Sarlo M, 2010, BIOL PSYCHOL, V85, P338, DOI 10.1016/j.biopsycho.2010.08.004; Schaefer A, 2010, COGNITION EMOTION, V24, P1153, DOI 10.1080/02699930903274322; Schirmer A, 2005, NEUROREPORT, V16, P635, DOI 10.1097/00001756-200504250-00024; Schmider E, 2010, METHODOLOGY-EUR, V6, P147, DOI 10.1027/1614-2241/a000016; Schneider F, 2000, HUM BRAIN MAPP, V9, P226, DOI 10.1002/(SICI)1097-0193(200004)9:4<226::AID-HBM4>3.0.CO;2-K; Troisi A, 2001, PHYSIOL BEHAV, V73, P443, DOI 10.1016/S0031-9384(01)00459-0; ULRICH RS, 1981, ENVIRON BEHAV, V13, P523, DOI 10.1177/0013916581135001; Westermann R, 1996, EUR J SOC PSYCHOL, V26, P557, DOI 10.1002/(SICI)1099-0992(199607)26:4<557::AID-EJSP769>3.0.CO;2-4; Wierzba M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01336	43	18	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145562	10.1371/journal.pone.0145562	http://dx.doi.org/10.1371/journal.pone.0145562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26717488	Green Submitted, gold, Green Published			2022-12-27	WOS:000367510500045
J	Yin, SH; Wang, T; Pan, WG; Liu, YJ; Chen, AT				Yin, Shouhang; Wang, Ting; Pan, Weigang; Liu, Yijun; Chen, Antao			Task-switching Cost and Intrinsic Functional Connectivity in the Human Brain: Toward Understanding Individual Differences in Cognitive Flexibility	PLOS ONE			English	Article							INFERIOR FRONTAL JUNCTION; PARIETAL CORTICES; PREFRONTAL CORTEX; NEURAL MECHANISMS; MOTOR CORTEX; NETWORKS; COMPONENTS; INTERFERENCE; ACTIVATION	The human ability to flexibly alternate between tasks (i.e., task-switching) represents a critical component of cognitive control. Many functional magnetic resonance imaging (fMRI) studies have explored the neural basis of the task-switching. However, no study to date has examined how individual differences in intrinsic functional architecture of the human brain are related to that of the task-switching. In the present study, we took 11 task-switching relevant areas from a meta-analysis study as the regions of interests (ROIs) and estimated their intrinsic functional connectivity (iFC) with the whole brain. This procedure was repeated for 32 healthy adults based upon their fMRI scans during resting-state (rfMRI) to investigate the correlations between switching cost and the iFC strength across these participants. This analysis found that switch cost was negatively correlated with a set of iFC involved ROIs including left inferior frontal junction, bilateral superior posterior parietal cortex, left precuneus, bilateral inferior parietal lobule, right middle frontal gyrus and bilateral middle occipital gyrus. These connectivity profiles represent an intrinsic functional architecture of task-switching where the left inferior frontal junction plays a hub role in this brain-behavior association. These findings are highly reproducible in another validation independent sample and provide a novel perspective for understanding the neural basis of individual differences in task-switching behaviors reflected in the intrinsic architecture of the human brain.	[Yin, Shouhang; Wang, Ting; Pan, Weigang; Liu, Yijun; Chen, Antao] Southwest Univ, Fac Psychol, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China	Southwest University - China	Chen, AT (corresponding author), Southwest Univ, Fac Psychol, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China.	xscat@swu.edu.cn		, Shouhang/0000-0001-5647-369X	National Natural Science Foundation of China [31170980, 81271477, 61431013]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China)	This work was supported by grants from the National Natural Science Foundation of China (31170980, 81271477, 61431013), and the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport A., 1994, ATTENTION PERFORMANC; Berkman ET, 2013, CURR DIR PSYCHOL SCI, V22, P45, DOI 10.1177/0963721412469394; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bode S, 2009, NEUROIMAGE, V45, P606, DOI 10.1016/j.neuroimage.2008.11.031; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Brass M, 2002, CEREB CORTEX, V12, P908, DOI 10.1093/cercor/12.9.908; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Cole MW, 2014, NEURON, V83, P238, DOI 10.1016/j.neuron.2014.05.014; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; De Baene W, 2012, NEUROIMAGE, V63, P203, DOI 10.1016/j.neuroimage.2012.06.050; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fox PT, 2014, ANNU REV NEUROSCI, V37, P409, DOI 10.1146/annurev-neuro-062012-170320; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gold BT, 2010, NEUROBIOL AGING, V31, P512, DOI 10.1016/j.neurobiolaging.2008.04.005; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Hebb D. O., 2005, ORG BEHAV NEUROPSYCH; Hester R, 2007, NEUROIMAGE, V34, P446, DOI 10.1016/j.neuroimage.2006.08.001; Kiesel A, 2010, PSYCHOL BULL, V136, P849, DOI 10.1037/a0019842; Kim C, 2011, J NEUROSCI, V31, P4771, DOI 10.1523/JNEUROSCI.5923-10.2011; Kim C, 2012, HUM BRAIN MAPP, V33, P130, DOI 10.1002/hbm.21199; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Liston C, 2006, NEURON, V50, P643, DOI 10.1016/j.neuron.2006.04.015; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Meiran N, 2000, COGNITIVE PSYCHOL, V41, P211, DOI 10.1006/cogp.2000.0736; Meiran N, 1996, J EXP PSYCHOL LEARN, V22, P1423, DOI 10.1037/0278-7393.22.6.1423; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Muhle-Karbe PS, 2014, NEUROIMAGE, V99, P332, DOI 10.1016/j.neuroimage.2014.05.058; Power JD, 2014, NEURON, V84, P681, DOI 10.1016/j.neuron.2014.09.007; Power JD, 2013, NEUROIMAGE, V76, P439, DOI 10.1016/j.neuroimage.2012.03.017; Powers AR, 2012, J NEUROSCI, V32, P6263, DOI 10.1523/JNEUROSCI.6138-11.2012; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rombouts SARB, 2003, NEUROIMAGE, V20, P1236, DOI 10.1016/S1053-8119(03)00386-0; Ruge H, 2005, NEUROPSYCHOLOGIA, V43, P340, DOI 10.1016/j.neuropsychologia.2004.06.014; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Song M, 2008, NEUROIMAGE, V41, P1168, DOI 10.1016/j.neuroimage.2008.02.036; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stelzel C, 2011, J COGNITIVE NEUROSCI, V23, P3529, DOI 10.1162/jocn_a_00062; Vahdat S, 2011, J NEUROSCI, V31, P16907, DOI 10.1523/JNEUROSCI.2737-11.2011; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Xiong JH, 1999, HUM BRAIN MAPP, V8, P151, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<151::AID-HBM13>3.0.CO;2-5; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013	58	14	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145826	10.1371/journal.pone.0145826	http://dx.doi.org/10.1371/journal.pone.0145826			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716447	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500079
J	Alvarez-Romero, JG; Pressey, RL; Ban, NC; Brodie, J				Alvarez-Romero, Jorge G.; Pressey, Robert L.; Ban, Natalie C.; Brodie, Jon			Advancing Land-Sea Conservation Planning: Integrating Modelling of Catchments, Land-Use Change, and River Plumes to Prioritise Catchment Management and Protection	PLOS ONE			English	Article							GREAT-BARRIER-REEF; COASTAL-MARINE ECOSYSTEMS; GULF-OF-CALIFORNIA; WATER-QUALITY; HUMAN IMPACT; FRESH-WATER; TRADE-OFFS; TERRESTRIAL; SEDIMENT; BIODIVERSITY	Human-induced changes to river loads of nutrients and sediments pose a significant threat to marine ecosystems. Ongoing land-use change can further increase these loads, and amplify the impacts of land-based threats on vulnerable marine ecosystems. Consequently, there is a need to assess these threats and prioritise actions to mitigate their impacts. A key question regarding prioritisation is whether actions in catchments tomaintain coastal-marine water quality can be spatially congruent with actions for other management objectives, such as conserving terrestrial biodiversity. In selected catchments draining into the Gulf of California, Mexico, we employed Land Change Modeller to assess the vulnerability of areas with native vegetation to conversion into crops, pasture, and urban areas. We then used SedNet, a catchment modelling tool, to map the sources and estimate pollutant loads delivered to the Gulf by these catchments. Following these analyses, we used modelled river plumes to identify marine areas likely influenced by land-based pollutants. Finally, we prioritised areas for catchment management based on objectives for conservation of terrestrial biodiversity and objectives for water quality that recognised links between pollutant sources and affected marine areas. Our objectives for coastal-marine water quality were to reduce sediment and nutrient discharges from anthropic areas, and minimise future increases in coastal sedimentation and eutrophication. Our objectives for protection of terrestrial biodiversity covered species of vertebrates. We used Marxan, a conservation planning tool, to prioritise interventions and explore spatial differences in priorities for both objectives. Notable differences in the distributions of land values for terrestrial biodiversity and coastal-marine water quality indicated the likely need for trade-offs between catchment management objectives. However, there were priority areas that contributed to both sets of objectives. Our study demonstrates a practical approach to integrating models of catchments, land-use change, and river plumes with conservation planning software to inform prioritisation of catchment management.	[Alvarez-Romero, Jorge G.; Pressey, Robert L.; Ban, Natalie C.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Ban, Natalie C.] Univ Victoria, Sch Environm Studies, Victoria, BC, Canada; [Brodie, Jon] James Cook Univ, Ctr Trop Water & Aquat Ecosyst Res TropWater, Catchment Reef Res Grp, Townsville, Qld 4811, Australia	James Cook University; University of Victoria; James Cook University	Alvarez-Romero, JG (corresponding author), James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	jorge.alvarez.romero@gmail.com	Alvarez-Romero, Jorge G./A-4557-2009	Alvarez-Romero, Jorge G./0000-0002-1141-0588; Ban, Natalie/0000-0002-4682-2144	Mexico's Consejo Nacional de Ciencia y Tecnologia; Secretaria de Educacion Publica; Australian Research Council Centre of Excellence for Coral Reef Studies; Mexico's Consejo Nacional de Ciencia y Tecnologia (CONACYT); Secretaria de Educacion Publica (SEP); Australian Research Council	Mexico's Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Educacion Publica; Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); Mexico's Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Educacion Publica (SEP); Australian Research Council(Australian Research Council)	Mexico's Consejo Nacional de Ciencia y Tecnologia (www.conacyt.mx) and Secretaria de Educacion Publica (www.sep.gob.mx) provided the main funding through PhD scholarships. JGAR, RLP and NCB also acknowledge the support of the Australian Research Council Centre of Excellence for Coral Reef Studies.; We thank Kirsten Oleson and an anonymous reviewer for their very helpful comments and suggestions. We thank the following persons for providing information and technical advice: Scott Wilkinson (CSIRO), Johnathan Kool (Geoscience Australia), Michelle Devlin (Trop-Water, James Cook University); Hector Cortes-Torres, Juan Francisco Gomez-Martinez and Pedro Rivera-Ruiz (IMTA); Rafael Hernandez (CIAD); Stephen Lewis (TropWater, James Cook University); Eusebio Ventura (UQRO); Alejandro Gonzalez-Serratos (CONAGUA); Arturo Flores-Martinez and Cleotilde Arellano (SEMARNAT); Jose Luis Perez-Damian (INE); and Melanie Kolb (CONABIO). We also thank the following organizations for providing software: Australia's Commonwealth Scientific and Industrial Research Organization (CSIRO) Land and Water (SedNet/ANNEX), and datasets: Servicio de Informacion Agroalimentaria y Pesquera (SIAP-SAGARPA); Comision Nacional para el Conocimiento y Uso de la Biodiversidad (CONABIO); Secretaria de Medio Ambiente y Recursos Naturales (SEMARNAT); Instituto Nacional de Ecologia (INE-SEMARNAT), and Instituto Nacional de Estadistica, Geografia e Informatica (INEGI). We also thank P. Visconti for support in scripting to analyse gauge data, Gordon Bailey for providing IT support, and the High Performance Computing Unit at James Cook University for computational facilities. JGAR gratefully acknowledges support from Mexico's Consejo Nacional de Ciencia y Tecnologia (CONACYT) and Secretaria de Educacion Publica (SEP), as well as from the Australian Research Council Centre of Excellence for Coral Reef Studies. RLP and NCB acknowledge the support of the Australian Research Council.	Adams VM, 2014, CONSERV LETT, V7, P425, DOI 10.1111/conl.12080; Alvarez-Cobelas M, 2008, ENVIRON POLLUT, V156, P261, DOI 10.1016/j.envpol.2008.02.016; Alvarez-Romero JG, 2015, BIOL CONSERV, V191, P799, DOI 10.1016/j.biocon.2015.07.003; Alvarez-Romero JG, 2014, J ENVIRON MANAGE, V146, P164, DOI 10.1016/j.jenvman.2014.07.007; Alvarez-Romero JG, 2013, AQUAT CONSERV, V23, P483, DOI 10.1002/aqc.2334; Alvarez-Romero JG, 2013, J ENVIRON MANAGE, V119, P194, DOI 10.1016/j.jenvman.2013.01.036; Alvarez-Romero JG, 2011, ANNU REV ECOL EVOL S, V42, P381, DOI 10.1146/annurev-ecolsys-102209-144702; Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; Ardron J. A., 2008, MARXAN GOOD PRACTICE; Bai Y, 2011, ECOL COMPLEX, V8, P177, DOI 10.1016/j.ecocom.2011.01.007; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Ban N. C., 2013, CONSERVATION PLANNIN, P175; Bartley R, 2014, RANGELAND J, V36, P67, DOI 10.1071/RJ13013; Bartley R, 2014, SCI TOTAL ENVIRON, V468, P1138, DOI 10.1016/j.scitotenv.2013.09.030; Bartley R, 2012, MAR POLLUT BULL, V65, P101, DOI 10.1016/j.marpolbul.2011.08.009; Beger M, 2010, CONSERV LETT, V3, P359, DOI 10.1111/j.1755-263X.2010.00123.x; Beger M, 2010, BIOL CONSERV, V143, P565, DOI 10.1016/j.biocon.2009.11.006; Beman JM, 2005, NATURE, V434, P211, DOI 10.1038/nature03370; Bennett F, 2015, WATER QUALITY IMPROV; Bohnet IC, 2011, LANDSCAPE ECOL, V26, P1179, DOI 10.1007/s10980-011-9640-0; Brodie J, 2014, 1433 TROPWATER J COO; Brodie JE, 2012, MAR POLLUT BULL, V65, P81, DOI 10.1016/j.marpolbul.2011.12.012; Brodie J, 2009, MAR FRESHWATER RES, V60, P1141, DOI 10.1071/MF08339; Brown DG, 2013, CURR OPIN ENV SUST, V5, P452, DOI 10.1016/j.cosust.2013.07.012; Burke L., 2006, HYDROLOGIC MODELING; Carroll C, 2012, MAR POLLUT BULL, V65, P136, DOI 10.1016/j.marpolbul.2011.11.022; Ceballos G., 2006, MODELADO DISTRIBUCIO; CEC (Commission for Environmental Cooperation), 1997, EC REG N AM COMM PER; Chan JCW, 2001, PHOTOGRAMM ENG REM S, V67, P213; Cimon-Morin J, 2013, BIOL CONSERV, V166, P144, DOI 10.1016/j.biocon.2013.06.023; CONABIO, 2007, AN VAC OM CONS BIOD; CONANP, 2010, CART COB AR NAT PROT; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Crist P., 2013, J CONSERV PLAN, V9, P21; De Almeida CM, 2005, INT J REMOTE SENS, V26, P759, DOI 10.1080/01431160512331316865; Devlin MJ, 2012, MAR POLLUT BULL, V65, P224, DOI 10.1016/j.marpolbul.2012.03.001; Devlin MJ, 2015, REMOTE SENS-BASEL, V7, P12909, DOI 10.3390/rs71012909; DGVS-SEMARNAT, 2010, CART SIST UN MAN APR; Djodjic F, 2002, J ENVIRON QUAL, V31, P937, DOI 10.2134/jeq2002.0937; Eastman R., 2007, LAND CHANGE MODELER; Egoh BN, 2011, J ENVIRON MANAGE, V92, P1642, DOI 10.1016/j.jenvman.2011.01.019; ESRI, 2006, ARCGIS 9 2; Geneletti D, 2008, LANDSCAPE URBAN PLAN, V85, P97, DOI 10.1016/j.landurbplan.2007.10.004; Gurney GG, 2015, CONSERV BIOL, V29, P1378, DOI 10.1111/cobi.12514; Gurney GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080137; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Halpern BS, 2009, CONSERV LETT, V2, P189, DOI 10.1111/j.1755-263X.2009.00060.x; Harris LR, 2014, J APPL ECOL, V51, P1504, DOI 10.1111/1365-2664.12345; Holland RA, 2011, ECOL APPL, V21, P2034, DOI 10.1890/09-2195.1; INEGI-INE-CONABIO, 2007, CART EC TERR MEX NIV, V4; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Kim OS, 2010, T GIS, V14, P631, DOI 10.1111/j.1467-9671.2010.01227.x; Klein CJ, 2014, MAR POLICY, V44, P360, DOI 10.1016/j.marpol.2013.10.001; Klein CJ, 2012, ECOL APPL, V22, P1246, DOI 10.1890/11-1718.1; Klein CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012431; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Langford WT, 2009, ECOL INFORM, V4, P123, DOI 10.1016/j.ecoinf.2009.04.002; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Lluch-Cota SE, 2007, PROG OCEANOGR, V73, P1, DOI 10.1016/j.pocean.2007.01.013; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; Mainstone CP, 2008, J HYDROL, V350, P131, DOI 10.1016/j.jhydrol.2007.10.035; Makino A, 2013, BIOL CONSERV, V165, P35, DOI 10.1016/j.biocon.2013.05.027; McKenzie E, 2012, DEV SCENARIOS ASSESS; Moilanen A, 2011, ECOL APPL, V21, P1419, DOI 10.1890/10-1865.1; Moravec J., 1998, Applied Vegetation Science, V1, P173, DOI 10.2307/1478946; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Navarro AG, 2007, MAPAS DISTRIBUCION P; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Ochoa-Ochoa L, 2006, MUSEO ZOOLOGIA FDC; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Onaindia M, 2013, FOREST ECOL MANAG, V289, P1, DOI 10.1016/j.foreco.2012.10.010; Paez-Osuna F, 2005, B ENVIRON CONTAM TOX, V74, P681, DOI 10.1007/s00128-005-0637-8; Paris CB, 2008, CORAL REEFS, V27, P773, DOI 10.1007/s00338-008-0396-1; Partelow S, 2015, MAR POLLUT BULL, V100, P352, DOI 10.1016/j.marpolbul.2015.08.026; Peterson GD, 2003, CONSERV BIOL, V17, P358, DOI 10.1046/j.1523-1739.2003.01491.x; Petus C, 2014, J ENVIRON MANAGE, V137, P163, DOI 10.1016/j.jenvman.2013.11.050; Pfeifer M, 2012, GLOBAL ECOL BIOGEOGR, V21, P603, DOI 10.1111/j.1466-8238.2011.00712.x; Pressey RL, 2009, ORYX, V43, P464, DOI 10.1017/S0030605309990500; Qiu JX, 2013, P NATL ACAD SCI USA, V110, P12149, DOI 10.1073/pnas.1310539110; RENARD KG, 1994, J HYDROL, V157, P287, DOI 10.1016/0022-1694(94)90110-4; Rouget M, 2003, BIOL CONSERV, V112, P63, DOI 10.1016/S0006-3207(02)00395-6; Rude J, 2016, AQUAT CONSERV, V26, P251, DOI 10.1002/aqc.2548; Rzedowski J., 1978, VEGETACION MEXICO; Schulz JJ, 2010, APPL GEOGR, V30, P436, DOI 10.1016/j.apgeog.2009.12.003; SEMARNAT-INE, 1991, IND US AGR MUN; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Stoeckl N, 2015, BIOL CONSERV, V191, P478, DOI 10.1016/j.biocon.2015.07.032; Stoms DM, 2005, FRONT ECOL ENVIRON, V3, P429, DOI 10.1890/1540-9295(2005)003[0429:ICRPMT]2.0.CO;2; Tallis H, 2008, CONSERV BIOL, V22, P120, DOI 10.1111/j.1523-1739.2007.00861.x; Thorburn PJ, 2013, AGR ECOSYST ENVIRON, V180, P4, DOI 10.1016/j.agee.2013.07.006; Thorburn PJ, 2013, AGR ECOSYST ENVIRON, V180, P192, DOI 10.1016/j.agee.2011.12.021; Urquiza-Haas T, 2009, GAP ANAL PROGRAM BRI, V61; Vanacker V, 2003, GEOMORPHOLOGY, V52, P299, DOI 10.1016/S0169-555X(02)00263-5; VELAZQUEZ A, 2002, ANALISIS CAMBIO USO; Visconti P, 2010, CONSERV LETT, V3, P404, DOI 10.1111/j.1755-263X.2010.00130.x; Walling DE, 2006, GEOMORPHOLOGY, V79, P192, DOI 10.1016/j.geomorph.2006.06.019; Waterhouse J, 2014, 1427 TROPWATER J COO; Weber M, 2006, WILDLIFE SOC B, V34, P1480, DOI 10.2193/0091-7648(2006)34[1480:TTOTCW]2.0.CO;2; Wilkinson C., 2011, CATCHMENT MANAGEMENT; Wilkinson S., 2004, SEDNET USER GUIDE VE; Wooldridge SA, 2015, MAR POLLUT BULL, V97, P262, DOI 10.1016/j.marpolbul.2015.06.007; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	105	29	31	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145574	10.1371/journal.pone.0145574	http://dx.doi.org/10.1371/journal.pone.0145574			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714166	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000367481900058
J	Gouvea, DY; Aprison, EZ; Ruvinsky, I				Gouvea, Devin Y.; Aprison, Erin Z.; Ruvinsky, Ilya			Experience Modulates the Reproductive Response to Heat Stress in C-elegans via Multiple Physiological Processes	PLOS ONE			English	Article							OOCYTE MEIOTIC MATURATION; CAENORHABDITIS-ELEGANS; NATURAL VARIATION; THERMAL PREFERENCE; SEX DETERMINATION; MOLECULAR-BASIS; SHOCK RESPONSE; MODEL SYSTEM; CELL LINEAGE; GERM-LINE	Natural environments are considerably more variable than laboratory settings and often involve transient exposure to stressful conditions. To fully understand how organisms have evolved to respond to any given stress, prior experience must therefore be considered. We investigated the effects of individual and ancestral experience on C. elegans reproduction. We documented ways in which cultivation at 15 degrees C or 25 degrees C affects developmental time, lifetime fecundity, and reproductive performance after severe heat stress that exceeds the fertile range of the organism but is compatible with survival and future fecundity. We found that experience modulates multiple aspects of reproductive physiology, including the male and female germ lines and the interaction between them. These responses vary in their environmental sensitivity, suggesting the existence of complex mechanisms for coping with unpredictable and stressful environments.	[Gouvea, Devin Y.] Univ Chicago, Comm Conceptual & Hist Studies Sci, Chicago, IL 60637 USA; [Gouvea, Devin Y.; Ruvinsky, Ilya] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Aprison, Erin Z.; Ruvinsky, Ilya] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Ruvinsky, Ilya] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Ruvinsky, I (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	ruvinsky@uchicago.edu			Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust [C-051]; Jacob K. Javits Fellowship	Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; Jacob K. Javits Fellowship	The work was partly funded by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust (award #C-051 to IR). DYG was supported by a Jacob K. Javits Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2007, J EXP BIOL, V210, P3107, DOI 10.1242/jeb.007351; Anderson JL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-157; Andux S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000295; Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Aprison EZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105513; Artyukhin AB, 2013, SCI REP-UK, V3, DOI 10.1038/srep02777; AVERY L, 1993, GENETICS, V133, P897; Bao ZR, 2008, DEV BIOL, V318, P65, DOI 10.1016/j.ydbio.2008.02.054; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Barriere A, 2007, GENETICS, V176, P999, DOI 10.1534/genetics.106.067223; Baugh LR, 2013, GENETICS, V194, P539, DOI 10.1534/genetics.113.150847; Begasse ML, 2015, CELL REP, V10, P647, DOI 10.1016/j.celrep.2015.01.006; Berry DB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002353; Braendle C, 2008, DEV CELL, V15, P714, DOI 10.1016/j.devcel.2008.09.011; Braendle C, 2008, CURR TOP DEV BIOL, V80, P171, DOI 10.1016/S0070-2153(07)80005-6; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; Calabrese EJ, 2002, HUM EXP TOXICOL, V21, P91, DOI 10.1191/0960327102ht217oa; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chen JJ, 2004, J NEMATOL, V36, P107; Chen JJ, 2003, NEMATOLOGY, V5, P641, DOI 10.1163/156854103322683355; Chisholm Andrew D, 2005, WormBook, P1; Cypser JR, 2006, EXP GERONTOL, V41, P935, DOI 10.1016/j.exger.2006.09.004; Dalfo D, 2012, CURR BIOL, V22, P712, DOI 10.1016/j.cub.2012.02.064; Dawe AS, 2006, BIOELECTROMAGNETICS, V27, P88, DOI 10.1002/bem.20192; DEPPE U, 1978, P NATL ACAD SCI USA, V75, P376, DOI 10.1073/pnas.75.1.376; Dolgin ES, 2008, HEREDITY, V100, P304, DOI 10.1038/sj.hdy.6801079; Ellis R, 2006, C ELEGANS RES COMMUN, DOI [10.1895/wormbook.1.82.1, DOI 10.1895/W0RMB00K.1.82.1]; Feder ME, 1997, J THERM BIOL, V22, P1, DOI 10.1016/S0306-4565(96)00028-9; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Frazier HN, 2009, CURR BIOL, V19, P859, DOI 10.1016/j.cub.2009.03.066; Frezal L, 2015, ELIFE, V4, DOI 10.7554/eLife.05849; FRIEDMAN S, 1972, PEABODY J EDUC, V49, P314, DOI 10.1080/01619567209537872; Gaertner BE, 2012, GENETICS, V192, P1533, DOI 10.1534/genetics.112.142877; Garigan D, 2002, GENETICS, V161, P1101; Ghosh R, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-85; Glauser Dominique A, 2013, Worm, V2, pe27285, DOI 10.4161/worm.27285; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Goodwin EB, 2002, CURR BIOL, V12, pR111, DOI 10.1016/S0960-9822(02)00675-9; GREWAL PS, 1991, NEMATOLOGICA, V37, P72, DOI 10.1163/187529291X00079; Harvey SC, 2007, J EXP ZOOL PART B, V308B, P409, DOI 10.1002/jez.b.21161; Harvey SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025840; Hayward SAL, 2007, ADV EXP MED BIOL, V594, P132; Hayward SAL, 2014, J EXP BIOL, V217, P6, DOI 10.1242/jeb.096537; HAZEL JR, 1991, LIPIDS, V26, P277, DOI 10.1007/BF02537137; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; HIRSH D, 1976, DEV BIOL, V49, P200, DOI 10.1016/0012-1606(76)90267-0; Hodgkin J, 1997, GENETICS, V146, P149; HODGKIN J, 1991, P ROY SOC B-BIOL SCI, V246, P19, DOI 10.1098/rspb.1991.0119; Hu PJ, 2007, WORMBOOK, DOI [10.1895/wormbook.1.144.1, DOI 10.1895/WORMBOOK.1.144.1]; James W., 1890, PRINCIPLES PSYCHOL, V1, DOI [10.1037/10538-000, DOI 10.1037/10538-000]; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; Jurado P, 2010, GENES BRAIN BEHAV, V9, P120, DOI 10.1111/j.1601-183X.2009.00549.x; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Kimble Judith, 2005, WormBook, P1; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Kourtis N, 2012, NATURE, V490, P213, DOI 10.1038/nature11417; Kuntz SG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004293; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; Leroy M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-187; Levy SF, 2012, ADV EXP MED BIOL, V751, P431, DOI 10.1007/978-1-4614-3567-9_20; Levy SF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001325; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; Luo SJ, 2011, GENESIS, V49, P53, DOI 10.1002/dvg.20694; Luo SJ, 2010, CELL, V143, P299, DOI 10.1016/j.cell.2010.09.013; Ma DKK, 2015, CELL, V161, P1152, DOI 10.1016/j.cell.2015.04.026; Maman M, 2013, J NEUROSCI, V33, P6102, DOI 10.1523/JNEUROSCI.4023-12.2013; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; McGovern M, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-41; McMullen PD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002338; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; Mori I, 2007, CURR OPIN NEUROBIOL, V17, P712, DOI 10.1016/j.conb.2007.11.010; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Murray P, 2007, P NATL ACAD SCI USA, V104, P5489, DOI 10.1073/pnas.0609590104; Murray RL, 2011, J EXP BIOL, V214, P1740, DOI 10.1242/jeb.053181; Neves A, 2015, ELIFE, V4, DOI 10.7554/eLife.04810; Ohta A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5412; Casanueva MO, 2012, SCIENCE, V335, P82, DOI 10.1126/science.1213491; Parker S, 2009, MOL BIOL CELL, V20, P1763, DOI 10.1091/mbc.E08-08-0837; Petrella LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112377; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Prasad A, 2011, EVOLUTION, V65, P52, DOI 10.1111/j.1558-5646.2010.01110.x; Richards JL, 2013, DEV BIOL, V374, P12, DOI 10.1016/j.ydbio.2012.11.034; Rodriguez M, 2012, EXP GERONTOL, V47, P581, DOI 10.1016/j.exger.2012.05.005; Ruaud AF, 2006, DEVELOPMENT, V133, P2211, DOI 10.1242/dev.02392; Schaedel ON, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001306; SCHEDL T, 1988, GENETICS, V119, P43; Schindler AJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004426; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Schott D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07387; Seidel HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028074; Sikkink KL, 2014, G3-GENES GENOM GENET, V4, P1103, DOI 10.1534/g3.114.010553; Simons AM, 2011, P ROY SOC B-BIOL SCI, V278, P1601, DOI 10.1098/rspb.2011.0176; SINGH RN, 1978, NEMATOLOGICA, V24, P63, DOI 10.1163/187529278X00074; Sivasundar A, 2005, CURR BIOL, V15, P1598, DOI 10.1016/j.cub.2005.08.034; Stiernagle Theresa, 2006, WormBook, P1; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sutphin GL, 2008, EXP GERONTOL, V43, P130, DOI 10.1016/j.exger.2007.10.019; Svensk E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003801; Svensson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021343; Tanaka T, 1996, LIPIDS, V31, P1173, DOI 10.1007/BF02524292; Tauffenberger A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004346; Thevenaz P, 2007, MICROSC RES TECHNIQ, V70, P135, DOI 10.1002/jemt.20393; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; Wolke U, 2007, DEVELOPMENT, V134, P2227, DOI 10.1242/dev.004952; Xiao R, 2013, CELL, V152, P806, DOI 10.1016/j.cell.2013.01.020; Zevian SC, 2014, METHODS, V68, P450, DOI 10.1016/j.ymeth.2014.04.015; Zhang B, 2015, CELL REP, V11, P1414, DOI 10.1016/j.celrep.2015.04.066	114	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145925	10.1371/journal.pone.0145925	http://dx.doi.org/10.1371/journal.pone.0145925			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713620	Green Submitted, Green Published, gold			2022-12-27	WOS:000367481900102
J	LaFaro, RJ; Pothula, S; Kubal, KP; Inchiosa, ME; Pothula, VM; Yuan, SC; Maerz, DA; Montes, L; Oleszkiewicz, SM; Yusupov, A; Perline, R; Inchiosa, MA				LaFaro, Rocco J.; Pothula, Suryanarayana; Kubal, Keshar Paul; Inchiosa, Mario Emil; Pothula, Venu M.; Yuan, Stanley C.; Maerz, David A.; Montes, Lucresia; Oleszkiewicz, Stephen M.; Yusupov, Albert; Perline, Richard; Inchiosa, Mario Anthony, Jr.			Neural Network Prediction of ICU Length of Stay Following Cardiac Surgery Based on Pre-Incision Variables	PLOS ONE			English	Article							MODEL	Background Advanced predictive analytical techniques are being increasingly applied to clinical risk assessment. This study compared a neural network model to several other models in predicting the length of stay (LOS) in the cardiac surgical intensive care unit (ICU) based on pre-incision patient characteristics. Methods Thirty six variables collected from 185 cardiac surgical patients were analyzed for contribution to ICU LOS. The Automatic Linear Modeling (ALM) module of IBM-SPSS software identified 8 factors with statistically significant associations with ICU LOS; these factors were also analyzed with the Artificial Neural Network (ANN) module of the same software. The weighted contributions of each factor ("trained" data) were then applied to data for a "new" patient to predict ICU LOS for that individual. Results Factors identified in the ALM model were: use of an intra-aortic balloon pump; O-2 delivery index; age; use of positive cardiac inotropic agents; hematocrit; serum creatinine >= 1.3 mg/deciliter; gender; arterial pCO(2). The r(2) value for ALM prediction of ICU LOS in the initial (training) model was 0.356, p < 0.0001. Cross validation in prediction of a "new" patient yielded r(2) = 0.200, p < 0.0001. The same 8 factors analyzed with ANN yielded a training prediction r(2) of 0.535 (p < 0.0001) and a cross validation prediction r(2) of 0.410, p < 0.0001. Two additional predictive algorithms were studied, but they had lower prediction accuracies. Our validated neural network model identified the upper quartile of ICU LOS with an odds ratio of 9.8(p < 0.0001). Conclusions ANN demonstrated a 2-fold greater accuracy than ALM in prediction of observed ICU LOS. This greater accuracy would be presumed to result from the capacity of ANN to capture nonlinear effects and higher order interactions. Predictive modeling may be of value in early anticipation of risks of post-operative morbidity and utilization of ICU facilities.	[LaFaro, Rocco J.] New York Med Coll, Dept Surg, Valhalla, NY 10595 USA; [Pothula, Suryanarayana; Yuan, Stanley C.; Yusupov, Albert] New York Med Coll, Dept Anesthesiol, Valhalla, NY 10595 USA; [Kubal, Keshar Paul; Pothula, Venu M.; Maerz, David A.; Montes, Lucresia; Oleszkiewicz, Stephen M.; Inchiosa, Mario Anthony, Jr.] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; [Inchiosa, Mario Emil] Revolut Analyt Inc, Mountain View, CA USA; [Perline, Richard] SAS Inst, Cary, NC USA	New York Medical College; New York Medical College; New York Medical College; SAS Institute Inc	Inchiosa, MA (corresponding author), New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA.	mario_inchiosa@nymc.edu		Pothula, Venu/0000-0002-5162-007X				Amato F, 2013, J APPL BIOMED, V11, P47, DOI 10.2478/v10136-012-0031-x; Atkov OY, 2012, J CARDIOL, V59, P190, DOI 10.1016/j.jjcc.2011.11.005; Atoui H, 2010, IEEE T INF TECHNOL B, V14, P883, DOI 10.1109/TITB.2010.2047754; Barili F, 2013, INT J CARDIOL, V168, P219, DOI 10.1016/j.ijcard.2012.09.091; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BUCHMAN TG, 1994, CRIT CARE MED, V22, P750, DOI 10.1097/00003246-199405000-00008; Deng ZH, 2015, IEEE T FUZZY SYST, V23, P813, DOI 10.1109/TFUZZ.2014.2328014; Geisser S., 2017, PREDICTIVE INFERENCE; Gholipour C, 2015, J CLIN DIAGN RES, V9, pOC19, DOI 10.7860/JCDR/2015/9467.5828; Hall LO, 2003, IEEE SYS MAN CYBERN, P2851; Harrison RF, 2005, ANN EMERG MED, V46, P431, DOI 10.1016/j.annemergmed.2004.09.012; Hashem S, 1997, NEURAL NETWORKS, V10, P599, DOI 10.1016/S0893-6080(96)00098-6; Mateo J., 2012, Journal of Medical Engineering & Technology, V36, P90, DOI 10.3109/03091902.2011.636859; Najafi Mahdi, 2012, J Tehran Heart Cent, V7, P170; Peng SY, 2008, ANAESTHESIA, V63, P705, DOI 10.1111/j.1365-2044.2008.05478.x; R Core Team, 2013, R LANG ENV STAT COMP; Rowan M, 2007, ARTIF INTELL MED, V40, P211, DOI 10.1016/j.artmed.2007.04.005; Tejera E, 2011, J MATERN-FETAL NEO M, V24, P1147, DOI 10.3109/14767058.2010.545916; TU JV, 1993, COMPUT BIOMED RES, V26, P220, DOI 10.1006/cbmr.1993.1015; Walsh P, 2004, EUR J EMERG MED, V11, P259, DOI 10.1097/00063110-200410000-00004; Zhang RX, 2007, IEEE ACM T COMPUT BI, V4, P485, DOI 10.1109/TCBB.2007.1012	21	33	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145395	10.1371/journal.pone.0145395	http://dx.doi.org/10.1371/journal.pone.0145395			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710254	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400043
J	Tuorto, SJ; Brown, CM; Bidle, KD; McGuinness, LR; Kerkhof, LJ				Tuorto, Steven J.; Brown, Chris M.; Bidle, Kay D.; McGuinness, Lora R.; Kerkhof, Lee J.			BioDry: An Inexpensive, Low-Power Method to Preserve Aquatic Microbial Biomass at Room Temperature	PLOS ONE			English	Article							BACTERIAL COMMUNITY; RNA; DNA; EXTRACTION; DIVERSITY; SAMPLES; SOIL	This report describes BioDry (patent pending), a method for reliably preserving the biomolecules associated with aquatic microbial biomass samples, without the need of hazardous materials (e.g. liquid nitrogen, preservatives, etc.), freezing, or bulky storage/sampling equipment. Gel electrophoresis analysis of nucleic acid extracts from samples treated in the lab with the BioDry method indicated that molecular integrity was protected in samples stored at room temperature for up to 30 days. Analysis of 16S/18S rRNA genes for presence/absence and relative abundance of microorganisms using both 454-pyrosequencing and TRFLP profiling revealed statistically indistinguishable communities from control samples that were frozen in liquid nitrogen immediately after collection. Seawater and river water biomass samples collected with a portable BioDry "field unit", constructed from off-the-shelf materials and a battery-operated pumping system, also displayed high levels of community rRNA preservation, despite a slight decrease in nucleic acid recovery over the course of storage for 30 days. Functional mRNA and protein pools from the field samples were also effectively conserved with BioDry, as assessed by respective RT-PCR amplification and western blot of ribulose-1-5-bisphosphate carboxylase/oxygenase. Collectively, these results demonstrate that BioDry can adequately preserve a suite of biomolecules from aquatic biomass at ambient temperatures for up to a month, giving it great potential for high resolution sampling in remote locations or on autonomous platforms where space and power are limited.	[Tuorto, Steven J.; Bidle, Kay D.; McGuinness, Lora R.; Kerkhof, Lee J.] Rutgers State Univ, Dept Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Brown, Chris M.] Environm Proteom NB Inc, Sackville, NB, Canada	Rutgers State University New Brunswick	Kerkhof, LJ (corresponding author), Rutgers State Univ, Dept Marine & Coastal Sci, New Brunswick, NJ 08903 USA.	lkerkhof@rutgers.edu		Kerkhof, Lee/0000-0001-9107-8695	National Science Foundation through an Ocean Technology and Interdisciplinary Program grant (NSF) [1131022]; Gordon and Betty Moore Foundation Grant [GBMF3789]; Division Of Ocean Sciences [1131022] Funding Source: National Science Foundation	National Science Foundation through an Ocean Technology and Interdisciplinary Program grant (NSF); Gordon and Betty Moore Foundation Grant; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was funded by the National Science Foundation through an Ocean Technology and Interdisciplinary Program grant to LJK (NSF #1131022), and in part by a Gordon and Betty Moore Foundation Grant to KDB (GBMF3789). Co-author Chris Brown is currently employed by Environmental Proteomics N.B. Inc. after all research had been completed on the BioDry project. Environmental Proteomics N.B, Inc. did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was primarily funded by the National Science Foundation through an Ocean Technology and Interdisciplinary Program grant to LJK (NSF #1131022), and in part by a Gordon and Betty Moore Foundation Grant to KDB (GBMF3789). The authors wish to thank the Rutgers Office of Technology Commercialization and Robert Netter for the assistance in obtaining the provisional patent (U.S. Provisional Application no. 61/911,195).	Brown CM, 2008, MAR BIOL, V154, P413, DOI 10.1007/s00227-008-0933-z; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Gray MA, 2013, FEMS MICROBIOL ECOL, V83, P468, DOI 10.1111/1574-6941.12008; John DE, 2007, MAR BIOTECHNOL, V9, P747, DOI 10.1007/s10126-007-9027-z; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kerkhof L, 1997, J BIOCHEM BIOPH METH, V34, P147, DOI 10.1016/S0165-022X(97)01212-8; Kerkhof LJ, 2011, ENVIRON SCI TECHNOL, V45, P1250, DOI 10.1021/es102893r; Kyrpides NC, 2009, NAT BIOTECHNOL, V27, P627, DOI 10.1038/nbt.1552; Maron PA, 2005, ATMOS ENVIRON, V39, P3687, DOI 10.1016/j.atmosenv.2005.03.002; McCarthy A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121659; McGuinness LM, 2006, ENVIRON SCI TECHNOL, V40, P509, DOI 10.1021/es050900l; Ottesen EA, 2011, ISME J, V5, P1881, DOI 10.1038/ismej.2011.70; Saito MA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00215; Sakano Y, 1998, APPL ENVIRON MICROB, V64, P4877; Sessitsch A, 2002, J MICROBIOL METH, V51, P171, DOI 10.1016/S0167-7012(02)00065-9; Simister RL, 2011, J EXP MAR BIOL ECOL, V397, P38, DOI 10.1016/j.jembe.2010.11.004; Stewart FJ, 2013, METHOD ENZYMOL, V531, P187, DOI 10.1016/B978-0-12-407863-5.00010-1; Tatangelo V, 2014, FEMS MICROBIOL LETT, V356, P32, DOI 10.1111/1574-6968.12475; Wilmes P, 2009, FEMS MICROBIOL REV, V33, P109, DOI 10.1111/j.1574-6976.2008.00144.x	20	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144686	10.1371/journal.pone.0144686	http://dx.doi.org/10.1371/journal.pone.0144686			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710122	gold, Green Published, Green Submitted			2022-12-27	WOS:000367451400010
J	Karlsson, H; Svensson, E; Gigg, C; Jarvius, M; Olsson-Stromberg, U; Savoldo, B; Dotti, G; Loskog, A				Karlsson, Hannah; Svensson, Emma; Gigg, Camilla; Jarvius, Malin; Olsson-Stromberg, Ulla; Savoldo, Barbara; Dotti, Gianpietro; Loskog, Angelica			Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors	PLOS ONE			English	Article							MODIFIED T-CELLS; ADOPTIVE IMMUNOTHERAPY; IN-VIVO; ANTITUMOR-ACTIVITY; CD28; LYMPHOMA; MEMORY; COSTIMULATION; ACTIVATION; SURVIVAL	CD19-targeting CAR T cells have shown potency in clinical trials targeting B cell leukemia. Although mainly second generation (2G) CARs carrying CD28 or 4-1BB have been investigated in patients, preclinical studies suggest that third generation (3G) CARs with both CD28 and 4-1BB have enhanced capacity. However, little is known about the intracellular signaling pathways downstream of CARs. In the present work, we have analyzed the signaling capacity post antigen stimulation in both 2G and 3G CARs. 3G CAR T cells expanded better than 2G CAR T cells upon repeated stimulation with IL-2 and autologous B cells. An antigen-driven accumulation of CAR+ cells was evident post antigen stimulation. The cytotoxicity of both 2G and 3G CAR T cells was maintained by repeated stimulation. The phosphorylation status of intracellular signaling proteins post antigen stimulation showed that 3G CAR T cells had a higher activation status than 2G. Several proteins involved in signaling downstream the TCR were activated, as were proteins involved in the cell cycle, cell adhesion and exocytosis. In conclusion, 3G CAR T cells had a higher degree of intracellular signaling activity than 2G CARs which may explain the increased proliferative capacity seen in 3G CAR T cells. The study also indicates that there may be other signaling pathways to consider when designing or evaluating new generations of CARs.	[Karlsson, Hannah; Svensson, Emma; Gigg, Camilla; Loskog, Angelica] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Jarvius, Malin; Olsson-Stromberg, Ulla] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Olsson-Stromberg, Ulla] Univ Uppsala Hosp, Sect Hematol, Uppsala, Sweden; [Savoldo, Barbara; Dotti, Gianpietro] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	Uppsala University; Uppsala University; Uppsala University; Uppsala University Hospital; Baylor College of Medicine	Loskog, A (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden.	angelica.loskog@igp.uu.se		Jarvius, Malin/0000-0002-1565-6155	Swedish Society for Childhood Cancer [PROJ08/028]; Swedish Cancer Society [CAN 2008/936]; Swedish Research Council [K2008-64P-20744-01-4]; AFA Insurance; Ake Wibergs Stiftelse; Magn. Bervalls Stiftelse; Erik; Karin o Gosta Selanders Stiftelse; Goransson-Sandvikens Stiftelse; Ellen Bachrachts stiftelse; foundation of GC Claeson; Medical Faculty at Uppsala University; foundation of A Karlsson; foundation of L Eriksson; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER	Swedish Society for Childhood Cancer; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); AFA Insurance; Ake Wibergs Stiftelse; Magn. Bervalls Stiftelse; Erik; Karin o Gosta Selanders Stiftelse; Goransson-Sandvikens Stiftelse; Ellen Bachrachts stiftelse; foundation of GC Claeson; Medical Faculty at Uppsala University; foundation of A Karlsson; foundation of L Eriksson; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by grants from the Swedish Society for Childhood Cancer (PROJ08/028), The Swedish Cancer Society (CAN 2008/936), The Swedish Research Council (K2008-64P-20744-01-4), AFA Insurance, Ake Wibergs Stiftelse, Magn. Bervalls Stiftelse, Erik, Karin o Gosta Selanders Stiftelse, Goransson-Sandvikens Stiftelse, Ellen Bachrachts stiftelse, foundation of GC Claeson, A Karlsson and L Eriksson and the Medical Faculty at Uppsala University.	Abate-Daga D, 2014, HUM GENE THER, V25, P1003, DOI 10.1089/hum.2013.209; Austgen K, 2012, NAT CELL BIOL, V14, P87, DOI 10.1038/ncb2395; Barrett DM, 2014, CYTOTHERAPY, V16, P619, DOI 10.1016/j.jcyt.2013.10.013; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Chapman NM, 2013, J IMMUNOL, V191, P6208, DOI 10.4049/jimmunol.1301587; Chunder N, 2012, J IMMUNOL, V189, P5659, DOI 10.4049/jimmunol.1202313; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; DUBOIS T, 1995, BIOCHEM J, V310, P243, DOI 10.1042/bj3100243; ESHHAR Z, 1993, P NATL ACAD SCI USA, V90, P720, DOI 10.1073/pnas.90.2.720; Essand M, 2013, J INTERN MED, V273, P166, DOI 10.1111/joim.12020; Finney HM, 2004, J IMMUNOL, V172, P104, DOI 10.4049/jimmunol.172.1.104; Gao HP, 2014, CLIN CANCER RES, V20, P6418, DOI 10.1158/1078-0432.CCR-14-1170; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Grebe C, 2011, CARDIOVASC RES, V90, P521, DOI 10.1093/cvr/cvr023; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Gu HJ, 2014, CELL IMMUNOL, V290, P138, DOI 10.1016/j.cellimm.2014.05.004; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hillerdal V, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-30; Hinrichs CS, 2009, P NATL ACAD SCI USA, V106, P17469, DOI 10.1073/pnas.0907448106; Hombach AA, 2013, HUM GENE THER, V24, P259, DOI 10.1089/hum.2012.247; Hudecek M, 2015, CANCER IMMUNOL RES, V3, P125, DOI 10.1158/2326-6066.CIR-14-0127; Imai C, 2004, LEUKEMIA, V18, P676, DOI 10.1038/sj.leu.2403302; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kang QZ, 2009, BLOOD, V113, P6128, DOI 10.1182/blood-2008-10-182329; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; KLEIN E, 1968, CANCER RES, V28, P1300; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Kowolik CM, 2006, CANCER RES, V66, P10995, DOI 10.1158/0008-5472.CAN-06-0160; Lamers C. H. J., 2006, J CLIN ONCOL, V24, pE20, DOI [10.1200/JCO.2006.05.9964, DOI 10.1200/JCO.2006.05.9964]; Lapinski PE, 2011, J IMMUNOL, V187, P151, DOI 10.4049/jimmunol.1100178; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Liu JO, 2009, IMMUNOL REV, V228, P184, DOI 10.1111/j.1600-065X.2008.00756.x; Loskog A, 2006, LEUKEMIA, V20, P1819, DOI 10.1038/sj.leu.2404366; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Maude SL, 2015, BLOOD, V125, P4017, DOI 10.1182/blood-2014-12-580068; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Miao TZ, 2013, J IMMUNOL, V190, P58, DOI 10.4049/jimmunol.1200868; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Morawski PA, 2013, J BIOL CHEM, V288, P24494, DOI 10.1074/jbc.M113.467704; Nicholson IC, 1997, MOL IMMUNOL, V34, P1157, DOI 10.1016/S0161-5890(97)00144-2; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Proust R, 2014, MOL IMMUNOL, V58, P206, DOI 10.1016/j.molimm.2013.12.002; Pule MA, 2005, MOL THER, V12, P933, DOI 10.1016/j.ymthe.2005.04.016; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; RIVIERE I, 1995, P NATL ACAD SCI USA, V92, P6733, DOI 10.1073/pnas.92.15.6733; Robertson LK, 2011, J IMMUNOL, V187, P5824, DOI 10.4049/jimmunol.1003690; Sampson JH, 2014, CLIN CANCER RES, V20, P972, DOI 10.1158/1078-0432.CCR-13-0709; Santoro SP, 2015, CANCER IMMUNOL RES, V3, P68, DOI 10.1158/2326-6066.CIR-14-0192; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064138; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Song DG, 2012, BLOOD, V119, P696, DOI 10.1182/blood-2011-03-344275; Tammana S, 2010, HUM GENE THER, V21, P75, DOI 10.1089/hum.2009.122; Till BG, 2008, BLOOD, V112, P2261, DOI 10.1182/blood-2007-12-128843; Till BG, 2012, BLOOD, V119, P3940, DOI 10.1182/blood-2011-10-387969; van Genderen HO, 2008, BBA-MOL CELL RES, V1783, P953, DOI 10.1016/j.bbamcr.2008.01.030; Vera J, 2006, BLOOD, V108, P3890, DOI 10.1182/blood-2006-04-017061; Wang J, 2007, HUM GENE THER, V18, P712, DOI 10.1089/hum.2007.028; WEISSMAN AM, 1988, P NATL ACAD SCI USA, V85, P9709, DOI 10.1073/pnas.85.24.9709; Weyd H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062449; Xu Y, 2014, BLOOD, V123, P3750, DOI 10.1182/blood-2014-01-552174; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023; Zhong XS, 2010, MOL THER, V18, P413, DOI 10.1038/mt.2009.210	67	71	76	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144787	10.1371/journal.pone.0144787	http://dx.doi.org/10.1371/journal.pone.0144787			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700307	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600032
J	Angeler, DG; Allen, CR; Garmestani, AS; Gunderson, LH; Hjerne, O; Winder, M				Angeler, David G.; Allen, Craig R.; Garmestani, Ahjond S.; Gunderson, Lance H.; Hjerne, Olle; Winder, Monika			Quantifying the Adaptive Cycle	PLOS ONE			English	Article							BALTIC SEA; PEG-MODEL; PHYTOPLANKTON; RESILIENCE; ECOSYSTEM; PLANKTON; MECHANISMS; SUCCESSION; SYSTEMS	The adaptive cycle was proposed as a conceptual model to portray patterns of change in complex systems. Despite the model having potential for elucidating change across systems, it has been used mainly as a metaphor, describing system dynamics qualitatively. We use a quantitative approach for testing premises (reorganisation, conservatism, adaptation) in the adaptive cycle, using Baltic Sea phytoplankton communities as an example of such complex system dynamics. Phytoplankton organizes in recurring spring and summer blooms, a well-established paradigm in planktology and succession theory, with characteristic temporal trajectories during blooms that may be consistent with adaptive cycle phases. We used long-term (1994-2011) data and multivariate analysis of community structure to assess key components of the adaptive cycle. Specifically, we tested predictions about: reorganisation: spring and summer blooms comprise distinct community states; conservatism: community trajectories during individual adaptive cycles are conservative; and adaptation: phytoplankton species during blooms change in the long term. All predictions were supported by our analyses. Results suggest that traditional ecological paradigms such as phytoplankton successional models have potential for moving the adaptive cycle from a metaphor to a framework that can improve our understanding how complex systems organize and reorganize following collapse. Quantifying reorganization, conservatism and adaptation provides opportunities to cope with the intricacies and uncertainties associated with fast ecological change, driven by shifting system controls. Ultimately, combining traditional ecological paradigms with heuristics of complex system dynamics using quantitative approaches may help refine ecological theory and improve our understanding of the resilience of ecosystems.	[Angeler, David G.; Hjerne, Olle; Winder, Monika] Stockholm Univ, Dept Ecol Evolut & Plant Sci, SE-10691 Stockholm, Sweden; [Angeler, David G.] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, SE-75007 Uppsala, Sweden; [Allen, Craig R.] Univ Nebraska, US Geol Survey, Nebraska Cooperat Fish & Wildlife Res Unit, Lincoln, NE 68583 USA; [Garmestani, Ahjond S.] US EPA, Natl Risk Management Res Lab, Cincinnati, OH 45268 USA; [Gunderson, Lance H.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA	Stockholm University; Swedish University of Agricultural Sciences; United States Department of the Interior; United States Geological Survey; University of Nebraska System; University of Nebraska Lincoln; United States Environmental Protection Agency; Emory University	Angeler, DG (corresponding author), Stockholm Univ, Dept Ecol Evolut & Plant Sci, SE-10691 Stockholm, Sweden.	david.angeler@slu.se		Garmestani, Ahjond/0000-0001-5678-7293	Department of Ecology, Environment and Plant Sciences, Stockholm University; Stockholm University's Strategic Marine Environmental Research Programme on Baltic Ecosystem Adaptive Management (BEAM); BONUS project [BIO-C3]; EU; Swedish Research Council FORMAS [2014-1193]; Swedish Research Council VR [2014-5828]	Department of Ecology, Environment and Plant Sciences, Stockholm University; Stockholm University's Strategic Marine Environmental Research Programme on Baltic Ecosystem Adaptive Management (BEAM); BONUS project; EU(European Commission); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council VR(Swedish Research Council)	Financial support from the Department of Ecology, Environment and Plant Sciences, Stockholm University, and by Stockholm University's Strategic Marine Environmental Research Programme on Baltic Ecosystem Adaptive Management (BEAM) and from the BONUS project BIO-C3, funded jointly by the EU and FORMAS is acknowledged. Additional support was provided by grants from the Swedish Research Councils VR (2014-5828) and FORMAS (2014-1193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel N, 2006, ECOL SOC, V11; Allen CR, 2016, JOURNAL OF APPLIED E; Allen CR, 2014, ECOSYSTEMS, V17, P578, DOI 10.1007/s10021-013-9744-2; Anderson M.J., 2005, PERMANOVA A FORTRAN; Angeler DG, 2016, J APPL ECOL, V53, P688, DOI 10.1111/1365-2664.12494; Angeler DG, 2014, AMBIO, V43, P113, DOI 10.1007/s13280-014-0566-z; Angeler DG, 2011, ECOL SOC, V16, DOI 10.5751/ES-04175-160305; Angeler DG, 2010, OECOLOGIA, V164, P231, DOI 10.1007/s00442-010-1640-2; [Anonymous], 2001, PANARCHY UNDERSTANDI; Bass B., 1998, ECOTARGETS GOAL FUNC, P193; Behrenfeld MJ, 2014, ANNU REV MAR SCI, V6, P167, DOI 10.1146/annurev-marine-052913-021325; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Burkhard B, 2011, ECOL MODEL, V222, P2878, DOI 10.1016/j.ecolmodel.2011.05.016; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clements F.E, 1916, PLANT SUCCESSION ANA, DOI [10.5962/bhl.title.56234, DOI 10.5962/BHL.TITLE.56234]; Cumming GS, 2005, ECOL SOC, V10; Daedlow K, 2011, ECOL SOC, V16; Diamond J., 2005, COLLAPSE HOW SOCIETI; ELMGREN R, 1989, AMBIO, V18, P326; Gilpin R, 2000, THE CHALLENGE OF GLO; Grundmann P, 2012, ENERG POLICY, V48, P118, DOI 10.1016/j.enpol.2012.04.051; Gunderson L, 2010, ECOL SOC, V15; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Hajdu S., 2002, THESIS; HELCOM, 2008, MANUAL FOR MARINE MO; Hoglander H, 2004, MAR ECOL PROG SER, V283, P15, DOI 10.3354/meps283015; Holling C.S., 1986, SUSTAINABLE DEV BIOS, V14, P292; Hukkinen JI, 2012, ECOL SOC, V17, DOI 10.5751/ES-05241-170430; Jaanus A, 2011, BOREAL ENVIRON RES, V16, P191; Janssen F, 2004, MAR ECOL PROG SER, V275, P59, DOI 10.3354/meps275059; Jorgensen Sven E., 2007, P1, DOI 10.1016/B978-044453160-5/50001-5; Klais R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021567; Leibold MA, 2004, LIMNOL OCEANOGR, V49, P1278, DOI 10.4319/lo.2004.49.4_part_2.1278; Lyon C, 2013, RURAL SOCIOL, V78, P528, DOI 10.1111/ruso.12018; MacGill V, 2011, SYST RES BEHAV SCI, V28, P526, DOI 10.1002/sres.1121; Moen J, 2010, ECOL SOC, V15; Olenina I, 2006, BALT SEA ENV P, V106, P1; Osterblom H, 2007, ECOSYSTEMS, V10, P877, DOI 10.1007/s10021-007-9069-0; Paina L, 2012, HEALTH POLICY PLANN, V27, P365, DOI 10.1093/heapol/czr054; Sinclair K, 2014, AGR HUM VALUES, V31, P371, DOI 10.1007/s10460-014-9488-4; SOMMER U, 1981, ACTA OECOL-OEC GEN, V2, P327; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Sommer U, 2012, ANNU REV ECOL EVOL S, V43, P429, DOI 10.1146/annurev-ecolsys-110411-160251; Suikkanen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066475; Waaland JR, 2007, WAALAND JR ALGAE AND; Wasmund N, 2003, ICES J MAR SCI, V60, P177, DOI 10.1016/S1054-3139(02)00280-1; WILLEN T, 1962, OIKOS, V13, P169, DOI 10.2307/3565084; Winder M, 2010, PHILOS T R SOC B, V365, P3215, DOI 10.1098/rstb.2010.0125	48	17	20	7	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146053	10.1371/journal.pone.0146053	http://dx.doi.org/10.1371/journal.pone.0146053			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716453	Green Published, gold, Green Accepted			2022-12-27	WOS:000367510500127
J	Forrester, GE; Flynn, RL; Forrester, LM; Jarecki, LL				Forrester, Graham E.; Flynn, Rebecca L.; Forrester, Linda M.; Jarecki, Lianna L.			Episodic Disturbance from Boat Anchoring Is a Major Contributor to, but Does Not Alter the Trajectory of, Long-Term Coral Reef Decline	PLOS ONE			English	Article							REGION-WIDE DECLINES; MULTIPLE STRESSORS; ECOLOGICAL SURPRISES; FISH COMMUNITIES; HABITAT; ECOSYSTEMS; RESILIENCE; ABUNDANCE; DYNAMICS; IMPACTS	Isolating the relative effects of episodic disturbances and chronic stressors on long-term community change is challenging. We assessed the impact of an episodic disturbance associated with human visitation (boat anchoring) relative to other drivers of long-term change on coral reefs. A one-time anchoring event at Crab Cove, British Virgin Islands, in 2004 caused rapid losses of coral and reef structural complexity that were equal to the cumulative decline over 23 years observed at an adjacent site. The abundance of small site-attached reef fishes dropped by approximately one quarter after the anchoring event, but this drop was not immediate and only fully apparent two years after the anchoring event. There was no obvious recovery from the impact, and no evidence that this episodic impact accelerated or retarded subsequent declines from other causes. This apparent lack of synergism between the effect of this episodic human impact and other chronic stressors is consistent with the few other long-term studies of episodic impacts, and suggests that action to mitigate anchor damage should yield predictable benefits.	[Forrester, Graham E.; Flynn, Rebecca L.; Jarecki, Lianna L.] Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA; [Forrester, Linda M.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA	University of Rhode Island; University of Rhode Island	Forrester, GE (corresponding author), Univ Rhode Isl, Dept Nat Resources Sci, 1 Greenhouse Rd, Kingston, RI 02881 USA.	gforrester@uri.edu		Forrester, Graham/0000-0001-5253-773X	Falconwood Foundation; Nature Conservancy's Global Marine Initiative; US National Science Foundation [HSD 0527304]	Falconwood Foundation; Nature Conservancy's Global Marine Initiative; US National Science Foundation(National Science Foundation (NSF))	This work was supported by the Falconwood Foundation, The Nature Conservancy's Global Marine Initiative (http://www.nature.org/ourinitiatives/habitats/oceanscoasts/), US National Science Foundation (http://www.nsf.gov/) grant # HSD 0527304. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Filip L, 2011, GLOBAL CHANGE BIOL, V17, P2470, DOI 10.1111/j.1365-2486.2010.02385.x; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; [Anonymous], 2007, PRAIRIE PERSPECTIVES; Ault TR, 1998, ECOL MONOGR, V68, P25, DOI 10.1890/0012-9615(1998)068[0025:SATPFO]2.0.CO;2; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Bonin MC, 2011, ECOLOGY, V92, P1503, DOI 10.1890/10-0627.1; Bostrom-Einarsson L, 2013, J EXP MAR BIOL ECOL, V448, P85, DOI 10.1016/j.jembe.2013.06.017; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065765; Burgin S, 2011, BIODIVERS CONSERV, V20, P683, DOI 10.1007/s10531-011-0003-6; Burke LM, 2011, REEFS AT RISK REVISI; Caley MJ, 1996, J ANIM ECOL, V65, P414, DOI 10.2307/5777; Coker DJ, 2012, CORAL REEFS, V31, P919, DOI 10.1007/s00338-012-0920-1; Council WTaT, 2014, TRAVEL AND TOURISM E; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Darling ES, 2010, CONSERV LETT, V3, P122, DOI 10.1111/j.1755-263X.2009.00089.x; Davenport J, 2006, ESTUAR COAST SHELF S, V67, P280, DOI 10.1016/j.ecss.2005.11.026; Dayton PK, 1972, COLLOQUIUM ON CONSER; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Doak DF, 2008, ECOLOGY, V89, P952, DOI 10.1890/07-0965.1; Flynn RL, 2015, BOAT ANCHORING CONTR; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Forrester G, 2015, J NAT CONSERV, V24, P1, DOI 10.1016/j.jnc.2015.01.002; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gardner TA, 2005, ECOLOGY, V86, P174, DOI 10.1890/04-0141; GOENAGA C, 1991, INTERCIENCIA, V16, P12; Graham NAJ, 2009, BIODIVERS CONSERV, V18, P3325, DOI 10.1007/s10531-009-9633-3; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Holbrook SJ, 2000, OECOLOGIA, V122, P109, DOI 10.1007/PL00008826; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 2014, STATUS AND TRENDS OF; Johnstone RW, 1998, AMBIO, V27, P700; Lewis AR, 1998, J EXP MAR BIOL ECOL, V230, P91, DOI 10.1016/S0022-0981(98)00087-2; Lindenmayer DB, 2010, P NATL ACAD SCI USA, V107, P21957, DOI 10.1073/pnas.1015696107; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; McCormick MI, 2012, P ROY SOC B-BIOL SCI, V279, P3899, DOI 10.1098/rspb.2012.0854; MCCORMICK MI, 1994, MAR ECOL PROG SER, V112, P87, DOI 10.3354/meps112087; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; Ohlhorst SL, 1988, P 6 INT COR REEF S T, V2, P319; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Piggott JJ, 2015, ECOL EVOL, V5, P1538, DOI 10.1002/ece3.1465; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schutte VGW, 2010, MAR ECOL PROG SER, V402, P115, DOI 10.3354/meps08438; Souter D, 2008, STATUS OF CARIBBEAN, P1; Stewart-Oaten A, 2001, ECOL MONOGR, V71, P305, DOI 10.1890/0012-9615(2001)071[0305:TASVIE]2.0.CO;2; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wackernagel M, 2002, P NATL ACAD SCI USA, V99, P9266, DOI 10.1073/pnas.142033699; Wilkinson C., 2008, STATUS OF CORAL REEF; Wilkinson CR, 2000, STATUS OF CORAL REEF	62	12	12	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0144498	10.1371/journal.pone.0144498	http://dx.doi.org/10.1371/journal.pone.0144498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717208	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500011
J	Ishaq, SL; Kim, CJ; Reis, D; Wright, ADG				Ishaq, Suzanne L.; Kim, Christina J.; Reis, Doug; Wright, Andre-Denis G.			Fibrolytic Bacteria Isolated from the Rumen of North American Moose (Alces alces) and Their Use as a Probiotic in Neonatal Lambs	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; COMPLETE GENOME; MILK-YIELD; DAIRY-COWS; BACILLUS; DIVERSITY; CALVES; BIFIDOBACTERIA; ESTABLISHMENT; FERMENTATION	Fibrolytic bacteria were isolated from the rumen of North American moose (Alces alces), which eat a high-fiber diet of woody browse. It was hypothesized that fibrolytic bacteria isolated from the moose rumen could be used as probiotics to improve fiber degradation and animal production. Thirty-one isolates (Bacillus, n = 26; Paenibacillus, n = 1; and Staphylococcus, n = 4) were cultured from moose rumen digesta samples collected in Vermont. Using Sanger sequencing of the 16S rRNA gene, culturing techniques, and optical densities, isolates were identified and screened for biochemical properties important to plant carbohydrate degradation. Five isolates were selected as candidates for use as a probiotic, which was administered daily to neonate lambs for 9 weeks. It was hypothesized that regular administration of a probiotic to improve fibrolysis to neonate animals through weaning would increase the developing rumen bacterial diversity, increase animal production, and allow for long-term colonization of the probiotic species. Neither weight gain nor wool quality was improved in lambs given a probiotic, however, dietary efficiency was increased as evidenced by the reduced feed intake (and rearing costs) without a loss to weight gain. Experimental lambs had a lower acetate to propionate ratio than control lambs, which was previously shown to indicate increased dietary efficiency. Fibrolytic bacteria made up the majority of sequences, mainly Prevotella, Butyrivibrio, and Ruminococcus. While protozoal densities increased over time and were stable, methanogen densities varied greatly in the first six months of life for lambs. This is likely due to the changing diet and bacterial populations in the developing rumen.	[Ishaq, Suzanne L.; Kim, Christina J.; Wright, Andre-Denis G.] Univ Vermont, Coll Agr & Life Sci, Dept Anim Sci, Burlington, VT USA; [Reis, Doug] Univ Vermont, Dept Microbiol & Mol Genet, Coll Agr & Life Sci, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Ishaq, SL (corresponding author), Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA.	suzanne.pellegrini@montana.edu	WRIGHT, ANDRE-DENIS/ABI-2584-2020	Ishaq, Suzanne/0000-0002-2615-8055	USDA National Institute of Food and Agriculture's Agriculture and Food Research Initiative [2013-67011-21152]	USDA National Institute of Food and Agriculture's Agriculture and Food Research Initiative	This project was funded by a Graduate Fellowship from the USDA National Institute of Food and Agriculture's Agriculture and Food Research Initiative (Grant #2013-67011-21152) to Suzanne Ishaq, http://nifa.usda.gov/grants. NIFA did not have any part in the concept, design, sample collection, or sample analysis of this project.	Abe F, 1995, J DAIRY SCI, V78, P2838, DOI 10.3168/jds.S0022-0302(95)76914-4; Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Aikman PC, 2011, J DAIRY SCI, V94, P2840, DOI 10.3168/jds.2010-3783; Archana A, 1997, ENZYME MICROB TECH, V21, P12, DOI 10.1016/S0141-0229(96)00207-4; AUSTIN PJ, 1989, J CHEM ECOL, V15, P1335, DOI 10.1007/BF01014834; Bandounas L, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-94; BELOVSKY GE, 1981, ECOLOGY, V62, P1020, DOI 10.2307/1937001; BELOVSKY GE, 1981, J MAMMAL, V62, P613, DOI 10.2307/1380408; Boyd J, 2011, J DAIRY SCI, V94, P4616, DOI 10.3168/jds.2010-3984; Carberry CA, 2012, APPL ENVIRON MICROB, V78, P4949, DOI 10.1128/AEM.07759-11; Chang ZL, 2008, CHINESE SCI BULL, V53, P1121, DOI 10.1007/s11434-008-0184-x; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Chao A, 2010, PROGRAM USERS GUIDE; Committee on the Nutrient Requirements of Small Ruminants, 2007, N R C NUTRIENT REQUI, P384; Cotta M, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P1002, DOI 10.1007/0-387-30744-3_35; Dailey RN, 2008, VET PATHOL, V45, P19, DOI 10.1354/vp.45-1-19; Dehority B.A., 1986, P307; DEHORITY BA, 1976, APPL ENVIRON MICROB, V32, P703, DOI 10.1128/AEM.32.5.703-710.1976; DEHORITY BA, 1974, J PROTOZOOL, V21, P26, DOI 10.1111/j.1550-7408.1974.tb03612.x; Denman SE, 2007, FEMS MICROBIOL ECOL, V62, P313, DOI 10.1111/j.1574-6941.2007.00394.x; DURIX A, 1991, CAN J ANIM SCI, V71, P115, DOI 10.4141/cjas91-013; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Evans J, 2006, J MOL EVOL, V62, P785, DOI 10.1007/s00239-005-0176-2; FONTY G, 1987, J GEN MICROBIOL, V133, P1835; FRANZMANN A W, 1984, Journal of Wildlife Diseases, V20, P333; GASAWAY W C, 1974, Naturaliste Canadien (Quebec), V101, P227; Georgalaki MD, 2002, APPL ENVIRON MICROB, V68, P5891, DOI 10.1128/AEM.68.12.5891-5903.2002; Georgalaki MD, 2000, J APPL MICROBIOL, V88, P817, DOI 10.1046/j.1365-2672.2000.01055.x; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gordon RE, 1973, THE GENUS BACILLUS, P283; Hobson P. N., 1997, RUMEN MICROBIAL ECOS, P661; Ishaq SL, 2014, MICROB ECOL, V68, P185, DOI 10.1007/s00248-014-0399-0; Ishaq SL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-212; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879; Kleta S, 2006, J APPL MICROBIOL, V101, P1357, DOI 10.1111/j.1365-2672.2006.03019.x; Kmet V, 1993, Arch Tierernahr, V44, P1, DOI 10.1080/17450399309386053; Kovacs N., 1928, IMMUNITATSFORSCH, V55, P311; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kumar B, 2013, VET WORLD, V6, P14, DOI 10.5455/vetworld.2013.14-17; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; LAUKOVA A, 1992, ZBL MIKROBIOL, V147, P489, DOI 10.1016/S0232-4393(11)80322-7; Lee JC, 2008, INT J SYST EVOL MICR, V58, P612, DOI 10.1099/ijs.0.65350-0; Lopez S, 1999, ANIM FEED SCI TECH, V78, P1, DOI 10.1016/S0377-8401(98)00273-9; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MAGLIONE G, 1992, APPL ENVIRON MICROB, V58, P3593, DOI 10.1128/AEM.58.11.3593-3597.1992; MINATO H, 1992, J GEN APPL MICROBIOL, V38, P447, DOI 10.2323/jgam.38.447; MOLVAR EM, 1993, OECOLOGIA, V94, P472, DOI 10.1007/BF00566961; Morgavi DP, 2012, BRIT J NUTR, V107, P388, DOI 10.1017/S0007114511002935; MORVAN B, 1994, FEMS MICROBIOL LETT, V117, P249, DOI 10.1111/j.1574-6968.1994.tb06775.x; Norouzian MA, 2001, TROP ANIM HEALTH PRO, V43, P1169; Odenyo AA, 2001, ANAEROBE, V7, P5, DOI 10.1006/anae.2000.0367; Pajarillo EA, 2015, ANIM FEED SCI TECHNO; Pattnaik P, 2001, J APPL MICROBIOL, V91, P636, DOI 10.1046/j.1365-2672.2001.01429.x; PAUL J, 1986, CURR SCI INDIA, V55, P710; Peter H., 1986, BERGEYS MANUAL SYSTE, V2, P1104; POE SE, 1971, J ANIM SCI, V32, P740; Prsteng KE, 2013, MICROB ECOL, V66, P840, DOI 10.1007/s00248-013-0279-z; Qiao GH, 2010, J ANIM PHYSIOL AN N, V94, P429, DOI 10.1111/j.1439-0396.2009.00926.x; Ripamonti B, 2011, ANAEROBE, V17, P97, DOI 10.1016/j.anaerobe.2011.05.001; Routledge Robert G., 2004, Alces, V40, P95; SAITO N, 1973, ARCH BIOCHEM BIOPHYS, V155, P290, DOI 10.1016/0003-9861(73)90117-3; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Seo JK, 2013, ASIAN AUSTRAL J ANIM, V26, P50, DOI 10.5713/ajas.2012.12506; Shannon C.E., 1949, MATH THEORY COMMUNIC, P144; Shimada Y, 2013, PLOS ONE, DOI [10.1371/journal.pone.0080604, DOI 10.1371/J0URNAL.P0NE.0080604]; Shipley Lisa A., 2010, Alces, V46, P1; Simmons JS, 1926, J INFECT DIS, V39, P209, DOI 10.1093/infdis/39.3.209; SINHA RN, 1983, J APPL BACTERIOL, V54, P1, DOI 10.1111/j.1365-2672.1983.tb01294.x; Suen G, 2011, J BACTERIOL, V193, P5574, DOI 10.1128/JB.05621-11; Sun P, 2010, J DAIRY SCI, V93, P5851, DOI 10.3168/jds.2010-3263; Sundset MA, 2008, NATURWISSENSCHAFTEN, V95, P741, DOI 10.1007/s00114-008-0381-0; Sylvester JT, 2004, J NUTR, V134, P3378, DOI 10.1093/jn/134.12.3378; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Soest P.J., 1982, NUTR ECOLOGY RUMINAN, V2nd, P488; Veith B, 2004, J MOL MICROB BIOTECH, V7, P204, DOI 10.1159/000079829; Veresegyhazy T, 2003, ACTA VET HUNG, V51, P189, DOI 10.1556/AVet.51.2003.2.7; Vlkova E, 2010, FOLIA MICROBIOL, V55, P390, DOI 10.1007/s12223-010-0066-x; Yanez-Ruiz DR, 2010, FEMS MICROBIOL ECOL, V72, P272, DOI 10.1111/j.1574-6941.2010.00852.x; Zuur AF, 2007, STAT BIOL HEALTH, P259	81	14	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0144804	10.1371/journal.pone.0144804	http://dx.doi.org/10.1371/journal.pone.0144804			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716685	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500016
J	Li, N; Richoux, R; Perruchot, MH; Boutinaud, M; Mayol, JF; Gagnaire, V				Li, Na; Richoux, Romain; Perruchot, Marie-Halene; Boutinaud, Marion; Mayol, Jean-Francois; Gagnaire, Valerie			Flow Cytometry Approach to Quantify the Viability of Milk Somatic Cell Counts after Various Physico-Chemical Treatments	PLOS ONE			English	Article							MAMMARY-GLAND; LYMPHOCYTE SUBPOPULATIONS; ESCHERICHIA-COLI; BOVINE; NEUTROPHIL; MASTITIS; CD14; MACROPHAGES; EXPRESSION; LEUKOCYTES	Flow cytometry has been used as a routine method to count somatic cells in milk, and to ascertain udder health and milk quality. However, few studies investigate the viability of somatic cells and even fewer at a subpopulation level to follow up how the cells can resist to various stresses that can be encountered during technological processes. To address this issue, a flow cytometry approach was used to simultaneously identify cell types of bovine milk using cell-specific antibodies and to measure the cell viability among the identified sub-populations by using a live/dead cell viability kit. Confirmation of the cell viability was performed by using conventional microscopy. Different physico-chemical treatments were carried out on standardized cell samples, such as heat treatment, various centrifugation rates and storage in milk or in PBS pH 7.4 for three days. Cytometry gating strategy was developed by using blood cell samples stored at 4 degrees C in PBS and milk cell samples heat-treated at 80 degrees C for 30 min as a control for the maximum (95.9%) and minimum (0.7%) values of cell viability respectively. Cell viability in the initial samples was 39.5% for all cells and varied for each cell population from 26.7% for PMNs, to 32.6% for macrophages, and 58.3% for lymphocytes. Regarding the physico-chemical treatments applied, somatic cells did not sustain heat treatment at 60 degrees C and 80 degrees C in contrast to changes in centrifugation rates, for which only the higher level, i. e. 5000xg led to a cell viability decrease, down to 9.4%, but no significant changes within the cell subpopulation distribution were observed. Finally, the somatic cells were better preserved in milk after 72h storage, in particular PMNs, that maintained a viability of 34.0 +/- 2.9% compared to 4.9 +/- 1.9% in PBS, while there was almost no changes for macrophages (41.7 +/- 5.7% in milk vs 31.2 +/- 2.4% in PBS) and lymphocytes (25.3 +/- 3.0% in milk vs 11.4 +/- 3.1% in PBS). This study provides a new array to better understand milk cell biology and to establish the relationship between the cell viability and the release of their endogenous enzymes in dairy matrix.	[Li, Na; Gagnaire, Valerie] INRA, UMR 1253, Sci & Technol Lait & OEuf, F-35042 Rennes, France; [Li, Na; Gagnaire, Valerie] Agrocampus Ouest, UMR 1253, Sci & Technol Lait & OEuf, F-35042 Rennes, France; [Li, Na; Richoux, Romain] Actalia, F-35009 Rennes, France; [Perruchot, Marie-Halene; Boutinaud, Marion] INRA, UMR 1348, Physiol Environm & Genet Anim & Syst Elevage, F-35590 St Gilles, France; [Perruchot, Marie-Halene; Boutinaud, Marion] Agrocampus Ouest, UMR 1348, Physiol Environm & Genet Anim & Syst Elevage, F-35000 Rennes, France; [Mayol, Jean-Francois] R&D TranscureBioserv, F-74160 Archamps, France	INRAE; Institut Agro; Agrocampus Ouest; INRAE; Institut Agro; Agrocampus Ouest	Gagnaire, V (corresponding author), INRA, UMR 1253, Sci & Technol Lait & OEuf, F-35042 Rennes, France.	valerie.gagnaire@rennes.inra.fr	Gagnaire, Valérie/V-1338-2017	Gagnaire, Valérie/0000-0003-3186-0620; Perruchot, Marie-Helene/0000-0002-6608-9445	Agence Nationale de la Recherche et de la Technologie [2011/0574]	Agence Nationale de la Recherche et de la Technologie(French National Research Agency (ANR))	Agence Nationale de la Recherche et de la Technologie funded the phD work of Na Li (Cifre contract reference 2011/0574), http://www.anrt.asso.fr/. JFM, with commercial affiliation R&D Transcure Bioservices, participated in the design of the study, the antibodies choices for flow cytometry and the corrections of the manuscript. No funding from R&D Transcure Bioservices was received for this study.	Albenzio M, 2011, J DAIRY RES, V78, P43, DOI 10.1017/S0022029910000798; Asai K, 2000, VET IMMUNOL IMMUNOP, V73, P233, DOI 10.1016/S0165-2427(00)00158-6; Blagitz MG, 2015, J DAIRY SCI, V98, P2401, DOI 10.3168/jds.2014-8727; Blagitz MG, 2015, J DAIRY RES, V82, P460, DOI 10.1017/S0022029915000308; Boisclair G, 2007, MED VET, V1, P45; Boulaaba A, 2011, SMALL RUMINANT RES, V97, P117, DOI 10.1016/j.smallrumres.2011.02.002; Burton JL, 2003, VET CLIN N AM-FOOD A, V19, P1, DOI 10.1016/S0749-0720(02)00073-7; CAPIAUMONT J, 1994, LAIT, V74, P127, DOI 10.1051/lait:1994211; Caroprese M, 2007, J DAIRY SCI, V90, P2767, DOI 10.3168/jds.2006-691; Dumas E, 2012, BBA-MOL CELL RES, V1823, P358, DOI 10.1016/j.bbamcr.2011.12.002; FAO, 1998, LAIT PROD LAIT NUTR; Harp JA, 2004, VET IMMUNOL IMMUNOP, V98, P69, DOI 10.1016/j.vetimm.2003.10.007; ISO, 2006, 14040 ISO, V2006, P1, DOI DOI 10.1136/BMJ.332.7550.1107; Kehrli ME, 2001, VET CLIN N AM-FOOD A, V17, P495, DOI 10.1016/S0749-0720(15)30003-7; Kelly AL, 2006, INT DAIRY J, V16, P563, DOI 10.1016/j.idairyj.2005.10.019; la Libera AMMP, 2015, VET RES, P46; Larsen LB, 2000, INT DAIRY J, V10, P67, DOI 10.1016/S0958-6946(00)00020-0; Lee JW, 2003, J DAIRY SCI, V86, P2382, DOI 10.3168/jds.S0022-0302(03)73832-6; Leitner G, 2000, J VET MED B, V47, P133, DOI 10.1046/j.1439-0450.2000.00329.x; Li N, 2014, DAIRY SCI TECHNOL, V94, P517, DOI 10.1007/s13594-014-0176-3; Lun S, 2007, REPROD DOMEST ANIM, V42, P126, DOI 10.1111/j.1439-0531.2006.00741.x; Mehne D, 2010, MILCHWISSENSCHAFT, V65, P235; Olechnowicz J, 2012, J VET MED SCI, V74, P681, DOI 10.1292/jvms.11-0506; Paape MJ, 1996, AM J VET RES, V57, P477; PAAPE MJ, 1979, J DAIRY SCI, V62, P135, DOI 10.3168/jds.S0022-0302(79)83215-4; Paape MJ, 2003, VET RES, V34, P597, DOI 10.1051/vetres:2003024; Piepers S, 2009, J DAIRY SCI, V92, P626, DOI 10.3168/jds.2008-1393; Schwarz D, 2011, J DAIRY SCI, V94, P5033, DOI 10.3168/jds.2011-4348; Sharma N, 2012, ASIAN J ANIM VET ADV, V7, P454, DOI 10.3923/ajava.2012.454.476; Sladek Z, 2006, COMP IMMUNOL MICROB, V29, P243, DOI 10.1016/j.cimid.2006.06.006; Sladek Z, 2006, ANAT HISTOL EMBRYOL, V35, P116, DOI 10.1111/j.1439-0264.2005.00647.x; Sladek Z, 2011, RES VET SCI, V90, P226, DOI 10.1016/j.rvsc.2010.06.017; WANG DIC, 1968, BIOTECHNOL BIOENG, V10, P641, DOI 10.1002/bit.260100509; Wauters J, 2012, RES VET SCI, V92, P132, DOI 10.1016/j.rvsc.2010.10.007; Yamaguchi T, 1999, J DAIRY SCI, V82, P1459, DOI 10.3168/jds.S0022-0302(99)75373-7	35	14	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146071	10.1371/journal.pone.0146071	http://dx.doi.org/10.1371/journal.pone.0146071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717151	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500131
J	Palumbo, P; Palmerini, L; Bandinelli, S; Chiari, L				Palumbo, Pierpaolo; Palmerini, Luca; Bandinelli, Stefania; Chiari, Lorenzo			Fall Risk Assessment Tools for Elderly Living in the Community: Can We Do Better?	PLOS ONE			English	Article							DWELLING OLDER-ADULTS; GO TEST; PREDICTOR; PEOPLE; UNCERTAINTY; PERFORMANCE; ABILITY	Background Falls are a common, serious threat to the health and self-confidence of the elderly. Assessment of fall risk is an important aspect of effective fall prevention programs. Objectives and methods In order to test whether it is possible to outperform current prognostic tools for falls, we analyzed 1010 variables pertaining to mobility collected from 976 elderly subjects (InCHIANTI study). We trained and validated a data-driven model that issues probabilistic predictions about future falls. We benchmarked the model against other fall risk indicators: history of falls, gait speed, Short Physical Performance Battery (Guralnik et al. 1994), and the literature- based fall risk assessment tool FRAT-up (Cattelani et al. 2015). Parsimony in the number of variables included in a tool is often considered a proxy for ease of administration. We studied how constraints on the number of variables affect predictive accuracy. Results The proposed model and FRAT-up both attained the same discriminative ability; the area under the Receiver Operating Characteristic (ROC) curve (AUC) for multiple falls was 0.71. They outperformed the other risk scores, which reported AUCs for multiple falls between 0.64 and 0.65. Thus, it appears that both data-driven and literature-based approaches are better at estimating fall risk than commonly used fall risk indicators. The accuracy-parsimony analysis revealed that tools with a small number of predictors (similar to 1-5) were suboptimal. Increasing the number of variables improved the predictive accuracy, reaching a plateau at similar to 20-30, which we can consider as the best trade-off between accuracy and parsimony. Obtaining the values of these similar to 20-30 variables does not compromise usability, since they are usually available in comprehensive geriatric assessments.	[Palumbo, Pierpaolo; Palmerini, Luca; Chiari, Lorenzo] Univ Bologna, Dept Elect Elect & Informat Engn Guglielmo Marcon, Bologna, Italy; [Bandinelli, Stefania] Azienda Sanit Firenze, Geriatr Unit, Florence, Italy	University of Bologna; Azienda Sanitaria di Firenze	Palumbo, P (corresponding author), Univ Bologna, Dept Elect Elect & Informat Engn Guglielmo Marcon, Bologna, Italy.	pierpaolo.palumbo@unibo.it	bandinelli, stefania/AAL-4570-2020; Chiari, Lorenzo/N-7622-2015	Chiari, Lorenzo/0000-0002-2318-4370; Bandinelli, Stefania/0000-0002-6491-0850; Palmerini, Luca/0000-0003-4758-662X	European Union [288940]; National Institute on Aging (NIH, NIA, Bethesda, USA); Italian Health Ministry; NIH	European Union(European Commission); National Institute on Aging (NIH, NIA, Bethesda, USA); Italian Health Ministry(Ministry of Health, Italy); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement FARSEEING No. 288940. The InCHIANTI Study (Invecchiare in Chianti, aging in the Chianti area) is currently supported by a grant from the National Institute on Aging (NIH, NIA, Bethesda, USA) and is coordinated by the Tuscany Regional Health Agency in a partnership with the Florence Health Care Agency, the local Administrators and the primary care physicians of Greve in Chianti and Bagno a Ripoli. The Study was initially managed by the National Institute on Research and Care of the Elderly (INRCA, Ancona, Italy) and it was funded by Italian Health Ministry and by a NIH contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Barry E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-14; Beauchet O, 2011, J NUTR HEALTH AGING, V15, P933, DOI 10.1007/s12603-011-0062-0; Cattelani L, 2014, FRAT UP WEB APPL; Cattelani Luca, 2015, J Med Internet Res, V17, pe41, DOI 10.2196/jmir.4064; Centers for Disease Control and Prevention, STAY IND BROCH; Centers for Disease Control and Prevention, ALG FALL RISK ASS IN; Close JCT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5153; Czado C, 2009, BIOMETRICS, V65, P1254, DOI 10.1111/j.1541-0420.2009.01191.x; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Edwards A, 2002, BMJ-BRIT MED J, V324, P827, DOI 10.1136/bmj.324.7341.827; Fabre JM, 2010, J GERIATR PHYS THER, V33, P184, DOI 10.1097/JPT.0b013e3181ff2a24; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Gates S, 2008, J REHABIL RES DEV, V45, P1105, DOI 10.1682/JRRD.2008.04.0057; Gneiting T, 2007, J R STAT SOC B, V69, P243, DOI 10.1111/j.1467-9868.2007.00587.x; Gneiting T, 2014, ANNU REV STAT APPL, V1, P125, DOI 10.1146/annurev-statistics-062713-085831; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Guralnik JM, 1994, J GERONTOL; Hastie T., 2009, UNSUPERVISED LEARNIN; Howcroft J, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-91; InCHIANTI, INCHIANTI STUDY DOOR; Joslyn S, 2013, CURR DIR PSYCHOL SCI, V22, P308, DOI 10.1177/0963721413481473; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Lee J, 2013, PM&R, V5, P609, DOI 10.1016/j.pmrj.2013.04.001; Muir SW, 2010, J GERIATR PHYS THER, V33, P165, DOI 10.1097/JPT.0b013e3181ff23cc; Murphy Allan H, 1977, J ROYAL STAT SOC C, V26, P41, DOI [DOI 10.2307/2346866, 10.2307/2346866]; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Palumbo P, 2015, METHOD INFORM MED, V54; Perell KL, 2001, J GERONTOL A-BIOL, V56, pM761, DOI 10.1093/gerona/56.12.M761; Persad CC, 2010, EUR J PHYS REHAB MED, V46, P249; Rapp K, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-105; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schoene D, 2013, J AM GERIATR SOC, V61, P202, DOI 10.1111/jgs.12106; Scott V, 2007, AGE AGEING, V36, P130, DOI 10.1093/ageing/afl165; Smith AF, 2002, BRIT MED J, V325, P548, DOI 10.1136/bmj.325.7363.548; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181; Stuck AE, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6799; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Buuren S, 2011, J STAT SOFTW, V45, P1; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Venables V.N., 2002, MODERN APPL STAT S; Veronese N, 2014, REJUV RES, V17, P276, DOI 10.1089/rej.2013.1491; Viccaro LJ, 2011, J AM GERIATR SOC, V59, P887, DOI 10.1111/j.1532-5415.2011.03336.x; Ward RE, 2015, J AM GERIATR SOC, V63, P315, DOI 10.1111/jgs.13203; WHO, 2007, WHO GLOB REP FALLP; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	49	50	50	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146247	10.1371/journal.pone.0146247	http://dx.doi.org/10.1371/journal.pone.0146247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716861	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000367510500145
J	Vernon, PJ; Schaub, LJ; Dallelucca, JJ; Pusateri, AE; Sheppard, FR				Vernon, Philip J.; Schaub, Leasha J.; Dallelucca, Jurandir J.; Pusateri, Anthony E.; Sheppard, Forest R.			Rapid Detection of Neutrophil Oxidative Burst Capacity is Predictive of Whole Blood Cytokine Responses	PLOS ONE			English	Article							NADPH OXIDASE; REPERFUSION INJURY; INTERFERON-GAMMA; T-CELLS; MECHANISMS; ISCHEMIA; ACCUMULATION	Background Maladaptive immune responses, particularly cytokine and chemokine-driven, are a significant contributor to the deleterious inflammation present in many types of injury and infection. Widely available applications to rapidly assess individual inflammatory capacity could permit identification of patients at risk for exacerbated immune responses and guide therapy. Here we evaluate neutrophil oxidative burst (NOX) capacity measured by plate reader to immuno-type Rhesus Macaques as an acute strategy to rapidly detect inflammatory capacity and predict maladaptive immune responses as assayed by cytokine array. Methods Whole blood was collected from anesthetized Rhesus Macaques (n = 25) and analyzed for plasma cytokine secretion (23-plex Luminex assay) and NOX capacity. For cytokine secretion, paired samples were either unstimulated or ex-vivo lipopolysaccharide (LPS)-stimulated (100 mu g/mL/24h). NOX capacity was measured in dihydrorhodamine-123 loaded samples following phorbol 12-myristate 13-acetate (PMA)/ionomycin treatment. Pearson's test was utilized to correlate NOX capacity with cytokine secretion, p< 0.05 considered significant. Results LPS stimulation induced secretion of the inflammatory molecules G-CSF, IL-1 beta, IL-1RA, IL6, IL-10, IL-12/23(p40), IL-18, MIP-1 alpha, MIP-1 beta, and TNF alpha. Although values were variable, several cytokines correlated with NOX capacity, p-values <= 0.0001. Specifically, IL-1 beta (r = 0.66), IL-6 (r = 0.74), the Th1-polarizing cytokine IL-12/23(p40) (r = 0.78), and TNF alpha (r = 0.76) were strongly associated with NOX. Conclusion NOX capacity correlated with Th1-polarizing cytokine secretion, indicating its ability to rapidly predict inflammatory responses. These data suggest that NOX capacity may quickly identify patients at risk for maladaptive immune responses and who may benefit from immuno-modulatory therapies. Future studies will assess the in-vivo predictive value of NOX in animal models of immune-mediated pathologies.	[Vernon, Philip J.; Schaub, Leasha J.; Sheppard, Forest R.] JBSA Ft Sam Houston, Naval Med Res Unit San Antonio, Duarte, CA 91010 USA; [Dallelucca, Jurandir J.] US Air Force, JBSA Ft Sam Houston, Houston, TX USA; [Pusateri, Anthony E.] US Army, Med Res & Mat Command, Ft Detrick, MD USA	Naval Medical Research Center (NMRC); United States Department of Defense; United States Air Force	Sheppard, FR (corresponding author), JBSA Ft Sam Houston, Naval Med Res Unit San Antonio, Duarte, CA 91010 USA.	forest.r.sheppard.mil@mail.mil			Department of Defense (DOD) Office of Naval Research (ONR) [G1017]	Department of Defense (DOD) Office of Naval Research (ONR)	This study was supported from funds from the Department of Defense (DOD) Office of Naval Research (ONR) under the work unit number G1017. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batal I, 2014, J LEUKOCYTE BIOL, V96, P283, DOI 10.1189/jlb.3A0113-033RR; Boehme AK, 2014, J STROKE CEREBROVASC, V23, pE271, DOI 10.1016/j.jstrokecerebrovasdis.2013.11.022; Brinkworth JF, 2014, CURR OPIN IMMUNOL, V31, P66, DOI 10.1016/j.coi.2014.09.008; Chen L, 2014, EXP DERMATOL, V23, P189, DOI 10.1111/exd.12346; Cuinn M, RECONSTITUTION DEFEC, P2438; Furmaga W, 2015, CLIN CHIM ACTA, V440, P87, DOI 10.1016/j.cca.2014.10.045; Gardiner GJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00295; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Gibbons D, 2014, NAT MED, V20, P1206, DOI 10.1038/nm.3670; Globig AM, 2014, INFLAMM BOWEL DIS, V20, P2321, DOI 10.1097/MIB.0000000000000210; Hashiba M, 2015, J SURG RES, V194, P248, DOI 10.1016/j.jss.2014.09.033; Ioannou A, 2011, CLIN IMMUNOL, V141, P3, DOI 10.1016/j.clim.2011.07.001; Kasus-Jacobi A, 2015, J LEUKOCYTE BIOL, V97, P341, DOI 10.1189/jlb.3A0214-104RR; Kearns SR, 2001, J BONE JOINT SURG BR, V83B, P1202, DOI 10.1302/0301-620X.83B8.11754; Li QS, 2015, PLATELETS, V26, P453, DOI 10.3109/09537104.2014.934217; Li XR, 2015, MOL CELL BIOCHEM, V399, P167, DOI 10.1007/s11010-014-2243-8; Lumsdaine W, 2014, INJURY, V45, P1144, DOI 10.1016/j.injury.2014.04.019; Mitroulis I, 2015, PHARMACOL THERAPEUT, V147, P123, DOI 10.1016/j.pharmthera.2014.11.008; Najarian K, 2009, ENG MED BIOL SOC 200; Oestreich KJ, 2012, CURR OPIN IMMUNOL, V24, P191, DOI 10.1016/j.coi.2011.12.004; Pandey GS, 2014, J INTERF CYTOK RES, V34, P931, DOI 10.1089/jir.2012.0136; Pliyev BK, 2015, EUR J CELL BIOL, V94, P67, DOI 10.1016/j.ejcb.2014.11.001; Rao JH, 2014, CURR OPIN ORGAN TRAN, V19, P115, DOI 10.1097/MOT.0000000000000064; Raphael I, 2015, CYTOKINE, V74, P5, DOI 10.1016/j.cyto.2014.09.011; Richardson MP, 1998, J IMMUNOL METHODS, V219, P187, DOI 10.1016/S0022-1759(98)00136-7; Roos D, 2014, CLIN EXP IMMUNOL, V175, P139, DOI 10.1111/cei.12202; Rubartelli A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00398; Santos EOL, J PHARM TOXICOLOGICA; Segel GB, 2011, J LEUKOCYTE BIOL, V89, P359, DOI 10.1189/jlb.0910538; Simone S, 2014, FREE RADICAL BIO MED, V74, P263, DOI 10.1016/j.freeradbiomed.2014.07.003; Toss A, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.09.06; Valparaiso AP, 2015, J SURG RES, V194, P220, DOI 10.1016/j.jss.2014.10.025; Vernon PJ, 2013, J IMMUNOL, V190, P1372, DOI 10.4049/jimmunol.1201151; Wang H, 2014, IMMUNOL REV, V258, P30, DOI 10.1111/imr.12151; Wang QS, 2014, GLIA, V62, P2034, DOI 10.1002/glia.22724; Wong HR, 2014, CRIT CARE MED, V42, P781, DOI 10.1097/CCM.0000000000000106; Wong YC, 2015, SHOCK, V43, P157, DOI 10.1097/SHK.0000000000000279; Yeh WI, 2014, J NEUROIMMUNOL, V267, P20, DOI 10.1016/j.jneuroim.2013.12.001; Zaidi MR, 2011, CLIN CANCER RES, V17, P6118, DOI 10.1158/1078-0432.CCR-11-0482; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x	40	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146105	10.1371/journal.pone.0146105	http://dx.doi.org/10.1371/journal.pone.0146105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716449	gold, Green Submitted, Green Published			2022-12-27	WOS:000367510500135
J	Chang, C; Lu, J; Zhang, HP; Ma, CX; Sun, GL				Chang, Cheng; Lu, Jie; Zhang, Hai-Ping; Ma, Chuan-Xi; Sun, Genlou			Copy Number Variation of Cytokinin Oxidase Gene Tackx4 Associated with Grain Weight and Chlorophyll Content of Flag Leaf in Common Wheat	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; RICE ORYZA-SATIVA; FLUORESCENCE PARAMETERS; YIELD COMPONENTS; SENESCENCE; ACCUMULATION; EXPRESSION; 6-BENZYLAMINOPURINE; PHOTOSYNTHESIS; TRANSLATION	As the main pigment in photosynthesis, chlorophyll significantly affects grain filling and grain weight of crop. Cytokinin (CTK) can effectively increase chlorophyll content and chloroplast stability, but it is irreversibly inactivated by cytokinin oxidase (CKX). In this study, therefore, twenty-four pairs of primers were designed to identify variations of wheat CKX (Tackx) genes associated with flag leaf chlorophyll content after anthesis, as well as grain weight in 169 recombinant inbred lines (RIL) derived from Triticum aestivum Jing 411 x Hongmangchun 21. Results indicated variation of Tackx4, identified by primer pair T19-20, was proven to significantly associate with chlorophyll content and grain weight in the RIL population. Here, two Tackx4 patterns were identified: one with two co-segregated fragments (Tackx4-1/Tackx4-2) containing 618 bp and 620 bp in size (as in Jing 411), and another with no PCR product. The two genotypes were designated as genotype-A and genotype-B, respectively. Grain weight and leaf chlorophyll content at 5 similar to 15 days after anthesis (DAA) were significantly higher in genotype-A lines than those in genotype-B lines. Mapping analysis indicated Tackx4 was closely linked to Xwmc169 on chromosome 3AL, as well as co-segregated with a major quantitative trait locus (QTL) for both grain weight and chlorophyll content of flag leaf at 5 similar to 15 DAA. This QTL explained 8.9 similar to 22.3% phenotypic variations of the two traits across four cropping seasons. Among 102 wheat varieties, a third genotype of Tackx4 was found and designated as genotype-C, also having two co-segregated fragments, Tackx4-2 and Tackx4-3 (615bp). The sequences of three fragments, Tackx4-1, Tackx4-2, and Tackx4-3, showed high identity (>98%). Therefore, these fragments could be considered as different copies at Tackx4 locus on chromosome 3AL. The effect of copy number variation (CNV) of Tackx4 was further validated. In general, genotype-A contains both significantly higher grain weight and flag leaf chlorophyll content at 5 similar to 15 DAA than those in genotype-B and genotype-C, among 102 varieties under various environments.	[Chang, Cheng; Lu, Jie; Zhang, Hai-Ping; Ma, Chuan-Xi; Sun, Genlou] Anhui Agr Univ, Coll Agron, Key Lab Wheat Biol & Genet Improvement Southern Y, Minist Agr, Hefei 230036, Peoples R China; [Sun, Genlou] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada	Anhui Agricultural University; Ministry of Agriculture & Rural Affairs; Saint Marys University - Canada	Zhang, HP (corresponding author), Anhui Agr Univ, Coll Agron, Key Lab Wheat Biol & Genet Improvement Southern Y, Minist Agr, Hefei 230036, Peoples R China.	zhhp20@163.com; genlou.sun@smu.ca			National Natural Science Foundation of China [31000705]; China Agriculture Research System [CARS-03]; Scientific Research Special Program of Agricultural Commonwealth [201203033-04]; Natural Science Foundation of Anhui Province [1508085MC57]; Agriculture Research System of Anhui Province [AHCYTX-02]; Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC); introduced leading talent research team for Universities in Anhui Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Scientific Research Special Program of Agricultural Commonwealth; Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Agriculture Research System of Anhui Province; Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC); introduced leading talent research team for Universities in Anhui Province	This work was supported by grants from the National Natural Science Foundation of China (31000705), the China Agriculture Research System (CARS-03), the Scientific Research Special Program of Agricultural Commonwealth (201203033-04), Natural Science Foundation of Anhui Province (1508085MC57), the Agriculture Research System of Anhui Province (AHCYTX-02), Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC) and the introduced leading talent research team for Universities in Anhui Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JS, 2006, J FOOD ENG, V77, P951, DOI 10.1016/j.jfoodeng.2005.08.024; Araus JL, 1997, PLANT PHYSIOL BIOCH, V35, P533; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; AUSTIN RB, 1977, ANN BOT-LONDON, V41, P1309, DOI 10.1093/oxfordjournals.aob.a085419; Avenson TJ, 2005, P NATL ACAD SCI USA, V102, P9709, DOI 10.1073/pnas.0503952102; Huynh BL, 2012, PLANT MOL BIOL, V80, P299, DOI 10.1007/s11103-012-9949-3; BIDINGER F, 1977, NATURE, V270, P431, DOI 10.1038/270431a0; CATSKY J, 1993, BIOL PLANTARUM, V35, P393, DOI 10.1007/BF02928516; Chang C, 2010, MOL BREEDING, V25, P481, DOI 10.1007/s11032-009-9346-z; Chang C, 2007, EUPHYTICA, V154, P181, DOI 10.1007/s10681-006-9285-2; Chang C, 2011, EUPHYTICA, V179, P343, DOI 10.1007/s10681-011-0348-7; CLARKE SF, 1994, PLANT GROWTH REGUL, V14, P21, DOI 10.1007/BF00024137; Cuthbert JL, 2008, THEOR APPL GENET, V117, P595, DOI 10.1007/s00122-008-0804-5; Czyczylo-Mysza I, 2013, MOL BREEDING, V32, P189, DOI 10.1007/s11032-013-9862-8; Czyczylo-Mysza I, 2011, PLANT GENET RESOUR-C, V9, P291, DOI 10.1017/S1479262111000207; De La Torre CM, 2015, PLANT CELL REP, V34, P111, DOI 10.1007/s00299-014-1691-7; Ding XT, 2013, ACTA PHYSIOL PLANT, V35, P1427, DOI 10.1007/s11738-012-1182-9; Evans LT., 1993, CROP EVOLUTION ADAPT; Feng DS, 2008, PLANT MOL BIOL REP, V26, P143, DOI 10.1007/s11105-008-0033-8; Fischer RA, 1998, CROP SCI, V38, P1467, DOI 10.2135/cropsci1998.0011183X003800060011x; FLETCHER RA, 1971, PLANTA, V101, P88, DOI 10.1007/BF00387693; Galuszka P, 2004, EUR J BIOCHEM, V271, P3990, DOI 10.1111/j.1432-1033.2004.04334.x; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Gupta NK, 2000, CEREAL RES COMMUN, V28, P287; Han Y, 2007, GENETICS, V176, P2625, DOI 10.1534/genetics.107.073650; Hanikenne M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003707; Huang XQ, 2004, THEOR APPL GENET, V109, P933, DOI 10.1007/s00122-004-1708-7; Kamo K, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-79; Kang HW, 1998, PLANT MOL BIOL REP, V16, P90, DOI 10.1023/A:1007418606098; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; Lee Eung Gwan, 2002, Journal of Plant Biology, V45, P71; Ma QH, 2009, PLANT CELL REP, V28, P1759, DOI 10.1007/s00299-009-0776-1; Ma X, 2011, PLANT MOL BIOL REP, V29, P98, DOI 10.1007/s11105-010-0209-x; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Monde RA, 2000, PLANT MOL BIOL, V44, P529, DOI 10.1023/A:1026540310934; Ookawa T, 2004, CROP SCI, V44, P2107, DOI 10.2135/cropsci2004.2107; Paradkar MR, 2001, J PLANT PHYSIOL, V158, P929, DOI 10.1078/0176-1617-00369; Ramesh K, 2002, J AGRON CROP SCI, V188, P102, DOI 10.1046/j.1439-037X.2002.00532.x; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; Rosyara UR, 2010, EUPHYTICA, V174, P377, DOI 10.1007/s10681-010-0136-9; Schluter T, 2011, J PLANT PHYSIOL, V168, P694, DOI 10.1016/j.jplph.2010.10.004; Shao GQ, 2013, J PLANT NUTR SOIL SC, V176, P595, DOI 10.1002/jpln.201100185; Shao RX, 2012, J FOOD AGRIC ENVIRON, V10, P1451; Simons G, 1998, PLANT CELL, V10, P1055, DOI 10.1105/tpc.10.6.1055; Sukumaran S, 2015, THEOR APPL GENET, V128, P353, DOI 10.1007/s00122-014-2435-3; Swartzberg D, 2008, EUR J PLANT PATHOL, V120, P289, DOI 10.1007/s10658-007-9217-6; Todorova D, 2006, ACTA PHYSIOL PLANT, V28, P613, DOI 10.1007/s11738-006-0057-3; Vignesh M, 2013, J PLANT BIOCHEM BIOT, V22, P401, DOI 10.1007/s13562-012-0168-4; Wang FH, 2008, J PLANT PHYSIOL, V165, P324, DOI 10.1016/j.jplph.2006.11.006; Wang RX, 2009, THEOR APPL GENET, V118, P313, DOI 10.1007/s00122-008-0901-5; Wingler A, 1998, PLANT PHYSIOL, V116, P329, DOI 10.1104/pp.116.1.329; Wu FB, 1998, FIELD CROP RES, V56, P309, DOI 10.1016/S0378-4290(97)00108-1; Yang DL, 2007, J INTEGR PLANT BIOL, V49, P646, DOI 10.1111/j.1744-7909.2007.00443.x; Zalewski W, 2010, J EXP BOT, V61, P1839, DOI 10.1093/jxb/erq052; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zhang HaiPing, 2010, Acta Agronomica Sinica, V36, P1649, DOI 10.1016/S1875-2780(09)60077-8; Zhang JP, 2011, MOL BIOL REP, V38, P2337, DOI 10.1007/s11033-010-0367-9; Zhang K, 2009, CEREAL RES COMMUN, V37, P499, DOI 10.1556/CRC.37.2009.4.3; Zhang Lei, 2008, Scientia Agricultura Sinica, V41, P636; Zhang Lei, 2007, Acta Agronomica Sinica, V33, P1419; Zhang L, 2012, NEW PHYTOL, V195, P574, DOI 10.1111/j.1469-8137.2012.04194.x; Zhao H, 2007, PLANT GROWTH REGUL, V51, P149, DOI 10.1007/s10725-006-9157-8; Zmienko A, 2014, THEOR APPL GENET, V127, P1, DOI 10.1007/s00122-013-2177-7	65	26	28	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145970	10.1371/journal.pone.0145970	http://dx.doi.org/10.1371/journal.pone.0145970			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714276	gold, Green Published, Green Submitted			2022-12-27	WOS:000367481900107
J	Esterhammer, R; Seppi, K; Reiter, E; Pinter, B; Mueller, C; Kremser, C; Zitzelsberger, T; Nocker, M; Scherfler, C; Poewe, W; Schocke, M				Esterhammer, Regina; Seppi, Klaus; Reiter, Eva; Pinter, Bernadette; Mueller, Christoph; Kremser, Christian; Zitzelsberger, Tanja; Nocker, Michael; Scherfler, Christoph; Poewe, Werner; Schocke, Michael			Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD)	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; SUBSTANTIA-NIGRA; IRON DEPOSITION; ALPHA-SYNUCLEIN; PATHOANATOMICAL CORRELATION; PUTAMINAL DEGENERATION; SIGNAL CHANGES; BASAL GANGLIA; NIGROSOME 1; BRAIN IRON	The purpose of the present study was to evaluate the potential of multimodal MR imaging including mean diffusivity (MD), fractional anisotropy (FA), relaxation rates R2 and R2* to detect disease specific alterations in Parkinson's Disease (PD). We enrolled 82 PD patients (PD-all) with varying disease durations (<= 5 years: PD <= 5, n = 43; >5 years: PD>5, n = 39) and 38 matched healthy controls (HC), receiving diffusion tensor imaging as well as R2 and R2* relaxometry calculated from multi-echo T2*-weighted and dual-echo TSE imaging, respectively. ROIs were drawn to delineate caudate nucleus (CN), putamen (PU), globus pallidus (GP) and substantia nigra (SN) on the co-registered maps. The SN was divided in 3 descending levels (SL 1-3). The most significant parameters were used for a flexible discrimination analysis (FDA) in a training collective consisting of 25 randomized subjects from each group in order to predict the classification of remaining subjects. PD-all showed significant increases in MD, R2 and R2* within SN and its subregions as well as in MD and R2* within different basal ganglia regions. Compared to the HC group, the PD <= 5 and the PD>5 group showed significant MD increases within the SN and its lower two subregions, while the PD <= 5 group exhibited significant increases in R2 and R2* within SN and its subregions, and tended to elevation within the basal ganglia. The PD>5 group had significantly increased MD in PU and GP, whereas the PD <= 5 group presented normal MD within the basal ganglia. FDA achieved right classification in 84% of study participants. Micro-structural damage affects primarily the SN of PD patients and in later disease stages the basal ganglia. Iron contents of PU, GP and SN are increased at early disease stages of PD.	[Esterhammer, Regina; Kremser, Christian; Zitzelsberger, Tanja; Schocke, Michael] Med Univ Innsbruck, Univ Hosp, Dept Radiol, A-6020 Innsbruck, Austria; [Seppi, Klaus; Reiter, Eva; Pinter, Bernadette; Mueller, Christoph; Nocker, Michael; Scherfler, Christoph; Poewe, Werner] Med Univ Innsbruck, Univ Hosp, Dept Neurol, A-6020 Innsbruck, Austria; [Zitzelsberger, Tanja] Univ Tubingen, Univ Hosp, Dept Radiol, D-72076 Tubingen, Germany	Medical University of Innsbruck; Medical University of Innsbruck; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schocke, M (corresponding author), Med Univ Innsbruck, Univ Hosp, Dept Radiol, Anichstr 35, A-6020 Innsbruck, Austria.	michael.schocke@i-med.ac.at	Schocke, Michael/AAC-3666-2020	Scherfler, Christoph/0000-0002-4885-5265; Seppi, Klaus/0000-0001-6503-1455	Oesterreichische Nationalbank (Austrian Central Bank, Anniversary Fund) [14171]; Austrian Science Fund (FWF: Der Wissenschaftsfonds) [KLI82-B00]; Austrian Science Fund (FWF) [KLI 82] Funding Source: researchfish	Oesterreichische Nationalbank (Austrian Central Bank, Anniversary Fund); Austrian Science Fund (FWF: Der Wissenschaftsfonds); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by funds of the Oesterreichische Nationalbank (Austrian Central Bank, Anniversary Fund, project number: 14171) and of the Austrian Science Fund (FWF: Der Wissenschaftsfonds, project number: KLI82-B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by funds of the Oesterreichische Nationalbank (Austrian Central Bank, Anniversary Fund, project number: 14171) and of the Austrian Science Fund (FWF: Der Wissenschaftsfonds, project number: KLI82-B00).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; ANTONINI A, 1993, NEUROLOGY, V43, P697, DOI 10.1212/WNL.43.4.697; Awasthi R, 2010, AM J NEURORADIOL, V31, P442, DOI 10.3174/ajnr.A1849; Baudrexel S, 2010, NEUROIMAGE, V51, P512, DOI 10.1016/j.neuroimage.2010.03.005; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Blazejewska AI, 2013, NEUROLOGY, V81, P534, DOI 10.1212/WNL.0b013e31829e6fd2; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chan LL, 2007, J NEUROL NEUROSUR PS, V78, P1383, DOI 10.1136/jnnp.2007.121525; Collingwood JF, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00191; Delgado R, 2011, J MAGN RESON IMAGING; Desai SV, 2007, J MAGN RESON IMAGING, V25, P715, DOI 10.1002/jmri.20830; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Du GW, 2011, MOVEMENT DISORD, V26, P1627, DOI 10.1002/mds.23643; FEARNLEY JM, 1990, BRAIN, V113, P1823, DOI 10.1093/brain/113.6.1823; GORELL JM, 1995, NEUROLOGY, V45, P1138, DOI 10.1212/WNL.45.6.1138; Gotz ME, 2004, ANN NY ACAD SCI, V1012, P193, DOI 10.1196/annals.1306.017; Graham JM, 2000, BRAIN, V123, P2423, DOI 10.1093/brain/123.12.2423; Gupta RK, 2012, NEURORADIOLOGY, V54, P565, DOI 10.1007/s00234-011-0952-1; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; HASTIE T, 1994, J AM STAT ASSOC, V89, P1255, DOI 10.2307/2290989; HASTIE T, 1995, ANN STAT, V23, P73, DOI 10.1214/aos/1176324456; Hwang Onyou, 2013, Exp Neurobiol, V22, P11, DOI 10.5607/en.2013.22.1.11; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kraft E, 1999, ARCH NEUROL-CHICAGO, V56, P225, DOI 10.1001/archneur.56.2.225; Langkammer C, 2010, RADIOLOGY, V257, P455, DOI 10.1148/radiol.10100495; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Martin WRW, 2008, NEUROLOGY, V70, P1411, DOI 10.1212/01.wnl.0000286384.31050.b5; Mascalchi M, 2005, RADIOL MED, V109, P155; Menke RA, 2009, NEUROIMAGE, V47, P435, DOI 10.1016/j.neuroimage.2009.05.017; Mori F, 2008, ACTA NEUROPATHOL, V115, P453, DOI 10.1007/s00401-007-0316-4; Mueller C, 2014, NEUROLOGY, V82, P1752, DOI 10.1212/WNL.0000000000000398; Nowosielski M, 2011, NEURORADIOLOGY, V53, P291, DOI 10.1007/s00234-010-0808-0; Peel S, 2011, J MAGN RESON IMAGING; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Pieper S, 2004, IEEE INT S BIOMED IM, V26, P632, DOI DOI 10.1109/ISBI.2004.1398617; Pieper S, 2006, P 3 IEEE INT S BIOM; Razek AAKA, 2011, ACAD RADIOL, V18, P70, DOI 10.1016/j.acra.2010.08.023; Reichmann H, 2010, NEURODEGENER DIS, V7, P284, DOI 10.1159/000314478; ROYSTON P, 1991, STAT MED, V10, P1283, DOI 10.1002/sim.4780100811; Scherfler C, 2013, BRAIN, V136, P3028, DOI 10.1093/brain/awt234; Schocke MFH, 2004, NEUROIMAGE, V21, P1443, DOI 10.1016/j.neuroimage.2003.12.005; Schocke MFH, 2002, NEUROLOGY, V58, P575, DOI 10.1212/WNL.58.4.575; Schwarz J, 1996, J NEUROL NEUROSUR PS, V60, P98, DOI 10.1136/jnnp.60.1.98; Schwarz ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093814; Schwarz ST, 2013, NEUROIMAGE-CLIN, V3, P481, DOI 10.1016/j.nicl.2013.10.006; Seppi K, 2005, CURR OPIN NEUROL, V18, P370, DOI 10.1097/01.wco.0000173141.74137.63; Seppi K, 2003, NEUROLOGY, V60, P922, DOI 10.1212/01.WNL.0000049911.91657.9D; Seppi K, 2006, MOVEMENT DISORD, V21, P847, DOI 10.1002/mds.20843; Seppi K, 2006, NEUROIMAGE, V31, P240, DOI 10.1016/j.neuroimage.2005.12.006; Sian-Hulsmann J, 2011, J NEUROCHEM, V118, P939, DOI 10.1111/j.1471-4159.2010.07132.x; Team R Development Core, 2009, R LANG ENV STAT COMP; Ulla M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057904; Vaillancourt DE, 2009, NEUROLOGY, V72, P1378, DOI 10.1212/01.wnl.0000340982.01727.6e; Wallis LI, 2008, J MAGN RESON IMAGING, V28, P1061, DOI 10.1002/jmri.21563; Xu SL, 2015, BIOMOLECULES, V5, P1122, DOI 10.3390/biom5021122; Yamada H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112411; Yoshikawa K, 2004, J NEUROL NEUROSUR PS, V75, P481, DOI 10.1136/jnnp.2003.021873; Zhang JQ, 2010, BRAIN RES, V1330, P124, DOI 10.1016/j.brainres.2010.03.036	62	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145493	10.1371/journal.pone.0145493	http://dx.doi.org/10.1371/journal.pone.0145493			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713760	gold, Green Published, Green Submitted			2022-12-27	WOS:000367481900047
J	Hayat, T; Aziz, A; Muhammad, T; Ahmad, B				Hayat, Tasawar; Aziz, Arsalan; Muhammad, Taseer; Ahmad, Bashir			Influence of Magnetic Field in Three-Dimensional Flow of Couple Stress Nanofluid over a Nonlinearly Stretching Surface with Convective Condition	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; HEAT-TRANSFER; MHD FLOW; MASS-TRANSFER; VISCOUS-FLOW; FLUID; RADIATION; SHEET; SLIP; MAGNETOHYDRODYNAMICS	This article investigates the magnetohydrodynamic (MHD) three-dimensional flow of couple stress nanofluid subject to the convective boundary condition. Flow is generated due to a nonlinear stretching of the surface in two lateral directions. Temperature and nanoparticles concentration distributions are studied through the Brownian motion and thermophoresis effects. Couple stress fluid is considered electrically conducting through a non-uniform applied magnetic field. Mathematical formulation is developed via boundary layer approach. Nonlinear ordinary differential systems are constructed by employing suitable transformations. The resulting systems have been solved for the convergent series solutions of velocities, temperature and nanoparticles concentration profiles. Graphs are sketched to see the effects of different interesting flow parameters on the temperature and nanoparticles concentration distributions. Numerical values are computed to analyze the values of skin-friction coefficients and Nusselt number.	[Hayat, Tasawar; Aziz, Arsalan; Muhammad, Taseer] Quaid I Azam Univ, Dept Math, Islamabad 45320, Pakistan; [Hayat, Tasawar; Ahmad, Bashir] King Abdulaziz Univ, Fac Sci, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Muhammad, T (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad 45320, Pakistan.	taseer_qau@yahoo.com	Muhammad, Taseer/F-9103-2018; Hayat, Tasawar/A-3853-2013; Ahmad, Bashir/B-1977-2012; Hayat, Tasawar/Y-2524-2019	Muhammad, Taseer/0000-0002-0838-2731; Ahmad, Bashir/0000-0001-5350-2977; Aziz, Arsalan/0000-0002-1985-7392				Abbasbandy S, 2014, INT J NUMER METHOD H, V24, P390, DOI 10.1108/HFF-05-2012-0096; [Anonymous], 1995, ENHANCING THERMAL CO; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Cortell R, 2008, PHYS LETT A, V372, P631, DOI 10.1016/j.physleta.2007.08.005; Cortell R, 2007, APPL MATH COMPUT, V184, P864, DOI 10.1016/j.amc.2006.06.077; Dong RY, 2015, MICROFLUID NANOFLUID, V19, P805, DOI 10.1007/s10404-015-1605-1; Dong RY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06120; Ellahi R, 2015, INT J HEAT MASS TRAN, V81, P449, DOI 10.1016/j.ijheatmasstransfer.2014.10.041; Gireesha BJ, 2015, J NANOFLUIDS, V4, P474, DOI 10.1166/jon.2015.1177; Hayat T, 2015, J MOL LIQ, V212, P272, DOI 10.1016/j.molliq.2015.09.023; Hayat T, 2015, J MAGN MAGN MATER, V389, P48, DOI 10.1016/j.jmmm.2015.04.019; Hayat T, 2015, J MAGN MAGN MATER, V385, P222, DOI 10.1016/j.jmmm.2015.02.046; Hayat T, 2013, APPL MATH MECH-ENGL, V34, P167, DOI 10.1007/s10483-013-1661-9; Hayat T, 2009, NONLINEAR ANAL-REAL, V10, P966, DOI 10.1016/j.nonrwa.2007.11.020; Hayat T, 2015, Z NATURFORSCH A, V70, P225, DOI 10.1515/zna-2014-0331; Hayat T, 2015, J MAGN MAGN MATER, V395, P294, DOI 10.1016/j.jmmm.2015.07.092; Hayat T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127646; Hsiao KL, 2014, COMPUT FLUIDS, V104, P1, DOI 10.1016/j.compfluid.2014.08.001; Ibrahim W, 2013, COMPUT FLUIDS, V86, P433, DOI 10.1016/j.compfluid.2013.07.029; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Kuznetsov AV, 2014, INT J THERM SCI, V77, P126, DOI 10.1016/j.ijthermalsci.2013.10.007; Liao S., 2012, HOMOTOPY ANAL METHOD; Lin YH, 2014, INT J HEAT MASS TRAN, V77, P708, DOI 10.1016/j.ijheatmasstransfer.2014.06.028; Mabood F, 2015, J MAGN MAGN MATER, V374, P569, DOI 10.1016/j.jmmm.2014.09.013; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Mukhopadhyay S, 2013, ALEX ENG J, V52, P563, DOI 10.1016/j.aej.2013.07.004; Mustafa M, 2015, J MOL LIQ, V211, P119, DOI 10.1016/j.molliq.2015.06.065; Mustafa M, 2015, IEEE T NANOTECHNOL, V14, P159, DOI 10.1109/TNANO.2014.2374732; Pujari S, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3139446; Ramzan M, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13049-5; Rana P, 2012, COMMUN NONLINEAR SCI, V17, P212, DOI 10.1016/j.cnsns.2011.05.009; Sheikholeslami M, 2014, J MOL LIQ, V194, P30, DOI 10.1016/j.molliq.2014.01.005; Sheikholeslami M, 2014, J MAGN MAGN MATER, V349, P188, DOI 10.1016/j.jmmm.2013.08.040; Sheikholeslami M, 2015, J MAGN MAGN MATER, V374, P36, DOI 10.1016/j.jmmm.2014.08.021; Srinivasacharya D, 2012, J APPL SCI ENG, V15, P415; STOKES VK, 1966, PHYS FLUIDS, V9, P1709, DOI 10.1063/1.1761925; Sui JZ, 2015, INT J HEAT MASS TRAN, V85, P1023, DOI 10.1016/j.ijheatmasstransfer.2015.02.014; Turkyilmazoglu M, 2014, INT J HEAT MASS TRAN, V72, P1, DOI 10.1016/j.ijheatmasstransfer.2014.01.009; Turkyilmazoglu M, 2012, CHEM ENG SCI, V84, P182, DOI 10.1016/j.ces.2012.08.029; Turkyilmazoglu M, 2012, COMMUN NONLINEAR SCI, V17, P4097, DOI 10.1016/j.cnsns.2012.01.030; Vajravelu K, 2001, APPL MATH COMPUT, V124, P281, DOI 10.1016/S0096-3003(00)00062-X; Wang ZL, 2013, SOFT MATTER, V9, P8697, DOI 10.1039/c3sm51456k; Zeeshan A, 2014, J COMPUT THEOR NANOS, V11, P646, DOI 10.1166/jctn.2014.3408; Zhang CL, 2015, APPL MATH MODEL, V39, P165, DOI 10.1016/j.apm.2014.05.023; Zhao YG, 2013, SOFT MATTER, V9, P7726, DOI 10.1039/c3sm27720h	45	64	64	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145332	10.1371/journal.pone.0145332	http://dx.doi.org/10.1371/journal.pone.0145332			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714259	Green Submitted, Green Published, gold			2022-12-27	WOS:000367481900035
J	Kikuta, A; Furukawa, E; Ogawa, R; Suganuma, N; Saitoh, M; Nishimaki, T; Katsumura, T; Oota, H; Kawamoto, T; Tatsukawa, H; Hashimoto, H; Hitomi, K				Kikuta, Ayaka; Furukawa, Eri; Ogawa, Ryota; Suganuma, Natsuki; Saitoh, Mai; Nishimaki, Toshiyuki; Katsumura, Takafumi; Oota, Hiroki; Kawamoto, Tadafumi; Tatsukawa, Hideki; Hashimoto, Hisashi; Hitomi, Kiyotaka			Biochemical Characterization of Medaka (Oryzias latipes) Transglutaminases, OlTGK1 and OlTGK2, as Orthologues of Human Keratinocyte-Type Transglutaminase	PLOS ONE			English	Article							IDENTIFICATION; PEPTIDE; DEATH; GENE	Calcium-dependent transglutaminases (TGs) are a family of enzymes that catalyze protein cross-linking and/or attachment of primary amines in a variety of organisms. Mammalian TGs are implicated in multiple biological events such as skin formation, blood coagulation, and extracellular matrix stabilization. Medaka (Oryzias latipes) has been used as a model fish to investigate the physiological functions of mammalian proteins. By analysis of the medaka genome, we found seven TGs orthologues, some of which apparently corresponded to the mammalian TG isozymes, TG1, TG2, and Factor XIII. All orthologues had preserved amino acid residues essential for enzymatic activity in their deduced primary structures. In this study, we analyzed biochemical properties of two orthologues (OlTGK1 and OlTGK2) of mammalian epithelium-specific TG (TG1) that are significantly expressed at the transcriptional level. Using purified recombinant proteins for OlTGK1 and OlTGK2, we characterized their catalytic reactions. Furthermore, immunohistochemical analyses of fish sections revealed higher expression in the pancreas (OTGK1), intervertebral disk (OlTGK2) and pharyngeal teeth (OlTGK2) as well as in the skin epidermis.	[Kikuta, Ayaka; Furukawa, Eri; Ogawa, Ryota; Suganuma, Natsuki; Saitoh, Mai; Tatsukawa, Hideki; Hitomi, Kiyotaka] Nagoya Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4648601, Japan; [Nishimaki, Toshiyuki; Katsumura, Takafumi; Oota, Hiroki] Kitasato Univ, Sch Med, Sagamihara, Kanagawa 2520734, Japan; [Kawamoto, Tadafumi] Tsurumi Univ, Sch Dent Med, Radioisotope Res Inst, Yokohama, Kanagawa 2308501, Japan; [Hashimoto, Hisashi] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan	Nagoya University; Kitasato University; Tsurumi University; Nagoya University	Hitomi, K (corresponding author), Nagoya Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4648601, Japan.	hitomi@ps.nagoya-u.ac.jp	Tatsukawa, Hideki/AAE-8377-2020		Ministry of Education, Sports, Science and Technology (JSPS, KAKENHI, Japan) [23380200, 26292912]; Japanese Science and Technology agency [23380200, 26292912]	Ministry of Education, Sports, Science and Technology (JSPS, KAKENHI, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Science and Technology agency(Japan Science & Technology Agency (JST))	This work was supported by Grant-in-Aid for Scientific Research (B) (No. 23380200 and No. 26292912 to K.H.) from the Ministry of Education, Sports, Science and Technology (JSPS, KAKENHI, Japan), from the Japanese Science and Technology agency (to K.H.).	Bachle LA, 2000, J PEPT RES, V56, P47, DOI 10.1034/j.1399-3011.2000.00742.x; Barut BA, 2000, PHYSIOL GENOMICS, V2, P49, DOI 10.1152/physiolgenomics.2000.2.2.49; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Deasey S, 2013, CELL SIGNAL, V25, P2646, DOI 10.1016/j.cellsig.2013.08.016; Deasey S, 2012, AMINO ACIDS, V42, P1065, DOI 10.1007/s00726-011-1021-0; Eckert RL, 2014, PHYSIOL REV, V94, P383, DOI 10.1152/physrev.00019.2013; Eckert RL, 2005, J INVEST DERMATOL, V124, P481, DOI 10.1111/j.0022-202X.2005.23627.x; Fukui M, 2013, FEBS J, V280, P1420, DOI 10.1111/febs.12133; Hiiragi T, 1999, J BIOL CHEM, V274, P34148, DOI 10.1074/jbc.274.48.34148; Hitomi K, 2005, EUR J DERMATOL, V15, P313; Hitomi K, 2009, ANAL BIOCHEM, V394, P281, DOI 10.1016/j.ab.2009.07.039; Itoh M, 2013, J HISTOCHEM CYTOCHEM, V61, P793, DOI 10.1369/0022155413501676; Itoh M, 2011, J HISTOCHEM CYTOCHEM, V59, P180, DOI 10.1369/jhc.2010.957225; Kanchan K, 2015, CELL MOL LIFE SCI, V72, P3009, DOI 10.1007/s00018-015-1909-z; Kawamoto T, 2014, METHODS MOL BIOL, V1130, P149, DOI 10.1007/978-1-62703-989-5_11; Kinoshita M., 2012, MEDAKA BIOL MANAGEME; Kirchmaier S, 2015, GENETICS, V199, P905, DOI 10.1534/genetics.114.173849; Koh D, 2004, GENE EXPR PATTERNS, V4, P263, DOI 10.1016/j.modgep.2003.11.004; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; Naruse K, 2011, MEDAKA: A MODEL FOR ORGANOGENESIS, HUMAN DISEASE, AND EVOLUTION, P19, DOI 10.1007/978-4-431-92691-7_2; Ponnusamy M, 2009, AM J PHYSIOL-RENAL, V297, pF1361, DOI 10.1152/ajprenal.00251.2009; Stieler M, 2013, ANGEW CHEM INT EDIT, V52, P11930, DOI 10.1002/anie.201305133; Sugimura Y, 2008, FEBS J, V275, P5667, DOI 10.1111/j.1742-4658.2008.06692.x	24	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144194	10.1371/journal.pone.0144194	http://dx.doi.org/10.1371/journal.pone.0144194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713442	gold, Green Submitted, Green Published			2022-12-27	WOS:000367481900005
J	Latham, K; Baranian, M; Timmis, M; Pardhan, S				Latham, Keziah; Baranian, Mohammad; Timmis, Matthew; Pardhan, Shahina			Emotional Health of People with Visual Impairment Caused by Retinitis Pigmentosa	PLOS ONE			English	Article							QUALITY-OF-LIFE; ICF ACTIVITY INVENTORY; SELF-MANAGEMENT; MACULAR DEGENERATION; VISION LOSS; DEPRESSION; AGE; DISABILITY; ADJUSTMENT; MORTALITY	Purpose To understand the emotional difficulties associated with living with the ocular condition Retinitis Pigmentosa, and to examine the functioning of a self-report instrument used to assess this construct. Methods The difficulty of goals and tasks in the emotional health domain of the Dutch ICF Activity Inventory were rated by 166 people with Retinitis Pigmentosa in a cross-sectional study. Demographic factors were also assessed. Results Responses to the 23 emotional health tasks were Rasch analysed and could be used to form either one 20 item overview scale with some multidimensionality, or three unidimensional subscales addressing feelings (4 items), communicating visual loss (5 items) and fatigue (7 items). The most difficult individual tasks related to communicating visual loss to other people, and dealing with feelings such as frustration, anxiety and stress. The use of mobility aids and female gender were associated with increased difficulty with emotional health, explaining 19% of the variance in the overview scale. Conclusions The emotional health domain of the Dutch ICF Activity Inventory is a valid tool to assess emotional difficulties arising from visual loss. Interventions to aid people with Retinitis Pigmentosa deal with emotional difficulties should particularly address communicating vision loss effectively to others and coping with negative feelings.	[Latham, Keziah] Anglia Ruskin Univ, Visual Funct & Physiol Res Grp, Cambridge, England; [Latham, Keziah; Baranian, Mohammad; Timmis, Matthew; Pardhan, Shahina] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England; [Baranian, Mohammad; Timmis, Matthew] Anglia Ruskin Univ, Sport & Exercise Sci Res Grp, Cambridge, England	Anglia Ruskin University; Anglia Ruskin University; Anglia Ruskin University	Latham, K (corresponding author), Anglia Ruskin Univ, Visual Funct & Physiol Res Grp, Cambridge, England.	Keziah.latham@anglia.ac.uk	Pardhan, Shahina/AAZ-7509-2020; Latham, Keziah/ABC-5905-2021	Latham, Keziah/0000-0002-4060-0006	Anglia Ruskin University Bursary	Anglia Ruskin University Bursary	MB was supported by an Anglia Ruskin University Bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; Azoulay L, 2015, OPHTHALMIC RES, V54, P78, DOI 10.1159/000435886; Bittner AK, 2010, OPTOMETRY, V81, P461, DOI 10.1016/j.optm.2010.03.006; Bond T., 2001, APPL RASCH MODEL FUN; Brody BL, 2006, J AM GERIATR SOC, V54, P1557, DOI 10.1111/j.1532-5415.2006.00881.x; Brody BL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1477, DOI 10.1001/archopht.120.11.1477; Bruijning J, 2012, OPTOMETRY VISION SCI, V89, P203, DOI 10.1097/OPX.0b013e31823e3217; Bruijning J, 2010, OPHTHAL EPIDEMIOL, V17, P366, DOI 10.3109/09286586.2010.528133; Bruijning JE, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0182-4; Bruijning JE, 2013, OPTOMETRY VISION SCI, V90, P806, DOI 10.1097/OPX.0b013e318282cdce; Bruijning JE, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-318; Bruijning JE, 2013, DEV DUTCH ICF ACTIVI; CARABELLESE C, 1993, J AM GERIATR SOC, V41, P401, DOI 10.1111/j.1532-5415.1993.tb06948.x; Christ SL, 2014, JAMA OPHTHALMOL, V132, P1400, DOI 10.1001/jamaophthalmol.2014.2847; De Leo D, 1999, PSYCHOSOMATICS, V40, P339, DOI 10.1016/S0033-3182(99)71229-6; Department of Health, 2013, CERT VIS IMP EXPL NO; Dogs Guide, 2014, MY GUID OP BUS 2014; Evans JR, 2007, OPHTHALMOLOGY, V114, P283, DOI 10.1016/j.ophtha.2006.10.006; Fahim AT, 1993, RETINITIS PIGMENTOSA; Gothwal VK, 2009, OPTOMETRY VISION SCI, V86, P1160, DOI 10.1097/OPX.0b013e3181bab10c; Guerin E, 2014, EYE, V28, P808, DOI 10.1038/eye.2014.66; HAIM M, 1992, ACTA OPHTHALMOL, V70, P417; Hayeems RZ, 2005, BRIT J OPHTHALMOL, V89, P615, DOI 10.1136/bjo.2003.036046; Herse Peter, 2005, Clin Exp Optom, V88, P335; Holloway EE, 2015, PATIENT EDUC COUNS, V98, P553, DOI 10.1016/j.pec.2015.01.013; Jangra D, 2007, OPHTHALMIC GENET, V28, P25, DOI 10.1080/13816810701201930; Karpa MJ, 2009, ARCH OPHTHALMOL-CHIC, V127, P1347, DOI 10.1001/archophthalmol.2009.240; Khadka J, 2013, OPTOMETRY VISION SCI, V90, P720, DOI 10.1097/OPX.0000000000000001; Kiser AK, 2008, CLIN EXP OPTOM, V91, P166, DOI 10.1111/j.1444-0938.2007.00224.x; Lam BL, 2008, ARCH OPHTHALMOL-CHIC, V126, P975, DOI 10.1001/archopht.126.7.975; Latham K, 2014, IMPLEMENTATION DUTCH; Latham K, 2015, INVEST OPHTH VIS SCI, V56, P2381, DOI 10.1167/iovs.14-16237; Latham K, 2013, OPTOMETRY VISION SCI, V90, P836, DOI 10.1097/OPX.0b013e31829d99ae; Liew G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004015; Linacre J., 2015, RELIABILITY SEPARATI; Linacre J. M., 2015, DIF DPF BIAS INTERAC; Linacre JM, 2008, WINSTEPS RASCH MEASU; Linacre JM, 2014, DIMENSIONALITY INVES; Marella M, 2009, OPTOMETRY VISION SCI, V86, P826, DOI 10.1097/OPX.0b013e3181ae1b3f; Nyman SR, 2012, DISABIL REHABIL, V34, P971, DOI 10.3109/09638288.2011.626487; Pesudovs K, 2007, OPTOMETRY VISION SCI, V84, P663, DOI 10.1097/OPX.0b013e318141fe75; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Rees G, 2015, PATIENT EDUC COUNS, V98, P174, DOI 10.1016/j.pec.2014.11.008; Rovner BW, 1996, J AM GERIATR SOC, V44, P181, DOI 10.1111/j.1532-5415.1996.tb02436.x; Rovner BW, 2002, AM J GERIAT PSYCHIAT, V10, P305; Rovner BW, 2001, J AM GERIATR SOC, V49, P1097, DOI 10.1046/j.1532-5415.2001.49215.x; Rovner BW, 1998, J AM GERIATR SOC, V46, P617, DOI 10.1111/j.1532-5415.1998.tb01080.x; Senra H, 2015, OPHTHALMOLOGY, V122, P851, DOI 10.1016/j.ophtha.2014.10.022; Tabrett DR, 2012, INVEST OPHTH VIS SCI, V53, P7227, DOI 10.1167/iovs.12-10404; Waern M, 2002, BMJ-BRIT MED J, V324, P1355, DOI 10.1136/bmj.324.7350.1355; WHO, 2001, WHO INT CLASS FUNCT; Wright BD., 1994, RASCH MEASUREMENT T, V8, P370, DOI DOI 10.1177/01461672012710004	52	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145866	10.1371/journal.pone.0145866	http://dx.doi.org/10.1371/journal.pone.0145866			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0IX	26713624	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000367481900094
J	Melzer, TR; Myall, DJ; MacAskill, MR; Pitcher, TL; Livingston, L; Watts, R; Keenan, RJ; Dalrymple-Alford, JC; Anderson, TJ				Melzer, Tracy R.; Myall, Daniel J.; MacAskill, Michael R.; Pitcher, Toni L.; Livingston, Leslie; Watts, Richard; Keenan, Ross J.; Dalrymple-Alford, John C.; Anderson, Tim J.			Tracking Parkinson's Disease over One Year with Multimodal Magnetic Resonance Imaging in a Group of Older Patients with Moderate Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; GREY-MATTER HYPOMETABOLISM; WHITE-MATTER; DIAGNOSTIC-CRITERIA; ALZHEIMERS-DISEASE; BRAIN ATROPHY; PERFUSION; RATES; MRI; RELIABILITY	Background & Objectives Cross-sectional magnetic resonance imaging (MRI) suggests that Parkinson's disease (PD) is associated with changes in cerebral tissue volume, diffusion tensor imaging metrics, and perfusion values. Here, we performed a longitudinal multimodal MRI study-including structural, diffusion tensor imaging (DTI), and perfusion MRI-to investigate progressive brain changes over one year in a group of older PD patients at a moderate stage of disease. Methods Twenty-three non-demented PD (mean age (SD) = 69.5 (6.4) years, disease duration (SD) = 5.6 (4.3) years) and 23 matched control participants (mean age: 70.6 (6.8)) completed extensive neuropsychological and clinical assessment, and multimodal 3T MRI scanning at baseline and one year later. We used a voxel-based approach to assess change over time and group-by-time interactions for cerebral structural and perfusion metrics. Results Compared to controls, in PD participants there was localized grey matter atrophy over time in bilateral inferior and right middle temporal, and left orbito-frontal cortices. Using a voxel-based approach that focused on the centers of principal white matter tracts, the PD and control cohorts exhibited similar levels of change in DTI metrics. There was no significant change in perfusion, cognitive, or motor severity measures. Conclusions In a cohort of older, non-demented PD participants, macrostructural MRI detected atrophy in the PD group compared with the control group in temporal and orbito-frontal cortices. Changes in diffusion MRI along principal white matter tracts over one year were found, but this was not differentially affected by PD.	[Melzer, Tracy R.; Myall, Daniel J.; MacAskill, Michael R.; Pitcher, Toni L.; Livingston, Leslie; Keenan, Ross J.; Dalrymple-Alford, John C.; Anderson, Tim J.] New Zealand Brain Res Inst, Christchurch, New Zealand; [Melzer, Tracy R.; MacAskill, Michael R.; Pitcher, Toni L.; Livingston, Leslie; Dalrymple-Alford, John C.; Anderson, Tim J.] Univ Otago, Dept Med, Christchurch, New Zealand; [Watts, Richard] Univ Vermont, Coll Med, Burlington, VT USA; [Keenan, Ross J.] Christchurch Radiol Grp, Christchurch, New Zealand; [Dalrymple-Alford, John C.] Univ Canterbury, Dept Psychol, Canterbury, New Zealand; [Anderson, Tim J.] Christchurch Hosp, Dept Neurol, Christchurch, New Zealand	University of Otago; University of Vermont; University of Canterbury; Christchurch Hospital New Zealand	Melzer, TR (corresponding author), New Zealand Brain Res Inst, Christchurch, New Zealand.	tracy.melzer@otago.ac.nz		Myall, Daniel/0000-0002-0032-6567; Pitcher, Toni/0000-0003-4661-5038	Neurological Foundation of New Zealand [1327-WF]; New Zealand Brain Research Institute; Canterbury Medical Research Foundation [12/01, 14/04]; Neurology Trust	Neurological Foundation of New Zealand; New Zealand Brain Research Institute; Canterbury Medical Research Foundation; Neurology Trust	This work was funded by the Neurological Foundation of New Zealand (http://www.neurological.org.nz) to TRM (No. 1327-WF) MRM, TLP, JCDA, and TJA; the New Zealand Brain Research Institute (www.nzbri.org) to TRM, MRM, and TJA; the Canterbury Medical Research Foundation (www.cmrf.org.nz) to TRM (No. 12/01 & 14/04), DJM, MRM, JCDA, and TJA; and the Neurology Trust to TJA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00197; Baba T, 2012, BRAIN, V135, P161, DOI 10.1093/brain/awr321; Beyer MK, 2007, J NEUROL NEUROSUR PS, V78, P254, DOI 10.1136/jnnp.2006.093849; Bohnen NI, 2011, J NUCL MED, V52, P848, DOI 10.2967/jnumed.111.089946; Borghammer P, 2010, BRAIN STRUCT FUNCT, V214, P303, DOI 10.1007/s00429-010-0246-0; Burton EJ, 2005, MOVEMENT DISORD, V20, P1571, DOI 10.1002/mds.20652; Camicioli R, 2011, MOVEMENT DISORD, V26, P1443, DOI 10.1002/mds.23700; Chetelat G, 2008, BRAIN, V131, P60, DOI 10.1093/brain/awm288; Compta Y, 2013, PARKINSONISM RELAT D, V19, P717, DOI 10.1016/j.parkreldis.2013.03.009; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Dalrymple-Alford JC, 2010, NEUROLOGY, V75, P1717, DOI 10.1212/WNL.0b013e3181fc29c9; Dalrymple-Alford JC, 2011, MOVEMENT DISORD, V26, P629, DOI 10.1002/mds.23592; Di Filippo M, 2010, J NEUROL NEUROSUR PS, V81, P204, DOI 10.1136/jnnp.2009.171769; Duncan GW, 2013, MOVEMENT DISORD, V28, P425, DOI 10.1002/mds.25352; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Engvig A, 2012, HUM BRAIN MAPP, V33, P2390, DOI 10.1002/hbm.21370; Firbank MJ, 2005, J NEUROL NEUROSUR PS, V76, P1448, DOI 10.1136/jnnp.2004.058685; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Gonzalez-Redondo R, 2014, BRAIN, V137, P2356, DOI 10.1093/brain/awu159; Haller S, 2010, J ALZHEIMERS DIS, V22, P315, DOI 10.3233/JAD-2010-100840; Hanganu A, 2014, BRAIN, V137, P1120, DOI 10.1093/brain/awu036; Hattori T, 2012, HUM BRAIN MAPP, V33, P727, DOI 10.1002/hbm.21245; Hu MTM, 2001, J NEURAL TRANSM, V108, P571, DOI 10.1007/s007020170057; Huang CR, 2007, BRAIN, V130, P1834, DOI 10.1093/brain/awm086; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ibarretxe-Bilbao N, 2012, MOVEMENT DISORD, V27, P1746, DOI 10.1002/mds.25240; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Kamagata K, 2011, J MAGN RESON IMAGING, V33, P803, DOI 10.1002/jmri.22515; Lewis MM, 2009, EUR J NEUROL, V16, P475, DOI 10.1111/j.1468-1331.2008.02430.x; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Melzer TR, 2013, NEUROLOGY, V80, P1841, DOI 10.1212/WNL.0b013e3182929f62; Melzer TR, 2012, J NEUROL NEUROSUR PS, V83, P188, DOI 10.1136/jnnp-2011-300828; Melzer TR, 2011, BRAIN, V134, P845, DOI 10.1093/brain/awq377; Nishio Y, 2010, EUR J NEUROL, V17, P1090, DOI 10.1111/j.1468-1331.2010.02980.x; Osaki Y, 2009, MOVEMENT DISORD, V24, P1475, DOI 10.1002/mds.22623; Paviour DC, 2006, BRAIN, V129, P1040, DOI 10.1093/brain/awl021; Poudel GR, 2012, SLEEP, V35, P1085, DOI 10.5665/sleep.1994; Ramirez-Ruiz B, 2005, J NEUROL, V252, P1345, DOI 10.1007/s00415-005-0864-2; Rossi ME, 2014, ACAD RADIOL, V21, P64, DOI 10.1016/j.acra.2013.09.018; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2011, MOVEMENT DISORD, V26, P289, DOI 10.1002/mds.23477; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Tessa C, 2014, HUM BRAIN MAPP, V35, P3932, DOI 10.1002/hbm.22449; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Weintraub D, 2011, ARCH NEUROL-CHICAGO, V68, P1562, DOI 10.1001/archneurol.2011.725; Wen MC, 2015, PARKINSONISM RELAT D, V21, P483, DOI 10.1016/j.parkreldis.2015.02.014; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wu B, 2014, J MAGN RESON IMAGING, V39, P402, DOI 10.1002/jmri.24175; Xu GF, 2010, NMR BIOMED, V23, P286, DOI 10.1002/nbm.1462	53	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0143923	10.1371/journal.pone.0143923	http://dx.doi.org/10.1371/journal.pone.0143923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714266	gold, Green Published			2022-12-27	WOS:000367481900003
J	Natoli, L; Guy, RJ; Shephard, M; Causer, L; Badman, SG; Hengel, B; Tangey, A; Ward, J; Coburn, T; Anderson, D; Kaldor, J; Maher, L				Natoli, Lisa; Guy, Rebecca J.; Shephard, Mark; Causer, Louise; Badman, Steven G.; Hengel, Belinda; Tangey, Annie; Ward, James; Coburn, Tony; Anderson, David; Kaldor, John; Maher, Lisa		TTANGO Investigators	"I Do Feel Like a Scientist at Times": A Qualitative Study of the Acceptability of Molecular Point-Of-Care Testing for Chlamydia and Gonorrhoea to Primary Care Professionals in a Remote High STI Burden Setting	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; ABORIGINAL COMMUNITIES; NEISSERIA-GONORRHOEAE; SOUTH-AFRICA; RISK-FACTORS; HEALTH-CARE; TRACHOMATIS; PROGRAMS; GENEXPERT	Background Point-of-care tests for chlamydia (CT) and gonorrhoea (NG) could increase the uptake and timeliness of testing and treatment, contribute to improved disease control and reduce reproductive morbidity. The GeneXpert (Xpert CT/NG assay), suited to use at the point-of-care, is being used in the TTANGO randomised controlled trial (RCT) in 12 remote Australian health services with a high burden of sexually transmissible infections (STIs). This represents the first ever routine use of a molecular point-of-care diagnostic for STIs in primary care. The purpose of this study was to explore the acceptability of the GeneXpert to primary care staff in remote Australia. Methods In-depth qualitative interviews were conducted with 16 staff (registered or enrolled nurses and Aboriginal Health Workers/Practitioners) trained and experienced with GeneXpert testing. Interviews were digitally-recorded and transcribed verbatim prior to content analysis. Results Most participants displayed positive attitudes, indicating the test was both easy to use and useful in their clinical context. Participants indicated that point-of-care testing had improved management of STIs, resulting in more timely and targeted treatment, earlier commencement of partner notification, and reduced follow up efforts associated with client recall. Staff expressed confidence in point-of-care test results and treating patients on this basis, and reported greater job satisfaction. While point-of-care testing did not negatively impact on client flow, several found the manual documentation processes time consuming, suggesting that improved electronic connectivity and test result transfer between the GeneXpert and patient management systems could overcome this. Managing positive test results in a shorter time frame was challenging for some but most found it satisfying to complete episodes of care more quickly. Conclusions In the context of a RCT, health professionals working in remote primary care in Australia found the GeneXpert highly acceptable. These findings have implications for use in other primary care settings around the world.	[Natoli, Lisa; Guy, Rebecca J.; Causer, Louise; Badman, Steven G.; Kaldor, John; Maher, Lisa] UNSW Australia, Kirby Inst, Sydney, NSW, Australia; [Natoli, Lisa; Anderson, David] Burnet Inst, Melbourne, Vic, Australia; [Shephard, Mark] Flinders Univ S Australia, Int Ctr Point Of Care Testing, Adelaide, SA 5001, Australia; [Hengel, Belinda] Apunipima Cape York Hlth Council, Cairns, Qld, Australia; [Tangey, Annie] Ngaanyatjarra Hlth Serv, Alice Springs, NT, Australia; [Ward, James] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Coburn, Tony] Queensland Aboriginal & Islander Hlth Council, Brisbane, Qld, Australia	University of New South Wales Sydney; Kirby Institute; Burnet Institute; Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI)	Natoli, L (corresponding author), UNSW Australia, Kirby Inst, Sydney, NSW, Australia.	lisan@burnet.edu.au	Ward, James/ABD-1439-2020; Whiley, David M/E-8955-2011	Ward, James/0000-0002-2892-4542; Whiley, David M/0000-0001-5969-3161; Regan, David/0000-0002-2893-0969; Christopher, Fairley/0000-0001-9081-1664; Causer, Louise/0000-0002-8814-0678; Donovan, Basil/0000-0001-8851-4126; Shephard, Mark DS/0000-0002-9181-1874; Anderson, David/0000-0002-9969-3905; Badman, Steven G/0000-0003-4222-3176; Guy, Rebecca/0000-0002-2929-4634; Maher, Lisa/0000-0001-6020-6519; Hengel, Belinda/0000-0002-3013-7716; Tangey, Annie/0000-0003-0798-0542	National Health and Medical Research Council (NHMRC) [109902]; Australian Government Department of Health and Ageing	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	TTANGO is funded by a National Health and Medical Research Council (NHMRC) Project Grant #109902. The Kirby Institute receives funding from the Australian Government Department of Health and Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; TTANGO is funded by a National Health and Medical Research Council (NHMRC) Project Grant #109902. The Kirby Institute receives funding from the Australian Government Department of Health and Ageing. We gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute.	Al-Humaidan OS, 2015, SAUDI MED J, V36, P1084, DOI 10.15537/smj.2015.9.12460; Alakarppa I, 2011, INT J MARKETING STUD, V3, P13; Benzaken AS, 2008, SEX TRANSM INFECT, V84, P297, DOI 10.1136/sti.2007.029462; Benzaken AS, 2006, SEX TRANSM INFECT, V82, pV26, DOI 10.1136/sti.2006.022566; Causer LM, 2013, STI AIDS WORLD C VIE; Causer LM, 2014, SEX HLTH; Cecil JA, 2001, J INFECT DIS, V184, P1216, DOI 10.1086/323662; Centre for Disease Control, 2008, NT GUID MAN SEX TRAN; Chikkodi SV, 2015, CL LYMPH MYELOM LEUK, V15, pS114, DOI 10.1016/j.clml.2015.03.014; Communicable Disease Control Directorate, 2006, GUID MAN SEX TRANSM; Detels R, 2011, SEX TRANSM DIS, V38, P503, DOI 10.1097/OLQ.0b013e318206c288; Drobniewski F, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19340; Engel N, 2015, TROP MED INT HEALTH, V20, P493, DOI 10.1111/tmi.12450; Engel N, 2015, EXPERT REV MOL DIAGN, V15, P71, DOI 10.1586/14737159.2015.960518; Fagan P, 2001, VENEREOLOGY, V14, P55; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Gibbs L, 2007, AUST NZ J PUBL HEAL, V31, P540, DOI 10.1111/j.1753-6405.2007.00140.x; Goldenberg SD, 2014, INFECT DIS THER; Guy R, 2015, SEX TRANSM INFECT, V91, P201, DOI 10.1136/sextrans-2014-051535; Guy R, 2012, SEX HEALTH, V9, P205, DOI 10.1071/SH11074; Guy RJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-485; Hengel B, 2015, SEX HLTH; Hengel B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1040; Holden RJ, 2010, J BIOMED INFORM, V43, P159, DOI 10.1016/j.jbi.2009.07.002; Hsieh YH, 2012, POINT CARE, V11, P126; Hsieh YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019263; Hsieh YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014144; Huang RL, 2008, MED J AUSTRALIA, V189, P442, DOI 10.5694/j.1326-5377.2008.tb02117.x; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Lebina L, 2015, TUBERCULOSIS, V95, P625, DOI 10.1016/j.tube.2015.05.006; Lenthall S, 2009, AUST J RURAL HEALTH, V17, P208, DOI 10.1111/j.1440-1584.2009.01073.x; Lorent N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130179; Natoli L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006922; Natoli LJ, 2011, PAPUA NEW GUINEA MED, V54, P123; Opie T, 2010, AUST J RURAL HEALTH, V18, P235, DOI 10.1111/j.1440-1584.2010.01161.x; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Peeling RW, 2013, SEX TRANSM INFECT, V89, P115, DOI 10.1136/sextrans-2012-050617; Peeling RW, 2011, SEX TRANSM INFECT, V87, pII28, DOI 10.1136/sti.2010.047647; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Shephard M SB, 2014, GLOBAL POINT OF CARE, P527; Shephard Mark D S, 2006, Clin Biochem Rev, V27, P161; Speers DJ, 2013, J ANTIMICROB CHEMOTH; Tabrizi SN, 2013, J CLIN MICROBIOL, V51, P1945, DOI 10.1128/JCM.00806-13; Yarbrough AK, 2007, MED CARE RES REV, V64, P650, DOI 10.1177/1077558707305942	44	31	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145993	10.1371/journal.pone.0145993	http://dx.doi.org/10.1371/journal.pone.0145993			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713441	Green Published, gold			2022-12-27	WOS:000367481900109
J	Tzeng, HH; Hsu, CH; Chung, TH; Lee, WC; Lin, CH; Wang, WC; Hsiao, CY; Leu, YW; Wang, TH				Tzeng, Hui-Hung; Hsu, Chi-Hung; Chung, Ting-Hao; Lee, Wen-Chien; Lin, Chi-Hsien; Wang, Wan-Chen; Hsiao, Chen-Yu; Leu, Yu-Wei; Wang, Tzu-Hsien			Cell Signaling and Differential Protein Expression in Neuronal Differentiation of Bone Marrow Mesenchymal Stem Cells with Hypermethylated Salvador/Warts/Hippo (SWH) Pathway Genes	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; STROMAL CELLS; NEUROTROPHIC FACTOR; FACTOR RECEPTOR; MAP KINASE; PC12 CELLS; IN-VITRO; ACTIVATION; SURVIVAL; PROLIFERATION	Human mesenchymal stem cells (MSCs) modified by targeting DNA hypermethylation of genes in the Salvador/Warts/Hippo pathway were induced to differentiate into neuronal cells in vitro. The differentiated cells secreted a significant level of brain-derived neurotrophy factor (BDNF) and the expression of BDNF receptor tyrosine receptor kinase B (TrkB) correlated well with the secretion of BDNF. In the differentiating cells, CREB was active after the binding of growth factors to induce phosphorylation of ERK in the MAPK/ERK pathway. Downstream of phosphorylated CREB led to the functional maturation of differentiated cells and secretion of BDNF, which contributed to the sustained expression of pERK and pCREB. In summary, both PI3K/Akt and MAPK/ERK signaling pathways play important roles in the neuronal differentiation of MSCs. The main function of the PI3K/Akt pathway is to maintain cell survival during neural differentiation; whereas the role of the MAPK/ERK pathway is probably to promote the maturation of differentiated MSCs. Further, cellular levels of protein kinase C epsilon type (PKC-epsilon) and kinesin heavy chain (KIF5B) increased with time of induction, whereas the level of NME/NM23 nucleoside diphosphate kinase 1 (Nm23-H1) decreased during the time course of differentiation. The correlation between PKC-e and TrkB suggested that there is cross-talk between PKC-e and the PI3K/Akt signaling pathway.	[Tzeng, Hui-Hung; Hsu, Chi-Hung; Chung, Ting-Hao; Lee, Wen-Chien; Lin, Chi-Hsien; Wang, Wan-Chen; Hsiao, Chen-Yu; Wang, Tzu-Hsien] Natl Chung Cheng Univ, Dept Chem Engn, Syst Biol & Tissue Engn Res Ctr, Chiayi 621, Taiwan; [Leu, Yu-Wei] Natl Chung Cheng Univ, Dept Life Sci, Chiayi 621, Taiwan	National Chung Cheng University; National Chung Cheng University	Lee, WC (corresponding author), Natl Chung Cheng Univ, Dept Chem Engn, Syst Biol & Tissue Engn Res Ctr, Chiayi 621, Taiwan.	chmwcl@ccu.edu.tw		Lee, Wen-Chien/0000-0001-9041-1396				Barzilay R, 2008, STEM CELLS DEV, V17, P547, DOI 10.1089/scd.2007.0172; Blondheim NR, 2006, STEM CELLS DEV, V15, P141, DOI 10.1089/scd.2006.15.141; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Cai Q, 2009, NEUROSCIENTIST, V15, P78, DOI 10.1177/1073858408329511; Cheng CH, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-63; Greco SJ, 2007, STEM CELLS DEV, V16, P811, DOI 10.1089/scd.2007.0011; Greco SJ, 2008, BIOL PROCED ONLINE, V10, P90, DOI 10.1251/bpo147; Heo JS, 2007, STEM CELLS, V25, P3069, DOI 10.1634/stemcells.2007-0550; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hermann Andreas, 2006, Expert Opin Biol Ther, V6, P653, DOI 10.1517/14712598.6.7.653; Kan I, 2007, NEUROSCI LETT, V419, P28, DOI 10.1016/j.neulet.2007.03.070; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kvezereli M, 2008, TRANSPL P, V40, P375, DOI 10.1016/j.transproceed.2008.01.014; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mishra A, 2009, PROTEOMICS, V9, P4017, DOI 10.1002/pmic.200800813; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sossin WS, 2007, NAT NEUROSCI, V10, P537, DOI 10.1038/nn0507-537; Sung JY, 2001, J BIOL CHEM, V276, P13858, DOI 10.1074/jbc.M010610200; Tatard VM, 2007, BONE, V40, P360, DOI 10.1016/j.bone.2006.09.013; Teng IW, 2011, CANCER RES, V71, P4653, DOI 10.1158/0008-5472.CAN-10-3418; Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x; Tondreau T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-166; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Trzaska KA, 2007, STEM CELLS, V25, P2797, DOI 10.1634/stemcells.2007-0212; Trzaska KA, 2009, J NEUROCHEM, V110, P1058, DOI 10.1111/j.1471-4159.2009.06201.x; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Vignali G, 1997, J NEUROCHEM, V69, P1840; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x	36	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145542	10.1371/journal.pone.0145542	http://dx.doi.org/10.1371/journal.pone.0145542			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713735	gold, Green Published, Green Submitted			2022-12-27	WOS:000367481900055
J	Choudhary, A; Sinha, S				Choudhary, Anshul; Sinha, Sudeshna			Balance of Interactions Determines Optimal Survival in Multi-Species Communities	PLOS ONE			English	Article							STABILITY; PROMOTES; SYNCHRONIZATION; BIODIVERSITY; DIVERSITY	We consider a multi-species community modelled as a complex network of populations, where the links are given by a random asymmetric connectivity matrix J, with fraction 1 - C of zero entries, where C reflects the over-all connectivity of the system. The non-zero elements of J are drawn from a Gaussian distribution with mean mu and standard deviation sigma. The signs of the elements J(ij) reflect the nature of density-dependent interactions, such as predatory-prey, mutualism or competition, and their magnitudes reflect the strength of the interaction. In this study we try to uncover the broad features of the inter-species interactions that determine the global robustness of this network, as indicated by the average number of active nodes (i.e. non-extinct species) in the network, and the total population, reflecting the biomass yield. We find that the network transitions from a completely extinct system to one where all nodes are active, as the mean interaction strength goes from negative to positive, with the transition getting sharper for increasing C and decreasing s. We also find that the total population, displays distinct non-monotonic scaling behaviour with respect to the product mu C, implying that survival is dependent not merely on the number of links, but rather on the combination of the sparseness of the connectivity matrix and the net interaction strength. Interestingly, in an intermediate window of positive mu C, the total population is maximal, indicating that too little or too much positive interactions is detrimental to survival. Rather, the total population levels are optimal when the network has intermediate net positive connection strengths. At the local level we observe marked qualitative changes in dynamical patterns, ranging from anti-phase clusters of period 2 cycles and chaotic bands, to fixed points, under the variation of mean mu of the interaction strengths. We also study the correlation between synchronization and survival, and find that synchronization does not necessarily lead to extinction. Lastly, we propose an effective low dimensional map to capture the behavior of the entire network, and this provides a broad understanding of the interplay of the local dynamical patterns and the global robustness trends in the network.	[Choudhary, Anshul; Sinha, Sudeshna] IISER Mohali, Dept Phys Sci, Manauli Po 140306, Punjab, India	Indian Institute of Science Education & Research (IISER) - Mohali	Sinha, S (corresponding author), IISER Mohali, Dept Phys Sci, Sect 81, Manauli Po 140306, Punjab, India.	sudeshna@iisermohali.ac.in		Choudhary, Anshul/0000-0001-6651-5224; Sinha, Sudeshna/0000-0002-1364-5276	Department of Biotechnology (DBT), India [BT/PR3260/BRB/10/967/2011]; project entitled: SysTB: A network program for resolving the intracellular dynamics of host-pathogen interactions in TB infection - Department of Biotechnology (DBT), India [BT/PR3260/BRB/10/967/2011]	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); project entitled: SysTB: A network program for resolving the intracellular dynamics of host-pathogen interactions in TB infection - Department of Biotechnology (DBT), India	SS was supported by funds from the Department of Biotechnology (DBT), India, Grant no. No. BT/PR3260/BRB/10/967/2011, project title "SysTB: A network program for resolving the intracellular dynamics of host-pathogen interactions in TB infection."; SS was supported by funds from a project entitled: SysTB: A network program for resolving the intracellular dynamics of host-pathogen interactions in TB infection, funded by the Department of Biotechnology (DBT), India, Grant no. No. BT/PR3260/BRB/10/967/2011.	Allesina S, 2015, POPUL ECOL, V57, P63, DOI 10.1007/s10144-014-0471-0; Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Amritkar RE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.258102; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Cazelles B, 2001, P ROY SOC B-BIOL SCI, V268, P2595, DOI 10.1098/rspb.2001.1843; Choudhary A, 2014, EUR PHYS J B, V87, DOI 10.1140/epjb/e2014-50382-y; Dey S, 2006, SCIENCE, V312, P434, DOI 10.1126/science.1125317; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Jacopo G, 2015, PLOS COMPUT BIOL, V11.5; Kamal NK, 2011, CHAOS SOLITON FRACT, V44, P71, DOI 10.1016/j.chaos.2010.12.002; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Levins R., 1970, SOME MATH PROBLEMS B, P77; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; MAY RM, 1973, ECOLOGY, V54, P638, DOI 10.2307/1935352; Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Reichenbach T, 2007, NATURE, V448, P1046, DOI 10.1038/nature06095; Scheffer M, 1997, ECOLOGY, V78, P272; Sinha S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.020902; Sorrentino F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.114101; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Taylor CM, 2012, BIOL LETTERS, V8, P477, DOI 10.1098/rsbl.2011.0916	27	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145278	10.1371/journal.pone.0145278	http://dx.doi.org/10.1371/journal.pone.0145278			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710077	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400033
J	Fajemila, OT; Langer, MR; Lipps, JH				Fajemila, Olugbenga T.; Langer, Martin R.; Lipps, Jere H.			Spatial Patterns in the Distribution, Diversity and Abundance of Benthic Foraminifera around Moorea (Society Archipelago, French Polynesia)	PLOS ONE			English	Article							INNER NERITIC SAND; CORAL-REEFS; NATURAL DISTURBANCES; PAPUAN-LAGOON; MUD FACIES; ASSEMBLAGES; COMMUNITIES; VARIABILITY; ISLAND; ATOLL	Coral reefs are now subject to global threats and influences from numerous anthropogenic sources. Foraminifera, a group of unicellular shelled organisms, are excellent indicators of water quality and reef health. Thus we studied a set of samples taken in 1992 to provide a foraminiferal baseline for future studies of environmental change. Our study provides the first island-wide analysis of shallow benthic foraminifera from around Moorea (Society Archipelago). We analyzed the composition, species richness, patterns of distribution and abundance of unstained foraminiferal assemblages from bays, fringing reefs, nearshore and back-and fore-reef environments. A total of 380 taxa of foraminifera were recorded, a number that almost doubles previous species counts. Spatial patterns of foraminiferal assemblages are characterized by numerical abundances of individual taxa, cluster groups and gradients of species richness, as documented by cluster, Fisher a, ternary plot and Principal Component Analyses (PCA). The inner bay inlets are dominated by stress-tolerant, mostly thin-shelled taxa of Bolivina, Bolivinella, Nonionoides, Elongobula, and Ammonia preferring low-oxygen and/or nutrient-rich habitats influenced by coastal factors such as fresh-water runoff and overhanging mangroves. The larger symbiont-bearing foraminifera (Borelis, Amphistegina, Heterostegina, Peneroplis) generally live in the oligotrophic, well-lit back- and fore-reef environments. Amphisteginids and peneroplids were among the few taxa found in the bay environments, probably due to their preferences for phytal substrates and tolerance to moderate levels of eutrophication. The fringing reef environments along the outer bay are characterized by Borelis schlumbergeri, Heterostegina depressa, Textularia spp. and various miliolids which represent a hotspot of diversity within the complex reef-lagoon system of Moorea. The high foraminiferal Fisher a and species richness diversity in outer bay fringing reefs is consistent with the disturbance-mosaic (microhabitat heterogeneity) hypothesis. Calculations of the FORAM Index (FI), a single metric index to assess reef vitality, indicate that all fore- and most back-reef environments support active carbonate accretion and provide habitat suitability for carbonate producers dependent on algal symbiosis. Lowest suitability values were recorded within the innermost bays, an area where natural and increasing anthropogenic influences continue to impact the reefs. The presence of habitat specific assemblages and numerical abundance values of individual taxa show that benthic foraminifera are excellent recorders of environmental perturbations and good indicators useful in modern and ancient ecological and environmental studies.	[Fajemila, Olugbenga T.; Langer, Martin R.] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany; [Fajemila, Olugbenga T.] Osun State Univ, Dept Geol Sci, Osogbo, Nigeria; [Lipps, Jere H.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Lipps, Jere H.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Lipps, Jere H.] JD Cooper Ctr, Santa Ana, CA USA	University of Bonn; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Langer, MR (corresponding author), Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany.	martin.langer@uni-bonn.de	Fajemila, Olugbenga T./AAT-7453-2021	Fajemila, Olugbenga T./0000-0002-9949-0091; Lipps, Jere/0000-0003-0592-7537	Swiss Science Foundation [8220-028385]; Deutsche Forschungsgemeinschaft [La884/5-1, La884/5-2, La884/10-1]; TETFund, Nigeria; Committee on Research, UC Berkeley; Museum of Paleontology, Berkeley; UC Pacific Rim Project; German Science Foundation [La884/5-1, La884/5-2, La884/10-1]	Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); TETFund, Nigeria; Committee on Research, UC Berkeley; Museum of Paleontology, Berkeley; UC Pacific Rim Project; German Science Foundation(German Research Foundation (DFG))	Financial support for MRL was provided by the Swiss Science Foundation (#8220-028385) and the Deutsche Forschungsgemeinschaft (La884/5-1,5-2, 10-1). OTF was supported by the TETFund, Nigeria. JHL received support from the Committee on Research, UC Berkeley, the Museum of Paleontology, Berkeley, and the UC Pacific Rim Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; M. R. Langer and J. H. Lipps are grateful for the support of the Museum of Paleontology, Berkeley. Financial support for M. R. Langer also was provided by the Swiss Science Foundation (8220-028385) and the Deutsche Forschungsgemeinschaft. O. T. Fajemila gratefully acknowledges support by the TETFund, Nigeria. This study is part of the Shallow-Water Biogeographic Key Regions project and was supported by a grant from the German Science Foundation awarded to ML (La884/5-1,5-2, 10-1). J. H. Lipps thanks the Committee on Research, UC Berkeley, the Museum of Paleontology, Berkeley, and the UC Pacific Rim Project for support of this project. This is UC Museum of Paleontology publication 2070, and a University of California, Berkeley, Richard B. Gump Biological Research Station contribution.	Adjeroud M, 2005, AQUAT LIVING RESOUR, V18, P111, DOI 10.1051/alr:2005014; Adjeroud M, 1997, MAR ECOL PROG SER, V159, P105, DOI 10.3354/meps159105; Adjeroud M, 2002, MAR ECOL PROG SER, V237, P121, DOI 10.3354/meps237121; Adjeroud M, 2007, HYDROBIOLOGIA, V589, P117, DOI 10.1007/s10750-007-0726-2; Adjeroud M, 2007, J EXP MAR BIOL ECOL, V341, P204, DOI 10.1016/j.jembe.2006.10.048; Baccaert J., 1987, DISTRIBUTION PATTERN; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barbosa CF, 2009, MAR MICROPALEONTOL, V73, P62, DOI 10.1016/j.marmicro.2009.07.002; Bernhard JM, 1999, MODERN FORAMINIFERA, P201; BERNHARD JM, 1986, J FORAMIN RES, V16, P207, DOI 10.2113/gsjfr.16.3.207; Bessat F, 2001, PALAEOGEOGR PALAEOCL, V175, P381, DOI 10.1016/S0031-0182(01)00381-9; Bicchi E, 2002, CORAL REEFS, V21, P275, DOI 10.1007/s00338-002-0245-6; BRADY HB, 1884, REPORT SCI RESULTS V, V9, P1; BRASIER M D, 1975, Journal of Foraminiferal Research, V5, P193; Caley MJ, 1997, ECOLOGY, p[78, 30]; CAMERON AM, 1991, MAR ECOL PROG SER, V75, P251, DOI 10.3354/meps075251; Carilli J, 2012, MAR ECOL PROG SER, V456, P87, DOI 10.3354/meps09684; CHAZOTTES V, 1995, PALAEOGEOGR PALAEOCL, V113, P189, DOI 10.1016/0031-0182(95)00043-L; Cushman J. A., 1933, Bulletin United States National Museum, V161, P1; Cushman J. A., 1932, Bulletin United States National Museum, V161, P1; CUSHMAN JOSEPH AUGUSTINE, 1942, BULL U S NATION MUS, V161, P1; Debenay JP, 2015, MAR POLLUT BULL, V93, P103, DOI 10.1016/j.marpolbul.2015.02.009; Debenay JP, 2000, MICROPALEONTOLOGY, V46, P153; Debenay JP, 2012, GUIDE 1000 FORAMINIF; DELESALLE B, 1992, CONT SHELF RES, V12, P939, DOI 10.1016/0278-4343(92)90053-M; DONE TJ, 1991, CORAL REEFS, V9, P183, DOI 10.1007/BF00290420; Engle V.D., 2000, EVALUATION GUIDELINE, V3, P1; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Fujita K, 2015, ISL ARC, V24, P47, DOI 10.1111/iar.12069; GALZIN R, 1987, MAR ECOL PROG SER, V41, P137, DOI 10.3354/meps041137; GLEASON MG, 1993, CORAL REEFS, V12, P193, DOI 10.1007/BF00334479; Gleason MG, 1996, J EXP MAR BIOL ECOL, V207, P79, DOI 10.1016/S0022-0981(96)02647-0; HAIG DW, 1993, J FORAMIN RES, V23, P162, DOI 10.2113/gsjfr.23.3.162; HAIG DW, 1988, J FORAMIN RES, V18, P203, DOI 10.2113/gsjfr.18.3.203; Hallock P, 2003, ENVIRON MONIT ASSESS, V81, P221, DOI 10.1023/A:1021337310386; HALLOCK P, 1981, J SEDIMENT PETROL, V51, P467; Hallock P, 2000, MICROPALEONTOLOGY, V46, P95; HALLOCK P., 2012, INT COR REEF S CAIRN, P9; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harmelin-Vivien M.L., 1994, J COASTAL RES, V12, P211, DOI DOI 10.1111/NYAS.13322; Hayward B. W., 1999, I GEOLOGICAL NUCL SC, P1; Hodgson G, 1999, MAR POLLUT BULL, V38, P345, DOI 10.1016/S0025-326X(99)00002-8; HOEGHGULDBERG O, 1995, MAR ECOL PROG SER, V121, P181, DOI 10.3354/meps121181; Hottinger Lukas, 1993, Slovenska Akademija Znanosti in Umetnosti Razred za Naravoslovne Vede Dela, V33, P1; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Juhasz A, 2010, MAR POLLUT BULL, V60, P2251, DOI 10.1016/j.marpolbul.2010.08.011; Kelmo F, 2013, ECOL INDIC, V30, P148, DOI 10.1016/j.ecolind.2013.02.009; Koukousioura O, 2011, J MARINE SYST, V88, P489, DOI 10.1016/j.jmarsys.2011.06.004; Langer MR, 2008, J EUKARYOT MICROBIOL, V55, P163, DOI 10.1111/j.1550-7408.2008.00321.x; Langer MR, 2006, MICROPALEONTOLOGY, V52, P343, DOI 10.2113/gsmicropal.52.4.343; Langer MR, 2013, NEUES JAHRB GEOL P-A, V267, P155, DOI 10.1127/0077-7749/2013/0302; Langer MR, 2000, MICROPALEONTOLOGY, V46, P105; Langer MR, 1997, J FORAMIN RES, V27, P271, DOI 10.2113/gsjfr.27.4.271; Langer MR, 2003, CORAL REEFS, V22, P143, DOI 10.1007/s00338-003-0298-1; Le Calvez Y., 1980, CAH MICROPALEONTOL, V4, P1; Lenhardt X, 1991, THESIS; Lipps JH, 1999, MICROPALEONTOLOGY, V45, P278, DOI 10.2307/1486137; Lipps JH, 2011, PALEONTOL SOC PAPERS, V17, P139; Lobegeier MK, 2002, J FORAMIN RES, V32, P201, DOI 10.2113/32.3.201; Loeblich Alfred R. Jr, 1994, Cushman Foundation for Foraminiferal Research Special Publication, V31, P1; Loeblich AR., 1987, FORAMINIFERAL GENERA; Makled WA, 2011, NEUES JAHRB GEOL P-A, V259, P231, DOI 10.1127/0077-7749/2011/0119; MARIE PIERRE, 1940, BULL MUS NATION HIST NAT [PARIS], V12, P348; MARTIN RE, 1986, J FORAMIN RES, V16, P201, DOI 10.2113/gsjfr.16.3.201; Millett FW, 1898, J ROY MICROSC SOC, V5, P1; Murray, 1973, DISTRIBUTION ECOLOGY; Murray J. W., 1991, ECOLOGY PALEOECOLOGY; Parker JH, 2011, MAR MICROPALEONTOL, V78, P30, DOI 10.1016/j.marmicro.2010.09.007; Parker Justin H., 2009, Memoir of the Association of Australasian Palaeontologists, V36, P1; Parker WC, 1999, MODERN FORAMINIFERA, P71; PAYRI CE, 1987, BOT MAR, V30, P141, DOI 10.1515/botm.1987.30.2.141; Penin L, 2007, CR BIOL, V330, P171, DOI 10.1016/j.crvi.2006.12.003; Richard G., 1982, THESIS; Richard G., 1985, P 5 INT COR REEF C, V1, P379; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Salvat B., 1982, Proceedings of the International Coral Reef Symposium, P767; Salvat B., 1987, HUMAN IMPACTS CORAL, P166; Salvat B, 2008, REV ECOL-TERRE VIE, V63, P145; SCOTT D. B., 2001, MONITORING COASTAL E; SOURNIA A, 1976, MAR BIOL, V37, P29, DOI 10.1007/BF00386775; Stephenson CM, 2015, ECOL INDIC, V48, P1, DOI 10.1016/j.ecolind.2014.07.004; Todd R., 1965, B US NAT MUS, V161, P1; Trapon Melanie L., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/807625; Venec-Peyre M.-T., 1984, Bulletin Centre de Recherches Exploration-Production Elf-Aquitaine Memoire, P573; Venec-Peyre M.T., 1985, P 5 INT COR REEF S, V5, P227; Venec-Peyre MT, 1985, P 5 INT COR REEF C T, V1, P393; VENECPEYRE MT, 1987, CORAL REEFS, V5, P205, DOI 10.1007/BF00300966; VENECPEYRE MT, 1981, ANN I OCEANOGR PARIS, V57, P79; VENECPEYRE MT, 1991, CORAL REEFS, V9, P193, DOI 10.1007/BF00290421; VENECPEYRE MT, 1988, J FORAMIN RES, V18, P1; VERON JEN, 1995, CORALS SPACE TIME BI; Yanko V, 1999, MODERN FORAMINIFERA, P217; [No title captured]	93	42	45	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145752	10.1371/journal.pone.0145752	http://dx.doi.org/10.1371/journal.pone.0145752			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710320	gold, Green Published, Green Submitted			2022-12-27	WOS:000367451400076
J	Park, SH; Kim, HS; Park, MS; Moon, S; Song, MK; Park, HS; Hahn, H; Kim, SJ; Bae, E; Kim, HJ; Han, BW				Park, Sang Ho; Kim, Hyoun Sook; Park, Mi Seul; Moon, Sojin; Song, Mi Kyung; Park, Han Su; Hahn, Hyunggu; Kim, Soon-Jong; Bae, Euiyoung; Kim, Hyun-Jung; Han, Byung Woo			Structure and Stability of the Dimeric Triosephosphate Isomerase from the Thermophilic Archaeon Thermoplasma acidophilum	PLOS ONE			English	Article							TRIOSE-PHOSPHATE ISOMERASE; CRYSTAL-STRUCTURE; BACILLUS-STEAROTHERMOPHILUS; TIM; DEFICIENCY; THERMOSTABILITY; FEATURES; SUBSTITUTION; INTERFACE; PROTEINS	Thermoplasma acidophilum is a thermophilic archaeon that uses both non-phosphorylative Entner-Doudoroff (ED) pathway and Embden-Meyerhof-Parnas (EMP) pathway for glucose degradation. While triosephosphate isomerase (TPI), a well-known glycolytic enzyme, is not involved in the ED pathway in T. acidophilum, it has been considered to play an important role in the EMP pathway. Here, we report crystal structures of apo- and glycerol-3-phosphate-bound TPI from T. acidophilum (TaTPI). TaTPI adopts the canonical TIM-barrel fold with eight alpha-helices and parallel eight beta-strands. Although TaTPI shares similar to 30% sequence identity to other TPIs from thermophilic species that adopt tetrameric conformation for enzymatic activity in their harsh physiological environments, TaTPI exists as a dimer in solution. We confirmed the dimeric conformation of TaTPI by analytical ultracentrifugation and size-exclusion chromatography. Helix 5 as well as helix 4 of thermostable tetrameric TPIs have been known to play crucial roles in oligomerization, forming a hydrophobic interface. However, TaTPI contains unique charged-amino acid residues in the helix 5 and adopts dimer conformation. TaTPI exhibits the apparent T-d value of 74.6 degrees C and maintains its overall structure with some changes in the secondary structure contents at extremely acidic conditions (pH 1-2). Based on our structural and biophysical analyses of TaTPI, more compact structure of the protomer with reduced length of loops and certain patches on the surface could account for the robust nature of Thermoplasma acidophilum TPI.	[Park, Sang Ho; Kim, Hyoun Sook; Park, Mi Seul; Song, Mi Kyung; Park, Han Su; Hahn, Hyunggu; Han, Byung Woo] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea; [Moon, Sojin; Bae, Euiyoung] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Soon-Jong] Mokpo Natl Univ, Dept Chem, Chungnam, South Korea; [Kim, Hyun-Jung] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Seoul National University (SNU); Seoul National University (SNU); Mokpo National University; Chung Ang University	Han, BW (corresponding author), Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea.	bwhan@snu.ac.kr		Park, Mi Seul/0000-0003-2519-7121	Ministry of Science, ICT and Future Planning of Korea [NRF-2011-0030001, NRF-2013M-3A6A-4043695]	Ministry of Science, ICT and Future Planning of Korea	This work was supported by Ministry of Science, ICT and Future Planning of Korea; Grant number: NRF-2011-0030001 and NRF-2013M-3A6A-4043695 (Tumor Microenvironment Global Core Research Center and Global Frontier Project funded through the National Research Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M, 1999, J BIOL CHEM, V274, P19181, DOI 10.1074/jbc.274.27.19181; Alvarez M, 1998, J BIOL CHEM, V273, P2199, DOI 10.1074/jbc.273.4.2199; Arya R, 1997, HUM MUTAT, V10, P290; BORCHERT TV, 1993, EUR J BIOCHEM, V211, P703, DOI 10.1111/j.1432-1033.1993.tb17599.x; Celotto AM, 2006, GENETICS, V174, P1237, DOI 10.1534/genetics.106.063206; DAAR IO, 1986, P NATL ACAD SCI USA, V83, P7903, DOI 10.1073/pnas.83.20.7903; Dams T, 2000, J MOL BIOL, V297, P659, DOI 10.1006/jmbi.2000.3570; DELBONI LF, 1995, PROTEIN SCI, V4, P2594, DOI 10.1002/pro.5560041217; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gayathri P, 2007, ACTA CRYSTALLOGR D, V63, P206, DOI 10.1107/S0907444906046488; Gopal B, 1999, BIOCHEMISTRY-US, V38, P478, DOI 10.1021/bi981495w; HOLLAN S, 1993, HUM GENET, V92, P486, DOI 10.1007/BF00216456; John DM, 2000, PROTEIN SCI, V9, P1416, DOI 10.1110/ps.9.7.1416; KNOTT GD, 1979, COMPUT PROG BIOMED, V10, P271, DOI 10.1016/0010-468X(79)90075-8; Laue TM, 1995, METHOD ENZYMOL, V259, P427; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maes D, 1999, PROTEINS, V37, P441, DOI 10.1002/(SICI)1097-0134(19991115)37:3<441::AID-PROT11>3.3.CO;2-Z; Mainfroid V, 1996, J MOL BIOL, V257, P441, DOI 10.1006/jmbi.1996.0174; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOBLE MEM, 1993, PROTEINS, V16, P311, DOI 10.1002/prot.340160402; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Romero-Romero S, 2015, PHYS CHEM CHEM PHYS, V17, P20699, DOI 10.1039/c5cp01599e; Ruepp A, 2000, NATURE, V407, P508, DOI 10.1038/35035069; Schneider AS, 2000, BEST PRACT RES CL HA, V13, P119, DOI 10.1053/beha.2000.0061; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Walden H, 2004, J MOL BIOL, V342, P861, DOI 10.1016/j.jmb.2004.07.067; Walden H, 2001, J MOL BIOL, V306, P745, DOI 10.1006/jmbi.2000.4433; Wierenga RK, 2010, CELL MOL LIFE SCI, V67, P3961, DOI 10.1007/s00018-010-0473-9; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Williams JC, 1999, PROTEIN ENG, V12, P243, DOI 10.1093/protein/12.3.243; Xiao L, 1999, J MOL BIOL, V289, P1435, DOI 10.1006/jmbi.1999.2810; ZHANG ZD, 1994, BIOCHEMISTRY-US, V33, P2830, DOI 10.1021/bi00176a012	35	0	0	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145331	10.1371/journal.pone.0145331	http://dx.doi.org/10.1371/journal.pone.0145331			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709515	Green Published, Green Submitted, gold			2022-12-27	WOS:000367451400037
J	Wang, FF; Okawa, H; Kamano, Y; Niibe, K; Kayashima, H; Osathanon, T; Pavasant, P; Saeki, M; Yatani, H; Egusa, H				Wang, Fangfang; Okawa, Hiroko; Kamano, Yuya; Niibe, Kunimichi; Kayashima, Hiroki; Osathanon, Thanaphum; Pavasant, Prasit; Saeki, Makio; Yatani, Hirofumi; Egusa, Hiroshi			Controlled Osteogenic Differentiation of Mouse Mesenchymal Stem Cells by Tetracycline-Controlled Transcriptional Activation of Amelogenin	PLOS ONE			English	Article							BONE SIALOPROTEIN BSP; IN-VITRO; OSTEOBLAST DIFFERENTIATION; RECOMBINANT AMELOGENIN; PERIODONTAL-LIGAMENT; OSTERIX EXPRESSION; CALCIUM-PHOSPHATE; MATRIX PROTEINS; GENE-EXPRESSION; STROMAL CELLS	Regenerative dental therapies for bone tissues rely on efficient targeting of endogenous and transplanted mesenchymal stem cells (MSCs) to guide bone formation. Amelogenin is the primary component of Emdogain, which is used to regenerate periodontal defects; however, the mechanisms underlying the therapeutic effects on alveolar bone remain unclear. The tetracycline (Tet)-dependent transcriptional regulatory system is a good candidate to investigate distinct roles of genes of interest during stem cell differentiation. Here, we investigated amelogenin-dependent regulation of osteogenesis in MSCs by establishing a Tet-controlled transcriptional activation system. Clonal mouse bone marrow-derived MSCs were lentivirally transduced with the Tet repressor (TetR) expression vector followed by drug selection to obtain MSCs constitutively expressing TetR (MSCs-TetR). Expression vectors that contained the Tet operator and amelogenin-coding (Amelx) cDNA fragments were constructed using the Gateway system and lentivirally introduced into MSCs-TetR to generate a Tet regulation system in MSCs (MSCs-TetR/Amelx). MSCs-TetR/Amelx significantly overexpressed the Amelx gene and protein in the presence of the tetracycline derivative doxycycline. Concomitant expression of osterix, bone sialoprotein (BSP), osteopontin, and osteocalcin was modulated by addition or removal of doxycycline under osteogenic guidance. During osteogenic induction, MSCs-TetR/Amelx treated with doxycycline showed significantly increased gene expression of osterix, type I collagen, BSP, and osteocalcin in addition to increased alkaline phosphatase activity and mineralized nodule formation. Enhanced extracellular matrix calcification was observed when forced Amelx expression commenced at the early stage but not at the intermediate or late stages of osteogenesis. These results suggest that a Tet-controlled Amelx gene regulation system for mouse MSCs was successfully established, in which transcriptional activation of Amelx was associated with enhanced osteogenic differentiation, especially in the early stage of biomineralization.	[Wang, Fangfang; Okawa, Hiroko; Kayashima, Hiroki; Yatani, Hirofumi; Egusa, Hiroshi] Osaka Univ, Grad Sch Dent, Dept Fixed Prosthodont, Suita, Osaka, Japan; [Okawa, Hiroko; Kamano, Yuya; Niibe, Kunimichi; Egusa, Hiroshi] Tohoku Univ, Grad Sch Dent, Div Mol & Regenerat Prosthodont, Sendai, Miyagi 980, Japan; [Osathanon, Thanaphum; Pavasant, Prasit] Chulalongkorn Univ, Fac Dent, Res Unit Mineralized Tissue, Bangkok, Thailand; [Saeki, Makio] Niigata Univ, Grad Sch Med & Dent Sci, Div Dent Pharmacol, Niigata, Japan	Osaka University; Tohoku University; Chulalongkorn University; Niigata University	Egusa, H (corresponding author), Osaka Univ, Grad Sch Dent, Dept Fixed Prosthodont, Suita, Osaka, Japan.	egu@dent.tohoku.ac.jp	Egusa, Hiroshi/AFT-9694-2022; wang, fang/GYD-4295-2022	Egusa, Hiroshi/0000-0002-0200-8132; Osathanon, Thanaphum/0000-0003-1649-6357	Japan Society for the Promotion of Science; National Research Council of Thailand; Grants-in-Aid for Scientific Research [24792151] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Research Council of Thailand(National Research Council of Thailand (NRCT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This investigation was supported in part by a Grant-in Aid for the 2013-2015 Bilateral Joint Research Projects from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html) (HE) and the National Research Council of Thailand (http://www.nrct.go.th/) (PP) (no numbers for the grants).	BIANCO P, 1993, J HISTOCHEM CYTOCHEM, V41, P193, DOI 10.1177/41.2.8419459; Boabaid F, 2004, J PERIODONTOL, V75, P1126, DOI 10.1902/jop.2004.75.8.1126; Bonucci E, 2012, FRONT BIOSCI-LANDMRK, V17, P100, DOI 10.2741/3918; BROOKES SJ, 1995, ARCH ORAL BIOL, V40, P1, DOI 10.1016/0003-9969(94)00135-X; Crane NJ, 2006, BONE, V39, P434, DOI 10.1016/j.bone.2006.02.059; Deshpande AS, 2010, J BIOL CHEM, V285, P19277, DOI 10.1074/jbc.M109.079939; Egusa H, 2005, J BIOL CHEM, V280, P23691, DOI 10.1074/jbc.M413796200; Egusa H, 2007, TISSUE ENG, V13, P2589, DOI 10.1089/ten.2007.0080; Egusa H, 2014, STEM CELLS DEV, V23, P2156, DOI 10.1089/scd.2013.0344; Egusa H, 2013, TISSUE ENG PT A, V19, P770, DOI [10.1089/ten.tea.2012.0164, 10.1089/ten.TEA.2012.0164]; Egusa H, 2012, J PROSTHODONT RES, V56, P229, DOI 10.1016/j.jpor.2012.10.001; Egusa H, 2012, J PROSTHODONT RES, V56, P151, DOI 10.1016/j.jpor.2012.06.001; Egusa H, 2011, BONE, V49, P264, DOI 10.1016/j.bone.2011.04.003; FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011; Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401; Gibson CW, 2008, CRIT REV EUKAR GENE, V18, P345, DOI 10.1615/CritRevEukarGeneExpr.v18.i4.30; Grandin HM, 2012, TISSUE ENG PART B-RE, V18, P181, DOI [10.1089/ten.teb.2011.0365, 10.1089/ten.TEB.2011.0365]; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Haze A, 2009, J CELL MOL MED, V13, P1110, DOI 10.1111/j.1582-4934.2009.00700.x; Hu JC, 2011, BIOCHEM BIOPH RES CO, V408, P437, DOI 10.1016/j.bbrc.2011.04.042; Kafri T, 2000, MOL THER, V1, P516, DOI 10.1006/mthe.2000.0083; Kaku M, 2015, J PROSTHODONT RES, V59, P96, DOI 10.1016/j.jpor.2015.02.001; Kaku M, 2014, J PROSTHODONT RES, V58, P193, DOI 10.1016/j.jpor.2014.08.003; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; LAU EC, 1989, GENOMICS, V4, P162, DOI 10.1016/0888-7543(89)90295-4; Lee DS, 2014, STEM CELLS, V32, P2467, DOI 10.1002/stem.1733; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105; Margolis HC, 2006, J DENT RES, V85, P775, DOI 10.1177/154405910608500902; Margolis H. C., 2010, AMELOGENINS MULTIFAC, P133, DOI 10.2174/978160805171711001010133; Masaki C, 2015, J PROSTHODONT RES, V59, P220, DOI 10.1016/j.jpor.2015.04.005; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Matsuzawa M, 2009, J PERIODONTAL RES, V44, P289, DOI 10.1111/j.1600-0765.2008.01091.x; Naidoo J, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/595410; Nakano M, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e40; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Olivares-Navarrete R, 2014, EUR CELLS MATER, V28, P1; Piper SL, 2012, J ORTHOP RES, V30, P1879, DOI 10.1002/jor.22162; ROBINSON C, 1988, CARIES RES, V22, P321, DOI 10.1159/000261131; Sasaki JI, 2015, J BIOMED MATER RES A, V103, P622, DOI 10.1002/jbm.a.35212; Sasaki JI, 2012, INTEGR BIOL-UK, V4, P1207, DOI 10.1039/c2ib20027a; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shimizu E, 2005, J PERIODONTOL, V76, P1482, DOI 10.1902/jop.2005.76.9.1482; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; Sun Y, 2007, ACTA BIOCH BIOPH SIN, V39, P235, DOI 10.1111/j.1745-7270.2007.00258.x; Swanson EC, 2006, EUR J ORAL SCI, V114, P239, DOI 10.1111/j.1600-0722.2006.00321.x; Tanimoto K, 2012, CELLS TISSUES ORGANS, V196, P411, DOI 10.1159/000335912; TERMINE JD, 1980, J BIOL CHEM, V255, P9760; Veis A, 2000, J BIOL CHEM, V275, P41263, DOI 10.1074/jbc.M002308200; Viswanathan HL, 2003, J PERIODONTOL, V74, P1423, DOI 10.1902/jop.2003.74.10.1423; Warotayanont R, 2008, BIOCHEM BIOPH RES CO, V367, P1, DOI 10.1016/j.bbrc.2007.12.048; Wen X, 2011, BIOMATERIALS, V32, P6478, DOI 10.1016/j.biomaterials.2011.05.045; Zhou BY, 2007, STEM CELLS, V25, P779, DOI 10.1634/stemcells.2006-0128	54	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145677	10.1371/journal.pone.0145677	http://dx.doi.org/10.1371/journal.pone.0145677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709694	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400070
J	Bigler, MB; Egli, SB; Hysek, CM; Hoenger, G; Schmied, L; Baldin, FS; Marquardsen, FA; Recher, M; Liechti, ME; Hess, C; Berger, CT				Bigler, Marc B.; Egli, Simon B.; Hysek, Cedric M.; Hoenger, Gideon; Schmied, Laurent; Baldin, Fabian S.; Marquardsen, Florian A.; Recher, Mike; Liechti, Matthias E.; Hess, Christoph; Berger, Christoph T.			Stress-Induced In Vivo Recruitment of Human Cytotoxic Natural Killer Cells Favors Subsets with Distinct Receptor Profiles and Associates with Increased Epinephrine Levels	PLOS ONE			English	Article							MEDIATED IMMUNE-RESPONSE; PSYCHOLOGICAL STRESS; NK; METHYLPHENIDATE; INFECTION; SYSTEM; 3,4-METHYLENEDIOXYMETHAMPHETAMINE; IDENTIFICATION; IMPAIRS	Background Acute stress drives a 'high-alert' response in the immune system. Psychoactive drugs induce distinct stress hormone profiles, offering a sought-after opportunity to dissect the in vivo immunological effects of acute stress in humans. Methods 3,4-methylenedioxymethamphetamine (MDMA), methylphenidate (MPH), or both, were administered to healthy volunteers in a randomized, double-blind, placebo-controlled crossover-study. Lymphocyte subset frequencies, natural killer (NK) cell immune-phenotypes, and changes in effector function were assessed, and linked to stress hormone levels and expression of CD62L, CX3CR1, CD18, and stress hormone receptors on NK cells. Results MDMA/MPH > MDMA > MPH robustly induced an epinephrine-dominant stress response. Immunologically, rapid redistribution of peripheral blood lymphocyte-subsets towards phenotypically mature NK cells occurred. NK cytotoxicity was unaltered, but they expressed slightly reduced levels of the activating receptor NKG2D. Preferential circulation of mature NK cells was associated with high epinephrine receptor expression among this subset, as well as expression of integrin ligands previously linked to epinephrine-induced endothelial detachment. Conclusion The acute epinephrine-induced stress response was characterized by rapid accumulation of mature and functional NK cells in the peripheral circulation. This is in line with studies using other acute stressors and supports the role of the acute stress response in rapidly mobilizing the innate immune system to counteract incoming threats.	[Bigler, Marc B.; Egli, Simon B.; Berger, Christoph T.] Univ Basel Hosp, Translat Immunol, Dept Biomed, CH-4031 Basel, Switzerland; [Hysek, Cedric M.; Liechti, Matthias E.] Univ Basel Hosp, Clin Pharmacol, Dept Internal Med, CH-4031 Basel, Switzerland; [Hoenger, Gideon; Hess, Christoph] Univ Basel Hosp, Immunobiol Lab, Dept Biomed, CH-4031 Basel, Switzerland; [Schmied, Laurent] Univ Basel Hosp, Immunotherapy Lab, Dept Biomed, CH-4031 Basel, Switzerland; [Baldin, Fabian S.; Marquardsen, Florian A.; Recher, Mike] Univ Basel Hosp, Immunodeficiency Lab, Dept Biomed, CH-4031 Basel, Switzerland; [Recher, Mike; Hess, Christoph; Berger, Christoph T.] Univ Basel Hosp, Med Outpatient Clin, Dept Internal Med, CH-4031 Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University of Basel; University of Basel	Liechti, ME (corresponding author), Univ Basel Hosp, Clin Pharmacol, Dept Internal Med, CH-4031 Basel, Switzerland.	matthias.liechti@usb.ch; christoph.berger@usb.ch	Berger, Christoph T/I-6126-2019	Berger, Christoph T/0000-0002-1730-8824; Recher, Mike/0000-0002-9121-6936; Bigler, Marc/0000-0002-8232-6228; Schmied, Laurent/0000-0002-3303-881X	Swiss National Science Foundation (SNSF) [PZ00P3-148000, SNSF 310030_153059, SNSF 320030_149493]; Swiss National Science Foundation [PP00P3_144863]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work was supported by the Swiss National Science Foundation (SNSF, www.snf.ch) to CTB (PZ00P3-148000), CH (SNSF 310030_153059), and ML (SNSF 320030_149493). MR holds a professorship from the Swiss National Science Foundation (PP00P3_144863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Careem MF, 2012, J INFECT DIS, V206, P167, DOI 10.1093/infdis/jis340; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Ashcraft KA, 2008, PSYCHONEUROENDOCRINO, V33, P951, DOI 10.1016/j.psyneuen.2008.04.010; Baeriswyl V, 2006, HAEMATOLOGICA, V91, P1538; BENSCHOP RJ, 1993, EUR J IMMUNOL, V23, P3242, DOI 10.1002/eji.1830231230; Boyle NT, 2010, BRIT J PHARMACOL, V161, P17, DOI 10.1111/j.1476-5381.2010.00899.x; Bush KA, 2012, CELL IMMUNOL, V275, P80, DOI 10.1016/j.cellimm.2012.02.014; CALLEWAERT DM, 1991, FEBS LETT, V285, P108, DOI 10.1016/0014-5793(91)80736-M; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Cosgrove C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105950; Crosby EJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003970; Dhabhar Firdaus S, 2008, Allergy Asthma Clin Immunol, V4, P2, DOI 10.1186/1710-1492-4-1-2; Dimitrov S, 2010, J IMMUNOL, V184, P503, DOI 10.4049/jimmunol.0902189; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Gotlieb N, 2015, BRAIN BEHAV IMMUN, V45, P277, DOI 10.1016/j.bbi.2014.12.020; Hanke ML, 2012, BRAIN BEHAV IMMUN, V26, P1150, DOI 10.1016/j.bbi.2012.07.011; Hysek CM, 2014, INT J NEUROPSYCHOPH, V17, P371, DOI 10.1017/S1461145713001132; Hysek CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036476; JOYCE PR, 1986, BIOL PSYCHIAT, V21, P1015, DOI 10.1016/0006-3223(86)90282-9; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Mas M, 1999, J PHARMACOL EXP THER, V290, P136; Pacifici R, 2004, J PHARMACOL EXP THER, V309, P285, DOI 10.1124/jpet.103.061374; Pacifici R, 2002, ANN NY ACAD SCI, V965, P421; Pacifici R, 2001, LIFE SCI, V69, P2931, DOI 10.1016/S0024-3205(01)01373-X; Pacifici R, 2000, ANN NY ACAD SCI, V914, P215, DOI 10.1111/j.1749-6632.2000.tb05198.x; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Pedersen A, 2010, PSYCHOSOM MED, V72, P823, DOI 10.1097/PSY.0b013e3181f1d003; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Schedlowski M, 1996, J IMMUNOL, V156, P93; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Seibert J, 2014, NEUROENDOCRINOLOGY, V100, P17, DOI 10.1159/000364879; Simmler Linda D, 2013, BMC Res Notes, V6, P220, DOI 10.1186/1756-0500-6-220; SOMERSALO K, 1995, J BIOL CHEM, V270, P8629, DOI 10.1074/jbc.270.15.8629; Venstrom JM, 2012, NEW ENGL J MED, V367, P805, DOI 10.1056/NEJMoa1200503; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720	36	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145635	10.1371/journal.pone.0145635	http://dx.doi.org/10.1371/journal.pone.0145635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700184	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000367092600111
J	Burke, AK; Duong, DA; Jensen, RV; Stevens, AM				Burke, Alison Kernell; Duong, Duy An; Jensen, Roderick V.; Stevens, Ann M.			Analyzing the Transcriptomes of Two Quorum-Sensing Controlled Transcription Factors, RcsA and LrhA, Important for Pantoea stewartii Virulence	PLOS ONE			English	Article							ESCHERICHIA-COLI; PHOSPHORELAY SYSTEM; EXPRESSION; GENE; ESAR; REGULATOR; EXOPOLYSACCHARIDE; IDENTIFICATION; PROMOTER; BACTERIA	The Gram-negative proteobacterium Pantoea stewartii subsp. stewartii causes wilt disease in corn plants. Wilting is primarily due to bacterial exopolysaccharide (EPS) production that blocks water transport in the xylem during the late stages of infection. EsaR, the master quorum-sensing (QS) regulator in P. stewartii, modulates EPS levels. At low cell densities EsaR represses or activates expression of a number of genes in the absence of its acyl homoserine lactone (AHL) ligand. At high cell densities, binding of AHL inactivates EsaR leading to derepression or deactivation of its direct targets. Two of these direct targets are the key transcription regulators RcsA and LrhA, which in turn control EPS production and surface motility/adhesion, respectively. In this study, RNA-Seq was used to further examine the physiological impact of deleting the genes encoding these two second-tier regulators. Quantitative reverse transcription PCR (qRT-PCR) was used to validate the regulation observed in the RNA-Seq data. A GFP transcriptional fusion reporter confirmed the existence of a regulatory feedback loop in the system between LrhA and RcsA. Plant virulence assays carried out with rcsA and lrhA deletion and complementation strains demonstrated that both transcription factors play roles during establishment of wilt disease in corn. These efforts further define the hierarchy of the QS-regulated network controlling plant virulence in P. stewartii.	[Burke, Alison Kernell; Duong, Duy An; Jensen, Roderick V.; Stevens, Ann M.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Stevens, AM (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	ams@vt.edu		Stevens, Ann/0000-0002-4942-0124	National Science Foundation [MCB-0919984]	National Science Foundation(National Science Foundation (NSF))	This work was initiated with support from National Science Foundation grant MCB-0919984 (A.M.S). Additional support to complete the work was provided by a Virginia Tech Graduate Student Association Graduate Research Development Program award (A.K.B), a Biological Sciences Graduate Student Development Award fellowship (A.K.B.), the Life Sciences I Building Fund, and Virginia Tech's Open Access Subvention Fund supported its publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Awano N, 2005, APPL ENVIRON MICROB, V71, P4149, DOI 10.1128/AEM.71.7.4149-4152.2005; Blumer C, 2005, MICROBIOL-SGM, V151, P3287, DOI 10.1099/mic.0.28098-0; BRAUN EJ, 1982, PHYTOPATHOLOGY, V72, P159, DOI 10.1094/Phyto-72-159; Burbank L, 2014, MOL PLANT MICROBE IN, V27, P479, DOI 10.1094/MPMI-11-13-0348-R; Carlier A, 2009, MOL MICROBIOL, V74, P903, DOI 10.1111/j.1365-2958.2009.06906.x; Carlier AL, 2006, J BACTERIOL, V188, P4581, DOI 10.1128/JB.00211-06; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Clemmer KM, 2007, RES MICROBIOL, V158, P295, DOI 10.1016/j.resmic.2006.11.010; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; DOLPH PJ, 1988, J BACTERIOL, V170, P865, DOI 10.1128/jb.170.2.865-871.1988; Ebel W, 1999, J BACTERIOL, V181, P577, DOI 10.1128/JB.181.2.577-584.1999; Esker PD, 2002, PHYTOPATHOLOGY, V92, P668, DOI 10.1094/PHYTO.2002.92.6.668; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Hagiwara D, 2003, J BACTERIOL, V185, P5735, DOI 10.1128/JB.185.19.5735-5746.2003; Herrera CM, 2008, MOL PLANT MICROBE IN, V21, P1359, DOI 10.1094/MPMI-21-10-1359; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Joint I, 2007, PHILOS T R SOC B, V362, P1115, DOI 10.1098/rstb.2007.2038; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; KEENLEYSIDE WJ, 1992, J BACTERIOL, V174, P8, DOI 10.1128/jb.174.1.8-16.1992; Kvitko Brian H, 2012, BMC Res Notes, V5, P157, DOI 10.1186/1756-0500-5-157; LABES M, 1990, GENE, V89, P37, DOI 10.1016/0378-1119(90)90203-4; Lehnen D, 2002, MOL MICROBIOL, V45, P521, DOI 10.1046/j.1365-2958.2002.03032.x; LEYH TS, 1988, J BIOL CHEM, V263, P2409; LUDOVICE M, 1992, J BACTERIOL, V174, P4606, DOI 10.1128/JB.174.14.4606-4613.1992; MALO MS, 1990, GENE, V87, P127, DOI 10.1016/0378-1119(90)90504-K; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Minogue TD, 2005, MOL MICROBIOL, V56, P189, DOI 10.1111/j.1365-2958.2004.04529.x; PARSOT C, 1988, GENE, V68, P275, DOI 10.1016/0378-1119(88)90030-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RALEIGH EA, 1988, NUCLEIC ACIDS RES, V16, P1563, DOI 10.1093/nar/16.4.1563; Ramachandran R, 2014, APPL ENVIRON MICROB, V80, P5790, DOI 10.1128/AEM.01489-14; Ramachandran R, 2013, APPL ENVIRON MICROB, V79, P6244, DOI 10.1128/AEM.01744-13; Roper MC, 2011, MOL PLANT PATHOL, V12, P628, DOI [10.1111/j.1364-3703.2010.00698.x, 10.1111/J.1364-3703.2010.00698.X]; Shong J, 2013, ACS CHEM BIOL, V8, P789, DOI 10.1021/cb3006402; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; Virlogeux I, 1996, J BACTERIOL, V178, P1691, DOI 10.1128/jb.178.6.1691-1698.1996; von Bodman SB, 2003, J BACTERIOL, V185, P7001, DOI 10.1128/JB.185.23.7001-7007.2003; von Bodman SB, 1998, P NATL ACAD SCI USA, V95, P7687, DOI 10.1073/pnas.95.13.7687; von Bodman SB, 2008, J BACTERIOL, V190, P4377, DOI 10.1128/JB.00486-08; VONBODMAN SB, 1995, J BACTERIOL, V177, P5000, DOI 10.1128/JB.177.17.5000-5008.1995; Wang QF, 2007, J BACTERIOL, V189, P8447, DOI 10.1128/JB.01198-07; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x	46	14	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145358	10.1371/journal.pone.0145358	http://dx.doi.org/10.1371/journal.pone.0145358			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699719	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600068
J	Staton, M; Best, T; Khodwekar, S; Owusu, S; Xu, T; Xu, Y; Jennings, T; Cronn, R; Arumuganathan, AK; Coggeshall, M; Gailing, O; Liang, HY; Romero-Severson, J; Schlarbaum, S; Carlson, JE				Staton, Margaret; Best, Teodora; Khodwekar, Sudhir; Owusu, Sandra; Xu, Tao; Xu, Yi; Jennings, Tara; Cronn, Richard; Arumuganathan, A. Kathiravetpilla; Coggeshall, Mark; Gailing, Oliver; Liang, Haiying; Romero-Severson, Jeanne; Schlarbaum, Scott; Carlson, John E.			Preliminary Genomic Characterization of Ten Hardwood Tree Species from Multiplexed Low Coverage Whole Genome Sequencing	PLOS ONE			English	Article							NUCLEAR-DNA AMOUNTS; MICROSATELLITE MARKERS; CLIMATE-CHANGE; RESOURCES; SELECTION; DATABASE; FLOW	Forest health issues are on the rise in the United States, resulting from introduction of alien pests and diseases, coupled with abiotic stresses related to climate change. Increasingly, forest scientists are finding genetic/genomic resources valuable in addressing forest health issues. For a set of ten ecologically and economically important native hardwood tree species representing a broad phylogenetic spectrum, we used low coverage whole genome sequencing from multiplex Illumina paired ends to economically profile their genomic content. For six species, the genome content was further analyzed by flow cytometry in order to determine the nuclear genome size. Sequencing yielded a depth of 0.8X to 7.5X, from which in silico analysis yielded preliminary estimates of gene and repetitive sequence content in the genome for each species. Thousands of genomic SSRs were identified, with a clear predisposition toward dinucleotide repeats and AT-rich repeat motifs. Flanking primers were designed for SSR loci for all ten species, ranging from 891 loci in sugar maple to 18,167 in redbay. In summary, we have demonstrated that useful preliminary genome information including repeat content, gene content and useful SSR markers can be obtained at low cost and time input from a single lane of Illumina multiplex sequence.	[Staton, Margaret] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Best, Teodora; Carlson, John E.] Penn State Univ, Schatz Ctr Tree Mol Genet, University Pk, PA 16802 USA; [Khodwekar, Sudhir; Owusu, Sandra; Gailing, Oliver] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Xu, Tao; Xu, Yi; Liang, Haiying] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA; [Jennings, Tara; Cronn, Richard] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Arumuganathan, A. Kathiravetpilla] Benaroya Res Inst Virginia Mason, Flow Cytometry & Imaging Core Lab, Seattle, WA USA; [Coggeshall, Mark] Univ Missouri, Dept Forestry, Columbia, MO USA; [Romero-Severson, Jeanne] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Schlarbaum, Scott] Univ Tennessee, Dept Forestry Wildlife & Fisheries, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Michigan Technological University; Clemson University; Oregon State University; Benaroya Research Institute; Virginia Mason Medical Center; University of Missouri System; University of Missouri Columbia; University of Notre Dame; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Staton, M (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA.	mstaton1@utk.edu	Gailing, Oliver/X-2690-2019; Romero-Severson, Jeanne/B-5259-2011	Gailing, Oliver/0000-0002-4572-2408; Romero-Severson, Jeanne/0000-0003-4112-7238; Staton, Margaret/0000-0003-2971-9353; Cronn, Richard/0000-0001-5342-3494	National Science Foundation Plant Genome Research Program [TRPGRA2 IOS-1025974)]	National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD))	MS, MC, OG, HL, JR-S, SS, and JEC received funding from the National Science Foundation Plant Genome Research Program (grant no. TRPGRA2 IOS-1025974) for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], NATL STRATEGY IMPLEM; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P229, DOI [10.1007/BF02672073, DOI 10.1007/BF02672073]; Barbara T, 2007, MOL ECOL, V16, P3759, DOI 10.1111/j.1365-294X.2007.03439.x; Bennett MD, 2000, ANN BOT-LONDON, V86, P859, DOI 10.1006/anbo.2000.1253; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Castoe TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030953; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chase MR, 1996, NATURE, V383, P398, DOI 10.1038/383398a0; Chen C-C, 2015, J PLANT SCI MOL BREE, V4; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Chornesky EA, 2005, BIOSCIENCE, V55, P335, DOI 10.1641/0006-3568(2005)055[0335:SPFRTT]2.0.CO;2; Dayanandan S, 1999, MOL ECOL, V8, P1585, DOI 10.1046/j.1365-294x.1999.00735.x; DICKSON EE, 1992, AM J BOT, V79, P1081, DOI 10.2307/2444917; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Eujayl I, 2001, EUPHYTICA, V119, P39, DOI 10.1023/A:1017537720475; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Horjales M, 2003, NUCL DNA AMOUNTS TRE, P13; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jenczewski E, 1997, THEOR APPL GENET, V94, P682, DOI 10.1007/s001220050466; Jennings TN, 2011, MOL ECOL RESOUR, V11, P1060, DOI 10.1111/j.1755-0998.2011.03033.x; Jennings TN, 2011, AM J BOT, V98, pE323, DOI 10.3732/ajb.1100317; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Khodwekar S, 2015, ANN FOR RES, V58, P193; Kirkness EF, 2003, SCIENCE, V301, P1898, DOI 10.1126/science.1086432; Koskela J, 2013, BIOL CONSERV, V157, P39, DOI 10.1016/j.biocon.2012.07.023; Kremer Antoine, 2007, V7, P161; Kron P, 2007, ANNU REV ECOL EVOL S, V38, P847, DOI 10.1146/annurev.ecolsys.38.091206.095504; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Logan JA, 2003, FRONT ECOL ENVIRON, V1, P130, DOI 10.2307/3867985; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Metzgar D, 2000, GENOME RES, V10, P72; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Neale D, 2011, BMC P, V5, P14, DOI [10.1186/1753-6561-5-S7-I4, DOI 10.1186/1753-6561-5-S7-I4]; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Ochatt SJ, 2008, CYTOM PART A, V73A, P581, DOI 10.1002/cyto.a.20562; OHRI D, 1986, CARYOLOGIA, V39, P303, DOI 10.1080/00087114.1986.10797792; Owusu SA, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1300050; Pimentel D., 2002, BIOL INVASIONS EC EN; Rasmussen DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-382; Rungis D, 2004, THEOR APPL GENET, V109, P1283, DOI 10.1007/s00122-004-1742-5; Schlarbaum SE, 2002, FADING FORESTS 2 TRA; Segelbacher G, 2010, CONSERV GENET, V11, P375, DOI 10.1007/s10592-009-0044-5; Siljak-Yakovlev S, 2010, ADV SCI LETT, V3, P190, DOI 10.1166/asl.2010.1115; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Slavov GT, 2012, NEW PHYTOL, V196, P713, DOI 10.1111/j.1469-8137.2012.04258.x; Smit A, 1996, REPEATMASKER OPEN 30; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Sork VL, 2013, TREE GENET GENOMES, V9, P901, DOI 10.1007/s11295-013-0596-x; Staub JE, 1996, HORTSCIENCE, V31, P729, DOI 10.21273/HORTSCI.31.5.729; Straub SCK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-211; STRAUSS SH, 1992, CAN J FOREST RES, V22, P1050, DOI 10.1139/x92-140; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Wicker T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-518; Wolf PG, 2015, GENOME BIOL EVOL, V7, P2533, DOI 10.1093/gbe/evv163	60	19	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145031	10.1371/journal.pone.0145031	http://dx.doi.org/10.1371/journal.pone.0145031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698853	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600044
J	Dassah, S; Sakyi, SA; Frempong, MT; Luuse, AT; Ephraim, RKD; Anto, EO; Oduro, A				Dassah, Sylvester; Sakyi, Samuel A.; Frempong, Margaret T.; Luuse, Arnold T.; Ephraim, Richard K. D.; Anto, Enoch O.; Oduro, Abraham			Seroconversion of Hepatitis B Vaccine in Young Children in the Kassena Nankana District of Ghana: A Cross-Sectional Study	PLOS ONE			English	Article							EPIDEMIOLOGY; PERSISTENCE; PROTECTION; DISEASE; IMPACT	Background Hepatitis B Virus (HBV) infection is an important public health problem that requires high priority efforts towards prevention and control. Active immunization is the single most important and effective preventive measure against HBV infection. As a protective measure, Ghana introduced the mass immunization program against hepatitis B infection in children in 2002 in her Expanded Programme on Immunization (EPI). This study evaluated seroconversion (the point in time when the amount of antibody in the blood becomes detectable) and seroprotection (the point in time when the amount of antibody in the blood is enough to confer protection from the antigen that induced it production) status of children under this mass immunization program and measured their antibody levels five years after immunization. Materials and Method 200 archived plasma samples of children between the ages of 1-10 years were retrieved from a previous cross-sectional study by researchers from NHRC between 2009 and 2010. Of these, 104 have completed the EPI and were screened for HBsAg. Those found to be HBsAg-seronegative were stratified into three groups according to their age at which the last vaccine was administered. Their anti-HBsAg titer levels were estimated by enzyme linked immunosorbant assay (ELISA). Results Two (1.9%) samples were HBsAg seropositive and were excluded from further analyses. 10 more samples were excluded from analyses because they were insufficient. The antiHBs titers recorded ranged from 1.021 IU/L to 751.64 IU/L indicating a 100% seroconversion rate. In group one (0-6 months), 87.9% were seroprotected. Group two (2-3yrs) had 78.3% seroprotection and group three (3-5yrs) had 41.7% seroprotection. There was no significant difference between group 1 and 2. However, there was a significant difference between group 1 and 3 (p = 0.0137) and between group 2 and 3 (p = 0.0390) respectively. There was no significant difference between male and female children. Conclusion All the children who received doses of hepatitis B vaccine at 6, 10 and 14 weeks in the immunization program seroconverted, but their levels of protection waned with increasing years. Booster doses are therefore recommended after 5 years.	[Sakyi, Samuel A.; Frempong, Margaret T.; Anto, Enoch O.] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Mol Med, Kumasi, Ghana; [Dassah, Sylvester; Oduro, Abraham] Navrongo Hlth Res Ctr, Navrongo, Upper East, Ghana; [Luuse, Arnold T.] Univ Hlth & Allied Sci, Fac Allied Hlth Sci, Ho, Ghana; [Ephraim, Richard K. D.] Univ Cape Coast, Dept Med Lab Technol, Cape Coast, Ghana	Kwame Nkrumah University Science & Technology; Navrongo Health Research Center; University of Cape Coast	Sakyi, SA (corresponding author), Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Mol Med, Kumasi, Ghana.	samasamoahsakyi@yahoo.co.uk	Sakyi, Samuel Asamoah/AAQ-3998-2021; Anto, Enoch Odame/AAJ-7426-2020; Ephraim, Richard KD/X-3000-2019	Anto, Enoch Odame/0000-0001-9023-6612; sakyi, samuel/0000-0001-5168-4762; Dassah, Sylvester/0000-0002-1880-5507; ODURO, ABRAHAM/0000-0002-4191-7419				Abhijit Guho, 2010, Journal of Medicine, V11, P143; Advanced Life Support Group, 2011, CTR DIS CONTROL, P1; Chakraborty B, 2011, STAMFORD J MICROBIOL, V1, P37; Cho Y, 2012, GUT LIVER, V6, P235, DOI 10.5009/gnl.2012.6.2.235; da Motta MSF, 2002, VACCINE, V20, P1557, DOI 10.1016/S0264-410X(01)00493-5; Dentinger CM, 2005, PEDIATR INFECT DIS J, V24, P786, DOI 10.1097/01.inf.0000176617.63457.9f; El Mazahi MM, 2014, J AM SCI, V10; El-Sayed B., 2009, ZAGAZIG J OCCUP HLTH, V2, P17; Gomber S, 2000, Indian Pediatr, V37, P411; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lu CY, 2008, J INFECT DIS, V197, P1419, DOI 10.1086/587695; Luo ZB, 2012, INT J INFECT DIS, V16, pE82, DOI 10.1016/j.ijid.2011.10.009; Puvacic Sandra, 2005, Bosn J Basic Med Sci, V5, P50; Ribeiro Tereza Monteiro, 2006, Clinics, V61, P387, DOI 10.1590/S1807-59322006000500004; Rufai T, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.53.3390; Salama Iman I, 2014, Egypt J Immunol, V21, P13; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Tsebe KV, 2001, VACCINE, V19, P3919, DOI 10.1016/S0264-410X(01)00120-7; Yazdanpanah B, 2010, HEPAT MON, V10, P17; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056	20	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145209	10.1371/journal.pone.0145209	http://dx.doi.org/10.1371/journal.pone.0145209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716979	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500026
J	Forati, E; Sabouni, A; Ray, S; Head, B; Schoen, C; Sievenpiper, D				Forati, Ebrahim; Sabouni, Abas; Ray, Supriyo; Head, Brian; Schoen, Christian; Sievenpiper, Dan			Neurotransmitter Specific, Cellular-Resolution Functional Brain Mapping Using Receptor Coated Nanoparticles: Assessment of the Possibility	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; BIOMEDICAL APPLICATIONS; DOPAMINE TRANSPORTERS; NEURONS; METAMATERIALS; SPECTROSCOPY; DISEASE; SITES	Receptor coated resonant nanoparticles and quantum dots are proposed to provide a cellular-level resolution image of neural activities inside the brain. The functionalized nanoparticles and quantum dots in this approach will selectively bind to different neurotransmitters in the extra-synaptic regions of neurons. This allows us to detect neural activities in real time by monitoring the nanoparticles and quantum dots optically. Gold nanoparticles (GNPs) with two different geometries (sphere and rod) and quantum dots (QDs) with different sizes were studied along with three different neurotransmitters: dopamine, gamma-Aminobutyric acid (GABA), and glycine. The absorption/emission spectra of GNPs and QDs before and after binding of neurotransmitters and their corresponding receptors are reported. The results using QDs and nanorods with diameter 25nm and aspect rations larger than three were promising for the development of the proposed functional brain mapping approach.	[Forati, Ebrahim; Sabouni, Abas; Sievenpiper, Dan] Univ Calif San Diego, Elect & Comp Engn Dept, La Jolla, CA 92098 USA; [Ray, Supriyo] Univ Calif San Diego, Biomed Sci, La Jolla, CA 92098 USA; [Head, Brian] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92098 USA; [Schoen, Christian] Nanopartz Inc, Loveland, CO 80537 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Forati, E (corresponding author), Univ Calif San Diego, Elect & Comp Engn Dept, La Jolla, CA 92098 USA.	forati@ieee.org	Ray, Supriyo/L-1020-2019		UC San Diego Center for Brain Activity Mapping	UC San Diego Center for Brain Activity Mapping	This work was funded by UC San Diego Center for Brain Activity Mapping. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AQUILONIUS SM, 1987, ACTA NEUROL SCAND, V76, P283, DOI 10.1111/j.1600-0404.1987.tb03582.x; Atwater HA, 2007, SCI AM, V296, P56, DOI 10.1038/scientificamerican0407-56; Badgaiyan RD, 2011, CURR MED IMAGING, V7, P98; Bohren C. F., 2008, ABSORPTION SCATTERIN, DOI DOI 10.1002/9783527618156; Devasena T, 2015, BRAIN, V29, P31; Fischman AJ, 2006, PEDIATRIC PET IMAGING, P385, DOI 10.1007/0-387-34641-4_21; Forati E, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.085414; FOWLER JS, 1989, SYNAPSE, V4, P371, DOI 10.1002/syn.890040412; Gangaraj SAH, 2015, OPT EXPRESS, V23, P22330, DOI 10.1364/OE.23.022330; Ge RC, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.205425; GROVES PM, 1975, SCIENCE, V190, P522, DOI 10.1126/science.242074; Hanson GW, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.235440; Hanson GW, 2009, J APPL PHYS, V106, DOI 10.1063/1.3204653; Howes O, 2015, J PSYCHOPHARMACOL, V29, P97, DOI 10.1177/0269881114563634; INNIS RB, 1993, P NATL ACAD SCI USA, V90, P11965, DOI 10.1073/pnas.90.24.11965; Khurgin JB, 2015, NAT NANOTECHNOL, V10, P2, DOI 10.1038/nnano.2014.310; Khurgin JB, 2014, NAT PHOTONICS, V8, P468, DOI 10.1038/nphoton.2014.94; Khurgin JB, 2012, MRS BULL, V37, P768, DOI 10.1557/mrs.2012.173; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kruss S, 2014, J AM CHEM SOC, V136, P713, DOI 10.1021/ja410433b; LARUELLE M, 1993, SYNAPSE, V13, P295, DOI 10.1002/syn.890130402; Lee J, 2014, NANOSCALE, V6, P616, DOI [10.1039/c3nr04752, 10.1039/c3nr04752k]; Li DX, 2012, IEEE T BIO-MED ENG, V59, P3468, DOI 10.1109/TBME.2012.2219049; Liao HW, 2006, NANOMEDICINE-UK, V1, P201, DOI 10.2217/17435889.1.2.201; Maier S.A., 2007, PLASMONICS FUNDAMENT, DOI DOI 10.1007/0-387-37825-1; Maier SA, 2005, J APPL PHYS, V98, DOI 10.1063/1.1951057; Mozley PD, 1998, J NUCL MED, V39, p221P; Nath N, 2004, ANAL CHEM, V76, P5370, DOI 10.1021/ac049741z; PURCELL EM, 1946, PHYS REV, V69, P681; Raether H., 1988, SURFACE PLASMONS SMO, DOI 10.1007/BFb0048319; SALLER CF, 1980, SCIENCE, V210, P1269, DOI 10.1126/science.6254155; Shariatgorji M, 2014, NEURON, V84, P697, DOI 10.1016/j.neuron.2014.10.011; Tsai GE, 2014, AM J PSYCHIAT, V155, P726; Vollmer F, 2008, NAT METHODS, V5, P591, DOI 10.1038/nmeth.1221; West PR, 2010, LASER PHOTONICS REV, V4, P795, DOI 10.1002/lpor.200900055; Willets KA, 2007, ANNU REV PHYS CHEM, V58, P267, DOI 10.1146/annurev.physchem.58.032806.104607; Zayats AV, 2003, J OPT A-PURE APPL OP, V5, pS16, DOI 10.1088/1464-4258/5/4/353; Zhang JZ, 2010, J PHYS CHEM LETT, V1, P686, DOI 10.1021/jz900366c	38	2	2	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145852	10.1371/journal.pone.0145852	http://dx.doi.org/10.1371/journal.pone.0145852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717196	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500083
J	Kuan, CS; Yew, SM; Toh, YF; Chan, CL; Lim, SK; Lee, KW; Na, SL; Hoh, CC; Yee, WY; Ng, KP				Kuan, Chee Sian; Yew, Su Mei; Toh, Yue Fen; Chan, Chai Ling; Lim, Soo Kun; Lee, Kok Wei; Na, Shiang Ling; Hoh, Chee-Choong; Yee, Wai-Yan; Ng, Kee Peng			Identification and Characterization of a Rare Fungus, Quambalana cyanescens, Isolated from the Peritoneal Fluid of a Patient after Nocturnal Intermittent Peritoneal Dialysis	PLOS ONE			English	Article							SPOROTHRIX-CYANESCENS; ECHINOCANDIN RESISTANCE; EMERGENCE	Peritonitis is the leading complication of peritoneal dialysis, which is primarily caused by bacteria rather than fungi. Peritonitis is responsible for approximately 18% of the infection-related mortality in peritoneal dialysis patients. In this paper, we report the isolation of a rare fungus, Quambalaria cyanescens, from the peritoneal fluid of a man after he switched from continuous ambulatory peritoneal dialysis to nocturnal intermittent peritoneal dialysis. Based on the morphological examination and multigene phylogeny, the clinical isolate was confirmed as Q. cyanescens. This pathogen exhibited low sensitivity to all tested echinocandins and 5-flucytosine. Interestingly, morphological characterization revealed that Q. cyanescens UM 1095 produced different pigments at low temperatures (25 degrees C and 30 degrees C) on various culture media. It is important to monitor the emergence of this rare fungus as a potential human pathogen in the tropics. This study provides insight into Q. cyanescens UM 1095 phenotype profiles using a Biolog phenotypic microarray (PM). Of the 760 nutrient sources tested, Q. cyanescens UM 1095 utilized 42 compounds, and the fungus can adapt to a broad range of osmotic and acidic environments. To our knowledge, this is the first report of the isolation of Q. cyanescens from peritoneal fluid, revealing this rare fungus as a potential human pathogen that may be misidentified using conventional methods. The detailed morphological, molecular and phenotypic characterization of Q. cyanescens UM 1095 provides the basis for future studies on its biology, lifestyle, and potential pathogenicity.	[Kuan, Chee Sian; Yew, Su Mei; Toh, Yue Fen; Chan, Chai Ling; Na, Shiang Ling; Ng, Kee Peng] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Lim, Soo Kun] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Lee, Kok Wei; Hoh, Chee-Choong; Yee, Wai-Yan] Codon Genom SB, Selangor Darul Ehsan, Malaysia	Universiti Malaya; Universiti Malaya	Ng, KP (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	kpng@ummc.edu.my	Lim, Soo Kun/Q-2012-2019; LIM, SOO KUN/B-8868-2010	Lim, Soo Kun/0000-0001-7589-5150; LIM, SOO KUN/0000-0001-7589-5150	High Impact Research MoE Grant from Ministry of Education Malaysia [UM.C/625/1/HIR/MOHE/MED/31, H-20001-00-E000070]; Codon Genomics SB	High Impact Research MoE Grant from Ministry of Education Malaysia; Codon Genomics SB	This study was supported by High Impact Research MoE Grant UM.C/625/1/HIR/MOHE/MED/31 (Account no. H-20001-00-E000070) from the Ministry of Education Malaysia. Codon Genomics SB provided support in the form of salaries for authors KWL, CCH and WYY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions section.	Amin R. M., 2010, Mycology - An International Journal on Fungal Biology, V1, P67; Antropova A B, 2014, Mikrobiologiia, V83, P605; Axner-Elings M, 2011, J CLIN MICROBIOL, V49, P2516, DOI 10.1128/JCM.00201-11; Baixench MT, 2007, J ANTIMICROB CHEMOTH, V59, P1076, DOI 10.1093/jac/dkm095; Cheewangkoon R, 2009, PERSOONIA, V23, P55, DOI 10.3767/003158509X474752; Dannaoui E, 2012, EMERG INFECT DIS, V18, P86, DOI 10.3201/eid1801.110556; de Beer ZW, 2006, STUD MYCOL, P289, DOI 10.3114/sim.55.1.289; DEHOOG GS, 1973, A VAN LEEUW J MICROB, V39, P515, DOI 10.1007/BF02578895; Fan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106949; Fekkar A, 2013, ANTIMICROB AGENTS CH, V57, P2380, DOI 10.1128/AAC.02037-12; Goldie SJ, 1996, AM J KIDNEY DIS, V28, P86, DOI 10.1016/S0272-6386(96)90135-3; Gunde-Cimerman N, 2000, FEMS MICROBIOL ECOL, V32, P235; Hamai K, 1999, CLIN EXP NEPHROL, V3, P59, DOI [10.1007/s101570050011, DOI 10.1007/S101570050011]; HAU T, 1990, WORLD J SURG, V14, P167, DOI 10.1007/BF01664869; Islam Saleem, 2002, Surg Infect (Larchmt), V3, P35, DOI 10.1089/109629602753681140; JACKSON L, 1990, J MED VET MYCOL, V28, P455; KERR CM, 1983, ANN INTERN MED, V99, P334, DOI 10.7326/0003-4819-99-3-334; Kleinpeter Myra A, 2004, Adv Perit Dial, V20, P58; Kogej T, 2007, MICROBIOL-SGM, V153, P4261, DOI 10.1099/mic.0.2007/010751-0; Kolarik Miroslav, 2006, Czech Mycology, V58, P81; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; MOORE RT, 1987, STUD MYCOL, P203; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; NAGAPPAN R, 1992, AM J KIDNEY DIS, V20, P492, DOI 10.1016/S0272-6386(12)70262-7; Paap T, 2008, MYCOL RES, V112, P57, DOI 10.1016/j.mycres.2007.10.005; Padhi S, 2013, ANN MICROBIOL, V63, P793, DOI 10.1007/s13213-012-0534-4; Pasquale T, 2008, J ANTIMICROB CHEMOTH, V61, P219, DOI 10.1093/jac/dkm453; Pfaller MA, 2008, J CLIN MICROBIOL, V46, P2620, DOI 10.1128/JCM.00566-08; Pfaller MA, 2011, DRUG RESIST UPDATE, V14, P164, DOI 10.1016/j.drup.2011.01.004; Prasad KN, 2004, J INFECTION, V48, P96, DOI 10.1016/S0163-4453(03)00119-1; SIGLER L, 1990, J CLIN MICROBIOL, V28, P1009, DOI 10.1128/JCM.28.5.1009-1015.1990; Simpson J. A., 2000, Australasian Mycologist, V19, P57; Stodulkova E, 2008, FOLIA MICROBIOL, V53, P15, DOI 10.1007/s12223-008-0002-5; Stodulkova E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118913; Tambini R, 1996, J MED VET MYCOL, V34, P195; Wang AYM, 2000, AM J KIDNEY DIS, V36, P1183, DOI 10.1053/ajkd.2000.19833; Yew SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104352	37	7	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145932	10.1371/journal.pone.0145932	http://dx.doi.org/10.1371/journal.pone.0145932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716988	gold, Green Submitted, Green Published			2022-12-27	WOS:000367510500098
J	Kupper, Z; Ramseyer, F; Hoffmann, H; Tschacher, W				Kupper, Zeno; Ramseyer, Fabian; Hoffmann, Holger; Tschacher, Wolfgang			Nonverbal Synchrony in Social Interactions of Patients with Schizophrenia Indicates Socio-Communicative Deficits	PLOS ONE			English	Article							VOCATIONAL-REHABILITATION; NEGATIVE SYMPTOMS; BODY MOVEMENT; BEHAVIOR; IMITATION; COGNITION; PATTERNS; NEUROCOGNITION; COORDINATION; RECOGNITION	Background Disordered interpersonal communication can be a serious problem in schizophrenia. Recent advances in computer-based measures allow reliable and objective quantification of nonverbal behavior. Research using these novel measures has shown that objective amounts of body and head movement in patients with schizophrenia during social interactions are closely related to the symptom profiles of these patients. In addition to and above mere amounts of movement, the degree of synchrony, or imitation, between patients and normal interactants may be indicative of core deficits underlying various problems in domains related to interpersonal communication, such as symptoms, social competence, and social functioning. Methods Nonverbal synchrony was assessed objectively using Motion Energy Analysis (MEA) in 378 brief, videotaped role-play scenes involving 27 stabilized outpatients diagnosed with paranoid-type schizophrenia. Results Low nonverbal synchrony was indicative of symptoms, low social competence, impaired social functioning, and low self-evaluation of competence. These relationships remained largely significant when correcting for the amounts of patients' movement. When patients showed reduced imitation of their interactants' movements, negative symptoms were likely to be prominent. Conversely, positive symptoms were more prominent in patients when their interaction partners' imitation of their movements was reduced. Conclusions Nonverbal synchrony can be an objective and sensitive indicator of the severity of patients' problems. Furthermore, quantitative analysis of nonverbal synchrony may provide novel insights into specific relationships between symptoms, cognition, and core communicative problems in schizophrenia.	[Kupper, Zeno] Univ Bern, Univ Hosp Psychiat, Translat Res Ctr, Div Mol Psychiat, Bern, Switzerland; [Ramseyer, Fabian] Univ Bern, Dept Clin Psychol & Psychotherapy, Bern, Switzerland; [Ramseyer, Fabian] Univ Bern, Univ Hosp Old Age Psychiat, ARTORG Gerontechnol & Rehabil, Bern, Switzerland; [Hoffmann, Holger] Univ Bern, Univ Hosp Psychiat, Ctr Psychiat Rehabil, Bern, Switzerland; [Tschacher, Wolfgang] Univ Bern, Univ Hosp Psychiat, Translat Res Ctr, Div Syst Neurosci Psychopathol, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Kupper, Z (corresponding author), Univ Bern, Univ Hosp Psychiat, Translat Res Ctr, Div Mol Psychiat, Bern, Switzerland.	zeno.kupper@spk.unibe.ch	Ramseyer, Fabian T/A-6995-2012	Ramseyer, Fabian T/0000-0001-6878-724X; Tschacher, Wolfgang/0000-0001-7357-0280	Swiss National Science Foundation (SNF) [3200-028795]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Science Foundation (SNF; grant number 3200-028795). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann U, 2011, LECT NOTES COMPUT SC, V6800, P335, DOI 10.1007/978-3-642-25775-9_31; ANDREASEN NC, 1986, SCHIZOPHRENIA BULL, V12, P348, DOI 10.1093/schbul/12.3.348; Annen S, 2012, J NERV MENT DIS, V200, P26, DOI 10.1097/NMD.0b013e31823e653b; [Anonymous], 1964, MESSUNG INTELLIGENZ; Bellack A. S., 1990, PSYCHOL ASSESSMENT J, V2, P248, DOI DOI 10.1037/1040-3590.2.3; Bellack AS, 2006, BEHAV THER, V37, P339, DOI 10.1016/j.beth.2006.01.005; Benjamini Y, 2001, ANN STAT, V29, P1165; Bernieri F.J., 1991, FUNDAMENTALS NONVERB, P401, DOI DOI 10.1017/CBO9781107415324.004; BERNIERI FJ, 1988, J PERS SOC PSYCHOL, V54, P243, DOI 10.1037/0022-3514.54.2.243; Bleuler E., 1911, DEMENTIA PRAECOX ODE; Boker SM, 2002, PSYCHOL METHODS, V7, P338, DOI 10.1037//1082-989X.7.3.338; Brune M, 2008, J NERV MENT DIS, V196, P282, DOI 10.1097/NMD.0b013e31816a4922; Chartrand TL, 2013, ANNU REV PSYCHOL, V64, P285, DOI 10.1146/annurev-psych-113011-143754; CONDON WS, 1966, J NERV MENT DIS, V143, P338, DOI 10.1097/00005053-196610000-00005; Del-Monte J, 2013, PSYCHIAT RES, V210, P29, DOI 10.1016/j.psychres.2013.05.034; Del-Monte J, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00137; Derrick TR, 2004, INNOVATIVE ANAL HUMA; Deusinger I.M., 1986, FRANKFURTER SELBSTKO; Dillman, 1995, INTERPERSONAL ADAPTA; ELLGRING H, 1986, EUR ARCH PSY CLIN N, V236, P31, DOI 10.1007/BF00641055; Gaebel W, 2004, EUR ARCH PSY CLIN N, V254, P335, DOI 10.1007/s00406-004-0510-5; Gallese V, 2006, BRAIN RES, V1079, P15, DOI 10.1016/j.brainres.2006.01.054; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V., 2005, PHENOMENOLOGY COGNIT, V4, P23, DOI [10.1007/s11097-005-4737-z, DOI 10.1007/S11097-005-4737-Z]; Gallese V, 2011, TRENDS COGN SCI, V15, P512, DOI 10.1016/j.tics.2011.09.003; Giacco D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050119; Grammer K, 1999, J PERS SOC PSYCHOL, V77, P487, DOI 10.1037/0022-3514.77.3.487; Grammer K, 1998, J NONVERBAL BEHAV, V22, P3, DOI 10.1023/A:1022986608835; Green MF, 2008, SCHIZOPHRENIA BULL, V34, P670, DOI 10.1093/schbul/sbn045; HARDIN SB, 1980, RES NURS HEALTH, V3, P57, DOI 10.1002/nur.4770030204; HILL D, 1974, BRIT J PSYCHIAT, V124, P221, DOI 10.1192/bjp.124.3.221; Hoffmann H, 1997, SCHIZOPHR RES, V23, P69, DOI 10.1016/S0920-9964(96)00082-5; Hoffmann H, 1998, J NERV MENT DIS, V186, P214, DOI 10.1097/00005053-199804000-00003; Hoffmann H, 2000, SCHIZOPHR RES, V43, P147, DOI 10.1016/S0920-9964(99)00148-6; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Janke W., 1985, STRESSVERARBEITUNGSF; Jung E, 1989, DISABILITY ASSESSMEN; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kohler CG, 2008, SCHIZOPHR RES, V105, P49, DOI 10.1016/j.schres.2008.05.010; Kuipers E, 2006, SCHIZOPHRENIA BULL, V32, pS24, DOI 10.1093/schbul/sbl014; Kupper Z, 2004, Z KLIN PSYCHOL PSYCH, V52, P59; Kupper Z, 2000, SCHIZOPHRENIA BULL, V26, P681, DOI 10.1093/oxfordjournals.schbul.a033486; Kupper Z, 2010, SCHIZOPHR RES, V121, P90, DOI 10.1016/j.schres.2010.03.032; Latif N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105036; Lavelle M., 2011, THESIS; Lavelle M, 2014, J NERV MENT DIS, V202, P47, DOI 10.1097/NMD.0000000000000031; Lavelle M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077506; Lavelle M, 2013, SCHIZOPHRENIA BULL, V39, P1150, DOI 10.1093/schbul/sbs091; Leclere C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113571; Lee J, 2011, PSYCHOL MED, V41, P2297, DOI 10.1017/S0033291711000614; LINDENMAYER JP, 1995, SCHIZOPHR RES, V14, P229, DOI 10.1016/0920-9964(94)00041-6; Mattes RM, 1995, SCHIZOPHR RES, V17, P249, DOI 10.1016/0920-9964(95)00014-3; Matthews N, 2013, SCHIZOPHRENIA BULL, V39, P94, DOI 10.1093/schbul/sbr062; McGarva AR, 2003, J PSYCHOLINGUIST RES, V32, P335, DOI 10.1023/A:1023547703110; Mehta UM, 2014, SCHIZOPHRENIA BULL, V40, P1083, DOI 10.1093/schbul/sbt155; Meyer EC, 2014, SCHIZOPHRENIA BULL, V40, P1452, DOI 10.1093/schbul/sbt235; Morrens M, 2015, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00145; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Nelson A., 2014, J OPEN PSYCHOL DATA, V2, pe5, DOI [10.5334/jopd.ae, DOI 10.5334/JOPD.AE, DOI 10.5334/J0PD.AE]; Park S, 2008, SCHIZOPHRENIA BULL, V34, P698, DOI 10.1093/schbul/sbn048; Parnas J, 2011, SCHIZOPHRENIA BULL, V37, P1121, DOI 10.1093/schbul/sbr081; Paxton A, 2013, BEHAV RES METHODS, V45, P329, DOI 10.3758/s13428-012-0249-2; Pounds Karen Goyette, 2010, Issues Ment Health Nurs, V31, P770, DOI 10.3109/01612840.2010.518337; Raffard S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08156; Ramseyer F, 2008, MEA COMPUTER PROGRAM; Ramseyer F., 2006, CONSTRUCTIVISM HUMAN, V11, P150, DOI DOI 10.1007/978-3-642-12397-9-15; Ramseyer F., 2008, SIMULTANEITY TEMPORA, P329, DOI DOI 10.1142/9789812792426_0020; Ramseyer F, 2011, J CONSULT CLIN PSYCH, V79, P284, DOI 10.1037/a0023419; Ramseyer F, 2010, LECT NOTES COMPUT SC, V5967, P182, DOI 10.1007/978-3-642-12397-9_15; Riggio R.E., 2005, APPL NONVERBAL COMMU; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Roder V, 2006, SCHIZOPHRENIA BULL, V32, pS81, DOI 10.1093/schbul/sbl021; RUMKE HC, 1941, ZENTRALBLATT GESAMTE, V102, P168; Scheflen A.E., 1973, COMMUNICATIONAL STRU; Schmidt SJ, 2011, SCHIZOPHRENIA BULL, V37, pS41, DOI 10.1093/schbul/sbr079; Segerstrale U, 1997, NONVERBAL COMMUNICAT; Tremeau F, 2005, AM J PSYCHIAT, V162, P92, DOI 10.1176/appi.ajp.162.1.92; Tschacher W, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01323; Varlet M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029772; Voelkl B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000611; Walther S, 2015, SCHIZOPHRENIA BULL, V41, P338, DOI 10.1093/schbul/sbu222; Walther S, 2014, SCHIZOPHRENIA BULL, V40, P585, DOI 10.1093/schbul/sbt038; Walther S, 2009, WORLD J BIOL PSYCHIA, V10, P746, DOI 10.1080/15622970701882425; Young JW, 2007, NEUROSCI BIOBEHAV R, V31, P882, DOI 10.1016/j.neubiorev.2007.05.009	85	67	67	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145882	10.1371/journal.pone.0145882	http://dx.doi.org/10.1371/journal.pone.0145882			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716444	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500087
J	Ritz, C; Baty, F; Streibig, JC; Gerhard, D				Ritz, Christian; Baty, Florent; Streibig, Jens C.; Gerhard, Daniel			Dose-Response Analysis Using R	PLOS ONE			English	Article							NONLINEAR-REGRESSION; SIMULTANEOUS INFERENCE; MODEL; TRANSFORMATIONS; BIOASSAY; POTENCY; PACKAGE; GROWTH	Dose-response analysis can be carried out using multi-purpose commercial statistical software, but except for a few special cases the analysis easily becomes cumbersome as relevant, non-standard output requires manual programming. The extension package drc for the statistical environment R provides a flexible and versatile infrastructure for dose-response analyses in general. The present version of the package, reflecting extensions and modifications over the last decade, provides a user-friendly interface to specify the model assumptions about the dose-response relationship and comes with a number of extractors for summarizing fitted models and carrying out inference on derived parameters. The aim of the present paper is to provide an overview of state-of-the-art dose-response analysis, both in terms of general concepts that have evolved and matured over the years and by means of concrete examples.	[Ritz, Christian] Univ Copenhagen, Dept Nutr Exercise & Sports, DK-1958 Frederiksberg C, Denmark; [Baty, Florent] Kantonsspital St Gallen, Pneumol, CH-9007 St Gallen, Switzerland; [Streibig, Jens C.] Univ Copenhagen, Dept Plant & Environm Sci, DK-2630 Taastrup, Denmark; [Gerhard, Daniel] Univ Canterbury, Sch Math & Stat, Christchurch 8140, New Zealand	University of Copenhagen; Kantonsspital St. Gallen; University of Copenhagen; University of Canterbury	Ritz, C (corresponding author), Univ Copenhagen, Dept Nutr Exercise & Sports, Rolighedsvej 26, DK-1958 Frederiksberg C, Denmark.	ritz@nexs.ku.dk	Gerhard, Daniel/J-7193-2017; He, Liye/C-8843-2015; Ritz, Christian/P-6159-2014; Streibig, Jens Carl/G-5959-2014	Gerhard, Daniel/0000-0002-9336-3454; He, Liye/0000-0002-6632-2112; Ritz, Christian/0000-0002-5095-0624; Streibig, Jens Carl/0000-0002-6204-4004				Altop EK, 2014, CROP PROT, V65, P202, DOI 10.1016/j.cropro.2014.07.011; Andersen Jens Strodl, 1998, Journal of Agricultural Biological and Environmental Statistics, V3, P405, DOI 10.2307/1400573; Andreasen C, 2014, HORTSCIENCE, V49, P538, DOI 10.21273/HORTSCI.49.5.538; Baty F, 2015, J STAT SOFTW, V66, P1; Belz RG, 2015, ENVIRON TOXICOL CHEM, V34, P1169, DOI 10.1002/etc.2857; Bornkamp B, 2009, J STAT SOFTW, V29, P1; BRAIN P, 1989, WEED RES, V29, P93, DOI 10.1111/j.1365-3180.1989.tb00845.x; CARROLL RJ, 1984, J AM STAT ASSOC, V79, P321, DOI 10.2307/2288271; Cedergreen N, 2005, ENVIRON TOXICOL CHEM, V24, P3166, DOI 10.1897/05-014R.1; Christensen MG, 2003, PEST MANAG SCI, V59, P1303, DOI 10.1002/ps.763; Cornou C, 2013, ANIM PROD SCI, V53, P585, DOI 10.1071/AN12091; Finney D.J., 1971, PROBIT ANAL; FINNEY DJ, 1979, INT STAT REV, V47, P1, DOI 10.2307/1403201; Garnier-Laplace J, 2010, J RADIOL PROT, V30, P215, DOI 10.1088/0952-4746/30/2/S02; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Huber P. H., 1981, ROBUST STAT; Jensen JE, 2000, HERBICIDES THEIR MEC; Jensen SM, 2015, RISK ANAL, V35, P68, DOI 10.1111/risa.12242; Kahm M, 2010, J STAT SOFTW, V33, P1; Kang SH, 2000, REGUL TOXICOL PHARM, V32, P68, DOI 10.1006/rtph.2000.1404; Kniss AR, 2011, WEED SCI, V59, P601, DOI 10.1614/WS-D-11-00034.1; Martin-Betancor K, 2015, SCI REP-UK, V5, DOI 10.1038/srep17200; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Namata H, 2008, RISK ANAL, V28, P891, DOI 10.1111/j.1539-6924.2008.01063.x; Nash JC, 2014, J STAT SOFTW, V60, P1; NORMOLLE DP, 1993, STAT MED, V12, P2025, DOI 10.1002/sim.4780122106; Pinheiro J, 2015, NLME LINEAR NONLINEA; Pinheiro J, 2014, STAT MED, V33, P1646, DOI 10.1002/sim.6052; Pires AM, 2002, ENVIRONMETRICS, V13, P15, DOI 10.1002/env.501; R Core Team, 2013, R LANG ENV STAT COMP; Ranke J., 2006, R NEWS, V3, P7; Ricketts JH, 1999, AM J PHYSIOL-REG I, V277, pR441, DOI 10.1152/ajpregu.1999.277.2.R441; Ritz C, 2005, J STAT SOFTW, V12, P1; Ritz C, 2015, MARGINALIZATIO UNPUB; Ritz C, 2006, WEED SCI, V54, P407, DOI 10.1614/WS-05-185R.1; Ritz C, 2013, STAT BIOPHARM RES, V5, P79, DOI 10.1080/19466315.2012.757559; Ritz C, 2013, EUR J AGRON, V45, P1, DOI 10.1016/j.eja.2012.10.003; Ritz C, 2008, USE R, P1; Ritz C, 2010, ENVIRON TOXICOL CHEM, V29, P220, DOI 10.1002/etc.7; Ritz C, 2009, ENVIRON TOXICOL CHEM, V28, P2009, DOI 10.1897/08-480.1; RUDEMO M, 1989, BIOMETRICS, V45, P349, DOI 10.2307/2531482; Streibig, 2014, SYNERGY, V1, P22, DOI [10.1016/j.synres.2014.07.010, DOI 10.1016/J.SYNRES.2014.07.010]; Streibig J. C., 1993, Herbicide bioassays., P29; STREIBIG JC, 1981, WEED SCI, V29, P469, DOI 10.1017/S0043174500040017; Streibig JC, 1998, PESTIC SCI, V53, P21, DOI 10.1002/(SICI)1096-9063(199805)53:1&lt;21::AID-PS748&gt;3.0.CO;2-L; STROMBERG AJ, 1993, J AM STAT ASSOC, V88, P237, DOI 10.2307/2290718; Therneau T.M., 2000, MODELING SURVIVAL DA; Van der Vaart AW, 2000, ASYMPTOTIC STAT, V3; Van der Vliet L, 2013, ENCY AQUATIC ECOTOXI, P1081, DOI [10.1007/978-94-007-5704-2_98, DOI 10.1007/978-94-007-5704-2_98]; Venables WN., 2002, MODERN APPL STAT S 4; Weimer M, 2012, TOXICOL LETT, V213, P292, DOI 10.1016/j.toxlet.2012.07.012; Weisberg S., 2005, APPL LINEAR REGRESSI, DOI DOI 10.1002/0471704091; Wheeler MW, 2009, ENVIRON ECOL STAT, V16, P37, DOI 10.1007/s10651-007-0071-7; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/; ZEILEIS A., 2006, J STAT SOFTW, V16, P1, DOI DOI 10.18637/JSS.V016.I09	55	1458	1488	10	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146021	10.1371/journal.pone.0146021	http://dx.doi.org/10.1371/journal.pone.0146021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717316	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500116
J	Tokuda, S; Kim, YH; Matsumoto, H; Muro, S; Hirai, T; Mishima, M; Furuse, M				Tokuda, Shinsaku; Kim, Young Hak; Matsumoto, Hisako; Muro, Shigeo; Hirai, Toyohiro; Mishima, Michiaki; Furuse, Mikio			Effects of Hydrostatic Pressure on Carcinogenic Properties of Epithelia	PLOS ONE			English	Article							INTERSTITIAL FLUID PRESSURE; TIGHT JUNCTION; ZONULAE-OCCLUDENTES; BARRIER FUNCTION; 2 STRAINS; IDENTIFICATION; EXPRESSION; CANCER; CELLS; INFLAMMATION	The relationship between chronic inflammation and cancer is well known. The inflammation increases the permeability of blood vessels and consequently elevates pressure in the interstitial tissues. However, there have been only a few reports on the effects of hydrostatic pressure on cultured cells, and the relationship between elevated hydrostatic pressure and cell properties related to malignant tumors is less well understood. Therefore, we investigated the effects of hydrostatic pressure on the cultured epithelial cells seeded on permeable filters. Surprisingly, hydrostatic pressure from basal to apical side induced epithelial stratification in Madin-Darby canine kidney (MDCK) I and Caco-2 cells, and cavities with microvilli and tight junctions around their surfaces were formed within the multi-layered epithelia. The hydrostatic pressure gradient also promoted cell proliferation, suppressed cell apoptosis, and increased transepithelial ion permeability. The inhibition of protein kinase A (PKA) promoted epithelial stratification by the hydrostatic pressure whereas the activation of PKA led to suppressed epithelial stratification. These results indicate the role of the hydrostatic pressure gradient in the regulation of various epithelial cell functions. The findings in this study may provide clues for the development of a novel strategy for the treatment of the carcinoma.	[Tokuda, Shinsaku; Kim, Young Hak; Matsumoto, Hisako; Muro, Shigeo; Hirai, Toyohiro; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Furuse, Mikio] Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 444, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Tokuda, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan.	tokku@kuhp.kyoto-u.ac.jp; furuse@nips.ac.jp		Furuse, Mikio/0000-0003-2847-8156	Funding Program for Next Generation World Leading Researchers from the Japan Society for the Promotion of Science [LS084]; Japan Society for the Promotion of Science [26291043]	Funding Program for Next Generation World Leading Researchers from the Japan Society for the Promotion of Science; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding Program for Next Generation World Leading Researchers from the Japan Society for the Promotion of Science, LS084, http://www.jsps.go.jp/, MF; The Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science, 26291043, http://www.jsps.go.jp/, MF.	Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Aung KZ, 2012, J ORTHOP RES, V30, P2038, DOI 10.1002/jor.22154; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; BARKER G, 1981, Q J EXP PHYSIOL CMS, V66, P61, DOI 10.1113/expphysiol.1981.sp002529; Chen YH, 1997, J CELL BIOL, V138, P891, DOI 10.1083/jcb.138.4.891; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DiResta GR, 2005, ANN BIOMED ENG, V33, P1270, DOI 10.1007/s10439-005-5732-9; DRAGSTEN PR, 1981, NATURE, V294, P718, DOI 10.1038/294718a0; EAGLE H, 1967, NATURE, V213, P1102, DOI 10.1038/2131102a0; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; ITOH M, 1991, J CELL BIOL, V115, P1449, DOI 10.1083/jcb.115.5.1449; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KIMIZUKA H, 1964, J THEOR BIOL, V6, P290, DOI 10.1016/0022-5193(64)90035-9; Lunt SJ, 2008, FUTURE ONCOL, V4, P793, DOI 10.2217/14796694.4.6.793; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; Milosevic M, 2001, CANCER RES, V61, P6400; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Reuss L., 2001, TIGHT JUNCTIONS, V2, P61; Saitou M, 1997, EUR J CELL BIOL, V73, P222; STAEHELIN LA, 1973, J CELL SCI, V13, P763; STEVENSON BR, 1988, J CELL BIOL, V107, P2401, DOI 10.1083/jcb.107.6.2401; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tokuda S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119869; Tokuda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104994; Tokuda S, 2009, BIOCHEM BIOPH RES CO, V390, P1315, DOI 10.1016/j.bbrc.2009.10.144; Turksen K, 2011, BBA-REV CANCER, V1816, P73, DOI 10.1016/j.bbcan.2011.04.001; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Vendramini-Costa DB, 2012, CURR PHARM DESIGN, V18, P3831; Weinberg R. A., 2013, BIOL CANC; Wu CJ, 2013, J BIOL CHEM, V288, P12253, DOI 10.1074/jbc.M113.457499; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154	45	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145522	10.1371/journal.pone.0145522	http://dx.doi.org/10.1371/journal.pone.0145522			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716691	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500040
J	Toscano, H; Schubert, TW				Toscano, Hugo; Schubert, Thomas W.			Judged and Remembered Trustworthiness of Faces Is Enhanced by Experiencing Multisensory Synchrony and Asynchrony in the Right Order	PLOS ONE			English	Article							SELF-OTHER BOUNDARIES; MOVEMENT SYNCHRONY; MIMICRY; TRUST; CATEGORIZATION; ENTITATIVITY; RECOGNITION; INTEGRATION; ILLUSION; AMYGDALA	This work builds on the enfacement effect. This effect occurs when experiencing a rhythmic stimulation on one's cheek while seeing someone else's face being touched in a synchronous way. This typically leads to cognitive and social-cognitive effects similar to self-other merging. In two studies, we demonstrate that this multisensory stimulation can change the evaluation of the other's face. In the first study, participants judged the stranger's face and similar faces as being more trustworthy after synchrony, but not after asynchrony. Synchrony interacted with the order of the stroking; hence trustworthiness only changed when the synchronous stimulation occurred before the asynchronous one. In the second study, a synchronous stimulation caused participants to remember the stranger's face as more trustworthy, but again only when the synchronous stimulation came before the asynchronous one. The results of both studies show that order of stroking creates a context in which multisensory synchrony can affect the trustworthiness of faces.	[Toscano, Hugo; Schubert, Thomas W.] Inst Univ Lisboa ISCTE IUL, Ctr Invest & Intervencao Social, Lisbon, Portugal; [Schubert, Thomas W.] Univ Oslo, Dept Psychol, Oslo, Norway	Instituto Universitario de Lisboa; University of Oslo	Schubert, TW (corresponding author), Inst Univ Lisboa ISCTE IUL, Ctr Invest & Intervencao Social, Lisbon, Portugal.	thomas.wolfgang.schubert@gmail.com		Schubert, Thomas/0000-0002-3797-4568	Fundacao para a Ciencia e a Tecnologia (FCT) grant SFRH(Science Foundation Research) [BD/75435/2010]	Fundacao para a Ciencia e a Tecnologia (FCT) grant SFRH(Science Foundation Research)	This research and development was supported by Fundacao para a Ciencia e a Tecnologia (FCT) grant SFRH(Science Foundation Research)/BD/75435/2010. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, FAC MAIN SOFTW DEV K; Blair IV, 2004, PSYCHOL SCI, V15, P674, DOI 10.1111/j.0956-7976.2004.00739.x; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; DeBruine LM, 2002, P ROY SOC B-BIOL SCI, V269, P1307, DOI 10.1098/rspb.2002.2034; DONALDSON TS, 1968, J AM STAT ASSOC, V63, P660, DOI 10.2307/2284037; Engell AD, 2007, J COGNITIVE NEUROSCI, V19, P1508, DOI 10.1162/jocn.2007.19.9.1508; Epley N, 2008, PERS SOC PSYCHOL B, V34, P1159, DOI 10.1177/0146167208318601; Farmer H, 2014, PSYCHOL SCI, V25, P290, DOI 10.1177/0956797613494852; Fiske AP, 2004, RELATIONAL MODELS THEORY: CONTEMPORARY OVERVIEW, P61; GLASS GV, 1972, REV EDUC RES, V42, P237, DOI 10.2307/1169991; Hall C.C., 2009, POLITICAL PSYCHOL DE, P73, DOI DOI 10.1093/ACPROF:OSO/9780195335453.001.0001; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Jacques C, 2006, PSYCHOL SCI, V17, P485, DOI 10.1111/j.1467-9280.2006.01733.x; Jones BC, 2007, J EVOL PSYCHOL, V5, P119, DOI DOI 10.1556/JEP.2007.1001; Kraus MW, 2010, PSYCHOL SCI, V21, P518, DOI 10.1177/0956797610364949; Kret ME, 2015, PSYCHOL SCI, V26, P1401, DOI 10.1177/0956797615588306; Lakens D, 2011, SOC COGNITION, V29, P1, DOI 10.1521/soco.2011.29.1.1; Lakens D, 2010, J EXP SOC PSYCHOL, V46, P701, DOI 10.1016/j.jesp.2010.03.015; Lakin JL, 2003, J NONVERBAL BEHAV, V27, P145, DOI 10.1023/A:1025389814290; Levin DT, 2000, PERCEPT PSYCHOPHYS, V62, P386, DOI 10.3758/BF03205558; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Mazzurega M, 2011, EXP BRAIN RES, V213, P213, DOI 10.1007/s00221-011-2744-6; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Paladino MP, 2010, PSYCHOL SCI, V21, P1202, DOI 10.1177/0956797610379234; Schubert TW, 2002, SELF IDENTITY, V1, P353, DOI 10.1080/152988602760328012; Schubert TW, 2015, ORDER EFFECTS UNPUB; Seibt B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01122; Sforza A, 2010, SOC NEUROSCI-UK, V5, P148, DOI 10.1080/17470910903205503; Tajadura-Jimenez A, 2013, CONSCIOUS COGN, V22, P1352, DOI 10.1016/j.concog.2013.09.002; Tajadura-Jimenez A, 2012, CONSCIOUS COGN, V21, P1725, DOI 10.1016/j.concog.2012.10.004; Tajadura-Jimenez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040682; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P303, DOI 10.1093/scan/nsn033; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004040; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; Verosky SC, 2013, J EXP SOC PSYCHOL, V49, P661, DOI 10.1016/j.jesp.2013.02.004; Verosky SC, 2010, PSYCHOL SCI, V21, P779, DOI 10.1177/0956797610371965; Wegner DM, 2004, J PERS SOC PSYCHOL, V86, P838, DOI 10.1037/0022-3514.86.6.838; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Zebrowitz L A, 1997, Pers Soc Psychol Rev, V1, P204, DOI 10.1207/s15327957pspr0103_2; Zebrowitz L. A., 1997, READING FACES WINDOW; ZEBROWITZ LA, 1991, LAW HUMAN BEHAV, V15, P603, DOI 10.1007/BF01065855	46	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145664	10.1371/journal.pone.0145664	http://dx.doi.org/10.1371/journal.pone.0145664			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716682	gold, Green Submitted, Green Published			2022-12-27	WOS:000367510500056
J	Cammaerts, S; Strazisar, M; Smets, B; Weckhuysen, S; Nordin, A; De Jonghe, P; Adolfsson, R; De Rijk, P; Del Favero, J				Cammaerts, Sophia; Strazisar, Mojca; Smets, Bart; Weckhuysen, Sarah; Nordin, Annelie; De Jonghe, Peter; Adolfsson, Rolf; De Rijk, Peter; Del Favero, Jurgen			Schizophrenia-Associated MIR204 Regulates Noncoding RNAs and Affects Neurotransmitter and Ion Channel Gene Sets	PLOS ONE			English	Article							PROSPECTIVE COHORT; NMDA RECEPTOR; MICRORNA; MIR-204; EXPRESSION; CELLS; PROLIFERATION; MECHANISMS; INVASION; MIR-618	As regulators of gene expression, microRNAs (miRNAs) are likely to play an important role in the development of disease. In this study we present a large-scale strategy to identify miRNAs with a role in the regulation of neuronal processes. Thereby we found variant rs7861254 located near the MIR204 gene to be significantly associated with schizophrenia. This variant resulted in reduced expression of miR-204 in neuronal-like SH-SY5Y cells. Analysis of the consequences of the altered miR-204 expression on the transcriptome of these cells uncovered a new mode of action for miR-204, being the regulation of noncoding RNAs (ncRNAs), including several miRNAs, such as MIR296. Furthermore, pathway analysis showed downstream effects of miR-204 on neurotransmitter and ion channel related gene sets, potentially mediated by miRNAs regulated through miR-204.	[Cammaerts, Sophia; Strazisar, Mojca; Smets, Bart; Weckhuysen, Sarah; De Jonghe, Peter; De Rijk, Peter; Del Favero, Jurgen] Univ Antwerp, B-2020 Antwerp, Belgium; [Cammaerts, Sophia; Strazisar, Mojca; De Rijk, Peter; Del Favero, Jurgen] VIB, Appl Mol Genom Unit, Dept Mol Genet, Antwerp, Belgium; [Smets, Bart] VIB, Dept Mol Genet, Centralized Serv Facil, Antwerp, Belgium; [Weckhuysen, Sarah; De Jonghe, Peter] VIB, Dept Mol Genet, Neurogenet Grp, Antwerp, Belgium; [Nordin, Annelie; Adolfsson, Rolf] Umea Univ, Dept Clin Sci, Div Psychiat, Umea, Sweden; [De Jonghe, Peter] Univ Antwerp Hosp, Antwerp, Belgium; [Del Favero, Jurgen] Multiplicom NV, Niel, Belgium	University of Antwerp; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Umea University; University of Antwerp	Del Favero, J (corresponding author), Univ Antwerp, B-2020 Antwerp, Belgium.	jurgen.delfavero@molgen.vib-ua.be	De Rijk, Peter/GXH-9837-2022; Weckhuysen, Sarah/HGB-9957-2022; Strazisar, Mojca/Z-2361-2019	De Rijk, Peter/0000-0001-8558-9288; Weckhuysen, Sarah/0000-0003-2878-1147; Strazisar, Mojca/0000-0001-8046-3408; Adolfsson, Rolf/0000-0001-9785-8473; /0000-0002-8114-7615	Research Foundation-Flanders [G027410N]; University Research Fund [UA-KP BOF/MS-2013 6264]; Multiplicom N.V.	Research Foundation-Flanders(FWO); University Research Fund; Multiplicom N.V.	This work was supported by Research Foundation-Flanders (G027410N to JDF, http://www.fwo.be/) and by the University Research Fund (UA-KP BOF/MS-2013 6264 to MS, https://www.uantwerpen.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JDF is besides his tenure track position at the University of Antwerp also acting CTO of Multiplicom N.V. Both mandates are independent from each other and Multiplicom N.V. has no financial interest nor investment in the current study. Multiplicom N.V. provided support in the form of salaries for author JDF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Almeida-Souza L, 2010, J BIOL CHEM, V285, P12778, DOI 10.1074/jbc.M109.082644; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Cammaerts S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv921; Chen PS, 2011, J CLIN INVEST, V121, P3442, DOI 10.1172/JCI45390; Cheng QP, 2014, ANN ENDOCRINOL-PARIS, V75, P187, DOI 10.1016/j.ando.2014.01.002; Chung TKH, 2012, INT J CANCER, V130, P1036, DOI 10.1002/ijc.26060; Conte I, 2015, P NATL ACAD SCI USA, V112, pE3236, DOI 10.1073/pnas.1401464112; Conte I, 2014, NUCLEIC ACIDS RES, V42, P7793, DOI 10.1093/nar/gku498; Conte I, 2010, P NATL ACAD SCI USA, V107, P15491, DOI 10.1073/pnas.0914785107; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Feliciano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076247; Feng JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006121; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fu A, 2014, EPIGENETICS-US, V9, P730, DOI 10.4161/epi.27996; Goossens D, 2009, HUM MUTAT, V30, P472, DOI 10.1002/humu.20873; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hall DP, 2014, CANCER CELL, V26, P738, DOI 10.1016/j.ccell.2014.09.015; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huang V, 2012, RNA BIOL, V9, P269, DOI 10.4161/rna.19354; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Kan AA, 2012, CELL MOL LIFE SCI, V69, P3127, DOI 10.1007/s00018-012-0992-7; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marin RM, 2011, NUCLEIC ACIDS RES, V39, P19, DOI 10.1093/nar/gkq768; Matkovich SJ, 2013, CIRC RES, V113, P62, DOI 10.1161/CIRCRESAHA.113.300975; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Moens LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023450; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633; Nilsson LG, 2004, AGING NEUROPSYCHOL C, V11, P134, DOI 10.1080/13825580490511026; Olsen O, 2005, J CELL BIOL, V170, P1127, DOI 10.1083/jcb.200503011; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Paylakhi SH, 2013, EXP EYE RES, V111, P112, DOI 10.1016/j.exer.2013.03.009; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reumers J, 2012, NAT BIOTECHNOL, V30, P61, DOI 10.1038/nbt.2053; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Strazisar M, 2015, MOL PSYCHIATR, V20, P472, DOI 10.1038/mp.2014.53; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Wei Y, 2014, J BIOL CHEM, V289, P10270, DOI 10.1074/jbc.C113.541417; Wu XJ, 2015, FEBS LETT, V589, P645, DOI 10.1016/j.febslet.2015.01.030; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yin Y, 2014, CLIN CANCER RES, V20, P6187, DOI 10.1158/1078-0432.CCR-14-1030; Ying Z, 2013, CANCER RES, V73, P990, DOI 10.1158/0008-5472.CAN-12-2895	57	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144428	10.1371/journal.pone.0144428	http://dx.doi.org/10.1371/journal.pone.0144428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714269	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900011
J	dos Santos, AB; do Nascimento, FS				dos Santos, Aline Borba; do Nascimento, Fabio Santos			Cuticular Hydrocarbons of Orchid Bees Males: Interspecific and Chemotaxonomy Variation	PLOS ONE			English	Article							APIS-MELLIFERA; INSECT HYDROCARBONS; HONEY-BEE; DISCRIMINATION; LIPIDS; DIFFERENTIATION; BIOCHEMISTRY; HYMENOPTERA; CHARACTERS; EUGLOSSINI	Recent studies have investigated the composition of compounds that cover the cuticle in social insects, but few studies have focused on solitary bees. Cuticular hydrocarbons may provide a tool for chemotaxonomy, and perhaps they can be used as a complement to morphology and genetic characters in phylogenetic studies. Orchid bees (Tribe Euglossini) are a highly diverse group of Neotropical bees with more than 200 species. Here, the cuticular hydrocarbons of 17 species were identified and statistical analysis revealed 108 compounds, which allowed for the taxonomic classification according to the genera. The most significant compounds discriminating the four genera were (Z)-9-pentacosene, (Z, Z)-pentatriacontene- 3, (Z)-9-tricosene, and (Z)-9-heptacosene. The analyses demonstrated the potential use of CHCs to identify different species.	[dos Santos, Aline Borba; do Nascimento, Fabio Santos] Univ Sao Paulo, FFCLRP, Dept Biol, Lab Comportamento & Ecol Insetos Sociais, BR-14040901 Sao Paulo, Brazil	Universidade de Sao Paulo	dos Santos, AB (corresponding author), Univ Sao Paulo, FFCLRP, Dept Biol, Lab Comportamento & Ecol Insetos Sociais, Av Bandeirantes 3900, BR-14040901 Sao Paulo, Brazil.	alineborba.s@gmail.com	Nascimento, Fabio S/E-4191-2013	Nascimento, Fabio S/0000-0002-3731-7111	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2010/10027-5, 2010/19449-0]; FAPESP [2010/10027-5, 2010/19449-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: grantes 2010/10027-5 and 2010/19449-0 to FSN and ABS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to FAPESP 2010/19449-0 and 2010/10027-5 for the financial support, to the SEMARH/SE (Secretaria de Estado de Meio Ambiente e Recursos Hidricos de Sergipe) for permission to work in the protect area as well as to Izabel C. C. Turatti for collaborating during the identification of compounds, and to Jennifer R. R. Jesus, Mayane Menezes and Eduarda G. Barreto for the helping during the bee collection.	Andrade-Silva ACR, 2012, NEOTROP ENTOMOL, V41, P296, DOI 10.1007/s13744-012-0053-9; Andrade-Silva ACR, ANIM BEHAV, V106, P43; BLOMQUIST GJ, 1987, ARCH INSECT BIOCHEM, V6, P227, DOI 10.1002/arch.940060404; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; BREED MD, 1992, ANIM BEHAV, V43, P875, DOI 10.1016/S0003-3472(06)80001-1; BREED MD, 1988, BEHAV GENET, V18, P439, DOI 10.1007/BF01065513; Buckner JS, 2009, COMP BIOCHEM PHYS B, V153, P200, DOI 10.1016/j.cbpb.2009.02.018; CARLSON DA, 1989, ANAL CHEM, V61, P1564, DOI 10.1021/ac00189a019; CHAPMAN RF, 1995, BIOCHEM SYST ECOL, V23, P383, DOI 10.1016/0305-1978(95)00032-P; Cruz-Landim C., 2009, ABELHAS MORFOLOGIA F; Dani FR, 2005, CHEM SENSES, V30, P477, DOI 10.1093/chemse/bji040; DRESSLER RL, 1982, ANNU REV ECOL SYST, V13, P373, DOI 10.1146/annurev.es.13.110182.002105; Eltz T, 2011, ZOOL J LINN SOC-LOND, V163, P1064, DOI 10.1111/j.1096-3642.2011.00740.x; ESPELIE KE, 1994, J CHEM ECOL, V20, P1677, DOI 10.1007/BF02059889; Gemeno C, 2012, B ENTOMOL RES, V102, P624, DOI 10.1017/S0007485312000193; GETZ WM, 1987, J COMP PHYSIOL A, V160, P239, DOI 10.1007/BF00609729; GIBBS A, 1995, COMP BIOCHEM PHYS B, V112, P243, DOI 10.1016/0305-0491(95)00081-X; Gibbs AG, 1998, AM ZOOL, V38, P471; GOROPASHNAYA A, 2003, PHYLOGEOGRAPHIC STRU; HAVERTY MI, 1990, J CHEM ECOL, V16, P1635, DOI 10.1007/BF01014096; HAVERTY MI, 1988, J CHEM ECOL, V14, P1035, DOI 10.1007/BF01018791; HOWARD RW, 1982, ANNU REV ENTOMOL, V27, P149, DOI 10.1146/annurev.en.27.010182.001053; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; JALLON JM, 1987, EVOLUTION, V41, P294, DOI 10.1111/j.1558-5646.1987.tb05798.x; Kather R, 2015, J CHEM ECOL, V41, P871, DOI 10.1007/s10886-015-0631-5; Kather R, 2012, PHYSIOL ENTOMOL, V37, P25, DOI 10.1111/j.1365-3032.2011.00826.x; Kather R, 2011, J CHEM ECOL, V37, P205, DOI 10.1007/s10886-011-9909-4; Martin S, 2009, J CHEM ECOL, V35, P1151, DOI 10.1007/s10886-009-9695-4; Martin SJ, 2007, P ROY SOC B-BIOL SCI, V274, P2717, DOI 10.1098/rspb.2007.0795; Michener C.D., 2000, BEES WORLD, V1st, DOI DOI 10.7171/JBT.12-2303-004; PAMILO P, 1978, HEREDITAS, V88, P93; Pokorny T, 2014, APIDOLOGIE, V45, P276, DOI 10.1007/s13592-013-0250-5; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramirez SR, 2010, BIOL J LINN SOC, V100, P552, DOI 10.1111/j.1095-8312.2010.01440.x; Singer Theresa L., 1998, P104; Sokal R., 1958, U KANSAS SCI B, V38, P1409; Ye GY, 2007, J MED ENTOMOL, V44, P450, DOI 10.1603/0022-2585(2007)44[450:CHCIPE]2.0.CO;2; Zimmermann Y, 2009, ECOLOGY, V90, P2994, DOI 10.1890/08-1858.1	39	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145070	10.1371/journal.pone.0145070	http://dx.doi.org/10.1371/journal.pone.0145070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713612	gold, Green Published			2022-12-27	WOS:000367481900030
J	Esposito, G; Ambrosio, R; Napolitano, F; Di Giuseppe, G				Esposito, Giuseppe; Ambrosio, Rossella; Napolitano, Francesco; Di Giuseppe, Gabriella			Women's Knowledge, Attitudes and Behavior about Maternal Risk Factors in Pregnancy	PLOS ONE			English	Article							PRECONCEPTION HEALTH; ALCOHOL-CONSUMPTION; CIGARETTE-SMOKING; CONGENITAL-ANOMALIES; PRETERM BIRTH; WEIGHT; METAANALYSIS; CHILDREN; OBESITY; TOBACCO	Background The aims of this study were to assess the levels of knowledge, attitudes and behaviors of women about the main maternal risk factors in pregnancy and to identify the factors linked to the main outcomes of interest. Materials and Methods A cross-sectional survey was conducted in 513 pregnant women randomly selected from the gynecological ambulatory services of five hospitals located in Naples, Italy. Results Only 42% of women correctly knew all the main maternal risk factors in pregnancy (alcohol, smoking, passive smoking and obesity). Only 21.7% of women were very worried about causing harm to the fetus or child with their risk behaviors, and 22.3% of women reported smoking during pregnancy. Approximately one-third of women (28.9%) reported regularly drinking alcohol before pregnancy and 74.8% of these women reported stopping drinking alcohol during pregnancy. However, only 27.3% of women who were drinking alcohol during pregnancy had the intention of stopping. Only 43.7% of women indicated that during ambulatory gynecological examinations they received information from physicians about the possible damage resulting from all the main risk factors in pregnancy (alcohol, smoking, passive smoking and obesity). Conclusion The results indicate that pregnant women lack knowledge regarding the main maternal risk factors. Pregnant women claim to receive little information during gynecological examinations and, therefore, some continue to smoke and drink alcohol during pregnancy. Our results suggest an urgent need for the design of interventions to improve women's levels of knowledge and to promote appropriate behavior in relation to the major risk factors in pregnancy.	[Esposito, Giuseppe; Ambrosio, Rossella; Napolitano, Francesco; Di Giuseppe, Gabriella] Univ Naples 2, Dept Expt Med, Naples, Italy	Universita della Campania Vanvitelli	Esposito, G (corresponding author), Univ Naples 2, Dept Expt Med, Naples, Italy.	gabriella.digiuseppe@unina2.it		DI GIUSEPPE, Gabriella/0000-0003-4466-6683; Napolitano, Francesco/0000-0003-4694-2418				Al-Sahab B, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-24; Bhanji S, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-16; Botto LD, 2004, AM J MED GENET C, V125C, P12, DOI 10.1002/ajmg.c.30004; BUTLER NR, 1972, BMJ-BRIT MED J, V2, P127, DOI 10.1136/bmj.2.5806.127; Chatenoud L, 1999, BRIT MED J, V318, P1012, DOI 10.1136/bmj.318.7189.1012; Chu SY, 2007, AM J OBSTET GYNECOL, V197, P223, DOI 10.1016/j.ajog.2007.03.027; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Coonrod DV, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.02.036; Cui Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084640; Dupraz J, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13795; Erlingsdottir A, 2014, SCAND J PRIM HEALTH, V32, P11, DOI 10.3109/02813432.2013.869409; Fraser A, 2010, CIRCULATION, V121, P2557, DOI 10.1161/CIRCULATIONAHA.109.906081; Frey KA, 2006, MATERN CHILD HLTH J, V10, pS73, DOI 10.1007/s10995-006-0110-2; Haustein KO, 1999, INT J CLIN PHARM TH, V37, P417; Hofhuis W, 2003, ARCH DIS CHILD, V88, P1086, DOI 10.1136/adc.88.12.1086; Johnson Kay, 2006, Morbidity and Mortality Weekly Report, V55, P1; Kyrklund-Blomberg NB, 2005, ACTA OBSTET GYN SCAN, V84, P572, DOI 10.1111/j.0001-6349.2005.00848.x; Lauria L, 2012, SCI WORLD J, P1, DOI 10.1100/2012/154910; Martinez-Beneyto Y, 2011, INT J GYNECOL OBSTET, V114, P18, DOI 10.1016/j.ijgo.2011.03.003; Mastroiacovo P, 2014, ITAL J PEDIATR, V40, DOI 10.1186/s13052-014-0091-5; Muckle G, 2011, ALCOHOL CLIN EXP RES, V35, P1081, DOI 10.1111/j.1530-0277.2011.01441.x; Nilsson C, 2014, PEDIATR DIABETES, V15, P57, DOI 10.1111/pedi.12059; Nitert MD, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-96; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Orton S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004915; Passey ME, 2014, DRUG ALCOHOL DEPEN, V134, P44, DOI 10.1016/j.drugalcdep.2013.09.008; Patra J, 2011, BJOG-INT J OBSTET GY, V118, P1411, DOI 10.1111/j.1471-0528.2011.03050.x; Ribeiro CP, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-31; Robbins CL, 2014, MMWR SURVEILL SUMM, V63, P1; Seshadri S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3467; Shah NR, 2000, AM J OBSTET GYNECOL, V182, P465, DOI 10.1016/S0002-9378(00)70240-7; Shub Alexis, 2013, BMC Res Notes, V6, P278, DOI 10.1186/1756-0500-6-278; Smedberg J, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-213; Smith L, 2014, MIDWIFERY, V30, P1173, DOI 10.1016/j.midw.2014.04.002; Stata Corporation, 2007, STAT REF MAN REF 10; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Temel S, 2014, EPIDEMIOL REV, V36, P19, DOI 10.1093/epirev/mxt003; Torres E, 2011, NICOTINE TOB RES, V13, P1220, DOI 10.1093/ntr/ntr193; World Health Organization, 2013, POL BRIEF; Yamamoto Y, 2008, J EPIDEMIOL, V18, P173, DOI 10.2188/jea.JE2007419	40	26	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145873	10.1371/journal.pone.0145873	http://dx.doi.org/10.1371/journal.pone.0145873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714032	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900097
J	Kawelke, S; Feussner, I				Kawelke, Steffen; Feussner, Ivo			Two Predicted Transmembrane Domains Exclude Very Long Chain Fatty acyl-CoAs from the Active Site of Mouse Wax Synthase	PLOS ONE			English	Article							TRIACYLGLYCEROL SYNTHESIS; ENZYME; ESTERS; DGAT2; ACID; ACYLTRANSFERASE-2; BIOSYNTHESIS; PURIFICATION; TOPOLOGY; BINDING	Wax esters are used as coatings or storage lipids in all kingdoms of life. They are synthesized from a fatty alcohol and an acyl-CoA by wax synthases. In order to get insights into the structure-function relationships of a wax synthase from Mus musculus, a domain swap experiment between the mouse acyl-CoA: wax alcohol acyltransferase (AWAT2) and the homologous mouse acyl-CoA: diacylglycerol O-acyltransferase 2 (DGAT2) was performed. This showed that the substrate specificity of AWAT2 is partially determined by two predicted transmembrane domains near the amino terminus of AWAT2. Upon exchange of the two domains for the respective part of DGAT2, the resulting chimeric enzyme was capable of incorporating up to 20% of very long acyl chains in the wax esters upon expression in S. cerevisiae strain H1246. The amount of very long acyl chains in wax esters synthesized by wild type AWAT2 was negligible. The effect was narrowed down to a single amino acid position within one of the predicted membrane domains, the AWAT2 N36R variant. Taken together, we provide first evidence that two predicted transmembrane domains in AWAT2 are involved in determining its acyl chain length specificity.	[Kawelke, Steffen; Feussner, Ivo] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, D-37077 Gottingen, Germany; [Feussner, Ivo] Univ Gottingen, Dept Plant Biochem, Goettingen Ctr Mol Biosci GZMB, D-37077 Gottingen, Germany; [Feussner, Ivo] Univ Gottingen, Dept Plant Biochem, Int Ctr Adv Studies Energy Convers, D-37077 Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Feussner, I (corresponding author), Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, Justus von Liebig Weg 11, D-37077 Gottingen, Germany.	ifeussn@gwdg.de	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003	Fond of the Chemical Industry (FCI); Biomolecules Ph.D. program of the Gottingen Graduate School of Neurosciences, Biophysics and Molecular Biology (GGNB); EU grant "Industrial crops producing value added oils for novel chemicals and energy (ICON)" from the 7th framework program (FP7-KBBE-1)	Fond of the Chemical Industry (FCI); Biomolecules Ph.D. program of the Gottingen Graduate School of Neurosciences, Biophysics and Molecular Biology (GGNB); EU grant "Industrial crops producing value added oils for novel chemicals and energy (ICON)" from the 7th framework program (FP7-KBBE-1)	SK received a stipend from the Fond of the Chemical Industry (FCI). SK was supported by the Biomolecules Ph.D. program of the Gottingen Graduate School of Neurosciences, Biophysics and Molecular Biology (GGNB). This work was supported by the EU grant "Industrial crops producing value added oils for novel chemicals and energy (ICON)" from the 7th framework program (FP7-KBBE-2007 1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2006, J LIPID RES, V47, P375, DOI 10.1194/jlr.M500344-JLR200; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; AUYOUNG J, 1992, P NATL ACAD SCI USA, V89, P4094, DOI 10.1073/pnas.89.9.4094; Barney BM, 2013, APPL ENVIRON MICROB, V79, P396, DOI 10.1128/AEM.02523-12; Barney BM, 2012, APPL ENVIRON MICROB, V78, P5734, DOI 10.1128/AEM.00534-12; Biester EM, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-4; Butovich IA, 2009, J LIPID RES, V50, P2471, DOI 10.1194/jlr.M900252-JLR200; Camera E, 2010, J LIPID RES, V51, P3377, DOI 10.1194/jlr.D008391; Cheng JB, 2004, J BIOL CHEM, V279, P37798, DOI 10.1074/jbc.M406226200; Hagstrom AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037230; Heilmann M, 2012, J LIPID RES, V53, P2153, DOI 10.1194/jlr.M029512; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hornung E, 2005, BBA-MOL CELL BIOL L, V1686, P181, DOI 10.1016/j.bbalip.2004.11.001; HUTCHISON CA, 1978, J BIOL CHEM, V253, P6551; Iven T, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-24; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Lardizabal KD, 2000, PLANT PHYSIOL, V122, P645, DOI 10.1104/pp.122.3.645; Larson TR, 2001, PLANT J, V25, P115, DOI 10.1046/j.1365-313x.2001.00929.x; LEHNER R, 1995, J BIOL CHEM, V270, P13630, DOI 10.1074/jbc.270.23.13630; Liu Q, 2011, J BIOL CHEM, V286, P13115, DOI 10.1074/jbc.M110.204412; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; Metz JG, 2000, PLANT PHYSIOL, V122, P635, DOI 10.1104/pp.122.3.635; Miklaszewska M, 2013, ACTA BIOCHIM POL, V60, P209; Rottig A, 2013, MICROBIOL MOL BIOL R, V77, P277, DOI 10.1128/MMBR.00010-13; ROSENDAL J, 1992, ANAL BIOCHEM, V207, P63, DOI 10.1016/0003-2697(92)90500-7; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stoeveken T, 2009, EUR J LIPID SCI TECH, V111, P112, DOI 10.1002/ejlt.200800167; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Turchetto-Zolet AC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-263; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Zhang J, 2014, J BIOL CHEM, V289, P10909, DOI 10.1074/jbc.M113.530022	38	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145797	10.1371/journal.pone.0145797	http://dx.doi.org/10.1371/journal.pone.0145797			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714272	gold, Green Submitted, Green Published			2022-12-27	WOS:000367481900083
J	Messeri, A; Morabito, M; Messeri, G; Brandani, G; Petralli, M; Natali, F; Grifoni, D; Crisci, A; Gensini, G; Orlandini, S				Messeri, Alessandro; Morabito, Marco; Messeri, Gianni; Brandani, Giada; Petralli, Martina; Natali, Francesca; Grifoni, Daniele; Crisci, Alfonso; Gensini, Gianfranco; Orlandini, Simone			Weather-Related Flood and Landslide Damage: A Risk Index for Italian Regions	PLOS ONE			English	Article							PRECIPITATION EXTREMES; HEALTH IMPACTS; VARIABILITY; CLIMATE; FREQUENCY; PATTERNS; TRENDS	The frequency of natural hazards has been increasing in the last decades in Europe and specifically in Mediterranean regions due to climate change. For example heavy precipitation events can lead to disasters through the interaction with exposed and vulnerable people and natural systems. It is therefore necessary a prevention planning to preserve human health and to reduce economic losses. Prevention should mainly be carried out with more adequate land management, also supported by the development of an appropriate risk prediction tool based on weather forecasts. The main aim of this study is to investigate the relationship between weather types (WTs) and the frequency of floods and landslides that have caused damage to properties, personal injuries, or deaths in the Italian regions over recent decades. In particular, a specific risk index (WT-FLARI) for each WT was developed at national and regional scale. This study has identified a specific risk index associated with each weather type, calibrated for each Italian region and applicable to both annual and seasonal levels. The risk index represents the seasonal and annual vulnerability of each Italian region and indicates that additional preventive actions are necessary for some regions. The results of this study represent a good starting point towards the development of a tool to support policy-makers, local authorities and health agencies in planning actions, mainly in the medium to long term, aimed at the weather damage reduction that represents an important issue of the World Meteorological Organization mission.	[Messeri, Alessandro; Morabito, Marco; Brandani, Giada; Petralli, Martina; Natali, Francesca; Orlandini, Simone] Univ Florence, Interdept Ctr Bioclimatol, I-50144 Florence, Italy; [Messeri, Alessandro; Brandani, Giada; Petralli, Martina; Natali, Francesca; Orlandini, Simone] Univ Florence, Dept Agrifood Prod & Environm Sci, DISPAA, I-50144 Florence, Italy; [Morabito, Marco; Messeri, Gianni; Grifoni, Daniele; Crisci, Alfonso] CNR, Inst Biometeorol, I-50145 Florence, Italy; [Messeri, Gianni; Grifoni, Daniele; Crisci, Alfonso] Consortium LaMMa Lab Monitoring & Environm Modell, I-50019 Florence, Italy; [Gensini, Gianfranco] Univ Florence, Clin Med & Cardiol, I-50134 Florence, Italy	University of Florence; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR); University of Florence	Messeri, A (corresponding author), Univ Florence, Interdept Ctr Bioclimatol, Piazzale Cascine 18, I-50144 Florence, Italy.	cpneme@tin.it	Crisci, Alfonso/AAX-3314-2020; Morabito, Marco/AAX-7261-2020; Grifoni, Daniele/B-8612-2011; petralli, martina/H-7244-2012	Morabito, Marco/0000-0002-8799-4866; Grifoni, Daniele/0000-0002-0811-1624; petralli, martina/0000-0003-0221-0776	European Project Horizon (H-DRS) Culture And RISkmanagement in Man-made And Natural Disasters (CARISMAND-G.A.) [635748]	European Project Horizon (H-DRS) Culture And RISkmanagement in Man-made And Natural Disasters (CARISMAND-G.A.)	This study was funded by the European Project Horizon 2020 (H2020-DRS-2014) Culture And RISkmanagement in Man-made and Natural Disasters (CARISMAND-G.A. 635748-Horizon 2020).; The authors wish to thank AVI Project(Inventory of areas affected by landslides and floods in Italy), carried out by CNR, which allows data consultation available at http://avi.gndci.cnr.it/welcome_en.htm. Our study was funded by the European Project Horizon 2020 (H2020-DRS2014) Culture And RISkmanagement in Man-made And Natural Disasters (CARISMAND-G.A. 635748-Horizon 2020). Thank you also the Regional MeteoSalute Project and the Regional Health System of Tuscany.	Adeola FO, 2009, HUM ECOL REV, V16, P195; Ahern M., 2006, FLOOD HAZARDS HLTH R, P28; ALPERT P, 1990, J CLIMATE, V3, P1474, DOI 10.1175/1520-0442(1990)003<1474:IVOCTI>2.0.CO;2; Alpert P., 1990, Tellus, Series A (Dynamic Meteorology and Oceanography), V42A, P65, DOI 10.1034/j.1600-0870.1990.00007.x; Armstrong WH, 2012, J AM WATER RESOUR AS, V48, P306, DOI 10.1111/j.1752-1688.2011.00613.x; Beck C, 2007, INT J CLIMATOL, V27, P473, DOI 10.1002/joc.1410; Benestad RE, 2012, NAT CLIM CHANGE, V2, P544, DOI 10.1038/NCLIMATE1497; Benestad RE, 2012, TELLUS A, V64, DOI 10.3402/tellusa.v64i0.14981; Brooks HE, 2009, ATMOS RES, V93, P546, DOI 10.1016/j.atmosres.2008.10.005; Cartwright L, 2005, J CONTEMP WAT RES ED, V130, P20, DOI 10.1111/j.1936-704X.2005.mp130001004.x; Cemaden, 2013, REP CTR NAT MON AL D; Christiansen B, 2007, J CLIMATE, V20, P2229, DOI [10.1175/JCLI4107.1, 10.1175/JCL14107.1]; Colon L, 2013, THESIS; Dankers R, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011523; Deser C, 2012, NAT CLIM CHANGE, V2, P775, DOI 10.1038/NCLIMATE1562; Dilley M, 2006, PHILOS T R SOC A, V364, P2217, DOI 10.1098/rsta.2006.1823; Dotzek N, 2009, ATMOS RES, V93, P575, DOI 10.1016/j.atmosres.2008.10.020; EASAC-European Academies' Science Advisory Council, 2013, EXTR WEATH EV EUR PR; EM-DAT, 2010, INT DIS DAT; Erpicum M., 2008, COST 733 MIDT C ADV, P33; Few R., 2014, 63 NORW TYND CTR CLI; Fewtrell L, 2008, PUBLIC HEALTH, V122, P446, DOI 10.1016/j.puhe.2007.09.010; Field CB, 2012, SPECIAL REPORT WORKI; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Gentle J. E., 2007, MATRIX ALGEBRA THEOR; Guha-Sapir D, 2011, NAT HAZARDS, V58, P845, DOI 10.1007/s11069-011-9775-y; Hannah DM, 2011, HYDROL PROCESS, V25, P1191, DOI 10.1002/hyp.7794; Harmeling S, 2010, GLOBAL CLIMATE RISK; Hawley K., 2012, UNDERSTANDING EC FLO; Huth R, 2000, THEOR APPL CLIMATOL, V67, P1, DOI 10.1007/s007040070012; Huth R, 2008, ANN NY ACAD SCI, V1146, P105, DOI 10.1196/annals.1446.019; Integracao, 2013, SIST INT INF DES S2I; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; ISPRA, 2013, ISPRA MAN LIN GUID; ISPRA, 2008, LANDSL IT; Jakubicka, 2010, HLTH IMPACTS FLOODS; Jonkman SN, 2005, DISASTERS, V29, P75, DOI 10.1111/j.0361-3666.2005.00275.x; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kharin VV, 2007, J CLIMATE, V20, P1419, DOI 10.1175/JCLI4066.1; Kirch W, 2005, EXTREME WEATHER EVEN, VXLVI, P303; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kumpulainen S., 2006, GEOLOGICAL SURVEY FI, V42, P65; Kundzewicz ZW, 2006, CLIM RES, V31, P51, DOI 10.3354/cr031051; Kunkel KE, 1999, B AM METEOROL SOC, V80, P1077, DOI 10.1175/1520-0477(1999)080<1077:TFIWAC>2.0.CO;2; Kunz M, 2009, INT J CLIMATOL, V29, P2283, DOI 10.1002/joc.1865; Lowe D, 2013, INT J ENV RES PUB HE, V10, P7015, DOI [10.3390/ijerph10127015, 10.3390/ijerph110100030]; Maheras P, 2001, INT J CLIMATOL, V21, P109, DOI 10.1002/joc.599; Maynard-Ford MC, 2008, 20081924 USG; Michelozzi Paola, 2014, Recenti Prog Med, V105, P48, DOI 10.1701/1417.15695; Milojevic A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-11; Neumayer E, 2011, GLOBAL ENVIRON CHANG, V21, P13, DOI 10.1016/j.gloenvcha.2010.10.004; Philipp A, 2009, THEOR APPL CLIMATOL, V96, P31, DOI 10.1007/s00704-008-0037-1; Philipp A, 2016, INT J CLIMATOL, V36, P2673, DOI 10.1002/joc.3920; Philipp A, 2010, PHYS CHEM EARTH, V35, P360, DOI 10.1016/j.pce.2009.12.010; Salinger MJ, 2015, INT J BIOMETEOROL, V59, P1799, DOI 10.1007/s00484-015-0988-8; Selvin S, 1991, STAT ANAL EPIDEMIOLO, P499; Svensson C, 2006, IAHS-AISH P, V305, P1; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; United Nations Development Programme, 2004, REP RED DIS RISK CHA; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Vorosmarty CJ, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0408; Wang L, 2016, ASIA-PAC J PUBLIC HE, V28, p59S, DOI 10.1177/1010539514549763; Weisheimer A, 2014, R SOC INTERFACE, V11; WHO, 2013, REP FLOODS WHO EUR R; WHO, 2010, REP CLIM CHANG EXTR; Wynne-Evans E, 2011, CHEM HAZARDS POISONS, V20, P44	66	31	31	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144468	10.1371/journal.pone.0144468	http://dx.doi.org/10.1371/journal.pone.0144468			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714309	Green Published, gold			2022-12-27	WOS:000367481900012
J	Schramm, C; Katsahian, S; Youssov, K; Demonet, JF; Krystkowiak, P; Supiot, F; Verny, C; de Langavant, LC; Bachoud-Levi, AC				Schramm, Catherine; Katsahian, Sandrine; Youssov, Katia; Demonet, Jean-Francois; Krystkowiak, Pierre; Supiot, Frederic; Verny, Christophe; de Langavant, Laurent Cleret; Bachoud-Levi, Anne-Catherine		European Huntington's Dis; Multictr Intracerebral Grafting	How to Capitalize on the Retest Effect in Future Trials on Huntington's Disease	PLOS ONE			English	Article							TRINUCLEOTIDE REPEAT LENGTH; CAG-REPEAT; CLINICAL PROGRESSION; FUNCTIONAL DECLINE; ALZHEIMERS-DISEASE; COGNITIVE DECLINE; CATEGORY FLUENCY; ALTERNATE FORMS; AGE; HD	The retest effect-improvement of performance on second exposure to a task-may impede the detection of cognitive decline in clinical trials for neurodegenerative diseases. We assessed the impact of the retest effect in Huntington's disease trials, and investigated its possible neutralization. We enrolled 54 patients in the Multicentric Intracerebral Grafting in Huntington's Disease (MIG-HD) trial and 39 in the placebo arm of the Riluzole trial in Huntington's Disease (RIL-HD). All were assessed with the Unified Huntington's Disease Rating Scale (UHDRS) plus additional cognitive tasks at baseline (A(1)), shortly after baseline (A(2)) and one year later (A(3)). We used paired t-tests to analyze the retest effect between A(1) and A(2). For each task of the MIG-HD study, we used a stepwise algorithm to design models predictive of patient performance at A(3), which we applied to the RIL-HD trial for external validation. We observed a retest effect in most cognitive tasks. A decline in performance at one year was detected in 3 of the 15 cognitive tasks with A(1) as the baseline, and 9 of the 15 cognitive tasks with A(2) as the baseline. We also included the retest effect in performance modeling and showed that it facilitated performance prediction one year later for 14 of the 15 cognitive tasks. The retest effect may mask cognitive decline in patients with neurodegenerative diseases. The dual baseline can improve clinical trial design, and better prediction should homogenize patient groups, resulting in smaller numbers of participants being required.	[Schramm, Catherine; Youssov, Katia; de Langavant, Laurent Cleret; Bachoud-Levi, Anne-Catherine] Hop Henri Mondor, INSERM, U955 E01, Neuropsychol Intervent,Inst Mondor Rech Biomed, F-94010 Creteil, France; [Schramm, Catherine; Katsahian, Sandrine] Univ Paris 06, INSERM, UMRS1138 E22,Univ Paris 5, Sci Informat Serv Med Personnalisee,Ctr Rech Cord, Paris, France; [Schramm, Catherine; Youssov, Katia; de Langavant, Laurent Cleret; Bachoud-Levi, Anne-Catherine] Univ Paris Est, Fac Med, Creteil, France; [Schramm, Catherine; Youssov, Katia; de Langavant, Laurent Cleret; Bachoud-Levi, Anne-Catherine] Ecole Normale Super, Inst Etud Cognit, F-75231 Paris, France; [Katsahian, Sandrine] Hop Europeen Georges Pompidou, AP HP, Serv Informat & Stat, Paris, France; [Youssov, Katia; de Langavant, Laurent Cleret; Bachoud-Levi, Anne-Catherine] Hop Henri Mondor, AP HP, Ctr Natl Reference Malad Huntington, F-94010 Creteil, France; [Demonet, Jean-Francois] CHU Vaudois, Clin Neurosci Dept, Leenaards Memory Ctr, CH-1011 Lausanne, Switzerland; [Krystkowiak, Pierre] Ctr Hosp Univ Amiens, Serv Neurol, Amiens, France; [Krystkowiak, Pierre] Univ Picardie Jules Verne, EA 4559, LNFP, Amiens, France; [Krystkowiak, Pierre] SFR CAP Sante FED 4231, Amiens, France; [Supiot, Frederic] Hop Erasme ULB, Serv Neurol, Brussels, Belgium; [Verny, Christophe] CHU Angers, Ctr Reference Malad Neurogenet, Serv Neurol, Angers, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); Universite Libre de Bruxelles; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Bachoud-Levi, AC (corresponding author), Hop Henri Mondor, INSERM, U955 E01, Neuropsychol Intervent,Inst Mondor Rech Biomed, F-94010 Creteil, France.	bachoud@gmail.com	Broussolle, Emmanuel/H-1592-2017; Schramm, Catherine/AAB-5104-2021; Bachoud-Lévi, Anne-Catherine/GYU-8680-2022	Broussolle, Emmanuel/0000-0002-0410-9519; Schramm, Catherine/0000-0002-1185-8809; Bachoud-Lévi, Anne-Catherine/0000-0003-3000-2210; Slama, Hichem/0000-0003-3856-4488; Cleret de Langavant, Laurent/0000-0001-6551-4641; Demonet, Jean-Francois/0000-0003-0100-6175; Simonin, Clemence/0000-0002-2282-4372; Goizet, Cyril/0000-0002-1913-889X; KATSAHIAN, Sandrine/0000-0002-7261-0671	investment for the future NeurATRIS: Infrastructure de recherche translationnelle pour les biotherapies en Neurosciences [ANR-11-INBS-0011]; European Community Seventh Framework Program Neurostemcell [222943]; European Community Seventh Framework Program Repair-HD [602245]; ANR grants from the French Research Agency [ANR-10-LABX-0087 IEC, ANR-10-IDEX-0001-02 PSL]; Assistance Publique-Hopitaux de Paris [NCT00190450]; Sanofi Aventis [NCT00277602]	investment for the future NeurATRIS: Infrastructure de recherche translationnelle pour les biotherapies en Neurosciences; European Community Seventh Framework Program Neurostemcell; European Community Seventh Framework Program Repair-HD; ANR grants from the French Research Agency(French National Research Agency (ANR)); Assistance Publique-Hopitaux de Paris; Sanofi Aventis(Sanofi-Aventis)	This study was supported by investment for the future NeurATRIS: Infrastructure de recherche translationnelle pour les biotherapies en Neurosciences (ANR-11-INBS-0011, http://www.agence-nationale-recherche.fr/), European Community Seventh Framework Program Neurostemcell (Grant Agreement no. 222943, http://ec.europa.eu/research/fp7/), European Community Seventh Framework Program Repair-HD (Grant Agreement no 602245, http://ec.europa.eu/research/fp7/). The Departement d'Etudes Cognitives of the Ecole Normale Superieure is supported by two ANR grants from the French Research Agency (ANR-10-LABX-0087 IEC and ANR-10-IDEX-0001-02 PSL, http://www.agence-nationale-recherche.fr/). Assistance Publique-Hopitaux de Paris is the sponsor for the MIG-HD study (Ref NCT00190450) and Sanofi Aventis for the Riluzole study (Ref NCT00277602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1998, INFORM THEORY EXTENS; Bachoud-Levi AC, 2001, NEUROLOGY, V56, P1052, DOI 10.1212/WNL.56.8.1052; Bachoud-Levi AC, 2002, MOVEMENT DISORD, V17, P439, DOI 10.1002/mds.10117; Beglinger LJ, 2005, ARCH CLIN NEUROPSYCH, V20, P517, DOI 10.1016/j.acn.2004.12.003; Benedict RHB, 1998, J CLIN EXP NEUROPSYC, V20, P339, DOI 10.1076/jcen.20.3.339.822; Brandt J, 1996, NEUROLOGY, V46, P527, DOI 10.1212/WNL.46.2.527; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; BUTTERS N, 1986, CORTEX, V22, P11, DOI 10.1016/S0010-9452(86)80030-2; Carcaillon L, 2011, J NUTR HEALTH AGING, V15, P361, DOI 10.1007/s12603-011-0047-z; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Cooper DB, 2004, ALZ DIS ASSOC DIS, V18, P120, DOI 10.1097/01.wad.0000127442.15689.92; Cooper DB, 2001, CLIN NEUROPSYCHOL, V15, P125, DOI 10.1076/clin.15.1.125.1914; Duff K, 2007, ARCH CLIN NEUROPSYCH, V22, P15, DOI 10.1016/j.acn.2006.08.013; Duff K, 2010, ARCH CLIN NEUROPSYCH, V25, P81, DOI 10.1093/arclin/acp105; FEIGIN A, 1995, MOVEMENT DISORD, V10, P211, DOI 10.1002/mds.870100213; Golden CJ., 1978, AGE, DOI DOI 10.4135/9781412952644.N441; HOCKING RR, 1976, BIOMETRICS, V32, P1, DOI 10.2307/2529336; Karusu T.B., 1976, GERIATRIC PSYCHIAT, P77; KIEBURTZ K, 1994, J MED GENET, V31, P872, DOI 10.1136/jmg.31.11.872; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Landwehrmeyer GB, 2007, ANN NEUROL, V62, P262, DOI 10.1002/ana.21181; Langbehn DR, 2010, AM J MED GENET B, V153B, P397, DOI 10.1002/ajmg.b.30992; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Marder K, 2000, NEUROLOGY, V54, P452, DOI 10.1212/WNL.54.2.452; McCaffrey RJ, 1995, NEUROPSYCHOL REV, V5, P203, DOI 10.1007/BF02214762; Naes T, 2001, J CHEMOMETR, V15, P413, DOI 10.1002/cem.676; Noda A, 2006, AM J GERIAT PSYCHIAT, V14, P931, DOI 10.1097/01.JGP.0000230660.39635.68; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rieu D, 2006, REV NEUROL-FRANCE, V162, P721, DOI 10.1016/S0035-3787(06)75069-X; Rosenblatt A, 2012, MOVEMENT DISORD, V27, P272, DOI 10.1002/mds.24024; Ruocco HH, 2008, J NEUROL NEUROSUR PS, V79, P130, DOI 10.1136/jnnp.2007.116244; Salthouse TA, 2004, DEV PSYCHOL, V40, P813, DOI 10.1037/0012-1649.40.5.813; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Snowden J, 2001, J INT NEUROPSYCH SOC, V7, P33, DOI 10.1017/S1355617701711046; Snowden J., 2014, HUNTINGTONS DIS, P36; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Stout JC, 2014, MOVEMENT DISORD, V29, P1281, DOI 10.1002/mds.25964; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0; Zazzo R., 1960, TEST DEUX BARRAGES E	40	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145842	10.1371/journal.pone.0145842	http://dx.doi.org/10.1371/journal.pone.0145842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0IX	26714284	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900091
J	Hang, JJ; Cai, BX; Xue, P; Wang, L; Hu, H; Zhou, YY; Ren, SJ; Wu, JJ; Zhu, MY; Chen, DH; Yang, HY; Wang, LW				Hang, Junjie; Cai, Binxin; Xue, Peng; Wang, Lei; Hu, Hai; Zhou, Yangyang; Ren, Shujuan; Wu, Jiajin; Zhu, Meiying; Chen, Donghui; Yang, Haiyan; Wang, Liwei			The Joint Effects of Lifestyle Factors and Comorbidities on the Risk of Colorectal Cancer: A Large Chinese Retrospective Case-Control Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SLEEP DURATION; EPIDEMIOLOGIC EVIDENCE; ALCOHOL-CONSUMPTION; METABOLIC SYNDROME; METAANALYSIS; PREVENTION; RECOMMENDATIONS; ASSOCIATION; POLYPHENOLS	Background Colorectal cancer (CRC) is a major cause of cancer morbidity and mortality. In previous epidemiologic studies, the respective correlation between lifestyle factors and comorbidity and CRC has been extensively studied. However, little is known about their joint effects on CRC. Methods We conducted a retrospective case-control study of 1,144 diagnosed CRC patients and 60,549 community controls. A structured questionnaire was administered to the participants about their socio-demographic factors, anthropometric measures, comorbidity history and lifestyle factors. Logistic regression model was used to calculate the odds ratio (ORs) and 95% confidence intervals (95% CIs) for each factor. According to the results from logistic regression model, we further developed healthy lifestyle index (HLI) and comorbidity history index (CHI) to investigate their independent and joint effects on CRC risk. Results Four lifestyle factors (including physical activities, sleep, red meat and vegetable consumption) and four types of comorbidity (including diabetes, hyperlipidemia, history of inflammatory bowel disease and polyps) were found to be independently associated with the risk of CRC in multivariant logistic regression model. Intriguingly, their combined pattern-HLI and CHI demonstrated significant correlation with CRC risk independently (ORHLI: 3.91, 95% CI: 3.13-4.88; ORCHI: 2.49, 95% CI: 2.11-2.93) and jointly (OR: 10.33, 95% CI: 6.59-16.18). Conclusions There are synergistic effects of lifestyle factors and comorbidity on the risk of colorectal cancer in the Chinese population.	[Hang, Junjie; Xue, Peng; Wang, Lei; Hu, Hai; Zhou, Yangyang; Ren, Shujuan; Chen, Donghui; Yang, Haiyan; Wang, Liwei] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Oncol, Shanghai 200030, Peoples R China; [Hang, Junjie; Xue, Peng; Wang, Lei; Hu, Hai; Zhou, Yangyang; Ren, Shujuan; Chen, Donghui; Yang, Haiyan; Wang, Liwei] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Pancreat Canc Ctr, Shanghai 200030, Peoples R China; [Hang, Junjie; Xue, Peng; Wang, Lei; Hu, Hai; Zhou, Yangyang; Ren, Shujuan; Chen, Donghui; Yang, Haiyan; Wang, Liwei] Shanghai Key Lab Pancreat Dis, Shanghai, Peoples R China; [Cai, Binxin; Wu, Jiajin; Zhu, Meiying] Shanghai Municipal Ctr Dis Control & Prevent, Songjiang Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Center for Disease Control & Prevention	Yang, HY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Oncol, Shanghai 200030, Peoples R China.	13916708215@163.com; yzwlw@hotmail.com			Songjiang Liandong Program [0702N14002]; National Key Clinical Discipline-Oncology; National Natural Science Foundation of China [81502017, 81502018, 81572315, 81171887, 91229117]	Songjiang Liandong Program; National Key Clinical Discipline-Oncology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Songjiang Liandong Program (0702N14002), by National Key Clinical Discipline-Oncology, and in part by the National Natural Science Foundation of China (grant nos. 81502017, 81502018, 81572315, 81171887 and 91229117), http://isisn.nsfc.gov.cn/egrantweb/. LW and LWW received the funding. The funder had a role in study design.	Ahmed RL, 2006, CANCER-AM CANCER SOC, V107, P28, DOI 10.1002/cncr.21950; Aleksandrova K, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0168-4; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Arranz S, 2012, NUTRIENTS, V4, P759, DOI 10.3390/nu4070759; Bener A, 2010, ASIAN PAC J CANCER P, V11, P963; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Chen WQ, 2015, CHINESE J CANCER RES, V27, P2, DOI 10.3978/j.issn.1000-9604.2015.01.06; Colangelo LA, 2002, CANCER EPIDEM BIOMAR, V11, P385; Dai Zhen, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P598; Derry MM, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00119; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Haas SL, 2012, CURR OPIN CLIN NUTR, V15, P457, DOI 10.1097/MCO.0b013e3283566699; Hassan MM, 2007, AM J GASTROENTEROL, V102, P2696, DOI 10.1111/j.1572-0241.2007.01510.x; He S, 2008, INT J MOL SCI, V9, P842, DOI 10.3390/ijms9050842; Hebels DGAJ, 2012, FOOD CHEM TOXICOL, V50, P95, DOI 10.1016/j.fct.2011.10.038; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Inoue I, 2014, WORLD J GASTROENTERO, V20, P1485, DOI 10.3748/wjg.v20.i6.1485; Jiao L, 2013, BRIT J CANCER, V108, P213, DOI 10.1038/bjc.2012.561; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kirkegaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5504; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Odegaard AO, 2013, CANCER PREV RES, V6, P360, DOI 10.1158/1940-6207.CAPR-12-0384; Pais R, 2009, WORLD J GASTROENTERO, V15, P5141, DOI 10.3748/wjg.15.5141; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V103, P506, DOI 10.1093/oxfordjournals.aje.a112252; Russo P, 2012, LIFE SCI, V91, P1087, DOI 10.1016/j.lfs.2012.05.003; Salim OEH, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-68; Samad AKA, 2005, COLORECTAL DIS, V7, P204, DOI 10.1111/j.1463-1318.2005.00747.x; Sauer J, 2010, BRIT J NUTR, V104, P24, DOI 10.1017/S0007114510000322; Signorello LB, 2009, AM J EPIDEMIOL, V170, P104, DOI 10.1093/aje/kwp098; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsoi KKF, 2009, CLIN GASTROENTEROL H, V7, P682, DOI 10.1016/j.cgh.2009.02.016; Vucenik I, 2012, ANN NY ACAD SCI, V1271, P37, DOI 10.1111/j.1749-6632.2012.06750.x; WATSON SA, 1988, BRIT J SURG, V75, P342, DOI 10.1002/bjs.1800750416; Winzer BM, 2011, CANCER CAUSE CONTROL, V22, P811, DOI 10.1007/s10552-011-9761-4; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; Zhang XH, 2013, SLEEP, V36, P681, DOI 10.5665/sleep.2626; Zhang Y, 2012, AM J EPIDEMIOL, V175, P441, DOI 10.1093/aje/kwr331; Zhao H, 2013, ASIAN PAC J CANCER P, V14, P7509, DOI 10.7314/APJCP.2013.14.12.7509; Zhiqin W, 2014, INTEST RES, V12, P194, DOI 10.5217/ir.2014.12.3.194; Zoratto F, 2014, TUMOR BIOL, V35, P6195, DOI 10.1007/s13277-014-1845-9	42	23	26	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0143696	10.1371/journal.pone.0143696	http://dx.doi.org/10.1371/journal.pone.0143696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710070	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400001
J	Lima, NBD; Silva, AIS; Gerson, PC; Goncalves, SMC; Simas, AM				Lima, Nathalia B. D.; Silva, Anderson I. S.; Gerson, P. C., Jr.; Goncalves, Simone M. C.; Simas, Alfredo M.			Faster Synthesis of Beta-Diketonate Ternary Europium Complexes: Elapsed Times & Reaction Yields	PLOS ONE			English	Article							EMISSION QUANTUM YIELD; LUMINESCENCE; PHOTOLUMINESCENT; DIPHENYLETHYNE; NANOPARTICLES; SENSORS	beta-diketonates are customary bidentate ligands in highly luminescent ternary europium complexes, such as Eu(beta-diketonate)(3)(L)(2), where L stands for a nonionic ligand. Usually, the syntheses of these complexes start by adding, to an europium salt such as EuCl3(H2O)(6), three equivalents of beta-diketonate ligands to form the complexes Eu(beta-diketonate)(3)(H2O)(2). The nonionic ligands are subsequently added to form the target complexes Eu(beta-diketonate)(3)(L)(2). However, the Eu(beta-diketonate)(3)(H2O)(2) intermediates are frequently both difficult and slow to purify by recrystallization, a step which usually takes a long time, varying from days to several weeks, depending on the chosen beta-diketonate. In this article, we advance a novel synthetic technique which does not use Eu(beta-diketonate)(3)(H2O)(2) as an intermediate. Instead, we start by adding 4 equivalents of a monodentate nonionic ligand L straight to EuCl3(H2O)(6) to form a new intermediate: EuCl3(L)(4)(H2O)(n), with n being either 3 or 4. The advantage is that these intermediates can now be easily, quickly, and efficiently purified. The beta-diketonates are then carefully added to this intermediate to form the target complexes Eu(beta-diketonate)(3)(L)(2). For the cases studied, the 20-day average elapsed time reduced to 10 days for the faster synthesis, together with an improvement in the overall yield from 42% to 69%.	[Lima, Nathalia B. D.; Silva, Anderson I. S.; Gerson, P. C., Jr.; Goncalves, Simone M. C.; Simas, Alfredo M.] Univ Fed Pernambuco, Dept Quim Fundamental, Recife, PE, Brazil	Universidade Federal de Pernambuco	Goncalves, SMC (corresponding author), Univ Fed Pernambuco, Dept Quim Fundamental, Recife, PE, Brazil.	simone@ufpe.br; simas@ufpe.br	Simas, Alfredo M/B-1096-2008; Lima, Nathalia/AAC-3530-2021; Castro, Gerson P/AAQ-1752-2021; Lima, Nathalia/O-8783-2015	Simas, Alfredo M/0000-0003-3653-6328; Lima, Nathalia/0000-0002-1550-5859; Castro, Gerson P/0000-0003-1548-8398; Lima, Nathalia/0000-0002-1550-5859; Goncalves, Simone/0000-0003-2009-8765	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), agency of the Brazilian Government; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco FACEPE (Pronex), agency of the Brazilian Government	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), agency of the Brazilian Government; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco FACEPE (Pronex), agency of the Brazilian Government	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco FACEPE (Pronex), agencies of the Brazilian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Centro de Tecnologias Estrategicas do Nordeste, CETENE, and Dr. Julia F. Campos for the MALDI-TOF mass spectrometry measurements. The authors also appreciate the financial support of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE), agencies of the Brazilian Government.	Binnemans K, 2005, HBK PHYS CHEM RARE, V35, P107, DOI 10.1016/S0168-1273(05)35003-3; Binnemans K, 2009, CHEM REV, V109, P4283, DOI 10.1021/cr8003983; Duarte AP, 2013, LANGMUIR, V29, P5878, DOI 10.1021/la400365c; He H, 2011, SPECTROCHIM ACTA A, V82, P493, DOI 10.1016/j.saa.2011.07.085; Hu WP, 2000, JPN J APPL PHYS 1, V39, P6445, DOI 10.1143/JJAP.39.6445; Hu ZJ, 2011, CHEM COMMUN, V47, P12467, DOI 10.1039/c1cc14968g; Khalil GE, 2004, REV SCI INSTRUM, V75, P192, DOI 10.1063/1.1632997; Li P, 2014, CHEM COMMUN, V50, P13680, DOI 10.1039/c4cc05635c; Lima NBD, 2016, J LUMIN, V170, P505, DOI 10.1016/j.jlumin.2015.04.044; Lima NBD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02395; Lima PP, 2014, ORG ELECTRON, V15, P798, DOI 10.1016/j.orgel.2014.01.009; Liu Y, 2014, MATER CHEM PHYS, V143, P1265, DOI 10.1016/j.matchemphys.2013.11.032; Lu Y, 2014, CHEM COMMUN, V50, P13323, DOI 10.1039/c4cc05508j; Malta OL, 1998, CHEM PHYS LETT, V282, P233, DOI 10.1016/S0009-2614(97)01283-9; Niyama E, 2005, SPECTROCHIM ACTA A, V61, P2643, DOI 10.1016/j.saa.2004.10.006; Panayiotidou L, 2013, POLYHEDRON, V52, P856, DOI 10.1016/j.poly.2012.07.029; Quirino W, 2011, SYNTHETIC MET, V161, P964, DOI 10.1016/j.synthmet.2011.03.001; Ratnakar SJ, 2012, J AM CHEM SOC, V134, P5798, DOI 10.1021/ja211601k; Ryu SJ, 2014, APPL CLAY SCI, V101, P52, DOI 10.1016/j.clay.2014.07.010; Shao G, 2014, PHYS CHEM CHEM PHYS, V16, P695, DOI 10.1039/c3cp53871k; Shao G, 2013, J LUMIN, V138, P195, DOI 10.1016/j.jlumin.2013.01.020; Shao G, 2012, SENSOR ACTUAT B-CHEM, V173, P692, DOI 10.1016/j.snb.2012.07.075; Shao YF, 2014, MICROPOR MESOPOR MAT, V193, P85, DOI 10.1016/j.micromeso.2014.03.019; Silva FRGE, 2000, J ALLOY COMPD, V303, P364, DOI 10.1016/S0925-8388(00)00642-3; Tambornino F, 2014, ACTA CRYSTALLOGR E, V70, pI27, DOI 10.1107/S1600536814010307; Teotonio EES, 2008, J LUMIN, V128, P190, DOI 10.1016/j.jlumin.2007.07.005; Urbain G., 1897, C R CHIMIE, V124, P618; Wang LP, 2011, J AGR FOOD CHEM, V59, P1607, DOI 10.1021/jf104484v; Wu YQ, 2014, BIOMATERIALS, V35, P5830, DOI 10.1016/j.biomaterials.2014.03.080	29	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0143998	10.1371/journal.pone.0143998	http://dx.doi.org/10.1371/journal.pone.0143998			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710103	Green Published, Green Submitted, gold			2022-12-27	WOS:000367451400002
J	Rughooputh, MS; Zeng, R; Yao, Y				Rughooputh, Mahesh Shumsher; Zeng, Rui; Yao, Ying			Protein Diet Restriction Slows Chronic Kidney Disease Progression in Non-Diabetic and in Type 1 Diabetic Patients, but Not in Type 2 Diabetic Patients: A Meta-Analysis of Randomized Controlled Trials Using Glomerular Filtration Rate as a Surrogate	PLOS ONE			English	Article							RENAL-FAILURE; ALBUMINURIA; NEPHROPATHY; MELLITUS	Background/Objective Studies, including various meta-analyses, on the effect of Protein Diet Restriction on Glomerular Filtration Rate (GFR) in Chronic Kidney Disease (CKD) have reported conflicting results. In this paper, we have provided an update on the evidence available on this topic. We have investigated the reasons why the effect has been inconsistent across studies. We have also compared the effect on GFR in various subgroups including type 1 diabetics, type 2 diabetics and non-diabetics. Method We searched for Randomized Controlled Trials on this intervention from MEDLINE, EMBASE, and other information sources. The PRISMA guidelines, as well as recommended meta-analysis practices were followed in the selection process, analysis and reporting of our findings. The effect estimate used was the change in mean GFR. Heterogeneity across the considered studies was explored using both subgroup analyses and meta-regression. Quality assessment was done using the Cochrane risk of bias tool and sensitivity analyses. Results 15 randomized controlled trials, including 1965 subjects, were analyzed. The pooled effect size, as assessed using random-effects model, for all the 15 studies was -0.95 ml/min/1.73m(2)/year (95% CI: -1.79, -0.11), with a significant p value of 0.03. The combined effect estimate for the non-diabetic and type 1 diabetic studies was -1.50 ml/min/1.73m(2)/year (95% CI: -2.73, -0.26) with p value of 0.02. The effect estimate for the type 2 diabetic group was -0.17 ml/min/1.73m(2)/year (95% CI: -1.88, 1.55) with p value of 0.85. There was significant heterogeneity across the included studies (I-2 = 74%, p value for Q < 0.0001), explained by major variations in the percentage of type 2 diabetic subjects, the number of subjects and overall compliance level to diet prescribed. Conclusion Our findings suggest that protein diet restriction slows chronic renal disease progression in non-diabetic and in type 1 diabetic patients, but not in type 2 diabetic patients.	[Rughooputh, Mahesh Shumsher; Zeng, Rui; Yao, Ying] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nephrol, Wuhan 430074, Peoples R China; [Yao, Ying] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Clin Nutr, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Rughooputh, MS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nephrol, Wuhan 430074, Peoples R China.	mrughooputh@hotmail.com; zengrui@tjh.tjmu.edu.cn; yaoyingkk@126.com	Zeng, RUI/AAF-7238-2019; Zeng, Rui/GRY-0646-2022	Zeng, Rui/0000-0003-1188-3198	National Natural Science Foundation of China [81170686]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81170686).	[Anonymous], 2014, EARL ID MAN CHRON KI; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BROUHARD BH, 1990, AM J MED, V89, P427, DOI 10.1016/0002-9343(90)90370-S; Cianciaruso B, 2009, AM J KIDNEY DIS, V54, P1052, DOI 10.1053/j.ajkd.2009.07.021; DAMICO G, 1994, NEPHROL DIAL TRANSPL, V9, P1590; DULLAART RPF, 1993, DIABETES CARE, V16, P483, DOI 10.2337/diacare.16.2.483; Dussol B, 2005, J RENAL NUTR, V15, P398, DOI 10.1053/j.jrn.2005.07.003; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; Emrich IE, 2015, AM J KIDNEY DIS, V65, P636, DOI 10.1053/j.ajkd.2014.12.006; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; Fouque D, 2015, NEPHROL DIAL TRANSPL, V30, P6, DOI 10.1093/ndt/gfu340; Gagnier Joel J., 2010, PRESENTATIO COCHRANE; Greene T, 2014, AM J KIDNEY DIS, V64, P867, DOI 10.1053/j.ajkd.2014.08.019; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Hansen HP, 2002, KIDNEY INT, V62, P220, DOI 10.1046/j.1523-1755.2002.00421.x; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hosmer David W, 2013, APPL LOGISTIC REGRES; IHLE BU, 1989, NEW ENGL J MED, V321, P1773, DOI 10.1056/NEJM198912283212601; Jesudason DR, 2013, AM J CLIN NUTR, V98, P494, DOI 10.3945/ajcn.113.060889; John Chambers M, 1983, GRAPHICAL METHODS DA, P194; Kasiske BL, 1998, AM J KIDNEY DIS, V31, P954, DOI 10.1053/ajkd.1998.v31.pm9631839; Klahr S, 2003, AM J KIDNEY DIS, V41, pS3, DOI 10.1053/ajkd.2003.50074; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Koya D, 2009, DIABETOLOGIA, V52, P2037, DOI 10.1007/s00125-009-1467-8; Larsen RN, 2011, DIABETOLOGIA, V54, P731, DOI 10.1007/s00125-010-2027-y; Levey AS, 1999, J AM SOC NEPHROL, V10, P2426; Levin A, 2012, KIDNEY INT S, V2013, P1, DOI DOI 10.1038/kisup.2012.73; MARONI BJ, 1985, KIDNEY INT, V27, P58, DOI 10.1038/ki.1985.10; Meloni C, 2004, J RENAL NUTR, V14, P208, DOI 10.1053/j.jm.2004.07.011; Metafor-project. org, METAFOR PACKAGE META; Mircescu G, 2007, J RENAL NUTR, V17, P179, DOI 10.1053/j.jrn.2006.12.012; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nezu U, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002934; Pan Y, 2008, AM J CLIN NUTR, V88, P660, DOI 10.1093/ajcn/88.3.660; Pedrini MT, 1996, ANN INTERN MED, V124, P627, DOI 10.7326/0003-4819-124-7-199604010-00002; Pijls LTJ, 2002, EUR J CLIN NUTR, V56, P1200, DOI 10.1038/sj.ejcn.1601474; Robertson L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002181.pub2; ROSMAN JB, 1984, LANCET, V2, P1291; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Schwingshackl L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097656; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; WILLIAMS PS, 1991, Q J MED, V81, P837; ZELLER K, 1991, NEW ENGL J MED, V324, P78, DOI 10.1056/NEJM199101103240202	44	30	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145505	10.1371/journal.pone.0145505	http://dx.doi.org/10.1371/journal.pone.0145505			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710078	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400057
J	Rahamim, G; Chemerovski-Glikman, M; Rahimipour, S; Amir, D; Haas, E				Rahamim, Gil; Chemerovski-Glikman, Marina; Rahimipour, Shai; Amir, Dan; Haas, Elisha			Resolution of Two Sub-Populations of Conformers and Their Individual Dynamics by Time Resolved Ensemble Level FRET Measurements	PLOS ONE			English	Article							SINGLE-MOLECULE FLUORESCENCE; RESONANCE ENERGY-TRANSFER; INTRAMOLECULAR DISTANCE DISTRIBUTIONS; PROTEIN COLLAPSE; GLOBAL ANALYSIS; CORRELATION SPECTROSCOPY; FOLDING REACTIONS; DENATURED STATE; CHAIN COLLAPSE; RIBONUCLEASE-A	Most active biopolymers are dynamic structures; thus, ensembles of such molecules should be characterized by distributions of intra-or intermolecular distances and their fast fluctuations. A method of choice to determine intramolecular distances is based on Forster resonance energy transfer (FRET) measurements. Major advances in such measurements were achieved by single molecule FRET measurements. Here, we show that by global analysis of the decay of the emission of both the donor and the acceptor it is also possible to resolve two sub-populations in a mixture of two ensembles of biopolymers by time resolved FRET (trFRET) measurements at the ensemble level. We show that two individual intramolecular distance distributions can be determined and characterized in terms of their individual means, full width at half maximum (FWHM), and two corresponding diffusion coefficients which reflect the rates of fast ns fluctuations within each sub-population. An important advantage of the ensemble level trFRET measurements is the ability to use low molecular weight small-sized probes and to determine nanosecond fluctuations of the distance between the probes. The limits of the possible resolution were first tested by simulation and then by preparation of mixtures of two model peptides. The first labeled polypeptide was a relatively rigid Pro(7) and the second polypeptide was a flexible molecule consisting of (Gly-Ser)(7) repeats. The end to end distance distributions and the diffusion coefficients of each peptide were determined. Global analysis of trFRET measurements of a series of mixtures of polypeptides recovered two end-to-end distance distributions and associated intramolecular diffusion coefficients, which were very close to those determined from each of the pure samples. This study is a proof of concept study demonstrating the power of ensemble level trFRET based methods in resolution of subpopulations in ensembles of flexible macromolecules.	[Rahamim, Gil; Amir, Dan; Haas, Elisha] Bar Ilan Univ, Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Chemerovski-Glikman, Marina; Rahimipour, Shai] Bar Ilan Univ, Dept Chem, IL-52900 Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Haas, E (corresponding author), Bar Ilan Univ, Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	Elisha.haas@biu.ac.il	Rahimipour, Shai/P-4770-2019	Rahimipour, Shai/0000-0002-3210-1645	Israel Science Foundation [ISF1464/10]; ISF-ICORE grant [1902/12]; United states-Israel Binational Science Foundation [2011143]	Israel Science Foundation(Israel Science Foundation); ISF-ICORE grant; United states-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This study was supported by grants from the Israel Science Foundation (ISF1464/10), the ISF-ICORE grant (1902/12) and the United states-Israel Binational Science Foundation (grant No. 2011143).	Aathavan K, 2009, NATURE, V461, P669, DOI 10.1038/nature08443; Alon A, 2012, NATURE, V488, P414, DOI 10.1038/nature11267; BEALS JM, 1991, BIOCHEMISTRY-US, V30, P7680, DOI 10.1021/bi00245a004; BEECHEM JM, 1989, BIOPHYS J, V55, P1225, DOI 10.1016/S0006-3495(89)82918-2; BEECHEM JM, 1992, METHOD ENZYMOL, V210, P37; BEECHEM JM, 1986, PHOTOCHEM PHOTOBIOL, V44, P323, DOI 10.1111/j.1751-1097.1986.tb04671.x; BEECHEM JM, 1989, CHEM PHYS LIPIDS, V50, P237, DOI 10.1016/0009-3084(89)90052-2; Ben Ishay E, 2012, J MOL BIOL, V423, P613, DOI 10.1016/j.jmb.2012.08.001; Ben Ishay E, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4737632; Bilsel O, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1834698; Borgia A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2204; Borst JW, 2008, BIOPHYS J, V95, P5399, DOI 10.1529/biophysj.107.114587; Buckler DR, 1995, BIOCHEMISTRY-US, V34, P15965, DOI 10.1021/bi00049a011; Butterfoss GL, 2012, P NATL ACAD SCI USA, V109, P14320, DOI 10.1073/pnas.1209945109; Chahine J, 2007, P NATL ACAD SCI USA, V104, P14646, DOI 10.1073/pnas.0606506104; CHEUNG HC, 1991, BIOPHYS CHEM, V40, P1, DOI 10.1016/0301-4622(91)85025-L; Chung HS, 2013, NATURE, V502, P685, DOI 10.1038/nature12649; Chung HS, 2012, SCIENCE, V335, P981, DOI 10.1126/science.1215768; Creighton T, 1993, PROTEINS STRUCTURE A; DeCamp SJ, 2009, BIOPHYS J, V97, P1772, DOI 10.1016/j.bpj.2009.07.003; Deniz AA, 2000, P NATL ACAD SCI USA, V97, P5179, DOI 10.1073/pnas.090104997; Deniz AA, 1999, P NATL ACAD SCI USA, V96, P3670, DOI 10.1073/pnas.96.7.3670; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Doose S, 2007, P NATL ACAD SCI USA, V104, P17400, DOI 10.1073/pnas.0705605104; Eaton WA, 2000, ANNU REV BIOPH BIOM, V29, P327, DOI 10.1146/annurev.biophys.29.1.327; Edelhoch H, 1963, ISR J CHEM, V1, P1; Enderlein J, 2007, CHEMPHYSCHEM, V8, P1607, DOI 10.1002/cphc.200700247; Fitzpatrick JAJ, 2011, CURR OPIN STRUC BIOL, V21, P650, DOI 10.1016/j.sbi.2011.06.006; FLORY PJ, 1973, P NATL ACAD SCI USA, V70, P1819, DOI 10.1073/pnas.70.6.1819; GRINVALD A, 1974, ANAL BIOCHEM, V59, P583, DOI 10.1016/0003-2697(74)90312-1; Grupi A, 2011, J MOL BIOL, V411, P234, DOI 10.1016/j.jmb.2011.04.056; HAAS E, 1984, BIOPHYS J, V46, P429, DOI 10.1016/S0006-3495(84)84040-0; HAAS E, 1978, BIOPOLYMERS, V17, P11, DOI 10.1002/bip.1978.360170103; Haas E, 2005, CHEMPHYSCHEM, V6, P858, DOI 10.1002/cphc.200400617; Haenni D, 2013, J PHYS CHEM B, V117, P13015, DOI 10.1021/jp402352s; Haran G, 2003, J PHYS-CONDENS MAT, V15, pR1291, DOI 10.1088/0953-8984/15/32/201; HARAN G, 1992, P NATL ACAD SCI USA, V89, P11764, DOI 10.1073/pnas.89.24.11764; Haran G, 2012, CURR OPIN STRUC BIOL, V22, P14, DOI 10.1016/j.sbi.2011.10.005; HENRY ER, 1987, P NATL ACAD SCI USA, V84, P6142, DOI 10.1073/pnas.84.17.6142; Heyduk T, 2002, CURR OPIN BIOTECH, V13, P292, DOI 10.1016/S0958-1669(02)00332-4; Hoefling M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019791; Hoffmann A, 2007, P NATL ACAD SCI USA, V104, P105, DOI 10.1073/pnas.0604353104; Hoffmann A, 2011, PHYS CHEM CHEM PHYS, V13, P1857, DOI 10.1039/c0cp01911a; Hofmann H, 2012, P NATL ACAD SCI USA, V109, P16155, DOI 10.1073/pnas.1207719109; Huang F, 2009, BIOCHEMISTRY-US, V48, P3468, DOI 10.1021/bi801890w; ITTAH V, 1995, BIOCHEMISTRY-US, V34, P4493, DOI 10.1021/bi00013a042; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; Kathuria SV, 2014, J MOL BIOL, V426, P1980, DOI 10.1016/j.jmb.2014.02.020; Kathuria SV, 2011, BIOPOLYMERS, V95, P550, DOI 10.1002/bip.21628; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; Knight JL, 2005, BIOPHYS J, V88, P925, DOI 10.1529/biophysj.104.050187; Lerner E, 2014, BIOPHYS J, V106, P667, DOI 10.1016/j.bpj.2013.11.4500; MALIWAL BP, 1993, BIOPHYS CHEM, V46, P273, DOI 10.1016/0301-4622(93)80020-J; Margittai M, 2003, P NATL ACAD SCI USA, V100, P15516, DOI 10.1073/pnas.2331232100; McCann JJ, 2012, P NATL ACAD SCI USA, V109, P15775, DOI 10.1073/pnas.1200254109; Mello CC, 2004, P NATL ACAD SCI USA, V101, P14102, DOI 10.1073/pnas.0403386101; Meng WL, 2013, BIOCHEMISTRY-US, V52, P2662, DOI 10.1021/bi301667u; Michalet X, 2006, NUCL INSTRUM METH A, V567, P133, DOI 10.1016/j.nima.2006.05.155; Mintzer MR, 2015, PHYS CHEM CHEM PHYS, V17, P7881, DOI 10.1039/c5cp00050e; Moeglich A, 2008, P NATL ACAD SCI USA, V105, P6787, DOI 10.1073/pnas.0803144105; Nettels D, 2008, J PHYS CHEM B, V112, P6137, DOI 10.1021/jp076971j; Nettels D, 2007, P NATL ACAD SCI USA, V104, P2655, DOI 10.1073/pnas.0611093104; Neuweiler H, 2003, J AM CHEM SOC, V125, P5324, DOI 10.1021/ja034040p; Nienhaus GU, 2006, MACROMOL BIOSCI, V6, P907, DOI 10.1002/mabi.200600158; Orevi T, 2014, FAST CLOSURE OF LONG; Orevi T, 2014, METHODS MOL BIOL, V1076, P113, DOI 10.1007/978-1-62703-649-8_7; Paz A, 2008, BIOPHYS J, V95, P1928, DOI 10.1529/biophysj.107.126995; Pirchi M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1504; Pletneva EV, 2005, P NATL ACAD SCI USA, V102, P18397, DOI 10.1073/pnas.0509076102; Religa TL, 2007, P NATL ACAD SCI USA, V104, P9272, DOI 10.1073/pnas.0703434104; Scheraga HA, 2007, ANNU REV PHYS CHEM, V58, P57, DOI 10.1146/annurev.physchem.58.032806.104614; Schroder GF, 2005, BIOPHYS J, V89, P3757, DOI 10.1529/biophysj.105.069500; Schuler B, 2005, CHEMPHYSCHEM, V6, P1206, DOI 10.1002/cphc.200400609; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; Schuler B, 2013, NATURE, V502, P632, DOI 10.1038/nature12697; Sinha KK, 2007, J MOL BIOL, V370, P385, DOI 10.1016/j.jmb.2007.04.061; SOSNICK TR, 1994, NAT STRUCT BIOL, V1, P149, DOI 10.1038/nsb0394-149; Sridevi K, 2004, J MOL BIOL, V337, P699, DOI 10.1016/j.jmb.2003.12.083; Stearns V, 2004, CLIN CANCER RES, V10, P8332, DOI 10.1158/1078-0432.CCR-04-0297; Tomescu AI, 2014, P NATL ACAD SCI USA, V111, pE3335, DOI 10.1073/pnas.1406056111; Udgaonkar JB, 2013, ARCH BIOCHEM BIOPHYS, V531, P24, DOI 10.1016/j.abb.2012.10.003; vd Meer BW, 1994, RESONANCE ENERGY TRA; Watkins LP, 2006, J PHYS CHEM A, V110, P5191, DOI 10.1021/jp055886d; Wozniak AK, 2005, RNA, V11, P1545, DOI 10.1261/rna.2950605; Wunderlich B, 2013, NAT PROTOC, V8, P1459, DOI 10.1038/nprot.2013.082; Xu JH, 2015, J PHYS CHEM B, V119, P4230, DOI 10.1021/acs.jpcb.5b01651; Xu WX, 2012, J PHYS CHEM B, V116, P5152, DOI 10.1021/jp212132v; Ziv G, 2009, J AM CHEM SOC, V131, P2942, DOI 10.1021/ja808305u	88	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0143732	10.1371/journal.pone.0143732	http://dx.doi.org/10.1371/journal.pone.0143732			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699718	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600008
J	Reblova, M; Jaklitsch, WM; Reblova, K; Stepanek, V				Reblova, Martina; Jaklitsch, Walter M.; Reblova, Kamila; Stepanek, Vaclav			Phylogenetic Reconstruction of the Calosphaeriales and Togniniales Using Five Genes and Predicted RNA Secondary Structures of ITS, and Flabellascus tenuirostris gen. et sp nov.	PLOS ONE			English	Article							RIBOSOMAL-RNA; BETA-TUBULIN; SUBCUTANEOUS PHEOHYPHOMYCOSIS; 3-WAY JUNCTIONS; ESCA DISEASE; PHAEOACREMONIUM; GRAPEVINE; TREES; ITS2; PLEUROSTOMOPHORA	The Calosphaeriales is revisited with new collection data, living cultures, morphological studies of ascoma centrum, secondary structures of the internal transcribed spacer (ITS) rDNA and phylogeny based on novel DNA sequences of five nuclear ribosomal and protein-coding loci. Morphological features, molecular evidence and information from predicted RNA secondary structures of ITS converged upon robust phylogenies of the Calosphaeriales and Togniniales. The current concept of the Calosphaeriales includes the Calosphaeriaceae and Pleurostomataceae encompassing five monophyletic genera, Calosphaeria, Flabellascus gen. nov., Jattaea, Pleurostoma and Togniniella, strongly supported by Bayesian and Maximum Likelihood methods. The structural elements of ITS1 form characteristic patterns that are phylogenetically conserved, corroborate observations based on morphology and have a high predictive value at the generic level. Three major clades containing 44 species of Phaeoacremonium were recovered in the closely related Togniniales based on ITS, actin and beta-tubulin sequences. They are newly characterized by sexual and RNA structural characters and ecology. This approach is a first step towards understanding of the molecular systematics of Phaeoacremonium and possibly its new classification. In the Calosphaeriales, Jattaea aphanospora sp. nov. and J. ribicola sp. nov. are introduced, Calosphaeria taediosa is combined in Jattaea and epitypified. The sexual morph of Phaeoacremonium cinereum was encountered for the first time on decaying wood and obtained in vitro. In order to achieve a single nomenclature, the genera of asexual morphs linked with the Calosphaeriales are transferred to synonymy of their sexual morphs following the principle of priority, i.e. Calosphaeriophora to Calosphaeria, Phaeocrella to Togniniella and Pleurostomophora to Pleurostoma. Three new combinations are proposed, i.e. Pleurostoma ochraceum comb. nov., P. repens comb. nov. and P. richardsiae comb. nov. The morphology-based key is provided to facilitate identification of genera accepted in the Calosphaeriales.	[Reblova, Martina] Acad Sci Czech Republ, Inst Bot, Dept Taxon, CS-25243 Pruhonice, Czech Republic; [Jaklitsch, Walter M.] BOKU Univ Nat Resources & Life Sci, Inst Forest Entomol, Dept Forest & Soil Sci Forest Pathol & Forest Pro, Vienna, Austria; [Jaklitsch, Walter M.] Univ Vienna, Div Systemat & Evolutionary Bot, Dept Bot & Biodivers Res, Vienna, Austria; [Reblova, Kamila] Masaryk Univ, Fac Med, Brno, Czech Republic; [Reblova, Kamila] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Stepanek, Vaclav] Acad Sci Czech Republ, Inst Microbiol, Lab Enzyme Technol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of Natural Resources & Life Sciences, Vienna; University of Vienna; Masaryk University Brno; Masaryk University Brno; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Reblova, M (corresponding author), Acad Sci Czech Republ, Inst Bot, Dept Taxon, CS-25243 Pruhonice, Czech Republic.	martina.reblova@ibot.cas.cz	Jaklitsch, Walter M/B-4970-2013; Štěpánek, Václav/H-7456-2014; Réblová, Martina/H-1620-2014	Jaklitsch, Walter M./0000-0002-4999-9199	Czech Science Foundation [GA CR 506/12/0038]; Institute of Botany, Academy of Sciences [RVO 67985939]; Faculty of Medicine Masaryk University; Project CEITEC - Central European Institute of Technology from European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; Ministry of Education, Youth, and Sports of the Czech Republic [LM2010005]; Institute of Microbiology, Academy of Sciences [RVO 61388971]	Czech Science Foundation(Grant Agency of the Czech Republic); Institute of Botany, Academy of Sciences; Faculty of Medicine Masaryk University; Project CEITEC - Central European Institute of Technology from European Regional Development Fund; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Institute of Microbiology, Academy of Sciences	This work was supported by the Czech Science Foundation (GA CR 506/12/0038; www.gacr.cz). Additional support was provided to MR by a longterm research development project of the Institute of Botany, Academy of Sciences (RVO 67985939). KR was funded by the Faculty of Medicine Masaryk University and the Project CEITEC - Central European Institute of Technology from European Regional Development Fund (CZ.1.05/1.1.00/02.0068; www.ceitec.eu). Access to the MetaCentrum computing facilities provided under the program "Projects of Large Infrastructure for Research, Development, and Innovations" (LM2010005) funded by the Ministry of Education, Youth, and Sports of the Czech Republic to KR is acknowledged. VS was funded by a long-term research development project of the Institute of Microbiology, Academy of Sciences (RVO 61388971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberts DP, 2010, RNA, V16, P1350, DOI 10.1261/rna.1831710; AJELLO L, 1974, MYCOLOGIA, V66, P490, DOI 10.2307/3758492; BARR ME, 1983, MYCOLOGIA, V75, P1, DOI 10.2307/3792917; Barr ME, 1998, CRYPTOGAMIE BRYOL L, V19, P169; BARR ME, 1993, MYCOTAXON, V48, P529; BARR ME, 1985, MYCOLOGIA, V77, P549, DOI 10.2307/3793354; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Berlese AN, 1900, ICONES FUNGORUM OMNI, V3; Besseova I, 2010, NUCLEIC ACIDS RES, V38, P6247, DOI 10.1093/nar/gkq414; Bridge PD, 2008, MYCOPATHOLOGIA, V166, P1, DOI 10.1007/s11046-008-9094-3; Chen CA, 2004, ZOOL STUD, V43, P759; Choi J, 2011, KOREAN J LAB MED, V31, P201, DOI 10.3343/kjlm.2011.31.3.201; Coleman AW, 2008, J MOL EVOL, V67, P389, DOI 10.1007/s00239-008-9160-y; Coleman AW, 1998, PROTIST, V149, P135, DOI 10.1016/S1434-4610(98)70018-5; Crous PW, 1996, MYCOLOGIA, V88, P786, DOI 10.2307/3760973; Cui JL, 2011, PHYTOTHER RES, V25, P1189, DOI 10.1002/ptr.3361; Damm U, 2008, PERSOONIA, V20, P87, DOI 10.3767/003158508X324227; Damm U, 2008, PERSOONIA, V20, P39, DOI 10.3767/003158508X313940; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; De Hoog GS, 2000, GENUS PHAEOACREMONIU, P846; Dupont J, 2000, MYCOLOGIA, V92, P499, DOI 10.2307/3761508; Ellis JB, 1890, P ACAD NAT SCI PHILA, V42, P219; Ellis JB, 1892, N AM PYRENOMYCETES; ERIKSSON O, 1981, OPERA BOT, V60, P1, DOI DOI 10.1111/J.1756-1051.1981.TB01167.X; Eriksson Ove E., 1994, Systema Ascomycetum, V13, P183; Essakhi S, 2008, PERSOONIA, V21, P119, DOI 10.3767/003158508X374385; Fernandez FA, 2004, MYCOLOGIA, V96, P175, DOI 10.2307/3762000; FORSTER AC, 1987, CELL, V49, P211, DOI 10.1016/0092-8674(87)90562-9; Gams W., 1971, CEPHALOSPORIUM ARTIG; Gams W, 1998, CBS COURSE MYCOLOGY; Geiser DM, 1998, MYCOLOGIA, V90, P831, DOI 10.2307/3761325; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Gottschling M, 2004, NUCLEIC ACIDS RES, V32, P307, DOI 10.1093/nar/gkh168; Gottschling M, 2001, PLANT BIOLOGY, V3, P629, DOI 10.1055/s-2001-19371; Graham AB, 2009, AUSTRALAS PLANT PATH, V38, P505, DOI 10.1071/AP09035; Gramaje D, 2012, PERSOONIA, V28, P1, DOI 10.3767/003158512X626155; Gramaje D, 2015, FUNGAL BIOL-UK, V119, P759, DOI 10.1016/j.funbio.2015.06.004; Gramaje D, 2014, IMA FUNGUS, V5, P67, DOI 10.5598/imafungus.2014.05.01.08; Gramaje D, 2009, MYCOLOGIA, V101, P920, DOI 10.3852/08-222; Groenewald M, 2001, MYCOL RES, V105, P651, DOI 10.1017/S0953756201004282; Guarro J, 2003, J CLIN MICROBIOL, V41, P1332, DOI 10.1128/JCM.41.3.1332-1336.2003; GUTELL RR, 1993, NUCLEIC ACIDS RES, V21, P3051, DOI 10.1093/nar/21.13.3051; GUTELL RR, 1993, NUCLEIC ACIDS RES, V21, P3055, DOI 10.1093/nar/21.13.3055; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HAUSNER G, 1992, CAN J BOT, V70, P724, DOI 10.1139/b92-093; Hawksworth DL, 2011, MYCOKEYS, P7, DOI 10.3897/mycokeys.1.2062; Hawksworth DL, 2011, IMA FUNGUS, V2, P105, DOI 10.5598/imafungus.2011.02.01.14; HIRONAGA M, 1989, J CLIN MICROBIOL, V27, P394, DOI 10.1128/JCM.27.3.394-399.1989; Holbrook SR, 2005, CURR OPIN STRUC BIOL, V15, P302, DOI 10.1016/j.sbi.2005.04.005; Hu DM, 2012, MYCOLOGIA, V104, P1478, DOI 10.3852/11-430; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huhndorf SM, 2009, MYCOLOGIA, V101, P904, DOI 10.3852/08-213; Kruger D, 2008, MYCOL RES, V112, P316, DOI 10.1016/j.mycres.2007.10.019; Kruger D., 2004, Feddes Repertorium, V115, P530, DOI 10.1002/fedr.200311052; Laing C, 2012, NUCLEIC ACIDS RES, V40, P487, DOI 10.1093/nar/gkr629; Lamiable A, 2012, COMPUT BIOL CHEM, V37, P1, DOI 10.1016/j.compbiolchem.2011.11.001; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Lee SB, 1990, PCR PROTOCOLS GUIDE; LEONTIS NB, 1995, BIOPHYS J, V68, P251, DOI 10.1016/S0006-3495(95)80182-7; Leontis NB, 2003, CURR OPIN STRUC BIOL, V13, P300, DOI 10.1016/S0959-440X(03)00076-9; Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009; Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106; LILLEY DMJ, 1995, NUCLEIC ACIDS RES, V23, P3363, DOI 10.1093/nar/23.17.3363; Lumbsch H. Thorsten, 2010, Fieldiana-Life and Earth Sciences, V1, P1, DOI 10.3158/1557.1; Malloch D, 1981, MOULDS THEIR ISOLATI; MARINCOWITZ S, 2008, CBS BIODIVERSITY SER, V7; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; Matsui T, 1999, Nihon Ishinkin Gakkai Zasshi, V40, P99; MEYERS WM, 1975, AM J CLIN PATHOL, V64, P549; Mhmoud NA, 2012, J CLIN MICROBIOL, V50, P2987, DOI 10.1128/JCM.01470-12; Mostert L, 2006, STUD MYCOL, P1; Mostert L, 2003, MYCOLOGIA, V95, P646, DOI 10.2307/3761941; Mostert L, 2005, J CLIN MICROBIOL, V43, P1752, DOI 10.1128/JCM.43.4.1752-1767.2005; MUNK A., 1957, DANSK BOT ARKIV, V17, P1; Nitschke T., 1867, BRESLAU, V1, P1; NOLLER HF, 1984, ANNU REV BIOCHEM, V53, P119, DOI 10.1146/annurev.bi.53.070184.001003; NOLLER HF, 1991, ANNU REV BIOCHEM, V60, P191, DOI 10.1146/annurev.biochem.60.1.191; Nylander J, 2008, MRMODELTEST2 V 2 3 P; Online Auction Color Chart C, 2004, ONL AUCT COL CHART N; Padhye AA, 1998, J CLIN MICROBIOL, V36, P2763, DOI 10.1128/JCM.36.9.2763-2765.1998; PIROZYNSKI KA, 1974, CAN J BOT, V52, P2129, DOI 10.1139/b74-274; Raimondo ML, 2014, MYCOLOGIA, V106, P1119, DOI 10.3852/14-080; Ramaley AW, 2005, MYCOTAXON, V93, P139; Rambaut A, 2013, MCMC TRACE ANAL TOOL; Rappaz F., 1987, Mycologia Helvetica, V2, P285; Reblova K, 2012, NUCLEIC ACIDS RES, V40, P6290, DOI 10.1093/nar/gks258; Reblova M, 2000, MYCOLOGIA, V92, P939, DOI 10.2307/3761589; Reblova M, 2004, STUD MYCOL, P533; Reblova M, 2015, PERSOONIA, V35, P21, DOI 10.3767/003158515X687434; Reblova M, 2011, STUD MYCOL, P163, DOI 10.3114/sim.2011.68.07; Reblova M, MYCOLOGIA, V207, P723; Reblova M, 2007, MYCOL RES, V111, P299, DOI 10.1016/j.mycres.2006.12.002; Reblova M, 2006, MYCOLOGIA, V98, P68, DOI 10.3852/mycologia.98.1.68; Reblova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063547; Reblova M, 2013, MYCOL PROG, V12, P305, DOI 10.1007/s11557-012-0836-8; Reblova M, 2011, FUNGAL DIVERS, V49, P167, DOI 10.1007/s13225-011-0099-8; Reblova M, 2009, MYCOL RES, V113, P991, DOI 10.1016/j.mycres.2009.06.003; Rodrigues A, 2011, FEMS MICROBIOL ECOL, V78, P244, DOI 10.1111/j.1574-6941.2011.01152.x; ROMERO A I, 1991, Sydowia, V43, P228; Saccardo PA, 1878, FUNGI ITALICI AUTOGR, P9; Samuels GJ, 1996, NOVA HEDWIGIA, V62, P47; Sanchez JA, 2007, MOL PHYLLOGENET EVOL, V43, P784; SCHOL-SCHWARZ M. BEATRICE., 1970, Persoonia, V6, P59; Scott WG, 1996, SCIENCE, V274, P2065, DOI 10.1126/science.274.5295.2065; Smith GJD, 2003, FUNGAL DIVERS, V13, P175; Spegazzini CL, 1888, FUNGI GUARANITIC PUG, pII; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sukosd Z, 2012, BIOINFORMATICS, V28, P2691, DOI 10.1093/bioinformatics/bts488; Takamatsu Susumu, 1998, Mycoscience, V39, P441, DOI 10.1007/BF02460905; Tegli S., 2000, Phytopathologia Mediterranea, V39, P134; To KKW, 2012, DIAGN MICR INFEC DIS, V74, P190, DOI 10.1016/j.diagmicrobio.2012.06.014; Trouillas FP, 2010, PLANT DIS, V94, P1167, DOI 10.1094/PDIS-94-9-1167A; Tulasne LR., 1863, SELECTA FUNGORUM CAR, V2; Ullrich B, 2010, J ZOOL SYST EVOL RES, V48, P219, DOI 10.1111/j.1439-0469.2009.00553.x; Vijaykrishna D, 2004, STUD MYCOL, P387; WALTER AE, 1994, BIOCHEMISTRY-US, V33, P12715, DOI 10.1021/bi00208a024; WEITZMAN I, 1984, SABOURAUDIA, V22, P331; Wieland M, 2009, RNA, V15, P968, DOI 10.1261/rna.1220309; Wingfield MJ, 2012, MOL PLANT PATHOL, V13, P604, DOI 10.1111/j.1364-3703.2011.00768.x; YAN ZH, 1995, MYCOLOGIA, V87, P72, DOI 10.2307/3760949; YANG JH, 1992, BIOCHEMISTRY-US, V31, P5005, DOI 10.1021/bi00136a013; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	123	27	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144616	10.1371/journal.pone.0144616	http://dx.doi.org/10.1371/journal.pone.0144616			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699541	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600027
J	Aguilera, MA; Valdivia, N; Broitman, BR				Aguilera, Moises A.; Valdivia, Nelson; Broitman, Bernardo R.			Facilitative Effect of a Generalist Herbivore on the Recovery of a Perennial Alga: Consequences for Persistence at the Edge of Their Geographic Range	PLOS ONE			English	Article							STRESS-GRADIENT HYPOTHESIS; SPECIES INTERACTIONS; BOTTOM-UP; INTERSPECIFIC COMPETITION; MAZZAELLA-LAMINARIOIDES; POSITIVE INTERACTIONS; INTERACTION STRENGTH; UNIFIED APPROACH; ROCKY SHORES; MARINE	Understanding the impacts of consumers on the abundance, growth rate, recovery and persistence of their resources across their distributional range can shed light on the role of trophic interactions in determining species range shifts. Here, we examined if consumptive effects of the intertidal grazer Scurria viridula positively influences the abundance and recovery from disturbances of the alga Mazzaella laminarioides at the edge of its geographic distributions in northern-central Chilean rocky shores. Through field experiments conducted at a site in the region where M. laminarioides overlaps with the polar range edge of S. viridula, we estimated the effects of grazing on different life stages of M. laminarioides. We also used long-term abundance surveys conducted across similar to 700 km of the shore to evaluate co-occurrence patterns of the study species across their range overlap. We found that S. viridula had positive net effects on M. laminarioides by increasing its cover and re-growth from perennial basal crusts. Probability of occurrence of M. laminarioides increased significantly with increasing density of S. viridula across the range overlap. The negative effect of S. viridula on the percentage cover of opportunistic green algae-shown to compete for space with corticated algae-suggests that competitive release may be part of the mechanism driving the positive effect of the limpet on the abundance and recovery from disturbance of M. laminarioides. We suggest that grazer populations contribute to enhance the abundance of M. laminarioides, facilitating its recolonization and persistence at its distributional range edge. Our study highlights that indirect facilitation can determine the recovery and persistence of a resource at the limit of its distribution, and may well contribute to the ecological mechanisms governing species distributions and range shifts.	[Aguilera, Moises A.; Broitman, Bernardo R.] Univ Catolica Norte, CEAZA, Coquimbo, Chile; [Valdivia, Nelson] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile	Universidad Catolica del Norte; Universidad Austral de Chile	Aguilera, MA (corresponding author), Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Larrondo 1281, Coquimbo, Chile.	moises.aguilera@ceaza.cl	Aguilera, Moisés/AAC-2981-2020; Broitman, Bernardo R/D-6007-2013; Valdivia, Nelson/C-3613-2009	Aguilera, Moisés/0000-0002-3517-6255; Broitman, Bernardo R/0000-0001-6582-3188; Valdivia, Nelson/0000-0002-5394-2072	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT) [11121360, 1090488, 1120988, 3100014, 1141037]; Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP) [AU50805]	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP)	Research was supported by grants from the Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT) to MM (grant #11121360), BRB (grant #1090488 and 1120988) and NV (grant #3100014 and 1141037), and by the Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP) to NV (grant #AU50805).	Aguilera MA, 2007, J EXP MAR BIOL ECOL, V349, P84, DOI 10.1016/j.jembe.2007.05.002; Aguilera MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137287; Aguilera MA, 2013, MAR ECOL PROG SER, V483, P185, DOI 10.3354/meps10293; Aguilera MA, 2012, ECOLOGY, V93, P75, DOI 10.1890/11-0434.1; Aguilera MA, 2011, MAR ECOL PROG SER, V431, P119, DOI 10.3354/meps09100; Aquilino KM, 2009, LIMNOL OCEANOGR, V54, P309, DOI 10.4319/lo.2009.54.1.0309; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2014, ECOGRAPHY, V37, P406, DOI 10.1111/j.1600-0587.2013.00643.x; Benedetti-Cecchi L, 2000, ECOL MONOGR, V70, P45, DOI 10.1890/0012-9615(2000)070[0045:PDAIID]2.0.CO;2; Berlow EL, 1999, ECOLOGY, V80, P2206, DOI 10.1890/0012-9658(1999)080[2206:QVITSO]2.0.CO;2; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; BRANCH GM, 1976, J ANIM ECOL, V45, P507, DOI 10.2307/3888; Broitman BR, 2011, REV CHIL HIST NAT, V84, P143, DOI 10.4067/S0716-078X2011000100011; Broitman BR, 2001, MAR ECOL PROG SER, V224, P21, DOI 10.3354/meps224021; Camus PA, 2008, MAR ECOL PROG SER, V361, P35, DOI 10.3354/meps07421; Case TJ, 2000, AM NAT, V155, P583, DOI 10.1086/303351; Coleman RA, 2006, OECOLOGIA, V147, P556, DOI 10.1007/s00442-005-0296-9; Coulson LA, 2011, BIOL J LINN SOC, V103, P849, DOI 10.1111/j.1095-8312.2011.01676.x; Daleo P, 2009, ECOLOGY, V90, P2368, DOI 10.1890/08-2330.1; DUTILLEUL P, 1993, ECOLOGY, V74, P1646, DOI 10.2307/1939923; Espoz C, 2004, REV CHIL HIST NAT, V77, P257; Fortin MJ., 2005, SPATIAL ANAL GUIDE E, P365, DOI [10.1017/CBO9780511542039, DOI 10.1017/CBO9780511542039]; GAINES SD, 1982, ANNU REV ECOL SYST, V13, P111, DOI 10.1146/annurev.es.13.110182.000551; Gaylord B, 2006, ECOL MONOGR, V76, P481, DOI 10.1890/0012-9615(2006)076[0481:MSDICE]2.0.CO;2; Ghedini G, 2015, ECOL LETT, V18, P182, DOI 10.1111/ele.12405; Godsoe W, 2012, ECOGRAPHY, V35, P811, DOI 10.1111/j.1600-0587.2011.07103.x; Gorman D, 2009, J APPL ECOL, V46, P1258, DOI 10.1111/j.1365-2664.2009.01711.x; Guidone M, 2010, MAR ECOL PROG SER, V420, P83, DOI 10.3354/meps08894; HANNACH G, 1985, MAR ECOL PROG SER, V22, P291, DOI 10.3354/meps022291; Harley CDG, 2003, ECOLOGY, V84, P1477, DOI 10.1890/0012-9658(2003)084[1477:ASAHIT]2.0.CO;2; HAWKINS SJ, 1983, OCEANOGR MAR BIOL, V21, P195; He Q, 2014, ECOLOGY, V95, P1437, DOI 10.1890/13-2226.1; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; Holt RD, 2009, P R SOC B, V276, P1435, DOI 10.1098/rspb.2008.1536; HORMAZABAL S, 2004, J GEOPHYS RES, P109; Jenkins SR, 2001, MAR ECOL PROG SER, V211, P193, DOI 10.3354/meps211193; Johnson MP, 2008, J EXP MAR BIOL ECOL, V365, P136, DOI 10.1016/j.jembe.2008.08.006; Jonsson PR, 2006, ECOLOGY, V87, P1169, DOI 10.1890/0012-9658(2006)87[1169:IBWAAG]2.0.CO;2; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Lima F. P., 2012, NATURE COMMUNICATION, V3; Lima FP, 2006, J BIOGEOGR, V33, P812, DOI 10.1111/j.1365-2699.2006.01457.x; Littler MM, 2006, HARMFUL ALGAE, V5, P565, DOI 10.1016/j.hal.2005.11.003; LITTLER MM, 1995, ECOLOGY, V76, P1666, DOI 10.2307/1938167; LUBCHENCO J, 1978, AM NAT, V112, P23, DOI 10.1086/283250; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Manly B.F.J., 2006, RANDOMIZATION BOOTST, P480; MENGE BA, 1995, ECOL MONOGR, V65, P21, DOI 10.2307/2937158; Montecinos A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-97; Navarrete SA, 2005, P NATL ACAD SCI USA, V102, P18046, DOI 10.1073/pnas.0509119102; Navarrete SA, 1996, ECOL MONOGR, V66, P409, DOI 10.2307/2963488; Nielsen KJ, 2004, ECOL LETT, V7, P31, DOI 10.1046/j.1461-0248.2003.00542.x; O'Connor MI, 2009, ECOLOGY, V90, P388, DOI 10.1890/08-0034.1; Osenberg Craig W., 1996, P134; Parmesan C, 2005, OIKOS, V108, P58, DOI 10.1111/j.0030-1299.2005.13150.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Plaganyi EE, 2000, MAR ECOL PROG SER, V194, P113, DOI 10.3354/meps194113; Poore AGB, 2014, OECOLOGIA, V174, P789, DOI 10.1007/s00442-013-2795-4; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; Rivadeneira MM, 2005, J BIOGEOGR, V32, P203, DOI 10.1111/j.1365-2699.2004.01133.x; Rivadeneira MM, 2002, MAR ECOL PROG SER, V245, P123, DOI 10.3354/meps245123; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Sala E, 2002, P NATL ACAD SCI USA, V99, P3678, DOI 10.1073/pnas.052028499; SANTELICES B, 1990, HYDROBIOLOGIA, V192, P35, DOI 10.1007/BF00006226; Santelices B, 1992, THE SYSTEMATICS ASSO, V46, P363; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; Scrosati R, 1998, J APPL PHYCOL, V10, P531, DOI 10.1023/A:1008029632351; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Stanton-Geddes J, 2012, ECOLOGY, V93, P1604, DOI 10.1890/11-1701.1; STENECK RS, 1982, MAR BIOL, V68, P299, DOI 10.1007/BF00409596; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Thornber C, 2006, ECOLOGY, V87, P2255, DOI 10.1890/0012-9658(2006)87[2255:TTMSHO]2.0.CO;2; UNDERWOOD AJ, 1981, OECOLOGIA, V48, P221, DOI 10.1007/BF00347968; Varela DA, 2006, J APPL PHYCOL, V18, P827, DOI 10.1007/s10811-006-9102-2; Von Ende C, 1993, DESIGN ANAL ECOLOGIC, P445; Wieters EA, 2005, MAR ECOL PROG SER, V301, P43, DOI 10.3354/meps301043; Worm B, 2000, MAR ECOL PROG SER, V202, P283, DOI 10.3354/meps202283; Zacherl D, 2003, J BIOGEOGR, V30, P913, DOI 10.1046/j.1365-2699.2003.00899.x	79	7	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146069	10.1371/journal.pone.0146069	http://dx.doi.org/10.1371/journal.pone.0146069			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716986	gold, Green Published, Green Submitted			2022-12-27	WOS:000367510500130
J	Garriga, C; de Olalla, PG; Miro, JM; Ocana, I; Knobel, H; Barbera, MJ; Humet, V; Domingo, P; Gatell, JM; Ribera, E; Gurgu, M; Marco, A; Cayla, JA				Garriga, Cesar; Garcia de Olalla, Patricia; Miro, Josep M.; Ocana, Inma; Knobel, Hernando; Jesus Barbera, Maria; Humet, Victoria; Domingo, Pere; Gatell, Josep M.; Ribera, Esteve; Gurgu, Merce; Marco, Andres; Cayla, Joan A.		Barcelona HIV AIDS Working Grp	Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS-INFECTION; DISEASE PROGRESSION; AIDS; PREDICTORS; DIAGNOSIS; SURVIVAL; RISK; LIFE; CARE	Introduction Antiretroviral therapy has led to a decrease in HIV-related mortality and to the emergence of non-AIDS defining diseases as competing causes of death. This study estimates the HIV mortality rate and their risk factors with regard to different causes in a large city from January 2001 to June 2013. Materials and Methods We followed-up 3137 newly diagnosed HIV non-AIDS cases. Causes of death were classified as HIV-related, non-HIV-related and external. We examined the effect of risk factors on survival using mortality rates, Kaplan-Meier plots and Cox models. Finally, we estimated survival for each main cause of death groups through Fine and Gray models. Mortality Results 182 deaths were found [14.0/1000 person-years of follow-up (py); 95% confidence interval (CI):12.0-16.1/1000 py], 81.3% of them had a known cause of death. Mortality rate by HIV-related causes and non-HIV-related causes was the same (4.9/1000 py; CI:3.7-6.1/1000 py), external was lower [1.7/1000 py; (1.0-2.4/1000 py)]. Survival Results Kaplan-Meier estimate showed worse survival in intravenous drug user (IDU) and heterosexuals than in men having sex with men (MSM). Factors associated with HIV-related causes of death include: IDU male (subHazard Ratio (sHR):3.2; CI:1.5-7.0) and <200 CD4 at diagnosis (sHR:2.7; CI:1.3-5.7) versus >= 500 CD4. Factors associated with non-HIV-related causes of death include: ageing (sHR:1.5; CI:1.4-1.7) and heterosexual female (sHR:2.8; CI:1.1-7.3) versus MSM. Factors associated with external causes of death were IDU male (sHR:28.7; CI:6.7-123.2) and heterosexual male (sHR:11.8; CI:2.5-56.4) versus MSM. Conclusion and Recommendation There are important differences in survival among transmission groups. Improved treatment is especially necessary in IDUs and heterosexual males.	[Garriga, Cesar; Garcia de Olalla, Patricia; Cayla, Joan A.] Publ Hlth Agcy Barcelona, Epidemiol Serv, Barcelona, Spain; [Garriga, Cesar] Inst Salud Carlos III, Natl Ctr Epidemiol, Spanish Field Epidemiol Training Programme, Madrid, Spain; [Garcia de Olalla, Patricia; Cayla, Joan A.] CIBERESP, Madrid, Spain; [Miro, Josep M.; Gatell, Josep M.] Univ Barcelona, Hosp Clin, August Pi & Sunyer Biomed Res Inst, Barcelona, Spain; [Ocana, Inma; Jesus Barbera, Maria; Ribera, Esteve] Univ Autonoma Barcelona, Hosp Vall de Hebron, Infect Dis, E-08193 Barcelona, Spain; [Knobel, Hernando] Hosp del Mar, Internal Med Infect Dis, Barcelona, Spain; [Humet, Victoria; Marco, Andres] Dept Justicia, Direccio Gen Serv Penitenciaris & Rehabil, Barcelona, Spain; [Domingo, Pere] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Infect Dis Unit, E-08193 Barcelona, Spain	Public Health Agency of Barcelona; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau	Garriga, C (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, Oxon, England.	cesar.garriga-fuentes@ndorms.ox.ac.uk; polalla@aspb.cat	Knobel, Hernando/B-5223-2016; Domingo, Pere/AAP-7571-2021; Garriga, Cesar/AEV-9080-2022; , Felipe/F-4242-2014; Knobel, Hernando/AAD-3582-2020; Domingo, Pere/CAF-3577-2022	Knobel, Hernando/0000-0003-3186-6416; Domingo, Pere/0000-0003-1138-5770; Garriga, Cesar/0000-0001-7073-3611; , Felipe/0000-0001-7658-5832; Knobel, Hernando/0000-0003-3186-6416; Vitaloni, Marianna/0000-0002-4250-3525; Ocana, Inma/0000-0003-3699-0790; Ribera, Esteban/0000-0002-3752-8808; Mallolas Masferrer, Josep/0000-0002-8365-141X; Cayla, Joan A./0000-0003-3891-111X	Programa de Epidemiologia Aplicada de Campo (Field Epidemiology Training Programme), Instituto de Salud Carlos III (Carlos III Public Health Institute) [12/PEAC-06]	Programa de Epidemiologia Aplicada de Campo (Field Epidemiology Training Programme), Instituto de Salud Carlos III (Carlos III Public Health Institute)	The work was supported by 12/PEAC-06, Programa de Epidemiologia Aplicada de Campo (Field Epidemiology Training Programme), Instituto de Salud Carlos III (Carlos III Public Health Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraido-Lanza AF, 1999, AM J PUBLIC HEALTH, V89, P1543, DOI 10.2105/AJPH.89.10.1543; Aldaz P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-300; Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; [Anonymous], 2014, INT STAT CLASS DIS H; Bakanda C, 2011, AIDS, V25, P701, DOI 10.1097/QAD.0b013e3283437ed7; Balderson BH, 2013, AIDS CARE, V25, P451, DOI 10.1080/09540121.2012.712669; Barcelona council technical programming office, 2014, DISTR TERR REND FAM; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Borrell C, 2006, EUR J PUBLIC HEALTH, V16, P601, DOI 10.1093/eurpub/ckl062; Brion JM, 2011, NURS HEALTH SCI, V13, P16, DOI 10.1111/j.1442-2018.2010.00572.x; Cescon A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083649; Collazos J, 2010, EPIDEMIOL INFECT, V138, P1016, DOI 10.1017/S0950268809991282; Corless IB, 2012, AIDS PATIENT CARE ST, V26, P335, DOI 10.1089/apc.2011.0404; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Delpierre C, 2008, SEX TRANSM INFECT, V84, P183, DOI 10.1136/sti.2007.027961; Diez M., 2014, EURO SURVEILL, V19; Dray-Spira R, 2007, AM J PUBLIC HEALTH, V97, P552, DOI 10.2105/AJPH.2005.081083; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; García de Olalla P., 2012, Rev. esp. sanid. penit., V14, P28, DOI [10.4321/s1575-06202012000100005, 10.1590/S1575-06202012000100005]; de Olalla PG, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-22; de Olalla PG, 2010, ENFERM INFEC MICR CL, V28, P580, DOI 10.1016/j.eimc.2010.07.004; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gess M., 2012, VAAT, V4, P93, DOI [10.2147/VAAT.S17830, DOI 10.2147/VAAT.S17830]; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Gras L, 2015, JAIDS-J ACQ IMM DEF, V68, P536, DOI 10.1097/QAI.0000000000000514; Greene M, 2013, JAMA-J AM MED ASSOC, V309, P1397, DOI 10.1001/jama.2013.2963; Grigoryan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004445; Hernando V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-382; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Huisman M, 2005, LANCET, V365, P493, DOI 10.1016/S0140-6736(05)17867-2; Jiang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083078; Langebeek N, 2014, BMC MED, V12, DOI [10.1186/s12916-014-0142-1, 10.1186/PREACCEPT-1453408941291432]; Lanoy E, 2006, J CLIN EPIDEMIOL, V59, P829, DOI 10.1016/j.jclinepi.2005.11.024; Legarth R, 2014, AIDS, V28, P1489, DOI 10.1097/QAD.0000000000000257; Legarth R, 2014, AIDS, V28, P387, DOI 10.1097/QAD.0000000000000032; Louie JK, 2002, J INFECT DIS, V186, P1023, DOI 10.1086/343862; Mari-Dell'Olmo M, 2007, J EPIDEMIOL COMMUN H, V61, P232, DOI 10.1136/jech.2006.048017; May MT, 2011, SEX HEALTH, V8, P526, DOI 10.1071/SH11046; Mensforth S, 2014, J INT AIDS SOC, V17, P130, DOI 10.7448/IAS.17.4.19692; Miller CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095061; Monge S, 2011, SEX TRANSM INFECT, V87, P571, DOI 10.1136/sextrans-2011-050125; Murray M, 2012, HIV MED, V13, P89, DOI 10.1111/j.1468-1293.2011.00940.x; Nakagawa F, 2013, CURR OPIN INFECT DIS, V26, P17, DOI 10.1097/QCO.0b013e32835ba6b1; Niaura R, 2000, CLIN INFECT DIS, V31, P808, DOI 10.1086/314048; Novoa AM, 2008, CURR HIV RES, V6, P77, DOI 10.2174/157016208783572017; Office for Official Publications of the European Communities, 2000, ANN REP STAT DRUGS P; Oliva J, 2010, ENFERM INFEC MICR CL, V28, P583, DOI 10.1016/j.eimc.2010.02.013; Ortego C, 2011, AIDS BEHAV, V15, P1381, DOI 10.1007/s10461-011-9942-x; PABLOSMENDEZ A, 1994, JAMA-J AM MED ASSOC, V271, P1237, DOI 10.1001/jama.1994.03510400023017; Panel de expertos de GeSIDA y Plan Nacional sobre el Sida, 2013, Enferm Infecc Microbiol Clin, V31, DOI 10.1016/j.eimc.2013.04.009; Panel Expertos Gesida & Plan Nacl, 2009, ENFERM INFEC MICR CL, V27, P222, DOI 10.1016/j.eimc.2008.11.002; Pavlova-McCalla E, 2012, J AIDS CLIN RES, V3; Peters L, 2014, J CLIN VIROL, V60, P295, DOI 10.1016/j.jcv.2014.03.017; Phung BC, 2014, WORLD J GASTROENTERO, V20, P17360, DOI 10.3748/wjg.v20.i46.17360; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; Rius C, 2006, MED CLIN-BARCELONA, V127, P167, DOI 10.1157/13090705; Rubio R, 2002, ENFERM INFEC MICR CL, V20, P244, DOI 10.1016/S0213-005X(02)72804-8; Selik RM, 2014, MMWR RECOMM REP, V63; Sobrino-Vegas P, 2012, ANTIVIR THER, V17, P1, DOI 10.3851/IMP1939; Spillane H, 2012, TROP MED INT HEALTH, V17, P1255, DOI 10.1111/j.1365-3156.2012.03056.x; Vives N, 2012, INT J STD AIDS, V23, P475, DOI 10.1258/ijsa.2011.011280; Wada N, 2013, AM J EPIDEMIOL, V177, P116, DOI 10.1093/aje/kws321; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; World Medical Association, 2013, DECL HELS ETH PRINC	65	20	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145701	10.1371/journal.pone.0145701	http://dx.doi.org/10.1371/journal.pone.0145701			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716982	Green Published, gold			2022-12-27	WOS:000367510500058
J	Hori, K; Nagai, T; Shan, W; Sakamoto, A; Abe, M; Yamazaki, M; Sakimura, K; Yamada, K; Hoshino, M				Hori, Kei; Nagai, Taku; Shan, Wei; Sakamoto, Asami; Abe, Manabu; Yamazaki, Maya; Sakimura, Kenji; Yamada, Kiyofumi; Hoshino, Mikio			Heterozygous Disruption of Autism susceptibility candidate 2 Causes Impaired Emotional Control and Cognitive Memory	PLOS ONE			English	Article							NEURONAL MIGRATION; AUTISM-SUSCEPTIBILITY-CANDIDATE-2 AUTS2; GENE; DOUBLECORTIN; TRANSLOCATION; LAMINATION; CORTEX; MICE	Mutations in the Autism susceptibility candidate 2 gene (AUTS2) have been associated with a broad range of psychiatric illnesses including autism spectrum disorders, intellectual disability and schizophrenia. We previously demonstrated that the cytoplasmic AUTS2 acts as an upstream factor for the Rho family small GTPase Rac1 and Cdc42 that regulate the cytoskeletal rearrangements in neural cells. Moreover, genetic ablation of the Auts2 gene in mice has resulted in defects in neuronal migration and neuritogenesis in the developing cerebral cortex caused by inactivation of Rac1-signaling pathway, suggesting that AUTS2 is required for neural development. In this study, we conducted a battery of behavioral analyses on Auts2 heterozygous mutant mice to examine the involvement of Auts2 in adult cognitive brain functions. Auts2-deficient mice displayed a decrease in exploratory behavior as well as lower anxiety-like behaviors in the absence of any motor dysfunction. Furthermore, the capability for novel object recognition and cued associative memory were impaired in Auts2 mutant mice. Social behavior and sensory motor gating functions were, however, normal in the mutant mice as assessed by the three-chamber test and prepulse inhibition test, respectively. Together, our findings indicate that AUTS2 is critical for the acquisition of neurocognitive function.	[Hori, Kei; Sakamoto, Asami; Hoshino, Mikio] NCNP, Natl Inst Neurosci, Dept Biochem & Cellular Biol, Tokyo, Japan; [Nagai, Taku; Shan, Wei; Yamada, Kiyofumi] Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol & Hosp Pharm, Nagoya, Aichi 4648601, Japan; [Abe, Manabu; Yamazaki, Maya; Sakimura, Kenji] Niigata Univ, Dept Cellular Neurobiol, Brain Res Inst, Niigata, Japan	National Center for Neurology & Psychiatry - Japan; Nagoya University; Niigata University	Hoshino, M (corresponding author), NCNP, Natl Inst Neurosci, Dept Biochem & Cellular Biol, Tokyo, Japan.	hoshino@ncnp.go.jp	Yamazaki, Maya/C-6952-2012; Nagai, Taku/I-7507-2014; Abe, Manabu/A-9221-2008; Sokabe, Masahiro/I-1565-2012	Nagai, Taku/0000-0001-5050-7748; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25115733, 25110742]; MEXT (Ministry of Education, Culture, Sports, Science and Technology); Astellas foundation; Naito foundation; Takeda foundation; Uehara foundation; NCNP (National Center of Neurology and Psychiatry) [24-12, 25-3]; Japanese Ministry of Health, Labor and Welfare [H23-001]; JSPS (Japan Society for the Promotion of Science) KAKENHI [23700406, 25840030]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas foundation(Astellas Pharmaceuticals); Naito foundation(Naito Memorial Foundation); Takeda foundation(Takeda Science Foundation (TSF)); Uehara foundation(Uehara Memorial Foundation); NCNP (National Center of Neurology and Psychiatry); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); JSPS (Japan Society for the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by Grants-in-Aid for Scientific Research on Innovative Areas "Mesoscopic Neurocircuitry" (Grant 25115733) and "Synapse and Neurocircuit Pathology" (Grant 25110742) of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; grants from MEXT (Ministry of Education, Culture, Sports, Science and Technology), Astellas foundation, Naito foundation, Takeda foundation, Uehara foundation, Intramural Research Grants (M.H., 24-12, 25-3) for Neurological and Psychiatric Disorders of NCNP (National Center of Neurology and Psychiatry), Health Science Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health (M.H., H23-001) from the Japanese Ministry of Health, Labor and Welfare, and JSPS (Japan Society for the Promotion of Science) KAKENHI Grant Numbers 23700406, 25840030 (K.H.).	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Bedogni F, 2010, GENE EXPR PATTERNS, V10, P9, DOI 10.1016/j.gep.2009.11.005; Beunders G, 2013, AM J HUM GENET, V92, P210, DOI 10.1016/j.ajhg.2012.12.011; Chen YH, 2013, DRUG ALCOHOL DEPEN, V128, P238, DOI 10.1016/j.drugalcdep.2012.08.029; Corbo JC, 2002, J NEUROSCI, V22, P7548; Dang W, 2014, J MOL NEUROSCI, V54, P811, DOI 10.1007/s12031-014-0421-5; des Portes V, 1998, CELL, V92, P51; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Gao ZH, 2014, NATURE, V516, P349, DOI 10.1038/nature13921; Girirajan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002334; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Hori K, 2014, CELL REP, V9, P2166, DOI 10.1016/j.celrep.2014.11.045; Ibi D, 2010, BEHAV BRAIN RES, V206, P32, DOI 10.1016/j.bbr.2009.08.027; Jolley A, 2013, AM J MED GENET A, V161A, P1508, DOI 10.1002/ajmg.a.35922; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Koike H, 2009, BEHAV BRAIN RES, V202, P114, DOI 10.1016/j.bbr.2009.03.028; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee PR, 2005, NEUROPSYCHOPHARMACOL, V30, P1883, DOI 10.1038/sj.npp.1300722; Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Nagai T, 2007, LEARN MEMORY, V14, P117, DOI 10.1101/lm.461407; Nagai T, 2010, NEUROSCI LETT, V470, P134, DOI 10.1016/j.neulet.2009.12.071; Oksenberg N, 2013, TRENDS GENET, V29, P600, DOI 10.1016/j.tig.2013.08.001; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Schumann G, 2011, P NATL ACAD SCI USA, V108, P7119, DOI 10.1073/pnas.1017288108; Sultana R, 2002, GENOMICS, V80, P129, DOI 10.1006/geno.2002.6810; Takahashi K, 2007, BIOL PSYCHIAT, V62, P148, DOI 10.1016/j.biopsych.2006.06.035; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003; Wu QF, 2012, CELL, V149, P1549, DOI 10.1016/j.cell.2012.04.046	35	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145979	10.1371/journal.pone.0145979	http://dx.doi.org/10.1371/journal.pone.0145979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26717414	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500108
J	Merk, B; Litskevich, D				Merk, Bruno; Litskevich, Dzianis			Transmutation of All German Transuranium under Nuclear Phase Out Conditions - Is This Feasible from Neutronic Point of View?	PLOS ONE			English	Article								The German government has decided for the nuclear phase out, but a decision on a strategy for the management of the highly radioactive waste is not defined yet. Partitioning and Transmutation (P&T) could be considered as a technological option for the management of highly radioactive waste, therefore a wide study has been conducted. In the study group objectives for P&T and the boundary conditions of the phase out have been discussed. The fulfillment of the given objectives is analyzed from neutronics point of view using simulations of a molten salt reactor with fast neutron spectrum. It is shown that the efficient transmutation of all existing transuranium isotopes would be possible from neutronic point of view in a time frame of about 60 years. For this task three reactors of a mostly new technology would have to be developed and a twofold life cycle consisting of a transmuter operation and a deep burn phase would be required. A basic insight for the optimization of the time duration of the deep burn phase is given. Further on, a detailed balance of different isotopic inventories is given to allow a deeper understanding of the processes during transmutation in the molten salt fast reactor. The effect of modeling and simulation is investigated based on three different modeling strategies and two different code versions.	[Merk, Bruno; Litskevich, Dzianis] Helmholtz Zentrum Dresden Rossendorf, Inst Resource Ecol, D-01314 Dresden, Germany; [Merk, Bruno] Univ Liverpool, Ctr Mat & Struct, Liverpool L69 3BX, Merseyside, England	Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); University of Liverpool	Merk, B (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Inst Resource Ecol, D-01314 Dresden, Germany.	b.merk@liverpool.ac.uk		Litskevich, Dzianis/0000-0002-3207-3058				Acatech, 2014, PART TRANSM NUKL ABF; Alekseev PN, 1996, NATO ASI SERIES, V15; [Anonymous], 2003, HELIOS METHODS STUDS; Brovchenko M, 2015, PROGR NUCL ENE UNPUB; Diakov A, 2012, DISPOSITION EXCESS R; Ignatiev V, 2014, ANN NUCL ENERGY, V64, P408, DOI 10.1016/j.anucene.2013.09.004; Ignatiev V, 2007, P INT C ADV NUCL POW; Ignatiev V, 2014, P ACT FISS PROD PART; Ingatiev V, 2012, P INT C ADV NUCL POW; Kim TK, 2014, 13 INF EXCH M SEOUL; MACPHERSON HG, 1985, NUCL SCI ENG, V90, P374, DOI 10.13182/NSE90-374; Mathieu L, 2005, P GOLBAL 2005 TSUK J; Merk B, 2008, ATOMWIRTSCHAFT, V6, P404; Merk B, 2006, 9 INF EXCH M P T NIM; Merk B, 2014, ACT FISS PROD PART T; Merk B, 2014, PHYSOR 2014; Merk B, 2015, TRANSMUTATION TRANSU, V11; Merk B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092776; Merk B, 2014, ANN NUCL ENERGY, V64, P441, DOI 10.1016/j.anucene.2013.07.014; Mikityuk K, 2015, CORE SAFETY ESNII WP; Oi N, 1998, IAEA B, V40-1; Rachamin R, 2013, ANN NUCL ENERGY, V55, P194, DOI 10.1016/j.anucene.2012.11.030; Renault C, 2005, FIKICT200120183 EURA; Renault C, 2010, 4 INPRO GIF INT M VI; Renn Ortwin, PARTITIONIERUNG TRAN; Salvatore M, 2004, P T POTENTIAL WASTE; Schwenk-Ferrero A, 2013, SCI TECHNOL NUCL INS, V2013, DOI 10.1155/2013/293792; Thomauske B, 2015, ANN NUCL EN IN PRESS; Uri GAT, 1992, MOLTEN SALT REACTOR, V100; Villarino EA, 1992, HELIOS ANGULARLY DEP, V112; Von Lensa W, RED IMPACT IMPACT PA, V15	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145652	10.1371/journal.pone.0145652	http://dx.doi.org/10.1371/journal.pone.0145652			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717509	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500053
J	Neal, ML; Carlson, BE; Thompson, CT; James, RC; Kim, KG; Tran, K; Crampin, EJ; Cook, DL; Gennari, JH				Neal, Maxwell L.; Carlson, Brian E.; Thompson, Christopher T.; James, Ryan C.; Kim, Karam G.; Tran, Kenneth; Crampin, Edmund J.; Cook, Daniel L.; Gennari, John H.			Semantics-Based Composition of Integrated Cardiomyocyte Models Motivated by Real-World Use Cases	PLOS ONE			English	Article							VENTRICULAR MYOCYTES; MATHEMATICAL-MODEL; ONTOLOGY; DATABASE; INFORMATICS; LANGUAGE; RESOURCE; NETWORK	Semantics-based model composition is an approach for generating complex biosimulation models from existing components that relies on capturing the biological meaning of model elements in a machine-readable fashion. This approach allows the user to work at the biological rather than computational level of abstraction and helps minimize the amount of manual effort required for model composition. To support this compositional approach, we have developed the SemGen software, and here report on SemGen's semantics-based merging capabilities using real-world modeling use cases. We successfully reproduced a large, manually-encoded, multi-model merge: the "Pandit-Hinch-Niederer" (PHN) cardiomyocyte excitation-contraction model, previously developed using CellML. We describe our approach for annotating the three component models used in the PHN composition and for merging them at the biological level of abstraction within SemGen. We demonstrate that we were able to reproduce the original PHN model results in a semi-automated, semantics-based fashion and also rapidly generate a second, novel cardiomyocyte model composed using an alternative, independently-developed tension generation component. We discuss the time-saving features of our compositional approach in the context of these merging exercises, the limitations we encountered, and potential solutions for enhancing the approach.	[Neal, Maxwell L.; James, Ryan C.; Kim, Karam G.; Gennari, John H.] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA; [Carlson, Brian E.; Thompson, Christopher T.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Tran, Kenneth] Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand; [Crampin, Edmund J.] Univ Melbourne, Melbourne Sch Engn, Syst Biol Lab, Melbourne, Vic 3010, Australia; [Crampin, Edmund J.] Univ Melbourne, Melbourne Sch Engn, ARC Ctr Excellence Convergent Bionano Sci & Techn, Melbourne, Vic 3010, Australia; [Crampin, Edmund J.] Univ Melbourne, Sch Math & Stat, Melbourne, Vic 3010, Australia; [Crampin, Edmund J.] Univ Melbourne, Sch Med, Melbourne, Vic 3010, Australia; [Cook, Daniel L.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Auckland; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Washington; University of Washington Seattle	Neal, ML (corresponding author), Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA.	mneal@uw.edu		Kim, Karam/0000-0001-8063-6081; Neal, Maxwell/0000-0002-2390-6572; Carlson, Brian/0000-0002-1353-5907; Gennari, John/0000-0001-8254-4957; Tran, Kenneth/0000-0002-8651-3557	National Institutes of Health [R01LM011969, P50GM094503, T15LM007442]; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology [CE140100036]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM094503] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007442, R01LM011969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was funded by National Institutes of Health (http://www.nih.gov/) grants R01LM011969 (MLN, BEC, CTT, KGK, DLC, JHG), P50GM094503 (BEC, CTT, KT, EJC) and T15LM007442 (RCJ) as well as Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology (http://www.bionano.org.au/ grant CE140100036 (EJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r21; Beard DA, 2012, ANN BIOMED ENG, V40, P2365, DOI 10.1007/s10439-012-0611-7; Bechhofer S., 2004, W3C RECOMM, V10; Brinkman Ryan R, 2010, J Biomed Semantics, V1 Suppl 1, pS7, DOI 10.1186/2041-1480-1-S1-S7; Butterworth Erik, 2013, F1000Res, V2, P288, DOI 10.12688/f1000research.2-288.v1; Cook DL, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-41; Cook Daniel L, 2013, J Biomed Semantics, V4 Suppl 1, pS2, DOI 10.1186/2041-1480-4-S1-S2; Cook DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028708; Cuellar AA, 2003, SIMUL-T SOC MOD SIM, V79, P740, DOI 10.1177/0037549703040939; Garny A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00026; Gennari JH, 2011, J BIOMED INFORM, V44, P146, DOI 10.1016/j.jbi.2010.06.007; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hastings J, 2013, NUCLEIC ACIDS RES, V41, pD456, DOI 10.1093/nar/gks1146; Hayamizu TF, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r29; Hinch R, 2004, BIOPHYS J, V87, P3723, DOI 10.1529/biophysj.104.049973; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Natale DA, 2014, NUCLEIC ACIDS RES, V42, pD415, DOI 10.1093/nar/gkt1173; Neal M, 2013, P ICBO, P16; Neal ML, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003849; Neal ML, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P304; Niederer SA, 2006, BIOPHYS J, V90, P1697, DOI 10.1529/biophysj.105.069534; Niederer SA, 2007, BIOPHYS J, V92, P4030, DOI 10.1529/biophysj.106.095463; Pandit SV, 2001, BIOPHYS J, V81, P3029, DOI 10.1016/S0006-3495(01)75943-7; Rice JJ, 2008, BIOPHYS J, V95, P2368, DOI 10.1529/biophysj.107.119487; Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007; Schulz M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-18; Schulz M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.41; Terkildsen JR, 2008, EXP PHYSIOL, V93, P919, DOI 10.1113/expphysiol.2007.041871; Tran K, 2010, BIOPHYS J, V98, P267, DOI 10.1016/j.bpj.2009.10.011	30	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145621	10.1371/journal.pone.0145621	http://dx.doi.org/10.1371/journal.pone.0145621			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716837	Green Published, gold			2022-12-27	WOS:000367510500049
J	Khare, SD; Whitehead, TA				Khare, Sagar D.; Whitehead, Timothy A.			Introduction to the Rosetta Special Collection	PLOS ONE			English	Editorial Material							PROTEIN; PREDICTION; DOCKING; DESIGN	The Rosetta macromolecular modeling software is a versatile, rapidly developing set of tools that are now being routinely utilized to address state-of-the-art research challenges in academia and industrial research settings. A Rosetta Conference (RosettaCon) describing updates to the Rosetta source code is held annually. Every two years, a Rosetta Conference (RosettaCon) special collection describing the results presented at the annual conference by participating RosettaCommons labs is published by the Public Library of Science (PLOS). This is the introduction to the third RosettaCon 2014 Special Collection published by PLOS.	[Khare, Sagar D.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Whitehead, Timothy A.] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Whitehead, Timothy A.] Michigan State Univ, Dept Biosyst & Agr Engn, E Lansing, MI 48824 USA	Rutgers State University New Brunswick; Michigan State University; Michigan State University	Khare, SD (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.	sagar.khare@rutgers.edu; taw@egr.msu.edu						Alford RF, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004398; Andre I, 2013, ROSETTACON 2012 SPEC; Baker D, 2006, PHILOS T ROY SOC B, V361, P459, DOI 10.1098/rstb.2005.1803; Bazzoli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140359; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Braun T, COMBINING E IN PRESS, DOI [10.1371/journal.pcbi.1004661, DOI 10.1371/JOURNAL.PCBI.1004661]; Conchuir SO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130433; DeLuca S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132508; Drew K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067051; Freedman LP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002165; Garijo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080278; Gonzalez-Beltran A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127612; Gowthaman R, 2015, J MED CHEM; Gowthaman R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131612; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Leaver-Fay A, 2013, METHOD ENZYMOL, V523, P109, DOI [10.1016/B978-0-12:394292-0.00006-0, 10.1016/B978-0-12-394292-0.00006-0]; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Ollikainen N, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004335; Pilla KB, 2015, CAPTURING CONFORMATI; Porter JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138220; Renfrew PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032637; Sevy AM, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004300; Song YF, 2011, PROTEINS, V79, P1898, DOI 10.1002/prot.23013	27	1	1	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144326	10.1371/journal.pone.0144326	http://dx.doi.org/10.1371/journal.pone.0144326			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714017	Green Submitted, Green Published, gold			2022-12-27	WOS:000367481900009
J	Potard, V; Reynes, J; Ferry, T; Aubin, C; Finkielsztejn, L; Yazdanpanah, Y; Costagliola, D				Potard, Valerie; Reynes, Jacques; Ferry, Tristan; Aubin, Celine; Finkielsztejn, Laurent; Yazdanpanah, Yazdan; Costagliola, Dominique		FHDH ANRS CO4	Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice	PLOS ONE			English	Article							TREATMENT-EXPERIENCED PATIENTS; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; CCR5 ANTAGONIST; EFFICACY; TRIAL; SAFETY	Introduction Limited data are available on the durability and effectiveness of maraviroc in routine clinical practice. We assessed the durability of maraviroc-containing regimens during a 30-month period, as well as their immunovirological and clinical efficacy, according to viral tropism in treatment-experienced individuals with viral load (VL) >50 copies/ml in the French Hospital Database on HIV. Methods Virological success was defined as VL<50 copies/ml, immunological success as a confirmed increase of at least 100 CD4 cells/mm(3) measured twice at least one month apart, and clinical failure as hospitalization for a non-AIDS event, an AIDS event, or death. Multivariable Cox regression models adjusted for potential confounders were used to assess the influence of viral tropism on durability, the immunovirological responses, and clinical outcome. Results 356 individuals started maraviroc with VL>50 copies/ml of whom 223 harbored R5 viruses, 44 non-R5 viruses and 89 viruses of unknown tropism. Individuals with non-R5 viruses were more likely than individuals with R5 viruses to discontinue maraviroc (75% vs 34%, p<0.0001). At 30 months, the estimated rates of virological and immunological success were respectively 89% and 51% in individuals with R5 viruses and 48% and 23% in individuals with non-R5 viruses. In multivariable analysis, non-R5 viruses were associated with a lower likelihood of both virological success (hazard ratio (HR): 0.42; 95% confidence interval (CI), 0.25-0.70) and immunological success (HR: 0.37; 95% CI, 0.18-0.77). No difference in clinical outcome was found between individuals with R5 and non-R5 viruses. The effectiveness of maraviroc-containing regimens in individuals with unknown viral tropism was not significantly different from that in individuals with R5 viruses. A limitation of the study is the absence of genotypic susceptibility score. Conclusion In this observational study, maraviroc-containing regimens yielded high rates of viral suppression and immunological responses in individuals with R5 viruses in whom prior regimens had failed.	[Potard, Valerie; Costagliola, Dominique] Univ Paris 06, Sorbonne Univ, UMR S 1136, Paris, France; [Potard, Valerie; Costagliola, Dominique] INSERM, UMR S 1136, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France; [Potard, Valerie] Inserm Transfert, Paris, France; [Reynes, Jacques] Univ Montpellier, F-34059 Montpellier, France; [Reynes, Jacques] IRD, UMI233 TransVIHMI Montpellier, Montpellier, France; [Reynes, Jacques] CHU Montpellier, Dept Malad Infect & Trop, Montpellier, France; [Ferry, Tristan] Hosp Civils Lyon, Serv Malad Infect & Trop, Lyon, France; [Ferry, Tristan] Univ Lyon 1, F-69365 Lyon, France; [Ferry, Tristan] INSERM, U1111, Int Ctr Infectiol Res, CIRI, F-69008 Lyon, France; [Aubin, Celine] GlaxoSmithKline Res & Dev Ltd, Marly Le Roi, France; [Finkielsztejn, Laurent] Lab ViiVHealthcare, Marly Le Roi, France; [Yazdanpanah, Yazdan] Univ Paris 07, Paris, France; [Yazdanpanah, Yazdan] INSERM, UMR S 1137, ATIP Avenir Inserm Modelisat Aide Decis & Cout Ef, Paris, France; [Yazdanpanah, Yazdan] Hop Bichat Claude Bernard, Serv Malad Infect & Trop, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CHU de Montpellier; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); GlaxoSmithKline; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Potard, V (corresponding author), Univ Paris 06, Sorbonne Univ, UMR S 1136, Paris, France.	valerie.potard@ccde.chups.jussieu.fr	Ferry, Tristan/M-5108-2014; KAHN, Jean-Emmanuel/S-8509-2018; Guiguet, Marguerite/L-8480-2018; Magy-Bertrand, Nadine/ABE-1285-2021; TISSOT-DUPONT, Hervé/P-5808-2016; Botelho-Nevers, Elisabeth/H-2063-2019; Costagliola, Dominique/H-5849-2011; Delobel, Pierre/K-3166-2014; Mahamat, Aba/V-7888-2019; Bergmann, Jean-Francois/L-6044-2017; Matheron, Sophie/D-7420-2017	KAHN, Jean-Emmanuel/0000-0002-9565-6074; Magy-Bertrand, Nadine/0000-0003-1117-5079; Botelho-Nevers, Elisabeth/0000-0003-2773-7750; Costagliola, Dominique/0000-0003-0765-0869; Delobel, Pierre/0000-0002-2874-3581; Mahamat, Aba/0000-0001-8755-0424; Couppie, Pierre/0000-0002-4213-2867; Dupin, Nicolas/0000-0002-6237-4951; Arvieux, Cedric/0000-0003-2332-2507; Bergmann, Jean-Francois/0000-0001-6861-9748; Kansau, Imad/0000-0002-1893-6822; Cabie, Andre/0000-0003-0117-3061; Matheron, Sophie/0000-0001-7879-6553; ferry, tristan/0000-0003-3082-7001; Croisier, Delphine/0000-0002-8744-5832; Sotto, Albert/0000-0002-6463-9386; ABEL, Sylvie/0000-0002-3351-0547	Agence Nationale de Recherches sur le Sida (ANRS); Institut National de la Sante et de la Recherche Medicale (INSERM); French Ministry of Health; ViiV Healthcare	Agence Nationale de Recherches sur le Sida (ANRS)(ANRSFrench National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministry of Health; ViiV Healthcare	FHDH is supported by Agence Nationale de Recherches sur le Sida (ANRS), Institut National de la Sante et de la Recherche Medicale (INSERM) and the French Ministry of Health. This study was funded by ViiV Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, MMWR RECOMM REP, V41, P1; [Anonymous], 2013, GUID US ANT AG HIV 1; Blackham J, 2005, AIDS, V19, P487; Cuzin L, 2012, JAIDS-J ACQ IMM DEF, V61, P557, DOI 10.1097/QAI.0b013e318273015f; Fatkenheuer G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMoa0803154; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Grabar S, 2004, AIDS, V18, P2029, DOI 10.1097/00002030-200410210-00007; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Hardy WD, 2010, JAIDS-J ACQ IMM DEF, V55, P558, DOI 10.1097/QAI.0b013e3181ee3d82; Mary-Krause M, 2014, INT J EPIDEMIOL, P1; Mugavero MJ, 2011, JAIDS-J ACQ IMM DEF, V58, P253, DOI 10.1097/QAI.0b013e318230372e; NOZZA S., 2015, CLIN MICROBIOL INFEC; Nozza S, 2011, JAIDS-J ACQ IMM DEF, V56, pE113, DOI 10.1097/QAI.0b013e31820a9ae4; Pichenot M, 2012, HIV MED, V13, P148, DOI 10.1111/j.1468-1293.2011.00953.x; Recordon-Pinson P, 2010, ANTIMICROB AGENTS CH, V54, P3335, DOI 10.1128/AAC.00148-10; Reuter S, 2010, EUR J MED RES, V15, P231, DOI 10.1186/2047-783X-15-6-231; Rossetti B, 2014, AIDS RES HUM RETROV, V30, P17, DOI [10.1089/aid.2012.0235, 10.1089/AID.2012.0235]; Ruiz-Mateos E, 2011, ANTIMICROB AGENTS CH, V55, P4664, DOI 10.1128/AAC.00753-11; Saag M, 2009, J INFECT DIS, V199, P1638, DOI 10.1086/598965; Schapiro JM, 2011, ANTIVIR THER, V16, P395, DOI 10.3851/IMP1759; Soulie C, 2014, AIDS RES HUM RETROVI; Vray M, 2003, ANTIVIR THER, V8, P427; Wilkin TJ, 2012, J INFECT DIS, V206, P534, DOI 10.1093/infdis/jis376; Wilkin TJ, 2010, HIV CLIN TRIALS, V11, P351, DOI 10.1310/hct1106-351	24	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144746	10.1371/journal.pone.0144746	http://dx.doi.org/10.1371/journal.pone.0144746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714012	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900017
J	Shiroma, EJ; Cook, NR; Manson, JE; Buring, JE; Rimm, EB; Lee, IM				Shiroma, Eric J.; Cook, Nancy R.; Manson, Joann E.; Buring, Julie E.; Rimm, Eric B.; Lee, I-Min			Comparison of Self-Reported and Accelerometer-Assessed Physical Activity in Older Women	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; LOW-DOSE ASPIRIN; SEDENTARY BEHAVIOR; ACTIVITY QUESTIONNAIRE; PRIMARY PREVENTION; CARDIOVASCULAR-DISEASE; UNITED-STATES; ADULTS; HEALTH; AGE	Background Self-reported physical activity measures continue to be validated against accelerometers; however, the absence of standardized, accelerometer moderate-to-vigorous physical activity (MVPA) definitions has made comparisons across studies difficult. Furthermore, recent accelerometer models assess accelerations in three axes, instead of only the vertical axis, but validation studies have yet to take incorporate triaxial data. Methods Participants (n = 10 115) from the Women's Health Study wore a hip-worn accelerometer (ActiGraph GT3X+) for seven days during waking hours (2011-2014). Women then completed a physical activity questionnaire. We compared self-reported with accelerometer-assessed MVPA, using four established cutpoints for MVPA: three using only vertical axis data (760, 1041 and 1952 counts per minute (cpm)) and one using triaxial data (2690 cpm). Results According to self-reported physical activity, 66.6% of women met the US federal physical activity guidelines, engaging in >= 150 minutes per week of MVPA. The percent of women who met guidelines varied widely depending on the accelerometer MVPA definition (760 cpm: 50.0%, 1041 cpm: 33.0%, 1952 cpm: 13.4%, and 2690 cpm: 19.3%). Conclusions Triaxial count data do not substantially reduce the difference between self-reported and accelerometer-assessed MVPA.	[Shiroma, Eric J.; Cook, Nancy R.; Manson, Joann E.; Buring, Julie E.; Rimm, Eric B.; Lee, I-Min] Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Sch Med, Boston, MA 02115 USA; [Shiroma, Eric J.; Cook, Nancy R.; Manson, Joann E.; Buring, Julie E.; Rimm, Eric B.; Lee, I-Min] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Shiroma, Eric J.] NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Shiroma, EJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Sch Med, Boston, MA 02115 USA.	Eric.shiroma@nih.gov	Lee, I-Min/ABD-5409-2021; Shiroma, Eric/AAV-5487-2021	Shiroma, Eric/0000-0003-4920-2642	National Institutes of Health [CA154647, CA047988, HL007575]; National Institute on Aging; NATIONAL CANCER INSTITUTE [R01CA047988, UM1CA182913, R01CA154647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG006020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by research grants CA154647 and CA047988 from the National Institutes of Health. EJS was supported in part by and the Intramural Research Program of the National Institutes of Health, National Institute on Aging and in part by training grant HL007575 from the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, J CLIN EPIDEMIOL, V46, P1403, DOI 10.1016/0895-4356(93)90140-V; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Bonnefoy M, 2001, J AM GERIATR SOC, V49, P28, DOI 10.1046/j.1532-5415.2001.49006.x; Bornstein DB, 2011, J SCI MED SPORT, V14, P404, DOI 10.1016/j.jsams.2011.03.013; Bull F.C., 2010, PHYS ACTIVITY GUIDEL; Canadian Society for Exercise Physiology, 2011, CAN PHYS ACT GUID CA; Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Colbert LH, 2011, MED SCI SPORT EXER, V43, P867, DOI 10.1249/MSS.0b013e3181fc7162; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Copeland JL, 2009, J AGING PHYS ACTIV, V17, P17, DOI 10.1123/japa.17.1.17; Crouter SE, 2010, MED SCI SPORT EXER, V42, P1029, DOI 10.1249/MSS.0b013e3181c37458; Dyrstad SM, 2014, MED SCI SPORT EXER, V46, P99, DOI 10.1249/MSS.0b013e3182a0595f; Evenson KR, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110109; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gabriel KP, 2009, MED SCI SPORT EXER, V41, P1403, DOI 10.1249/MSS.0b013e31819b2482; Hagstromer M, 2010, AM J EPIDEMIOL, V171, P1055, DOI 10.1093/aje/kwq069; Hall KS, 2013, MED SCI SPORT EXER, V45, P574, DOI 10.1249/MSS.0b013e318276c73c; Hamer M, 2012, J EPIDEMIOL COMMUN H, V66, P1110, DOI 10.1136/jech-2011-200505; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; Harris TJ, 2009, MED SCI SPORT EXER, V41, P1392, DOI 10.1249/MSS.0b013e31819b3533; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; Howard VJ, 2015, MED SCI SPORT EXER, V47, P1531, DOI 10.1249/MSS.0000000000000549; Jacobi D, 2009, EUR J EPIDEMIOL, V24, P171, DOI 10.1007/s10654-009-9329-8; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Jefferis BJ, 2015, MED SCI SPORT EXER, V47, P2119, DOI 10.1249/MSS.0000000000000635; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee I-M, 2009, EPIDEMIOLOGIC METHOD, P100; Lee IM, 2014, BRIT J SPORT MED, V48, P197, DOI 10.1136/bjsports-2013-093154; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Lyden K, 2014, MED SCI SPORT EXER, V46, P386, DOI 10.1249/MSS.0b013e3182a42a2d; Mathews CE, 2012, EXERC SPORT SCI REV, V40, P118, DOI 10.1097/JES.0b013e31825b34a0; Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d; Matthews CE, 2005, MED SCI SPORT EXER, V37, P986, DOI 10.1249/01.mss.0000171615.76521.69; Miller NE, 2010, J AGING PHYS ACTIV, V18, P158, DOI 10.1123/japa.18.2.158; Murphy SL, 2009, PREV MED, V48, P108, DOI 10.1016/j.ypmed.2008.12.001; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Physical Activity Guidelines Committee, 2008, PHYS ACT GUID ADV CO; Pruitt LA, 2008, J AGING PHYS ACTIV, V16, P416, DOI 10.1123/japa.16.4.416; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rillamas-Sun Eileen, 2015, BMC Res Notes, V8, P270, DOI 10.1186/s13104-015-1229-2; Rowlands AV, 2014, MED SCI SPORT EXER, V46, P1235, DOI 10.1249/MSS.0000000000000224; Sabia S, 2014, AM J EPIDEMIOL, V179, P781, DOI 10.1093/aje/kwt330; Salvo D, 2015, J PHYS ACT HEALTH, V12, P307, DOI 10.1123/jpah.2013-0087; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Scholes S, 2014, AM J EPIDEMIOL, V179, P1493, DOI 10.1093/aje/kwu087; Schrack JA, 2014, J GERONTOL A-BIOL, V69, P973, DOI 10.1093/gerona/glt199; Schuna JM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-126; Shiroma EJ, 2013, JAMA-J AM MED ASSOC, V310, P2562, DOI 10.1001/jama.2013.278896; Shiroma EJ, 2010, CIRCULATION, V122, P743, DOI 10.1161/CIRCULATIONAHA.109.914721; Swartz AM, 2000, MED SCI SPORT EXER, V32, pS450, DOI 10.1097/00005768-200009001-00003; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Tudor-Locke C, 2002, MED SCI SPORT EXER, V34, P2045, DOI 10.1097/00005768-200212000-00027; Tudor-Locke C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-60; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Van Holle V, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1785-3; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	64	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145950	10.1371/journal.pone.0145950	http://dx.doi.org/10.1371/journal.pone.0145950			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0IX	26713857	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900104
J	Thomas, RG; Moon, MJ; Kim, JH; Lee, JH; Jeong, YY				Thomas, Reju George; Moon, Myeong Ju; Kim, Jo Heon; Lee, Jae Hyuk; Jeong, Yong Yeon			Effectiveness of Losartan-Loaded Hyaluronic Acid (HA) Micelles for the Reduction of Advanced Hepatic Fibrosis in C3H/HeN Mice Model	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; STELLATE CELLS; RECEPTOR ANTAGONIST; TARGETED DELIVERY; LIVER FIBROSIS; CIRRHOSIS; RAT; NANOPARTICLES; PATHOGENESIS; SUPPRESSION	Advanced hepatic fibrosis therapy using drug-delivering nanoparticles is a relatively unexplored area. Angiotensin type 1 (AT1) receptor blockers such as losartan can be delivered to hepatic stellate cells (HSC), blocking their activation and thereby reducing fibrosis progression in the liver. In our study, we analyzed the possibility of utilizing drug-loaded vehicles such as hyaluronic acid (HA) micelles carrying losartan to attenuate HSC activation. Losartan, which exhibits inherent lipophilicity, was loaded into the hydrophobic core of HA micelles with a 19.5% drug loading efficiency. An advanced liver fibrosis model was developed using C3H/HeN mice subjected to 20 weeks of prolonged TAA/ethanol weight-adapted treatment. The cytocompatibility and cell uptake profile of losartan-HA micelles were studied in murine fibroblast cells (NIH3T3), human hepatic stellate cells (hHSC) and FL83B cells (hepatocyte cell line). The ability of these nanoparticles to attenuate HSC activation was studied in activated HSC cells based on alpha smooth muscle actin (alpha-sma) expression. Mice treated with oral losartan or losartan-HA micelles were analyzed for serum enzyme levels (ALT/AST, CK and LDH) and collagen deposition (hydroxyproline levels) in the liver. The accumulation of HA micelles was observed in fibrotic livers, which suggests increased delivery of losartan compared to normal livers and specific uptake by HSC. Active reduction of alpha-sma was observed in hHSC and the liver sections of losartan-HA micelle-treated mice. The serum enzyme levels and collagen deposition of losartan-HA micelle-treated mice was reduced significantly compared to the oral losartan group. Losartan-HA micelles demonstrated significant attenuation of hepatic fibrosis via an HSC-targeting mechanism in our in vitro and in vivo studies. These nanoparticles can be considered as an alternative therapy for liver fibrosis.	[Thomas, Reju George; Jeong, Yong Yeon] Chonnam Natl Univ, Sch Med, Hwasun Hosp, Dept Radiol, Gwangju, South Korea; [Moon, Myeong Ju] DKC Corp BioActs, Inchon, South Korea; [Kim, Jo Heon; Lee, Jae Hyuk] Chonnam Natl Univ, Sch Med, Hwasun Hosp, Dept Pathol, Gwangju, South Korea	Chonnam National University; Chonnam National University	Jeong, YY (corresponding author), Chonnam Natl Univ, Sch Med, Hwasun Hosp, Dept Radiol, Gwangju, South Korea.	yjeong@jnu.ac.kr	Thomas, Reju/R-9111-2019		Basic Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and future Planning [2015R1A2A2A01007798]; DKC Corporation (BioActs)	Basic Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and future Planning; DKC Corporation (BioActs)	This research was supported by Basic Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and future Planning (2015R1A2A2A01007798). The funder (DKC Corporation (BioActs)) provided support in the form of salaries for authors and/or research materials [MMJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bahde R, 2011, LIVER INT, V31, P642, DOI 10.1111/j.1478-3231.2011.02493.x; Bakris G, 2008, KIDNEY INT, V74, P364, DOI 10.1038/ki.2008.204; Bataller R, 2005, ANTIOXID REDOX SIGN, V7, P1346, DOI 10.1089/ars.2005.7.1346; Bataller R, 2003, GASTROENTEROLOGY, V125, P117, DOI 10.1016/S0016-5085(03)00695-4; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Beljaars L, 2001, LIVER, V21, P320, DOI 10.1034/j.1600-0676.2001.210504.x; Bisht S, 2011, LAB INVEST, V91, P1383, DOI 10.1038/labinvest.2011.86; Bosetti C, 2007, J HEPATOL, V46, P827, DOI 10.1016/j.jhep.2007.01.025; Choi KY, 2009, J MATER CHEM, V19, P4102, DOI 10.1039/b900456d; Colmenero J, 2009, AM J PHYSIOL-GASTR L, V297, pG726, DOI 10.1152/ajpgi.00162.2009; Guerra R. R., 2010, Brazilian Journal of Veterinary Pathology, V3, P9; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Jin Yu-Jin, 2010, Journal of Pharmaceutical Investigation, V40, P33, DOI 10.4333/KPS.2010.40.S.033; Kabir N, 2014, RSC ADV, V4, P9012, DOI 10.1039/c3ra46093b; Kikuchi S, 2005, J BIOL CHEM, V280, P15398, DOI 10.1074/jbc.M414048200; Kim KS, 2010, ACS NANO, V4, P3005, DOI 10.1021/nn100589y; Kim M, 2008, J GASTROENTEROL, V43, P889, DOI 10.1007/s00535-008-2239-9; Kornek M, 2006, J HEPATOL, V45, P370, DOI 10.1016/j.jhep.2006.03.017; Kurikawa N, 2003, BRIT J PHARMACOL, V139, P1085, DOI 10.1038/sj.bjp.0705339; Levy BI, 2008, CIRCULATION, V118, P968, DOI 10.1161/CIRCULATIONAHA.107.763730; Li XN, 2002, J HEPATOL, V36, P488, DOI 10.1016/S0168-8278(02)00011-9; Liu YH, 2011, INT J PHARMACEUT, V421, P160, DOI 10.1016/j.ijpharm.2011.09.006; Moreno M, 2010, HEPATOLOGY, V51, P942, DOI 10.1002/hep.23419; Munshi MK, 2011, EXP BIOL MED, V236, P557, DOI 10.1258/ebm.2011.010375; Pereira RM, 2009, WORLD J GASTROENTERO, V15, P2579, DOI 10.3748/wjg.15.2579; Rehm J, 2013, J HEPATOL, V59, P160, DOI 10.1016/j.jhep.2013.03.007; Satoh T, 2000, J GASTROEN HEPATOL, V15, P402, DOI 10.1046/j.1440-1746.2000.02164.x; Schneider AW, 1999, HEPATOLOGY, V29, P334, DOI 10.1002/hep.510290203; Takei Y, 2004, FASEB J, V10; Thomas RG, 2015, INT J BIOL MACROMOL, V72, P510, DOI 10.1016/j.ijbiomac.2014.08.054; Urashima S, 2000, ALCOHOL CLIN EXP RES, V24, p34S, DOI 10.1111/j.1530-0277.2000.tb00009.x	31	35	36	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145512	10.1371/journal.pone.0145512	http://dx.doi.org/10.1371/journal.pone.0145512			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714035	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900049
J	Zhang, YY				Zhang, Yong-Yuan			Duck Hepatitis B Virus cccDNA Amplification Efficiency in Natural Infection Is Regulated by Virus Secretion Efficiency	PLOS ONE			English	Article							CLOSED CIRCULAR DNA; AVIAN HEPADNAVIRUS; ENVELOPE PROTEINS; VIRAL-DNA; GENOME; REPLICATION; LIVER; HEPATOCYTES; THERAPY; INTERMEDIATE	Previous mutation based studies showed that ablating synthesis of viral envelope proteins led to elevated hepadnaviral covalently closed circular DNA (cccDNA) amplification, but it remains unknown how cccDNA amplification is regulated in natural hepadnaviral infection because of a lack of research system. In this study we report a simple procedure to prepare two identical duck hepatitis B virus inocula, but they possess 10-100-fold difference in cccDNA amplification in infected cell culture. We demonstrate that the infected cells with higher cccDNA amplification significantly reduce the virus secretion efficiency that results in higher accumulation of relaxed circular DNA (rcDNA) and DHBsAg in the cells. The infected cells with lower cccDNA amplification significantly increase the virus secretion efficiency that leads to lower intracellular rcDNA and DHBsAg accumulation. In contrast with the findings generated in the mutation based experimental system, the regulation of cccDNA amplification in natural hepadnaviral infection bypasses direct regulation of the cellular envelope proteins concentration, instead it modulates virus secretion efficiency that ultimately impacts the intracellular rcDNA concentration, an important factor determining the destination of the synthesized rcDNA in infected cells.	[Zhang, Yong-Yuan] HBVtech, Germantown, MD 20874 USA		Zhang, YY (corresponding author), HBVtech, Germantown, MD 20874 USA.	yongyuanzhang50@gmail.com						BARTENSCHLAGER R, 1990, J VIROL, V64, P5324, DOI 10.1128/JVI.64.11.5324-5332.1990; Bourne EJ, 2007, J VIRAL HEPATITIS, V14, P55, DOI 10.1111/j.1365-2893.2006.00775.x; Funk A, 2004, J VIROL, V78, P8289, DOI 10.1128/jvi.78.15.8289-8300.2004; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gao WF, 2007, J VIROL, V81, P6164, DOI 10.1128/JVI.02721-06; Gerlich WH, 2007, J VIRAL HEPATITIS, V14, P16, DOI 10.1111/j.1365-2893.2007.00912.x; Ghany MG, 2012, ALIMENT PHARM THER, V35, P1027, DOI 10.1111/j.1365-2036.2012.05059.x; Guo H, 2007, J VIROL, V81, P12472, DOI 10.1128/JVI.01123-07; HADZIYANNIS S, 1973, ARCH PATHOL, V96, P327; HEERMANN KH, 1984, J VIROL, V52, P396, DOI 10.1128/JVI.52.2.396-402.1984; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Lee JM, 2011, HEPATOLOGY, V53, P1486, DOI 10.1002/hep.24221; Lenhoff RJ, 1999, HEPATOLOGY, V29, P563, DOI 10.1002/hep.510290236; LENHOFF RJ, 1994, J VIROL, V68, P5706, DOI 10.1128/JVI.68.9.5706-5713.1994; Lenhoff RJ, 1998, VIROLOGY, V251, P85, DOI 10.1006/viro.1998.9394; LENHOFF RJ, 1994, J VIROL, V68, P4565, DOI 10.1128/JVI.68.7.4565-4571.1994; Lentz TB, 2011, J VIROL, V85, P11916, DOI 10.1128/JVI.05373-11; MANDART E, 1984, J VIROL, V49, P782, DOI 10.1128/JVI.49.3.782-792.1984; MASON WS, 1983, VIROLOGY, V131, P375, DOI 10.1016/0042-6822(83)90505-6; Miller Darren S, 2004, Methods Mol Med, V96, P3; MILLER RH, 1989, HEPATOLOGY, V9, P322, DOI 10.1002/hep.1840090226; MILLER RH, 1984, VIROLOGY, V137, P390, DOI 10.1016/0042-6822(84)90231-9; PUGH JC, 1995, J VIROL, V69, P4814, DOI 10.1128/JVI.69.8.4814-4822.1995; SEEGER C, 1986, SCIENCE, V232, P477, DOI 10.1126/science.3961490; SUMMERS J, 1981, HEPATOLOGY, V1, P179, DOI 10.1002/hep.1840010215; SUMMERS J, 1990, J VIROL, V64, P2819, DOI 10.1128/JVI.64.6.2819-2824.1990; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; SUMMERS J, 1991, J VIROL, V65, P1310, DOI 10.1128/JVI.65.3.1310-1317.1991; SUMMERS J, 1975, P NATL ACAD SCI USA, V72, P4597, DOI 10.1073/pnas.72.11.4597; TUTTLEMAN JS, 1986, J VIROL, V58, P17, DOI 10.1128/JVI.58.1.17-25.1986; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; WU TT, 1990, VIROLOGY, V175, P255, DOI 10.1016/0042-6822(90)90206-7; Wursthorn K, 2006, HEPATOLOGY, V44, P675, DOI 10.1002/hep.21282; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Zhang YY, 2000, J VIROL, V74, P5257, DOI 10.1128/JVI.74.11.5257-5265.2000; Zhang YY, 2005, J VIROL, V79, P9896, DOI 10.1128/JVI.79.15.9896-9903.2005; Zhang YY, 1999, J VIROL, V73, P3616, DOI 10.1128/JVI.73.5.3616-3622.1999; Zhang YZ, 2003, P NATL ACAD SCI USA, V100, P12372, DOI 10.1073/pnas.2033898100; Zhu Y, 2001, J VIROL, V75, P311, DOI 10.1128/JVI.75.1.311-322.2001	40	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145465	10.1371/journal.pone.0145465	http://dx.doi.org/10.1371/journal.pone.0145465			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713436	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900045
J	Lee, YA; Kim, HR; Lee, JS; Jung, HW; Kim, HY; Lee, GM; Lee, J; Sim, JH; Oh, SJ; Chung, DH; Shin, CH; Yang, SW				Lee, Young Ah; Kim, Hang-Rae; Lee, Jeong Seon; Jung, Hae Woon; Kim, Hwa Young; Lee, Gyung Min; Lee, Jieun; Sim, Ji Hyun; Oh, Sae Jin; Chung, Doo Hyun; Shin, Choong Ho; Yang, Sei Won			CD4(+)FOXP3(+) Regulatory T Cells Exhibit Impaired Ability to Suppress Effector T Cell Proliferation in Patients with Turner Syndrome	PLOS ONE			English	Article							WOMEN; LYMPHOCYTES; FOXP3	Objective We investigated whether the frequency, phenotype, and suppressive function of CD4(+)FOXP3(+) regulatory T cells (Tregs) are altered in young TS patients with the 45, X karyotype compared to age-matched controls. Design and Methods Peripheral blood mononuclear cells from young TS patients (n = 24, 17.4-35.9 years) and healthy controls (n = 16) were stained with various Treg markers to characterize their phenotypes. Based on the presence of thyroid autoimmunity, patients were categorized into TS (-) (n = 7) and TS (+) (n = 17). Tregs sorted for CD4(+)CD25(bright) were co-cultured with autologous CD4(+)CD25(-) target cells in the presence of anti-CD3 and -CD28 antibodies to assess their suppressive function. Results Despite a lower frequency of CD4(+) T cells in the TS (-) and TS (+) patients (mean 30.8% and 31.7%, vs. 41.2%; P = 0.003 and P < 0.001, respectively), both groups exhibited a higher frequency of FOXP3(+) Tregs among CD4(+) T cells compared with controls (means 1.99% and 2.05%, vs. 1.33%; P = 0.029 and P = 0.004, respectively). There were no differences in the expression of CTLA-4 and the frequency of Tregs expressing CXCR3(+), and CCR4(+)CCR6(+) among the three groups. However, the ability of Tregs to suppress the in vitro proliferation of autologous CD4(+)CD25(-) T cells was significantly impaired in the TS (-) and TS (+) patients compared to controls (P = 0.003 and P = 0.041). Meanwhile, both the TS (-) and TS (+) groups had lower frequencies of naive cells (P = 0.001 for both) but higher frequencies of effector memory cells (P = 0.004 and P = 0.002) than did the healthy control group. Conclusions The Tregs of the TS patients could not efficiently suppress the proliferation of autologous effector T cells, despite their increased frequency in peripheral CD4(+) T cells.	[Lee, Young Ah; Lee, Jeong Seon; Jung, Hae Woon; Kim, Hwa Young; Lee, Gyung Min; Lee, Jieun; Shin, Choong Ho; Yang, Sei Won] Seoul Natl Univ, Coll Med, Childrens Hosp, Dept Pediat, Seoul, South Korea; [Kim, Hang-Rae; Sim, Ji Hyun] Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea; [Kim, Hang-Rae; Oh, Sae Jin; Chung, Doo Hyun] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Chung, Doo Hyun] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Pathol, Seoul, South Korea; [Chung, Doo Hyun] Seoul Natl Univ, Coll Med, Ischemic Hypoxia Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Shin, CH (corresponding author), Seoul Natl Univ, Coll Med, Childrens Hosp, Dept Pediat, 103 Daehak Ro, Seoul, South Korea.	chshinpd@snu.ac.kr	Kim, Hang-Rae/J-5448-2012; Jung, Hae Woon/AAR-6728-2020	Jung, Hae Woon/0000-0003-0494-4626; Kim, Hang-Rae/0000-0002-3983-6193; Lee, Jieun/0000-0002-9776-4204	Seoul National University Hospital Research Fund [04-2011-1050]	Seoul National University Hospital Research Fund	This work was supported by from the Seoul National University Hospital Research Fund (Grant number 04-2011-1050).	Bakalov VK, 2012, J AUTOIMMUN, V38, P315, DOI 10.1016/j.jaut.2012.01.015; Bondy CA, 2007, J CLIN ENDOCR METAB, V92, P10, DOI 10.1210/jc.2006-1374; Booth NJ, 2010, J IMMUNOL, V184, P4317, DOI 10.4049/jimmunol.0903781; Brusko TM, 2008, IMMUNOL REV, V223, P371, DOI 10.1111/j.1600-065X.2008.00637.x; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; El-Mansoury M, 2005, J CLIN ENDOCR METAB, V90, P2131, DOI 10.1210/jc.2004-1262; Fan HY, 2012, ARCH GYNECOL OBSTET, V285, P749, DOI 10.1007/s00404-011-2049-9; Figueroa-Vega N, 2010, J CLIN ENDOCR METAB, V95, P953, DOI 10.1210/jc.2009-1719; Hwang KA, 2009, MECH AGEING DEV, V130, P509, DOI 10.1016/j.mad.2009.06.003; Jez Waclaw, 2010, Pol Merkur Lekarski, V29, P247; Jorgensen KT, 2010, ARTHRITIS RHEUM-US, V62, P658, DOI 10.1002/art.27270; Livadas S, 2005, THYROID, V15, P1061, DOI 10.1089/thy.2005.15.1061; Marazuela M, 2006, J CLIN ENDOCR METAB, V91, P3639, DOI 10.1210/jc.2005-2337; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Shin Choong Ho, 2008, Clinical and Experimental Pediatrics, V51, P569; Stenberg Annika E, 2004, J Negat Results Biomed, V3, P6, DOI 10.1186/1477-5751-3-6; Su MA, 2009, CLIN IMMUNOL, V131, P139, DOI 10.1016/j.clim.2008.11.007; Wing K, 2011, TRENDS IMMUNOL, V32, P428, DOI 10.1016/j.it.2011.06.002; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zinn AR, 1998, AM J HUM GENET, V63, P1757, DOI 10.1086/302152	23	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144549	10.1371/journal.pone.0144549	http://dx.doi.org/10.1371/journal.pone.0144549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709833	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400007
J	Ortega, A; Tarazon, E; Rosello-Lleti, E; Gil-Cayuela, C; Lago, F; Gonzalez-Juanatey, JR; Cinca, J; Jorge, E; Martinez-Dolz, L; Portoles, M; Rivera, M				Ortega, Ana; Tarazon, Estefania; Rosello-Lleti, Esther; Gil-Cayuela, Carolina; Lago, Francisca; Gonzalez-Juanatey, Jose-Ramon; Cinca, Juan; Jorge, Esther; Martinez-Dolz, Luis; Portoles, Manuel; Rivera, Miguel			Patients with Dilated Cardiomyopathy and Sustained Monomorphic Ventricular Tachycardia Show Up-Regulation of KCNN3 and KCNJ2 Genes and CACNG8-Linked Left Ventricular Dysfunction	PLOS ONE			English	Article							SHORT QT SYNDROME; HEART-FAILURE; ATRIAL-FIBRILLATION; POTASSIUM CHANNELS; MOLECULAR-BASIS; EXPRESSION; GUIDELINES; CARDIOLOGY; TRANSPORT; MUTATION	Aims Disruptions in cardiac ion channels have shown to influence the impaired cardiac contraction in heart failure. We sought to determine the altered gene expression profile of this category in dilated cardiomyopathy (DCM) patients and relate the altered gene expression with the clinical signs present in our patients, such as ventricular dysfunction and sustained monomorphic ventricular tachycardia (SMVT). Methods and Results Left ventricular (LV) tissue samples were used in RNA-sequencing technique to elucidate the transcriptomic changes of 13 DCM patients compared to controls (n = 10). We analyzed the differential gene expression of cardiac ion channels, and we found a total of 34 altered genes. We found that the calcium channel CACNG8 mRNA and protein levels were down-regulated and highly and inversely related with LV ejection fraction (LVEF) (r = -0.78, P<0.01). Furthermore, the potassium channels KCNN3 and KCNJ2 mRNA and protein levels were up-regulated and showed also a significant and inverse correlation with LVEF (r = -0.61, P<0.05; r = -0.60, P<0.05) in patients with SMVT. Conclusion A broad set of deregulated genes have been identified by RNA-sequencing technique. The relationship of CACNG8, KCNN3 and KCNJ2 with LVEF, and the up-regulation of KCNN3 and KCNJ2 in all patients with SMVT, irrespective of CACNG8 expression, suggest a significant role for these three ion flux related genes in the LV dysfunction present in this cardiomyopathy and an important relationship between KCNN3 and KCNJ2 up-regulation and the presence of SMVT.	[Ortega, Ana; Tarazon, Estefania; Rosello-Lleti, Esther; Gil-Cayuela, Carolina; Portoles, Manuel; Rivera, Miguel] La Fe Univ Hosp, Hlth Res Inst, Cardiocirculatory Unit, IIS La Fe, Valencia, Spain; [Lago, Francisca; Gonzalez-Juanatey, Jose-Ramon] Univ Clin Hosp, Dept Cardiol, Cellular & Mol Cardiol Res Unit, Santiago De Compostela, Spain; [Lago, Francisca; Gonzalez-Juanatey, Jose-Ramon] Univ Clin Hosp, Inst Biomed Res, Santiago De Compostela, Spain; [Cinca, Juan; Jorge, Esther] Santa Creu & St Pau Hosp, Serv Cardiol, Barcelona, Spain; [Martinez-Dolz, Luis] La Fe Univ Hosp, Dept Cardiol, Heart Failure & Transplantat Unit, Valencia, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Rivera, M (corresponding author), La Fe Univ Hosp, Hlth Res Inst, Cardiocirculatory Unit, IIS La Fe, Valencia, Spain.	miguelrivera492@gmail.com	Roselló Lletí, Esther/ABG-8503-2020; Ortega, Ana/AAG-5941-2020; Gil-Cayuela, Carolina/D-6996-2017; PORTOLES, MANUEL/B-4789-2009; Ortega, Ana AO/D-3027-2017; Dolz, Luis Martinez/X-4627-2018; Tarazón, Estefanía/D-6950-2017; jorge, esther/D-4206-2014; Roselló-Lletí, Esther/B-2695-2017	Roselló Lletí, Esther/0000-0003-2627-6104; Ortega, Ana/0000-0002-9763-0505; Gil-Cayuela, Carolina/0000-0002-1106-7935; PORTOLES, MANUEL/0000-0002-4415-7160; Ortega, Ana AO/0000-0002-9763-0505; Dolz, Luis Martinez/0000-0001-5145-8191; Tarazón, Estefanía/0000-0003-3466-2558; jorge, esther/0000-0002-2777-0000; Roselló-Lletí, Esther/0000-0003-2627-6104; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388	National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III" [PI13/00100, PI14/01506]; European Regional Development Fund (FEDER); RETICS (Red Tematica en Investigacion Cooperativa en Salud) [12/0042/0003]	National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III"; European Regional Development Fund (FEDER)(European Commission); RETICS (Red Tematica en Investigacion Cooperativa en Salud)	This work was supported by the National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III" [PI13/00100; PI14/01506], the European Regional Development Fund (FEDER), and RETICS (Red Tematica en Investigacion Cooperativa en Salud) [12/0042/0003] (AO, ET, ERL, CGC, FL, MP, MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronsen JM, 2013, J MOL CELL CARDIOL, V61, P11, DOI 10.1016/j.yjmcc.2013.06.003; Bonilla IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108824; Chang PC, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004713; Cho CH, 2007, NEURON, V55, P890, DOI 10.1016/j.neuron.2007.08.024; Chua SK, 2011, CIRC RES, V108, P971, DOI 10.1161/CIRCRESAHA.110.238386; Decher N, 2001, CARDIOVASC RES, V52, P255, DOI 10.1016/S0008-6363(01)00374-1; Despa S, 2013, J MOL CELL CARDIOL, V61, P2, DOI 10.1016/j.yjmcc.2013.04.011; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ertl G, 2014, EUR HEART J, V35, P470, DOI 10.1093/eurheartj/eht555; Fischer TH, 2014, EUR J HEART FAIL, V16, P1292, DOI 10.1002/ejhf.163; Grubb S, 2014, J CARDIOVASC ELECTR, V25, P896, DOI 10.1111/jce.12422; Gui L, 2013, AM J PHYSIOL-HEART C, V304, pH118, DOI 10.1152/ajpheart.00820.2011; Hardziyenka M, 2012, J AM COLL CARDIOL, V59, P2193, DOI 10.1016/j.jacc.2012.01.063; Iqbal K, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113928; Jankowska EA, 2013, EUR HEART J, V34, P816, DOI 10.1093/eurheartj/ehs224; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; Li N, 2009, J PHYSIOL-LONDON, V587, P1087, DOI 10.1113/jphysiol.2008.167718; Macrae Duncan J, 2007, Proc Am Thorac Soc, V4, P176, DOI 10.1513/pats.200701-011GC; Mahida S, 2014, CARDIOVASC RES, V101, P326, DOI 10.1093/cvr/cvt269; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Molina-Navarro MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079792; Nerbonne JM, 2000, J PHYSIOL-LONDON, V525, P285, DOI 10.1111/j.1469-7793.2000.t01-1-00285.x; Ni YJ, 2013, MOL CELL BIOCHEM, V384, P95, DOI 10.1007/s11010-013-1785-5; Ortega A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107635; Patel C, 2010, CIRC-ARRHYTHMIA ELEC, V3, P401, DOI 10.1161/CIRCEP.109.921056; Priori SG, 2005, CIRC RES, V96, P800, DOI 10.1161/01.RES.0000162101.76263.8c; Qi XY, 2015, CIRC RES, V116, P836, DOI 10.1161/CIRCRESAHA.116.305326; Radicke S, 2006, CARDIOVASC RES, V71, P695, DOI 10.1016/j.cardiores.2006.06.017; Rosello-Lleti E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112971; Speerschneider T, 2013, J PHYSIOL-LONDON, V591, P5923, DOI 10.1113/jphysiol.2013.263483; Szuts V, 2013, CAN J PHYSIOL PHARM, V91, P648, DOI 10.1139/cjpp-2012-0413; Tarazon E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048957; Walmsley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056359; Xia M, 2005, BIOCHEM BIOPH RES CO, V332, P1012, DOI 10.1016/j.bbrc.2005.05.054; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yang DD, 2015, J MEMBRANE BIOL, V248, P1181, DOI 10.1007/s00232-015-9839-0; Yanni J, 2011, CIRC-HEART FAIL, V4, P496, DOI 10.1161/CIRCHEARTFAILURE.110.957647	38	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145518	10.1371/journal.pone.0145518	http://dx.doi.org/10.1371/journal.pone.0145518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710323	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400060
J	Onken, A; Said, AK; Jorstad, M; Jenum, PA; Blomberg, B				Onken, Annette; Said, Abdulrahman K.; Jorstad, Melissa; Jenum, Pal A.; Blomberg, Bjorn			Prevalence and Antimicrobial Resistance of Microbes Causing Bloodstream Infections in Unguja, Zanzibar	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; GRAM-NEGATIVE BACTERIA; HEALTH-CARE; AFRICA; ENTEROBACTERIACEAE; COUNTRIES; TANZANIA; HOSPITALS; SEPSIS; DEATH	Background Bloodstream infections (BSI) are frequent and cause high case-fatality rates. Urgent antibiotic treatment can save patients' lives, but antibiotic resistance can render antibiotic therapy futile. This study is the first to collect epidemiological data on BSI from Unguja, Zanzibar. Methods Clinical data and blood for culturing and susceptibility testing of isolated microbes were obtained from 469 consecutively enrolled neonates, children and adults presenting with signs of systemic infections at Mnazi Mmoja Hospital (MMH), Zanzibar. Results Pathogenic bacteria were recovered from the blood of 14% of the patients (66/469). The most frequently isolated microbes were Klebsiella pneumoniae, Escherichia coli, Acinetobacter spp. and Staphylococcus aureus. Infections were community-acquired in 56 patients (85%) and hospital-acquired in 8 (12%) (data missing for 2 patients). BSI caused by extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae (E. coli, K. pneumoniae) was found in 5 cases, of which 3 were community-acquired and 2 hospital-acquired. Three of these patients died. Six of 7 Salmonella Typhi isolates were multidrug resistant. Streptococcus pneumoniae was found in one patient only. Conclusions This is the first report of ESBL-producing bacteria causing BSI from the Zanzibar archipelago. Our finding of community-acquired BSI caused by ESBL-producing bacteria is alarming, as it implies that these difficult-to-treat bacteria have already spread in the society. In the local setting these infections are virtually impossible to cure. The findings call for increased awareness of rational antibiotic use, infection control and surveillance to counteract the problem of emerging antimicrobial resistance.	[Onken, Annette; Jenum, Pal A.] Vestre Viken Hlth Trust, Dept Med Microbiol, Drammen, Norway; [Said, Abdulrahman K.] Mnazi Mmoja Hosp, Dept Med, Zanzibar, Tanzania; [Jorstad, Melissa; Blomberg, Bjorn] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Blomberg, Bjorn] Haukeland Hosp, Natl Ctr Trop Infect Dis, N-5021 Bergen, Norway; [Blomberg, Bjorn] Univ Bergen, Dept Clin Sci, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen	Onken, A (corresponding author), Vestre Viken Hlth Trust, Dept Med Microbiol, Drammen, Norway.	annetteonken@yahoo.com	; Blomberg, Bjorn/B-9605-2015	Davidsen Jorstad, Melissa/0000-0003-3516-5297; Blomberg, Bjorn/0000-0001-5647-4297	National Center for Tropical Infectious Diseases; Haukeland University Hospital, Bergen, Norway	National Center for Tropical Infectious Diseases; Haukeland University Hospital, Bergen, Norway	The National Center for Tropical Infectious Diseases, Haukeland University Hospital, Bergen, Norway funded all material used in the study including analysis of the samples in Zanzibar and Norway and transport of the samples from Zanzibar to Norway as well as payment to the local collaborators in Zanzibar, both at the laboratory and at the wards, and part of the travel expenses and accommodation expenses of AO.	Aisenberg G, 2004, CANCER-AM CANCER SOC, V101, P2134, DOI 10.1002/cncr.20604; Alp E, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-36; [Anonymous], 1981, Scand J Infect Dis, V13, P148; [Anonymous], 2005, PRINCIPLES PRACTICE; Archibald LK, 2001, EMERG INFECT DIS, V7, P302, DOI 10.3201/eid0702.010232; Archibald LK, 2000, J CLIN MICROBIOL, V38, P2994, DOI 10.1128/JCM.38.8.2994-2997.2000; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Becker JU, 2009, LANCET INFECT DIS, V9, P577, DOI 10.1016/S1473-3099(09)70135-5; Birkett CI, 2007, J MED MICROBIOL, V56, P52, DOI 10.1099/jmm.0.46909-0; Blomberg B, 2005, J CLIN MICROBIOL, V43, P745, DOI 10.1128/JCM.43.2.745-749.2005; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Collee JG, 1996, MACKIE MCCARTNEY PRA, V14th; Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Silva BNG, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007934.pub2; Kothari C, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-136; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Mnyika Kagoma S, 2012, East Afr J Public Health, V9, P123; Moyo S, 2015, ANTIMICROB AGENTS CH, V59, P682, DOI 10.1128/AAC.01436-13; Mshana SE, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-466; Mshana Stephen E, 2009, BMC Res Notes, V2, P49, DOI 10.1186/1756-0500-2-49; Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741; Paterson DL, 2006, AM J INFECT CONTROL, V34, pS20, DOI 10.1016/j.ajic.2006.05.238; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Saied T, 2011, AM J INFECT CONTROL, V39, pE61, DOI 10.1016/j.ajic.2011.04.009; Sturod K, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0217-3; Tansarli GS, 2014, J ANTIMICROB CHEMOTH, V69, P1177, DOI 10.1093/jac/dkt500; Tansarli GS, 2013, EXPERT REV ANTI-INFE, V11, P321, DOI [10.1586/eri.13.4, 10.1586/ERI.13.4]; Thriemer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030350; Vlieghe E, 2009, INT J ANTIMICROB AG, V34, P295, DOI 10.1016/j.ijantimicag.2009.04.015	31	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145632	10.1371/journal.pone.0145632	http://dx.doi.org/10.1371/journal.pone.0145632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700032	gold, Green Published			2022-12-27	WOS:000367092600110
J	Browne, LD; Bashar, K; Griffin, P; Kavanagh, EG; Walsh, SR; Walsh, MT				Browne, Leonard D.; Bashar, Khalid; Griffin, Philip; Kavanagh, Eamon G.; Walsh, Stewart R.; Walsh, Michael T.			The Role of Shear Stress in Arteriovenous Fistula Maturation and Failure: A Systematic Review	PLOS ONE			English	Review							INTIMAL-MEDIAL HYPERPLASIA; VASCULAR ACCESS SURGERY; CELLULAR PHENOTYPES; HEMODIALYSIS ACCESS; VENOUS STENOSIS; BLOOD-FLOW; MATRIX METALLOPROTEINASES; ARTERIAL ENLARGEMENT; INCREASED EXPRESSION; LOOP GRAFTS	Introduction Non-maturation and post-maturation venous stenosis are the primary causes of failure within arteriovenous fistulae (AVFs). Although the exact mechanisms triggering failure remain unclear, abnormal hemodynamic profiles are thought to mediate vascular remodelling and can adversely impact on fistula patency. Aim The review aims to clarify the role of shear stress on outward remodelling during maturation and evaluate the evidence supporting theories related to the localisation and development of intimal hyperplasia within AVFs. Methods A systematic review of studies comparing remodelling data with hemodynamic data obtained from computational fluid dynamics of AVFs during and after maturation was conducted. Results Outward remodelling occurred to reduce or normalise the level of shear stress over time in fistulae with a large radius of curvature (curved) whereas shear stress was found to augment over time in fistulae with a small radius of curvature (straight) coinciding with minimal to no increases in lumen area. Although this review highlighted that there is a growing body of evidence suggesting low and oscillating shear stress may stimulate the initiation and development of intimal medial thickening within AVFs. Further lines of evidence are needed to support the disturbed flow theory and outward remodelling findings before surgical configurations and treatment strategies are optimised to conform to them. This review highlighted that variation between the time of analysis, classification of IH, resolution of simulations, data processing techniques and omission of various shear stress metrics prevented forming pooling of data amongst studies. Conclusion Standardised measurements and data processing techniques are needed to comprehensively evaluate the relationship between shear stress and intimal medial thickening. Advances in image acquisition and flow quantifications coupled with the increasing prevalence of longitudinal studies commencing from fistula creation offer viable techniques and strategies to robustly evaluate the relationship between shear stress and remodelling during maturation and thereafter.	[Browne, Leonard D.; Griffin, Philip; Walsh, Michael T.] Univ Limerick, CABER, Dept Mech Aeronaut & Biomed Engn, Mat & Surface Sci Inst,Hlth Res Inst, Limerick, Ireland; [Bashar, Khalid; Kavanagh, Eamon G.; Walsh, Stewart R.] Limerick Univ Hosp, Dept Vasc Surg, Limerick, Ireland; [Walsh, Stewart R.] Natl Univ Ireland, Dept Surg, Galway, Ireland	University of Limerick; University of Limerick; Ollscoil na Gaillimhe-University of Galway	Walsh, MT (corresponding author), Univ Limerick, CABER, Dept Mech Aeronaut & Biomed Engn, Mat & Surface Sci Inst,Hlth Res Inst, Limerick, Ireland.	michael.walsh@ul.ie	Walsh, Stewart R/AAC-1229-2021; Griffin, Philip/G-7458-2012; Walsh, Michael T/C-1405-2010	Walsh, Michael T/0000-0002-1672-8106; Walsh, Stewart/0000-0002-1006-9541; Browne, Leonard/0000-0002-9203-1212	Irish Research Council for Science Engineering and Technology (IRCSET); European Union [324487]	Irish Research Council for Science Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); European Union(European Commission)	LB received funding from The Irish Research Council for Science Engineering and Technology (IRCSET). LB and MW received funding from The European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 324487.	Allon M, 2011, AM J KIDNEY DIS, V58, P437, DOI 10.1053/j.ajkd.2011.04.018; Botti L, 2013, CARDIOVASC ENG TECHN, V4, P485; Browne LD, 2015, CARDIOVASC ENG TECHN, V6, P450, DOI 10.1007/s13239-015-0246-6; Browne LD, 2015, ANN BIOMED ENG, V43, P1275, DOI 10.1007/s10439-015-1295-6; Carroll GT, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003310; Carroll GT, 2009, CELL MOL BIOENG, V2, P591, DOI 10.1007/s12195-009-0089-z; Chan CY, 2007, J VASC SURG, V45, P804, DOI 10.1016/j.jvs.2006.12.063; Chang CJ, 2005, KIDNEY INT, V68, P1312, DOI 10.1111/j.1523-1755.2005.00529.x; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Corpataux JM, 2002, NEPHROL DIAL TRANSPL, V17, P1057, DOI 10.1093/ndt/17.6.1057; Decorato I, 2014, INT J NUMER METH BIO, V30, P143, DOI 10.1002/cnm.2595; Dixon BS, 2006, KIDNEY INT, V70, P1413, DOI 10.1038/sj.ki.5001747; Ene-Iordache B, 2015, J BIOMECH, DOI [10.1016/j.jbiomech.2015.04.013, DOI 10.1016/J.JBI0MECH.2015.04.013]; FILLINGER MF, 1989, AM J SURG, V158, P87, DOI 10.1016/0002-9610(89)90353-X; FILLINGER MF, 1990, J VASC SURG, V11, P556, DOI 10.1067/mva.1990.18322; Gelbfish GA, 2008, TECH VASC INTERV RAD, V11, P156, DOI 10.1053/j.tvir.2008.09.002; Gusic RJ, 2005, J BIOMECH, V38, P1760, DOI 10.1016/j.jbiomech.2004.10.030; He Y, 2013, J BIOMECH, V46, P165, DOI 10.1016/j.jbiomech.2012.09.005; Huynh TN, 2007, J BIOMECH, V40, P2158, DOI 10.1016/j.jbiomech.2006.10.028; Johansson M, 2010, ATHEROSCLEROSIS, V211, P159, DOI 10.1016/j.atherosclerosis.2010.01.031; Kharboutly Z, 2007, MED ENG PHYS, V29, P999, DOI 10.1016/j.medengphy.2006.10.018; Kharboutly Z, 2010, MED ENG PHYS, V32, P111, DOI 10.1016/j.medengphy.2009.10.013; Kheda MF, 2010, NEPHROL DIAL TRANSPL, V25, P525, DOI 10.1093/ndt/gfp462; Korten E, 2009, EUR J VASC ENDOVASC, V38, P375, DOI 10.1016/j.ejvs.2009.03.029; Krishnamoorthy A, 2008, J VASC ACCESS, V9, P28, DOI 10.1177/112972980800900105; Krishnamoorthy MK, 2008, KIDNEY INT, V74, P1410, DOI 10.1038/ki.2008.379; Lee ES, 2011, J VASC SURG, V54, P454, DOI 10.1016/j.jvs.2011.02.056; Lee SW, 2007, J BIOMECH, V40, P981, DOI 10.1016/j.jbiomech.2006.03.024; Lee SW, 2005, J FLUID STRUCT, V20, P837, DOI 10.1016/j.jfluidstructs.2005.04.006; Lee T, 2014, SEMIN DIALYSIS, V27, P303, DOI 10.1111/sdi.12172; Lee T, 2012, SEMIN DIALYSIS, V25, P592, DOI 10.1111/j.1525-139X.2012.01063.x; Loth F, 2003, J BIOMECH ENG-T ASME, V125, P49, DOI 10.1115/1.1537737; Mangrum A., 2007, DRUG DISCOV TODAY DI, V4, P147, DOI [10.1016/j.ddmec.2008.02007, DOI 10.1016/J.DDMEC.2008.02.007]; McCormick Susan M, 2012, Cardiovasc Eng Technol, V3, P439; McGah PM, 2014, BIOMECH MODEL MECHAN, V13, P679, DOI 10.1007/s10237-013-0527-7; Mcgah PM, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023133; Mills B, 2012, PERFUSION-UK, V27, P529, DOI 10.1177/0267659112465807; Misra S, 2005, KIDNEY INT, V68, P2890, DOI 10.1111/j.1523-1755.2005.00763.x; Misra S, 2008, AM J PHYSIOL-HEART C, V294, pH2219, DOI 10.1152/ajpheart.00650.2007; Misra S, 2008, J VASC INTERV RADIOL, V19, P587, DOI 10.1016/j.jvir.2008.01.005; Moe SM, 2004, CIRC RES, V95, P560, DOI 10.1161/01.RES.0000141775.67189.98; Moore JA, 1999, ANN BIOMED ENG, V27, P627, DOI 10.1114/1.221; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Rajabi-Jagahrgh E, 2013, SEMIN DIALYSIS, V26, P511, DOI 10.1111/sdi.12045; Rajabi-Jagahrgh E, 2013, SEMIN DIALYSIS, V26, P208, DOI 10.1111/j.1525-139X.2012.01112.x; Ravani P, 2007, J NEPHROL, V20, P141; Rothuizen TC, 2013, NEPHROL DIAL TRANSPL, V28, P1085, DOI 10.1093/ndt/gft068; Roy-Chaudhury P, 2009, NEPHROL DIAL TRANSPL, V24, P2786, DOI 10.1093/ndt/gfn708; Shenoy S, 2007, SEMIN VASC SURG, V20, P141, DOI 10.1053/j.semvascsurg.2007.07.005; Shenoy S, 2009, J VASC ACCESS, V10, P223, DOI 10.1177/112972980901000401; Sho E, 2002, EXP MOL PATHOL, V73, P142, DOI 10.1006/exmp.2002.2457; Sho M, 2002, EXP MOL PATHOL, V72, P150, DOI 10.1006/exmp.2002.2426; Sigovan M, 2013, ANN BIOMED ENG, V41, P657, DOI 10.1007/s10439-012-0703-4; Tordoir J, 2007, NEPHROL DIAL TRANSPL, V22, P88, DOI 10.1093/ndt/gfm021; Tronc F, 2000, ARTERIOSCL THROM VAS, V20, pE120, DOI 10.1161/01.ATV.20.12.e120; Unnikrishnan S, 2005, J BIOMECH ENG-T ASME, V127, P1141, DOI 10.1115/1.2112927; van der Linden J, 2006, AM J KIDNEY DIS, V47, P1013, DOI 10.1053/j.ajkd.2006.01.033; Wang Y, 2008, NEPHROL DIAL TRANSPL, V23, P525, DOI 10.1093/ndt/gfm547; Weiss MF, 2001, AM J KIDNEY DIS, V37, P970, DOI 10.1016/S0272-6386(05)80013-7	60	50	52	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145795	10.1371/journal.pone.0145795	http://dx.doi.org/10.1371/journal.pone.0145795			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716840	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500073
J	Caffarel-Salvador, E; Brady, AJ; Eltayib, E; Meng, T; Alonso-Vicente, A; Gonzalez-Vazquez, P; Torrisi, BM; Vicente-Perez, EM; Mooney, K; Jones, DS; Bell, SEJ; McCoy, CP; McCarthy, HO; McElnay, JC; Donnelly, RF				Caffarel-Salvador, Ester; Brady, Aaron J.; Eltayib, Eyman; Meng, Teng; Alonso-Vicente, Ana; Gonzalez-Vazquez, Patricia; Torrisi, Barbara M.; Vicente-Perez, Eva Maria; Mooney, Karen; Jones, David S.; Bell, Steven E. J.; McCoy, Colin P.; McCarthy, Helen O.; McElnay, James C.; Donnelly, Ryan F.			Hydrogel-Forming Microneedle Arrays Allow Detection of Drugs and Glucose In Vivo: Potential for Use in Diagnosis and Therapeutic Drug Monitoring	PLOS ONE			English	Article							INTERSTITIAL FLUID; MICROPROJECTION ARRAYS; TIME-LAG; THEOPHYLLINE; SKIN; PERFORMANCE; BLOOD; PAIN; BIOSENSOR; SERUM	We describe, for the first time the use of hydrogel-forming microneedle (MN) arrays for minimally-invasive extraction and quantification of drug substances and glucose from skin in vitro and in vivo. MN prepared from aqueous blends of hydrolysed poly(methyl-vinylether-co-maleic anhydride) (11.1% w/w) and poly(ethyleneglycol) 10,000 daltons (5.6% w/w) and crosslinked by esterification swelled upon skin insertion by uptake of fluid. Post-removal, theophylline and caffeine were extracted from MN and determined using HPLC, with glucose quantified using a proprietary kit. In vitro studies using excised neonatal porcine skin bathed on the underside by physiologically-relevant analyte concentrations showed rapid (5 min) analyte uptake. For example, mean concentrations of 0.16 mu g/mL and 0.85 mu g/mL, respectively, were detected for the lowest (5 mu g/mL) and highest (35 mu g/mL) Franz cell concentrations of theophylline after 5 min insertion. A mean concentration of 0.10 mu g/mL was obtained by extraction of MN inserted for 5 min into skin bathed with 5 mu g/mL caffeine, while the mean concentration obtained by extraction of MN inserted into skin bathed with 15 mu g/mL caffeine was 0.33 mu g/mL. The mean detected glucose concentration after 5 min insertion into skin bathed with 4 mmol/L was 19.46 nmol/L. The highest theophylline concentration detected following extraction from a hydrogel-forming MN inserted for 1 h into the skin of a rat dosed orally with 10 mg/kg was of 0.363 mu g/mL, whilst a maximum concentration of 0.063 mu g/mL was detected following extraction from a MN inserted for 1 h into the skin of a rat dosed with 5 mg/kg theophylline. In human volunteers, the highest mean concentration of caffeine detected using MN was 91.31 mu g/mL over the period from 1 to 2 h post-consumption of 100 mg Proplus (R) tablets. The highest mean blood glucose level was 7.89 nmol/L detected 1 h following ingestion of 75 g of glucose, while the highest mean glucose concentration extracted from MN was 4.29 nmol/L, detected after 3 hours skin insertion in human volunteers. Whilst not directly correlated, concentrations extracted from MN were clearly indicative of trends in blood in both rats and human volunteers. This work strongly illustrates the potential of hydrogel-forming MN in minimally-invasive patient monitoring and diagnosis. Further studies are now ongoing to reduce clinical insertion times and develop mathematical algorithms enabling determination of blood levels directly from MN measurements.	[Caffarel-Salvador, Ester; Brady, Aaron J.; Eltayib, Eyman; Meng, Teng; Alonso-Vicente, Ana; Gonzalez-Vazquez, Patricia; Torrisi, Barbara M.; Vicente-Perez, Eva Maria; Mooney, Karen; Jones, David S.; McCoy, Colin P.; McCarthy, Helen O.; McElnay, James C.; Donnelly, Ryan F.] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland; [Bell, Steven E. J.] Queens Univ Belfast, Sch Chem & Chem Engn, Belfast BT9 5AG, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Donnelly, RF (corresponding author), Queens Univ Belfast, Sch Pharm, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	r.donnelly@qub.ac.uk	McCoy, Colin P/A-6815-2008	McCoy, Colin P/0000-0002-6468-2018; McCarthy, Helen/0000-0002-1254-3745; Caffarel-Salvador, Ester/0000-0002-2844-7598; /0000-0003-3767-8985; Donnelly, Ryan/0000-0002-0766-4147	EPSRC [EP/H021647/1]; Action Medical Research Grant through the Henry Smith Charity [GN2024]; Northern Pharmacies Trust; Engineering and Physical Sciences Research Council [EP/H021647/1] Funding Source: researchfish; Action Medical Research [2024] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Action Medical Research Grant through the Henry Smith Charity; Northern Pharmacies Trust; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Action Medical Research	This work was supported by EPSRC Grant EP/H021647/1 and Action Medical Research Grant number GN2024 through the Henry Smith Charity and The Northern Pharmacies Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, INTERNATIONAL CONFER; ARONSON JK, 1992, BRIT MED J, V305, P1078, DOI 10.1136/bmj.305.6861.1078; Bal SM, 2008, EUR J PHARM SCI, V35, P193, DOI 10.1016/j.ejps.2008.06.016; Basu A, 2013, DIABETES, V62, P4083, DOI 10.2337/db13-1132; Bhargav A, 2012, ACS APPL MATER INTER, V4, P2483, DOI 10.1021/am3001727; Brunner M, 2006, TRAC-TREND ANAL CHEM, V25, P674, DOI 10.1016/j.trac.2006.05.004; Coffey JW, 2013, BIOMATERIALS, V34, P9572, DOI 10.1016/j.biomaterials.2013.08.078; Corrie SR, 2010, LAB CHIP, V10, P2655, DOI [10.1039/c0lc00068j, 10.1039/c01c00068j]; Donnelly RF, 2010, EP H021647 1; Donnelly RF, 2012, MICRONEEDLE ENHANCED; Donnelly RF, 2007, British Patent Application, Patent No. [0718996.2, W02009040548, 07189962]; Donnelly RF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111547; Donnelly RF, 2014, J PHARM SCI-US, V103, P1478, DOI 10.1002/jps.23921; Donnelly RF, 2014, THER DRUG MONIT, V36, P10, DOI 10.1097/FTD.0000000000000022; Donnelly RF, 2012, ADV FUNCT MATER, V22, P4879, DOI 10.1002/adfm.201200864; Donnelly RF, 2010, J CONTROL RELEASE, V147, P333, DOI 10.1016/j.jconrel.2010.08.008; Donnelly RF, 2011, PHARM RES-DORDR, V28, P41, DOI 10.1007/s11095-010-0169-8; Donnelly RF, 2009, DRUG DEV IND PHARM, V35, P1242, DOI 10.1080/03639040902882280; EVENSON MA, 1976, CLIN CHEM, V22, P851; Ferapontova EE, 2008, J AM CHEM SOC, V130, P4256, DOI 10.1021/ja711326b; Garg SK, 2010, DIABETES RES CLIN PR, V87, P348, DOI 10.1016/j.diabres.2009.11.014; Garland MJ, 2012, INT J PHARMACEUT, V434, P80, DOI 10.1016/j.ijpharm.2012.05.069; Garland MJ, 2008, INT J PHARMACEUT, V406, P91; Gill HS, 2008, CLIN J PAIN, V24, P585, DOI 10.1097/AJP.0b013e31816778f9; Giudice EL, 2006, ADV DRUG DELIVER REV, V58, P68, DOI 10.1016/j.addr.2005.12.003; Groenendaal Willemijn, 2010, J Diabetes Sci Technol, V4, P1032; HABEL D, 1993, ANALYST, V118, P1511, DOI 10.1039/an9931801511; Hafeli UO, 2011, CLIN CHEM LAB MED, V49, P2123, DOI 10.1515/CCLM.2011.727; HAMILTON JG, 1995, J FAM PRACTICE, V41, P169; Haq MI, 2009, BIOMED MICRODEVICES, V11, P35, DOI 10.1007/s10544-008-9208-1; Hawwa AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089908; Ito Y, 2014, BIOL PHARM BULL, V37, P1776, DOI 10.1248/bpb.b14-00406; Jenkins D, 2012, RSC ADV, V2, P3490, DOI 10.1039/c2ra20153d; Jina Arvind, 2014, J Diabetes Sci Technol, V8, P483, DOI 10.1177/1932296814526191; Kaushik S, 2001, ANESTH ANALG, V92, P502, DOI 10.1213/00000539-200102000-00041; Kersten G, 2007, EXPERT OPIN DRUG DEL, V4, P459, DOI 10.1517/17425247.4.5.459; Kiang TKL, 2012, J PHARM SCI-US, V101, P4642, DOI 10.1002/jps.23309; KUME H, 1994, J CLIN INVEST, V93, P371, DOI 10.1172/JCI116969; Lawson G, 2012, ISRN CHROMATOGRAPHY; Leboulanger B, 2004, PHYSIOL MEAS, V25, pR35, DOI 10.1088/0967-3334/25/3/R01; LEUNG P, 1977, J ALLERGY CLIN IMMUN, V59, P440, DOI 10.1016/0091-6749(77)90007-0; Li CG, 2013, BIOMED MICRODEVICES, V15, P17, DOI 10.1007/s10544-012-9683-2; Liguori A, 1997, PHARMACOL BIOCHEM BE, V58, P721, DOI 10.1016/S0091-3057(97)00003-8; Mahdavinia GR, 2009, EXPRESS POLYM LETT, V3, P279, DOI 10.3144/expresspolymlett.2009.35; Migalska K, 2011, PHARM RES-DORDR, V28, P1919, DOI 10.1007/s11095-011-0419-4; MILAVETZ G, 1986, J PEDIATR-US, V109, P351, DOI 10.1016/S0022-3476(86)80403-6; Miller PR, 2012, TALANTA, V88, P739, DOI 10.1016/j.talanta.2011.11.046; Moniz Anna Radomska Bothelo, 2012, J Diabetes Sci Technol, V6, P479; Muller DA, 2012, ANAL CHEM, V84, P3262, DOI 10.1021/ac2034387; Nirogi RVS, 2007, J CHROMATOGR B, V848, P271, DOI 10.1016/j.jchromb.2006.10.035; Nwobodo N, 2014, JRSM OPEN, V8, P5; PAPADOYANNIS IN, 1993, ANAL LETT, V26, P2127, DOI 10.1080/00032719308017457; Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4; PIAFSKY KM, 1975, NEW ENGL J MED, V292, P1218, DOI 10.1056/NEJM197506052922305; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Romanyuk AV, 2014, ANAL CHEM, V86, P10520, DOI 10.1021/ac503823p; Sakaguchi K, 2012, DIABETES TECHNOL THE, V14, P485, DOI 10.1089/dia.2011.0255; Sakamoto K, 2013, J DIABETES INVEST, V4, P552, DOI 10.1111/jdi.12096; Schumacher GE, 1995, THER DRUG MONIT, P1; Sekkat N, 2002, J CONTROL RELEASE, V81, P83, DOI 10.1016/S0168-3659(02)00046-9; Silber HE, 2010, J CLIN PHARMACOL, V50, P246, DOI 10.1177/0091270009341185; Singh TRR, 2009, EUR POLYM J, V45, P1239, DOI 10.1016/j.eurpolymj.2008.12.019; Strambini LM, 2015, BIOSENS BIOELECTRON, V66, P162, DOI 10.1016/j.bios.2014.11.010; TEUNISSEN MWE, 1985, XENOBIOTICA, V15, P165, DOI 10.3109/00498258509045346; Thakur RRS, 2010, J PHARM PHARMACOL, V62, P829, DOI DOI 10.1211/JPP.62.06.0003; Trzebinski J, 2012, LAB CHIP, V12, P348, DOI 10.1039/c1lc20885c; Umemura T, 1998, ANALYST, V123, P1767, DOI 10.1039/a803153c; Wang Ping M, 2005, Diabetes Technol Ther, V7, P131, DOI 10.1089/dia.2005.7.131; Windmiller JR, 2011, ELECTROANAL, V23, P2302, DOI 10.1002/elan.201100361; Windmiller JR, 2011, ANALYST, V136, P1846, DOI 10.1039/c1an00012h; Yoshikawa H, 2007, ACTA NEUROL SCAND, V115, P57, DOI 10.1111/j.1600-0404.2007.00810.x; Yu JC, 2015, P NATL ACAD SCI USA, V112, P8260, DOI 10.1073/pnas.1505405112	72	90	92	7	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145644	10.1371/journal.pone.0145644	http://dx.doi.org/10.1371/journal.pone.0145644			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717198	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500051
J	Cohen, AT; Hamilton, M; Mitchell, SA; Phatak, H; Liu, X; Bird, A; Tushabe, D; Batson, S				Cohen, A. T.; Hamilton, M.; Mitchell, S. A.; Phatak, H.; Liu, X.; Bird, A.; Tushabe, D.; Batson, S.			Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis	PLOS ONE			English	Review							DEEP-VEIN THROMBOSIS; ED AMERICAN-COLLEGE; PULMONARY-EMBOLISM; ANTITHROMBOTIC THERAPY; SAFETY; RECURRENCE; GUIDELINES; WARFARIN; EFFICACY; OUTCOMES	Background Anticoagulation with low molecular weight heparin and vitamin K antagonists is the current standard of care (SOC) for venous thromboembolism (VTE) treatment and prevention. Although novel oral anti-coagulants (NOACs) have been compared with SOC in this indication, no head-to-head randomised controlled trials (RCTs) have directly compared NOACs. A systematic review and network meta-analysis (NMA) were conducted to compare the efficacy and safety of NOACs for the initial and long-term treatment of VTE. Methods Electronic databases (accessed July 2014) were systematically searched to identify RCTs evaluating apixaban, dabigatran, edoxaban, and rivaroxaban versus SOC. Eligible patients included adults with an objectively confirmed deep vein thrombosis (DVT), pulmonary embolism (PE) or both. A fixed-effect Bayesian NMA was conducted for outcomes of interest, and results were presented as relative risks (RR) and 95% credible intervals (Crl). Results Six Phase III RCTs met criteria for inclusion: apixaban (one RCT; n = 5,395); rivaroxaban (two RCTs; n = 3,423/4,832); dabigatran (two RCTs; n = 2,539/2,568); edoxaban (one RCT; n = 8,240). There were no statistically significant differences between the NOACs with regard to the risk of 'VTE and VTE-related death. Apixaban treatment was associated with the most favourable safety profile of the NOACs, showing a statistically significantly reduced risk of 'major or clinically relevant non-major (CRNM) bleed' compared with rivaroxaban (0.47 [0.36, 0.61]), dabigatran (0.69 [0.51, 0.94]), and edoxaban (0.54 [0.41, 0.69]). Dabigatran was also associated with a significantly lower risk of 'major or CRNM bleed' compared with rivaroxaban (0.68 [0.53, 0.87]) and edoxaban (0.77 [0.60, 0.99]). Conclusions Indirect comparisons showed statistically similar reductions in the risk of 'VTE or VTE-related death for all NOACs. In contrast, reductions in 'major or CRNM bleed' for initial/longterm treatment were significantly better with apixaban compared with all other NOACs, and with dabigatran compared with rivaroxaban and edoxaban. Results from the current analysis indicate that the NOACs offer clinical benefit over conventional therapy while highlighting relative differences in their bleeding profile.	[Cohen, A. T.] Kings Coll London, Guys Hosp, London WC2R 2LS, England; [Cohen, A. T.] Kings Coll London, St Thomas Hosp, London WC2R 2LS, England; [Hamilton, M.; Phatak, H.] BMS, Princeton, NJ USA; [Mitchell, S. A.; Batson, S.] Abacus Int, Bicester, Oxon, England; [Liu, X.] Pfizer, New York, NY USA; [Bird, A.] Pfizer, Walton Oaks, England; [Tushabe, D.] TUSH D UK LTD, Birmingham, W Midlands, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Pfizer; Pfizer	Mitchell, SA (corresponding author), Abacus Int, Bicester, Oxon, England.	smitchell@dresourcesgroup.com			Bristol Myers Squibb; Pfizer; Abacus International	Bristol Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); Abacus International	This study was funded by Bristol Myers Squibb and Pfizer. Bristol Myers Squibb provided support in the form of salaries for authors Melissa Hamilton and Hemant Phatak, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pfizer provided support in the form of salaries for authors Xianchen Liu, Doreen Tushabe, and Alex Bird, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Abacus International provided support in the form of salaries for authors Stephen Mitchell and Sarah Batson, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; Nieto JA, 2008, THROMB HAEMOSTASIS, V100, P789, DOI 10.1160/TH08-06-0390; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Beyer-Westendorf J, 2011, J THROMB HAEMOST, V9, P2153, DOI 10.1111/j.1538-7836.2011.04507.x; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Buller H, 2008, J THROMB HAEMOST, V6, P1313, DOI 10.1111/j.1538-7836.2008.03054.x; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Castellucci LA, 2014, JAMA-J AM MED ASSOC, V312, P1122, DOI 10.1001/jama.2014.10538; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Dias S., 2011, NICE DSU TECHNICAL S; Dobesh PP, 2009, PHARMACOTHERAPY, V29, P943, DOI 10.1592/phco.29.8.943; Eichinger S, 2010, CIRCULATION, V121, P1630, DOI 10.1161/CIRCULATIONAHA.109.925214; Fox BD, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7498; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Hass B, 2012, THROMB J, V10, DOI 10.1186/1477-9560-10-24; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Heit JA, 2005, J THROMB HAEMOST, V3, P1611, DOI 10.1111/j.1538-7836.2005.01415.x; Heit JA, 2001, THROMB HAEMOSTASIS, V86, P452, DOI 10.1161/ATVBAHA.108.162545; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Kang N, 2014, THROMB RES, V133, P1145, DOI 10.1016/j.thromres.2014.03.035; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Lang IM, 2004, NEW ENGL J MED, V350, P2236, DOI 10.1056/NEJMp048088; Lyman GH, 2013, J CLIN ONCOL, V31, P2189, DOI 10.1200/JCO.2013.49.1118; Mantha S, 2015, J THROMB THROMBOLYS, V39, P155, DOI 10.1007/s11239-014-1102-5; National Institute for Health and Care Excellence, 2009, THE GUIDELINES MANUA; National Institute for Health and Care Excellence, 2010, CG92 VENOUS THROMBOE; Nicolaides AN, 2006, INT ANGIOL, V25, P101; Palareti G, 2012, RECURRENT VENOUS THR; Prandoni P, 2010, J THROMB HAEMOST, V8, P2575, DOI 10.1111/j.1538-7836.2010.04039.x; Prandoni P, 2007, HAEMATOLOGICA, V92, P199, DOI 10.3324/haematol.10516; Prandoni P, 2009, BRIT J HAEMATOL, V145, P286, DOI 10.1111/j.1365-2141.2009.07601.x; Prins MH, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-21; Ruppert Andras, 2011, J Med Econ, V14, P65, DOI 10.3111/13696998.2010.546465; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schulman S, 2014, CIRCULATION, V129, P764, DOI 10.1161/CIRCULATIONAHA.113.004450; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Spencer FA, 2009, THROMB HAEMOSTASIS, V101, P878, DOI 10.1160/TH08-06-0352; Tagalakis V, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.02.024; van der Hulle T, 2014, J THROMB HAEMOST, V12, P320, DOI 10.1111/jth.12485; Weitz JI, 2012, AM J HEMATOL, V87, pS133, DOI 10.1002/ajh.23139; Yusuf Hussain R., 2012, Morbidity and Mortality Weekly Report, V61, P401; Zhu TN, 2009, ARTERIOSCL THROM VAS, V29, P298, DOI 10.1161/ATVBAHA.108.182428	44	101	107	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0144856	10.1371/journal.pone.0144856	http://dx.doi.org/10.1371/journal.pone.0144856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716830	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500017
J	Hecker, J; Prokopenko, D; Lange, C; Fier, HL				Hecker, Julian; Prokopenko, Dmitry; Lange, Christoph; Fier, Heide Loehlein			On the Recombination Rate Estimation in the Presence of Population Substructure	PLOS ONE			English	Article							GEOGRAPHICALLY STRUCTURED POPULATIONS; 2-LOCUS SAMPLING DISTRIBUTIONS; STRONG-MIGRATION LIMIT; HUMAN GENOME; GENETIC-VARIATION; COALESCENT; DIFFUSION; NUMBER; SITES; MODEL	As recombination events are not uniformly distributed along the human genome, the estimation of fine-scale recombination maps, e.g. HapMap Project, has been one of the major research endeavors over the last couple of years. For simulation studies, these estimates provide realistic reference scenarios to design future study and to develop novel methodology. To achieve a feasible framework for the estimation of such recombination maps, existing methodology uses sample probabilities for a two-locus model with recombination, with recent advances allowing for computationally fast implementations. In this work, we extend the existing theoretical framework for the recombination rate estimation to the presence of population substructure. We show under which assumptions the existing methodology can still be applied. We illustrate our extension of the methodology by an extensive simulation study.	[Hecker, Julian; Prokopenko, Dmitry; Lange, Christoph; Fier, Heide Loehlein] Univ Bonn, Inst Genom Math, Bonn, Germany; [Lange, Christoph; Fier, Heide Loehlein] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Lange, Christoph] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Lange, Christoph] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany	University of Bonn; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Hecker, J (corresponding author), Univ Bonn, Inst Genom Math, Bonn, Germany.	julian.heckerIGM@uni-bonn.de		Prokopenko, Dmitry/0000-0002-1844-5652	Cure Alzheimer's fund from the National Institute of Mental Health [R01 MH081862, R01 MH087590]; National Heart, Lung, and Blood Institute [R01 HL089856, R01 HL089897]; National Research Foundation of Korea Grant - Korean Government [NRF-2014S1A2A2028559]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089856, R01HL089897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087590, R01MH081862] Funding Source: NIH RePORTER	Cure Alzheimer's fund from the National Institute of Mental Health; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Research Foundation of Korea Grant - Korean Government; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	HLF and CL were supported by Cure Alzheimer's fund, Award Number (R01 MH081862, R01 MH087590) from the National Institute of Mental Health. The project described was supported by the National Heart, Lung, and Blood Institute, Award Number (R01 HL089856, R01 HL089897). The research of C. Lange was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2014S1A2A2028559).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Auton A, 2007, THESIS; Auton A, 2007, GENOME RES, V17, P1219, DOI 10.1101/gr.6386707; Bahlo M, 2001, J MATH BIOL, V43, P397, DOI 10.1007/s002850100104; ETHIER SN, 1990, ADV APPL PROBAB, V22, P773, DOI 10.2307/1427561; ETHIER SN, 1989, J MATH BIOL, V27, P17, DOI 10.1007/BF00276078; Ewens W.J., 2004, MATH POPULATION GENE; Fearnhead P, 2001, GENETICS, V159, P1299; Hudson RR, 2001, GENETICS, V159, P1805; Jeffreys AJ, 2005, NAT GENET, V37, P601, DOI 10.1038/ng1565; Jenkins PA, 2012, ANN APPL PROBAB, V22, P576, DOI 10.1214/11-AAP780; Jenkins PA, 2010, ANN APPL PROBAB, V20, P1005, DOI 10.1214/09-AAP646; Jenkins PA, 2009, GENETICS, V183, P1087, DOI 10.1534/genetics.109.107995; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kurtz TG, 2005, WILES SERIES PROBABI; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; NAGYLAKI T, 1983, THEOR POPUL BIOL, V24, P268, DOI 10.1016/0040-5809(83)90029-1; NAGYLAKI T, 1980, J MATH BIOL, V9, P101, DOI 10.1007/BF00275916; Nagylaki T, 1998, GENETICS, V149, P1599; Nordborg M, 1997, GENETICS, V146, P1501; NOTOHARA M, 1993, J MATH BIOL, V31, P115; Notohara M, 1997, J MATH BIOL, V36, P188, DOI 10.1007/s002850050097; Notohara M, 2000, J APPL PROBAB, V37, P148, DOI 10.1017/S002190020001531X; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305	26	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145152	10.1371/journal.pone.0145152	http://dx.doi.org/10.1371/journal.pone.0145152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716445	Green Submitted, gold, Green Published			2022-12-27	WOS:000367510500023
J	Lindsay, KL; Hellmuth, C; Uhl, O; Buss, C; Wadhwa, PD; Koletzko, B; Entringer, S				Lindsay, Karen L.; Hellmuth, Christian; Uhl, Olaf; Buss, Claudia; Wadhwa, Pathik D.; Koletzko, Berthold; Entringer, Sonja			Longitudinal Metabolomic Profiling of Amino Acids and Lipids across Healthy Pregnancy	PLOS ONE			English	Article							FATTY-ACID; L-CARNITINE; PLASMA CARNITINE; METABOLITES; STARVATION; CLEARANCE; LEUCINE; TAURINE; PROTEIN; OBESITY	Pregnancy is characterized by a complexity of metabolic processes that may impact fetal development and ultimately, infant health outcomes. However, our understanding of whole body maternal and fetal metabolism during this critical life stage remains incomplete. The objective of this study is to utilize metabolomics to profile longitudinal patterns of fasting maternal metabolites among a cohort of non-diabetic, healthy pregnant women in order to advance our understanding of changes in protein and lipid concentrations across gestation, the biochemical pathways by which they are metabolized and to describe variation in maternal metabolites between ethnic groups. Among 160 pregnant women, amino acids, tricarboxylic acid (TCA) cycle intermediates, keto-bodies and non-esterified fatty acids were detected by liquid chromatography coupled with mass spectrometry, while polar lipids were detected through flow-injected mass spectrometry. The maternal plasma concentration of several essential and non-essential amino acids, long-chain polyunsaturated fatty acids, free carnitine, acetylcarnitine, phosphatidylcholines and sphingomyelins significantly decreased across pregnancy. Concentrations of several TCA intermediates increase as pregnancy progresses, as well as the keto-body beta-hydroxybutyrate. Ratios of specific acylcarnitines used as indicators of metabolic pathways suggest a decreased beta-oxidation rate and increased carnitine palmitoyltransferase-1 enzyme activity with advancing gestation. Decreasing amino acid concentrations likely reflects placental uptake and tissue biosynthesis. The absence of any increase in plasma non-esterified fatty acids is unexpected in the catabolic phase of later pregnancy and may reflect enhanced placental fatty acid uptake and utilization for fetal tissue growth. While it appears that energy production through the TCA cycle increases as pregnancy progresses, decreasing patterns of free carnitine and acetylcarnitine as well as increased carnitine palmitoyltransferase-1 rate and beta-hydroxybutyrate levels suggest a concomitant upregulation of ketogenesis to ensure sufficient energy supply in the fasting state. Several differences in metabolomic profiles between Hispanic and non-Hispanic women demonstrate phenotypic variations in prenatal metabolism which should be considered in future studies.	[Lindsay, Karen L.; Buss, Claudia; Wadhwa, Pathik D.; Entringer, Sonja] Univ Calif Irvine, Sch Med, Dev Hlth & Dis Res Program, Irvine, CA 92697 USA; [Hellmuth, Christian; Uhl, Olaf; Koletzko, Berthold] Univ Munich, Div Metab & Nutr Med, Dr von Hauner Childrens Hosp, Med Ctr, D-80337 Munich, Germany; [Buss, Claudia; Entringer, Sonja] Charite, Inst Med Psychol, D-13353 Berlin, Germany	University of California System; University of California Irvine; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hellmuth, C (corresponding author), Univ Munich, Div Metab & Nutr Med, Dr von Hauner Childrens Hosp, Med Ctr, Lindwurmstr 4, D-80337 Munich, Germany.	christian.hellmuth@med.uni-muenchen.de	Buss, Claudia/ABC-3687-2020; Lindsay, Karen/J-4383-2019; Entringer, Sonja/ABB-9405-2020; Hellmuth, Christian/C-2575-2017	Lindsay, Karen/0000-0002-4481-9363; Buss, Claudia/0000-0002-8738-3133; Entringer, Sonja/0000-0002-9926-7076; Hellmuth, Christian/0000-0001-9778-497X; Uhl, Olaf/0000-0001-8064-7717	Commission of the European Communities [FP7-289346-EARLY NUTRITION]; European Research Council Advanced Grant [322605 META-GROWTH]; National Competence Network on Obesity [01 GI 0825]; University of Munich Innovative Research Priority Project MC-Health; US National Institutes of Health [R01 HD-060628, RO1 HD-065825, R01 MH-091351, R21 RDK-098765]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065825, R01HD060628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091351] Funding Source: NIH RePORTER	Commission of the European Communities(European Commission); European Research Council Advanced Grant(European Research Council (ERC)); National Competence Network on Obesity; University of Munich Innovative Research Priority Project MC-Health; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research is supported by the Commission of the European Communities, the 7th Framework Programme, contract FP7-289346-EARLY NUTRITION and the European Research Council Advanced Grant ERC-2012-AdG-no. 322605 META-GROWTH. This manuscript does not necessarily reflect the views of the Commission and in no way anticipates the future policy in this area. Additional support is gratefully acknowledged from the National Competence Network on Obesity, Grant Nr. 01 GI 0825, German Ministry of Education and Research, Berlin; the University of Munich Innovative Research Priority Project MC-Health (sub-project I); and the US National Institutes of Health Grants R01 HD-060628, RO1 HD-065825, R01 MH-091351 and R21 RDK-098765. The funders had no role in study design data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas J, 1998, EARLY HUM DEV, V53, pS43, DOI 10.1016/S0378-3782(98)00064-4; Battaglia FC, 2001, PLACENTA, V22, P145, DOI 10.1053/plac.2000.0612; Birkler RID, 2010, J PHARMACEUT BIOMED, V53, P983, DOI 10.1016/j.jpba.2010.06.005; Butte NF, 2000, AM J CLIN NUTR, V71, p1256S, DOI 10.1093/ajcn/71.5.1256s; CAMPBELL FM, 1995, BIOCHEM BIOPH RES CO, V209, P1011, DOI 10.1006/bbrc.1995.1598; CEDERBLAD G, 1986, AM J CLIN NUTR, V44, P379, DOI 10.1093/ajcn/44.3.379; Cetin I, 2005, AM J OBSTET GYNECOL, V192, P610, DOI 10.1016/j.ajog.2004.08.011; Cetina I, 2008, CURR OPIN CLIN NUTR, V11, P297, DOI 10.1097/MCO.0b013e3282f795e6; Cho SW, 2005, BRIT J NUTR, V93, P685, DOI 10.1079/BJN20041403; DARMAUN D, 1991, AM J PHYSIOL, V260, pE326, DOI 10.1152/ajpendo.1991.260.2.E326; Di Giulio A M, 2004, J Matern Fetal Neonatal Med, V15, P356, DOI 10.1080/14767050410001725578; Diaz SO, 2013, J PROTEOME RES, V12, P969, DOI 10.1021/pr301022e; Ditchfield AM, 2015, INT J OBESITY, V39, P557, DOI 10.1038/ijo.2014.212; Duggleby SL, 2002, AM J CLIN NUTR, V76, P852, DOI 10.1093/ajcn/76.4.852; Dumas ME, 2006, ANAL CHEM, V78, P2199, DOI 10.1021/ac0517085; ELLIOTT JA, 1975, EUR J CLIN INVEST, V5, P159, DOI 10.1111/j.1365-2362.1975.tb00442.x; FELIG P, 1972, J CLIN INVEST, V51, P1195, DOI 10.1172/JCI106913; Gibbons H, 2015, CURR OPIN LIPIDOL, V26, P30, DOI 10.1097/MOL.0000000000000140; Grube M, 2005, DRUG METAB DISPOS, V33, P31, DOI 10.1124/dmd.104.001560; Hadden DR, 2009, SEMIN FETAL NEONAT M, V14, P66, DOI 10.1016/j.siny.2008.09.004; Harder U, 2011, J CHROMATOGR B, V879, P495, DOI 10.1016/j.jchromb.2011.01.010; Hellmuth C, 2012, ANAL CHEM, V84, P1483, DOI 10.1021/ac202602u; Herrera E, 2006, HORM RES, V65, P59, DOI 10.1159/000091507; Herrera E, 2002, ENDOCRINE, V19, P43, DOI 10.1385/ENDO:19:1:43; Herrera E, 2000, EUR J CLIN NUTR, V54, pS47, DOI 10.1038/sj.ejcn.1600984; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Iva SK, 2013, RES OBSTET GYNECOL, V2, P37, DOI DOI 10.5923/J.R0G.20130204.01; Kalhan SC, 2006, J NUTR, V136, p281S, DOI 10.1093/jn/136.1.281S; Kalhan SC, 2000, AM J CLIN NUTR, V71, p1249S, DOI 10.1093/ajcn/71.5.1249s; Krajcovicova-Kudlackova M, 2000, PHYSIOL RES, V49, P399; Larque E, 2011, AM J CLIN NUTR, V94, p1908S, DOI 10.3945/ajcn.110.001230; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Luan HM, 2014, J PROTEOME RES, V13, P1527, DOI 10.1021/pr401068k; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; MARZO A, 1994, GYNECOL ENDOCRINOL, V8, P115, DOI 10.3109/09513599409058032; McCormack SE, 2013, PEDIATR OBES, V8, P52, DOI 10.1111/j.2047-6310.2012.00087.x; METZGER BE, 1982, LANCET, V1, P588; NAISMITH DJ, 1987, HUM NUTR-CLIN NUTR, V41C, P37; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nochera CL, 2011, NUTR CLIN PRACT, V26, P445, DOI 10.1177/0884533611406133; Oey NA, 2006, PLACENTA, V27, P841, DOI 10.1016/j.placenta.2005.10.002; Pappa KI, 2007, AM J OBSTET GYNECOL, V196, P65, DOI 10.1016/j.ajog.2006.06.094; Pinto J, 2015, J PROTEOME RES, V14, P1263, DOI 10.1021/pr5011982; Rauschert S, 2014, ANN NUTR METAB, V64, P314, DOI 10.1159/000365040; Rees WD, 2006, REPROD NUTR DEV, V46, P227, DOI 10.1051/rnd:2006015; Reuter SE, 2012, CLIN PHARMACOKINET, V51, P553, DOI 10.2165/11633940-000000000-00000; Scholtens DM, 2014, DIABETES CARE, V37, P158, DOI 10.2337/dc13-0989; van den Akker CHP, 2009, AM J CLIN NUTR, V89, P153, DOI 10.3945/ajcn.2008.26553; Violante S, 2013, BBA-MOL BASIS DIS, V1832, P773, DOI 10.1016/j.bbadis.2013.02.012; Whittaker PG, 1999, METABOLISM, V48, P849, DOI 10.1016/S0026-0495(99)90217-2	50	99	102	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145794	10.1371/journal.pone.0145794	http://dx.doi.org/10.1371/journal.pone.0145794			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716698	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500072
J	Chen, HW; Hu, HM; Wu, SH; Chiang, CY; Hsiao, YJ; Wu, CK; Hsieh, CH; Chung, HH; Chong, P; Leng, CH; Pan, CH				Chen, Hsin-Wei; Hu, Hui-Mei; Wu, Szu-Hsien; Chiang, Chen-Yi; Hsiao, Yu-Ju; Wu, Chia-Kai; Hsieh, Chun-Hsiang; Chung, Han-Hsuan; Chong, Pele; Leng, Chih-Hsiang; Pan, Chien-Hsiung			The Immunodominance Change and Protection of CD4(+) T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in Mice	PLOS ONE			English	Article							NEUTRALIZING ANTIBODIES; VIRUS-INFECTION; LYMPHOCYTE RESPONSES; NONHUMAN-PRIMATES; EPITOPES; INDUCTION; IMMUNITY; GLYCOPROTEIN; HIERARCHY; SEROTYPES	Dengue is the leading cause of mosquito-borne viral infections and no vaccine is available now. Envelope protein domain III (ED3) is the major target for the binding of dengue virus neutralizing antibodies; however, the ED3-specifc T-cell response is less well understood. To investigate the T-cell responses to four serotypes of dengue virus (DENV-1 to 4), we immunized mice using either a tetravalent ED3-based DNA or protein vaccine, or combined both as a DNA prime-protein boost strategy (prime-boost). A significant serotype-dependent IFN-gamma or IL-4 response was observed in mice immunized with either the DNA or protein vaccine. TheIFN-gamma response was dominant to DENV-1 to 3, whereas the IL-4 response was dominant to DENV-4. Although the similar IgG titers for the four serotypes were observed in mice immunized with the tetravalent vaccines, the neutralizing antibody titers varied and followed the order of 2 = 3>1>4. Interestingly, the lower IFN-gamma response to DENV-4 is attributable to the immunodominance change between two CD4(+) T-cell epitopes; one T-cell epitope located at E349-363 of DENV-1 to 3 was more immunogenic than the DENV-4 epitope E313-327. Despite DENV-4 specific IFN-gamma responses were suppressed by immunodominance change, either DENV-4-specific IFN-gamma or neutralizing antibody responses were still recalled after DENV-4 challenge and contributed to virus clearance. Immunization with the prime-boost elicited both IFN-gamma and neutralizing antibody responses and provided better protection than either DNA or protein immunization. Our findings shed light on how ED3-based tetravalent dengue vaccines sharpen host CD4 T-cell responses and contribute to protection against dengue virus.	[Chen, Hsin-Wei; Hu, Hui-Mei; Wu, Szu-Hsien; Chiang, Chen-Yi; Hsiao, Yu-Ju; Wu, Chia-Kai; Hsieh, Chun-Hsiang; Chung, Han-Hsuan; Chong, Pele; Leng, Chih-Hsiang; Pan, Chien-Hsiung] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan; [Chen, Hsin-Wei; Chong, Pele; Leng, Chih-Hsiang; Pan, Chien-Hsiung] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; China Medical University Taiwan	Leng, CH (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan.	leoleng@nhri.org.tw; cpan@nhri.org.tw	Chen, Hsin-Wei/ABA-7436-2021	Chen, Hsin-Wei/0000-0002-3207-2397	National Health Research Institutes [00A1-VCPP09, 01A1-IVPP29]; Ministry of Science and Technology, Taiwan [NSC99-2320-B-400-004-MY3]	National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants 00A1-VCPP09 and 01A1-IVPP29 (CHP) from the National Health Research Institutes (www.nhri.org.tw) and NSC99-2320-B-400-004-MY3 (CHP) from the Ministry of Science and Technology, Taiwan (www.most.gov.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apt D, 2006, VACCINE, V24, P335, DOI 10.1016/j.vaccine.2005.07.100; Azevedo AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020528; Bashyam HS, 2006, J IMMUNOL, V176, P2817, DOI 10.4049/jimmunol.176.5.2817; Chen HW, 2013, ARCH VIROL, V158, P1523, DOI 10.1007/s00705-013-1639-1; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; Chiang CY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002432; Fuchs J, 2014, VACCINE, V32, P6537, DOI 10.1016/j.vaccine.2014.08.087; Hatch S, 2011, J INFECT DIS, V203, P1282, DOI 10.1093/infdis/jir012; Hermida L, 2006, VACCINE, V24, P3165, DOI 10.1016/j.vaccine.2006.01.036; Im EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002041; Kastenmuller W, 2007, J EXP MED, V204, P2187, DOI 10.1084/jem.20070489; Khanam S, 2006, VACCINE, V24, P6513, DOI 10.1016/j.vaccine.2006.06.031; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; La Gruta NL, 2006, P NATL ACAD SCI USA, V103, P994, DOI 10.1073/pnas.0510429103; Leng CH, 2009, MICROBES INFECT, V11, P288, DOI 10.1016/j.micinf.2008.12.004; Li SF, 2011, VACCINE, V29, P3695, DOI 10.1016/j.vaccine.2011.03.002; Lin LCW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003329; Manuel ER, 2009, J VIROL, V83, P10028, DOI 10.1128/JVI.01015-09; McArthur MA, 2013, EXPERT REV VACCINES, V12, P933, DOI 10.1586/14760584.2013.815412; Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Mota J, 2005, VACCINE, V23, P3469, DOI 10.1016/j.vaccine.2004.12.028; Nascimento EJM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002497; Pan CH, 2010, J VIROL, V84, P3798, DOI 10.1128/JVI.01566-09; Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12; ROEHRIG JT, 1994, VIROLOGY, V198, P31, DOI 10.1006/viro.1994.1005; Rothman AL, 1996, J VIROL, V70, P6540, DOI 10.1128/JVI.70.10.6540-6546.1996; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Rothman AL, 2009, ANN NY ACAD SCI, V1171, pE36, DOI 10.1111/j.1749-6632.2009.05055.x; Schneeweiss A, 2011, VACCINE, V29, P6352, DOI 10.1016/j.vaccine.2011.04.116; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Thomas SJ, 2011, HUM VACCINES, V7, P674, DOI 10.4161/hv.7.6.14985; Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037; Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374; Webby RJ, 2003, P NATL ACAD SCI USA, V100, P7235, DOI 10.1073/pnas.1232449100; Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112; Yamanaka A, 2009, VACCINE, V27, P3735, DOI 10.1016/j.vaccine.2009.03.083; Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709; Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723; Zuest R, 2015, VACCINE, V33, P1474, DOI 10.1016/j.vaccine.2015.01.074	41	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145717	10.1371/journal.pone.0145717	http://dx.doi.org/10.1371/journal.pone.0145717			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714037	gold, Green Published, Green Submitted			2022-12-27	WOS:000367481900073
J	Clark, MW; Yie, AM; Eder, EK; Dennis, RG; Basting, PJ; Martinez, KA; Jones, BD; Slonczewski, JL				Clark, Michelle W.; Yie, Anna M.; Eder, Elizabeth K.; Dennis, Richard G.; Basting, Preston J.; Martinez, Keith A., II; Jones, Brian D.; Slonczewski, Joan L.			Periplasmic Acid Stress Increases Cell Division Asymmetry (Polar Aging) of Escherichia coli	PLOS ONE			English	Article							PH HOMEOSTASIS; BACTERIA; RESISTANCE; GROWTH; CONSEQUENCES; REJUVENATION; MICROSCOPY; MECHANISMS; CHAPERONE; HDEB	Under certain kinds of cytoplasmic stress, Escherichia coli selectively reproduce by distributing the newer cytoplasmic components to new-pole cells while sequestering older, damaged components in cells inheriting the old pole. This phenomenon is termed polar aging or cell division asymmetry. It is unknown whether cell division asymmetry can arise from a periplasmic stress, such as the stress of extracellular acid, which is mediated by the periplasm. We tested the effect of periplasmic acid stress on growth and division of adherent single cells. We tracked individual cell lineages over five or more generations, using fluorescence microscopy with ratiometric pHluorin to measure cytoplasmic pH. Adherent colonies were perfused continually with LBK medium buffered at pH 6.00 or at pH 7.50; the external pH determines periplasmic pH. In each experiment, cell lineages were mapped to correlate division time, pole age and cell generation number. In colonies perfused at pH 6.0, the cells inheriting the oldest pole divided significantly more slowly than the cells inheriting the newest pole. In colonies perfused at pH 7.50 (near or above cytoplasmic pH), no significant cell division asymmetry was observed. Under both conditions (periplasmic pH 6.0 or pH 7.5) the cells maintained cytoplasmic pH values at 7.2-7.3. No evidence of cytoplasmic protein aggregation was seen. Thus, periplasmic acid stress leads to cell division asymmetry with minimal cytoplasmic stress.	[Clark, Michelle W.; Yie, Anna M.; Eder, Elizabeth K.; Dennis, Richard G.; Basting, Preston J.; Martinez, Keith A., II; Slonczewski, Joan L.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA; [Jones, Brian D.] Kenyon Coll, Dept Math & Stat, Gambier, OH 43022 USA	Kenyon College; Kenyon College	Slonczewski, JL (corresponding author), Kenyon Coll, Dept Biol, Gambier, OH 43022 USA.	slonczewski@kenyon.edu		Eder, Elizabeth/0000-0002-1486-7591; Basting, Preston/0000-0001-9290-8339	National Science Foundation (US) [MCB 1329815]; National Science Foundation [MCB-1329815]; Div Of Molecular and Cellular Bioscience [1329815] Funding Source: National Science Foundation	National Science Foundation (US)(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation (US) awarded the grant MCB 1329815 to JLS and the grant is the sole funding source of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Science Foundation grant MCB-1329815.	Ackermann M, 2008, BIOTECHNIQUES, V44, P564, DOI 10.2144/000112829; Ackermann M, 2007, AGING CELL, V6, P235, DOI 10.1111/j.1474-9726.2007.00281.x; Aldridge BB, 2012, SCIENCE, V335, P100, DOI 10.1126/science.1216166; Brown PJB, 2012, P NATL ACAD SCI USA, V109, P1697, DOI 10.1073/pnas.1114476109; Dahl JU, 2015, J BIOL CHEM, V290, P65, DOI 10.1074/jbc.M114.612986; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Hong WZ, 2012, TRENDS MICROBIOL, V20, P328, DOI 10.1016/j.tim.2012.03.001; Johnson LR, 2006, MECH AGEING DEV, V127, P786, DOI 10.1016/j.mad.2006.07.004; Kanjee U, 2013, ANNU REV MICROBIOL, V67, P65, DOI 10.1146/annurev-micro-092412-155708; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Kysela DT, 2013, ANNU REV MICROBIOL, V67, P417, DOI 10.1146/annurev-micro-092412-155622; Lambert LA, 1997, J BACTERIOL, V179, P7595, DOI 10.1128/jb.179.23.7595-7599.1997; Lele UN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014516; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Lloyd-Price J, 2012, J BACTERIOL, V194, P1747, DOI 10.1128/JB.06500-11; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lybarger SR, 2001, J BACTERIOL, V183, P3261, DOI 10.1128/JB.183.11.3261-3267.2001; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; Malki A, 2008, J BIOL CHEM, V283, P13679, DOI 10.1074/jbc.M800869200; Martinez KA, 2012, APPL ENVIRON MICROB, V78, P3706, DOI 10.1128/AEM.00354-12; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Moore T, 2005, INTRO PRACTICE STAT; PRATT JW, 1959, J AM STAT ASSOC, V54, P655, DOI 10.2307/2282543; Rang CU, 2012, MICROBIOL-SGM, V158, P1553, DOI 10.1099/mic.0.057240-0; Rang CU, 2011, CURR BIOL, V21, P1813, DOI 10.1016/j.cub.2011.09.018; SALMOND CV, 1984, J GEN MICROBIOL, V130, P2845; SLONCZEWSKI JL, 1981, P NATL ACAD SCI-BIOL, V78, P6271, DOI 10.1073/pnas.78.10.6271; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Watve M, 2006, P NATL ACAD SCI USA, V103, P14831, DOI 10.1073/pnas.0606499103; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Winkler J, 2010, EMBO J, V29, P910, DOI 10.1038/emboj.2009.412; Wolfe D. A., 1973, NONPARAMETRIC STAT M	33	6	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144650	10.1371/journal.pone.0144650	http://dx.doi.org/10.1371/journal.pone.0144650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713733	Green Submitted, Green Published, gold			2022-12-27	WOS:000367481900015
J	Kim, KJ; Wen, XY; Yang, HK; Kim, WH; Kang, GH				Kim, Kyung-Ju; Wen, Xian-Yu; Yang, Han Kwang; Kim, Woo Ho; Kang, Gyeong Hoon			Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma	PLOS ONE			English	Article							COLORECTAL-CANCER; T-CELLS; POOR-PROGNOSIS; SURVIVAL; INSTABILITY; IMMUNOSCORE; LOCATION	Tumor associated macrophages are major inflammatory cells that play an important role in the tumor microenvironment. In this study, we investigated the prognostic significance of tumor associated macrophages (TAMs) in MSI-high gastric cancers using immunohistochemistry. CD68 and CD163 were used as markers for total infiltrating macrophages and M2-polarized macrophages, respectively. The density of CD68+ or CD163+ TAMs in four different areas (epithelial and stromal compartments of both the tumor center and invasive front) were analyzed in 143 cases of MSI-high advanced gastric cancers using a computerized image analysis system. Gastric cancers were scored as "0" or "1" in each area when the density of CD68+ and CD163+ TAMs was below or above the median value. Low density of CD68+ or CD163+ macrophages in four combined areas was closely associated with more frequent low-grade histology and the intestinal type tumor of the Lauren classification. In survival analysis, the low density of CD163+ TAMs was significantly associated with poor disease-free survival. In multivariate survival analysis, CD163+ TAMs in four combined areas, stromal and epithelial compartments of both tumor center and invasive front were independent prognostic indicator in MSI-high gastric cancers. In addition, the density of CD163+ TAMs correlated with tumor infiltrating lymphocytes (TILs). Our results indicate that the high density of CD163+ TAMs is an independent prognostic marker heralding prolonged disease-free survival and that the prognostic implication of CD163+ TAMs might be determined by the proportional balance of TAMs and TILs in MSI-high gastric cancers.	[Kim, Kyung-Ju; Wen, Xian-Yu; Kang, Gyeong Hoon] Seoul Natl Univ, Coll Med, Canc Res Inst, Lab Epigenet, Seoul, South Korea; [Kim, Kyung-Ju] Soonchunhyang Univ, Cheonan Hosp, Dept Pathol, Cheonan, South Korea; [Yang, Han Kwang] Seoul Natl Univ, Coll Med, Dept Gen Surg, Seoul, South Korea; [Kim, Woo Ho; Kang, Gyeong Hoon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Kim, Woo Ho; Kang, Gyeong Hoon] Seoul Natl Univ, Coll Med, Seoul, South Korea	Seoul National University (SNU); Soonchunhyang University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kang, GH (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Lab Epigenet, Seoul, South Korea.	ghkang@snu.ac.kr	Kang, Gyeong Hoon/F-1051-2010	Kang, Gyeong Hoon/0000-0003-2380-6675	Priority Research Center Program through the National Research Foundation of Korea (NRF) - MEST [2009-0093820]; NRF grant - Ministry of Science, ICT and Future Planning (MSIP) [2011-0030049]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1277]	Priority Research Center Program through the National Research Foundation of Korea (NRF) - MEST; NRF grant - Ministry of Science, ICT and Future Planning (MSIP); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Priority Research Center Program through the National Research Foundation of Korea (NRF) funded by MEST (2009-0093820), a NRF grant funded by the Ministry of Science, ICT and Future Planning (MSIP) (2011-0030049), and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI14C1277).; This study was supported by a grant from the Priority Research Center Program through the National Research Foundation of Korea (NRF) funded by MEST (2009-0093820), a NRF grant funded by the Ministry of Science, ICT and Future Planning (MSIP) (2011-0030049), and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI14C1277).	Algars A, 2012, INT J CANCER, V131, P864, DOI 10.1002/ijc.26457; Anitei MG, 2014, CLIN CANCER RES, V20, P1891, DOI 10.1158/1078-0432.CCR-13-2830; Bauer K, 2011, FAM CANCER, V10, P557, DOI 10.1007/s10689-011-9449-7; Behnes CL, 2014, VIRCHOWS ARCH, V464, P191, DOI 10.1007/s00428-013-1523-0; Biswas SK, 2013, SEMIN IMMUNOPATHOL, V35, P585, DOI 10.1007/s00281-013-0367-7; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Busuttil RA, 2014, CLIN CANCER RES, V20, P2761, DOI 10.1158/1078-0432.CCR-13-3049; Chiaravalli AM, 2006, VIRCHOWS ARCH, V448, P344, DOI 10.1007/s00428-005-0066-4; Choi YY, 2014, J SURG ONCOL, V110, P129, DOI 10.1002/jso.23618; Dannenmann SR, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23562; Edin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074982; Edin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047045; Erreni M, 2011, CANCER MICROENVIRON, V4, P141, DOI 10.1007/s12307-010-0052-5; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forssell J, 2007, CLIN CANCER RES, V13, P1472, DOI 10.1158/1078-0432.CCR-06-2073; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Hernandez C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098458; Ishigami S, 2003, ANTICANCER RES, V23, P4079; Kim KJ, 2014, HUM PATHOL, V45, P285, DOI 10.1016/j.humpath.2013.09.004; Komohara Y, 2014, CANCER SCI, V105, P1, DOI 10.1111/cas.12314; Kubler K, 2014, GYNECOL ONCOL, V135, P176, DOI 10.1016/j.ygyno.2014.08.028; Kumagai S, 2014, LUNG CANCER, V85; MacDonald WC, 2008, HUM PATHOL, V39, P641, DOI 10.1016/j.humpath.2007.10.003; Mantovani A, 2014, CURR OPIN PHARMACOL, V17, P38, DOI 10.1016/j.coph.2014.07.004; Nam SJ, 2014, LEUKEMIA LYMPHOMA, V55, P2466, DOI 10.3109/10428194.2013.879713; Ong SM, 2012, EUR J IMMUNOL, V42, P89, DOI 10.1002/eji.201141825; Pei BX, 2014, J THORAC CARDIOV SUR, V148, P1208, DOI 10.1016/j.jtcvs.2014.05.003; Phillips SM, 2004, BRIT J SURG, V91, P469, DOI 10.1002/bjs.4472; Ramanathan S, 2014, IRAN J CANCER PREV, V7, P1; Reinartz S, 2014, INT J CANCER, V134, P32, DOI 10.1002/ijc.28335; Shokal U, 2012, INDIAN J MED RES, V135, P599; Tham M, 2014, ONCOTARGET, V5, P12027, DOI 10.18632/oncotarget.2482; Wang B, 2011, ANN SURG ONCOL, V18, P2585, DOI 10.1245/s10434-011-1609-3; Wu H, 2012, J SURG ONCOL, V106, P462, DOI 10.1002/jso.23110; Yang L, 2015, ONCOTARGET, V6, P10592, DOI 10.18632/oncotarget.3547; Yuan ZY, 2014, ONCOTARGETS THER, V7, P1, DOI 10.2147/OTT.S61838; Zhang H, 2015, GASTRIC CANCER, V18, P740, DOI 10.1007/s10120-014-0422-7; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076147; Zilberstein Bruno, 2004, Gastric Cancer, V7, P254, DOI 10.1007/s10120-004-0301-8	40	47	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144192	10.1371/journal.pone.0144192	http://dx.doi.org/10.1371/journal.pone.0144192			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714314	gold, Green Published, Green Submitted			2022-12-27	WOS:000367481900004
J	Konitzer, JD; Sieron, A; Wacker, A; Enenkel, B				Koenitzer, Jennifer D.; Sieron, Annette; Wacker, Angelika; Enenkel, Barbara			Reformatting Rituximab into Human IgG2 and IgG4 Isotypes Dramatically Improves Apoptosis Induction In Vitro	PLOS ONE			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; FIBROBLAST ACTIVATION PROTEIN; MONOCLONAL-ANTIBODIES; EFFECTOR FUNCTIONS; CD20 ANTIBODIES; TYROSINE PHOSPHORYLATION; SEGMENTAL FLEXIBILITY; GLYCOFORM SELECTION; CASPASE ACTIVATION; LEUKEMIA-CELLS	The direct induction of cell death, or apoptosis, in target cells is one of the effector mechanisms for the anti CD20 antibody Rituximab. Here we provide evidence that Rituximab's apoptotic ability is linked to the antibody IgG isotype. Reformatting Rituximab from the standard human IgG1 heavy chain into IgG2 or IgG4 boosted in vitro apoptosis induction in the Burkitt's lymphoma B cell line Ramos five and four-fold respectively. The determinants for this behavior are located in the hinge region and CH1 domain of the heavy chain. By transplanting individual IgG2 or IgG4 specific amino acid residues onto otherwise IgG1 like backbones, thereby creating hybrid antibodies, the same enhancement of apoptosis induction could be achieved. The cysteines at position 131 of the CH1 domain and 219 in the hinge region, involved in IgG2 and IgG4 disulfide formation, were found to be of particular structural importance. Our data indicates that the hybrid antibodies possess a different CD20 binding mode than standard Rituximab, which appears to be key in enhancing apoptotic ability. The presented work opens up an interesting engineering route for enhancing the direct cytotoxic ability of therapeutic antibodies.	[Koenitzer, Jennifer D.] Boehringer Ingelheim GmbH & Co KG, Div Res Germany, Immune Modulat & Biotherapeut Discovery, Biberach, Germany; [Wacker, Angelika; Enenkel, Barbara] Boehringer Ingelheim GmbH & Co KG, Bioproc & Pharmaceut Dev, Biberach, Germany; [Sieron, Annette] Boehringer Ingelheim GmbH & Co KG, Biopharma Operat Germany, Biberach, Germany	Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim	Konitzer, JD (corresponding author), Boehringer Ingelheim GmbH & Co KG, Div Res Germany, Immune Modulat & Biotherapeut Discovery, Biberach, Germany.	jennifer.koenitzer@boehringer-ingelheim.com			Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	Boehringer Ingelheim provided all funding for this study.	Alduaij W, 2011, BLOOD, V117, P4519, DOI 10.1182/blood-2010-07-296913; ANGAL S, 1993, MOL IMMUNOL, V30, P105, DOI 10.1016/0161-5890(93)90432-B; Boross P, 2012, AM J CANCER RES, V2, P676; Braman J, 1996, Methods Mol Biol, V57, P31; BREKKE OH, 1995, IMMUNOL TODAY, V16, P85, DOI 10.1016/0167-5699(95)80094-8; Byrd JC, 2002, BLOOD, V99, P1038, DOI 10.1182/blood.V99.3.1038; Cai QQ, 2014, ANN HEMATOL, V93, P541, DOI 10.1007/s00277-013-1979-7; Cardarelli PM, 2002, CANCER IMMUNOL IMMUN, V51, P15, DOI 10.1007/s00262-001-0247; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; Chan HTC, 2003, CANCER RES, V63, P5480; Cragg MS, 2011, BLOOD, V118, P219, DOI 10.1182/blood-2011-04-346700; DANGL JL, 1988, EMBO J, V7, P1989, DOI 10.1002/j.1460-2075.1988.tb03037.x; DEANS JP, 1993, J IMMUNOL, V151, P4494; Deans JP, 2002, IMMUNOLOGY, V107, P176, DOI 10.1046/j.1365-2567.2002.01495.x; Durocher Y, 2011, US Patent, Patent No. [2011/0039339 A1, 20110039339]; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Glennie MJ, 2007, MOL IMMUNOL, V44, P3823, DOI 10.1016/j.molimm.2007.06.151; Hagihara Y, 2014, BBA-PROTEINS PROTEOM, V1844, P2016, DOI 10.1016/j.bbapap.2014.07.005; Hofmeister JK, 2000, BLOOD CELL MOL DIS, V26, P133, DOI 10.1006/bcmd.2000.0287; Holland M, 2004, CLIN EXP IMMUNOL, V138, P183, DOI 10.1111/j.1365-2249.2004.02566.x; Honeychurch J, 2012, BLOOD, V119, P3523, DOI 10.1182/blood-2011-12-395541; Iida S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-58; Ivanov A, 2009, J CLIN INVEST, V119, P2143, DOI 10.1172/JCI37884; Jefferis R, 2007, EXPERT OPIN BIOL TH, V7, P1401, DOI 10.1517/14712598.7.9.1401; Jefferis R, 2012, ARCH BIOCHEM BIOPHYS, V526, P159, DOI 10.1016/j.abb.2012.03.021; Johnson P, 2003, SEMIN ONCOL, V30, P3, DOI 10.1053/sonc.2003.50025; Kaneko E, 2011, BIODRUGS, V25, P1, DOI 10.2165/11537830-000000000-00000; Kellner C, 2014, METHODS, V65, P105, DOI 10.1016/j.ymeth.2013.06.036; Klein C, 2013, MABS-AUSTIN, V5, P22, DOI 10.4161/mabs.22771; Kubota T, 2009, CANCER SCI, V100, P1566, DOI 10.1111/j.1349-7006.2009.01222.x; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; LICHTENFELS R, 1994, J IMMUNOL METHODS, V172, P227, DOI 10.1016/0022-1759(94)90110-4; Lightle S, 2010, PROTEIN SCI, V19, P753, DOI 10.1002/pro.352; Liu HC, 2012, MABS-AUSTIN, V4, P17, DOI 10.4161/mabs.4.1.18347; Ludwig DL, 2003, ONCOGENE, V22, P9097, DOI 10.1038/sj.onc.1207104; Maloney DG, 2001, ANTI-CANCER DRUG, V12, pS1; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; McCloskey N, 1996, IMMUNOLOGY, V88, P169, DOI 10.1111/j.1365-2567.1996.tb00001.x; Mossner E, 2010, BLOOD, V115, P4393, DOI 10.1182/blood-2009-06-225979; Moore GL, 2010, MABS-AUSTIN, V2, P181, DOI 10.4161/mabs.2.2.11158; Niederfellner G, 2011, BLOOD, V118, P358, DOI 10.1182/blood-2010-09-305847; Niwa R, 2005, J IMMUNOL METHODS, V306, P151, DOI 10.1016/j.jim.2005.08.009; Niwa R, 2005, CLIN CANCER RES, V11, P2327, DOI 10.1158/1078-0432.CCR-04-2263; OI VT, 1984, NATURE, V307, P136, DOI 10.1038/307136a0; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Peipp M, 2011, BEST PRACT RES CL HA, V24, P217, DOI 10.1016/j.beha.2011.03.004; Rayner LE, 2014, J BIOL CHEM, V289, P20740, DOI 10.1074/jbc.M114.572404; Reddy MP, 2000, J IMMUNOL, V164, P1925, DOI 10.4049/jimmunol.164.4.1925; RETTIG WJ, 1993, CANCER RES, V53, P3327; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Roux KH, 1997, J IMMUNOL, V159, P3372; Salfeld JG, 2007, NAT BIOTECHNOL, V25, P1369, DOI 10.1038/nbt1207-1369; Sambrook J., 2001, MOL CLONING; Scott AM, 2003, CLIN CANCER RES, V9, P1639; Semac I, 2003, CANCER RES, V63, P534; Shan D, 1998, BLOOD, V91, P1644, DOI 10.1182/blood.V91.5.1644.1644_1644_1652; Teeling JL, 2006, J IMMUNOL, V177, P362, DOI 10.4049/jimmunol.177.1.362; Teeling JL, 2004, BLOOD, V104, P1793, DOI 10.1182/blood-2004-01-0039; van der Kolk LE, 2002, LEUKEMIA, V16, P1735, DOI 10.1038/sj.leu.2402559; van MT, 2010, SEMIN HEMATOL, V47, P199, DOI [10.1053/j.seminhematol.2010.01.007, DOI 10.1053/J.SEMINHEMATOL.2010.01.007]; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; Weiner GJ, 2010, SEMIN HEMATOL, V47, P115, DOI 10.1053/j.seminhematol.2010.01.011; White AL, 2015, CANCER CELL, V27, P138, DOI 10.1016/j.ccell.2014.11.001; Wildes TM, 2014, THER ADV HEMATOL, V5, P3, DOI 10.1177/2040620713514682	65	21	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145633	10.1371/journal.pone.0145633	http://dx.doi.org/10.1371/journal.pone.0145633			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713448	Green Submitted, Green Published, gold			2022-12-27	WOS:000367481900061
J	Bowers, LW; Wiese, M; Brenner, AJ; Rossi, EL; Tekmal, RR; Hursting, SD; deGraffenried, LA				Bowers, Laura W.; Wiese, Megan; Brenner, Andrew J.; Rossi, Emily L.; Tekmal, Rajeshwar R.; Hursting, Stephen D.; deGraffenried, Linda A.			Obesity Suppresses Estrogen Receptor Beta Expression in Breast Cancer Cells via a HER2-Mediated Pathway	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; FACTOR-I RECEPTOR; ER-BETA; NEOADJUVANT CHEMOTHERAPY; TAMOXIFEN THERAPY; POOLED ANALYSIS; GROWTH; ALPHA; CARCINOMA; INSULIN	Obesity is associated with a worse breast cancer prognosis, while greater breast tumor estrogen receptor beta (ER beta) expression is correlated with improved therapy response and survival. The objective of this study was to determine the impact of obesity on breast cancer cell ER beta expression, which is currently unknown. We utilized an in vitro model of obesity in which breast cancer cells were exposed to patient serum pooled by body mass index category (obese (OB): >= 30 kg/m(2); normal weight (N): 18.5-24.9 kg/m(2)). Four human mammary tumor cell lines representing the major breast cancer subtypes (SKBR3, MCF-7, ZR75, MDA-MB-231) and mammary tumor cells from MMTV-neu mice were used. ER beta expression, assessed by qPCR and western blotting, was suppressed in the two HER2-overexpressing cell lines (SKBR3, MMTV-neu) following OB versus N sera exposure, but did not vary in the other cell lines. Expression of Bcl-2 and cyclin D1, two genes negatively regulated by ER beta, was elevated in SKBR3 cells following exposure to OB versus N sera, but this difference was eliminated when the ER beta gene was silenced with siRNA. Herceptin, a HER2 antagonist, and siRNA to HER2 were used to evaluate the role of HER2 in sera-induced ER beta modulation. SKBR3 cell treatment with OB sera plus Herceptin increased ER beta expression three-fold. Similar results were obtained when HER2 expression was silenced with siRNA. OB sera also promoted greater SKBR3 cell viability and growth, but this variance was not present when ER beta was silenced or the cells were modified to overexpress ER beta. Based on this data, we conclude that obesity-associated systemic factors suppress ER beta expression in breast cancer cells via a HER2-mediated pathway, leading to greater cell viability and growth. Elucidation of the mechanism(s) mediating this effect could provide important insights into how ER beta expression is regulated as well as how obesity promotes a more aggressive disease.	[Bowers, Laura W.; Rossi, Emily L.; Hursting, Stephen D.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Wiese, Megan; deGraffenried, Linda A.] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Brenner, Andrew J.] Univ Texas Hlth Sci Ctr San Antonio, Div Hematol & Med Oncol, San Antonio, TX 78229 USA; [Tekmal, Rajeshwar R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	deGraffenried, LA (corresponding author), Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA.	degraffenried@austin.utexas.edu		Rossi, Emily/0000-0002-2312-4239	National Cancer Institute [R25CA057726]; United States Department of Defense, Breast Cancer Research Program of the Congressionally Directed Medical Research Programs [W81XWH-11-1-0132]; NATIONAL CANCER INSTITUTE [P30CA016086, R25CA057726] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Defense, Breast Cancer Research Program of the Congressionally Directed Medical Research Programs(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	LB is supported by a grant from the National Cancer Institute (http://www.cancer.gov/; R25CA057726) and was previously supported by a Predoctoral Traineeship Award from the United States Department of Defense, Breast Cancer Research Program of the Congressionally Directed Medical Research Programs (http://cdmrp.army.mil/bcrp/; W81XWH-11-1-0132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowers LW, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3453; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Camirand Anne, 2002, Med Sci Monit, V8, pBR521; Chakraborty AK, 2008, CANCER RES, V68, P1538, DOI 10.1158/0008-5472.CAN-07-5935; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Chen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041380; Cortez V, 2010, Minerva Ginecol, V62, P573; Del Fabbro E, 2012, ONCOLOGIST, V17, P1240, DOI 10.1634/theoncologist.2012-0169; Dotzlaw H, 1997, J CLIN ENDOCR METAB, V82, P2371, DOI 10.1210/jc.82.7.2371; Esslimani-Sahla M, 2004, CLIN CANCER RES, V10, P5769, DOI 10.1158/1078-0432.CCR-04-0389; Esteva FJ, 2004, BREAST CANCER RES, V6, P109, DOI 10.1186/bcr777; Fiorio E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-305; FRYSTYK J, 1995, METABOLISM, V44, P37, DOI 10.1016/0026-0495(95)90219-8; Galang CK, 1996, J BIOL CHEM, V271, P7992, DOI 10.1074/jbc.271.14.7992; Hartman J, 2006, CANCER RES, V66, P11207, DOI 10.1158/0008-5472.CAN-06-0017; Honma N, 2008, J CLIN ONCOL, V26, P3727, DOI 10.1200/JCO.2007.14.2968; Hopp TA, 2004, CLIN CANCER RES, V10, P7490, DOI 10.1158/1078-0432.CCR-04-1114; Howlader N, 2014, SEER CANC STAT REV; Iwao K, 2000, CANCER, V89, P1732, DOI 10.1002/1097-0142(20001015)89:8<1732::AID-CNCR13>3.0.CO;2-2; Iwase H, 2003, CANCER CHEMOTH PHARM, V52, pS34, DOI 10.1007/s00280-003-0592-1; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Leygue E, 1998, CANCER RES, V58, P3197; Li LC, 2000, BIOCHEM BIOPH RES CO, V275, P682, DOI 10.1006/bbrc.2000.3363; Litton JK, 2008, J CLIN ONCOL, V26, P4072, DOI 10.1200/JCO.2007.14.4527; Majed B, 2008, BREAST CANCER RES TR, V111, P329, DOI 10.1007/s10549-007-9785-3; Mann S, 2001, HUM PATHOL, V32, P113, DOI 10.1053/hupa.2001.21506; Mazzarella L, 2013, EUR J CANCER, V49, P3588, DOI 10.1016/j.ejca.2013.07.016; Mendoza RA, 2011, J ENDOCRINOL, V208, P1, DOI 10.1677/JOE-10-0235; Murphy L, 2003, ANN MED, V35, P614, DOI 10.1080/07853890310014579; Myers E, 2004, BRIT J CANCER, V91, P1687, DOI 10.1038/sj.bjc.6602156; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Nakopoulou L, 2004, J CLIN PATHOL, V57, P523, DOI 10.1136/jcp.2003.008599; Nam SY, 1997, INT J OBESITY, V21, P355, DOI 10.1038/sj.ijo.0800412; Pajares B, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3572; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Protani M, 2010, BREAST CANCER RES TR, V123, P627, DOI 10.1007/s10549-010-0990-0; Qiu Y, 1998, NATURE, V393, P83, DOI 10.1038/30012; Rody A, 2005, ENDOCR-RELAT CANCER, V12, P903, DOI 10.1677/erc.1.01088; Roger P, 2001, CANCER RES, V61, P2537; SENIE RT, 1992, ANN INTERN MED, V116, P26, DOI 10.7326/0003-4819-116-1-26; Shaw JA, 2002, J PATHOL, V198, P450, DOI 10.1002/path.1230; Sims AH, 2007, NAT CLIN PRACT ONCOL, V4, P516, DOI 10.1038/ncponc0908; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Travis RC, 2003, BREAST CANCER RES, V5, P239, DOI 10.1186/bcr628; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526; Zhao Chunyan, 2008, Nucl Recept Signal, V6, pe003, DOI 10.1621/nrs.06003; Zhao CY, 2003, ONCOGENE, V22, P7600, DOI 10.1038/sj.onc.1207100	47	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145452	10.1371/journal.pone.0145452	http://dx.doi.org/10.1371/journal.pone.0145452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709918	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400048
J	Chen, EI; Crew, KD; Trivedi, M; Awad, D; Maurer, M; Kalinsky, K; Koller, A; Patel, P; Kim, JK; Hershman, DL				Chen, Emily I.; Crew, Katherine D.; Trivedi, Meghna; Awad, Danielle; Maurer, Mathew; Kalinsky, Kevin; Koller, Antonius; Patel, Purvi; Kim, Jenny Kim; Hershman, Dawn L.			Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology	PLOS ONE			English	Article							NEUROTOXICITY CIPN; BETA; MICROPARTICLES; INTERLEUKIN-6; INFLAMMATION; ASSOCIATION; PACLITAXEL; PROTEINS; EXOSOMES; DISTINCT	Major advances in early detection and therapy have significantly increased the survival of breast cancer patients. Unfortunately, most cancer therapies are known to carry a substantial risk of adverse long-term treatment-related effects. Little is known about patient susceptibility to severe side effects after chemotherapy. Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of taxanes. Recent advances in genome-wide genotyping and sequencing technologies have supported the discoveries of a number of pharmacogenetic markers that predict response to chemotherapy. However, effectively implementing these pharmacogenetic markers in the clinic remains a major challenge. On the other hand, recent advances in proteomic technologies incorporating mass spectrometry (MS) for biomarker discovery show great promise to provide clinically relevant protein biomarkers. In this study, we evaluated the association between protein content in serum exosomes and severity of CIPN. Women with early stage breast cancer receiving adjuvant taxane chemotherapy were assessed with the FACT-Ntx score and serum was collected before and after the taxane treatment. Based on the change in FACT-Ntx score from baseline to 12 month follow-up, we separated patients into two groups: those who had no change (Group 1, N = 9) and those who had a >= 20% worsening (Group 1, N = 8). MS-based proteomics technology was used to identify proteins present in serum exosomes to determine potential biomarkers. Mann-Whitney-Wilcoxon analysis was applied and maximum FDR was controlled at 20%. From the serum exosomes derived from this cohort, we identified over 700 proteins known to be in different subcellular locations and have different functions. Statistical analysis revealed a 12-protein signature that resulted in a distinct separation between baseline serum samples of both groups (q<0.2) suggesting that the baseline samples can predict subsequent neurotoxicity. These toxicity-associated biomarkers can be further validated in larger retrospective cohorts for their utility in identifying patients at high risk for CIPN.	[Chen, Emily I.] Columbia Univ, Med Ctr, Dept Pharmacol, New York, NY USA; [Crew, Katherine D.; Trivedi, Meghna; Maurer, Mathew; Kalinsky, Kevin; Hershman, Dawn L.] Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA; [Crew, Katherine D.; Hershman, Dawn L.] Columbia Univ, Med Ctr, Dept Epidemiol, New York, NY USA; [Chen, Emily I.; Crew, Katherine D.; Awad, Danielle; Maurer, Mathew; Kalinsky, Kevin; Koller, Antonius; Patel, Purvi; Kim, Jenny Kim; Hershman, Dawn L.] Columbia Univ, Med Ctr, Prote Shared Resource, Herbert Irving Comprehens Canc Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University	Hershman, DL (corresponding author), Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA.	dlh23@cumc.columbia.edu	Patel, Purvi/AAE-1804-2020; Hershman, Dawn/AAG-2114-2020	Patel, Purvi/0000-0003-1914-3004; 	Breast Cancer Research Foundation; Thompson Family Foundation; NIH/NCI [5 P30 CA013696-39S3]; NATIONAL CANCER INSTITUTE [P30CA013696] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Thompson Family Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the following: Breast Cancer Research Foundation (DLH), The Thompson Family Foundation (DLH), and NIH/NCI 5 P30 CA013696-39S3 (EC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JE, 2014, CLIN CANCER RES, V20, P2466, DOI 10.1158/1078-0432.CCR-13-3232; Alonzi T, 1997, IMMUNOBIOLOGY, V198, P144, DOI 10.1016/S0171-2985(97)80035-6; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Argyriou AA, 2012, CRIT REV ONCOL HEMAT, V82, P51, DOI 10.1016/j.critrevonc.2011.04.012; Bakhti M, 2011, J BIOL CHEM, V286, P787, DOI 10.1074/jbc.M110.190009; Baldwin RM, 2012, CLIN CANCER RES, V18, P5099, DOI 10.1158/1078-0432.CCR-12-1590; Beutler AS, 2014, ANN NEUROL, V76, P727, DOI 10.1002/ana.24265; Boukouris S, 2015, PROTEOM CLIN APPL, V9, P358, DOI 10.1002/prca.201400114; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Cata JP, 2006, MINERVA ANESTESIOL, V72, P151; Cavaletti G, 2014, J PERIPHER NERV SYST, V19, P66, DOI 10.1111/jns5.12073; Cavaletti G, 2011, LANCET ONCOL, V12, P1151, DOI 10.1016/S1470-2045(11)70131-0; Cavaletti G, 2010, NAT REV NEUROL, V6, P657, DOI 10.1038/nrneurol.2010.160; Cella D, 2010, GYNECOL ONCOL, V119, P538, DOI 10.1016/j.ygyno.2010.08.022; Chen EI, 2006, MOL CELL PROTEOMICS, V5, P53, DOI 10.1074/mcp.T500013-MCP200; Chen EI, 2007, J PROTEOME RES, V6, P2529, DOI 10.1021/pr060682a; Dalli J, 2013, MOL CELL PROTEOMICS, V12, P2205, DOI 10.1074/mcp.M113.028589; Dawes JM, 2013, NEUROSCI LETT, V557, P1, DOI 10.1016/j.neulet.2013.10.004; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Flatters SJL, 2004, EUR J PHARMACOL, V484, P183, DOI 10.1016/j.ejphar.2003.11.013; Hershman DL, 2013, J CLIN ONCOL, V31, P2627, DOI 10.1200/JCO.2012.44.8738; Hershman DL, 2011, BREAST CANCER RES TR, V125, P767, DOI 10.1007/s10549-010-1278-0; Hertz DL, 2013, ANN ONCOL, V24, P1472, DOI 10.1093/annonc/mdt018; Hulsmans M, 2013, CARDIOVASC RES, V100, P7, DOI 10.1093/cvr/cvt161; Markman M, 1996, J CANCER RES CLIN, V122, P511, DOI 10.1007/BF01213547; Meckes DG, 2013, P NATL ACAD SCI USA, V110, pE2925, DOI 10.1073/pnas.1303906110; Miltenburg NC, 2014, CANCER TREAT REV, V40, P872, DOI 10.1016/j.ctrv.2014.04.004; Moen EL, 2012, GENOME MED, V4, DOI 10.1186/gm391; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Ng YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058502; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Popernack PM, 2001, J HEMATOTH STEM CELL, V10, P631, DOI 10.1089/152581601753193841; Prokopi M, 2009, BLOOD, V114, P723, DOI 10.1182/blood-2009-02-205930; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Seretny M, 2014, PAIN, V155, P2461, DOI 10.1016/j.pain.2014.09.020; Shimozuma K, 2009, SUPPORT CARE CANCER, V17, P1483, DOI 10.1007/s00520-009-0613-7; Sisignano M, 2014, NAT REV NEUROL, V10, P694, DOI 10.1038/nrneurol.2014.211; Smith EML, 2013, JAMA-J AM MED ASSOC, V309, P1359, DOI 10.1001/jama.2013.2813; Starkweather A, 2010, NURS RES PRACT, V2010, DOI 10.1155/2010/281531; Sucheston LE, 2011, BREAST CANCER RES TR, V130, P993, DOI 10.1007/s10549-011-1671-3; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Ung TH, 2014, CANCER SCI, V105, P1384, DOI 10.1111/cas.12534; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Washburn MP, 2002, ANAL CHEM, V74, P1650, DOI 10.1021/ac015704l; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	47	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145816	10.1371/journal.pone.0145816	http://dx.doi.org/10.1371/journal.pone.0145816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710119	Green Published, Green Submitted, gold			2022-12-27	WOS:000367451400082
J	Crown, SB; Marze, N; Antoniewicz, MR				Crown, Scott B.; Marze, Nicholas; Antoniewicz, Maciek R.			Catabolism of Branched Chain Amino Acids Contributes Significantly to Synthesis of Odd-Chain and Even-Chain Fatty Acids in 3T3-L1 Adipocytes	PLOS ONE			English	Article							PARALLEL LABELING EXPERIMENTS; METABOLIC FLUX ANALYSIS; MASS ISOTOPOMER DISTRIBUTIONS; MODEL; LIPOGENESIS; EXPRESSION; GROWTH; LIPIDS; ALPHA; CELLS	The branched chain amino acids (BCAA) valine, leucine and isoleucine have been implicated in a number of diseases including obesity, insulin resistance, and type 2 diabetes mellitus, although the mechanisms are still poorly understood. Adipose tissue plays an important role in BCAA homeostasis by actively metabolizing circulating BCAA. In this work, we have investigated the link between BCAA catabolism and fatty acid synthesis in 3T3-L1 adipocytes using parallel C-13-labeling experiments, mass spectrometry and model-based isotopomer data analysis. Specifically, we performed parallel labeling experiments with four fully C-13-labeled tracers, [U-C-13] valine, [U-C-13] leucine, [U-C-13] isoleucine and [U-C-13] glutamine. We measured mass isotopomer distributions of fatty acids and intracellular metabolites by GC-MS and analyzed the data using the isotopomer spectral analysis (ISA) framework. We demonstrate that 3T3-L1 adipocytes accumulate significant amounts of even chain length (C14:0, C16:0 and C18:0) and odd chain length (C15:0 and C17:0) fatty acids under standard cell culture conditions. Using a novel GC-MS method, we demonstrate that propionyl-CoA acts as the primer on fatty acid synthase for the production of odd chain fatty acids. BCAA contributed significantly to the production of all fatty acids. Leucine and isoleucine contributed at least 25% to lipogenic acetyl-CoA pool, and valine and isoleucine contributed 100% to lipogenic propionyl-CoA pool. Our results further suggest that low activity of methylmalonyl-CoA mutase and mass action kinetics of propionyl-CoA on fatty acid synthase result in high rates of odd chain fatty acid synthesis in 3T3-L1 cells. Overall, this work provides important new insights into the connection between BCAA catabolism and fatty acid synthesis in adipocytes and underscores the high capacity of adipocytes for metabolizing BCAA.	[Crown, Scott B.; Marze, Nicholas; Antoniewicz, Maciek R.] Univ Delaware, Metab Engn & Syst Biol Lab, Dept Chem & Biomol Engn, Newark, DE USA	University of Delaware	Antoniewicz, MR (corresponding author), Univ Delaware, Metab Engn & Syst Biol Lab, Dept Chem & Biomol Engn, Newark, DE USA.	mranton@udel.edu		Crown, Scott/0000-0002-1983-2101; Antoniewicz, Maciek/0000-0002-0087-2875	University of Delaware Research Foundation (UDRF) Strategic Initiatives Grant; NSF CAREER Award [CBET-1054120]; NSF; HHMI Undergraduate Science Education Grant at the University of Delaware	University of Delaware Research Foundation (UDRF) Strategic Initiatives Grant; NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); HHMI Undergraduate Science Education Grant at the University of Delaware	This work was supported by the University of Delaware Research Foundation (UDRF) Strategic Initiatives Grant and NSF CAREER Award (CBET-1054120). SBC was supported by NSF Graduate Fellowship. NM was supported by HHMI Undergraduate Science Education Grant at the University of Delaware. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn WS, 2013, METAB ENG, V15, P34, DOI 10.1016/j.ymben.2012.10.001; Ahn WS, 2012, BIOTECHNOL J, V7, P61, DOI 10.1002/biot.201100052; Ahn WS, 2011, METAB ENG, V13, P598, DOI 10.1016/j.ymben.2011.07.002; Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; Antoniewicz MR, 2007, METAB ENG, V9, P68, DOI 10.1016/j.ymben.2006.09.001; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Antoniewicz MR, 2015, CURR OPIN BIOTECH, V36, P91, DOI 10.1016/j.copbio.2015.08.014; Antoniewicz MR, 2015, J IND MICROBIOL BIOT, V42, P317, DOI 10.1007/s10295-015-1585-x; Au J, 2014, METAB ENG, V26, P23, DOI 10.1016/j.ymben.2014.08.002; CHUANG DT, 1983, BIOCHEM J, V214, P177, DOI 10.1042/bj2140177; Clifton P, 2010, NAT REV ENDOCRINOL, V6, P191, DOI 10.1038/nrendo.2010.23; Coker M, 1996, PRENATAL DIAG, V16, P941, DOI 10.1002/(SICI)1097-0223(199610)16:10<941::AID-PD965>3.0.CO;2-T; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Crown SB, 2015, METAB ENG, V28, P151, DOI 10.1016/j.ymben.2015.01.001; Crown SB, 2013, METAB ENG, V20, P42, DOI 10.1016/j.ymben.2013.08.005; Crown SB, 2013, METAB ENG, V16, P21, DOI 10.1016/j.ymben.2012.11.010; Decsi T, 1997, J INHERIT METAB DIS, V20, P778, DOI 10.1023/A:1005315717106; Destaillats F, 2002, J AM OIL CHEM SOC, V79, P253, DOI 10.1007/s11746-002-0469-7; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; FRERMAN FE, 1983, J BIOL CHEM, V258, P7087; Guo L, 2010, J BIOL CHEM, V285, P25438, DOI 10.1074/jbc.M110.119933; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; KEDISHVILI NY, 1994, ARCH BIOCHEM BIOPHYS, V315, P317, DOI 10.1006/abbi.1994.1506; KHARROUBI AT, 1992, AM J PHYSIOL, V263, pE667, DOI 10.1152/ajpendo.1992.263.4.E667; Lackey DE, 2013, AM J PHYSL ENDOCRINO; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Leighty RW, 2013, METAB ENG, V20, P56, DOI 10.1016/j.ymben.2013.08.006; Long CP, 2014, ANAL CHEM, V86, P9423, DOI 10.1021/ac502734e; MASORO EJ, 1961, J LIPID RES, V2, P177; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Roberts LD, 2009, PHYSIOL GENOMICS, V39, P109, DOI 10.1152/physiolgenomics.90365.2008; Shah SH, 2012, DIABETOLOGIA, V55, P321, DOI 10.1007/s00125-011-2356-5; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Simicevic J, 2013, NAT METHODS; Su X, 2004, BIOCHEMISTRY-US, V43, P5033, DOI 10.1021/bi035867z; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; WAHREN J, 1976, J CLIN INVEST, V57, P987, DOI 10.1172/JCI108375; Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Yang SM, 2006, J AM SOC MASS SPECTR, V17, P1620, DOI 10.1016/j.jasms.2006.07.004; Yoo H, 2004, J LIPID RES, V45, P1324, DOI 10.1194/jlr.M400031-JLR200; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200	51	111	115	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145850	10.1371/journal.pone.0145850	http://dx.doi.org/10.1371/journal.pone.0145850			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710334	Green Published, Green Submitted, gold			2022-12-27	WOS:000367451400084
J	Hesketh, AJ; Maloney, C; Behr, CA; Edelman, MC; Glick, RD; Al-Abed, Y; Symons, M; Soffer, SZ; Steinberg, BM				Hesketh, Anthony J.; Maloney, Caroline; Behr, Christopher A.; Edelman, Morris C.; Glick, Richard D.; Al-Abed, Yousef; Symons, Marc; Soffer, Samuel Z.; Steinberg, Bettie M.			The Macrophage Inhibitor CNI-1493 Blocks Metastasis in a Mouse Model of Ewing Sarcoma through Inhibition of Extravasation	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; IN-VITRO; CANCER METASTASIS; CELL MIGRATION; POOR-PROGNOSIS; VAGUS NERVE; POLARIZATION; SUPPRESSION; PROGRESSION; MONOCYTES	Metastatic Ewing Sarcoma carries a poor prognosis, and novel therapeutics to prevent and treat metastatic disease are greatly needed. Recent evidence demonstrates that tumor-associated macrophages in Ewing Sarcoma are associated with more advanced disease. While some macrophage phenotypes (M1) exhibit anti-tumor activity, distinct phenotypes (M2) may contribute to malignant progression and metastasis. In this study, we show that M2 macrophages promote Ewing Sarcoma invasion and extravasation, pointing to a potential target of anti-metastatic therapy. CNI-1493 is a selective inhibitor of macrophage function and has shown to be safe in clinical trials as an anti-inflammatory agent. In a xenograft mouse model of metastatic Ewing Sarcoma, CNI-1493 treatment dramatically reduces metastatic tumor burden. Furthermore, metastases in treated animals have a less invasive morphology. We show in vitro that CNI-1493 decreases M2-stimulated Ewing Sarcoma tumor cell invasion and extravasation, offering a functional mechanism through which CNI-1493 attenuates metastasis. These data indicate that CNI-1493 may be a safe and effective adjuvant agent for the prevention and treatment of metastatic Ewing Sarcoma.	[Hesketh, Anthony J.; Maloney, Caroline; Al-Abed, Yousef; Symons, Marc; Steinberg, Bettie M.] North Shore LIJ Hlth Syst, Elmezzi Grad Sch Mol Med, Manhasset, NY USA; [Hesketh, Anthony J.; Maloney, Caroline; Behr, Christopher A.; Symons, Marc; Soffer, Samuel Z.; Steinberg, Bettie M.] North Shore LIJ Hlth Syst, Feinstein Inst Med Res, Ctr Oncol & Cell Biol, Manhasset, NY USA; [Maloney, Caroline; Behr, Christopher A.; Glick, Richard D.; Soffer, Samuel Z.] Hofstra North Shore LIJ Sch Med, Dept Surg, New Hyde Pk, NY USA; [Edelman, Morris C.] Hofstra North Shore LIJ Sch Med, Dept Pathol & Lab Med, New Hyde Pk, NY USA; [Al-Abed, Yousef] North Shore LIJ Hlth Syst, Feinstein Inst Med Res, Ctr Mol Innovat, Manhasset, NY USA; [Al-Abed, Yousef; Symons, Marc; Steinberg, Bettie M.] Hofstra North Shore LIJ Sch Med, Dept Mol Med, Manhasset, NY USA	Northwell Health; Northwell Health; Hofstra University; Northwell Health; Hofstra University; Northwell Health; Northwell Health; Hofstra University; Northwell Health	Steinberg, BM (corresponding author), North Shore LIJ Hlth Syst, Elmezzi Grad Sch Mol Med, Manhasset, NY USA.	bsteinbe@nshs.edu	Steinberg, Bettie/K-3414-2012	Steinberg, Bettie/0000-0003-2372-8099	Elmezzi Foundation; Feinstein Institute for Medical Research	Elmezzi Foundation; Feinstein Institute for Medical Research	This study was supported by The Elmezzi Foundation (AJH) (elmezzi.org) and The Feinstein Institute for Medical Research (www.FeinsteinInstitute.org). The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Atkins HB, 2001, CLIN CANCER RES, V7, P486; Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Barlow M, 2012, J PEDIATR SURG, V47, P1223, DOI 10.1016/j.jpedsurg.2012.03.031; Batra S, 2004, CANCER RES, V64, P5415, DOI 10.1158/0008-5472.CAN-04-0377; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Bianchi M, 1996, J EXP MED, V183, P927, DOI 10.1084/jem.183.3.927; BIANCHI M, 1995, MOL MED, V1, P254, DOI 10.1007/BF03401550; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2013, SEMIN IMMUNOPATHOL, V35, P585, DOI 10.1007/s00281-013-0367-7; Bjork L, 1997, J INFECT DIS, V176, P1303; Borovikova LV, 2000, AUTON NEUROSCI-BASIC, V85, P141, DOI 10.1016/S1566-0702(00)00233-2; Chan A, 2007, MOL MED, V13, P297, DOI 10.2119/2007-00025.Chan; Chernoguz A, 2012, J SURG RES, V173, P1, DOI 10.1016/j.jss.2011.04.041; Cohen PS, 1996, P NATL ACAD SCI USA, V93, P3967, DOI 10.1073/pnas.93.9.3967; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dotan I, 2010, GUT, V59, P760, DOI 10.1136/gut.2009.179994; Dovas A, 2013, J MICROSC-OXFORD, V251, P261, DOI 10.1111/j.1365-2818.2012.03667.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Erin N, 2012, REGUL PEPTIDES, V179, P101, DOI 10.1016/j.regpep.2012.08.001; Feng MY, 2015, P NATL ACAD SCI USA, V112, P2145, DOI 10.1073/pnas.1424907112; Flexman ML, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.016014; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Fujiwara T, 2011, AM J PATHOL, V179, P1157, DOI 10.1016/j.ajpath.2011.05.034; Gendy AS, 2011, J PEDIATR SURG, V46, P108, DOI 10.1016/j.jpedsurg.2010.09.074; Germano G, 2013, CANCER CELL, V23, P249, DOI 10.1016/j.ccr.2013.01.008; Gil-Bernabe AM, 2012, BLOOD, V119, P3164, DOI 10.1182/blood-2011-08-376426; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Kang MH, 2011, PEDIATR BLOOD CANCER, V56, P239, DOI 10.1002/pbc.22801; Kovar H, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00054; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385; Lin EY, 2002, J MAMMARY GLAND BIOL, V7, P147, DOI 10.1023/A:1020399802795; Lipskar AM, 2009, J PEDIATR SURG, V44, P1139, DOI 10.1016/j.jpedsurg.2009.02.037; Lowenberg M, 2005, J IMMUNOL, V175, P2293, DOI 10.4049/jimmunol.175.4.2293; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; May WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080060; McGovern M, 2009, P NATL ACAD SCI USA, V106, P11617, DOI 10.1073/pnas.0903768106; Meyers PA, 2014, ADV EXP MED BIOL, V804, P307, DOI 10.1007/978-3-319-04843-7_17; Miller IS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095885; Mu W, 2013, NEOPLASIA, V15, P875, DOI 10.1593/neo.13786; Murdoch C, 2004, MECH REGULATING RECR, V2004, P2224; Nabeshima A, 2015, BRIT J CANCER, V112, P547, DOI 10.1038/bjc.2014.637; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Potratz J, 2012, PEDIATR HEMAT ONCOL, V29, P1, DOI 10.3109/08880018.2011.622034; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rana S, 2013, NEOPLASIA, V15, P281, DOI 10.1593/neo.122010; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Sierra-Filardi E, 2010, IMMUNOBIOLOGY, V215, P788, DOI 10.1016/j.imbio.2010.05.020; Smith MA, 2008, PEDIATR BLOOD CANCER, V50, P703, DOI 10.1002/pbc.21099; Swierczak A, 2014, CANCER IMMUNOL RES, V2, P765, DOI 10.1158/2326-6066.CIR-13-0190; Thompson PM, 2001, CANCER RES, V61, P679; van Deventer HW, 2013, J IMMUNOL, V190, P4861, DOI 10.4049/jimmunol.1202857; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Wang YL, 2000, CLIN CANCER RES, V6, P551; WHANGPENG J, 1986, CANCER GENET CYTOGEN, V21, P185, DOI 10.1016/0165-4608(86)90001-4; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zinser E, 2004, IMMUNOBIOLOGY, V209, P89, DOI 10.1016/j.imbio.2004.04.004	75	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145197	10.1371/journal.pone.0145197	http://dx.doi.org/10.1371/journal.pone.0145197			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709919	gold, Green Submitted, Green Published			2022-12-27	WOS:000367451400024
J	Li, LH; Zhao, D; Jin, Z; Zhang, J; Paul, C; Wang, YG				Li, Longhu; Zhao, Dong; Jin, Zhe; Zhang, Jian; Paul, Christian; Wang, Yigang			Phosphodiesterase 5a Inhibition with Adenoviral Short Hairpin RNA Benefits Infarcted Heart Partially through Activation of Akt Signaling Pathway and Reduction of Inflammatory Cytokines	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; FAILURE; CELLS; DYSFUNCTION; NEURONS; PHOSPHORYLATION; HYPERTENSION; MODULATION; EXPRESSION	Introduction Treatment with short hairpin RNA (shRNA) interference therapy targeting phosphodiesterase 5a after myocardial infarction (MI) has been shown to mitigate post-MI heart failure. We investigated the mechanisms that underpin the beneficial effects of PDE5a inhibition through shRNA on post-MI heart failure. Methods An adenoviral vector with an shRNA sequence inserted was adopted for the inhibition of phosphodiesterase 5a (Ad-shPDE5a) in vivo and in vitro. Myocardial infarction (MI) was induced in male C57BL/6J mice by left coronary artery ligation, and immediately after that, the Ad-shPDE5a was injected intramyocardially around the MI region and border areas. Results Four weeks post-MI, the Ad-shPDE5a-treated mice showed significant mitigation of the left ventricular (LV) dilatation and dysfunction compared to control mice. Infarction size and fibrosis were also significantly reduced in Ad-shPDE5a-treated mice. Additionally, AdshPDE5a treatment decreased the MI-induced inflammatory cytokines interleukin (IL)-1 beta, IL-6, tumor necrosis factor-a, and transforming growth factor-beta 1, which was confirmed in vitro in Ad-shPDE5a transfected myofibroblasts cultured under oxygen glucose deprivation. Finally, Ad-shPDE5a treatment was found to activate the myocardial Akt signaling pathway in both in vivo and in vitro experiments. Conclusion These findings indicate that PDE5a inhibition by Ad-shPDE5a via the Akt signal pathway could be of significant value in the design of future therapeutics for post-MI heart failure.	[Li, Longhu; Jin, Zhe] First Hosp Qiqihaer City, Dept Cardiol, Qiqihar, Peoples R China; [Li, Longhu] Dalian Univ, Affiliated Zhongshan Hosp, Dept Cardiol, Dalian 116012, Peoples R China; [Zhao, Dong] China Univ Polit Sci & Law, Collaborat Innovat Ctr Judicial Civilizat, Key Lab Evidence Sci, Minist Educ, Beijing, Peoples R China; [Zhang, Jian] Dalian Univ, Affiliated Zhongshan Hosp, Dept EICU, Dalian 116012, Peoples R China; [Paul, Christian; Wang, Yigang] Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA	Dalian University; China University of Political Science & Law; Dalian University; University System of Ohio; University of Cincinnati	Wang, YG (corresponding author), Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	yi-gang.wang@uc.edu			National Natural Science Foundation of China [81170187]; National Heart, Lung and Blood Institute [HL-107957, HL-110740]; Program for Young Innovative Research Team in China University of Political Science and Law [1000-10814344]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110740, R01HL107957] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Program for Young Innovative Research Team in China University of Political Science and Law; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Natural Science Foundation of China, No.81170187 (to LL). The authors thank the Program for Young Innovative Research Team in China University of Political Science and Law, No. 1000-10814344 (to DZ). This work was supported by National Heart, Lung and Blood Institute grants HL-107957 and HL-110740 (YW).; This work was supported by National Natural Science Foundation of China, No.81170187 (to L. Li). We thank the Program for Young Innovative Research Team in China University of Political Science and Law, No. 1000-10814344 (to D. Zhao). This work was supported by National Heart, Lung and Blood Institute grants HL-107957 and HL-110740 (Y Wang).	Aldashev AA, 2005, THORAX, V60, P683, DOI 10.1136/thx.2005.041954; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Boerrigter Guido, 2009, V191, P485, DOI 10.1007/978-3-540-68964-5_21; BOURASSA MG, 1993, J AM COLL CARDIOL, V22, pA14, DOI 10.1016/0735-1097(93)90456-B; Choi DH, 2012, BIOCHEM BIOPH RES CO, V422, P274, DOI 10.1016/j.bbrc.2012.04.147; Deswal A, 2001, CIRCULATION, V103, P2055; Deswal A, 2001, Heart Fail Rev, V6, P143; Devaux B, 1997, EUR HEART J, V18, P470; Fiedler B, 2006, J BIOL CHEM, V281, P32831, DOI 10.1074/jbc.M603416200; Garcia LA, 2014, INT J MOL SCI, V15, P17204, DOI 10.3390/ijms151017204; Gheorghiade M, 2006, CIRCULATION, V114, P1202, DOI 10.1161/CIRCULATIONAHA.106.623199; Gou D, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh129; Guazzi M, 2007, CURR MED CHEM, V14, P2181; Isele NB, 2007, NEUROCHEM INT, V50, P243, DOI 10.1016/j.neuint.2006.08.007; JALIL JE, 1989, CIRC RES, V64, P1041, DOI 10.1161/01.RES.64.6.1041; Kanwar Manreet, 2013, Curr Heart Fail Rep, V10, P26, DOI 10.1007/s11897-012-0121-9; Kass DA, 2007, CIRC RES, V101, P1084, DOI 10.1161/CIRCRESAHA.107.162511; Knight W, 2013, FUTURE MED CHEM, V5, P1607, DOI 10.4155/fmc.13.127; Lee SH, 2010, KOREAN J PHYSIOL PHA, V14, P37, DOI 10.4196/kjpp.2010.14.1.37; Li LH, 2012, AM J PHYSIOL-HEART C, V302, pH2112, DOI 10.1152/ajpheart.00339.2011; Li LH, 2009, AM J PHYSIOL-HEART C, V297, pH1504, DOI 10.1152/ajpheart.00194.2009; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; Mejia-Garcia TA, 2013, CELL SIGNAL, V25, P2424, DOI 10.1016/j.cellsig.2013.08.001; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Ono K, 1998, CIRCULATION, V98, P149, DOI 10.1161/01.CIR.98.2.149; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pokreisz P, 2009, CIRCULATION, V119, P408, DOI 10.1161/CIRCULATIONAHA.108.822072; REIMER KA, 1993, AM J CARDIOL, V72, P13; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Testa M, 1996, J AM COLL CARDIOL, V28, P964, DOI 10.1016/S0735-1097(96)00268-9; TorreAmione G, 1996, J AM COLL CARDIOL, V27, P1201, DOI 10.1016/0735-1097(95)00589-7; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Wang L, 1996, CIRC RES, V79, P79, DOI 10.1161/01.RES.79.1.79	33	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145766	10.1371/journal.pone.0145766	http://dx.doi.org/10.1371/journal.pone.0145766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709517	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400077
J	Lu, Y; Starkey, N; Lei, W; Li, JL; Cheng, JL; Folk, WR; Lubahn, DB				Lu, Yuan; Starkey, Nicholas; Lei, Wei; Li, Jilong; Cheng, Jianlin; Folk, William R.; Lubahn, Dennis B.			Inhibition of Hedgehog-Signaling Driven Genes in Prostate Cancer Cells by Sutherlandia frutescens Extract	PLOS ONE			English	Article							PATHWAY	Sutherlandia frutescens (L) R. Br. (Sutherlandia) is a South African botanical that is traditionally used to treat a variety of health conditions, infections and diseases, including cancer. We hypothesized Sutherlandia might act through Gli/Hedgehog (Hh)-signaling in prostate cancer cells and used RNA-Seq transcription profiling to profile gene expression in TRAMPC2 murine prostate cancer cells with or without Sutherlandia extracts. We found 50% of Hh-responsive genes can be repressed by Sutherlandia ethanol extract, including the canonical Hh-responsive genes Gli1 and Ptch1 as well as newly distinguished Hh-responsive genes Hsd11b1 and Penk.	[Lu, Yuan; Starkey, Nicholas; Folk, William R.; Lubahn, Dennis B.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Lu, Yuan; Starkey, Nicholas; Lei, Wei; Li, Jilong; Cheng, Jianlin; Folk, William R.; Lubahn, Dennis B.] Univ Missouri, MU Ctr Bot Interact Studies, Columbia, MO 65211 USA; [Lei, Wei] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Li, Jilong; Cheng, Jianlin] Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA; [Li, Jilong; Cheng, Jianlin] Univ Missouri, Inst Informat, Columbia, MO 65211 USA; [Lu, Yuan] Texas State Univ, Xiphophorus Genet Stock Ctr, San Marcos, TX 78666 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Texas State University System; Texas State University San Marcos	Lubahn, DB (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	lubahnd@missouri.edu	Cheng, Jianlin/N-8209-2013	Lei, Wei/0000-0002-0374-8642; Cheng, Jianlin/0000-0003-0305-2853; Folk, William/0000-0003-2216-3233	National Center for Complementary and Integrative Health (NCCIH) [P50AT006273]; Office of Dietary Supplements (ODS); National Cancer Institute (NCI); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT006273] Funding Source: NIH RePORTER	National Center for Complementary and Integrative Health (NCCIH); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This publication or project was made possible in part by Grant Number P50AT006273 from the National Center for Complementary and Integrative Health (NCCIH), the Office of Dietary Supplements (ODS), and the National Cancer Institute (NCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This publication or project was made possible in part by Grant Number P50AT006273 from the National Center for Complementary and Integrative Health (NCCIH), the Office of Dietary Supplements (ODS), and the National Cancer Institute (NCI). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCCAM, ODS, NCI, or the National Institutes of Health.	Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bisi-Johnson MA, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-14; Chadwick WA, 2007, J ETHNOPHARMACOL, V109, P121, DOI 10.1016/j.jep.2006.07.012; Chen M, 2011, EXPERT REV ENDOCRINO, V6, P453, DOI 10.1586/EEM.11.24; Chinkwo KA, 2005, J ETHNOPHARMACOL, V98, P163, DOI 10.1016/j.jep.2005.01.016; De Smaele E, 2010, CURR OPIN INVEST DR, V11, P707; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Dormoy V, 2012, CARCINOGENESIS, V33, P2084, DOI 10.1093/carcin/bgs255; Dovio A, 2009, J STEROID BIOCHEM, V116, P29, DOI 10.1016/j.jsbmb.2009.04.007; Goo Young Ah, 2005, BMC Urol, V5, P17, DOI 10.1186/1471-2490-5-17; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lei W, 2015, J ETHNOPHARMACOL; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin H, 2015, CELL BIOL INT; Lu Y, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0049-1; Lu Y, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0047-3; Maity T, 2005, P NATL ACAD SCI USA, V102, P17026, DOI 10.1073/pnas.0507848102; Muller AC, 2012, J PHARM PHARM SCI, V15, P221; NATH N, 1993, PROSTATE, V23, P225, DOI 10.1002/pros.2990230305; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Prevoo D, 2004, ENDOCR RES, V30, P745, DOI 10.1081/ERC-200044020; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Slusarz A, 2010, CANCER RES, V70, P3382, DOI 10.1158/0008-5472.CAN-09-3012; Tai J, 2004, J ETHNOPHARMACOL, V93, P9, DOI 10.1016/j.jep.2004.02.028; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Wyk BE, 2008, J ETHNOPHARMACOL, V119, P620, DOI 10.1016/j.jep.2008.08.003; VANKAMPE.KR, 1972, J ENDOCRINOL, V52, P549, DOI 10.1677/joe.0.0520549; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Vorster C, 2012, J ETHNOPHARMACOL, V140, P123, DOI 10.1016/j.jep.2011.12.045; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Yu M, 2009, J BIOL CHEM, V284, P5620, DOI 10.1074/jbc.M809172200	37	5	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145507	10.1371/journal.pone.0145507	http://dx.doi.org/10.1371/journal.pone.0145507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710108	gold, Green Published, Green Submitted			2022-12-27	WOS:000367451400058
J	Helliwell, JF; Wang, S				Helliwell, John F.; Wang, Shun			How Was the Weekend? How the Social Context Underlies Weekend Effects in Happiness and Other Emotions for US Workers	PLOS ONE			English	Article							BLUE MONDAY; MOOD; MATTER	In this paper we estimate the size of weekend effects for seven emotions and then explore their main determinants for the working population in the United States, using the Gallup/Healthways US Daily Poll 2008-2012. We first find that weekend effects exist for all emotions, and that these effects are not explained by sample selection bias. Full-time workers have larger weekend effects than do part-time workers. We then explore the sources of weekend effects and find that workplace trust and workplace social relations, combined with differences in social time spent with family and friends, together almost fully explain the weekend effects for happiness, laughter, enjoyment and sadness, for both full-time and part-time workers, with significant but smaller proportions explained for the remaining three emotions-worry, anger and stress. Finally, we show that workplace trust and social relations significantly improve emotions and life evaluations on both weekends and weekdays for all workers.	[Helliwell, John F.] Univ British Columbia, Vancouver Sch Econ, Vancouver, BC V5Z 1M9, Canada; [Helliwell, John F.] Canadian Inst Adv Res CIFAR, Toronto, ON, Canada; [Wang, Shun] Korea Dev Inst, Sch Publ Policy & Management, Sejong, South Korea	University of British Columbia; Canadian Institute for Advanced Research (CIFAR); Korea Development Institute (KDI)	Helliwell, JF (corresponding author), Univ British Columbia, Vancouver Sch Econ, Vancouver, BC V5Z 1M9, Canada.	john.fhelliwell@ubc.ca			Canadian Institute for Advanced Research, through its Social Interactions, Identity and Well-being program; Korea Development Institute (KDI) School of Public Policy and Management	Canadian Institute for Advanced Research, through its Social Interactions, Identity and Well-being program; Korea Development Institute (KDI) School of Public Policy and Management	The Canadian Institute for Advanced Research, through its Social Interactions, Identity and Well-being program, which JFH directs, supports the broad program of research that includes this paper. SW gratefully acknowledges financial support from the Korea Development Institute (KDI) School of Public Policy and Management. The funders have no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.; The Canadian Institute for Advanced Research, through its Social Interactions, Identity and Well-being program, which JFH directs, supports the broad program of research that includes this paper. SW gratefully acknowledges financial support from the Korea Development Institute (KDI) School of Public Policy and Management. The funders have no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. We thank the Gallup Organization for access to data from the Gallup/Healthways US Daily Poll.	Durand M, 2013, OECD APPROACH MEASUR, P112; Helliwell JF, 2014, SOC INDIC RES, V116, P389, DOI 10.1007/s11205-013-0306-y; Helliwell JF, 2010, IND LABOR RELAT REV, V63, P205, DOI 10.1177/001979391006300202; Kahneman D, 2006, J ECON PERSPECT, V20, P3, DOI 10.1257/089533006776526030; KENNEDYMOORE E, 1992, MOTIV EMOTION, V16, P143, DOI 10.1007/BF00995516; Lee WS, 2013, EMPIR ECON, V44, P47, DOI 10.1007/s00181-011-0481-0; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Ryan RM, 2010, J SOC CLIN PSYCHOL, V29, P95, DOI 10.1521/jscp.2010.29.1.95; STONE AA, 1985, J PERS SOC PSYCHOL, V49, P129, DOI 10.1037/0022-3514.49.1.129; Taylor MR, 2006, J R STAT SOC A STAT, V169, P127, DOI 10.1111/j.1467-985X.2005.00376.x; Tumen S, 2014, SOC INDIC RES, V119, P139, DOI 10.1007/s11205-013-0477-6; Young C, 2014, SOCIOL SCI, V1, P10, DOI 10.15195/v1.a2	13	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145123	10.1371/journal.pone.0145123	http://dx.doi.org/10.1371/journal.pone.0145123			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26699709	Green Published, gold			2022-12-27	WOS:000367092600048
J	Qu, LH; Yu, L; Wang, YL; Jin, X; Zhang, QL; Lu, P; Yu, XF; Zhong, WW; Zheng, XD; Cui, NR; Jiang, C; Zhu, DL				Qu, Lihui; Yu, Lei; Wang, Yanli; Jin, Xin; Zhang, Qianlong; Lu, Ping; Yu, Xiufeng; Zhong, Weiwei; Zheng, Xiaodong; Cui, Ningren; Jiang, Chun; Zhu, Daling			Inward Rectifier K+ Currents Are Regulated by CaMKII in Endothelial Cells of Primarily Cultured Bovine Pulmonary Arteries	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; POTASSIUM CHANNELS; KINASE-II; SHEAR-STRESS; MODULATION; ACTIVATION; EXPRESSION; CALCIUM; PH	Endothelium lines the interior surface of vascular walls and regulates vascular tones. The endothelial cells sense and respond to chemical and mechanical stimuli in the circulation, and couple the stimulus signals to vascular smooth muscles, in which inward rectifier K+ currents (Kir) play an important role. Here we applied several complementary strategies to determine the Kir subunit in primarily cultured pulmonary arterial endothelial cells (PAECs) that was regulated by the Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII). In whole-cell voltage clamp, the Kir currents were sensitive to micromolar concentrations of extracellular Ba2+. In excised inside-out patches, an inward rectifier K+ current was observed with single-channel conductance 32.43 +/- 0.45 pS and Popen 0.27 +/- 0.04, which were consistent with known unitary conductance of Kir 2.1. RT-PCR and western blot results showed that expression of Kir 2.1 was significantly stronger than that of other sub-types in PAECs. Pharmacological analysis of the Kir currents demonstrated that insensitivity to intracellular ATP, pinacidil, glibenclamide, pH, GDP-beta-S and choleratoxin suggested that currents weren't determined by K-ATP, Kir2.3, Kir2.4 and Kir3.x. The currents were strongly suppressed by exposure to CaMKII inhibitor W-7 and KN-62. The expression of Kir2.1 was inhibited by knocking down CaMKII. Consistently, vasodilation was suppressed by Ba2+, W-7 and KN-62 in isolated and perfused pulmonary arterial rings. These results suggest that the PAECs express an inward rectifier K+ current that is carried dominantly by Kir2.1, and this K+ channel appears to be targeted by CaMKII-dependent intracellular signaling systems.	[Qu, Lihui; Wang, Yanli; Zhang, Qianlong] Harbin Med Univ Daqing, Dept Physiol, Coll Basic Med Sci, Daqing 163319, Heilongjiang, Peoples R China; [Yu, Lei] Harbin Med Univ Daqing, Dept Biopharmaceut Sci, Coll Pharm, Daqing 163319, Heilongjiang, Peoples R China; [Yu, Lei; Lu, Ping; Yu, Xiufeng; Zheng, Xiaodong; Zhu, Daling] Biopharmaceut Key Lab Heilongjiang Prov, Harbin 150086, Heilongjiang, Peoples R China; [Yu, Lei; Jin, Xin; Zhong, Weiwei; Cui, Ningren; Jiang, Chun] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA; [Wang, Yanli] Harbin Med Univ, Dept Rheumatol & Immunol, Affiliated Hosp 1, Harbin 150086, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; University System of Georgia; Georgia State University; Harbin Medical University	Jiang, C (corresponding author), Georgia State Univ, Dept Biol, 50 Decatur St, Atlanta, GA 30302 USA.	biocjj@gmail.com; dalingz@yahoo.com			National Natural Science Foundation of China [81270113, 31471095]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by National Natural Science Foundation of China grants 81270113 and 31471095 (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2004, J CARDIOVASC ELECTR, V15, P598, DOI 10.1046/j.1540-8167.2004.03277.x; Cai H, 2008, CARDIOVASC RES, V77, P30, DOI 10.1093/cvr/cvm010; COULTER KL, 1995, NEURON, V15, P1157, DOI 10.1016/0896-6273(95)90103-5; Dries E, 2013, CIRC RES, V113, P1242, DOI 10.1161/CIRCRESAHA.113.301896; Edwards G, 1998, NATURE, V396, P269, DOI 10.1038/24388; Fang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1134, DOI 10.1152/ajpcell.00077.2005; FORSTERMANN U, 1991, P NATL ACAD SCI USA, V88, P1788, DOI 10.1073/pnas.88.5.1788; Jang SS, 2011, AM J PHYSIOL-CELL PH, V301, pC150, DOI 10.1152/ajpcell.00002.2010; Kamouchi M, 1997, J PHYSIOL-LONDON, V504, P545, DOI 10.1111/j.1469-7793.1997.545bd.x; Kobayashi T, 2012, CLIN SCI, V123, P375, DOI 10.1042/CS20110621; Kofuji P, 2002, GLIA, V39, P292, DOI 10.1002/glia.10112; Levitan I, 2000, ANN BIOMED ENG, V28, P1184, DOI 10.1114/1.1317529; Lieu DK, 2004, AM J PHYSIOL-CELL PH, V286, pC1367, DOI 10.1152/ajpcell.00243.2003; Ma C, 2011, HYPERTENSION, V58, P679, DOI 10.1161/HYPERTENSIONAHA.111.171561; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; OLESEN SP, 1988, NATURE, V331, P168, DOI 10.1038/331168a0; Ramirez-Sanchez I, 2010, HYPERTENSION, V55, P1398, DOI 10.1161/HYPERTENSIONAHA.109.147892; Reichenbach A, 2007, GRAEF ARCH CLIN EXP, V245, P627, DOI 10.1007/s00417-006-0516-y; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; RUSKO J, 1992, J PHYSIOL-LONDON, V455, P601, DOI 10.1113/jphysiol.1992.sp019318; Scharbrodt W, 2004, ARTERIOSCL THROM VAS, V24, P1229, DOI 10.1161/01.ATV.0000130663.37663.6a; Sorensen CM, 2012, AM J PHYSIOL-RENAL, V302, pF505, DOI 10.1152/ajprenal.00052.2011; vonBeckerath N, 1996, J PHYSIOL-LONDON, V491, P357, DOI 10.1113/jphysiol.1996.sp021221; Wang WH, 2009, PFLUG ARCH EUR J PHY, V458, P157, DOI 10.1007/s00424-008-0593-3; Yang ZJ, 2000, J GEN PHYSIOL, V116, P33, DOI 10.1085/jgp.116.1.33	26	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145508	10.1371/journal.pone.0145508	http://dx.doi.org/10.1371/journal.pone.0145508			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700160	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092600091
J	Riley, CM; Wenzel, SE; Castro, M; Erzurum, SC; Chung, KF; Fitzpatrick, AM; Gaston, B; Israel, E; Moore, WC; Bleecker, ER; Calhoun, WJ; Jarjour, NN; Busse, WW; Peters, SP; Teague, WG; Sorkness, R; Holguin, F				Riley, Craig M.; Wenzel, Sally E.; Castro, Mario; Erzurum, Serpil C.; Chung, Kian Fan; Fitzpatrick, Anne M.; Gaston, Benjamin; Israel, Elliot; Moore, Wendy C.; Bleecker, Eugene R.; Calhoun, William J.; Jarjour, Nizar N.; Busse, William W.; Peters, Stephen P.; Teague, W. Gerald; Sorkness, Ronald; Holguin, Fernando			Clinical Implications of Having Reduced Mid Forced Expiratory Flow Rates (FEF25-75), Independently of FEV1, in Adult Patients with Asthma	PLOS ONE			English	Article							LUNG; STANDARDIZATION; OBSTRUCTION; SPIROMETRY	Introduction FEF25-75 is one of the standard results provided in spirometry reports; however, in adult asthmatics there is limited information on how this physiological measure relates to clinical or biological outcomes independently of the FEV1 or the FEV1/FVC ratio. Purpose To determine the association between Hankinson's percent-predicted FEF25-75 (FEF25-75%) levels with changes in healthcare utilization, respiratory symptom frequency, and biomarkers of distal airway inflammation. Methods In participants enrolled in the Severe Asthma Research Program 1-2, we compared outcomes across FEF25-75% quartiles. Multivariable analyses were done to avoid confounding by demographic characteristics, FEV1, and the FEV1/FVC ratio. In a sensitivity analysis, we also compared outcomes across participants with FEF25-75% below the lower limit of normal (LLN) and FEV1/FVC above LLN. Results Subjects in the lowest FEF25-75% quartile had greater rates of healthcare utilization and higher exhaled nitric oxide and sputum eosinophils. In multivariable analysis, being in the lowest FEF25-75% quartile remained significantly associated with nocturnal symptoms (OR 3.0 [95% CI 1.3-6.9]), persistent symptoms (OR 3.3 [95% CI 1-11], ICU admission for asthma (3.7 [1.3-10.8]) and blood eosinophil %(0.18 [0.07, 0.29]). In the sensitivity analysis, those with FEF25-75%< LLN had significantly more nocturnal and persistent symptoms, emergency room visits, higher serum eosinophil levels and increased methacholine responsiveness. Conclusions After controlling for demographic variables, FEV1 and FEV1/FVC, a reduced FEF25-75% is independently associated with previous ICU admission, persistent symptoms, nocturnal symptoms, blood eosinophilia and bronchial hyperreactivity. This suggests that in some asthmatics, a reduced FEF25-75% is an independent biomarker for more severe asthma.	[Riley, Craig M.] Univ Pittsburgh, Med Ctr, Dept Med, Div Internal Med, Pittsburgh, PA USA; [Wenzel, Sally E.; Holguin, Fernando] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Castro, Mario] Washington Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA; [Erzurum, Serpil C.] Cleveland Clin Fdn, Dept Pathol, Cleveland, OH 44195 USA; [Chung, Kian Fan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Fitzpatrick, Anne M.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Gaston, Benjamin] Univ Hosp Cleveland, Dept Pediat, Div Pediat Pulm Med, Cleveland, OH 44106 USA; [Israel, Elliot] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Moore, Wendy C.; Bleecker, Eugene R.; Peters, Stephen P.] Wake Forest Univ, Bowman Gray Sch Med, Div Pulm Crit Care Allergy & Immunol Med, Dept Med, Winston Salem, NC USA; [Calhoun, William J.] Univ Texas Med Branch, Dept Med, Div Pulm Crit Care & Sleep Med, Galveston, TX 77555 USA; [Jarjour, Nizar N.] Univ Wisconsin, Dept Med, Div Pulm & Crit Care Med, Sch Med & Publ Hlth, Madison, WI USA; [Busse, William W.] Univ Wisconsin, Dept Med, Div Allergy & Immunol, Sch Med & Publ Hlth, Madison, WI USA; [Peters, Stephen P.] Univ Virginia, Dept Pediat, Div Resp Med, Childrens Hosp, Charlottesville, VA USA; [Sorkness, Ronald] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); Cleveland Clinic Foundation; Imperial College London; Emory University; University Hospitals of Cleveland; Harvard University; Brigham & Women's Hospital; Wake Forest University; Wake Forest Baptist Medical Center; University of Texas System; University of Texas Medical Branch Galveston; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Virginia; University of Wisconsin System; University of Wisconsin Madison	Holguin, F (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA.	holguinf@upmc.edu	Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426; Wenzel, Sally/0000-0002-4242-0164; Calhoun, William/0000-0001-7075-712X; Fitzpatrick, Anne/0000-0002-2933-5926	National Institutes of Health [HL069174-06]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069174, U10HL109172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Institutes of Health HL069174-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic S, 2005, AM J RESP CRIT CARE, V171, P912, DOI DOI 10.1164/RCCM.200406-710ST; [Anonymous], 1987, AM REV RESPIR DIS, V136, P1285; [Anonymous], 2007, EXPERT PANEL REPORT; Dweik RA, 2010, AM J RESP CRIT CARE, V181, P1033, DOI 10.1164/rccm.200905-0695OC; GARDNER RM, 1988, J OCCUP ENVIRON MED, V30, P272; HANKINSON JL, 1988, AM REV RESPIR DIS, V137, P493, DOI 10.1164/ajrccm/137.2.493c; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Jarjour NN, 2012, AM J RESP CRIT CARE, V185, P356, DOI 10.1164/rccm.201107-1317PP; Jones SE, 2006, J COMMUN HEALTH, V31, P469, DOI 10.1007/s10900-006-9026-4; MCFADDEN ER, 1972, AM J MED, V52, P725, DOI 10.1016/0002-9343(72)90078-2; Niimi A, 2000, AM J RESP CRIT CARE, V162, P1518, DOI 10.1164/ajrccm.162.4.9909044; Perez T, 2013, RESP MED, V107, P1667, DOI 10.1016/j.rmed.2013.08.009; Program NAEaP, 2007, EXP PAN REP 3; Quanjer PH, 2014, EUR RESPIR J, V43, P1051, DOI 10.1183/09031936.00128113; Rao DR, 2012, J ASTHMA, V49, P586, DOI 10.3109/02770903.2012.690481; Sorkness RL, 2008, J APPL PHYSIOL, V104, P394, DOI 10.1152/japplphysiol.00329.2007; Sutherland ER, 2004, J ALLERGY CLIN IMMUN, V113, P1046, DOI 10.1016/j.jaci.2004.03.016; TERRA M, 1986, ALLERGOL IMMUNOPATH, V14, P199	18	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145476	10.1371/journal.pone.0145476	http://dx.doi.org/10.1371/journal.pone.0145476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717486	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000367510500037
J	Sun, XL; Sun, MZ; Jia, BW; Chen, C; Qin, ZW; Yang, KJ; Shen, Y; Zhang, MP; Cong, MY; Zhu, YM				Sun, Xiaoli; Sun, Mingzhe; Jia, Bowei; Chen, Chao; Qin, Zhiwei; Yang, Kejun; Shen, Yang; Zhang Meiping; Cong Mingyang; Zhu, Yanming			A 14-3-3 Family Protein from Wild Soybean (Glycine Soja) Regulates ABA Sensitivity in Arabidopsis	PLOS ONE			English	Article							ABSCISIC-ACID ABA; ROOT-GROWTH; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; PSEUDOMONAS-SYRINGAE; SIGNAL-TRANSDUCTION; DROUGHT TOLERANCE; PLASMA-MEMBRANE; OSMOTIC-STRESS; CRITICAL ROLES	It is widely accepted that the 14-3-3 family proteins are key regulators of multiple stress signal transduction cascades. By conducting genome-wide analysis, researchers have identified the soybean 14-3-3 family proteins; however, until now, there is still no direct genetic evidence showing the involvement of soybean 14-3-3s in ABA responses. Hence, in this study, based on the latest Glycine max genome on Phytozome v10.3, we initially analyzed the evolutionary relationship, genome organization, gene structure and duplication, and three-dimensional structure of soybean 14-3-3 family proteins systematically. Our results suggested that soybean 14-3-3 family was highly evolutionary conserved and possessed segmental duplication in evolution. Then, based on our previous functional characterization of a Glycine soja 14-3-3 protein GsGF14o in drought stress responses, we further investigated the expression characteristics of GsGF14o in detail, and demonstrated its positive roles in ABA sensitivity. Quantitative real-time PCR analyses in Glycine soja seedlings and GUS activity assays in PGsGF14O: GUS transgenic Arabidopsis showed that GsGF14o expression was moderately and rapidly induced by ABA treatment. As expected, GsGF14o overexpression in Arabidopsis augmented the ABA inhibition of seed germination and seedling growth, promoted the ABA induced stomata closure, and up-regulated the expression levels of ABA induced genes. Moreover, through yeast two hybrid analyses, we further demonstrated that GsGF14o physically interacted with the AREB/ABF transcription factors in yeast cells. Taken together, results presented in this study strongly suggested that GsGF14o played an important role in regulation of ABA sensitivity in Arabidopsis.	[Sun, Xiaoli; Sun, Mingzhe; Jia, Bowei; Qin, Zhiwei; Yang, Kejun; Shen, Yang; Zhang Meiping; Cong Mingyang; Zhu, Yanming] Heilongjiang Bayi Agr Univ, Crop Stress Mol Biol Lab, Daqing, Peoples R China; [Sun, Mingzhe; Jia, Bowei; Chen, Chao; Qin, Zhiwei; Zhu, Yanming] Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin, Peoples R China	Heilongjiang Bayi Agricultural University; Northeast Agricultural University - China	Zhu, YM (corresponding author), Heilongjiang Bayi Agr Univ, Crop Stress Mol Biol Lab, Daqing, Peoples R China.	ymzhu@neau.edu.cn	Sun, Xiaoli/AAH-2265-2020	Sun, Xiaoli/0000-0003-1134-3976; Sun, Mingzhe/0000-0001-7557-623X	Natural Science Foundation of Heilongjiang Province [C2015035]; National Natural Science Foundation of China [31500204]; China Postdoctoral Science Foundation [2015M581494]; Postdoctoral Science Foundation of Heilongjiang Province [LBH-Z15186]; Startup Foundation of Heilongjiang Bayi Agricultural University [XYB 2015-01]; Student's Platform for Innovation and Entrepreneurship Training Program [XC2015003]	Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Science Foundation of Heilongjiang Province(China Postdoctoral Science Foundation); Startup Foundation of Heilongjiang Bayi Agricultural University; Student's Platform for Innovation and Entrepreneurship Training Program	Funded by Natural Science Foundation of Heilongjiang Province (C2015035 to XLS) http://nsf.hlkj.cn/zrjj/, National Natural Science Foundation of China (31500204 to XLS) http://www.nsfc.gov.cn/, China Postdoctoral Science Foundation (2015M581494 to XLS) http://www.chinapostdoctor.org.cn/WebSite/program/Default asps, Postdoctoral Science Foundation of Heilongjiang Province (LBH-Z15186 to XLS) http://www.hljbsh.org/index.asp, Startup Foundation of Heilongjiang Bayi Agricultural University (XYB 2015-01 to XLS) http://www.hlau.cn/, and Student's Platform for Innovation and Entrepreneurship Training Program (XC2015003 to YS) http://www.hlau.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams E, 2014, INT J MOL SCI, V15, P22801, DOI 10.3390/ijms151222801; Arc E, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00063; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Benesova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038017; Cai SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116646; Chang IF, 2009, PROTEOMICS, V9, P2967, DOI 10.1002/pmic.200800445; Chen F, 2006, DNA RES, V13, P53, DOI 10.1093/dnares/dsl001; Chen JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139466; Chen Q, 2015, PLANT CELL PHYSIOL, V56, P1144, DOI 10.1093/pcp/pcv038; Chi JC, 2015, J BIOL INORG CHEM, V20, P277, DOI 10.1007/s00775-014-1232-4; de Boer AH, 2013, PROTOPLASMA, V250, P425, DOI 10.1007/s00709-012-0437-z; de Ollas C, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1078953; del Viso F, 2007, PLANTA, V227, P167, DOI 10.1007/s00425-007-0604-1; DeLille JM, PLANT PHYSL; Denison FC, 2011, SEMIN CELL DEV BIOL, V22, P720, DOI 10.1016/j.semcdb.2011.08.006; DuanMu HZ, 2015, FUNCT INTEGR GENOMIC, V15, P651, DOI 10.1007/s10142-015-0439-y; Ferl RJ, 2004, PHYSIOL PLANTARUM, V120, P173, DOI 10.1111/j.0031-9317.2004.0239.x; Finkelstein R, 2005, PLANT MOL BIOL, V59, P253, DOI 10.1007/s11103-005-8767-2; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Fujita Y, 2013, PHYSIOL PLANTARUM, V147, P15, DOI 10.1111/j.1399-3054.2012.01635.x; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Giska F, 2013, PLANT PHYSIOL, V161, P2049, DOI 10.1104/pp.112.209023; Gonzalez-Garcia MP, 2003, PLANT PHYSIOL, V133, P135, DOI 10.1104/pp.103.025569; Hattori T, 2002, PLANT CELL PHYSIOL, V43, P136, DOI 10.1093/pcp/pcf014; He YC, 2015, J EXP BOT, V66, P2271, DOI 10.1093/jxb/erv149; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Ichimura T, 2008, FEBS LETT, V582, P661, DOI 10.1016/j.febslet.2008.01.037; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kaplan B, 2006, PLANT CELL, V18, P2733, DOI 10.1105/tpc.106.042713; Kobayashi Y, 2005, PLANT J, V44, P939, DOI 10.1111/j.1365-313X.2005.02583.x; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Li W, 2013, PLANT PHYSIOL, V161, P2062, DOI 10.1104/pp.112.211748; Li XY, 2012, PLANT SIGNAL BEHAV, V7, P965, DOI 10.4161/psb.20940; Li XY, 2011, PLANTA, V233, P569, DOI 10.1007/s00425-010-1315-6; Lim S, 2014, PLANT MOL BIOL, V86, P513, DOI 10.1007/s11103-014-0242-5; Liu Q, 2015, ENVIRON MICROBIOL, V17, P1444, DOI 10.1111/1462-2920.12634; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Lozano-Duran R, MOL PLANT MICROBE IN; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mayfield JD, 2007, PLANT PHYSIOL, V145, P1692, DOI 10.1104/pp.107.108654; Mayfield JD, 2012, J EXP BOT, V63, P3061, DOI 10.1093/jxb/ers022; Nakashima K, 2006, PLANT MOL BIOL, V60, P51, DOI 10.1007/s11103-005-2418-5; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Nambara E, 2003, TRENDS PLANT SCI, V8, P213, DOI 10.1016/S1360-1385(03)00060-8; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Okamoto M, 2013, P NATL ACAD SCI USA, V110, P12132, DOI 10.1073/pnas.1305919110; Osakabe Y, 2014, NEW PHYTOL, V202, P35, DOI 10.1111/nph.12613; Ou XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101587; Radwan O, 2012, PLANT PHYSIOL, V160, P2125, DOI 10.1104/pp.112.207027; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Roberts MR, 2003, TRENDS PLANT SCI, V8, P218, DOI 10.1016/S1360-1385(03)00056-6; Rogozin IB, 2005, BRIEF BIOINFORM, V6, P118, DOI 10.1093/bib/6.2.118; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schoonheim PJ, 2007, PLANT PHYSIOL, V143, P670, DOI 10.1104/pp.106.090159; Schoonheim PJ, 2007, PLANT J, V49, P289, DOI 10.1111/j.1365-313X.2006.02955.x; Schoonheim PJ, 2009, PLANT CELL ENVIRON, V32, P439, DOI 10.1111/j.1365-3040.2009.01932.x; Sehnke PC, 2002, PLANT MOL BIOL, V50, P1011, DOI 10.1023/A:1021289127519; Sharma S, 2010, PLANT CELL ENVIRON, V33, P1838, DOI 10.1111/j.1365-3040.2010.02188.x; Singh A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125168; Sirichandra C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013935; Sridha S, 2006, PLANT J, V46, P124, DOI 10.1111/j.1365-313X.2006.02678.x; Sun GL, 2011, FUNCT INTEGR GENOMIC, V11, P627, DOI 10.1007/s10142-011-0242-3; Sun XL, 2014, PLANT CELL PHYSIOL, V55, P99, DOI 10.1093/pcp/pct161; Takahashi Y, 2007, PLANT CELL PHYSIOL, V48, P1182, DOI 10.1093/pcp/pcm093; Tian FX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123225; Tocquin Pierre, 2003, BMC Plant Biology, V3, P2, DOI 10.1186/1471-2229-3-2; Tseng TS, 2012, PLANT CELL, V24, P1114, DOI 10.1105/tpc.111.092130; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; van Kleeff PJM, 2014, J EXP BOT, V65, P5877, DOI 10.1093/jxb/eru338; Vysotskii DA, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22672; Wang JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124442; Wang YZ, 2013, PLANT PHYSIOL, V163, P566, DOI 10.1104/pp.113.219758; Wu K, 1997, PLANT PHYSIOL, V114, P1421, DOI 10.1104/pp.114.4.1421; Xu DB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116385; Xu DQ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004197; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Xu WF, 2006, ANN BOT-LONDON, V98, P965, DOI 10.1093/aob/mcl189; Yang CY, 2005, PLANT PHYSIOL, V139, P836, DOI 10.1104/pp.105.065458; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033838; Yang X, 2011, PLANT PHYSIOL, V156, P1397, DOI 10.1104/pp.111.173427; Yang Y, 2015, PLANT MOL BIOL REP I; Yao Y, 2007, J BIOCHEM MOL BIOL, V40, P349; Yi JX, 2010, PLANT J, V62, P1019, DOI 10.1111/j.1365-313X.2010.04214.x; Yoshida R, 2006, J BIOL CHEM, V281, P5310, DOI 10.1074/jbc.M509820200; Yoshida T, 2015, PLANT CELL ENVIRON, V38, P35, DOI 10.1111/pce.12351; Zhan GM, 2010, AGR SCI CHINA, V9, P942, DOI 10.1016/S1671-2927(09)60175-9	95	3	5	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146163	10.1371/journal.pone.0146163	http://dx.doi.org/10.1371/journal.pone.0146163			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717241	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500139
J	Zhang, DM; Cheng, D; Liu, T; Zhang, YC; Chen, ZJ; Zhang, C				Zhang, Dongmei; Cheng, Dong; Liu, Tao; Zhang, Yachao; Chen, Zi-Jiang; Zhang, Cong			Dysfunction of Liver Receptor Homo log-1 in Decidua: Possible Relevance to the Pathogenesis of Preeclampsia	PLOS ONE			English	Article							STEROIDOGENIC-FACTOR-I; PREGNANCY COMPLICATIONS; SIGNALING PATHWAY; EXPRESSION; DECIDUALIZATION; ENDOMETRIUM; MECHANISMS; HOMOLOG-1; MOUSE; LRH-1	Preeclampsia (PE) is a multisystem disorder unique to Homo sapiens that is known to cause maternal and perinatal mortality and morbidity. Between 5-7% of all pregnancies are affected by PE and it is responsible for approximately 50,000 maternal deaths annually. The pathogenesis of PE remains poorly understood. However, the results of this study indicated that insufficient decidualization plays a significant role. NR5A1 and NR5A2 are orphan members of the Ftz-F1 subfamily of nuclear receptors and are involved in mammal follicular development, female reproduction, steroidogenesis, and decidualization. The expression of NR5A1 and NR5A2 in the human decidua and their functions during decidualization were investigated using in vitro cultured cells by real-time PCR, immunohistochemistry, western blotting, and siRNA techniques. The results demonstrated that the levels of NR5A2 mRNA and protein in the decidual tissues of women with PE were lower than those of normal pregnant women. However, the levels of NR5A1 mRNA and protein did not significantly differ between groups. The expression of NR5A2 was upregulated after in vitro decidualization, but the expression of NR5A1 remained low and showed no difference compared with that of the control cells. Knocking down of NR5A2 in human endometrial stromal cells (hESC) resulted in a significant reduction in their expression of decidualization markers (IGFBP1 and PRL) and signaling pathway molecules (WNT4 and BMP2) (P < 0.05). From these data, we concluded that NR5A2 is pivotal for the decidualization of decidual tissues and cultured human endometrial stromal cells. Disorders of the endometrium in decidual tissues may be associated with the abnormal decidualization thought to cause PE.	[Zhang, Dongmei; Liu, Tao; Chen, Zi-Jiang; Zhang, Cong] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Ctr Reprod Med, Shanghai 200030, Peoples R China; [Zhang, Dongmei; Liu, Tao; Chen, Zi-Jiang; Zhang, Cong] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai, Peoples R China; [Cheng, Dong] Shandong Ctr Dis Control & Prevent, Jinan 250014, Shandong, Peoples R China; [Zhang, Dongmei; Liu, Tao; Zhang, Yachao] Shandong Normal Univ, Coll Life Sci, Key Lab Anim Resistance Res, Jinan, Shandong, Peoples R China	Shanghai Jiao Tong University; Shandong Normal University	Zhang, C (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Ctr Reprod Med, Shanghai 200030, Peoples R China.	zhangxinyunlife@163.com	Chen, Zi-Jiang/GOE-6119-2022; Yan, Junhao/AAH-8310-2019		National Natural Science Foundation of China [31172040, 31471399, 81490743]; Shanghai Commission of Science and Technology [12DZ2260600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee)	This study was supported by the National Natural Science Foundation of China (31172040 and 31471399) to C. Z., and by the Major Program of National Natural Science Foundation of China (81490743) to Z.-J. C., as well as by the Shanghai Commission of Science and Technology (12DZ2260600). Dr. CongZhang had an important role in study design.	Duggavathi R, 2008, GENE DEV, V22, P1871, DOI 10.1101/gad.472008; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Dunn Carolyn L, 2003, Reprod Biomed Online, V7, P151; Falender AE, 2003, ENDOCRINOLOGY, V144, P3598, DOI 10.1210/en.2002-0137; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Hinshelwood MM, 2003, MOL CELL ENDOCRINOL, V207, P39, DOI 10.1016/S0303-7207(03)00257-0; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Labelle-Dumais C, 2007, BIOL REPROD, V77, P217, DOI 10.1095/biolreprod.106.059121; Lash GE, 2015, J REPROD IMMUNOL, V108, P83, DOI 10.1016/j.jri.2015.02.003; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Li QX, 2013, ENDOCRINOLOGY, V154, P446, DOI 10.1210/en.2012-1585; Lin L, 2008, SEX DEV, V2, P200, DOI 10.1159/000152036; Liu DL, 2003, BIOL REPROD, V69, P508, DOI 10.1095/biolreprod.102.011767; Loke YW, 1995, HUM REPROD, V10, P14, DOI 10.1093/humrep/10.suppl_2.14; Louwen F, 2012, ONCOTARGET, V3, P759; Maruyama T, 2008, ENDOCR J, V55, P795, DOI 10.1507/endocrj.K08E-067; Mouzat K, 2013, MOL CELL ENDOCRINOL, V368, P47, DOI 10.1016/j.mce.2012.06.009; Noris M, 2005, NAT CLIN PRACT NEPHR, V1, P98, DOI 10.1038/ncpneph0035; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rabaglino MB, 2015, HYPERTENSION, V65, P421, DOI 10.1161/HYPERTENSIONAHA.114.04481; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; REDMAN CWG, 1991, PLACENTA, V12, P301, DOI 10.1016/0143-4004(91)90339-H; Sadovsky Y, 1998, J SOC GYNECOL INVEST, V5, P6, DOI 10.1016/S1071-5576(97)00096-8; Sattar N, 2002, BMJ-BRIT MED J, V325, P157, DOI 10.1136/bmj.325.7356.157; Sirianni R, 2002, J ENDOCRINOL, V174, pR13, DOI 10.1677/joe.0.174R013; Sones JL, 2014, AM J PHYSIOL-REG I, V307, pR490, DOI 10.1152/ajpregu.00176.2014; Tang XF, 2011, ENDOCRINE, V40, P187, DOI 10.1007/s12020-011-9477-y; Winn VD, 2009, ENDOCRINOLOGY, V150, P452, DOI 10.1210/en.2008-0990; Xue Q, 2007, J CLIN ENDOCR METAB, V92, P3261, DOI 10.1210/jc.2007-0494; Zeitoun K, 1999, MOL ENDOCRINOL, V13, P239, DOI 10.1210/me.13.2.239; Zhang C, 2013, NAT MED, V19, P1061, DOI 10.1038/nm.3192; Zhang T, 2014, REPRODUCTION, V147, P141, DOI 10.1530/REP-13-0470	37	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145968	10.1371/journal.pone.0145968	http://dx.doi.org/10.1371/journal.pone.0145968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717016	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500106
J	Benbaba, S; Isaakidis, P; Das, M; Jadhav, S; Reid, T; Furin, J				Benbaba, Stella; Isaakidis, Petros; Das, Mrinalini; Jadhav, Sonakshi; Reid, Tony; Furin, Jennifer			Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?	PLOS ONE			English	Article							EXPERIENCES; ADHERENCE; THERAPY; HIV	Introduction Directly-observed therapy (DOT) is recommended for drug-resistant tuberculosis (DR-TB) patients during their entire treatment duration. However, there is limited published evidence on implementation of direct observation (DO) in the field. This study aims to detail whether DO was followed with DR-TB patients in a Medecins Sans Frontieres (MSF) tuberculosis program in Mumbai, India. Methods This was a cross-sectional, mixed-methods study. Existing qualitative data from a purposively-selected subset of 12 patients, 5 DOT-providers and 5 family members, were assessed in order to determine how DO was implemented. A questionnaire-based survey of DR-TB patients, their DOT-providers and MSF staff was completed between June and August 2014. Patients were defined as "following Strict DO" and "following DO" if a DOT-provider had seen the patient swallow his/her medications "every day" or "most of the days" respectively. If DO was not followed, reasons were also recorded. The qualitative data were analysed for theme and content and used to supplement the questionnaire-based data. Results A total of 70 DR-TB patients, 65 DOT-providers and 21 MSF health staff were included. Fifty-five per cent of the patients were HIV-co-infected and 41% had multidrug-resistant-TB plus additional resistance to a fluoroquinolone. Among all patients, only 14% (10/70) and 20% (14/70) self-reported "following Strict DO" and "following DO" respectively. Among DOT-providers, 46% (30/65) reported that their patients "followed DO". MSF health staff reported none of the patients "followed DO". Reasons for not implementing DO included the unavailability of DOT-provider, time spent, stigma and treatment adverse events. The qualitative data also revealed that "Strict DO" was rarely followed and noted the same reasons for lack of implementation. Conclusion This mixed-methods study has found that a majority of patients with DR-TB in Mumbai did not follow DO, and this was reported by patients and care-providers. These data likely reflect the reality of DO implementation in many high-burden settings, since this relatively small cohort was supported and closely monitored by a skilled team with access to multiple resources. The findings raise important concerns about the necessity of DO as a "pillar" of DR-TB treatment which need further validation in other settings. They also suggest that patient-centred adherence strategies might be better approaches for supporting patients on treatment.	[Benbaba, Stella; Isaakidis, Petros; Das, Mrinalini; Jadhav, Sonakshi] Medecins Sans Frontieres, Bombay, Maharashtra, India; [Isaakidis, Petros; Reid, Tony] Medecins Sans Frontieres, Operat Res Unit, Luxembourg, Luxembourg; [Furin, Jennifer] Case Western Reserve Univ, TB Res Unit, Cleveland, OH 44106 USA	Doctors Without Borders; Case Western Reserve University	Isaakidis, P (corresponding author), Medecins Sans Frontieres, Bombay, Maharashtra, India.	msfocb-asia-epidemio@brussels.msf.org		Isaakidis, Petros/0000-0002-7881-1554				Curry International Tuberculosis Center California Department of Public Health, 2011, DRUG RES TUB SURV GU; Daftary A, 2014, GLOB PUBLIC HEALTH, V9, P1107, DOI 10.1080/17441692.2014.934266; Furin J, 2014, INT J TUBERC LUNG D, V18, P1479, DOI 10.5588/ijtld.14.0277; Isaakidis P, 2013, TROP MED INT HEALTH, V18, P1128, DOI 10.1111/tmi.12146; O'Donnell MR, 2014, JAIDS-J ACQ IMM DEF, V67, P22, DOI 10.1097/QAI.0000000000000221; Okanurak K, 2007, INT J TUBERC LUNG D, V11, P762; Pasipanodya JG, 2013, CLIN INFECT DIS, V57, P21, DOI 10.1093/cid/cit167; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; World Health Organization, 2013, GLOB STRAT TARG TUB; World Health Organization, 2014, TUB COUNTR PROF; World Health Organization, 2014, COMP HDB WHO GUID PR; Wright CM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0945-5	13	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144936	10.1371/journal.pone.0144936	http://dx.doi.org/10.1371/journal.pone.0144936			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713873	Green Published, gold			2022-12-27	WOS:000367481900024
J	Daniel, AE; Timmerman, I; Kovacevic, I; Hordijk, PL; Adriaanse, L; Paatero, I; Belting, HG; van Buul, JD				Daniel, Anna E.; Timmerman, Ilse; Kovacevic, Igor; Hordijk, Peter L.; Adriaanse, Luc; Paatero, Ilkka; Belting, Heinz-Georg; van Buul, Jaap D.			Plasminogen Activator Inhibitor-1 Controls Vascular Integrity by Regulating VE-Cadherin Trafficking	PLOS ONE			English	Article							ENDOTHELIAL-CELL JUNCTIONS; BETA-CATENIN; TUMOR-GROWTH; PERMEABILITY; EXPRESSION; TIPLAXTININ; ZEBRAFISH; APOPTOSIS; CLEAVAGE; MODEL	Background Plasminogen activator inhibitor-1 (PAI-1), a serine protease inhibitor, is expressed and secreted by endothelial cells. Patients with PAI-1 deficiency show a mild to moderate bleeding diathesis, which has been exclusively ascribed to the function of PAI-1 in down-regulating fibrinolysis. We tested the hypothesis that PAI-1 function plays a direct role in controlling vascular integrity and permeability by keeping endothelial cell-cell junctions intact. Methodology/Principal Findings We utilized PAI-039, a specific small molecule inhibitor of PAI-1, to investigate the role of PAI-1 in protecting endothelial integrity. In vivo inhibition of PAI-1 resulted in vascular leakage from intersegmental vessels and in the hindbrain of zebrafish embryos. In addition PAI-1 inhibition in human umbilical vein endothelial cell (HUVEC) monolayers leads to a marked decrease of transendothelial resistance and disrupted endothelial junctions. The total level of the endothelial junction regulator VE-cadherin was reduced, whereas surface VE-cadherin expression was unaltered. Moreover, PAI-1 inhibition reduced the shedding of VE-cadherin. Finally, we detected an accumulation of VE-cadherin at the Golgi apparatus. Conclusions/Significance Our findings indicate that PAI-1 function is important for the maintenance of endothelial monolayer and vascular integrity by controlling VE-cadherin trafficking to and from the plasma membrane. Our data further suggest that therapies using PAI-1 antagonists like PAI-039 ought to be used with caution to avoid disruption of the vessel wall.	[Daniel, Anna E.; Timmerman, Ilse; Kovacevic, Igor; Hordijk, Peter L.; Adriaanse, Luc; van Buul, Jaap D.] Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Paatero, Ilkka; Belting, Heinz-Georg] Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland	University of Amsterdam; Academic Medical Center Amsterdam; University of Basel	van Buul, JD (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.vanbuul@sanquin.nl	van Buul, Jaap D/AAJ-4371-2021; Paatero, Ilkka/AAE-7542-2019	van Buul, Jaap D/0000-0003-0054-7949; Paatero, Ilkka/0000-0001-5926-2396; Hordijk, Peter/0000-0002-3348-078X; Belting, Heinz-Georg/0000-0002-1538-4364; Kovacevic, Igor/0000-0003-1834-2378	Landsteiner Foundation for Blood Transfusion Research [1701, 1311]; Finnish Cultural Foundation [00140020, 00151103]; LSBR fellowship [1701]; LSBR grant [1311]	Landsteiner Foundation for Blood Transfusion Research; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); LSBR fellowship; LSBR grant	This work was supported by AED (awarded to JDvB): Landsteiner Foundation for Blood Transfusion Research, Grant number 1701, http://www.lsbr.nl/; IP: The Finnish Cultural Foundation, Grant numbers: 00140020 and 00151103, https://skr.fi/en/finnish-cultural-foundation; IK (awarded to Prof Peter Hordijk): Landsteiner Foundation for Blood Transfusion Research, Grant number 1311, http://www.lsbr.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Sacha Zeerleder for providing rabbit polyclonal PAI-1 antibody. AED is supported by a LSBR fellowship(#1701). IK is supported by a LSBR grant (#1311). IP is supported by a post-doctoral fellowship from Finnish Cultural Foundation (00140020 and 00151103).	Aimes RT, 2003, THROMB HAEMOSTASIS, V89, P561, DOI 10.1055/s-0037-1613388; Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Bager R, 2013, J MOL BIOL, V425, P2867, DOI 10.1016/j.jmb.2013.05.007; Baxi S, 2008, THROMB HAEMOSTASIS, V99, P749, DOI 10.1160/TH07-11-0669; Boncela J, 2011, J BIOL CHEM, V286, P6820, DOI 10.1074/jbc.M110.173781; Chen SC, 2008, MOL CANCER THER, V7, P1227, DOI 10.1158/1535-7163.MCT-08-0051; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Czekay RP, 2003, J CELL BIOL, V160, P781, DOI 10.1083/jcb.200208117; Degryse B, 2004, J BIOL CHEM, V279, P22595, DOI 10.1074/jbc.M313004200; Dejana E, 2009, CELL TISSUE RES, V335, P1, DOI 10.1007/s00441-008-0697-2; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Elokdah H, 2004, J MED CHEM, V47, P3491, DOI 10.1021/jm049766q; Fernandez-Martin L, 2012, ARTERIOSCLERTHROMBVA; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gorlatova NV, 2007, J BIOL CHEM, V282, P9288, DOI 10.1074/jbc.M611642200; Hennan JK, 2008, J THROMB HAEMOST, V6, P1558, DOI 10.1111/j.1538-7836.2008.03063.x; Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589; Hofmann S, 2002, EUR J MED RES, V7, P171; Hordijk PL, 1999, J CELL SCI, V112, P1915; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Isogai C, 2001, CANCER RES, V61, P5587; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Izuhara Y, 2010, J CEREBR BLOOD F MET, V30, P904, DOI 10.1038/jcbfm.2009.272; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; Lang MR, 2010, J THROMB HAEMOST, V8, P1159, DOI 10.1111/j.1538-7836.2010.03815.x; Mehta R, 2008, HAEMOPHILIA, V14, P1255, DOI 10.1111/j.1365-2516.2008.01834.x; Montero-Balaguer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005772; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Navaratna D, 2007, DIABETES, V56, P2380, DOI 10.2337/db06-1694; Noda K, 2010, MOL BIOL CELL, V21, P584, DOI 10.1091/mbc.E09-07-0580; Nwariaku FE, 2002, SHOCK, V18, P82, DOI 10.1097/00024382-200207000-00015; Ploplis VA, 2004, J BIOL CHEM, V279, P6143, DOI 10.1074/jbc.M307297200; Rudini N, 2008, EMBO J, V27, P993, DOI 10.1038/emboj.2008.46; Sidibe A, 2012, ARTHRITIS RHEUM-US, V64, P77, DOI 10.1002/art.33336; Soeda S, 2001, MOL BRAIN RES, V91, P96, DOI 10.1016/S0169-328X(01)00133-4; Timmerman I, 2015, LOCAL VE CADHERIN TR; Trani M, 2015, CURR OPIN HEMATOL, V22, P267, DOI 10.1097/MOH.0000000000000137; Ukropec JA, 2002, EXP CELL RES, V273, P240, DOI 10.1006/excr.2001.5453; Vaughan Douglas E, 2011, Trans Am Clin Climatol Assoc, V122, P312; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Zanetta L, 2005, THROMB HAEMOSTASIS, V93, P1041, DOI 10.1160/TH04-10-0680	47	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145684	10.1371/journal.pone.0145684	http://dx.doi.org/10.1371/journal.pone.0145684			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714278	gold, Green Submitted, Green Published			2022-12-27	WOS:000367481900067
J	Dirks, JAMC; van Liere, GAFS; Bogers, S; Dukers-Muijrers, NHTM; Wolffs, PFG; Hoebe, CJPA				Dirks, J. A. M. C.; van Liere, G. A. F. S.; Bogers, S.; Dukers-Muijrers, N. H. T. M.; Wolffs, P. F. G.; Hoebe, C. J. P. A.			Natural Course of Chlamydia trachomatis Bacterial Load in the Time Interval between Screening and Treatment in Anogenital Samples	PLOS ONE			English	Article							GENITAL-TRACT; IMMUNE-RESPONSES; INFECTION; MURIDARUM; DURATION; TRANSMISSION; RESOLUTION; HISTORY; WOMEN	Introduction Although Chlamydia trachomatis (CT) is the most common bacterial sexually transmitted infection worldwide, little is known about the natural course of the bacterial load during infection. We investigated the natural course of the bacterial load in the interval between screening and returning for treatment in genital and anorectal CT-infections. Materials & Methods CT-positive patients, visiting our STI-clinic in the Netherlands from June 2011-January 2014, provided a second urogenital and/or anorectal sample when returning for treatment (diagnostic sample = T1; treatment sample = T2). Patient-record provided data about the days between samples and the date of last unsafe sex. Included patients were >= 18 years old, HIV-negative and did not report antibiotic use in the study-interval. CT load was quantified using qPCR. CT load was log-transformed, and a CT load difference (Delta-CT load) of > 1 log was deemed clinically relevant. Chi-square test compared load category distributions over time (decrease/equal/increase), between sample types. Results 274 patients provided 296 paired samples. Majority of samples had a stable CT load in the interval T1-T2 (66.3%, 73.1% and 48.6% for vaginal swabs, urine and anorectal swabs resp. p = 0.07). Load decreased in 17-41% of patients, while +/- 10% of patients showed an increase in CT load. No association between Delta-CT load and the interval T1-T2 was observed. Large variations can be seen in CT load at T1 and over time. Discussion The majority (+/- 90%) of patients have a stable or decreasing CT load in the time interval between screening and returning for treatment. The number of days between sampling was not associated with change in CT load. In the first month after the last unsafe sex, only stable CT loads were seen. Our data seems to indicate that when most patients visit an STI-clinic, recommended 2 weeks after infection, the infection has already been established or is in its downward phase.	[Dirks, J. A. M. C.; van Liere, G. A. F. S.; Bogers, S.; Dukers-Muijrers, N. H. T. M.; Wolffs, P. F. G.; Hoebe, C. J. P. A.] Maastricht Univ, Med Ctr, Sch Publ Hlth & Primary Care, Dept Med Microbiol, NL-6200 MD Maastricht, Netherlands; [Dirks, J. A. M. C.; van Liere, G. A. F. S.; Dukers-Muijrers, N. H. T. M.; Hoebe, C. J. P. A.] Publ Hlth Serv South Limburg, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands	Maastricht University	Dirks, JAMC (corresponding author), Maastricht Univ, Med Ctr, Sch Publ Hlth & Primary Care, Dept Med Microbiol, NL-6200 MD Maastricht, Netherlands.	anne.dirks@mumc.nl	Dukers-Muijrers, Nicole/M-7178-2014	Wolffs, Petra/0000-0002-5326-3985; Dukers-Muijrers, Nicole/0000-0003-4896-758X; van Liere, Genevieve/0000-0002-9286-4548; Hoebe, Christian/0000-0003-1815-0974	Public Health Service South Limburg; Department of Medical Microbiology, Maastricht University Medical Center	Public Health Service South Limburg; Department of Medical Microbiology, Maastricht University Medical Center	This work was supported by the Public Health Service South Limburg and the Department of Medical Microbiology, Maastricht University Medical Center.	Agrawal T, 2013, BRIT J BIOMED SCI, V70, P51, DOI 10.1080/09674845.2013.11669935; Anglemyer A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009153.pub3; [Anonymous], 2011, PREVALENCE INCIDENCE; Apewokin SK, 2010, SEX TRANSM DIS, V37, P343, DOI 10.1097/OLQ.0b013e3181d73639; Brocail M., 2015, SOON CAN I GET TESTE; Carey AJ, 2009, IMMUNOL CELL BIOL, V87, P337, DOI 10.1038/icb.2009.3; Chappell CA, 2014, INFECT DIS CLIN N AM, V28, P529, DOI 10.1016/j.idc.2014.08.002; Cook RL, 2005, ANN INTERN MED, V142, P914, DOI 10.7326/0003-4819-142-11-200506070-00010; Dionne-Odom J, 2016, AM J OBSTET GYNECOL, V214, P6, DOI 10.1016/j.ajog.2015.09.100; Dirks JAMC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121433; Family Planning Association, 2014, CHLAM LOOK YOUR SEX; Garcia-Tejedor A, 2015, EUR J OBSTET GYN R B, V194, P173, DOI 10.1016/j.ejogrb.2015.09.009; Geisler WM, 2008, SEX TRANSM INFECT, V84, P541, DOI 10.1136/sti.2008.030825; Geisler WM, 2008, SEX TRANSM DIS, V35, P119, DOI 10.1097/OLQ.0b013e318151497d; Geisler WM, 2013, J INFECT DIS, V207, P1850, DOI 10.1093/infdis/jit094; Geisler WM, 2010, J INFECT DIS, V201, pS104, DOI 10.1086/652402; Golden MR, 2000, SEX TRANSM DIS, V27, P329, DOI 10.1097/00007435-200007000-00006; Gomes JP, 2006, MICROBES INFECT, V8, P16, DOI 10.1016/j.micinf.2005.05.014; Gupta R, 2014, MOL IMAGING BIOL, V16, P635, DOI 10.1007/s11307-014-0732-5; Hafner LM, 2013, MUCOSAL IMMUNOL, V6, P859, DOI 10.1038/mi.2013.46; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; HANDSFIELD H H, 1976, Journal of the American Venereal Disease Association, V2, P5; He Q, 2013, J STEROID BIOCHEM, V135, P7, DOI 10.1016/j.jsbmb.2012.11.002; Hobbs MM, 2008, SEX TRANSM DIS, V35, P8, DOI 10.1097/OLQ.0b013e31815d968d; Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836; Ljubin-Sternak S, 2014, J PATHOG, V2014, DOI 10.1155/2014/183167; Marrazzo J, 2014, CLIN MANIFESTATIONS; Maxion HK, 2004, INFECT IMMUN, V72, P6330, DOI 10.1128/IAI.72.11.6330-6340.2004; Molano M, 2005, J INFECT DIS, V191, P907, DOI 10.1086/428287; Morre SA, 2002, INT J STD AIDS, V13, P12, DOI 10.1258/095646202762226092; Price MJ, 2013, STAT MED, V32, P1547, DOI 10.1002/sim.5603; Radcliffe K, 2008, TESTING CHLAMYDIA WI; Russell AN, 2016, J INFECT DIS, V213, P523, DOI 10.1093/infdis/jiv438; Schachter J, 1997, IMMUNOL INVEST, V26, P157, DOI 10.3109/08820139709048923; Su H, 2000, INFECT IMMUN, V68, P192, DOI 10.1128/IAI.68.1.192-196.2000; Van Der Pol B, 2013, SEX TRANSM DIS, V40, P247, DOI 10.1097/OLQ.0b013e3182717833; van Rooijen MS, 2015, SEX TRANSM INFECT, V91, P157, DOI 10.1136/sextrans-2014-051633; Vodstrcil LA, 2014, J INFECT DIS; Walker J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037778; Wan C, 2014, AM J REPROD IMMUNOL, V71, P165, DOI 10.1111/aji.12168	40	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145693	10.1371/journal.pone.0145693	http://dx.doi.org/10.1371/journal.pone.0145693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713628	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900070
J	Duncan, RN; Panahi, S; Piotrowski, T; Dorsky, RI				Duncan, Robert N.; Panahi, Samin; Piotrowski, Tatjana; Dorsky, Richard I.			Identification of Wnt Genes Expressed in Neural Progenitor Zones during Zebrafish Brain Development	PLOS ONE			English	Article							STEM-CELLS; DIFFERENTIATION; NEUROGENESIS; PATHWAY; CNS; PROLIFERATION; TELENCEPHALON; MORPHOGENESIS; MAINTENANCE; INITIATION	Wnt signaling regulates multiple aspects of vertebrate central nervous system (CNS) development, including neurogenesis. However, vertebrate genomes can contain up to 25 Wnt genes, the functions of which are poorly characterized partly due to redundancy in their expression. To identify candidate Wnt genes as candidate mediators of pathway activity in specific brain progenitor zones, we have performed a comprehensive expression analysis at three different stages during zebrafish development. Antisense RNA probes for 21 Wnt genes were generated from existing and newly synthesized cDNA clones and used for in situ hybridization on whole embryos and dissected brains. As in other species, we found that Wnt expression patterns in the embryonic zebrafish CNS are complex and often redundant. We observed that progenitor zones in the telencephalon, dorsal diencephalon, hypothalamus, midbrain, midbrain-hindbrain boundary, cerebellum and retina all express multiple Wnt genes. Our data identify 12 specific ligands that can now be tested using loss-of-function approaches.	[Duncan, Robert N.; Panahi, Samin; Dorsky, Richard I.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; [Piotrowski, Tatjana] Stowers Inst Med Res, Kansas City, MO USA	Utah System of Higher Education; University of Utah; Stowers Institute for Medical Research	Dorsky, RI (corresponding author), Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA.	Richard.Dorsky@neuro.utah.edu			National Institutes of Health [R01NS082645, T32DC008553]; NIH [RO1NS082645]; NIDCD [5T32 DC008553]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC008553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health, R01NS082645 (R.I.D.), T32DC008553 (R.N.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Wilson Clements, Elke Ober, Matthias Carl, Gilbert Weidinger and Arne Lekven for generously sharing plasmid templates for in situ probes. R.I.D. was funded by NIH RO1NS082645 and R.N.D. was funded by NIDCD 5T32 DC008553.	Agathocleous M, 2009, DEVELOPMENT, V136, P3289, DOI 10.1242/dev.040451; Beretta CA, 2011, GENE EXPR PATTERNS, V11, P277, DOI 10.1016/j.gep.2011.01.004; Carl M, 2007, NEURON, V55, P393, DOI 10.1016/j.neuron.2007.07.007; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; Clements WK, 2009, DEV DYNAM, V238, P1788, DOI 10.1002/dvdy.21977; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Fotaki V, 2010, DEV DYNAM, V239, P284, DOI 10.1002/dvdy.22137; Gordon LR, 2012, DEVELOPMENT, V139, P1023, DOI 10.1242/dev.071555; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Imura T, 2010, STEM CELLS, V28, P2053, DOI 10.1002/stem.524; Ito Y, 2010, DEV BIOL, V342, P26, DOI 10.1016/j.ydbio.2010.03.008; Jing LL, 2009, NEURON, V61, P721, DOI 10.1016/j.neuron.2008.12.025; Kaslin J, 2009, J NEUROSCI, V29, P6142, DOI 10.1523/JNEUROSCI.0072-09.2009; Katoh M, 2008, CURR DRUG TARGETS, V9, P565, DOI 10.2174/138945008784911750; KELLY GM, 1995, DEVELOPMENT, V121, P1787; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lu FI, 2011, P NATL ACAD SCI USA, V108, P15876, DOI 10.1073/pnas.1106801108; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Megason SG, 2002, DEVELOPMENT, V129, P2087; Mueller T, 2003, DEV BRAIN RES, V140, P137, DOI 10.1016/S0165-3806(02)00583-7; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Qu QH, 2010, NAT CELL BIOL, V12, P31, DOI 10.1038/ncb2001; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Ulrich F, 2003, DEVELOPMENT, V130, P5375, DOI 10.1242/dev.00758; UNGAR AR, 1995, MECH DEVELOP, V52, P153, DOI 10.1016/0925-4773(95)00386-F; Veien ES, 2008, DEVELOPMENT, V135, P4101, DOI 10.1242/dev.027367; Wang X, 2012, DEV CELL, V23, P624, DOI 10.1016/j.devcel.2012.07.012; Wehman AM, 2005, DEV BIOL, V281, P53, DOI 10.1016/j.ydbio.2005.02.010	36	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145810	10.1371/journal.pone.0145810	http://dx.doi.org/10.1371/journal.pone.0145810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713625	gold, Green Published, Green Submitted			2022-12-27	WOS:000367481900086
J	Hendriks, SH; van Hateren, KJJ; Groenier, KH; Houweling, ST; Maas, AHEM; Kleefstra, N; Bilo, HJG				Hendriks, Steven H.; van Hateren, Kornelis J. J.; Groenier, Klaas H.; Houweling, Sebastiaan T.; Maas, Angela H. E. M.; Kleefstra, Nanne; Bilo, Henk J. G.			Sex Differences in the Quality of Diabetes Care in the Netherlands (ZODIAC-45)	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; RISK-FACTORS; TYPE-2; COMPLICATIONS; METAANALYSIS; DISPARITIES; WOMEN; MEN	Objective Our aim was to investigate whether trends in quality of diabetes care differ between sexes in the Netherlands from 1998 till 2013. Research Design and Methods In this prospective observational cohort study quality of care was measured using process and outcome measures in patients with type 2 diabetes in primary care. Trend and absolute differences between sexes were investigated for patients <75 years. Subgroup analyses were performed in patients >= 75 years. 10-year mortality risk was assessed with the Globorisk risk equation in patients without cardiovascular diseases <75 years. Results The number of patients increased from 2,644 in 1998 to 62,230 in 2013. In 1998, 51% of the men and 60% of the women <75 years had an HbA1c >53 mmol/mol; this decreased to approximately 29% in both sexes in 2013. Patients having a systolic blood pressure >140 mmHg decreased from 70% to 42%, and from 80% to 40% in men and women <75 years, respectively. In patients >= 75 years it decreased from 72% to 50% in men and 85% to 56% in women. Obesity increased in both sexes, whereas smoking in men and women declined in patients <75 years (men: 34% to 22%; women: 22% to 18%). The number of patients with a mortality risk >20% over 10 years decreased from 15% to 3% in men and from 18% to 3% in women. Conclusions Quality of diabetes care has improved considerably in the period 1998-2013 in both sexes. Possibly relevant trend differences between sexes were observed for HbA1c, systolic blood pressure, BMI and smoking. The predicted mortality risk decreased over time in both sexes. Except for BMI in both age groups and systolic blood pressure in patients >= 75 years, no evident poorer risk factor control in women compared to men was found at the end of the study period.	[Hendriks, Steven H.; van Hateren, Kornelis J. J.; Houweling, Sebastiaan T.; Kleefstra, Nanne; Bilo, Henk J. G.] Isala, Ctr Diabet, Zwolle, Netherlands; [Groenier, Klaas H.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands; [Houweling, Sebastiaan T.; Kleefstra, Nanne] Langerhans Med Res Grp, Zwolle, Netherlands; [Maas, Angela H. E. M.] Radboud Univ Nijmegen, Dept Cardiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kleefstra, Nanne; Bilo, Henk J. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Bilo, Henk J. G.] Isala, Dept Internal Med, Zwolle, Netherlands	University of Groningen; Langerhans Medical Research Group; Radboud University Nijmegen; University of Groningen	Hendriks, SH (corresponding author), Isala, Ctr Diabet, Zwolle, Netherlands.	s.hendriks@isala.nl	Maas, A.H.E.M./H-8070-2014	Maas, A.H.E.M./0000-0001-5782-9926; Kleefstra, Nanne/0000-0003-1473-8519				Alzahrani SH, 2012, J CLIN ENDOCR METAB, V97, pE2282, DOI 10.1210/jc.2012-2128; Boonman-de Winter LJM, 2012, DIABETOLOGIA, V55, P2154, DOI 10.1007/s00125-012-2579-0; Ferrara A, 2008, DIABETES CARE, V31, P69, DOI 10.2337/dc07-1244; Franzini L, 2013, NUTR METAB CARDIOVAS, V23, P235, DOI 10.1016/j.numecd.2011.12.003; Hajifathalian K, 2015, LANCET DIABETES ENDO; Health Consumer Powerhouse, 2014, EUR IND; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Kanaya AM, 2002, ARCH INTERN MED, V162, P1737, DOI 10.1001/archinte.162.15.1737; Kautzky-Willer A, 2009, EUR J CLIN INVEST, V39, P631, DOI 10.1111/j.1365-2362.2009.02161.x; Kautzky-Willer A, 2010, GENDER MED, V7, P571, DOI 10.1016/j.genm.2010.12.001; Lee WL, 2000, DIABETES CARE, V23, P962, DOI 10.2337/diacare.23.7.962; Miller Donald R, 2008, J Diabetes Sci Technol, V2, P24; Penno G, 2013, J INTERN MED, V274, P176, DOI 10.1111/joim.12073; Pilote L, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.051455; Tamis-Holland JE, 2013, J AM COLL CARDIOL, V61, P1767, DOI 10.1016/j.jacc.2013.01.062; Ubink-Vetmaat LJ, 2005, NETH J MED, V63, P103; van Hateren KJJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001387; Wexler DJ, 2005, DIABETES CARE, V28, P514, DOI 10.2337/diacare.28.3.514; Zheng BY, 2000, STAT MED, V19, P1771, DOI 10.1002/1097-0258(20000715)19:13<1771::AID-SIM485>3.3.CO;2-G	19	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145907	10.1371/journal.pone.0145907	http://dx.doi.org/10.1371/journal.pone.0145907			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713444	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900101
J	Lopes, JS; Abril-de-Abreu, R; Oliveira, RF				Lopes, Joao Sollari; Abril-de-Abreu, Rodrigo; Oliveira, Rui F.			Brain Transcriptomic Response to Social Eavesdropping in Zebrafish (Danio rerio)	PLOS ONE			English	Article							C-FOS; GENE; EXPRESSION; MEMORY; FAMILY; NKX3.1; DIFFERENTIATION; INFORMATION; PLASTICITY; MULTIPLE	Public information is widely available at low cost to animals living in social groups. For instance, bystanders may eavesdrop on signaling interactions between conspecifics and use it to adapt their subsequent behavior towards the observed individuals. This social eavesdropping ability is expected to require specialized mechanisms such as social attention, which selects social information available for learning. To begin exploring the genetic basis of social eavesdropping, we used a previously established attention paradigm in the lab to study the brain gene expression profile of male zebrafish (Danio rerio) in relation to the attention they paid towards conspecifics involved or not involved in agonistic interactions. Microarray gene chips were used to characterize their brain transcriptomes based on differential expression of single genes and gene sets. These analyses were complemented by promoter region-based techniques. Using data from both approaches, we further drafted protein interaction networks. Our results suggest that attentiveness towards conspecifics, whether interacting or not, activates pathways linked to neuronal plasticity and memory formation. The network analyses suggested that fos and jun are key players on this response, and that npas4a, nr4a1 and egr4 may also play an important role. Furthermore, specifically observing fighting interactions further triggered pathways associated to a change in the alertness status (dnajb5) and to other genes related to memory formation (btg2, npas4b), which suggests that the acquisition of eavesdropped information about social relationships activates specific processes on top of those already activated just by observing conspecifics.	[Lopes, Joao Sollari; Abril-de-Abreu, Rodrigo; Oliveira, Rui F.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Lopes, Joao Sollari; Abril-de-Abreu, Rodrigo; Oliveira, Rui F.] ISPA Inst Univ, Lisbon, Portugal; [Abril-de-Abreu, Rodrigo; Oliveira, Rui F.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal	Instituto Gulbenkian de Ciencia; Instituto Superior Psicologia Aplicada (ISPA); Fundacao Champalimaud	Oliveira, RF (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	ruiol@ispa.pt	Lopes, Joao S/A-1493-2013; Oliveira, Rui/A-3581-2013	Lopes, Joao S/0000-0001-5670-2069; Oliveira, Rui/0000-0003-1528-618X	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/33280/2007]; Champalimaud Neuroscience Programme; FCT [EXCL/BIA-ANM/0549/2012, PTDC/PSI-PCO/118776/2010]; Fundação para a Ciência e a Tecnologia [EXCL/BIA-ANM/0549/2012, PTDC/PSI-PCO/118776/2010] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Champalimaud Neuroscience Programme; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	RA was supported by a Ph.D. fellowship from Fundacao para a Ciencia e a Tecnologia (FCT, reference SFRH/BD/33280/2007) and by the Champalimaud Neuroscience Programme. JSL was supported by a post-doc fellowship within the FCT research grant EXCL/BIA-ANM/0549/2012. This work was funded by FCT research grant PTDC/PSI-PCO/118776/2010 given to RFO.	Abril-de-Abreu R, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150220; Abril-de-Abreu R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12678; Ament SA, 2012, P NATL ACAD SCI USA, V109, pE1801, DOI 10.1073/pnas.1205283109; [Anonymous], NUCLEIC ACIDS RES; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basheer R, 2001, MOL BRAIN RES, V89, P153, DOI 10.1016/S0169-328X(01)00045-6; Ben-Tov M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7476; Byrne RW, 1989, MACHIAVELLIAN INTELL, P599, DOI [10.1016/0003-3472(89)90054-7, DOI 10.1016/0003-3472(89)90054-7]; Cardoso SD, 2015, J EXP BIOL, V218, P140, DOI 10.1242/jeb.106997; Chen WV, 2013, DEVELOPMENT, V140, P3297, DOI 10.1242/dev.090621; Choe SK, 2008, ZEBRAFISH, V5, P179, DOI 10.1089/zeb.2008.0534; Cole CJ, 2012, NAT NEUROSCI, V15, P1255, DOI 10.1038/nn.3189; Crockford C, 2007, ANIM BEHAV, V73, P885, DOI 10.1016/j.anbehav.2006.10.016; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Earley RL, 2002, P ROY SOC B-BIOL SCI, V269, P943, DOI 10.1098/rspb.2002.1973; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hawk JD, 2011, BRAIN RES BULL, V85, P21, DOI 10.1016/j.brainresbull.2011.02.001; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Heyes C, 2012, J COMP PSYCHOL, V126, P193, DOI 10.1037/a0025180; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Humphrey N., 1976, GROWING POINTS ETHOL, P303; Kala K, 2009, DEVELOPMENT, V136, P253, DOI 10.1242/dev.029900; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kelder T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006447; Laitinen S, 1999, J LIPID RES, V40, P2204; Lee HG, 2009, AM J PATHOL, V174, P891, DOI 10.2353/ajpath.2009.080583; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Maciejewski H, 2014, BRIEF BIOINFORM, V15, P504, DOI 10.1093/bib/bbt002; Marquer C, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-60; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; MCGREGOR PK, 1993, PHILOS T ROY SOC B, V340, P237, DOI 10.1098/rstb.1993.0063; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; Muroyama Y, 2005, NATURE, V438, P360, DOI 10.1038/nature04139; Nagoshi E, 2010, NAT NEUROSCI, V13, P60, DOI 10.1038/nn.2451; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; Peake Tom M., 2005, P13, DOI 10.1017/CBO9780511610363.004; Ploski JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023760; Popov N, 2007, CELL CYCLE, V6, P2327, DOI 10.4161/cc.6.19.4804; Possner M, 2008, INT J ONCOL, V32, P877; Potter CS, 2006, J BIOL CHEM, V281, P29245, DOI 10.1074/jbc.M603646200; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Sanogo YO, 2012, P ROY SOC B-BIOL SCI, V279, P4929, DOI 10.1098/rspb.2012.2087; Schwartz PT, 2000, J BIOL CHEM, V275, P19106, DOI 10.1074/jbc.M000655200; Shipp S, 2004, TRENDS COGN SCI, V8, P223, DOI 10.1016/j.tics.2004.03.004; Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Strekalova T, 2003, GENES BRAIN BEHAV, V2, P3, DOI 10.1034/j.1601-183X.2003.00001.x; Sumbre G, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00091; Tanaka M, 1999, MECH DEVELOP, V85, P179, DOI 10.1016/S0925-4773(99)00084-2; Tariq H, 2002, BIOANALYZER SOFTWARE; Terao A, 2003, NEUROSCIENCE, V120, P1115, DOI 10.1016/S0306-4522(03)00395-6; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Wang L, 2007, J NEUROSCI, V27, P12555, DOI 10.1523/JNEUROSCI.3681-07.2007; Wang P, 2009, CANCER INVEST, V27, P369, DOI 10.1080/07357900802232749; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yang HJ, 2008, J BIOL CHEM, V283, P5287, DOI 10.1074/jbc.M706917200; Zearfoss NR, 2008, J NEUROSCI, V28, P8502, DOI 10.1523/JNEUROSCI.1756-08.2008; Zhao M, 1999, MOL CELL BIOL, V19, P21; Zhao TY, 2014, DEVELOPMENT, V141, P148, DOI 10.1242/dev.101550	66	10	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145801	10.1371/journal.pone.0145801	http://dx.doi.org/10.1371/journal.pone.0145801			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713440	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900085
J	Lu, PY; Hontecillas, R; Abedi, V; Kale, S; Leber, A; Heltzel, C; Langowski, M; Godfrey, V; Philipson, C; Tubau-Juni, N; Carbo, A; Girardin, S; Uren, A; Bassaganya-Riera, J				Lu, Pinyi; Hontecillas, Raquel; Abedi, Vida; Kale, Shiv; Leber, Andrew; Heltzel, Chase; Langowski, Mark; Godfrey, Victoria; Philipson, Casandra; Tubau-Juni, Nuria; Carbo, Adria; Girardin, Stephen; Uren, Aykut; Bassaganya-Riera, Josep			Modeling-Enabled Characterization of Novel NLRX1 Ligands	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; OXYGEN SPECIES PRODUCTION; DOMAIN-LIKE RECEPTORS; FAMILY-MEMBER NLRX1; NUCLEOTIDE-BINDING; PUNICIC ACID; PPAR-GAMMA; MEDIATES PROTECTION; ANTIVIRAL IMMUNITY	Nucleotide-binding domain and leucine-rich repeat containing (NLR) family are intracellular sentinels of cytosolic homeostasis that orchestrate immune and inflammatory responses in infectious and immune-mediated diseases. NLRX1 is a mitochondrial-associated NOD-like receptor involved in the modulation of immune and metabolic responses. This study utilizes molecular docking approaches to investigate the structure of NLRX1 and experimentally assesses binding to naturally occurring compounds from several natural product and lipid databases. Screening of compound libraries predicts targeting of NLRX1 by conjugated trienes, polyketides, prenol lipids, sterol lipids, and coenzyme A-containing fatty acids for activating the NLRX1 pathway. The ligands of NLRX1 were identified by docking punicic acid (PUA), eleostearic acid (ESA), and docosahexaenoic acid (DHA) to the C-terminal fragment of the human NLRX1 (cNLRX1). Their binding and that of positive control RNA to cNLRX1 were experimentally determined by surface plasmon resonance (SPR) spectroscopy. In addition, the ligand binding sites of cNLRX1 were predicted in silico and validated experimentally. Target mutagenesis studies demonstrate that mutation of 4 critical residues ASP677, PHE680, PHE681, and GLU684 to alanine resulted in diminished affinity of PUA, ESA, and DHA to NLRX1. Consistent with the regulatory actions of NLRX1 on the NF-kappa B pathway, treatment of bone marrow derived macrophages (BMDM)s with PUA and DHA suppressed NF-kappa B activity in a NLRX1 dependent mechanism. In addition, a series of preclinical efficacy studies were performed using a mouse model of dextran sodium sulfate (DSS)-induced colitis. Our findings showed that the regulatory function of PUA on colitis is NLRX1 dependent. Thus, we identified novel small molecules that bind to NLRX1 and exert anti-inflammatory actions.	[Lu, Pinyi; Hontecillas, Raquel; Abedi, Vida; Kale, Shiv; Leber, Andrew; Heltzel, Chase; Langowski, Mark; Godfrey, Victoria; Tubau-Juni, Nuria; Bassaganya-Riera, Josep] Virginia Tech, Virginia Bioinformat Inst, Ctr Modeling Immun Enter Pathogens, Blacksburg, VA 24061 USA; [Lu, Pinyi; Hontecillas, Raquel; Abedi, Vida; Kale, Shiv; Leber, Andrew; Heltzel, Chase; Langowski, Mark; Godfrey, Victoria; Tubau-Juni, Nuria; Bassaganya-Riera, Josep] Virginia Tech, Virginia Bioinformat Inst, Nutr Immunol & Mol Med Lab Www Nimml Org, Blacksburg, VA 24061 USA; [Philipson, Casandra; Carbo, Adria] BioTherapeutics, Blacksburg, VA 24060 USA; [Girardin, Stephen] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada; [Uren, Aykut] Georgetown Univ, Med Ctr, Washington, DC 20057 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Toronto; Georgetown University	Bassaganya-Riera, J (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Ctr Modeling Immun Enter Pathogens, Blacksburg, VA 24061 USA.	jbassaga@vt.edu	Philipson, Casandra/AAY-5746-2021; Lu, Pinyi/U-4513-2017	Abedi, Vida/0000-0001-7689-933X	National Institute of Allergy and Infectious Diseases [HHSN272201000056C]; Nutritional Immunology and Molecular Medicine Laboratory; BioTherapeutics; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Nutritional Immunology and Molecular Medicine Laboratory; BioTherapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institute of Allergy and Infectious Diseases Contract No. HHSN272201000056C to JB-R and funds from the Nutritional Immunology and Molecular Medicine Laboratory (www.nimml.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BioTherapeutics provided support in the form of salary for author [AC] after he graduated from NIMML with a PhD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdul-Sater AA, 2010, J BIOL CHEM, V285, P41637, DOI 10.1074/jbc.M110.137885; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; AHLERS NHE, 1954, NATURE, V173, P1045, DOI 10.1038/1731045a0; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Anighoro A, 2014, J MED CHEM, V57, P7874, DOI 10.1021/jm5006463; Asrat S, 2015, CELLULAR MICROBIOLOG; Badami R C, 1980, Prog Lipid Res, V19, P119; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Bassaganya-Riera J, 2011, BRIT J NUTR, V106, P878, DOI 10.1017/S0007114511001188; Brodsky IE, 2009, SEMINARS IMMUNOLOGY; Brull F, 2009, CLIN LIPIDOL, V4, P355, DOI 10.2217/CLP.09.26; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; de Zoete MR, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00462; Durai P, 2013, FEBS J, V280, P6196, DOI 10.1111/febs.12541; Eitas TK, 2014, J BIOL CHEM, V289, P4173, DOI 10.1074/jbc.M113.533034; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Franchi L, 2006, J IMMUNOL, V177, P3507, DOI 10.4049/jimmunol.177.6.3507; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Fukata M, 2009, SEMIN IMMUNOL, V21, P242, DOI 10.1016/j.smim.2009.06.005; Guesnet P, 2011, BIOCHIMIE, V93, P7, DOI 10.1016/j.biochi.2010.05.005; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Hong M, 2012, IMMUNITY, V36, P337, DOI 10.1016/j.immuni.2011.12.018; Hontecillas R, 2009, J AM COLL NUTR, V28, P184, DOI 10.1080/07315724.2009.10719770; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Jaworska J, 2014, P NATL ACAD SCI USA, V111, pE2110, DOI 10.1073/pnas.1322118111; Jha Sushmita, 2015, F1000Prime Rep, V7, P15, DOI 10.12703/P7-15; Jin CC, 2013, J ALLERGY CLIN IMMUN, V132, P287, DOI 10.1016/j.jaci.2013.06.022; JOH YG, 1995, J AM OIL CHEM SOC, V72, P1037, DOI 10.1007/BF02660718; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kuzuyama T, 2003, NAT PROD REP, V20, P171, DOI 10.1039/b109860h; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Lewis SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024031; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; Lu PY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034643; Lu PY, 2011, J MOL MODEL, V17, P543, DOI 10.1007/s00894-010-0748-y; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mason DR, 2012, J INNATE IMMUN, V4, P16, DOI 10.1159/000334247; Minto RE, 2008, PROG LIPID RES, V47, P233, DOI 10.1016/j.plipres.2008.02.002; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Neal MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065779; Oehlers SH, 2011, DIS MODEL MECH, V4, P832, DOI 10.1242/dmm.006122; Philipson CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137839; Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012; Russell RK, 2008, GENES IMMUN, V9, P556, DOI 10.1038/gene.2008.44; Sassano G, 2009, J SCI FOOD AGR, V89, P1046, DOI 10.1002/jsfa.3552; Savar Nastaran Sadat, 2014, Adv Biomed Res, V3, P41, DOI 10.4103/2277-9175.125730; Saxena M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00327; Shaw PJ, 2011, TRENDS MOL MED, V17, P57, DOI 10.1016/j.molmed.2010.11.001; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Soares F, 2014, J BIOL CHEM, V289, P19317, DOI 10.1074/jbc.M114.550111; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Van Limbergen J, 2015, GUT, V64, P353, DOI 10.1136/gutjnl-2013-305077; Viladomiu M, 2013, J NUTR BIOCHEM, V24, P929, DOI 10.1016/j.jnutbio.2013.01.006; Wang YL, 2014, NUCLEIC ACIDS RES, V42, pD1075, DOI 10.1093/nar/gkt978; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022	63	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145420	10.1371/journal.pone.0145420	http://dx.doi.org/10.1371/journal.pone.0145420			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714018	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900041
J	Razzaq, M; Ahmad, J				Razzaq, Misbah; Ahmad, Jamil			Petri Net and Probabilistic Model Checking Based Approach for the Modelling, Simulation and Verification of Internet Worm Propagation	PLOS ONE			English	Article							EPIDEMIC MODEL; SPREAD; TRANSMISSION	Internet worms are analogous to biological viruses since they can infect a host and have the ability to propagate through a chosen medium. To prevent the spread of a worm or to grasp how to regulate a prevailing worm, compartmental models are commonly used as a means to examine and understand the patterns and mechanisms of a worm spread. However, one of the greatest challenge is to produce methods to verify and validate the behavioural properties of a compartmental model. This is why in this study we suggest a framework based on Petri Nets and Model Checking through which we can meticulously examine and validate these models. We investigate Susceptible-Exposed-Infectious-Recovered (SEIR) model and propose a new model Susceptible-Exposed-Infectious-Recovered-Delayed-Quarantined (Susceptible/Recovered) (SEIDQR(S/I)) along with hybrid quarantine strategy, which is then constructed and analysed using Stochastic Petri Nets and Continuous Time Markov Chain. The analysis shows that the hybrid quarantine strategy is extremely effective in reducing the risk of propagating the worm. Through Model Checking, we gained insight into the functionality of compartmental models. Model Checking results validate simulation ones well, which fully support the proposed framework.	[Razzaq, Misbah; Ahmad, Jamil] Natl Univ Sci & Technol, Dept Computat Sci, RCMS, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan	Ahmad, J (corresponding author), Natl Univ Sci & Technol, Dept Computat Sci, RCMS, Islamabad, Pakistan.	jamil.ahmad@rcms.nust.edu.pk	razzaq, misbah/T-4661-2019; Razzaq, Misbah/AFP-2991-2022; Ahmad, Jamil/AAF-5499-2021	Razzaq, Misbah/0000-0003-4961-6802; Ahmad, Jamil/0000-0001-6618-6811				ANDERSON R M, 1991; ANDERSON RM, 1982, POPULATION BIOL INFE; Aziz A., 2000, ACM T COMPUT LOG, V1, P162, DOI DOI 10.1145/343369.343402; Aziz A, 1996, LNCS, P269, DOI DOI 10.1007/3-540-61474-5_75; Baier C, 2008, PRINCIPLES OF MODEL CHECKING, P1; Bailey M, 2005, IEEE SECUR PRIV, V3, P26, DOI 10.1109/MSP.2005.106; Bhat AA, 2004, STOCHASTIC PETRI NET; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Chen ZQ, 2015, APPL MATH COMPUT, V265, P983, DOI 10.1016/j.amc.2015.06.003; Chen ZQ, 2015, ENTROPY-SWITZ, V17, P3710, DOI 10.3390/e17063710; Chen ZQ, 2014, ENTROPY-SWITZ, V16, P5416, DOI 10.3390/e16105416; Chen ZS, 2003, IEEE INFOCOM SER, P1890; Clarke EM, 1999, MODEL CHECKING, P1; David R., 2010, DISCR CONT HYBR, P554; Dong T, 2012, STABILITY HOPF BIFUR; Feily M, 2009, 2009 THIRD INTERNATIONAL CONFERENCE ON EMERGING SECURITY INFORMATION, SYSTEMS, AND TECHNOLOGIES, P268, DOI 10.1109/SECURWARE.2009.48; Gan CQ, 2012, DISCRETE DYN NAT SOC, V2012, DOI 10.1155/2012/106950; Kabiri P., 2005, INT J NETWORK SECURI, V1, P84, DOI DOI 10.6633/IJNS.200509.1(2).05; Katoen JP, 2007, LECT NOTES COMPUT SC, V4763, P1; Kwiatkowska M, 2011, PROBABILISTIC MODEL; Kwiatkowska M, 2010, SYMBOLIC SYSTEMS BIO, P31; Kwiatkowska M, 2006, ELECTRON NOTES THEOR, V153, P5, DOI 10.1016/j.entcs.2005.10.030; Li P, 2008, IEEE COMMUN SURV TUT, V10, P20, DOI 10.1109/COMST.2008.4483668; Lu N, 2002, POWER SYSTEM MODELIN; Mishra Bimal Kumar, 2014, International Journal of Information Technology and Computer Science, V6, P12, DOI 10.5815/ijitcs.2014.03.02; Mishra BK, 2007, APPL MATH COMPUT, V187, P929, DOI 10.1016/j.amc.2006.09.062; Mishra BK, 2007, APPL MATH COMPUT, V188, P1476, DOI 10.1016/j.amc.2006.11.012; Misslinger S., 2003, INTERNET WORM PROPAG; Mukamurenzi NM, 2008, STORM WORM P2P BOTNE; MURATA T, 1989, P IEEE, V77, P541, DOI 10.1109/5.24143; Ren JG, 2012, NONLINEAR ANAL-REAL, V13, P376, DOI 10.1016/j.nonrwa.2011.07.048; Sanz J, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041005; Shannon C, 2004, IEEE SECUR PRIV, V2, P46, DOI 10.1109/MSP.2004.59; Shin S, 2010, 26TH ANNUAL COMPUTER SECURITY APPLICATIONS CONFERENCE (ACSAC 2010), P151; Thomas R., 1990, BIOL FEEDBACK; van den Driessche P, 2007, MATH BIOSCI, V207, P89, DOI 10.1016/j.mbs.2006.09.017; Wang FW, 2010, COMPUT SECUR, V29, P410, DOI 10.1016/j.cose.2009.10.002; Wang L, 2014, CHINESE SCI BULL, V59, P3511, DOI 10.1007/s11434-014-0499-8; Xia CY, 2009, INT J MOD PHYS B, V23, P2203, DOI 10.1142/S021797920905211X; Xia Cheng-yi, 2008, Control and Decision, V23, P468; Xia CY, 2012, NONLINEAR DYNAM, V69, P927, DOI 10.1007/s11071-011-0313-y; Yang LX, 2012, DISCRETE DYN NAT SOC, V2012, DOI 10.1155/2012/693695; Yao Y, 2012, COMPUT ELECTR ENG, V38, P1047, DOI 10.1016/j.compeleceng.2011.07.009; Zhang Y, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/68002; Zhu QY, 2012, COMMUN NONLINEAR SCI, V17, P5117, DOI 10.1016/j.cnsns.2012.05.030; Zou C.C., 2002, P 9 ACM C COMPUTER C, P138, DOI 10.1145/586110.586130; Zou C. C., 2003, P 2003 ACM WORKSHOP, P51, DOI DOI 10.1145/948187.948197; Zou CC, 2005, IEEE ACM T NETWORK, V13, P961, DOI 10.1109/TNET.2005.857113	49	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145690	10.1371/journal.pone.0145690	http://dx.doi.org/10.1371/journal.pone.0145690			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713449	Green Submitted, Green Published, gold			2022-12-27	WOS:000367481900069
J	Jin, ZX; Li, J,M; Li, YL				Jin, Zexin; Li, Junmin; Li, Yueling			Interactive Effects of Arbuscular Mycorrhizal Fungi and Copper Stress on Flowering Phenology and Reproduction of Elsholtzia splendens	PLOS ONE			English	Article							METAL-CONTAMINATED SOIL; AGRICULTURAL PLANTS; GROWTH; TOLERANCE; INOCULATION; ACCUMULATION; METALLOPHYTE; GLOMALIN; PROTEIN; SIZE	Plant responses to heavy metal contamination may depend on the presence of arbuscular mycorrhizal fungi (AMF). Elsholtzia splendens is an indicator species for the presence of copper (Cu) mines because both its flowering phenology and reproduction are tolerant to heavy metals. To test whether effects of Cu on the flowering phenology and reproduction of E. splendens depend on the presence of AMF, we conducted a factorial experiment with two Cu treatments (with or without Cu addition) crossed with two AMF treatments (with or without AMF inoculation). Without AMF, Cu addition significantly delayed the onset dates, ending dates and peak dates of flowering and decreased flowering duration. However, AMF inoculation reversed the effects of Cu stress, with recovered flowering onset and ending dates and increased the flowering duration. Cu addition significantly decreased inflorescence width and number, inflorescence biomass, vegetative biomass and total seed number, but significantly increased 1000-seed weight. AMF inoculation significantly increased vegetative biomass. Two-way ANOVA results showed that the interactive effects between Cu addition and AMF inoculation were significant on the inflorescence number, vegetative biomass and total seed number. These results indicate that AMF can alleviate the Cu stress on the flowering phenology and reproduction of E. splendens.	[Jin, Zexin; Li, Junmin; Li, Yueling] Zhejiang Prov Key Lab Plant Evolutionary & Conser, Taizhou, Peoples R China; [Jin, Zexin; Li, Junmin; Li, Yueling] Taizhou Univ, Inst Ecol, Taizhou, Peoples R China	Taizhou University	Li, J,M (corresponding author), Zhejiang Prov Key Lab Plant Evolutionary & Conser, Taizhou, Peoples R China.	lijmtzc@126.com	李, 钧敏/L-7390-2019		Zhejiang Provincial National Natural Science Foundation of China [LY12C03002]; Zhejiang Provincial Nature Science Foundation [LY12C03002]	Zhejiang Provincial National Natural Science Foundation of China; Zhejiang Provincial Nature Science Foundation	Support was provided by the Zhejiang Provincial National Natural Science Foundation of China (No. LY12C03002) [http://www.zjnsf.gov.cn/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to W.S. Ke and M. Guan for their help in sampling soil and seeds. We also thank the editors and reviewers for their valuable comments. This study was financially supported by Zhejiang Provincial Nature Science Foundation (LY12C03002).	Andrade SAL, 2009, CHEMOSPHERE, V75, P1363, DOI 10.1016/j.chemosphere.2009.02.008; Andre CM, 2010, CURR NUTR FOOD SCI, V6, P2, DOI 10.2174/157340110790909563; Arunakumara KKIU, 2013, J KOREAN SOC APPL BI, V56, P505, DOI 10.1007/s13765-013-3126-5; Barber NA, 2015, J PLANT ECOL, V8, P1, DOI 10.1093/jpe/rtu012; Bhakuni G, 2009, J PLANT NUTR, V32, P703, DOI 10.1080/01904160902743258; Brun LA, 2003, ENVIRON POLLUT, V122, P361, DOI 10.1016/S0269-7491(02)00312-3; Carvalho LM, 2006, PLANT SOIL, V285, P161, DOI 10.1007/s11104-006-9001-y; Cornejo P, 2008, SCI TOTAL ENVIRON, V406, P154, DOI 10.1016/j.scitotenv.2008.07.045; Ferrol N, 2009, PHYTOCHEM REV, V8, P551, DOI 10.1007/s11101-009-9133-9; Gan JH, 2013, ECOTOX ENVIRON SAFE, V89, P204, DOI 10.1016/j.ecoenv.2012.11.033; Gaur A, 2000, SCI HORTIC-AMSTERDAM, V84, P151, DOI 10.1016/S0304-4238(99)00105-3; Gonzalez-Chavez MC, 2004, ENVIRON POLLUT, V130, P317, DOI 10.1016/j.envpol.2004.01.004; GRAHAM JH, 1985, NEW PHYTOL, V101, P667, DOI 10.1111/j.1469-8137.1985.tb02872.x; Gutierrez HF, 2006, NEW ZEAL J BOT, V44, P47, DOI 10.1080/0028825X.2006.9513005; Hildebrandt U, 2007, PHYTOCHEMISTRY, V68, P139, DOI 10.1016/j.phytochem.2006.09.023; Huang WX, 2011, ECOTOX ENVIRON SAFE, V74, P1043, DOI 10.1016/j.ecoenv.2011.01.020; Jiang LY, 2008, J PLANT NUTR, V31, P1382, DOI 10.1080/01904160802206257; Kamali M, 2012, J ORNA HORTI PLANTS, V2, P95; KORMANIK PP, 1980, CAN J MICROBIOL, V26, P536, DOI 10.1139/m80-090; Kovacik J, 2010, PLANT SCI, V178, P307, DOI 10.1016/j.plantsci.2010.01.009; Liu TT, 2014, BIOL TRACE ELEM RES, V160, P418, DOI 10.1007/s12011-014-0043-3; Lou LQ, 2004, ENVIRON EXP BOT, V51, P111, DOI 10.1016/j.envexpbot.2003.08.002; Meier S, 2012, APPL SOIL ECOL, V61, P280, DOI 10.1016/j.apsoil.2011.10.018; Ollerton J, 1999, OECOLOGIA, V119, P340, DOI 10.1007/s004420050794; Ryser P, 2006, ENVIRON POLLUT, V140, P52, DOI 10.1016/j.envpol.2005.06.026; Sadras VO, 2007, FIELD CROP RES, V100, P125, DOI 10.1016/j.fcr.2006.07.004; Shamshiri MH, 2012, ISRN AGRON, DOI [10.5402/2012/535846, DOI 10.5402/2012/535846]; Sohn BK, 2003, SCI HORTIC-AMSTERDAM, V98, P173, DOI 10.1016/S0304-4238(02)00210-8; Song H., 2007, THESIS; Sun Y, 2008, SYMBIOSIS, V46, P121; Tang SR, 1999, PLANT SOIL, V209, P225, DOI 10.1023/A:1004599715411; Torimaru T, 2006, CAN J BOT, V84, P1860, DOI 10.1139/B06-129; Wang FY, 2006, APPL SOIL ECOL, V31, P110, DOI 10.1016/j.apsoil.2005.03.002; Yang RY, 2010, APPL SOIL ECOL, V44, P191, DOI 10.1016/j.apsoil.2009.12.005; Zafar S, 2007, BIORESOURCE TECHNOL, V98, P2557, DOI 10.1016/j.biortech.2006.09.051	35	16	16	6	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145793	10.1371/journal.pone.0145793	http://dx.doi.org/10.1371/journal.pone.0145793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709921	Green Published, Green Submitted, gold			2022-12-27	WOS:000367451400080
J	McKimpson, WM; Yuan, ZQ; Zheng, M; Crabtree, JS; Libutti, SK; Kitsis, RN				McKimpson, Wendy M.; Yuan, Ziqiang; Zheng, Min; Crabtree, Judy S.; Libutti, Steven K.; Kitsis, Richard N.			The Cell Death Inhibitor ARC Is Induced in a Tissue-Specific Manner by Deletion of the Tumor Suppressor Gene Men1, but Not Required for Tumor Development and Growth	PLOS ONE			English	Article							MULTIPLE ENDOCRINE NEOPLASIA; CASPASE RECRUITMENT DOMAIN; APOPTOSIS REPRESSOR; ANTIAPOPTOTIC PROTEIN; EXPRESSION; TYPE-1; CANCER; DEGRADATION; RADIATION; CLONING	Multiple endocrine neoplasia type 1 (MEN1) is a genetic disorder characterized by tissue-specific tumors in the endocrine pancreas, parathyroid, and pituitary glands. Although tumor development in these tissues is dependent upon genetic inactivation of the tumor suppressor Men1, loss of both alleles of this gene is not sufficient to induce these cancers. Men1 encodes menin, a nuclear protein that influences transcription. A previous ChIP on chip analysis suggested that menin binds promoter sequences of nol3, encoding ARC, which is a cell death inhibitor that has been implicated in cancer pathogenesis. We hypothesized that ARC functions as a co-factor with Men1 loss to induce the tissue-restricted distribution of tumors seen in MEN1. Using mouse models that recapitulate this syndrome, we found that biallelic deletion of Men1 results in selective induction of ARC expression in tissues that develop tumors. Specifically, loss of Men1 in all cells of the pancreas resulted inmarked increases in ARC mRNA and protein in the endocrine, but not exocrine, pancreas. Similarly, ARC expression increased in the parathyroid with inactivation of Men1 in that tissue. To test if ARC contributes to MEN1 tumor development in the endocrine pancreas, we generated mice that lacked none, one, or both copies of ARC in the context of Men1 deletion. Studies in a cohort of 126 mice demonstrated that, although mice lacking Men1 developed insulinomas as expected, elimination of ARC in this context did not significantly alter tumor load. Cellular rates of proliferation and death in these tumors were also not perturbed in the absence of ARC. These results indicate that ARC is upregulated by loss Men1 in the tissue-restricted distribution of MEN1 tumors, but that ARC is not required for tumor development in this syndrome.	[McKimpson, Wendy M.; Zheng, Min; Kitsis, Richard N.] Albert Einstein Coll Med, Dept Med Cardiol, Bronx, NY 10461 USA; [McKimpson, Wendy M.; Kitsis, Richard N.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Yuan, Ziqiang; Libutti, Steven K.] Albert Einstein Coll Med, Dept Surg, Bronx, NY 10461 USA; [Libutti, Steven K.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [McKimpson, Wendy M.; Zheng, Min; Kitsis, Richard N.] Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Bronx, NY 10461 USA; [Libutti, Steven K.; Kitsis, Richard N.] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA; [Kitsis, Richard N.] Albert Einstein Coll Med, Einstein Sinai Diabet Res Ctr, Bronx, NY 10461 USA; [Crabtree, Judy S.] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA 70112 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Kitsis, RN (corresponding author), Albert Einstein Coll Med, Dept Med Cardiol, Bronx, NY 10461 USA.	richard.kitsis@einstein.yu.edu		McKimpson, Wendy/0000-0002-2262-5998	National Institute of Health [R01CA170911, R01HL060665, P30CA013330, P30DK020541, T32GM007491]; Louisiana State Board of Regents [LSQSF(2013-2015)-RD-A-04]; NIH [R01CA170911, R01HL060665, P30CA013330, P30DK020541, T32GM007491]; Dr. Gerald and Myra Dorris Chair in Cardiovascular Disease; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA170911] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296, P30DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana State Board of Regents; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Gerald and Myra Dorris Chair in Cardiovascular Disease; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of Health: R01CA170911 to RNK and SKL, R01HL060665 to RNK, P30CA013330 (institutional core facilities), P30DK020541 (pilot project) to RNK, and T32GM007491 to WMM. This work was also supported by Louisiana State Board of Regents funding #LSQSF(2013-2015)-RD-A-04 to JSC. RNK is supported by the Dr. Gerald and Myra Dorros Chair in Cardiovascular Disease. The authors thank the generosity of the Wilf Family for their ongoing support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the technical assistance of Asha Adem and Carmen Sanchez Claros. This work was supported by NIH grants R01CA170911, R01HL060665, P30CA013330, P30DK020541, and T32GM007491; and Louisiana State Board of Regents funding #LSQSF (2013-2015)-RD-A-04. R.N.K. is supported by the Dr. Gerald and Myra Dorris Chair in Cardiovascular Disease. We thank the generosity of the Wilf Family for their support.	Bassett JHD, 1998, AM J HUM GENET, V62, P232, DOI 10.1086/301729; Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Bertolino P, 2003, CANCER RES, V63, P4836; Carter BZ, 2011, BLOOD, V117, P780, DOI 10.1182/blood-2010-04-280503; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Crabtree JS, 2003, MOL CELL BIOL, V23, P6075, DOI 10.1128/MCB.23.17.6075-6085.2003; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; Foo RSY, 2007, P NATL ACAD SCI USA, V104, P20826, DOI 10.1073/pnas.0710017104; Foo RSY, 2007, J BIOL CHEM, V282, P5529, DOI 10.1074/jbc.M609046200; Friedman E. LC, 1994, THE PARATHYROIDS, P647; Gallo A, 2002, ONCOGENE, V21, P6434, DOI 10.1038/sj.onc.1205822; Geertman R, 1996, BBA-GENE STRUCT EXPR, V1306, P147, DOI 10.1016/0167-4781(96)00036-X; Guru SC, 1998, P NATL ACAD SCI USA, V95, P1630, DOI 10.1073/pnas.95.4.1630; Gustafsson AB, 2004, J BIOL CHEM, V279, P21233, DOI 10.1074/jbc.M400695200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heikaus S, 2008, APOPTOSIS, V13, P938, DOI 10.1007/s10495-008-0225-6; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; Li J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6177; Li YZ, 2008, MOL CELL BIOL, V28, P564, DOI 10.1128/MCB.00738-07; Libutti SK, 2003, CANCER RES, V63, P8022; Lin WC, 2015, MOL CANCER RES, V13, P689, DOI 10.1158/1541-7786.MCR-14-0457; Mak PY, 2014, BRIT J HAEMATOL, V167, P376, DOI 10.1111/bjh.13054; Matkar S, 2013, TRENDS BIOCHEM SCI, V38, P394, DOI [10.1016/j.tibs.2013.0S.005, 10.1016/j.tibs.2013.05.005]; McKimpson WM, 2013, DIABETES, V62, P183, DOI 10.2337/db12-0504; Medina-Ramirez CM, 2011, CANCER RES, V71, P7705, DOI 10.1158/0008-5472.CAN-11-2192; Mercier I, 2005, CELL DEATH DIFFER, V12, P682, DOI 10.1038/sj.cdd.4401631; Mercier I, 2008, CELL CYCLE, V7, P1640, DOI 10.4161/cc.7.11.5979; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Nam YJ, 2004, MOL CELL, V15, P901, DOI 10.1016/j.molcel.2004.08.020; Nam YJ, 2007, J BIOL CHEM, V282, P5522, DOI 10.1074/jbc.M609186200; Scacheri PC, 2004, MAMM GENOME, V15, P872, DOI 10.1007/s00335-004-2395-z; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Shen HCJ, 2009, CANCER RES, V69, P1858, DOI 10.1158/0008-5472.CAN-08-3662; Stewart C, 1998, ONCOGENE, V17, P2485, DOI 10.1038/sj.onc.1202164; Subramaniam K, 2013, CANCER LETT, V332, P151, DOI 10.1016/j.canlet.2012.07.005; Wang M, 2005, FEBS LETT, V579, P2411, DOI 10.1016/j.febslet.2005.03.040; Wu L, 2010, J BIOL CHEM, V285, P19235, DOI 10.1074/jbc.M110.114892; Wu P, 2013, ONCOL REP, V30, P1807, DOI 10.3892/or.2013.2622; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Zaiman AL, 2011, CIRCULATION, V124, P2533, DOI 10.1161/CIRCULATIONAHA.111.034512	44	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145792	10.1371/journal.pone.0145792	http://dx.doi.org/10.1371/journal.pone.0145792			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709830	gold, Green Published, Green Submitted			2022-12-27	WOS:000367451400079
J	Zheng, PX; Chan, YC; Chiou, CS; Chuan, CN; Wang, SY; Tsai, PJ; Chuang, WJ; Lin, YS; Liu, CC; Wu, JJ				Zheng, Po-Xing; Chan, Yuen-Chi; Chiou, Chien-Shun; Chuan Chiang-Ni; Wang, Shu-Ying; Tsai, Pei-Jane; Chuang, Woei-Jer; Lin, Yee-Shin; Liu, Ching-Chuan; Wu, Jiunn-Jong			Clustered Regularly Interspaced Short Palindromic Repeats Are emm Type-Specific in Highly Prevalent Group A Streptococci	PLOS ONE			English	Article							TYPING METHODS; DIVERSITY; STRAINS; EPIDEMIOLOGY; DISEASE; SYSTEMS; CRISPRS; TAIWAN; TIME; TOOL	Clustered regularly interspaced short palindromic repeats (CRISPR) are the bacterial adaptive immune system against foreign nucleic acids. Given the variable nature of CRISPR, it could be a good marker for molecular epidemiology. Group A streptococcus is one of the major human pathogens. It has two CRISPR loci, including CRISPR01 and CRISPR02. The aim of this study was to analyze the distribution of CRISPR-associated gene cassettes (cas) and CRISPR arrays in highly prevalent emm types. The cas cassette and CRISPR array in two CRISPR loci were analyzed in a total of 332 strains, including emm1, emm3, emm4, emm12, and emm28 strains. The CRISPR type was defined by the spacer content of each CRISPR array. All strains had at least one cas cassette or CRISPR array. More than 90% of the spacers were found in one emm type, specifically. Comparing the consistency between emm and CRISPR types by Simpson's index of diversity and the adjusted Wallace coefficient, CRISPR01 type was concordant to emm type, and CRISPR02 showed unidirectional congruence to emm type, suggesting that at least for the majority of isolates causing infection in high income countries, the emm type can be inferred from CRISPR analysis, which can further discriminate isolates sharing the same emm type.	[Zheng, Po-Xing; Wu, Jiunn-Jong] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chan, Yuen-Chi; Tsai, Pei-Jane; Wu, Jiunn-Jong] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Chiou, Chien-Shun] Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Taichung, Taiwan; [Chuan Chiang-Ni] Chang Gung Univ, Dept Microbiol & Immunol, Coll Med, Taoyuan, Taiwan; [Wang, Shu-Ying; Lin, Yee-Shin] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Chuang, Woei-Jer] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Liu, Ching-Chuan] Natl Cheng Kung Univ, Coll Med, Dept Pediat, Tainan 70101, Taiwan; [Wu, Jiunn-Jong] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Wu, Jiunn-Jong] Natl Yang Ming Univ, Sch Biomed Sci & Engn, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan	National Cheng Kung University; National Cheng Kung University; Centers For Disease Control - Taiwan; Chang Gung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Yang Ming Chiao Tung University	Wu, JJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan.	jjwu@mail.ncku.edu.tw	wang, shuying/HHZ-4516-2022; Zheng, Po Xing/M-3244-2014; Chiang-Ni, Chuan/ABD-9765-2021; Chiou, Chien-Shun/I-5355-2014	Zheng, Po Xing/0000-0001-5827-5865; Chiang-Ni, Chuan/0000-0002-0753-035X; Chiou, Chien-Shun/0000-0003-3674-1030	National Science Council in Taiwan [NSC101-2320-B-006-020-MY3, NSC101-2320-B-006-029-MY3]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants NSC101-2320-B-006-020-MY3 and NSC101-2320-B-006-029-MY3 from the National Science Council in Taiwan (http://www.most.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beall B, 2000, MICROBIOL-SGM, V146, P1195, DOI 10.1099/00221287-146-5-1195; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Chiou CS, 2004, J CLIN MICROBIOL, V42, P3998, DOI 10.1128/JCM.42.9.3998-4006.2004; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Davies MR, 2015, NAT GENET, V47, P84, DOI 10.1038/ng.3147; Delannoy S, 2012, J CLIN MICROBIOL, V50, P4035, DOI 10.1128/JCM.02097-12; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Friaes A, 2013, EUR J CLIN MICROBIOL, V32, P115, DOI 10.1007/s10096-012-1726-3; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Hoe N, 1999, EMERG INFECT DIS, V5, P254, DOI 10.3201/eid0502.990210; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lin HC, 2008, EUR J CLIN MICROBIOL, V27, P1253, DOI 10.1007/s10096-008-0561-z; McMillan DJ, 2013, CLIN MICROBIOL INFEC, V19, pE222, DOI 10.1111/1469-0691.12134; Mick E, 2013, RNA BIOL, V10, P900, DOI 10.4161/rna.23929; Nasser W, 2014, P NATL ACAD SCI USA, V111, pE1768, DOI 10.1073/pnas.1403138111; Nozawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019543; Plainvert C, 2012, CLIN MICROBIOL INFEC, V18, P702, DOI 10.1111/j.1469-0691.2011.03624.x; Pride DT, 2011, GENOME RES, V21, P126, DOI 10.1101/gr.111732.110; Rezzonico F, 2011, APPL ENVIRON MICROB, V77, P3819, DOI 10.1128/AEM.00177-11; Rho M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002441; Sesto N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004065; Severiano A, 2011, J CLIN MICROBIOL, V49, P3997, DOI 10.1128/JCM.00624-11; Severiano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019539; Shariat N, 2014, APPL ENVIRON MICROB, V80, P430, DOI 10.1128/AEM.02790-13; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Stern A, 2012, GENOME RES, V22, P1985, DOI 10.1101/gr.138297.112; Vale PF, 2010, P ROY SOC B-BIOL SCI, V277, P2097, DOI 10.1098/rspb.2010.0055; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zheng PX, 2014, CLIN MICROBIOL INFEC, V20, P516, DOI 10.1111/1469-0691.12379; Zheng PX, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00149-12	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145223	10.1371/journal.pone.0145223	http://dx.doi.org/10.1371/journal.pone.0145223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710228	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400027
J	Islam, A; Teo, SH; Rahman, MA; Taufiq-Yap, YH				Islam, Aminul; Teo, Siow Hwa; Rahman, M. Aminur; Taufiq-Yap, Yun Hin			Seeded Growth Route to Noble Calcium Carbonate Nanocrystal	PLOS ONE			English	Article							CRYSTAL-GROWTH; FABRICATION; NETWORKS; NANOPARTICLES; SURFACTANT; MODEL; SHAPE; SIZE	A solution-phase route has been considered as the most promising route to synthesize noble nanostructures. A majority of their synthesis approaches of calcium carbonate (CaCO3) are based on either using fungi or the CO2 bubbling methods. Here, we approached the preparation of nano-precipitated calcium carbonate single crystal from salmacis sphaeroides in the presence of zwitterionic or cationic biosurfactants without external source of CO2. The calcium carbonate crystals were rhombohedron structure and regularly shaped with side dimension ranging from 33-41 nm. The high degree of morphological control of CaCO3 nanocrystals suggested that surfactants are capable of strongly interacting with the CaCO3 surface and control the nucleation and growth direction of calcium carbonate nanocrystals. Finally, the mechanism of formation of nanocrystals in light of proposed routes was also discussed.	[Islam, Aminul; Teo, Siow Hwa; Taufiq-Yap, Yun Hin] Univ Putra Malaysia, Catalysis & Sci Res Ctr, Fac Sci, Upm Serdang 43400, Selangor, Malaysia; [Islam, Aminul; Teo, Siow Hwa; Taufiq-Yap, Yun Hin] Univ Putra Malaysia, Dept Chem, Fac Sci, Upm Serdang 43400, Selangor, Malaysia; [Rahman, M. Aminur] Univ Putra Malaysia, Lab Marine Biotechnol, Inst Biosci, Upm Serdang 43400, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Islam, A (corresponding author), Univ Putra Malaysia, Catalysis & Sci Res Ctr, Fac Sci, Upm Serdang 43400, Selangor, Malaysia.	aminul@upm.edu.my; taufiq@upm.edu.my	Teo, Siow Hwa/B-2099-2016; Islam, Aminul/J-1628-2016; Islam, Aminul/W-6383-2019; Yap, Yun Hin Taufiq/AAB-8959-2019	Teo, Siow Hwa/0000-0001-9927-8309; Yap, Yun Hin Taufiq/0000-0002-3994-6720; Islam, Aminul/0000-0001-9933-143X	Catalysis Science and Technology Research Centre, Faculty of Science, University Putra Malaysia, Malaysia	Catalysis Science and Technology Research Centre, Faculty of Science, University Putra Malaysia, Malaysia	The authors gratefully acknowledge the financial support from Catalysis Science and Technology Research Centre, Faculty of Science, University Putra Malaysia, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors gratefully acknowledge the financial support from Catalysis Science and Technology Research Centre, Faculty of Science, University Putra Malaysia, Malaysia.	Asenath-Smith E, 2012, ADV FUNCT MATER, V22, P2891, DOI 10.1002/adfm.201200300; CASES JM, 1992, LANGMUIR, V8, P1251, DOI 10.1021/la00041a005; Cushing BL, 2004, CHEM REV, V104, P3893, DOI 10.1021/cr030027b; El-Sheikh SM, 2013, COLLOID SURFACE A, V422, P44, DOI 10.1016/j.colsurfa.2013.01.020; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Gao F, 2012, CHEM SOC REV, V41, P8009, DOI 10.1039/c2cs35160a; Han SJ, 2011, ENERG FUEL, V25, P3825, DOI 10.1021/ef200415p; Helgason T, 2009, J COLLOID INTERF SCI, V334, P75, DOI 10.1016/j.jcis.2009.03.012; Islam A, 2014, RSC ADV, V4, P65127, DOI 10.1039/c4ra11653d; Kim YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5341; Kinge S, 2006, APPL ORGANOMET CHEM, V20, P784, DOI 10.1002/aoc.1126; Li D, 2006, J AM CHEM SOC, V128, P968, DOI 10.1021/ja056609n; Li DS, 2012, SCIENCE, V336, P1014, DOI 10.1126/science.1219643; Min W, 2000, MATER RES BULL, V35, P2199, DOI 10.1016/S0025-5408(00)00429-3; Mishra YK, 2013, PART PART SYST CHAR, V30, P775, DOI 10.1002/ppsc.201300197; Mishra YK, 2015, ACS APPL MATER INTER, V7, P14303, DOI 10.1021/acsami.5b02816; Mishra YK, 2014, KONA POWDER PART J, P92; NARSIMHAN G, 1961, CHEM ENG SCI, V16, P7, DOI 10.1016/0009-2509(61)87002-4; Pastoriza-Santos I, 2006, CHEM MATER, V18, P2465, DOI 10.1021/cm060293g; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Rautaray D, 2004, J MATER CHEM, V14, P2333, DOI 10.1039/b401431f; Ribeiro C, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2779932; ROMERO B, 1994, INORG CHEM, V33, P1869, DOI 10.1021/ic00087a023; Song RQ, 2009, ACS NANO, V3, P1966, DOI 10.1021/nn900377d; Vagenas NV, 2003, TALANTA, V59, P831, DOI 10.1016/S0039-9140(02)00638-0; Xu XJ, 2011, SMALL, V7, P445, DOI 10.1002/smll.201001849; Zeng HB, 2009, ADV FUNCT MATER, V19, P3165, DOI 10.1002/adfm.200900714	28	8	8	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144805	10.1371/journal.pone.0144805	http://dx.doi.org/10.1371/journal.pone.0144805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700479	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092600033
J	Ntokou, E; Hansen, LH; Kongsted, J; Vester, B				Ntokou, Eleni; Hansen, Lykke Haastrup; Kongsted, Jacob; Vester, Birte			Biochemical and Computational Analysis of the Substrate Specificities of Cfr and RlmN Methyltransferases	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; CONFERS ANTIBIOTIC-RESISTANCE; RADICAL SAM ENZYMES; 23S RIBOSOMAL-RNA; LINEZOLID RESISTANCE; MEDIATED RESISTANCE; METHYL TRANSFER; IDENTIFICATION; MECHANISM; PLASMID	Cfr and RlmN methyltransferases both modify adenine 2503 in 23S rRNA (Escherichia coli numbering). RlmN methylates position C2 of adenine while Cfr methylates position C8, and to a lesser extent C2, conferring antibiotic resistance to peptidyl transferase inhibitors. Cfr and RlmN show high sequence homology and may be evolutionarily linked to a common ancestor. To explore their individual specificity and similarity we performed two sets of experiments. We created a homology model of Cfr and explored the C2/C8 specificity using docking and binding energy calculations on the Cfr homology model and an X-ray structure of RlmN. We used a trinucleotide as target sequence and assessed its positioning at the active site for methylation. The calculations are in accordance with different poses of the trinucleotide in the two enzymes indicating major evolutionary changes to shift the C2/C8 specificities. To explore interchangeability between Cfr and RlmN we constructed various combinations of their genes. The function of the mixed genes was investigated by RNA primer extension analysis to reveal methylation at 23S rRNA position A2503 and by MIC analysis to reveal antibiotic resistance. The catalytic site is expected to be responsible for the C2/C8 specificity and most of the combinations involve interchanging segments at this site. Almost all replacements showed no function in the primer extension assay, apart from a few that had a weak effect. Thus Cfr and RlmN appear to be much less similar than expected from their sequence similarity and common target.	[Ntokou, Eleni; Hansen, Lykke Haastrup; Vester, Birte] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Kongsted, Jacob] Univ Southern Denmark, Dept Phys Chem & Pharm, Odense, Denmark	University of Southern Denmark; University of Southern Denmark	Ntokou, E (corresponding author), Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark.	elenin@bmb.sdu.dk	Kongsted, Jacob/AAD-3458-2022	Kongsted, Jacob/0000-0002-7725-2164; Vester, Birte/0000-0002-5368-0500; Ntokou, Eleni/0000-0003-1869-1121	Danish Council for Independent Research - Natural Sciences [12-125943]	Danish Council for Independent Research - Natural Sciences(Det Frie Forskningsrad (DFF))	This work was supported by the Danish Council for Independent Research - Natural Sciences, Grant 12-125943 (http://ufm.dk/forskning-og-innovation/rad-og-udvalg/det-frie-forskningsrad). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson GC, 2013, ANTIMICROB AGENTS CH, V57, P4019, DOI 10.1128/AAC.00448-13; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baos E, 2013, DIAGN MICR INFEC DIS, V76, P325, DOI 10.1016/j.diagmicrobio.2013.04.002; Bender J, 2015, J ANTIMICROB CHEMOTH, V70, P1630, DOI 10.1093/jac/dkv025; Benitez-Paez A, 2012, RNA, V18, P1783, DOI 10.1261/rna.033266.112; Boal AK, 2011, SCIENCE, V332, P1089, DOI 10.1126/science.1205358; Cai JC, 2015, ANTIMICROB AGENTS CH, V59, P3669, DOI 10.1128/AAC.04580-14; Cui LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057096; Deshpande LM, 2015, ANTIMICROB AGENTS CH, V59, P6256, DOI 10.1128/AAC.01473-15; Diaz L, 2012, ANTIMICROB AGENTS CH, V56, P3917, DOI 10.1128/AAC.00419-12; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Giessing AMB, 2009, RNA, V15, P327, DOI 10.1261/rna.1371409; Grove TL, 2013, NAT CHEM BIOL, V9, P422, DOI [10.1038/NCHEMBIO.1251, 10.1038/nchembio.1251]; Grove TL, 2011, J AM CHEM SOC, V133, P19586, DOI 10.1021/ja207327v; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Hansen LH, 2015, ANTIMICROB AGENTS CH, V59, P5841, DOI 10.1128/AAC.01274-15; Hansen LH, 2012, ANTIMICROB AGENTS CH, V56, P3563, DOI 10.1128/AAC.00673-12; Kaminska KH, 2010, NUCLEIC ACIDS RES, V38, P1652, DOI 10.1093/nar/gkp1142; Kehrenberg C, 2005, MOL MICROBIOL, V57, P1064, DOI 10.1111/j.1365-2958.2005.04754.x; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KOWALAK JA, 1995, J BIOL CHEM, V270, P17758, DOI 10.1074/jbc.270.30.17758; Layer G, 2004, CURR OPIN CHEM BIOL, V8, P468, DOI 10.1016/j.cbpa.2004.08.001; Livermore DM, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg249; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; Mendes RE, 2008, ANTIMICROB AGENTS CH, V52, P2244, DOI 10.1128/AAC.00231-08; Motorin Y, 2007, METHOD ENZYMOL, V425, P21; Patel SN, 2013, DIAGN MICR INFEC DIS, V77, P350, DOI 10.1016/j.diagmicrobio.2013.08.012; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schwarz S, 2000, ANTIMICROB AGENTS CH, V44, P2530, DOI 10.1128/AAC.44.9.2530-2533.2000; SEKIGUCHI M, 1967, P NATL ACAD SCI USA, V58, P2315, DOI 10.1073/pnas.58.6.2315; Smith LK, 2008, ANTIMICROB AGENTS CH, V52, P1703, DOI 10.1128/AAC.01583-07; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; STERN S, 1988, METHOD ENZYMOL, V164, P481; SUTCLIFFE JG, 1979, COLD SPRING HARB SYM, V43, P77, DOI 10.1101/SQB.1979.043.01.013; Toh SM, 2007, MOL MICROBIOL, V64, P1506, DOI 10.1111/j.1365-2958.2007.05744.x; Toh SM, 2008, RNA, V14, P98, DOI 10.1261/rna.814408; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; Yan F, 2011, P NATL ACAD SCI USA, V108, P3930, DOI 10.1073/pnas.1017781108	38	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145655	10.1371/journal.pone.0145655	http://dx.doi.org/10.1371/journal.pone.0145655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700482	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092600113
J	Uchida, S; Chang, WX; Ota, T; Tamura, Y; Shiraishi, T; Kumagai, T; Shibata, S; Fujigaki, Y; Hosoyamada, M; Kaneko, K; Shen, ZY; Fujimori, S				Uchida, Shunya; Chang, Wen Xiu; Ota, Tatsuru; Tamura, Yoshifuru; Shiraishi, Takeshi; Kumagai, Takanori; Shibata, Shigeru; Fujigaki, Yoshihide; Hosoyamada, Makoto; Kaneko, Kiyoko; Shen, Zhong Yang; Fujimori, Shin			Targeting Uric Acid and the Inhibition of Progression to End-Stage Renal Disease-A Propensity Score Analysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR EVENTS; TREAT; CKD; TIME; ALLOPURINOL; OUTCOMES; HYPERURICEMIA; METAANALYSIS; REDUCTION	Background The role of uric acid (UA) in the progression of chronic kidney disease (CKD) remains controversial due to the unavoidable cause and result relationship. This study was aimed to clarify the independent impact of UA on the subsequent risk of end-stage renal disease (ESRD) by a propensity score analysis. Methods A retrospective CKD cohort was used (n = 803). Baseline 23 covariates were subjected to a multivariate binary logistic regression with the targeted time-averaged UA of 6.0, 6.5 or 7.0 mg/dL. The participants trimmed 2.5 percentile from the extreme ends of the cohort underwent propensity score analyses consisting of matching, stratification on quintile and covariate adjustment. Covariate balances after 1: 1 matching without replacement were tested for by paired analysis and standardized differences. A stratified Cox regression and a Cox regression adjusted for logit of propensity scores were examined. Results After propensity score matching, the higher UA showed elevated hazard ratios (HRs) by Kaplan-Meier analysis (>= 6.0 mg/dL, HR 4.53, 95% CI 1.79-11.43; >= 6.5 mg/dL, HR 3.39, 95% CI 1.55-7.42; >= 7.0 mg/dL, HR 2.19, 95% CI 1.28-3.75). The number needed to treat was 8 to 9 over 5 years. A stratified Cox regression likewise showed significant crude HRs (>= 6.0 mg/dL, HR 3.63, 95% CI 1.25-10.58; >= 6.5 mg/dL, HR 3.46, 95% CI 1.56-7.68; >= 7.0 mg/dL, HR 2.05, 95% CI 1.21-3.48). Adjusted HR lost its significance at 6.0 mg/dL. The adjustment for the logit of the propensity scores showed the similar results but with worse model fittings than the stratification method. Upon further adjustment for other covariates the significance was attained at 6.5 mg/dL. Conclusions Three different methods of the propensity score analysis showed consistent results that the higher UA accelerates the progression to the subsequent ESRD. A stratified Cox regression outperforms other methods in generalizability and adjusting for residual bias. Serum UA should be targeted less than 6.5 mg/dL.	[Uchida, Shunya; Ota, Tatsuru; Tamura, Yoshifuru; Shiraishi, Takeshi; Kumagai, Takanori; Shibata, Shigeru; Fujigaki, Yoshihide; Fujimori, Shin] Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan; [Chang, Wen Xiu] Tianjin First Cent Hosp, Dept Nephrol, Tianjin, Peoples R China; [Shiraishi, Takeshi; Kumagai, Takanori] Teikyo Univ, Sch Med, Tokyo 173, Japan; [Hosoyamada, Makoto] Teikyo Univ, Fac Pharma Sci, Human Physiol & Pathol, Tokyo 173, Japan; [Kaneko, Kiyoko] Teikyo Univ, Fac Pharma Sci, Biomed & Analyt Sci, Tokyo 173, Japan; [Shen, Zhong Yang] Tianjin First Cent Hosp, Dept Organ Transplantat, Tianjin, Peoples R China	Teikyo University; Tianjin Medical University; Teikyo University; Teikyo University; Teikyo University; Tianjin Medical University	Uchida, S (corresponding author), Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan.	s_uchida@netjoy.ne.jp		, wen xiu/0000-0001-6269-5694; Shibata, Shigeru/0000-0002-6868-0626	Ministry of Health, Labour and Welfare of Japan; Gout Research Foundation	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Gout Research Foundation	This study was supported in part by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Rare and Intractable Disease, from the Ministry of Health, Labour and Welfare of Japan (to SU) and Gout Research Foundation (to SU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bellomo G, 2015, AM J KIDNEY DIS, V65, P525, DOI 10.1053/j.ajkd.2015.01.001; Borghi C, 2015, J HYPERTENS, V33, P1729, DOI 10.1097/HJH.0000000000000701; Bose B, 2014, NEPHROL DIAL TRANSPL, V29, P406, DOI 10.1093/ndt/gft378; Chang WX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132927; Chang WX, 2016, CLIN EXP NEPHROL, V20, P58, DOI 10.1007/s10157-015-1132-0; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Cookson J, 2006, INT CLIN PSYCHOPHARM, V21, P267, DOI 10.1097/00004850-200609000-00004; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; De Cosmo S, 2015, CLIN J AM SOC NEPHRO, V10, P1921, DOI 10.2215/CJN.03140315; Dousdampanis P, 2014, RENAL FAILURE, V36, P1351, DOI 10.3109/0886022X.2014.947516; Giordano C, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/382918; Goicoechea M, 2015, AM J KIDNEY DIS, V65, P543, DOI 10.1053/j.ajkd.2014.11.016; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Hosoya T, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-26; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Jalal DI, 2013, AM J KIDNEY DIS, V61, P134, DOI 10.1053/j.ajkd.2012.07.021; Johnson RJ, 2013, NEPHROL DIAL TRANSPL, V28, P2221, DOI 10.1093/ndt/gft029; Kanbay M, 2010, BLOOD PURIFICAT, V30, P288, DOI 10.1159/000321074; Kuriyama S, 2015, CLIN EXP NEPHROL, V19, P1127, DOI 10.1007/s10157-015-1120-4; Little RJ, 2000, ANNU REV PUBL HEALTH, V21, P121, DOI 10.1146/annurev.publhealth.21.1.121; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nacak H, 2015, NEPHROL DIAL TRANSPL, V30, P2039, DOI 10.1093/ndt/gfv225; Nacak H, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-91; Nakhoul GN, 2015, CLIN J AM SOC NEPHRO, V10, P1119, DOI 10.2215/CJN.11121114; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Petersen ML, 2012, STAT METHODS MED RES, V21, P31, DOI 10.1177/0962280210386207; Rosenbaum P, 1983, BIOGEOSCIENCES, V40, P41; Rubin DB, 2004, PHARMACOEPIDEM DR S, V13, P855, DOI 10.1002/pds.968; Santos RD, 2009, CARDIOLOGY, V114, P298, DOI 10.1159/000239859; Sinclair JC, 2001, J CLIN EPIDEMIOL, V54, P253, DOI 10.1016/S0895-4356(01)00347-X; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; Vansteelandt S, 2014, STAT MED, V33, P4053, DOI 10.1002/sim.6207; Yamamoto R, 2010, AM J KIDNEY DIS, V56, P313, DOI 10.1053/j.ajkd.2010.02.351; Zhu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100801	42	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145506	10.1371/journal.pone.0145506	http://dx.doi.org/10.1371/journal.pone.0145506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700005	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600090
J	Yu, WJ; Zhu, H; Wang, YM; Li, GJ; Wang, LH; Li, HF				Yu, Wenjuan; Zhu, Hao; Wang, Yueming; Li, Guanjun; Wang, Lihua; Li, Huafang			Reactive Transformation and Increased BDNF Signaling by Hippocampal Astrocytes in Response to MK-801	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; RAT FRONTAL-CORTEX; PROTEIN-SYNTHESIS; SCHIZOPHRENIA; BRAIN; RECEPTOR; EXPRESSION; ROLES; ACTIVATION; MECHANISMS	MK-801, also known as dizocilpine, is a noncompetitive N-methyl-D-aspartic acid (NMDA) receptor antagonist that induces schizophrenia-like symptoms. While astrocytes have been implicated in the pathophysiology of psychiatric disorders, including schizophrenia, astrocytic responses to MK-801 and their significance to schizotypic symptoms are unclear. Changes in the expression levels of glial fibrillary acid protein (GFAP), a marker of astrocyte activation in response to a variety of pathogenic stimuli, were examined in the hippocampus of rats treated with the repeated MK-801 injection (0.5 mg/10ml/kg body weight for 6 days) and in primary cultured hippocampal astrocytes incubated with MK-801 (5 or 20 mu M for 24 h). Moreover, the expression levels of BDNF and its receptors TrkB and p75 were examined in MK-801-treated astrocyte cultures. MK-801 treatment enhanced GFAP expression in the rat hippocampus and also increased the levels of GFAP protein and mRNA in hippocampal astrocytes in vitro. Treatment of cultured hippocampal astrocytes with MK-801 enhanced protein and mRNA levels of BDNF, TrkB, and p75. Collectively, our results suggest that hippocampal astrocytes may contribute to the pathophysiology of schizophrenia symptoms associated with NMDA receptor hypofunction by reactive transformation and altered BDNF signaling.	[Yu, Wenjuan; Li, Guanjun; Wang, Lihua; Li, Huafang] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Shanghai 200030, Peoples R China; [Zhu, Hao] Shanghai Jiao Tong Univ, Dept Anesthesiol, Sch Med, Renji Hosp, Shanghai 200030, Peoples R China; [Wang, Yueming] Shanghai Jiao Tong Univ, Dept Anat, Sch Med, Shanghai 200030, Peoples R China; [Li, Huafang] Shanghai Key Lab Psychot Disorders, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, HF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Shanghai 200030, Peoples R China.	smhcmict@163.com			national key project [2012ZX09303-003]; national natural science foundation of China [81201505, 31100782]; Shanghai natural science foundation [12ZR1446000]; Shanghai municipal incubation grant for talented researcher of health care [XBR2011049]; Shanghai health bureau scientific research foundation [20134Y066]; Shanghai mental health center research foundation [2013-YJ-06]	national key project; national natural science foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai natural science foundation(Natural Science Foundation of Shanghai); Shanghai municipal incubation grant for talented researcher of health care; Shanghai health bureau scientific research foundation; Shanghai mental health center research foundation	This study was supported by the national key project (2012ZX09303-003), national natural science foundation of China (81201505, 31100782), Shanghai natural science foundation (12ZR1446000), Shanghai municipal incubation grant for talented researcher of health care (XBR2011049), Shanghai health bureau scientific research foundation (20134Y066), and Shanghai mental health center research foundation (2013-YJ-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YM, 2005, INT J NEUROPSYCHOPH, V8, P607, DOI 10.1017/S1461145705005353; Andrews JL, 2015, PROG NEURO-PSYCHOPH, V63, P91, DOI 10.1016/j.pnpbp.2015.06.003; Aroeira RI, 2015, GLIA, V63, P2181, DOI 10.1002/glia.22884; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Capuano B, 2002, CURR MED CHEM, V9, P521, DOI 10.2174/0929867024606939; Cardile V, 2003, BRAIN RES, V976, P227, DOI 10.1016/S0006-8993(03)02720-3; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Cragnolini AB, 2008, TRENDS NEUROSCI, V31, P99, DOI 10.1016/j.tins.2007.11.005; Balderas PMD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126314; Eyjolfsson EM, 2006, NEUROCHEM INT, V48, P541, DOI 10.1016/j.neuint.2005.11.019; FIX AS, 1995, NEUROTOXICOLOGY, V16, P229; Fulmer CG, 2014, J NEUROSCI, V34, P8186, DOI 10.1523/JNEUROSCI.4267-13.2014; Fumagalli F, 2003, J NEUROSCI RES, V72, P622, DOI 10.1002/jnr.10609; Gomes FV, 2015, SCHIZOPHR RES, V164, P155, DOI 10.1016/j.schres.2015.01.015; Guest PC, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00180; Gui T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082449; Guo CM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/783297; Hansen HH, 2004, NEUROBIOL DIS, V16, P440, DOI 10.1016/j.nbd.2004.03.013; Heja L, 2014, CURR MED CHEM, V21, P755, DOI 10.2174/0929867320666131119160445; Kato H, 2006, SYNAPSE, V59, P10, DOI 10.1002/syn.20213; Kondziella D, 2006, NEUROPSYCHOPHARMACOL, V31, P1880, DOI 10.1038/sj.npp.1300993; Kornhuber J, 1997, BIOL PSYCHIAT, V41, P135, DOI 10.1016/S0006-3223(96)00047-9; Koyama Y, 2003, EUR J NEUROSCI, V18, P887, DOI 10.1046/j.1460-9568.2003.02797.x; Kuczewski N, 2010, EUR J NEUROSCI, V32, P1239, DOI 10.1111/j.1460-9568.2010.07378.x; Lu Bai, 2008, Novartis Found Symp, V289, P119; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Martins-de-Souza D, 2011, EUR ARCH PSY CLIN N, V261, P217, DOI 10.1007/s00406-010-0166-2; OLNEY JW, 1995, NEUROPSYCHOPHARMACOL, V13, P335, DOI 10.1038/sj.npp.1380292; Parpura V, 2010, BRAIN RES REV, V63, P83, DOI 10.1016/j.brainresrev.2009.11.008; Quesseveur G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.30; Seo MS, 2007, INT J NEUROPSYCHOPH, V10, P359, DOI 10.1017/S1461145706006869; Takahashi N, 2013, NEUROBIOL DIS, V53, P49, DOI 10.1016/j.nbd.2012.11.001; Theberge J, 2002, AM J PSYCHIAT, V159, P1944, DOI 10.1176/appi.ajp.159.11.1944; van Elst LT, 2005, BIOL PSYCHIAT, V58, P724, DOI 10.1016/j.biopsych.2005.04.041; Vaz SH, 2011, J BIOL CHEM, V286, P40464, DOI 10.1074/jbc.M111.232009; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; Xia Y, 2010, NEUROPHARMACOLOGY, V58, P330, DOI 10.1016/j.neuropharm.2009.10.009; [于文娟 Yu Wenjuan], 2011, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V37, P621; Zaccaro MC, 2001, J BIOL CHEM, V276, P31023, DOI 10.1074/jbc.M104630200; Zhang XY, 2012, HUM GENET, V131, P1187, DOI 10.1007/s00439-012-1150-x; Zhou XF, 2007, J NEUROSCI RES, V85, P1601, DOI 10.1002/jnr.21220; Zhu H, 2012, BRAIN RES, V1439, P1, DOI 10.1016/j.brainres.2011.12.035; Zhu SH, 2014, NEUROCHEM RES, V39, P2385, DOI 10.1007/s11064-014-1441-9	45	16	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145651	10.1371/journal.pone.0145651	http://dx.doi.org/10.1371/journal.pone.0145651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700309	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092600112
J	Bu, ZQ; Sun, YP				Bu, Zhiqin; Sun, Yingpu			The Impact of Endometrial Thickness on the Day of Human Chorionic Gonadotrophin (hCG) Administration on Ongoing Pregnancy Rate in Patients with Different Ovarian Response	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; EMBRYO-TRANSFER; PATTERN; COHORT; IVF; WOMEN	In order to explore the impact of endometrial thickness on hCG administration day on ongoing pregnancy rate (OPR) in IVF-ET cycles, we retrospectively analyzed data from 10,406 patients undergoing their first IVF cycles with standard gonadotropin releasing hormone analogue (GnRH-a) long protocol. Firstly, patients were divided into poor (<= 5 oocytes), medium (6-14 oocytes), and high (>= 15 oocytes) ovarian responders based on the number of oocytes retrieved. In each group, patients were sub-divided into three groups according to the endometrial thickness on the day of hCG administration: Group A, thin endometrial thickness (<= 7 mm); Group B, medium endometrial thickness (8-13 mm); Group C, thick endometrial thickness (>= 14 mm). (1) For poor responders, OPRs were significantly different in the three endometrial thickness groups (28.57%, 44.25%, and 51.34%; P = 0.008). The association between thin endometrial thickness and OPR was significant after controlling for age, number of embryos transferred by multivariate logistic regression analysis (adjusted OR: 0.408; 95% CI: 0.186-0.898; P = 0.026. Reference = thick endometrial thickness). (2) For medium responders, OPRs were 31.58%, 55.56%, and 63.01% (P = 0.000) in the three groups. Adjusted OR for thin endometrial thickness was 0.284 (95% CI: 0.182-0.444; P = 0.000). (3) For high responders, OPRs were also significantly different in the three groups (28.13%, 52.63%, and 63.18; P = 0.000). Adjusted OR for thin endometrial thickness was 0.233 (95% CI: 0.105-0.514; P = 0.000). For patients undergoing IVF with different ovarian response, a thin endometrium on the day of hCG administration adversely affects ongoing pregnancy rate.	[Bu, Zhiqin; Sun, Yingpu] Zhengzhou Univ, Affiliated Hosp 1, Reprod Med Ctr, Zhengzhou 450052, Peoples R China	Zhengzhou University	Sun, YP (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Reprod Med Ctr, Zhengzhou 450052, Peoples R China.	syp2008@vip.sina.com			Youth Foundation of The First Affiliated Hospital of Zhengzhou University; National Natural Science Foundation of China [31271605]	Youth Foundation of The First Affiliated Hospital of Zhengzhou University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Youth Foundation of The First Affiliated Hospital of Zhengzhou University, and the National Natural Science Foundation of China (Grant No. 31271605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghamdi A, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-37; Barker MA, 2009, J ASSIST REPROD GEN, V26, P243, DOI 10.1007/s10815-009-9312-z; Bassil S, 2001, ULTRASOUND OBST GYN, V18, P258, DOI 10.1046/j.1469-0705.2001.00502.x; Casper RF, 2011, FERTIL STERIL, V96, P519, DOI 10.1016/j.fertnstert.2011.07.1096; De Geyter C, 2000, FERTIL STERIL, V73, P106, DOI 10.1016/S0015-0282(99)00484-7; Gleicher N, 2013, HUM REPROD, V28, P172, DOI 10.1093/humrep/des370; Hu LL, 2014, INT J CLIN EXP MED, V7, P1128; Jin HX, 2015, SYST BIOL REPROD MED, V61, P96, DOI 10.3109/19396368.2014.986693; Kasius A, 2014, HUM REPROD UPDATE, V20, P530, DOI 10.1093/humupd/dmu011; Kovacs P, 2003, HUM REPROD, V18, P2337, DOI 10.1093/humrep/deg461; Momeni Mazdak, 2011, J Hum Reprod Sci, V4, P130, DOI 10.4103/0974-1208.92287; Reynolds K, 2010, FERTIL STERIL, V93, P2091, DOI 10.1016/j.fertnstert.2009.08.038; Traub ML, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-33; Zhao J, 2014, REPROD BIOMED ONLINE, V29, P291, DOI 10.1016/j.rbmo.2014.05.011	14	21	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145703	10.1371/journal.pone.0145703	http://dx.doi.org/10.1371/journal.pone.0145703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717148	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500059
J	Gupta, N; Benjamin, M; Kar, A; Munjal, SD; Sarangi, AN; Dalal, A; Aggarwal, R				Gupta, Neha; Benjamin, Mercilena; Kar, Anjana; Munjal, Sachin Dev; Sarangi, Aditya N.; Dalal, Ashwin; Aggarwal, Rakesh			Identification of Promotor and Exonic Variations, and Functional Characterization of a Splice Site Mutation in Indian Patients with Unconjugated Hyperbilirubinemia	PLOS ONE			English	Article							DIPHOSPHATE-GLUCURONOSYLTRANSFERASE GENE; CRIGLER-NAJJAR-SYNDROME; UGT1A1 GENE; GILBERTS-SYNDROME; UDP-GLUCURONOSYLTRANSFERASE; BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE-1; PROTEIN MUTATIONS; POLYMORPHISMS; VARIANTS; ALLELE	Background Mild unconjugated hyperbilirubinemia (UH), due to reduced activity of the enzyme uridine diphosphoglucuronate-glucuronosyltransferase family, polypeptide 1 (UGT1A1), is a common clinical condition. Most cases are caused by presence in homozygous form of an A (TA)(7)TAA nucleotide sequence instead of the usual A(TA)(6)TAA sequence in promoter region of the UGT1A1 gene. In some cases, other genetic variations have been identified which differ between populations. There is need for more data on such genetic variations from India. Methods DNA from subjects with unexplained persistent or recurrent UH was tested for the presence of TA promoter insertions. In addition, all five exons and splicing site regions of UGT1A1 gene were sequenced. Several bioinformatics tools were used to determine the biological significance of the observed genetic changes. Functional analysis was done to look for effect of a splice site mutation in UGT1A1. Results Of 71 subjects with UH (68 male; median age [range], 26 [16-63] years; serum bilirubin 56 [26-219] mu M/L, predominantly unconjugated) studied, 65 (91.5%) subjects were homozygous for A(TA)7TAA allele, five (7.0%) were heterozygous, and one (1.4%) lacked this change. Fifteen subjects with UH had missense exonic single nucleotide changes (14 heterozygous, 1 homozygous), including one subject with a novel nucleotide change (p. Thr205Asn). Bioinformatics tools predicted some of these variations (p.Arg108Cys, p. lle159Thr and p.Glu463Val) to be deleterious. Functional characterization of an exonic variation (c.1084G>A) located at a splice site revealed that it results in frameshift deletion of 31 nucleotides and premature truncation of the protein. Conclusion Our study revealed several single nucleotide variations in UGT1A1 gene in Indian subjects with UH. Functional characterization of a splice site variation indicated that it leads to disordered splicing. These variations may explain UH in subjects who lacked homozygous A (TA)(7)TAA promoter alleles.	[Gupta, Neha; Benjamin, Mercilena; Munjal, Sachin Dev; Aggarwal, Rakesh] Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow 226014, Uttar Pradesh, India; [Sarangi, Aditya N.; Aggarwal, Rakesh] Sanjay Gandhi Postgrad Inst Med Sci, Biomed Informat Ctr, Lucknow 226014, Uttar Pradesh, India; [Kar, Anjana; Dalal, Ashwin] Ctr DNA Fingerprinting & Diagnost, Div Diagnost, Hyderabad 500001, Andhra Pradesh, India; [Kar, Anjana] Manipal Univ, Grad Studies, Manipal 576104, Karnataka, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE)	Aggarwal, R (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow 226014, Uttar Pradesh, India.	aggarwal.ra@gmail.com	Aggarwal, Rakesh/D-1583-2009; BENJAMIN, MERCILENA/X-4459-2019; DALAL, ASHWIN/GXF-0028-2022	Aggarwal, Rakesh/0000-0001-9689-494X; BENJAMIN, MERCILENA/0000-0003-3919-0254; DALAL, ASHWIN/0000-0001-5929-745X; MUNJAL, SACHIN/0000-0002-5330-1603; Sarangi, Arkaprabha/0000-0002-9820-679X	Department of Science and Technology, Government of India under FIST program; Indian Council of Medical Research (ICMR), New Delhi; University Grants Commission, New Delhi	Department of Science and Technology, Government of India under FIST program; Indian Council of Medical Research (ICMR), New Delhi(Indian Council of Medical Research (ICMR)); University Grants Commission, New Delhi(University Grants Commission, India)	The sequencing facility at the authors' institution is supported by the Department of Science and Technology, Government of India, under its FIST program, and Biomedical Informatics Center is supported by the Indian Council of Medical Research (ICMR), New Delhi. During this work, NG was supported by University Grants Commission, New Delhi, and MB and ANS by ICMR, New Delhi.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Aggarwal V, 2010, PEDIATR BLOOD CANCER, V54, P627, DOI 10.1002/pbc.22313; Agrawal SK, 2009, PEDIATR RES, V65, P675, DOI 10.1203/PDR.0b013e31819ed5de; Akaba K, 1999, J HUM GENET, V44, P22, DOI 10.1007/s100380050100; Balram C, 2002, PHARMACOGENETICS, V12, P81, DOI 10.1097/00008571-200201000-00012; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Canu G, 2013, BLOOD CELL MOL DIS, V50, P273, DOI 10.1016/j.bcmd.2013.01.003; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Farheen S, 2006, WORLD J GASTROENTERO, V12, P2269, DOI 10.3748/wjg.v12.i14.2269; Gaildrat P, 2012, J MED GENET, V49, P609, DOI 10.1136/jmedgenet-2012-100965; Gong QH, 2001, PHARMACOGENETICS, V11, P357, DOI 10.1097/00008571-200106000-00011; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kadakol A, 2000, HUM MUTAT, V16, P297, DOI 10.1002/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z; Kadakol A, 2001, J MED GENET, V38, P244, DOI 10.1136/jmg.38.4.244; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; Liu X, 2014, PHARMACOGENOMICS J, V14, P120, DOI 10.1038/tpj.2013.10; Mort M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r19; POWELL LW, 1967, NEW ENGL J MED, V277, P1108, DOI 10.1056/NEJM196711232772102; Premawardhena A, 2003, BLOOD CELL MOL DIS, V31, P98, DOI 10.1016/S1079-9796(03)00071-8; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Rodrigues C, 2012, BLOOD CELL MOL DIS, V48, P166, DOI 10.1016/j.bcmd.2012.01.004; Rotger M, 2005, J INFECT DIS, V192, P1381, DOI 10.1086/466531; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Skierka JM, 2013, J PEDIATR-US, V162, P1146, DOI 10.1016/j.jpeds.2012.11.042; Takeuchi K, 2004, J GASTROEN HEPATOL, V19, P1023, DOI 10.1111/j.1440-1746.2004.03370.x; Tournier I, 2008, HUM MUTAT, V29, P1412, DOI 10.1002/humu.20796; Yamamoto K, 1998, BBA-MOL BASIS DIS, V1406, P267, DOI 10.1016/S0925-4439(98)00013-1	31	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145967	10.1371/journal.pone.0145967	http://dx.doi.org/10.1371/journal.pone.0145967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716871	gold, Green Submitted, Green Published			2022-12-27	WOS:000367510500105
J	Hoffmann, LS; Kretschmer, A; Lawrenz, B; Hocher, B; Stasch, JP				Hoffmann, Linda S.; Kretschmer, Axel; Lawrenz, Bettina; Hocher, Berthold; Stasch, Johannes-Peter			Chronic Activation of Heme Free Guanylate Cyclase Leads to Renal Protection in Dahl Salt-Sensitive Rats	PLOS ONE			English	Article							NITRIC-OXIDE; OXIDATIVE STRESS; INDEPENDENT ACTIVATION; ENDOTHELIAL DYSFUNCTION; PULMONARY-HYPERTENSION; CARDIOVASCULAR-DISEASE; NO; CGMP; RECEPTOR; BINDING	The nitric oxide (NO)/soluble guanylate cyclase (sGC)/cyclic guanosine monophasphate (cGMP)-signalling pathway is impaired under oxidative stress conditions due to oxidation and subsequent loss of the prosthetic sGC heme group as observed in particular in chronic renal failure. Thus, the pool of heme free sGC is increased under pathological conditions. sGC activators such as cinaciguat selectively activate the heme free form of sGC and target the disease associated enzyme. In this study, a therapeutic effect of long-term activation of heme free sGC by the sGC activator cinaciguat was investigated in an experimental model of salt-sensitive hypertension, a condition that is associated with increased oxidative stress, heme loss from sGC and development of chronic renal failure. For that purpose Dahl/ss rats, which develop severe hypertension upon high salt intake, were fed a high salt diet (8% NaCl) containing either placebo or cinaciguat for 21 weeks. Cinaciguat markedly improved survival and ameliorated the salt-induced increase in blood pressure upon treatment with cinaciguat compared to placebo. Renal function was significantly improved in the cinaciguat group compared to the placebo group as indicated by a significantly improved glomerular filtration rate and reduced urinary protein excretion. This was due to anti-fibrotic and antiinflammatory effects of the cinaciguat treatment. Taken together, this is the first study showing that long-term activation of heme free sGC leads to renal protection in an experimental model of hypertension and chronic kidney disease. These results underline the promising potential of cinaciguat to treat renal diseases by targeting the disease associated heme free form of sGC.	[Hoffmann, Linda S.; Kretschmer, Axel; Lawrenz, Bettina; Stasch, Johannes-Peter] Bayer HealthCare, Pharma Res Ctr, Wuppertal, Germany; [Hocher, Berthold] Univ Potsdam, Instute Nutr Sci, Potsdam, Germany; [Hocher, Berthold] IFLb Labs Med Berlin GmbH, Berlin, Germany; [Stasch, Johannes-Peter] Univ Halle Wittenberg, Sch Pharm, D-06108 Halle, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; University of Potsdam; Martin Luther University Halle Wittenberg	Hoffmann, LS (corresponding author), Bayer HealthCare, Pharma Res Ctr, Wuppertal, Germany.	linda.s.hoffmann@uni-bonn.de	Hocher, Berthold/AAC-3510-2020	Hocher, Berthold/0000-0001-8143-0579	Bayer Pharma AG	Bayer Pharma AG	The authors received no specific funding for this work. Bayer Pharma AG provided support in the form of salaries for authors LSH, AK, BL, and JPS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions section.	Alfadda AA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/936486; Armitage ME, 2009, J MOL MED, V87, P1071, DOI 10.1007/s00109-009-0544-2; Beckman JS, 2009, ARCH BIOCHEM BIOPHYS, V484, P114, DOI 10.1016/j.abb.2009.03.013; Boerrigter G, 2007, HYPERTENSION, V49, P1128, DOI 10.1161/HYPERTENSIONAHA.106.083832; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Chirkov YY, 2007, PHARMACOL THERAPEUT, V116, P287, DOI 10.1016/j.pharmthera.2007.06.012; Cosyns SM, 2014, NEUROGASTROENT MOTIL, V8, P12424; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Dumitrascu R, 2006, CIRCULATION, V113, P286, DOI 10.1161/CIRCULATIONAHA.105.581405; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Geschka S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021853; Gladwin MT, 2006, J CLIN INVEST, V116, P2330, DOI 10.1172/JCI29807; Glynos C, 2013, AM J RESP CRIT CARE, V188, P789, DOI 10.1164/rccm.201210-1884OC; Grossman E, 2008, DIABETES CARE, V31, pS185, DOI 10.2337/dc08-s246; Haffner D, 2005, J HYPERTENS, V23, P1067, DOI 10.1097/01.hjh.0000166849.72721.1c; Han WK, 2008, KIDNEY INT, V73, P863, DOI 10.1038/sj.ki.5002715; Harrison DG, 2009, MED CLIN N AM, V93, P621, DOI 10.1016/j.mcna.2009.02.015; Hobbs AJ, 1996, METHOD ENZYMOL, V269, P134; Hobbs AJ, 2002, BRIT J PHARMACOL, V136, P637, DOI 10.1038/sj.bjp.0704779; Hobbs AJ, 1999, ANNU REV PHARMACOL, V39, P191, DOI 10.1146/annurev.pharmtox.39.1.191; Hocher B, 2000, J HYPERTENS, V18, P1807, DOI 10.1097/00004872-200018120-00015; Hoffmann LS, 2009, BRIT J PHARMACOL, V157, P781, DOI 10.1111/j.1476-5381.2009.00263.x; Hoffmann LS, 2014, N-S ARCH PHARMACOL, V387, P707, DOI 10.1007/s00210-014-0999-8; Hsia HC, 2005, J BIOL CHEM, V280, P26641, DOI 10.1074/jbc.R500005200; Kalk P, 2006, BRIT J PHARMACOL, V148, P853, DOI 10.1038/sj.bjp.0706792; Knorr A, 2008, ARZNEIMITTEL-FORSCH, V58, P71, DOI 10.1055/s-0031-1296471; Korkmaz S, 2013, J CARDIOVASC PHARM T, V18, P70, DOI 10.1177/1074248412455696; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Lucas KA, 2000, PHARMACOL REV, V52, P375; Melichar VO, 2004, P NATL ACAD SCI USA, V101, P16671, DOI 10.1073/pnas.0405509101; Meng SM, 2003, HYPERTENSION, V41, P1346, DOI 10.1161/01.HYP.0000070028.99408.E8; Meurer S, 2009, CIRC RES, V105, P33, DOI 10.1161/CIRCRESAHA.109.198234; Niu JL, 2009, CLIN SCI, V117, P95, DOI 10.1042/CS20080581; Okamoto H, 2007, MOL CELL BIOCHEM, V300, P1, DOI 10.1007/s11010-006-9368-3; Rosenberg M, 2008, CIRC-HEART FAIL, V1, P43, DOI 10.1161/CIRCHEARTFAILURE.107.746172; Rothkegel C, 2006, FEBS LETT, V580, P4205, DOI 10.1016/j.febslet.2006.06.079; Roy B, 2008, BRIT J PHARMACOL, V153, P1495, DOI 10.1038/sj.bjp.0707687; Santos Maria Gisele dos, 2008, Arq Bras Cardiol, V90, P276; Schmidt Harald H. H. W., 2009, V191, P309, DOI 10.1007/978-3-540-68964-5_14; SCHMIDT HHHW, 1993, BIOCHIM BIOPHYS ACTA, V1178, P153, DOI 10.1016/0167-4889(93)90006-B; Schmidt P, 2003, ANAL BIOCHEM, V314, P162, DOI 10.1016/S0003-2697(02)00660-7; Schmidt PM, 2004, J BIOL CHEM, V279, P3025, DOI 10.1074/jbc.M310141200; Schulz E, 2008, ANTIOXID REDOX SIGN, V10, P1115, DOI 10.1089/ars.2007.1989; Schwarz ER, 1998, BASIC RES CARDIOL, V93, P477, DOI 10.1007/s003950050118; Simchon S, 1996, HYPERTENSION, V27, P653, DOI 10.1161/01.HYP.27.3.653; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch JP, 2015, CURR OPIN PHARMACOL, V21, P95, DOI 10.1016/j.coph.2014.12.014; Stasch Johannes-Peter, 2009, V191, P277, DOI 10.1007/978-3-540-68964-5_13; Stasch JP, 2002, BRIT J PHARMACOL, V136, P773, DOI 10.1038/sj.bjp.0704778; Stasch JP, 2002, BRIT J PHARMACOL, V135, P344, DOI 10.1038/sj.bjp.0704483; Stasch JP, 1997, ARZNEIMITTELFORSCH, V47, P1016; Surmeli NB, 2012, CHEMBIOCHEM, V13, P977, DOI 10.1002/cbic.201100809; Taylor NE, 2006, HYPERTENSION, V47, P692, DOI 10.1161/01.HYP.0000203161.02046.8d; Wang YR, 2006, AM J PHYSIOL-RENAL, V290, pF167, DOI 10.1152/ajprenal.00197.2005; Wedgwood S, 2005, AM J PHYSIOL-LUNG C, V289, pL660, DOI 10.1152/ajplung.00369.2004	56	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145048	10.1371/journal.pone.0145048	http://dx.doi.org/10.1371/journal.pone.0145048			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717150	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500019
J	Liu, XM; He, C; Huang, T; Gu, J				Liu, Xingmu; He, Chao; Huang, Tao; Gu, Jiang			Development of a New Technique for Reconstruction of Hepatic Artery during Liver Transplantation in Sprague-Dawley Rat	PLOS ONE			English	Article							FACTOR-KAPPA-B; SLEEVE ANASTOMOSIS; REPERFUSION INJURY; REARTERIALIZATION; GRAFT; ARTERIALIZATION; COMPLICATIONS; EXPERIENCE; ISCHEMIA; SYSTEM	Background Sleeve anastomosis is the most common technique used to rearterialize orthotopic liver transplants (OLT). However, this technique has a number of disadvantages, including difficulty of performance of the technique visually unaided. We herein describe a novel rearterialized OLT model in the rat. Materials and Methods Forty-six male Sprague Dawley rats (300-400 g) were used as donors and recipients. Based on Kamada's cuff technique, the new model involved performing a modified "sleeve" anastomosis between the celiac trunk of the donor and common hepatic artery of the recipient to reconstruct blood flow to the hepatic artery. An additional ten male Sprague Dawley rats underwent liver transplantation without artery reconstruction. Liver grafts were retrieved from the two groups and histological examination was performed following surgery. Results Total mean operating times were similar to 42 minutes for the donor liver extraction and 57 minutes for the recipient transplantation. Graft preparation took an additional 15 minutes and the time to fix the arterial bracket was similar to 3 minutes. During transplantation, the anhepatic phase lasted 18 +/- 2.5 min and the artery reconstruction only required similar to 3 minutes. The patency rate was 94.44% and the 4-week survival rate was 90%. Histology indicated obvious fibrosis in the liver grafts without artery reconstruction, while normal histology was observed in the arterialized graft. Conclusions This new method allows for the surgical procedure to be performed visually unaided with good survival and patency rates and represents an alternative model investigating OLT in rats.	[Liu, Xingmu; Huang, Tao; Gu, Jiang] Shantou Univ, Coll Med, Dept Pathol, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Guangdong, Peoples R China; [Liu, Xingmu; Huang, Tao; Gu, Jiang] Shantou Univ, Coll Med, Collaborat & Creat Ctr, Shantou, Guangdong, Peoples R China; [Liu, Xingmu; Huang, Tao; Gu, Jiang] Shantou Univ, Coll Med, Ctr Translat Med, Shantou, Guangdong, Peoples R China; [Liu, Xingmu; He, Chao] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Gen Surg, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University; Shantou University	Gu, J (corresponding author), Shantou Univ, Coll Med, Dept Pathol, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Guangdong, Peoples R China.	2523381625@qq.com	Huang, Tao/AHE-8511-2022	Gu, Jiang/0000-0002-0706-8329	National Natural Science Foundation of China [81030033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the Major Program of National Natural Science Foundation of China (No. 81030033 to JG), [http://isisn.nsfc.gov.cn/egrantweb/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyakhagorn V, 2009, J SURG RES, V153, P332, DOI 10.1016/j.jss.2008.04.003; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; CHALAND P, 1990, TRANSPLANTATION, V49, P675, DOI 10.1097/00007890-199004000-00003; DUMINY FJ, 1989, J SURG RES, V46, P189, DOI 10.1016/0022-4804(89)90054-1; ENGEMANN R, 1982, TRANSPLANTATION, V33, P566; HOWDEN B, 1989, TRANSPLANTATION, V47, P428, DOI 10.1097/00007890-198903000-00005; Imamura H, 1997, HEPATOLOGY, V26, P198; KAMADA N, 1983, SURGERY, V93, P64; KNOOP M, 1994, AM J SURG, V167, P360, DOI 10.1016/0002-9610(94)90215-1; LAURITZEN C, 1978, SCAND J PLAST RECONS, V12, P291, DOI 10.3109/02844317809013008; LEE S, 1973, TRANSPLANTATION, V16, P664, DOI 10.1097/00007890-197312000-00019; Li J, 2002, MICROSURG, V22, P62, DOI 10.1002/micr.21726; LIU T, 1992, TRANSPLANTATION, V54, P179; Lu JL, 2014, J SURG RES, V187, P690, DOI 10.1016/j.jss.2013.11.1080; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; NOACK K, 1993, TRANSPLANTATION, V56, P495, DOI 10.1097/00007890-199309000-00001; Nosaka T, 1999, SURG TODAY, V29, P963; Oldani G, 2008, J SURG RES, V149, P303, DOI 10.1016/j.jss.2007.12.779; POST S, 1992, TRANSPLANTATION, V54, P789, DOI 10.1097/00007890-199211000-00005; Reck T, 1996, TRANSPLANTATION, V62, P582, DOI 10.1097/00007890-199609150-00007; Sato Y, 1996, EASY PHYSL ARTERIAL; Spiegel HU, 1998, J INVEST SURG, V11, P83, DOI 10.3109/08941939809032187; STEFFEN R, 1989, TRANSPLANTATION, V48, P166, DOI 10.1097/00007890-198907000-00044; Vivarelli M, 2004, ARCH SURG-CHICAGO, V139, P1069, DOI 10.1001/archsurg.139.10.1069; Yoshidome H, 1999, HEPATOLOGY, V30, P203, DOI 10.1002/hep.510300120; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x; Zhang XY, 1996, MICROSURG, V17, P472, DOI 10.1002/(SICI)1098-2752(1996)17:8<472::AID-MICR11>3.3.CO;2-P; ZHAO D, 1993, EUR SURG RES, V25, P294, DOI 10.1159/000129292	28	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145662	10.1371/journal.pone.0145662	http://dx.doi.org/10.1371/journal.pone.0145662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716457	gold, Green Submitted, Green Published			2022-12-27	WOS:000367510500055
J	Nam, KH; Kim, J; Ra, G; Lee, CH; Paeng, DG				Nam, Kweon-Ho; Kim, Juho; Ra, Gicheol; Lee, Chong Hyun; Paeng, Dong-Guk			Feasibility Study of Ex Ovo Chick Chorioallantoic Artery Model for Investigating Pulsatile Variation of Arterial Geometry	PLOS ONE			English	Article							ENDOTHELIAL SHEAR-STRESS; CAROTID-ARTERY; BLOOD-FLOW; IN-VIVO; WALL-MOTION; VESSEL WALL; INTRAVASCULAR ULTRASOUND; ATHEROSCLEROTIC PLAQUES; VELOCITY PROFILES; BIFURCATION MODEL	Despite considerable research efforts on the relationship between arterial geometry and cardiovascular pathology, information is lacking on the pulsatile geometrical variation caused by arterial distensibility and cardiomotility because of the lack of suitable in vivo experimental models and the methodological difficulties in examining the arterial dynamics. We aimed to investigate the feasibility of using a chick embryo system as an experimental model for basic research on the pulsatile variation of arterial geometry. Optical microscope video images of various arterial shapes in chick chorioallantoic circulation were recorded from different locations and different embryo samples. The high optical transparency of the chorioallantoic membrane (CAM) allowed clear observation of tiny vessels and their movements. Systolic and diastolic changes in arterial geometry were visualized by detecting the wall boundaries from binary images. Several to hundreds of microns of wall displacement variations were recognized during a pulsatile cycle. The spatial maps of the wall motion harmonics and magnitude ratio of harmonic components were obtained by analyzing the temporal brightness variation at each pixel in sequential grayscale images using spectral analysis techniques. The local variations in the spectral characteristics of the arterial wall motion were reflected well in the analysis results. In addition, mapping the phase angle of the fundamental frequency identified the regional variations in the wall motion directivity and phase shift. Regional variations in wall motion phase angle and fundamental-to-second harmonic ratio were remarkable near the bifurcation area. In summary, wall motion in various arterial geometry including straight, curved and bifurcated shapes was well observed in the CAM artery model, and their local and cyclic variations could be characterized by Fourier and wavelet transforms of the acquired video images. The CAM artery model with the spectral analysis method is a useful in vivo experimental model for studying pulsatile variation in arterial geometry.	[Nam, Kweon-Ho; Paeng, Dong-Guk] Jeju Natl Univ, Interdisciplinary Postgrad Program Biomed Engn, Jeju, South Korea; [Nam, Kweon-Ho; Kim, Juho; Ra, Gicheol; Lee, Chong Hyun; Paeng, Dong-Guk] Jeju Natl Univ, Dept Ocean Syst Engn, Jeju, South Korea	Jeju National University; Jeju National University	Paeng, DG (corresponding author), Jeju Natl Univ, Interdisciplinary Postgrad Program Biomed Engn, Jeju, South Korea.	paeng@jejunu.ac.kr	Paeng, Dong-Guk/AAJ-2143-2021; Lee, Chong Hyun/AHA-8514-2022	Lee, Chong Hyun/0000-0003-0268-5333	MSIP (Ministry of Science, ICT and Future Planning), Korea under C-ITRC (Convergence Information Technology Research Center) [IITP-2015-H8601-15-1004]; Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A2043478]	MSIP (Ministry of Science, ICT and Future Planning), Korea under C-ITRC (Convergence Information Technology Research Center); Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by the MSIP (Ministry of Science, ICT and Future Planning), Korea, under the C-ITRC (Convergence Information Technology Research Center) (IITP-2015-H8601-15-1004) supervised by the IITP (Institute for Information & communications Technology Promotion). This research was also supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2043478).	Addison PS, 2005, PHYSIOL MEAS, V26, pR155, DOI 10.1088/0967-3334/26/5/R01; Bishop JJ, 2001, AM J PHYSIOL-HEART C, V280, pH222, DOI 10.1152/ajpheart.2001.280.1.H222; BRINKMAN AM, 1994, ANN BIOMED ENG, V22, P34, DOI 10.1007/BF02368220; Chatzizisis YS, 2008, CIRCULATION, V117, P993, DOI 10.1161/CIRCULATIONAHA.107.695254; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Danilouchkine MG, 2009, PHYS MED BIOL, V54, P1397, DOI 10.1088/0031-9155/54/6/002; DEFOUW DO, 1989, MICROVASC RES, V38, P136, DOI 10.1016/0026-2862(89)90022-8; DELEON H, 1995, CIRC RES, V77, P64, DOI 10.1161/01.RES.77.1.64; Deryugina EI, 2008, HISTOCHEM CELL BIOL, V130, P1119, DOI 10.1007/s00418-008-0536-2; Feaver RE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2530; FISHER M, 1990, STROKE, V21, P267, DOI 10.1161/01.STR.21.2.267; Fisher M, 2012, NAT REV NEUROL, V8, P127, DOI 10.1038/nrneurol.2012.1; Geyer MJ, 2004, J REHABIL RES DEV, V41, P797, DOI 10.1682/JRRD.2003.10.0159; Ha H, 2012, MICROVASC RES, V84, P242, DOI 10.1016/j.mvr.2012.07.004; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hartley CJ, 2004, AM J PHYSIOL-HEART C, V287, pH1426, DOI 10.1152/ajpheart.01185.2003; Hoskins PR, 2009, BRIT J RADIOL, V82, pS3, DOI 10.1259/bjr/96847348; Huo YL, 2009, J BIOMECH, V42, P594, DOI 10.1016/j.jbiomech.2008.12.011; Jimenez RF, 1997, BIOL RES, V30, P53; Kanai H, 2000, ULTRASONICS, V38, P381, DOI 10.1016/S0041-624X(99)00118-3; Kim S, 2007, AM J PHYSIOL-HEART C, V293, pH1526, DOI 10.1152/ajpheart.01090.2006; Kim YH, 2008, ANN BIOMED ENG, V36, P1753, DOI 10.1007/s10439-008-9558-0; Klanchar M, 1990, CIRC RES, V66, P1624; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Latka M, 2005, AM J PHYSIOL-HEART C, V289, pH2272, DOI 10.1152/ajpheart.01307.2004; Lee Grace S, 2010, J Angiogenes Res, V2, P11, DOI 10.1186/2040-2384-2-11; Lee SJ, 2011, MICROVASC RES, V82, P296, DOI 10.1016/j.mvr.2011.09.005; Liu Y, 2008, AM J PHYSIOL-HEART C, V294, pH514, DOI 10.1152/ajpheart.00670.2007; Liu Y, 2007, AM J PHYSIOL-HEART C, V293, pH3290, DOI 10.1152/ajpheart.00666.2007; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Markl M, 2010, CIRC-CARDIOVASC IMAG, V3, P647, DOI 10.1161/CIRCIMAGING.110.958504; Martinsen BJ, 2005, DEV DYNAM, V233, P1217, DOI 10.1002/dvdy.20468; Nam KH, 2014, ULTRASONICS, V54, P233, DOI 10.1016/j.ultras.2013.04.012; Nelson TR, 2000, ULTRASOUND OBST GYN, V16, P374, DOI 10.1046/j.1469-0705.2000.00180.x; NGUYEN M, 1994, MICROVASC RES, V47, P31, DOI 10.1006/mvre.1994.1003; Nowak-Sliwinska P, 2010, ANGIOGENESIS, V13, P281, DOI 10.1007/s10456-010-9185-x; PERKTOLD K, 1995, J BIOMECH, V28, P845, DOI 10.1016/0021-9290(95)95273-8; Potter DR, 2009, CIRC RES, V104, P1318, DOI 10.1161/CIRCRESAHA.108.191585; Rabben SI, 2002, ULTRASOUND MED BIOL, V28, P507, DOI 10.1016/S0301-5629(02)00487-8; Stone PH, 2003, CIRCULATION, V108, P438, DOI 10.1161/01.CIR.0000080882.35274.AD; Svedlund S, 2011, CLIN PHYSIOL FUNCT I, V31, P32, DOI 10.1111/j.1475-097X.2010.00976.x; Vargas A, 2007, ADV DRUG DELIVER REV, V59, P1162, DOI 10.1016/j.addr.2007.04.019; WEIZSACKER HW, 1983, J BIOMECH, V16, P703, DOI 10.1016/0021-9290(83)90080-5; Woods RE, 2004, DIGITAL IMAGE PROCES, Vxiv; Yalcin Huseyin C, 2010, J Vis Exp, DOI 10.3791/2154; ZARINS CK, 1983, CIRC RES, V53, P502, DOI 10.1161/01.RES.53.4.502; Zhao SZ, 2000, J BIOMECH, V33, P975, DOI 10.1016/S0021-9290(00)00043-9	47	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145969	10.1371/journal.pone.0145969	http://dx.doi.org/10.1371/journal.pone.0145969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717244	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500107
J	Patrick, WG; Nielsen, AAK; Keating, SJ; Levy, TJ; Wang, W; Rivera, JJ; Mondragn-Palomino, O; Carr, PA; Voigt, CA; Oxman, N; Kong, DS				Patrick, William G.; Nielsen, Alec A. K.; Keating, Steven J.; Levy, Taylor J.; Wang, Wei; Rivera, Jaime J.; Mondragn-Palomino, Octavio; Carr, Peter A.; Voigt, Christopher A.; Oxman, Neri; Kong, David S.			DNA Assembly in 3D Printed Fluidics	PLOS ONE			English	Article							GENE SYNTHESIS; SYNTHETIC BIOLOGY; ESCHERICHIA-COLI; CHIP; OPTIMIZATION; SEQUENCE; DEVICES; DESIGN; LAB	The process of connecting genetic parts-DNA assembly-is a foundational technology for synthetic biology. Microfluidics present an attractive solution for minimizing use of costly reagents, enabling multiplexed reactions, and automating protocols by integrating multiple protocol steps. However, microfluidics fabrication and operation can be expensive and requires expertise, limiting access to the technology. With advances in commodity digital fabrication tools, it is now possible to directly print fluidic devices and supporting hardware. 3D printed micro-and millifluidic devices are inexpensive, easy to make and quick to produce. We demonstrate Golden Gate DNA assembly in 3D-printed fluidics with reaction volumes as small as 490 nL, channel widths as fine as 220 microns, and per unit part costs ranging from $0.61 to $ 5.71. A 3D-printed syringe pump with an accompanying programmable software interface was designed and fabricated to operate the devices. Quick turnaround and inexpensive materials allowed for rapid exploration of device parameters, demonstrating a manufacturing paradigm for designing and fabricating hardware for synthetic biology.	[Patrick, William G.; Keating, Steven J.; Levy, Taylor J.; Wang, Wei; Oxman, Neri] MIT, Media Lab, Sch Architecture & Planning, Cambridge, MA 02139 USA; [Nielsen, Alec A. K.; Rivera, Jaime J.; Mondragn-Palomino, Octavio; Voigt, Christopher A.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Keating, Steven J.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Carr, Peter A.; Kong, David S.] MIT, Lincoln Lab, Lexington, MA 02173 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Lincoln Laboratory; Massachusetts Institute of Technology (MIT)	Kong, DS (corresponding author), MIT, Lincoln Lab, 244 Wood St, Lexington, MA 02173 USA.	dkong@ll.mit.edu			Defense for Research & Engineering under Air Force [FA8721-05-C-0002]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES027306, F31ES027304] Funding Source: NIH RePORTER	Defense for Research & Engineering under Air Force; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was sponsored by the Assistant Secretary of Defense for Research & Engineering under Air Force Contract #FA8721-05-C-0002. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the United States Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CH, 2004, P IEEE, V92, P154, DOI 10.1109/JPROC.2003.820548; Anderson KB, 2013, ANAL CHEM, V85, P5622, DOI 10.1021/ac4009594; [Anonymous], 2009, DREMELFUGE A ONE PIE; Anzalone GC, 2013, SENSORS-BASEL, V13, P5338, DOI 10.3390/s130405338; Au AK, 2015, LAB CHIP, V15, P1934, DOI 10.1039/c5lc00126a; Au AK, 2014, LAB CHIP, V14, P1294, DOI 10.1039/c3lc51360b; Baden T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002086; Bhargava KC, 2014, P NATL ACAD SCI USA, V111, P15013, DOI 10.1073/pnas.1414764111; Carriere P, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2804959; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen CP, 2014, ANALYST, V139, P3219, DOI 10.1039/c3an02357e; Chen YJ, 2013, NAT METHODS, V10, P659, DOI [10.1038/NMETH.2515, 10.1038/nmeth.2515]; Chen ZY, 2007, ANN NY ACAD SCI, V1098, P429, DOI 10.1196/annals.1384.024; Cheng AA, 2012, ANNU REV BIOMED ENG, V14, P155, DOI [10.1146/annurev-bioeng-071811-150118, 10.1146/annurev.bioeng-071811-150118]; Chin CD, 2012, LAB CHIP, V12, P2118, DOI 10.1039/c2lc21204h; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Engler C, 2009, PLOS ONE, P4, DOI [DOI 10.1371/J0URNAL.P0NE.0005553, 10.1371/journal.pone.0005553]; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Erkal JL, 2014, LAB CHIP, V14, P2023, DOI 10.1039/c4lc00171k; Farasat I, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20134955; Follett J, 2015, DESIGNING FOR EMERGI, P379; Huang MC, 2009, LAB CHIP, V9, P276, DOI 10.1039/b807688j; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kitson PJ, 2012, LAB CHIP, V12, P3267, DOI 10.1039/c2lc40761b; Kong DS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm121; Krejcova L, 2014, BIOSENS BIOELECTRON, V54, P421, DOI 10.1016/j.bios.2013.10.031; Kuo JS, 2011, LAB CHIP, V11, P2656, DOI 10.1039/c1lc20125e; Lee KG, 2014, RSC ADV, V4, P32876, DOI 10.1039/c4ra05072j; Liao Y, 2012, LAB CHIP, V12, P746, DOI 10.1039/c2lc21015k; Linshiz G, 2014, ACS SYNTH BIOL, V3, P515, DOI 10.1021/sb4001728; Lou CB, 2012, NAT BIOTECHNOL, V30, P1137, DOI 10.1038/nbt.2401; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Rogers C., 2015, B CKLUND DARBOUX TRA, P1; Shallan A.I., 2014, ANAL CHEM; Smanski MJ, 2014, NAT BIOTECHNOL, V32, P1241, DOI 10.1038/nbt.3063; SUTCLIFFE JG, 1978, P NATL ACAD SCI USA, V75, P3737, DOI 10.1073/pnas.75.8.3737; Takahashi CN, 2015, ACS SYNTH BIOL; Wang J, 2006, LAB CHIP, V6, P46, DOI 10.1039/b511494b; Weber E, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016765, DOI 10.1371/J0URNAL.P0NE.0016765]; Weber W, 2012, NAT REV GENET, V13, P21, DOI 10.1038/nrg3094; Wijnen B, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0107216, DOI 10.1371/J0URNAL.P0NE.0107216]; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059840; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	44	35	35	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0143636	10.1371/journal.pone.0143636	http://dx.doi.org/10.1371/journal.pone.0143636			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716448	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500007
J	Protzner, A; Szmodis, M; Udvardy, A; Bosnyak, E; Trajer, E; Komka, Z; Gyore, I; Toth, M				Protzner, Anna; Szmodis, Marta; Udvardy, Anna; Bosnyak, Edit; Trajer, Emese; Komka, Zsolt; Gyoere, Istvan; Toth, Miklos			Hormonal Neuroendocrine and Vasoconstrictor Peptide Responses of Ball Game and Cyclic Sport Elite Athletes by Treadmill Test	PLOS ONE			English	Article							ENDURANCE-TRAINED MEN; CATECHOLAMINE RESPONSES; SUPRAMAXIMAL EXERCISE; PERFORMANCE; ENDOTHELIN-1; INTENSITY; PLAYERS	Objective Our objective was to evaluate complex hormonal response in ball game and cyclic sport elite athletes through an incremental treadmill test, since, so far, variables in experimental procedures have often hampered comparisons of data. Methods We determined anthropometric data, heart rate, maximal oxygen uptake, workload, plasma levels of lactate, adrenaline, noradrenaline, dopamine, cortisol, angiontensinogen and endothelin in control (n = 6), soccer (n = 8), handball (n = 12), kayaking (n = 9) and triathlon (n = 9) groups based on a Bruce protocol through a maximal exercise type of spiroergometric test. Results We obtained significant increases for adrenaline, 2.9- and 3.9-fold by comparing the normalized means for soccer players and kayakers and soccer players and triathletes after/before test, respectively. For noradrenaline, we observed an even stronger, three-time significant difference between each type of ball game and cyclic sport activity. Conclusions Exercise related adrenaline and noradrenaline changes were more pronounced than dopamine plasma level changes and revealed an opportunity to differentiate cyclic and ball game activities and control group upon these parameters. Normalization of concentration ratios of the monitored compounds by the corresponding maximal oxygen uptake reflected better the differences in the response level of adrenaline, noradrenaline, dopamine and cortisol.	[Protzner, Anna; Szmodis, Marta; Udvardy, Anna; Bosnyak, Edit; Trajer, Emese; Komka, Zsolt; Toth, Miklos] Univ Phys Educ, Dept Hlth Sci & Sport Med, Budapest, Hungary; [Gyoere, Istvan] Aeromed Hosp, Res Inst Hungarian Armed Forces, Kecskemet, Hungary	University of Physical Education	Protzner, A (corresponding author), Univ Phys Educ, Dept Hlth Sci & Sport Med, Budapest, Hungary.	annaprotzner@gmail.com		Bosnyak, Edit/0000-0003-0632-4279	Research and Technology Innovation Fund of the National Development Agency [KTIA_AIK_12-1-2013-0017]	Research and Technology Innovation Fund of the National Development Agency	This study was supported by the Research and Technology Innovation Fund of the National Development Agency, no. KTIA_AIK_12-1-2013-0017, http://bioklima.org/node/12.	Ahmetov II, 2007, MOL BIOL+, V41, P776, DOI 10.1134/S002689330705010X; Bonifazi M, 2001, LIFE SCI, V69, P961, DOI 10.1016/S0024-3205(01)01190-0; Chmura J, 1998, EUR J APPL PHYSIOL O, V77, P77; Cosenzi A, 1996, AM J HYPERTENS, V9, P819, DOI 10.1016/0895-7061(96)00019-2; da Silva ASR, 2011, SCI SPORT, V26, P278, DOI 10.1016/j.scispo.2010.12.006; DEVALON ML, 1989, J LAB CLIN MED, V114, P321; Drinkwater D.T., 1980, KINANTHROPOMETRY, V2, P178; Frenkl R, 2001, Acta Physiol Hung, V88, P251, DOI 10.1556/APhysiol.88.2001.3-4.7; Fry AC, 1998, J APPL PHYSIOL, V85, P2352; Genth-Zotz S, 1998, INT J CARDIOL, V66, P137, DOI 10.1016/S0167-5273(98)00225-3; Greiwe JS, 1999, J APPL PHYSIOL, V86, P531, DOI 10.1152/jappl.1999.86.2.531; Hartley HL, 1972, J APPL PHYSIOL, V33, P602; HICKSON RC, 1979, EUR J APPL PHYSIOL O, V41, P211, DOI 10.1007/BF00430013; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; Jacob C, 2004, EUR J APPL PHYSIOL, V91, P35, DOI 10.1007/s00421-003-1002-4; KRAEMER WJ, 1992, INT J SPORTS MED, V13, P103, DOI 10.1055/s-2007-1021240; Legakis IN, 2003, BRIT J SPORT MED, V37, P92, DOI 10.1136/bjsm.37.1.92-a; Lehmann M, 1983, INT SERIES SPORT SCI, V13, P738; Maeda S, 1997, J APPL PHYSIOL, V82, P1107, DOI 10.1152/jappl.1997.82.4.1107; Moussa E, 2003, J SPORT MED PHYS FIT, V43, P546; Oikonomidis DL, 2010, J INTERV CARD ELECTR, V28, P157, DOI 10.1007/s10840-010-9493-5; Piacentini MF, 2002, MED SCI SPORT EXER, V34, P1189; SAGNOL M, 1989, INT J SPORTS MED, V10, P202, DOI 10.1055/s-2007-1024901; Schulpis KH, 2009, METABOLISM, V58, P1080, DOI 10.1016/j.metabol.2009.04.001; Strobel G, 1999, MED SCI SPORT EXER, V31, P560, DOI 10.1097/00005768-199904000-00011; Tanner AV, 2014, J SPORT SCI, V32, P680, DOI 10.1080/02640414.2013.850594; Vuori I, 1981, BIOCH EXERCISE B, P107; WINDER WW, 1979, J APPL PHYSIOL, V46, P766, DOI 10.1152/jappl.1979.46.4.766; Zouhal H, 1999, INT J SPORTS MED, V20, P343, DOI 10.1055/s-2007-971142; Zouhal H, 2008, SPORTS MED, V38, P401, DOI 10.2165/00007256-200838050-00004	30	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0144691	10.1371/journal.pone.0144691	http://dx.doi.org/10.1371/journal.pone.0144691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717409	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500012
J	Spellmon, N; Sun, XN; Sirinupong, N; Edwards, B; Li, CY; Yang, Z				Spellmon, Nicholas; Sun, Xiaonan; Sirinupong, Nualpun; Edwards, Brian; Li, Chunying; Yang, Zhe			Molecular Dynamics Simulation Reveals Correlated Inter-Lobe Motion in Protein Lysine Methyltransferase SMYD2	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE; MYND DOMAIN; STRUCTURAL INSIGHTS; METHYLATION; SET; RECOGNITION; ENCODES	SMYD proteins are an exciting field of study as they are linked to many types of cancer-related pathways. Cardiac and skeletal muscle development and function also depend on SMYD proteins opening a possible avenue for cardiac-related treatment. Previous crystal structure studies have revealed that this special class of protein lysine methyltransferases have a bilobal structure, and an open-closed motion may regulate substrate specificity. Here we use the molecular dynamics simulation to investigate the still-poorly-understood SMYD2 dynamics. Cross-correlation analysis reveals that SMYD2 exhibits a negative correlated inter-lobe motion. Principle component analysis suggests that this correlated dynamic is contributed to by a twisting motion of the C-lobe with respect to the N-lobe and a clamshell-like motion between the lobes. Dynamical network analysis defines possible allosteric paths for the correlated dynamics. There are nine communities in the dynamical network with six in the N-lobe and three in the C-lobe, and the communication between the lobes is mediated by a lobe-bridging beta hairpin. This study provides insight into the dynamical nature of SMYD2 and could facilitate better understanding of SMYD2 substrate specificity.	[Spellmon, Nicholas; Sun, Xiaonan; Edwards, Brian; Li, Chunying; Yang, Zhe] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA; [Sirinupong, Nualpun] Prince Songkla Univ, Nutraceut & Funct Food Res & Dev Ctr, Hat Yai, Songkhla, Thailand	Wayne State University; Prince of Songkla University	Li, CY (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA.	cl@med.wayne.edu; zyang@med.wayne.edu	Sirinupong, Nualpun/AAX-4886-2020	Sirinupong, Nualpun/0000-0002-9986-3011	National Institutes of Health [1R01HL128647-01]; National Science Foundation [ACI-1053575]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by the National Institutes of Health grant number 1R01HL128647-01 (to CL and ZY). This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by the National Science Foundation grant number ACI-1053575. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Abu-Farha M, 2011, J MOL CELL BIOL, V3, P301, DOI 10.1093/jmcb/mjr025; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Fenwick RB, 2011, EUR BIOPHYS J BIOPHY, V40, P1339, DOI 10.1007/s00249-011-0754-8; Cho HS, 2012, NEOPLASIA, V14, P476, DOI 10.1593/neo.12656; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; Esteban-Martin S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003721; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang YY, 2014, J MOL BIOL, V426, P3413, DOI 10.1016/j.jmb.2014.02.019; Jiang YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021640; Liu YZ, 2007, CANCER CELL, V11, P483, DOI 10.1016/j.ccr.2007.04.010; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Saddic LA, 2010, J BIOL CHEM, V285, P37733, DOI 10.1074/jbc.M110.137612; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Sirinupong N, 2011, J MOL BIOL, V406, P149, DOI 10.1016/j.jmb.2010.12.014; Sirinupong N, 2010, J BIOL CHEM, V285, P40635, DOI 10.1074/jbc.M110.168187; Spadaccini R, 2006, J MOL BIOL, V358, P498, DOI 10.1016/j.jmb.2006.01.087; Spellmon N, 2015, INT J MOL SCI, V16, P1406, DOI 10.3390/ijms16011406; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Wang L, 2011, J BIOL CHEM, V286, P38725, DOI 10.1074/jbc.M111.262410; Xu ST, 2011, NUCLEIC ACIDS RES, V39, P4438, DOI 10.1093/nar/gkr019	27	10	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145758	10.1371/journal.pone.0145758	http://dx.doi.org/10.1371/journal.pone.0145758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717235	Green Published, gold			2022-12-27	WOS:000367510500067
J	Zeng, HL; Tan, FX; Shu, YH; Zhang, YY; Feng, YJ; Wang, JW				Zeng, Huilan; Tan, Fengxiao; Shu, Yinghua; Zhang, Yanyan; Feng, Yuanjiao; Wang, Jianwu			The Cry1Ab Protein Has Minor Effects on the Arbuscular Mycorrhizal Fungal Communities after Five Seasons of Continuous Bt Maize Cultivation	PLOS ONE			English	Article							IN-FIELD PLOTS; BACILLUS-THURINGIENSIS; SOIL; CORN; DIVERSITY; IMPACT; NEMATODES; REPRODUCTION; RESPONSES; PLANTS	The cultivation of genetically modified plants (GMP) has raised concerns regarding the plants' ecological safety. A greenhouse experiment was conducted to assess the impact of five seasons of continuous Bt (Bacillus thuringiensis) maize cultivation on the colonisation and community structure of the non-target organisms arbuscular mycorrhizal fungi (AMF) in the maize roots, bulk soils and rhizospheric soils using the terminal restriction fragment length polymorphism (T-RFLP) analysis of the 28S ribosomal DNA and sequencing methods. AMF colonisation was significantly higher in the two Bt maize lines that express Cry1Ab, 5422Bt1 (event Bt11) and 5422CBCL (MON810) than in the non-Bt isoline 5422. No significant differences were observed in the diversity of the AMF community between the roots, bulk soils and rhizospheric soils of the Bt and non-Bt maize cultivars. The AMF genus Glomus was dominant in most of the samples, as detected by DNA sequencing. A clustering analysis based on the DNA sequence data suggested that the sample types (i. e., the samples from the roots, bulk soils or rhizospheric soils) might have greater influence on the AMF community phylotypes than the maize cultivars. This study indicated that the Cry1Ab protein has minor effects on the AMF communities after five seasons of continuous Bt maize cultivation.	[Zeng, Huilan; Tan, Fengxiao; Shu, Yinghua; Zhang, Yanyan; Feng, Yuanjiao; Wang, Jianwu] South China Agr Univ, Dept Ecol, Coll Agr, Guangzhou 510642, Guangdong, Peoples R China; [Zeng, Huilan; Tan, Fengxiao; Shu, Yinghua; Zhang, Yanyan; Feng, Yuanjiao; Wang, Jianwu] South China Agr Univ, Key Lab Agroecol & Rural Environm Guangdong Regul, Guangzhou 510642, Guangdong, Peoples R China; [Zeng, Huilan; Tan, Fengxiao; Shu, Yinghua; Zhang, Yanyan; Feng, Yuanjiao; Wang, Jianwu] South China Agr Univ, Key Lab Agroenvironm Trop, Minist Agr, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University; Ministry of Agriculture & Rural Affairs; South China Agricultural University	Wang, JW (corresponding author), South China Agr Univ, Dept Ecol, Coll Agr, Guangzhou 510642, Guangdong, Peoples R China.	wangjw@scau.edu.cn	Wang, Jianwu/E-4994-2011	Wang, Jianwu/0000-0002-4421-8058	National Natural Science Foundation of China [31170506]; Science and Technology Program of Guangdong province, China [2015B090903077]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangdong province, China	The present work was supported by grants from National Natural Science Foundation of China (31170506) received by Jianwu Wang and the Science and Technology Program of Guangdong province, China (No. 2015B090903077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alguacil MM, 2008, ECOL APPL, V18, P527, DOI 10.1890/07-0521.1; Bainard LD, 2012, SOIL BIOL BIOCHEM, V45, P172, DOI 10.1016/j.soilbio.2011.10.008; Barriuso J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035481; Carvalho LM, 2003, PLANT SOIL, V251, P227, DOI 10.1023/A:1023016317269; Castaldini M, 2005, APPL ENVIRON MICROB, V71, P6719, DOI 10.1128/AEM.71.11.6719-6729.2005; Cheeke TE, 2012, AM J BOT, V99, P700, DOI 10.3732/ajb.1100529; Cheeke TE, 2013, ADV AGROECOL, P1; Crecchio C, 1998, SOIL BIOL BIOCHEM, V30, P463, DOI 10.1016/S0038-0717(97)00147-8; de Vaufleury A, 2007, PEDOBIOLOGIA, V51, P185, DOI 10.1016/j.pedobi.2007.04.005; Donegan KK, 1996, TRANSGENIC RES, V5, P25, DOI 10.1007/BF01979919; Ferreira LHPL, 2003, PLANT SOIL, V256, P161, DOI 10.1023/A:1026256700237; Griffiths BS, 2008, PLANT SOIL, V308, P93, DOI 10.1007/s11104-008-9609-1; Griffiths BS, 2007, PLANT BIOTECHNOL J, V5, P60, DOI 10.1111/j.1467-7652.2006.00215.x; Griffiths BS, 2006, J ENVIRON QUAL, V35, P734, DOI 10.2134/jeq2005.0344; Griffiths BS, 2005, PLANT SOIL, V275, P135, DOI 10.1007/s11104-005-1093-2; Hajiboland R, 2010, PLANT SOIL, V331, P313, DOI 10.1007/s11104-009-0255-z; Hannula SE, 2010, SOIL BIOL BIOCHEM, V42, P2211, DOI 10.1016/j.soilbio.2010.08.020; Hannula SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033819; Hijri I, 2006, MOL ECOL, V15, P2277, DOI 10.1111/j.1365-294X.2006.02921.x; Honemann L, 2009, EUR J SOIL BIOL, V45, P351, DOI 10.1016/j.ejsobi.2009.03.001; Hoss S, 2008, ECOTOX ENVIRON SAFE, V70, P334, DOI 10.1016/j.ecoenv.2007.10.017; Hoss S, 2011, SCI TOTAL ENVIRON, V409, P2674, DOI 10.1016/j.scitotenv.2011.03.041; James C, 2012, GLOBAL STATUS COMMER, P44; JASPER DA, 1989, NEW PHYTOL, V112, P93, DOI 10.1111/j.1469-8137.1989.tb00313.x; Jurat-Fuentes JL, 2012, BACILLUS THURINGIENS, P283, DOI DOI 10.1007/978-94-007-3021-2_15; Karasawa T, 2012, PLANT CELL ENVIRON, V35, P819, DOI 10.1111/j.1365-3040.2011.02455.x; Khan MQ, 2010, PAK J BOT, V42, P2903; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Liu B, 2009, FRONT BIOSCI, V14, P4008, DOI [10.2741/3508, 10.2735/3508]; Liu B, 2009, SOIL BIOL BIOCHEM, V41, P1841, DOI 10.1016/j.soilbio.2009.06.004; Liu W, 2008, ACTA AGR SCAND B-S P, V58, P187, DOI 10.1080/09064710701478339; Lopez-Garcia A, 2013, PLANT SOIL, V370, P355, DOI 10.1007/s11104-013-1625-0; Oehl F, 2004, OECOLOGIA, V138, P574, DOI 10.1007/s00442-003-1458-2; Oehl F, 2003, APPL ENVIRON MICROB, V69, P2816, DOI 10.1128/AEM.69.5.2816-2824.2003; Oliveira AP, 2008, SCI TOTAL ENVIRON, V405, P351, DOI 10.1016/j.scitotenv.2008.05.046; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Santos-Gonzalez JC, 2011, MICROB ECOL, V62, P25, DOI 10.1007/s00248-011-9834-7; Saxena D, 2002, PLANT SOIL, V239, P165, DOI 10.1023/A:1015057509357; Saxena D, 2001, AM J BOT, V88, P1704, DOI 10.2307/3558416; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Stanley-Horn DE, 2001, P NATL ACAD SCI USA, V98, P11931, DOI 10.1073/pnas.211277798; Steinkellner S, 2012, MYCORRHIZA, V22, P189, DOI 10.1007/s00572-011-0393-z; Stotzky G, 2004, PLANT SOIL, V266, P77; Sturmer SL, 2011, MYCORRHIZA, V21, P255, DOI 10.1007/s00572-010-0330-6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan FX, 2011, SOIL BIOL BIOCHEM, V43, P2473, DOI 10.1016/j.soilbio.2011.08.014; Torrecillas E, 2012, APPL ENVIRON MICROB, V78, P6180, DOI 10.1128/AEM.01287-12; Turrini A, 2004, PLANT SOIL, V266, P69; van der Gast CJ, 2011, ENVIRON MICROBIOL, V13, P241, DOI 10.1111/j.1462-2920.2010.02326.x; Verbruggen E, 2012, APPL ENVIRON MICROB, V78, P7384, DOI 10.1128/AEM.01372-12; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Wetzel K, 2014, SOIL BIOL BIOCHEM, V72, P88, DOI 10.1016/j.soilbio.2014.01.033; Willis A, 2013, CRIT REV PLANT SCI, V32, P1, DOI 10.1080/07352689.2012.683375; Wu WX, 2004, SOIL BIOL BIOCHEM, V36, P289, DOI 10.1016/j.soilbio.2003.09.014; Zeng HL, 2014, SOIL BIOL BIOCHEM, V75, P254, DOI 10.1016/j.soilbio.2014.04.024	56	9	12	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146041	10.1371/journal.pone.0146041	http://dx.doi.org/10.1371/journal.pone.0146041			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717324	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500124
J	Badoud, D; Luyten, P; Fonseca-Pedrero, E; Eliez, S; Fonagy, P; Debbane, M				Badoud, Deborah; Luyten, Patrick; Fonseca-Pedrero, Eduardo; Eliez, Stephan; Fonagy, Peter; Debbane, Martin			The French Version of the Reflective Functioning Questionnaire: Validity Data for Adolescents and Adults and Its Association with Non-Suicidal Self-Injury	PLOS ONE			English	Article							BORDERLINE PERSONALITY-INVENTORY; TORONTO-ALEXITHYMIA-SCALE; MENTALIZATION; ATTACHMENT; TRANSMISSION; PREVALENCE; VALIDATION; BEHAVIOR; HARM; MIND	Introduction The capacity to understand one's own actions and those of others in terms of cognitive and affective mental states (i.e., reflective functioning or mentalizing) is thought to play a critical role in both typical and atypical development. To date, however, no self-report tool is available for assessing reflective functioning ability in French-speaking samples. The first aim of this study is to investigate the reliability and validity of the reflective functioning questionnaire (RFQ) in French-speaking adolescents and adults. Secondly, we investigate whether low levels of reflective functioning were associated with non-suicidal self-injury. Methods 130 adolescents (66 females, Mage = 15.72, SDage = 1.74) and 253 adults (168 females, Mage = 23.10, SDage = 2.56) completed a French translation of the RFQ and a battery of self-reported questionnaires to assess a set of clinical (alexithymia; borderline traits; internalizing and externalizing symptoms) and psychological (empathy; mindfulness) variables. Results The current results showed configural invariance of the original two-factor structure of the RFQ across French-speaking adolescents and adults and satisfactory reliability and construct validity of the two subscales. Furthermore, we observed that recent episodes of nonsuicidal self-injury were associated with lower levels of reflective functioning in the adult, but not in the adolescent, sample. Discussion The present research has methodological and clinical implications in that it provides the first evidence that the RFQ can be used to reliably assess reflective functioning in French-speaking population. The study further shows that impaired ability to consider mental states that lie behind behaviors might play a role in non-suicidal self-injury, at least in adults.	[Badoud, Deborah; Debbane, Martin] Univ Geneva, Fac Psychol, Dev Clin Psychol Unit, Geneva, Switzerland; [Badoud, Deborah; Eliez, Stephan; Debbane, Martin] Univ Geneva, Sch Med, Dept Psychiat, Off Med Pedag Res Unit, CH-1211 Geneva, Switzerland; [Luyten, Patrick; Fonagy, Peter; Debbane, Martin] UCL, Res Dept Clin Educ & Hlth Psychol, London, England; [Luyten, Patrick] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium; [Fonseca-Pedrero, Eduardo] Univ La Rioja, Dept Educ Sci, La Rioja, Spain; [Fonseca-Pedrero, Eduardo] Ctr Biomed Res Mental Hlth Network CIBERSAM, Madrid, Spain	University of Geneva; University of Geneva; University of London; University College London; KU Leuven; Universidad de La Rioja; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Badoud, D (corresponding author), Univ Geneva, Fac Psychol, Dev Clin Psychol Unit, Geneva, Switzerland.	deborah.badoud@unige.ch	Fonseca, Eduardo/L-4848-2019; Fonseca-Pedrero, Eduardo/C-4171-2011	Debbane, Martin/0000-0002-4677-8753; Fonagy, Peter/0000-0003-0229-0091; Fonseca-Pedrero, Eduardo/0000-0001-7453-5225	Swiss National Research Fund [100014-135311/1]; National Institute for Health Research [NF-SI-0514-10157, NF-SI-0510-10228] Funding Source: researchfish	Swiss National Research Fund(Swiss National Science Foundation (SNSF)); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by the Swiss National Research Fund to Pr. Martin Debbane and Pr. Stephan Eliez (100014-135311/1), http://www.snf.ch/fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, MANUAL ASEBA ADULT F, P61; Allen J. G., 2006, HDB MENTALIZATION BA; Baer RA, 2004, ASSESSMENT, V11, P191, DOI 10.1177/1073191104268029; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Bateman A., 2012, HDB MENTALIZING MENT; BEATON D, 2002, RECOMMENDATIONS CROS; Benbassat N, 2012, J ADOLESCENCE, V35, P163, DOI 10.1016/j.adolescence.2011.03.004; BRIGGS SR, 1986, J PERS, V54, P106, DOI 10.1111/j.1467-6494.1986.tb00391.x; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Brunner R, 2007, ARCH PEDIAT ADOL MED, V161, P641, DOI 10.1001/archpedi.161.7.641; Brunner R, 2014, J CHILD PSYCHOL PSYC, V55, P337, DOI 10.1111/jcpp.12166; Byrne BM, 2006, STRUCT EQU MODELING, V13, P287, DOI 10.1207/s15328007sem1302_7; Chabrol H, 2004, EUR J PSYCHOL ASSESS, V20, P59, DOI 10.1027/1015-5759.20.1.59; Chanen AM, 2012, CURR PSYCHIAT REP, V14, P45, DOI 10.1007/s11920-011-0242-y; Choi-Kain LW, 2008, AM J PSYCHIAT, V165, P1127, DOI 10.1176/appi.ajp.2008.07081360; D'Ambrosio F, 2009, PERS INDIV DIFFER, V46, P160, DOI 10.1016/j.paid.2008.09.020; Ensink K., 2004, THESIS; Fonagy P, 1996, INT J PSYCHOANAL, V77, P217; Fonagy P, 1996, J CONSULT CLIN PSYCH, V64, P22, DOI 10.1037/0022-006X.64.1.22; Fonagy P, 2015, DEV VALIDATION UNPUB; Fonagy P., 2002, AFFECT REGULATION ME; Fonagy P., 1998, REFLECTIVE FUNCTIONI; Fonagy P, 2014, PSYCHOTHERAPY, V51, P372, DOI 10.1037/a0036505; Fonagy P, 2009, DEV PSYCHOPATHOL, V21, P1355, DOI 10.1017/S0954579409990198; George C., 1996, ADULT ATTACHME UNPUB; Gergely G, 1996, INT J PSYCHOANAL, V77, P1181; Grienenberger J, 2005, ATTACH HUM DEV, V7, P299, DOI 10.1080/14616730500245963; Ha C, 2013, J ADOLESCENCE, V36, P1215, DOI 10.1016/j.adolescence.2013.09.008; Hawton K, 2002, BMJ-BRIT MED J, V325, P1207, DOI 10.1136/bmj.325.7374.1207; Heene M, 2012, STRUCT EQU MODELING, V19, P36, DOI 10.1080/10705511.2012.634710; Herpertz SC, 2013, CURR OPIN PSYCHIATR, V27, P1; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jolliffe D, 2006, J ADOLESCENCE, V29, P589, DOI 10.1016/j.adolescence.2005.08.010; Kakhnovets R., 2010, J MENTAL HLTH COUNSE, V32, P309, DOI [10.17744/mehc.32.4.a7370773244lq808, DOI 10.17744/MEHC.32.4.A7370773244LQ808]; Karlsson R, 2006, PSYCHOTHERAPY, V43, P65, DOI 10.1037/0033-3204.43.1.65; Katznelson H, 2014, CLIN PSYCHOL REV, V34, P107, DOI 10.1016/j.cpr.2013.12.003; Kerr PL, 2010, J AM BOARD FAM MED, V23, P240, DOI 10.3122/jabfm.2010.02.090110; Klonsky ED, 2007, J CLIN PSYCHOL, V63, P1045, DOI 10.1002/jclp.20412; Leichsenring F, 1999, J PERS ASSESS, V73, P45, DOI 10.1207/S15327752JPA730104; Levy KN, 2006, J CONSULT CLIN PSYCH, V74, P1027, DOI 10.1037/0022-006X.74.6.1027; Loas G, 1996, PSYCHOPATHOLOGY, V29, P139, DOI 10.1159/000284983; Manca M, 2014, PSYCHIAT RES, V215, P111, DOI 10.1016/j.psychres.2013.10.010; Muthen LK., 2017, MPLUS, VEight; Perkins A, 2009, THESIS; Perkins A, 2011, SPR BACP C LIV UK; Sharp C, 2011, J AM ACAD CHILD PSY, V50, P563, DOI 10.1016/j.jaac.2011.01.017; Slade A, 2005, ATTACH HUM DEV, V7, P283, DOI 10.1080/14616730500245880; Swannell SV, 2014, SUICIDE LIFE-THREAT, V44, P273, DOI 10.1111/sltb.12070; Target M., 2001, CHILD REFLECTI UNPUB; Taubner S, 2013, PSIHOLOGIJA, V46, P177, DOI 10.2298/PSI1302177T; Taubner S, 2013, J ABNORM CHILD PSYCH, V41, P929, DOI 10.1007/s10802-013-9736-x; Taubner S, 2011, PSYCHIATRY, V74, P49, DOI 10.1521/psyc.2011.74.1.49; Vermote R, 2010, J NERV MENT DIS, V198, P110, DOI 10.1097/NMD.0b013e3181cc0d59; Whitlock JL, NONSUICIDAL IN PRESS; Wyss CA, 2003, CAN J BEHAV SCI, V35, P67, DOI 10.1037/h0087189; Yu C.-Y., 2002, THESIS; Zanarini MC, 2006, J PERS DISORD, V20, P9, DOI 10.1521/pedi.2006.20.1.9; Zimmermann G, 2007, ENCEPHALE, V33, P1	58	61	66	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145892	10.1371/journal.pone.0145892	http://dx.doi.org/10.1371/journal.pone.0145892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0IX	26714319	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900100
J	De Pourcq, K; Thomas, E; Arts, B; Vranckx, A; Leon-Sicard, T; Van Damme, P				De Pourcq, Kobe; Thomas, Evert; Arts, Bas; Vranckx, An; Leon-Sicard, Tomas; Van Damme, Patrick			Conflict in Protected Areas: Who Says Co-Management Does Not Work?	PLOS ONE			English	Article							COMMUNITY; INSTITUTIONS; ORGANIZATIONS; GOVERNANCE; SUCCESS; TRUST	Natural resource-related conflicts can be extremely destructive and undermine environmental protection. Since the 1990s co-management schemes, whereby the management of resources is shared by public and/or private sector stakeholders, have been a main strategy for reducing these conflicts worldwide. Despite initial high hopes, in recent years co-management has been perceived as falling short of expectations. However, systematic assessments of its role in conflict prevention or mitigation are non-existent. Interviews with 584 residents from ten protected areas in Colombia revealed that co-management can be successful in reducing conflict at grassroots level, as long as some critical enabling conditions, such as effective participation in the co-management process, are fulfilled not only on paper but also by praxis. We hope these findings will re-incentivize global efforts to make co-management work in protected areas and other common pool resource contexts, such as fisheries, agriculture, forestry and water management.	[De Pourcq, Kobe; Van Damme, Patrick] Univ Ghent, Lab Trop & Subtrop Agr & Ethnobot, B-9000 Ghent, Belgium; [De Pourcq, Kobe; Vranckx, An] Univ Ghent, Conflict & Dev Studies, B-9000 Ghent, Belgium; [De Pourcq, Kobe; Leon-Sicard, Tomas] Univ Nacl Colombia, Inst Estudios Ambientales, Bogota, Colombia; [Thomas, Evert] Reg Off Amer, Biovers Int, Cali, Colombia; [Arts, Bas] Wageningen Univ, Forest & Nat Conservat Policy Grp, NL-6700 AP Wageningen, Netherlands; [Van Damme, Patrick] Czech Univ Life Sci Prague, Fac Trop AgriSci, Prague, Czech Republic	Ghent University; Ghent University; Universidad Nacional de Colombia; Alliance; Bioversity International; Wageningen University & Research; Czech University of Life Sciences Prague	De Pourcq, K (corresponding author), Univ Ghent, Lab Trop & Subtrop Agr & Ethnobot, B-9000 Ghent, Belgium.	kobedepourcq@gmail.com	Van Damme, Patrick/H-6693-2018; , Patrick/AAI-8779-2020	Van Damme, Patrick/0000-0002-2548-633X; De Pourcq, Kobe/0000-0001-5778-7594	Flemish Inter-University Council (VLIR-UOS); CGIAR research program on Forests Trees and Agroforesty and Conservation International, Colombian	Flemish Inter-University Council (VLIR-UOS); CGIAR research program on Forests Trees and Agroforesty and Conservation International, Colombian	Research was financed by a grant of the Flemish Inter-University Council (VLIR-UOS) to Kobe De Pourcq. Supplementary funding was provided by the CGIAR research program on Forests Trees and Agroforesty and Conservation International, Colombian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WM, 2003, SCIENCE, V302, P1915, DOI 10.1126/science.1087771; Adams WM, 2001, ORYX, V35, P193, DOI 10.1017/S0030605300031847; Agrawal A, 2006, WORLD DEV, V34, P149, DOI 10.1016/j.worlddev.2005.07.013; Agrawal A, 1999, WORLD DEV, V27, P629, DOI 10.1016/S0305-750X(98)00161-2; Agrawal A, 2001, WORLD DEV, V29, P1649, DOI 10.1016/S0305-750X(01)00063-8; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Andersson K, 2011, GLOBAL ENVIRON CHANG, V21, P866, DOI 10.1016/j.gloenvcha.2011.03.004; Berkes F, 2009, J ENVIRON MANAGE, V90, P1692, DOI 10.1016/j.jenvman.2008.12.001; Campbell B., 2001, CONSERV ECOL, V5, P22, DOI DOI 10.5751/ES-00316-050222; Carlsson L, 2005, J ENVIRON MANAGE, V75, P65, DOI 10.1016/j.jenvman.2004.11.008; Castro A. P., 2001, ENVIRON SCI POLICY, V4, P229, DOI DOI 10.1016/S1462-9011(01)00022-3; Cooke B, 2001, PARTICIPATION NEW TY; Cox M, 2010, ECOLOGY SOC; Cundill G, 2013, LAND USE POLICY, V35, P171, DOI 10.1016/j.landusepol.2013.05.016; De Pourcq K, 2009, INT FOREST REV, V11, P12, DOI 10.1505/ifor.11.1.12; Dressler W, 2010, ENVIRON CONSERV, V37, P5, DOI 10.1017/S0376892910000044; Glasl F., 1999, CONFRONTING CONFLICT; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Idrissou L, 2013, FOREST POLICY ECON, V27, P65, DOI 10.1016/j.forpol.2012.11.005; Kramer RM, 1999, ANNU REV PSYCHOL, V50, P569, DOI 10.1146/annurev.psych.50.1.569; Kutner M. H., 2004, APPL LINEAR REGRESSI; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Le Saout S, PROTECTED AREAS EFFE, P1; Leach M, 1999, WORLD DEV, V27, P225, DOI 10.1016/S0305-750X(98)00141-7; Lewicki RJ., 2006, HDB CONFLICT RESOLUT, P92; Lijeblad A, 2009, ENVIRON MANAGE, V43, P571, DOI 10.1007/s00267-008-9230-3; Lynam T, 2007, ECOLOGY SOC; Marfo E, 2009, LAND USE POLICY, V26, P619, DOI 10.1016/j.landusepol.2008.08.009; Miller G, 2002, USING CONFLICT THEOR, P223; Ostrom E., 1990, GOVERNING COMMONS EV; Pomeroy RS, 2001, MAR POLICY, V25, P197, DOI 10.1016/S0308-597X(01)00010-0; Pomeroy RS, 2004, OCEAN COAST MANAGE, V47, P429, DOI 10.1016/j.ocecoaman.2004.09.005; Pomeroy RS, 1997, MAR POLICY, V21, P465, DOI 10.1016/S0308-597X(97)00017-1; Porter-Bolland L, 2012, FOREST ECOL MANAG, V268, P6, DOI 10.1016/j.foreco.2011.05.034; Siegel S., 1988, NONPARAMETRIC STAT B, P213, DOI DOI 10.1177/014662168901300212; Stringer LC, 2006, ECOLOGY SOC; Thomas W. I., 1928, THE CHILD IN AM; Turnhout E, 2010, ECOLOGY SOC; Unidad Administrativa Especial del Sistema de Parques Nacionales Naturales, 2007, BAS TECN LEG POL PAR, P296; Vergara-Asenjo G, 2014, GLOBAL ENVIRON CHANG, V28, P205, DOI 10.1016/j.gloenvcha.2014.07.002; Wollenberg E, 2009, ECOLOGY SOC; Yasmi Y, 2006, ENVIRON SCI POLICY, V9, P538, DOI 10.1016/j.envsci.2006.04.003; Zuur Alain F., 2009, P1	43	41	43	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144943	10.1371/journal.pone.0144943	http://dx.doi.org/10.1371/journal.pone.0144943			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0IX	26714036	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900025
J	Engelke, W; Lazzarini, M; Stuhmer, W; Beltran, V				Engelke, Wilfried; Lazzarini, Marcio; Stuehmer, Walter; Beltran, Victor			Support Immersion Endoscopy in Post-Extraction Alveolar Bone Chambers: A New Window for Microscopic Bone Imaging In Vivo	PLOS ONE			English	Article							IMPLANT SITES; DENSITY; ASSESSMENTS	Using an endoscopic approach, small intraoral bone chambers, which are routinely obtained during tooth extraction and implantation, provide visual in vivo access to internal bone structures. The aim of the present paper is to present a new method to quantify bone microstructure and vascularisation in vivo. Ten extraction sockets and 6 implant sites in 14 patients (6 men / 8 women) were examined by support immersion endoscopy (SIE). After tooth extraction or implant site preparation, microscopic bone analysis (MBA) was performed using short distance SIE video sequences of representative bone areas for off-line analysis with ImageJ. Quantitative assessment of the microstructure and vascularisation of the bone in dental extraction and implant sites in vivo was performed using ImageJ. MBA revealed bone morphology details such as unmineralised and mineralised areas, vascular canals and the presence of bleeding through vascular canals. Morphometric examination revealed that there was more unmineralised bone and less vascular canal area in the implant sites than in the extraction sockets.	[Engelke, Wilfried; Beltran, Victor] Georg August Univ Hosp, Dept Oral & Maxillofacial Surg, Gottingen, Germany; [Lazzarini, Marcio; Stuehmer, Walter] Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, D-37075 Gottingen, Germany; [Beltran, Victor] Univ La Frontera, Sch Dent, Res Ctr Dent Sci CICO, Temuco, Chile	University of Gottingen; Max Planck Society; Universidad de La Frontera	Engelke, W (corresponding author), Georg August Univ Hosp, Dept Oral & Maxillofacial Surg, Gottingen, Germany.	wengelke@med.uni-oettingen.de	Stuehmer, Walter/A-2176-2009	Stuehmer, Walter/0000-0002-0642-7764				[Anonymous], 2011, J STAT MODELING ANAL, DOI DOI 10.1515/BILE-2015-0008; Beltran V., 2012, J ORAL MAXILLOFAC SU, V70, P6; BRANEMARK P I, 1959, Scand J Clin Lab Invest, V11 Supp 38, P1; BRANEMARK P I, 1964, Blut, V10, P236, DOI 10.1007/BF01630647; Brown E, 2010, COLD SPRING HARB PRO, P5452; DEMPSTER WT, 1959, ANAT REC, V135, P189, DOI 10.1002/ar.1091350305; Desmons SO, 2010, LASER SURG MED, V42, P631, DOI 10.1002/lsm.20971; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Engelke W, 2005, INT J ORAL MAX IMPL, V20, P891; Engelke W, 2008, INT J ODONTOSTOMATOL, V2, P153; Engelke WGH, 2002, INT J ORAL MAX IMPL, V17, P703; Engelke W, 2014, J CRANIO MAXILL SURG, V42, P213, DOI 10.1016/j.jcms.2013.05.003; Engelke W, 2011, CLIN ORAL INVEST, V15, P165, DOI 10.1007/s00784-009-0367-0; de Oliveira RCG, 2012, CLIN ORAL IMPLAN RES, V23, P981, DOI 10.1111/j.1600-0501.2011.02243.x; Hao Y, 2014, EUR REV MED PHARMACO, V18, P1398; Hsieh AS, 2001, BONE, V28, P94, DOI 10.1016/S8756-3282(00)00415-4; Juodzbalys G, 2008, J PERIODONTOL, V79, P64, DOI 10.1902/jop.2008.070253 ; Kingsmill VJ, 2007, J DENT RES, V86, P368, DOI 10.1177/154405910708600413; Mishra Awadhesh Kumar, 2014, Med J Armed Forces India, V70, P257, DOI 10.1016/j.mjafi.2014.04.007; Miyamoto W, 2013, ARTHROSC TEC, V2, pE467, DOI 10.1016/j.eats.2013.07.001; Nahlieli O, 2011, J ORAL MAXIL SURG, V69, P186, DOI 10.1016/j.joms.2010.07.071; Nkenke E, 2003, J CRANIO MAXILL SURG, V31, P362, DOI 10.1016/j.jcms.2003.07.001; Norton MR, 2001, CLIN ORAL IMPLAN RES, V12, P79, DOI 10.1034/j.1600-0501.2001.012001079.x; Nyarady J, 2012, J ORTHOP TRAUMA, V26, P200, DOI 10.1097/BOT.0b013e31822c8376; PARFITT AM, 1987, AM J MED, V82, P68, DOI 10.1016/0002-9343(87)90274-9; Pautke C, 2010, J ANAT, V217, P76, DOI 10.1111/j.1469-7580.2010.01237.x; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Taleb C, 2010, CHIR MAIN, V29, P78, DOI 10.1016/j.main.2009.12.001; Turkyilmaz I, 2007, J ORAL REHABIL, V34, P267, DOI 10.1111/j.1365-2842.2006.01689.x; Turkyilmaz I, 2006, J ORAL REHABIL, V33, P881, DOI 10.1111/j.1365-2842.2006.01692.x; Villa MM, 2013, TISSUE ENG PART C-ME, V19, P839, DOI [10.1089/ten.tec.2012.0490, 10.1089/ten.TEC.2012.0490]; von Arx T, 2003, INT ENDOD J, V36, P691, DOI 10.1046/j.1365-2591.2003.00718.x; WINET H, 1990, J BONE MINER RES, V5, P19, DOI 10.1002/jbmr.5650050106	33	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145767	10.1371/journal.pone.0145767	http://dx.doi.org/10.1371/journal.pone.0145767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713617	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900078
J	Raza, H; John, A				Raza, Haider; John, Annie			Differential Cytotoxicity of Acetaminophen in Mouse Macrophage J774.2 and Human Hepatoma HepG2 Cells: Protection by Diallyl Sulfide	PLOS ONE			English	Article							RESPIRATORY ENZYME-ACTIVITIES; INDUCED HEPATOTOXICITY; OXIDATIVE STRESS; INDUCED TOXICITY; MICE; APOPTOSIS; PARACETAMOL; GLUTATHIONE; MECHANISMS; HEPATOCYTES	Non-steroidal anti-inflammatory drugs (NSAIDs), including acetaminophen (APAP), have been reported to induce cytotoxicity in cancer and non-cancerous cells. Overdose of acetaminophen (APAP) causes liver injury in humans and animals. Hepatic glutathione (GSH) depletion followed by oxidative stress and mitochondrial dysfunction are believed to be the main causes of APAP toxicity. The precise molecular mechanism of APAP toxicity in different cellular systems is, however, not clearly understood. Our previous studies on mouse macrophage J774.2 cells treated with APAP strongly suggest induction of apoptosis associated with mitochondrial dysfunction and oxidative stress. In the present study, using human hepatoma HepG2 cells, we have further demonstrated that macrophages are a more sensitive target for APAP-induced toxicity than HepG2 cells. Using similar dose- and time-point studies, a marked increase in apoptosis and DNA fragmentation were seen in macrophages compared to HepG2 cells. Differential effects of APAP on mitochondrial respiratory functions and oxidative stress were observed in the two cell lines which are presumably dependent on the varying degree of drug metabolism by the different cytochrome P450s and detoxification by glutathione S-transferase enzyme systems. Our results demonstrate a marked increase in the activity and expression of glutathione transferase (GST) and multidrug resistance (MDR1) proteins in APAP-treated HepG2 cells compared to macrophages. This may explain the apparent resistance of HepG2 cells to APAP toxicity. However, treatment of these cells with diallyl sulfide (DAS, 200 mu M), a known chemopreventive agent from garlic extract, 24 h prior to APAP (10 mu mol/ml for 18h) exhibited comparable cytoprotective effects in the two cell lines. These results may help in better understanding the mechanism of cytotoxicity caused by APAP and cytoprotection by chemopreventive agents in cancer and non-cancerous cellular systems.	[Raza, Haider; John, Annie] UAE Univ, Dept Biochem, Coll Med & Hlth Sci, Al Ain, U Arab Emirates	United Arab Emirates University	Raza, H (corresponding author), UAE Univ, Dept Biochem, Coll Med & Hlth Sci, POB 17666, Al Ain, U Arab Emirates.	h.raza@uaeu.ac.ae		Raza, Haider/0000-0001-9680-5388	Research Committee Grant, CMHS (College of Medicine and Health Sciences), UAE University, UAE; Sheikh Hamdan bin Rashid Al Maktoum Medical Research Award; Terry Fox Cancer Research Fund (UAE)	Research Committee Grant, CMHS (College of Medicine and Health Sciences), UAE University, UAE; Sheikh Hamdan bin Rashid Al Maktoum Medical Research Award; Terry Fox Cancer Research Fund (UAE)	Authors wish to acknowledge the support from the Research Committee Grant, CMHS (College of Medicine and Health Sciences), UAE University, UAE. Supports from Sheikh Hamdan bin Rashid Al Maktoum Medical Research Award and Terry Fox Cancer Research Fund (UAE) are also acknowledged.	Al-Belooshi T., 2010, AM J BIOMED LIFE SCI, V2, P142, DOI [10.5099/aj100200142, DOI 10.5099/AJ100200142]; Al-Belooshi T, 2010, FOOD CHEM TOXICOL, V48, P2624, DOI 10.1016/j.fct.2010.06.031; Andringa KK, 2008, TOXICOL LETT, V177, P188, DOI 10.1016/j.toxlet.2008.01.010; Arakawa S, 2012, J TOXICOL SCI, V37, P595; Bajt ML, 2004, TOXICOL SCI, V80, P343, DOI 10.1093/toxsci/kfh151; BOOBIS AR, 1990, BIOCHEM PHARMACOL, V39, P1277, DOI 10.1016/0006-2952(90)90003-4; BOOBIS AR, 1986, FOOD CHEM TOXICOL, V24, P731, DOI 10.1016/0278-6915(86)90172-9; BURCHAM PC, 1991, J BIOL CHEM, V266, P5049; DAI Y, 1995, J PHARMACOL EXP THER, V273, P1497; Dambach DM, 2006, TOXICOL APPL PHARM, V211, P157, DOI 10.1016/j.taap.2005.06.024; Ghanem CI, 2011, BIOCHEM PHARMACOL, V81, P244, DOI 10.1016/j.bcp.2010.10.006; Gujral JS, 2002, TOXICOL SCI, V67, P322, DOI 10.1093/toxsci/67.2.322; HARVISON PJ, 1988, CHEM RES TOXICOL, V1, P47, DOI 10.1021/tx00001a009; Hinz B, 2008, FASEB J, V22, P383, DOI 10.1096/fj.07-8506com; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Hu JJ, 1996, FOOD CHEM TOXICOL, V34, P963, DOI 10.1016/S0278-6915(96)00057-9; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Ishida Y, 2006, EUR J IMMUNOL, V36, P1028, DOI 10.1002/eji.200535261; Jaeschke H, 2010, COMPREHENSIVE TOXICOLOGY, VOL 9: HEPATIC TOXICOLOGY, 2ND EDITION, P457; Jaeschke H, 2004, LIVER INT, V24, P85, DOI 10.1111/j.1478-3231.2004.0906.x; James LP, 2003, DRUG METAB DISPOS, V31, P1499, DOI 10.1124/dmd.31.12.1499; Kon K, 2007, J GASTROEN HEPATOL, V22, pS49, DOI 10.1111/j.1440-1746.2007.04962.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lazerow SK, 2005, CURR OPIN GASTROEN, V21, P283, DOI 10.1097/01.mog.0000160043.10804.60; Lee WM, 2004, HEPATOLOGY, V40, P6, DOI 10.1002/hep.20293; Liu ZX, 2004, GASTROENTEROLOGY, V127, P1760, DOI 10.1053/j.gastro.2004.08.053; Maity P, 2009, J BIOL CHEM, V284, P3058, DOI 10.1074/jbc.M805329200; Manov I, 2006, BASIC CLIN PHARMACOL, V99, P213, DOI 10.1111/j.1742-7843.2006.pto_443.x; Ni HM, 2012, HEPATOLOGY, V55, P222, DOI 10.1002/hep.24690; Pachkoria K, 2007, CURR DRUG SAF, V2, P97, DOI 10.2174/157488607780598287; Raza H., 2014, HAMDAN MED J, V7, P219, DOI DOI 10.7707/HMJ.V7I2.316); Raza H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103379; Raza H, 2013, CELL PHYSIOL BIOCHEM, V31, P683, DOI 10.1159/000350087; Raza H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036325; Raza H, 2011, EUR J PHARMACOL, V668, P15, DOI 10.1016/j.ejphar.2011.06.016; Reid AB, 2005, J PHARMACOL EXP THER, V312, P509, DOI 10.1124/jpet.104.075945; Russmann S, 2009, CURR MED CHEM, V16, P3041, DOI 10.2174/092986709788803097; Saito C, 2010, HEPATOLOGY, V51, P246, DOI 10.1002/hep.23267; Sener G, 2003, J PINEAL RES, V35, P61, DOI 10.1034/j.1600-079X.2003.00050.x; Shaik IH, 2008, PHARM RES-DORDR, V25, P2231, DOI 10.1007/s11095-008-9601-8; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; THUMMEL KE, 1993, BIOCHEM PHARMACOL, V45, P1563, DOI 10.1016/0006-2952(93)90295-8; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VERMEULEN NPE, 1992, DRUG METAB REV, V24, P367, DOI 10.3109/03602539208996298	45	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145965	10.1371/journal.pone.0145965	http://dx.doi.org/10.1371/journal.pone.0145965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714183	Green Submitted, gold, Green Published			2022-12-27	WOS:000367481900106
J	Nikolaus, S; Bode, C; Taal, E; Vonkeman, HE; Glas, CAW; van de Laar, MAFJ				Nikolaus, Stephanie; Bode, Christina; Taal, Erik; Vonkeman, Harald E.; Glas, Cees A. W.; van de Laar, Mart A. F. J.			Construct Validation of a Multidimensional Computerized Adaptive Test for Fatigue in Rheumatoid Arthritis	PLOS ONE			English	Article							OUTCOMES; QUALITY; EXPERIENCE; DIMENSIONS; SCALES; SF-36; ITEM	Objective Multidimensional computerized adaptive testing enables precise measurements of patient-reported outcomes at an individual level across different dimensions. This study examined the construct validity of a multidimensional computerized adaptive test (CAT) for fatigue in rheumatoid arthritis (RA). Methods The 'CAT Fatigue RA' was constructed based on a previously calibrated item bank. It contains 196 items and three dimensions: 'severity', 'impact' and 'variability' of fatigue. The CAT was administered to 166 patients with RA. They also completed a traditional, multidimensional fatigue questionnaire (BRAF-MDQ) and the SF-36 in order to examine the CAT's construct validity. A priori criterion for construct validity was that 75% of the correlations between the CAT dimensions and the subscales of the other questionnaires were as expected. Furthermore, comprehensive use of the item bank, measurement precision and score distribution were investigated. Results The a priori criterion for construct validity was supported for two of the three CAT dimensions (severity and impact but not for variability). For severity and impact, 87% of the correlations with the subscales of the well-established questionnaires were as expected but for variability, 53% of the hypothesised relations were found. Eighty-nine percent of the items were selected between one and 137 times for CAT administrations. Measurement precision was excellent for the severity and impact dimensions, with more than 90% of the CAT administrations reaching a standard error below 0.32. The variability dimension showed good measurement precision with 90% of the CAT administrations reaching a standard error below 0.44. No floor- or ceiling-effects were found for the three dimensions. Conclusion The CAT Fatigue RA showed good construct validity and excellent measurement precision on the dimensions severity and impact. The dimension variability had less ideal measurement characteristics, pointing to the need to recalibrate the CAT item bank with a two-dimensional model, solely consisting of severity and impact.	[Nikolaus, Stephanie; Bode, Christina; Taal, Erik; Vonkeman, Harald E.; van de Laar, Mart A. F. J.] Univ Twente, Fac Behav Management & Social Sci, Dept Psychol Hlth & Technol, NL-7500 AE Enschede, Netherlands; [Glas, Cees A. W.] Univ Twente, Fac Behav Management & Social Sci, Dept Res Methodol Measurement & Data Anal, NL-7500 AE Enschede, Netherlands; [Vonkeman, Harald E.; van de Laar, Mart A. F. J.] Med Spectrum Twente, Dept Rheumatol & Clin Immunol, Enschede, Netherlands; [Nikolaus, Stephanie] Radboud Univ Nijmegen, Med Ctr, Expert Ctr Chron Fatigue, NL-6525 ED Nijmegen, Netherlands	University of Twente; University of Twente; Medical Spectrum Twente; Radboud University Nijmegen	Bode, C (corresponding author), Univ Twente, Fac Behav Management & Social Sci, Dept Psychol Hlth & Technol, POB 217, NL-7500 AE Enschede, Netherlands.	c.bode@utwente.nl			Dutch Arthritis Foundation (Reumafonds)	Dutch Arthritis Foundation (Reumafonds)	The study was financed by the Dutch Arthritis Foundation (Reumafonds), http://www.reumafonds.nl/. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELZA BL, 1993, NURS RES, V42, P93; Bode C, ANN RHEUM DIS S2, V73; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2011, SUPPORT CARE CANCER, V19, P1441, DOI 10.1007/s00520-010-0971-1; Dures EK, 2013, RHEUMATOLOGY, V52, P1832, DOI 10.1093/rheumatology/ket218; Fayers P., 2007, QUALITY LIFE ASSESSM; Fliege H, 2009, INT J METH PSYCH RES, V18, P23, DOI 10.1002/mpr.274; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hambleton R. K., 1991, FUNDAMENTALS ITEM RE; Hewlett S, 2007, ARTHRIT RHEUM-ARTHR, V57, P429, DOI 10.1002/art.22611; Hewlett S, 2005, ARTHRIT RHEUM-ARTHR, V53, P697, DOI 10.1002/art.21450; Hewlett S, 2005, MUSCULOSKELET CARE, V3, P131, DOI 10.1002/msc.3; Kirwan JR, 2009, J RHEUMATOL, V36, P2067, DOI 10.3899/jrheum.090359; Kocalevent RD, 2009, J CLIN EPIDEMIOL, V62, P278, DOI 10.1016/j.jclinepi.2008.03.003; MISLEVY RJ, 1991, PSYCHOMETRIKA, V56, P177, DOI 10.1007/BF02294457; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Nicklin J, 2010, ARTHRIT CARE RES, V62, P1559, DOI 10.1002/acr.20282; Nikolaus S, 2012, CLIN EXP RHEUMATOL, V30, P79; Nikolaus Stephanie, 2014, JMIR Hum Factors, V1, pe4, DOI 10.2196/humanfactors.3424; Nikolaus S, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0215-7; Nikolaus S, 2013, J CLIN EPIDEMIOL, V66, P1175, DOI 10.1016/j.jclinepi.2013.05.010; Nikolaus S, 2013, ARTHRIT CARE RES, V65, P1128, DOI 10.1002/acr.21949; Nikolaus S, 2012, QUAL LIFE RES, V21, P863, DOI 10.1007/s11136-011-9982-8; Nikolaus S, 2012, MUSCULOSKELET CARE, V10, P13, DOI 10.1002/msc.222; Nikolaus S, 2010, RHEUMATOLOGY, V49, P2191, DOI 10.1093/rheumatology/keq210; Nikolaus S, 2010, ANN RHEUM DIS, V69, P895, DOI 10.1136/ard.2009.118067; Norweg A, 2011, ARCH PHYS MED REHAB, V92, P1561, DOI 10.1016/j.apmr.2011.05.020; Petersen MA, 2006, QUAL LIFE RES, V15, P315, DOI 10.1007/s11136-005-3214-z; Reckase MD, 2009, STAT SOC BEHAV SC, P311, DOI 10.1007/978-0-387-89976-3_10; Reeve B. B., 2005, ASSESSING QUALITY LI, P55, DOI DOI 10.1007/S11136-007-9198-0; Reeve B, 2013, QUAL LIFE RES, V22, P1889, DOI 10.1007/s11136-012-0344-y; Repping-Wuts H, 2008, INT J NURS STUD, V45, P995, DOI 10.1016/j.ijnurstu.2007.06.007; Segall DO, 2010, STAT SOC BEHAV SC, P57, DOI 10.1007/978-0-387-85461-8_3; Streiner D. L., 2003, HLTH MEASUREMENT SCA; Tack B B, 1990, Arthritis Care Res, V3, P65, DOI 10.1002/1529-0131(199006)3:2<65::AID-ANR1790030203>3.0.CO;2-6; Tack BB, 1991, THESIS; ten Klooster PM, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-77; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Voshaar MAHO, 2015, J RHEUMATOL, V42, P413, DOI 10.3899/jrheum.140389; Wainer H.W., 1990, COMPUTERIZED ADAPTIV; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wolfe F, 1996, J RHEUMATOL, V23, P1407; Yorkston KM, 2010, QUAL LIFE RES, V19, P243, DOI 10.1007/s11136-009-9572-1	43	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145008	10.1371/journal.pone.0145008	http://dx.doi.org/10.1371/journal.pone.0145008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ9XO	26710104	Green Published, Green Submitted, gold			2022-12-27	WOS:000367451400018
J	Schkolnik, G; Schmidt, M; Mazza, MG; Harnisch, F; Musat, N				Schkolnik, Gal; Schmidt, Matthias; Mazza, Marco G.; Harnisch, Falk; Musat, Niculina			In Situ Analysis of a Silver Nanoparticle-Precipitating Shewanella Biofilm by Surface Enhanced Confocal Raman Microscopy	PLOS ONE			English	Article							INTERFACIAL ELECTRON-TRANSFER; BACTERIAL NANOWIRES; MICROBIAL BIOFILMS; ANAEROBIC RESPIRATION; PROTEIN DYNAMICS; CYTOCHROME-C; ONEIDENSIS; SPECTROSCOPY; MR-1; SCATTERING	Shewanella oneidensis MR-1 is an electroactive bacterium, capable of reducing extracellular insoluble electron acceptors, making it important for both nutrient cycling in nature and microbial electrochemical technologies, such as microbial fuel cells and microbial electrosynthesis. When allowed to anaerobically colonize an Ag/AgCl solid interface, S. oneidensis has precipitated silver nanoparticles (AgNp), thus providing the means for a surface enhanced confocal Raman microscopy (SECRaM) investigation of its biofilm. The result is the in-situ chemical mapping of the biofilm as it developed over time, where the distribution of cytochromes, reduced and oxidized flavins, polysaccharides and phosphate in the undisturbed biofilm is monitored. Utilizing AgNp bio-produced by the bacteria colonizing the Ag/AgCl interface, we could perform SECRaM while avoiding the use of a patterned or roughened support or the introduction of noble metal salts and reducing agents. This new method will allow a spatially and temporally resolved chemical investigation not only of Shewanella biofilms at an insoluble electron acceptor, but also of other noble metal nanoparticle-precipitating bacteria in laboratory cultures or in complex microbial communities in their natural habitats.	[Schkolnik, Gal; Mazza, Marco G.] Max Planck Inst Dynam & Self Org, Dept Dynam Complex Fluids, Gottingen, Germany; [Schkolnik, Gal; Harnisch, Falk] Helmholtz Ctr Environm Res, Dept Environm Microbiol, Leipzig, Germany; [Schkolnik, Gal; Schmidt, Matthias; Musat, Niculina] Helmholtz Ctr Environm Res, Dept Isotope Biogeochem, Leipzig, Germany	Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Schkolnik, G (corresponding author), Max Planck Inst Dynam & Self Org, Dept Dynam Complex Fluids, Gottingen, Germany.	gal.schkonik@ufz.de	Harnisch, Falk/J-5888-2012; Mazza, Marco/AAL-3983-2021; Rudich, Yinon/K-1498-2012; Musat, Niculina/ABA-2180-2021	Harnisch, Falk/0000-0002-0014-4640; Rudich, Yinon/0000-0003-3149-0201; Musat, Niculina/0000-0001-9539-189X; Schmidt, Matthias/0000-0002-0161-8326; Mazza, Marco/0000-0002-5625-9121; Schkolnik, Gal/0000-0002-5422-4566	Europaischer Fonds fur regionale Entwicklung (EFRE) Sachsen [SAB 100112100]; Initiative and Networking Fund of the Helmholtz Association [PD - 165]; Max Planck Society; Helmholtz Centre for Environmental Research	Europaischer Fonds fur regionale Entwicklung (EFRE) Sachsen; Initiative and Networking Fund of the Helmholtz Association; Max Planck Society(Max Planck SocietyFoundation CELLEX); Helmholtz Centre for Environmental Research	This work was supported by Europaischer Fonds fur regionale Entwicklung (EFRE) Sachsen, grant number SAB 100112100 (http://www.eu-info.de/foerderprogramme/strukturfonds/EFRE/); the Initiative and Networking Fund of the Helmholtz Association, funding number PD - 165 (http://www.helmholtz.de/en/about_us/initiating_and_networking/); the Max Planck Society, no funding number (http://www.mpg.de/en); and the Helmholtz Centre for Environmental Research, no funding number (http://www.ufz.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Paggi D, 2013, J PHYS CHEM B, V117, P6061, DOI 10.1021/jp400832m; Bewley KD, 2013, BBA-BIOENERGETICS, V1827, P938, DOI 10.1016/j.bbabio.2013.03.010; Biju V, 2007, LANGMUIR, V23, P1333, DOI 10.1021/la061343z; BLAKE RC, 1993, ENVIRON TOXICOL CHEM, V12, P1365, DOI 10.1002/etc.5620120806; Bowler MW, 2010, NEW J CHEM, V34, P784, DOI 10.1039/b9nj00718k; Brayner R, 2007, J NANOSCI NANOTECHNO, V7, P2696, DOI 10.1166/jnn.2007.600; Bretschger O, 2007, APPL ENVIRON MICROB, V73, P7003, DOI 10.1128/AEM.01087-07; Bretschger O, 2010, ELECTROANAL, V22, P883, DOI 10.1002/elan.200800016; Breuer M, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1117; Cao B, 2011, ENVIRON MICROBIOL, V13, P1018, DOI 10.1111/j.1462-2920.2010.02407.x; Cescutti P, 2010, MICROBIAL GLYCOBIOLO, P93; Coursolle D, 2010, J BACTERIOL, V192, P467, DOI 10.1128/JB.00925-09; Creamer NJ, 2006, BIOTECHNOL LETT, V28, P1475, DOI 10.1007/s10529-006-9120-9; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Edwards MJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11677; Edwards MJ, 2012, STRUCTURE, V20, P1275, DOI 10.1016/j.str.2012.04.016; Efrima S, 2009, J RAMAN SPECTROSC, V40, P277, DOI 10.1002/jrs.2121; El-Naggar MY, 2010, P NATL ACAD SCI USA, V107, P18127, DOI 10.1073/pnas.1004880107; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; GREAVES SJ, 1988, J RAMAN SPECTROSC, V19, P503, DOI 10.1002/jrs.1250190803; Guerrini L, 2015, ANGEW CHEM INT EDIT, V54, P1144, DOI 10.1002/anie.201408558; Haes AJ, 2004, ANAL BIOANAL CHEM, V379, P920, DOI 10.1007/s00216-004-2708-9; Haider S, 2010, MOL MICROBIOL, V77, P687, DOI 10.1111/j.1365-2958.2010.07241.x; Halbhuber KJ, 2003, ANN ANAT, V185, P1, DOI 10.1016/S0940-9602(03)80002-X; Haynes CL, 2005, ANAL CHEM, V77, p338A, DOI 10.1021/ac053456d; Hennebel T, 2009, TRENDS BIOTECHNOL, V27, P90, DOI 10.1016/j.tibtech.2008.11.002; Holmes DE, 2004, APPL ENVIRON MICROB, V70, P1234, DOI 10.1128/AEM.70.2.1234-1237.2004; HU SZ, 1993, J AM CHEM SOC, V115, P12446, DOI 10.1021/ja00079a028; Hua X, 2014, ANALYST, V139, P1609, DOI 10.1039/c3an02262e; Ivleva NP, 2010, J PHYS CHEM B, V114, P10184, DOI 10.1021/jp102466c; Jarvis RM, 2008, ANAL CHEM, V80, P6741, DOI 10.1021/ac800838v; Jarvis RM, 2008, CHEM SOC REV, V37, P931, DOI 10.1039/b705973f; Jin RC, 2003, NATURE, V425, P487, DOI 10.1038/nature02020; Jones ME, 2010, ENVIRON MICROBIOL, V12, P938, DOI 10.1111/j.1462-2920.2009.02137.x; Kalaivani G, 2012, LANGMUIR, V28, P14357, DOI 10.1021/la303136v; Kalathil S, 2014, CHEMELECTROCHEM, V1, P1840, DOI 10.1002/celc.201402195; Karthikeyan S, 2002, ENVIRON MICROBIOL, V4, P667, DOI 10.1046/j.1462-2920.2002.00353.x; Kazanci M, 2009, APPL SPECTROSC, V63, P214, DOI 10.1366/000370209787391987; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Kim M, 2012, ACS APPL MATER INTER, V4, P5038, DOI 10.1021/am3015058; Klaus T, 1999, P NATL ACAD SCI USA, V96, P13611, DOI 10.1073/pnas.96.24.13611; Klupfel L, 2014, NAT GEOSCI, V7, P195, DOI 10.1038/NGEO2084; Kniggendorf AK, 2011, WATER RES, V45, P4571, DOI 10.1016/j.watres.2011.06.007; Knirel YA, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P57; Kotloski NJ, 2013, MBIO, V4, DOI 10.1128/mBio.00553-12; Kouzuma A, 2010, APPL ENVIRON MICROB, V76, P4151, DOI 10.1128/AEM.00117-10; Kranich A, 2008, J AM CHEM SOC, V130, P9844, DOI 10.1021/ja8016895; Kurouski D, 2013, ANALYST, V138, P1665, DOI 10.1039/c2an36478f; Lanekoff I, 2015, ANAL BIOANAL CHEM, V407, P2063, DOI 10.1007/s00216-014-8174-0; Lanni EJ, 2014, ANAL CHEM, V86, P9139, DOI 10.1021/ac5020222; Lebedev N, 2014, CHEMPHYSCHEM, V15, P320, DOI 10.1002/cphc.201300984; Leung KM, 2011, SOFT MATTER, V7, P6617, DOI 10.1039/c1sm05611e; Li R, 2012, ENVIRON SCI TECHNOL, V46, P2813, DOI 10.1021/es204302w; Liang YL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015295, 10.1371/journal.pone.0012860]; Lide David R., C R C HDB CHEM PHYS; Liu JT, 2015, NATURE, V523, P550, DOI 10.1038/nature14660; Logan BE, 2012, SCIENCE, V337, P686, DOI 10.1126/science.1217412; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Lovley DR, 2006, CURR OPIN BIOTECH, V17, P327, DOI 10.1016/j.copbio.2006.04.006; LOVLEY DR, 1991, MICROBIOL REV, V55, P259, DOI 10.1128/MMBR.55.2.259-287.1991; Ly HK, 2011, J ELECTROANAL CHEM, V660, P367, DOI 10.1016/j.jelechem.2010.12.020; Ly HK, 2013, CHEMSUSCHEM, V6, P487, DOI 10.1002/cssc.201200626; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; Marshall MJ, 2006, PLOS BIOL, V4, P1324, DOI 10.1371/journal.pbio.0040268; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Melton ED, 2014, NAT REV MICROBIOL, V12, P797, DOI 10.1038/nrmicro3347; Melzer S, 2015, MICROB BIOTECHNOL, V8, P379, DOI 10.1111/1751-7915.12154; Millo D, 2011, ANGEW CHEM INT EDIT, V50, P2625, DOI 10.1002/anie.201006046; Murgida DH, 2001, J MOL STRUCT, V565, P97, DOI 10.1016/S0022-2860(00)00781-X; Nair B, 2002, CRYST GROWTH DES, V2, P293, DOI 10.1021/cg0255164; Nealson KH, 2002, ANTON LEEUW INT J G, V81, P215, DOI 10.1023/A:1020518818647; NEALSON KH, 1994, ANNU REV MICROBIOL, V48, P311, DOI 10.1146/annurev.mi.48.100194.001523; Neu TR, 2015, TRENDS MICROBIOL, V23, P233, DOI 10.1016/j.tim.2014.12.010; Neu TR, 2014, METHODS MOL BIOL, V1147, P43, DOI 10.1007/978-1-4939-0467-9_4; Neu TR, MICROBIAL GLYCOBIOLO, P733; Oates TWH, 2009, J PHYS CHEM C, V113, P4820, DOI 10.1021/jp8097654; Oellerich S, 2002, J PHYS CHEM B, V106, P6566, DOI 10.1021/jp013841g; Okamoto A, 2013, P NATL ACAD SCI USA, V110, P7856, DOI 10.1073/pnas.1220823110; Patzold R, 2008, J MICROBIOL METH, V72, P241, DOI 10.1016/j.mimet.2007.12.003; Pagba CV, 2010, J RAMAN SPECTROSC, V41, P241, DOI 10.1002/jrs.2428; Paquete CM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00318; Parikh RY, 2008, CHEMBIOCHEM, V9, P1415, DOI 10.1002/cbic.200700592; Pemberton RM, 2010, MICROCHIM ACTA, V170, P321, DOI 10.1007/s00604-010-0326-0; Pirbadian S, 2014, P NATL ACAD SCI USA, V111, P12883, DOI 10.1073/pnas.1410551111; Preciado-Flores S, 2011, CHEM COMMUN, V47, P4129, DOI 10.1039/c0cc05517d; Ramanathan R, 2011, LANGMUIR, V27, P714, DOI 10.1021/la1036162; Rang M, 2008, NANO LETT, V8, P3357, DOI 10.1021/nl801808b; Ray R, 2010, J MICROBIOL METH, V82, P187, DOI 10.1016/j.mimet.2010.05.011; Renslow RS, 2013, ENERG ENVIRON SCI, V6, P1827, DOI 10.1039/c3ee40203g; Renslow RS, 2013, ENERG ENVIRON SCI, V6, P595, DOI 10.1039/c2ee23394k; Roden EE, 2010, NAT GEOSCI, V3, P417, DOI 10.1038/NGEO870; Rosenbaum MA, 2014, APPL MICROBIOL BIOT, V98, P509, DOI 10.1007/s00253-013-5396-6; Rycenga M, 2011, CHEM REV, V111, P3669, DOI 10.1021/cr100275d; Salas EC, 2010, GEOCHIM COSMOCHIM AC, V74, P574, DOI 10.1016/j.gca.2009.10.039; Sandt C, 2009, APPL MICROBIOL BIOT, V83, P1171, DOI 10.1007/s00253-009-2072-y; Schroder U, 2015, ENERG ENVIRON SCI, V8, P513, DOI 10.1039/c4ee03359k; Shakibaie MR, 1999, CAN J MICROBIOL, V45, P995, DOI 10.1139/cjm-45-12-995; SHOTTON DM, 1989, J CELL SCI, V94, P175; Siebert F., 2008, VIB SPECTROSC, P11, DOI DOI 10.1002/9783527621347.CH2; Smith-Palmer T, 2010, VIB SPECTROSC, V53, P103, DOI 10.1016/j.vibspec.2010.02.012; Strycharz-Glaven SM, 2011, ENERG ENVIRON SCI, V4, P4366, DOI 10.1039/c1ee01753e; Sturm G, 2015, ISME J, V9, P1802, DOI 10.1038/ismej.2014.264; Suresh AK, 2010, ENVIRON SCI TECHNOL, V44, P5210, DOI 10.1021/es903684r; Taillefert M, 2007, J INORG BIOCHEM, V101, P1760, DOI 10.1016/j.jinorgbio.2007.07.020; Teal TK, 2006, APPL ENVIRON MICROB, V72, P7324, DOI 10.1128/AEM.01163-06; Valle L, 2012, PHOTOCH PHOTOBIO SCI, V11, P1051, DOI 10.1039/c2pp05385c; Vigneshwaran N, 2007, MATER LETT, V61, P1413, DOI 10.1016/j.matlet.2006.07.042; Virdis B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089918; Virdis B, 2012, ENERG ENVIRON SCI, V5, P7017, DOI 10.1039/c2ee03374g; Wang H, 2010, J BACTERIOL, V192, P1143, DOI 10.1128/JB.01277-09; Xie CG, 2003, J APPL PHYS, V93, P2982, DOI 10.1063/1.1542654; Xu LJ, 2015, J AM CHEM SOC, V137, P5149, DOI 10.1021/jacs.5b01426; Zeiri L, 2004, APPL SPECTROSC, V58, P33, DOI 10.1366/000370204322729441; Zhang YD, 2014, MOL BIOSYST, V10, P1035, DOI 10.1039/c3mb70520j	115	10	10	3	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145871	10.1371/journal.pone.0145871	http://dx.doi.org/10.1371/journal.pone.0145871			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709923	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400088
J	Shin, KC; Choi, HY; Seo, MJ; Oh, DK				Shin, Kyung-Chul; Choi, Hye-Yeon; Seo, Min-Ju; Oh, Deok-Kun			Compound K Production from Red Ginseng Extract by beta-Glycosidase from Sulfolobus solfataricus Supplemented with alpha-L-Arabinofuranosidase from Caldicellulosiruptor saccharolyticus	PLOS ONE			English	Article							PANAX-GINSENG; PROTOPANAXADIOL GINSENOSIDES; MICROBIAL TRANSFORMATION; INTESTINAL BACTERIA; UVB IRRADIATION; BIOTRANSFORMATION; SAPONINS; RB1; GLUCOSIDASE; METABOLITE	Ginsenoside compound K (C-K) is attracting a lot of interest because of its biological and pharmaceutical activities, including hepatoprotective, antitumor, anti-wrinkling, and anti-skin aging activities. C-K has been used as the principal ingredient in skin care products. For the effective application of ginseng extracts to the manufacture of cosmetics, the PPD-type ginsenosides in ginseng extracts should be converted to C-K by enzymatic conversion. For increased yield of C-K from the protopanaxadiol (PPD)-type ginsenosides in red-ginseng extract (RGE), the alpha-L-arabinofuranoside-hydrolyzing alpha-L-arabinofuranosidase from Caldicellulosiruptor saccharolyticus (CS-abf) was used along with the beta-D-glucopyranoside/alpha-L-arabinopyranoside-hydrolyzing beta-glycosidase from Sulfolobus solfataricus (SS-bgly) because SS-bgly showed very low hydrolytic activity on the alpha-L-arabinofuranoside linkage in ginsenosides. The optimal reaction conditions for C-K production were as follows: pH 6.0, 80 degrees C, 2 U/mL SS-bgly, 3 U/mL CS-abf, and 7.5 g/L PPD-type ginsenosides in RGE. Under these optimized conditions, SS-bgly supplemented with CS-abf produced 4.2 g/L C-K from 7.5 g/L PPD-type ginsenosides in 12 h without other ginsenosides, with a molar yield of 100% and a productivity of 348 mg/L/h. To the best of our knowledge, this is the highest concentration and productivity of C-K from ginseng extract ever published in literature.	[Shin, Kyung-Chul; Choi, Hye-Yeon; Seo, Min-Ju; Oh, Deok-Kun] Konkuk Univ, Dept Biosci & Biotechnol, Seoul 05029, South Korea	Konkuk University	Oh, DK (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul 05029, South Korea.	deokkun@konkuk.ac.kr	Shin, Kyung-Chul/E-9681-2017	Shin, Kyung-Chul/0000-0002-1527-0164				Akao T, 1998, BIOL PHARM BULL, V21, P245, DOI 10.1248/bpb.21.245; Bae EA, 2002, BIOL PHARM BULL, V25, P743, DOI 10.1248/bpb.25.743; Bang CS, 2014, J GINSENG RES, V38, P167, DOI 10.1016/j.jgr.2014.04.002; Chi H, 2005, BIOL PHARM BULL, V28, P2102, DOI 10.1248/bpb.28.2102; Chi H, 2005, BIOTECHNOL LETT, V27, P765, DOI 10.1007/s10529-005-5632-y; Cho WCS, 2006, EUR J PHARMACOL, V550, P173, DOI 10.1016/j.ejphar.2006.08.056; Choi HJ, 2014, MYCOBIOLOGY, V42, P256, DOI 10.5941/MYCO.2014.42.3.256; Fu Y, 2014, LETT APPL MICROBIOL, V58, P138, DOI 10.1111/lam.12166; Hou JG, 2012, J APPL MICROBIOL, V113, P807, DOI 10.1111/j.1365-2672.2012.05400.x; Hsu BY, 2013, FOOD CHEM, V141, P4186, DOI 10.1016/j.foodchem.2013.06.134; Hwang E, 2013, J GINSENG RES, V37, P425, DOI 10.5142/jgr.2013.37.425; Jin XF, 2012, J MICROBIOL BIOTECHN, V22, P343, DOI 10.4014/jmb.1107.07066; Kang TH, 2009, J ETHNOPHARMACOL, V123, P446, DOI 10.1016/j.jep.2009.03.022; Kim BH, 2006, BIOL PHARM BULL, V29, P2472, DOI 10.1248/bpb.29.2472; Kim BG, 2011, APPL BIOCHEM BIOTECH, V165, P1107, DOI 10.1007/s12010-011-9328-6; Kim EH, 2013, BIOSCI BIOTECH BIOCH, V77, P1138, DOI 10.1271/bbb.120823; Kim MK, 2005, J MICROBIOL, V43, P456; Kimura Y, 2006, BRIT J PHARMACOL, V148, P860, DOI 10.1038/sj.bjp.0706794; Ko S, 2007, CHEM PHARM BULL, V55, P1522, DOI 10.1248/cpb.55.1522; Lee HU, 2005, LIVER INT, V25, P1069, DOI 10.1111/j.1478-3231.2005.01068.x; Lee HS, 2012, J MED FOOD, V15, P1015, DOI 10.1089/jmf.2012.2187; Lee SY, 2009, PHARMAZIE, V64, P242, DOI 10.1691/ph.2009.8734; Li W, 2011, MOLECULES, V16, P10093, DOI 10.3390/molecules161210093; Lim TG, 2015, INT J MOL MED, V35, P1388, DOI 10.3892/ijmm.2015.2121; Lim YR, 2010, J APPL MICROBIOL, V109, P1188, DOI 10.1111/j.1365-2672.2010.04744.x; Liu C-Y, 2014, J GINSENG RES; Liu CY, 2014, PROCESS BIOCHEM, V49, P813, DOI 10.1016/j.procbio.2014.02.011; Lu JM, 2009, CURR VASC PHARMACOL, V7, P293, DOI 10.2174/157016109788340767; Noh KH, 2009, BIOL PHARM BULL, V32, P1830, DOI 10.1248/bpb.32.1830; Noh KH, 2009, BIOSCI BIOTECH BIOCH, V73, P316, DOI 10.1271/bbb.80525; Oh SH, 2004, ARCH PHARM RES, V27, P402, DOI 10.1007/BF02980081; Park AR, 2010, APPL BIOCHEM BIOTECH, V160, P2236, DOI 10.1007/s12010-009-8705-x; Park CS, 2010, APPL MICROBIOL BIOT, V87, P9, DOI 10.1007/s00253-010-2567-6; Park SY, 2001, BIOSCI BIOTECH BIOCH, V65, P1163, DOI 10.1271/bbb.65.1163; Qin Y, 2008, J MICROBIOL BIOTECHN, V18, P1081; Quan LH, 2013, WORLD J MICROB BIOT, V29, P1001, DOI 10.1007/s11274-013-1260-1; Quan LH, 2012, J AGR FOOD CHEM, V60, P3776, DOI 10.1021/jf300186a; Shin DJ, 2014, J CELL BIOCHEM, V115, P1702, DOI 10.1002/jcb.24833; Shin KC, 2013, J BIOTECHNOL, V167, P33, DOI 10.1016/j.jbiotec.2013.06.003; Shin KC, 2013, J MICROBIOL BIOTECHN, V23, P483, DOI 10.4014/jmb.1211.11012; Son JW, 2008, BIOTECHNOL LETT, V30, P713, DOI 10.1007/s10529-007-9590-4; Wakabayashi C, 1998, BIOCHEM BIOPH RES CO, V246, P725, DOI 10.1006/bbrc.1998.8690; Wang L, 2012, J SURG RES, V176, P267, DOI 10.1016/j.jss.2011.06.038; Wu LP, 2012, J IND MICROBIOL BIOT, V39, P521, DOI 10.1007/s10295-011-1058-9; Yan X, 2014, CELL RES, V24, P770, DOI 10.1038/cr.2014.28; Yoshikawa M, 2003, J NAT PROD, V66, P922, DOI 10.1021/np030015l; Yu HS, 2007, CHEM PHARM BULL, V55, P231, DOI 10.1248/cpb.55.231; Zhou W, 2008, J APPL MICROBIOL, V104, P699, DOI 10.1111/j.1365-2672.2007.03586.x	48	27	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145876	10.1371/journal.pone.0145876	http://dx.doi.org/10.1371/journal.pone.0145876			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710074	gold, Green Submitted, Green Published			2022-12-27	WOS:000367451400089
J	Hendrickson, C; Euler, CW; Nguyen, SV; Rahman, M; McCullor, KA; King, CJ; Fischetti, VA; McShan, WM				Hendrickson, Christina; Euler, Chad W.; Nguyen, Scott V.; Rahman, Maliha; McCullor, Kimberly A.; King, Catherine J.; Fischetti, Vincent A.; McShan, W. Michael			Elimination of Chromosomal Island SpyCIM1 from Streptococcus pyogenes Strain SF370 Reverses the Mutator Phenotype and Alters Global Transcription	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; COMPLETE GENOME SEQUENCE; FLUOROQUINOLONE RESISTANCE; CYSTEINE PROTEINASE; M3 STRAIN; IN-VITRO; VIRULENCE; GENE; PATHOGEN; CLONE	Streptococcus pyogenes chromosomal island M1 (SpyCIM1) integrates by site-specific recombination into the 5' end of DNA mismatch repair (MMR) gene mutL in strain SF370SmR, blocking transcription of it and the downstream operon genes. During exponential growth, SpyCIM1 excises from the chromosome and replicates as an episome, restoring mutL transcription. This process is reversed in stationary phase with SpyCIM1 re-integrating into mutL, returning the cells to a mutator phenotype. Here we show that elimination of SpyCIM1 relieves this mutator phenotype. The downstream MMR operon genes, multidrug efflux pump lmrP, Holliday junction resolution helicase ruvA, and DNA base excision repair glycosylase tag, are also restored to constitutive expression by elimination of SpyCIM1. The presence of SpyCIM1 alters global transcription patterns in SF370SmR. RNA sequencing (RNA-Seq) demonstrated that loss of SpyCIM1 in the SpyCIM1 deletion mutant, CEM1 Delta 4, impacted the expression of over 100 genes involved in virulence and metabolism both in early exponential phase, when the SpyCIM1 is episomal, as well as at the onset of stationary phase, when SpyCIM1 has reintegrated into mutL. Among these changes, the up-regulation of the genes for the antiphagocytic M protein (emm1), streptolysin O (slo), capsule operon (hasABC), and streptococcal pyrogenic exotoxin (speB), are particularly notable. The expression pattern of the MMR operon confirmed our earlier observations that these genes are transcribed in early exponential phase but silenced as stationary phase is approached. Thus, the direct role of SpyCIM1 in causing the mutator phenotype is confirmed, and further, its influence upon the biology of S. pyogenes was found to impact multiple genes in addition to the MMR operon, which is a novel function for a mobile genetic element. We suggest that such chromosomal islands are a remarkable evolutionary adaptation to promote the survival of its S. pyogenes host cell in changing environments.	[Hendrickson, Christina; Nguyen, Scott V.; Rahman, Maliha; McCullor, Kimberly A.; King, Catherine J.; McShan, W. Michael] Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK 73190 USA; [Nguyen, Scott V.; McShan, W. Michael] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Hendrickson, Christina] Univ Cent Oklahoma, Dept Biol, Edmond, OK USA; [Euler, Chad W.; Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10021 USA; [Euler, Chad W.] CUNY Hunter Coll, Dept Med Lab Sci, New York, NY 10021 USA; [Euler, Chad W.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Central Oklahoma; Rockefeller University; City University of New York (CUNY) System; Hunter College (CUNY); Cornell University	McShan, WM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK 73190 USA.	William-McShan@ouhsc.edu	Nguyen, Scott/H-8721-2019	Nguyen, Scott/0000-0001-6498-2232	NIH [R15A1072718, AI11822]; OCAST [HR11-133]; Oklahoma Center for the Advancement of Science and Technology (OCAST) [HR11-133]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI011822, R01AI011822] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OCAST; Oklahoma Center for the Advancement of Science and Technology (OCAST); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH Grant R15A1072718 www.nih.gov WMM, NIH Grant AI11822 www.nih.gov VAF, and OCAST grant HR11-133 www.ok.gov/ocast/ WMM.; This work was made possible by an Oklahoma Center for the Advancement of Science and Technology (OCAST) grant HR11-133 and by NIH Grant Number R15A1072718 to WMM and NIH Grant AI11822 to VAF.	Banks DJ, 2004, J INFECT DIS, V190, P727, DOI 10.1086/422697; BARKSDALE L, 1974, ANNU REV MICROBIOL, V28, P265, DOI 10.1146/annurev.mi.28.100174.001405; Beres SB, 2006, P NATL ACAD SCI USA, V103, P7059, DOI 10.1073/pnas.0510279103; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Berge M, 2002, MOL MICROBIOL, V45, P411, DOI 10.1046/j.1365-2958.2002.03013.x; Bessen DE, 2011, J BACTERIOL, V193, P6651, DOI 10.1128/JB.05263-11; BOLHUIS H, 1995, J BIOL CHEM, V270, P26092, DOI 10.1074/jbc.270.44.26092; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Canchaya C, 2002, VIROLOGY, V302, P245, DOI 10.1006/viro.2002.1570; CAPARON MG, 1991, INFECT IMMUN, V59, P1811, DOI 10.1128/IAI.59.5.1811-1817.1991; Carroll RK, 2011, MOL MICROBIOL, V81, P588, DOI 10.1111/j.1365-2958.2011.07709.x; Chang JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002190; Chaussee MS, 1997, INFECT IMMUN, V65, P1956, DOI 10.1128/IAI.65.5.1956-1959.1997; Chaussee MS, 1999, INFECT IMMUN, V67, P1715; COULONDRE C, 1977, J MOL BIOL, V117, P577, DOI 10.1016/0022-2836(77)90059-6; Cusumano ZT, 2015, J BACTERIOL, V197, P1288, DOI 10.1128/JB.02517-14; Desiere F, 2001, VIROLOGY, V288, P325, DOI 10.1006/viro.2001.1085; Euler CW, 2015, TARGETED CURING OF A; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Fittipaldi N, 2012, AM J PATHOL, V180, P1522, DOI 10.1016/j.ajpath.2011.12.037; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gonzalez K, 2012, MOL MICROBIOL, V85, P361, DOI 10.1111/j.1365-2958.2012.08116.x; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; GRZESIUK E, 1993, MUTAT RES, V297, P313, DOI 10.1016/0165-1110(93)90022-F; Hause LL, 2012, J BACTERIOL, V194, P4904, DOI 10.1128/JB.00809-12; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; Kietzman CC, 2010, INFECT IMMUN, V78, P241, DOI 10.1128/IAI.00746-09; KJEMS EBBE, 1958, ACTA PATHOL ET MICROBIOL SCAND, V44, P429; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Kreikemeyer B, 2007, INFECT IMMUN, V75, P5698, DOI 10.1128/IAI.00175-07; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Luria SE, 1943, GENETICS, V28, P491; Lyon WR, 1998, EMBO J, V17, P6263, DOI 10.1093/emboj/17.21.6263; MA WT, 1992, J APPL PROBAB, V29, P255, DOI 10.2307/3214564; Malhotra-Kumar S, 2009, J ANTIMICROB CHEMOTH, V63, P886, DOI 10.1093/jac/dkp057; Marks LR, 2014, J INFECT DIS, V210, P25, DOI 10.1093/infdis/jiu058; Mazurkiewicz P, 2004, J BIOL CHEM, V279, P103, DOI 10.1074/jbc.M306579200; McClure R, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt444; McShan WM, 2008, J BACTERIOL, V190, P7773, DOI 10.1128/JB.00672-08; McShan W. Michael, 2007, P229; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mirouze N, 2013, P NATL ACAD SCI USA, V110, P352, DOI 10.1073/pnas.1219868110; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; NEYFAKH AA, 1993, ANTIMICROB AGENTS CH, V37, P128, DOI 10.1128/AAC.37.1.128; Nguyen Scott V, 2014, Front Cell Infect Microbiol, V4, P109, DOI 10.3389/fcimb.2014.00109; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Paluscio E, 2015, INFECT IMMUN, V83, P1162, DOI 10.1128/IAI.02814-14; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Pletz MWR, 2006, ANTIMICROB AGENTS CH, V50, P943, DOI 10.1128/AAC.50.3.943-948.2006; Putman M, 2001, MICROBIOL-SGM, V147, P2873, DOI 10.1099/00221287-147-10-2873; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Rudan M, 2015, ELIFE, V4, DOI 10.7554/eLife.04745; Sambrook J., 2001, MOL CLONING LAB MANU; Scott J, 2008, J BACTERIOL, V190, P6290, DOI 10.1128/JB.01569-07; Scott J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00317; Shaver AC, 2003, J BACTERIOL, V185, P6076, DOI 10.1128/JB.185.20.6076-6082.2003; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; STEWART FM, 1994, GENETICS, V137, P1139; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002; Watson ME, 2013, INFECT IMMUN, V81, P1606, DOI 10.1128/IAI.00021-13; WINKLE SA, 1982, NUCLEIC ACIDS RES, V10, P8211, DOI 10.1093/nar/10.24.8211	64	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145884	10.1371/journal.pone.0145884	http://dx.doi.org/10.1371/journal.pone.0145884			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701803	Green Published, gold			2022-12-27	WOS:000367092600139
J	Williams, AD; Brown, BE; Putchim, L; Sweet, MJ				Williams, Alex D.; Brown, Barbara E.; Putchim, Lalita; Sweet, Michael J.			Age-Related Shifts in Bacterial Diversity in a Reef Coral	PLOS ONE			English	Article							MICROBIAL COMMUNITY; GONIASTREA-ASPERA; WHITE SYNDROME; BAND DISEASE; MUCUS; ALGAE; SUSCEPTIBILITY; SUCCESSION; MORTALITY; CILIATE	This study investigated the relationship between microbial communities in differently sized colonies of the massive coral Coelastrea aspera at Phuket, Thailand where colony size could be used as a proxy for age. Results indicated significant differences between the bacterial diversity (ANOSIM, R = 0.76, p = 0.001) of differently sized colonies from the same intertidal reef habitat. Juvenile and small colonies (<6cm mean diam) harboured a lower bacterial richness than medium (similar to 10cm mean diam) and large colonies (>28 cm mean diam). Bacterial diversity increased in a step-wise pattern from juveniles<small<medium colonies, which was then followed by a slight decrease in the two largest size classes. These changes appear to resemble a successional process which occurs over time, similar to that observed in the ageing human gut. Furthermore, the dominant bacterial ribotypes present in the tissues of medium and large sized colonies of C. aspera, (such as Halomicronema, an Oscillospira and an unidentified cyanobacterium) were also the dominant ribotypes found within the endolithic algal band of the coral skeleton; a result providing some support for the hypothesis that the endolithic algae of corals may directly influence the bacterial community present in coral tissues.	[Williams, Alex D.; Sweet, Michael J.] Univ Derby, Coll Life & Nat Sci, Mol Hlth & Dis Lab, Environm Sustainabil Res Ctr, Derby DE22 1GB, England; [Brown, Barbara E.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Brown, Barbara E.] North Highland Coll, Environm Res Inst, Caithness, England; [Putchim, Lalita] Phuket Marine Biol Ctr, Phuket 83000, Thailand	University of Derby; Newcastle University - UK	Williams, AD (corresponding author), Univ Derby, Coll Life & Nat Sci, Mol Hlth & Dis Lab, Environm Sustainabil Res Ctr, Derby DE22 1GB, England.	alexdwilliams@virginmedia.com	Brown, Barbara/AAT-7991-2021; Sweet, Michael/E-9661-2012	Sweet, Michael/0000-0003-4983-8333	Leverhulme Trust [EM-2013-058]	Leverhulme Trust(Leverhulme Trust)	Barbara Brown recieved funding from the Leverhulme Trust [www.leverhulme.ac.uk]; Grant number: EM-2013-058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Director and staff of Phuket Marine Biological Centre for support of this work. Thanks also to Richard Dunne for preparation of S1 Fig and to the Leverhulme Trust for support of BEB.	Agostini S, 2012, CORAL REEFS, V31, P147, DOI 10.1007/s00338-011-0831-6; Ainsworth TD, 2015, ISME J, V9, P2261, DOI 10.1038/ismej.2015.39; Anthony KRN, 2002, LIMNOL OCEANOGR, V47, P1417, DOI 10.4319/lo.2002.47.5.1417; Apprill A, 2009, ISME J, V3, P685, DOI 10.1038/ismej.2009.3; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; Baigi E, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010667, DOI 10.1371/J0URNAL.P0NE.0010667]; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Biebl H, 2005, INT J SYST EVOL MICR, V55, P1089, DOI 10.1099/ijs.0.63511-0; Brown BE, 2008, MAR ECOL PROG SER, V362, P99, DOI 10.3354/meps07439; Brown BE, 2014, CORAL REEFS, V33, P395, DOI 10.1007/s00338-013-1120-3; Brown BE, 2005, MAR ECOL PROG SER, V296, P291, DOI 10.3354/meps296291; Brown BE, 2002, CORAL REEFS, V21, P119, DOI 10.1007/s00338-002-0215-z; Brown BE, 1997, ADV MAR BIOL, V31, P221, DOI 10.1016/S0065-2881(08)60224-2; BROWN BE, 1994, MAR ECOL PROG SER, V105, P219, DOI 10.3354/meps105219; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; Brown BE, 1999, MAR ECOL PROG SER, V191, P53, DOI 10.3354/meps191053; Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11; Bythell J.C., 1988, P535; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Ceh J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036920; Darzynkiewicz Z, 1990, Methods Cell Biol, V33, P285; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EDMUNDS PJ, 1986, MAR BIOL, V92, P339, DOI 10.1007/BF00392674; Elahi R, 2007, BIOL BULL-US, V212, P20, DOI 10.2307/25066577; Fine M, 2006, CORAL REEFS, V25, P577, DOI 10.1007/s00338-006-0143-4; Fine M, 2002, P ROY SOC B-BIOL SCI, V269, P1205, DOI 10.1098/rspb.2002.1983; Garren M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007319; Gorley C.K., 2006, GETTING STARTED PRIM; Hawkridge JM, 1998, THESIS U NEWCASTLE U, P354; HUGHES TP, 1980, SCIENCE, V209, P713, DOI 10.1126/science.209.4457.713; Jatkar A, 2008, THESIS; Jessen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062091; Kvennefors ECE, 2012, MICROB ECOL, V63, P605, DOI 10.1007/s00248-011-9946-0; LEYDEN JJ, 1975, J INVEST DERMATOL, V65, P379, DOI 10.1111/1523-1747.ep12607630; Li N, 2015, ANTON LEEUW INT J G, V107, P305, DOI 10.1007/s10482-014-0327-9; Li SJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06205; Lillie RD, 1963, HISTOPATHOLOGIC TECH, P506; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Martinez JM, 2014, ISME J, V8, P1079, DOI 10.1038/ismej.2013.214; MassolDeya A, 1997, APPL ENVIRON MICROB, V63, P270; MEESTERS EH, 1995, MAR ECOL PROG SER, V121, P203, DOI 10.3354/meps121203; Meron D, 2011, ISME J, V5, P51, DOI 10.1038/ismej.2010.102; Miller AW, 2011, DIS AQUAT ORGAN, V93, P179, DOI 10.3354/dao02305; Morrow KM, 2012, APPL ENVIRON MICROB, V78, P6438, DOI 10.1128/AEM.01162-12; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nissimov J, 2009, FEMS MICROBIOL LETT, V292, P210, DOI 10.1111/j.1574-6968.2009.01490.x; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Ovreas L, 2003, MICROB ECOL, V46, P291, DOI 10.1007/s00248-003-3006-3; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; RINKEVICH B, 1986, EXPERIENTIA, V42, P320, DOI 10.1007/BF01942521; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Sakai K, 1998, BIOL BULL, V195, P319, DOI 10.2307/1543143; Sakai K, 1998, RES POPUL ECOL, V40, P287, DOI 10.1007/BF02763460; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sanchez O, 2007, APPL ENVIRON MICROB, V73, P5962, DOI 10.1128/AEM.00817-07; Sekar R, 2008, MAR ECOL PROG SER, V362, P85, DOI 10.3354/meps07496; Sharp KH, 2012, ISME J, V6, P790, DOI 10.1038/ismej.2011.144; Sharp KH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010898; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Sweet MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0094; Sweet MJ, 2011, CORAL REEFS, V30, P39, DOI 10.1007/s00338-010-0695-1; Sweet M, 2015, MOL ECOL, V24, P1150, DOI 10.1111/mec.13097; Sweet M, 2012, ENVIRON MICROBIOL, V14, P2184, DOI 10.1111/j.1462-2920.2012.02746.x; Sweet MJ, 2010, AQUAT MICROB ECOL, V61, P1, DOI 10.3354/ame01433; Taniguchi A, 2015, J EXP MAR BIOL ECOL, V469, P105, DOI 10.1016/j.jembe.2015.04.020; Thompson JR, 2015, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00176; Tremblay P, 2012, J EXP BIOL, V215, P1384, DOI 10.1242/jeb.065201; van Dongen WFD, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-11; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x	72	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144902	10.1371/journal.pone.0144902	http://dx.doi.org/10.1371/journal.pone.0144902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700869	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092600035
J	Kugler, G; 't Hart, BM; Kohlbecher, S; Einhauser, W; Schneider, E				Kugler, Guenter; 't Hart, Bernard Marius; Kohlbecher, Stefan; Einhaeuser, Wolfgang; Schneider, Erich			Gaze in Visual Search Is Guided More Efficiently by Positive Cues than by Negative Cues	PLOS ONE			English	Article							WORKING-MEMORY; ATTENTION; MODEL; SELECTION; MECHANISM	Visual search can be accelerated when properties of the target are known. Such knowledge allows the searcher to direct attention to items sharing these properties. Recent work indicates that information about properties of non-targets (i.e., negative cues) can also guide search. In the present study, we examine whether negative cues lead to different search behavior compared to positive cues. We asked observers to search for a target defined by a certain shape singleton (broken line among solid lines). Each line was embedded in a colored disk. In "positive cue" blocks, participants were informed about possible colors of the target item. In "negative cue" blocks, the participants were informed about colors that could not contain the target. Search displays were designed such that with both the positive and negative cues, the same number of items could potentially contain the broken line ("relevant items"). Thus, both cues were equally informative. We measured response times and eye movements. Participants exhibited longer response times when provided with negative cues compared to positive cues. Although negative cues did guide the eyes to relevant items, there were marked differences in eye movements. Negative cues resulted in smaller proportions of fixations on relevant items, longer duration of fixations and in higher rates of fixations per item as compared to positive cues. The effectiveness of both cue types, as measured by fixations on relevant items, increased over the course of each search. In sum, a negative color cue can guide attention to relevant items, but it is less efficient than a positive cue of the same informational value.	[Kugler, Guenter; Kohlbecher, Stefan] Univ Munich, Inst Clin Neurosci, Munich, Germany; [Kugler, Guenter; Kohlbecher, Stefan] Univ Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; ['t Hart, Bernard Marius; Einhaeuser, Wolfgang] Univ Marburg, Neurophys, Marburg, Germany; ['t Hart, Bernard Marius] York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada; [Einhaeuser, Wolfgang] Tech Univ Chemnitz, Inst Phys, Chemnitz, Germany; [Schneider, Erich] Brandenburg Univ Technol Cottbus Senftenberg, Inst Med Technol, Senftenberg, Germany	University of Munich; University of Munich; Philipps University Marburg; York University - Canada; Technische Universitat Chemnitz; Brandenburg University of Technology Cottbus	't Hart, BM (corresponding author), Univ Marburg, Neurophys, Marburg, Germany.	thartbm@gmail.com	't Hart, Bernard/AHD-9519-2022; Einhäuser, Wolfgang/A-3041-2012	't Hart, Bernard/0000-0002-0045-3769; Einhäuser, Wolfgang/0000-0001-7516-9589	German Federal Ministry of Education and Research [01 EO0901]; DFG cluster of excellence CoTeSys [SFB/TRR135, HA 6861/2-1]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); DFG cluster of excellence CoTeSys	The study was supported by the German Federal Ministry of Education and Research (Grant 01 EO0901), and by DFG cluster of excellence CoTeSys (www.cotesys.org), SFB/TRR135 (WE) and HA 6861/2-1 (BMtH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EyeSeeTec GmbH did not provide salaries for any author during the study design, data collection and analysis, or decision to publish. EyeSeeTec did provide salaries for two authors [GK, SK] in the final stage of the revision, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions section.	Arita JT, 2012, J EXP PSYCHOL HUMAN, V38, P580, DOI 10.1037/a0027885; Brainard DH, 1997, SPAT VIS; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Cave KR, 1999, PSYCHOL RES-PSYCH FO, V62, P182, DOI 10.1007/s004260050050; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Eckstein MP, 2011, J VISION, V11, DOI 10.1167/11.5.14; EGETH HE, 1966, PERCEPT PSYCHOPHYS, V1, P245, DOI 10.3758/BF03207389; HOFFMAN JE, 1979, PERCEPT PSYCHOPHYS, V25, P319, DOI 10.3758/BF03198811; Hollingworth A, 2014, J VIS, V14, P1050; Kleiner M., 2007, WHATS NEW PSYCHTOOLB; Kohlbecher S, 2010, LOW LATENCY COMBINED, P117; Kristjansson A, 2008, VISION RES, V48, P1217, DOI 10.1016/j.visres.2008.02.007; Logan GD, 2004, ANNU REV PSYCHOL, V55, P207, DOI 10.1146/annurev.psych.55.090902.141415; Marini F, 2013, J EXP PSYCHOL GEN, V142, P906, DOI 10.1037/a0029905; Moher J, 2012, ATTEN PERCEPT PSYCHO, V74, P1590, DOI 10.3758/s13414-012-0358-0; Munneke J, 2008, ACTA PSYCHOL AMST; Noudoost B, 2010, CURR OPIN NEUROBIOL, V20, P183, DOI 10.1016/j.conb.2010.02.003; Olds ES, 2009, VISION RES, V49, P1428, DOI 10.1016/j.visres.2009.02.008; Olivers CNL, 2011, TRENDS COGN SCI, V15, P327, DOI 10.1016/j.tics.2011.05.004; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; R Core Team, 2013, R VERS 3 0, P1; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Rutishauser U, 2007, J VISION, V7, DOI 10.1167/7.6.5; Salvucci D.D., 2000, P EYE TRACKING RES A, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; WASON PC, 1959, Q J EXP PSYCHOL, V11, P92, DOI 10.1080/17470215908416296; WILLIAMS LG, 1967, ACTA PSYCHOL, V27, P355, DOI 10.1016/0001-6918(67)90080-7; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; Wolff Jerry O., 2007, P99; Woodman GF, 2007, J EXP PSYCHOL HUMAN, V33, P363, DOI 10.1037/0096-1523.33.2.363	36	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145910	10.1371/journal.pone.0145910	http://dx.doi.org/10.1371/journal.pone.0145910			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26717307	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500092
J	Myers, T; Szucs, D				Myers, Timothy; Szuecs, Denes			Arithmetic Memory Is Modality Specific	PLOS ONE			English	Article							NUMBER; REPRESENTATION; INFORMATION; ADULTS	In regards to numerical cognition and working memory, it is an open question as to whether numbers are stored into and retrieved from a central abstract representation or from separate notation-specific representations. This study seeks to help answer this by utilizing the numeral modality effect (NME) in three experiments to explore how numbers are processed by the human brain. The participants were presented with numbers (1-9) as either Arabic digits or written number words (Arabic digits and dot matrices in Experiment 2) at the first (S1) and second (S2) stimuli. The participant's task was to add the first two stimuli together and verify whether the answer (S3), presented simultaneously with S2, was correct. We hypothesized that if reaction time (RT) at S2/S3 depends on the modality of S1 then numbers are retrieved from modality specific memory stores. Indeed, RT depended on the modality of S1 whenever S2 was an Arabic digit which argues against the concept of numbers being stored and retrieved from a central, abstract representation.	[Myers, Timothy; Szuecs, Denes] Univ Cambridge, Dept Psychol, Ctr Neurosci Educ, Cambridge, England	University of Cambridge	Myers, T (corresponding author), Univ Cambridge, Dept Psychol, Ctr Neurosci Educ, Cambridge, England.	tm471@cam.ac.uk; ds377@cam.ac.uk		Szucs, Denes/0000-0002-9477-0801				Campbell JID, 2004, CAN J EXP PSYCHOL, V58, P229, DOI 10.1037/h0087447; Campbell JID, 2004, J EXP PSYCHOL LEARN, V30, P51, DOI 10.1037/0278-7393.30.1.51; CAMPBELL JID, 1988, J EXP PSYCHOL GEN, V117, P204, DOI 10.1037/0096-3445.117.2.204; Campbell JID, 2001, COGNITION, V80, pB21, DOI 10.1016/S0010-0277(01)00115-9; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1995, J EXP PSYCHOL LEARN, V21, P314, DOI 10.1037/0278-7393.21.2.314; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Dehaene S., 1995, MATH COGNITION, V1, P83, DOI DOI 10.1155/2014/461647; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; ERIKSEN CW, 1979, PERCEPT PSYCHOPHYS, V25, P249, DOI 10.3758/BF03198804; Gebuis T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025405; Ito Y, 2003, MEM COGNITION, V31, P360, DOI 10.3758/BF03194394; Jarmasz J., 2010, CANADIAN J EXPT PSYC, V63, P124; Kadosh RC, 2008, NEUROPSYCHOLOGIA, V46, P2872, DOI 10.1016/j.neuropsychologia.2008.05.025; Kadosh RC, 2009, BEHAV BRAIN SCI, V32, P313, DOI 10.1017/S0140525X09990938; MCCLOSKEY M, 1995, AM PSYCHOL, V50, P351, DOI 10.1037/0003-066X.50.5.351; MCCLOSKEY M, 1991, BRAIN COGNITION, V17, P154, DOI 10.1016/0278-2626(91)90074-I; MCCLOSKEY M, 1985, BRAIN COGNITION, V4, P171, DOI 10.1016/0278-2626(85)90069-7; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; Peirce J., 2007, J NEUROSCI METH, V13, P1621; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Soltesz F, 2014, BIOL PSYCHOL, V103, P203, DOI 10.1016/j.biopsycho.2014.09.006; Szucs D, 2004, COGNITIVE BRAIN RES, V19, P10, DOI 10.1016/j.cogbrainres.2003.11.002; Szucs D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00444; Szucs D, 2009, BEHAV BRAIN SCI, V32, P352, DOI 10.1017/S0140525X09990884; Thevenot C, 2006, MEM COGNITION, V34, P938, DOI 10.3758/BF03193439; Thevenot C, 2010, EUR J COGN PSYCHOL, V22, P348, DOI 10.1080/09541440903130743; Venkatraman V, 2005, NEUROPSYCHOLOGIA, V43, P744, DOI 10.1016/j.neuropsychologia.2004.08.005	33	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145614	10.1371/journal.pone.0145614	http://dx.doi.org/10.1371/journal.pone.0145614			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716692	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500048
J	Picq, JL; Villain, N; Gary, C; Pifferi, F; Dhenain, M				Picq, Jean-Luc; Villain, Nicolas; Gary, Charlotte; Pifferi, Fabien; Dhenain, Marc			Jumping Stand Apparatus Reveals Rapidly Specific Age-Related Cognitive Impairments in Mouse Lemur Primates	PLOS ONE			English	Article							VISUAL-DISCRIMINATION; NONHUMAN PRIMATE; RHESUS-MONKEY; OBJECT MEMORY; HIPPOCAMPUS; ACQUISITION; RETENTION; AMNESIA; SYSTEMS; CORTEX	The mouse lemur (Microcebus murinus) is a promising primate model for investigating normal and pathological cerebral aging. The locomotor behavior of this arboreal primate is characterized by jumps to and from trunks and branches. Many reports indicate insufficient adaptation of the mouse lemur to experimental devices used to evaluate its cognition, which is an impediment to the efficient use of this animal in research. In order to develop cognitive testing methods appropriate to the behavioral and biological traits of this species, we adapted the Lashley jumping stand apparatus, initially designed for rats, to the mouse lemur. We used this jumping stand apparatus to compare performances of young (n = 12) and aged (n = 8) adults in acquisition and long-term retention of visual discriminations. All mouse lemurs completed the tasks and only 25 trials, on average, were needed to master the first discrimination problem with no age-related differences. A month later, all mouse lemurs made progress for acquiring the second discrimination problem but only the young group reached immediately the criterion in the retention test of the first discrimination problem. This study shows that the jumping stand apparatus allows rapid and efficient evaluation of cognition in mouse lemurs and demonstrates that about half of the old mouse lemurs display a specific deficit in long-term retention but not in acquisition of visual discrimination.	[Picq, Jean-Luc] Univ Paris 08, EA 2027, Lab Psychopathol & Neuropsychol, F-93000 St Denis, France; [Picq, Jean-Luc; Gary, Charlotte; Dhenain, Marc] Univ Paris Saclay, Univ Paris Sud, CNRS, Neurodegenerat Dis Lab,UMR 9199, F-92265 Fontenay Aux Roses, France; [Picq, Jean-Luc; Gary, Charlotte; Dhenain, Marc] Commissariat Energie Atom & Energies Alternat CEA, MIRCen, Inst Imagerie Biomed I2BM, DSV, F-92265 Fontenay Aux Roses, France; [Villain, Nicolas; Pifferi, Fabien] CNRS, Adapt Mech & Evolut MECADEV, MNHN, UMR 7179, F-91800 Brunoy, France	Universite Paris-VIII; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Picq, JL (corresponding author), Univ Paris 08, EA 2027, Lab Psychopathol & Neuropsychol, 2 Rue Liberte, F-93000 St Denis, France.	jean_lucpicq@hotmail.com	Dhenain, Marc/K-5630-2013	Dhenain, Marc/0000-0001-8804-4101; Pifferi, Fabien/0000-0001-9316-1935	Association France Alzheimer	Association France Alzheimer	This work was supported by the Association France Alzheimer. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTUS RT, 1979, J GERONTOL, V34, P209, DOI 10.1093/geronj/34.2.209; BONS N, 1992, NEUROBIOL AGING, V13, P99, DOI 10.1016/0197-4580(92)90016-Q; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; DELACOURTE A, 1995, CR ACAD SCI III-VIE, V318, P85; Dhenain M, 2000, NEUROBIOL AGING, V21, P81, DOI 10.1016/S0197-4580(00)00098-1; Dhenain M, 1998, NEUROBIOL AGING, V19, P65, DOI 10.1016/S0197-4580(98)00005-0; Dias R, 1997, J NEUROSCI, V17, P9285; Epp J, 2008, LEARN MEMORY, V15, P214, DOI 10.1101/lm.788008; Gabrieli JDE, 1996, P NATL ACAD SCI USA, V93, P13534, DOI 10.1073/pnas.93.24.13534; Gilbert PE, 2009, ANN NY ACAD SCI, V1170, P718, DOI 10.1111/j.1749-6632.2009.03929.x; Jallageas V, 1998, ANN NY ACAD SCI, V839, P628, DOI 10.1111/j.1749-6632.1998.tb10899.x; Joly M, 2004, PHYSIOL BEHAV, V82, P325, DOI 10.1016/j.physbeh.2004.03.019; Joly M, 2006, NEUROBIOL AGING, V27, P1045, DOI 10.1016/j.neurobiolaging.2005.05.001; Joly M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109393; Kappeler PM, 1998, AM J PRIMATOL, V46, P7; LAI ZC, 1995, NEUROBIOL AGING, V16, P947, DOI 10.1016/0197-4580(95)02014-4; Languille S, 2012, AGEING RES REV, V11, P150, DOI 10.1016/j.arr.2011.07.001; Languille S, 2015, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00446; Lashley KS, 1930, PEDAGOG SEMIN J GEN, V37, P453; LEVISOHN LF, 1991, BRAIN RES, V564, P230, DOI 10.1016/0006-8993(91)91458-D; MESTRE N, 1993, NEURODEGENERATION, V2, P25; Mestre-Frances N., 1996, ALZHEIMERS RES, V2, P19; Moore TL, 2002, BEHAV NEUROSCI, V116, P387, DOI 10.1037//0735-7044.116.3.387; Moore TL, 2003, NEUROBIOL AGING, V24, P125, DOI 10.1016/S0197-4580(02)00054-4; Petri HL, 1984, NEUROPSYCHOLOGY MEMO, P287; Picq JL, 2007, EXP GERONTOL, V42, P223, DOI 10.1016/j.exger.2006.09.013; Picq JL, 2012, NEUROBIOL AGING, V33, P1096, DOI 10.1016/j.neurobiolaging.2010.09.009; RAPP PR, 1990, BEHAV NEUROSCI, V104, P876, DOI 10.1037/0735-7044.104.6.876; RITCHIE K, 1997, ALZHEIMERS RES, V3, P37; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Sutherland NS., 1971, MECH ANIMAL DISCRIMI; Trouche SG, 2010, NEUROBIOL LEARN MEM, V94, P100, DOI 10.1016/j.nlm.2010.04.006; Vinot N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020491; Vnek N, 1996, J NEUROSCI, V16, P2780; VNEK N, 1995, J NEUROSCI, V15, P3193	35	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146238	10.1371/journal.pone.0146238	http://dx.doi.org/10.1371/journal.pone.0146238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716699	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500144
J	Aktas, B; De Wolfe, TJ; Tandee, K; Safdar, N; Darien, BJ; Steele, JL				Aktas, Busra; De Wolfe, Travis J.; Tandee, Kanokwan; Safdar, Nasia; Darien, Benjamin J.; Steele, James L.			The Effect of Lactobacillus casei 32G on the Mouse Cecum Microbiota and Innate Immune Response Is Dose and Time Dependent	PLOS ONE			English	Article							GUT MICROBIOTA; INTESTINAL MICROBIOTA; EXPRESSION; RECOGNITION; DEFENSINS; PLANTARUM; BACTERIA; OBESITY; SYSTEM; IMPACT	Lactobacilli have been associated with a variety of immunomodulatory effects and some of these effects have been related to changes in gastrointestinal microbiota. However, the relationship between probiotic dose, time since probiotic consumption, changes in the microbiota, and immune system requires further investigation. The objective of this study was to determine if the effect of Lactobacillus casei 32G on the murine gastrointestinal microbiota and immune function are dose and time dependent. Mice were fed L. casei 32G at doses of 10(6), 10(7), or 10(8) CFU/day/ mouse for seven days and were sacrificed 0.5h, 3.5h, 12h, or 24h after the last administration. The ileum tissue and the cecal content were collected for immune profiling by qPCR and microbiota analysis, respectively. The time required for L. casei 32G to reach the cecum was monitored by qPCR and the 32G bolus reaches the cecum 3.5h after the last administration. L. casei 32G altered the cecal microbiota with the predominance of Lachnospiraceae IS, and Oscillospira decreasing significantly (p < 0.05) in the mice receiving 108 CFU/mouse 32G relative to the control mice, while a significant (p < 0.05) increase was observed in the prevalence of lactobacilli. The lactobacilli that increased were determined to be a commensal lactobacilli. Interestingly, no significant difference in the overall microbiota composition, regardless of 32G doses, was observed at the 12h time point. A likely explanation for this observation is the level of feed derived-nutrients resulting from the 12h light/dark cycle. 32G results in consistent increases in Clec2h expression and reductions in TLR-2, alpha-defensins, and lysozyme. Changes in expression of these components of the innate immune system are one possible explanation for the observed changes in the cecal microbiota. Additionally, 32G administration was observed to alter the expression of cytokines (IL-10rb and TNF-alpha) in a manner consistent with an anti-inflammatory response.	[Aktas, Busra; De Wolfe, Travis J.; Steele, James L.] Univ Wisconsin, Dept Food Sci, Madison, WI 53706 USA; [Tandee, Kanokwan] Maejo Univ, Food Sci & Technol, Chiangmai, Thailand; [Safdar, Nasia] Univ Wisconsin, Dept Med, Div Infect Dis, Madison, WI USA; [Safdar, Nasia] William S Middleton Vet Affairs Hosp, Madison, WI USA; [Darien, Benjamin J.] Univ Wisconsin, Anim Hlth & Biomed Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Maejo University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Steele, JL (corresponding author), Univ Wisconsin, Dept Food Sci, 1605 Linden Dr, Madison, WI 53706 USA.	JLSteele@wisc.edu	De Wolfe, Travis J/C-6827-2013	De Wolfe, Travis J/0000-0001-6261-1235; Aktas, Busra/0000-0001-9863-683X	DuPont Inc [PRJ19MQ]; WARF [PRJ66JZ]	DuPont Inc; WARF	This work was funded by the DuPont Inc (Grant no. PRJ19MQ) and by the WARF (Grant no. PRJ66JZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; [Anonymous], 2015, YAK 80 ANN REP; [Anonymous], 2013, R LANG ENV STAT COMP; [Anonymous], 2013, DIVERSITY-BASEL, DOI DOI 10.3390/d5030627; Anukam K.-C, 2007, COMMUNICATING CURREN, V1, P466; Aoki T, 2014, SCAND J GASTROENTERO, V49, P552, DOI 10.3109/00365521.2013.848469; Batista ML, 2010, CYTOKINE, V49, P102, DOI 10.1016/j.cyto.2009.10.007; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Britton RA, 2014, GASTROENTEROLOGY, V146, P1547, DOI 10.1053/j.gastro.2014.01.059; Broadbent JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-533; Bruzzese E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087796; Busch RA, 2014, ANN SURG, V260, P432, DOI 10.1097/SLA.0000000000000871; Cai H, 2007, MICROBIOL-SGM, V153, P2655, DOI 10.1099/mic.0.2007/006452-0; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Ceapa C, 2013, BEST PRACT RES CL GA, V27, P139, DOI 10.1016/j.bpg.2013.04.004; Chen X, 2013, FORMATEX, V2, P1154; Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635; Corridoni D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042067; Cunliffe RN, 2003, MOL IMMUNOL, V40, P463, DOI 10.1016/S0161-5890(03)00157-3; Daniel C, 2013, APPL ENVIRON MICROB, V79, P1086, DOI 10.1128/AEM.03221-12; de Carcer DA, 2011, ISME J, V5, P801, DOI 10.1038/ismej.2010.177; Derrien M, 2015, TRENDS MICROBIOL, V23, P354, DOI 10.1016/j.tim.2015.03.002; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dietrich CG, 2014, WORLD J GASTROENTERO, V20, P15837, DOI 10.3748/wjg.v20.i42.15837; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Eloe-Fadrosh EA, 2015, MBIO, V6, DOI 10.1128/mBio.00231-15; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Hormannsperger G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004365; Hotel ACP., 2001, PREVENTION, V5, P1; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Kamada N, 2014, GASTROENTEROLOGY, V146, P1477, DOI 10.1053/j.gastro.2014.01.060; Kandler O, 1986, BERGEYS MANUAL SYSTE, V2, P1063; Kearney N, 2008, FUNCT FOOD NUTRA SER, P25; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P2029, DOI 10.3748/wjg.14.2029; Kirschning CJ, 2002, TOLL LIKE RECEPTOR F; Kohl KD, 2014, FEMS MICROBIOL ECOL, V90, P883, DOI 10.1111/1574-6941.12442; Kondepudi KK, 2014, MICROBIOL IMMUNOL, V58, P552, DOI 10.1111/1348-0421.12184; Lacy P, 2011, BLOOD, V118, P9, DOI 10.1182/blood-2010-08-265892; Leyer GJ, 2009, PEDIATRICS, V124, pE172, DOI 10.1542/peds.2008-2666; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Mackie RI, 2003, APPL ENVIRON MICROB, V69, P6808, DOI 10.1128/AEM.69.11.6808-6815.2003; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Marco ML, 2007, APPL ENVIRON MICROB, V73, P124, DOI 10.1128/AEM.01475-06; Mayer EA, 2014, GASTROENTEROLOGY, V146, P1500, DOI 10.1053/j.gastro.2014.02.037; Menendez A, 2013, J INNATE IMMUN, V5, P39, DOI 10.1159/000341630; Nieuwdorp M, 2014, GASTROENTEROLOGY, V146, P1525, DOI 10.1053/j.gastro.2014.02.008; Ohno H, 2015, SEMIN IMMUNOPATHOL, V37, P1, DOI 10.1007/s00281-014-0472-2; Ostaff MJ, 2013, EMBO MOL MED, V5, P1465, DOI 10.1002/emmm.201201773; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Owyang C, 2014, GASTROENTEROLOGY, V146, P1433, DOI 10.1053/j.gastro.2014.03.032; Paul W. E., 2003, FUNDAMENTAL IMMUNOLO, V5th; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Proctor LM, 2011, CELL HOST MICROBE, V10, P287, DOI 10.1016/j.chom.2011.10.001; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; Reeves AE, 2011, GUT MICROBES, V2, P145, DOI 10.4161/gmic.2.3.16333; Salminen SJ, 2005, J NUTR, V135, P1294, DOI 10.1093/jn/135.5.1294; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sanchez-Alavez M, 2007, P NATL ACAD SCI USA, V104, P3009, DOI 10.1073/pnas.0611209104; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Schuijt TJ, 2013, TRENDS MICROBIOL, V21, P221, DOI 10.1016/j.tim.2013.02.001; Schwab M, 2008, IMMUNOLOGY, V125, P241, DOI 10.1111/j.1365-2567.2008.02834.x; Sohn M, 2010, P NATL ACAD SCI USA, V107, P21943, DOI [10.1073/pnas.1016618107, DOI 10.1073/PNAS.1016618107]; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Sunkara LT, 2014, MOL IMMUNOL, V57, P171, DOI 10.1016/j.molimm.2013.09.003; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tandee K., 2013, THESIS; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Vogler I, 2011, J INNATE IMMUN, V3, P227, DOI 10.1159/000324112; Wagner RD, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-58; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Yoon JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044053; Zakostelska Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027961; Zeng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072922; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093	82	21	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145784	10.1371/journal.pone.0145784	http://dx.doi.org/10.1371/journal.pone.0145784			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714177	Green Submitted, Green Published, gold			2022-12-27	WOS:000367481900082
J	Chrzanowska-Wodnicka, M; White, GC; Quilliam, LA; Whitehead, KJ				Chrzanowska-Wodnicka, Magdalena; White, Gilbert C., II; Quilliam, Lawrence A.; Whitehead, Kevin J.			Small GTPase Rap1 Is Essential for Mouse Development and Formation of Functional Vasculature	PLOS ONE			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; CELL-CELL JUNCTIONS; DROSOPHILA EMBRYO; ENCODING KRIT1; KEY REGULATOR; GROWTH-FACTOR; PROTEIN; CCM1; MICE; GENE	Background Small GTPase Rap1 has been implicated in a number of basic cellular functions, including cell-cell and cell-matrix adhesion, proliferation and regulation of polarity. Evolutionarily conserved, Rap1 has been studied in model organisms: yeast, Drosophila and mice. Mouse in vivo studies implicate Rap1 in the control of multiple stem cell, leukocyte and vascular cell functions. In vitro, several Rap1 effectors and regulatory mechanisms have been proposed. In particular, Rap1 has been implicated in maintaining epithelial and endothelial cell junction integrity and linked with cerebral cavernous malformations. Rationale How Rap1 signaling network controls mammalian development is not clear. As a first step in addressing this question, we present phenotypes of murine total and vascular-specific Rap1a, Rap1b and double Rap1a and Rap1b (Rap1) knockout (KO) mice. Results and Conclusions The majority of total Rap1 KO mice die before E10.5, consistent with the critical role of Rap1 in epithelial morphogenesis. At that time point, about 50% of Tie2-double Rap1 KOs appear grossly normal and develop normal vasculature, while the remaining 50% suffer tissue degeneration and show vascular abnormalities, including hemorrhages and engorgement of perineural vessels, albeit with normal branchial arches. However, no Tie2-double Rap1 KO embryos are present at E15.5, with hemorrhages a likely cause of death. Therefore, at least one Rap1 allele is required for development prior to the formation of the vascular system; and in endothelium-for the life-supporting function of the vasculature.	[Chrzanowska-Wodnicka, Magdalena; White, Gilbert C., II] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53201 USA; [Quilliam, Lawrence A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Whitehead, Kevin J.] Univ Utah, Div Cardiovasc Med, Program Mol Med, Pediat Cardiol, Salt Lake City, UT 84112 USA	Versiti Blood Center of Wisconsin; Indiana University System; Indiana University Bloomington; Utah System of Higher Education; University of Utah	Chrzanowska-Wodnicka, M (corresponding author), BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53201 USA.	Magdalena.Chrzanowska@bcw.edu	Quilliam, Lawrence/Q-4987-2019	Chrzanowska, Magdalena/0000-0003-4182-2126	American Heart Association [0950118G]; National Institutes of Health [HL111583, NS075168]; Biomedical Research Grant from Indiana University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075168] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Research Grant from Indiana University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by American Heart Association grant 0950118G (to M.C.-W.), the National Institutes of Health grants (HL111583 to M.C.-W. and NS075168 to K.J.W.) and a Biomedical Research Grant from Indiana University School of Medicine (to L.A.Q.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asha H, 1999, EMBO J, V18, P605, DOI 10.1093/emboj/18.3.605; Awasthi A, 2010, J EXP MED, V207, P1923, DOI 10.1084/jem.20100040; Beraud-Dufour S, 2007, FEBS J, V274, P5518, DOI 10.1111/j.1742-4658.2007.06068.x; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Boettner B, 2003, GENETICS, V165, P159; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Boulday G, 2011, J EXP MED, V208, P1835, DOI 10.1084/jem.20110571; Boulday G, 2009, DIS MODEL MECH, V2, P168, DOI 10.1242/dmm.001263; Carmena Ana, 2012, Small GTPases, V3, P159, DOI 10.4161/sgtp.19631; Choi WS, 2013, MOL BIOL CELL, V24, P945, DOI 10.1091/mbc.E12-10-0736; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Chrzanowska-Wodnicka M, 2008, BLOOD, V111, P2647, DOI 10.1182/blood-2007-08-109710; Chrzanowska-Wodnicka M, 2013, EXP CELL RES, V319, P2350, DOI 10.1016/j.yexcr.2013.07.022; Chu H, 2008, J IMMUNOL, V181, P3373, DOI 10.4049/jimmunol.181.5.3373; Cunningham K, 2011, HUM MOL GENET, V20, P3198, DOI 10.1093/hmg/ddr225; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Duchniewicz M, 2006, MOL CELL BIOL, V26, P643, DOI 10.1128/MCB.26.2.643-653.2006; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Gloerich M, 2011, TRENDS CELL BIOL, V21, P615, DOI 10.1016/j.tcb.2011.07.001; Gore AV, 2008, DIS MODEL MECH, V1, P275, DOI 10.1242/dmm.000513; He Y, 2003, SCI SIGNAL, V3; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Kumar S, 2014, J EXP MED, V211, P1741, DOI 10.1084/jem.20131706; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Lakshmikanthan S, 2015, EMBO REP, V16, P628, DOI 10.15252/embr.201439846; Lakshmikanthan S, 2014, ARTERIOSCL THROM VAS, V34, P1486, DOI 10.1161/ATVBAHA.114.303678; Lakshmikanthan S, 2011, BLOOD, V118, P2015, DOI 10.1182/blood-2011-04-349282; Li XF, 2012, J BIOL CHEM, V287, P22317, DOI 10.1074/jbc.M112.361295; Li Y, 2007, J IMMUNOL, V179, P8322, DOI 10.4049/jimmunol.179.12.8322; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Liu JJ, 2011, MOL BIOL CELL, V22, P2509, DOI 10.1091/mbc.E11-02-0157; Minato N, 2007, ADV IMMUNOL, V93, P229, DOI 10.1016/S0065-2776(06)93006-5; Mitin NY, 2004, J BIOL CHEM, V279, P22353, DOI 10.1074/jbc.M312867200; Mleynek TM, 2014, HUM MOL GENET, V23, P6223, DOI 10.1093/hmg/ddu342; Pan BX, 2008, J NEUROSCI, V28, P2089, DOI 10.1523/JNEUROSCI.5156-07.2008; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; PIZON V, 1988, NUCLEIC ACIDS RES, V16, P7719, DOI 10.1093/nar/16.15.7719; Plummer NW, 2004, AM J PATHOL, V165, P1509, DOI 10.1016/S0002-9440(10)63409-8; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Sawyer JK, 2009, J CELL BIOL, V186, P57, DOI 10.1083/jcb.200904001; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Tawa H, 2010, CIRC RES, V106, P1731, DOI 10.1161/CIRCRESAHA.110.216747; Tsai IC, 2007, DEV CELL, V12, P335, DOI 10.1016/j.devcel.2007.02.009; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Wilson CW, 2013, BLOOD, V122, P3678, DOI 10.1182/blood-2013-02-483156; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Xu K, 2011, DEV CELL, V20, P526, DOI 10.1016/j.devcel.2011.02.010; Xu K, 2009, DEV BIOL, V329, P269, DOI 10.1016/j.ydbio.2009.02.033; Yan JL, 2008, MOL CELL BIOL, V28, P5803, DOI 10.1128/MCB.00393-08; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256	55	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145689	10.1371/journal.pone.0145689	http://dx.doi.org/10.1371/journal.pone.0145689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714318	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900068
J	Cunning, R; Yost, DM; Guarinello, ML; Putnam, HM; Gates, RD				Cunning, Ross; Yost, Denise M.; Guarinello, Marisa L.; Putnam, Hollie M.; Gates, Ruth D.			Variability of Symbiodinium Communities in Waters, Sediments, and Corals of Thermally Distinct Reef Pools in American Samoa	PLOS ONE			English	Article							FREE-LIVING SYMBIODINIUM; POCILLOPORA-DAMICORNIS; SCLERACTINIAN CORALS; ACROPORA CORALS; CLADE-D; DIVERSITY; SPECIFICITY; SYMBIONTS; ENDOSYMBIONTS; ZOOXANTHELLAE	Reef-building corals host assemblages of symbiotic algae (Symbiodinium spp.) whose diversity and abundance may fluctuate under different conditions, potentially facilitating acclimatization to environmental change. The composition of free-living Symbiodinium in reef waters and sediments may also be environmentally labile and may influence symbiotic assemblages by mediating supply and dispersal. The magnitude and spatial scales of environmental influence over Symbiodinium composition in different reef habitat compartments are, however, not well understood. We used pyrosequencing to compare Symbiodinium in sediments, water, and ten coral species between two backreef pools in American Samoa with contrasting thermal environments. We found distinct compartmental assemblages of clades A, C, D, F, and/or G Symbiodinium types, with strong differences between pools in water, sediments, and two coral species. In the pool with higher and more variable temperatures, abundance of various clade A and C types differed compared to the other pool, while abundance of D types was lower in sediments but higher in water and in Pavona venosa, revealing an altered habitat distribution and potential linkages among compartments. The lack of between-pool effects in other coral species was due to either low overall variability (in the case of Porites) or high within-pool variability. Symbiodinium communities in water and sediment also showed within-pool structure, indicating that environmental influences may operate over multiple, small spatial scales. This work suggests that Symbiodinium composition is highly labile in reef waters, sediments, and some corals, but the underlying drivers and functional consequences of this plasticity require further testing with high spatial resolution biological and environmental sampling.	[Cunning, Ross; Yost, Denise M.; Putnam, Hollie M.; Gates, Ruth D.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Guarinello, Marisa L.] Univ Idaho, Northwest Knowledge Network, Moscow, ID 83844 USA	University of Hawaii System; Idaho; University of Idaho	Cunning, R (corresponding author), Univ Hawaii, Hawaii Inst Marine Biol, POB 1346, Kaneohe, HI 96744 USA.	ross.cunning@gmail.com		Guarinello, Marisa/0000-0002-8334-2166; Cunning, Ross/0000-0001-7241-1181; Putnam, Hollie/0000-0003-2322-3269	National Park Service; United States Geological Survey; National Park of American Samoa; Division Of Ocean Sciences [1323822] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1400787] Funding Source: National Science Foundation	National Park Service; United States Geological Survey(United States Geological Survey); National Park of American Samoa; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the National Park Service in a collaboration between RDG and the National Park of American Samoa. Additional funding was provided by the United States Geological Survey to RDG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; [Anonymous], 2014, R LANG ENV STAT COMP; Arif C, 2014, MOL ECOL, V23, P4418, DOI 10.1111/mec.12869; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castro-Sanguino C, 2012, BIOL LETTERS, V8, P282, DOI 10.1098/rsbl.2011.0836; Coffroth MA, 2006, CURR BIOL, V16, pR985, DOI 10.1016/j.cub.2006.10.049; Coffroth MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013258; Correa AMS, 2011, GLOBAL CHANGE BIOL, V17, P68, DOI 10.1111/j.1365-2486.2010.02242.x; Craig P, 2001, CORAL REEFS, V20, P185, DOI 10.1007/s003380100159; Cunning R, 2015, CORAL REEFS, V34, P155, DOI 10.1007/s00338-014-1216-4; Edmunds PJ, 2014, MAR ECOL PROG SER, V506, P129, DOI 10.3354/meps10808; Frade PR, 2008, CORAL REEFS, V27, P913, DOI 10.1007/s00338-008-0406-3; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Green EA, 2014, PEERJ, V2, DOI 10.7717/peerj.386; Gu Z., CIRCLIZE CIRCULAR VI; Hoegh-Guldberg O, 2014, CURR OPIN ENV SUST, V7, P127, DOI 10.1016/j.cosust.2014.01.005; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones Alison M., 2011, Journal of Marine Biology, V2011, P1; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Manning MM, 2008, LIMNOL OCEANOGR, V53, P1853, DOI 10.4319/lo.2008.53.5.1853; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Matz MV., MCMC OTU BAYESIAN AN; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; Mihaljevic JR, 2012, TRENDS ECOL EVOL, V27, P323, DOI 10.1016/j.tree.2012.01.011; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Oksanen J., **DATA OBJECT**; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Pochon X, 2010, J PHYCOL, V46, P53, DOI 10.1111/j.1529-8817.2009.00797.x; Putnam HM, 2012, P R SOC B, V279, P226; Quigley KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094297; Research and Testing Laboratory, DAT AN METH; Robert J.H., **DATA OBJECT**; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sampayo EM, 2007, MOL ECOL, V16, P3721, DOI 10.1111/j.1365-294X.2007.03403.x; Silverstein RN, 2015, GLOBAL CHANGE BIOL, V21, P236, DOI 10.1111/gcb.12706; Silverstein RN, 2012, P ROY SOC B-BIOL SCI, V279, P2609, DOI 10.1098/rspb.2012.0055; Silverstein RN, 2011, MAR ECOL PROG SER, V422, P63, DOI 10.3354/meps08934; Smith LW, 2007, J EXP MAR BIOL ECOL, V341, P282, DOI 10.1016/j.jembe.2006.10.053; Stat M, 2008, BIOL INVASIONS, V10, P579, DOI 10.1007/s10530-007-9167-0; Stat M, 2013, ECOL EVOL, V3, P1317, DOI 10.1002/ece3.556; Stat M, 2012, ADV MAR BIOL, V63, P1, DOI 10.1016/B978-0-12-394282-1.00001-6; Stat Michael, 2011, Journal of Marine Biology, V2011, P1; Stat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015854; Stat M, 2009, MAR ECOL PROG SER, V386, P83, DOI 10.3354/meps08080; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; Sweet MJ, 2013, MAR ECOL, V35, P343, DOI DOI 10.1111/MAEC.12092; Takabayashi M, 2012, CORAL REEFS, V31, P157, DOI 10.1007/s00338-011-0832-5; Thomas L, 2014, MOL ECOL, V23, P3113, DOI 10.1111/mec.12801; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; van Hooidonk R, 2013, NAT CLIM CHANGE, V3, P508, DOI [10.1038/NCLIMATE1829, 10.1038/nclimate1829]; Wilkinson SP, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0325-1; Wirshing HH, 2013, MOL ECOL, V22, P4413, DOI 10.1111/mec.12405	63	47	47	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145099	10.1371/journal.pone.0145099	http://dx.doi.org/10.1371/journal.pone.0145099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713847	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900032
J	Garcia, T; Zamalloa, CZ; Jackson, PR; Murphy, EA; Garcia, MH				Garcia, Tatiana; Zamalloa, Carlo Zuniga; Jackson, P. Ryan; Murphy, Elizabeth A.; Garcia, Marcelo H.			A Laboratory Investigation of the Suspension, Transport, and Settling of Silver Carp Eggs Using Synthetic Surrogates	PLOS ONE			English	Article							WATER HARDNESS; HATCHING SUCCESS; SUITABILITY; TURBULENCE; SIZE	Asian carp eggs are semi-buoyant and must remain suspended in the water to survive, supported by the turbulence of the flow, until they hatch and develop the ability to swim. Analysis of the transport and dispersal patterns of Asian carp eggs will facilitate the development and implementation of control strategies to target the early life stages. Experimenting with Asian carp eggs is complicated due to practical issues of obtaining eggs in close proximity to experimental facilities and extensive handling of eggs tends to damage them. Herein, we describe laboratory experiments using styrene beads (4.85 mm diameter) as synthetic surrogate eggs to mimic the physical properties of water-hardened silver carp eggs. The first set of experiments was completed in a rectangular vertical column filled with salt water. The salinity of the water was adjusted in an iterative fashion to obtain a close approximation of the fall velocity of the styrene beads to the mean fall velocity of silver carp water-hardened eggs. The terminal fall velocity of synthetic eggs was measured using an image processing method. The second set of experiments was performed in a temperature-controlled recirculatory flume with a sediment bed. The flume was filled with salt water, and synthetic eggs were allowed to drift under different flow conditions. Drifting behavior, suspension conditions, and settling characteristics of synthetic eggs were observed. At high velocities, eggs were suspended and distributed through the water column. Eggs that touched the sediment bed were re-entrained by the flow. Eggs saltated when they touched the bed, especially at moderate velocities and with a relatively flat bed. At lower velocities, some settling of the eggs was observed. With lower velocities and a flat bed, eggs were trapped near the walls of the flume. When bedforms were present, eggs were trapped in the lee of the bedforms in addition to being trapped near the flume walls. Results of this research study provide insights about transport, suspension, and dispersion of silver carp eggs. The knowledge gained from this study is useful to characterize the critical hydrodynamic conditions of the flow at which surrogates for silver carp water-hardened eggs settle out of suspension, and provides insight into how eggs may interact with riverbed sediments and morphology.	[Garcia, Tatiana; Jackson, P. Ryan; Murphy, Elizabeth A.] US Geol Survey, Illinois Water Sci Ctr, Urbana, IL 61801 USA; [Garcia, Tatiana; Zamalloa, Carlo Zuniga; Garcia, Marcelo H.] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA	United States Department of the Interior; United States Geological Survey; University of Illinois System; University of Illinois Urbana-Champaign	Garcia, T (corresponding author), US Geol Survey, Illinois Water Sci Ctr, Urbana, IL 61801 USA.	tgarcia@usgs.gov	Garcia, Marcelo H/A-9982-2016	Garcia, Marcelo H/0000-0003-0643-489X; Jackson, P. Ryan/0000-0002-3154-6108	U. S. Geological Survey; U.S. Environmental Protection Agency-Great Lakes Restoration Initiative; National Great Rivers Research and Educational Center	U. S. Geological Survey(United States Geological Survey); U.S. Environmental Protection Agency-Great Lakes Restoration Initiative; National Great Rivers Research and Educational Center	This work was supported by the U. S. Geological Survey, the U.S. Environmental Protection Agency-Great Lakes Restoration Initiative, and the National Great Rivers Research and Educational Center.	Brammeier J., 2008, PRELIMINARY FEASIBIL; Chapman D. C, 2006, US GEOLOGICAL SURVEY, V239; Chapman D.C., 2011, 20115076 USGS; Chapman DC, SPECIFIC GRAVI UNPUB; Chapman DC, 2013, J GREAT LAKES RES, V39, P547, DOI 10.1016/j.jglr.2013.09.019; Chapman DC, 2009, T AM FISH SOC, V138, P1226, DOI 10.1577/T09-004.1; Chick JH, 2001, SCIENCE, V292, P2250, DOI 10.1126/science.292.5525.2250; DEGRANDCHAMP KA, 2006, HABITAT SELECTION MO; Dudley RK, 1999, J FRESHWATER ECOL, V14, P423, DOI 10.1080/02705060.1999.9663700; Garcia CM, 2005, J HYDRAUL ENG, V131, P1062, DOI 10.1061/(ASCE)0733-9429(2005)131:12(1062); Garcia M.H, 2008, SEDIMENTATION ENG PR; Garcia T, 2015, J GREAT LAKES RES, V41, P374, DOI 10.1016/j.jglr.2015.02.003; Garcia T, 2013, ECOL MODEL, V263, P211, DOI 10.1016/j.ecolmodel.2013.05.005; GONZAL AC, 1987, AQUACULTURE, V64, P111, DOI 10.1016/0044-8486(87)90347-4; Hearn C. J., 2008, DYNAMICS COASTAL MOD; Jackson PR, 2014, J PHYS OCEANOGR, V44, P2661, DOI 10.1175/JPO-D-14-0027.1; Jennings DP, 1988, US FISH WILD SERV BI, V88, P35; Kim SC, 2000, J HYDRAUL ENG-ASCE, V126, P399, DOI 10.1061/(ASCE)0733-9429(2000)126:6(399); Kocovsky PM, 2012, J GREAT LAKES RES, V38, P159, DOI 10.1016/j.jglr.2011.11.015; KOLAR CS, 2007, BIGHEADED CARPS BIOL; Lenaerts AW, 2015, AQUATIC INV IN PRESS, P10; Lohmeyer AM, 2008, LARVAL ASIAN CARP UP; Murphy EA., 2013, SCI INVESTIGATIONS R; ODELL GM, 1971, J FLUID MECH, V50, P535, DOI 10.1017/S002211207100274X; Rach JJ, 2010, N AM J FISH MANAGE, V30, P230, DOI 10.1577/M09-067.1; Ruebush B.C., 2011, IN SITU TESTS SOUND; Soulsby R.L., 1983, ELSEVIER OCEANOG SER, V35, P189, DOI DOI 10.1016/S0422-9894(08)70503-8; U S Army Corps of Engineers, 2012, GREAT LAK MISS RIV I; VANRIJN LC, 1984, J HYDRAUL ENG-ASCE, V110, P1613, DOI 10.1061/(ASCE)0733-9429(1984)110:11(1613); Yi YJ, 2010, J HYDROL, V387, P283, DOI 10.1016/j.jhydrol.2010.04.018; Yih P., 1964, ACTA HYDROBIOL, V5, P1, DOI DOI 10.2108/ZSJ.30.296	31	12	14	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145775	10.1371/journal.pone.0145775	http://dx.doi.org/10.1371/journal.pone.0145775			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713855	gold, Green Published, Green Submitted			2022-12-27	WOS:000367481900080
J	Micheal, S; Ayub, H; Islam, F; Siddiqui, SN; Khan, WA; Akhtar, F; Qamar, R; Khan, MI; den Hollander, AI				Micheal, Shazia; Ayub, Humaira; Islam, Farrah; Siddiqui, Sorath Noorani; Khan, Wajid Ali; Akhtar, Farah; Qamar, Raheel; Khan, Muhammad Imran; den Hollander, Anneke I.			Variants in the ASB10 Gene Are Associated with Primary Open Angle Glaucoma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NUMBER; IDENTIFICATION; MUTATIONS; WORLDWIDE; PEOPLE	Background Recently nonsynonymous coding variants in the ankyrin repeats and suppressor of cytokine signaling box-containing protein 10 (ASB10) gene were found to be associated with primary open angle glaucoma (POAG) in cohorts from Oregon and Germany, but this finding was not confirmed in an independent cohort from Iowa. The aim of the current study was to assess the role of ASB10 gene variants in Pakistani glaucoma patients. Methods Sanger sequencing of the coding exons and splice junctions of the ASB10 gene was performed in 30 probands of multiplex POAG families, 208 sporadic POAG patients and 151 healthy controls from Pakistan. Genotypic associations of individual variants with POAG were analyzed with the Fisher's exact or Chi-square test. Results In total 24 variants were identified in POAG probands and sporadic patients, including 11 novel variants and 13 known variants. 13 of the variants were nonsynonymous, 6 were synonymous, and 5 were intronic. Three nonsynonymous variants (p.Arg49Cys, p.Arg237Gly, p.Arg453Cys) identified in the probands were not segregating in the respective families. This is not surprising since glaucoma is a multifactorial disease, and multiple factors are likely to be involved in the disease manifestation in these families. However a nonsynonymous variant, p.Arg453Cys (rs3800791), was found in 6 sporadic POAG patients but not in controls, suggesting that it infers increased risk for the disease. In addition, one synonymous variant was found to be associated with sporadic POAG: p.Ala290Ala and the association of the variant with POAG remained significant after correction for multiple testing (uncorrected p-value 0.002, corrected p-value 0.047). The cumulative burden of rare, nonsynonymous variants was significantly higher in sporadic POAG patients compared to control individuals (p-value 0.000006). Conclusions Variants in ASB10 were found to be significantly associated with sporadic POAG in the Pakistani population. This supports previous findings that sequence variants in the ASB10 gene may act as a risk factor for glaucoma.	[Micheal, Shazia; Ayub, Humaira; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Ayub, Humaira; Qamar, Raheel] COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan; [Islam, Farrah; Siddiqui, Sorath Noorani; Khan, Wajid Ali; Akhtar, Farah] Al Shifa Eye Trust Hosp, Rawalpindi 46000, Pakistan; [Qamar, Raheel] Isra Univ, Al Nafees Med Coll & Hosp, Islamabad 45600, Pakistan; [Khan, Muhammad Imran; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; COMSATS University Islamabad (CUI); Radboud University Nijmegen	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands.	Anneke.denHollander@radboudumc.nl	Hollander, Anneke den/N-4911-2014; Siddiqui, Sorath Noorani/AAT-9861-2020	Khan, Muhammad Imran/0000-0003-0276-5480	Stichting Blindenhulp; Glaucoma Research Foundation; Glaucoomfonds; Oogfonds; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid	Stichting Blindenhulp; Glaucoma Research Foundation; Glaucoomfonds; Oogfonds; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid	This study was supported by the Stichting Blindenhulp, a Shaffer grant from the Glaucoma Research Foundation, the Glaucoomfonds, Oogfonds, and the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (awarded to A. I. den Hollander and S. Micheal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; Fingert JH, 2012, HUM MOL GENET, V21, P4543, DOI 10.1093/hmg/dds288; Fingert JH, 2011, HUM MOL GENET, V20, P2482, DOI 10.1093/hmg/ddr123; Francis BA, 2011, INVEST OPHTH VIS SCI, V52, P6257, DOI 10.1167/iovs.09-5126; Keller KE, 2013, MOL VIS, V19, P1639; Khor CC, 2011, HUM MOL GENET, V20, P1864, DOI 10.1093/hmg/ddr060; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Liu YT, 2011, EXP EYE RES, V93, P331, DOI 10.1016/j.exer.2011.08.007; Melki R, 2004, J MED GENET, V41, P647, DOI 10.1136/jmg.2004.020024; Micheal S, 2015, CLIN EXP OPHTHALMOL, V43, P31, DOI 10.1111/ceo.12369; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pasutto F, 2012, HUM MOL GENET, V21, P1336, DOI 10.1093/hmg/ddr572; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Ramdas WD, 2011, OPHTHALMOLOGY, V118, P2389, DOI 10.1016/j.ophtha.2011.05.040; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Sambrook J., 2006, CONDENSED PROTOCOLS; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661	24	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145005	10.1371/journal.pone.0145005	http://dx.doi.org/10.1371/journal.pone.0145005			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713451	Green Submitted, Green Published, gold			2022-12-27	WOS:000367481900029
J	Raffegerst, S; Steer, B; Hohloch, M; Adler, H				Raffegerst, S.; Steer, B.; Hohloch, M.; Adler, H.			Prevention of Tumor Formation by Latent Gammaherpesvirus Infection	PLOS ONE			English	Article							BACTERIAL-INFECTION; MICE; VIRUS; ESTABLISHMENT; REPLICATION; PROTECTION; HIV-1	Recent reports suggested that chronic herpesvirus infection, as a constituent of the so-called virome, may not only exert harmful effects but may also be beneficial to the host, for example mediating increased resistance to secondary infections or to tumors. To further challenge this concept, specifically regarding increased resistance to tumors, we infected chimeric HLA-DR4-H2-E (DR4) mice, a mouse strain which spontaneously develops hematological tumors, with the rodent herpesvirus murine gammaherpesvirus 68 (MHV-68). Using this model, we observed that infection with wildtype MHV-68 completely prevented tumor formation. This happened, however, at the cost of hyposplenism. In contrast to wildtype infection, infection with a latency-deficient mutant of MHV-68 neither prevented tumor formation nor induced hyposplenism. The underlying mechanisms are not known but might be related to an infection-mediated priming of the immune response, resulting in the suppression of a tumor promoting endogenous retrovirus. Thus, under certain circumstances, chronic herpesvirus infection may prevent the development of tumors.	[Raffegerst, S.; Hohloch, M.] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany; [Steer, B.; Adler, H.] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Res Unit Gene Vectors, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Raffegerst, S (corresponding author), Medigene Immunotherapies GmbH, Lochhamer Str 11, D-82152 Martinsried, Germany.	silke.raffegerst@helmholtz-muenchen.de; h.adler@helmholtz-muenchen.de			Bundesministerium fur Bildung und Forschung (NGFNplus) [FKZ PIM-01GS0802-3]; Wilhelm Sander-Stiftung [2009.046.1+2]	Bundesministerium fur Bildung und Forschung (NGFNplus)(Federal Ministry of Education & Research (BMBF)); Wilhelm Sander-Stiftung	This work was supported by grants from the Bundesministerium fur Bildung und Forschung (NGFNplus, FKZ PIM-01GS0802-3) and the Wilhelm Sander-Stiftung (grant 2009.046.1+2) to HA.	AB RICKINSON, 2001, FIELDS VIROLOGY, P2575; Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Auger S, 2014, EUR J HAEMATOL, V92, P421, DOI 10.1111/ejh.12260; Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Chauhan VS, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-11; Crowley RW, 1996, J IMMUNOL, V156, P2004; Ebrahimi B, 2001, AM J PATHOL, V158, P2117, DOI 10.1016/S0002-9440(10)64683-4; Fowler P, 2003, J GEN VIROL, V84, P3405, DOI 10.1099/vir.0.19594-0; Guggemoos S, 2008, J IMMUNOL, V180, P438, DOI 10.4049/jimmunol.180.1.438; Ito K, 1996, J EXP MED, V183, P2635, DOI 10.1084/jem.183.6.2635; Larson JD, 2012, P NATL ACAD SCI USA, V109, pE1092, DOI 10.1073/pnas.1203019109; Lisco A, 2007, J VIROL, V81, P708, DOI 10.1128/JVI.01367-06; Moorman NJ, 2003, J VIROL, V77, P10295, DOI 10.1128/JVI.77.19.10295-10303.2003; Raffegerst SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008539; Raymond AD, 2007, CURR HIV RES, V5, P79, DOI 10.2174/157016207779316314; Saghafian-Hedengren S, 2010, J ALLERGY CLIN IMMUN, V125, P433, DOI 10.1016/j.jaci.2009.09.033; Saito F, 2013, INFLAMMATION, V36, P1295, DOI 10.1007/s10753-013-9668-1; Schulz TF, 1998, J GEN VIROL, V79, P1573, DOI 10.1099/0022-1317-79-7-1573; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; White DW, 2010, BLOOD, V115, P4377, DOI 10.1182/blood-2009-09-245464; Yager EJ, 2009, VIRAL IMMUNOL, V22, P67, DOI 10.1089/vim.2008.0086; Yu P, 2012, IMMUNITY, V37, P867, DOI 10.1016/j.immuni.2012.07.018	24	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145678	10.1371/journal.pone.0145678	http://dx.doi.org/10.1371/journal.pone.0145678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714031	gold, Green Published, Green Submitted			2022-12-27	WOS:000367481900065
J	Wasik, S; Fratczak, F; Krzyskow, J; Wulnikowski, J				Wasik, Szymon; Fratczak, Filip; Krzyskow, Jakub; Wulnikowski, Jaroslaw			Inferring Mathematical Equations Using Crowdsourcing	PLOS ONE			English	Article							WORLD; RNA	Crowdsourcing, understood as outsourcing work to a large network of people in the form of an open call, has been utilized successfully many times, including a very interesting concept involving the implementation of computer games with the objective of solving a scientific problem by employing users to play a game-so-called crowdsourced serious games. Our main objective was to verify whether such an approach could be successfully applied to the discovery of mathematical equations that explain experimental data gathered during the observation of a given dynamic system. Moreover, we wanted to compare it with an approach based on artificial intelligence that uses symbolic regression to find such formulae automatically. To achieve this, we designed and implemented an Internet game in which players attempt to design a spaceship representing an equation that models the observed system. The game was designed while considering that it should be easy to use for people without strong mathematical backgrounds. Moreover, we tried to make use of the collective intelligence observed in crowdsourced systems by enabling many players to collaborate on a single solution. The idea was tested on several hundred players playing almost 10,000 games and conducting a user opinion survey. The results prove that the proposed solution has very high potential. The function generated during weeklong tests was almost as precise as the analytical solution of the model of the system and, up to a certain complexity level of the formulae, it explained data better than the solution generated automatically by Eureqa, the leading software application for the implementation of symbolic regression. Moreover, we observed benefits of using crowdsourcing; the chain of consecutive solutions that led to the best solution was obtained by the continuous collaboration of several players.	[Wasik, Szymon; Fratczak, Filip; Krzyskow, Jakub; Wulnikowski, Jaroslaw] Poznan Univ Tech, Inst Comp Sci, Poznan, Poland; [Wasik, Szymon] Poznan Univ Tech, European Ctr Bioinformat & Genom, Poznan, Poland	Poznan University of Technology; Poznan University of Technology	Wasik, S (corresponding author), Poznan Univ Tech, Inst Comp Sci, Poznan, Poland.	szymon.wasik@cs.put.poznan.pl	Wasik, Szymon/F-7677-2014	Wasik, Szymon/0000-0002-2753-2862	Polish National Science Center [2012/05/B/ST6/03026]; Polish National Center for Research and Development [LIDER/004/103/L-5/13/NCBR/2014]	Polish National Science Center; Polish National Center for Research and Development	This study was partially supported by the Polish National Science Center under grant 2012/05/B/ST6/03026 (https://www.ncn.gov.pl/, SW) and the Polish National Center for Research and Development under grant LIDER/004/103/L-5/13/NCBR/2014 (http://www.ncbir.pl/, FF, JK, JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affenzeller M, 2014, GENETIC PROGRAMMING, P175; AHO AV, 1976, J ACM, V23, P488, DOI 10.1145/321958.321970; [Anonymous], 2014 COMPUTER GAMES; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Cornforth TW, 2012, PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P735, DOI 10.1145/2330163.2330266; Cortez P, 2014, USE R, P63, DOI 10.1007/978-3-319-08263-9_5; Dahari H, 2007, HEPATOLOGY, V46, P16, DOI 10.1002/hep.21657; Daniels BC, 2014, ARXIV14046283; Dawson R, 2011, GETTING RESULTS CROW, P9; Doan A, 2011, COMMUN ACM, V54, P86, DOI 10.1145/1924421.1924442; Estelles-Arolas E, 2012, J INF SCI, V38, P189, DOI 10.1177/0165551512437638; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; Gaucel Sebastien, 2014, Genetic Programming. 17th European Conference (EuroGP 2014). Revised Selected Papers: LNCS 8599, P25, DOI 10.1007/978-3-662-44303-3_3; Giannakos MN, 2013, BEHAV INFORM TECHNOL, V32, P594, DOI 10.1080/0144929X.2012.659218; Gouveia A, 2014, 2010 WASTING TIME WO; Helmstaedter M, 2014, NATURE, V514, DOI 10.1038/nature13877; Isaksen A, 2015, EXPLORING GAME SPACE; Jaskowski W, 2011, EVOL COMPUT, V19, P639, DOI 10.1162/EVCO_a_00046; Krawiec Krzysztof, 2009, Foundations of Computing and Decision Sciences, V34, P265; Lee J, 2014, P NATL ACAD SCI USA, V111, P2122, DOI 10.1073/pnas.1313039111; Logas H., 2014, FDN DIGITAL GAMES 20, P1; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Schmidt MD, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/055011; Searson DP, 2010, LECT NOTES ENG COMP, P77; Szalay A, 2006, NATURE, V440, P413, DOI 10.1038/440413a; Villars R.L., 2011, CISC VIS NETW IND GL; Wasik S, 2014, ARTIF INTELL MED, V60, P123, DOI 10.1016/j.artmed.2013.11.001; Willis M.-J., 1997, Second International Conference on Genetic Algorithms in Engineering Systems: Innovations and Applications (Conf. Publ. No.446), P314, DOI 10.1049/cp:19971199; Wired Howe J., 2006, WIRED            JUN	29	8	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145557	10.1371/journal.pone.0145557	http://dx.doi.org/10.1371/journal.pone.0145557			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713846	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900056
J	Zhao, XQ; Zhang, GL; Wang, Y; Zhang, F; Wang, WS; Zhang, WH; Fu, BY; Xu, JL; Li, ZK				Zhao, Xiuqin; Zhang, Guilian; Wang, Yun; Zhang, Fan; Wang, Wensheng; Zhang, Wenhao; Fu, Binying; Xu, Jianlong; Li, Zhikang			Metabolic Profiling and Physiological Analysis of a Novel Rice Introgression Line with Broad Leaf Size	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; DROUGHT TOLERANCE; NATURAL VARIATION; GRAIN WIDTH; YIELD; PRODUCTIVITY; ENCODES; WEIGHT; GENE; DISSECTION	A rice introgression line, NIL-SS1, and its recurrent parent, Teqing, were used to investigate the influence of the introgression segment on plant growth. The current research showed NIL-SS1 had an increased flag leaf width, total leaf area, spikelet number per panicle and grain yield, but a decreased photosynthetic rate. The metabolite differences in NIL-SS1 and Teqing at different developmental stages were assessed using gas chromatography-mass spectrometry technology. Significant metabolite differences were observed across the different stages. NIL-SS1 increased the plant leaf nitrogen content, and the greatest differences between NIL-SS1 and Teqing occurred at the booting stage. Compared to Teqing, the metabolic phenotype of NIL-SS1 at the booting stage has closer association with those at the flowering stage. The introgression segment induced more active competition for sugars and organic acids (OAs) from leaves to the growing young spikes, which resulted in more spikelet number per plant (SNP). The results indicated the introgression segment could improve rice grain yield by increasing the SNP and total leaf area per plant, which resulted from the higher plant nitrogen content across growth stages and stronger competition for sugars and OAs of young spikes at the booting stage.	[Zhao, Xiuqin; Zhang, Fan; Wang, Wensheng; Fu, Binying; Xu, Jianlong; Li, Zhikang] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China; [Zhang, Guilian] Shanghai Landscape Gardening Res Inst, Shanghai 200232, Peoples R China; [Wang, Yun] Shenyang Agr Univ, Rice Inst, Key Lab Crop Physiol Ecol Genet & Breeding, Minist Agr, Shenyang 110866, Peoples R China; [Zhang, Wenhao] China Univ Min & Technol, Beijing 100083, Peoples R China; [Fu, Binying; Xu, Jianlong; Li, Zhikang] Chinese Acad Agr Sci, Shenzhen Inst Innovat Breeding, Shenzhen 518120, Peoples R China; [Xu, Jianlong] Chinese Acad Agr Sci, Agr Genom Inst, Shenzhen 518120, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Shenyang Agricultural University; China University of Mining & Technology; Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS	Fu, BY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China.	fubinying@caas.cn; xujianlong@caas.cn	Xu, Jianlong/AAI-8310-2020		National Natural Science Foundation [31261140369]; Shenzhen Technology Research Development [JSGG20121026152117750]; "948" Project from the Chinese Ministry of Agriculture [2011-G2B]; Bill & Melinda Gates Foundation [OPP51587]; 863 key Project from the Chinese Ministry of Science Technology [2014AA10A601]; Shenzhen Peacock Plan [20130415095710361]; CAAS Innovative Team Award	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shenzhen Technology Research Development; "948" Project from the Chinese Ministry of Agriculture; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); 863 key Project from the Chinese Ministry of Science Technology; Shenzhen Peacock Plan; CAAS Innovative Team Award	This research was funded by the National Natural Science Foundation (31261140369) to JLX; the Shenzhen Technology Research & Development (JSGG20121026152117750) to JLX; "948" Project (2011-G2B) from the Chinese Ministry of Agriculture to ZKL; the Bill & Melinda Gates Foundation Project (OPP51587) to ZKL; 863 key Project (2014AA10A601) from the Chinese Ministry of Science & Technology to JLX; the Shenzhen Peacock Plan (20130415095710361) to ZKL, and the CAAS Innovative Team Award to ZK Li's team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Barneix AJ, 1996, J PLANT PHYSIOL, V149, P358; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Bowne JB, 2012, MOL PLANT, V5, P418, DOI 10.1093/mp/ssr114; Bush D R, 1993, ANN REV PLANT PHYSL; Cameron K. C., 1986, Mineral nitrogen in the plant-soil system., P166; Cassman KG, 2003, ANNU REV ENV RESOUR, V28, P315, DOI 10.1146/annurev.energy.28.040202.122858; CHARLESEDWARDS DA, 1978, ANN BOT-LONDON, V42, P717, DOI 10.1093/oxfordjournals.aob.a085506; Chen ML, 2012, PLANT CELL REP, V31, P863, DOI 10.1007/s00299-011-1207-7; Cock J. H., 1972, Proceedings of the Crop Science Society of Japan, V41, P226; EARLY EB, 1967, CROP SCI, V7, P151, DOI 10.2135/cropsci1967.0011183X000700020018x; EVANS LT, 1970, AUST J BIOL SCI, V23, P725, DOI 10.1071/BI9700725; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fernie AR, 2009, TRENDS GENET, V25, P39, DOI 10.1016/j.tig.2008.10.010; FISCHER RA, 1975, CROP SCI, V15, P607, DOI 10.2135/cropsci1975.0011183X001500050002x; GIFFORD RM, 1981, ANNU REV PLANT PHYS, V32, P485, DOI 10.1146/annurev.pp.32.060181.002413; HO LC, 1988, ANNU REV PLANT PHYS, V39, P355, DOI 10.1146/annurev.arplant.39.1.355; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Ingestad TKM, 1985, PHYSIOL PLANTARUM, V45, P37; Ishimaru K, 2007, PLANT PHYSIOL BIOCH, V45, P799, DOI 10.1016/j.plaphy.2007.07.004; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Junker BH, 2004, PLANT MOL BIOL, V56, P91, DOI 10.1007/s11103-004-2525-8; Korn M, 2010, MOL PLANT, V3, P224, DOI 10.1093/mp/ssp105; Li ZK, 2005, PLANT MOL BIOL, V59, P33, DOI 10.1007/s11103-005-8519-3; Long S. P., 1998, P124; Marcelis LFM, 1996, J EXP BOT, V47, P1281, DOI 10.1093/jxb/47.Special_Issue.1281; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Morino K, 2005, PLANT CELL PHYSIOL, V46, P514, DOI 10.1093/pcp/pci051; OAKS A, 1994, CAN J BOT, V72, P739, DOI 10.1139/b94-094; Qi J, 2008, PLANT PHYSIOL, V147, P1947, DOI 10.1104/pp.108.118778; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Schauer N, 2006, TRENDS PLANT SCI, V11, P508, DOI 10.1016/j.tplants.2006.08.007; Seck PA, 2012, FOOD SECUR, V4, P7, DOI 10.1007/s12571-012-0168-1; Settle WH, 1996, ECOLOGY, V77, P1975, DOI 10.2307/2265694; Shah J, 2009, CURR OPIN PLANT BIOL, V12, P459, DOI 10.1016/j.pbi.2009.05.011; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Takai T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02149; Ujiie K, 2012, EUPHYTICA, V187, P325, DOI 10.1007/s10681-012-0660-x; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Xing YZ, 2008, THEOR APPL GENET, V116, P789, DOI 10.1007/s00122-008-0711-9; Xu JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132060; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan WH, 2011, MOL PLANT, V4, P319, DOI 10.1093/mp/ssq070; Zhang GH, 2014, MOL PLANT, V7, P1350, DOI 10.1093/mp/ssu055; Zhao XQ, 2008, PLANT SCI, V174, P618, DOI 10.1016/j.plantsci.2008.03.009; Zhao XQ, 2013, RICE, V6, DOI 10.1186/1939-8433-6-23	49	3	3	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145646	10.1371/journal.pone.0145646	http://dx.doi.org/10.1371/journal.pone.0145646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713754	Green Submitted, Green Published, gold			2022-12-27	WOS:000367481900063
J	Cheng, JY; Hou, JL; Ding, HG; Chen, GF; Xie, Q; Wang, YM; Zeng, MD; Ou, XJ; Ma, H; Jia, JD				Cheng, Jieyao; Hou, Jinlin; Ding, Huiguo; Chen, Guofeng; Xie, Qing; Wang, Yuming; Zeng, Minde; Ou, Xiaojuan; Ma, Hong; Jia, Jidong			Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B	PLOS ONE			English	Article							INDEX; CIRRHOSIS; MARKERS	Background and Aims Noninvasive models have been developed for fibrosis assessment in patients with chronic hepatitis B. However, the sensitivity, specificity and diagnostic accuracy in evaluating liver fibrosis of these methods have not been validated and compared in the same group of patients. The aim of this study was to verify the diagnostic performance and reproducibility of ten reported noninvasive models in a large cohort of Asian CHB patients. Methods The diagnostic performance of ten noninvasive models (HALF index, FibroScan, S index, Zeng model, Youyi model, Hui model, APAG, APRI, FIB-4 and FibroTest) was assessed against the liver histology by ROC curve analysis in CHB patients. The reproducibility of the ten models were evaluated by recalculating the diagnostic values at the given cut-off values defined by the original studies. Results Six models (HALF index, FibroScan, Zeng model, Youyi model, S index and FibroTest) had AUROCs higher than 0.70 in predicting any fibrosis stage and 2 of them had best diagnostic performance with AUROCs to predict F >= 2, F >= 3 and F4 being 0.83, 0.89 and 0.89 for HALF index, 0.82, 0.87 and 0.87 for FibroScan, respectively. Four models (HALF index, FibroScan, Zeng model and Youyi model) showed good diagnostic values at given cut-offs. Conclusions HALF index, FibroScan, Zeng model, Youyi model, S index and FibroTest show a good diagnostic performance and all of them, except S index and FibroTest, have good reproducibility for evaluating liver fibrosis in CHB patients.	[Cheng, Jieyao; Ou, Xiaojuan; Ma, Hong; Jia, Jidong] Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing Key Lab Translat Med Liver Cirrhosis, Beijing, Peoples R China; [Cheng, Jieyao; Ou, Xiaojuan; Ma, Hong; Jia, Jidong] Natl Clin Res Ctr Digest Dis, Beijing, Peoples R China; [Hou, Jinlin] Southern Med Univ, Nanfang Hosp, Hepatol Dept, Guangzhou, Guangdong, Peoples R China; [Ding, Huiguo] Capital Med Univ, Beijing Youan Hosp, Dept Gastroenterol & Hepatol, Beijing, Peoples R China; [Chen, Guofeng] 302 Hosp China, Diag & Treatment Ctr Liver Fibrosis, Beijing, Peoples R China; [Xie, Qing] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Infect Dis, Shanghai 200030, Peoples R China; [Wang, Yuming] Third Mil Med Univ, Southwest Hosp, Dept Infect Dis, Chongqing, Peoples R China; [Zeng, Minde] Shanghai Jiao Tong Univ, Renji Hosp, Dept Gastroenterol, Shanghai 200030, Peoples R China	Capital Medical University; Southern Medical University - China; Capital Medical University; Fifth Medical Center of Chinese PLA General Hospital; Shanghai Jiao Tong University; Army Medical University; Shanghai Jiao Tong University	Ma, H (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing Key Lab Translat Med Liver Cirrhosis, Beijing, Peoples R China.	mahongmd@163.com			Wang Bao-En Liver Fibrosis Fund (China Foundation for Hepatitis Prevention and Control) [ChiCTR-DCS-07000039]; Major Science and Technology Special Project of China Twelfth Five-year Plan [2012ZX10002003]; Beijing Municipal Science and Technology Commission [Z09050700940902, D121100003912002, D121100003912003]	Wang Bao-En Liver Fibrosis Fund (China Foundation for Hepatitis Prevention and Control); Major Science and Technology Special Project of China Twelfth Five-year Plan; Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	JYC received the funding from Wang Bao-En Liver Fibrosis Fund (an unrestricted grant from China Foundation for Hepatitis Prevention and Control, ChiCTR-DCS-07000039), Major Science and Technology Special Project of China Twelfth Five-year Plan (2012ZX10002003) and Key Project from Beijing Municipal Science and Technology Commission (Z09050700940902, D121100003912002, D121100003912003) in study design and data collection.	Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Chen Xue-bing, 2011, Zhonghua Gan Zang Bing Za Zhi, V19, P286, DOI 10.3760/cma.j.issn.1007-3418.2011.04.013; Chen YP, 2008, J GASTROEN HEPATOL, V23, P1228, DOI 10.1111/j.1440-1746.2008.05421.x; Cheng Jieyao, 2014, Zhonghua Gan Zang Bing Za Zhi, V22, P231; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Friedrich-Rust M, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-103; Hui AY, 2005, AM J GASTROENTEROL, V100, P616, DOI 10.1111/j.1572-0241.2005.41289.x; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Kim BK, 2007, LIVER INT, V27, P969, DOI 10.1111/j.1478-3231.2007.01519.x; Kim BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035825; Lee HJ, 2011, J GASTROEN HEPATOL, V26, P987, DOI 10.1111/j.1440-1746.2010.06609.x; Liu Wei-Ping, 2008, Zhonghua Nei Ke Za Zhi, V47, P308; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Mohamadnejad M, 2006, AM J GASTROENTEROL, V101, P2537, DOI 10.1111/j.1572-0241.2006.00788.x; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Park SH, 2010, CLIN BIOCHEM, V43, P877, DOI 10.1016/j.clinbiochem.2010.04.063; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Tu Xiang-Lin, 2009, Zhonghua Gan Zang Bing Za Zhi, V17, P28; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wu SD, 2010, WORLD J GASTROENTERO, V16, P501, DOI 10.3748/wjg.v16.i4.501; Zeng MD, 2005, HEPATOLOGY, V42, P1437, DOI 10.1002/hep.20960; Zhang Wen-sheng, 2006, Zhonghua Gan Zang Bing Za Zhi, V14, P169; Zhou K, 2010, J GASTROEN HEPATOL, V25, P1569, DOI 10.1111/j.1440-1746.2010.06383.x; 吴盛迪, 2010, [中华消化杂志, Chinese Journal of Digestion], V30, P478	26	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144425	10.1371/journal.pone.0144425	http://dx.doi.org/10.1371/journal.pone.0144425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709706	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400006
J	Hsiao, WY; Lin, YC; Liao, FH; Chan, YC; Huang, CY				Hsiao, Wan-Yi; Lin, Yu-Chun; Liao, Fang-Hsuean; Chan, Yi-Chiao; Huang, Ching-Yu			Dual-Specificity Phosphatase 4 Regulates STAT5 Protein Stability and Helper T Cell Polarization	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; KINASE PHOSPHATASE-2; TYROSINE DEPHOSPHORYLATION; IMMUNE-RESPONSES; ACTIVATED STAT5A; CUTTING EDGE; IN-VIVO; TRANSCRIPTION; EXPRESSION	Immune responses are critically regulated by the functions of CD4 helper T cells. Based on their secreted cytokines, helper T cells are further categorized into different subsets like Treg or Th17 cells, which suppress or promote inflammatory responses, respectively. Signals from IL-2 activate the transcription factor STAT5 to promote Treg but suppress Th17 cell differentiation. Our previous results found that the deficiency of a dual-specificity phosphatase, DUSP4, induced STAT5 hyper-activation, enhanced IL-2 signaling, and increased T cell proliferation. In this report, we examined the effects of DUSP4 deficiency on helper T cell differentiation and STAT5 regulation. Our in vivo data showed that DUSP4 mice were more resistant to the induction of autoimmune encephalitis, while in vitro differentiations revealed enhanced iTreg and reduced Th17 polarization in DUSP4-deficient T cells. To study the cause of this altered helper T cell polarization, we performed luciferase reporter assays and confirmed that, as predicted by our previous report, DUSP4 over-expression suppressed the transcription factor activity of STAT5. Surprisingly, we also found that DUSP4-deficient T but not B cells exhibited elevated STAT5 protein levels, and over-expressed DUSP4 destabilized STAT5 in vitro; moreover, this destabilization required the phosphatase activity of DUSP4, and was insensitive to MG132 treatment. Finally, domain-mapping results showed that both the substrate-interacting and the phosphatase domains of DUSP4 were required for its optimal interaction with STAT5, while the coiled-coil domain of STAT5 appeared to hinder this interaction. Our data thus provide the first genetic evidence that DUSP4 is important for helper T cell development. In addition, they also help uncover the novel, DUSP4-mediated regulation of STAT5 protein stability.	[Hsiao, Wan-Yi; Lin, Yu-Chun; Liao, Fang-Hsuean; Chan, Yi-Chiao; Huang, Ching-Yu] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan, Miaoli County, Taiwan	National Health Research Institutes - Taiwan	Huang, CY (corresponding author), Natl Hlth Res Inst, Immunol Res Ctr, Zhunan, Miaoli County, Taiwan.	cyhuang@nhri.org.tw	Liao, Fang-Hsuean/H-4373-2018	Liao, Fang-Hsuean/0000-0001-5085-3763; Huang, Ching-yu/0000-0002-5758-281X	National Health Research Institutes, Taiwan [104-A1-IMPP03-014]; Ministry of Science and Technology, Taiwan [101-2320-B-400-004-MY3]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in whole or in part by grant 104-A1-IMPP03-014 from the National Health Research Institutes (http://www.nhri.org.tw/), Taiwan, as well as grants 101-2320-B-400-004-MY3 from the Ministry of Science and Technology (http://www.most.gov.tw/), Taiwan to CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; F. L. was supported by a post-doctoral grant from the Ministry of Science and Technology, Taiwan. W. H. and Y. L. designed and performed experiments as well as analyzed data. F. L. and Y. C. performed experiments. C. H. designed and performed experiments, analyzed data, and prepared the manuscript. We wish to thank Dr. Toshio Kitamura at the University of Tokyo for the STAT5a cDNA construct, Dr. Richard J. Ross at the University of Sheffield for the STAT5 LHRE reporter construct, Dr. Robert E. Campbell at the University of Alberta for the ametrine construct, Dr. Alexander Rudensky at the Memorial Sloan Kettering Cancer Center for the FOXP3-GFP mice, Dr. Yi-Rong Chen for help in the generation of tetracycline-inducible cells, and Claire Y. Huang for proofreading the manuscript. We also thank the staff at the flow cytometry, sequencing and animal core facilities at the NHRI for their services.	Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Al-Mutairi MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001192; Aoki N, 2000, J BIOL CHEM, V275, P39718, DOI 10.1074/jbc.M005615200; Auger-Messier M, 2013, CIRC RES, V112, P48, DOI 10.1161/CIRCRESAHA.112.272963; Beadling C, 1996, EMBO J, V15, P1902, DOI 10.1002/j.1460-2075.1996.tb00541.x; Bettini ML, 2007, P NATL ACAD SCI USA, V104, P16257, DOI 10.1073/pnas.0705321104; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chang CF, 2012, J IMMUNOL, V189, P721, DOI 10.4049/jimmunol.1103015; Chen Q, 2011, J IMMUNOL, V186, P6329, DOI 10.4049/jimmunol.1100061; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Cornell TT, 2010, INFECT IMMUN, V78, P2868, DOI 10.1128/IAI.00018-10; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Domingues HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015531; Ferraro A, 2014, P NATL ACAD SCI USA, V111, pE1111, DOI 10.1073/pnas.1401343111; Fievez L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000727; Floyd ZE, 2007, AM J PHYSIOL-ENDOC M, V292, pE461, DOI 10.1152/ajpendo.00334.2006; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; GUAN KL, 1995, J BIOL CHEM, V270, P7197, DOI 10.1074/jbc.270.13.7197; Hoyt R, 2007, J IMMUNOL, V179, P3402, DOI 10.4049/jimmunol.179.6.3402; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; Huang CY, 2012, EUR J IMMUNOL, V42, P476, DOI 10.1002/eji.201041295; Iyer J, 2008, FASEB J, V22, P391, DOI 10.1096/fj.07-8965com; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Jeong DG, 2014, ACTA CRYSTALLOGR D, V70, P421, DOI 10.1107/S1399004713029866; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Ke SA, 1999, PROG BIOPHYS MOL BIO, V71, P405, DOI 10.1016/S0079-6107(98)00051-0; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; King AG, 1995, ONCOGENE, V11, P2553; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kovanen PE, 2008, J BIOL CHEM, V283, P17362, DOI 10.1074/jbc.M709887200; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Meier A, 2007, EMBO J, V26, P2707, DOI 10.1038/sj.emboj.7601719; Meinke A, 1996, MOL CELL BIOL, V16, P6937; Moon SJ, 2014, ARTHRITIS RHEUMATOL, V66, P3083, DOI 10.1002/art.38787; Neculai D, 2005, J BIOL CHEM, V280, P40782, DOI 10.1074/jbc.M507682200; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Oda A, 2002, BLOOD, V99, P1850, DOI 10.1182/blood.V99.5.1850; Ramesh S, 2008, EMBO REP, V9, P990, DOI 10.1038/embor.2008.158; Reich Nancy C, 2013, JAKSTAT, V2, pe27080, DOI 10.4161/jkst.27080; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Shen WH, 2006, CANCER RES, V66, P6033, DOI 10.1158/0008-5472.CAN-05-3878; Shin HY, 2013, J CELL SCI, V126, P3333, DOI 10.1242/jcs.123042; Sloss CM, 2005, CELL SIGNAL, V17, P709, DOI 10.1016/j.cellsig.2004.10.010; Teng CH, 2007, J BIOL CHEM, V282, P28395, DOI 10.1074/jbc.M705142200; Torres C, 2003, EXP CELL RES, V290, P195, DOI 10.1016/S0014-4827(03)00309-4; von Laue S, 2000, J ENDOCRINOL, V165, P301, DOI 10.1677/joe.0.1650301; Wang DM, 2000, EMBO J, V19, P392, DOI 10.1093/emboj/19.3.392; Wang H, 2007, J BIOL CHEM, V282, P16164, DOI 10.1074/jbc.M610556200; Wei L, 2008, SEMIN CELL DEV BIOL, V19, P394, DOI 10.1016/j.semcdb.2008.07.011; Xiao WB, 2009, CANCER CELL, V16, P161, DOI 10.1016/j.ccr.2009.05.018; Yamashita H, 2001, MOL CELL ENDOCRINOL, V183, P151, DOI 10.1016/S0303-7207(01)00546-9; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yu CL, 2000, J BIOL CHEM, V275, P599, DOI 10.1074/jbc.275.1.599; Yu MC, 2012, P NATL ACAD SCI USA, V109, pE879, DOI 10.1073/pnas.1109797109; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764	60	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145880	10.1371/journal.pone.0145880	http://dx.doi.org/10.1371/journal.pone.0145880			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710253	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400091
J	Luo, YH; Zhang, X; Tan, Z; Wu, PR; Xiang, XL; Dang, YW; Chen, G				Luo, Yihuan; Zhang, Xin; Tan, Zhong; Wu, Peirong; Xiang, Xuelian; Dang, Yiwu; Chen, Gang			Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HEPATOCELLULAR-CARCINOMA; POOR-PROGNOSIS; COLORECTAL-CARCINOMA; AEG-1 EXPRESSION; METASTASIS; METADHERIN; OVEREXPRESSION; PROGRESSION; IDENTIFICATION	Background There have been numerous articles as to whether the staining index (SI) of astrocyte elevated gene-1 (AEG-1) adversely affects clinical progression and prognosis of gastrointestinal cancers. Nevertheless, controversy still exists in terms of correlations between AEG-1 SI and clinicopathological parameters including survival data. Consequently, we conducted a comprehensive meta-analysis to confirm the role of AEG-1 in clinical outcomes of gastrointestinal carcinoma patients. Methods We performed a comprehensive search in PubMed, ISI Web of Science, Cochrane Central Register of Controlled Trials, EMBASE, Science Direct, Wiley Online Library, China National Knowledge Infrastructure (CNKI), WanFang and Chinese VIP databases. STATA 12.0 (STATA Corp., College, TX) was used to analyze the data extracted from suitable studies and Newcastle-Ottawa Scale was applied to assess the quality of included articles. Results The current meta-analysis included 2999 patients and our results suggested that strong associations emerged between AEG-1 SI and histological differentiation (OR = 2.129, 95% CI: 1.377-3.290, P = 0.001), tumor (T) classification (OR = 2.272, 95% CI: 1.147-4.502, P = 0.019), lymph node (N) classification (OR = 2.696, 95% CI: 2.178-3.337, P<0.001) and metastasis (M) classification (OR = 3.731, 95% CI: 2.167-6.426, P<0.001). Furthermore, high AEG-1 SI was significantly associated with poor overall survival (OS) (HR = 2.369, 95% CI: 2.005-2.800, P<0.001) and deteriorated disease-free survival (DFS) (HR = 1.538, 95% CI: 1.171-2.020, P = 0.002). For disease-specific survival (DSS) and relapse-free survival (RFS), no statistically significant results were observed (HR = 1.573, 95% CI: 0.7613.250, P = 0.222; HR = 1.432, 95% CI: 0.108-19.085, P = 0.786). Subgroup analysis demonstrated that high AEG-1 SI was significantly related to poor prognosis in esophageal squamous cell carcinoma (ESCC) (HR = 1.715, 95% CI: 1.211-2.410, P = 0.002), gastric carcinoma (GC) (HR = 2.255, 95% CI: 1.547-3.288, P<0.001),colorectal carcinoma (CRC) (HR = 2.922, 95% CI: 1.921-4.444, P<0.001), gallbladder carcinoma (GBC) (HR = 3.047, 95% CI: 1.685-5.509, P<0.001), hepatocellular carcinoma (HCC) (HR = 2.245, 95% CI: 1.620-3.113, P<0.001), pancreatic adenocarcinoma (PAC) (HR = 2.408, 95% CI: 1.625-3.568, P<0.001). Conclusions The current meta-analysis indicated that high AEG-1 SI might be associated with tumor progression and poor survival status in patients with gastrointestinal cancer. AEG-1 might play a vital role in promoting tumor aggression and could serve as a potential target for molecular treatments. Further clinical trials are needed to validate whether AEG-1 SI provides valuable insights into improving treatment decisions.	[Luo, Yihuan; Zhang, Xin; Tan, Zhong; Wu, Peirong; Xiang, Xuelian; Dang, Yiwu; Chen, Gang] Guangxi Med Univ, Affiliated Hosp 1, Dept Pathol, Nanning, Guangxi Zhuang, Peoples R China	Guangxi Medical University	Chen, G (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Pathol, Nanning, Guangxi Zhuang, Peoples R China.	chen_gang_triones@163.com	Zhang, Daniel Xin/L-5143-2019	Zhang, Daniel Xin/0000-0001-8561-6928	Fund of Guangxi Zhuang Autonomous Region University Student Innovative Plan [201410598003]; Guangxi Provincial Health Bureau Scientific Research Project [Z2014054]; Youth Science Foundation of Guangxi Medical University [GXMUYSF201311]; Guangxi University Science and Technology Research Projects [LX2014075]; Fund of National Natural Science Foundation of China [NSFC81360327]	Fund of Guangxi Zhuang Autonomous Region University Student Innovative Plan; Guangxi Provincial Health Bureau Scientific Research Project; Youth Science Foundation of Guangxi Medical University; Guangxi University Science and Technology Research Projects; Fund of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was partly supported by the Fund of Guangxi Zhuang Autonomous Region University Student Innovative Plan (No. 201410598003), Guangxi Provincial Health Bureau Scientific Research Project (Z2014054), Youth Science Foundation of Guangxi Medical University (GXMUYSF201311), Guangxi University Science and Technology Research Projects (LX2014075), and the Fund of National Natural Science Foundation of China (NSFC81360327). The funders had no role in study design, data collection and analysis, preparation of the manuscript, or decision to publish.	Ahn S, 2013, GUT LIVER, V7, P206, DOI 10.5009/gnl.2013.7.2.206; Britt DE, 2004, EXP CELL RES, V300, P134, DOI 10.1016/j.yexcr.2004.06.026; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Casimiro S, 2014, CLIN EXP METASTAS, V31, P689, DOI 10.1007/s10585-014-9659-0; [陈徐艰 Chen Xujian], 2013, [中华肝胆外科杂志, Chinese Journal of Hepatobiliary Surgery], V19, P597; Deng H, 2014, ONCOL LETT, V7, P101, DOI 10.3892/ol.2013.1645; Dong LP, 2015, TUMOR BIOL, V36, P2169, DOI 10.1007/s13277-014-2827-7; Emdad L, 2010, MOL CANCER THER, V9, P79, DOI 10.1158/1535-7163.MCT-09-0752; Emdad L, 2009, P NATL ACAD SCI USA, V106, P21300, DOI 10.1073/pnas.0910936106; Gnosa S, 2014, BRIT J CANCER, V111, P166, DOI 10.1038/bjc.2014.250; Gong ZB, 2012, ONCOL REP, V27, P2073, DOI 10.3892/or.2012.1749; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Huang WB, 2013, DIGEST DIS SCI, V58, P2873, DOI 10.1007/s10620-013-2735-5; Il Jung H, 2015, ANN SURG TREAT RES, V88, P77, DOI 10.4174/astr.2015.88.2.77; Jiang T, 2012, MED ONCOL, V29, P2858, DOI 10.1007/s12032-012-0186-z; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Lee SG, 2009, ONCOGENE, V28, P2476, DOI 10.1038/onc.2009.93; Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103; Li C, 2015, INT J BIOL MACROMOL, V75, P115, DOI 10.1016/j.ijbiomac.2015.01.016; Li GH, 2014, CANCER RES, V74, P5541, DOI 10.1158/0008-5472.CAN-14-0968; Li JM, 2015, CHIN J BASES CLIN GE, P597; [李琦 Li Qi], 2014, [中国肿瘤生物治疗杂志, Chinese Journal of Cancer Biotherapy], V21, P565; Li SH, 2014, ONCOL LETT, V7, P1447, DOI 10.3892/ol.2014.1950; Liu DC, 2013, DIAGN CYTOPATHOL, V41, P199, DOI 10.1002/dc.21821; Liu XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017582; Meng XB, 2013, ADV CANCER RES, V120, P135, DOI 10.1016/B978-0-12-401676-7.00005-X; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Nohata N, 2011, J HUM GENET, V56, P595, DOI 10.1038/jhg.2011.66; Rajasekaran D, 2015, BIOCONJUGATE CHEM, V26, P1651, DOI 10.1021/acs.bioconjchem.5b00254; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Sarkar D, 2013, ADV CANCER RES, V120, P39, DOI 10.1016/B978-0-12-401676-7.00002-4; Shi X, 2015, INT J CLIN EXP MED, V8, P4795; Song HT, 2010, INT J GYNECOL CANCER, V20, P1188, DOI 10.1111/IGC.0b013e3181ef8e21; Song HT, 2010, INT J COLORECTAL DIS, V25, P1201, DOI 10.1007/s00384-010-1009-3; Song LB, 2009, J PATHOL, V219, P317, DOI 10.1002/path.2595; Srivastava J, 2015, J BIOL CHEM, V290, P15549, DOI 10.1074/jbc.M115.649707; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Su ZZ, 2002, ONCOGENE, V21, P3592, DOI 10.1038/sj.onc.1205445; Sun W, 2011, ONCOL REP, V26, P1133, DOI 10.3892/or.2011.1387; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang B, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1438-z; Wang K, 2013, HEPATOLOGY, V58, P706, DOI 10.1002/hep.26402; Wang N, 2012, MOL BIOL REP, V39, P10497, DOI 10.1007/s11033-012-1933-0; Xu JB, 2011, MED ONCOL, V28, P455, DOI 10.1007/s12032-010-9475-6; Yang CC, 2015, TRANSL RES, V166, P614, DOI 10.1016/j.trsl.2015.05.004; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460; Yu CP, 2009, CARCINOGENESIS, V30, P894, DOI 10.1093/carcin/bgp064; Zhang Cai-feng, 2013, Zhonghua Zhong Liu Za Zhi, V35, P22, DOI 10.3760/cma.j.issn.0253-3766.2013.01.005; Zhang FF, 2013, MOL CARCINOGEN, V52, P603, DOI 10.1002/mc.21894; Zhao J, 2014, DNA CELL BIOL, V33, P715, DOI 10.1089/dna.2014.2376; Zhou ZZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100372	54	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145659	10.1371/journal.pone.0145659	http://dx.doi.org/10.1371/journal.pone.0145659			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710214	Green Submitted, gold, Green Published			2022-12-27	WOS:000367451400067
J	Rahman, SA; Adjeroh, D				Rahman, Syed Ashiqur; Adjeroh, Donald			Surface-Based Body Shape Index and Its Relationship with All-Cause Mortality	PLOS ONE			English	Article							TO-HEIGHT RATIO; MASS INDEX; WAIST CIRCUMFERENCE; FAT DISTRIBUTION; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CENTRAL OBESITY; SCREENING TOOL; WEIGHT-GAIN; MEN	Background Obesity is a global public health challenge. In the US, for instance, obesity prevalence remains high at more than one-third of the adult population, while over two-thirds are obese or overweight. Obesity is associated with various health problems, such as diabetes, cardiovascular diseases (CVDs), depression, some forms of cancer, sleep apnea, osteoarthritis, among others. The body mass index (BMI) is one of the best known measures of obesity. The BMI, however, has serious limitations, for instance, its inability to capture the distribution of lean mass and adipose tissue, which is a better predictor of diabetes and CVDs, and its curved ("U-shaped") relationship with mortality hazard. Other anthropometric measures and their relation to obesity have been studied, each with its advantages and limitations. In this work, we introduce a new anthropometric measure (called Surface-based Body Shape Index, SBSI) that accounts for both body shape and body size, and evaluate its performance as a predictor of all-cause mortality. Methods and Findings We analyzed data on 11,808 subjects (ages 18-85), from the National Health and Human Nutrition Examination Survey (NHANES) 1999-2004, with 8-year mortality follow up. Based on the analysis, we introduce a new body shape index constructed from four important anthropometric determinants of body shape and body size: body surface area (BSA), vertical trunk circumference (VTC), height (H) and waist circumference (WC). The surface-based body shape index (SBSI) is defined as follows: SBSI = (H-7/4) (WC5/6)/BSA VTC (1) SBSI has negative correlation with BMI and weight respectively, no correlation with WC, and shows a generally linear relationship with age. Results on mortality hazard prediction using both the Cox proportionality model, and Kaplan-Meier curves each show that SBSI outperforms currently popular body shape indices (e.g., BMI, WC, waist-to-height ratio (WHtR), waist-to-hip ratio (WHR), A Body Shape Index (ABSI)) in predicting all-cause mortality. Conclusions We combine measures of both body shape and body size to construct a novel anthropometric measure, the surface-based body shape index (SBSI). SBSI is generally linear with age, and increases with increasing mortality, when compared with other popular anthropometric indices of body shape.	[Rahman, Syed Ashiqur; Adjeroh, Donald] W Virginia Univ, Lane Dept Comp Sci & Elect Engn, Morgantown, WV 26506 USA	West Virginia University	Rahman, SA (corresponding author), W Virginia Univ, Lane Dept Comp Sci & Elect Engn, Morgantown, WV 26506 USA.	srahman2@mix.wvu.edu; don@csee.wvu.edu						Adjeroh D, 2010, P 2010 IEEE INT WORK, P1; Allison DB, 1997, AM J EPIDEMIOL, V146, P339, DOI 10.1093/oxfordjournals.aje.a009275; Allison DB, 2002, INT J OBESITY, V26, P410, DOI 10.1038/sj.ijo.0801925; [Anonymous], 2011, IEEE C DEC CONTR EUR; ASHWELL M, 1985, BRIT MED J, V290, P1692, DOI 10.1136/bmj.290.6483.1692; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Bigaard J, 2004, OBES RES, V12, P1042, DOI 10.1038/oby.2004.131; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Cox D. R., 1984, ANAL SURVIVAL DATA, V21; Daniell N, 2012, AM J PHYS ANTHROPOL, V148, P148, DOI 10.1002/ajpa.22051; Deng Cao, 2012, 2012 IEEE Fifth International Conference On Biometrics: Theory, Applications And Systems (BTAS 2012), P162, DOI 10.1109/BTAS.2012.6374572; Doehner W, 2009, EUROPEAN HEART J; Eckel RH, 1998, CIRCULATION, V97, P2099, DOI 10.1161/01.CIR.97.21.2099; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Gallicchio L, 2007, CANCER DETECT PREV, V31, P95, DOI 10.1016/j.cdp.2007.02.004; Han TS, 1997, INT J OBESITY, V21, P587, DOI 10.1038/sj.ijo.0800446; He S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050573; Hsieh SD, 2003, INT J OBESITY, V27, P610, DOI 10.1038/sj.ijo.0802259; Janssen I, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2006.00248.x; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Kanaya AM, 2003, AM J EPIDEMIOL, V158, P1161, DOI 10.1093/aje/kwg271; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Lainscak M, 2012, J CACHEXIA SARCOPENI, V3, P1, DOI 10.1007/s13539-012-0059-5; LEW EA, 1979, J CHRON DIS, V32, P563, DOI 10.1016/0021-9681(79)90119-X; Li WC, 2013, EUR J NUTR, V52, P57, DOI 10.1007/s00394-011-0286-0; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Morkedal B, 2011, EUR J EPIDEMIOL, V26, P457, DOI 10.1007/s10654-011-9572-7; National Center for Health Statistics (NCHS), 2011, NAT HLTH NUTR EX SUR; NCHS, 2006, TECHNICAL REPORT; NHANES, 2002, TECHNICAL REPORT; Ogden CL, 2012, PREVALENCE OBESITY U; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ohrvall M, 2000, INT J OBESITY, V24, P497, DOI 10.1038/sj.ijo.0801186; Onat A, 2009, CLIN NUTR, V28, P46, DOI 10.1016/j.clnu.2008.10.006; Padwal RS, 2011, CAN MED ASSOC J, V183, pE1059, DOI 10.1503/cmaj.110387; Petursson H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026621; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Racette SB, 2003, PHYS THER, V83, P276, DOI 10.1093/ptj/83.3.276; Raghuveer G, 2010, AM J CLIN NUTR, V91, p1514S, DOI 10.3945/ajcn.2010.28701D; Robinette K. M., 1999, Second International Conference on 3-D Digital Imaging and Modeling (Cat. No.PR00062), P380, DOI 10.1109/IM.1999.805368; Romero-Corral A, 2008, OBESITY, V16, pS124; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Shuter B, 2000, EUR J APPL PHYSIOL, V82, P250, DOI 10.1007/s004210050679; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; Tahrani A, 2008, BODY VOLUME INDEX TI; Treleaven P, 2007, COMPUTER, V40, P28, DOI 10.1109/MC.2007.225; Wells JCK, 2007, AM J CLIN NUTR, V85, P419, DOI 10.1093/ajcn/85.2.419; World Health Organization, 2000, WHO TECHN REP SER, P894; Yu CY, 2010, BURNS, V36, P616, DOI 10.1016/j.burns.2009.05.013; Zhang ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070893	62	25	26	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144639	10.1371/journal.pone.0144639	http://dx.doi.org/10.1371/journal.pone.0144639			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709925	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400008
J	Sekhar, S; Gharat, SA; Panda, BB; Mohaptra, T; Das, K; Kariali, E; Mohapatra, PK; Shaw, BP				Sekhar, Sudhanshu; Gharat, Sachin Ashruba; Panda, Binay Bhushan; Mohaptra, Trupti; Das, Kaushik; Kariali, Ekamber; Mohapatra, Pravat Kumar; Shaw, Birendra Prasad			Identification and Characterization of Differentially Expressed Genes in Inferior and Superior Spikelets of Rice Cultivars with Contrasting Panicle-Compactness and Grain-Filling Properties	PLOS ONE			English	Article							ENDOSPERM; GROWTH; RISBZ1; PROGRESS; REVEALS; RPBF	Breeding programs for increasing spikelet number in rice have resulted in compactness of the panicle, accompanied by poor grain filling in inferior spikelets. Although the inefficient utilization of assimilate has been indicated as responsible for this poor grain filling, the underlying cause remains elusive. The current study utilized the suppression subtractive hybridization technique to identify 57 and 79 genes that overexpressed in the superior and inferior spikelets (with respect to each other), respectively, of the compact-panicle rice cultivar Mahalaxmi. Functional categorization of these differentially expressed genes revealed a marked metabolic difference between the spikelets according to their spatial location on the panicle. The expression of genes encoding seed storage proteins was dominant in inferior spikelets, whereas genes encoding regulatory proteins, such as serine- threonine kinase, zinc finger protein and E3 ligase, were highly expressed in superior spikelets. The expression patterns of these genes in the inferior and superior spikelets of Mahalaxmi were similar to those observed in another compact-panicle cultivar, OR-1918, but differed from those obtained in two lax-panicle cultivars, Upahar and Lalat. The results first suggest that the regulatory proteins abundantly expressed in the superior spikelets of compact-panicle cultivars and in both the superior and inferior spikelets of lax-panicle cultivars but poorly expressed in the inferior spikelets of compact-panicle cultivars promote grain filling. Second, the high expression of seed-storage proteins observed in the inferior spikelets of compact-panicle cultivars appears to inhibit the grain filling process. Third, the low expression of enzymes of the Krebs cycle in inferior spikelets compared with superior spikelets of compact-panicle cultivars is bound to lead to poor ATP generation in the former and consequently limit starch biosynthesis, an ATP-consuming process, resulting in poor grain filling.	[Sekhar, Sudhanshu; Gharat, Sachin Ashruba; Panda, Binay Bhushan; Mohaptra, Trupti; Das, Kaushik; Shaw, Birendra Prasad] Inst Life Sci, Environm Biotechnol Lab, Bhubaneswar, Orissa, India; [Kariali, Ekamber; Mohapatra, Pravat Kumar] Sambalpur Univ, Sch Life Sci, Sambalpur, Odisha, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Sambalpur University	Shaw, BP (corresponding author), Inst Life Sci, Environm Biotechnol Lab, Bhubaneswar, Orissa, India.	bpshaw@ils.res.in	Shaw, Birendra Prasad/AAU-1232-2020	Shaw, Birendra Prasad/0000-0003-0541-3296; SEKHAR, SUDHANSHU/0000-0003-2045-4520; Gharat, Sachin Ashruba/0000-0002-2888-6371	Department of Biotechnology, Ministry of Science and Technology [BT/PR-10975/AGR/02/619/2008]	Department of Biotechnology, Ministry of Science and Technology	This work was supported by BT/PR-10975/AGR/02/619/2008, from the Department of Biotechnology, Ministry of Science and Technology, http://www.dbtindia.nic.in, to BPS and PKM.	Araujo WL, 2008, PLANT PHYSIOL, V148, P1782, DOI 10.1104/pp.108.126219; Duan MJ, 2005, PLANT MOL BIOL, V59, P165, DOI 10.1007/s11103-004-7507-3; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; Gupta M., 2014, SYNTH LECT DATA MIN, V5, P1, DOI DOI 10.2200/S00573ED1V01Y201403DMK008; Kang BH, 2009, PLANT PHYSIOL, V151, P1366, DOI 10.1104/pp.109.142331; Kato T, 2004, J AGR SCI, V142, P177, DOI 10.1017/S0021859604004265; Kawakatsu T, 2009, PLANT J, V59, P908, DOI 10.1111/j.1365-313X.2009.03925.x; Khush G, 2003, NUTR REV, V61, pS114, DOI 10.1301/nr.2003.jun.S114-S116; Khush GS, 1996, INCREASING YIELD POT, P36; Kobayashi H, 2013, PLANTA, V237, P1393, DOI 10.1007/s00425-013-1854-8; Liu XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-730; Mohapatra PK, 2009, PLANT SCI, V176, P256, DOI 10.1016/j.plantsci.2008.11.001; Mohapatra PK, 2004, FUNCT PLANT BIOL, V31, P131, DOI 10.1071/FP03177; Mohapatra PK, 2000, AUST J PLANT PHYSIOL, V27, P311, DOI 10.1071/PP99057; Mohapatra PK, 2011, ADV AGRON, V110, P333, DOI 10.1016/B978-0-12-385531-2.00005-0; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Onodera Y, 2001, J BIOL CHEM, V276, P14139, DOI 10.1074/jbc.M007405200; OPARKA KJ, 1981, PLANT CELL ENVIRON, V4, P355, DOI 10.1111/j.1365-3040.1981.tb02112.x; Panda BB, 2015, FUNCT PLANT BIOL, V42, P875, DOI 10.1071/FP14363; Panda B, 2009, PLANT GROWTH REGUL, V58, P141, DOI 10.1007/s10725-009-9362-3; Peng SB, 2008, FIELD CROP RES, V108, P32, DOI 10.1016/j.fcr.2008.04.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sahu BB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-69; Santos L., 2006, ADV AGRIL FOOD BIOTE, V37, P1; Tichtinsky G, 1998, BBA-GENE STRUCT EXPR, V1442, P261, DOI 10.1016/S0167-4781(98)00187-0; UMEMOTO T, 1994, PHYTOCHEMISTRY, V36, P843, DOI 10.1016/S0031-9422(00)90448-5; United Nations. Department of Economic and Social Affairs P. D., 2012, ESAPWP228; Virk P. S., 2004, International Rice Research Notes, V29, P5; Wang F, 2008, J SCI FOOD AGR, V88, P897, DOI 10.1002/jsfa.3167; YAMAGATA H, 1982, PLANT PHYSIOL, V70, P1094, DOI 10.1104/pp.70.4.1094; Yamamoto MP, 2006, PLANT PHYSIOL, V141, P1694, DOI 10.1104/pp.106.082826; YAMAMOTO Y, 1991, JPN J CROP SCI, V60, P365, DOI 10.1626/jcs.60.365; Yang JC, 2006, J EXP BOT, V57, P149, DOI 10.1093/jxb/erj018; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; Zhang ZX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100416, 10.1371/journal.pone.0089140, 10.1371/journal.pone.0099511]	36	15	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145749	10.1371/journal.pone.0145749	http://dx.doi.org/10.1371/journal.pone.0145749			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710230	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400075
J	Larkin, J; Hatswell, AJ; Nathan, P; Lebmeier, M; Lee, D				Larkin, James; Hatswell, Anthony J.; Nathan, Paul; Lebmeier, Maximilian; Lee, Dawn			The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UK	PLOS ONE			English	Article							OPEN-LABEL; FOLLOW-UP; VEMURAFENIB; BLOCKADE; MUTATION; PHASE-3	Background Evaluating long-term prognosis is important for physicians, patients and payers. This study reports the results of a model developed to predict long-term survival for UK patients receiving second-line ipilimumab. Methods MDX010-20 trial data were used to predict survival for ipilimumab versus UK best supportive care. Two aspects of this analysis required novel approaches: 1) The overall survival Kaplan-Meier data shape is unusual: an initial steep decline is observed before a 'plateau'. 2) The need to extrapolate beyond the trial end (4.6 years). Based upon UK clinician advice, a three-part curve fit was used: from 0-1.5 years, Kaplan-Meier data from the trial; from 1.5-5 years, standard parametric curve fits; after 5 years, long-term data from the American Joint Committee on Cancer registry. Results This approach provided good internal validity: low mean absolute error and good match to median and mean trial data. Lifetime predicted means were 2.77 years for ipilimumab and 1.07 for best supportive care, driven by increased long-term survival with ipilimumab. Conclusion To understand the full benefit of treatment and to meet reimbursement requirements, accurate estimation of treatment benefit is key. Models, such as the one presented, can be used to extrapolate beyond trials.	[Larkin, James] Royal Marsden Fdn NHS Trust, London SW3 6JJ, England; [Hatswell, Anthony J.; Lee, Dawn] BresMed, Sheffield S1 2DW, S Yorkshire, England; [Nathan, Paul] Mt Vernon Canc Ctr, Northwood HA6 2RN, Middx, England; [Lebmeier, Maximilian] Bristol Myers Squibb Pharmaceut Ltd, Uxbridge UB8 1DH, Middx, England	Royal Marsden NHS Foundation Trust; Mount Vernon Cancer Centre; Bristol-Myers Squibb	Lee, D (corresponding author), BresMed, 84 Queen St, Sheffield S1 2DW, S Yorkshire, England.	dlee@bresmed.co.uk	lee, dawn/GRJ-7459-2022	Larkin, James/0000-0001-5569-9523; Hatswell, Anthony/0000-0003-1129-326X; Nathan, Paul/0000-0002-2327-3250; Lebmeier, Maximilian/0000-0002-5343-0122	Bristol-Myers Squibb Pharmaceuticals Limited	Bristol-Myers Squibb Pharmaceuticals Limited	Financial support for this study was provided by Bristol-Myers Squibb Pharmaceuticals Limited. The author Maximillian Lebmeier, who was employed by the sponsor at the time, was responsible for data acquisition, coordination of the analysis and review of the manuscript for content.	Annemans L, 2012, ISPOR CONNECTIONS, V18, P5; Ascierto PA, 2014, CANCER-AM CANCER SOC, V120, P1617, DOI 10.1002/cncr.28622; Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Bhatia S, 2014, LANCET, V384, P1078, DOI 10.1016/S0140-6736(14)61140-5; Buxton MJ, 1997, HEALTH ECON, V6, P217, DOI 10.1002/(SICI)1099-1050(199705)6:3<217::AID-HEC267>3.0.CO;2-W; Cancer Research UK, 2014, SKIN CANC CANC STAT; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Collinson FJ, NAT CANC RES I C; Gogas HJ, 2007, CANCER-AM CANCER SOC, V109, P455, DOI 10.1002/cncr.22427; Hauschild A, 2013, 10 INT M SOC MEL RES; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Jang S, 2013, LANCET ONCOL, V14, pE60, DOI 10.1016/S1470-2045(12)70539-9; Johnson DB, 2013, CURR TREAT OPTION ON, V14, P280, DOI 10.1007/s11864-013-0226-8; Korn EL, 2008, J CLIN ONCOL, V26, P527, DOI 10.1200/JCO.2007.12.7837; Kotapati S, 2011, AM SOC CLIN ONC 47 A; Latimer N., 14 NICE DSU; Livingstone E, 2010, EXPERT OPIN INV DRUG, V19, P1439, DOI 10.1517/13543784.2010.527945; Lorigan P, 2014, BRIT J DERMATOL, V170, P87, DOI 10.1111/bjd.12503; McArthur GA, 2014, LANCET ONCOL, V15, P323, DOI 10.1016/S1470-2045(14)70012-9; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; National Institute for Health and Care Excellence (NICE), 2014, TA319 MEL STAG 3 4 I; National Institute for Health and Clinical Excellence (NICE), TA268 MEL STAG 3 4 I; National Institute for Health and Clinical Excellence (NICE), TA343 MEL STAG 3 4 D; National Institute for Health and Clinical Excellence (NICE), TA269 MEL STAG 3 4 V; Office for National Statistics, 2010, INT LIF TABL; Prieto PA, 2012, CLIN CANCER RES, V18, P2039, DOI 10.1158/1078-0432.CCR-11-1823; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Salama AKS, 2011, CLIN CANCER RES, V17, P4622, DOI 10.1158/1078-0432.CCR-10-2232; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736	30	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145524	10.1371/journal.pone.0145524	http://dx.doi.org/10.1371/journal.pone.0145524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700304	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092600092
J	Trampe, D; Quoidbach, J; Taquet, M				Trampe, Debra; Quoidbach, Jordi; Taquet, Maxime			Emotions in Everyday Life	PLOS ONE			English	Article							CIRCUMPLEX MODEL; EXPERIENCE; SELF	Despite decades of research establishing the causes and consequences of emotions in the laboratory, we know surprisingly little about emotions in everyday life. We developed a smartphone application that monitored real-time emotions of an exceptionally large (N = 11,000+) and heterogeneous participants sample. People's everyday life seems profoundly emotional: participants experienced at least one emotion 90% of the time. The most frequent emotion was joy, followed by love and anxiety. People experienced positive emotions 2.5 times more often than negative emotions, but also experienced positive and negative emotions simultaneously relatively frequently. We also characterized the interconnections between people's emotions using network analysis. This novel approach to emotion research suggests that specific emotions can fall into the following categories 1) connector emotions (e.g., joy), which stimulate same valence emotions while inhibiting opposite valence emotions, 2) provincial emotions (e.g., gratitude), which stimulate same valence emotions only, or 3) distal emotions (e.g., embarrassment), which have little interaction with other emotions and are typically experienced in isolation. Providing both basic foundations and novel tools to the study of emotions in everyday life, these findings demonstrate that emotions are ubiquitous to life and can exist together and distinctly, which has important implications for both emotional interventions and theory.	[Trampe, Debra] Univ Groningen, Fac Econ & Business, Dept Mkt, Groningen, Netherlands; [Quoidbach, Jordi] Pompeu Fabra Univ, Dept Econ & Business, Barcelona, Spain; [Taquet, Maxime] Harvard Univ, Sch Med, Computat Radiol Lab, Boston Childrens Hosp, Boston, MA USA	University of Groningen; Pompeu Fabra University; Harvard University; Boston Children's Hospital; Harvard Medical School	Quoidbach, J (corresponding author), Pompeu Fabra Univ, Dept Econ & Business, Barcelona, Spain.	Jordi.quoidbach@upf.edu		Taquet, Maxime/0000-0002-8987-952X	Barcelona School of Management; Spanish Ministry of Science and Education [PSI2013-41909-P]; Helaers Foundation	Barcelona School of Management; Spanish Ministry of Science and Education(Spanish Government); Helaers Foundation	JQ was supported by the Barcelona School of Management and grant PSI2013-41909-P from the Spanish Ministry of Science and Education. MT was supported by the Helaers Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Jennifer Jordan, Yating Le, Hans Risselada, Yves-Alexandre de Monjoye, and Martin Desseilles for their help during various stages of the research. JQ was supported by the Barcelona School of Management and grant PSI2013-41909-P from the Spanish Ministry of Science and Education. MT was supported by the Helaers Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	aan het Rot M, 2012, CLIN PSYCHOL REV, V32, P510, DOI 10.1016/j.cpr.2012.05.007; Barrett LF, 2000, PERS SOC PSYCHOL B, V26, P1027, DOI 10.1177/01461672002611001; Barrett LF, 2001, COGNITION EMOTION, V15, P713, DOI 10.1080/02699930143000239; Barrett LF, 2006, PERSPECT PSYCHOL SCI, V1, P28, DOI 10.1111/j.1745-6916.2006.00003.x; BERKOWITZ L, 1990, AM PSYCHOL, V45, P494, DOI 10.1037/0003-066X.45.4.494; Bigot R., 2013, DIFFUSION TECHNOLOGI; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; CHAIKEN S, 1989, P212; Diener E, 2014, PERS SOC PSYCHOL REV, P1; Emmons RA, 2003, J PERS SOC PSYCHOL, V84, P377, DOI 10.1037/0022-3514.84.2.377; FORGAS JP, 1995, PSYCHOL BULL, V117, P39, DOI 10.1037/0033-2909.117.1.39; Fredrickson B., 2013, LOVE 2 0 CREATING HA; Fredrickson BL, 2003, J PERS SOC PSYCHOL, V84, P365, DOI 10.1037/0022-3514.84.2.365; Frijda N. H., 1986, EMOTIONS STUDIES EMO; Heiy JE, 2014, EMOTION, V14, P878, DOI 10.1037/a0037231; Hutcherson CA, 2008, EMOTION, V8, P720, DOI 10.1037/a0013237; Izard C. E., 1977, HUMAN EMOTIONS; Larsen JT, 2011, J PERS SOC PSYCHOL, V100, P1095, DOI 10.1037/a0021846; Lerner J. S., 2015, PSYCHOLOGY, P66; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; PHILIPPOT P, 1993, COGNITION EMOTION, V7, P171, DOI 10.1080/02699939308409183; Philippot P, 2003, EMOTION, V3, P270, DOI 10.1037/1528-3542.3.3.270; Quoidbach J, 2014, J EXP PSYCHOL GEN, V143, P2057, DOI 10.1037/a0038025; Remington NA, 2000, J PERS SOC PSYCHOL, V79, P286, DOI 10.1037//0022-3514.79.2.286; Rudd M, 2012, PSYCHOL SCI, V23, P1130, DOI 10.1177/0956797612438731; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schaefer A, 2010, COGNITION EMOTION, V24, P1153, DOI 10.1080/02699930903274322; SCHLOSBERG H, 1952, J EXP PSYCHOL, V44, P229, DOI 10.1037/h0055778; SMITH CA, 1993, COGNITION EMOTION, V7, P233, DOI 10.1080/02699939308409189; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Tichy N. M., 1979, ACAD MANAGE REV, V4, P507, DOI [10.5465/AMR.1979.4498309, DOI 10.5465/AMR.1979.4498309]; Tugade MM, 2004, J PERS, V72, P1161, DOI 10.1111/j.1467-6494.2004.00294.x; van den Heuvel MP, 2013, J NEUROSCI, V33, P14489, DOI 10.1523/JNEUROSCI.2128-13.2013; Vansteelandt K, 2005, J RES PERS, V39, P325, DOI 10.1016/j.jrp.2004.05.006; Weis R, 2011, PSYCHOL WELL-BEING, V1, DOI 10.1186/2211-1522-1-5; Wood AM, 2010, CLIN PSYCHOL REV, V30, P890, DOI 10.1016/j.cpr.2010.03.005; Youngstrom EA, 2003, EDUC PSYCHOL MEAS, V63, P279, DOI 10.1177/0013164403253226; Zelenski JM, 2000, J RES PERS, V34, P178, DOI 10.1006/jrpe.1999.2275	39	73	74	10	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145450	10.1371/journal.pone.0145450	http://dx.doi.org/10.1371/journal.pone.0145450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26698124	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600081
J	Zostautiene, I; Jorde, R; Schirmer, H; Mathiesen, EB; Njolstad, I; Lochen, ML; Wilsgaard, T; Joakimsen, RM; Kamycheva, E				Zostautiene, Ieva; Jorde, Rolf; Schirmer, Henrik; Mathiesen, Ellisiv Bogeberg; Njolstad, Inger; Lochen, Maja-Lisa; Wilsgaard, Tom; Joakimsen, Ragnar Martin; Kamycheva, Elena			Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromso Study	PLOS ONE			English	Article							25-HYDROXYVITAMIN D LEVELS; CORONARY-ARTERY-DISEASE; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; GENERAL-POPULATION; RISK-FACTORS; CANCER-RISK; VDR GENE; POLYMORPHISMS; OUTCOMES	Background Though the associations between low serum 25-hydroxyvitamin D (25(OH) D) levels and health outcomes such as type 2 diabetes (T2D), myocardial infarction (MI), cancer, and mortality are well-studied, the effect of supplementation with vitamin D is uncertain. This may be related to genetic differences. Thus, rs7968585, a single nucleotide polymorphism (SNP) of the vitamin D receptor (VDR), has recently been reported as a predictor of composite health outcome. We therefore aimed to evaluate whether rs7968585 predicts separate clinical outcomes such as T2D, MI, cancer, and mortality in a community-based Norwegian population. Methods and Findings Measurements and DNA were obtained from the participants in the Tromso Study in 1994-1995, registered with the outcomes of interest and a randomly selected control group. The impact of the rs7968585 genotypes was evaluated with Cox proportional hazards. A total of 8,461 subjects were included among whom 1,054 subjects were registered with T2D, 2,287 with MI, 3,166 with cancer, and 4,336 with death. Mean follow-up time from birth was 60.8 years for T2D and MI, 61.2 years for cancer, while mean follow-up time from examination date was 16.5 years for survival. Mean serum 25(OH) D levels did not differ across the rs7968585 genotypes. With the major homozygote genotype as reference, the minor homozygote subjects had hazard ratios of 1.25 (95% CI 1.05-1.49) for T2D and 1.14 (1.02-1.28) for MI (P = 0.011 and 0.023, respectively, without the Bonferroni correction). No significant interaction between serum 25(OH) D status and the rs7968585 genotype was found for any of the endpoints. Conclusions The VDR-related SNP rs7968585 minor allele is a significant and positive predictor for T2D and possibly for MI. Since the functional mechanism of this SNP is not yet understood, and the association with T2D is reported for the first time, confirmatory studies are needed.	[Zostautiene, Ieva; Jorde, Rolf; Joakimsen, Ragnar Martin; Kamycheva, Elena] UiT, Dept Clin Med, Tromso Endocrine Res Grp, Tromso, Norway; [Zostautiene, Ieva; Jorde, Rolf; Joakimsen, Ragnar Martin; Kamycheva, Elena] Univ Hosp North Norway, Div Internal Med, Tromso, Norway; [Schirmer, Henrik] UiT, Dept Clin Med, Tromso, Norway; [Schirmer, Henrik] Univ Hosp North Norway, Div Cardiothorac & Resp Med, Tromso, Norway; [Mathiesen, Ellisiv Bogeberg] UiT, Dept Clin Med, Brain & Circulat Res Grp, Tromso, Norway; [Mathiesen, Ellisiv Bogeberg] Univ Hosp North Norway, Dept Neurol & Neurophysiol, Tromso, Norway; [Njolstad, Inger; Lochen, Maja-Lisa; Wilsgaard, Tom] UiT, Dept Community Med, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Zostautiene, I (corresponding author), UiT, Dept Clin Med, Tromso Endocrine Res Grp, Tromso, Norway.	ieva.zostautiene@unn.no	Njolstad, Inger/X-3784-2019	Lochen, Maja-Lisa/0000-0002-8532-6573; Kamycheva, Elena/0000-0003-0642-5125; Schirmer, Henrik/0000-0002-9348-3149; Joakimsen, Ragnar Martin/0000-0002-2125-8081	Northern Norway Regional Health Authority [SFP1215-14]; Research Council of Norway [213787]	Northern Norway Regional Health Authority; Research Council of Norway(Research Council of Norway)	The authors are indebted to the Norwegian Insitute of Public Health for their participation in collection of data in the fourth survey of the Tromso Study (http://www.fhi.no/artikler/?id=28291), The Northern Norway Regional Health Authority (http://www.helse-nord.no/about-helse-nord/category5770.html; IZ grant No. SFP1215-14), and The Research Council of Norway (https://www.forskningsradet.no/prosjektbanken/#!/project/213787/no; RJ grant 213787). The funding institutions had no role in study design, data analysis and interpretation, decision to publish, or preparation of the manuscript.	Ahn J, 2009, CARCINOGENESIS, V30, P769, DOI 10.1093/carcin/bgp055; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; Barry EL, 2014, J CLIN ENDOCR METAB, V99, pE2133, DOI 10.1210/jc.2014-1389; Berntsen GKR, 2001, AM J EPIDEMIOL, V153, P465; Borch KH, 2009, J THROMB HAEMOST, V7, P739, DOI 10.1111/j.1538-7836.2008.03234.x; Buttigliero C, 2011, ONCOLOGIST, V16, P1215, DOI 10.1634/theoncologist.2011-0098; Chen S, 2008, HYPERTENSION, V52, P1106, DOI 10.1161/HYPERTENSIONAHA.108.119602; CHESKIS B, 1994, MOL CELL BIOL, V14, P3329, DOI 10.1128/MCB.14.5.3329; Chuang JC, 2008, MOL ENDOCRINOL, V22, P2353, DOI 10.1210/me.2007-0568; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Evans A, 2005, INT J EPIDEMIOL, V34, P21, DOI 10.1093/ije/dyh327; Ferrarezi DAF, 2013, DIABETES METAB, V39, P263, DOI 10.1016/j.diabet.2012.11.004; Gandini Sara, 2014, Adv Exp Med Biol, V810, P69; Gangula Pandu R, 2013, Front Biosci (Schol Ed), V5, P134; Gardner DG, 2013, AM J PHYSIOL-REG I, V305, pR969, DOI 10.1152/ajpregu.00322.2013; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Grimnes G, 2010, EUR J ENDOCRINOL, V163, P339, DOI 10.1530/EJE-10-0150; Hansen CM, 2001, FRONT BIOSCI-LANDMRK, V6, pD820, DOI 10.2741/Hansen; Hossein-nezhad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058725; Hutchinson MS, 2011, SCAND J CLIN LAB INV, V71, P399, DOI 10.3109/00365513.2011.575235; Hutchinson MS, 2010, EUR J ENDOCRINOL, V162, P935, DOI 10.1530/EJE-09-1041; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jorde R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037295; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Joseph J, 2010, SCAND J PUBLIC HEALT, V38, P768, DOI 10.1177/1403494810380299; Kostner K, 2009, ANTICANCER RES, V29, P3511; Kulathinal S, 2007, PROJECT EPIDEMIOLOGI, V4, P15, DOI DOI 10.1186/1742-5573-4-15; Levin GP, 2012, JAMA-J AM MED ASSOC, V308, P1898, DOI 10.1001/jama.2012.17304; Li L, 2013, ARCH MED RES, V44, P235, DOI 10.1016/j.arcmed.2013.02.002; Mannsverk J, 2012, EUR J PREV CARDIOL, V19, P927, DOI 10.1177/1741826711421081; Ortlepp JR, 2005, INT J CARDIOL, V105, P90, DOI 10.1016/j.ijcard.2005.03.004; Perna L, 2013, CANCER EPIDEMIOL, V37, P905, DOI 10.1016/j.canep.2013.09.007; Pescador N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077251; Pilz S, 2013, CURR DIABETES REP, V13, P261, DOI 10.1007/s11892-012-0358-4; Pludowski P, 2013, AUTOIMMUN REV, V12, P976, DOI 10.1016/j.autrev.2013.02.004; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Saccone D, 2015, GENE, V561, P171, DOI 10.1016/j.gene.2015.02.024; Schottker B, 2013, AM J CLIN NUTR, V97, P782, DOI 10.3945/ajcn.112.047712; Slattery ML, 2007, CANCER EPIDEM BIOMAR, V16, P2752, DOI 10.1158/1055-9965.EPI-07-2611; THELLE DS, 1976, ACTA MED SCAND, V200, P107; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Vaidya A, 2011, CLIN ENDOCRINOL, V74, P783, DOI 10.1111/j.1365-2265.2011.03991.x; Van Belle TL, 2013, TRENDS ENDOCRIN MET, V24, P561, DOI 10.1016/j.tem.2013.07.002; Van Schooten FJ, 1998, FASEB J, V12, P1409, DOI 10.1096/fasebj.12.13.1409; Vimaleswaran KS, 2014, DIABETES METAB, V40, P386, DOI 10.1016/j.diabet.2014.01.003; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Xu YQ, 2014, TUMOR BIOL, V35, P4153, DOI 10.1007/s13277-013-1544-y	48	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145359	10.1371/journal.pone.0145359	http://dx.doi.org/10.1371/journal.pone.0145359			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699871	Green Published, gold			2022-12-27	WOS:000367092600069
J	Cao, WL; Li, LN; Tran, B; Kajiura, S; Amoh, Y; Liu, F; Hoffman, RM				Cao, Wenluo; Li, Lingna; Tran, Benjamin; Kajiura, Satoshi; Amoh, Yasuyuki; Liu, Fang; Hoffman, Robert M.			Extensive Hair Shaft Growth after Mouse Whisker Follicle Isolation, Cryopreservation and Transplantation in Nude Mice	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; PERIPHERAL-NERVE INJURY; DERMAL PAPILLA; PROMOTE REGENERATION; PROGENITOR CELLS; HFPS CELLS; REPAIR; RECOVERY; SHEATH	We previously demonstrated that whole hair follicles could be cryopreserved to maintain their stem-cells differentation potential. In the present study, we demonstrated that cryopreserved mouse whisker hair follicles maintain their hair growth potential. DMSO better cryopreserved mouse whisker follicles compared to glycerol. Cryopreserved hair follicles also maintained the hair follicle-associated-pluripotent (HAP) stem cells, evidenced by p75(NTR) expression. Subcutaneous transplantation of DMSO-cryopreserved hair follicles in nude mice resulted in extensive hair fiber growth over 8 weeks, indicating the functional recovery of hair shaft growth of cryopreserved hair follicles.	[Cao, Wenluo; Li, Lingna; Tran, Benjamin; Kajiura, Satoshi; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Cao, Wenluo; Kajiura, Satoshi; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Cao, Wenluo; Liu, Fang] Second Mil Med Univ, Dept Anat, Shanghai 200433, Peoples R China; [Kajiura, Satoshi; Amoh, Yasuyuki] Kitasato Univ, Dept Dermatol, Sagamihara 2288555, Japan	Anti Cancer Inc; University of California System; University of California San Diego; Naval Medical University; Kitasato University	Amoh, Y (corresponding author), Kitasato Univ, Dept Dermatol, Sagamihara 2288555, Japan.	yasuyukiamoh@yahoo.co.jp; liu_fang403@163.com; all@anticancer.com			National Institute of Neurological Disorders and Stroke [NS086217]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R43NS086217] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institute of Neurological Disorders and Stroke grant NS086217. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Lingna Li is an employee of AntiCancer Inc. Wenluo Cao, Satoshi Kajiura and Robert M. Hoffman are unpaid affiliates of AntiCancer Inc. Benjamin Tran, Yasuyuki Amoh and Fang Liu were former unpaid affiliates of AntiCancer Inc. Robert M. Hoffman is a PLOS ONE Editorial Board Member. Anti Cancer Inc. markets animal models of cancer. There are no other competing interests. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. This does not alter the authors' adherence to PLOS ONE Editorial policies and criteria.	Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102; Amoh Y, 2008, CELL CYCLE, V7, P1865, DOI 10.4161/cc.7.12.6056; Amoh Y, 2012, J DERMATOL, V39, P33, DOI 10.1111/j.1346-8138.2011.01413.x; Amoh Y, 2010, J CELL BIOCHEM, V110, P272, DOI 10.1002/jcb.22534; Amoh Y, 2009, J CELL BIOCHEM, V107, P1016, DOI 10.1002/jcb.22204; Duong J, 2012, IN VITRO CELL DEV-AN, V48, P301, DOI 10.1007/s11626-012-9514-z; Hiroshima Y, 2014, J SURG RES, V187, P510, DOI 10.1016/j.jss.2013.11.1083; Hoffman RM, 2014, CELLS TISSUES ORGANS, V200, P42, DOI 10.1159/000366098; JAHODA CAB, 1984, NATURE, V311, P560, DOI 10.1038/311560a0; Kajiura S, 2015, TISSUE ENG PART C-ME, V21, P825, DOI [10.1089/ten.tec.2014.0500, 10.1089/ten.TEC.2014.0500]; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Liu F, 2011, CELL CYCLE, V10, P830, DOI 10.4161/cc.10.5.14969; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mii S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067153; Mii S, 2013, J CELL BIOCHEM, V114, P1674, DOI 10.1002/jcb.24509; Rahmani W, 2014, DEV CELL, V31, P543, DOI 10.1016/j.devcel.2014.10.022; Yashiro M, 2015, CELL CYCLE, V14, P2362, DOI 10.1080/15384101.2015.1042633	18	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145997	10.1371/journal.pone.0145997	http://dx.doi.org/10.1371/journal.pone.0145997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716690	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500112
J	Chung, BH; Kim, KW; Kim, BM; Doh, KC; Cho, ML; Yang, CW				Chung, Byung Ha; Kim, Kyoung Woon; Kim, Bo-Mi; Doh, Kyoung Chan; Cho, Mi-La; Yang, Chul Woo			Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction	PLOS ONE			English	Article							REGULATORY T-CELLS; RENAL EPITHELIAL-CELLS; PREDICTIVE PARAMETER; GRAFT FUNCTION; REJECTION; INTERLEUKIN-17; LYMPHOCYTES; EXPRESSION; MEMORY; T(H)17	This study was performed to determine the association of Th17 cell phenotype with chronic allograft dysfunction in kidney transplant recipients (KTRs). We compared the expression of Th17 cell phenotype in KTRs with chronic allograft dysfunction group (CAD, n = 52) with four control groups (long-term stable KTRs (LTS, n = 67), early stable KTRs (ES, n = 28), end stage renal disease (ESRD, n = 45), and healthy control (HC, n = 26). We also performed in vitro study using human proximal renal tubular epithelial cell line (HPRTEpiC) to evaluate the effect of IL-17 on human renal tubular epithelial cells. The CAD group showed increased percentage of Th17 cells out of CD4(+)T cells and also increased proportion of IL-17 producing cells out of effector memory T cells or out of CCR4+ CCR6(+)/CD4(+)T cells compared to the LTS group and other control groups. Also, the serum level of IL-17, IL-33, and RAGE, and the expression of IL-1beta, RAGE, and HMGB1 mRNA showed an increase in the CAD group compared to the LTS group. In vitro study revealed that IL-17 increased production of IL-6 and IL-8 and up-regulated profibrotic gene expression such as ACTA-2 and CTGF in HPRTEpiC in a dose-dependent manner, which suggests that IL-17 has a role in the development of renal tubular cell injury. The results of our study may suggest that increase of Th17 cell phenotype could be a marker for the chronic allograft injury; hence there is a need to develop diagnostic and therapeutic tools targeting the Th17 cells pathway.	[Chung, Byung Ha; Kim, Kyoung Woon; Kim, Bo-Mi; Doh, Kyoung Chan; Cho, Mi-La; Yang, Chul Woo] Catholic Univ Korea Seoul, Coll Med, St Marys Hosp, Convergent Res Consortium Immunol Dis, Seoul, South Korea; [Chung, Byung Ha; Kim, Kyoung Woon; Kim, Bo-Mi; Doh, Kyoung Chan; Yang, Chul Woo] Catholic Univ Korea Seoul, Coll Med, St Marys Hosp, Transplant Res Ctr, Seoul, South Korea; [Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea Seoul, Coll Med, Seoul St Marys Hosp, Div Nephrol,Dept Internal Med, Seoul, South Korea	Catholic University of Korea; Catholic University Korea Hospital; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University Korea Hospital; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Yang, CW (corresponding author), Catholic Univ Korea Seoul, Coll Med, St Marys Hosp, Convergent Res Consortium Immunol Dis, Seoul, South Korea.	yangch@catholic.ac.kr			Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C1232]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant (HI13C1232) of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Alvarez-Lara MA, 2004, NEPHROL DIAL TRANSPL, V19, P3084, DOI 10.1093/ndt/gfh382; Andrew DP, 1998, J IMMUNOL, V161, P5027; Bererhi L, 2012, TRANSPL INT, V25, P545, DOI 10.1111/j.1432-2277.2012.01451.x; Bestard O, 2008, J AM SOC NEPHROL, V19, P1419, DOI 10.1681/ASN.2007050539; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Braudeau C, 2007, TRANSPL INT, V20, P845, DOI 10.1111/j.1432-2277.2007.00537.x; Bunnag S, 2008, AM J TRANSPLANT, V8, P1423, DOI 10.1111/j.1600-6143.2008.02268.x; Chung BH, 2011, IMMUNOL LETT; Chung BH, 2011, EXP MOL MED; Chung BH, 2012, IMMUNOLOGY, V136, P344, DOI 10.1111/j.1365-2567.2012.03588.x; Chung BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042011; Coenen JJA, 2006, BLOOD, V107, P1018, DOI 10.1182/blood-2005-07-3032; Crispim JCO, 2009, TRANSPL P, V41, P1562, DOI 10.1016/j.transproceed.2009.01.092; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; Emoto T, 2014, CIRC J, V78, P2935, DOI 10.1253/circj.CJ-14-0644; Gore-Hyer E, 2002, AM J PHYSIOL-RENAL, V283, pF707, DOI 10.1152/ajprenal.00007.2002; Gupta S, 2004, EXP GERONTOL, V39, P545, DOI 10.1016/j.exger.2003.08.013; Hsieh HG, 2001, TRANSPL INT, V14, P287; Jagger A, 2014, GERONTOLOGY, V60, P130, DOI 10.1159/000355303; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Li Y, 2011, INT IMMUNOPHARMACOL, V11, P2033, DOI 10.1016/j.intimp.2011.08.015; Lohr J, 2006, J EXP MED, V203, P2785, DOI 10.1084/jem.20061341; Loong CC, 2000, TRANSPL P, V32, P1773, DOI 10.1016/S0041-1345(00)01382-8; Louis S, 2006, TRANSPLANTATION, V81, P398, DOI 10.1097/01.tp.0000203166.44968.86; Maluf DG, 2014, AM J TRANSPLANT, V14, P1152, DOI 10.1111/ajt.12696; Mitchell P, 2009, CURR OPIN ORGAN TRAN, V14, P326, DOI 10.1097/MOT.0b013e32832ce88e; Muthukumar T, 2005, NEW ENGL J MED, V353, P2342, DOI 10.1056/NEJMoa051907; Nistala K, 2009, RHEUMATOLOGY, V48, P602, DOI 10.1093/rheumatology/kep028; Ochs HD, 2009, J ALLERGY CLIN IMMUN, V123, P977, DOI 10.1016/j.jaci.2009.03.030; Paantjens AWM, 2011, CLIN EXP IMMUNOL, V166, P103, DOI 10.1111/j.1365-2249.2011.04450.x; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pearl JP, 2005, AM J TRANSPLANT, V5, P465, DOI 10.1111/j.1600-6143.2005.00759.x; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Segundo DS, 2008, TRANSPL P, V40, P2885, DOI 10.1016/j.transproceed.2008.09.043; Schiffrin EL, 2014, CLIN SCI, V126, P267, DOI 10.1042/CS20130407; Segundo DS, 2006, TRANSPLANTATION, V82, P550, DOI 10.1097/01.tp.0000229473.95202.50; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Taflin C, 2010, TRANSPLANTATION, V89, P194, DOI 10.1097/TP.0b013e3181c3ca11; Trzonkowski P, 2008, AM J TRANSPLANT, V8, P338, DOI 10.1111/j.1600-6143.2007.02078.x; Van Kooten C, 1998, J AM SOC NEPHROL, V9, P1526; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Woltman AM, 2000, J AM SOC NEPHROL, V11, P2044, DOI 10.1681/ASN.V11112044; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391	47	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145258	10.1371/journal.pone.0145258	http://dx.doi.org/10.1371/journal.pone.0145258			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717145	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500027
J	Royo-Esnal, A; Gesch, RW; Forcella, F; Torra, J; Recasens, J; Necajeva, J				Royo-Esnal, Aritz; Gesch, Russell W.; Forcella, Frank; Torra, Joel; Recasens, Jordi; Necajeva, Jevgenija			The Role of Light in the Emergence of Weeds: Using Camelina microcarpa as an Example	PLOS ONE			English	Article							ENVIRONMENTAL-CONTROL; SEEDLING EMERGENCE; DORMANCY; GERMINATION; DEPTH; MODEL; SEEDS; SOIL	When modelling the emergence of weeds, two main factors are considered that condition this process: temperature and soil moisture. Optimum temperature is necessary for metabolic processes that generate energy for growth, while turgor pressure is necessary for root and shoot elongation which eventually leads to seedling emergence from the soil. Most emergence models do not usually consider light as a residual factor, but it could have an important role as it can alter directly or indirectly the dormancy and germination of seeds. In this paper, inclusion of light as an additional factor to photoperiod and radiation in emergence models is explored and compared with the classical hydrothermal time (HTT) model using Camelina microcarpa as an example. HTT based on hourly estimates is also compared with that based on daily estimates. Results suggest that, although HTT based models are accurate enough for local applications, the precision of these models is improved when HTT is estimated hourly and solar radiation is included as a factor.	[Royo-Esnal, Aritz; Torra, Joel; Recasens, Jordi] Univ Lleida, Agrotecnio, Dept Hortofruticultura Bot & Jardineria, Lleida 25198, Spain; [Necajeva, Jevgenija] Univ Latvia, Dept Plant Physiol, LV-1586 Riga, Latvia; [Gesch, Russell W.; Forcella, Frank] USDA ARS, N Cent Soil Conservat Res Lab, Morris, MN 56267 USA	Universitat de Lleida; University of Latvia; United States Department of Agriculture (USDA)	Royo-Esnal, A (corresponding author), Univ Lleida, Agrotecnio, Dept Hortofruticultura Bot & Jardineria, Alcalde Rovira Roure 191, Lleida 25198, Spain.	aritz@hbj.udl.cat	Recasens, Jordi/B-3970-2011; Torra, Joel/B-3959-2011; Royo-Esnal, Aritz/B-4174-2011; Necajeva, Jevgenija/AAA-2029-2022; Necajeva, Jevgenija/AAF-9811-2019	Recasens, Jordi/0000-0002-8799-9958; Torra, Joel/0000-0002-8666-6780; Royo-Esnal, Aritz/0000-0003-2534-8372; Necajeva, Jevgenija/0000-0002-0828-9721	Ministerio de Educacion y Ciencia de Espana [AGL2010-22084-C02-01]; ARS [ARS-0425705] Funding Source: Federal RePORTER	Ministerio de Educacion y Ciencia de Espana(Spanish Government); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the Ministerio de Educacion y Ciencia de Espana (AGL2010-22084-C02-01).	Batlla D, 2005, NEW PHYTOL, V165, P445, DOI 10.1111/j.1469-8137.2004.01262.x; Benech-Arnold RL, 2000, FIELD CROP RES, V67, P105, DOI 10.1016/S0378-4290(00)00087-3; Boyd NS, 2003, WEED SCI, V51, P725, DOI 10.1614/P2002-111; Deen W, 1998, WEED SCI, V46, P561, DOI 10.1017/S0043174500091104; Forcella F, 2000, FIELD CROP RES, V67, P123, DOI 10.1016/S0378-4290(00)00088-5; Francis A, 2009, CAN J PLANT SCI, V89, P791, DOI 10.4141/CJPS08185; Gardarin A, 2012, ECOL MODEL, V240, P123, DOI 10.1016/j.ecolmodel.2012.05.004; Grundy AC, 2003, J APPL ECOL, V40, P757, DOI 10.1046/j.1365-2664.2003.00836.x; HAZEBROEK JP, 1990, AM J BOT, V77, P945, DOI 10.2307/2444510; Martinson K, 2007, WEED SCI, V55, P584, DOI 10.1614/WS-07-059.1; Masin R, 2012, WEED SCI, V60, P254, DOI 10.1614/WS-D-11-00124.1; MAYER DG, 1993, ECOL MODEL, V68, P21, DOI 10.1016/0304-3800(93)90105-2; Roman ES, 2000, WEED SCI, V48, P217, DOI 10.1614/0043-1745(2000)048[0217:SOCASE]2.0.CO;2; Royo-Esnal A, 2015, IND CROP PROD, V66, P161, DOI 10.1016/j.indcrop.2014.12.010; Royo-Esnal A, 2010, WEED SCI, V58, P10, DOI 10.1614/WS-09-063.1; Spokas K, 2006, WEED SCI, V54, P182, DOI 10.1614/WS-05-098R.1; Spokas K, 2009, WEED SCI, V57, P216, DOI 10.1614/WS-08-142.1; Vleeshouwers LM, 1995, J ECOL, V83, P1031, DOI 10.2307/2261184; Vleeshouwers LM, 2000, NEW PHYTOL, V148, P445, DOI 10.1046/j.1469-8137.2000.00773.x; Werle R, 2014, WEED SCI, V62, P83, DOI 10.1614/WS-D-13-00091.1	20	7	8	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146079	10.1371/journal.pone.0146079	http://dx.doi.org/10.1371/journal.pone.0146079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717481	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500133
J	Velicer, C; Glantz, SA				Velicer, Clayton; Glantz, Stanton A.			Hiding in the Shadows: Philip Morris and the Use of Third Parties to Oppose Ingredient Disclosure Regulations	PLOS ONE			English	Article							YOUTH SMOKING PREVENTION; TOBACCO INDUSTRY STRATEGY; PROGRAM; STANDARD	Background In 1996 Massachusetts proposed regulations that would require tobacco companies to disclose information about the ingredients in their products on a by-brand basis. This paper examines the strategies employed by Philip Morris to stop these regulations from being implemented. Methods and Finding We used previously secret tobacco industry documents and published literature to examine the activities of the tobacco companies after the regulations were proposed. Philip Morris hired a public relations firm to establish a coalition that was instructed to oppose the regulations by linking them to other industrial sectors (the slippery slope) and stating they would damage the state's economy. Philip Morris also retained a polling firm to test the popularity of specific arguments against ingredient disclosure and developed a strategic plan for opposing similar regulations in Vermont. Conclusion Tobacco companies have historically used third parties to form coalitions to oppose ingredient disclosure regulations. These coalitions have had success preventing regulations from being implemented after they are initially proposed by creating the appearance of local opposition. With countries around the world currently implementing ingredient disclosure regulations in the WHO Framework Convention on Tobacco, governments and regulatory agencies should be aware of the political strategies that the tobacco companies have used to create the impression of popular opposition to these measures.	[Velicer, Clayton] Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA; [Glantz, Stanton A.] Univ Calif San Francisco, Dept Med, Helen Diller Family Comprehens Canc Ctr, Ctr Tobacco Control Res & Educ,Cardiovasc Res Ins, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Glantz, SA (corresponding author), Univ Calif San Francisco, Dept Med, Helen Diller Family Comprehens Canc Ctr, Ctr Tobacco Control Res & Educ,Cardiovasc Res Ins, San Francisco, CA 94143 USA.	Stanton.Glantz@ucsf.edu			National Cancer Institute [CA-87472]; NATIONAL CANCER INSTITUTE [R01CA087472] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute Grant CA-87472. The funding agency played no role in the conduct of the research or preparation of the manuscript.	Anderson SJ, 2011, TOB CONTROL, V20, pII8, DOI 10.1136/tc.2010.041921; [Anonymous], IMPLEMENTATION DATAB; Apollonio DE, 2007, AM J PUBLIC HEALTH, V97, P419, DOI 10.2105/AJPH.2005.081117; Apollonio DE, 2010, AM J PUBLIC HEALTH, V100, P1188, DOI 10.2105/AJPH.2009.169573; Assunta M, 2004, TOB CONTROL, V13, P37, DOI 10.1136/tc.2004.007732; Berlind M, 1997, LETTER TO NEIL CHAYE; Bialous SA, 2002, TOB CONTROL, V11, P315, DOI 10.1136/tc.11.4.315; Bonhomme J, 1993, MARKET RESEARCH CONS; Campbell RB, 2009, AM J PUBLIC HEALTH, V99, P1188, DOI 10.2105/AJPH.2008.143131; Carnovale M, 1997, MA TRADE SECRETS; Chapman S, 2003, TOB CONTROL, V12, P107; Chayet N, 1996, INGREDIENT DISCLOSUR; Chayet N, 1997, LETTER OT JOSEPH TOM; Chayet N, 1996, LETTER OT CALVIN COL; Dearlove JV, 2002, TOB CONTROL, V11, P94, DOI 10.1136/tc.11.2.94; Department of Public Health, REPORTS OF ADDED CON; Doherty M, 1991, MARKET RESEARCH CONS; FCTC Secretariat, 2014, GLOBAL PROGRESS IN I; Firestone M, 1996, SERVICES AGREEMENT; Flathery C, 1992, PROPOSAL; Gee E, 1993, MARKET RESEARCH CONS; Gonzalez M, 2013, EUR J PUBLIC HEALTH, V23, P139, DOI 10.1093/eurpub/ckr173; Henriksen L, 2006, TOB CONTROL, V15, P13, DOI 10.1136/tc.2003.006361; Landman A, 2002, AM J PUBLIC HEALTH, V92, P917, DOI 10.2105/AJPH.92.6.917; Malone RE, 2000, TOB CONTROL, V9, P334, DOI 10.1136/tc.9.3.334; Mamudu HM, 2008, AM J PUBLIC HEALTH, V98, P1630, DOI 10.2105/AJPH.2007.129478; Mandel LL, 2006, J ADOLESCENT HEALTH, V39, P868, DOI 10.1016/j.jadohealth.2006.06.010; McCarthy P, 1995, LETTER CAMPAIGN ON B; Neilsen K, 2004, TOB CONTROL, V13, P20, DOI 10.1136/tc.2003.004721; Pierce WJ, 1997, COMMUNICATION; Pottorff M, 1994, IHA COURTESY OF CHOI; Salinsky R, 1997, STATEMENT OF RICHARD; SAMUELS B, 1991, JAMA-J AM MED ASSOC, V266, P2110, DOI 10.1001/jama.266.15.2110; Sebrie EM, 2007, TOB CONTROL, V16, DOI 10.1136/tc.2006.018275; Sebrie EM, 2007, AM J PUBLIC HEALTH, V97, P1357, DOI 10.2105/AJPH.2006.094128; Smith KE, 2013, TOB CONTROL, V22, P144, DOI 10.1136/tobaccocontrol-2011-050098; Sussman Steve, 2002, Prev Sci, V3, P57, DOI 10.1023/A:1014623426877; Tesler LE, 2010, AM J PUBLIC HEALTH, V100, P1174, DOI 10.2105/AJPH.2009.179150; TRAYNOR MP, 1993, JAMA-J AM MED ASSOC, V270, P479, DOI 10.1001/jama.270.4.479; Velicer C, 2015, TOB CONTROL, DOI [10.1136/tobaccocontrol-2015-052392, DOI 10.1136/T0BACC0C0NTR0L-2015-052392]; Wakefield M, 2006, AM J PUBLIC HEALTH, V96, P2154, DOI 10.2105/AJPH.2005.083352; Wakefield M, 2006, TOB CONTROL, V15, P44; WHO Framework Convention on Tobacco Control Conference of the Parties, 2010, GUIDELINES FOR IMPLE; World Health Organization, WHO FRAMEWORK CONVEN	44	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0142032	10.1371/journal.pone.0142032	http://dx.doi.org/10.1371/journal.pone.0142032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26717245	Green Published, gold			2022-12-27	WOS:000367510500003
J	Alcantara, BK; Machemer-Noonan, K; Silva, FG; Azevedo, RA				Alcantara, Berenice Kussumoto; Machemer-Noonan, Katja; Silva Junior, Francides Gomes; Azevedo, Ricardo Antunes			Dry Priming of Maize Seeds Reduces Aluminum Stress	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; L-ASCORBIC-ACID; TRANSCRIPTION FACTORS; SUPEROXIDE-DISMUTASE; ANTIOXIDANT RESPONSES; PHOSPHORUS EFFICIENCY; ARABIDOPSIS-THALIANA; PEROXIDASE-ACTIVITY; SULFUR EFFICIENCY; SENSITIVE METHOD	Aluminum (Al) toxicity is directly related to acidic soils and substantially limits maize yield. Earlier studies using hormones and other substances to treat the seeds of various crops have been carried out with the aim of inducing tolerance to abiotic stress, especially chilling, drought and salinity. However, more studies regarding the effects of seed treatments on the induction of Al tolerance are necessary. In this study, two independent experiments were performed to determine the effect of ascorbic acid (AsA) seed treatment on the tolerance response of maize to acidic soil and Al stress. In the first experiment (greenhouse), the AsA seed treatment was tested in B73 (Al-sensitive genotype). This study demonstrates the potential of AsA for use as a pre-sowing seed treatment (seed priming) because this metabolite increased root and shoot growth under acidic and Al stress conditions. In the second test, the evidence from field experiments using an Al-sensitive genotype (Mo17) and an Altolerant genotype (DA) suggested that prior AsA seed treatment increased the growth of both genotypes. Enhanced productivity was observed for DA under Al stress after priming the seeds. Furthermore, the AsA treatment decreased the activity of oxidative stress-related enzymes in the DA genotype. In this study, remarkable effects using AsA seed treatment in maize were observed, demonstrating the potential future use of AsA in seed priming.	[Alcantara, Berenice Kussumoto; Azevedo, Ricardo Antunes] Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Sao Paulo, Brazil; [Machemer-Noonan, Katja] Ohio State Univ, Ctr Appl Plant Sci, Columbus, OH 43210 USA; [Silva Junior, Francides Gomes] Univ Sao Paulo, Dept Ciencias Florestais, Escola Super Agr Luiz de Queiroz, Sao Paulo, Brazil	Universidade de Sao Paulo; University System of Ohio; Ohio State University; Universidade de Sao Paulo	Azevedo, RA (corresponding author), Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Sao Paulo, Brazil.	raa@usp.br	JUNIOR, FRANCIDES G SILVA/F-1946-2013; de Alcântara da Silva, Berenice Kussumoto/AAT-1857-2020; Azevedo, Ricardo Antunes/F-8863-2011	JUNIOR, FRANCIDES G SILVA/0000-0002-9142-7442; de Alcântara da Silva, Berenice Kussumoto/0000-0002-5758-7530; Azevedo, Ricardo Antunes/0000-0001-7316-125X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Brazil) [2009/54676-0, 2010/50497-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FAPESP; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; FULBRIGHT Institution (CAPES-FULBRIGHT) [15112171]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FULBRIGHT Institution (CAPES-FULBRIGHT)	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Brazil, Grants 2009/54676-0 and 2010/50497-0). We thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (RAA) (http://www.cnpq.br/) and FAPESP (BKA) (http://www.fapesp.br/) for the fellowship and scholarships granted, respectively. BKA also thanks the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and FULBRIGHT Institution (CAPES-FULBRIGHT) (http://www.capes.gov.br/cooperacao-internacional/estados-unidos/capescomissao-fulbright) for financial support during Sandwich Program in United States of America (Grant. 15112171).	ACEVEDO A, 1991, DEV GENET, V12, P423, DOI 10.1002/dvg.1020120607; Ahmad A, 2005, PLANT SCI, V169, P842, DOI 10.1016/j.plantsci.2005.05.036; Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; ARAKAWA N, 1981, AGR BIOL CHEM TOKYO, V45, P1289, DOI 10.1080/00021369.1981.10864697; Arrigoni O, 2002, BBA-GEN SUBJECTS, V1569, P1, DOI 10.1016/S0304-4165(01)00235-5; Ashraf M, 2005, ADV AGRON, V88, P223, DOI 10.1016/S0065-2113(05)88006-X; Ashraf M, 2001, ACTA PHYSIOL PLANT, V23, P407, DOI 10.1007/s11738-001-0050-9; Azevedo RA, 1998, PHYSIOL PLANTARUM, V104, P280, DOI 10.1034/j.1399-3054.1998.1040217.x; Balint T, 2009, CROP PASTURE SCI, V60, P262, DOI 10.1071/CP08224; Barinaga M, 1997, SCIENCE, V276, P1497, DOI 10.1126/science.276.5318.1497; Barth C, 2006, J EXP BOT, V57, P1657, DOI 10.1093/jxb/erj198; BASU U, 1994, PLANT PHYSIOL, V106, P151, DOI 10.1104/pp.106.1.151; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Boscolo PRS, 2003, PHYTOCHEMISTRY, V62, P181, DOI 10.1016/S0031-9422(02)00491-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branduardi P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001092; Braun EL, 1999, PLANT PHYSIOL, V121, P21, DOI 10.1104/pp.121.1.21; CAKMAK I, 1991, PHYSIOL PLANTARUM, V83, P463, DOI 10.1111/j.1399-3054.1991.tb00121.x; Carvalho RF, 2011, SCI AGR, V68, P598, DOI 10.1590/S0103-90162011000500014; Cassiolato ME, 2000, BRAZ ARCH BIOL TECHN, V43, P533, DOI 10.1590/S1516-89132000000500014; Cia MC, 2012, ANN APPL BIOL, V161, P313, DOI 10.1111/j.1744-7348.2012.00575.x; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Corrales I, 2007, J PLANT NUTR, V30, P887, DOI 10.1080/15226510701375085; Cosio C, 2009, J EXP BOT, V60, P391, DOI 10.1093/jxb/ern318; Davey MW, 2000, J SCI FOOD AGR, V80, P825, DOI [10.1002/(SICI)1097-0010(20000515)80:7<825::AID-JSFA598>3.0.CO;2-6, 10.1002/(SICI)1097-0010(20000515)80:7&lt;825::AID-JSFA598&gt;3.0.CO;2-6]; de Alcantara BK, 2015, AN ACAD BRAS CIENC, V87, P1063, DOI 10.1590/0001-3765201520140322; Degenhardt J, 1998, PLANT PHYSIOL, V117, P19, DOI 10.1104/pp.117.1.19; Dourado MN, 2013, ANN APPL BIOL, V163, P494, DOI 10.1111/aab.12066; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Erdal S, 2012, PLANT PHYSIOL BIOCH, V57, P1, DOI 10.1016/j.plaphy.2012.04.016; Ezaki B, 2005, J EXP BOT, V56, P2661, DOI 10.1093/jxb/eri259; Farooq M, 2008, J AGRON CROP SCI, V194, P438, DOI 10.1111/j.1439-037X.2008.00334.x; Farooq M, 2013, J AGRON CROP SCI, V199, P12, DOI 10.1111/j.1439-037X.2012.00521.x; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Fornale S, 2006, PLANT MOL BIOL, V62, P809, DOI 10.1007/s11103-006-9058-2; Fornale S, 2010, PLANT J, V64, P633, DOI 10.1111/j.1365-313X.2010.04363.x; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; GRANADOS G, 1995, CROP SCI, V35, P1236, DOI 10.2135/cropsci1995.0011183X003500040099x; Gratao PL, 2008, ANN APPL BIOL, V153, P321, DOI 10.1111/j.1744-7348.2008.00299.x; Gratao PL, 2005, FUNCT PLANT BIOL, V32, P481, DOI 10.1071/FP05016; Gratao PL, 2015, BIOMETALS, V28, P803, DOI 10.1007/s10534-015-9867-3; Hiraga S, 2001, PLANT CELL PHYSIOL, V42, P462, DOI 10.1093/pcp/pce061; Horemans N, 2000, PLANT PHYSIOL BIOCH, V38, P531, DOI 10.1016/S0981-9428(00)00782-8; Kochian Leon V., 2009, P367, DOI 10.1007/978-0-387-79418-1_18; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Krill AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009958; Kubala S, 2015, PLANT SCI, V231, P94, DOI 10.1016/j.plantsci.2014.11.008; Kumari M, 2008, MOL GENET GENOMICS, V279, P339, DOI 10.1007/s00438-007-0316-z; LAWRENCE GB, 1995, NATURE, V378, P162, DOI 10.1038/378162a0; Lidon FC, 1999, J PLANT NUTR, V22, P397, DOI 10.1080/01904169909365637; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Ma JF, 2007, INT REV CYTOL, V264, P225, DOI 10.1016/S0074-7696(07)64005-4; Malavolta E., 1997, AVALIA O ESTADO NUTR, V2nd; MATHRE DE, 1995, PLANT DIS, V79, P1145, DOI 10.1094/PD-79-1145; McCue P, 2000, PROCESS BIOCHEM, V35, P603, DOI 10.1016/S0032-9592(99)00111-9; Medici LO, 2004, FUNCT PLANT BIOL, V31, P1, DOI 10.1071/FP03130; MITTLER R, 1993, ANAL BIOCHEM, V212, P540, DOI 10.1006/abio.1993.1366; Morohashi K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000396; Nault BA, 2006, CROP PROT, V25, P58, DOI 10.1016/j.cropro.2005.03.020; Nguyen NT, 2003, TREE PHYSIOL, V23, P1041, DOI 10.1093/treephys/23.15.1041; Nogueirol RC, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4282-3; Nogueirol RC, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4366-0; Obst J.R., 1988, METHOD ENZYMOL, V161, P87, DOI 10.1016/0076-6879(88)61014-7; Ogawa K, 1997, PLANT CELL PHYSIOL, V38, P1118, DOI 10.1093/oxfordjournals.pcp.a029096; Patade VY, 2012, MOL BIOL REP, V39, P10603, DOI 10.1007/s11033-012-1948-6; Pavet V, 2005, PLANT PHYSIOL, V139, P1291, DOI 10.1104/pp.105.067686; PELLET DM, 1995, PLANTA, V196, P788, DOI 10.1007/BF01106775; Pineros MA, 2002, PLANT PHYSIOL, V129, P1194, DOI 10.1104/pp.002295; Pineros MA, 2005, PLANT PHYSIOL, V137, P231, DOI 10.1104/pp.104.047357; PRASAD TK, 1995, PLANT PHYSIOL, V108, P1597, DOI 10.1104/pp.108.4.1597; Reddy SK, 2014, J PLANT PHYSIOL, V171, P1289, DOI 10.1016/j.jplph.2014.05.005; Scandalios JG, 2005, BRAZ J MED BIOL RES, V38, P995, DOI 10.1590/S0100-879X2005000700003; Shaul O, 2002, BIOMETALS, V15, P309, DOI 10.1023/A:1016091118585; Shenoy VV, 2005, BIOTECHNOL ADV, V23, P501, DOI 10.1016/j.biotechadv.2005.01.004; Sonbol FM, 2009, PLANT MOL BIOL, V70, P283, DOI 10.1007/s11103-009-9473-2; Tahara K, 2008, PLANT SOIL, V302, P175, DOI 10.1007/s11104-007-9464-5; Talaar NB, 2014, PLANT PHYSIOL BIOCH, V80, P136, DOI 10.1016/j.plaphy.2014.03.035; Taylor GJ, 1997, PLANT PHYSIOL, V114, P363, DOI 10.1104/pp.114.1.363; Traber MG, 2011, FREE RADICAL BIO MED, V51, P1000, DOI 10.1016/j.freeradbiomed.2011.05.017; Valadez-Gonzalez N, 2007, J PLANT GROWTH REGUL, V26, P69, DOI 10.1007/s00344-006-0039-0; Valpuesta V, 2004, TRENDS PLANT SCI, V9, P573, DOI 10.1016/j.tplants.2004.10.002; Wang JW, 2007, BIOL PLANTARUM, V51, P493, DOI 10.1007/s10535-007-0104-y; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Xue YJ, 2008, J AGR FOOD CHEM, V56, P9676, DOI 10.1021/jf802001v; Yachandra VK, 1996, CHEM REV, V96, P2927, DOI 10.1021/cr950052k; Yamada T, 2005, SOIL SCI PLANT NUTR, V51, P617, DOI 10.1111/j.1747-0765.2005.tb00076.x; Yi M., 2009, ENVIRON TOXICOL, V25, P124; Yin LN, 2010, PLANTA, V231, P609, DOI 10.1007/s00425-009-1075-3; Zamocky M, 2000, GENE, V256, P169, DOI 10.1016/S0378-1119(00)00358-9	90	19	19	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145742	10.1371/journal.pone.0145742	http://dx.doi.org/10.1371/journal.pone.0145742			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714286	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900075
J	Caballero, A; Gregori, J; Homs, M; Tabernero, D; Gonzalez, C; Quer, J; Blasi, M; Casillas, R; Nieto, L; Riveiro-Barciela, M; Esteban, R; Buti, M; Rodriguez-Frias, F				Caballero, Andrea; Gregori, Josep; Homs, Maria; Tabernero, David; Gonzalez, Carolina; Quer, Josep; Blasi, Maria; Casillas, Rosario; Nieto, Leonardo; Riveiro-Barciela, Mar; Esteban, Rafael; Buti, Maria; Rodriguez-Frias, Francisco			Complex Genotype Mixtures Analyzed by Deep Sequencing in Two Different Regions of Hepatitis B Virus	PLOS ONE			English	Article							INNO-LIPA HBV; MUTATIONS; INFECTION; IDENTIFICATION; RECOMBINANTS; RESISTANCE; EVOLUTION; GENESIS; ASSAY; LOAD	This study assesses the presence and outcome of genotype mixtures in the polymerase/surface and X/preCore regions of the HBV genome in patients with chronic hepatitis B virus (HBV) infection. Thirty samples from ten chronic hepatitis B patients were included. The polymerase/surface and X/preCore regions were analyzed by deep sequencing (UDPS) in the first available sample at diagnosis, a pre-treatment sample, and a sample while under treatment. HBV genotype was determined by phylogenesis. Quasispecies complexity was evaluated by mutation frequency and nucleotide diversity. The polymerase/surface and X/preCore regions were validated for genotyping from 113 GenBank reference sequences. UDPS yielded a median of 10,960 sequences per sample (IQR 16,645) in the polymerase/surface region and 11,595 sequences per sample (IQR 14,682) in X/preCore. Genotype mixtures were more common in X/preCore (90%) than in polymerase/surface (30%) (p<0.001). On X/preCore genotyping, all samples were genotype A, whereas polymerase/surface yielded genotypes A (80%), D (16.7%), and F (3.3%) (p = 0.036). Genotype changes in polymerase/surface were observed in four patients during natural quasispecies dynamics and in two patients during treatment. There were no genotype changes in X/preCore. Quasispecies complexity was higher in X/preCore than in polymerase/surface (p = 0.004). The results provide evidence of genotype mixtures and differential genotype proportions in the polymerase/surface and X/preCore regions. The genotype dynamics in HBV infection and the different patterns of quasispecies complexity in the HBV genome suggest a new paradigm for HBV genotype classification.	[Caballero, Andrea; Homs, Maria; Tabernero, David; Gonzalez, Carolina; Blasi, Maria; Nieto, Leonardo; Rodriguez-Frias, Francisco] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Biochem, Liver Pathol Unit, E-08193 Barcelona, Spain; [Caballero, Andrea; Homs, Maria; Tabernero, David; Gonzalez, Carolina; Blasi, Maria; Nieto, Leonardo; Rodriguez-Frias, Francisco] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Microbiol, Liver Pathol Unit, E-08193 Barcelona, Spain; [Gregori, Josep; Homs, Maria; Tabernero, David; Quer, Josep; Blasi, Maria; Riveiro-Barciela, Mar; Esteban, Rafael; Buti, Maria; Rodriguez-Frias, Francisco] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Gregori, Josep; Quer, Josep; Casillas, Rosario] Vall dHebron Res Inst, Liver Dis Unit, Barcelona, Spain; [Gregori, Josep] Roche Diagnost SL, Sant Cugat Del Valles, Spain; [Riveiro-Barciela, Mar; Esteban, Rafael; Buti, Maria] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Liver Unit, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Roche Holding; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Rodriguez-Frias, F (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Biochem, Liver Pathol Unit, E-08193 Barcelona, Spain.	frarodri@vhebron.net	Gregori, Josep/J-2586-2015; Fernandez, Carolina González/Z-6166-2019; Tabernero, David/AAB-3848-2019; Quer, Josep/A-6741-2012; Rodriguez-Frias, Francisco/AAC-3507-2020	Gregori, Josep/0000-0002-4253-8015; Tabernero, David/0000-0002-1146-4084; Quer, Josep/0000-0003-0014-084X; Casillas, Rosario/0000-0002-6758-6734; rodriguez-frias, francisco/0000-0002-9128-7013; Nieto, Leonardo/0000-0002-1336-5645; CABALLERO, ANDREA/0000-0003-2891-6347; esteban, rafael/0000-0001-5280-392X; Buti Ferret, Maria/0000-0002-0732-3078; Gonzalez-Fernandez, Carolina/0000-0002-7458-0090; Gonzalez Fernandez, Carolina/0000-0002-0169-5874; Homs, Maria/0000-0002-8370-8375	Instituto de Salud Carlos III [PI12/01893]; European Regional Development Fund (ERDF); Roche Diagnostics	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund (ERDF)(European Commission); Roche Diagnostics	Dr F Rodriguez-Frias received a fund from the Instituto de Salud Carlos III (grant PI12/01893) for supplies and reagents. The study was cofinanced by the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Roche Diagnostics provided support in the form of a salary for JG, but did not have any role in the study design or execution, data collection or analysis, decision to publish, or preparation of the manuscript. The specific roles of JG are described in the Author Contributions section.	Araujo NM, 2013, J GEN VIROL, V94, P150, DOI 10.1099/vir.0.047324-0; Bekondi C, 2007, J CLIN VIROL, V40, P31, DOI 10.1016/j.jcv.2007.05.009; Borg I, 2010, MODERN MULTIDIMENSIO; Bull RA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002243; Bunnik EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002106; Buti M, 2007, J HEPATOL, V47, P366, DOI 10.1016/j.jhep.2007.04.011; Cuadras C, 1991, MATH PREPRINT SERIES; Cuadras C, 1989, STAT DATA ANAL INFER, P459; Deterding K, 2008, J MED VIROL, V80, P1707, DOI 10.1002/jmv.21294; GEORGIGEISBERGER P, 1992, ONCOLOGY, V49, P386; Ghedin E, 2009, J VIROL, V83, P8832, DOI 10.1128/JVI.00773-09; Gregori J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083361; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Homs M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112306; Homs M, 2011, NUCLEIC ACIDS RES, V39, P8457, DOI 10.1093/nar/gkr451; Hsieh TH, 2009, ANTIVIR THER, V14, P1157, DOI 10.3851/IMP1454; Jardi R, 2008, J HEPATOL, V49, P695, DOI 10.1016/j.jhep.2008.03.030; Kao JH, 2001, HEPATOLOGY, V34, P817, DOI 10.1053/jhep.2001.28188; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kramvis A, 2005, J VIRAL HEPATITIS, V12, P456, DOI 10.1111/j.1365-2893.2005.00624.x; Kramvis A, 2014, INTERVIROLOGY, V57, P141, DOI 10.1159/000360947; Kumar S, 2000, J MOL EVOL, V51, P544, DOI 10.1007/s002390010118; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Mese S, 2013, J GEN VIROL, V94, P2729, DOI 10.1099/vir.0.053041-0; Neumann AU, 2005, HEPATOLOGY, V42, P249, DOI 10.1002/hep.20831; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Osiowy C, 2003, J CLIN MICROBIOL, V41, P5473, DOI 10.1128/JCM.41.12.5473-5477.2003; Pages H, BIOCONDUCTOR BIOSTRI; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Ramirez C, 2013, ANTIVIR RES, V98, P273, DOI 10.1016/j.antiviral.2013.03.007; Rodriguez-Frias F, 2006, J VIRAL HEPATITIS, V13, P343, DOI 10.1111/j.1365-2893.2005.00691.x; Shi WF, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-116; Shi WF, 2012, VIROLOGY, V427, P51, DOI 10.1016/j.virol.2012.01.030; Simmonds P, 2005, J VIROL, V79, P15467, DOI 10.1128/JVI.79.24.15467-15476.2005; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; World Health Organization, 2015, WHO HEP B; Yang J, 2006, J GEN VIROL, V87, P2203, DOI 10.1099/vir.0.81752-0; Zhang Q, 2011, HEPAT MON, V11, P86	39	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144816	10.1371/journal.pone.0144816	http://dx.doi.org/10.1371/journal.pone.0144816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714168	Green Submitted, Green Published, gold			2022-12-27	WOS:000367481900018
J	Chai, WM; Wang, R; Wei, MK; Zou, ZR; Deng, RG; Liu, WS; Peng, YY				Chai, Wei-Ming; Wang, Rui; Wei, Man-Kun; Zou, Zheng-Rong; Deng, Rong-Gen; Liu, Wei-Sheng; Peng, Yi-Yuan			Proanthocyanidins Extracted from Rhododendron pulchrum Leaves as Source of Tyrosinase Inhibitors: Structure, Activity, and Mechanism	PLOS ONE			English	Article							MUSHROOM TYROSINASE; CONDENSED TANNINS; MELANOGENESIS; ANTITYROSINASE	The objective of this study was to assess the structure, anti-tyrosinase activity, and mechanism of proanthocyanidins extracted from Rhododendron pulchrum leaves. Results obtained from mass spectra of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and high performance liquid chromatography electrospray ionization mass spectrometry (HPLC-ESI-MS) revealed that proanthocyanidins were complex mixtures of procyanidins, prodelphinidins, propelargonidins, and their derivatives, among which procyanidins were the main components. The anti-tyrosinase analysis results indicated that the mixtures were reversible and mixed competitive inhibitors of tyrosinase. Interactions between proanthocyanidins with substrate (L-tyrosine and 3,4-dihydroxyphenylalanine) and with copper ions were the important molecular mechanisms for explaining their efficient inhibition. This research would provide scientific evidence for the use of R. pulchrum leaf proanthocyanidins as new novel tyrosinase inhibitors.	[Chai, Wei-Ming; Wang, Rui; Wei, Man-Kun; Zou, Zheng-Rong; Deng, Rong-Gen; Liu, Wei-Sheng; Peng, Yi-Yuan] Jiangxi Normal Univ, Minist Educ, Coll Life Sci, Nanchang 330022, Jiangxi, Peoples R China; [Chai, Wei-Ming; Wang, Rui; Wei, Man-Kun; Zou, Zheng-Rong; Deng, Rong-Gen; Liu, Wei-Sheng; Peng, Yi-Yuan] Jiangxi Normal Univ, Minist Educ, Key Lab Small Funct Organ Mol, Nanchang 330022, Jiangxi, Peoples R China; [Chai, Wei-Ming] Jiangxi Normal Univ, Key Lab Poyang Lake Wetland & Watershed Res, Nanchang 330022, Jiangxi, Peoples R China	Jiangxi Normal University; Jiangxi Normal University; Jiangxi Normal University	Chai, WM (corresponding author), Jiangxi Normal Univ, Minist Educ, Coll Life Sci, Nanchang 330022, Jiangxi, Peoples R China.	chaiweiming@jxnu.edu.cn; yiyuanpeng@jxnu.edu.cn			Natural Science Foundation of China [31501414, 21362014, 31260082]; Open Project Program of Key Laboratory of Functional Small Organic Molecule, Ministry of Education, Jiangxi Normal University [KLFSKF-201419]; Dr. Start-up fund projects, Jiangxi Normal University; Open Project Program of Key Laboratory of Functional Small Organic Molecule, Ministry of Education; Jiangxi Normal University [KLFSKF-201419]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Project Program of Key Laboratory of Functional Small Organic Molecule, Ministry of Education, Jiangxi Normal University; Dr. Start-up fund projects, Jiangxi Normal University; Open Project Program of Key Laboratory of Functional Small Organic Molecule, Ministry of Education; Jiangxi Normal University	The present investigation was supported by the Natural Science Foundation of China (No. 31501414, 21362014, 31260082), the Open Project Program of Key Laboratory of Functional Small Organic Molecule, Ministry of Education, Jiangxi Normal University (KLFSKF-201419). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present investigation was supported by the Natural Science Foundation of China (No. 31501414, 21362014, 31260082), the Open Project Program of Key Laboratory of Functional Small Organic Molecule, Ministry of Education, and Jiangxi Normal University (KLFSKF-201419) and Dr. Start-up fund projects, Jiangxi Normal University.	Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Chai WM, 2014, J AGR FOOD CHEM, V62, P6382, DOI 10.1021/jf501009v; Chai WM, 2014, J AGR FOOD CHEM, V62, P123, DOI 10.1021/jf405385j; Chai WM, 2012, J AGR FOOD CHEM, V60, P5013, DOI 10.1021/jf300740d; Chase MR, 2000, INSECT BIOCHEM MOLEC, V30, P953, DOI 10.1016/S0965-1748(00)00068-0; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; Fu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096162; Gowda LR, 2002, J AGR FOOD CHEM, V50, P1608, DOI 10.1021/jf010913s; Gupta SD, 2013, CHIN J NAT MEDICINES, V11, P616, DOI 10.1016/S1875-5364(13)60071-0; Hummer W, 2008, MOL NUTR FOOD RES, V52, P1381, DOI 10.1002/mnfr.200700463; Khanbabaee K, 2001, NAT PROD REP, V18, P641, DOI 10.1039/b101061l; KORNER A, 1982, SCIENCE, V217, P1163, DOI 10.1126/science.6810464; Lv Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120480; MARTINEZ MV, 1995, TRENDS FOOD SCI TECH, V6, P195, DOI 10.1016/S0924-2244(00)89054-8; Pan ZZ, 2011, J AGR FOOD CHEM, V59, P6645, DOI 10.1021/jf200990g; Reed JD, 2005, PHYTOCHEMISTRY, V66, P2248, DOI 10.1016/j.phytochem.2005.05.015; Schallreuter KU, 2008, EXP DERMATOL, V17, P395, DOI 10.1111/j.1600-0625.2007.00675.x; Seo SY, 2003, J AGR FOOD CHEM, V51, P2837, DOI 10.1021/jf020826f; Slominski A, 1998, ANTICANCER RES, V18, P3709; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Wu LC, 2003, J AGR FOOD CHEM, V51, P4240, DOI 10.1021/jf034064f; Xiang P, 2007, J APPL POLYM SCI, V105, P859, DOI 10.1002/app.26373; Yi W, 2010, EUR J MED CHEM, V45, P639, DOI 10.1016/j.ejmech.2009.11.007; Zhang Mei, 2012, Medicinal Plant, V3, P21; Zhou HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107606; Zhou HC, 2011, FOOD CHEM, V129, P1710, DOI 10.1016/j.foodchem.2011.06.036	28	16	17	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145483	10.1371/journal.pone.0145483	http://dx.doi.org/10.1371/journal.pone.0145483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713623	gold, Green Published, Green Submitted			2022-12-27	WOS:000367481900046
J	Haines, JD; Fulton, DL; Richard, S; Almazan, G				Haines, Jeffery D.; Fulton, Debra L.; Richard, Stephane; Almazan, Guillermina			p38 Mitogen-Activated Protein Kinase Pathway Regulates Genes during Proliferation and Differentiation in Oligodendrocytes	PLOS ONE			English	Article							FYN TYROSINE KINASE; TRANSCRIPTION FACTOR; MYELINATION; CELLS; IDENTIFICATION; EXPRESSION; IDENTITY; DATABASE; NEURONS; GROWTH	We have previously shown that p38 mitogen-activated protein kinase (p38 MAPK) is important for oligodendrocyte (OLG) differentiation and myelination. However, the precise cellular mechanisms by which p38 regulates OLG differentiation remain largely unknown. To determine whether p38 functions in part through transcriptional events in regulating OLG identity, we performed microarray analysis on differentiating oligodendrocyte progenitors (OLPs) treated with a p38 inhibitor. Consistent with a role in OLG differentiation, pharmacological inhibition of p38 down-regulated the transcription of genes that are involved in myelin biogenesis, transcriptional control and cell cycle. Proliferation assays showed that OLPs treated with the p38 inhibitor retained a proliferative capacity which could be induced upon application of mitogens demonstrating that after two days of p38-inhibition OLGs remained poised to continue mitosis. Together, our results suggest that the p38 pathway regulates gene transcription which can coordinate OLG differentiation. Our microarray dataset will provide a useful resource for future studies investigating the molecular mechanisms by which p38 regulates oligodendrocyte differentiation and myelination.	[Haines, Jeffery D.; Almazan, Guillermina] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Fulton, Debra L.; Almazan, Guillermina] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst & Hosp, Montreal, PQ H3A 2B4, Canada; [Richard, Stephane] McGill Univ, Terry Fox Mol Oncol Grp, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Richard, Stephane] McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; [Richard, Stephane] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada	McGill University; McGill University; Lady Davis Institute; McGill University; McGill University; McGill University	Almazan, G (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Sir William Osler Promenade, Montreal, PQ H3G 1Y6, Canada.	guillermina.almazan@mcgill.ca			Multiple Sclerosis Society of Canada (MSSC); Canadian Institutes of Health Research (CIHR); MSSC	Multiple Sclerosis Society of Canada (MSSC); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); MSSC	This work was supported by operating grants from the Multiple Sclerosis Society of Canada (MSSC) to SR and GA and Canadian Institutes of Health Research (CIHR) to GA. JDH held a studentship from the MSSC. DLF held a postdoctoral fellowship from MSSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by two operating grants from the Multiple Sclerosis Society of Canada (MSSC) to SR and GA and one operating grant from the Canadian Institutes of Health Research (CIHR) to GA. JDH held a doctoral studentship from the MSSC. DLF held a postdoctoral fellowship from MSSC.	Abe I, 2007, BIOCHEM BIOPH RES CO, V352, P259, DOI 10.1016/j.bbrc.2006.11.014; Almazan G, 2001, MICROSC RES TECHNIQ, V52, P753, DOI 10.1002/jemt.1060; Ambrosino C, 2003, MOL CELL BIOL, V23, P370, DOI 10.1128/MCB.23.1.370-381.2003; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayllon V, 2007, ONCOGENE, V26, P3451, DOI 10.1038/sj.onc.1210142; Baroti T, 2016, GLIA, V64, P122, DOI 10.1002/glia.22919; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Billon N, 2002, EMBO J, V21, P6452, DOI 10.1093/emboj/cdf662; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cai J, 2010, GLIA, V58, P458, DOI 10.1002/glia.20937; Casaccia-Bonnefil P, 1999, DEVELOPMENT, V126, P4027; Chew LJ, 2010, J NEUROSCI, V30, P11011, DOI 10.1523/JNEUROSCI.2546-10.2010; Chung SH, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.119; Dougherty JD, 2005, J NEUROSCI, V25, P10773, DOI 10.1523/JNEUROSCI.3207-05.2005; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Engel FB, 2006, J MOL CELL CARDIOL, V41, P601, DOI 10.1016/j.yjmcc.2006.06.012; Ferreiro I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-144; Fragoso G, 2007, GLIA, V55, P1531, DOI 10.1002/glia.20567; Haines JD, 2008, J MOL NEUROSCI, V35, P23, DOI 10.1007/s12031-007-9011-0; Haines JD, 2010, GLIA, V58, P1384, DOI 10.1002/glia.21014; Hammond E, 2015, J NEUROSCI, V35, P5007, DOI 10.1523/JNEUROSCI.4787-14.2015; HOLZMAN LB, 1994, J BIOL CHEM, V269, P30808; Lavoie J N, 1996, Prog Cell Cycle Res, V2, P49; Li HL, 2009, CURR OPIN NEUROBIOL, V19, P479, DOI 10.1016/j.conb.2009.08.004; Liu H, 2009, GLIA, V57, P1, DOI 10.1002/glia.20729; Liu RG, 2003, DEVELOPMENT, V130, P6221, DOI 10.1242/dev.00868; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Saher G, 2005, NAT NEUROSCI, V8, P468, DOI 10.1038/nn1426; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Tenhunen O, 2006, CIRC RES, V99, P485, DOI 10.1161/01.RES.0000238387.85144.92; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Umemori H, 1999, J NEUROSCI, V19, P1393; Wang SZ, 2006, DEVELOPMENT, V133, P3389, DOI 10.1242/dev.02522; Wegner M, 2008, J MOL NEUROSCI, V35, P3, DOI 10.1007/s12031-007-9008-8; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164; Yu Y, 2010, EPIGENETICS-US, V5, P124, DOI 10.4161/epi.5.2.11160; Zezula J, 2001, EMBO REP, V2, P27, DOI 10.1093/embo-reports/kve008; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	41	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145843	10.1371/journal.pone.0145843	http://dx.doi.org/10.1371/journal.pone.0145843			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714323	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900092
J	Laceulle, OM; Kleber, RJ; Alisic, E				Laceulle, Odilia M.; Kleber, Rolf J.; Alisic, Eva			Children's Experience of Posttraumatic Growth: Distinguishing General from Domain-Specific Correlates	PLOS ONE			English	Article							QUALITY-OF-LIFE; GENDER-DIFFERENCES; ADOLESCENTS; BENEFIT; INVENTORY; SURVIVORS; CANCER	Although the five domains of posttraumatic growth (new possibilities, relating to others, personal strength, spiritual change and appreciation of life) have been studied extensively in adults, little is known about these domains and their correlates in children. We aimed to examine whether demographic and/or social characteristics are related to children's reports of overall posttraumatic growth and of growth in specific domains. In a general population study, children aged 8-12 years who had been exposed to adverse events (N = 1290) filled out questionnaires on their experiences, demographic characteristics (gender, age, time lag since event), stress reactions, peer support, religiosity and posttraumatic growth. All demographic and social characteristics were related to overall posttraumatic growth, except time lag. Associations varied across the five domains with the strongest effects being found for stress reactions and religiosity. A higher level of stress reactions was related to more growth in all domains (general effect), whereas religious children experienced more spiritual growth than non-religious children without differences on other domains (domain specific effect). Other effects were small, and some did not remain significant after Bonferroni corrections. These findings suggest the presence of both general and domain-specific correlates of child posttraumatic growth. Although effects were generally small, the current findings show the need to differentiate between the domains of posttraumatic growth in both further research and clinical practice. This will allow a better understanding of the mechanisms of posttraumatic growth in children as well as more tailored assessment and intervention.	[Laceulle, Odilia M.] Tilburg Univ, Med & Clin Psychol, NL-5000 LE Tilburg, Netherlands; [Kleber, Rolf J.] Univ Utrecht, Clin & Hlth Psychol, Utrecht, Netherlands; [Kleber, Rolf J.] Netherlands & Fdn Arq, Diemen, Netherlands; [Alisic, Eva] Monash Univ, UMC Utrecht, Australia & Natl Psychotrauma Ctr Children & Yout, Monash Injury Res Insititute, Utrecht, Netherlands	Tilburg University; Utrecht University; Utrecht University; Utrecht University Medical Center	Alisic, E (corresponding author), Monash Univ, UMC Utrecht, Australia & Natl Psychotrauma Ctr Children & Yout, Monash Injury Res Insititute, Utrecht, Netherlands.	eva.alisic@monash.edu	Laceulle, Odilia M./R-5049-2018	Laceulle, Odilia M./0000-0002-4305-512X; Alisic, Eva/0000-0002-7225-606X	Madurodamfonds (The Hague, the Netherlands); Fonds Slachtofferhulp (The Hague, the Netherlands); Stichting Achmea Slachtoffer en Samenleving (Zeist, the Netherlands); Monash University (Australia)	Madurodamfonds (The Hague, the Netherlands)(Netherlands Government); Fonds Slachtofferhulp (The Hague, the Netherlands)(Netherlands Government); Stichting Achmea Slachtoffer en Samenleving (Zeist, the Netherlands)(Netherlands Government); Monash University (Australia)(Monash University)	This study was supported by grants from Prof. H.A. Wijerstichting (Utrecht, the Netherlands), Madurodamfonds (The Hague, the Netherlands), Fonds Slachtofferhulp (The Hague, the Netherlands), Stichting Achmea Slachtoffer en Samenleving (Zeist, the Netherlands), and Monash University (Australia).	Alisic E, 2010, J CHILD ADOLESCENT T, V3, P192, DOI DOI 10.1080/19361521.2010.500979; Alisic E, 2008, J CLIN PSYCHIAT, V69, P1455, DOI 10.4088/JCP.v69n0913; Barakat LP, 2006, J PEDIATR PSYCHOL, V31, P413, DOI 10.1093/jpepsy/jsj058; Calhoun L. G., 2006, HDB POSTTRAUMATIC GR, P3; Cohen LH, 1998, LEA SER PER CLIN PSY, P23; Currier JM, 2009, J PEDIATR PSYCHOL, V34, P1129, DOI 10.1093/jpepsy/jsp021; Gallaway MS, 2011, J CLIN PSYCHOL, V67, P1151, DOI 10.1002/jclp.20837; Hafstad GS, 2010, AM J ORTHOPSYCHIAT, V80, P248, DOI 10.1111/j.1939-0025.2010.01028.x; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Janoff-Bulman R, 2004, PSYCHOL INQ, V15, P30; Karanci AN, 2012, EUROPEAN J PSYCHOTRA, P3; Kilmer R. P., 2006, HDB POSTTRAUMATIC GR, P264; Kilmer RP, 2009, J TRAUMA STRESS, V22, P248, DOI 10.1002/jts.20410; Kimhi S, 2010, COMMUNITY MENT HLT J, V46, P10, DOI 10.1007/s10597-009-9183-x; Laufer A, 2006, J SOC CLIN PSYCHOL, V25, P429, DOI 10.1521/jscp.2006.25.4.429; Laufer A, 2009, J SOC CLIN PSYCHOL, V28, P862, DOI 10.1521/jscp.2009.28.7.862; MCMILLEN C, 1995, J CONSULT CLIN PSYCH, V63, P1037, DOI 10.1037/0022-006X.63.6.1037; Meyerson DA, 2011, CLIN PSYCHOL REV, V31, P949, DOI 10.1016/j.cpr.2011.06.003; Milam JE, 2004, J ADOLESCENT RES, V19, P192, DOI 10.1177/0743558403258273; Morris BA, 2005, J TRAUMA STRESS, V18, P575, DOI 10.1002/jts.20067; Nishi D, 2010, RES POSTTRAUMATIC GR; Nolen-Hoeksema S, 2004, PSYCHOL INQ, V15, P60; NOLENHOEKSEMA S, 1994, PSYCHOL BULL, V115, P424, DOI 10.1037/0033-2909.115.3.424; Prati G, 2009, J LOSS TRAUMA, V14, P364, DOI 10.1080/15325020902724271; Ravens-Sieberer U, 2007, QUAL LIFE RES, V16, P1347, DOI 10.1007/s11136-007-9240-2; Salter E, 2004, J TRAUMA STRESS, V17, P335, DOI 10.1023/B:JOTS.0000038482.53911.01; Stanton AL, 2006, POSTTRAUMATIC GROWTH; Tedeschi R.G., 1995, TRAUMA TRANSFORMATIO, V1st; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Vishnevsky T, 2010, PSYCHOL WOMEN QUART, V34, P110, DOI 10.1111/j.1471-6402.2009.01546.x; Wolchik SA, 2008, OMEGA-J DEATH DYING, V58, P107, DOI 10.2190/OM.58.2.b; Yu XN, 2010, J AFFECT DISORDERS, V123, P327, DOI 10.1016/j.jad.2009.09.019	33	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145736	10.1371/journal.pone.0145736	http://dx.doi.org/10.1371/journal.pone.0145736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0IX	26714193	Green Published, gold			2022-12-27	WOS:000367481900074
J	Wu, HY; Cao, DN; Liu, TX; Zhao, JM; Hu, XX; Li, N				Wu, Hanyu; Cao, Dainan; Liu, Tongxin; Zhao, Jianmin; Hu, Xiaoxiang; Li, Ning			Purification and Characterization of Recombinant Human Lysozyme from Eggs of Transgenic Chickens	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; OVERCOMING ANTIMICROBIAL RESISTANCE; IMPROVES GROWTH-PERFORMANCE; OVIDUCT-SPECIFIC EXPRESSION; SMALL-INTESTINAL MORPHOLOGY; MAMMARY-GLAND; NURSERY PIGS; WHITE; MILK; ANTIBACTERIAL	Transgenic chickens as bioreactors have several advantages, such as the simple establishment procedure, correct glycosylation profile of expressed proteins, etc. Lysozyme is widely used in food industry, livestock farming, and medical field as a replacement of antibiotics because of its antibacterial and complement system-modulating activity. In this study, we used RT-PCR, Western blot, and immunofluorescence to detect the expression of recombinant human lysozyme (rhLY) in the transgenic chicken. We demonstrated that the transgene of rhLY was genetically stable across different generations. We next optimized the purification procedure of rhLY from the transgenic eggs by utilizing two steps of cationex-change chromatography and one gel-filtration chromatography. About 6 mg rhLY with the purity exceeding 90% was obtained from ten eggs, and the purification efficiency was about 75%. The purified rhLY had similar physicochemical and biological properties in molecular mass and antibacterial activity compared to the commercial human lysozyme. Additionally, both of them exhibited thermal stability at 60 degrees C and tolerated an extensive pH range of 2 to 11. In conclusion, our study proved that the transgenic chickens we have previously generated were genetically stable and suitable for the production of active rhLY. We also provided a pipeline for purifying the recombinant proteins from transgenic eggs, which could be useful for other studies.	[Wu, Hanyu; Cao, Dainan; Liu, Tongxin; Hu, Xiaoxiang; Li, Ning] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Zhao, Jianmin] Wuxi KGBIO Biotechnol Ltd Liabil Co, Wuxi 214145, Jiangsu, Peoples R China	China Agricultural University	Hu, XX (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	huxx@cau.edu.cn		Cao, Dainan/0000-0001-6119-9357	Key Technology Research and Development Program of Guangdong Emerging Strategic Industries [2012A020800005]; National Advanced Technology Research and Development Program of China [2011AA100301]; National Key Technology RD Program [2011BAD28B03]	Key Technology Research and Development Program of Guangdong Emerging Strategic Industries; National Advanced Technology Research and Development Program of China; National Key Technology RD Program(National Key Technology R&D Program)	This work was financially supported by Key Technology Research and Development Program of Guangdong Emerging Strategic Industries (2012A020800005), National Advanced Technology Research and Development Program of China (2011AA100301), and National Key Technology R&D Program (2011BAD28B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERTON G, 1945, J BIOL CHEM, V157, P43; Baase WA, 2010, PROTEIN SCI, V19, P631, DOI 10.1002/pro.344; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Cao DN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118626; ELLISON RT, 1991, J CLIN INVEST, V88, P1080, DOI 10.1172/JCI115407; Fang EF, 2012, ARCH TOXICOL, V86, P293, DOI 10.1007/s00204-011-0751-9; FAURE A, 1970, FEBS LETT, V10, P237, DOI 10.1016/0014-5793(70)80637-8; Fleming A, 1922, P R SOC LOND B-CONTA, V93, P306, DOI 10.1098/rspb.1922.0023; GRUTTER MG, 1979, J MOL BIOL, V135, P1029, DOI 10.1016/0022-2836(79)90527-8; Huang JM, 2002, TRANSGENIC RES, V11, P229, DOI 10.1023/A:1015663706259; Humphrey BD, 2002, J NUTR, V132, P1214, DOI 10.1093/jn/132.6.1214; JOLLES J, 1967, BIOCHEMISTRY-US, V6, P411, DOI 10.1021/bi00854a007; Kaleri HA, 2011, GENET MOL RES, V10, P3046, DOI 10.4238/2011.December.8.1; Larsen MR, 2006, BIOTECHNIQUES, V40, P790, DOI 10.2144/000112201; Leclercq R, 2001, J ANTIMICROB CHEMOTH, V48, P9, DOI 10.1093/jac/48.suppl_2.9; Lee M, 2009, J AGR FOOD CHEM, V57, P2233, DOI 10.1021/jf803133b; Lee-Huang S, 1999, P NATL ACAD SCI USA, V96, P2678, DOI 10.1073/pnas.96.6.2678; LI YM, 1995, NAT MED, V1, P1057, DOI 10.1038/nm1095-1057; LICHAN E, 1985, CAN I FOOD SC TECH J, V18, pR38; Lillico SG, 2007, P NATL ACAD SCI USA, V104, P1771, DOI 10.1073/pnas.0610401104; Lillico SG, 2005, DRUG DISCOV TODAY, V10, P191, DOI 10.1016/S1359-6446(04)03317-3; Liu S, 2012, TRANSGENIC RES, V21, P407, DOI 10.1007/s11248-011-9536-4; Liu TX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127922; Lu D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089130; Macdonald J, 2012, P NATL ACAD SCI USA, V109, pE1466, DOI 10.1073/pnas.1118715109; Maga EA, 2006, J DAIRY SCI, V89, P518, DOI 10.3168/jds.S0022-0302(06)72114-2; Maga EA, 1995, J DAIRY SCI, V78, P2645, DOI 10.3168/jds.S0022-0302(95)76894-1; Maullu C, 1999, APPL ENVIRON MICROB, V65, P2745; May KD, 2012, J ANIM SCI, V90, P1118, DOI 10.2527/jas.2011-4297; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; MINE Y, 1995, TRENDS FOOD SCI TECH, V6, P225, DOI 10.1016/S0924-2244(00)89083-4; Nakajima H, 1997, PLANT CELL REP, V16, P674, DOI 10.1007/s002990050300; Ogundele MO, 1998, MEDIAT INFLAMM, V7, P363, DOI 10.1080/09629359890893; Oka C, 1999, BIOSCI BIOTECH BIOCH, V63, P1977, DOI 10.1271/bbb.63.1977; Oliver WT, 2014, J ANIM SCI, V92, P4927, DOI 10.2527/jas.2014-8033; Oliver WT, 2013, J ANIM SCI, V91, P3129, DOI 10.2527/jas.2012-5782; Park TS, 2015, FASEB J, V29, P2386, DOI 10.1096/fj.14-264739; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; Phillips JC, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051916; Poole K, 2001, J PHARM PHARMACOL, V53, P283, DOI 10.1211/0022357011775514; PROCTOR VA, 1988, CRC CR REV FOOD SCI, V26, P359, DOI 10.1080/10408398809527473; SALTON MRJ, 1957, BACTERIOL REV, V21, P82, DOI 10.1128/MMBR.21.2.82-100.1957; Schusser B, 2013, P NATL ACAD SCI USA, V110, P20170, DOI 10.1073/pnas.1317106110; SHUGAR D, 1952, BIOCHIM BIOPHYS ACTA, V8, P302, DOI 10.1016/0006-3002(52)90045-0; Spencer A, 1999, PROTEIN EXPRES PURIF, V16, P171, DOI 10.1006/prep.1999.1036; Su CK, 2006, PROCESS BIOCHEM, V41, P257, DOI 10.1016/j.procbio.2005.06.026; Tong J, 2011, TRANSGENIC RES, V20, P417, DOI 10.1007/s11248-010-9409-2; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Wang SY, 2005, BIOCHEM BIOPH RES CO, V327, P820, DOI 10.1016/j.bbrc.2004.12.077; Wilken LR, 2006, BIOTECHNOL PROGR, V22, P745, DOI 10.1021/bp0600536; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017593; Ye XJ, 2011, J AGR FOOD CHEM, V59, P10232, DOI 10.1021/jf201874j; Yu Z, 2006, J DAIRY SCI, V89, P2911, DOI 10.3168/jds.S0022-0302(06)72563-2	54	13	15	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0146032	10.1371/journal.pone.0146032	http://dx.doi.org/10.1371/journal.pone.0146032			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713728	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900111
J	Brassine, E; Parker, D				Brassine, Eleanor; Parker, Daniel			Trapping Elusive Cats: Using Intensive Camera Trapping to Estimate the Density of a Rare African Felid	PLOS ONE			English	Article							CHEETAH ACINONYX-JUBATUS; RANGING BEHAVIOR; POPULATION; PARDALIS; BOLIVIA; EXAMPLE; LAND	Camera trapping studies have become increasingly popular to produce population estimates of individually recognisable mammals. Yet, monitoring techniques for rare species which occur at extremely low densities are lacking. Additionally, species which have unpredictable movements may make obtaining reliable population estimates challenging due to low detectability. Our study explores the effectiveness of intensive camera trapping for estimating cheetah (Acinonyx jubatus) numbers. Using both a more traditional, systematic grid approach and pre-determined, targeted sites for camera placement, the cheetah population of the Northern Tuli Game Reserve, Botswana was sampled between December 2012 and October 2013. Placement of cameras in a regular grid pattern yielded very few (n = 9) cheetah images and these were insufficient to estimate cheetah density. However, pre-selected cheetah scent-marking posts provided 53 images of seven adult cheetahs (0.61 +/- 0.18 cheetahs/100km(2)). While increasing the length of the camera trapping survey from 90 to 130 days increased the total number of cheetah images obtained (from 53 to 200), no new individuals were recorded and the estimated population density remained stable. Thus, our study demonstrates that targeted camera placement (irrespective of survey duration) is necessary for reliably assessing cheetah densities where populations are naturally very low or dominated by transient individuals. Significantly our approach can easily be applied to other rare predator species.	[Brassine, Eleanor; Parker, Daniel] Rhodes Univ, Dept Zool & Entomol, Wildlife & Reserve Management Res Grp, ZA-6140 Grahamstown, South Africa	Rhodes University	Brassine, E (corresponding author), Rhodes Univ, Dept Zool & Entomol, Wildlife & Reserve Management Res Grp, ZA-6140 Grahamstown, South Africa.	alienor.brassine@gmail.com	Parker, Daniel/J-2649-2019	Parker, Daniel/0000-0001-7555-5674	National Geographic Society's Big Cat Initiative Grants [B4-12]; Rufford Small Grants Foundation [11858-1]; Idea Wild; Zoofari Foundation; Mashatu Game Reserve; Botswana Ministry of Environment, Wildlife and Tourism; Department of Wildlife and National Park; Northern Tuli Game Reserve	National Geographic Society's Big Cat Initiative Grants; Rufford Small Grants Foundation; Idea Wild; Zoofari Foundation; Mashatu Game Reserve; Botswana Ministry of Environment, Wildlife and Tourism; Department of Wildlife and National Park; Northern Tuli Game Reserve	This work was supported by the National Geographic Society's Big Cat Initiative Grants, Grant B4-12, http://animals.nationalgeographic.com/animals/big-cats-initiative/. The funds were received by EB. It also received support from the Rufford Small Grants Foundation, Grant 11858-1, http://www.rufford.org/; Idea Wild, www.ideawild.org/; Zoofari Foundation, http://www.wildwonders.org/zoofari-foundation/; and Mashatu Game Reserve, http://mashatu.com/. The funds from each of these sources were received by EB. The authors are also thankful to The Northern Tuli Game Reserve landowners. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Botswana Ministry of Environment, Wildlife and Tourism and the Department of Wildlife and National Park for granting permission to conduct research in Botswana. We are also thankful to Mashatu Game Reserve and The Northern Tuli Game Reserve landowners for authorising and supporting this research. Thanks to the field guides of Mashatu Game Reserve, particularly Fish Maila, Bashi Patane and Elvis Ramogale for assisting with finding of scent marking posts. We would like to thank particularly Mike Dexter for help with data collection in the field and Andy Royle for assistance with the SPACECAP program.	Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; Belbachir F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115136; Blake John G, 2014, Mastozool. neotrop., V21, P17; Borah J, 2014, ORYX, V48, P149, DOI 10.1017/S0030605312000373; Bothma J.d.P., 1999, LARGER CARNIVORES AF, P22, DOI [10.1007/978-3-662-03766-9_2/COVER, DOI 10.1007/978-3-662-03766-9_2/COVER]; Brassine E. I., 2014, THESIS; Buk K., 2010, Africa Insight, V39, P212; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; Caro T., 1994, CHEETAHS SERENGETI P; Dillon A, 2007, ORYX, V41, P469, DOI 10.1017/S0030605307000518; Durant SM, 2007, CONSERV BIOL, V21, P602, DOI 10.1111/j.1523-1739.2007.00702.x; Durant Sarah M., 2010, P373; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; Gray TNE, 2012, J WILDLIFE MANAGE, V76, P163, DOI 10.1002/jwmg.230; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Götze Albie R., 2008, Koedoe, V50, P72; Gopalaswamy AM, 2013, PACKAGE SPACECAP PRO; Gopalaswamy AM, 2012, METHODS ECOL EVOL, V3, P1067, DOI 10.1111/j.2041-210X.2012.00241.x; Gros PM, 1998, BIOL CONSERV, V85, P137, DOI 10.1016/S0006-3207(97)00135-3; Hayward MW, 2009, S AFR J WILDL RES, V39, P109, DOI 10.3957/056.039.0207; Heilbrun RD, 2003, WILDLIFE SOC B, V31, P748; Henschel P, 2003, LEOPARDS AFRICAN RAI; Houser A, 2009, S AFR J WILDL RES, V39, P11, DOI 10.3957/056.039.0102; Hunter L., 1998, CHEETAHS GAME RANCH, P72; IUCN, 2013, IUCN RED LIST THREAT; Jackson CR, 2012, WILDLIFE RES, V39, P31, DOI 10.1071/WR11070; Jenness J., 2012, REPEATING SHAPES ARC; Karanth K.U., 2002, MONITORING TIGERS TH, DOI [10.1111/j.1523-1739.2003.01769.x, DOI 10.1111/J.1523-1739.2003.01769.X]; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Karanth KU, 1998, ECOLOGY, V79, P2852; Kelly MJ, 2008, J MAMMAL, V89, P408, DOI 10.1644/06-MAMM-A-424R.1; Kelly MJ, 1998, J ZOOL, V244, P473, DOI 10.1017/S0952836998004014; Kelly MJ, 2001, J MAMMAL, V82, P440, DOI 10.1644/1545-1542(2001)082<0440:CAPMIS>2.0.CO;2; Lind P, 1974, UNPUB; Long RA, 2008, NONINVASIVE SURVEY M; Maffei L, 2005, J TROP ECOL, V21, P349, DOI 10.1017/S0266467405002397; Marker LL, 2008, J ZOOL, V274, P226, DOI 10.1111/j.1469-7998.2007.00375.x; Marker L.L., 2002, THESIS; Marker Laurie L., 2008, Cat News, V49, P22; Marnewick KA, 2006, S AFR J WILDL RES, V36, P139; Marnewick K, 2008, S AFR J WILDL RES, V38, P59, DOI 10.3957/0379-4369-38.1.59; McKenzie AA, 1990, THESIS; Mills M.G.L., 1984, Koedoe, V27, P237; Negroes N, 2012, ECOL RES, V27, P639, DOI 10.1007/s11284-012-0938-4; Negroes N, 2010, J WILDLIFE MANAGE, V74, P1195, DOI 10.2193/2009-256; Noss A, 2013, EVALUATING JAGUAR DE; O'Brien TG, 2011, ECOL APPL, V21, P2908, DOI 10.1890/10-2284.1; OConnell AF, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P1, DOI 10.1007/978-4-431-99495-4; OTIS DL, 1978, WILDLIFE MONOGR, P1; Otis DL., 1982, CAPTURE RECAPTURE RE; Pettorelli N, 2009, J ZOOL, V277, P141, DOI 10.1111/j.1469-7998.2008.00522.x; Ray JC, 2005, 24 WCS; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Silvers S, 2004, ASSESSING JAGUAR ABU; Soisalo MK, 2006, BIOL CONSERV, V129, P487, DOI 10.1016/j.biocon.2005.11.023; Stanley TR, 1999, ENVIRON ECOL STAT, V6, P197, DOI 10.1023/A:1009674322348; Steyn T., 2004, NO TULI GAME RESERVE; Thompson SK, 1998, MONITORING VERTEBRAT; Trolle M, 2003, J MAMMAL, V84, P607, DOI 10.1644/1545-1542(2003)084<0607:EOODIT>2.0.CO;2; Walker CH, 1971, FIELD IMPRESS UNPUB; Wilson K., 2006, THESIS	62	35	35	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0142508	10.1371/journal.pone.0142508	http://dx.doi.org/10.1371/journal.pone.0142508			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698574	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092600003
J	Cornman, RS; Otto, CRV; Iwanowicz, D; Pettis, JS				Cornman, R. Scott; Otto, Clint R. V.; Iwanowicz, Deborah; Pettis, Jeffery S.			Taxonomic Characterization of Honey Bee (Apis mellifera) Pollen Foraging Based on Non-Overlapping Paired-End Sequencing of Nuclear Ribosomal Loci	PLOS ONE			English	Article							NORTHERN GREAT-PLAINS; READ ALIGNMENT; PLANTS; POLLINATORS; VISITATION; PHYLOGENY; FORAGERS; BEHAVIOR; TRENDS	Identifying plant taxa that honey bees (Apis mellifera) forage upon is of great apicultural interest, but traditional methods are labor intensive and may lack resolution. Here we evaluate a high-throughput genetic barcoding approach to characterize trap-collected pollen from multiple North Dakota apiaries across multiple years. We used the Illumina MiSeq platform to generate sequence scaffolds from non-overlapping 300-bp paired-end sequencing reads of the ribosomal internal transcribed spacers (ITS). Full-length sequence scaffolds represented similar to 530 bp of ITS sequence after adapter trimming, drawn from the 5' of ITS1 and the 3' of ITS2, while skipping the uninformative 5.8S region. Operational taxonomic units (OTUs) were picked from scaffolds clustered at 97% identity, searched by BLAST against the nt database, and given taxonomic assignments using the paired-read lowest common ancestor approach. Taxonomic assignments and quantitative patterns were consistent with known plant distributions, phenology, and observational reports of pollen foraging, but revealed an unexpected contribution from non-crop graminoids and wetland plants. The mean number of plant species assignments per sample was 23.0 (+/-5.5) and the mean species diversity (effective number of equally abundant species) was 3.3 (+/-1.2). Bray-Curtis similarities showed good agreement among samples from the same apiary and sampling date. Rarefaction plots indicated that fewer than 50,000 reads are typically needed to characterize pollen samples of this complexity. Our results show that a pre-compiled, curated reference database is not essential for genus-level assignments, but species-level assignments are hindered by database gaps, reference length variation, and probable errors in the taxonomic assignment, requiring post-hoc evaluation. Although the effective per-sample yield achieved using custom MiSeq amplicon primers was less than the machine maximum, primarily due to lower "read2" quality, further protocol optimization and/or a modest reduction in multiplex scale should offset this difficulty. As small quantities of pollen are sufficient for amplification, our approach might be extendable to other questions or species for which large pollen samples are not available.	[Cornman, R. Scott] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA; [Otto, Clint R. V.] US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND 58401 USA; [Iwanowicz, Deborah] US Geol Survey, Leetown Sci Ctr, Kearneysville, WV 25430 USA; [Pettis, Jeffery S.] USDA ARS, Beltsville Agr Res Ctr, Bee Res Lab, Beltsville, MD 20705 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA)	Cornman, RS (corresponding author), US Geol Survey, Ft Collins Sci Ctr, 2150 Ctr Ave, Ft Collins, CO 80526 USA.	rcornman@usgs.gov			US Department of Agriculture-Farm Service Agency; USDA-Natural Resources Conservation Service; US Geological Survey Ecosystems Mission Area	US Department of Agriculture-Farm Service Agency; USDA-Natural Resources Conservation Service(United States Department of Agriculture (USDA)); US Geological Survey Ecosystems Mission Area	Funding was provided by the US Department of Agriculture-Farm Service Agency and USDA-Natural Resources Conservation Service (JSP, CRVO), and by the US Geological Survey Ecosystems Mission Area (CRVO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Arnheim N., 1983, P38; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; Becher MA, 2014, J APPL ECOL, V51, P470, DOI 10.1111/1365-2664.12222; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bosch J, 2009, ECOL LETT, V12, P409, DOI 10.1111/j.1461-0248.2009.01296.x; Brosi BJ, 2009, FOREST ECOL MANAG, V258, P1846, DOI 10.1016/j.foreco.2009.02.027; Buckler ES, 1997, GENETICS, V145, P821; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; CORRIVEAU JL, 1991, DEV BIOL, V147, P271, DOI 10.1016/S0012-1606(05)80024-7; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; Dunnell KL, 2011, AM J BOT, V98, P935, DOI 10.3732/ajb.1000363; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FEWELL JH, 1992, BEHAV ECOL SOCIOBIOL, V30, P387, DOI 10.1007/BF00176173; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Harano K, 2014, NATURWISSENSCHAFTEN, V101, P595, DOI 10.1007/s00114-014-1185-z; Herbert E.W., 1992, HIVE HONEY BEE, P197; Hooper T, 1985, ILLUSTRATED ENCY BEE; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jeffree E., 1957, J ECON ENTOMOL, V50, P211, DOI 10.1093/jee/50.2.211; Kalle Elena, 2014, Biomol Detect Quantif, V2, P11; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Keller A, 2015, PLANT BIOLOGY, V17, P558, DOI 10.1111/plb.12251; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kraaijeveld K, 2015, MOL ECOL RESOUR, V15, P8, DOI 10.1111/1755-0998.12288; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larson DL, 2006, BIOL CONSERV, V130, P148, DOI 10.1016/j.biocon.2005.12.009; Larson DL, 2014, J APPL ECOL, V51, P1024, DOI 10.1111/1365-2664.12273; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lihoreau Mathieu, 2013, Commun Integr Biol, V6, pe22701, DOI 10.4161/cib.22701; Marcon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090289; Mitra S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S12; Morandin LA, 2013, RESTOR ECOL, V21, P26, DOI 10.1111/j.1526-100X.2012.00876.x; National Honey Bee Health Stakeholder Conference Steering Committee, 2012, REP NAT STAK C HON B; North Dakota Department of Agriculture, ABS WORMW ART ABS; Noyes RD, 1999, AM J BOT, V86, P398, DOI 10.2307/2656761; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Pankiw T, 1998, BEHAV ECOL SOCIOBIOL, V44, P193, DOI 10.1007/s002650050531; Pernal SF, 2001, BEHAV ECOL SOCIOBIOL, V51, P53, DOI 10.1007/s002650100412; Pollinator Health Task Force, 2015, POLL RES ACT PLAN; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Reiter R., 1947, OHIO JOUR SCI, V47, P137; Richardson RT, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400066; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Sakamoto Wataru, 2008, Arabidopsis Book, V6, pe0110, DOI 10.1199/tab.0110; Seeley T. D., 2009, WISDOM HIVE SOCIAL P; Shipunov A, 2012, FLORA N DAKOTA CHECK; Sickel W, 2015, BMC ECOL, V15, DOI 10.1186/s12898-015-0051-y; Simone-Finstrom M, 2010, APIDOLOGIE, V41, P295, DOI 10.1051/apido/2010016; SIMS PL, 2000, N AM TERRESTRIAL VEG, P324; Slagle MW, 2009, OECOLOGIA, V161, P813, DOI 10.1007/s00442-009-1429-3; Slotta Tracey A. Bodo, 2012, Plants-Basel, V1, P61, DOI 10.3390/plants1020061; Smart MD, 2015, THESIS; Stanford AM, 2000, AM J BOT, V87, P872, DOI 10.2307/2656895; Travers S. E., 2009, Ecology, V90, P2332, DOI 10.1890/08-2135.1; Tuell JK, 2008, ENVIRON ENTOMOL, V37, P707, DOI 10.1603/0046-225X(2008)37[707:VBWAMB]2.0.CO;2; US Department of Agriculture National Resources Conservation Service, USDA NRCS PLANTS DAT; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vaughan DM, 2002, INSECT SOC, V49, P23, DOI 10.1007/s00040-002-8273-3; Wang H, 2014, APIDOLOGIE, V45, P618, DOI 10.1007/s13592-014-0276-3; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wilson EE, 2010, MOL ECOL, V19, P4823, DOI 10.1111/j.1365-294X.2010.04849.x; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110	76	36	36	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145365	10.1371/journal.pone.0145365	http://dx.doi.org/10.1371/journal.pone.0145365			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700168	gold, Green Submitted, Green Published			2022-12-27	WOS:000367092600071
J	Greene, SL; Kesoju, SR; Martin, RC; Kramer, M				Greene, Stephanie L.; Kesoju, Sandya R.; Martin, Ruth C.; Kramer, Matthew			Occurrence of Transgenic Feral Alfalfa (Medicago sativa subsp sativa L.) in Alfalfa Seed Production Areas in the United States	PLOS ONE			English	Article							GENE FLOW; OILSEED RAPE; HERBICIDE RESISTANCE; BRASSICA-NAPUS; CREEPING BENTGRASS; TRAIT CONFINEMENT; WESTERN CANADA; POPULATIONS; ORIGIN; PLANTS	The potential environmental risks of transgene exposure are not clear for alfalfa (Medicago sativa subsp. sativa), a perennial crop that is cross-pollinated by insects. We gathered data on feral alfalfa in major alfalfa seed-production areas in the western United States to (1) evaluate evidence that feral transgenic plants spread transgenes and (2) determine environmental and agricultural production factors influencing the location of feral alfalfa, especially transgenic plants. Road verges in Fresno, California; Canyon, Idaho; and Walla Walla, Washington were surveyed in 2011 and 2012 for feral plants, and samples were tested for the CP4 EPSPS protein that conveys resistance to glyphosate. Of 4580 sites surveyed, feral plants were observed at 404 sites. Twenty-seven percent of these sites had transgenic plants. The frequency of sites having transgenic feral plants varied among our study areas. Transgenic plants were found in 32.7%, 21.4.7% and 8.3% of feral plant sites in Fresno, Canyon and Walla Walla, respectively. Spatial analysis suggested that feral populations started independently and tended to cluster in seed and hay production areas, places where seed tended to drop. Significant but low spatial auto correlation suggested that in some instances, plants colonized nearby locations. Neighboring feral plants were frequently within pollinator foraging range; however, further research is needed to confirm transgene flow. Locations of feral plant clusters were not well predicted by environmental and production variables. However, the likelihood of seed spillage during production and transport had predictive value in explaining the occurrence of transgenic feral populations. Our study confirms that genetically engineered alfalfa has dispersed into the environment, and suggests that minimizing seed spillage and eradicating feral alfalfa along road sides would be effective strategies to minimize transgene dispersal.	[Greene, Stephanie L.] ARS, Plant & Anim Genet Resource Preservat Unit, USDA, Ft Collins, CO 80521 USA; [Kesoju, Sandya R.] Washington State Univ, Irrigated Agr Res & Extens Ctr, Prosser, WA 99350 USA; [Martin, Ruth C.] ARS, Forage Seed & Cereal Res Unit, USDA, Corvallis, OR USA; [Kramer, Matthew] ARS, Stat Grp, USDA, Beltsville, MD USA	United States Department of Agriculture (USDA); Washington State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Greene, SL (corresponding author), ARS, Plant & Anim Genet Resource Preservat Unit, USDA, Ft Collins, CO 80521 USA.	stephanie.greene@ars.usda.gov		Greene, Stephanie/0000-0002-3624-5021	USDA Office of the Secretary Biotechnology Funds; Biotechnology Risk Assessment Grant Program competitive grant from the USDA NIFA [2011-33522-30733]; USDA, Agricultural Research Service	USDA Office of the Secretary Biotechnology Funds; Biotechnology Risk Assessment Grant Program competitive grant from the USDA NIFA; USDA, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the USDA Office of the Secretary Biotechnology Funds, Biotechnology Risk Assessment Grant Program competitive grant no. 2011-33522-30733 from the USDA NIFA, and the USDA, Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amand PCS, 2000, THEOR APPL GENET, V101, P107, DOI 10.1007/s001220051457; [Anonymous], 2000, CROP POLLINATION BEE; AOSCA, 2015, AOSCA ALF SEED STEW; Bagavathiannan MV, 2008, AGR ECOSYST ENVIRON, V127, P1, DOI 10.1016/j.agee.2008.03.009; Bagavathiannan MV, 2009, CRIT REV PLANT SCI, V28, P69, DOI 10.1080/07352680902753613; Bagavathiannan MV, 2010, TRANSGENIC RES, DOI [10.1007/s11248-010-9425-2.42, DOI 10.1007/S11248-010-9425-2.42]; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Booker H., 2012, AgBioForum, V15, P31; Booker H. M., 2014, AgBioForum, V17, P75; Burgeff C., 2014, AgBioForum, V17, P90; Council for Agricultural Science (CAST), 2008, CAST SPEC PUBL, V28; Devos Y, 2012, TRANSGENIC RES, V21, P1, DOI 10.1007/s11248-011-9515-9; Ellstrand NC, 2014, AM J BOT, V101, P737, DOI 10.3732/ajb.1400024; Ellstrand NC, 2013, ANNU REV ECOL EVOL S, V44, P325, DOI 10.1146/annurev-ecolsys-110512-135840; Engels JMM, 2006, GENET RESOUR CROP EV, V53, P1675, DOI 10.1007/s10722-005-1215-y; Franz J., 1997, MONOGRAFIS ACS, V189, P27; Friesen LF, 2003, AGRON J, V95, P1342, DOI 10.2134/agronj2003.1342; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Gesch D., 2007, DIGITAL ELEVATION MO, P99; Getis A, 1995, GEOGR ANAL, V27, P287; Hecht M, 2014, ENVIRON SCI POLLUT R, V21, P1455, DOI 10.1007/s11356-013-1881-9; Heuberger Shannon, 2008, Environmental Biosafety Research, V7, P87, DOI 10.1051/ebr:2008005; Heuberger S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014128; Kendrick DL, 2005, P 60 N CENTR WEED SC; Knispel AL, 2008, WEED SCI, V56, P72, DOI 10.1614/WS-07-097.1; Knispel AL, 2010, ENVIRON SCI POLLUT R, V17, P13, DOI 10.1007/s11356-009-0219-0; Mallory-Smith C, 2008, PEST MANAG SCI, V64, P428, DOI 10.1002/ps.1517; Mitchell A., 2005, ESRI GUIDE GIS ANAL, V2; National Alfalfa and Forage Alliance (NAFA), 2015, GROW OPP ZON NONGE S; National Alfalfa and Forage Alliance (NAFA), 2015, NAFA COEX DOC; National Resources Conservation Services (NRCS), 2015, PLANTS DAT MED SAT F; Packer JS, 1971, THESIS; Padon SA, 2015, J STAT SOFTW, V63, P1; Pivard S, 2008, J APPL ECOL, V45, P476, DOI 10.1111/j.1365-2664.2007.01358.x; Reichman JR, MOL ECOL, V15; Rissler J, 2004, GONE SEED TRANSGENIC, P40; Schoenenberger Nicola, 2012, Environmental Sciences Europe, V24, P23, DOI 10.1186/2190-4715-24-23; Schulze J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114477; Shafer MG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone0025736, DOI 10.1371/J0URNAL.P0NE.0025736]; Small E., 2011, ALFALFA RELATIVES EV; STEINER JJ, 1995, NUCLEIC ACIDS RES, V23, P2569, DOI 10.1093/nar/23.13.2569-a; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; TEPEDINO VJ, 1983, J APICULT RES, V22, P64, DOI 10.1080/00218839.1983.11100561; Theobald DM, 2007, ENVIRON MANAGE, V40, P134, DOI 10.1007/s00267-005-0199-x; United States Department of Agriculture (USDA), 2014, AD GEN ENG CROPS US; WADDINGTON KD, 1994, BEHAV ECOL SOCIOBIOL, V35, P423, DOI 10.1007/BF00165845; Warwick SI, 2008, MOL ECOL, V17, P1387, DOI 10.1111/j.1365-294X.2007.03567.x; Watrud LS, 2004, P NATL ACAD SCI USA, V101, P14533, DOI 10.1073/pnas.0405154101; Wegier A, 2011, MOL ECOL, V20, P4182, DOI 10.1111/j.1365-294X.2011.05258.x; Wolfenbarger LL, 2000, SCIENCE, V290, P2088, DOI 10.1126/science.290.5499.2088; Yoshimura Yasuyuki, 2006, Environmental Biosafety Research, V5, P67, DOI 10.1051/ebr:2006019; Zapiola ML, 2008, J APPL ECOL, V45, P486, DOI 10.1111/j.1365-2664.2007.01430.x	52	19	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0143296	10.1371/journal.pone.0143296	http://dx.doi.org/10.1371/journal.pone.0143296			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699337	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600006
J	Gruchattka, E; Kayser, O				Gruchattka, Evamaria; Kayser, Oliver			In Vivo Validation of In Silico Predicted Metabolic Engineering Strategies in Yeast: Disruption of alpha-Ketoglutarate Dehydrogenase and Expression of ATP-Citrate Lyase for Terpenoid Production	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; HIGH-LEVEL PRODUCTION; COENZYME-A REDUCTASE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; CATALYTIC DOMAIN; ACETYL-COENZYME; ACID; PRECURSOR; SESQUITERPENES	Background Engineering of the central carbon metabolism of Saccharomyces cerevisiae to redirect metabolic flux towards cytosolic acetyl-CoA has become a central topic in yeast biotechnology. A cell factory with increased flux into acetyl-CoA can be used for heterologous production of terpenoids for pharmaceuticals, biofuels, fragrances, or other acetyl-CoA derived compounds. In a previous study, we identified promising metabolic engineering targets in S. cerevisiae using an in silico stoichiometric metabolic network analysis. Here, we validate selected in silico strategies in vivo. Results Patchoulol was produced by yeast via a heterologous patchoulol synthase of Pogostemon cablin. To increase the metabolic flux from acetyl-CoA towards patchoulol, a truncated HMG-CoA reductase was overexpressed and farnesyl diphosphate synthase was fused with patchoulol synthase. The highest increase in production could be achieved by modifying the carbon source; sesquiterpenoid titer increased from glucose to ethanol by a factor of 8.4. Two strategies predicted in silico were chosen for validation in this work. Disruption of a-ketoglutarate dehydrogenase gene (KGD1) was predicted to redirect the metabolic flux via the pyruvate dehydrogenase bypass towards acetyl-CoA. The metabolic flux was redirected as predicted, however, the effect was dependent on cultivation conditions and the flux was interrupted at the level of acetate. High amounts of acetate were produced. As an alternative pathway to synthesize cytosolic acetyl-CoA, ATP-citrate lyase was expressed as a polycistronic construct, however, in vivo performance of the enzyme needs to be optimized to increase terpenoid production. Conclusions Stoichiometric metabolic network analysis can be used successfully as a metabolic prediction tool. However, this study highlights that kinetics, regulation and cultivation conditions may interfere, resulting in poor in vivo performance. Main sites of regulation need to be released and improved enzymes are essential to meet the required activities for an increased product formation in vivo.	[Gruchattka, Evamaria; Kayser, Oliver] TU Dortmund Univ, Dept Biochem & Chem Engn, Tech Biochem, D-44227 Dortmund, Germany	Dortmund University of Technology	Kayser, O (corresponding author), TU Dortmund Univ, Dept Biochem & Chem Engn, Tech Biochem, Emil Figge Str 66, D-44227 Dortmund, Germany.	Oliver.Kayser@bci.tu-dortmund.de	Kayser, Oliver/B-1431-2016; Gruchattka, Evamaria/K-2687-2016	Kayser, Oliver/0000-0001-6131-2495; Gruchattka, Evamaria/0000-0002-8160-4118	Ministry of Innovation, Science and Research of the German Federal State of North Rhine-Westphalia (NRW); TU Dortmund through CLIB-Graduate Cluster Industrial Biotechnology (CLIB)	Ministry of Innovation, Science and Research of the German Federal State of North Rhine-Westphalia (NRW); TU Dortmund through CLIB-Graduate Cluster Industrial Biotechnology (CLIB)	This work was partly funded by the Ministry of Innovation, Science and Research of the German Federal State of North Rhine-Westphalia (NRW) and by TU Dortmund through a scholarship to EG from the CLIB-Graduate Cluster Industrial Biotechnology (CLIB2021; www.graduatecluster.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen L, 2011, APPL ENVIRON MICROB, V77, P1033, DOI 10.1128/AEM.01361-10; Asadollahi MA, 2008, BIOTECHNOL BIOENG, V99, P666, DOI 10.1002/bit.21581; Asadollahi MA, 2010, BIOTECHNOL BIOENG, V106, P86, DOI 10.1002/bit.22668; Asadollahi MA, 2009, METAB ENG, V11, P328, DOI 10.1016/j.ymben.2009.07.001; Becker J, 2003, APPL ENVIRON MICROB, V69, P4144, DOI 10.1128/AEM.69.7.4144-4150.2003; Beekwilder J, 2014, J BIOTECHNOL, V192, P383, DOI 10.1016/j.jbiotec.2013.12.016; BOWMAN SB, 1992, MOL GEN GENET, V231, P296, DOI 10.1007/BF00279803; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodelius M, 2002, EUR J BIOCHEM, V269, P3570, DOI 10.1046/j.1432-1033.2002.03044.x; Carvalheiro F, 2008, J SCI IND RES INDIA, V67, P849; Chavez-Cabrera C, 2010, APPL MICROBIOL BIOT, V85, P1953, DOI 10.1007/s00253-009-2271-6; Chen LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084853; Chen Y, 2015, FEMS YEAST RES, DOI [10.1093/femsyr/fov015, DOI 10.1093/FEMSYR/F0V015]; Chen Y, 2014, METAB ENG, V22, P104, DOI 10.1016/j.ymben.2014.01.005; Chen Y, 2013, METAB ENG, V15, P48, DOI 10.1016/j.ymben.2012.11.002; Chen Y, 2012, FEMS YEAST RES, V12, P598, DOI 10.1111/j.1567-1364.2012.00809.x; CIRIACY M, 1975, MOL GEN GENET, V138, P157, DOI 10.1007/BF02428119; de Jong BW, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-39; Deguerry F, 2006, ARCH BIOCHEM BIOPHYS, V454, P123, DOI 10.1016/j.abb.2006.08.006; Donald KAG, 1997, APPL ENVIRON MICROB, V63, P3341, DOI 10.1128/AEM.63.9.3341-3344.1997; Engels B, 2008, METAB ENG, V10, P201, DOI 10.1016/j.ymben.2008.03.001; Farhi M, 2011, METAB ENG, V13, P474, DOI 10.1016/j.ymben.2011.05.001; Fatland BL, 2002, PLANT PHYSIOL, V130, P740, DOI 10.1104/pp.008110; George KW, 2015, ADV BIOCHEM ENG BIOT, V148, P469, DOI 10.1007/10_2015_310; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Guaragnella N, 2011, BIOCHEM SOC T, V39, P1538, DOI 10.1042/BST0391538; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hadicke O, 2011, METAB ENG, V13, P204, DOI 10.1016/j.ymben.2010.12.004; HEIPIEPER HJ, 1994, TRENDS BIOTECHNOL, V12, P409, DOI 10.1016/0167-7799(94)90029-9; Ignea C, 2014, ACS SYNTH BIOL, V3, P298, DOI 10.1021/sb400115e; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jackson BE, 2003, ORG LETT, V5, P1629, DOI 10.1021/ol034231x; Jullesson D, 2015, BIOTECHNOL ADV, V33, P1395, DOI 10.1016/j.biotechadv.2015.02.011; Kirby J, 2009, ANNU REV PLANT BIOL, V60, P335, DOI 10.1146/annurev.arplant.043008.091955; Knorre DA, 2005, BIOCHEMISTRY-MOSCOW+, V70, P264, DOI 10.1007/s10541-005-0110-7; Koch B, 2014, FEMS MICROBIOL REV, V38, P892, DOI 10.1111/1574-6976.12069; Kocharin K, 2013, BIOTECHNOL BIOENG, V110, P2216, DOI 10.1002/bit.24888; Kocharin K, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-52; Kozak BU, 2014, MBIO, V5, DOI 10.1128/mBio.01696-14; Kozak BU, 2014, METAB ENG, V21, P46, DOI 10.1016/j.ymben.2013.11.005; Krivoruchko A, 2013, J IND MICROBIOL BIOT, V40, P1051, DOI 10.1007/s10295-013-1296-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lian JZ, 2014, METAB ENG, V24, P139, DOI 10.1016/j.ymben.2014.05.010; Liesen T, 1996, MOL MICROBIOL, V21, P621, DOI 10.1111/j.1365-2958.1996.tb02570.x; LOGRASSO PV, 1993, ARCH BIOCHEM BIOPHYS, V307, P193, DOI 10.1006/abbi.1993.1578; MUNCK SL, 1990, ARCH BIOCHEM BIOPHYS, V282, P58, DOI 10.1016/0003-9861(90)90086-E; Navarro-Avino JP, 1999, YEAST, V15, P829, DOI 10.1002/(SICI)1097-0061(199907)15:10A<829::AID-YEA423>3.0.CO;2-9; Nielsen J, 2011, NAT BIOTECHNOL, V29, P693, DOI 10.1038/nbt.1937; Papini M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-136; Papini M, 2012, APPL MICROBIOL BIOT, V95, P1001, DOI 10.1007/s00253-012-3936-0; Paradise EM, 2008, BIOTECHNOL BIOENG, V100, P371, DOI 10.1002/bit.21766; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Polakowski T, 1998, APPL MICROBIOL BIOT, V49, P66, DOI 10.1007/s002530051138; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Przybyla-Zawislak B, 1999, GENETICS, V152, P153; Rico J, 2010, APPL ENVIRON MICROB, V76, P6449, DOI 10.1128/AEM.02987-09; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Sarria S, 2014, ACS SYNTH BIOL, V3, P466, DOI 10.1021/sb4001382; Scalcinati G, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-117; Scalcinati G, 2012, METAB ENG, V14, P91, DOI 10.1016/j.ymben.2012.01.007; Shiba Y, 2007, METAB ENG, V9, P160, DOI 10.1016/j.ymben.2006.10.005; Tang XL, 2013, METAB ENG, V16, P95, DOI 10.1016/j.ymben.2013.01.003; Tippmann S, 2013, BIOTECHNOL J, V8, P1435, DOI 10.1002/biot.201300028; vandenBerg MA, 1996, J BIOL CHEM, V271, P28953, DOI 10.1074/jbc.271.46.28953; VERDUYN C, 1991, ANTON LEEUW INT J G, V60, P325, DOI 10.1007/BF00430373; Verwaal R, 2007, APPL ENVIRON MICROB, V73, P4342, DOI 10.1128/AEM.02759-06; Westfall PJ, 2012, P NATL ACAD SCI USA, V109, P111, DOI 10.1073/pnas.1110740109	68	19	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144981	10.1371/journal.pone.0144981	http://dx.doi.org/10.1371/journal.pone.0144981			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701782	gold, Green Submitted, Green Published			2022-12-27	WOS:000367092600039
J	Herberich, SE; Klose, R; Moll, I; Yang, WJ; Wustehube-Lausch, J; Fischer, A				Herberich, Stefanie E.; Klose, Ralph; Moll, Iris; Yang, Wan-Jen; Wuestehube-Lausch, Joycelyn; Fischer, Andreas			ANKS1B Interacts with the Cerebral Cavernous Malformation Protein-1 and Controls Endothelial Permeability but Not Sprouting Angiogenesis	PLOS ONE			English	Article							CELL-CELL JUNCTIONS; VASCULAR INTEGRITY; RHO KINASE; KRIT1; PATHOGENESIS; CCM2; MECHANISM; COMPLEX; RAP1; STABILIZATION	Cerebral cavernous malformations are fragile blood vessel conglomerates in the central nervous system that are caused by mutations in the CCM1/KRIT1, CCM2 or CCM3 genes. The gene products form a protein complex at adherens junctions and loss of either CCM protein disrupts endothelial cell quiescence leading to increased permeability and excessive angiogenesis. We performed a yeast 2-hybrid screen to identify novel proteins directly interacting with KRIT1. The ankyrin repeat and sterile alpha motif domain-containing protein 1B (ANKS1B) was identified as a novel binding partner of KRIT1. Silencing of ANKS1B or the related gene ANKS1A in primary human endothelial cells had no significant effects on cellular proliferation, migration and sprouting angiogenesis. However, silencing of ANKS1B expression disturbed endothelial cell barrier functions leading to increased permeability. Forced ANKS1B expression reduced permeability. This was independent of Rho kinase activity and the presence of KRIT1. Taken together, ANKS1B was identified as a novel KRIT1-interacting protein that selectively controls endothelial permeability but not angiogenesis.	[Herberich, Stefanie E.; Klose, Ralph; Moll, Iris; Yang, Wan-Jen; Wuestehube-Lausch, Joycelyn; Fischer, Andreas] German Canc Res Ctr DKFZ ZMBH Alliance, Vasc Signaling & Canc A270, D-69120 Heidelberg, Germany; [Herberich, Stefanie E.; Wuestehube-Lausch, Joycelyn; Fischer, Andreas] Heidelberg Univ, Med Fac Mannheim CBTM, Vasc Biol & Tumor Angiogenesis, D-68167 Mannheim, Germany; [Fischer, Andreas] Univ Heidelberg Hosp, Dept Med & Clin Chem 1, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Klose, R (corresponding author), German Canc Res Ctr DKFZ ZMBH Alliance, Vasc Signaling & Canc A270, D-69120 Heidelberg, Germany.	r.klose@dkfz-heidelberg.de; a.fischer@dkfz-heidelberg.de			EU; BMBF (ERA-NET Neuron grant CCM); Deutsche Forschungsgemeinschaft (DFG) [SFB-TR23]	EU(European Commission); BMBF (ERA-NET Neuron grant CCM)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants of the EU and BMBF (ERA-NET Neuron grant CCM) and the Deutsche Forschungsgemeinschaft (DFG; SFB-TR23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Batra S, 2009, NAT REV NEUROL, V5, P659, DOI 10.1038/nrneurol.2009.177; Borikova AL, 2010, J BIOL CHEM, V285, P11760, DOI 10.1074/jbc.C109.097220; Boulday G, 2009, DIS MODEL MECH, V2, P168, DOI 10.1242/dmm.001263; Brutsch R, 2010, CIRC RES, V107, P592, DOI 10.1161/CIRCRESAHA.110.217257; Chan AC, 2011, J CLIN INVEST, V121, P1871, DOI 10.1172/JCI44393; Cunningham K, 2011, HUM MOL GENET, V20, P3198, DOI 10.1093/hmg/ddr225; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Faurobert E, 2013, J CELL BIOL, V202, P545, DOI 10.1083/jcb.201303044; Faurobert E, 2010, FEBS J, V277, P1084, DOI 10.1111/j.1742-4658.2009.07537.x; Fischer A, 2013, TRENDS MOL MED, V19, P302, DOI 10.1016/j.molmed.2013.02.004; Fisher OS, 2015, J BIOL CHEM, V290, P2842, DOI 10.1074/jbc.M114.616433; Fu XY, 1999, ONCOGENE, V18, P4920, DOI 10.1038/sj.onc.1202874; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Gunel M, 2002, P NATL ACAD SCI USA, V99, P10677, DOI 10.1073/pnas.122354499; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Hilder TL, 2007, J PROTEOME RES, V6, P4343, DOI 10.1021/pr0704276; Jordan BA, 2007, NAT NEUROSCI, V10, P427, DOI 10.1038/nn1867; Kim J, 2010, MOL CELL BIOL, V30, P1582, DOI 10.1128/MCB.01605-09; Kristiansen TZ, 2004, DNA RES, V11, P285; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Liu JJ, 2011, MOL BIOL CELL, V22, P2509, DOI 10.1091/mbc.E11-02-0157; Liu WZ, 2013, MOL CELL, V49, P719, DOI 10.1016/j.molcel.2012.12.005; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Pagenstecher A, 2009, HUM MOL GENET, V18, P911, DOI 10.1093/hmg/ddn420; Pandey A, 2002, ONCOGENE, V21, P8029, DOI 10.1038/sj.onc.1205988; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Wustehube J, 2010, P NATL ACAD SCI USA, V107, P12640, DOI 10.1073/pnas.1000132107; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953; Zhang J, 2007, NEUROSURGERY, V60, P353, DOI 10.1227/01.NEU.0000249268.11074.83; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679; Zhong J, 2011, J PROTEOMICS, V74, P294, DOI 10.1016/j.jprot.2010.11.006	36	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145304	10.1371/journal.pone.0145304	http://dx.doi.org/10.1371/journal.pone.0145304			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698571	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600063
J	Holldorf, ET; Siers, SR; Richmond, JQ; Klug, PE; Reed, RN				Holldorf, Elden T.; Siers, Shane R.; Richmond, Jonathan Q.; Klug, Page E.; Reed, Robert N.			Invaded Invaders: Infection of Invasive Brown Treesnakes on Guam by an Exotic Larval Cestode with a Life Cycle Comprised of Non-Native Hosts	PLOS ONE			English	Article							ENEMY RELEASE HYPOTHESIS; REPRODUCTIVE SUCCESS; CYSTEINE PROTEINASE; BOIGA-IRREGULARIS; CONDITION INDEXES; PACIFIC ISLAND; PARASITE LOAD; SELECTION; ECOLOGY; FITNESS	Background Multiple host introductions to the same non-native environment have the potential to complete life cycles of parasites incidentally transported with them. Our goal was to identify a recently detected parasitic flatworm in the invasive Brown Treesnake (Boiga irregularis) on the remote Pacific island of Guam. We considered possible factors influencing parasite transmission, and tested for correlations between infection status and potential indicators of host fitness. We used genetic data from the parasite and information about the native ranges of other possible non-native hosts to hypothesize how it arrived on Guam and how its life cycle may be currently supported. Methods We identified the parasite by comparing larval morphology and mtDNA sequences with other Pseudophyllid tapeworms. We assessed probability of infection in individual snakes using logistic regression and examined different factors influencing presence of parasites in hosts. Results We identified the parasite as the pseudophyllid cestode Spirometra erinaceieuropaei, with all sampled worms from multiple snakes sharing a single mtDNA haplotype. Infection appears to be limited to the only freshwater watershed on the island, where infection prevalence was high (77.5%). Larger snakes had a higher probability of being infected, consistent with the chronic nature of such infections. While infection status was positively correlated with body condition, infected snakes tended to have lower intra-peritoneal fat body mass, potentially indicating a negative effect on energy stores. Conclusions We discovered that B. irregularis inhabiting a small area of forested habitat in a freshwater watershed on Guam are often infected by a novel parasite of Asian origin. While further work is needed, this species of Spirometra, itself a non-native species, likely depends on a suite of recently introduced hosts from different parts of the world to complete the life cycle. This baseline study provides little evidence of any effects on host fitness, but additional data are needed to more thoroughly explore the consequences of infection in this invasive snake population.	[Holldorf, Elden T.] Cherokee Serv Grp LLC, Yigo, GU 96929 USA; [Siers, Shane R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Richmond, Jonathan Q.] US Geol Survey, Western Ecol Res Ctr, San Diego, CA USA; [Klug, Page E.; Reed, Robert N.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA	Colorado State University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Holldorf, ET (corresponding author), Cherokee Serv Grp LLC, Yigo, GU 96929 USA.	eholldorf@usgs.gov	Morand, Serge/M-5433-2018	Morand, Serge/0000-0003-3986-7659; Klug, Page/0000-0002-0836-3901	U.S. Department of the Navy (MIPR) [N61755-13-MP-001GS]; U.S. Department of the Interior's Office of Insular Affairs; Invasive Species Program of the U.S. Geological Survey	U.S. Department of the Navy (MIPR); U.S. Department of the Interior's Office of Insular Affairs; Invasive Species Program of the U.S. Geological Survey	Funding for this project was provided by the U.S. Department of the Navy (MIPR #N61755-13-MP-001GS; navy.mil), U.S. Department of the Interior's Office of Insular Affairs (doi.gov//oia), and the Invasive Species Program of the U.S. Geological Survey (usgs.gov/ecosystems/invasive_species). No funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer SM, 2011, PATHOGENS CONSERVATI; Amundsen PA, 2013, OECOLOGIA, V171, P993, DOI 10.1007/s00442-012-2461-2; [Anonymous], 2014, TRACER V1 6; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Brown GP, 2006, CAN J ZOOL, V84, P668, DOI 10.1139/Z06-044; Brown GP, 1996, CAN J ZOOL, V74, P1671; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caudell JN, 2002, INT BIODETER BIODEGR, V49, P113, DOI 10.1016/S0964-8305(01)00111-1; Centers for Disease Control and Prevention, ATL DPDX LAB ID PAR; Christy MT, 2007, DIVERS DISTRIB, V13, P598, DOI 10.1111/j.1472-4642.2007.00378.x; Christy MT, 2010, J APPL ECOL, V47, P106, DOI 10.1111/j.1365-2664.2009.01753.x; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Congdon J.D., 1982, Biology of Reptilia, V13, P233; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; DUNLAP KD, 1995, PHYSIOL ZOOL, V68, P608, DOI 10.1086/physzool.68.4.30166347; Hadley N. F., 1985, ADAPTIVE ROLE LIPIDS; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; KENNEDY CEJ, 1987, BEHAV ECOL SOCIOBIOL, V21, P291, DOI 10.1007/BF00299966; KENNEDY CR, 1994, PARASITOLOGY, V109, P187, DOI 10.1017/S0031182000076290; Klein SL, 2005, BEHAV PROCESS, V68, P219, DOI 10.1016/j.beproc.2004.07.009; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lee S.-H., 1990, Korean Journal of Parasitology, V28, P161, DOI 10.3347/kjp.1990.28.3.161; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Li MW, 2008, ELECTROPHORESIS, V29, P2912, DOI 10.1002/elps.200700752; Liu H, 2006, BIOL INVASIONS, V8, P1535, DOI 10.1007/s10530-005-5845-y; Liu W, 2010, VET PARASITOL, V173, P152, DOI 10.1016/j.vetpar.2010.06.005; Mankin RW, 2010, J ECON ENTOMOL, V103, P1135, DOI 10.1603/EC09214; MARLER T. E., 2011, J ENVIRON SCI ENG, V5, P1198; Mayer M, 2015, AUSTR ECOL IN PRESS; MOLLER AP, 1990, J EVOLUTION BIOL, V3, P319, DOI 10.1046/j.1420-9101.1990.3050319.x; Moore J., 2002, PARASITES BEHAV ANIM; Phares K, 1996, J PARASITOL, V82, P210, DOI 10.2307/3284147; Popovic Vera, 2002, Hormones (Athens), V1, P204; Poulin R, 2003, J BIOGEOGR, V30, P837, DOI 10.1046/j.1365-2699.2003.00868.x; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; Preston BT, 2003, P ROY SOC B-BIOL SCI, V270, P633, DOI 10.1098/rspb.2002.2268; Reed P, 1968, J PARASITOL, V54, P51; Richmond JQ, 2015, BIOL INVASIONS, V17, P337, DOI 10.1007/s10530-014-0733-y; Richmond JQ, 2012, 10SISEED01007SI1733; Rodda GH, 1997, BIOSCIENCE, V47, P565, DOI 10.2307/1313163; Rodda GH, 1999, PROBLEM SNAKE MANAGEMENT, P44; Rodda GH, 2007, PAC SCI, V61, P307, DOI 10.2984/1534-6188(2007)61[307:BAIOPI]2.0.CO;2; Rodda Gordon H., 2007, P257; SAVIDGE JA, 1987, ECOLOGY, V68, P660, DOI 10.2307/1938471; Schulte-Hostedde AI, 2004, BEHAV ECOL SOCIOBIOL, V55, P272, DOI 10.1007/s00265-003-0707-z; Shaw JC, 2010, J PARASITOL, V96, P482, DOI 10.1645/GE-2188.1; SONG CY, 1993, J PARASITOL, V79, P517, DOI 10.2307/3283376; Sorci G, 1995, J EVOLUTION BIOL, V8, P711, DOI 10.1046/j.1420-9101.1995.8060711.x; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1169, DOI 10.1093/icb/icl052; Tyrrell CL, 2009, J APPL ECOL, V46, P128, DOI 10.1111/j.1365-2664.2008.01591.x; Wang F, 2014, SCI WORLD J; Wang FM, 2011, J PARASITOL, V97, P170, DOI 10.1645/GE-2519.1; WHITTIER JM, 1998, SURVEY PARASITES DIS; Zhu XQ, 2002, MOL CELL PROBE, V16, P159, DOI 10.1006/mcpr.2001.0406	57	5	5	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0143718	10.1371/journal.pone.0143718	http://dx.doi.org/10.1371/journal.pone.0143718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699614	Green Published, gold			2022-12-27	WOS:000367092600007
J	Li, ZG; Fan, KS; Tian, LD; Shi, BL; Zhang, SH; Zhang, JJ				Li, Zhiguo; Fan, Kuangsheng; Tian, Lide; Shi, Benlin; Zhang, Shuhong; Zhang, Jingjing			Response of Glacier and Lake Dynamics in Four Inland Basins to Climate Change at the Transition Zone between the Karakorum And Himalayas	PLOS ONE			English	Article							TIBETAN PLATEAU; IMPACTS; REGION; EXPANSION; EVEREST; CHINA; SHAN	Inland glacier and lake dynamics on the Tibetan Plateau (TP) and its surroundings over recent decades are good indicators of climate change and have a significant impact on the local water supply and ecosystem. The glacier and lake changes in Karakoram are quite different from those of the Himalayas. The mechanisms of the complex and regionally heterogeneous behavior of the glacier and lake changes between the Karakorum and Himalayas are poorly understood. Based on satellite images and meteorological data of Shiquanhe, Hetian, and Yutian stations, we demonstrate that the overall retreat of glaciers and increase of lake area at the transition zone between the Karakoram and Himalayas (TKH) have occurred since 1968 in response to a significant global climate change. Glacial areas in the Songmuxi Co basin, Zepu Co basin, Mang Co basin and Unnamed Co decreased by -1.98 +/- 0.02 km(2), -5.39 +/- 0.02 km(2), -0.01 +/- 0.02 km(2), and -0.12 +/- 0.02 km(2) during the study period, corresponding to losses of -1.42%, -2.86%, -1.54%, and -1.57%, respectively. The lake area of the Songmuxi Co, Zepu Co, Mang Co and Unnamed Co increased by 7.57 +/- 0.02 km(2), 8.53 +/- 0.02 km(2), 1.35 +/- 0.02 km(2), and 0.53 +/- 0.02 km(2), corresponding to growths of 30.22%, 7.55%, 11.39%, and 8.05%, respectively. Increases in temperature was the main reason for glacier retreat, whereas decreases in potential evapotranspiration of lakes, increases in precipitation, and increases in melt water from glaciers and frozen soil all contributed to lake area expansion.	[Li, Zhiguo; Fan, Kuangsheng; Shi, Benlin; Zhang, Jingjing] Shangqiu Normal Univ, Coll Environm & Planning, Shangqiu, Peoples R China; [Li, Zhiguo; Tian, Lide] Chinese Acad Sci, Inst Tibetan Plateau Res, Beijing, Peoples R China; [Zhang, Shuhong] Shangqiu Normal Univ, Coll Life Sci, Shangqiu, Peoples R China	Shangqiu Normal University; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; Shangqiu Normal University	Li, ZG (corresponding author), Shangqiu Normal Univ, Coll Environm & Planning, Shangqiu, Peoples R China.	lizhiguo999999@163.com			National Natural Science Foundation of China [41101072, 41025002, 31100369]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 41101072, No. 41025002 and No. 31100369).	Bao WJ, 2015, J MT SCI-ENGL, V12, P344, DOI 10.1007/s11629-014-3220-0; [CAS Integrated Scientific SurveyTeam of Qinghai-Tibet Plateau], 1984, CLIM IN TIB; Gardelle J, 2011, GLOBAL PLANET CHANGE, V75, P47, DOI 10.1016/j.gloplacha.2010.10.003; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; Janes TJ, 2012, J CLIMATE, V25, P8308, DOI 10.1175/JCLI-D-11-00436.1; Lei YB, 2014, CLIMATIC CHANGE, V125, P281, DOI 10.1007/s10584-014-1175-3; Li Junli, 2011, Hupo Kexue, V23, P311; Li L, 2014, QUATERN INT, V349, P339, DOI 10.1016/j.quaint.2014.04.051; Li YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111890; Li Z.G., 2011, GEOGRAPHICAL RES, V26, P836; Li ZhiGuo, 2014, Journal of Resources and Ecology, V5, P123, DOI 10.5814/j.issn.1674-764X.2014.02.004; [李治国 LI Zhiguo], 2011, [地理研究, Geographical Research], V30, P939; Liu SY, 2003, J GLACIOL, V49, P117, DOI 10.3189/172756503781830926; Neckel N, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/1/014009; Nie Y, 2013, ENVIRON EARTH SCI, V68, P251, DOI 10.1007/s12665-012-1736-6; Oerlemans J, 2005, SCIENCE, V308, P675, DOI 10.1126/science.1107046; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Qiu J, 2008, NATURE, V454, P393, DOI 10.1038/454393a; Raup B, 2007, COMPUT GEOSCI-UK, V33, P104, DOI 10.1016/j.cageo.2006.05.015; Shi Y.F., 2005, CONCISE CHINA GLACIE; Song CQ, 2014, WATER RESOUR RES, V50, P3170, DOI 10.1002/2013WR014724; [王解先 Wang Jiexian], 2003, [大地测量与地球动力学, Journal of Geodesy and Geodynamics], V23, P70; Wang WC, 2015, HYDROL PROCESS, V29, P859, DOI 10.1002/hyp.10199; Wang X, 2012, MT RES DEV, V32, P203, DOI 10.1659/MRD-JOURNAL-D-11-00044.1; Wei JF, 2015, ARCT ANTARCT ALP RES, V47, P301, DOI 10.1657/AAAR00C-13-129; Wiltshire AJ, 2014, CRYOSPHERE, V8, P941, DOI 10.5194/tc-8-941-2014; Xu BQ, 2009, P NATL ACAD SCI USA, V106, P22114, DOI [10.1073/pnas.0910444106, 10.1073/pnas.pnas.0910444106]; Yang K, 2014, GLOBAL PLANET CHANGE, V112, P79, DOI 10.1016/j.gloplacha.2013.12.001; Yang XG, 2011, ARCT ANTARCT ALP RES, V43, P147, DOI 10.1657/1938-4246-43.1.147; Yao TD, 2012, NAT CLIM CHANGE, V2, P663, DOI [10.1038/NCLIMATE1580, 10.1038/nclimate1580]; Yao TD, 2010, CHINESE SCI BULL, V55, P2071, DOI 10.1007/s11434-010-4327-5; Yao XJ, 2014, J GEOGR SCI, V24, P689, DOI 10.1007/s11442-014-1113-3; Ye QH, 2008, J GLACIOL, V54, P933, DOI 10.3189/002214308787779997; Zhang GQ, 2015, GLOBAL PLANET CHANGE, V131, P148, DOI 10.1016/j.gloplacha.2015.05.013; Zhang GQ, 2013, GEOPHYS RES LETT, V40, P2125, DOI 10.1002/grl.50462	36	3	4	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144696	10.1371/journal.pone.0144696	http://dx.doi.org/10.1371/journal.pone.0144696			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699717	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092600028
J	Zapalski, MK; Clarkson, ENK				Zapalski, Mikolaj K.; Clarkson, Euan N. K.			Enigmatic Fossils from the Lower Carboniferous Shrimp Bed, Granton, Scotland	PLOS ONE			English	Article							PHYLUM CNIDARIA; HYDROZOA; SHALE; PHYLOGENETICS; ANTHOMEDUSAE; ZANCLEIDAE; DEPOSITION; EDINBURGH; DIVERSITY	The Lower Carboniferous (Visean) Granton Lagerstatte (Edinburgh, Scotland) is principally known for the discovery of the conodont animal, but has also yielded numerous crustaceans and other faunas. Here we report on small branching colonies, reaching 10 mm in length. They are small, erect, arborescent, and irregularly branched with predominant monopodial and dichotomous growth. They bud in a single plane. In one specimen the wall microstructure is well preserved and it is composed of evenly spaced, linear fibers, running parallel to the axis of the stems, and connected by transverse bars. We discuss possible biological affinities of these organisms; we consider algal, poriferan, hydrozoan and bryozoan affinities. The general pattern of branching, presence of fan-like structures (interpreted here as possible gonophores) and microstructure suggests affinity to Hydrozoa, affinity to non-calcifying algae is less likely. Assuming hydrozoan nature; the microstructure might suggest affinities with the extant family Solanderiidae Marshall, 1892 that possess an internal chitinous skeleton. The EDS analysis shows that fossils discussed here are preserved as phosphates. The skeletons were probably not mineralized, the presence of phosphorus suggests that the colonies were originally composed of chitin. We describe these organisms as Caledonicratis caridum gen. et sp. nov. (Solanderiidae?, Capitata?). Colonies of C. caridum gen et. sp. nov. sometimes encrust the exuviae of crustaceans, which very probably lived in fresh to brackish water thus indicating a likely habitat of Caledonicratis.	[Zapalski, Mikolaj K.] Univ Warsaw, Fac Geol, PL-02089 Warsaw, Poland; [Clarkson, Euan N. K.] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland	University of Warsaw; University of Edinburgh	Zapalski, MK (corresponding author), Univ Warsaw, Fac Geol, Zwirki & Wigury 93, PL-02089 Warsaw, Poland.	m.zapalski@uw.edu.pl	Zapalski, Mikolaj/D-6359-2017	Zapalski, Mikolaj/0000-0002-9853-3707	University of Warsaw, Faculty of Geology	University of Warsaw, Faculty of Geology	Funding provided by University of Warsaw, Faculty of Geology (http://www.geo.uw.edu.pl/) research grant to MKZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE RJ, 1986, LETHAIA, V19, P279, DOI 10.1111/j.1502-3931.1986.tb00741.x; ALDRIDGE RJ, 1993, PHILOS T R SOC B, V340, P405, DOI 10.1098/rstb.1993.0082; Balinski A, 2014, PALAEONTOL Z, V88, P1, DOI 10.1007/s12542-013-0169-1; Bassler RS, TREATISE INVERTEBRAT, P1; BOERO F, 1992, CAN J ZOOL, V70, P1645, DOI 10.1139/z92-229; Boero F, 2000, ITAL J ZOOL, V67, P93, DOI 10.1080/11250000009356301; BOERO F, 1991, ZOOL J LINN SOC-LOND, V101, P189, DOI 10.1111/j.1096-3642.1991.tb00893.x; Bouillon J., 1987, Indo-Malayan Zoology, V4, P279; Bouillon J., 1992, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V62, P5; BOUILLON J, 1988, J NAT HIST, V22, P1551, DOI 10.1080/00222938800770971; Briggs D. E. G., 1983, SPEC PAP PALAEONTOL, V30, P161; BRIGGS DEG, 1983, LETHAIA, V16, P1, DOI 10.1111/j.1502-3931.1983.tb01139.x; BRIGGS DEG, 1987, LETHAIA, V20, P107, DOI 10.1111/j.1502-3931.1987.tb00767.x; BRIGGS DEG, 1987, LETHAIA, V20, P257, DOI 10.1111/j.1502-3931.1987.tb00786.x; BRIGGS DEG, 1991, T ROY SOC EDIN-EARTH, V82, P65, DOI 10.1017/S0263593300007525; Calder DR, 2010, ZOOTAXA, P1; Cartwright P, 2008, J MAR BIOL ASSOC UK, V88, P1663, DOI 10.1017/S0025315408002257; CATER J M L, 1987, Transactions of the Royal Society of Edinburgh Earth Sciences, V78, P29; CATER J M L, 1989, Transactions of the Royal Society of Edinburgh Earth Sciences, V80, P5; Clark N., 2014, EDINB GEOL, V55, P14; CLARKSON ENK, 1985, EARTH SCI CONSERVATI, V22, P3; Clarkson ENK, 1985, T ROY SOC EDIN-EARTH, V76, P1773; Daly M, 2007, ZOOTAXA, P127, DOI 10.11646/zootaxa.1668.1.11; Dvoretsky AG, 2010, ICES J MAR SCI, V67, P204, DOI 10.1093/icesjms/fsp243; Fernandez-Leborans G, 2008, ACTA ZOOL-STOCKHOLM, V89, P1, DOI 10.1111/j.1463-6395.2007.00287.x; Fryer G, 2004, PALAEONTOLOGY, V47, P1109, DOI 10.1111/j.0031-0239.2004.00402.x; Gabilondo R, 2006, ACTA ZOOLOGICA, V87, P33, DOI [10.1111/j.1463-6395.2006.00218x, DOI 10.1111/J.1463-6395.2006.00218.X]; GREENSMITH JT, 1962, J GEOL, V70, P355, DOI 10.1086/626825; Hayward P.J., 1985, SYNOPSES BRIT FAUNA, V33, P1; HESSELBO SP, 1984, SCOT J GEOL, V20, P281, DOI 10.1144/sjg20030281; Kadtubowska JZ, 1975, ZARYS ALGOLOGII, P1; Kayal E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-5; Knell SJ, 2012, GREAT FOSSIL ENIGMA; Krings M, 2007, BOT J LINN SOC, V153, P477, DOI 10.1111/j.1095-8339.2007.00616.x; Mamet B, 2004, REV ESPANOLA PALEONT, V19, P151; MAMET B, 1981, REV MICROPALEONTOL, V23, P151; Mamet B. L., 1991, CALCAREOUS ALGAE STR, P370, DOI 10.1007/978-3-642-52335-9_19; Millard NAH, 1975, ANN S AFR MUS, V68, P1; Moore RA, 2009, PALAEOGEOGR PALAEOCL, V277, P57, DOI 10.1016/j.palaeo.2009.02.014; Muir LA, 2007, SCOT J GEOL, V43, P51, DOI 10.1144/sjg43010051; Muscente AD, 2013, J PALEONTOL, V87, P710, DOI 10.1666/12-125; Nawrocki AM, 2010, ZOOL SCR, V39, P290, DOI 10.1111/j.1463-6409.2009.00419.x; NITECKI M H, 1972, Fieldiana Geology, V30, P1; Orr PJ, 1998, SCIENCE, V281, P1173, DOI 10.1126/science.281.5380.1173; Peach B. N., 1908, MEMOIRS GEOLOGICAL S, V1908, P1; PENNAK RW, 1985, AM ZOOL, V25, P671; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Porter JS, 2004, J MAR BIOL ASSOC UK, V84, P243, DOI 10.1017/S0025315404009117h; ROGICK MARY D., 1950, OHIO JOUR SCI, V50, P136; SCHRAM FR, 1975, J PALEONTOL, V49, P549; Stepanjants SD, 2000, SCI MAR, V64, P225, DOI 10.3989/scimar.2000.64s1225; Tait D., 1925, T EDINB GEOL SOC, V11, P346; TOOMEY DONALD FRANCIS, 1968, J PALEONTOL, V42, P556; Van Iten H, 2014, PALAEONTOLOGY, V57, P677, DOI 10.1111/pala.12116; VanSoest RWM, 2002, SYSTEMA PORIFERA, V1, P817, DOI [10.1007/978-1-4615-0747-5_85, DOI 10.1007/978-1-4615-0747-5_85]; VERVOORT W., 1962, BULL MAR SCI GULF AND CARIBBEAN, V12, P508; Vervoort W., 1966, Symposia of the Zoological Society of London, VNo. 16, P372; Walzl M.G., 2005, Denisia, V16, P49; Weaver PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028195; WEDLER E, 1986, STUD NEOTROP FAUNA E, V21, P69, DOI 10.1080/01650528609360698; Widmer CL, 2010, MAR BIOL, V157, P49, DOI 10.1007/s00227-009-1294-y; Williams JD, 2004, J EXP MAR BIOL ECOL, V305, P1, DOI 10.1016/j.jembe.2004.02.020; WILSON E. C., 1963, PALEONTOLOGY, V6, P246; Wineera J. S., 1968, Zoology Publications from Victoria University of Wellington, VNo. 43, P1; Wood TS, 2001, J N AM BENTHOL SOC, V20, P133, DOI 10.2307/1468194; Wray J. L., 1977, DEV PALAEONTOLOGY ST, V4, P1; Zaton M, 2014, LETHAIA, V47, P352, DOI 10.1111/let.12062	67	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144220	10.1371/journal.pone.0144220	http://dx.doi.org/10.1371/journal.pone.0144220			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701306	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600017
J	Dolman, MEM; van der Ploeg, I; Koster, J; Bate-Eya, LT; Versteeg, R; Caron, HN; Molenaar, JJ				Dolman, M. Emmy M.; van der Ploeg, Ida; Koster, Jan; Bate-Eya, Laurel Tabe; Versteeg, Rogier; Caron, Huib N.; Molenaar, Jan J.			DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of Neuroblastoma Cells	PLOS ONE			English	Article							STRAND BREAK REPAIR; CANCER-CELLS; IONIZING-RADIATION; INHIBITION; PK; GEMCITABINE; DAMAGE; IDENTIFICATION; RECOMBINATION; CYTOTOXICITY	Tumor cells might resist therapy with ionizing radiation (IR) by non-homologous end-joining (NHEJ) of IR-induced double-strand breaks. One of the key players in NHEJ is DNA-dependent protein kinase (DNA-PK). The catalytic subunit of DNA-PK, i.e. DNA-PKcs, can be inhibited with the small-molecule inhibitor NU7026. In the current study, the in vitro potential of NU7026 to radiosensitize neuroblastoma cells was investigated. DNA-PKcs is encoded by the PRKDC (protein kinase, DNA-activated, catalytic polypeptide) gene. We showed that PRKDC levels were enhanced in neuroblastoma patients and correlated with a more advanced tumor stage and poor prognosis, making DNA-PKcs an interesting target for radiosensitization of neuroblastoma tumors. Optimal dose finding for combination treatment with NU7026 and IR was performed using NGP cells. One hour pre-treatment with 10 mu M NU7026 synergistically sensitized NGP cells to 0.63 Gy IR. Radiosensitizing effects of NU7026 increased in time, with maximum effects observed from 96 h after IR-exposure on. Combined treatment of NGP cells with 10 mu M NU7026 and 0.63 Gy IR resulted in apoptosis, while no apoptotic response was observed for either of the therapies alone. Inhibition of IR-induced DNA-PK activation by NU7026 confirmed the capability of NGP cells to, at least partially, resist IR by NHEJ. NU7026 also synergistically radiosensitized other neuroblastoma cell lines, while no synergistic effect was observed for low DNA-PKcs-expressing non-cancerous fibroblasts. Results obtained for NU7026 were confirmed by PRKDC knockdown in NGP cells. Taken together, the current study shows that DNA-PKcs is a promising target for neuroblastoma radiosensitization.	[Dolman, M. Emmy M.; van der Ploeg, Ida; Koster, Jan; Bate-Eya, Laurel Tabe; Versteeg, Rogier; Molenaar, Jan J.] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands; [Caron, Huib N.] Univ Amsterdam, Acad Med Ctr, Emma Kinderziekenhuis, Dept Pediat Oncol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Dolman, MEM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Oncogen, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	memdolman@gmail.com	Versteeg, Rogier/AAQ-1765-2020; Koster, Jan/C-5934-2008	Koster, Jan/0000-0002-0890-7585; Versteeg, Rogier/0000-0001-7172-0388; Dolman, Emmy/0000-0002-0567-5918	Dutch Cancer Foundation; Dutch Children Cancer Free Foundation; Villa Joep; Tom Voute Fund	Dutch Cancer Foundation(KWF Kankerbestrijding); Dutch Children Cancer Free Foundation; Villa Joep; Tom Voute Fund	The research in this paper was supported by grants from the Dutch Cancer Foundation, the Dutch Children Cancer Free Foundation, Villa Joep and the Tom Voute Fund.	Amrein L, 2007, J PHARMACOL EXP THER, V321, P848, DOI 10.1124/jpet.106.118356; An J, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-18; Burma S, 2004, DNA REPAIR, V3, P909, DOI 10.1016/j.dnarep.2004.03.021; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; CHOU TC, 1977, J BIOL CHEM, V252, P6438; Ciszewski WM, 2014, BREAST CANCER RES TR, V143, P47, DOI 10.1007/s10549-013-2785-6; Davidson D, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00005; Davidson D, 2012, INVEST NEW DRUG, V30, P1248, DOI 10.1007/s10637-010-9626-9; Fix A, 2008, GENE CHROMOSOME CANC, V47, P819, DOI 10.1002/gcc.20583; Frosina G, 2009, MOL CANCER RES, V7, P989, DOI 10.1158/1541-7786.MCR-09-0030; Fuhrman CB, 2008, GYNECOL ONCOL, V110, P93, DOI 10.1016/j.ygyno.2007.08.073; Golden EB, 2012, FRONT ONCOL, V2, P1, DOI [10.3389/fonc.2012.00088, 10.3389/fonc.2012.00153]; Gupta AK, 2003, INT J RADIAT ONCOL, V56, P846, DOI 10.1016/S0360-3016(03)00214-1; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hosoya N, 2014, CANCER SCI, V105, P370, DOI 10.1111/cas.12366; Hsu FM, 2012, TRANSL CANCER RES, V1, P22, DOI 10.3978/j.issn.2218-676X.2012.04.01; Jekimovs C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00086; LAUREYS G, 1995, ONCOGENE, V10, P1087; Li YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039588; Liu Y, 2011, INT J GYNECOL CANCER, V21, P100, DOI 10.1097/IGC.0b013e3182021bfd; Lord CJ, 2006, CLIN CANCER RES, V12, P4463, DOI 10.1158/1078-0432.CCR-06-1269; Luqmani YA, 2005, MED PRIN PRACT, V14, P35, DOI 10.1159/000086183; Madhusudan S, 2005, TRENDS MOL MED, V11, P503, DOI 10.1016/j.molmed.2005.09.004; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Molenaar JJ, 2012, NAT GENET, V44, P1199, DOI 10.1038/ng.2436; Molenaar JJ, 2012, GENE CHROMOSOME CANC, V51, P10, DOI 10.1002/gcc.20926; Molenaar JJ, 2009, P NATL ACAD SCI USA, V106, P12968, DOI 10.1073/pnas.0901418106; Moll U, 1999, ONCOGENE, V18, P3114, DOI 10.1038/sj.onc.1202640; Morgan MA, 2008, CLIN CANCER RES, V14, P6744, DOI 10.1158/1078-0432.CCR-08-1032; Morrison R, 2011, J ONCOL, V2011, DOI 10.1155/2011/941876; Mukherjee B, 2010, SEMIN RADIAT ONCOL, V20, P250, DOI 10.1016/j.semradonc.2010.05.002; Niazi MT, 2014, CURR ONCOL, V21, P91, DOI 10.3747/co.21.1509; Nuchtern Jed G, 2006, Semin Pediatr Surg, V15, P10, DOI 10.1053/j.sempedsurg.2005.11.003; Nutley BP, 2005, BRIT J CANCER, V93, P1011, DOI 10.1038/sj.bjc.6602823; O'Connor MJ, 2007, ONCOGENE, V26, P7816, DOI 10.1038/sj.onc.1210879; Pacini S, 1999, TUMORI, V85, P503, DOI 10.1177/030089169908500615; Park JR, 2008, PEDIATR CLIN N AM, V55, P97, DOI 10.1016/j.pcl.2007.10.014; Pauwels B, 2005, RADIAT RES, V164, P642, DOI 10.1667/RR3445.1; Plummer R, 2010, CLIN CANCER RES, V16, P4527, DOI 10.1158/1078-0432.CCR-10-0984; Salles B, 2006, PATHOL BIOL, V54, P185, DOI 10.1016/j.patbio.2006.01.012; Shaheen FS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020311; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Tavecchio M, 2012, CANCER CHEMOTH PHARM, V69, P155, DOI 10.1007/s00280-011-1662-4; Thiele CJ, 1999, HUMAN CELL CULTURE, V1, P21; TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Verissimo CS, 2011, ENDOCR-RELAT CANCER, V18, pR213, DOI 10.1530/ERC-11-0251; Veuger SJ, 2003, CANCER RES, V63, P6008; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Yu L, 2015, ONCOTARGET, V6, P3848, DOI 10.18632/oncotarget.2975; Zha S, 2011, P NATL ACAD SCI USA, V108, P2028, DOI 10.1073/pnas.1019293108; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275	53	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145744	10.1371/journal.pone.0145744	http://dx.doi.org/10.1371/journal.pone.0145744			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716839	Green Submitted, gold, Green Published			2022-12-27	WOS:000367510500065
J	Hahn, S; Kim, D				Hahn, Seungsoo; Kim, Dongsup			Identifying and Reducing Systematic Errors in Chromosome Conformation Capture Data	PLOS ONE			English	Article							HI-C DATA; CHROMATIN INTERACTIONS; GENOME; ORGANIZATION; PRINCIPLES; ENSEMBLE; DYNAMICS; BIASES; MODEL	Chromosome conformation capture (3C)-based techniques have recently been used to uncover the mystic genomic architecture in the nucleus. These techniques yield indirect data on the distances between genomic loci in the form of contact frequencies that must be normalized to remove various errors. This normalization process determines the quality of data analysis. In this study, we describe two systematic errors that result from the heterogeneous local density of restriction sites and different local chromatin states, methods to identify and remove those artifacts, and three previously described sources of systematic errors in 3C-based data: fragment length, mappability, and local DNA composition. To explain the effect of systematic errors on the results, we used three different published data sets to show the dependence of the results on restriction enzymes and experimental methods. Comparison of the results from different restriction enzymes shows a higher correlation after removing systematic errors. In contrast, using different methods with the same restriction enzymes shows a lower correlation after removing systematic errors. Notably, the improved correlation of the latter case caused by systematic errors indicates that a higher correlation between results does not ensure the validity of the normalization methods. Finally, we suggest a method to analyze random error and provide guidance for the maximum reproducibility of contact frequency maps.	[Hahn, Seungsoo] Chung Ang Univ, Dept Chem, Seoul 156756, South Korea; [Kim, Dongsup] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea	Chung Ang University; Korea Advanced Institute of Science & Technology (KAIST)	Hahn, S (corresponding author), Chung Ang Univ, Dept Chem, Seoul 156756, South Korea.	hahnss@cau.ac.kr; kds@kaist.ac.kr	Hahn, Seungsoo/C-8026-2016; Kim, Dongsup/C-1612-2011	Hahn, Seungsoo/0000-0002-2763-1166; 	Ministry for Health and Welfare [2012M3A9B4027957, A092006]; National Research Foundation of Korea	Ministry for Health and Welfare; National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by grant number: 2012M3A9B4027957, A092006, (funder: Ministry for Health and Welfare, http://english.mw.go.kr/front_eng/index.jsp) to DK; and grant number: NRF-2010-0012649, (funder: National Research Foundation of Korea, http://www.nrf.re.kr/nrf_eng_cms/) to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cournac A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-436; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; Fox J., 2019, R COMPANION APPL REG, V.; Glass CK, 2000, GENE DEV, V14, P121; Hahn S, 2013, BIOPHYS J, V105, P1786, DOI 10.1016/j.bpj.2013.08.043; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th; Hilser VJ, 2006, CHEM REV, V106, P1545, DOI 10.1021/cr040423+; Hu M, 2012, BIOINFORMATICS, V28, P3131, DOI 10.1093/bioinformatics/bts570; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; R Core Team, 2013, R LANG ENV STAT COMP; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	24	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146007	10.1371/journal.pone.0146007	http://dx.doi.org/10.1371/journal.pone.0146007			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717152	Green Published, gold			2022-12-27	WOS:000367510500115
J	Kang, SH; Jung, DJ; Choi, EW; Cho, KH; Park, JW; Do, JY				Kang, Seok Hui; Jung, Da Jung; Choi, Eun Woo; Cho, Kyu Hyang; Park, Jong Won; Do, Jun Young			HbA1c Levels Are Associated with Chronic Kidney Disease in a Non-Diabetic Adult Population: A Nationwide Survey (KNHANES 2011-2013)	PLOS ONE			English	Article							INTENSIVE GLUCOSE CONTROL; METABOLIC SYNDROME; GLYCATED HEMOGLOBIN; GLYCOSYLATED HEMOGLOBIN; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; RISK; A1C; ALBUMINURIA	Background Many studies have reported an association between glycated hemoglobin A1c (HbA1c) and metabolic syndrome (MetS) in non-diabetes patients. Each component of MetS is in fact related to chronic kidney disease (CKD) incidence and progression. Therefore, HbA1c in non-diabetic mellitus (DM) may be intrinsically associated with the prevalence of CKD. The hypothesis of the present study was that high HbA1c in non-DM patients is associated with CKD. Patients and Methods The total number of participants in this study was 24,594. The participants were divided into three groups according to their HbA1c levels: a Low group (<5.7% or <39 mmol/mol), a Middle group (5.7-6.0% or 39-42 mmol/mol), and a High group (>6.0% or >42 mmol/mol). The estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration equation. Results The number of participants allocated to the Low, Middle, and High groups was 8,651, 4,634, and 1,387, respectively. Linear regression analyses were performed to evaluate the association between variables. Standardized beta +/- standard error was 0.25 +/- 0.22 for waist circumference, 0.44 +/- 0.20 for fasting glucose, -0.14 +/- 0.30 for high-density lipoprotein cholesterol levels, 0.15 +/- 2.31 for triglyceride levels, 0.21 +/- 0.00 for systolic blood pressure, 0.10 +/- 0.00 for diastolic blood pressure, and -0.22 +/- 0.42 for eGFR (P < 0.001 for all variables). eGFR in non-diabetes participants was inversely associated with the HbA1c level, where eGFR decreased as HbA1c levels increased. Standardized beta s were -0.04 +/- 0.42 in multivariable analysis (P < 0.001). The proportion of participants with only MetS, only CKD, or both MetS and CKD was higher in the High group than in the Low and Middle groups. Conclusion High HbA1c in non-DM patients may be associated with CKD. Renal function in patients with high HbA1c levels may need to be monitored.	[Kang, Seok Hui; Choi, Eun Woo; Cho, Kyu Hyang; Park, Jong Won; Do, Jun Young] Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea; [Jung, Da Jung] Kyungpook Natl Univ Hosp, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Daegu, South Korea	Yeungnam University; Yeungnam University Hospital; Kyungpook National University; Kyungpook National University Hospital	Do, JY (corresponding author), Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea.	jydo@med.yu.ac.kr			Yeungnam University Research Grant	Yeungnam University Research Grant	This work was supported by the 2014 Yeungnam University Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Dilley J, 2007, DIABETES CARE, V30, P1527, DOI 10.2337/dc06-2414; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Fox CS, 2005, DIABETES CARE, V28, P2436, DOI 10.2337/diacare.28.10.2436; Gerstein HC, 2005, DIABETOLOGIA, V48, P1749, DOI 10.1007/s00125-005-1858-4; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hernandez D, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-151; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Jin DC, 2014, KIDNEY RES CLIN PRAC, V33, P9, DOI 10.1016/j.krcp.2014.01.002; Johnson DW, 2013, NEPHROLOGY, V18, P340, DOI 10.1111/nep.12052; Kim Jin Hwa, 2008, Diabetes and Metabolism Journal, V32, P435; Kim Y, 2016, DIABETIC MED, V33, P428, DOI 10.1111/dme.12970; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lim AKH, 2014, INT J NEPHROL RENOV, V7, P361, DOI 10.2147/IJNRD.S40172; McNeely MJ, 2009, DIABETES CARE, V32, P1727, DOI 10.2337/dc09-0074; Moebus S, 2009, DIABETOLOGIA, V52, P81, DOI 10.1007/s00125-008-1173-y; NELSON RG, 1989, DIABETOLOGIA, V32, P870, DOI 10.1007/BF00297452; Nguyen QM, 2008, METABOLISM, V57, P1487, DOI 10.1016/j.metabol.2008.04.011; Ong KL, 2010, DIABETES CARE, V33, P1856, DOI 10.2337/dc10-0190; Osei K, 2003, J CLIN ENDOCR METAB, V88, P4596, DOI 10.1210/jc.2003-030686; Park SH, 2012, J KOREAN MED SCI, V27, P1057, DOI 10.3346/jkms.2012.27.9.1057; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Perkovic V, 2013, KIDNEY INT, V83, P517, DOI 10.1038/ki.2012.401; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P673, DOI 10.2215/CJN.07891109; Prasad G V Ramesh, 2014, World J Nephrol, V3, P210, DOI 10.5527/wjn.v3.i4.210; Rehm J, 2004, COMP QUANTIFICATION, P959; Schottker B, 2013, PREV MED, V57, P596, DOI 10.1016/j.ypmed.2013.08.002; Selvin E, 2014, CIRCULATION, V130, P1374, DOI 10.1161/CIRCULATIONAHA.114.010815; Selvin E, 2011, DIABETES, V60, P298, DOI 10.2337/db10-1198; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sung KC, 2007, DIABETIC MED, V24, P848, DOI 10.1111/j.1464-5491.2007.02146.x; Thomas SS, 2015, KIDNEY INT, V88, P1233, DOI 10.1038/ki.2015.305; U. S. Renal Data System, 2014, USRDS 2014 ANN DAT R; Veeranna V, 2011, METAB SYNDR RELAT D, V9, P361, DOI 10.1089/met.2011.0032; WISEMAN M, 1984, DIABETOLOGIA, V26, P401; Xing FYF, 2014, DIABETES VASC DIS RE, V11, P11, DOI 10.1177/1479164113514239; Zhang QL, 2009, PREV MED, V48, P122, DOI 10.1016/j.ypmed.2008.10.026	43	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145827	10.1371/journal.pone.0145827	http://dx.doi.org/10.1371/journal.pone.0145827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716684	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500080
J	Yang, JC; Lin, YC; Gao, ZQ; Lv, ZH; Wei, W; Song, HB				Yang, Jiachen; Lin, Yancong; Gao, Zhiqun; Lv, Zhihan; Wei, Wei; Song, Houbing			Quality Index for Stereoscopic Images by Separately Evaluating Adding and Subtracting	PLOS ONE			English	Article							BINOCULAR VISION; INFORMATION; VISIBILITY; PARAMETERS	The human visual system (HVS) plays an important role in stereo image quality perception. Therefore, it has aroused many people's interest in how to take advantage of the knowledge of the visual perception in image quality assessment models. This paper proposes a full-reference metric for quality assessment of stereoscopic images based on the binocular difference channel and binocular summation channel. For a stereo pair, the binocular summation map and binocular difference map are computed first by adding and subtracting the left image and right image. Then the binocular summation is decoupled into two parts, namely additive impairments and detail losses. The quality of binocular summation is obtained as the adaptive combination of the quality of detail losses and additive impairments. The quality of binocular summation is computed by using the Contrast Sensitivity Function (CSF) and weighted multi-scale (MS-SSIM). Finally, the quality of binocular summation and binocular difference is integrated into an overall quality index. The experimental results indicate that compared with existing metrics, the proposed metric is highly consistent with the subjective quality assessment and is a robust measure. The result have also indirectly proved hypothesis of the existence of binocular summation and binocular difference channels.	[Yang, Jiachen; Lin, Yancong; Gao, Zhiqun] Tianjin Univ, Sch Elect Informat Engn, Tianjin 300072, Peoples R China; [Lv, Zhihan] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen 518055, Peoples R China; [Wei, Wei] Xian Univ Technol, Sch Comp Sci & Engn, Xian 710048, Shaanxi, Peoples R China; [Song, Houbing] W Virginia Univ, Dept Elect & Comp Engn, Montgomery, WV 25136 USA	Tianjin University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Xi'an University of Technology; West Virginia University	Song, HB (corresponding author), W Virginia Univ, Dept Elect & Comp Engn, Montgomery, WV 25136 USA.	Houbing.Song@mail.wvu.edu	Yang, Jiachen/ABH-5032-2020; Song, Houbing/E-3628-2010; Lv, Zhihan/I-3187-2014; Lv, Zhihan/GLR-6000-2022	Yang, Jiachen/0000-0003-2558-552X; Song, Houbing/0000-0003-2631-9223; Lv, Zhihan/0000-0003-2525-3074; Lv, Zhihan/0000-0003-2525-3074	National Natural Science Foundation of China [61471260, 61271324]; Program for New Century Excellent Talents in University [NCET-12-0400]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20136118120010]; China Postdoctoral Science Foundation [2013M542370]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research is partially supported by the National Natural Science Foundation of China (No. 61471260 and No. 61271324), supported by Program for New Century Excellent Talents in University (NCET-12-0400). This work is also supported by the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20136118120010) and China Postdoctoral Science Foundation (No. 2013M542370).	Akhter R., 2010, IS T SPIE ELECT IMAG; Banks MS, 2012, SMPTE MOTION IMAG J, V121, P24, DOI 10.5594/j18173; Benoit A, 2008, IEEE IMAGE PROC, P389, DOI 10.1109/ICIP.2008.4711773; Bensalma R, 2013, MULTIDIM SYST SIGN P, V24, P281, DOI 10.1007/s11045-012-0178-3; Boev A, 2006, 7TH IEEE SOUTHWEST SYMPOSIUM ON IMAGE ANALYSIS AND INTERPRETATION, P218; Bosc E, 2011, IEEE J-STSP, V5, P1332, DOI 10.1109/JSTSP.2011.2166245; Chen CW, 2014, J DISP TECHNOL, V10, P198, DOI 10.1109/JDT.2013.2293272; Chen MJ, 2013, SIGNAL PROCESS-IMAGE, V28, P1143, DOI 10.1016/j.image.2013.05.006; COHN TE, 1976, SCIENCE, V192, P561, DOI 10.1126/science.1257791; Faria FDEC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080745; IJsselsteijn WA, 2000, IEEE T CIRC SYST VID, V10, P225, DOI 10.1109/76.825722; Kingdom FAA, 2012, CURR BIOL, V22, pR22, DOI 10.1016/j.cub.2011.11.048; Kwangsung Ha, 2011, 2011 18th IEEE International Conference on Image Processing (ICIP 2011), P2525, DOI 10.1109/ICIP.2011.6116176; Lee JS, 2013, MULTIMED TOOLS APPL, V67, P31, DOI 10.1007/s11042-012-1011-6; Li SN, 2011, IEEE T MULTIMEDIA, V13, P935, DOI 10.1109/TMM.2011.2152382; Lin YH, 2014, IEEE T IMAGE PROCESS, V23, P1527, DOI 10.1109/TIP.2014.2302686; Maalouf A, 2011, INT CONF ACOUST SPEE, P1161; May KA, 2012, CURR BIOL, V22, P28, DOI 10.1016/j.cub.2011.11.025; Qi F, 2012, IEEE INT SYMP CIRC S, P1712; Rogers BJ, 1995, BINOCULAR VISION AND; Scharstein D, 2002, INT J COMPUT VISION, V47, P7, DOI 10.1023/A:1014573219977; Shao F, 2013, IEEE T IMAGE PROCESS, V22, P1940, DOI 10.1109/TIP.2013.2240003; Sheikh HR, 2006, IEEE T IMAGE PROCESS, V15, P430, DOI 10.1109/TIP.2005.859378; Shen LL, 2012, 2012 5TH INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING (CISP), P1119; Shibata T, 2011, IS T SPIE ELECT IMAG; Sizintsev M, 2014, IEEE T PATTERN ANAL, V36, P2241, DOI 10.1109/TPAMI.2014.2321373; Vimal RLP, 1997, J OPT SOC AM A, V14, P2622, DOI 10.1364/JOSAA.14.002622; Wang XM, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/419343; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; WATANABE A, 1968, VISION RES, V8, P1245, DOI 10.1016/0042-6989(68)90031-X; Watson AB, 1997, IEEE T IMAGE PROCESS, V6, P1164, DOI 10.1109/83.605413; Wopking M., 1995, Journal of the Society for Information Display, V3, P101; Xu C, 2014, IEEE T PATTERN ANAL, V36, P1559, DOI 10.1109/TPAMI.2013.2296528; Yang J., 2009, P 3DTV C TRUE VIS CA, P1, DOI DOI 10.1109/3DTV.2009.5069615; Yang JC, 2015, IEEE SENS J, V15, P4508, DOI 10.1109/JSEN.2015.2421518; You J., 2010, P INT WORKSH VID PRO; Yun N, 2013, NEUROCOMPUTING, V120, P121, DOI 10.1016/j.neucom.2012.06.059; Zhang F, 2010, PROC SPIE, V7744, DOI 10.1117/12.863083; Zhang GF, 2009, IEEE T PATTERN ANAL, V31, P974, DOI 10.1109/TPAMI.2009.52; Zhou F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116312; Zhou J., 2011, P IEEE INT INSTR MEA, P1, DOI DOI 10.1109/IMTC.2011.5944170	42	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145800	10.1371/journal.pone.0145800	http://dx.doi.org/10.1371/journal.pone.0145800			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717412	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500076
J	Zhu, GY; Mao, Y; Zhou, WD; Jiang, YL				Zhu, Guiyu; Mao, Yong; Zhou, Wendi; Jiang, Yunliang			Dynamic Changes in the Follicular Transcriptome and Promoter DNA Methylation Pattern of Steroidogenic Genes in Chicken Follicles throughout the Ovulation Cycle	PLOS ONE			English	Article							CASPASE-MEDIATED APOPTOSIS; GRANULOSA-CELLS; DOMESTIC-FOWL; POSTOVULATORY FOLLICLE; MESSENGER-RNA; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; OVARIAN STEROIDOGENESIS; ENZYME-ACTIVITY; BETA-CATENIN; HEN OVARY	The molecular mechanisms associated with follicle maturation and ovulation are not well defined in avian species. In this study, we used RNA-seq to study the gene expression profiles of the chicken follicles from different developmental stages (pre-hierarchical, pre-ovulatory and post-ovulatory). Transcriptomic analysis revealed a total of 1,277 and 2,310 genes were differentially expressed when follicles progressed through the pre-hierarchical to hierarchical and pre-ovulatory to post-ovulatory transitions, respectively. The differentially expressed genes (DEG) were involved in signaling pathways such as adherens junction, apoptosis and steroid biosynthesis. We further investigated the transcriptional regulation of follicular steroidogenesis by examining the follicle-specific methylation profiles of Star (steroidogenic acute regulatory protein), Cyp11a1 (cytochrome P450, family 11, subfamily a, polypeptide 1) and Hsd3b (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1), genes encoding the key enzymes for progesterone synthesis. The varied patterns of DNA methylation in proximal promoters of Star and Cyp11a1 but not Hsd3b in different follicles could play a major role in controlling gene expression as well as follicular steroidogenic activity. Finally, the promoter-reporter analysis suggests that TGF-beta could be involved in the regulation of Hsd3b expression during ovulation. Together, current data not only provide novel insights into the molecular mechanisms of follicular physiology in chicken follicles, but also present the first evidence of epigenetic regulation of ovarian steroidogenesis in avian species.	[Zhu, Guiyu] Taishan Univ, Dept Biol Sci & Technol, Tai An 271021, Shandong, Peoples R China; [Zhu, Guiyu; Zhou, Wendi; Jiang, Yunliang] Shandong Agr Univ, Coll Anim Sci & Vet Med, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An 271018, Shandong, Peoples R China; [Mao, Yong] Taian Materal & Child Hlth Hosp, Dept Gynecol, Tai An 271021, Shandong, Peoples R China	Taishan University; Key Laboratory of Animal Biotechnology & Disease Control & Prevention of Shandong Province; Shandong Agricultural University	Zhu, GY (corresponding author), Taishan Univ, Dept Biol Sci & Technol, Tai An 271021, Shandong, Peoples R China.	guiyuzhu@hotmail.com; yljiang723@aliyun.com			National Natural Science Foundation of China [31301974, 31272435]; Natural Science Foundation of Shandong Province [ZR2013CQ002]; Agricultural Elite Breeds Project of Shandong Province; Taishan University [Y-01-2014015]; Science and Technology Development Programme of Taian City [20140630-7]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Agricultural Elite Breeds Project of Shandong Province; Taishan University; Science and Technology Development Programme of Taian City	This work was supported by the National Natural Science Foundation of China (31301974), National Natural Science Foundation of China (31272435), Natural Science Foundation of Shandong Province (ZR2013CQ002), Agricultural Elite Breeds Project of Shandong Province (2015), Talent Project of Taishan University (Y-01-2014015) and the Science and Technology Development Programme of Taian City (20140630-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG DG, 1977, J REPROD FERTIL, V49, P253, DOI 10.1530/jrf.0.0490253; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BAHR JM, 1983, BIOL REPROD, V29, P326, DOI 10.1095/biolreprod29.2.326; Bauer MP, 2000, MOL CELL ENDOCRINOL, V168, P119, DOI 10.1016/S0303-7207(00)00316-6; Camacho-Arroyo I, 2007, COMP BIOCHEM PHYS A, V146, P644, DOI 10.1016/j.cbpa.2006.04.023; CHALANA RK, 1978, POULTRY SCI, V57, P814, DOI 10.3382/ps.0570814; Davis DE, 1942, ANAT REC, V82, P297, DOI 10.1002/ar.1090820305; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DICK HR, 1978, J REPROD FERTIL, V53, P103, DOI 10.1530/jrf.0.0530103; Fan HY, 2010, MOL ENDOCRINOL, V24, P1529, DOI 10.1210/me.2010-0141; GILBERT AB, 1978, J REPROD FERTIL, V52, P227, DOI 10.1530/jrf.0.0520227; Glister C, 2005, ENDOCRINOLOGY, V146, P1883, DOI 10.1210/en.2004-1303; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HUANG ESR, 1979, BIOL REPROD, V20, P454, DOI 10.1095/biolreprod20.3.454; HUM DW, 1993, CLIN CHEM, V39, P333; Johnson AL, 2007, REPRODUCTION, V133, P609, DOI 10.1530/REP-06-0287; Johnson AL, 2000, BIOL SIGNAL RECEPT, V9, P96; Johnson AL, 2003, ANIM REPROD SCI, V78, P185, DOI 10.1016/S0378-4320(03)00090-3; Johnson AL, 2002, REPRODUCTION, V124, P19, DOI 10.1530/rep.0.1240019; Johnson AL, 2002, BIOL REPROD, V67, P1313, DOI 10.1095/biolreprod67.4.1313; Johnson AL, 1996, ENDOCRINOLOGY, V137, P2059, DOI 10.1210/en.137.5.2059; Johnson AL, 2000, BIOL REPROD, V62, P589, DOI 10.1095/biolreprod62.3.589; Johnson PA, 2012, REPROD DOMEST ANIM, V47, P283, DOI 10.1111/j.1439-0531.2012.02087.x; Johnson PA, 2013, NAT REV CANCER, V13, P432, DOI 10.1038/nrc3535; Knight PG, 2009, POULT SCI S, V29, P89, DOI 10.1079/9781845933753.0089; LaVoie HA, 2009, EXP BIOL MED, V234, P880, DOI 10.3181/0903-MR-97; LAW AS, 1995, GEN COMP ENDOCR, V98, P227, DOI 10.1006/gcen.1995.1064; Lee L, 2013, ENDOCRINOLOGY, V154, P458, DOI 10.1210/en.2012-1610; Li E, 2013, ENDOCR J, V60, P1065, DOI 10.1507/endocrj.EJ13-0045; Li L, 2014, MOL CELL ENDOCRINOL, V382, P915, DOI 10.1016/j.mce.2013.11.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machell NH, 2000, BIOL REPROD, V63, P797, DOI 10.1095/biolreprod63.3.797; MARRONE BL, 1989, BIOL REPROD, V40, P1007, DOI 10.1095/biolreprod40.5.1007; Mora JM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096156; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Niswender GD, 2002, REPRODUCTION, V123, P333, DOI 10.1530/rep.0.1230333; NITTA H, 1993, BIOL REPROD, V48, P110, DOI 10.1095/biolreprod48.1.110; NITTA H, 1991, DOMEST ANIM ENDOCRIN, V8, P587, DOI 10.1016/0739-7240(91)90028-I; Onagbesan O, 2009, ANIM REPROD SCI, V111, P121, DOI 10.1016/j.anireprosci.2008.09.017; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; ROBINSON FE, 1986, BIOL REPROD, V35, P1096, DOI 10.1095/biolreprod35.5.1096; Rossetti MF, 2015, MOL CELL ENDOCRINOL, V412, P330, DOI 10.1016/j.mce.2015.05.024; Rowlands TM, 2000, REV REPROD, V5, P53; SAIDAPUR SK, 1982, INT REV CYTOL, V75, P243, DOI 10.1016/S0074-7696(08)61007-4; Sundaresan NR, 2008, VET RES COMMUN, V32, P13, DOI 10.1007/s11259-007-9005-y; TILLY JL, 1991, BIOL REPROD, V45, P967, DOI 10.1095/biolreprod45.6.967; TILLY JL, 1991, ENDOCRINOLOGY, V129, P2799, DOI 10.1210/endo-129-5-2799; TILLY JL, 1991, BIOL REPROD, V44, P305, DOI 10.1095/biolreprod44.2.305; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; Usongo M, 2012, REPRODUCTION, V144, P669, DOI 10.1530/REP-12-0291; Vanselow J., 2010, Animal Reproduction, V7, P134; Vanselow J, 2010, DNA METHYLATION IS N, V298, P289, DOI [10.1095/biolreprod.109.079251, DOI 10.1095/BI0LREPR0D.109.079251]; Wang TT, 2011, TOXICOL APPL PHARM, V257, P328, DOI 10.1016/j.taap.2011.09.016; Whittow GC, 2015, AVIAN PHYSL, DOI [10.1016/B978-0-12-407160-5.00028-2, DOI 10.1016/B978-0-12-407160-5.00028-2]; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; YU MW, 1992, POULTRY SCI, V71, P346, DOI 10.3382/ps.0710346; Zheng XF, 2008, REPRODUCTION, V136, P447, DOI 10.1530/REP-07-0316; Zhu GY, 2014, ASIAN AUSTRAL J ANIM, V27, P1526, DOI 10.5713/ajas.2014.14209; Zhu GY, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114249; Zhu GY, 2012, GEN COMP ENDOCR, V178, P314, DOI 10.1016/j.ygcen.2012.06.018	60	14	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146028	10.1371/journal.pone.0146028	http://dx.doi.org/10.1371/journal.pone.0146028			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716441	gold, Green Published, Green Submitted			2022-12-27	WOS:000367510500119
J	Brookes, VJ; Jordan, D; Davis, S; Ward, MP; Heller, J				Brookes, Victoria J.; Jordan, David; Davis, Stephen; Ward, Michael P.; Heller, Jane			Saltelli Global Sensitivity Analysis and Simulation Modelling to Identify Intervention Strategies to Reduce the Prevalence of Escherichia coli O157 Contaminated Beef Carcasses	PLOS ONE			English	Article							IN-GROUND BEEF; RISK-ASSESSMENT; UNITED-STATES; FEEDLOT CATTLE; AMBIENT-TEMPERATURE; DOMESTIC RUMINANTS; SLAUGHTER; FECES; TRANSMISSION; PATHOGENS	Introduction Strains of Shiga-toxin producing Escherichia coli O157 (STEC O157) are important food-borne pathogens in humans, and outbreaks of illness have been associated with consumption of undercooked beef. Here, we determine the most effective intervention strategies to reduce the prevalence of STEC O157 contaminated beef carcasses using a modelling approach. Method A computational model simulated events and processes in the beef harvest chain. Information from empirical studies was used to parameterise the model. Variance-based global sensitivity analysis (GSA) using the Saltelli method identified variables with the greatest influence on the prevalence of STEC O157 contaminated carcasses. Following a baseline scenario (no interventions), a series of simulations systematically introduced and tested interventions based on influential variables identified by repeated Saltelli GSA, to determine the most effective intervention strategy. Results Transfer of STEC O157 from hide or gastro-intestinal tract to carcass (improved abattoir hygiene) had the greatest influence on the prevalence of contaminated carcases. Due to interactions between inputs (identified by Saltelli GSA), combinations of interventions based on improved abattoir hygiene achieved a greater reduction in maximum prevalence than would be expected from an additive effect of single interventions. The most effective combination was improved abattoir hygiene with vaccination, which achieved a greater than ten-fold decrease in maximum prevalence compared to the baseline scenario. Conclusion Study results suggest that effective interventions to reduce the prevalence of STEC O157 contaminated carcasses should initially be based on improved abattoir hygiene. However, the effect of improved abattoir hygiene on the distribution of STEC O157 concentration on carcasses is an important information gap-further empirical research is required to determine whether reduced prevalence of contaminated carcasses is likely to result in reduced incidence of STEC O157 associated illness in humans. This is the first use of variance-based GSA to assess the drivers of STEC O157 contamination of beef carcasses.	[Brookes, Victoria J.; Heller, Jane] Graham Ctr Agr Innovat, NSW Dept Primary Ind, Wagga Wagga, NSW 2650, Australia; [Brookes, Victoria J.; Heller, Jane] Charles Sturt Univ, Wagga Wagga, NSW 2650, Australia; [Brookes, Victoria J.; Heller, Jane] Charles Sturt Univ, Sch Anim & Vet Sci, Fac Sci, Wagga Wagga, NSW 2678, Australia; [Jordan, David] NSW Dept Primary Ind, Wollongbar, NSW, Australia; [Davis, Stephen] RMIT Univ, Sch Math & Geospatial Sci, Melbourne, Vic 3001, Australia; [Ward, Michael P.] Univ Sydney, Fac Vet Sci, Camden, NSW 2570, Australia	NSW Department of Primary Industries; Charles Sturt University; Charles Sturt University; NSW Department of Primary Industries; Royal Melbourne Institute of Technology (RMIT); University of Sydney	Brookes, VJ (corresponding author), Graham Ctr Agr Innovat, NSW Dept Primary Ind, Pugsley Pl, Wagga Wagga, NSW 2650, Australia.	victoria.brookes@sydney.edu.au	Jordan, David/P-7281-2019; Ward, Michael Patrick/W-1897-2019; Heller, Jane/H-9596-2016; Ward, Michael/C-5758-2009; Brookes, Victoria/W-1311-2019; Ward, Michael Patrick/GRX-1851-2022	Heller, Jane/0000-0003-3993-0160; Ward, Michael/0000-0002-9921-4986; Brookes, Victoria/0000-0003-0963-4926; Ward, Michael Patrick/0000-0002-9921-4986	Meat and Livestock Australia [A.MFS.0247]; National Collaborative Research Infrastructure Strategy (NCRIS)	Meat and Livestock Australia(Meat and Livestock Australia); National Collaborative Research Infrastructure Strategy (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science)	This research was funded by Meat and Livestock Australia (A.MFS.0247). The funders reviewed the manuscript prior to submission and made no changes to the content. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.; The authors thank Geraldine Lammers, Karen Williams, Andreas Kiermeier, Salome Durr, Long Huynh (MLA) and Ian Jenson MLA) for information and advice during this study. We also gratefully acknowledge the use of computing resources from the NeCTAR Research Cloud, http://www.nectar.org.au. NeCTAR is an Australian Government project conducted as part of the Super Science initiative and financed by the Education Investment Fund and National Collaborative Research Infrastructure Strategy (NCRIS).	ABBEY HELEN, 1952, HUMAN BIOL, V24, P201; Aperce CC, 2014, J ANIM SCI, V92, P676, DOI 10.2527/jas.2013-6712; Arthur TM, 2007, J FOOD PROTECT, V70, P280, DOI 10.4315/0362-028X-70.2.280; Arthur TM, 2010, MEAT SCI, V86, P32, DOI 10.1016/j.meatsci.2010.04.019; Arthur TM, 2009, APPL ENVIRON MICROB, V75, P6515, DOI 10.1128/AEM.00081-09; Bosilevac JM, 2005, J FOOD PROTECT, V68, P265, DOI 10.4315/0362-028X-68.2.265; Brichta-Harhay DM, 2008, APPL ENVIRON MICROB, V74, P6289, DOI 10.1128/AEM.00700-08; Cassin MH, 1998, INT J FOOD MICROBIOL, V41, P21, DOI 10.1016/S0168-1605(98)00028-2; Cobbold RN, 2007, APPL ENVIRON MICROB, V73, P1563, DOI 10.1128/AEM.01742-06; Crim SM, 2014, MMWR-MORBID MORTAL W, V63, P328; Davis S, 2011, PARASITOLOGY, V138, P516, DOI 10.1017/S0031182010001496; Department of Agriculture Fisheries and Forestry, 2012, AUSTR AN WELF STAND; Dewell GA, 2008, J FOOD PROTECT, V71, P1114, DOI 10.4315/0362-028X-71.6.1114; Duffy G, 2006, MEAT SCI, V74, P76, DOI 10.1016/j.meatsci.2006.04.011; Ebel E, 2004, J FOOD PROTECT, V67, P1991, DOI 10.4315/0362-028X-67.9.1991; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; Fegan N, 2005, J FOOD PROTECT, V68, P451, DOI 10.4315/0362-028X-68.3.451; Fegan N, 2004, J APPL MICROBIOL, V97, P362, DOI 10.1111/j.1365-2672.2004.02300.x; Fegan N, 2009, FOODBORNE PATHOG DIS, V6, P1113, DOI 10.1089/fpd.2009.0338; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Gautam R, 2015, EPIDEMIOL INFECT, V143, P274, DOI 10.1017/S0950268814000867; Gautam R, 2011, PREV VET MED, V102, P10, DOI 10.1016/j.prevetmed.2011.06.008; Greig JD, 2012, FOOD CONTROL, V27, P385, DOI 10.1016/j.foodcont.2012.03.019; Heller J, 2014, ARBP0015 MEAT LIV AU; Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417; Homma T, 1995, J NUCL SCI TECHNOL, V32, P1164, DOI 10.3327/jnst.32.1164; Jonsson ME, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-43; Jordan D, 1999, PREV VET MED, V41, P37, DOI 10.1016/S0167-5877(99)00033-1; Jordan D, 1999, PREV VET MED, V41, P55, DOI 10.1016/S0167-5877(99)00032-X; Kiermeier A, 2006, INT J FOOD MICROBIOL, V111, P263, DOI 10.1016/j.ijfoodmicro.2006.05.006; Kiermeier A, 2015, RISK ANAL, V35, P77, DOI 10.1111/risa.12248; Kulow MJ, 2012, APPL ENVIRON MICROB, V78, P8045, DOI 10.1128/AEM.02363-12; Lammers GAC, 2015, EPIDEMIOL INFECT, V143, P3244, DOI 10.1017/S0950268815000588; Masana MO, 2010, J FOOD PROTECT, V73, P649, DOI 10.4315/0362-028X-73.4.649; Nossent J, 2011, ENVIRON MODELL SOFTW, V26, P1515, DOI 10.1016/j.envsoft.2011.08.010; Nou XW, 2003, J FOOD PROT, V66; Pennington H, 2010, LANCET, V376, P1428, DOI 10.1016/S0140-6736(10)60963-4; Peterson RE, 2007, J FOOD PROTECT, V70, P287, DOI 10.4315/0362-028X-70.2.287; Petherick JC, 2005, APPL ANIM BEHAV SCI, V92, P211, DOI 10.1016/j.applanim.2005.05.009; Pollock KGJ, 2008, EPIDEMIOL INFECT, V136, P115, DOI 10.1017/S0950268807008217; Pollock KGJ, 2010, EMERG INFECT DIS, V16, P881, DOI 10.3201/eid1605.091919; Potter AA, 2004, VACCINE, V22, P362, DOI 10.1016/j.vaccine.2003.08.007; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Saltelli A, 2002, COMPUT PHYS COMMUN, V145, P280, DOI 10.1016/S0010-4655(02)00280-1; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; Sargeant JM, 2007, ZOONOSES PUBLIC HLTH, V54, P260, DOI 10.1111/j.1863-2378.2007.01059.x; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Smith BA, 2013, FOOD CONTROL, V29, P364, DOI 10.1016/j.foodcont.2012.03.003; Snedeker KG, 2012, ZOONOSES PUBLIC HLTH, V59, P126, DOI 10.1111/j.1863-2378.2011.01426.x; Sobol I.M., 1990, MAT MODEL, V2, P112, DOI DOI 10.18287/0134-2452-2015-39-4-459-461; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Thomas DE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-799; Vynnycky E., 2010, INTRO INFECT DIS MOD, DOI DOI 10.1038/NRMICRO1845; Wang XY, 2014, J MATH BIOL, V69, P501, DOI 10.1007/s00285-013-0707-1; Williams KJ, 2015, EPIDEMIOL INFECT, V143, P1388, DOI 10.1017/S0950268814002374; Williams KJ, 2014, VET MICROBIOL, V173, P101, DOI 10.1016/j.vetmic.2014.07.001; Wisener LV, 2015, ZOONOSES PUBLIC HLTH, V62, P75, DOI 10.1111/zph.12112	59	3	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0146016	10.1371/journal.pone.0146016	http://dx.doi.org/10.1371/journal.pone.0146016			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713610	Green Submitted, gold, Green Published			2022-12-27	WOS:000367481900110
J	Altarelli, F; Braunstein, A; Dall'Asta, L; De Bacco, C; Franz, S				Altarelli, Fabrizio; Braunstein, Alfredo; Dall'Asta, Luca; De Bacco, Caterina; Franz, Silvio			The Edge-Disjoint Path Problem on Random Graphs by Message-Passing	PLOS ONE			English	Article							WAVELENGTH ASSIGNMENT; APPROXIMATION ALGORITHMS; OPTICAL NETWORKS; OPTIMIZATION; QOS	We present a message-passing algorithm to solve a series of edge-disjoint path problems on graphs based on the zero-temperature cavity equations. Edge-disjoint paths problems are important in the general context of routing, that can be defined by incorporating under a unique framework both traffic optimization and total path length minimization. The computation of the cavity equations can be performed efficiently by exploiting a mapping of a generalized edge-disjoint path problem on a star graph onto a weighted maximum matching problem. We perform extensive numerical simulations on random graphs of various types to test the performance both in terms of path length minimization and maximization of the number of accommodated paths. In addition, we test the performance on benchmark instances on various graphs by comparison with state-of-the-art algorithms and results found in the literature. Our message-passing algorithm always outperforms the others in terms of the number of accommodated paths when considering non trivial instances (otherwise it gives the same trivial results). Remarkably, the largest improvement in performance with respect to the other methods employed is found in the case of benchmarks with meshes, where the validity hypothesis behind message-passing is expected to worsen. In these cases, even though the exact message-passing equations do not converge, by introducing a reinforcement parameter to force convergence towards a sub optimal solution, we were able to always outperform the other algorithms with a peak of 27% performance improvement in terms of accommodated paths. On random graphs, we numerically observe two separated regimes: one in which all paths can be accommodated and one in which this is not possible. We also investigate the behavior of both the number of paths to be accommodated and their minimum total length.	[Altarelli, Fabrizio; Braunstein, Alfredo; Dall'Asta, Luca] Politecn Torino, DISAT, I-10129 Turin, Italy; [Altarelli, Fabrizio; Braunstein, Alfredo; Dall'Asta, Luca] Politecn Torino, Ctr Computat Sci, I-10129 Turin, Italy; [Altarelli, Fabrizio; Braunstein, Alfredo; Dall'Asta, Luca] Coll Carlo Alberto, I-10024 Moncalieri, Italy; [Braunstein, Alfredo] Human Genet Fdn, I-10126 Turin, Italy; [De Bacco, Caterina; Franz, Silvio] Univ Paris Saclay, Univ Paris Sud, CNRS, LPTMS, F-91405 Orsay, France	Polytechnic University of Turin; Polytechnic University of Turin; Collegio Carlo Alberto; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	De Bacco, C (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, LPTMS, F-91405 Orsay, France.	caterina.de-bacco@lptms.u-psud.fr	Franz, Silvio/B-2137-2019; Braunstein, Alfredo/E-6924-2012	Franz, Silvio/0000-0001-8300-8443; De Bacco, Caterina/0000-0002-8634-0211; Braunstein, Alfredo/0000-0002-4562-3610	Marie Curie Training Network NETADIS (FP7) [413 290038, 290038]; Italian FIRB Project [RBFR10QUW4]; ERC [267915]	Marie Curie Training Network NETADIS (FP7); Italian FIRB Project(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); ERC(European Research Council (ERC)European Commission)	This work was supported by the Marie Curie Training Network NETADIS (FP7, grant 413 290038). L.D. also acknowledges the Italian FIRB Project No. RBFR10QUW4 and 414 ERC grant No. 267915. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thanks P. Quang Dung for kindly providing us the detailed benchmark instances. This work was supported by the Marie Curie Training Network NETADIS (FP7, grant 290038). L.D. also acknowledges the Italian FIRB Project No. RBFR10QUW4 and ERC grant No. 267915.	Akkaya K., 2005, Ad Hoc Networks, V3, P325, DOI 10.1016/j.adhoc.2003.09.010; Altarelli F, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/P07002; Ash GR, 2006, TRAFFIC ENG QOS OPTI; AUMANN Y, 1995, PROCEEDINGS OF THE SIXTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P567; Awerbuch B., 1994, Proceedings. 35th Annual Symposium on Foundations of Computer Science (Cat. No.94CH35717), P412, DOI 10.1109/SFCS.1994.365675; Banerjee D, 1996, IEEE J SEL AREA COMM, V14, P903, DOI 10.1109/49.510913; Baveja A, 2000, MATH OPER RES, V25, P255, DOI 10.1287/moor.25.2.255.12228; Bayati M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.037208; Bayati M, 2008, IEEE T INFORM THEORY, V54, P1241, DOI 10.1109/TIT.2007.915695; Bayati M, 2008, J MATH PHYS, V49, DOI 10.1063/1.2982805; Belgacem L, 2014, EUR J OPER RES, V232, P298, DOI 10.1016/j.ejor.2013.06.050; Blesa M, 2004, LECT NOTES COMPUT SC, V3005, P160; Braunstein A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030201; Chan WT, 2003, ALGORITHMICA, V36, P343, DOI 10.1007/s00453-003-1023-8; Chatterjee BC, 2013, IETE TECH REV, V30, P12, DOI 10.4103/0256-4602.107335; Chekuri C., 2006, THEORY COMPUT, V2, P137, DOI DOI 10.4086/T0C.2006.V002A007; Chen C, 1996, IEEE INFOCOM SER, P164, DOI 10.1109/INFCOM.1996.497890; Chuzhoy J, 2005, NEW HARDNESS RESULTS; De Bacco C, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/07/P07009; ERDOS P, 1960, B INT STATIST INST, V38, P343; Erlebach T, 2006, LECT NOTES COMPUT SC, V3484, P97, DOI 10.1007/11671541_4; Erlebach T, 2001, SIAM J DISCRETE MATH, V14, P326, DOI 10.1137/S0895480199361259; GALIL Z, 1986, SIAM J COMPUT, V15, P120, DOI 10.1137/0215009; Gamarnik D, 2010, CMMI0726733 NAT SCI; Garey M.R., 1979, COMPUTERS INTRACTABI; Garg N, 1997, ALGORITHMICA, V18, P3, DOI 10.1007/BF02523685; Gerez S. H, 1999, ALGORITHMS VLSI DESI, V8; Gerla M, 1995, WIREL NETW, V1, P255, DOI 10.1007/BF01200845; Hassan A, 2007, EPSRC POSTGRADATE NE; Hsu CC, 2014, GENETIC EVOLUTIONARY, P95; Hsu CC, 2014, NEUROCOMPUTING; Hummeltenberg W, 2008, NETWORK MODELS OPTIM; Jain S, 2008, AD HOC NETW, V6, P805, DOI 10.1016/j.adhoc.2007.07.002; Karp Richard M, 1972, REDUCIBILITY COMBINA; Kleinberg J, 2005, ANN IEEE SYMP FOUND, P627, DOI 10.1109/SFCS.2005.18; Kleinberg J, 1995, AN S FDN CO, P52, DOI 10.1109/SFCS.1995.492462; Kleinberg JM., 1996, APPROXIMATION ALGORI; Kolliopoulos SG, 2004, MATH PROGRAM, V99, P63, DOI 10.1007/s10107-002-0370-6; Li X, 2004, P 1 ACM INT WORKSH P, P23; Lovasz L, 2009, AMS CHELSEA PUBLISHI; Mahapatra A, 2006, COMPUT COMMUN, V29, P437, DOI 10.1016/j.comcom.2004.12.028; Manohar P, 2002, IEEE COMMUN LETT, V6, P211, DOI 10.1109/4234.1001667; Masip-Bruin X, 2006, COMPUT COMMUN, V29, P563, DOI 10.1016/j.comcom.2005.06.008; Medina A, 2001, NINTH INTERNATIONAL SYMPOSIUM ON MODELING, ANALYSIS AND SIMULATION OF COMPUTER AND TELECOMMUNICATION SYSTEMS, PROCEEDINGS, P346, DOI 10.1109/MASCOT.2001.948886; Mezard M, 2003, J STAT PHYS, V111, P1, DOI 10.1023/A:1022221005097; Mezard M, 2002, SCIENCE, V297, P812, DOI 10.1126/science.1073287; Mezard M, 2001, EUR PHYS J B, V20, P217, DOI 10.1007/PL00011099; Mezard M., 2009, INFORM PHYS COMPUTAT, pp 584, DOI [10.1093/acprof:oso/9780198570837.001.0001, DOI 10.1093/ACPROF:OSO/9780198570837.001, DOI 10.1093/ACPROF:OSO/9780198570837.001.0001]; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026118; Noronha TF, 2011, J GLOBAL OPTIM, V50, P503, DOI 10.1007/s10898-010-9608-7; Ozdaglar AE, 2003, IEEE ACM T NETWORK, V11, P259, DOI 10.1109/TNET.2003.810321; Pham QD, 2012, CONSTRAINTS, V17, P357, DOI 10.1007/s10601-012-9124-0; ROBERTSON N, 1995, J COMB THEORY B, V63, P65, DOI 10.1006/jctb.1995.1006; Salama HF, 1997, IEEE J SEL AREA COMM, V15, P332, DOI 10.1109/49.564132; SHIN KG, 1994, P IEEE, V82, P6, DOI 10.1109/5.259423; Skorin-Kapov N, 2007, EUR J OPER RES, V177, P1167, DOI 10.1016/j.ejor.2006.01.003; Srinivas A, 2003, P 9 ANN INT C MOBILE, P122; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Sumpter Z, 2013, IEEE GLOBECOM 2013 C; Tanenbaum A. S., 2003, COMPUT NETW; Virasoro M, 1987, SPIN GLASS THEORY, V9; Vygen J., 1994, DISJOINT PATHS; Yeung CH, 2013, P NATL ACAD SCI USA, V110, P13717, DOI 10.1073/pnas.1301111110; Yeung CH, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208701	64	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145222	10.1371/journal.pone.0145222	http://dx.doi.org/10.1371/journal.pone.0145222			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710102	Green Submitted, gold, Green Published			2022-12-27	WOS:000367451400026
J	Broekgaarden, C; Bucher, J; Bac-Molenaar, J; Keurentjes, JJB; Kruijer, W; Voorrips, RE; Vosman, B				Broekgaarden, Colette; Bucher, Johan; Bac-Molenaar, Johanna; Keurentjes, Joost J. B.; Kruijer, Willem; Voorrips, Roeland E.; Vosman, Ben			Novel Genes Affecting the Interaction between the Cabbage Whitefly and Arabidopsis Uncovered by Genome-Wide Association Mapping	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; INSECT HERBIVORES DRIVE; NATURAL VARIATION; BEMISIA-TABACI; GLUCOSINOLATE ACCUMULATION; SIGNALING PATHWAYS; APHID RESISTANCE; PLANT DEFENSES; THALIANA; POPULATIONS	Plants have evolved a variety of ways to defend themselves against biotic attackers. This has resulted in the presence of substantial variation in defense mechanisms among plants, even within a species. Genome-wide association GWA) mapping is a useful tool to study the genetic architecture of traits, but has so far only had limited exploitation in studies of plant defense. Here, we study the genetic architecture of defense against the phloem-feeding insect cabbage whitefly Aleyrodes proletella) in Arabidopsis thaliana. We determined whitefly performance, i.e. the survival and reproduction of whitefly females, on 360 worldwide selected natural accessions and subsequently performed GWA mapping using 214,051 SNPs. Substantial variation for whitefly adult survival and oviposition rate number of eggs laid per female per day) was observed between the accessions. We identified 39 candidate SNPs for either whitefly adult survival or oviposition rate, all with relatively small effects, underpinning the complex architecture of defense traits. Among the corresponding candidate genes, i.e. genes in linkage disequilibrium LD) with candidate SNPs, none have previously been identified as a gene playing a role in the interaction between plants and phloem-feeding insects. Whitefly performance on knock-out mutants of a number of candidate genes was significantly affected, validating the potential of GWA mapping for novel gene discovery in plant-insect interactions. Our results show that GWA analysis is a very useful tool to gain insight into the genetic architecture of plant defense against herbivorous insects, i.e. we identified and validated several genes affecting whitefly performance that have not previously been related to plant defense against herbivorous insects.	[Broekgaarden, Colette; Bucher, Johan; Voorrips, Roeland E.; Vosman, Ben] Wageningen Univ, Wageningen UR Plant Breeding, NL-6700 AP Wageningen, Netherlands; [Broekgaarden, Colette] Univ Utrecht, Plant Microbe Interact, Dept Biol, Utrecht, Netherlands; [Bac-Molenaar, Johanna] Wageningen Univ, Lab Plant Physiol, NL-6700 AP Wageningen, Netherlands; [Bac-Molenaar, Johanna; Keurentjes, Joost J. B.] Wageningen Univ, Genet Lab, NL-6700 AP Wageningen, Netherlands; [Kruijer, Willem] Wageningen Univ, Biometris Appl Stat, Dept Plant Sci, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Utrecht University; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Vosman, B (corresponding author), Wageningen Univ, Wageningen UR Plant Breeding, NL-6700 AP Wageningen, Netherlands.	ben.vosman@wur.nl	Vosman, Ben/C-5494-2013; Voorrips, Roeland E/H-3458-2011; Bac-Molenaar, Johanna/R-2265-2016; Kruijer, Willem/AAJ-7245-2020	Vosman, Ben/0000-0003-4942-8342; Voorrips, Roeland E/0000-0003-4388-9244; Keurentjes, Joost/0000-0001-8918-0711	Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs [10994, 13087]; Syngenta Seeds BV; Plant Research International BV	Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs; Syngenta Seeds BV(Syngenta); Plant Research International BV(Plant Research International)	This research was supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organisation for Scientific Research (NWO) and partly funded by the Ministry of Economic Affairs (Learning from Nature perspective grant no. 10994; VENI grant no. 13087 to CB). The project is financially supported by Syngenta Seeds BV and Plant Research International BV. The funders had an advisory role on the study design, data collection and analysis, and decision to publish. Plant Research International contributed to the preparation of the manuscript, whereas Syngenta had no role in manuscript preparation.	Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; Assaad FF, 2004, MOL BIOL CELL, V15, P5118, DOI 10.1091/mbc.E04-02-0140; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Bergelson J, 2010, NAT REV GENET, V11, P867, DOI 10.1038/nrg2896; Bhullar NK, 2009, P NATL ACAD SCI USA, V106, P9519, DOI 10.1073/pnas.0904152106; Broekgaarden C, 2012, ENTOMOL EXP APPL, V142, P153, DOI 10.1111/j.1570-7458.2011.01210.x; Broekgaarden C, 2011, PLANT BIOTECHNOL J, V9, P819, DOI 10.1111/j.1467-7652.2011.00635.x; Bruce TJA, 2015, J EXP BOT, V66, P455, DOI 10.1093/jxb/eru391; BYRNE DN, 1991, ANNU REV ENTOMOL, V36, P431, DOI 10.1146/annurev.en.36.010191.002243; Cabrera Y, 1998, PLANT SCI, V138, P209; Chan EKF, 2010, GENETICS, V185, P991, DOI 10.1534/genetics.109.108522; Chen X, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0217-3; Chen X, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070914, 10.1371/journal.pone.0079652]; Chen X, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-33; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Darrow K, 1997, BIOCHEM SYST ECOL, V25, P1, DOI 10.1016/S0305-1978(96)00090-7; de Vos M, 2007, BIOESSAYS, V29, P871, DOI 10.1002/bies.20624; Domergue F, 2010, PLANT PHYSIOL, V153, P1539, DOI 10.1104/pp.110.158238; Ellis C, 2002, PLANT CELL, V14, P1557, DOI 10.1105/tpc.002022; Firdaus S, 2012, EUPHYTICA, V187, P31, DOI 10.1007/s10681-012-0704-2; Hare JD, 2012, SCIENCE, V338, P50, DOI 10.1126/science.1228893; Hosy E, 2003, P NATL ACAD SCI USA, V100, P5549, DOI 10.1073/pnas.0733970100; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Johansson ON, 2014, PLANT J, V79, P466, DOI 10.1111/tpj.12571; Johnson MTJ, 2011, FUNCT ECOL, V25, P305, DOI 10.1111/j.1365-2435.2011.01838.x; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kempema LA, 2007, PLANT PHYSIOL, V143, P849, DOI 10.1104/pp.106.090662; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kliebenstein D, 2002, GENETICS, V161, P325; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.010416; Kruijer W, 2015, GENETICS, V199, P379, DOI 10.1534/genetics.114.167916; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lee S, 2010, P NATL ACAD SCI USA, V107, P21205, DOI 10.1073/pnas.1009975107; Li Y, 2010, P NATL ACAD SCI USA, V107, P21199, DOI 10.1073/pnas.1007431107; Lucatti AF, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0142-3; Lucatti AF, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-175; Maharijaya A, 2011, EUPHYTICA, V177, P401, DOI 10.1007/s10681-010-0277-x; Markovich O, 2013, J CHEM ECOL, V39, P1361, DOI 10.1007/s10886-013-0358-0; Mewis I, 2006, PHYTOCHEMISTRY, V67, P2450, DOI 10.1016/j.phytochem.2006.09.004; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Mooney KA, 2010, SCIENCE, V327, P1642, DOI 10.1126/science.1184814; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Pegadaraju V, 2005, PLANT PHYSIOL, V139, P1927, DOI 10.1104/pp.105.070433; Pfalz M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000578; Pfalz M, 2009, PLANT CELL, V21, P985, DOI 10.1105/tpc.108.063115; Pieterse CM, 2004, CURR OPIN PLANT BIOL, V7, P456, DOI 10.1016/j.pbi.2004.05.006; Samayoa LF, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0403-3; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Snoeren TAL, 2010, J EXP BOT, V61, P3041, DOI 10.1093/jxb/erq127; Thompson GA, 2006, J EXP BOT, V57, P755, DOI 10.1093/jxb/erj135; Thompson JN, 2005, CURR BIOL, V15, pR992, DOI 10.1016/j.cub.2005.11.046; Van Poecke RMP, 2001, J CHEM ECOL, V27, P1911, DOI 10.1023/A:1012213116515; Xiang T, 2006, ORG LETT, V8, P2835, DOI 10.1021/ol060973p; ZANGERL AR, 1993, ECOLOGY, V74, P47, DOI 10.2307/1939500; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; Zust T, 2012, SCIENCE, V338, P116, DOI 10.1126/science.1226397	61	5	5	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145124	10.1371/journal.pone.0145124	http://dx.doi.org/10.1371/journal.pone.0145124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699853	gold, Green Submitted, Green Published			2022-12-27	WOS:000367092600049
J	Devi, KR; Bhutia, R; Bhowmick, S; Mukherjee, K; Mahanta, J; Narain, K				Devi, Kangjam Rekha; Bhutia, Rinchenla; Bhowmick, Shovonlal; Mukherjee, Kaustab; Mahanta, Jagadish; Narain, Kanwar			Genetic Diversity of Mycobacterium tuberculosis Isolates from Assam, India: Dominance of Beijing Family and Discovery of Two New Clades Related to CAS1_Delhi and EAI Family Based on Spoligotyping and MIRU-VNTR Typing	PLOS ONE			English	Article							INTERSPERSED REPETITIVE UNITS; MOLECULAR EPIDEMIOLOGY; PULMONARY TUBERCULOSIS; DRUG-RESISTANCE; GENOTYPIC DIVERSITY; SOUTH-INDIA; NORTH-INDIA; STRAINS; COMPLEX; DELHI	Tuberculosis (TB) is one of the major public health concerns in Assam, a remote state located in the northeastern (NE) region of India. The present study was undertaken to explore the circulating genotypes of Mycobacterium tuberculosis complex (MTBC) in this region. A total of 189 MTBC strains were collected from smear positive pulmonary tuberculosis cases from different designated microscopy centres (DMC) from various localities of Assam. AII MTBC isolates were cultured on Lowenstein-Jensen (LJ) media and subsequently genotyped using spoligotyping and 24-loci mycobacterial interspersed repetitive units-variable number of tandem repeats (MIRU-VNTR) typing. Spoligotyping of MTBC isolates revealed 89 distinct spoligo patterns. The most dominant MTBC strain belonged to Beijing lineage and was represented by 35.45%(n = 67) of total isolates, followed by MTBC strains belonging to Central Asian-Delhi (CAS/Delhi) lineage and East African Indian (EAI5) lineage. In addition, in the present study 43 unknown spoligo patterns were detected. The discriminatory power of spoligotyping was found to be 0.8637 based on Hunter Gaston Discriminatory Index (HGDI). On the other hand, 24-loci MIRU-VNTR typing revealed that out of total 189 MTBC isolates from Assam 185 (97.9%) isolates had unique MIRU-VNTR profiles and 4 isolates grouped into 2 clusters. Phylogenetic analysis of 67 Beijing isolates based on 24-loci MIRU-VNTR typing revealed that Beijing isolates from Assam represent two major groups, each comprising of several subgroups. Neighbour-Joining (NJ) phylogenetic tree analysis based on combined spoligotyping and 24-loci MIRU-VNTR data of 78 Non-Beijing isolates was carried out for strain lineage identification as implemented by MIRU-VNTRplus database. The important lineages of MTBC identified were CAS/CAS1_Delhi (41.02%, n = 78) and East-African-Indian (EAI, 33.33%). Interestingly, phylogenetic analysis of orphan (23.28%) MTBC spoligotypes revealed that majority of these orphan isolates from Assam represent two new sub-clades Assam/EAI and Assam/CAS. The prevalence of multidrug resistance (MDR) in Beijing and Non-Beijing strains was found to be 10.44% and 9.01% respectively. In conclusion, the present study has shown the predominance of Beijing isolates in Assam which is a matter of great concern because Beijing strains are considered to be ecologically more fit enabling wider dissemination of M. tuberculosis. Other interesting finding of the present study is the discovery of two new clades of MTBC isolates circulating in Assam. More elaborate longitudinal studies are required to be undertaken in this region to understand the transmission dynamics of MTBC.	[Devi, Kangjam Rekha; Bhutia, Rinchenla; Bhowmick, Shovonlal; Mukherjee, Kaustab; Mahanta, Jagadish; Narain, Kanwar] NE Reg Indian Council Med Res, Reg Med Res Ctr, Dibrugarh 786001, Assam, India	Indian Council of Medical Research (ICMR); ICMR - Regional Medical Research Centre, North East Region (RMRC NE)	Narain, K (corresponding author), NE Reg Indian Council Med Res, Reg Med Res Ctr, Post Box 105, Dibrugarh 786001, Assam, India.	kanwar_narain@hotmail.com	Mukherjee, Kaustab/T-9807-2017	Narain, Kanwar/0000-0002-3463-535X	Indian Council of Medical Research [NER/17/2012-ECD-I]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by the Indian Council of Medical Research; NER/17/2012-ECD-I.; The authors are thankful to Indian Council of Medical Research for funding this research project. We also thank Mr. S.K. Rajguru, Mr. Kamal Gogoi and Mr. Rajeev for helping in data entry.	Ahmed N, 2011, TUBERCULOSIS, V91, P407, DOI 10.1016/j.tube.2011.03.006; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Almeida D, 2005, CLIN INFECT DIS, V40, P881, DOI 10.1086/427940; [Anonymous], 2009, TRAIN MAN MYC TUB CU, P1; Arora J, 2009, INFECT GENET EVOL, V9, P832, DOI 10.1016/j.meegid.2009.05.008; Banu S, 2004, J CLIN MICROBIOL, V42, P674, DOI 10.1128/JCM.42.2.674-682.2004; Banu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124976; Bhanu NV, 2002, TUBERCULOSIS, V82, P105, DOI 10.1054/tube.2002.0332; Brudey K, 2006, J CLIN MICROBIOL, V44, P183, DOI 10.1128/JCM.44.1.183-191.2006; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Buu TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042323; Cerezo I, 2012, INFECT GENET EVOL, V12, P657, DOI 10.1016/j.meegid.2011.07.006; Chang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043018; Chatterjee A, 2013, TUBERCULOSIS, V93, P250, DOI 10.1016/j.tube.2012.10.004; Chatterjee A, 2010, J CLIN MICROBIOL, V48, P3593, DOI 10.1128/JCM.00430-10; de Steenwinkel JEM, 2012, EMERG INFECT DIS, V18, P660, DOI 10.3201/eid1804.110912; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Desikan P, 2012, INDIAN J MED MICROBI, V30, P470, DOI 10.4103/0255-0857.103774; Diriba B, 2013, INT J TUBERC LUNG D, V17, P246, DOI 10.5588/ijtld.12.0195; Dymova MA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-77; Fenner L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024737; Gupta A, 2014, INDIAN J MED RES, V139, P892; Hasan Z, 2006, J CLIN MICROBIOL, V44, P1763, DOI 10.1128/JCM.44.5.1763-1768.2006; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; John TJ, 2014, INDIAN PEDIATR, V51, P523, DOI 10.1007/s13312-014-0440-x; Joseph BV, 2013, INFECT GENET EVOL, V16, P157, DOI 10.1016/j.meegid.2013.01.012; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Kent PT, 1985, GUIDE LEVEL 3 LAB; Kisa O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030331; Kulkarni S, 2005, RES MICROBIOL, V156, P588, DOI 10.1016/j.resmic.2005.01.005; Le Fleche P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-37; Liu Y, 2009, ELECT J DIFFERENTIAL, V32, P117, DOI DOI 10.1371/J0URNAL.P0NE.0106787; Mathuria JP, 2008, INFECT GENET EVOL, V8, P346, DOI 10.1016/j.meegid.2008.02.005; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Mokrousov I, 2004, J CLIN MICROBIOL, V42, P2438, DOI 10.1128/JCM.42.6.2438-2444.2004; Nakanishi N, 2013, INFECT GENET EVOL, V16, P174, DOI 10.1016/j.meegid.2013.02.007; Narayanan S, 2008, INFECT GENET EVOL, V8, P474, DOI 10.1016/j.meegid.2007.09.007; Noguti EN, 2010, MEM I OSWALDO CRUZ, V105, P779, DOI 10.1590/S0074-02762010000600008; Oelemann MC, 2007, J CLIN MICROBIOL, V45, P691, DOI 10.1128/JCM.01393-06; Purwar S, 2011, INFECT GENET EVOL, V11, P469, DOI 10.1016/j.meegid.2010.12.010; Rajapaksa US, 2008, T ROY SOC TROP MED H, V102, P997, DOI 10.1016/j.trstmh.2008.04.025; Rao KR, 2006, J CLIN MICROBIOL, V44, P274, DOI 10.1128/JCM.44.1.274-277.2006; Refaya AK, 2012, J MED MICROBIOL, V61, P1352, DOI 10.1099/jmm.0.044453-0; Reyes JF, 2012, INFECT GENET EVOL, V12, P811, DOI 10.1016/j.meegid.2011.05.018; Ribeiro SCM, 2014, J CLIN MICROBIOL, V52, P2615, DOI 10.1128/JCM.00498-14; Rindi L, 2012, INFECT GENET EVOL, V12, P1551, DOI 10.1016/j.meegid.2012.06.008; Roetzer A, 2011, J CLIN MICROBIOL, V49, P4173, DOI 10.1128/JCM.05293-11; Sankar MM, 2013, TUBERCULOSIS, V93, P75, DOI 10.1016/j.tube.2012.10.005; Shanmugam S, 2011, INFECT GENET EVOL, V11, P980, DOI 10.1016/j.meegid.2011.03.011; Sharma P, 2008, INFECT GENET EVOL, V8, P621, DOI 10.1016/j.meegid.2008.05.002; Sharma R, 2008, INT J TUBERC LUNG D, V12, P1122; Singh UB, 2004, EMERG INFECT DIS, V10, P1138, DOI 10.3201/eid1006.030575; Singh UB, 2007, INFECT GENET EVOL, V7, P441, DOI 10.1016/j.meegid.2007.01.003; Somerville W, 2005, J CLIN MICROBIOL, V43, P2996, DOI 10.1128/JCM.43.6.2996-2997.2005; Stavrum R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004540; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Suresh N, 2007, J MICROBIOL METH, V68, P291, DOI 10.1016/j.mimet.2006.09.001; Thomas SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027584; Vadwai V, 2012, TUBERCULOSIS, V92, P264, DOI 10.1016/j.tube.2012.01.002; Vadwai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024770; Varma-Basil M, 2011, MEM I OSWALDO CRUZ, V106, P524, DOI 10.1590/S0074-02762011000500002; Vasconcellos SEG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107747; Wang CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013594; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; WHO, 2014, GLOB TUB REP	67	29	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145860	10.1371/journal.pone.0145860	http://dx.doi.org/10.1371/journal.pone.0145860			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701129	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092600136
J	Hickson, DA; Truong, NL; Smith-Bankhead, N; Sturdevant, N; Duncan, DT; Schnorr, J; Gipson, JA; Mena, LA				Hickson, DeMarc A.; Truong, Nhan L.; Smith-Bankhead, Neena; Sturdevant, Nikendrick; Duncan, Dustin T.; Schnorr, Jordan; Gipson, June A.; Mena, Leandro A.			Rationale, Design and Methods of the Ecological Study of Sexual Behaviors and HIV/STI among African American Men Who Have Sex with Men in the Southeastern United States (The MARI Study)	PLOS ONE			English	Article							YOUNG BLACK-MEN; HIV-INFECTION; FORMATIVE RESEARCH; WHITE MEN; HEALTH; RISK; SCALE; GAY; MSM; DISCRIMINATION	Background This paper describes the rationale, design, and methodology of the Ecological Study of Sexual Behaviors and HIV/STI among African American Men Who Have Sex with Men (MSM) in the Southeastern United States (U.S.; known locally simply as the MARI Study). Methods Participants are African American MSM aged 18 years and older residing in the deep South. Results Between 2013 and 2015, 800 African American MSM recruited from two study sites (Jackson, MS and Atlanta, GA) will undergo a 1.5-hour examination to obtain anthropometric and blood pressure measures as well as to undergo testing for sexually transmitted infections (STI), including HIV. Intrapersonal, interpersonal, and environmental factors are assessed by audio computer-assisted self-interview survey. Primary outcomes include sexual risk behaviors (e.g., condomless anal sex) and prevalent STIs (HIV, syphilis, gonorrhea, and Chlamydia). Conclusion The MARI Study will typify the HIV environmental 'riskscape' and provide empirical evidence into novel ecological correlates of HIV risk among African American MSM in the deep South, a population most heavily impacted by HIV. The study's anticipated findings will be of interest to a broad audience and lead to more informed prevention efforts, including effective policies and interventions, that achieve the goals of the updated 2020 U.S. National HIV/AIDS Strategy.	[Hickson, DeMarc A.; Truong, Nhan L.; Sturdevant, Nikendrick] My Bros Keeper Inc, Ctr Res Evaluat & Environm & Policy Change, Jackson, MS 39202 USA; [Hickson, DeMarc A.; Mena, Leandro A.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39213 USA; [Smith-Bankhead, Neena; Schnorr, Jordan] AID Atlanta Inc, RED Inst, Atlanta, GA 30309 USA; [Duncan, Dustin T.] New York Univ, Sch Med, Dept Populat Hlth, New York, NY 10016 USA; [Gipson, June A.] My Bros Keeper Inc, Ctr Community Based Programs, Ridgeland, MS USA	University of Mississippi; University of Mississippi Medical Center; New York University	Hickson, DA (corresponding author), My Bros Keeper Inc, Ctr Res Evaluat & Environm & Policy Change, 510 George St,Unit 100, Jackson, MS 39202 USA.	dhickson@mbk-inc.org			Centers for Disease Control and Prevention [U01PS003315]; Centers for Disease Control and Prevention, Minority HIV/AIDS Research Initiative [U01PS003315]; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U01PS003315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Centers for Disease Control and Prevention, Minority HIV/AIDS Research Initiative(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Ecological Study of Sexual Behaviors and HIV/STI among African American Men Who Have Sex with Men in the Southeastern United States (The MARI Study) is supported by a cooperative agreement U01PS003315 from the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Centers for Disease Control and Prevention cooperative agreement U01PS003315 as part of the Minority HIV/AIDS Research Initiative. The authors gratefully thank The MARI Study participants. In addition, the authors thank the staff of The MARI Study [Jackson, MS: DeMarc, A. Hickson, PhD (PI); June A. Gipson (co-I); Leandro A. Mena, MD, MPH (co-I); Dantrell L. Simmons, PhD (Data Analyst); Christopher R. Roby, PhD(c) (Data Analyst), Nhan L. Truong, PhD (PostDoc & Data Analyst); Nikendrick Sturdevant (Project Coordinator); Angela D. Johnson (Quality Assurance Manager); William L. Johnson (PostDoc & Data Manager); Cordarian Draper (Recruiter); Obie S. McNair (Research Associate); Atlanta, GA: Neena Smith-Bankhead (co-I; Sub-Award PI); Craig Washington (co-I); John Stanton (Project Coordinator and Quality Assurance Manager); Ricardo Rush (Recruiter); NAESM, Inc: Darwin Thompson (co-I) and Damon Johnson (Project Coordinator)] and CDC Project Officers and Collaborators [Madeline Y. Sutton, MD (Team Lead and Project Officer); Leigh A. Willis, PhD (Project Officer); Kim Elmore (co-I and Mentor); Zaneta Gaul (ACASI Programmer and Data Analyst)] for their contributions and commitment to the successful implementation of the study.	Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P77; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P681; [Anonymous], HIV SURV REP; Balaji AB, 2012, AIDS PATIENT CARE ST, V26, P730, DOI 10.1089/apc.2012.0177; Baral S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-482; BAREFOOT JC, 1989, PSYCHOSOM MED, V51, P46, DOI 10.1097/00006842-198901000-00005; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Bingham TA, 2003, AIDS EDUC PREV, V15, P39, DOI 10.1521/aeap.15.1.5.39.23613; Bogart Laura M, 2013, AIDS Behav, V17, P1431, DOI 10.1007/s10461-012-0397-5; Bowen AM, 2007, HEALTH EDUC RES, V22, P120, DOI 10.1093/her/cyl057; Buchele G, 2005, EPIDEMIOLOGY, V16, P130; Buot MLG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091711; Cash TF, 2002, INT J EAT DISORDER, V31, P455, DOI 10.1002/eat.10033; Centers for Disease Control and Prevention, 2012, DIAGN HIV INF US DEP, V24; CHAVIS DM, 1990, AM J COMMUN PSYCHOL, V18, P55, DOI 10.1007/BF00922689; Clark CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063254; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Coulter RWS, 2014, AM J PUBLIC HEALTH, V104, pE105, DOI 10.2105/AJPH.2013.301501; Crosby RA, 2015, AIDS BEHAV; Duncan DT, 2014, DRUG ALCOHOL DEPEN, V135, P65, DOI 10.1016/j.drugalcdep.2013.11.001; Duncan DT, 2011, GEOSPATIAL HEALTH, V5, P265, DOI 10.4081/gh.2011.179; Egan JE, 2011, AIDS BEHAV, V15, pS35, DOI 10.1007/s10461-011-9902-5; Ellen JM, 2013, INT J STD AIDS, V24, P335, DOI 10.1177/0956462412472459; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fields EL, 2015, AM J PUBLIC HEALTH, V105, P122, DOI 10.2105/AJPH.2013.301866; Fullilove R. E., 2006, AFRICAN AM HLTH DISP; Georgia Department of Public Health, HIV AIDS EP SECT; Ghanem KG, 2005, SEX TRANSM INFECT, V81, P421, DOI 10.1136/sti.2004.013193; Goldbaum G, 1996, PUBLIC HEALTH REP, V111, P36; Hamlin-Palmer S, 2013, AM PUBL HLTH ASS ANN; HART EA, 1989, J SPORT EXERCISE PSY, V11, P94, DOI 10.1123/jsep.11.1.94; Hickson DA, 2014, 142 ANN M AM PUBL HL; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Institute of Medicine, 2011, HLTH LESB GAY BISEX; Irvin R, 2014, AIDS BEHAV, V18, P1272, DOI 10.1007/s10461-014-0734-y; Kelly JA, 2013, AIDS EDUC PREV, V25, P49, DOI 10.1521/aeap.2013.25.1.49; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075878; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Kraft JM, 2000, HEALTH EDUC BEHAV, V27, P430, DOI 10.1177/109019810002700406; Lanier Y, 2013, AM J PUBLIC HEALTH, V103, P262, DOI 10.2105/AJPH.2012.300921; Latkin C, 2012, AIDS BEHAV, V16, P535, DOI 10.1007/s10461-011-0014-z; Lieb S, 2011, AIDS BEHAV, V15, P596, DOI 10.1007/s10461-010-9820-y; Lieb S, 2009, J URBAN HEALTH, V86, P887, DOI 10.1007/s11524-009-9401-4; Magnus M, 2014, J PUBLIC HEALTH MAN, V20, pE1, DOI 10.1097/PHH.0000000000000025; Mansergh G, 2014, SEX TRANSM INFECT; Martinez O, 2014, J MED INTERNET RES, V16, P168, DOI 10.2196/jmir.3311; Maulsby C, 2014, AIDS BEHAV; Maulsby C, 2014, AIDS BEHAV, V18, P10, DOI 10.1007/s10461-013-0476-2; McCree DH, 2010, AFRICAN AMERICANS AND HIV/AIDS: UNDERSTANDING AND ADDRESSING THE EPIDEMIC, P1; Miller R. S., 1991, J PSYCHOL HUMAN SEXU, V4, P43; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Morello-Frosch R, 2006, ENVIRON HEALTH PERSP, V114, P1150, DOI 10.1289/ehp.8930; Mujahid MS, 2007, AM J EPIDEMIOL, V165, P858, DOI 10.1093/aje/kwm040; O'Leary A, 2014, AIDS BEHAV, V18, P2080, DOI 10.1007/s10461-014-0708-0; [Office of Disease Prevention and Health Promotion U.S. Department of Health and Human Services], OFF DIS PREV HLTH PR; Peterson JL, 2009, HEALTH EDUC RES, V24, P119, DOI 10.1093/her/cyn003; Peterson JL, 2014, JAIDS-J ACQ IMM DEF, V66, P538, DOI 10.1097/QAI.0000000000000203; Phillips G, 2014, ARCH SEX BEHAV, V43, P771, DOI 10.1007/s10508-014-0267-5; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reif S, 2015, J COMMUN HEALTH, V40, P642, DOI 10.1007/s10900-014-9979-7; Reif SS, 2014, AIDS CARE, V26, P351, DOI 10.1080/09540121.2013.824535; Reisner SL, 2009, AIDS BEHAV, V13, P798, DOI 10.1007/s10461-009-9571-9; Robinson JC, 2010, J URBAN HEALTH, V87, P136, DOI 10.1007/s11524-009-9403-2; Rosenberg ES, 2014, LANCET HIV, V1, pE112, DOI 10.1016/S2352-3018(14)00011-3; Ross CE, 2001, J HEALTH SOC BEHAV, V42, P258, DOI 10.2307/3090214; Roux AVD, 2001, ANN EPIDEMIOL, V11, P395, DOI 10.1016/S1047-2797(01)00221-6; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Sexton ME, 2013, J FAM PRACTICE, V62, P70; Silver E, 2002, SOC SCI MED, V55, P1457, DOI 10.1016/S0277-9536(01)00266-0; Silvera Richard, 2010, Open AIDS J, V4, P76, DOI 10.2174/1874613601004010076; Smith DK, 2012, AIDS EDUC PREV, V24, P408, DOI 10.1521/aeap.2012.24.5.408; Southern AIDS Coalition, 2010, STILL CAUGHT STORM C; Spielberger C.D., 1988, HLTH PSYCHOL INDIVID, P89, DOI DOI 10.1007/978-1-4612-3824-9_5; [STD/HIV Office Mississippi State Department of Health], HIV DIS 2009 ANN SUR; Steele C, 2007, HLTH DISPARITIES HIV; Steptoe A, 2001, ANN BEHAV MED, V23, P177, DOI 10.1207/S15324796ABM2303_5; Stunkard A J, 1983, Res Publ Assoc Res Nerv Ment Dis, V60, P115; Sullivan PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090514; Tieu HV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134085; Truong N, GLOB PUBLIC IN PRESS; Underwood LG, 2002, ANN BEHAV MED, V24, P22, DOI 10.1207/S15324796ABM2401_04; US Census Bureau, 2010, STAT COUNT QUICK FAC; ViiV Healthcare, 2015, IN INV HELP RES ID A; Wheeler DP, 2008, ARCH SEX BEHAV, V37, P697, DOI 10.1007/s10508-008-9372-7; WILLIAMS DR, 1997, J HLTH PSYCHOL, V0002; Wolff LS, 2010, J HEALTH PSYCHOL, V15, P560, DOI 10.1177/1359105309354345; Wylie SA, 2010, SEX ROLES, V63, P264, DOI 10.1007/s11199-010-9798-y; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	90	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0143823	10.1371/journal.pone.0143823	http://dx.doi.org/10.1371/journal.pone.0143823			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26700018	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600010
J	Kaleebu, P; Kirungi, W; Watera, C; Asio, J; Lyagoba, F; Lutalo, T; Kapaata, AA; Nanyonga, F; Parry, CM; Magambo, B; Nazziwa, J; Nannyonjo, M; Hughes, P; Hladik, W; Ruberantwari, A; Namuwenge, N; Musinguzi, J; Downing, R; Katongole-Mbidde, E				Kaleebu, Pontiano; Kirungi, Wilford; Watera, Christine; Asio, Juliet; Lyagoba, Fred; Lutalo, Tom; Kapaata, Anne A.; Nanyonga, Faith; Parry, Chris M.; Magambo, Brian; Nazziwa, Jamirah; Nannyonjo, Maria; Hughes, Peter; Hladik, Wolfgang; Ruberantwari, Anthony; Namuwenge, Norah; Musinguzi, Joshua; Downing, Robert; Katongole-Mbidde, Edward		HIV Drug Resistance Working Grp	Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; TRANSMISSION CLUSTERS; NAIVE INDIVIDUALS; SURVEILLANCE; PREVENTION; INITIATION; CLINICS	Background With the scale-up of antiretroviral therapy (ART), monitoring programme performance is needed to maximize ART efficacy and limit HIV drug resistance (HIVDR). Methods We implemented a WHO HIVDR prospective survey protocol at three treatment centers between 2012 and 2013. Data were abstracted from patient records at ART start (T1) and after 12 months (T2). Genotyping was performed in the HIV pol region at the two time points. Results Of the 425 patients enrolled, at T2, 20 (4.7%) had died, 66 (15.5%) were lost to follow-up, 313 (73.6%) were still on first-line, 8 (1.9%) had switched to second-line, 17 (4.0%) had transferred out and 1 (0.2%) had stopped treatment. At T2, 272 out of 321 on first and second line (84.7%) suppressed below 1000 copies/ml and the HIV DR prevention rate was 70.1%, just within the WHO threshold of >= 70%. The proportion of participants with potential HIVDR was 20.9%, which is higher than the 18.8% based on pooled analyses from African studies. Of the 35 patients with mutations at T2, 80% had M184V/I, 65.7% Y181C, and 48.6% (54.8% excluding those not on Tenofovir) had K65R mutations. 22.9% had Thymidine Analogue Mutations (TAMs). Factors significantly associated with HIVDR prevention at T2 were: baseline viral load (VL) <100,000 copies/ml [Adjusted odds ratio (AOR) 3.13, 95% confidence interval (CI): 1.36-7.19] and facility. Independent baseline predictors for HIVDR mutations at T2 were: CD4 count <250 cells/mu l (AOR 2.80, 95% CI: 1.08-7.29) and viral load >= 100,000 copies/ml (AOR 2.48, 95% CI: 1.00-6.14). Conclusion Strengthening defaulter tracing, intensified follow-up for patients with low CD4 counts and/or high VL at ART initiation together with early treatment initiation above 250 CD4 cells/ul and adequate patient counselling would improve ART efficacy and HIVDR prevention. The high rate of K65R and TAMs could compromise second line regimens including NRTIs.	[Kaleebu, Pontiano; Watera, Christine; Asio, Juliet; Lyagoba, Fred; Lutalo, Tom; Nanyonga, Faith; Magambo, Brian; Ruberantwari, Anthony; Downing, Robert; Katongole-Mbidde, Edward] Uganda Virus Res Inst, Entebbe, Uganda; [Kaleebu, Pontiano; Lyagoba, Fred; Kapaata, Anne A.; Parry, Chris M.; Magambo, Brian; Nazziwa, Jamirah; Nannyonjo, Maria; Hughes, Peter] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Kaleebu, Pontiano] London Sch Hyg & Trop Med, London WC1, England; [Kirungi, Wilford; Namuwenge, Norah; Musinguzi, Joshua] Minist Hlth, AIDS Control Programme, Kampala, Uganda; [Hladik, Wolfgang] US Ctr Dis Control & Prevent, Entebbe, Uganda	Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine	Kaleebu, P (corresponding author), Uganda Virus Res Inst, Entebbe, Uganda.	Pontiano.kaleebu@mrcuganda.org		Ndagije, Helen/0000-0001-5802-4791; Nazziwa, Jamirah/0000-0001-9029-7976; Nanyonga, Faith Elizabeth/0000-0003-2691-4401	PEPFAR [1U2GGH000785-01, 3U2GPS000586-05S1]; UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement; Medical Research Council [MC_U950080938] Funding Source: researchfish; MRC [MC_U950080938] Funding Source: UKRI	PEPFAR; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by PEPFAR grant Nos. 1U2GGH000785-01 and 3U2GPS000586-05S1 to UVRI and by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement.	Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bennett DE, 2008, ANTIVIR THER, V13, P1; Billong SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072680; Commonwealth of Australia, 2015, NAT INV REP 2015, P1; Hamers RL, 2012, LANCET INFECT DIS, V12, P307, DOI 10.1016/S1473-3099(11)70255-9; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hamers RL, 2012, CLIN INFECTIOUS DIS; Hong SY, 2015, JAIDS-J ACQ IMM DEF, V68, P463, DOI 10.1097/QAI.0000000000000509; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jordan MR, 2008, ANTIVIR THER, V13, P15; Kapaata A, 2013, AIDS RES HUM RETROV, V29, P520, DOI [10.1089/aid.2012.0170, 10.1089/AID.2012.0170]; Lahuerta M, 2013, CLIN INFECTIOUS DIS; Liegeois F, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17985; MOH, 2013, UG TREATM GUID ADD N; Nazziwa J, 2013, AIDS RES HUM RETROV, V29, P788, DOI [10.1089/aid.2012.0123, 10.1089/AID.2012.0123]; Ndembi N, 2008, AIDS RES HUM RETROV, V24, P889, DOI 10.1089/aid.2007.0317; Ndembi N, 2011, AIDS, V25, P905, DOI 10.1097/QAD.0b013e328346260f; Ssemwanga D, 2012, CLIN INFECT DIS, V54, pS339, DOI 10.1093/cid/cir937; Ugbena R, 2012, CLIN INFECT DIS, V54, pS375, DOI 10.1093/cid/cir1064; UNAIDS, 2014, UG HIV AIDS COUNTR P; UNAIDS, 2020, UNAIDS 2020 GLOB REP; Wadonda-Kabondo N, 2012, CLIN INFECT DIS, V54, pS355, DOI 10.1093/cid/cis004; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642; WHO, 2012, WHO GLOB STRAT SURV; WHO, 2012, WHO HIV DRUG RES REP	25	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145536	10.1371/journal.pone.0145536	http://dx.doi.org/10.1371/journal.pone.0145536			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700639	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000367092600094
J	Kono, M; Miura, N; Fujii, T; Ohmura, K; Yoshifuji, H; Yukawa, N; Imura, Y; Nakashima, R; Ikeda, T; Umemura, S; Miyatake, T; Mimori, T				Kono, Miyuki; Miura, Naoto; Fujii, Takao; Ohmura, Koichiro; Yoshifuji, Hajime; Yukawa, Naoichiro; Imura, Yoshitaka; Nakashima, Ran; Ikeda, Takaharu; Umemura, Shin-ichiro; Miyatake, Takafumi; Mimori, Tsuneyo			Personal Authentication Analysis Using Finger-Vein Patterns in Patients with Connective Tissue Diseases-Possible Association with Vascular Disease and Seasonal Change -	PLOS ONE			English	Article							EXTRACTION; SYSTEM	Objective To examine how connective tissue diseases affect finger-vein pattern authentication. Methods The finger-vein patterns of 68 patients with connective tissue diseases and 24 healthy volunteers were acquired. Captured as CCD (charge-coupled device) images by transmitting near-infrared light through fingers, they were followed up in once in each season for one year. The similarity of the follow-up patterns and the initial one was evaluated in terms of their normalized cross-correlation C. Results The mean C values calculated for patients tended to be lower than those calculated for healthy volunteers. In midwinter (February in Japan) they showed statistically significant reduction both as compared with patients in other seasons and as compared with season-matched healthy controls, whereas the values calculated for healthy controls showed no significant seasonal changes. Values calculated for patients with systemic sclerosis (SSc) or mixed connective tissue disease (MCTD) showed major reductions in November and, especially, February. Patients with rheumatoid arthritis (RA) and patients with dermatomyositis or polymyositis (DM/PM) did not show statistically significant seasonal changes in C values. Conclusions Finger-vein patterns can be used throughout the year to identify patients with connective tissue diseases, but some attention is needed for patients with advanced disease such as SSc.	[Kono, Miyuki; Miura, Naoto; Miyatake, Takafumi] Hitachi Ltd, Cent Res Lab, Kokubunji, Tokyo, Japan; [Fujii, Takao; Ohmura, Koichiro; Yoshifuji, Hajime; Yukawa, Naoichiro; Imura, Yoshitaka; Nakashima, Ran; Mimori, Tsuneyo] Kyoto Univ, Dept Rheumatol & Clin Immunol, Grad Sch Med, Kyoto, Japan; [Ikeda, Takaharu] Wakayama Med Univ, Dept Dermatol, Wakayama, Japan; [Umemura, Shin-ichiro] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan	Hitachi Limited; Kyoto University; Wakayama Medical University; Tohoku University	Kono, M (corresponding author), Hitachi Ltd, Cent Res Lab, Kokubunji, Tokyo, Japan.	miyuki.kono@nifty.ne.jp; mimorit@kuhp.kyoto-u.ac.jp	Yoshifuji, Hajime/AAZ-1657-2020		Hitachi Ltd.; Ministry of Health, Labor and Welfare in Japan; Grants-in-Aid for Scientific Research [25461472] Funding Source: KAKEN	Hitachi Ltd.; Ministry of Health, Labor and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was funded in part by Hitachi Ltd. TM (Tsuneyo Mimori) received a grant for MCTD study group in intractable diseases from the Ministry of Health, Labor and Welfare in Japan. This grant has no specific number. (http://www.hitachi.com/http://www.mhlw.go.jp/english/). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. As for decision to publish, Ministry of Health, Lab or and Welfare in Japan had no role and Hitachi Ltd. gave approval for publication.	Allanore Y, 2007, ARTHRITIS RHEUM-US, V56, P2747, DOI 10.1002/art.22734; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bledsoe WW, 1966, MODEL METHOD FACIAL; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Cohen J., 1988, STAT POWER ANAL BEHA, P2146; DAUGMAN JG, 1993, IEEE T PATTERN ANAL, V15, P1148, DOI 10.1109/34.244676; Daugman JG, MATH EXPLANATION IRI; Fujibayashi Takashi, 2004, Mod Rheumatol, V14, P425, DOI 10.3109/s10165-004-0338-x; HARDY JD, 1956, J APPL PHYSIOL, V9, P257, DOI 10.1152/jappl.1956.9.2.257; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Im SK, 2003, ETRI J, V25, P101, DOI 10.4218/etrij.03.0102.0211; Im SK, 2001, J KOREAN PHYS SOC, V38, P268; International Organization for Standardization, JTC 1 SC37 TECHN COM; Jain AK, 1997, P IEEE, V85, P1365, DOI 10.1109/5.628674; Kanade T., 1974, COMPUT VISION GRAPH, V2; Kasukawa R, 1987, MIXED CONNECTIVE TIS, P41; KEY H, 1988, J BIOMED ENG, V10, P113, DOI 10.1016/0141-5425(88)90084-2; Kono M, 2002, APPL OPTICS, V41, P7429, DOI 10.1364/AO.41.007429; Maltoni D., 2009, HDB FINGERPRINT RECO; Miura N, 2004, MACH VISION APPL, V15, P194, DOI 10.1007/s00138-004-0149-2; Miura N, 2007, IEICE T INF SYST, VE90D, P1185, DOI 10.1093/ietisy/e90-d.8.1185; Ross A, 1999, P 2 INT C AUD VID BA, P166; Shimizu, 1992, JPN J MED PHILOS, V11, P620; Sidlauskas DP, 1988, US Patent, Patent No. [4,736,203, 19884736203]; Tico M, 2001, ELECTRON LETT, V37, P21, DOI 10.1049/el:20010031; TRAURING M, 1963, NATURE, V197, P938, DOI 10.1038/197938a0; Turk M. A., 1991, Proceedings 1991 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (91CH2983-5), P586, DOI 10.1109/CVPR.1991.139758; WILSON BC, 1988, LIGHT BIOL MED, V1, P45	29	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144952	10.1371/journal.pone.0144952	http://dx.doi.org/10.1371/journal.pone.0144952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701644	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600038
J	Phillips, M; Bauer, TL; Cataneo, RN; Lebauer, C; Mundada, M; Pass, HI; Ramakrishna, N; Rom, WN; Vallieres, E				Phillips, Michael; Bauer, Thomas L.; Cataneo, Renee N.; Lebauer, Cassie; Mundada, Mayur; Pass, Harvey I.; Ramakrishna, Naren; Rom, William N.; Vallieres, Eric			Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; QUANTITATIVE-ANALYSIS; EXHALED BREATH; MARKERS; THERAPY; DISEASE; VAPOR; AIR	Background Breath volatile organic compounds (VOCs) have been reported as biomarkers of lung cancer, but it is not known if biomarkers identified in one group can identify disease in a separate independent cohort. Also, it is not known if combining breath biomarkers with chest CT has the potential to improve the sensitivity and specificity of lung cancer screening. Methods Model-building phase (unblinded): Breath VOCs were analyzed with gas chromatography mass spectrometry in 82 asymptomatic smokers having screening chest CT, 84 symptomatic high-risk subjects with a tissue diagnosis, 100 without a tissue diagnosis, and 35 healthy subjects. Multiple Monte Carlo simulations identified breath VOC mass ions with greater than random diagnostic accuracy for lung cancer, and these were combined in a multivariate predictive algorithm. Model-testing phase (blinded validation): We analyzed breath VOCs in an independent cohort of similar subjects (n = 70, 51, 75 and 19 respectively). The algorithm predicted discriminant function (DF) values in blinded replicate breath VOC samples analyzed independently at two laboratories (A and B). Outcome modeling: We modeled the expected effects of combining breath biomarkers with chest CT on the sensitivity and specificity of lung cancer screening. Results Unblinded model-building phase. The algorithm identified lung cancer with sensitivity 74.0%, specificity 70.7% and C-statistic 0.78. Blinded model-testing phase: The algorithm identified lung cancer at Laboratory A with sensitivity 68.0%, specificity 68.4%, C-statistic 0.71; and at Laboratory B with sensitivity 70.1%, specificity 68.0%, C-statistic 0.70, with linear correlation between replicates (r = 0.88). In a projected outcome model, breath biomarkers increased the sensitivity, specificity, and positive and negative predictive values of chest CT for lung cancer when the tests were combined in series or parallel. Conclusions Breath VOC mass ion biomarkers identified lung cancer in a separate independent cohort, in a blinded replicated study. Combining breath biomarkers with chest CT could potentially improve the sensitivity and specificity of lung cancer screening.	[Phillips, Michael; Cataneo, Renee N.; Mundada, Mayur] Menssana Res Inc, Breath Res Lab, Newark, NJ 07103 USA; [Phillips, Michael] New York Med Coll, Dept Med, Valhalla, NY 10595 USA; [Bauer, Thomas L.] Christiana Care Hlth Syst, Newark, DE USA; [Lebauer, Cassie] Schmitt & Associates, Newark, NJ 07103 USA; [Pass, Harvey I.; Rom, William N.] NYU, Langone Med Ctr, New York, NY USA; [Ramakrishna, Naren] Univ Florida, Hlth Canc Ctr, Orlando Hlth, Orlando, FL USA; [Vallieres, Eric] Swedish Canc Inst, Seattle, WA 98104 USA	New York Medical College; Christiana Care Health System; New York University; NYU Langone Medical Center; State University System of Florida; University of Florida; Swedish Cancer Institute; Swedish Medical Center	Phillips, M (corresponding author), Menssana Res Inc, Breath Res Lab, 211 Warren St, Newark, NJ 07103 USA.	mphillips@menssanaresearch.com		Rom, William/0000-0002-8793-7028; Vallieres, Eric/0000-0003-1732-2658; Pass, Harvey/0000-0003-3222-3471	NIH [9R44HL070411-04A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL070411] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Michael Phillips is President and CEO of Menssana Research, Inc. Renee N. Cataneo and Mayur Mundada are employed by Menssana Research, Inc. The project was funded by NIH grant 9R44HL070411-04A1. ClinicalTrials.gov Identifier: NCT00639067. The funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials. The funder provided support in the form of salaries for authors MP, RNC and MM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. None of the other coauthors declare any competing commercial interests.; The project was funded by NIH grant 9R44HL070411-04A1. ClinicalTrials.gov Identifier: NCT00639067. Michael Phillips is President and CEO of Menssana Research, Inc. American Westech, Inc., Harrisburg, PA (now Microbac Laboratories, Inc) and Menssana Research, Inc. analyzed replicate breath samples. Robert Schiff PhD, Jodi Panucci and Mary Ann Weinberg (Schiff & Co, West Caldwell, NJ) monitored participating sites for Good Clinical Practice and maintained a blinded clinical database. Schmitt & Associates, Newark, NJ, maintained a database of chromatograms and analyzed the data. James J Grady DrPH (University of Connecticut Health Center, Farmington, CT) reviewed statistical analysis of data.	Aberle DR, 2013, NEW ENGL J MED, V369, P920, DOI 10.1056/NEJMoa1208962; Adiguzel Y, 2015, BIOSENS BIOELECTRON, V65, P121, DOI 10.1016/j.bios.2014.10.023; Boedeker E, 2012, INTERACT CARDIOV TH, V14, P511, DOI 10.1093/icvts/ivr070; Bousamra M, 2014, J THORAC CARDIOV SUR, V148, P1074, DOI 10.1016/j.jtcvs.2014.06.006; Carlile Paul V, 2015, J Okla State Med Assoc, V108, P14; Carpagnano GE, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0952-1; Centers for Disease Control & Prevention, LUNG CANCER STATISTI; Chen X, 2007, CANCER-AM CANCER SOC, V110, P835, DOI 10.1002/cncr.22844; Christensen JD, 2015, CLIN CHEST MED, V36, P147, DOI 10.1016/j.ccm.2015.02.002; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Davies SJ, 2014, BIOANALYSIS, V6, P843, DOI 10.4155/bio.14.26; Eng K, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/2/026002; Filipiak W, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/2/027111; GORDON SM, 1985, CLIN CHEM, V31, P1278; Gowda H, 2014, ANAL CHEM, V86, P6931, DOI 10.1021/ac500734c; Hakim Meggie, 2012, CHEM REV; Handa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114555; Jeffers CD, 2013, CURR PROBL DIAGN RAD, V42, P220, DOI 10.1067/j.cpradiol.2013.05.001; Kischkel S, 2012, EUR RESPIR J, V40, P706, DOI 10.1183/09031936.00125411; Kwak J, 2014, METABOLITES, V4, P879, DOI 10.3390/metabo4040879; Martin AN, 2010, ANAL BIOANAL CHEM, V396, P739, DOI 10.1007/s00216-009-3217-7; Mente S, 2012, CURR TOP MED CHEM, V12, P1957, DOI 10.2174/156802612804910322; Miekisch W, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/3/036007; Mozzoni P, 2013, BIOMARKERS, V18, P679, DOI 10.3109/1354750X.2013.845610; PAULING L, 1971, P NATL ACAD SCI USA, V68, P2374, DOI 10.1073/pnas.68.10.2374; Peng G, 2010, BRIT J CANCER, V103, P542, DOI 10.1038/sj.bjc.6605810; Phillips M, 1999, LANCET, V353, P1930, DOI 10.1016/S0140-6736(98)07552-7; Phillips M, 1997, ANAL BIOCHEM, V247, P272, DOI 10.1006/abio.1997.2069; Phillips M, 2000, J LAB CLIN MED, V136, P243, DOI 10.1067/mlc.2000.108943; Phillips M, 2003, CHEST, V123, P2115, DOI 10.1378/chest.123.6.2115; Phillips M, 2008, CLIN CHIM ACTA, V393, P76, DOI 10.1016/j.cca.2008.02.021; Phillips Michael, 2007, Cancer Biomarkers, V3, P95; Phillips M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075274; Phillips M, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/3/036002; Phillips M, 2010, TUBERCULOSIS, V90, P145, DOI 10.1016/j.tube.2010.01.003; PRETI G, 1988, J CHROMATOGR-BIOMED, V432, P1, DOI 10.1016/S0378-4347(00)80627-1; Roche Nicolas, 2014, Ann Am Thorac Soc, V11 Suppl 2, pS99, DOI 10.1513/AnnalsATS.201309-300RM; Sather MR, 2003, CONTROL CLIN TRIALS, V24, P570, DOI 10.1016/S0197-2456(03)00074-6; Silkoff PE, 2004, J ALLERGY CLIN IMMUN, V114, P1241, DOI 10.1016/j.jaci.2004.08.042; Smolinska A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095668; Stein S, 2012, ANAL CHEM, V84, P7274, DOI 10.1021/ac301205z; Thekedar B, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/1/016001; Van Berkel JJBN, 2010, RESP MED, V104, P557, DOI 10.1016/j.rmed.2009.10.018; van der Schee MP, 2015, CHEST, V147, P224, DOI 10.1378/chest.14-0781; Weinstein S, 2005, AM J ROENTGENOL, V184, P14, DOI 10.2214/ajr.184.1.01840014; Westhoff M, 2009, THORAX, V64, P744, DOI 10.1136/thx.2008.099465; Yeh RW, 2015, CIRC-CARDIOVASC QUAL, V8, P96, DOI 10.1161/CIRCOUTCOMES.114.001239	47	32	33	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0142484	10.1371/journal.pone.0142484	http://dx.doi.org/10.1371/journal.pone.0142484			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698306	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600002
J	Fokina, AV; Chechenova, MB; Karginov, AV; Ter-Avanesyan, MD; Agaphonov, MO				Fokina, Anastasia V.; Chechenova, Maria B.; Karginov, Azamat V.; Ter-Avanesyan, Michael D.; Agaphonov, Michael O.			Genetic Evidence for the Role of the Vacuole in Supplying Secretory Organelles with Ca2+ in Hansenula polymorpha	PLOS ONE			English	Article							YEAST ENDOPLASMIC-RETICULUM; PROTEIN SORTING MUTANTS; SACCHAROMYCES-CEREVISIAE; CARBOXYPEPTIDASE-Y; PLASMINOGEN-ACTIVATOR; ENDOSOME FUNCTION; PUMP PMR1; PATHWAY; DEGRADATION; ENDOCYTOSIS	Processes taking place in the secretory organelles require Ca2+ and Mn2+, which in yeast are supplied by the Pmr1 ion pump. Here we observed that in the yeast Hansenula polymorpha Ca2+ deficiency in the secretory pathway caused by Pmr1 inactivation is exacerbated by (i) the ret1-27 mutation affecting COPI-mediated vesicular transport, (ii) inactivation of the vacuolar Ca2+ ATPase Pmc1 and (iii) inactivation of Vps35, which is a component of the retromer complex responsible for protein transport between the vacuole and secretory organelles. The ret1-27 mutation also exerted phenotypes indicating alterations in transport between the vacuole and secretory organelles. These data indicate that ret1-27, pmc1 and vps35 affect a previously unknown Pmr1-independent route of the Ca2+ delivery to the secretory pathway. We also observed that the vacuolar protein carboxypeptidase Y receives additional modifications of its glycoside chains if it escapes the Vps10-dependent sorting to the vacuole.	[Fokina, Anastasia V.; Chechenova, Maria B.; Karginov, Azamat V.; Ter-Avanesyan, Michael D.; Agaphonov, Michael O.] Russian Acad Sci, AN Bach Inst Biochem, Biotechnol Res Ctr, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences	Agaphonov, MO (corresponding author), Russian Acad Sci, AN Bach Inst Biochem, Biotechnol Res Ctr, Moscow, Russia.	agaphonov@inbi.ras.ru	Agaphonov, Michael/U-7791-2018	Agaphonov, Michael/0000-0002-9270-9476	Russian Science Foundation [14-14-00361]	Russian Science Foundation(Russian Science Foundation (RSF))	AVF, AVK, MDT, and MOA were supported by Russian Science Foundation grant 14-14-00361.	Agaphonov M, 2005, FEMS YEAST RES, V5, P1029, DOI 10.1016/j.femsyr.2005.07.003; Agaphonov MO, 2007, FEMS YEAST RES, V7, P1145, DOI 10.1111/j.1567-1364.2007.00247.x; Agaphonov M, 2014, FEMS YEAST RES, V14, P1048, DOI 10.1111/1567-1364.12197; Agaphonov MO, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-15; Agaphonov MO, 1999, YEAST, V15, P541, DOI 10.1002/(SICI)1097-0061(199905)15:7<541::AID-YEA392>3.0.CO;2-G; AGAPHONOV MO, 1995, YEAST, V11, P1241, DOI 10.1002/yea.320111304; BALLOU L, 1990, P NATL ACAD SCI USA, V87, P3368, DOI 10.1073/pnas.87.9.3368; BELLU AR, 1999, CHARACTERIZATION OF, V15, P181, DOI DOI 10.1002/(SICI)1097-0061(199902)15:3<181::AID-YEA355>3.0.CO;2-Y; BOGDANOVA AI, 1995, YEAST, V11, P343, DOI 10.1002/yea.320110407; Bryant NJ, 1998, MICROBIOL MOL BIOL R, V62, P230, DOI 10.1128/MMBR.62.1.230-247.1998; Chechenova MB, 2004, EUKARYOT CELL, V3, P52, DOI 10.1128/EC.3.1.52-60.2004; Cohen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085519; Cooper AA, 1996, J CELL BIOL, V133, P529, DOI 10.1083/jcb.133.3.529; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Cunningham KW, 2011, CELL CALCIUM, V50, P129, DOI 10.1016/j.ceca.2011.01.010; Daro E, 1997, J CELL BIOL, V139, P1747, DOI 10.1083/jcb.139.7.1747; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; Fokina AV, 2012, CELL CYCLE, V11, P778, DOI 10.4161/cc.11.4.19220; Gabriely G, 2007, MOL CELL BIOL, V27, P526, DOI 10.1128/MCB.00577-06; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; Garcia-Rodriguez N, 2015, J BIOL CHEM, V290, P9335, DOI 10.1074/jbc.M114.616334; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; Glick BS, 1997, FEBS LETT, V414, P177, DOI 10.1016/S0014-5793(97)00984-8; Gu F, 1997, J CELL BIOL, V139, P1183, DOI 10.1083/jcb.139.5.1183; Harsay E, 2002, J CELL BIOL, V156, P271, DOI 10.1083/jcb.200109077; HASELBECK A, 1986, P NATL ACAD SCI USA, V83, P2017, DOI 10.1073/pnas.83.7.2017; Jensen LT, 2009, MOL BIOL CELL, V20, P2810, DOI 10.1091/mbc.E08-10-1084; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu JX, 2007, TRAFFIC, V8, P1375, DOI 10.1111/j.1600-0854.2007.00616.x; LOUKIN S, 1995, J CELL BIOL, V131, P1025, DOI 10.1083/jcb.131.4.1025; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; NAKAJIMA T, 1975, P NATL ACAD SCI USA, V72, P3912, DOI 10.1073/pnas.72.10.3912; Nizhnikov AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116003; Paidhungat M, 1998, GENETICS, V148, P1777; PARODI AJ, 1979, J BIOL CHEM, V254, P8343; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Pozos TC, 1996, MOL CELL BIOL, V16, P3730; Ramsay LM, 1997, FEMS MICROBIOL LETT, V152, P293, DOI 10.1016/S0378-1097(97)00213-9; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Roy A, 2014, J BIOL CHEM, V289, P7247, DOI 10.1074/jbc.M113.539411; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; SHARMA CB, 1974, EUR J BIOCHEM, V46, P35, DOI 10.1111/j.1432-1033.1974.tb03594.x; SIKORSKI RS, 1989, GENETICS, V122, P19; Sohn JH, 1996, J BACTERIOL, V178, P4420, DOI 10.1128/jb.178.15.4420-4428.1996; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Strayle J, 1999, EMBO J, V18, P4733, DOI 10.1093/emboj/18.17.4733; Vashist S, 2002, MOL BIOL CELL, V13, P3955, DOI 10.1091/mbc.02-06-0090; WHITNEY JA, 1995, CELL, V83, P703; Yang M, 2005, BIOCHEM J, V386, P479, DOI 10.1042/BJ20041582	51	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145915	10.1371/journal.pone.0145915	http://dx.doi.org/10.1371/journal.pone.0145915			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717478	gold, Green Published, Green Submitted			2022-12-27	WOS:000367510500093
J	Pereira, E; Camacho-Vanegas, O; Anand, S; Sebra, R; Camacho, SC; Garnar-Wortzel, L; Nair, N; Moshier, E; Wooten, M; Uzilov, A; Chen, R; Prasad-Hayes, M; Zakashansky, K; Beddoe, AM; Schadt, E; Dottino, P; Martignetti, JA				Pereira, Elena; Camacho-Vanegas, Olga; Anand, Sanya; Sebra, Robert; Camacho, Sandra Catalina; Garnar-Wortzel, Leopold; Nair, Navya; Moshier, Erin; Wooten, Melissa; Uzilov, Andrew; Chen, Rong; Prasad-Hayes, Monica; Zakashansky, Konstantin; Beddoe, Ann Marie; Schadt, Eric; Dottino, Peter; Martignetti, John A.			Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers	PLOS ONE			English	Article							EPITHELIAL OVARIAN-CANCER; CA-125	Background High-grade serous ovarian and endometrial cancers are the most lethal female reproductive tract malignancies worldwide. In part, failure to treat these two aggressive cancers successfully centers on the fact that while the majority of patients are diagnosed based on current surveillance strategies as having a complete clinical response to their primary therapy, nearly half will develop disease recurrence within 18 months and the majority will die from disease recurrence within 5 years. Moreover, no currently used biomarkers or imaging studies can predict outcome following initial treatment. Circulating tumor DNA (ctDNA) represents a theoretically powerful biomarker for detecting otherwise occult disease. We therefore explored the use of personalized ctDNA markers as both a surveillance and prognostic biomarker in gynecologic cancers and compared this to current FDA-approved surveillance tools. Methods and Findings Tumor and serum samples were collected at time of surgery and then throughout treatment course for 44 patients with gynecologic cancers, representing 22 ovarian cancer cases, 17 uterine cancer cases, one peritoneal, three fallopian tube, and one patient with synchronous fallopian tube and uterine cancer. Patient/tumor-specific mutations were identified using whole-exome and targeted gene sequencing and ctDNA levels quantified using droplet digital PCR. CtDNA was detected in 93.8% of patients for whom probes were designed and levels were highly correlated with CA-125 serum and computed tomography (CT) scanning results. In six patients, ctDNA detected the presence of cancer even when CT scanning was negative and, on average, had a predictive lead time of seven months over CT imaging. Most notably, undetectable levels of ctDNA at six months following initial treatment was associated with markedly improved progression free and overall survival. Conclusions Detection of residual disease in gynecologic, and indeed all cancers, represents a diagnostic dilemma and a potential critical inflection point in precision medicine. This study suggests that the use of personalized ctDNA biomarkers in gynecologic cancers can identify the presence of residual tumor while also more dynamically predicting response to treatment relative to currently used serum and imaging studies. Of particular interest, ctDNA was an independent predictor of survival in patients with ovarian and endometrial cancers. Earlier recognition of disease persistence and/or recurrence and the ability to stratify into better and worse outcome groups through ctDNA surveillance may open the window for improved survival and quality and life in these cancers.	[Pereira, Elena; Nair, Navya; Prasad-Hayes, Monica; Zakashansky, Konstantin; Beddoe, Ann Marie; Dottino, Peter; Martignetti, John A.] Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA; [Camacho-Vanegas, Olga; Anand, Sanya; Sebra, Robert; Camacho, Sandra Catalina; Garnar-Wortzel, Leopold; Wooten, Melissa; Uzilov, Andrew; Chen, Rong; Schadt, Eric; Dottino, Peter; Martignetti, John A.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Martignetti, John A.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Moshier, Erin] Icahn Sch Med Mt Sinai, Dept Biostat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Martignetti, JA (corresponding author), Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA.	john.martignetti@mssm.edu		Garnar-Wortzel, Leopold/0000-0001-5055-7817	Varadi Ovarian Initiative in Cancer Education (VOICE); Derald H. Ruttenberg Foundation; M.S. Gordon family	Varadi Ovarian Initiative in Cancer Education (VOICE); Derald H. Ruttenberg Foundation; M.S. Gordon family	These studies were funded, in part, by donations from the Varadi Ovarian Initiative in Cancer Education (VOICE), the Derald H. Ruttenberg Foundation and the M.S. Gordon family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2015, CANC FACTS FIGS 2015; Bast RC, 2010, CANCER-AM CANCER SOC, V116, P2850, DOI 10.1002/cncr.25203; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Chang HW, 2002, JNCI-J NATL CANCER I, V94, P1697; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Freidin MB, 2015, CLIN CHEM; Garcia-Murillas I, 2015, SCI TRANSL MED, V7, DOI [10.1126/scitranslmed.aab0021, 10.1126/scitranslmed.aac7551]; Hamakawa T, 2015, BRIT J CANCER, V112, P352, DOI 10.1038/bjc.2014.609; Kamat AA, 2006, ANN NY ACAD SCI, V1075, P230, DOI 10.1196/annals.1368.031; Martignetti JA, 2014, NEOPLASIA, V16, P97, DOI 10.1593/neo.131900; McMeekin DS, 2012, CLIN GYNECOLOGIC ONC, pi; Meyer T, 2000, BRIT J CANCER, V82, P1535; National Comprehensive Cancer Network, 2015, NCCN CLIN PRACT GUID; Reinert T, 2015, GUT; Riedinger JM, 2006, ANN ONCOL, V17, P1234, DOI 10.1093/annonc/mdl120; Swisher EM, 2005, AM J OBSTET GYNECOL, V193, P662, DOI 10.1016/j.ajog.2005.01.054; Testa AC, 2014, BEST PRACT RES CL OB, V28, P769, DOI 10.1016/j.bpobgyn.2014.04.008; Ueland FR, 2003, GYNECOL ONCOL, V91, P46, DOI 10.1016/S0090-8258(03)00414-1	20	93	101	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145754	10.1371/journal.pone.0145754	http://dx.doi.org/10.1371/journal.pone.0145754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717006	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500066
J	Zhang, J; Zhang, L; Hong, JX; Wu, D; Xu, JJ				Zhang, Jing; Zhang, Lu; Hong, Jiaxu; Wu, Dan; Xu, Jianjiang			Association of Common Variants in LOX with Keratoconus: A Meta-Analysis	PLOS ONE			English	Article							LYSYL OXIDASE; CANDIDATE GENE; ETHNIC-ORIGIN; IDENTIFICATION; POLYMORPHISMS; DISEASE	Background Several case-control studies have been performed to examine the association of genetic variants in lysyl oxidase (LOX) with keratoconus. However, the results remained inconclusive and great heterogeneity might exist across populations. Method A comprehensive literature search for studies that published up to June 25, 2015 was performed. Summary odds ratios (OR) and 95% confidence intervals (CI) of each single nucleotide polymorphism (SNP) were estimated with fixed effects model when I-2<50% in the test for heterogeneity or random effects model when I-2>50%. Publication bias was evaluated using funnel plots and Egger's test. Results A total of four studies including 1,467 keratoconus cases and 4,490 controls were involved in this meta-analysis. SNPs rs2956540 and rs10519694 showed significant association with keratoconus, with ORs of 0.71 (95% CI: 0.63-0.80, P = 1.43E-08) and 0.77 (95% CI: 0.61-0.97, P = 0.026), respectively. In contrast, our study lacked sufficient evidences to support the association of rs1800449/rs2288393 with keratoconus across populations. Conclusion This meta-analysis suggested that two LOX variants, rs2956540 and rs10519694, may affect individual susceptibility to keratoconus, while distinct heterogeneity existed within this locus. Larger-scale and multi-ethnic genetic studies on keratoconus are required to further validate the results.	[Zhang, Jing] Fudan Univ, Res Ctr, Eye & ENT Hosp, Key Lab Myopia,Minist Hlth, Shanghai 200433, Peoples R China; [Hong, Jiaxu; Wu, Dan; Xu, Jianjiang] Fudan Univ, Dept Ophthalmol & Visual Sci, Eye & ENT Hosp, Key Lab Myopia,Minist Hlth, Shanghai 200433, Peoples R China; [Zhang, Lu] City Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Hong, Jiaxu] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA USA	Fudan University; Fudan University; City University of Hong Kong; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Xu, JJ (corresponding author), Fudan Univ, Dept Ophthalmol & Visual Sci, Eye & ENT Hosp, Key Lab Myopia,Minist Hlth, Shanghai 200433, Peoples R China.	jianjiangxu@126.com	Zhang, Lu/AAV-2606-2020	Zhang, Lu/0000-0002-2794-7371; Xu, Jianjiang/0000-0002-3191-3668	Key Clinic Medicine Research Program, the Ministry of Health, China [201302015]; National Science and Technology Research Program, the Ministry of Science and Technology, China [2012BAI08B01]; National Natural Science Foundation of China [81170817, 81200658, 81300735, 81270978, U1205025, 81330022]; Chinese Postdoctoral Fund [XMU135890]; Scientific Research Program, Science and Technology Commission of Shanghai Municipality, Shanghai [13441900900, 13430720400]; New Technology Joint Research Project in Shanghai Hospitals [SHDC12014114]	Key Clinic Medicine Research Program, the Ministry of Health, China; National Science and Technology Research Program, the Ministry of Science and Technology, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Fund; Scientific Research Program, Science and Technology Commission of Shanghai Municipality, Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); New Technology Joint Research Project in Shanghai Hospitals	The authors were supported by grants from the Key Clinic Medicine Research Program, the Ministry of Health, China (201302015); the National Science and Technology Research Program, the Ministry of Science and Technology, China (2012BAI08B01); the National Natural Science Foundation of China (81170817, 81200658, 81300735, 81270978, U1205025, and 81330022); the Chinese Postdoctoral Fund (XMU135890); and the Scientific Research Program, Science and Technology Commission of Shanghai Municipality, Shanghai (13441900900, 13430720400); New Technology Joint Research Project in Shanghai Hospitals (SHDC12014114). The sponsor or funding organization had no role in the design or conduct of this research.	Abu-Amero KK, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/641708; Bisceglia L, 2009, INVEST OPHTH VIS SCI, V50, P1081, DOI 10.1167/iovs.08-2382; Bykhovskaya Y, 2012, INVEST OPHTH VIS SCI, V53, P4152, DOI 10.1167/iovs.11-9268; Chang HYP, 2013, SEMIN OPHTHALMOL, V28, P275, DOI 10.3109/08820538.2013.825295; Dudakova L, 2015, EUROPEAN J HUMAN GEN; Dudakova L, 2012, EXP EYE RES, V104, P74, DOI 10.1016/j.exer.2012.09.005; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Georgiou T, 2004, EYE, V18, P379, DOI 10.1038/sj.eye.6700652; Guan T, 2012, GENE, V503, P137, DOI 10.1016/j.gene.2012.04.061; Hao XD, 2015, OPHTHALMIC GENET, V36, P132, DOI 10.3109/13816810.2015.1005317; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Hasanian-Langroudi F., 2014, OPHTHALMIC GENETICS; Heon E, 2002, HUM MOL GENET, V11, P1029, DOI 10.1093/hmg/11.9.1029; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jonas JB, 2009, AM J OPHTHALMOL, V148, P760, DOI 10.1016/j.ajo.2009.06.024; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lau LCM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109142; Pearson AR, 2000, EYE, V14, P625, DOI 10.1038/eye.2000.154; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Shetty R, 2015, MOL VIS, V21, P12; Stabuc-Silih M, 2009, MOL VIS, V15, P2848; Tuft SJ, 2012, ACTA OPHTHALMOL, V90, pe482, DOI 10.1111/j.1755-3768.2012.02448.x; Udar N, 2006, INVEST OPHTH VIS SCI, V47, P3345, DOI 10.1167/iovs.05-1500; Wang YN, 2013, OPHTHALMIC GENET, V34, P160, DOI 10.3109/13816810.2012.743569	24	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145815	10.1371/journal.pone.0145815	http://dx.doi.org/10.1371/journal.pone.0145815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713757	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900087
J	Chattopadhyay, N; Berger, AJ; Koenig, E; Bannerman, B; Garnsey, J; Bernard, H; Hales, P; Lopez, AM; Yang, Y; Donelan, J; Jordan, K; Tirrell, S; Stringer, B; Xia, C; Hather, G; Galvin, K; Manfredi, M; Rhodes, N; Amidon, B				Chattopadhyay, Nibedita; Berger, Allison J.; Koenig, Erik; Bannerman, Bret; Garnsey, James; Bernard, Hugues; Hales, Paul; Lopez, Angel Maldonado; Yang, Yu; Donelan, Jill; Jordan, Kristen; Tirrell, Stephen; Stringer, Bradley; Xia, Cindy; Hather, Greg; Galvin, Katherine; Manfredi, Mark; Rhodes, Nelson; Amidon, Ben			KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism	PLOS ONE			English	Article							MULTIPLE-MYELOMA CELLS; ANTITUMOR-ACTIVITY; ANTICANCER DRUGS; FATTY-ACID; THERAPY; PATHWAY; MLN9708; SENSITIVITY; MUTATION; STRESS	In non-clinical studies, the proteasome inhibitor ixazomib inhibits cell growth in a broad panel of solid tumor cell lines in vitro. In contrast, antitumor activity in xenograft tumors is model-dependent, with some solid tumors showing no response to ixazomib. In this study we examined factors responsible for ixazomib sensitivity or resistance using mouse xenograft models. A survey of 14 non-small cell lung cancer (NSCLC) and 6 colon xenografts showed a striking relationship between ixazomib activity and KRAS genotype; tumors with wild-type (WT) KRAS were more sensitive to ixazomib than tumors harboring KRAS activating mutations. To confirm the association between KRAS genotype and ixazomib sensitivity, we used SW48 isogenic colon cancer cell lines. Either KRAS-G13D or KRAS-G12V mutations were introduced into KRAS-WT SW48 cells to generate cells that stably express activated KRAS. SW48 KRAS WT tumors, but neither SW48-KRAS-G13D tumors nor SW48-KRAS-G12V tumors, were sensitive to ixazomib in vivo. Since activated KRAS is known to be associated with metabolic reprogramming, we compared metabolite profiling of SW48-WT and SW48-KRAS-G13D tumors treated with or without ixazomib. Prior to treatment there were significant metabolic differences between SW48 WT and SW48-KRAS-G13D tumors, reflecting higher oxidative stress and glucose utilization in the KRAS-G13D tumors. Ixazomib treatment resulted in significant metabolic regulation, and some of these changes were specific to KRAS WT tumors. Depletion of free amino acid pools and activation of GCN2-eIF2 alpha-pathways were observed both in tumor types. However, changes in lipid beta oxidation were observed in only the KRAS WT tumors. The non-clinical data presented here show a correlation between KRAS genotype and ixazomib sensitivity in NSCLC and colon xenografts and provide new evidence of regulation of key metabolic pathways by proteasome inhibition.	[Chattopadhyay, Nibedita; Berger, Allison J.; Koenig, Erik; Bannerman, Bret; Garnsey, James; Bernard, Hugues; Hales, Paul; Lopez, Angel Maldonado; Yang, Yu; Donelan, Jill; Jordan, Kristen; Tirrell, Stephen; Stringer, Bradley; Xia, Cindy; Hather, Greg; Galvin, Katherine; Manfredi, Mark; Amidon, Ben] Takeda Pharmaceut Int Co, Cambridge, MA USA; [Rhodes, Nelson] Metabolon Inc, Durham, NC USA	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.; Metabolon	Chattopadhyay, N (corresponding author), Takeda Pharmaceut Int Co, Cambridge, MA USA.	nibedita.chattopadhyay@takeda.com			Takeda Pharmaceuticals International Co.; Metabolon Inc.; Takeda Pharmaceuticals	Takeda Pharmaceuticals International Co.; Metabolon Inc.; Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd)	This study was funded by Takeda Pharmaceuticals International Co. Moreover, Takeda Pharmaceuticals provided support in the form of salaries for authors (NC, AJB, EK, BB, JG, HB, PH, AML, YY, JD, KJ, ST, BS, CX, GK, MM, and BA). Metabolon Inc. provided support in the form of salaries for author NR, but did not have any additional role in the decision to publish or preparation of the manuscript.	Adams J, 2003, DRUG DISCOV TODAY, V8, P307, DOI 10.1016/S1359-6446(03)02647-3; Adams J, 2002, CURR OPIN ONCOL, V14, P628, DOI 10.1097/00001622-200211000-00007; Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Balendiran GK, 2004, CELL BIOCHEM FUNCT, V22, P343, DOI 10.1002/cbf.1149; Bianchi G, 2009, BLOOD, V113, P3040, DOI 10.1182/blood-2008-08-172734; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Chauhan D, 2011, CLIN CANCER RES, V17, P5311, DOI 10.1158/1078-0432.CCR-11-0476; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Demo SD, 2007, CANCER RES, V67, P6383, DOI 10.1158/0008-5472.CAN-06-4086; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Frankland-Searby S, 2012, BBA-REV CANCER, V1825, P64, DOI 10.1016/j.bbcan.2011.10.003; Garcia-Gomez A, 2014, CLIN CANCER RES, V20, P1542, DOI 10.1158/1078-0432.CCR-13-1657; Hamburger A W, 1980, Prog Clin Biol Res, V48, P63; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim MJ, 2011, J BIOL CHEM, V286, P12924, DOI 10.1074/jbc.M110.138958; Kupperman E, 2010, CANCER RES, V70, P1970, DOI 10.1158/0008-5472.CAN-09-2766; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Mulligan G, 2014, BLOOD, V123, P632, DOI 10.1182/blood-2013-05-504340; Oliva J, 2012, EXP MOL PATHOL, V93, P26, DOI 10.1016/j.yexmp.2012.03.006; Petrocca F, 2013, CANCER CELL, V24, P182, DOI 10.1016/j.ccr.2013.07.008; Poff AM, 2014, INT J CANC; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Veech RL, 2001, IUBMB LIFE, V51, P241; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229	39	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144825	10.1371/journal.pone.0144825	http://dx.doi.org/10.1371/journal.pone.0144825			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709701	Green Submitted, gold, Green Published			2022-12-27	WOS:000367451400014
J	Olkkonen, J; Kouri, VP; Hynninen, J; Konttinen, YT; Mandelin, J				Olkkonen, Juri; Kouri, Vesa-Petteri; Hynninen, Joel; Konttinen, Yrjo T.; Mandelin, Jami			Differentially Expressed in Chondrocytes 2 (DEC2) Increases the Expression of IL-1 beta and Is Abundantly Present in Synovial Membrane in Rheumatoid Arthritis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CIRCADIAN-RHYTHMS; TNF-ALPHA; TRANSCRIPTION; CLOCK; LOOP; FIBROBLASTS; CYTOKINES; FATIGUE; BIOLOGY	Objective Patients with rheumatoid arthritis (RA) have altered circadian rhythm of circulating serum cortisol, melatonin and IL-6, as well as disturbance in the expression of clock genes ARNTL2 and NPAS2. In humans, TNF alpha increases the expression ARNTL2 and NPAS2 but paradoxically suppresses clock output genes DPB and PER3. Our objective was to investigate the expression of direct clock suppressors DEC1 and DEC2 (BHLHE 40 and 41 proteins) in response to TNF alpha and investigate their role during inflammation. Methods Cultured primary fibroblasts were stimulated with TNF alpha. Effects on DEC2 were studied using RT-qPCR and immunofluorescence staining. The role of NF-kappa B in DEC2 increase was analyzed using IKK-2 specific inhibitor IMD-0354. Cloned DEC2 was transfected into HEK293 cells to study its effects on gene expression. Transfections into primary human fibroblasts were used to confirm the results. The presence of DEC2 was analyzed in (RA) and osteoarthritis (OA) synovial membranes by immunohistochemistry. Results TNF alpha increased DEC2 mRNA and DEC2 was mainly detected at nuclei after the stimulus. The effects of TNF alpha on DEC2 expression were mediated via NF-kappa B. Overexpression, siRNA and promoter activity studies disclosed that DEC2 directly regulates IL-1 beta, in both HEK293 cells and primary human fibroblasts. DEC2 was increased in synovial membrane in RA compared to OA. Conclusion Not only ARNTL2 and NPAS2 but also DEC2 is regulated by TNF alpha in human fibroblasts. NF-kappa B mediates the effect on DEC2, which upregulates IL-1 beta. Circadian clock has a direct effect on inflammation in human fibroblasts.	[Olkkonen, Juri; Kouri, Vesa-Petteri; Konttinen, Yrjo T.; Mandelin, Jami] Univ Helsinki, Dept Med, Helsinki, Finland; [Olkkonen, Juri; Kouri, Vesa-Petteri; Konttinen, Yrjo T.; Mandelin, Jami] Helsinki Univ Hosp, Helsinki, Finland; [Hynninen, Joel] ORTON Orthopaed Hosp, Invalid Fdn, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Mandelin, J (corresponding author), Univ Helsinki, Dept Med, Helsinki, Finland.	jami.mandelin@helsinki.fi	Mandelin, Jami/A-7943-2008; Kouri, Vesa-Petteri/M-7436-2015	Kouri, Vesa-Petteri/0000-0001-6256-0642	Maire Lisko Saatio; University of Helsinki; Reumatautien tutkimussaatio; Orionin Tutkimussaatio; Paulo Foundation; Duodecim; Orionin Tutkimusaatio; Suomen Kulttuurirahasto; Medcare Foundation; Otto Malm's Foundation; Finska Lakaresallskapet; ORTON Orthopaedic Hospital of the ORTON Foundation; Danish Council for Strategic Research; Sigrid Juselius Foundation; Academy of Finland; Finnish Society for Rheumatology; Orion-Farmos Research Fund	Maire Lisko Saatio; University of Helsinki; Reumatautien tutkimussaatio; Orionin Tutkimussaatio; Paulo Foundation; Duodecim; Orionin Tutkimusaatio; Suomen Kulttuurirahasto; Medcare Foundation; Otto Malm's Foundation; Finska Lakaresallskapet; ORTON Orthopaedic Hospital of the ORTON Foundation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Society for Rheumatology; Orion-Farmos Research Fund	JO received support from Maire Lisko Saatio, University of Helsinki, Reumatautien tutkimussaatio, Orionin Tutkimussaatio, The Paulo Foundation and Duodecim. VPK received support from Orionin Tutkimusaatio, Reumatautien tutkimussaatio, Suomen Kulttuurirahasto, Medcare Foundation, and Otto Malm's Foundation. YTK received support from Finska Lakaresallskapet, ORTON Orthopaedic Hospital of the ORTON Foundation and Danish Council for Strategic Research, and The Sigrid Juselius Foundation. JM received support from Academy of Finland, Finnish Society for Rheumatology, The Paulo Foundation, University of Helsinki and Orion-Farmos Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; Cutolo M, 2005, AUTOIMMUN REV, V4, P497, DOI 10.1016/j.autrev.2005.04.019; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; GUDEWILL S, 1992, EUR ARCH PSY CLIN N, V242, P53, DOI 10.1007/BF02190343; Haas S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3852; Hamilton K, 2000, Expert Opin Pharmacother, V1, P1041, DOI 10.1517/14656566.1.5.1041; Hashiramoto A, 2010, J IMMUNOL, V184, P1560, DOI 10.4049/jimmunol.0903284; Hewlett S, 2005, ARTHRIT RHEUM-ARTHR, V53, P697, DOI 10.1002/art.21450; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Johnston JD, 2014, EXP PHYSIOL, V99, P1133, DOI 10.1113/expphysiol.2014.078295; Kawamoto T, 2004, BIOCHEM BIOPH RES CO, V313, P117, DOI 10.1016/j.bbrc.2003.11.099; Kouri VP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054049; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Mandelin J, 2005, J RHEUMATOL, V32, P713; Meyer-Hermann M, 2009, ARTHRITIS RHEUM, V60, P2585, DOI 10.1002/art.24797; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mor A, 2005, CLIN IMMUNOL, V115, P118, DOI 10.1016/j.clim.2004.12.009; Moreland LW, 2006, ARTHRIT RHEUM-ARTHR, V55, P287, DOI 10.1002/art.21838; NEIDEL J, 1995, INFLAMM RES, V44, P217, DOI 10.1007/BF01782262; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Petrovsky N, 1998, CYTOKINE, V10, P307, DOI 10.1006/cyto.1997.0289; Sierakowski S, 2011, SCAND J RHEUMATOL, V40, P1, DOI 10.3109/03009742.2011.566433; Straub RH, 2007, ARTHRITIS RHEUM, V56, P399, DOI 10.1002/art.22368; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Tak PP, 1996, ARTHRITIS RHEUM, V39, P1077, DOI 10.1002/art.1780390702; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wu YY, 2011, INT J MOL MED, V27, P491, DOI 10.3892/ijmm.2011.617; Yang XO, 2009, NAT IMMUNOL, V10, P1260, DOI 10.1038/ni.1821	29	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145279	10.1371/journal.pone.0145279	http://dx.doi.org/10.1371/journal.pone.0145279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710124	Green Published, Green Submitted, gold			2022-12-27	WOS:000367451400034
J	Pengo, V; Zambon, CF; Fogar, P; Padoan, A; Nante, G; Pelloso, M; Moz, S; Frigo, AC; Groppa, F; Bozzato, D; Tiso, E; Gnatta, E; Denas, G; Jose, SP; Padrini, R; Basso, D; Plebani, M				Pengo, Vittorio; Zambon, Carlo-Federico; Fogar, Paola; Padoan, Andrea; Nante, Giovanni; Pelloso, Michela; Moz, Stefania; Frigo, Anna Chiara; Groppa, Francesca; Bozzato, Dania; Tiso, Enrico; Gnatta, Elisa; Denas, Gentian; Jose, Seena Padayattil; Padrini, Roberto; Basso, Daniela; Plebani, Mario			A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation	PLOS ONE			English	Article							ORAL ANTICOAGULANT TREATMENT; INCEPTION-COHORT; BLEEDING COMPLICATIONS; THERAPY; CYP2C9; RISK; ALGORITHMS; PREDICT; VKORC1; ISCOAT	Genotype-guided warfarin dosing have been proposed to improve patient's management. This study is aimed to determine whether a CYP2C9- VKORC1- CYP4F2-based pharmacogenetic algorithm is superior to a standard, clinically adopted, pharmacodynamic method. Two-hundred naive patients with non-valvular atrial fibrillation were randomized to trial arms and 180 completed the study. No significant differences were found in the number of out-of-range INRs (INR<2.0 or >3.0) (p = 0.79) and in the mean percentage of time spent in the therapeutic range (TTR) after 19 days in the pharmacogenetic (51.9%) and in the control arm (53.2%, p = 0.71). The percentage of time spent at INR>4.0 was significantly lower in the pharmacogenetic (0.7%) than in the control arm (1.8%) (p = 0.02). Genotype-guided warfarin dosing is not superior in overall anticoagulation control when compared to accurate clinical standard of care.	[Pengo, Vittorio; Nante, Giovanni; Frigo, Anna Chiara; Tiso, Enrico; Denas, Gentian; Jose, Seena Padayattil] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy; [Zambon, Carlo-Federico; Padoan, Andrea; Moz, Stefania; Groppa, Francesca; Bozzato, Dania; Padrini, Roberto; Plebani, Mario] Univ Padua, Dept Med, DIMED, Padua, Italy; [Zambon, Carlo-Federico; Fogar, Paola; Padoan, Andrea; Pelloso, Michela; Moz, Stefania; Bozzato, Dania; Gnatta, Elisa; Basso, Daniela; Plebani, Mario] Univ Padua, Dept Lab Med, Padua, Italy	University of Padua; University of Padua; University of Padua	Zambon, CF (corresponding author), Univ Padua, Dept Med, DIMED, Padua, Italy.	carlofederico.zambon@unipd.it	pelloso, michela/K-5615-2018; Plebani, Mario/AAF-4953-2020; Basso, Daniela/J-7855-2016; Bozzato, Dania/AAA-5142-2019; Zambon, Carlo Federico/J-8187-2016; Padoan, Andrea/J-7869-2016; Denas, Gentian/ABD-6979-2020	Basso, Daniela/0000-0001-8745-6171; Zambon, Carlo Federico/0000-0002-4244-879X; Padoan, Andrea/0000-0003-1284-7885; Denas, Gentian/0000-0001-6484-0007; moz, stefania/0000-0002-7485-520X; Pelloso, Michela/0000-0002-2853-4499	University of Padova Research Grant [CPDR111507]	University of Padova Research Grant	D. Bozzato was supported by the University of Padova (http://www.unipd.it/) Research Grant - protocol ID: CPDR111507. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all the patients who participated in the study. DBo was supported by the University of Padova Research Grant-protocol ID: CPDR111507.	Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Anderson JL, 2012, CIRCULATION, V125, P1997, DOI 10.1161/CIRCULATIONAHA.111.070920; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; CANNEGIETER SC, 1995, NEW ENGL J MED, V333, P11, DOI 10.1056/NEJM199507063330103; Caraco Y, 2008, CLIN PHARMACOL THER, V83, P460, DOI 10.1038/sj.clpt.6100316; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; Eriksson N, 2012, PHARMACOGENOMICS, V13, P429, DOI [10.2217/pgs.11.184, 10.2217/PGS.11.184]; Fang MC, 2008, J AM COLL CARDIOL, V51, P810, DOI 10.1016/j.jacc.2007.09.065; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Gong IY, 2011, BLOOD, V118, P3163, DOI 10.1182/blood-2011-03-345173; Hillman MA, 2005, CLIN MED RES, V3, P137, DOI 10.3121/cmr.3.3.137; Kimmel SE, 2015, J THROMB HAEMOST, V13, pS266, DOI 10.1111/jth.12978; Kimmel SE, 2013, NEW ENGL J MED, V369, P2283, DOI 10.1056/NEJMoa1310669; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Mahtani KR, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858; Manotti C, 2001, HAEMATOLOGICA, V86, P1060; Palareti G, 1997, THROMB HAEMOSTASIS, V78, P1438; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Pengo V, 2001, AM J CARDIOL, V88, P1214, DOI 10.1016/S0002-9149(01)02069-0; Pengo V, 2001, THROMB HAEMOSTASIS, V85, P418; Petty GW, 1999, ANN INTERN MED, V130, P14, DOI 10.7326/0003-4819-130-1-199901050-00004; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Scordo MG, 2002, CLIN PHARMACOL THER, V72, P702, DOI 10.1067/mcp.2002.129321; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; Verhoef TI, 2013, NEW ENGL J MED, V369, P2304, DOI 10.1056/NEJMoa1311388; Wu AHB, 2007, PHARMACOGENOMICS, V8, P851, DOI 10.2217/14622416.8.7.851; Zambon CF, 2011, PHARMACOGENOMICS, V12, P15, DOI [10.2217/pgs.10.162, 10.2217/PGS.10.162]	28	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145318	10.1371/journal.pone.0145318	http://dx.doi.org/10.1371/journal.pone.0145318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710337	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400036
J	Wang, XM; Peng, L; Chi, TH; Li, MZ; Yao, XJ; Shao, J				Wang, Xiaomeng; Peng, Ling; Chi, Tianhe; Li, Mengzhu; Yao, Xiaojing; Shao, Jing			A Hidden Markov Model for Urban-Scale Traffic Estimation Using Floating Car Data	PLOS ONE			English	Article							DYNAMICS; SYSTEMS; FLOW	Urban-scale traffic monitoring plays a vital role in reducing traffic congestion. Owing to its low cost and wide coverage, floating car data (FCD) serves as a novel approach to collecting traffic data. However, sparse probe data represents the vast majority of the data available on arterial roads in most urban environments. In order to overcome the problem of data sparseness, this paper proposes a hidden Markov model (HMM)-based traffic estimation model, in which the traffic condition on a road segment is considered as a hidden state that can be estimated according to the conditions of road segments having similar traffic characteristics. An algorithm based on clustering and pattern mining rather than on adjacency relationships is proposed to find clusters with road segments having similar traffic characteristics. A multi-clustering strategy is adopted to achieve a trade-off between clustering accuracy and coverage. Finally, the proposed model is designed and implemented on the basis of a real-time algorithm. Results of experiments based on real FCD confirm the applicability, accuracy, and efficiency of the model. In addition, the results indicate that the model is practicable for traffic estimation on urban arterials and works well even when more than 70% of the probe data are missing.	[Wang, Xiaomeng; Peng, Ling; Chi, Tianhe; Yao, Xiaojing; Shao, Jing] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Wang, Xiaomeng; Yao, Xiaojing; Shao, Jing] Chinese Acad Sci, Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Mengzhu] Southwest Univ, Coll Econ & Management, Chongqing, Peoples R China	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Southwest University - China	Peng, L (corresponding author), Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China.	pengl20158@163.com	Yao, Xiaojing/HHN-3072-2022	Yao, Xiaojing/0000-0001-9745-3150	National Key Technology Support Program [2015BAJ02B00]; Ministry of Science and Technology Policy Guidance Project [2011FU125Z24]	National Key Technology Support Program(National Key Technology R&D Program); Ministry of Science and Technology Policy Guidance Project	TC is supported by a National Key Technology Support Program (2015BAJ02B00) and Ministry of Science and Technology Policy Guidance Project (2011FU125Z24). URL: http://program.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Gera H, 2007, TRANSPORT RES C-EMER, V15, P380, DOI 10.1016/j.trc.2007.06.003; Bejan AI, 2011, IEEE INT C INTELL TR, P746, DOI 10.1109/ITSC.2011.6082904; Bramberger M, 2004, RTAS 2004: 10TH IEEE REAL-TIME AND EMBEDDED TECHNOLOGY AND APPLICATIONS SYMPOSIUM, PROCEEDINGS, P174, DOI 10.1109/RTTAS.2004.1317262; Breitenberger S., 2004, TRAFFIC ENG CONTROL, V45, P396; Chen BY, 2014, INT J GEOGR INF SCI, V28, P22, DOI 10.1080/13658816.2013.816427; de Fabritiis C, 2008, PROCEEDINGS OF THE 11TH INTERNATIONAL IEEE CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS, P197, DOI 10.1109/ITSC.2008.4732534; Fowe AJ, 2013, TRANSPORT RES C-EMER, V36, P245, DOI 10.1016/j.trc.2013.08.011; Ge JI, 2014, TRANSPORT RES C-EMER, V46, P46, DOI 10.1016/j.trc.2014.04.014; Gupta A.K., 2013, INT J MOD PHYS C, P24; Gupta AK, 2014, COMMUN THEOR PHYS, V62, P393, DOI 10.1088/0253-6102/62/3/17; Gupta AK, 2013, PHYS LETT A, V377, P2027, DOI 10.1016/j.physleta.2013.06.009; He ZC, 2013, IET INTELL TRANSP SY, V7, P404, DOI 10.1049/iet-its.2011.0226; Herrera JC, 2007, TRB 87 ANN M COMP; Herrera JC, 2010, TRANSPORT RES C-EMER, V18, P568, DOI 10.1016/j.trc.2009.10.006; Herring Ryan, 2010, 2010 13th International IEEE Conference on Intelligent Transportation Systems (ITSC 2010), P929, DOI 10.1109/ITSC.2010.5624994; Hiribarren G, 2014, TRANSPORT RES B-METH, V69, P19, DOI 10.1016/j.trb.2014.07.003; Hofleitner A, 2012, IEEE T INTELL TRANSP, V13, P1679, DOI 10.1109/TITS.2012.2200474; Kong QJ, 2013, IEEE T INTELL TRANSP, V14, P398, DOI 10.1109/TITS.2012.2218237; Leontiadis I, 2011, IEEE T INTELL TRANSP, V12, P1537, DOI 10.1109/TITS.2011.2161469; Ramezani M, 2015, COMPUT-AIDED CIV INF, V30, P414, DOI 10.1111/mice.12095; Raymond R, 2012, INT C PATT RECOG, P2242; Seo T, 2015, TRANSPORT RES C-EMER, V53, P134, DOI 10.1016/j.trc.2015.01.033; Tang TQ, 2010, PHYS LETT A, V374, P3951, DOI 10.1016/j.physleta.2010.07.062; Tang TQ, 2014, MEASUREMENT, V58, P286, DOI 10.1016/j.measurement.2014.08.051; Tang TQ, 2010, INT J MOD PHYS C, V21, P159, DOI 10.1142/S0129183110015038; Vandenberghe W, 2012, IET INTELL TRANSP SY, V6, P347, DOI 10.1049/iet-its.2011.0221; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang J., 2015, MATH PROBL ENG; Work DB, 2010, APPL MATH RES EXPRES, P1, DOI 10.1093/amrx/abq002; Yeon J, 2008, TRANSPORT RES B-METH, V42, P325, DOI 10.1016/j.trb.2007.08.005; Yu SW, 2015, MEASUREMENT, V70, P137, DOI 10.1016/j.measurement.2015.03.031; Yu SW, 2015, PHYSICA A, V421, P1, DOI 10.1016/j.physa.2014.11.008; Yu SW, 2015, MEASUREMENT, V64, P34, DOI 10.1016/j.measurement.2014.12.036; Yu SW, 2014, PHYSICA A, V407, P152, DOI 10.1016/j.physa.2014.03.081; Yu SW, 2013, COMMUN NONLINEAR SCI, V18, P1229, DOI 10.1016/j.cnsns.2012.09.014; Zhu YM, 2013, IEEE T MOBILE COMPUT, V12, P2289, DOI 10.1109/TMC.2012.205	36	3	4	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145348	10.1371/journal.pone.0145348	http://dx.doi.org/10.1371/journal.pone.0145348			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710073	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400041
J	Dai, MM; Yu, CM; Fang, T; Fu, L; Wang, J; Zhang, J; Ren, J; Xu, JJ; Zhang, XP; Chen, W				Dai, Mengmeng; Yu, Changming; Fang, Ting; Fu, Ling; Wang, Jing; Zhang, Jun; Ren, Jun; Xu, Junjie; Zhang, Xiaopeng; Chen, Wei			Identification and Functional Characterization of Glycosylation of Recombinant Human Platelet- Derived Growth Factor-BB in Pichia pastoris	PLOS ONE			English	Article							PROTEIN O-MANNOSYLATION; LINKED MANNOSYLATION; RECOGNITION; EXPRESSION; INCREASES; GLYCANS; BINDING; PRODUCE; ASSAY	Yeast Pichia pastoris is a widely used system for heterologous protein expression. However, post-translational modifications, especially glycosylation, usually impede pharmaceutical application of recombinant proteins because of unexpected alterations in protein structure and function. The aim of this study was to identify glycosylation sites on recombinant human platelet-derived growth factor-BB (rhPDGF-BB) secreted by P. pastoris, and investigate possible effects of O-linked glycans on PDGF-BB functional activity. PDGF-BB secreted by P. pastoris is very heterogeneous and contains multiple isoforms. We demonstrated that PDGF-BB was O-glycosylated during the secretion process and detected putative O-glycosylation sites using glycosylation staining and immunoblotting. By site-directed mutagenesis and high-resolution LC/MS analysis, we, for the first time, identified two threonine residues at the C-terminus as the major O-glycosylation sites on rhPDGF-BB produced in P. pastoris. Although O-glycosylation resulted in heterogeneous protein expression, the removal of glycosylation sites did not affect rhPDGF-BB mitogenic activity. In addition, the unglycosylated PDGF-BB Delta Gly mutant exhibited the immunogenicity comparable to that of the wild-type form. Furthermore, antiserum against PDGF-BB Delta Gly also recognized glycosylated PDGF-BB, indicating that protein immunogenicity was unaltered by glycosylation. These findings elucidate the effect of glycosylation on PDGF-BB structure and biological activity, and can potentially contribute to the design and production of homogeneously expressed unglycosylated or human-type glycosylated PDGF-BB in P. pastoris for pharmaceutical applications.	[Dai, Mengmeng; Yu, Changming; Fang, Ting; Fu, Ling; Wang, Jing; Zhang, Jun; Ren, Jun; Xu, Junjie; Zhang, Xiaopeng; Chen, Wei] Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing, Peoples R China; [Dai, Mengmeng] PLA, Hosp 148, Clin Lab, Zibo, Peoples R China		Zhang, XP (corresponding author), Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing, Peoples R China.	zxp8565@aliyun.com; cw0226@foxmail.com	Zhang, XP/AAY-9089-2020		National Natural Science Foundation of China [81301965, 81172980]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants (81301965, 81172980) from National Natural Science Foundation of China (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046959; Ahmad M, 2014, APPL MICROBIOL BIOT, V98, P5301, DOI 10.1007/s00253-014-5732-5; Amon R, 2014, CARBOHYD RES, V389, P115, DOI 10.1016/j.carres.2014.02.004; An HJ, 2009, CURR OPIN CHEM BIOL, V13, P421, DOI 10.1016/j.cbpa.2009.07.022; CLEMENTS JM, 1991, EMBO J, V10, P4113, DOI 10.1002/j.1460-2075.1991.tb04988.x; Costa AR, 2014, CRIT REV BIOTECHNOL, V34, P281, DOI 10.3109/07388551.2013.793649; Cukan MC, 2012, J IMMUNOL METHODS, V386, P34, DOI 10.1016/j.jim.2012.08.015; Damasceno LM, 2012, APPL MICROBIOL BIOT, V93, P31, DOI 10.1007/s00253-011-3654-z; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Dicker M, 2015, EXPERT OPIN BIOL TH, V15, P1501, DOI 10.1517/14712598.2015.1069271; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Dobson CM, 2013, CELL MOL LIFE SCI, V70, P2849, DOI 10.1007/s00018-012-1193-0; Gomathinayagam S, 2014, APPL MICROBIOL BIOT, V98, P2545, DOI 10.1007/s00253-013-5478-5; Hamilton SR, 2013, GLYCOBIOLOGY, V23, P1192, DOI 10.1093/glycob/cwt056; HANIU M, 1993, BIOCHEMISTRY-US, V32, P2431, DOI 10.1021/bi00060a039; Hopkins D, 2015, APPL MICROBIOL BIOT, V99, P3913, DOI 10.1007/s00253-014-6189-2; Jacobs PP, 2009, NAT PROTOC, V4, P58, DOI 10.1038/nprot.2008.213; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; Krainer FW, 2013, SCI REP-UK, V3, DOI 10.1038/srep03279; Lam JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001009; Laukens B, 2015, FUTURE MICROBIOL, V10, P21, DOI 10.2217/fmb.14.104; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Luong M, 2007, VACCINE, V25, P4340, DOI 10.1016/j.vaccine.2007.03.027; Nagai MK, 2002, EXPERT OPIN BIOL TH, V2, P211, DOI 10.1517/14712598.2.2.211; Nakamura N, 2010, SEMIN CELL DEV BIOL, V21, P622, DOI 10.1016/j.semcdb.2010.03.010; Nett JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068325; Oberg F, 2011, J BIOL CHEM, V286, P31915, DOI 10.1074/jbc.M111.242677; Piirainen MA, 2014, NEW BIOTECHNOL, V31, P532, DOI 10.1016/j.nbt.2014.03.001; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Stalnaker SH, 2011, CURR OPIN STRUC BIOL, V21, P603, DOI 10.1016/j.sbi.2011.09.001; Tan AS, 2000, J IMMUNOL METHODS, V238, P59, DOI 10.1016/S0022-1759(00)00156-3; Upreti GC, 2012, BIOTECHNIQUES, V52, P159, DOI 10.2144/000113818; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Vogl T, 2013, CURR OPIN BIOTECH, V24, P1094, DOI 10.1016/j.copbio.2013.02.024; Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040; Yin JC, 2007, J BIOTECHNOL, V127, P335, DOI 10.1016/j.jbiotec.2006.07.012; Zauner G, 2012, BIOL CHEM, V393, P687, DOI 10.1515/hsz-2012-0144	37	15	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145419	10.1371/journal.pone.0145419	http://dx.doi.org/10.1371/journal.pone.0145419			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701617	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600078
J	Elkis, Y; Bel, S; Rahimi, R; Lerer-Goldstein, T; Levin-Zaidman, S; Babushkin, T; Shpungin, S; Nir, U				Elkis, Yoav; Bel, Shai; Rahimi, Roni; Lerer-Goldstein, Tali; Levin-Zaidman, Smadar; Babushkin, Tatiana; Shpungin, Sally; Nir, Uri			TMF/ARA160 Governs the Dynamic Spatial Orientation of the Golgi Apparatus during Sperm Development	PLOS ONE			English	Article							MEMBRANE TRAFFICKING; ACROSOME FORMATION; CHROMATOID BODY; PROTEIN; COMPLEX; MICROTUBULES; MICE; ORGANIZATION; ACROPLAXOME; RAT	TMF/ARA160 is known to be a TATA element Modulatory Factor (TMF). It was initially identified as a DNA-binding factor and a coactivator of the Androgen receptor. It was also characterized as a Golgi-associated protein, which is essential for acrosome formation during functional sperm development. However, the molecular roles of TMF in this intricate process have not been revealed. Here, we show that during spermiogenesis, TMF undergoes a dynamic change of localization throughout the Golgi apparatus. Specifically, TMF translocates from the cis-Golgi to the trans-Golgi network and to the emerging vesicles surface, as the round spermatids develop. Notably, lack of TMF led to an abnormal spatial orientation of the Golgi and to the deviation of the trans-Golgi surface away from the nucleus of the developing round spermatids. Concomitantly, pro-acrosomal vesicles derived from the TMF-/- Golgi lacked targeting properties and did not tether to the spermatid nuclear membrane thereby failing to form the acrosome anchoring scaffold, the acroplaxome, around the cell-nucleus. Absence of TMF also perturbed the positioning of microtubules, which normally lie in proximity to the Golgi and are important for maintaining Golgi spatial orientation and dynamics and for chromatoid body formation, which is impaired in TMF-/- spermatids. In-silico evaluation combined with molecular and electron microscopic analyses revealed the presence of a microtubule interacting domain (MIT) in TMF, and confirmed the association of TMF with microtubules in spermatogenic cells. Furthermore, the MIT domain in TMF, along with microtubules integrity, are required for stable association of TMF with the Golgi apparatus. Collectively, we show here for the first time that a Golgi and microtubules associated protein is crucial for maintaining proper Golgi orientation during a cell developmental process.	[Elkis, Yoav; Bel, Shai; Rahimi, Roni; Lerer-Goldstein, Tali; Babushkin, Tatiana; Shpungin, Sally; Nir, Uri] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Levin-Zaidman, Smadar] Weizmann Inst Sci, Electron Microscopy Unit, IL-7610001 Rehovot, Israel	Bar Ilan University; Weizmann Institute of Science	Nir, U (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	uri.nir@biu.ac.il	Bel, Shai/AAH-7870-2021	Bel, Shai/0000-0002-7166-4870	Ihel Foundation	Ihel Foundation	This work was supported by a grant from the Ihel Foundation. This grant is an inner university grant therefore has no number or website.; This work was supported by a grant from the Ihel Foundation.	Abou-Haila A, 2000, ARCH BIOCHEM BIOPHYS, V379, P173, DOI 10.1006/abbi.2000.1880; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Berruti Giovanna, 2011, Spermatogenesis, V1, P95; BLOOM GS, 1989, J BIOL CHEM, V264, P16083; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Brown A. A., 2014, BIORXIV; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Clermont Y., 1993, FRONT ENDOCRINOL, P332; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Dadoune J P, 1994, Bull Assoc Anat (Nancy), V78, P33; Donkor FF, 2004, J CELL SCI, V117, P4643, DOI 10.1242/jcs.01303; Elkis Y, 2012, MOL CELL ENDOCRINOL; Farquhar MG, 1998, TRENDS CELL BIOL, V8, P2, DOI 10.1016/S0962-8924(97)01187-2; Fridmann-Sirkis Y, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-18; Fujihara Y, 2012, DEVELOPMENT, V139, P3583, DOI 10.1242/dev.081778; GRIFFITHS G, 1981, EUR J CELL BIOL, V26, P52; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Huang WP, 2006, CELL TISSUE RES, V323, P495, DOI 10.1007/s00441-005-0097-9; Kang-Decker N, 2001, SCIENCE, V294, P1531, DOI 10.1126/science.1063665; Kierszenbaum Abraham L, 2011, Spermatogenesis, V1, P221; Kierszenbaum AL, 2004, BIOL REPROD, V70, P1400, DOI 10.1095/biolreprod.103.025346; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Kotaja N, 2006, J CELL SCI, V119, P2819, DOI 10.1242/jcs.03022; Lerer-Goldshtein T, 2010, DEV BIOL, V348, P12, DOI 10.1016/j.ydbio.2010.07.033; Lippincott-Schwartz J, 1998, CURR OPIN CELL BIOL, V10, P52, DOI 10.1016/S0955-0674(98)80086-0; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Liu G, 2010, ASIAN J ANDROL, V12, P556, DOI 10.1038/aja.2010.47; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Meikar O, 2011, REPRODUCTION, V142, P195, DOI 10.1530/REP-11-0057; Miller VJ, 2013, J BIOL CHEM, V288, P4229, DOI 10.1074/jbc.M112.426767; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; Miyazaki T, 2013, HISTOCHEM CELL BIOL, V139, P339, DOI 10.1007/s00418-012-1031-3; Moreno RD, 2000, CELL MOTIL CYTOSKEL, V46, P235, DOI 10.1002/1097-0169(200008)46:4<235::AID-CM1>3.0.CO;2-G; Moreno RD, 2006, DEV BIOL, V293, P218, DOI 10.1016/j.ydbio.2006.02.001; Moreno RD, 2006, MOL REPROD DEV, V73, P1430, DOI 10.1002/mrd.20581; Munro S., 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A005256; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; Pathak R, 2012, DEV CELL, V23, P397, DOI 10.1016/j.devcel.2012.06.014; PAVELKA M, 1983, J CELL BIOL, V97, P737, DOI 10.1083/jcb.97.3.737; Perry E, 2004, ONCOGENE, V23, P8908, DOI 10.1038/sj.onc.1208149; Pierre V, 2012, DEVELOPMENT, V139, P2955, DOI 10.1242/dev.077982; Ramalho-Santos J, 2002, BIOL REPROD, V67, P1043, DOI 10.1095/biolreprod67.4.1043; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; Shao XP, 1999, DEV BIOL, V211, P109, DOI 10.1006/dbio.1999.9297; Skinner MA, 2010, NAT REV MOL CELL BIO, V11, P234, DOI 10.1038/nrm2870; Starr T, 2010, TRAFFIC, V11, P626, DOI 10.1111/j.1600-0854.2010.01051.x; Stephens DJ, 2012, J CELL SCI, V125, P2795, DOI 10.1242/jcs.097675; THORNETJOMSLAND G, 1988, ANAT REC, V221, P591, DOI 10.1002/ar.1092210205; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; TURNER JR, 1989, J CELL BIOL, V109, P2081, DOI 10.1083/jcb.109.5.2081; Ventela S, 2003, MOL BIOL CELL, V14, P2768, DOI 10.1091/mbc.E02-10-0647; Xiao N, 2009, J CLIN INVEST, V119, P802, DOI 10.1172/JCI36230; Yamane J, 2007, EXP CELL RES, V313, P3472, DOI 10.1016/j.yexcr.2007.07.010; Yao RJ, 2002, P NATL ACAD SCI USA, V99, P11211, DOI 10.1073/pnas.162027899	59	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145277	10.1371/journal.pone.0145277	http://dx.doi.org/10.1371/journal.pone.0145277			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701263	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600057
J	Francis, AW; Wanek, J; Lim, JI; Shahidi, M				Francis, Andrew W.; Wanek, Justin; Lim, Jennifer I.; Shahidi, Mahnaz			Enface Thickness Mapping and Reflectance Imaging of Retinal Layers in Diabetic Retinopathy	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MACULAR EDEMA; VISUAL-ACUITY; AUTOMATIC SEGMENTATION; IMAGES; INNER; RANIBIZUMAB; JUNCTION; FEATURES; HOLE	Purpose To present a method for image segmentation and generation of enface thickness maps and reflectance images of retinal layers in healthy and diabetic retinopathy (DR) subjects. Methods High density spectral domain optical coherence tomography (SDOCT) images were acquired in 10 healthy and 4 DR subjects. Customized image analysis software identified 5 retinal cell layer interfaces and generated thickness maps and reflectance images of the total retina (TR), inner retina (IR), outer retina (OR), and the inner segment ellipsoid (ISe) band. Thickness maps in DR subjects were compared to those of healthy subjects by generating deviation maps which displayed retinal locations with thickness below, within, and above the normal 95% confidence interval. Results In healthy subjects, TR and IR thickness maps displayed the foveal depression and increased thickness in the parafoveal region. OR and ISe thickness maps showed increased thickness at the fovea, consistent with normal retinal anatomy. In DR subjects, thickening and thinning in localized regions were demonstrated on TR, IR, OR, and ISe thickness maps, corresponding to retinal edema and atrophy, respectively. TR and OR reflectance images showed reduced reflectivity in regions of increased thickness. Hard exudates appeared as hyper-reflective spots in IR reflectance images and casted shadows on the deeper OR and ISe reflectance images. The ISe reflectance image clearly showed the presence of focal laser scars. Conclusions Enface thickness mapping and reflectance imaging of retinal layers is a potentially useful method for quantifying the spatial and axial extent of pathologies due to DR.	[Francis, Andrew W.; Wanek, Justin; Lim, Jennifer I.; Shahidi, Mahnaz] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shahidi, M (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA.	mahnshah@uic.edu			NIH [DK104393, EY001792]; Department of VA; Senior Scientific Investigator; unrestricted departmental awards from Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY001792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK104393] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of VA; Senior Scientific Investigator; unrestricted departmental awards from Research to Prevent Blindness; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH research grants DK104393 and EY001792, Department of VA, Senior Scientific Investigator (MS) and unrestricted departmental awards from Research to Prevent Blindness. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Adhi M, 2013, CURR OPIN OPHTHALMOL, V24, P213, DOI 10.1097/ICU.0b013e32835f8bf8; Alasil T, 2010, OPHTHALMOLOGY, V117, P2379, DOI 10.1016/j.ophtha.2010.03.051; Alkabes M, 2011, INVEST OPHTH VIS SCI, V52, P8349, DOI 10.1167/iovs.11-8043; Baba T, 2008, RETINA-J RET VIT DIS, V28, P453, DOI 10.1097/IAE.0b013e3181571398; Biedermann BR, 2008, OPT LETT, V33, P2556, DOI 10.1364/OL.33.002556; Brown DM, 2013, OPHTHALMOLOGY, V120, P2013, DOI 10.1016/j.ophtha.2013.02.034; Chiu SJ, 2015, BIOMED OPT EXPRESS, V6, P1172, DOI 10.1364/BOE.6.001172; Chiu SJ, 2012, BIOMED OPT EXPRESS, V3, P1127, DOI 10.1364/BOE.3.001127; Chiu SJ, 2010, OPT EXPRESS, V18, P19413, DOI 10.1364/OE.18.019413; Clamp MF, 2014, RETINA-J RET VIT DIS, V34, P1360, DOI 10.1097/IAE.0000000000000115; Cucu RG, 2006, OPT LETT, V31, P1684, DOI 10.1364/OL.31.001684; Elman MJ, 2015, OPHTHALMOLOGY, V122, P375, DOI 10.1016/j.ophtha.2014.08.047; Esmaeelpour M, 2012, INVEST OPHTH VIS SCI, V53, P6803, DOI 10.1167/iovs.12-10314; Esmaeelpour M, 2011, INVEST OPHTH VIS SCI, V52, P5311, DOI 10.1167/iovs.10-6875; Ferrara D, 2014, OPHTHALMOLOGY, V121, P719, DOI 10.1016/j.ophtha.2013.10.014; Fong DS, 2007, RETINA-J RET VIT DIS, V27, P816, DOI 10.1097/IAE.0b013e318042d32c; Forooghian F, 2010, RETINA-J RET VIT DIS, V30, P63, DOI 10.1097/IAE.0b013e3181bd2c5a; Forte R, 2007, EYE, V21, P436, DOI 10.1038/sj.eye.6702598; Forte R, 2007, EYE, V21, P111, DOI 10.1038/sj.eye.6702418; Garvin MK, 2009, IEEE T MED IMAGING, V28, P1436, DOI 10.1109/TMI.2009.2016958; Helmy YM, 2013, CLIN OPHTHALMOL, V7, P1731, DOI 10.2147/OPTH.S47987; Hood DC, 2011, INVEST OPHTH VIS SCI, V52, P9703, DOI 10.1167/iovs.11-8650; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huang YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082922; Jampol LM, 2015, JAMA OPHTHALMOL, V133, P983, DOI 10.1001/jamaophthalmol.2015.1880; Kim BY, 2006, AM J OPHTHALMOL, V142, P405, DOI 10.1016/j.ajo.2006.04.023; Kitaya N, 2004, AM J OPHTHALMOL, V138, P308, DOI 10.1016/j.ajo.2004.03.004; Lee JY, 2013, INVEST OPHTH VIS SCI, V54, P7595, DOI 10.1167/iovs.13-11762; Lim JI, 2015, OSLI RETINA, V46, P316, DOI 10.3928/23258160-20150323-03; Lim LT, 2015, SINGAP MED J, V56, P237, DOI 10.11622/smedj.2015071; Maheshwary AS, 2010, AM J OPHTHALMOL, V150, P63, DOI 10.1016/j.ajo.2010.01.039; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Mohammad F, 2015, BIOMED OPT EXPRESS, V6, P1904, DOI 10.1364/BOE.6.001904; Murakami T, 2012, INVEST OPHTH VIS SCI, V53, P1506, DOI 10.1167/iovs.11-9231; Murakami T, 2011, AM J OPHTHALMOL, V151, P310, DOI 10.1016/j.ajo.2010.08.022; Otani T, 1999, AM J OPHTHALMOL, V127, P688, DOI 10.1016/S0002-9394(99)00033-1; Otani T, 2010, RETINA-J RET VIT DIS, V30, P774, DOI 10.1097/IAE.0b013e3181c2e0d6; Puche N, 2014, GRAEF ARCH CLIN EXP, V252, P555, DOI 10.1007/s00417-013-2493-2; Quan DN, 2010, OPHTHALMOLOGY, V117, P2146, DOI 10.1016/j.ophtha.2010.08.016; Rajendram R, 2012, ARCH OPHTHALMOL-CHIC, V130, P972, DOI 10.1001/archophthalmol.2012.393; Regatieri CV, 2012, RETINA-J RET VIT DIS, V32, P563, DOI [10.1097/IAE.0B013E31822F5678, 10.1097/IAE.0b013e31822f5678]; Regatieri CV, 2012, RETINA-J RET VIT DIS, V32, P865, DOI 10.1097/IAE.0b013e318251a3a8; Reznicek L, 2014, SAUDI J OPHTHALMOL, V28, P134, DOI 10.1016/j.sjopt.2014.03.009; Rispoli M, 2012, RETINA-J RET VIT DIS, V32, P2070, DOI 10.1097/IAE.0b013e3182562076; Rosen RB, 2009, OPT EXPRESS, V17, P4112, DOI 10.1364/OE.17.004112; Sakamoto A, 2009, GRAEF ARCH CLIN EXP, V247, P1325, DOI 10.1007/s00417-009-1107-5; Sallo FB, 2012, INVEST OPHTH VIS SCI, V53, P6145, DOI 10.1167/iovs.12-10580; Shimura M, 2003, OPHTHALMOLOGY, V110, P2386, DOI 10.1016/j.ophtha.2003.05.008; Shin HJ, 2012, GRAEF ARCH CLIN EXP, V250, P61, DOI 10.1007/s00417-011-1774-x; Sikorski BL, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/434560; Sim DA, 2014, INVEST OPHTH VIS SCI, V55, P417, DOI 10.1167/iovs.13-12677; Sonoda S, 2013, INVEST OPHTH VIS SCI, V54, P5367, DOI 10.1167/iovs.13-12382; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; van Velthoven MEJ, 2005, BRIT J OPHTHALMOL, V89, P1483, DOI 10.1136/bjo.2005.073056; Van Velthoven MEJ, 2006, RETINA-J RET VIT DIS, V26, P129, DOI 10.1097/00006982-200602000-00001; Vermeer KA, 2011, BIOMED OPT EXPRESS, V2, P1743, DOI 10.1364/BOE.2.001743; Wanek J, 2011, AM J OPHTHALMOL, V152, P807, DOI 10.1016/j.ajo.2011.04.027; Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264; Wong IY, 2012, CURR OPIN OPHTHALMOL, V23, P210, DOI 10.1097/ICU.0b013e3283524162; Yamauchi Y, 2011, CLIN OPHTHALMOL, V5, P1649, DOI 10.2147/OPTH.S26661	61	10	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145628	10.1371/journal.pone.0145628	http://dx.doi.org/10.1371/journal.pone.0145628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699878	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600109
J	Kim, KH; Hwang, JH; Han, DY; Park, M; Kim, S; Choi, D; Kim, Y; Lee, GP; Kim, ST; Park, YH				Kim, Kwang-Hwan; Hwang, Ji-Hyun; Han, Dong-Yeup; Park, Minkyu; Kim, Seungill; Choi, Doil; Kim, Yongjae; Lee, Gung Pyo; Kim, Sun-Tae; Park, Young-Hoon			Major Quantitative Trait Loci and Putative Candidate Genes for Powdery Mildew Resistance and Fruit-Related Traits Revealed by an Intraspecific Genetic Map for Watermelon (Citrullus lanatus var. lanatus)	PLOS ONE			English	Article							LINKAGE MAP; GENOME; DIVERSITY; L.; TOMATO; MELON; SUN; RECOMBINATION; COLOCYNTHIS; INHERITANCE	An intraspecific genetic map for watermelon was constructed using an F-2 population derived from 'Arka Manik' x 'TS34' and transcript sequence variants and quantitative trait loci (QTL) for resistance to powdery mildew (PMR), seed size (SS), and fruit shape (FS) were analyzed. The map consists of 14 linkage groups (LGs) defined by 174 cleaved amplified polymorphic sequences (CAPS), 2 derived-cleaved amplified polymorphic sequence markers, 20 sequence-characterized amplified regions, and 8 expressed sequence tag-simple sequence repeat markers spanning 1,404.3 cM, with a mean marker interval of 6.9 cM and an average of 14.6 markers per LG. Genetic inheritance and QTL analyses indicated that each of the PMR, SS, and FS traits is controlled by an incompletely dominant effect of major QTLs designated as pmr2.1, ss2.1, and fsi3.1, respectively. The pmr2.1, detected on chromosome 2 (Chr02), explained 80.0% of the phenotypic variation (LOD = 30.76). This QTL was flanked by two CAPS markers, wsb2-24 (4.00 cM) and wsb2-39 (13.97 cM). The ss2.1, located close to pmr2.1 and CAPS marker wsb2-13 (1.00 cM) on Chr02, explained 92.3% of the phenotypic variation (LOD = 68.78). The fsi3.1, detected on Chr03, explained 79.7% of the phenotypic variation (LOD = 31.37) and was flanked by two CAPS, wsb3-24 (1.91 cM) and wsb3-9 (7.00 cM). Candidate gene-based CAPS markers were developed from the disease resistance and fruit shape gene homologs located on Chr.02 and Chr03 and were mapped on the intraspecific map. Colocalization of these markers with the major QTLs indicated that watermelon orthologs of a nucleotide-binding site-leucine-rich repeat class gene containing an RPW8 domain and a member of SUN containing the IQ67 domain are candidate genes for pmr2.1 and fsi3.1, respectively. The results presented herein provide useful information for marker-assisted breeding and gene cloning for PMR and fruit-related traits.	[Kim, Kwang-Hwan; Hwang, Ji-Hyun; Han, Dong-Yeup; Park, Young-Hoon] Pusan Natl Univ, Dept Hort Biosci, Miryang, South Korea; [Park, Minkyu; Kim, Seungill; Choi, Doil] Seoul Natl Univ, Dept Plant Sci, Seoul, South Korea; [Park, Minkyu] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Kim, Yongjae] Partner Seed, Ansung, South Korea; [Lee, Gung Pyo] Chung Ang Univ, Dept Integrat Plant Sci, Coll Biotechnol & Nat Resources, Ansung, South Korea; [Kim, Sun-Tae] Pusan Natl Univ, Dept Plant Biosci, Miryang, South Korea; [Park, Young-Hoon] Pusan Natl Univ, Life & Ind Convergence Res Inst, Miryang, South Korea	Pusan National University; Seoul National University (SNU); University System of Georgia; University of Georgia; Chung Ang University; Pusan National University; Pusan National University	Park, YH (corresponding author), Pusan Natl Univ, Dept Hort Biosci, Miryang, South Korea.	ypark@pusan.ac.kr	Choi, Doil/F-5002-2011; Kim, Seungill/AAR-1099-2021	Kim, Seungill/0000-0001-6287-8693; Kim, Sun Tae/0000-0002-3853-1419; gim, seontae/0000-0001-9705-6868	Ministry of Agriculture, Food and Rural Affairs (MAFRA), Korea; Vegetable Breeding Research Center [710001-07-5]; Golden Seed Project, MAFRA [213002-04-1-SBR20]; Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA); Korea Forest Service (KFS); Vegetable Breeding Research Center through Agriculture, Food and Rural Affairs Research Center Support Program, Ministry of Agriculture, Food and Rural Affairs (MAFRA), Korea [710001-07-5]	Ministry of Agriculture, Food and Rural Affairs (MAFRA), Korea; Vegetable Breeding Research Center; Golden Seed Project, MAFRA; Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); Korea Forest Service (KFS); Vegetable Breeding Research Center through Agriculture, Food and Rural Affairs Research Center Support Program, Ministry of Agriculture, Food and Rural Affairs (MAFRA), Korea	This research was fully funded by the Ministry of Agriculture, Food and Rural Affairs (MAFRA), Korea, by a grant (710001-07-5) from the Vegetable Breeding Research Center. Further, this research was supported by the Golden Seed Project (213002-04-1-SBR20), MAFRA, the Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA), and Korea Forest Service (KFS). The funders provided in the form of salaries for authors (KHK, JHH, and DYH), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. A commercial affiliation, "Partner Seed" (affiliated author: Yongjae Kim) did not provide financial support, but played a role in the study design and data collection by field evaluation of the F2 population. Phenotyping of the F2 population was conducted by Yongjae Kim (the owner of "Partner Seed") at the breeding field owned by Partner Seed Company which collaborated for this study.; This work was supported by a grant (710001-07-5) from the Vegetable Breeding Research Center through Agriculture, Food and Rural Affairs Research Center Support Program, Ministry of Agriculture, Food and Rural Affairs (MAFRA), Korea. Further, this research was supported by the Golden Seed Project (213002-04-1-SBR20), MAFRA, the Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA), and Korea Forest Service (KFS).	Brotman Y, 2002, THEOR APPL GENET, V104, P1055, DOI 10.1007/s00122-001-0808-x; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Davis AR, 2007, J AM SOC HORTIC SCI, V132, P790, DOI 10.21273/JASHS.132.6.790; Gowda BS, 2002, EUPHYTICA, V126, P365, DOI 10.1023/A:1019956208240; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Huang ZJ, 2013, MOL GENET GENOMICS, V288, P111, DOI 10.1007/s00438-013-0733-0; Hwang JH, 2011, SCI HORTIC-AMSTERDAM, V130, P715, DOI 10.1016/j.scienta.2011.08.014; Hwang J, 2014, MOL BREEDING, V34, P949, DOI 10.1007/s11032-014-0088-1; Jae HJ, 2009, KOREAN J HORTIC SCI, V27, P448; JEFFREY C, 1975, Kew Bulletin, V30, P475, DOI 10.2307/4103075; Kim KH, 2013, HORTIC ENVIRON BIOTE, V54, P134, DOI 10.1007/s13580-013-0156-1; Kim S, 2015, DNA RES, V22, P19, DOI 10.1093/dnares/dsu035; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Kim YongJae, 2009, Korean Journal of Breeding Science, V41, P412; Kim YongJae, 2009, Korean Journal of Breeding Science, V41, P403; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee WM, 2010, KOR J HORT SCI TE S2, V28, P73; Levi A, 2006, J AM SOC HORTIC SCI, V131, P393, DOI 10.21273/JASHS.131.3.393; Levi A, 2002, THEOR APPL GENET, V105, P555, DOI [10.1007/s00122-001-0860-6, 10.1007/S00122-001-0860-6]; Levi A, 2001, GENET RESOUR CROP EV, V48, P559, DOI 10.1023/A:1013888418442; Levi A, 2001, HORTSCIENCE, V36, P1096, DOI 10.21273/HORTSCI.36.6.1096; Levi A, 2012, GENETICS GENOMICS BR, P309; McGrath MT, 1996, COMPENDIUM CUCURBIT, P28; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Monforte AJ, 2014, J EXP BOT, V65, P4625, DOI 10.1093/jxb/eru017; Moose SP, 2008, PLANT PHYSIOL, V147, P969, DOI 10.1104/pp.108.118232; Park Y, 2012, ISR J PLANT SCI, V60, P415, DOI 10.1560/IJPS.60.4.415; Poole CF, 1941, J AGRIC RES, V63, P0433; Poole CF, 1944, J HERED, V89, P50; Prothro J, 2012, J AM SOC HORTIC SCI, V137, P452, DOI 10.21273/JASHS.137.6.452; Reddy UK, 2014, G3-GENES GENOM GENET, V4, P2219, DOI 10.1534/g3.114.012815; Ren Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-33; Ren Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029453; Rodriguez GR, 2011, PLANT PHYSIOL, V156, P275, DOI 10.1104/pp.110.167577; Sandlin K, 2012, THEOR APPL GENET, V125, P1603, DOI 10.1007/s00122-012-1938-z; Tetteh AY, 2010, CROP SCI, V50, P933, DOI 10.2135/cropsci2009.03.0135; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Wehner TC, 2003, CUCURBIT GENET COOP, V26, P76; Wei FS, 1999, GENETICS, V153, P1929; Whitaker T. W., 1976, Evolution of crop plants., P64; Whitaker T.W., 1962, CUCURBITS BOT CULTIV; Wu S, 2011, PLANT PHYSIOL, V157, P1175, DOI 10.1104/pp.111.181065; Xiao SY, 2003, PLANT CELL, V15, P33, DOI 10.1105/tpc.006940; Xiao SY, 2001, SCIENCE, V291, P118, DOI 10.1126/science.291.5501.118; Yahiaoui N, 2004, PLANT J, V37, P528, DOI 10.1046/j.1365-313X.2003.01977.x; Yuste-Lisbona FJ, 2011, THEOR APPL GENET, V122, P747, DOI 10.1007/s00122-010-1483-6	49	34	42	9	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145665	10.1371/journal.pone.0145665	http://dx.doi.org/10.1371/journal.pone.0145665			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700647	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092600114
J	Steven, R; Morrison, C; Arthur, JM; Castley, JG				Steven, Rochelle; Morrison, Clare; Arthur, J. Michael; Castley, J. Guy			Avitourism and Australian Important Bird and Biodiversity Areas	PLOS ONE			English	Article							PROTECTED AREAS; TOURISM; AFRICA; CONSERVATION; ECOTOURISM; IMPACTS; SYSTEM	Formal protected areas will not provide adequate protection to conserve all biodiversity, and are not always designated using systematic or strategic criteria. Using a systematic process, the Important Bird and Biodiversity Area (IBA) network was designed to highlight areas of conservation significance for birds (i.e. IBA trigger species), and more recently general biodiversity. Land use activities that take place in IBAs are diverse, including consumptive and non-consumptive activities. Avitourism in Australia, generally a non-consumptive activity, is reliant on the IBA network and the birds IBAs aim to protect. However, companies tend not to mention IBAs in their marketing. Furthermore, avitourism, like other nature-based tourism has the potential to be both a threatening process as well as a conservation tool. We aimed to assess the current use of IBAs among Australian-based avitour companies' marketing, giving some indication of which IBAs are visited by avitourists on organised tours. We reviewed online avitour itineraries, recorded sites featuring in descriptions of avitours and which IBA trigger species are used to sell those tours. Of the 209 avitours reviewed, Queensland is the most featured state (n = 59 tours), and 73% feature at least one IBA. Daintree (n = 22) and Bruny Island (n = 17) IBAs are the most popular, nationally. Trigger species represent 34% (n = 254 out of 747) of species used in avitour descriptions. The most popular trigger species' are wetland species including; Brolga (n = 37), Black-necked Stork (n = 30) and Magpie Goose (n = 27). Opportunities exist to increase collaboration between avitour companies and IBA stakeholders. Our results can provide guidance for managing sustainability of the avitourism industry at sites that feature heavily in avitour descriptions and enhance potential cooperation between avitour companies, IBA stakeholders and bird conservation organisations.	[Steven, Rochelle; Castley, J. Guy] Griffith Univ, Griffith Sch Environm, Environm Futures Res Inst, Gold Coast, Qld 4222, Australia; [Morrison, Clare] Griffith Univ, Griffith Sch Environm, Gold Coast, Qld 4222, Australia; [Arthur, J. Michael] Griffith Univ, Griffith Sch Environm, Australian Rivers Inst, Gold Coast, Qld 4222, Australia	Griffith University; Griffith University; Griffith University	Steven, R (corresponding author), Griffith Univ, Griffith Sch Environm, Environm Futures Res Inst, Gold Coast Campus, Gold Coast, Qld 4222, Australia.	rochelle.steven@griffithuni.edu.au	Steven, Rochelle/AAD-5898-2020; Castley, James Guy/A-7056-2010; Arthur, James Michael/C-3502-2008	Castley, James Guy/0000-0002-8418-5828; Arthur, James Michael/0000-0003-4540-4511; Steven, Rochelle/0000-0002-3474-6818				[Anonymous], 2006, SUSTAINABLE FINANCIN; Arinaitwe JA, 2007, OSTRICH, V78, P139, DOI 10.2989/OSTRICH.2007.78.2.5.85; Ballantyne R, 2007, ENVIRON EDUC RES, V13, P367, DOI DOI 10.1080/13504620701430604; Bennun L, 2005, BIODIVERS CONSERV, V14, P2575, DOI 10.1007/s10531-005-8389-7; Beresford AE, 2011, ANIM CONSERV, V14, P99, DOI 10.1111/j.1469-1795.2010.00398.x; Biggs D., 2011, Conservation and Society, V9, P80, DOI 10.4103/0972-4923.79198; BirdLife International, 2013, IMP BIRD BIOD AR DAN; BirdLife International, 2014, IMP BIRD BIOD AR IBA; BirdLife International, 2007, IBA TOOLB STRA UNPUB; BirdLife International BirdLife International Data Zone, 2014, GLOB IBA CRIT; Bireline HR, 2005, THESIS; Brooks TM, 2004, BIOSCIENCE, V54, P1081, DOI 10.1641/0006-3568(2004)054[1081:CPBTGP]2.0.CO;2; Buchanan GM, 2009, BIRD CONSERV INT, V19, P49, DOI 10.1017/S0959270908007697; Buckley R, 2012, ANN TOURISM RES, V39, P528, DOI 10.1016/j.annals.2012.02.003; Butchart SHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032529; Castley JG, 2013, GEOGR RES-AUST, V51, P59, DOI 10.1111/j.1745-5871.2012.00767.x; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Choi S, 2007, TOURISM MANAGE, V28, P118, DOI 10.1016/j.tourman.2006.03.002; Dharmaratne GS, 2000, ANN TOURISM RES, V27, P590, DOI 10.1016/S0160-7383(99)00109-7; DTI (The Department of Trade and Industry), 2010, AV S AFR; Dutson G, 2009, AUSTRALIAS IMPORTANT; Gallo JA, 2009, BIOL CONSERV, V142, P446, DOI 10.1016/j.biocon.2008.10.025; Goodwin H, 1996, BIODIVERS CONSERV, V5, P277, DOI 10.1007/BF00051774; Green R., 2010, PRACTICES NEEDS ATTI; Hodur NM, 2004, CHARACTERISTICS EXPE; Hvenegaard GT, 1998, ANN TOURISM RES, V25, P700, DOI 10.1016/S0160-7383(98)00020-6; Jones D. N., 2005, IMPACTS BIRD WATCHIN; Jones D.N., 2001, BIRDWATCHING TOURISM; Li F, 2013, TOURISM ECON, V19, P257, DOI 10.5367/te.2013.0201; Lyons K., 2009, M BEST EN THINK TANK; McLeod EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082008; Mwangi MAK, 2010, BIRD CONSERV INT, V20, P215, DOI 10.1017/S0959270910000456; Pasquini L, 2011, ORYX, V45, P373, DOI 10.1017/S0030605310000876; Puhakka L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026786; Rodger K., 2007, Journal of Sustainable Tourism, V15, P160, DOI 10.2167/jost619.0; Sekercioglu CH, 2002, ENVIRON CONSERV, V29, P282, DOI 10.1017/S0376892902000206; Simango S. S, 2011, THESIS; Steven R, 2015, J SUSTAIN TOUR, V23, P1257, DOI 10.1080/09669582.2014.924955; Steven R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062598; Steven R, 2013, BIODIVERS CONSERV, V22, P1063, DOI 10.1007/s10531-013-0470-z; Steven R, 2011, J ENVIRON MANAGE, V92, P2287, DOI 10.1016/j.jenvman.2011.05.005; Stoll JR, 1999, AVITOURISM TEXAS 2 S; Trainor C. R., 2008, BIRDING ASIA, V9, P16; Welford M, 2013, J NAT CONSERV, V21, P401, DOI 10.1016/j.jnc.2013.05.002; Weston MA, 2012, EMU, V112, P269, DOI 10.1071/MU12026; Willemen L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129785	46	7	9	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144445	10.1371/journal.pone.0144445	http://dx.doi.org/10.1371/journal.pone.0144445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26701779	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600019
J	Ahn, JK; Kim, S; Hwang, J; Kim, J; Lee, YS; Koh, EM; Kim, KH; Cha, HS				Ahn, Joong Kyong; Kim, Sooah; Hwang, Jiwon; Kim, Jungyeon; Lee, You Sun; Koh, Eun-Mi; Kim, Kyoung Heon; Cha, Hoon-Suk			Metabolomic Elucidation of the Effects of Curcumin on Fibroblast-Like Synoviocytes in Rheumatoid Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; CELLS; INHIBITION; DISEASES; LONGA	Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by synovial inflammation and joint disability. Curcumin is known to be effective in ameliorating joint inflammation in RA. To obtain new insights into the effect of curcumin on primary fibroblast-like synoviocytes (FLS, N = 3), which are key effector cells in RA, we employed gas chromatography/time-of-flight mass spectrometry (GC/TOF-MS)-based metabolomics. Metabolomic profiling of tumor necrosis factor (TNF)-alpha-stimulated and curcumin-treated FLS was performed using GC/TOF-MS in conjunction with univariate and multivariate statistical analyses. A total of 119 metabolites were identified. Metabolomic analysis revealed that metabolite profiles were clearly distinct between TNF-alpha-stimulated vs. the control group (not stimulated by TNF-alpha or curcumin). Treatment of FLS with curcumin showed that the metabolic perturbation by TNF-alpha could be reversed to that of the control group to a considerable extent. Curcumin-treated FLS had higher restoration of amino acid and fatty acid metabolism, as indicated by the prominent metabolic restoration of intermediates of amino acid and fatty acid metabolism, compared with that observed in TNF-alpha-stimulated FLS. In particular, the abundance of glycine, citrulline, arachidonic acid, and saturated fatty acids in TNF-alpha-stimulated FLS was restored to the control level after treatment with curcumin, suggesting that the effect of curcumin on preventing joint inflammation may be elucidated with the levels of these metabolites. Our results suggest that GC/TOF-MS-based metabolomic investigation using FLS has the potential for discovering the mechanism of action of curcumin and new targets for therapeutic drugs in RA.	[Ahn, Joong Kyong] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med,Div Rheumatol, Seoul, South Korea; [Kim, Sooah; Kim, Jungyeon; Kim, Kyoung Heon] Korea Univ, Grad Sch, Dept Biotechnol, Seoul, South Korea; [Hwang, Jiwon] Natl Police Hosp, Dept Internal Med, Seoul, South Korea; [Lee, You Sun] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Internal Med,Div Rheumatol, Chang Won, South Korea; [Koh, Eun-Mi; Cha, Hoon-Suk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Rheumatol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Korea University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, KH (corresponding author), Korea Univ, Grad Sch, Dept Biotechnol, Seoul, South Korea.	khekim@korea.ac.kr; hoonsuk.cha@samsung.com	Kim, Kyoung Heon/F-1059-2013	Kim, Kyoung Heon/0000-0003-4600-8668	Advanced Biomass R&D Center of Korea [2011-0031353]; National Research Foundation of Korea - Ministry of Education [NRF-2013R1A1A2059103]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare - Korean Government [HI14C2285]	Advanced Biomass R&D Center of Korea; National Research Foundation of Korea - Ministry of Education; Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare - Korean Government	This work was supported by the Advanced Biomass R&D Center of Korea (http://www.biomass.re.kr/en, 2011-0031353) to KHK, the National Research Foundation of Korea funded by the Ministry of Education (http://www.nrf.re.kr/nrf_eng_cmsf/, NRF-2013R1A1A2059103) to HSC, and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare (http://www.khidi.or.kr/kps, HI14C2285) to HSC, which are funded by the Korean Government. Experiments were performed using facilities of the Institute of Biomedical Science and Food Safety at the Korea University Food Safety Hall.	AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Bayet-Robert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057971; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Bullinger Dino, 2007, BMC Biochemistry, V8, P25, DOI 10.1186/1471-2091-8-25; Cao H, 2014, PHYTOTHER RES; Chen XP, 2009, CELL BIOCHEM FUNCT, V27, P407, DOI 10.1002/cbf.1596; Cuperlovic-Culf M, 2010, DRUG DISCOV TODAY, V15, P610, DOI 10.1016/j.drudis.2010.06.012; D'Alessandro A, 2013, EXPERT REV PROTEOMIC, V10, P473, DOI 10.1586/14789450.2013.840440; Frommer KW, 2015, ANN RHEUM DIS, V74, P303, DOI 10.1136/annrheumdis-2013-203755; Funk JL, 2006, J NAT PROD, V69, P351, DOI 10.1021/np050327j; Gallois C, 1998, J BIOL CHEM, V273, P23183, DOI 10.1074/jbc.273.36.23183; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Gupta SC, 2014, ARCH BIOCHEM BIOPHYS, V559, P91, DOI 10.1016/j.abb.2014.06.006; Iqbal M, 2009, MOL CELL BIOCHEM, V324, P157, DOI 10.1007/s11010-008-9994-z; Jurenka JS, 2009, ALTERN MED REV, V14, P141; Kim HY, 2003, J IMMUNOL, V171, P6072, DOI 10.4049/jimmunol.171.11.6072; Kim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097501; Kim S, 2013, ANAL CHEM, V85, P2169, DOI 10.1021/ac302881e; Kloesch B, 2013, INT IMMUNOPHARMACOL, V15, P400, DOI 10.1016/j.intimp.2013.01.003; Lee DY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-7; Ling S, 2013, ARTHRITIS RHEUM-US, V65, P618, DOI 10.1002/art.37814; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Moon DO, 2010, INT IMMUNOPHARMACOL, V10, P605, DOI 10.1016/j.intimp.2010.02.011; Mun SH, 2009, J PHARMACOL SCI, V111, P13, DOI 10.1254/jphs.09134FP; Noguchi Y, 2011, MOL BIOSYST, V7, P1409, DOI 10.1039/c0mb00309c; Punithavathi D, 2000, BRIT J PHARMACOL, V131, P169, DOI 10.1038/sj.bjp.0703578; Rausch-Fan XH, 2005, J PERIODONTOL, V76, P1182, DOI 10.1902/jop.2005.76.7.1182; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sandur SK, 2007, FREE RADICAL BIO MED, V43, P568, DOI 10.1016/j.freeradbiomed.2007.05.009; Shehzad A, 2013, BIOFACTORS, V39, P69, DOI 10.1002/biof.1066; Surh YJ, 2007, ADV EXP MED BIOL, V595, P149; Visioli F, 2011, CRIT REV FOOD SCI, V51, P524, DOI 10.1080/10408391003698677; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356	36	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145539	10.1371/journal.pone.0145539	http://dx.doi.org/10.1371/journal.pone.0145539			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716989	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500042
J	Gerage, AM; Benedetti, TRB; Farah, BQ; Santana, FD; Ohara, D; Andersen, LB; Ritti-Dias, RM				Gerage, Aline M.; Benedetti, Tania R. B.; Farah, Breno Q.; Santana, Fabio da S.; Ohara, David; Andersen, Lars B.; Ritti-Dias, Raphael M.			Sedentary Behavior and Light Physical Activity Are Associated with Brachial and Central Blood Pressure in Hypertensive Patients	PLOS ONE			English	Article							ARTERIAL STIFFNESS; METABOLIC SYNDROME; LIFE-STYLE; EXERCISE; TIME; OBESITY; ADULTS; RISK; METAANALYSIS; MORTALITY	Background Physical activity is recommended as a part of a comprehensive lifestyle approach in the treatment of hypertension, but there is a lack of data about the relationship between different intensities of physical activity and cardiovascular parameters in hypertensive patients. The purpose of this study was to investigate the association between the time spent in physical activities of different intensities and blood pressure levels, arterial stiffness and autonomic modulation in hypertensive patients. Methods In this cross-sectional study, 87 hypertensive patients (57.5 +/- 9.9 years of age) had their physical activity assessed over a 7 day period using an accelerometer and the time spent in sedentary activities, light physical activities, moderate physical activities and moderate-to-vigorous physical activities was obtained. The primary outcomes were brachial and central blood pressure. Arterial stiffness parameters (augmentation index and pulse wave velocity) and cardiac autonomic modulation (sympathetic and parasympathetic modulation in the heart) were also obtained as secondary outcomes. Results Sedentary activities and light physical activities were positively and inversely associated, respectively, with brachial systolic (r = 0.56; P < 0.01), central systolic (r = 0.51; P < 0.05), brachial diastolic (r = 0.45; P < 0.01) and central diastolic (r = 0.42; P < 0.05) blood pressures, after adjustment for sex, age, trunk fat, number of antihypertensive drugs, accelerometer wear time and moderate-to-vigorous physical activities. Arterial stiffness parameters and cardiac autonomic modulation were not associated with the time spent in sedentary activities and in light physical activities (P > 0.05). Conclusion Lower time spent in sedentary activities and higher time spent in light physical activities are associated with lower blood pressure, without affecting arterial stiffness and cardiac autonomic modulation in hypertensive patients.	[Gerage, Aline M.; Benedetti, Tania R. B.] Univ Fed Santa Catarina, Dept Phys Educ, Florianopolis, SC, Brazil; [Farah, Breno Q.; Santana, Fabio da S.] Univ Fed Pernambuco, Super Sch Phys Educ, Recife, PE, Brazil; [Ohara, David] Univ Estadual Londrina, Metab Nutr & Exercise Res Grp, Londrina, Parana, Brazil; [Andersen, Lars B.] Univ Southern Denmark, Dept Exercise Sci & Clin Biomech, Odense, Denmark; [Andersen, Lars B.] Sogn & Fjordane Univ Coll, Sogndal, Norway; [Ritti-Dias, Raphael M.] Hosp Israelita Albert Einstein, Sao Paulo, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Pernambuco; Universidade Estadual de Londrina; University of Southern Denmark; Western Norway University of Applied Sciences; Hospital Israelita Albert Einstein	Gerage, AM (corresponding author), Univ Fed Santa Catarina, Dept Phys Educ, Florianopolis, SC, Brazil.	alinegerage@yahoo.com.br	Farah, Breno Quintella/GSD-8036-2022; Farah, Breno Quintella/O-8933-2017; Gerage, Aline M/G-8545-2016; Ritti-Dias, Raphael/G-4200-2013; Gerage, Aline/GVU-1502-2022; Stefanadis, Christodoulos/ABH-2232-2020; Ohara, David/R-8296-2017; Ohara, David/GQY-8039-2022	Farah, Breno Quintella/0000-0003-2286-5892; Farah, Breno Quintella/0000-0003-2286-5892; Gerage, Aline M/0000-0002-0555-5422; Ritti-Dias, Raphael/0000-0001-7883-6746; Stefanadis, Christodoulos/0000-0001-5974-6454; Ohara, David/0000-0003-0477-8234; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	AMG was supported by a grant (PhD scholarship) from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and RMRD from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (grant productivity).	Andersson C, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001528; Ashor AW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110034; Camm AJ, 1996, CIRCULATION, V93, P1043; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Ciolac EG, 2010, HYPERTENS RES, V33, P836, DOI 10.1038/hr.2010.72; Cornelissen VA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004473; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; Ellis KJ, 2000, PHYSIOL REV, V80, P649, DOI 10.1152/physrev.2000.80.2.649; Fitzgerald JD, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001288; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gando Y, 2010, HYPERTENSION, V56, P540, DOI 10.1161/HYPERTENSIONAHA.110.156331; Gomez-Marcos MA, 2014, ATHEROSCLEROSIS, V234, P366, DOI 10.1016/j.atherosclerosis.2014.02.028; Green AN, 2014, EUR J APPL PHYSIOL, V114, P907, DOI 10.1007/s00421-014-2822-0; Hall ME, 2014, INT J NEPHROL RENOV, V7, P75, DOI 10.2147/IJNRD.S39739; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Heffernan KS, 2013, HYPERTENS RES, V36, P422, DOI 10.1038/hr.2012.198; Horta BL, 2015, ATHEROSCLEROSIS, V243, P148, DOI 10.1016/j.atherosclerosis.2015.09.005; Joyner MJ, 2014, EUR J APPL PHYSIOL, V114, P445, DOI 10.1007/s00421-013-2636-5; Kawamoto R, 2014, HYPERTENS RES, V37, P933, DOI 10.1038/hr.2014.108; Kim J, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-30; Koster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037696; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Luke A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-387; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Manisty CH, 2013, BRIT J CLIN PHARMACO, V75, P79, DOI 10.1111/j.1365-2125.2012.04342.x; Munk PS, 2010, INT J CARDIOL, V145, P312, DOI 10.1016/j.ijcard.2009.11.015; O'Donovan C, 2014, J PHYS ACT HEALTH, V11, P272, DOI 10.1123/jpah.2012-0075; Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Trudeau L, 2014, CAN J CARDIOL, V30, pS23, DOI 10.1016/j.cjca.2014.03.010; Van Bortel LM, 2002, AM J HYPERTENS, V15, P445, DOI 10.1016/S0895-7061(01)02326-3; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496	36	32	34	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146078	10.1371/journal.pone.0146078	http://dx.doi.org/10.1371/journal.pone.0146078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717310	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500132
J	Grealy, R; Herruer, J; Smith, CLE; Hiller, D; Haseler, LJ; Griffiths, LR				Grealy, Rebecca; Herruer, Jasper; Smith, Carl L. E.; Hiller, Doug; Haseler, Luke J.; Griffiths, Lyn R.			Evaluation of a 7-Gene Genetic Profile for Athletic Endurance Phenotype in Ironman Championship Triathletes	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING-ENZYME; CREATINE-KINASE; WORLD-CLASS; HEREDITARY HEMOCHROMATOSIS; MITOCHONDRIAL BIOGENESIS; SPORTS PERFORMANCE; ACTN3 R577X; GENOTYPE; MUTATION; POLYMORPHISM	Polygenic profiling has been proposed for elite endurance performance, using an additive model determining the proportion of optimal alleles in endurance athletes. To investigate this model's utility for elite triathletes, we genotyped seven polymorphisms previously associated with an endurance polygenic profile (ACE Ins/Del, ACTN3 Arg577Ter, AMPD1 Gln12Ter, CKMM 1170bp/985+185bp, HFE His63Asp, GDF8 Lys153Arg and PPARGC1A Gly482Ser) in a cohort of 196 elite athletes who participated in the 2008 Kona Ironman championship triathlon. Mean performance time (PT) was not significantly different in individual marker analysis. Age, sex, and continent of origin had a significant influence on PT and were adjusted for. Only the AMPD1 endurance-optimal Gln allele was found to be significantly associated with an improvement in PT (model p = 5.79 x 10(-17), AMPD1 genotype p = 0.01). Individual genotypes were combined into a total genotype score (TGS); TGS distribution ranged from 28.6 to 92.9, concordant with prior studies in endurance athletes (mean +/- SD: 60.75 +/- 12.95). TGS distribution was shifted toward higher TGS in the top 10% of athletes, though the mean TGS was not significantly different (p = 0.164) and not significantly associated with PT even when adjusted for age, sex, and origin. Receiver operating characteristic curve analysis determined that TGS alone could not significantly predict athlete finishing time with discriminating sensitivity and specificity for three outcomes (less than median PT, less than mean PT, or in the top 10%), though models with the age, sex, continent of origin, and either TGS or AMPD1 genotype could. These results suggest three things: that more sophisticated genetic models may be necessary to accurately predict athlete finishing time in endurance events; that non-genetic factors such as training are hugely influential and should be included in genetic analyses to prevent confounding; and that large collaborations may be necessary to obtain sufficient sample sizes for powerful and complex analyses of endurance performance.	[Grealy, Rebecca; Herruer, Jasper; Smith, Carl L. E.] Griffith Univ, Sch Med Sci, Gold Coast, Australia; [Hiller, Doug] Univ Hawaii, John A Burns Sch Med, North Hawaii Community Hosp, Honolulu, HI 96822 USA; [Haseler, Luke J.] Griffith Univ, Sch Physiotherapy & Exercise Sci, Heart Fdn Res Ctr, Gold Coast, Australia; [Grealy, Rebecca; Herruer, Jasper; Smith, Carl L. E.; Griffiths, Lyn R.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Genom Res Ctr, Kelvin Grove, Australia	Griffith University; University of Hawaii System; Griffith University; Queensland University of Technology (QUT)	Griffiths, LR (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Genom Res Ctr, Kelvin Grove, Australia.	lyn.griffiths@qut.edu.au		Haseler, Luke/0000-0003-1607-4402	Australian International Science Linkages grant; Australian Government EIF Super Science Funds as part of the Therapeutic Innovation Australia - Queensland Node project	Australian International Science Linkages grant(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Government EIF Super Science Funds as part of the Therapeutic Innovation Australia - Queensland Node project(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by an Australian International Science Linkages grant and by infrastructure purchased with Australian Government EIF Super Science Funds as part of the Therapeutic Innovation Australia - Queensland Node project with equipment and technical support staff from the National Collaborative Research Infrastructure Strategy (NCRIS) government funding.	Ahmetov II, 2009, HUM GENET, V126, P751, DOI 10.1007/s00439-009-0728-4; Arnold J, 2008, MED HYPOTHESES, V70, P1197, DOI 10.1016/j.mehy.2007.10.007; Bray MS, 2009, MED SCI SPORT EXER, V41, P34, DOI 10.1249/MSS.0b013e3181844179; Burden RJ, 2015, BRIT J SPORT MED, V49, P1389, DOI 10.1136/bjsports-2014-093624; Buxens A, 2011, SCAND J MED SCI SPOR, V21, P570, DOI 10.1111/j.1600-0838.2009.01079.x; Chicharro JL, 2004, BRIT J SPORT MED, V38, P418, DOI 10.1136/bjsm.2002.003921; Chiu LL, 2012, J PHYSIOL SCI, V62, P115, DOI 10.1007/s12576-011-0189-0; de Diego C, 2007, EUR J HAEMATOL, V78, P66, DOI 10.1111/j.1600-0609.2006.00775.x; Eynon N, 2010, SCAND J MED SCI SPOR, V20, pE145, DOI 10.1111/j.1600-0838.2009.00930.x; Eynon N, 2011, J PHYSIOL-LONDON, V589, P3063, DOI 10.1113/jphysiol.2011.207035; Eynon N, 2011, MITOCHONDRION, V11, P64, DOI 10.1016/j.mito.2010.07.004; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gomez-Gallego F, 2009, INT J SPORTS MED, V30, P66, DOI 10.1055/s-2008-1038677; Gomez-Gallego F, 2010, PHYSIOL GENOMICS, V41, P82, DOI 10.1152/physiolgenomics.00183.2009; Gonzalez-Freire M, 2009, BRIT J SPORT MED, V43, P307, DOI 10.1136/bjsm.2008.049809; Grealy R, 2013, J SCI MED SPORT, V16, P365, DOI 10.1016/j.jsams.2012.08.013; Heled Y, 2007, J APPL PHYSIOL, V103, P504, DOI 10.1152/japplphysiol.00081.2007; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; Huygens W, 2004, PHYSIOL GENOMICS, V17, P264, DOI 10.1152/physiolgenomics.00224.2003; Jones A, 2002, EXERC SPORT SCI REV, V30, P184, DOI 10.1097/00003677-200210000-00008; Keavney B, 2000, LANCET, V355, P434; Kostek M, 2011, AM J LIFESTYLE MED, V5, P156, DOI 10.1177/1559827610387251; Lea RA, 2005, MOL BRAIN RES, V136, P112, DOI 10.1016/j.molbrainres.2005.01.006; Little JP, 2010, J PHYSIOL-LONDON, V588, P1011, DOI 10.1113/jphysiol.2009.181743; Lucia A, 2005, J APPL PHYSIOL, V99, P344, DOI 10.1152/japplphysiol.00037.2005; McLaren CE, 2006, TRANSL RES, V148, P196, DOI 10.1016/j.trsl.2006.05.006; Myburgh KH, 2003, COMP BIOCHEM PHYS A, V136, P171, DOI 10.1016/S1095-6433(03)00220-4; De Matos LDNJ, 2013, INT J CARDIOL, V167, P2341, DOI 10.1016/j.ijcard.2012.11.041; Park SH, 2004, KOREAN J RADIOL, V5, P11, DOI 10.3348/kjr.2004.5.1.11; Partridge S, 2008, FORD IRONMAN WORLD C; Rankinen T, 2006, MED SCI SPORT EXER, V38, P1863, DOI 10.1249/01.mss.0000233789.01164.4f; Rivera MA, 1997, MED SCI SPORT EXER, V29, P1311, DOI 10.1097/00005768-199710000-00006; Rubio JC, 2005, J APPL PHYSIOL, V98, P2108, DOI 10.1152/japplphysiol.01371.2004; Ruiz JR, 2010, J APPL PHYSIOL, V108, P561, DOI 10.1152/japplphysiol.01242.2009; Ruiz JR, 2009, J PHYSIOL-LONDON, V587, P1527, DOI 10.1113/jphysiol.2008.166645; Samarasena J, 2006, DIGEST DIS SCI, V51, P803, DOI 10.1007/s10620-006-3210-3; Santiago C, 2010, SCAND J MED SCI SPOR, V20, pE188, DOI 10.1111/j.1600-0838.2009.00943.x; Saunders CJ, 2006, HUM MOL GENET, V15, P979, DOI 10.1093/hmg/ddl014; Sayed-Tabatabaei FA, 2006, CIRC RES, V98, P1123, DOI 10.1161/01.RES.0000223145.74217.e7; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shizukuda Y, 2012, AM J PHYS MED REHAB, V91, P418, DOI 10.1097/PHM.0b013e3182465f5f; Steinbacher P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123881; TSUJINO S, 1995, NEUROMUSCULAR DISORD, V5, P263, DOI 10.1016/0960-8966(94)00062-E; Williams AG, 2008, J PHYSIOL-LONDON, V586, P113, DOI 10.1113/jphysiol.2007.141887; WILSON IA, 1995, BIOCHEM J, V308, P599, DOI 10.1042/bj3080599; World Triathlon Corporation, 2010, FORD IR WORLD CHAMP; ZWEIG MH, 1993, CLIN CHEM, V39, P561	48	34	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145171	10.1371/journal.pone.0145171	http://dx.doi.org/10.1371/journal.pone.0145171			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716680	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500024
J	Mustafa, DAM; Sieuwerts, AM; Smid, M; de Weerd, V; van der Weiden, M; Meijer-van Gelder, ME; Martens, JWM; Foekens, JA; Kros, JM				Mustafa, Dana A. M.; Sieuwerts, Anieta M.; Smid, Marcel; de Weerd, Vania; van der Weiden, Marcel; Meijer-van Gelder, Marion E.; Martens, John W. M.; Foekens, John A.; Kros, Johan M.			A Method to Correlate mRNA Expression Datasets Obtained from Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Tissue Samples: A Matter of Thresholds	PLOS ONE			English	Article							GENOME-DASL ASSAY; GENE-EXPRESSION; BREAST-CANCER; LIVER-TISSUE; TUMORS; PCR; MICROARRAY; SIGNATURES	Background Gene expression profiling of tumors is a successful tool for the discovery of new cancer bio-markers and potential targets for the development of new therapeutic strategies. Reliable profiling is preferably performed on fresh frozen (FF) tissues in which the quality of nucleic acids is better preserved than in formalin-fixed paraffin-embedded (FFPE) material. However, since snap-freezing of biopsy materials is often not part of daily routine in pathology laboratories, one may have to rely on archival FFPE material. Procedures to retrieve the RNAs from FFPE materials have been developed and therefore, datasets obtained from FFPE and FF materials need to be made compatible to ensure reliable comparisons are possible. Aim To develop an efficient method to compare gene expression profiles obtained from FFPE and FF samples using the same platform. Methods Twenty-six FFPE-FF sample pairs of the same tumors representing various cancer types, and two FFPE-FF sample pairs of breast cancer cell lines, were included. Total RNA was extracted and gene expression profiling was carried out using Illumina's Whole-Genome cDNA-mediated Annealing, Selection, extension and Ligation (WG-DASL) V3 arrays, enabling the simultaneous detection of 24,526 mRNA transcripts. A sample exclusion criterion was created based on the expression of 11 stably expressed reference genes. Pearson correlation at the probe level was calculated for paired FFPE-FF, and three cut-off values were chosen. Spearman correlation coefficients between the matched FFPE and FF samples were calculated for three probe lists with varying levels of significance and compared to the correlation based on all measured probes. Unsupervised hierarchical cluster analysis was performed to verify performance of the included probe lists to compare matched FPPE-FF samples. Results Twenty-seven FFPE-FF pairs passed the sample exclusion criterion. From the profiles of 27 FFPE and FF matched samples, the best correlating probes were identified for various levels of significance (Pearson P<0.01, n = 1,432; P<0.05, n = 2,530; and P<0.10, n = 3,351 probes). Unsupervised hierarchical clustering of the 27 pairs using the resulting probes yielded 25, 21, and 19 correctly clustered pairs, respectively, compared to 1 pair when all probes were used. Conclusion The proposed method enables comparison of gene expression profiles of FFPE and/or FF origin measured on the same platform.	[Mustafa, Dana A. M.; van der Weiden, Marcel; Kros, Johan M.] Erasmus Univ, Dept Pathol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Sieuwerts, Anieta M.; Smid, Marcel; de Weerd, Vania; Meijer-van Gelder, Marion E.; Martens, John W. M.; Foekens, John A.] Erasmus Univ, Med Ctr, Dept Med Oncol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Mustafa, DAM (corresponding author), Erasmus Univ, Dept Pathol, Med Ctr, POB 1738, NL-3000 DR Rotterdam, Netherlands.	d.mustafa@erasmusmc.nl	Mustafa, Dana/AAQ-6530-2021	Mustafa, Dana/0000-0003-0644-078X; Smid, Marcel/0000-0003-0605-1901	Dutch Cancer Society (KWF) [EMCR 2009-4553]	Dutch Cancer Society (KWF)(KWF Kankerbestrijding)	The study was supported by the Dutch Cancer Society (KWF Grant EMCR 2009-4553).	Abdueva D, 2010, J MOL DIAGN, V12, P409, DOI 10.2353/jmoldx.2010.090155; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; April C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008162; April CS, 2011, METHODS MOL BIOL, V784, P77, DOI 10.1007/978-1-61779-289-2_6; Berg AO, 2009, GENET MED, V11, P66, DOI 10.1097/GIM.0b013e3181928f56; BRESTERS D, 1994, J VIROL METHODS, V48, P267, DOI 10.1016/0166-0934(94)90125-2; Cotoi CG, 2012, ROM J MORPHOL EMBRYO, V53, P893; De Weerd V S A, 2010, CANC GENERICS CYTOGE; Dominguez-Valentin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071755; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erdem-Eraslan L, 2013, J CLIN ONCOL, V31, P328, DOI 10.1200/JCO.2012.44.1444; Fan JB, 2004, GENOME RES, V14, P878, DOI 10.1101/gr.2167504; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; FINKE J, 1993, BIOTECHNIQUES, V14, P448; Freedman JA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-58; Hall JS, 2012, BRIT J CANCER, V107, P684, DOI 10.1038/bjc.2012.294; Kelly AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025357; Kissel HD, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/576842; Kojima K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086961; Kumar R, 2012, J PHARM BIOALLIED SC, V4, P21, DOI 10.4103/0975-7406.92726; Lebbe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029143; Linton KM, 2008, BRIT J CANCER, V98, P1403, DOI 10.1038/sj.bjc.6604316; Mittempergher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017163; Oberli A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-9; Rodriguez-Gonzalez FG, 2013, METHODS, V59, P47, DOI 10.1016/j.ymeth.2012.05.005; Sfakianos GP, 2013, GYNECOL ONCOL, V129, P159, DOI 10.1016/j.ygyno.2012.12.030; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Thomas Marlene, 2013, J Clin Bioinforma, V3, P10, DOI 10.1186/2043-9113-3-10; Ton CC, 2011, BREAST CANCER RES TR, V125, P879, DOI 10.1007/s10549-010-1159-6; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vargas AC, 2012, BREAST CANCER RES TR, V135, P153, DOI 10.1007/s10549-012-2123-4; Waddell N, 2010, J PATHOL, V221, P452, DOI 10.1002/path.2728; Winn ME, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-412	34	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0144097	10.1371/journal.pone.0144097	http://dx.doi.org/10.1371/journal.pone.0144097			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716838	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500009
J	Santoro, ML; do Carmo, T; Cunha, BHL; Alves, AF; Zelanis, A; Serrano, SMD; Grego, KF; Sant'Anna, SS; Barbaro, KC; Fernandes, W				Santoro, Marcelo Larami; do Carmo, Thais; Lopes Cunha, Bruna Heloisa; Alves, Andre Fonseca; Zelanis, Andre; de Toledo Serrano, Solange Maria; Grego, Kathleen Fernandes; Sant'Anna, Savio Stefanini; Barbaro, Katia Cristina; Fernandes, Wilson			Ontogenetic Variation in Biological Activities of Venoms from Hybrids between Bothrops erythromelas and Bothrops neuwiedi Snakes	PLOS ONE			English	Article							SOUTH-AMERICAN PITVIPERS; THROMBIN-LIKE ENZYME; CONTACT ZONE; VIPERA-BERUS; HYBRIDIZATION; VARIABILITY; ATROX; SERPENTES; PHYLOGENY; SPECIMENS	Lance-headed snakes are found in Central and South America, and they account for most snakebites in Brazil. The phylogeny of South American pitvipers has been reviewed, and the presence of natural and non-natural hybrids between different species of Bothrops snakes demonstrates that reproductive isolation of several species is still incomplete. The present study aimed to analyze the biological features, particularly the thrombin-like activity, of venoms from hybrids born in captivity, from the mating of a female Bothrops erythromelas and a male Bothrops neuwiedi, two species whose venoms are known to display ontogenetic variation. Proteolytic activity on azocoll and amidolytic activity on N-benzoyl-DL-arginine-p-nitroanilide hydrochloride (BAPNA) were lowest when hybrids were 3 months old, and increased over body growth, reaching values similar to those of the father when hybrids were 12 months old. The clotting activity on plasma diminished as hybrids grew; venoms from 3- and 6-months old hybrids showed low clotting activity on fibrinogen (i.e., thrombinlike activity), like the mother venom, and such activity was detected only when hybrids were older than 1 year of age. Altogether, these results point out that venom features in hybrid snakes are genetically controlled during the ontogenetic development. Despite the presence of the thrombin-like enzyme gene(s) in hybrid snakes, they are silenced during the first six months of life.	[Santoro, Marcelo Larami; do Carmo, Thais; Lopes Cunha, Bruna Heloisa; Alves, Andre Fonseca] Inst Butantan, Lab Fisiopatol, Sao Paulo, SP, Brazil; [Zelanis, Andre; de Toledo Serrano, Solange Maria] Inst Butantan, Lab Especial Toxinol Aplicada, Sao Paulo, SP, Brazil; [Zelanis, Andre; de Toledo Serrano, Solange Maria] Inst Butantan, Ctr Toxins Immune Response & Cell Signaling, Sao Paulo, SP, Brazil; [Grego, Kathleen Fernandes; Sant'Anna, Savio Stefanini; Fernandes, Wilson] Inst Butantan, Lab Herpetol, Sao Paulo, SP, Brazil; [Barbaro, Katia Cristina] Inst Butantan, Lab Imunopatol, Sao Paulo, SP, Brazil	Instituto Butantan; Instituto Butantan; Instituto Butantan; Instituto Butantan; Instituto Butantan	Santoro, ML (corresponding author), Inst Butantan, Lab Fisiopatol, Sao Paulo, SP, Brazil.	marcelo.santoro@butantan.gov.br	Zelanis, André/AAD-4618-2019; Serrano, Solange/ABB-7569-2021; Santoro, Marcelo L./K-7064-2019; Sant'Anna, Sávio S/I-5217-2016; Barbaro, Katia/M-2664-2013; Grego, Kathleen/GOV-3529-2022; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Grego, Kathleen F/A-6394-2014; Santoro, Marcelo/H-3892-2012; Serrano, Solange M. T./A-7132-2008	Zelanis, André/0000-0003-3066-6527; Serrano, Solange/0000-0001-8994-1904; Santoro, Marcelo L./0000-0001-6364-3757; Sant'Anna, Sávio S/0000-0003-2224-0913; Grego, Kathleen/0000-0003-4769-5818; Grego, Kathleen F/0000-0003-4769-5818; Serrano, Solange M. T./0000-0001-8994-1904	Sao Paulo Research Foundation (FAPESP) [2008/02996-8, 2010/08162-1, 2013/25177-0, 2013/07467-1, 2013/13548-4, 2009/15413-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [475924/2010-0]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Sao Paulo Research Foundation (FAPESP, grants # 2008/02996-8, 2010/08162-1, 2013/25177-0, 2013/07467-1, 2013/13548-4, 2009/15413-3), URL: www.fapesp.br; and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant # 475924/2010-0), URL: www.cnpq.br.	AIRD SD, 1989, J HERPETOL, V23, P131, DOI 10.2307/1564018; Aird SD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1832-6; Alape-Giron A, 2008, J PROTEOME RES, V7, P3556, DOI 10.1021/pr800332p; Antunes TC, 2010, TOXICON, V56, P1443, DOI 10.1016/j.toxicon.2010.08.011; Balestrin Rafael Lucchesi, 2002, Iheringia, Sér. Zool., V92, P85, DOI 10.1590/S0073-47212002000100007; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BULLINI L, 1994, TRENDS ECOL EVOL, V9, P422, DOI 10.1016/0169-5347(94)90124-4; Butantan-British IBothrops/I Systematics Project, 2002, P111; Calvete JJ, 2011, J PROTEOMICS, V74, P510, DOI 10.1016/j.jprot.2011.01.003; Campbell J. A., 2004, VENOMOUS REPTILES W; Carlsson M, 2004, MOL ECOL, V13, P3147, DOI 10.1111/j.1365-294X.2004.02315.x; Carrasco PA, 2012, ZOOL SCR, V41, P109, DOI 10.1111/j.1463-6409.2011.00511.x; Castoe TA, 2006, MOL PHYLOGENET EVOL, V39, P91, DOI 10.1016/j.ympev.2005.12.014; CHIPPAUX JP, 1982, TOXICON, V20, P521, DOI 10.1016/0041-0101(82)90019-8; CHIPPAUX JP, 1991, TOXICON, V29, P1279, DOI 10.1016/0041-0101(91)90116-9; CONANT ROGER, 1963, AMER MUS NOVITATES, V2122, P1; Cook S. F. Jr., 1955, P139; Dias GS, 2013, J PROTEOME RES, V12, P4585, DOI 10.1021/pr4007393; Dirksen Lutz, 1998, Zoologische Abhandlungen (Dresden), V50, P45; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Durban J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-234; Fenker J, 2014, DIVERS DISTRIB, V20, P1108, DOI 10.1111/ddi.12217; Fenwick AM, 2009, ZOOL J LINN SOC-LOND, V156, P617, DOI 10.1111/j.1096-3642.2008.00495.x; Franca F.O.S., 2009, ANIMAIS PE ONHENTOS, P81; FURTADO FD, 1991, TOXICON, V29, P219, DOI 10.1016/0041-0101(91)90106-2; Gao JF, 2011, TOXICON, V57, P970, DOI 10.1016/j.toxicon.2011.03.019; Gibbs HL, 2006, MOL ECOL, V15, P3755, DOI 10.1111/j.1365-294X.2006.03056.x; GLENN JL, 1990, TOXICON, V28, P857, DOI 10.1016/S0041-0101(09)80008-1; Grazziotin F, 2005, BRAZ ARCH BIOL TECHN, V48, P359, DOI 10.1590/S1516-89132005000300005; Guercio RAP, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-11; GUTIERREZ JM, 1980, REV BIOL TROP, V28, P341; Hanna SL, 2000, MICROBIOL-UK, V146, P2495, DOI 10.1099/00221287-146-10-2495; Hey J, 2003, TRENDS ECOL EVOL, V18, P597, DOI 10.1016/j.tree.2003.08.014; HOLLEMAN WH, 1976, J BIOL CHEM, V251, P1663; Holliday TW, 2003, CURR ANTHROPOL, V44, P653, DOI 10.1086/377663; ITOH N, 1987, J BIOL CHEM, V262, P3132; Jorge RJB, 2015, J PROTEOMICS, V114, P93, DOI 10.1016/j.jprot.2014.11.011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWSON R, 1991, ALLOZYME VARIATION S, P638; Lopez-Lozano JL, 2002, TOXICON, V40, P997, DOI 10.1016/S0041-0101(02)00096-X; Machado T, 2014, MOL PHYLOGENET EVOL, V71, P1, DOI 10.1016/j.ympev.2013.10.003; Markland FS, 1998, TOXICON, V36, P1749, DOI 10.1016/S0041-0101(98)00126-3; Martinez-Freiria F, 2008, DIVERS DISTRIB, V14, P452, DOI 10.1111/j.1472-4642.2007.00446.x; Martins Marcio, 2002, P307; MARUYAMA M, 1992, ANN TROP MED PARASIT, V86, P549, DOI 10.1080/00034983.1992.11812706; Mayr E, 1996, PHILOS SCI, V63, P262, DOI 10.1086/289912; Mebert K, 2008, MOL ECOL, V17, P1918, DOI 10.1111/j.1365-294X.2008.03725.x; NAHAS L, 1979, THROMB HAEMOSTASIS, V41, P314; Nunez V, 2009, J PROTEOMICS, V73, P57, DOI 10.1016/j.jprot.2009.07.013; Oliveira FN, 2010, REV SOC BRAS MED TRO, V43, P662, DOI 10.1590/S0037-86822010000600012; Pisciolaro AM, 2008, INTERSPECIFIC REPROD, P407; Prudente ALC, 1995, BIOCIENCIAS, V3, P231; Pukac LA, 1997, BIOTECHNIQUES, V23, P385, DOI 10.2144/97233bm08; Queiroz K, 2005, SYSTEMATICS ORIGIN S, P243; REDINBAUGH MG, 1986, ANAL BIOCHEM, V153, P267, DOI 10.1016/0003-2697(86)90091-6; Saint Girons H, 1990, B SOC HERP FR, V54, P62; Saldarriaga MM, 2003, TOXICON, V42, P405, DOI 10.1016/S0041-0101(03)00171-5; SANCHEZ EF, 1992, TOXICON, V30, P95, DOI 10.1016/0041-0101(92)90505-Y; Sazima Ivan, 1992, P199; Serrano SMT, 2005, TOXICON, V45, P1115, DOI 10.1016/j.toxicon.2005.02.020; Silva MMS, 2002, ESTUDO VARIABILIDADE; Stocker K., 1976, Methods Enzymol, V45, P214; Tarroso P, 2014, MOL ECOL, V23, P1108, DOI 10.1111/mec.12671; THEAKSTON RDG, 1983, B WORLD HEALTH ORGAN, V61, P949; Vasconcelos CML, 1996, ESTUDO PECONHA BOTHR, P110; Werman SD, 2002, BIOL VIPERS, P21; Yamashita KM, 2011, J THROMB HAEMOST, V9, P2057, DOI 10.1111/j.1538-7836.2011.04449.x; You WK, 2004, FEBS LETT, V571, P67, DOI 10.1016/j.febslet.2004.06.060; Zappellini A, 1991, ESTUDOS BIOQUIMICO F; Zelanis A, 2007, COMP BIOCHEM PHYS C, V145, P601, DOI 10.1016/j.cbpc.2007.02.009; Zelanis A, 2011, PROTEOMICS, V11, P4218, DOI 10.1002/pmic.201100287; Zelanis A, 2010, J PROTEOME RES, V9, P2278, DOI 10.1021/pr901027r; Zinenko O. I., 2003, Vestnik Zoologii, V37, P101; Zinenko Oleksander, 2004, Mertensiella, V15, P17; Zinenko O, 2010, AMPHIBIA-REPTILIA, V31, P51, DOI 10.1163/156853810790457885	75	15	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145516	10.1371/journal.pone.0145516	http://dx.doi.org/10.1371/journal.pone.0145516			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714190	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900050
J	Sorte, CJB; Bracken, MES				Sorte, Cascade J. B.; Bracken, Matthew E. S.			Warming and Elevated CO2 Interact to Drive Rapid Shifts in Marine Community Production	PLOS ONE			English	Article							OCEAN ACIDIFICATION; CLIMATE-CHANGE; TEMPERATURE; NITROGEN; RESPONSES; IMPACTS; PHOTOSYNTHESIS; FUTURE	Predicting the outcome of future climate change requires an understanding of how alterations in multiple environmental factors manifest in natural communities and affect ecosystem functioning. We conducted an in situ, fully factorial field manipulation of CO2 and temperature on a rocky shoreline in southeastern Alaska, USA. Warming strongly impacted functioning of tide pool systems within one month, with the rate of net community production (NCP) more than doubling in warmed pools under ambient CO2 levels relative to initial NCP values. However, in pools with added CO2, NCP was unaffected by warming. Productivity responses paralleled changes in the carbon-to-nitrogen ratio of a red alga, the most abundant primary producer species in the system, highlighting the direct link between physiology and ecosystem functioning. These observed changes in algal physiology and community productivity in response to our manipulations indicate the potential for natural systems to shift rapidly in response to changing climatic conditions and for multiple environmental factors to act antagonistically.	[Sorte, Cascade J. B.; Bracken, Matthew E. S.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Sorte, CJB (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, 321 Steinhaus Hall, Irvine, CA 92697 USA.	csorte@uci.edu	Bracken, Matthew E.S./I-9359-2019	Bracken, Matthew E.S./0000-0002-0068-7485	National Science Foundation, Office of Polar Programs; NSF [PLR 1023704]	National Science Foundation, Office of Polar Programs(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This work was supported by the National Science Foundation, Office of Polar Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank L. Tang for capable and cheerful field assistance; G. Bernatchez for help with sample processing and data analyses; and family, friends, and members of the public who joined us in the field. We appreciate the Sitka Sound Science Center hosting us as part of the Scientist-in-Residency Fellowship Program (funded by NSF award PLR 1023704 to J. Straley) and the University of Alaska Southeast for providing office space. We thank the anonymous reviewers for helpful comments that improved the manuscript.	Alsterberg C, 2013, P NATL ACAD SCI USA, V110, P8603, DOI 10.1073/pnas.1303797110; Andria JR, 1999, EUR J PHYCOL, V34, P497, DOI 10.1017/S0967026299002334; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bracken MES, 2015, OIKOS, V124, P113, DOI 10.1111/oik.01215; Bracken MES, 2013, ECOLOGY, V94, P1944, DOI 10.1890/12-2182.1; Bracken MES, 2004, J PHYCOL, V40, P1032, DOI 10.1111/j.1529-8817.2004.03106.x; Colvard NB, 2014, J EXP MAR BIOL ECOL, V458, P6, DOI 10.1016/j.jembe.2014.05.001; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; DAVISON IR, 1991, MAR BIOL, V110, P449, DOI 10.1007/BF01344363; DELIA CF, 1978, J PHYCOL, V14, P266, DOI 10.1111/j.1529-8817.1978.tb00297.x; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; DICKSON AG, 1993, DEEP-SEA RES PT I, V40, P107, DOI 10.1016/0967-0637(93)90055-8; Dieleman WIJ, 2012, GLOBAL CHANGE BIOL, V18, P2681, DOI 10.1111/j.1365-2486.2012.02745.x; Ferrari MCO, 2011, ECOL LETT, V14, P1143, DOI 10.1111/j.1461-0248.2011.01683.x; Gedan KB, 2009, ECOL LETT, V12, P842, DOI 10.1111/j.1461-0248.2009.01337.x; Gillis BC, 2014, THESIS; Hale R, 2011, OIKOS, V120, P661, DOI 10.1111/j.1600-0706.2010.19469.x; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; HERNANDEZ I, 1993, MAR ECOL PROG SER, V99, P301, DOI 10.3354/meps099301; IPCC, 2014, CLIM CHANG 2013 IMP; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; JOHNSTON AM, 1990, BRIT PHYCOL J, V25, P75, DOI 10.1080/00071619000650071; Kline DI, 2012, SCI REP-UK, V2, DOI 10.1038/srep00413; Kordas RL, 2011, J EXP MAR BIOL ECOL, V400, P218, DOI 10.1016/j.jembe.2011.02.029; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Langley JA, 2010, NATURE, V466, P96, DOI 10.1038/nature09176; Noel LMLJ, 2010, ESTUAR COAST SHELF S, V88, P153, DOI 10.1016/j.ecss.2010.03.005; O'Connor MI, 2009, ECOLOGY, V90, P388, DOI 10.1890/08-0034.1; Olabarria C, 2013, OIKOS, V122, P1065, DOI 10.1111/j.1600-0706.2012.20825.x; Pedersen O., 2007, AQUAT GARD, V20, P24; Pfister CA, 2014, ENVIRON SCI TECHNOL, V48, P9982, DOI 10.1021/es501936p; Ruesink JL, 1998, J PHYCOL, V34, P29, DOI 10.1046/j.1529-8817.1998.340029.x; SHACHAK M, 1995, LINKING SPECIES & ECOSYSTEMS, P280; Smale DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016050; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; Sorte CJB, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0572; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x	37	13	13	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145191	10.1371/journal.pone.0145191	http://dx.doi.org/10.1371/journal.pone.0145191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714167	Green Published, gold			2022-12-27	WOS:000367481900034
J	Wu, GC; Tey, WG; Li, HW; Chang, CF				Wu, Guan-Chung; Tey, Wei-Guan; Li, Hau-Wen; Chang, Ching-Fong			Sexual Fate Reprogramming in the Steroid-Induced Bi-Directional Sex Change in the Protogynous Orange-Spotted Grouper, Epinephelus coioides	PLOS ONE			English	Article							PROTANDROUS BLACK PORGY; ACANTHOPAGRUS-SCHLEGELI BLEEKER; GONADOTROPIN-RELEASING-HORMONE; GERM-CELLS; TELEOST FISH; THALASSOMA-BIFASCIATUM; LUTEINIZING-HORMONE; HERMAPHRODITIC FISH; MOLECULAR-CLONING; BLUEHEAD WRASSE	Androgen administration has been widely used for masculinization in fish. The mechanism of the sex change in sexual fate regulation is not clear. Oral administration or pellet implantation was applied. We orally applied an aromatase inhibitor (AI, to decrease estrogen levels) and 17 alpha-methyltestosterone (MT, to increase androgen levels) to induce masculinization to clarify the mechanism of the sex change in the protogynous orange-spotted grouper. After 3 mo of AI/MT administration, male characteristics were observed in the female-to-male sex change fish. These male characteristics included increased plasma 11-ketotestosterone (11-KT), decreased estradiol (E2) levels, increased male-related gene (dmrt1, sox9, and cyp11b2) expression, and decreased female-related gene (figla, foxl2, and cyp19a1a) expression. However, the reduced male characteristics and male-to-female sex change occurred after AI/MT-termination in the AI- and MT-induced maleness. Furthermore, the MT-induced oocyte-depleted follicle cells (from MT-implantation) had increased proliferating activity, and the sexual fate in a portion of female gonadal soma cells was altered to male function during the female-to-male sex change. In contrast, the gonadal soma cells were not proliferative during the early process of the male-to-female sex change. Additionally, the male gonadal soma cells did not alter to female function during the male-to-female sex change in the AI/MT-terminated fish. After MT termination in the male-to-female sex-changed fish, the differentiated male germ cells showed increased proliferating activities together with dormancy and did not show characteristics of both sexes in the early germ cells. In conclusion, these findings indicate for the first time in a single species that the mechanism involved in the replacement of soma cells is different between the female-to-male and male-to-female sex change processes in grouper. These results also demonstrate that sexual fate determination (secondary sex determination) is regulated by endogenous sex steroid levels.	[Wu, Guan-Chung; Tey, Wei-Guan; Li, Hau-Wen; Chang, Ching-Fong] Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung 20224, Taiwan; [Wu, Guan-Chung; Chang, Ching-Fong] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung 20224, Taiwan	National Taiwan Ocean University; National Taiwan Ocean University	Wu, GC (corresponding author), Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung 20224, Taiwan.	gcwu@mail.ntou.edu.tw; b0044@mail.ntou.edu.tw			Ministry of Science and Technology [99-2313-B-019-014-MY3, 102-2628-B-019 -004 -MY3]; Ministry of Education	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education	This work was supported by the Ministry of Science and Technology Project no. 99-2313-B-019-014-MY3 and no. 102-2628-B-019-004-MY3, and the Ministry of Education.	Alam MA, 2006, MOL REPROD DEV, V73, P206, DOI 10.1002/mrd.20393; Alam MA, 2008, GEN COMP ENDOCR, V157, P75, DOI 10.1016/j.ygcen.2008.03.018; Bahamonde PA, 2013, GEN COMP ENDOCR, V192, P25, DOI 10.1016/j.ygcen.2013.04.005; Bhandari RK, 2005, J EXP ZOOL PART A, V303A, P497, DOI 10.1002/jez.a.178; Bhandari RK, 2003, ZOOL SCI, V20, P1399, DOI 10.2108/zsj.20.1399; Chang Ching-Fong, 1997, Chinese Journal of Physiology, V40, P197; Chao T, 1990, SINGAPORE J PRIMARY, V18, P1; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Du JL, 2005, BIOL REPROD, V72, P922, DOI 10.1095/biolreprod.104.033159; Elofsson U, 1997, J COMP PHYSIOL A, V181, P484, DOI 10.1007/s003590050132; Elofsson UOE, 1999, J COMP NEUROL, V410, P158; Fujimoto T, 2010, P NATL ACAD SCI USA, V107, P17211, DOI 10.1073/pnas.1007032107; Glamuzina B, 1998, AQUAC RES, V29, P563, DOI 10.1111/j.1365-2109.1998.tb01168.x; Goto R, 2012, DEV BIOL, V370, P98, DOI 10.1016/j.ydbio.2012.07.010; GROBER MS, 1994, BRAIN BEHAV EVOLUT, V43, P61, DOI 10.1159/000113625; Guigon CJ, 2006, BIOL REPROD, V74, P450, DOI 10.1095/biolreprod.105.047134; Guiguen Y, 2010, GEN COMP ENDOCR, V165, P352, DOI 10.1016/j.ygcen.2009.03.002; Huang W, 2009, MOL CELL ENDOCRINOL, V307, P224, DOI 10.1016/j.mce.2009.04.003; Kim Y, 2006, DEV DYNAM, V235, P2292, DOI 10.1002/dvdy.20894; Kobayashi Y, 2010, BIOL REPROD, V82, P1030, DOI 10.1095/biolreprod.109.080986; Kobayashi Y, 2009, ENDOCRINOLOGY, V150, P1503, DOI 10.1210/en.2008-0569; KOULISH S, 1989, J EXP ZOOL, V252, P156, DOI 10.1002/jez.1402520207; KRAMER CR, 1993, J FISH BIOL, V42, P185; KUO CM, 1988, AQUACULTURE, V74, P113, DOI 10.1016/0044-8486(88)90091-9; Kurokawa H, 2007, P NATL ACAD SCI USA, V104, P16958, DOI 10.1073/pnas.0609932104; Lau EL, 1997, J FISH BIOL, V51, P327, DOI 10.1006/jfbi.1997.0438; Lee YH, 2004, BIOL REPROD, V71, P1270, DOI 10.1095/biolreprod.104.030221; Lee YH, 2002, BIOL REPROD, V66, P1749, DOI 10.1095/biolreprod66.6.1749; Mei J, 2015, SCI CHINA LIFE SCI, V58, P124, DOI 10.1007/s11427-014-4797-9; Miyake Y, 2012, ZOOL SCI, V29, P690, DOI 10.2108/zsj.29.690; Muncaster S, 2013, J FISH BIOL, V82, P1858, DOI 10.1111/jfb.12113; Munday PL, 2006, TRENDS ECOL EVOL, V21, P89, DOI 10.1016/j.tree.2005.10.020; Murata R, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.115378; Nozu R, 2013, FISH PHYSIOL BIOCHEM, V39, P47, DOI 10.1007/s10695-012-9632-2; Sarter K, 2006, AQUACULTURE, V256, P443, DOI 10.1016/j.aquaculture.2006.01.034; Siegfried KR, 2008, DEV BIOL, V324, P277, DOI 10.1016/j.ydbio.2008.09.025; Sun LN, 2014, ENDOCRINOLOGY, V155, P1476, DOI 10.1210/en.2013-1959; TANFERMIN JD, 1994, JPN J ICHTHYOL, V40, P413; Tsai YJ, 2011, ZOOL STUD, V50, P693; WARNER RR, 1975, SCIENCE, V190, P633, DOI 10.1126/science.1188360; Wu GC, 2008, BIOL REPROD, V78, P200, DOI 10.1095/biolreprod.107.062612; Wu GC, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104398; Wu GC, 2013, FISH PHYSIOL BIOCHEM, V39, P33, DOI 10.1007/s10695-012-9618-0; Wu GC, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095695; Wu GC, 2008, BIOL REPROD, V79, P1111, DOI 10.1095/biolreprod.108.069146; Xia W, 2007, MOL CELL ENDOCRINOL, V263, P156, DOI 10.1016/j.mce.2006.09.014; Yeh SL, 2003, COMP BIOCHEM PHYS C, V135, P375, DOI 10.1016/S1532-0456(03)00136-4; Yoshizaki G, 2010, DEVELOPMENT, V137, P1227, DOI 10.1242/dev.044982; Yue HM, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108043; Zhang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10898; Zhang WM, 2007, MOL REPROD DEV, V74, P665, DOI 10.1002/mrd.20642; Zhou L, 2010, FISH PHYSIOL BIOCHEM, V36, P181, DOI 10.1007/s10695-008-9219-0	52	28	31	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145438	10.1371/journal.pone.0145438	http://dx.doi.org/10.1371/journal.pone.0145438			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714271	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900043
J	Jiang, D; Chen, YP; Li, N; Li, W; Wang, ZG; Zhu, JL; Zhang, H; Liu, B; Xu, S				Jiang, Dan; Chen, Yunping; Li, Na; Li, Wen; Wang, Zhenguo; Zhu, Jingli; Zhang, Hong; Liu, Bin; Xu, Shan			Synthesis of Luminescent Graphene Quantum Dots with High Quantum Yield and Their Toxicity Study	PLOS ONE			English	Article							ONE-STEP SYNTHESIS; FUNCTIONALIZED GRAPHENE; PHOTOVOLTAIC DEVICES; CARBON NANOTUBES; IN-VITRO; OXIDE; PHOTOLUMINESCENCE; FLUORESCENT; REDUCTION; SINGLE	High fluorescence quantum yield graphene quantum dots (GQDs) have showed up as a new generation for bioimaging. In this work, luminescent GQDs were prepared by an ameliorative photo-Fenton reaction and a subsequent hydrothermal process using graphene oxide sheets as the precursor. The as-prepared GQDs were nanomaterials with size ranging from 2.3 to 6.4 nm and emitted intense green luminescence in water. The fluorescence quantum yield was as high as 24.6%(excited at 340 nm) and the fluorescence was strongest at pH 7. Moreover, the influences of low-concentration (12.5, 25 mu g/mL) GQDs on the morphology, viability, membrane integrity, internal cellular reactive oxygen species level and mortality of HeLa cells were relatively weak, and the in vitro imaging demonstrated GQDs were mainly in the cytoplasm region. More strikingly, zebrafish embryos were co-cultured with GQDs for in vivo imaging, and the results of heart rate test showed the intake of small amounts of GQDs brought little harm to the cardiovascular of zebrafish. GQDs with high quantum yield and strong photoluminescence show good biocompatibility, thus they show good promising for cell imaging, biolabeling and other biomedical applications.	[Jiang, Dan; Chen, Yunping; Li, Na; Li, Wen; Wang, Zhenguo; Zhu, Jingli; Liu, Bin] Lanzhou Univ, Sch Stomatol, Lanzhou 730000, Peoples R China; [Jiang, Dan; Chen, Yunping; Xu, Shan] Chinese Acad Sci, Lanzhou Inst Chem Phys, State Key Lab Oxo Synth & Select, Lanzhou 730000, Peoples R China; [Wang, Zhenguo; Zhang, Hong] Chinese Acad Sci, Inst Modern Phys, Dept Heavy Ion Radiat Med, Lanzhou, Peoples R China	Lanzhou University; Chinese Academy of Sciences; Lanzhou Institute of Chemical Physics, CAS; Chinese Academy of Sciences; Institute of Modern Physics, CAS	Liu, B (corresponding author), Lanzhou Univ, Sch Stomatol, Lanzhou 730000, Peoples R China.	liubkq@lzu.edu.cn; xushan@licp.cas.cn			Nature Science Foundations of China [21103205]	Nature Science Foundations of China(National Natural Science Foundation of China (NSFC))	The authors are grateful for the financial support by the Nature Science Foundations of China (21103205).	Asharani PV, 2011, NANOTOXICOLOGY, V5, P43, DOI 10.3109/17435390.2010.489207; Chong Y, 2014, BIOMATERIALS, V35, P5041, DOI 10.1016/j.biomaterials.2014.03.021; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Dong YQ, 2013, CARBON, V64, P245, DOI 10.1016/j.carbon.2013.07.059; Favaro M, 2015, ACS CATAL, V5, P129, DOI 10.1021/cs501211h; Feng YQ, 2014, CARBON, V66, P334, DOI 10.1016/j.carbon.2013.09.008; Ge JC, 2015, ADV MATER, V27, P4169, DOI 10.1002/adma.201500323; Ge JC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5596; Gollavelli G, 2012, BIOMATERIALS, V33, P2532, DOI 10.1016/j.biomaterials.2011.12.010; Gupta V, 2011, J AM CHEM SOC, V133, P9960, DOI 10.1021/ja2036749; Habiba K, 2013, CARBON, V64, P341, DOI 10.1016/j.carbon.2013.07.084; Hu CF, 2013, J MATER CHEM B, V1, P39, DOI 10.1039/c2tb00189f; Jiang F, 2013, NANOSCALE, V5, P1137, DOI 10.1039/c2nr33191h; Kang B, 2010, SMALL, V6, P2362, DOI 10.1002/smll.201001260; Lai LF, 2011, CARBON, V49, P3250, DOI 10.1016/j.carbon.2011.03.051; Liu F, 2013, ADV MATER, V25, P3657, DOI 10.1002/adma.201300233; Liu YS, 2015, CHEM MATER, V27, P4319, DOI 10.1021/acs.chemmater.5b00774; Liu YS, 2007, J PHYS CHEM C, V111, P2872, DOI 10.1021/jp0654718; Lovric J, 2005, CHEM BIOL, V12, P1227, DOI 10.1016/j.chembiol.2005.09.008; Markovic ZM, 2012, BIOMATERIALS, V33, P7084, DOI 10.1016/j.biomaterials.2012.06.060; Miao W, 2015, AQUAT TOXICOL, V161, P117, DOI 10.1016/j.aquatox.2015.02.002; Pan DY, 2012, J MATER CHEM, V22, P3314, DOI 10.1039/c2jm16005f; Parimal R, 2013, ACS APPL MATER INTER, V5, P12672, DOI [10.1021/am4040174, DOI 10.1021/AM4040174]; Peng J, 2012, NANO LETT, V12, P844, DOI 10.1021/nl2038979; Ponomarenko LA, 2008, SCIENCE, V320, P356, DOI 10.1126/science.1154663; Qu D, 2014, SCI REP-UK, V4, DOI 10.1038/srep05294; Ran X, 2013, CHEM COMMUN, V49, P1079, DOI 10.1039/c2cc38403e; Sahu S, 2012, CHEM COMMUN, V48, P8835, DOI 10.1039/c2cc33796g; Shen JH, 2012, CHEM COMMUN, V48, P3686, DOI 10.1039/c2cc00110a; Singh SK, 2012, ACS NANO, V6, P2731, DOI 10.1021/nn300172t; Sun HJ, 2015, CHEM-EUR J, V21, P3791, DOI 10.1002/chem.201406345; Sun HJ, 2013, ACS APPL MATER INTER, V5, P1174, DOI 10.1021/am3030849; Sun YQ, 2013, PHYS CHEM CHEM PHYS, V15, P9907, DOI 10.1039/c3cp50691f; Tang LB, 2012, ACS NANO, V6, P5102, DOI 10.1021/nn300760g; Wang SJ, 2015, CARBON, V82, P304, DOI 10.1016/j.carbon.2014.10.075; Wu CY, 2013, ADV HEALTHC MATER, V2, P1613, DOI 10.1002/adhm.201300066; Wu X, 2013, J MATER CHEM C, V1, P4676, DOI 10.1039/c3tc30820k; Xu FZ, 2015, ANALYST, V140, P3925, DOI 10.1039/c5an00468c; Yan L, 2012, J MATER CHEM, V22, P8367, DOI 10.1039/c2jm30961k; Yan XB, 2010, ACS APPL MATER INTER, V2, P2521, DOI 10.1021/am100293r; Yuan XC, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-108; Zhang X, 2014, J BIOMED MATER RES A, V102, P732, DOI 10.1002/jbm.a.34751; Zhou XJ, 2012, ACS NANO, V6, P6592, DOI 10.1021/nn301629v; Zhu SJ, 2012, ADV FUNCT MATER, V22, P4732, DOI 10.1002/adfm.201201499; Zhu SJ, 2012, CHEM COMMUN, V48, P4527, DOI 10.1039/c2cc31201h	45	75	75	1	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144906	10.1371/journal.pone.0144906	http://dx.doi.org/10.1371/journal.pone.0144906			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709828	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400015
J	Othman, I; Mirand, A; Slama, I; Mastouri, M; Peigue-Lafeuille, H; Aouni, M; Bailly, JL				Othman, Ines; Mirand, Audrey; Slama, Ichrak; Mastouri, Maha; Peigue-Lafeuille, Helene; Aouni, Mahjoub; Bailly, Jean-Luc			Enterovirus Migration Patterns between France and Tunisia	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; MOUTH-DISEASE; PHYLOGENETIC ANALYSIS; POPULATION-DYNAMICS; ASEPTIC-MENINGITIS; COXSACKIEVIRUS A9; PHYLOGEOGRAPHY; EVOLUTION; INFECTION; OUTBREAK	The enterovirus (EV) types echovirus (E-) 5, E-9, and E-18, and coxsackievirus (CV-) A9 are infrequently reported in human diseases and their epidemiologic features are poorly defined. Virus transmission patterns between countries have been estimated with phylogenetic data derived from the 1D/VP1 and 3CD gene sequences of a sample of 74 strains obtained in France (2000-2012) and Tunisia (2011-2013) and from the publicly available sequences. The EV types (E-5, E-9, and E-18) exhibited a lower worldwide genetic diversity (respective number of genogroups: 4, 5, and 3) in comparison to CV-A9 (n = 10). The phylogenetic trees estimated with both 1D/VP1 and 3CD sequence data showed variations in the number of co-circulating lineages over the last 20 years among the four EV types. Despite the low number of genogroups in E-18, the virus exhibited the highest number of recombinant 3CD lineages (n = 10) versus 4 (E-5) to 8 (E-9). The phylogenies provided evidence of multiple transportation events between France and Tunisia involving E-5, E-9, E-18, and CV-A9 strains. Virus spread events between France and 17 other countries in five continents had high probabilities of occurrence as those between Tunisia and two European countries other than France. All transportation events were supported by BF values > 10. Inferring the source of virus transmission from phylogenetic data may provide insights into the patterns of sporadic and epidemic diseases caused by EVs.	[Othman, Ines; Slama, Ichrak; Mastouri, Maha; Aouni, Mahjoub] Univ Monastir, Fac Pharm, LR99 ES27, Monastir, Tunisia; [Othman, Ines; Slama, Ichrak] Univ Carthage, Fac Sci Bizerte, Carthage, Tunisia; [Mirand, Audrey; Peigue-Lafeuille, Helene; Bailly, Jean-Luc] Univ Auvergne, EPIE, EA 4843, Clermont Ferrand, France; [Mirand, Audrey; Peigue-Lafeuille, Helene] CHU Clermont Ferrand, Serv Virol, Ctr Natl Reference Enterovirus Parechovirus, Clermont Ferrand, France; [Mastouri, Maha] Fattouma Bourguiba Univ Hosp, Microbiol Lab, Monastir, Tunisia	Universite de Monastir; Universite de Carthage; Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Universite de Monastir; Hopital Fattouma Bourguiba	Bailly, JL (corresponding author), Univ Auvergne, EPIE, EA 4843, Clermont Ferrand, France.	j-luc.bailly@udamail.fr	Bailly, Jean-Luc/ABE-9210-2020	Bailly, Jean-Luc/0000-0002-9770-6450	Ministere de l'Enseignement Superieur et de la Recherche Scientifique of Tunisia; Ministere de l'Education Nationale et de la Recherche (France)	Ministere de l'Enseignement Superieur et de la Recherche Scientifique of Tunisia; Ministere de l'Education Nationale et de la Recherche (France)	Ines Othman was enrolled in the Faculty of Sciences in Bizerte, University of Carthage, Tunisia, and received a fellowship grant from the Ministere de l'Enseignement Superieur et de la Recherche Scientifique of Tunisia. The study was funded by the Ministere de l'Education Nationale et de la Recherche (France). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkhalek I, 2015, ARCH VIROL, V160, P2815, DOI 10.1007/s00705-015-2561-5; Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320; Antona D, 2007, EUR J CLIN MICROBIOL, V26, P403, DOI 10.1007/s10096-007-0306-4; Baek K, 2009, J MICROBIOL BIOTECHN, V19, P1055, DOI 10.4014/jmb.0810.584; Bahri O, 2005, J MED MICROBIOL, V54, P63, DOI 10.1099/jmm.0.45695-0; Bailly JL, 2011, INFECT GENET EVOL, V11, P276, DOI 10.1016/j.meegid.2010.06.019; Bailly JL, 2009, INFECT GENET EVOL, V9, P699, DOI 10.1016/j.meegid.2008.04.009; Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Brunel D, 2007, J CLIN MICROBIOL, V45, P2068, DOI 10.1128/JCM.00320-07; Cabrerizo M, 2014, CLIN MICROBIOL INFEC, V20, pO150, DOI 10.1111/1469-0691.12361; Chapin M., 2013, TUNISIE SECTEUR TOUR; Chu PY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129272; Cui AL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-72; Danthanarayana N, 2015, J MED VIROL, V87, P2033, DOI 10.1002/jmv.24267; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; EL Hiar R, 2012, INDIAN J VIROL, V23, P294, DOI 10.1007/s13337-012-0104-1; Faria NR, 2011, CURR OPIN VIROL, V1, P423, DOI 10.1016/j.coviro.2011.10.003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fischer TK, 2014, EURO SURVEILL, V19; Hassel C, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES.2015.20.34.30005; Huang YC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-33; Ke GM, 2011, VIRUS GENES, V42, P178, DOI 10.1007/s11262-010-0565-5; Khetsuriani N, 2006, MMWR-MORBID MORTAL W, V55, P1; Kyriakopoulou Z, 2015, INFECT GENET EVOL, V32, P305, DOI 10.1016/j.meegid.2015.03.008; Lang M, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.44.20952; Lefterova MI, 2013, J CLIN MICROBIOL, V51, P684, DOI 10.1128/JCM.02405-12; Leitch ECM, 2010, J VIROL, V84, P9292, DOI 10.1128/JVI.00783-10; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lindberg AM, 2003, J GEN VIROL, V84, P1223, DOI 10.1099/vir.0.18971-0; Lu QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052073; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; McMinn PC, 2012, CURR OPIN VIROL, V2, P199, DOI 10.1016/j.coviro.2012.02.009; Meijer A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.42.20935; Messacar K, 2015, LANCET, V385, P1662, DOI 10.1016/S0140-6736(14)62457-0; Mirand A, 2012, CLIN MICROBIOL INFEC, V18, pE110, DOI 10.1111/j.1469-0691.2012.03789.x; Mirand A, 2008, J CLIN MICROBIOL, V46, P87, DOI 10.1128/JCM.01020-07; Moreau Brigitte, 2011, Case Rep Gastroenterol, V5, P617, DOI 10.1159/000333135; Nasri D, 2007, EXPERT REV MOL DIAGN, V7, P419, DOI 10.1586/14737159.7.4.419; Othman I, 2015, DIAGN MICRO IN PRESS; Piralla A, 2014, J MED VIROL, V86, P1590, DOI 10.1002/jmv.23821; Puenpa J, 2013, EMERG INFECT DIS, V19, P641, DOI 10.3201/eid1904.121666; Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Roda D, 2015, EUR J PEDIATR, V174, P1549, DOI 10.1007/s00431-015-2571-z; Santti J, 2000, J GEN VIROL, V81, P1361, DOI 10.1099/0022-1317-81-5-1361; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Stack JC, 2010, J R SOC INTERFACE, V7, P1119, DOI 10.1098/rsif.2009.0530; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tryfonos C, 2011, J MED MICROBIOL, V60, P1433, DOI 10.1099/jmm.0.029892-0; Tsai HP, 2011, J MED MICROBIOL, V60, P1360, DOI 10.1099/jmm.0.027698-0; Vedrine H, 2013, PARTNERSHIP FUTURE 1; Volle R, 2014, J INFECT DIS, V210, P576, DOI 10.1093/infdis/jiu178; Yarmolskaya MS, 2015, INFECT GENET EVOL, V30, P244, DOI 10.1016/j.meegid.2014.12.033; Yip Cyril C Y, 2013, Emerg Health Threats J, V6, P19780, DOI 10.3402/ehtj.v6i0.19780	58	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145674	10.1371/journal.pone.0145674	http://dx.doi.org/10.1371/journal.pone.0145674			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709514	Green Published, Green Submitted, gold			2022-12-27	WOS:000367451400069
J	Seimon, TA; Ayebare, S; Sekisambu, R; Muhindo, E; Mitamba, G; Greenbaum, E; Menegon, M; Pupin, F; McAloose, D; Ammazzalorso, A; Meirte, D; Lukwago, W; Behangana, M; Seimon, A; Plumptre, AJ				Seimon, Tracie A.; Ayebare, Samuel; Sekisambu, Robert; Muhindo, Emmanuel; Mitamba, Guillain; Greenbaum, Eli; Menegon, Michele; Pupin, Fabio; McAloose, Denise; Ammazzalorso, Alyssa; Meirte, Danny; Lukwago, Wilbur; Behangana, Mathias; Seimon, Anton; Plumptre, Andrew J.			Assessing the Threat of Amphibian Chytrid Fungus in the Albertine Rift: Past, Present and Future	PLOS ONE			English	Article							AFRICAN CLAWED FROGS; BATRACHOCHYTRIUM-DENDROBATIDIS; HIGH PREVALENCE; ANURA ARTHROLEPTIDAE; CHYTRIDIOMYCOSIS; PATHOGEN; CLIMATE; DISEASE; CONSERVATION; TEMPERATURE	Batrachochytrium dendrobatidis (Bd), the cause of chytridiomycosis, is a pathogenic fungus that is found worldwide and is a major contributor to amphibian declines and extinctions. We report results of a comprehensive effort to assess the distribution and threat of Bd in one of the Earth's most important biodiversity hotspots, the Albertine Rift in central Africa. In herpetological surveys conducted between 2010 and 2014, 1018 skin swabs from 17 amphibian genera in 39 sites across the Albertine Rift were tested for Bd by PCR. Overall, 19.5% of amphibians tested positive from all sites combined. Skin tissue samples from 163 amphibians were examined histologically; of these two had superficial epidermal intracorneal fungal colonization and lesions consistent with the disease chytridiomycosis. One amphibian was found dead during the surveys, and all others encountered appeared healthy. We found no evidence for Bd-induced mortality events, a finding consistent with other studies. To gain a historical perspective about Bd in the Albertine Rift, skin swabs from 232 museum-archived amphibians collected as voucher specimens from 1925-1994 were tested for Bd. Of these, one sample was positive; an Itombwe River frog (Phrynobatrachus asper) collected in 1950 in the Itombwe highlands. This finding represents the earliest record of Bd in the Democratic Republic of Congo. We modeled the distribution of Bd in the Albertine Rift using MaxEnt software, and trained our model for improved predictability. Our model predicts that Bd is currently widespread across the Albertine Rift, with moderate habitat suitability extending into the lowlands. Under climatic modeling scenarios our model predicts that optimal habitat suitability of Bd will decrease causing a major range contraction of the fungus by 2080. Our baseline data and modeling predictions are important for comparative studies, especially if significant changes in amphibian health status or climactic conditions are encountered in the future.	[Seimon, Tracie A.; Ayebare, Samuel; Muhindo, Emmanuel; Mitamba, Guillain; McAloose, Denise; Ammazzalorso, Alyssa; Seimon, Anton; Plumptre, Andrew J.] Wildlife Conservat Soc, Bronx, NY USA; [Sekisambu, Robert; Lukwago, Wilbur; Behangana, Mathias] Makerere Univ, Dept Environm Sci, Kampala, Uganda; [Greenbaum, Eli] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Menegon, Michele; Pupin, Fabio] Sci Museum Trento, MUSE, Trop Biodivers Sect, Trento, Italy; [Meirte, Danny] Royal Museum Cent Africa, Dept African Biol, Tervuren, Belgium	Wildlife Conservation Society; Makerere University; University of Texas System; University of Texas El Paso; Royal Museum for Central Africa	Seimon, TA (corresponding author), Wildlife Conservat Soc, Bronx, NY USA.	tseimon@wcs.org	Plumptre, Andrew J./X-3145-2019	Plumptre, Andrew J./0000-0002-9333-4047; Seimon, Anton/0000-0001-7326-0442	United States Fish and the Wildlife Service's (USFWS) Amphibian in Decline Fund [F12AP01162, F13AP00871]; IUCN Save our Species Fund [2011A-012]; John D. and Catherine T. MacArthur Foundation [09-93424-000 GSS]; Institute of Tropical Forest Conservation (ITFC); Institut Congolais pour la Conservation de la Nature (ICCN); Ugandan Wildlife Authority; Rwandan Development Board; Direct For Biological Sciences [1145459] Funding Source: National Science Foundation	United States Fish and the Wildlife Service's (USFWS) Amphibian in Decline Fund; IUCN Save our Species Fund; John D. and Catherine T. MacArthur Foundation; Institute of Tropical Forest Conservation (ITFC); Institut Congolais pour la Conservation de la Nature (ICCN); Ugandan Wildlife Authority; Rwandan Development Board; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was made possible by the generous support from the United States Fish and the Wildlife Service's (USFWS) Amphibian in Decline Fund (F12AP01162; F13AP00871) and the IUCN Save our Species Fund to AP (2011A-012), the John D. and Catherine T. MacArthur Foundation to AS (09-93424-000 GSS), the Institute of Tropical Forest Conservation (ITFC) and donors supporting the Wildlife Conservation Society Zoological and Health Programs to TAS and RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Institut Congolais pour la Conservation de la Nature (ICCN), Ugandan Wildlife Authority, and Rwandan Development Board for support for this research and help with the export of specimens for testing. We are grateful to WCS Rwanda, Uganda and DRC Programs, particularily Simon Nampindo, Deo Kujirakwinja, Doug Sheil, Miriam van Heist, who provided intellectual and logistical support, or helped arrange permits, and Mwenebatu M. Aristote and Wandege M. Moninga, who helped our teams collect specimens.	Annis SL, 2004, J WILDLIFE DIS, V40, P420, DOI 10.7589/0090-3558-40.3.420; Balaz V, 2012, HERPETOL J, V22, P191; Bell RC, 2011, ECOHEALTH, V8, P116, DOI 10.1007/s10393-010-0364-4; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Bletz MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08633; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brem F., 2007, FIELD SAMPLING PROTO; Brooks T, 2001, BIOSCIENCE, V51, P613, DOI 10.1641/0006-3568(2001)051[0613:TABFCI]2.0.CO;2; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Bustamante HM, 2010, INTEGR ZOOL, V5, P143, DOI 10.1111/j.1749-4877.2010.00197.x; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Catenazzi A, 2014, CONSERV BIOL, V28, P509, DOI 10.1111/cobi.12194; Catenazzi A, 2013, BIOL CONSERV, V159, P413, DOI 10.1016/j.biocon.2012.11.023; Channing Alan, 2006, Journal of East African Natural History, V95, P117, DOI 10.2982/0012-8317(2006)95[117:TBARHO]2.0.CO;2; Daszak P, 2004, HERPETOL J, V14, P201; Dehling JM, 2012, ZOOTAXA, P52; Doherty-Bone TM, 2013, DIS AQUAT ORGAN, V102, P187, DOI 10.3354/dao02557; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Evans BJ, 2011, J ZOOL, V283, P276, DOI 10.1111/j.1469-7998.2010.00769.x; Evans Ben J., 2008, Zootaxa, V1780, P55; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Forrest MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028444; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Gervasi SS, 2013, ECOHEALTH, V10, P166, DOI 10.1007/s10393-013-0832-8; Gilbert M, 2012, ECOHEALTH, V9, P386, DOI 10.1007/s10393-013-0817-7; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Goldberg TL, 2007, J WILDLIFE DIS, V43, P521, DOI 10.7589/0090-3558-43.3.521; Gower DJ, 2012, HERPETOL J, V22, P225; Greenbaum E, 2015, HERPETOL J, V25, P91; Greenbaum Eli, 2014, Herpetological Review, V45, P610; Greenbaum E, 2013, ZOOTAXA, V3731, P473, DOI 10.11646/zootaxa.3731.4.3; Greenbaum Eli, 2012, Herpetological Review, V43, P253; Greenbaum Eli, 2008, Herpetological Review, V39, P70; Herrmann SM, 2011, J APPL METEOROL CLIM, V50, P2504, DOI 10.1175/JAMC-D-11-024.1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Imasuen AA, 2009, FROGLOG, V90, P6; James TY, 2015, ECOL EVOL, V5, P4079, DOI 10.1002/ece3.1672; Kielgast J, 2010, ANIM CONSERV, V13, P36, DOI 10.1111/j.1469-1795.2009.00297.x; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Lane EP, 2003, J S AFR VET ASSOC, P20; Longo AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059499; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; McMenamin SK, 2008, P NATL ACAD SCI USA, V105, P16988, DOI 10.1073/pnas.0809090105; Muths E, 2008, BIOL CONSERV, V141, P1484, DOI 10.1016/j.biocon.2008.03.011; Nakicenovic N, 2000, EMM SCEN; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Parker JM, 2002, COMPARATIVE MED, V52, P265; Penner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056236; Pessier AP, 2009, MANUAL CONTROL INFEC; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Plumptre AJ, 2007, BIOL CONSERV, V134, P178, DOI 10.1016/j.biocon.2006.08.021; Portillo F, 2014, J HERPETOL, V48, P394, DOI 10.1670/13-043; Portillo F, 2014, HERPETOLOGICA, V70, P100, DOI 10.1655/HERPETOLOGICA-D-12-00087; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Reeder Natalie M.M., 2011, Herpetology Notes, V4, P83; Retallick RWR, 2007, DIS AQUAT ORGAN, V75, P201, DOI 10.3354/dao075201; Rodriguez D, 2014, MOL ECOL, V23, P774, DOI 10.1111/mec.12615; Roedder Dennis, 2009, Diversity, V1, P52; Rodder D, 2010, DIS AQUAT ORGAN, V92, P201, DOI 10.3354/dao02197; Rohr JR, 2008, P NATL ACAD SCI USA, V105, P17436, DOI 10.1073/pnas.0806368105; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Rosenblum EB, 2010, DIS AQUAT ORGAN, V92, P131, DOI 10.3354/dao02179; Rosenblum EB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000550; Rowley JJL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01515; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Schloegel LM, 2010, DIS AQUAT ORGAN, V92, P101, DOI 10.3354/dao02140; Seimon A, 2012, ALBERTINE RIFT CONSE; Seimon A, 2012, REGIONAL CLIMATOLOGY; Seimon A, 2013, CONSERVATION STRATEG, P103; Seimon TA, 2007, GLOBAL CHANGE BIOL, V13, P288, DOI 10.1111/j.1365-2486.2006.01278.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Soto-Azat C, 2009, DIS AQUAT ORGAN, V84, P163, DOI 10.3354/dao02029; Soto-Azat C, 2010, DIVERS DISTRIB, V16, P126, DOI 10.1111/j.1472-4642.2009.00618.x; Stevenson LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074456; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Talley BL, 2015, BIOL CONSERV, V182, P254, DOI 10.1016/j.biocon.2014.12.007; Tarrant J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069591; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063791; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065	89	13	13	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145841	10.1371/journal.pone.0145841	http://dx.doi.org/10.1371/journal.pone.0145841			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710251	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400083
J	De Hert, M; Van Bos, L; Sweers, K; Wampers, M; De Lepeleire, J; Correll, CU				De Hert, Marc; Van Bos, Liesbet; Sweers, Kim; Wampers, Martien; De Lepeleire, Jan; Correll, Christophe U.			Attitudes of Psychiatric Nurses about the Request for Euthanasia on the Basis of Unbearable Mental Suffering(UMS)	PLOS ONE			English	Article							PHYSICIAN-ASSISTED SUICIDE; PALLIATIVE CARE; INVOLVEMENT	Introduction When psychiatric patients express a wish for euthanasia, this should first and foremost be interpreted as a cry for help. Due to their close day-to-day relationship, psychiatric nurses may play an important and central role in responding to such requests. However, little is known about nurses' attitudes towards euthanasia motivated by unbearable mental suffering. Objectives The aim of this study was to provide insight into the attitudes and actions taken by psychiatric nurses when confronted with a patient's euthanasia request based on unbearable mental suffering (UMS). Method A questionnaire was sent to 11 psychiatric hospitals in the Flemish part of Belgium. Results The overall response rate was 70% (N = 627). Psychiatric nurses were frequently confronted with a request for euthanasia, either directly (N = 329, 53%) or through a colleague (N = 427, 69%). A majority (N = 536, 84%) did not object to euthanasia in a psychiatrically ill population with UMS. Confounding factors were the psychiatric diagnosis and the type of ward where the nurses were working. Most participants acknowledged a lack of knowledge and skills to adequately address the euthanasia request (N = 434, 71%). Nearly unanimously (N = 618, 99%), study participants indicated that dealing with euthanasia requests and other end-of-life issues should be part of the formal training of nurses. Conclusion The results highlight the need for ethically sound and comprehensive provision of care. Psychiatric nurses play an important role in dealing with the complex issue of requests for euthanasia. There is also a need for education, training and clear guidelines on the level of health care organizations.	[De Hert, Marc; Van Bos, Liesbet; Sweers, Kim; Wampers, Martien; De Lepeleire, Jan] Katholieke Univ Leuven, Dept Neurosci, Univ Psychiat Ctr Z Org, Leuven, Belgium; [De Lepeleire, Jan] Acad Ctr Gen Practice, Leuven, Belgium; [De Lepeleire, Jan] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Kortenberg, Belgium; [Correll, Christophe U.] Zucker Hillside Hosp, Glen Oaks, NY USA	KU Leuven; KU Leuven; Northwell Health	Sweers, K (corresponding author), Katholieke Univ Leuven, Dept Neurosci, Univ Psychiat Ctr Z Org, Leuven, Belgium.	kim.sweers@upckuleuven.be	Correll, Christoph/D-3530-2011; Correll, Christoph U/AAY-3179-2021; De Hert, Marc/AAH-6090-2021; De Lepeleire, Jan/AAE-5876-2019	Correll, Christoph/0000-0002-7254-5646; De Lepeleire, Jan/0000-0001-6152-2134; De Hert, Marc/0000-0003-4255-5920				Berghmans R, 2013, INT J LAW PSYCHIAT, V36, P436, DOI 10.1016/j.ijlp.2013.06.020; Bernheim J, 2012, TIJDSCHR GENEESK, V68, P549; Brzostek T, 2008, NURS ETHICS, V15, P761, DOI 10.1177/0969733008095386; de Casterle BD, 2006, J MED ETHICS, V32, P187, DOI 10.1136/jme.2005.011783; De Hert M, 2012, NEURON, V17, P4; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; De Lepeleire J, 2013, LEUVEN LEUVEN METAFO, P1; de Scheur GGV, 2008, J MED ETHICS, V34, P254, DOI 10.1136/jme.2006.018507; Denier Y, 2009, J PALLIAT CARE, V25, P264, DOI 10.1177/082585970902500404; Distelmans W, 2012, LEDEREEN HEEFT RECHT, P1; Finoulst M, 2013, INTERVIEW VANLOON TH, P32; Gielen J, 2009, INT J PALLIAT NURS, V15, P488, DOI 10.12968/ijpn.2009.15.10.44886; Goethals S, 2010, INT J NURS STUD, V47, P635, DOI 10.1016/j.ijnurstu.2009.12.010; Haarhuis JM, 2007, ONDERWIJS GEZONDHEID, V31, P236; Inghelbrecht E, 2010, CAN MED ASSOC J, V182, P905, DOI 10.1503/cmaj.091881; Inghelbrecht E, 2009, INT J NURS STUD, V46, P1209, DOI 10.1016/j.ijnurstu.2009.02.009; Janssen W, 2012, BUNNIK AGORA ONDERST, P1; Klimkiewicz A, 2015, PSYCHIATR POL, V49, P277, DOI 10.12740/PP/26071; Lynn J, 2003, RAND HLTH, P1; Macdonald E, 2009, EASEFUL DEATH IS THE, P1; Milders C F A, 2011, Tijdschr Psychiatr, V53, P415; Quaghebeur T, 2009, NURS ETHICS, V16, P466, DOI 10.1177/0969733009104610; Ruissen A, 2011, Tijdschr Psychiatr, V53, P405; Schotsmans P, 2009, CAMB Q HEALTHC ETHIC, V18, P420, DOI 10.1017/S0963180109090616; Sweers K, 2011, PSYCHIAT VERPLEGING, V87, P156; Sweers K, 2013, ARCH PSYCHIAT NURS, V27, P246, DOI 10.1016/j.apnu.2013.05.003; Thienpont L, 2011, UITGEGEVEN VZW VONKE, P1; Thienpont L, 2012, GOEDE DOOD 2002 2012, P191; Tholen AJ, 2009, RICHTLIJN OMGAAN MET, P1; Vandenberghe J, 2013, 11 KU LEUV MET, P1; Vandenberghe J, 2012, EUTHANASIE PSYCHIAT; Wasserman J, 2005, OMEGA-J DEATH DYING, V51, P229, DOI 10.2190/FGHE-YXHX-QJEA-MTM0	32	22	22	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144749	10.1371/journal.pone.0144749	http://dx.doi.org/10.1371/journal.pone.0144749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26700007	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600030
J	Martinez-Bonet, M; Palladino, C; Briz, V; Rudolph, JM; Fackler, OT; Relloso, M; Munoz-Fernandez, MA; Madrid, R				Martinez-Bonet, Marta; Palladino, Claudia; Briz, Veronica; Rudolph, Jochen M.; Fackler, Oliver T.; Relloso, Miguel; Angeles Munoz-Fernandez, Maria; Madrid, Ricardo			A Conserved GPG-Motif in the HIV-1 Nef Core Is Required for Principal Nef-Activities	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ADAPTER PROTEIN COMPLEXES; PATHOGENICITY FACTOR NEF; CD4 DOWN-REGULATION; TYPE-1 NEF; T-CELLS; DISEASE PROGRESSION; BINDING SURFACE; LCK; TRAFFICKING	To find out new determinants required for Nef activity we performed a functional alanine scanning analysis along a discrete but highly conserved region at the core of HIV-1 Nef. We identified the GPG-motif, located at the 121-137 region of HIV-1 NL4.3 Nef, as a novel protein signature strictly required for the p56(Lck) dependent Nef-induced CD4-downregulation in T-cells. Since the Nef-GPG motif was dispensable for CD4-downregulation in HeLa-CD4 cells, Nef/AP-1 interaction and Nef-dependent effects on Tf-R trafficking, the observed effects on CD4 downregulation cannot be attributed to structure constraints or to alterations on general protein trafficking. Besides, we found that the GPG-motif was also required for Nef-dependent inhibition of ring actin re-organization upon TCR triggering and MHCI downregulation, suggesting that the GPG-motif could actively cooperate with the Nef PxxP motif for these HIV-1 Nef-related effects. Finally, we observed that the Nef-GPG motif was required for optimal infectivity of those viruses produced in T-cells. According to these findings, we propose the conserved GPG-motif in HIV-1 Nef as functional region required for HIV-1 infectivity and therefore with a potential interest for the interference of Nef activity during HIV-1 infection.	[Martinez-Bonet, Marta; Palladino, Claudia; Briz, Veronica; Relloso, Miguel; Angeles Munoz-Fernandez, Maria] Inst Invest Biomed Gregorio Maranon IISGM, Lab Inmunobiol Mol, Madrid 28007, Spain; [Rudolph, Jochen M.; Fackler, Oliver T.] Univ Heidelberg Hosp, Dept Infect Dis, Integrat Virol, Heidelberg, Germany; [Madrid, Ricardo] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Dept Virol, Madrid, Spain	Ruprecht Karls University Heidelberg; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Madrid, R (corresponding author), UAM, CSIC, Ctr Biol Mol Severo Ochoa, Dept Virol, Madrid, Spain.	ricardo-m@cbm.csic.es	iMed.ULisboa, EEPHIV/B-4222-2014; Palladino, Claudia/E-2523-2014; Briz, Veronica VB/T-4183-2017; Relloso, Miguel/K-2238-2014	Palladino, Claudia/0000-0002-8148-0928; Briz, Veronica VB/0000-0003-2297-5098; Martinez Bonet, Marta/0000-0003-0715-403X; Relloso, Miguel/0000-0002-9181-2244; Fackler, Oliver Till/0000-0003-2982-4209; Munoz-Fernandez/0000-0002-0813-4500; Madrid Gonzalez, Ricardo/0000-0002-1350-9864	Ramon y Cajal research program [MICIIN-RYC-2005-002174]; Fondo de Investigacion Sanitaria en Espana [FIS-PS09/01386]; Comunidad de Madrid [S-2010/BMD-2332]; Deutsche Forschungsgemeinschaft [TRR83, 15]; Fondo de Investigacion Sanitaria en Espana (FIS)	Ramon y Cajal research program(Spanish Government); Fondo de Investigacion Sanitaria en Espana; Comunidad de Madrid(Comunidad de Madrid); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fondo de Investigacion Sanitaria en Espana (FIS)	This work was supported by the Ramon y Cajal research program (MICIIN-RYC-2005-002174; http://www.mineco.gob.es/portal/site/mineco/idi), Fondo de Investigacion Sanitaria en Espana (FIS-PS09/01386; http://www.isciii.es/) to RM, and Comunidad de Madrid (S-2010/BMD-2332; http://www.madrimasd.org/) to MAM-F, and the Deutsche Forschungsgemeinschaft (TRR83, project 15 to OTF). MM-B, CP and VB hold a fellowship from the Fondo de Investigacion Sanitaria en Espana (FIS, http://www.isciii.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham L, 2012, J IMMUNOL, V189, P1898, DOI 10.4049/jimmunol.1200652; Agopian K, 2006, J VIROL, V80, P3050, DOI 10.1128/JVI.80.6.3050-3061.2006; Atkins KM, 2008, J BIOL CHEM, V283, P11772, DOI 10.1074/jbc.M707572200; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; Birch MR, 2001, J CLIN VIROL, V22, P263, DOI 10.1016/S1386-6532(01)00198-6; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Burtey A, 2007, TRAFFIC, V8, P61, DOI 10.1111/j.1600-0854.2006.00512.x; Carl S, 2001, J VIROL, V75, P3657, DOI 10.1128/JVI.75.8.3657-3665.2001; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Coleman SH, 2006, J VIROL, V80, P1837, DOI 10.1128/JVI.80.4.1837-1849.2006; Collette Y, 1996, J BIOL CHEM, V271, P6333, DOI 10.1074/jbc.271.11.6333; Costa LJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-33; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; Craig HM, 2000, VIROLOGY, V271, P9, DOI 10.1006/viro.2000.0277; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Dubey S, 2008, J CLIN VIROL, V43, P25, DOI 10.1016/j.jcv.2008.03.026; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Guyader M, 2002, J VIROL, V76, P10356, DOI 10.1128/JVI.76.20.10356-10364.2002; Haller C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001212; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Haller C, 2011, EUR J CELL BIOL, V90, P913, DOI 10.1016/j.ejcb.2010.09.010; Imle A, 2015, MBIO, V6, DOI 10.1128/mBio.01309-15; Janvier K, 2003, J BIOL CHEM, V278, P8725, DOI 10.1074/jbc.M210115200; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Laguette N, 2010, MOL ASPECTS MED, V31, P418, DOI 10.1016/j.mam.2010.05.003; Laguette N, 2009, J VIROL, V83, P7117, DOI 10.1128/JVI.01648-08; Madrid R, 2005, J BIOL CHEM, V280, P5032, DOI 10.1074/jbc.M401202200; Manninen A, 2001, J VIROL, V75, P3034, DOI 10.1128/JVI.75.6.3034-3037.2001; Meuwissen PJ, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-34; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Pan XY, 2012, BLOOD, V119, P786, DOI 10.1182/blood-2011-08-373209; Rodes B, 2004, AIDS, V18, P1109, DOI [10.1097/00002030-200405210-00004, 10.1097/01.aids.0000125962.16506.f9]; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Rose JJ, 2005, J BIOL CHEM, V280, P7413, DOI 10.1074/jbc.M409420200; Rudolph JM, 2009, J VIROL, V83, P11528, DOI 10.1128/JVI.01423-09; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Saksela K, 2011, CURR HIV RES, V9, P531, DOI 10.2174/157016211798842107; Sarmady M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020735; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; Sol-Foulon N, 2002, IMMUNITY, V16, P145, DOI 10.1016/S1074-7613(02)00260-1; Stolp B, 2012, P NATL ACAD SCI USA, V109, P18541, DOI 10.1073/pnas.1204322109; Stolp B, 2010, J VIROL, V84, P3935, DOI 10.1128/JVI.02467-09; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Strasner AB, 2008, J IMMUNOL, V181, P3706, DOI 10.4049/jimmunol.181.5.3706; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Swigut T, 2001, EMBO J, V20, P1593, DOI 10.1093/emboj/20.7.1593; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Venzke S, 2006, J VIROL, V80, P11141, DOI 10.1128/JVI.01556-06; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1	53	2	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145239	10.1371/journal.pone.0145239	http://dx.doi.org/10.1371/journal.pone.0145239			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700863	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600055
J	Normann-Eide, E; Johansen, MS; Normann-Eide, T; Egeland, J; Wilberg, T				Normann-Eide, Eivind; Johansen, Merete Selsbakk; Normann-Eide, Tone; Egeland, Jens; Wilberg, Theresa			Personality Disorder and Changes in Affect Consciousness: A 3-Year Follow-Up Study of Patients with Avoidant and Borderline Personality Disorder	PLOS ONE			English	Article							MENTALIZATION-BASED TREATMENT; SEVERITY INDEXES; OUTPATIENT PSYCHOTHERAPY; INTENSIVE PSYCHOTHERAPY; EMOTION DYSREGULATION; AFFECT INTEGRATION; PROBLEMS SIPP-118; STEP-DOWN; SELF; THERAPY	Personality disorders (PDs) are highly prevalent in patients receiving psychiatric services, and are associated with significant personal and social costs. Over the past two decades, an increasing number of treatment studies have documented the effectiveness of treatment for patients with PDs, especially when it comes to reduction of symptom distress, risk taking behavior, self-harm, or suicide attempts. However, less is known about the more complex aims of improving the personality structure itself, such as identity-and interpersonal disturbances. Emotional dysfunction is closely associated with PD pathology. The present study investigated changes in affect consciousness (AC) in patients with avoidant or borderline PD, and how these changes were associated with clinical status after 3 years of follow-up. The study included 52 individuals; 79 percent were females, and mean age was 30 years. The evaluations included the Affect Consciousness Interview, Symptom Checklist-90-R, Circumplex of Interpersonal Problems, the Index of Self-Esteem, and three domains (Identity Integration, Relational Capacities, and Self-Control) of the Severity Indices of Personality Problems (SIPP-118). There was a significant increase in the Global AC and AC scores for most of the specific affects from baseline to follow-up. As the present study did not include a control group, it cannot be concluded that changes in AC are effects of psychotherapy, and the possibility of age-related maturation processes cannot be excluded. The change in Global AC contributed significantly to explained variance in the follow-up levels of Circumplex of Interpersonal Problems, and the two SIPP-118 domains Relational Capacities and Identity Integration. Improved AC was not associated with change in the Self-Control domain or the Global Severity Index of Symptom Checklist-90-R. The results suggest that AC may be altered for patients with borderline and avoidant PDs, and this is the first study to report that improvement in AC contribute significantly to the variance in the selfand interpersonal domains of personality functioning.	[Normann-Eide, Eivind; Johansen, Merete Selsbakk] Oslo Univ Hosp, Div Mental Hlth & Addict, Dept Personal Psychiat, Oslo, Norway; [Normann-Eide, Eivind; Normann-Eide, Tone; Egeland, Jens] Vestfold Hosp Trust, Div Mental Hlth & Addict, Res Dept, Tonsberg, Norway; [Johansen, Merete Selsbakk; Wilberg, Theresa] Univ Oslo, Inst Clin Med, Oslo, Norway; [Wilberg, Theresa] Oslo Univ Hosp, Div Mental Hlth & Addict, Dept Res & Dev, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Normann-Eide, E (corresponding author), Oslo Univ Hosp, Div Mental Hlth & Addict, Dept Personal Psychiat, Oslo, Norway.	norei2@ous-hf.no			Vestfold Hospital Trust; Oslo University Hospital	Vestfold Hospital Trust; Oslo University Hospital	This research was funded by the Vestfold Hospital Trust and Oslo University Hospital. The funding sources had no further role in the study design; collection, analysis or interpretation of data; the writing of the report; or the decision to submit the paper for publication.	ALDEN LE, 1990, J PERS ASSESS, V55, P521, DOI 10.1207/s15327752jpa5503&4_10; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Andrea H, 2007, SIPP118 VISPD ER U R; Antonsen BT, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-119; Arnevik E, 2009, PERSONAL MENT HEALTH, V3, P41, DOI 10.1002/pmh.60; Arnevik E, 2010, J PERS DISORD, V24, P188, DOI 10.1521/pedi.2010.24.2.188; Arnevik E, 2009, EUR PSYCHIAT, V24, P71, DOI 10.1016/j.eurpsy.2008.09.004; Bales D, 2012, J PERS DISORD, V26, P568, DOI 10.1521/pedi.2012.26.4.568; Bales DL, 2015, CLIN PSYCHOL PSYCHOT, V22, P409, DOI 10.1002/cpp.1914; Bastiaansen L, 2013, PERSONAL DISORD, V4, P293, DOI 10.1037/per0000018; Bateman A, 2008, AM J PSYCHIAT, V165, P631, DOI 10.1176/appi.ajp.2007.07040636; Bateman AW, 2015, LANCET, V385, P735, DOI 10.1016/S0140-6736(14)61394-5; Beblo T, 2013, PSYCHIAT RES, V210, P505, DOI 10.1016/j.psychres.2013.06.036; Berggraf L, 2014, PSYCHOTHERAPY, V51, P246, DOI 10.1037/a0036581; Berking M, 2012, CURR OPIN PSYCHIATR, V25, P128, DOI 10.1097/YCO.0b013e3283503669; Butler EA, 2003, EMOTION, V3, P48, DOI 10.1037/1528-3542.3.1.48; Chiesa M, 2002, PSYCHOL PSYCHOTHER-T, V75, P381, DOI 10.1348/147608302321151899; Choi-Kain LW, 2008, AM J PSYCHIAT, V165, P1127, DOI 10.1176/appi.ajp.2008.07081360; Clark LA, 2009, CURR DIR PSYCHOL SCI, V18, P27, DOI 10.1111/j.1467-8721.2009.01600.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conklin CZ, 2006, J NERV MENT DIS, V194, P69, DOI 10.1097/01.nmd.0000198138.41709.4f; Derogatis LR, 1983, SCL 90 R MANUAL ADM; Dimaggio G., 2015, METACOGNITIVE INTERP; Dimaggio G, 2013, PSYCHOTHER RES, V23, P624, DOI 10.1080/10503307.2013.845921; Dimaggio G, 2013, J PERS DISORD, V27, P371, DOI 10.1521/pedi_2012_26_043; Feenstra DJ, 2014, J PERS DISORD, V28, P101, DOI 10.1521/pedi.2014.28.1.101; Feenstra DJ, 2011, PSYCHOL ASSESSMENT, V23, P646, DOI 10.1037/a0022995; First M.B., 2016, STRUCTURED CLIN INTE; Geir P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109394; Giesen-Bloo J, 2006, ARCH GEN PSYCHIAT, V63, P649, DOI 10.1001/archpsyc.63.6.649; Glenn CR, 2009, J PERS DISORD, V23, P20, DOI 10.1521/pedi.2009.23.1.20; Gratz KL, 2006, J ABNORM PSYCHOL, V115, P850, DOI 10.1037/0021-843X.115.4.850; Greenberg L. S., 2008, HDB EMOTIONS, P88; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI 10.1037/1089-2680.2.3.271; Gude T, 2001, PSYCHOTHER RES, V11, P85, DOI 10.1080/713663854; Gullestad FS, 2012, PSYCHOTHER RES, V22, P426, DOI 10.1080/10503307.2012.662608; Holmqvist R, 2008, J INTERPERS VIOLENCE, V23, P209, DOI 10.1177/0886260507309341; Hopwood CJ, 2011, J PERS DISORD, V25, P305, DOI 10.1521/pedi.2011.25.3.305; Hudson WW, 1992, WALLMYR ASSESSMENT S; Hudson WW, 1982, CLIN MEASUREMENT PAC; Hummelen B, 2006, COMPR PSYCHIAT, V47, P376, DOI 10.1016/j.comppsych.2006.01.006; Hurley, 2003, TREATING AFFECT PHOB; Johansen MS, 2013, SCAND J PSYCHOL, V54, P515, DOI 10.1111/sjop.12076; Johnson JG, 2008, ACTA PSYCHIAT SCAND, V118, P410, DOI 10.1111/j.1600-0447.2008.01231.x; Joyce AS, 2013, PSYCHOTHER RES, V23, P690, DOI 10.1080/10503307.2013.803628; Jurist EL, 2005, PSYCHOANAL PSYCHOL, V22, P426, DOI 10.1037/0736-9735.22.3.426; Karterud S, 2007, GROUP, V31, P31; Kernberg OF, 2008, INT J PSYCHOANAL, V89, P601, DOI 10.1111/j.1745-8315.2008.00046.x; Koenigsberg HW, 2014, AM J PSYCHIAT, V171, P82, DOI 10.1176/appi.ajp.2013.13070852; Kvarstein EH, 2013, PERSONAL MENT HEALTH, V7, P265, DOI 10.1002/pmh.1226; Laurenceau JP, 1998, J PERS SOC PSYCHOL, V74, P1238, DOI 10.1037/0022-3514.74.5.1238; Lech B, 2012, PSYCHOLOGY, V3, P675, DOI DOI 10.4236/PSYCH.2012.39102; Lech B, 2012, EUR EAT DISORD REV, V20, pe50, DOI 10.1002/erv.1091; Lech B, 2008, SCAND J PSYCHOL, V49, P515, DOI 10.1111/j.1467-9450.2008.00666.x; Lecours S, 2011, PSYCHOL PSYCHOTHER-T, V84, P26, DOI 10.1111/j.2044-8341.2010.02006.x; Lynum LI, 2008, SCAND J PSYCHOL, V49, P469, DOI 10.1111/j.1467-9450.2008.00655.x; Magai C, 1999, HDB ATTACHMENT THEOR, P787; McCullough Vaillant L., 1997, CHANGING CHARACTER S; McMain S, 2013, PSYCHOTHER RES, V23, P658, DOI 10.1080/10503307.2013.838653; McMain SF, 2009, AM J PSYCHIAT, V166, P1365, DOI 10.1176/appi.ajp.2009.09010039; Mohaupt H, 2006, SCAND J PSYCHOL, V47, P237, DOI 10.1111/j.1467-9450.2006.00513.x; Monsen, 1999, PLURALISM SELF PSYCH, V15, P287; MONSEN J, 1995, SCAND J PSYCHOL, V36, P256, DOI 10.1111/j.1467-9450.1995.tb00985.x; Monsen J T, 1996, J Psychother Pract Res, V5, P238; Monsen J.T., 2008, AFFECT CONSCIOUSNESS; MONSEN JT, 1995, PSYCHOTHER RES, V5, P33, DOI 10.1080/10503309512331331126; Monsen JT, 1989, PSYCHOANALYSIS PSYCH, V7, P171; Monsen K, 2000, PSYCHOTHERAPY, V37, P257, DOI 10.1037/h0087658; Nicolo G, 2011, PSYCHIAT RES, V190, P37, DOI 10.1016/j.psychres.2010.07.046; Normann-Eide E, 2013, COMPR PSYCHIAT, V54, P149, DOI 10.1016/j.comppsych.2012.07.003; Pedersen G. A., 2002, J NORWEGIAN PSYCHOL, V39, P25; Ridings LE, 2014, PERS INDIV DIFFER, V57, P14, DOI 10.1016/j.paid.2013.09.008; Rime B, 2009, EMOT REV, V1, P60, DOI 10.1177/1754073908097189; Schanche E, 2011, PSYCHOTHERAPY, V48, P293, DOI 10.1037/a0022012; Sempertegui GA, 2013, CLIN PSYCHOL REV, V33, P426, DOI 10.1016/j.cpr.2012.11.006; Sheehan D. V., 1994, MINIINTERNATIONAL NE; Skodol AE, 2005, PSYCHOL MED, V35, P443, DOI 10.1017/S003329170400354X; Solbakken OA, 2012, PSYCHOTHER RES, V22, P656, DOI 10.1080/10503307.2012.700871; Solbakken OA, 2011, PSYCHOTHER RES, V21, P482, DOI 10.1080/10503307.2011.583696; Solbakken OA, 2011, J PERS ASSESS, V93, P257, DOI 10.1080/00223891.2011.558874; Svartberg M, 2004, AM J PSYCHIAT, V161, P810, DOI 10.1176/appi.ajp.161.5.810; Taylor CT, 2004, J PERS DISORD, V18, P571, DOI 10.1521/pedi.18.6.571.54792; Torgersen S, 2009, SCAND J PSYCHOL, V50, P624, DOI 10.1111/j.1467-9450.2009.00788.x; Verheul R, 2008, PSYCHOL ASSESSMENT, V20, P23, DOI 10.1037/1040-3590.20.1.23; Waller E, 2004, J PSYCHOSOM RES, V57, P239, DOI 10.1016/S0022-3999(03)00613-5; Zimmerman M, 2005, AM J PSYCHIAT, V162, P1911, DOI 10.1176/appi.ajp.162.10.1911	86	4	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145625	10.1371/journal.pone.0145625	http://dx.doi.org/10.1371/journal.pone.0145625			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26699730	Green Published, gold			2022-12-27	WOS:000367092600108
J	Pechey, R; Attwood, AS; Couturier, DL; Munafo, MR; Scott-Samuel, NE; Woods, A; Marteau, TM				Pechey, Rachel; Attwood, Angela S.; Couturier, Dominique-Laurent; Munafo, Marcus R.; Scott-Samuel, Nicholas E.; Woods, Andy; Marteau, Theresa M.			Does Glass Size and Shape Influence Judgements of the Volume of Wine?	PLOS ONE			English	Article							FOOD PORTION SIZE; DIMENSIONS; PERCEPTION; DRINKS; BIAS	Background Judgements of volume may influence the rate of consumption of alcohol and, in turn, the amount consumed. The aim of the current study was to examine the impact of the size and shape of wine glasses on perceptions of wine volume. Methods Online experiment: Participants (n = 360; recruited via Mechanical Turk) were asked to match the volume of wine in two wine glasses, specifically: 1. the Reference glass holding a fixed reference volume, and 2. the Comparison glass, for which the volume could be altered until participants perceived it matched the reference volume. One of three comparison glasses was shown in each trial: 'wider' (20% wider but same capacity); 'larger' (same width but 25% greater capacity); or 'wider-and-larger' (20% wider and 25% greater capacity). Reference volumes were 125ml, 175ml and 250ml, in a fully factorial within-subjects design: 3 (comparison glass) x 3 (reference volume). Non-zero differences between the volumes with which participants filled comparison glasses and the corresponding reference volumes were identified using sign-rank tests. Results Participants under-filled the wider glass relative to the reference glass for larger reference volumes, and over-filled the larger glass relative to the reference glass for all reference volumes. Results for the wider-and-larger glass showed a mixed pattern across reference volume. For all comparison glasses, in trials with larger reference volumes participants tended to fill the comparison glass less, relative to trials with smaller reference volumes for the same comparison glass. Conclusions These results are broadly consistent with people using the relative fullness of glasses to judge volume, and suggest both the shape and capacity of wine glasses may influence perceived volume. Perceptions that smaller glasses contain more than larger ones (despite containing the same volume), could slow drinking speed and overall consumption by serving standard portions in smaller glasses. This hypothesis awaits testing.	[Pechey, Rachel; Couturier, Dominique-Laurent; Marteau, Theresa M.] Univ Cambridge, Behaviour & Hlth Res Unit, Inst Publ Hlth, Cambridge, England; [Attwood, Angela S.; Munafo, Marcus R.] Univ Bristol, UK Ctr Tobacco & Alcohol Studies, Sch Expt Psychol, MRC Integrat Epidemiol Unit IEU, Bristol, Avon, England; [Scott-Samuel, Nicholas E.; Woods, Andy] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Woods, Andy] Univ Oxford, Dept Expt Psychol, Crossmodal Res Lab, Oxford OX1 3UD, England	University of Cambridge; University of Bristol; University of Bristol; University of Oxford	Marteau, TM (corresponding author), Univ Cambridge, Behaviour & Hlth Res Unit, Inst Publ Hlth, Cambridge, England.	tm388@cam.ac.uk	Attwood, Angela S/F-7071-2011; Munafo, Marcus/AAE-2306-2020	Attwood, Angela S/0000-0003-3696-4349; Munafo, Marcus/0000-0002-4049-993X; Woods, Andy/0000-0003-3797-3845; Marteau, Theresa/0000-0003-3025-1129; Couturier, Dominique-Laurent/0000-0001-5774-5036; Scott-Samuel, Nicholas/0000-0002-8270-8437; Pechey, Rachel/0000-0002-6558-388X	Department of Health Policy Research Programme (Policy Research Unit in Behaviour and Health) [PR-UN-0409-10109]; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research, under UK Clinical Research Collaboration; MRC [MC_UU_12013/6] Funding Source: UKRI; Medical Research Council [MC_UU_12013/6] Funding Source: researchfish	Department of Health Policy Research Programme (Policy Research Unit in Behaviour and Health); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research, under UK Clinical Research Collaboration(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the Department of Health Policy Research Programme (http://prp.dh.gov.uk/) (Policy Research Unit in Behaviour and Health [PR-UN-0409-10109]). ASA and MRM are members of the UK Centre for Tobacco and Alcohol Studies, a UKCRC Public Health Research: Centre of Excellence. Funding from British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. None of the funders had a role in the study design, data collection, analysis, interpretation, or decision to submit for publication. The research was conducted independently of the funders, and the views expressed in this paper are those of the authors and not necessarily those of the funders.	Attwood AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043007; Brunstrom JM, 2008, APPETITE, V51, P604, DOI 10.1016/j.appet.2008.04.017; Chandon P, 2009, J MARKETING RES, V46, P739, DOI 10.1509/jmkr.46.6.739; FRAYMAN BJ, 1981, PERCEPT PSYCHOPHYS, V29, P56, DOI 10.3758/BF03198840; Geier AB, 2006, PSYCHOL SCI, V17, P521, DOI 10.1111/j.1467-9280.2006.01738.x; Hock HS, 2010, SEEING PERCEIVING, V23, P173, DOI 10.1163/187847510X503597; Hollands JG, 2000, PSYCHOL REV, V107, P500, DOI 10.1037/0033-295X.107.3.500; Jackson R., 2010, INTERVENTIONS CONTRO; Kerr WC, 2009, DRUG ALCOHOL REV, V28, P360, DOI 10.1111/j.1465-3362.2009.00056.x; McClain AD, 2014, INT J OBESITY, V38, P657, DOI 10.1038/ijo.2013.169; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; NELSON M, 1994, BRIT J NUTR, V72, P649, DOI 10.1079/BJN19940069; *NICE, 2010, ALC US DIS PREV HARM; NISBETT RE, 1968, SCIENCE, V159, P1254, DOI 10.1126/science.159.3820.1254; PEARSON R G, 1964, Percept Mot Skills, V18, P889; Raghubir P, 1999, J MARKETING RES, V36, P313, DOI 10.2307/3152079; Turconi G, 2005, EUR J CLIN NUTR, V59, P923, DOI 10.1038/sj.ejcn.1602162; van Kleef E, 2014, PSYCHOL HEALTH, V29, P1081, DOI 10.1080/08870446.2014.909426; VAREY CA, 1990, J EXP PSYCHOL HUMAN, V16, P613, DOI 10.1037/0096-1523.16.3.613; Walker D, 2014, SUBST USE MISUSE, V49, P295, DOI 10.3109/10826084.2013.832327; Wansink B, 2003, J CONSUM RES, V30, P455, DOI 10.1086/378621; Wansink B, 2013, J EXP PSYCHOL-APPL, V19, P320, DOI 10.1037/a0035053; White AM, 2003, ALCOHOL CLIN EXP RES, V27, P1750, DOI 10.1097/01.ALC.0000095866.17973.AF; World Health Organization, 2009, EV EFF COST EFF INT; Yang S, 2005, J RETAILING, V81, P269, DOI 10.1016/j.jretai.2004.11.003	25	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144536	10.1371/journal.pone.0144536	http://dx.doi.org/10.1371/journal.pone.0144536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26698577	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600023
J	Sakashita, A; Kawabata, Y; Jincho, Y; Tajima, S; Kumamoto, S; Kobayashi, H; Matsui, Y; Kono, T				Sakashita, Akihiko; Kawabata, Yukiko; Jincho, Yuko; Tajima, Shiun; Kumamoto, Soichiro; Kobayashi, Hisato; Matsui, Yasuhisa; Kono, Tomohiro			Sex Specification and Heterogeneity of Primordial Germ Cells in Mice	PLOS ONE			English	Article							MEIOTIC PROPHASE; DNA METHYLATION; GENE-EXPRESSION; SERTOLI-CELLS; STEM-CELLS; IN-VIVO; MOUSE; DIFFERENTIATION; MEIOSIS; FETAL	In mice, primordial germ cells migrate into the genital ridges by embryonic day 13.5 (E13.5), where they are then subjected to a sex-specific fate with female and male primordial germ cells undergoing mitotic arrest and meiosis, respectively. However, the sex-specific basis of primordial germ cell differentiation is poorly understood. The aim of this study was to investigate the sex-specific features of mouse primordial germ cells. We performed RNA-sequencing (seq) of E13.5 female and male mouse primordial germ cells using next-generation sequencing. We identified 651 and 428 differentially expressed transcripts (>2-fold, P <0.05) in female and male primordial germ cells, respectively. Of these, many transcription factors were identified. Gene ontology and network analysis revealed differing functions of the identified female-and male-specific genes that were associated with primordial germ cell acquisition of sex-specific properties required for differentiation into germ cells. Furthermore, DNA methylation and ChIP-seq analysis of histone modifications showed that hypo-methylated gene promoter regions were bound with H3K4me3 and H3K27me3. Our global transcriptome data showed that in mice, primordial germ cells are decisively assigned to a sex-specific differentiation program by E13.5, which is necessary for the development of vital germ cells.	[Sakashita, Akihiko; Kawabata, Yukiko; Jincho, Yuko; Tajima, Shiun; Kumamoto, Soichiro; Kono, Tomohiro] Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo, Japan; [Kobayashi, Hisato; Kono, Tomohiro] Tokyo Univ Agr, NODAI Genome Res Ctr, Setagaya Ku, Tokyo, Japan; [Matsui, Yasuhisa] Tohoku Univ, Cell Resource Ctr Biomed Res, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan	Tokyo University of Agriculture; Tokyo University of Agriculture; Tohoku University	Kono, T (corresponding author), Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo, Japan.	tomohiro@nodai.ac.jp	Kobayashi, Hisato/AAP-7910-2020	Matsui, Yasuhisa/0000-0001-7026-6355; Kumamoto, Soichiro/0000-0002-3492-117X; Kobayashi, Hisato/0000-0003-3800-4691	JST; CREST; Grants-in-Aid for Scientific Research [25114003] Funding Source: KAKEN	JST(Japan Science & Technology Agency (JST)); CREST(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TK was supported by Grants-in-Aid for Scientific Research from JST and from CREST.	Adams IR, 2002, DEVELOPMENT, V129, P1155; Albrecht KH, 2001, DEV BIOL, V240, P92, DOI 10.1006/dbio.2001.0438; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Ben-Shushan E, 2015, STEM CELLS, V33, P403, DOI 10.1002/stem.1873; Bowles J, 2007, DEVELOPMENT, V134, P3401, DOI 10.1242/dev.001107; Brind'Amour J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7033; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; COUCOUVANIS EC, 1993, EXP CELL RES, V209, P238, DOI 10.1006/excr.1993.1307; De Gobbi M, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-9; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Garcia TX, 2013, CELL CYCLE, V12, P2538, DOI 10.4161/cc.25627; Ghafari F, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-87; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; Green DR, 2000, J CELL BIOL, V150, pF5, DOI 10.1083/jcb.150.1.F5; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; Ho DWY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037159; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kobayashi H, 2013, GENOME RES, V23, P616, DOI 10.1101/gr.148023.112; Lei L, 2013, DEVELOPMENT, V140, P2075, DOI 10.1242/dev.093864; Lesch BJ, 2013, P NATL ACAD SCI USA, V110, P16061, DOI 10.1073/pnas.1315204110; Malki S, 2014, DEV CELL, V29, P521, DOI 10.1016/j.devcel.2014.04.027; McClellan KA, 2003, DEV BIOL, V258, P334, DOI 10.1016/S0012-1606(03)00132-5; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morita Y, 2001, CELL DEATH DIFFER, V8, P614, DOI 10.1038/sj.cdd.4400845; Nakato R, 2013, GENES CELLS, V18, P589, DOI 10.1111/gtc.12058; Ng JH, 2013, DEV CELL, V24, P324, DOI 10.1016/j.devcel.2012.12.011; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Sabour D, 2011, HUM MOL GENET, V20, P115, DOI 10.1093/hmg/ddq450; Sachs M, 2013, CELL REP, V3, P1777, DOI 10.1016/j.celrep.2013.04.032; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Souquet B, 2012, ENDOCRINOLOGY, V153, P2466, DOI 10.1210/en.2011-2056; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; Tanaka SS, 2014, CELL MOL LIFE SCI, V71, P4781, DOI 10.1007/s00018-014-1703-3; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Wang RA, 1998, BIOL REPROD, V58, P1250, DOI 10.1095/biolreprod58.5.1250; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Wu Q, 2013, DEVELOPMENT, V140, P291, DOI 10.1242/dev.087882; Xu XN, 2001, NAT IMMUNOL, V2, P384, DOI 10.1038/87682; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yokobayashi S, 2013, NATURE, V495, P236, DOI 10.1038/nature11918; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675	53	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144836	10.1371/journal.pone.0144836	http://dx.doi.org/10.1371/journal.pone.0144836			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700643	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092600034
J	Brodie, BS; Smith, MA; Lawrence, J; Gries, G				Brodie, Bekka S.; Smith, Maia A.; Lawrence, Jason; Gries, Gerhard			Effects of Floral Scent, Color and Pollen on Foraging Decisions and Oocyte Development of Common Green Bottle Flies	PLOS ONE			English	Article							COCHLIOMYIA-HOMINIVORAX DIPTERA; BLOWFLY LUCILIA-SERICATA; OVARIAN DEVELOPMENT; FEEDING PREFERENCES; SARCOPHAGA-BULLATA; OVIPOSITION SITES; RESOURCE-LOCATION; NEW-ZEALAND; CALLIPHORIDAE; CUPRINA	The common green bottle fly Lucilia sericata (Meigen) and other filth flies frequently visit pollen-rich composite flowers such as the Oxeye daisy, Leucanthemum vulgare Lam. In laboratory experiments with L. sericata, we investigated the effect of generic floral scent and color cues, and of Oxeye daisy-specific cues, on foraging decisions by recently eclosed flies. We also tested the effect of a floral pollen diet with 0-35% moisture content on the ability of females to mature their oocytes. Our data indicate that (1) young flies in the presence of generic floral scent respond more strongly to a uniformly yellow cue than to any other uniform color cue (green, white, black, blue, red) except for ultraviolet (UV); (2) the floral scent of Oxeye daisies enhances the attractiveness of a yellow cue; and (3) moisture-rich pollen provides nutrients that facilitate ovary maturation of flies. With evidence that L. sericata exploits floral cues during foraging, and that pollen can be an alternate protein source to animal feces and carrion, Pollen apparently plays a major role in the foraging ecology of L. sericata and possibly other filth flies. These flies, in turn, may play a significant role as pollinators, as supported by a recently published study.	[Brodie, Bekka S.; Smith, Maia A.; Lawrence, Jason; Gries, Gerhard] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Brodie, BS (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	bekkasbrodie@gmail.com			Natural Sciences and Engineering Research Council of Canada (NSERC) - Industrial Research Chair; Scotts Canada Limited [IRCPJ/310420-2013]	Natural Sciences and Engineering Research Council of Canada (NSERC) - Industrial Research Chair(Natural Sciences and Engineering Research Council of Canada (NSERC)); Scotts Canada Limited	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) - Industrial Research Chair to G. G., with Scotts Canada Limited as the industrial partner (Project funding sources number: IRCPJ/310420-2013).	Aak A, 2011, ENTOMOL EXP APPL, V139, P25, DOI 10.1111/j.1570-7458.2011.01103.x; ADAMS TS, 1979, J MED ENTOMOL, V15, P472, DOI 10.1093/jmedent/15.5-6.472; Ahmad A, 2006, J MED ENTOMOL, V43, P1129, DOI 10.1603/0022-2585(2006)43[1129:EOSOBI]2.0.CO;2; Blowflies Erzinclioglu Z., 1996, GREAT BRITAIN RICHMO; Blystone AM, 2014, J MED ENTOMOL, V51, P1296, DOI 10.1603/ME13157; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Brodie B, 2014, ENTOMOL EXP APPL, V153, P114, DOI 10.1111/eea.12238; Browne LB, 2001, ENTOMOL EXP APPL, V100, P137, DOI 10.1046/j.1570-7458.2001.00859.x; BROWNE LB, 1979, J INSECT PHYSIOL, V25, P147, DOI 10.1016/0022-1910(79)90093-3; Byrd JH., 2010, FORENSIC ENTOMOLOGY, P41; Carter DO, 2007, NATURWISSENSCHAFTEN, V94, P12, DOI 10.1007/s00114-006-0159-1; Castellanos MC, 2004, J EVOLUTION BIOL, V17, P876, DOI 10.1111/j.1420-9101.2004.00729.x; Chaudhury MF, 2010, J MED ENTOMOL, V47, P349, DOI 10.1603/ME09235; Chittka L, 1997, ISRAEL J PLANT SCI, V45, P115, DOI 10.1080/07929978.1997.10676678; Chittka L, 1996, J THEOR BIOL, V181, P179, DOI 10.1006/jtbi.1996.0124; CLIFT AD, 1976, AUST J ZOOL, V24, P87, DOI 10.1071/ZO9760087; COOK DF, 1991, B ENTOMOL RES, V81, P249, DOI 10.1017/S0007485300033502; CURRAH L, 1984, ANN APPL BIOL, V105, P167, DOI 10.1111/j.1744-7348.1984.tb02812.x; DAY S, 1990, J APICULT RES, V29, P138, DOI 10.1080/00218839.1990.11101210; DESALOMON CH, 1983, J COMP PHYSIOL, V150, P31, DOI 10.1007/BF00605285; Diclaro JW, 2012, J MED ENTOMOL, V49, P94, DOI 10.1603/ME10257; Dinkel T, 2001, J INSECT PHYSIOL, V47, P1111, DOI 10.1016/S0022-1910(01)00080-4; Dobson HEM, 2006, BIOLOGY OF FLORAL SCENT, P147; Dobson Heidi E.M., 1994, P47; Douglas JM, 2007, J EXP BIOL, V210, P788, DOI 10.1242/jeb.02713; Dudareva N, 2006, BIOL FLORAL SCENT; Evans A. C., 1935, Bulletin of Entomological Research London, V26, P115, DOI 10.1017/S0007485300024949; Fuenmayor C, 2014, REV MVZ CORDOBA, V19, P4003, DOI 10.21897/rmvz.120; FUKUSHI T, 1989, J COMP PHYSIOL A, V166, P57, DOI 10.1007/BF00190210; Galloway Alison, 1997, P139; Geraci D, 1989, POLLINOSIS, P240; Gilbert F, 1998, BIOL J LINN SOC, V63, P495, DOI 10.1111/j.1095-8312.1998.tb00327.x; Gomes L, 2007, NEOTROP ENTOMOL, V36, P633, DOI 10.1590/S1519-566X2007000500001; Hall DJ, 1948, BLOW FLIES N AM; HASLETT JR, 1983, PHYSIOL ENTOMOL, V8, P167, DOI 10.1111/j.1365-3032.1983.tb00345.x; HEATH ACG, 1982, NZ ENTOMOL, V7, P343, DOI 10.1080/00779962.1982.9722422; HERBERT EW, 1978, APIDOLOGIE, V9, P33, DOI 10.1051/apido:19780103; Hikl AL, 2011, J INSECT SCI, V11, P1, DOI 10.1673/031.011.9901; Jurgens A, 2013, ECOL LETT, V16, P1157, DOI 10.1111/ele.12152; KARCZEWSKI J, 1967, Fragmenta Faunistica (Warsaw), V13, P407; KAY QON, 1976, NATURE, V261, P230, DOI 10.1038/261230a0; Kessler D, 2008, SCIENCE, V321, P1200, DOI 10.1126/science.1160072; King C, 2013, METHODS ECOL EVOL, V4, P811, DOI 10.1111/2041-210X.12074; Koski MH, 2014, FUNCT ECOL, V28, P868, DOI 10.1111/1365-2435.12242; Kroon G.H., 1974, Journal apic Res, V13, P177; Larson BMH, 2001, CAN ENTOMOL, V133, P439, DOI 10.4039/Ent133439-4; Leonard AS, 2011, J EXP BIOL, V214, P113, DOI 10.1242/jeb.047407; LUNAU K, 1995, J COMP PHYSIOL A, V177, P1; Mackerras M. J., 1933, Bulletin of Entomological Research London, V24, P353, DOI 10.1017/S0007485300031680; Mohr RM, 2015, INT J LEGAL MED, V129, P851, DOI 10.1007/s00414-014-1094-x; Mohr RM, 2014, J MED ENTOMOL, V51, P702, DOI 10.1603/ME13149; Munawar M. S., 2011, Journal of Agricultural Research (Lahore), V49, P49; Nuttman CV, 2006, BIOL J LINN SOC, V87, P427, DOI 10.1111/j.1095-8312.2006.00582.x; Orford KA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2934; Pietro Z, 2013, ARTHROPOD-PLANT INTE, V7, P485; Pombal ECP, 2000, PLANT SYST EVOL, V221, P141, DOI 10.1007/BF01089290; POTTER CF, 1988, AM MIDL NAT, V120, P156, DOI 10.2307/2425896; PRIMACK RB, 1983, NEW ZEAL J BOT, V21, P317, DOI 10.1080/0028825X.1983.10428561; Proctor M., 1996, NATURAL HIST POLLINA; Raguso RA, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P83, DOI 10.1017/CBO9780511542268.006; RATHMAN ES, 1990, AM MIDL NAT, V124, P379, DOI 10.2307/2426188; READSHAW JL, 1983, J ANIM ECOL, V52, P879, DOI 10.2307/4461; Richard R, 2012, FUNCT ECOL, V26, P1399, DOI 10.1111/j.1365-2435.2012.02050.x; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Sasaki H, 2001, APPL ENTOMOL ZOOL, V36, P515, DOI 10.1303/aez.2001.515; Shuttleworth A, 2010, P ROY SOC B-BIOL SCI, V277, P2811, DOI 10.1098/rspb.2010.0491; Singh B, 2015, APPL MICROBIOL BIOT, V99, P869, DOI 10.1007/s00253-014-6115-7; SPIVAK M, 1991, ANN ENTOMOL SOC AM, V84, P447, DOI 10.1093/aesa/84.4.447; Stensmyr MC, 2002, NATURE, V420, P625, DOI 10.1038/420625a; STOFFOLANO JG, 1995, MED VET ENTOMOL, V9, P388, DOI 10.1111/j.1365-2915.1995.tb00010.x; Stone CM, 2009, J MED ENTOMOL, V46, P1327, DOI 10.1603/033.046.0611; Thapa R.B., 2006, Journal of the Institute of Agriculture and Animal Science, V27, P1; Tomberlin JK, 2012, ANIM BEHAV, V84, P1449, DOI 10.1016/j.anbehav.2012.09.013; TORR SJ, 1992, B ENTOMOL RES, V82, P417, DOI 10.1017/S0007485300041213; Urru I, 2010, BIOL J LINN SOC, V101, P991, DOI 10.1111/j.1095-8312.2010.01537.x; Wall R, 1996, MED VET ENTOMOL, V10, P235, DOI 10.1111/j.1365-2915.1996.tb00736.x; WALL R, 1992, MED VET ENTOMOL, V6, P67, DOI 10.1111/j.1365-2915.1992.tb00038.x; Wall R, 2001, PHYSIOL ENTOMOL, V26, P212, DOI 10.1046/j.0307-6962.2001.00237.x; Wardhaugh KG, 2008, ENTOMOL EXP APPL, V126, P179, DOI 10.1111/j.1570-7458.2007.00659.x; Webber LG, 1956, AUST J ZOOL, V5, P164; WILLIAMS KL, 1979, INT J INVER REP DEV, V1, P75	81	15	16	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145055	10.1371/journal.pone.0145055	http://dx.doi.org/10.1371/journal.pone.0145055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717311	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500020
J	Chaves-Moreno, D; Wos-Oxley, ML; Jauregui, R; Medina, E; Oxley, APA; Pieper, DH				Chaves-Moreno, Diego; Wos-Oxley, Melissa L.; Jauregui, Ruy; Medina, Eva; Oxley, Andrew P. A.; Pieper, Dietmar H.			Application of a Novel "Pan-Genome"-Based Strategy for Assigning RNAseq Transcript Reads to Staphylococcus aureus Strains	PLOS ONE			English	Article							NASAL EPITHELIAL-CELLS; SURFACE PROTEIN SASG; METHICILLIN-RESISTANT; IDENTIFICATION; VIRULENCE; DIVERSITY; EVOLUTION; ADHERENCE; SEQUENCE; GENES	Understanding the behaviour of opportunistic pathogens such as Staphylococcus aureus in their natural human niche holds great medical interest. With the development of sensitive molecular methods and deep-sequencing technology, it is now possible to robustly assess the global transcriptome of bacterial species in their human habitat. However, as the genomes of the colonizing strains are often not available compiling the pan-genome for the species of interest may provide an effective method to reliably and rapidly compile the transcriptome of a bacterial species. The pan-genome of S. aureus and its associated core and accessory components were compiled based on 25 genomes and comprises a total of 65,557 proteins clustering into 4,198 Orthologous Groups (OGs). The generated gene catalogue was used to assign RNAseq-derived sequence reads to S. aureus in a variety of in vitro and in vivo samples. In all cases, the number of reads that could be assigned to S. aureus was greater using the OG database than using a reference genome. Growth of two S. aureus strains in synthetic nasal medium confirmed that both strains experienced strong iron starvation. Traits such as purine metabolism appeared to be more affected in a typical nasal colonizer than in a strain representative of the S. aureus USA300 lineage. Mapping sequencing reads from a metatranscriptome generated from the human anterior nares allowed the identification of genes highly expressed by S. aureus in vivo. The OG database generated in this study represents a useful tool to obtain a snapshot of the functional attributes of S. aureus under different in vitro and in vivo conditions. The approach proved to be advantageous to assign sequencing reads to bacterial strains when RNAseq data is derived from samples where strain information and/or the corresponding genome/s are unavailable.	[Chaves-Moreno, Diego; Wos-Oxley, Melissa L.; Jauregui, Ruy; Pieper, Dietmar H.] Helmholtz Ctr Infect Res, Microbial Interact & Proc Res Grp, Braunschweig, Germany; [Medina, Eva; Oxley, Andrew P. A.] Helmholtz Ctr Infect Res, Infect & Immunol Res Grp, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research	Pieper, DH (corresponding author), Helmholtz Ctr Infect Res, Microbial Interact & Proc Res Grp, Braunschweig, Germany.	dpi@helmholtz-hzi.de		Jauregui, Ruy/0000-0002-3484-8937; Oxley, Andrew/0000-0002-6056-7602	Federal Ministry of Education and Research BMBF project "Medical Infection Genomics" [0315832B]; BMBF [01KI1009A]	Federal Ministry of Education and Research BMBF project "Medical Infection Genomics"; BMBF(Federal Ministry of Education & Research (BMBF))	This work was funded by the Federal Ministry of Education and Research [http://www.bmbf.de/en/index.php] BMBF project "Medical Infection Genomics" to DHP (0315832B) and in part by the BMBF project "Skin Staph" to DHP (01KI1009A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A., 2013, J BACTERIOL PARASITO, V4, P167, DOI [10.4172/2155-9597.1000167, DOI 10.4172/2155-9597.1000167]; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beasley FC, 2009, MOL MICROBIOL, V72, P947, DOI 10.1111/j.1365-2958.2009.06698.x; Boissy R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-187; Boyle-Vavra S, 2015, MBIO, P6; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Cheung J, 2009, MOL MICROBIOL, V74, P594, DOI 10.1111/j.1365-2958.2009.06880.x; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-234; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; Corrigan RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-22; Croucher NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/j.mib.2010.09.009; Dale SE, 2004, INFECT IMMUN, V72, P29, DOI 10.1128/IAI.72.1.29-37.2004; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Friedman DB, 2006, PLOS PATHOG, V2, P777, DOI 10.1371/journal.ppat.0020087; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Goerke C, 2009, J BACTERIOL, V191, P3462, DOI 10.1128/JB.01804-08; Gorley C.K., 2006, GETTING STARTED PRIM; Grigg JC, 2010, J BIOL CHEM, V285, P11162, DOI 10.1074/jbc.M109.097865; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Huang Y, 2009, BIOINFORMATICS, V25, P1338, DOI 10.1093/bioinformatics/btp161; Kampen AH, 2005, INFECT IMMUN, V73, P1578, DOI 10.1128/IAI.73.3.1578-1583.2005; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kiser KB, 1999, INFECT IMMUN, V67, P5001, DOI 10.1128/IAI.67.10.5001-5006.1999; Krebes J, 2011, J CLIN MICROBIOL, V49, P430, DOI 10.1128/JCM.02039-10; Krismer B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003862; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuroda M, 2005, P NATL ACAD SCI USA, V102, P13272, DOI 10.1073/pnas.0502950102; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lindsay JA, 2010, INT J MED MICROBIOL, V300, P98, DOI 10.1016/j.ijmm.2009.08.013; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Meric G, 2015, GENOME BIOL EVOL, V7, P1313, DOI 10.1093/gbe/evv066; Miller RR, 2014, J INFECTION, V68, P426, DOI 10.1016/j.jinf.2013.12.013; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Muthukrishnan G, 2011, J PROTEOME RES, V10, P2064, DOI 10.1021/pr200029r; Pfingsten-Wurzburg S, 2011, J HOSP INFECT, V78, P108, DOI 10.1016/j.jhin.2011.02.011; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roche FM, 2003, MICROBIOL-SGM, V149, P2759, DOI 10.1099/mic.0.26412-0; Stewart FJ, 2010, ISME J, V4, P896, DOI 10.1038/ismej.2010.18; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Suzuki H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-38; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Wos-Oxley ML, 2010, ISME J, V4, P839, DOI 10.1038/ismej.2010.15; Xu Y, 2004, J INFECT DIS, V189, P2323, DOI 10.1086/420851	50	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145861	10.1371/journal.pone.0145861	http://dx.doi.org/10.1371/journal.pone.0145861			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717500	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500085
J	Flabouris, A; Nandal, S; Vater, L; Flabouris, K; O'Connell, A; Thompson, C				Flabouris, Arthas; Nandal, Savvy; Vater, Luke; Flabouris, Katerina; O'Connell, Alice; Thompson, Campbell			Multi-Tiered Observation and Response Charts: Prevalence and Incidence of Triggers, Modifications and Calls, to Acutely Deteriorating Adult Patients	PLOS ONE			English	Article							CARE LEFT UNDONE; MONITOR; ASSOCIATION; WORKLOAD; PATTERNS; CRITERIA; QUALITY	Background Observation charts are the primary tool for recording patient vital signs. They have a critical role in documenting triggers for a multi-tiered escalation response to the deteriorating patient. The objectives of this study were to ascertain the prevalence and incidence of triggers, trigger modifications and escalation response (Call) amongst general medical and surgical inpatients following the introduction of an observation and response chart (ORC). Methods Prospective (prevalence), over two 24-hour periods, and retrospective (incidence), over entire hospital stay, observational study of documented patient observations intended to trigger one of three escalation responses, being a MER-Medical Emergency Response [ highest tier], MDT-Multidisciplinary Team [ admitting team], or Nursesenior ward nurse [ lowest tier] response amongst adult general medical and surgical patients. Results Prevalence: 416 patients, 321 (77.2%) being medical admissions, median age 76 years (IQR 62, 85) and 95 (22.8%) Not for Resuscitation (NFR). Overall, 193 (46.4%) patients had a Trigger, being 17 (4.1%) MER, 45 (10.8%) MDT and 178 (42.8%) Nurse triggers. 60 (14.4%) patients had a Call, and 72 (17.3%) a modified Trigger. Incidence: 206 patients, of similar age, of whom 166 (80.5%) had a Trigger, 122 (59.2%) a Call, and 91 (44.2%) a modified Trigger. Prevalence and incidence of failure to Call was 33.2% and 68% of patients, respectively, particular for Nurse Triggers (26.7% and 62.1%, respectively). The number of Modifications, Calls, and failure to Call, correlated with the number of Triggers (0.912 [p< 0.01], 0.631 [p< 0.01], 0.988 [p< 0.01]). Conclusion Within a multi-tiered response system for the detection and response to the deteriorating patient Triggers, their Modifications and failure to Call are common, particularly within the lower tiers of escalation. The number of Triggers and their Modifications may erode the structure, compliance, and potential efficacy of structured observation and response charts within a multi-tiered response system.	[Flabouris, Arthas; O'Connell, Alice] Royal Adelaide Hosp, Intens Care Unit, Adelaide, SA 5000, Australia; [Flabouris, Arthas] Univ Adelaide, Discipline Acute Care Med, Adelaide, SA, Australia; [Nandal, Savvy; Thompson, Campbell] Royal Adelaide Hosp, Dept Med, Adelaide, SA 5000, Australia; [Vater, Luke; Flabouris, Katerina] Royal Adelaide Hosp, Fac Hlth Sci, Sch Med, Adelaide, SA 5000, Australia; [O'Connell, Alice; Thompson, Campbell] Univ Adelaide, Sch Med, Adelaide, SA, Australia	Royal Adelaide Hospital; University of Adelaide; Royal Adelaide Hospital; Royal Adelaide Hospital; University of Adelaide	Flabouris, A (corresponding author), Royal Adelaide Hosp, Intens Care Unit, Adelaide, SA 5000, Australia.	Arthas.Flabouris@health.sa.gov.au	Flabouris, Arthas/AAF-9477-2019; Flabouris, Arthas/L-1347-2019; Thompson, Campbell/E-2885-2010	Flabouris, Arthas/0000-0002-1535-9441; Thompson, Campbell/0000-0002-5164-3327; Vater, Luke/0000-0002-7754-8002				Ausserhofer D, 2014, BMJ QUAL SAF, V23, P126, DOI 10.1136/bmjqs-2013-002318; Azzopardi P, 2011, RESUSCITATION, V82, P167, DOI 10.1016/j.resuscitation.2010.10.013; Ball JE, 2014, BMJ QUAL SAF, V23, P116, DOI 10.1136/bmjqs-2012-001767; Bell MB, 2006, RESUSCITATION, V70, P66, DOI 10.1016/j.resuscitation.2005.11.011; Boniatti MM, 2014, CRIT CARE MED, V42, P26, DOI 10.1097/CCM.0b013e31829e53b9; Bucknall TK, 2013, RESUSCITATION, V84, P179, DOI 10.1016/j.resuscitation.2012.06.015; Buist M, 2004, RESUSCITATION, V62, P137, DOI 10.1016/j.resuscitation.2004.03.005; Casamento Andrew J, 2008, Crit Care Resusc, V10, P29; Chatterjee MT, 2005, POSTGRAD MED J, V81, P663, DOI 10.1136/pgmj.2004.031872; Chen J, 2009, CRIT CARE MED, V37, P148, DOI 10.1097/CCM.0b013e3181928ce3; Coventry C, 2013, RESUSCITATION, V84, P1035, DOI 10.1016/j.resuscitation.2013.01.021; Cretikos M, 2007, RESUSCITATION, V73, P62, DOI 10.1016/j.resuscitation.2006.08.020; Cretikos Michelle A, 2007, Crit Care Resusc, V9, P205; Cvach Maria, 2012, Biomed Instrum Technol, V46, P268, DOI 10.2345/0899-8205-46.4.268; Department of Health and Ageing. Government of South Australia, 2013, REC RESP CLIN DET BR; Elliott DJ, 2014, JAMA INTERN MED, V174, P786, DOI 10.1001/jamainternmed.2014.300; Garner JP, 2006, COLORECTAL DIS, V8, P273, DOI 10.1111/j.1463-1318.2005.00932.x; Graham KC, 2010, AM J CRIT CARE, V19, P28, DOI 10.4037/ajcc2010651; Hillman KM, 2001, INTERN MED J, V31, P343, DOI 10.1046/j.1445-5994.2001.00077.x; Jaderling G, 2011, INTENS CARE MED, V37, P1000, DOI 10.1007/s00134-011-2156-x; Jenkins PF, 2011, MED J AUSTRALIA, V195, P49, DOI 10.5694/j.1326-5377.2011.tb03192.x; Leuvan Chris H Van, 2008, Crit Care Resusc, V10, P111; Patrician PA, 2011, J NURS ADMIN, V41, P64, DOI 10.1097/NNA.0b013e31820594bf; Preece MHW, 2012, RESUSCITATION, V83, P1111, DOI 10.1016/j.resuscitation.2012.02.009; Schmid F, 2011, ANESTH ANALG, V112, P78, DOI 10.1213/ANE.0b013e3181fcc504; Sundararajan K, 2014, AUST HEALTH REV, V38, P218, DOI 10.1071/AH13138; Trinkle RM, 2011, RESUSCITATION, V82, P810, DOI 10.1016/j.resuscitation.2011.03.019; Varpio L, 2012, CIN-COMPUT INFORM NU, V30, P210, DOI 10.1097/NCN.0b013e31823eb581; Winters BD, 2013, ANN INTERN MED, V158, P417, DOI 10.7326/0003-4819-158-5-201303051-00009	29	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145339	10.1371/journal.pone.0145339	http://dx.doi.org/10.1371/journal.pone.0145339			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717479	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500029
J	Liao, TYA; Lau, A; Joseph, S; Hytonen, V; Hmama, Z				Liao, Ting-Yu Angela; Lau, Alice; Joseph, Sunil; Hytonen, Vesa; Hmama, Zakaria			Improving the Immunogenicity of the Mycobacterium bovis BCG Vaccine by NonGenetic Bacterial Surface Decoration Using the Avidin-Biotin System	PLOS ONE			English	Article							ANTIGEN CROSS-PRESENTATION; BACILLUS-CALMETTE-GUERIN; T-CELLS; IN-VIVO; RESISTANT TUBERCULOSIS; PHAGOSOME MATURATION; PROTECTION; EFFICACY; IMMUNITY; EXPRESSION	Current strategies to improve the current BCG vaccine attempt to over-express genes encoding specific M. tuberculosis (Mtb) antigens and/or regulators of antigen presentation function, which indeed have the potential to reshape BCG in many ways. However, these approaches often face serious difficulties, in particular the efficiency and stability of gene expression via nucleic acid complementation and safety concerns associated with the introduction of exogenous DNA. As an alternative, we developed a novel non-genetic approach for rapid and efficient display of exogenous proteins on bacterial cell surface. The technology involves expression of proteins of interest in fusion with a mutant version of monomeric avidin that has the feature of reversible binding to biotin. Fusion proteins are then used to decorate the surface of biotinylated BCG. Surface coating of BCG with recombinant proteins was highly reproducible and stable. It also resisted to the freeze-drying shock routinely used in manufacturing conventional BCG. Modifications of BCG surface did not affect its growth in culture media neither its survival within the host cell. Macrophages phagocytized coated BCG bacteria, which efficiently delivered their surface cargo of avidin fusion proteins to MHC class I and class II antigen presentation compartments. Thereafter, chimeric proteins corresponding to a surrogate antigen derived from ovalbumin and the Mtb specific ESAT6 antigen were generated and tested for immunogenicity in vaccinated mice. We found that BCG displaying ovalbumin antigen induces an immune response with a magnitude similar to that induced by BCG genetically expressing the same surrogate antigen. We also found that BCG decorated with Mtb specific antigen ESAT6 successfully induces the expansion of specific T cell responses. This novel technology, therefore, represents a practical and effective alternative to DNA-based gene expression for upgrading the current BCG vaccine.	[Liao, Ting-Yu Angela; Lau, Alice; Joseph, Sunil; Hmama, Zakaria] Univ British Columbia, Div Infect Dis, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Liao, Ting-Yu Angela; Lau, Alice; Joseph, Sunil; Hmama, Zakaria] Univ British Columbia, Vancouver Costal Hlth Res Inst, Vancouver, BC V5Z 1M9, Canada; [Hytonen, Vesa] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland	University of British Columbia; University of British Columbia; Tampere University	Hmama, Z (corresponding author), Univ British Columbia, Div Infect Dis, Dept Med, Vancouver, BC V5Z 1M9, Canada.	hmama@mail.ubc.ca	Hytonen, Vesa P./E-8855-2013	Hytonen, Vesa P./0000-0002-9357-1480	TB Veteran Association; British Columbia Lung Association; Canadian Institute of Health Research [MOP-97898]	TB Veteran Association; British Columbia Lung Association; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	Funding for this research was provided by the TB Veteran Association, British Columbia Lung Association and the Canadian Institute of Health Research Operating Grant MOP-97898. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zarouni M, 2002, TUBERCULOSIS, V82, P283, DOI 10.1054/tube.2002.0374; Bastos RG, 2009, VACCINE, V27, P6495, DOI 10.1016/j.vaccine.2009.08.044; Basu S, 2008, EPIDEMIOL INFECT, V136, P1585, DOI 10.1017/S0950268808000964; Behar SM, 2013, ADV EXP MED BIOL, V783, P141, DOI 10.1007/978-1-4614-6111-1_8; Bigini P, 2014, ACS NANO, V8, P175, DOI 10.1021/nn402669w; BUBB MO, 1993, IMMUNOL LETT, V35, P277, DOI 10.1016/0165-2478(93)90194-7; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Cummings JF, 2014, VACCINE, V32, P2251, DOI 10.1016/j.vaccine.2013.10.017; da Costa AC, 2014, RECOMBINANT BCG INNO, P5; Deghmane AE, 2007, J CELL SCI, V120, P2796, DOI 10.1242/jcs.006221; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Dudani R, 2002, J IMMUNOL, V168, P5737, DOI 10.4049/jimmunol.168.11.5737; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; FINE PEM, 1989, REV INFECT DIS, V11, pS353; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Horwitz MA, 2003, INFECT IMMUN, V71, P1672, DOI 10.1128/IAI.71.4.1672-1679.2003; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Kamath AT, 2005, VACCINE, V23, P3753, DOI 10.1016/j.vaccine.2005.03.001; Kolotilin I, 2014, VET RES, V45, DOI 10.1186/s13567-014-0117-4; LABIDI A, 1985, ANN INST PASTEUR MIC, V136B, P209, DOI 10.1016/S0769-2609(85)80045-4; Laitinen OH, 2003, J BIOL CHEM, V278, P4010, DOI 10.1074/jbc.M205844200; Lesch HP, 2010, EXPERT OPIN DRUG DEL, V7, P551, DOI 10.1517/17425241003677749; Mederle I, 2002, INFECT IMMUN, V70, P303, DOI 10.1128/IAI.70.1.303-314.2002; Moro ML, 1998, AIDS, V12, P1095, DOI 10.1097/00002030-199809000-00017; Oizumi S, 2007, J IMMUNOL, V179, P2310, DOI 10.4049/jimmunol.179.4.2310; Paganelli G, 2006, NEUROL RES, V28, P518, DOI 10.1179/016164106X116782; Petronzelli F, 2010, CANCER BIOTHER RADIO, V25, P563, DOI 10.1089/cbr.2010.0797; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Russell MS, 2007, J IMMUNOL, V179, P211, DOI 10.4049/jimmunol.179.1.211; Sendide K, 2005, J IMMUNOL, V174, P4210, DOI 10.4049/jimmunol.174.7.4210; Sharif-Paghaleh E, 2014, EUR J IMMUNOL, V44, P2188, DOI 10.1002/eji.201344337; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Soualhine H, 2007, J IMMUNOL, V179, P5137, DOI 10.4049/jimmunol.179.8.5137; Sun J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003499; Sun J, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008769, 10.1371/journal.pone.0011351]; Sun J, 2009, PLASMID, V62, P158, DOI 10.1016/j.plasmid.2009.07.003; Sun R, 2009, VACCINE, V27, P4412, DOI 10.1016/j.vaccine.2009.05.048; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001	47	7	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145833	10.1371/journal.pone.0145833	http://dx.doi.org/10.1371/journal.pone.0145833			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716832	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500081
J	Abo, H; Soga, K; Tanaka, A; Tateno, H; Hirabayashi, J; Yamamoto, K				Abo, Hirohito; Soga, Keisuke; Tanaka, Atsuhiro; Tateno, Hiroaki; Hirabayashi, Jun; Yamamoto, Kazuo			Mutated Leguminous Lectin Containing a Heparin-Binding like Motif in a Carbohydrate-Binding Loop Specifically Binds to Heparin	PLOS ONE			English	Article							SULFATE BIOSYNTHESIS; EFFICIENT; PROTEINS; SITE	We previously introduced random mutations in the sugar-binding loops of a leguminous lectin and screened the resulting mutated lectins for novel specificities using cell surface display. Screening of a mutated peanut agglutinin (PNA), revealed a mutated PNA with a distinct preference for heparin. Glycan microarray analyses using the mutated lectin fused to the Fc region of human immunoglobulin, revealed that a particular sulfated glycosaminoglycan (GAG), heparin, had the highest binding affinity for mutated PNA among 97 glycans tested, although wild-type PNA showed affinity towards Gal beta 1-3GalNAc and similar galactosylated glycans. Further analyses of binding specificity using an enzyme-linked immunoadsorbent assay demonstrated that the mutated PNA specifically binds to heparin, and weakly to de-2-O-sulfated heparin, but not to other GAG chains including de-6-O-sulfated and de-N-sulfated heparins. The mutated PNA had six amino acid substitutions within the eight amino acid-long sugar-binding loop. In this loop, the heparin-binding like motif comprised three arginine residues at positions 124, 128, and 129, and a histidine at position 125 was present. Substitution of each arginine or histidine residue to alanine reduced heparin-binding ability, indicating that all of these basic amino acid residues contributed to heparin binding. Inhibition assay demonstrated that heparin and dextran sulfate strongly inhibited mutated PNA binding to heparin in dose-dependent manner. The mutated PNA could distinguish between CHO cells and proteoglycan-deficient mutant cells. This is the first report establishing a novel leguminous lectin that preferentially binds to highly sulfated heparin and may provide novel GAG-binding probes to distinguish between heterogeneous GAG repeating units.	[Abo, Hirohito; Soga, Keisuke; Tanaka, Atsuhiro; Yamamoto, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; [Tateno, Hiroaki; Hirabayashi, Jun] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058568, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Yamamoto, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan.	yamamoto@k.u-tokyo.ac.jp	Hirabayashi, Jun/M-3998-2018; Tateno, Hiroaki/M-2706-2018	Hirabayashi, Jun/0000-0002-8571-359X; Tateno, Hiroaki/0000-0003-3006-1659; abo, hirohito/0000-0002-3066-8584; SOGA, Keisuke/0000-0001-7387-468X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [15K14948, 24390015, 24659026, 25117710]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (https://www.jsps.go.jp/j-grantsinaid/) [grant numbers 15K14948 (to KY), 24390015 (to KY), 24659026 (to KY), and 25117710 (to KY)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ms. Jinko Murakami and Ms. Kayo Suzuki for help in glycan microarray production. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [grant numbers 15K14948 (to KY), 24390015 (to KY), 24659026 (to KY), and 25117710 (to KY)].	CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; ESKO JD, 1987, J BIOL CHEM, V262, P12189; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; ESKO JD, 1988, SCIENCE, V241, P1092, DOI 10.1126/science.3137658; Ishihara M, 1997, J BIOCH, V121, P354; Ishitsuka R, 1998, J BIOL CHEM, V273, P9935, DOI 10.1074/jbc.273.16.9935; KONAMI Y, 1994, J BIOCHEM-TOKYO, V115, P767, DOI 10.1093/oxfordjournals.jbchem.a124408; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Liener IE, 1986, LECTINS PROPERTIES F, P43; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohtsuka M, 2004, P NATL ACAD SCI USA, V101, P8126, DOI 10.1073/pnas.0401119101; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; Saito A, 2007, BBA-GEN SUBJECTS, V1770, P241, DOI 10.1016/j.bbagen.2006.10.015; Sharma V, 1997, J MOL BIOL, V267, P433, DOI 10.1006/jmbi.1996.0863; Sharon N, 1993, LECTINS, P179; Soga K, 2015, BIOMOLECULES, V5, P1540, DOI 10.3390/biom5031540; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Tateno H, 2008, GLYCOBIOLOGY, V18, P789, DOI 10.1093/glycob/cwn068; Torrent M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042692; Yamamoto K, 1997, J BIOCHEM-TOKYO, V121, P756	21	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145834	10.1371/journal.pone.0145834	http://dx.doi.org/10.1371/journal.pone.0145834			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714191	Green Submitted, Green Published, gold			2022-12-27	WOS:000367481900090
J	Loffler, SG; Rago, V; Martinez, M; Uhart, M; Florin-Christensen, M; Romero, G; Brihuega, B				Loffler, Sylvia Grune; Rago, Virginia; Martinez, Mara; Uhart, Marcela; Florin-Christensen, Monica; Romero, Graciela; Brihuega, Bibiana			Isolation of a Seawater Tolerant Leptospira spp. from a Southern Right Whale (Eubalaena australis)	PLOS ONE			English	Article							CALIFORNIA SEA LIONS; PATHOGENIC LEPTOSPIRA; ZALOPHUS-CALIFORNIANUS; HARBOR SEALS; PCR; SEROPREVALENCE; IDENTIFICATION; DISEASE	Leptospirosis is the most widespread zoonotic disease in the world. It is caused by pathogenic spirochetes of the genus Leptospira spp. and is maintained in nature through chronic renal infection of carrier animals. Rodents and other small mammals are the main reservoirs. Information on leptospirosis in marine mammals is scarce; however, cases of leptospirosis have been documented in pinniped populations from the Pacific coast of North America from southern California to British Columbia. We report the isolation of a Leptospira spp. strain, here named Manara, from a kidney sample obtained from a Southern Right Whale (Eubalaena australis) calf, which stranded dead in Playa Manara, Peninsula Valdes, Argentina. This strain showed motility and morphology typical of the genus Leptospira spp. under dark-field microscopy; and grew in Ellinghausen-McCullough-Johnson-Harris (EMJH) medium and Fletcher medium after 90 days of incubation at 28 degrees C. Considering the source of this bacterium, we tested its ability to grow in Fletcher medium diluted with seawater at different percentages (1%, 3%, 5%, 7% and 10% v/v). Bacterial growth was detected 48 h after inoculation of Fletcher medium supplemented with 5% sea water, demonstrating the halophilic nature of the strain Manara. Phylogenetic analysis of 16S rRNA gene sequences placed this novel strain within the radiation of the pathogenic species of the genus Leptospira spp., with sequence similarities within the range 97-100%, and closely related to L. interrogans. Two different PCR protocols targeting genus-specific pathogenic genes (G1-G2, B64I-B64II and LigB) gave positive results, which indicates that the strain Manara is likely pathogenic. Further studies are needed to confirm this possibility as well as determine its serogroup. These results could modify our understanding of the epidemiology of this zoonosis. Until now, the resistance and ability to grow in seawater for long periods of time had been proven for the strain Muggia of L. biflexa, a saprophytic species. To the best of our knowledge, this is the first isolation of a Leptospira sp. from cetaceans. Our phenotypic data indicate that strain Manara represents a novel species of the genus Leptospira, for which the name Leptospira brihuegai sp. nov. is proposed.	[Loffler, Sylvia Grune; Martinez, Mara; Florin-Christensen, Monica; Romero, Graciela; Brihuega, Bibiana] Natl Inst Agr Technol, Inst Pathobiol, Buenos Aires, DF, Argentina; [Loffler, Sylvia Grune; Florin-Christensen, Monica] Natl Res Council Argentina CONICET, Buenos Aires, DF, Argentina; [Rago, Virginia] Univ Buenos Aires, Natl Res Council Argentina CONICET, Inst Ecol Genet & Evolut, Buenos Aires, DF, Argentina; [Rago, Virginia; Uhart, Marcela] Southern Right Whale Hlth Monitoring Program, Puerto Madryn, Chubut, Argentina; [Uhart, Marcela] Univ Calif Davis, Sch Vet Med, Hlth Inst 1, Davis, CA 95616 USA	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of California System; University of California Davis	Loffler, SG (corresponding author), Natl Inst Agr Technol, Inst Pathobiol, Buenos Aires, DF, Argentina.	grune.sylvia@inta.gob.ar	Grune, Sylvia/ADH-3537-2022	Grune, Sylvia/0000-0002-3049-289X; Florin-Christensen, Monica/0000-0003-0456-3970				Brihuega B., 2007, Rev. argent. microbiol., V39, P19; Cameron CE, 2008, J CLIN MICROBIOL, V46, P1728, DOI 10.1128/JCM.02022-07; Cerqueira GM, 2009, J MED MICROBIOL, V58, P1173, DOI 10.1099/jmm.0.009175-0; Cerqueira GM, 2009, INFECT GENET EVOL, V9, P760, DOI 10.1016/j.meegid.2009.06.009; CINCO M, 1975, ZBL BAKT-INT J MED M, V233, P400; CINCO M, 1974, INT J SYST BACTERIOL, V24, P131, DOI 10.1099/00207713-24-1-131; Colagross-Schouten AM, 2002, J WILDLIFE DIS, V38, P7, DOI 10.7589/0090-3558-38.1.7; Colegrove KM, 2005, J WILDLIFE DIS, V41, P426, DOI 10.7589/0090-3558-41.2.426; Delgado Patrick Mathews, 2015, Latin American Journal of Aquatic Mammals, V10, P58; Djadid ND, 2009, DIAGN MICR INFEC DIS, V63, P251, DOI 10.1016/j.diagmicrobio.2008.10.017; Pavan ME, 2011, COMP IMMUNOL MICROB, V34, P135, DOI 10.1016/j.cimid.2010.06.002; Faine S., 1982, WHO OFFS PUBL, V67; Francois S, 2013, REV CUBANA MED TROPI; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; GRAVEKAMP C, 1993, J GEN MICROBIOL, V139, P1691, DOI 10.1099/00221287-139-8-1691; Greig DJ, 2014, DIS AQUAT ORGAN, V111, P93, DOI 10.3354/dao02762; Loffler SG, 2014, REV ARGENT MICROBIOL, V46, P201, DOI 10.1016/S0325-7541(14)70073-2; Loffler SG, 2014, MEM I OSWALDO CRUZ, V109, P163, DOI 10.1590/0074-0276140295; Grune S., 2014, THESIS; Gulland FMD, 1996, J WILDLIFE DIS, V32, P572, DOI 10.7589/0090-3558-32.4.572; Khairani-Bejo S., 2004, Journal of Animal and Veterinary Advances, V3, P123; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lloyd-Smith JO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-125; Martinez M, 2014, REVISTA ARGENTINA DE, V9, P41; McClellan WA, 2004, RIGHT WHALE NECROPSY; Nalam K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012637; Norman SA, 2008, J WILDLIFE DIS, V44, P837, DOI 10.7589/0090-3558-44.4.837; Pavan ME, 2008, COMP IMMUNOL MICROB, V31, P37, DOI 10.1016/j.cimid.2007.03.004; Saito M, 2014, APPL ENVIRON MICROB, V80, P6926, DOI 10.1128/AEM.02568-14; Sepulveda MA, 2015, J WILDLIFE DIS, V51, P279, DOI 10.7589/2013-07-161; SMITH AW, 1977, J WILDLIFE DIS, V13, P144, DOI 10.7589/0090-3558-13.2.144; Stamper MA, 1998, J WILDLIFE DIS, V34, P407, DOI 10.7589/0090-3558-34.2.407; STERLING CR, 1981, VET PATHOL, V18, P628, DOI 10.1177/030098588101800508; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trueba G, 2004, INT MICROBIOL, V7, P35; Waltzek TB, 2012, ZOONOSES PUBLIC HLTH, V59, P521, DOI 10.1111/j.1863-2378.2012.01492.x; Zuerner RL, 2009, VET MICROBIOL, V137, P105, DOI 10.1016/j.vetmic.2008.12.017	37	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144974	10.1371/journal.pone.0144974	http://dx.doi.org/10.1371/journal.pone.0144974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714322	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900028
J	Andrieu, P; Billot, PE; Millot, JL; Gharbi, T				Andrieu, Patrice; Billot, Pierre-Edouard; Millot, Jean-Louis; Gharbi, Tijani			Pulse Width Modulation Applied to Olfactory Stimulation for Intensity Tuning	PLOS ONE			English	Article							ODOR DISCRIMINATION; IDENTIFICATION; FMRI	For most olfactometers described in the literature, adjusting olfactory stimulation intensity involves modifying the dilution of the odorant in a neutral solution (water, mineral, oil, etc.), the dilution of the odorant air in neutral airflow, or the surface of the odorant in contact with airflow. But, for most of these above-mentioned devices, manual intervention is necessary for adjusting concentration. We present in this article a method of controlling odorant concentration via a computer which can be implemented on even the most dynamic olfactometers. We used Pulse Width Modulation (PWM), a technique commonly used in electronic or electrical engineering, and we have applied it to odor delivery. PWM, when applied to odor delivery, comprises an alternative presentation of odorant air and clean air at a high frequency. The cycle period (odor presentation and rest) is 200 ms. In order to modify odorant concentration, the ratio between the odorant period and clean air presentation during a cycle is modified. This ratio is named duty cycle. Gas chromatography measurements show that this method offers a range of mixing factors from 33% to 100% (continuous presentation of odor). Proof of principle is provided via a psychophysical experiment. Three odors (isoamyl acetate, butanol and pyridine) were presented to twenty subjects. Each odor was delivered three times with five values of duty cycles. After each stimulation, the subjects were asked to estimate the intensity of the stimulus on a 10 point scale, ranging from 0 (undetectable) to 9 (very strong). Results show a main effect of the duty cycles on the intensity ratings for all tested odors.	[Andrieu, Patrice; Billot, Pierre-Edouard; Millot, Jean-Louis] Univ Franche Comte, EA Lab Integrat & Clin Neurosci 481, F-25030 Besancon, France; [Gharbi, Tijani] Univ Franche Comte, EA Nanomed Imagery & Therapeut Lab 4662, F-25030 Besancon, France	Universite de Franche-Comte; Universite de Franche-Comte	Andrieu, P (corresponding author), Univ Franche Comte, EA Lab Integrat & Clin Neurosci 481, F-25030 Besancon, France.	patrice.andrieu@univ-fcomte.fr		Billot, Pierre-Edouard/0000-0002-6279-9183				Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Andrieu P, 2014, BEHAV RES METHODS, V46, P178, DOI 10.3758/s13428-013-0362-x; BERGLUND B, 1971, PERCEPT PSYCHOPHYS, V9, P379, DOI 10.3758/BF03212672; Bozza G, 1960, ACTA OTOLARYNG, V52, P189, DOI [DOI 10.3109/00016486009123141, 10.3109/00016486009123141]; CLARKE RW, 1994, J LARYNGOL OTOL, V108, P1045, DOI 10.1017/S0022215100128853; DOTY RL, 1975, PHYSIOL BEHAV, V14, P855, DOI 10.1016/0031-9384(75)90081-5; EYFERTH K, 1970, BEHAV RES METH INSTR, V2, P19, DOI 10.3758/BF03205719; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Ischer M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00736; Jacquot L, 2004, BRAIN RES, V1002, P51, DOI 10.1016/j.brainres.2003.12.011; Johnson BN, 2007, J NEUROSCI METH, V160, P231, DOI 10.1016/j.jneumeth.2006.09.008; KOBAL G, 1988, ELECTROEN CLIN NEURO, V71, P241, DOI 10.1016/0168-5597(88)90023-8; Lorig TS, 1999, BEHAV RES METH INS C, V31, P370, DOI 10.3758/BF03207734; Lowen SB, 2006, BEHAV RES METHODS, V38, P307, DOI 10.3758/BF03192782; Lundstrom JN, 2010, INT J PSYCHOPHYSIOL, V78, P179, DOI 10.1016/j.ijpsycho.2010.07.007; MOSKOWITZ HR, 1976, PERCEPT PSYCHOPHYS, V19, P122, DOI 10.3758/BF03204218; Pool E, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00158; Sezille C, 2013, J NEUROSCI METH, V218, P29, DOI 10.1016/j.jneumeth.2013.04.021; Sommer JU, 2012, J NEUROSCIENCE METHO; Zwaardemaker H, 1889, LANCET, V133, P1300, DOI [10.1016/S0140-6736(01)91626-5, DOI 10.1016/S0140-6736(01)91626-5]	21	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145373	10.1371/journal.pone.0145373	http://dx.doi.org/10.1371/journal.pone.0145373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710120	Green Published, Green Submitted, gold			2022-12-27	WOS:000367451400042
J	Beam, A; Goede, D; Fox, A; McCool, MJ; Wall, G; Haley, C; Morrison, R				Beam, Andrea; Goede, Dane; Fox, Andrew; McCool, Mary Jane; Wall, Goldlin; Haley, Charles; Morrison, Robert			A Porcine Epidemic Diarrhea Virus Outbreak in One Geographic Region of the United States: Descriptive Epidemiology and Investigation of the Possibility of Airborne Virus Spread	PLOS ONE			English	Article								This study describes a spring 2013 outbreak of porcine epidemic diarrhea virus (PEDv), using data from 222 swine sites in 14 counties area in 4 contiguous states in the United States. During the outbreak, the premises-level incidence of PEDv was 40.5 percent (90/222 sites). One of the three companies from which data were collected had a lower incidence (19.5 percent) than the other two companies (41.1 and 47.2 percent). Sow sites had the highest incidence of PEDv during the outbreak (80.0 percent). Spatial analysis showed that PEDv was clustered rather than randomly distributed, which suggested that sites near a positive site had increased risk of acquiring PEDv infection. Meteorological data were used to investigate the hypothesis that PEDv was spread by air. If airborne dissemination played a role in this outbreak, we would expect the direction of disease spread to correlate with the predominant wind direction. Two methods were used to determine the direction of disease spread-linear direction mean analysis in ArcGIS and the direction test in Cluster-Seer. The former method indicated PEDv spread was south to slightly southwest, and the latter indicated spread was to the southeast. The predominant wind direction during the month of the outbreak was toward the south, with some southeast and southwest winds; the strongest wind gusts were toward the southwest. These findings support the hypothesis that PEDv was spread by air. The results, however, should be interpreted cautiously because we did not have information on direct and indirect contacts between sites, such as movement of trucks, feed, pigs or people. These types of contacts should be evaluated before pathogen spread is attributed to airborne mechanisms. Although this study did not provide a definitive assessment of airborne spread of PEDv, we believe the findings justify additional research to investigate this potential mechanism of transmission.	[Beam, Andrea; Fox, Andrew; McCool, Mary Jane; Wall, Goldlin; Haley, Charles] USDA Anim & Plant Hlth Inspect Serv, Vet Serv Sci Technol & Anal Serv, Ctr Epidemiol & Anim Hlth, Perrine, FL USA; [Goede, Dane; Morrison, Robert] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities	Haley, C (corresponding author), USDA Anim & Plant Hlth Inspect Serv, Plant Protect & Quarantine, Ctr Plant Hlth Sci & Technol, Perrine, FL USA.	charles.a.haley@aphis.usda.gov			National Pork Board	National Pork Board	This study was conducted in part with funding from National Pork Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the three swine companies for sharing their data. This study was conducted in part with funding from National Pork Board. We are indebted to Peter Davies, Paul Sundberg, Harry Snelson, and Brian McCluskey for their participation in planning the study. We are also grateful to Andres Perez for his guidance in using ClusterSeer.	Alonso C, 2014, VET RES, V45, DOI 10.1186/s13567-014-0073-z; American Association of Swine Veterinarians, 2013, STUD EX ROL TRANSP S; De La Hamaide S, 2014, DEADLY PIG VIRUS EAS; Harris HDL, 2012, THE MERCK MANUAL; Jacquez G.M., 1994, USER MANUAL STAT STA; Kocherhans R, 2001, VIRUS GENES, V23, P137, DOI 10.1023/A:1011831902219; Li WG, 2011, PHYS RES INT, V2011, P1, DOI [10.1155/2011/791545, DOI 10.1155/2011/791545]; National Oceanic and Atmospheric Administration, 2013, NAT CLIM DAT; Pospischil A, 2002, J SWINE HEALTH PROD, V10, P81; Truong QL, 2013, J VET MED SCI, V75, P1647, DOI 10.1292/jvms.12-0568; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Swine Health Monitoring Project, 2014, PED VIR INF ASS BIRD; Swine Health Monitoring Project, 2013, ENV STAB PEDV; Swine Health Monitoring Project, 2014, PORC EP DIARRH VIR R	14	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144818	10.1371/journal.pone.0144818	http://dx.doi.org/10.1371/journal.pone.0144818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709512	gold, Green Submitted, Green Published			2022-12-27	WOS:000367451400013
J	Higuchi, M; Topiol, DD; Ahmed, B; Morita, H; Carbunaru, S; Hess, CW; Bowers, D; Ward, HE; Warren, LR; DeFranco, MM; Troche, MS; Kulkarni, SJ; Hastings, E; Foote, KD; Okun, MS; Martinez-Ramirez, D				Higuchi, Masa-aki; Topiol, Dan D.; Ahmed, Bilal; Morita, Hokuto; Carbunaru, Samuel; Hess, Christopher W.; Bowers, Dawn; Ward, Herbert E.; Warren, Lisa R.; DeFranco, Meredith M.; Troche, Michelle S.; Kulkarni, Shankar J.; Hastings, Erin; Foote, Kelly D.; Okun, Michael S.; Martinez-Ramirez, Daniel			Impact of an Interdisciplinary Deep Brain Stimulation Screening Model on Post-Surgical Complications in Essential Tremor Patients	PLOS ONE			English	Article							QUALITY-OF-LIFE; UPDATE; DISORDER	Objective To investigate the relationship of our interdisciplinary screening process on post-operative unintended hospitalizations and quality of life. Background There are currently no standardized criteria for selection of appropriate Deep Brain Stimulation candidates and little hard data exists to support the use of any singular method. Methods An Essential Tremor cohort was selected from our institutional Deep Brain Stimulation database. The interdisciplinary model utilized seven specialties who pre-operatively screened all potential Deep Brain Stimulation candidates. Concerns for surgery raised by each specialty were documented and classified as none, minor, or major. Charts were reviewed to identify unintended hospitalizations and quality of life measurements at 1 year post-surgery. Results Eighty-six percent (44/51) of the potential screened candidates were approved for Deep Brain Stimulation. Eight (18%) patients had an unintended hospitalization during the follow-up period. Patients with minor or major concerns raised by any specialty service had significantly more unintended hospitalizations when compared to patients without concerns (75% vs. 25%, p < 0.005). The rate of hospitalization revealed a direct relationship to the "level of concern"; ranging from 100% if major concerns, 42% if minor concerns, and 7% if no concerns raised, p = 0.001. Quality of life scores significantly worsened in patients with unintended hospitalizations at 6 (p = 0.046) and 12 months (p = 0.027) when compared to baseline scores. No significant differences in tremor scores between unintended and nonunintended hospitalizations were observed. Conclusions The number and level of concerns raised during interdisciplinary Deep Brain Stimulation screenings were significantly related to unintended hospitalizations and to a reduced quality of life. The interdisciplinary evaluation may help to stratify risk for these complications. However, data should be interpreted with caution due to the limitations of our study. Further prospective comparative and larger studies are required to confirm our results.	[Higuchi, Masa-aki; Topiol, Dan D.; Ahmed, Bilal; Morita, Hokuto; Carbunaru, Samuel; Hess, Christopher W.; Hastings, Erin; Okun, Michael S.; Martinez-Ramirez, Daniel] Univ Florida, Coll Med, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA; [Foote, Kelly D.; Okun, Michael S.] Univ Florida, Coll Med, Dept Neurosurg, Gainesville, FL USA; [Ward, Herbert E.] Univ Florida, Dept Psychiat, Coll Med, Gainesville, FL 32611 USA; [Bowers, Dawn] Univ Florida, Dept Clin & Hlth Psychol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Troche, Michelle S.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Speech Language & Hearing Sci, Gainesville, FL USA; [Warren, Lisa R.; DeFranco, Meredith M.; Kulkarni, Shankar J.] Univ Florida, Ctr Movement Disorders & Neurorestorat, Rehabil Serv, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Martinez-Ramirez, D (corresponding author), Univ Florida, Coll Med, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA.	Daniel.Martinez-Ramirez@neurology.ufl.edu	Ahmed, Bilal/A-6926-2016; Martinez-Ramirez, Daniel/H-2546-2016; Ramirez, Daniel Martinez/O-6719-2018	Ahmed, Bilal/0000-0001-9110-4136; Martinez-Ramirez, Daniel/0000-0001-8003-0610; Ramirez, Daniel Martinez/0000-0001-8003-0610; Foote, Kelly/0000-0002-2436-4138; Hastings Monari, Erin/0000-0002-4075-3360; Troche, Michelle/0000-0002-5746-5867	National Parkinson Foundation; UF INFORM database; UF Foundation; Tyler's Hope Foundation; Bachmann-Strauss Foundation	National Parkinson Foundation; UF INFORM database; UF Foundation; Tyler's Hope Foundation; Bachmann-Strauss Foundation	We would like to acknowledge the support of the National Parkinson Foundation, the UF INFORM database, the UF Foundation, the Tyler's Hope and the Bachmann-Strauss Foundations to the UF Center for Movement Disorders and Neurorestoration. This manuscript was run through the iThenticate system provided by the University of Florida and the 1st author takes all responsibility for ensuring originality.	Arkadir D, 2013, THER ADV NEUROL DISO, V6, P229, DOI 10.1177/1756285612471415; Benito-Leon J, 2007, LANCET, V369, P1152, DOI 10.1016/S0140-6736(07)60544-3; Chandran V, 2013, PARKINSONISM RELAT D, V19, P62, DOI 10.1016/j.parkreldis.2012.06.011; Chandran V, 2012, PARKINSONISM RELAT D, V18, P407, DOI 10.1016/j.parkreldis.2011.12.003; Hariz GM, 2008, ACTA NEUROL SCAND, V118, P387, DOI 10.1111/j.1600-0404.2008.01065.x; Louis ED, 2001, MOVEMENT DISORD, V16, P914, DOI 10.1002/mds.1184; Louis ED, 2014, TREMOR OTHER HYPERK, V4, DOI 10.7916/D8TT4P4B; Louis ED, 2011, PARKINSONISM RELAT D, V17, P516, DOI 10.1016/j.parkreldis.2011.03.012; Louis ED, 2010, MOVEMENT DISORD, V25, P534, DOI 10.1002/mds.22838; Martinez-Ramirez D, 2014, GERONTOLOGY, V60, P38, DOI 10.1159/000354880; Nazzaro JM, 2012, J NEUROSURG, V117, P156, DOI 10.3171/2012.3.JNS112316; Resnick AS, 2010, J NEUROL, V257, P122, DOI 10.1007/s00415-009-5343-8; Schneier FR, 2001, J CLIN PSYCHIAT, V62, P367, DOI 10.4088/JCP.v62n0511; Stacy MA, 2007, MOVEMENT DISORD, V22, P833, DOI 10.1002/mds.21412; Sydow O, 2003, J NEUROL NEUROSUR PS, V74, P1387, DOI 10.1136/jnnp.74.10.1387; Teive Helio A G, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS140, DOI 10.1016/S1353-8020(11)70044-X; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Zesiewicz TA, 2011, NEUROLOGY, V77, P1752, DOI 10.1212/WNL.0b013e318236f0fd	18	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145623	10.1371/journal.pone.0145623	http://dx.doi.org/10.1371/journal.pone.0145623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710099	gold, Green Submitted, Green Published			2022-12-27	WOS:000367451400066
J	Boore, AL; Hoekstra, RM; Iwamoto, M; Fields, PI; Bishop, RD; Swerdlow, DL				Boore, Amy L.; Hoekstra, R. Michael; Iwamoto, Martha; Fields, Patricia I.; Bishop, Richard D.; Swerdlow, David L.			Salmonella enterica Infections in the United States and Assessment of Coefficients of Variation: A Novel Approach to Identify Epidemiologic Characteristics of Individual Serotypes, 1996-2011	PLOS ONE			English	Article							REPTILE-ASSOCIATED SALMONELLOSIS; ENTERITIDIS INFECTIONS; INCREASING INCIDENCE; MULTISTATE OUTBREAK; CONSUMPTION; CONTACT; DISEASE; EMERGENCE; JAVIANA; BURDEN	Background Despite control efforts, salmonellosis continues to cause an estimated 1.2 million infections in the United States (US) annually. We describe the incidence of salmonellosis in the US and introduce a novel approach to examine the epidemiologic similarities and differences of individual serotypes. Methods Cases of salmonellosis in humans reported to the laboratory-based National Salmonella Surveillance System during 1996-2011 from US states were included. Coefficients of variation were used to describe distribution of incidence rates of common Salmonella serotypes by geographic region, age group and sex of patient, and month of sample isolation. Results During 1996-2011, more than 600,000 Salmonella isolates from humans were reported, with an average annual incidence of 13.1 cases/100,000 persons. The annual reported rate of Salmonella infections did not decrease during the study period. The top five most commonly reported serotypes, Typhimurium, Enteritidis, Newport, Heidelberg, and Javiana, accounted for 62% of fully serotyped isolates. Coefficients of variation showed the most geographically concentrated serotypes were often clustered in Gulf Coast states and were also more frequently found to be increasing in incidence. Serotypes clustered in particular months, age groups, and sex were also identified and described. Conclusions Although overall incidence rates of Salmonella did not change over time, trends and epidemiological factors differed remarkably by serotype. A better understanding of Salmonella, facilitated by this comprehensive description of overall trends and unique characteristics of individual serotypes, will assist in responding to this disease and in planning and implementing prevention activities.	[Boore, Amy L.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Sci Educ & Profess Dev Program Off, Atlanta, GA 30333 USA; [Boore, Amy L.; Hoekstra, R. Michael; Iwamoto, Martha; Fields, Patricia I.; Bishop, Richard D.; Swerdlow, David L.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Boore, AL (corresponding author), Ctr Dis Control & Prevent, Div Global HIV AIDS, Maputo, Mozambique.	aboore@cdc.gov		Hoekstra, Robert Michael/0000-0002-0340-8015				ACKMAN DM, 1995, PEDIATR INFECT DIS J, V14, P955, DOI 10.1097/00006454-199511000-00006; Angulo FJ, 1997, AM J PUBLIC HEALTH, V87, P580, DOI 10.2105/AJPH.87.4.580; Behravesh CB, 2011, NEW ENGL J MED, V364, P918, DOI 10.1056/NEJMoa1005741; Boehmer TK, 2009, AM J INFECT CONTROL, V37, P49, DOI 10.1016/j.ajic.2007.12.012; Braden CR, 2006, CLIN INFECT DIS, V43, P512, DOI 10.1086/505973; Brenner FW, 2000, J CLIN MICROBIOL, V38, P2465, DOI 10.1128/JCM.38.7.2465-2467.2000; Campbell JV, 2001, J INFECT DIS, V183, P984, DOI 10.1086/319254; Cavallaro E, 2011, NEW ENGL J MED, V365, P601, DOI 10.1056/NEJMoa1011208; Centers for Disease Control and Prevention, 2011, TYPHOID AND PARATYPH; Centers for Disease Control and Prevention, NATIONAL ENTERIC DIS; Chai SJ, 2012, CLIN INFECT DIS, V54, pS488, DOI 10.1093/cid/cis231; Gould LH, 2013, MMWR SURVEILL SUMM, V62, P1; Gray JT, 1996, APPL ENVIRON MICROB, V62, P141, DOI 10.1128/AEM.62.1.141-146.1996; Greene SK, 2008, EPIDEMIOL INFECT, V136, P157, DOI 10.1017/S095026880700859X; Gupta SK, 2007, EPIDEMIOL INFECT, V135, P1165, DOI 10.1017/S0950268807007911; Hale CR, 2012, CLIN INFECT DIS, V54, pS472, DOI 10.1093/cid/cis051; HEDBERG CW, 1992, JAMA-J AM MED ASSOC, V268, P3203, DOI 10.1001/jama.268.22.3203; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Kimura AC, 2004, CLIN INFECT DIS, V38, pS244, DOI 10.1086/381576; Kingsley RA, 2000, MOL MICROBIOL, V36, P1006, DOI 10.1046/j.1365-2958.2000.01907.x; Li R, 2000, AM J PUBLIC HEALTH, V90, P777; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; Lynch MF, 2009, BACTERIAL INFECT HUM, P677; Mahon BE, 1997, J INFECT DIS, V175, P876, DOI 10.1086/513985; Maurer JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128937; Mermin J, 2004, CLIN INFECT DIS, V38, pS253, DOI 10.1086/381594; Mermin J, 1997, PEDIATRICS, V99, P399, DOI 10.1542/peds.99.3.399; MISHU B, 1994, J INFECT DIS, V169, P547, DOI 10.1093/infdis/169.3.547; [Office of Disease Prevention and Health Promotion US Department of Health and Human Services], FOOD SAF OBJ HLTH PE; Olsen SJ, 2001, J INFECT DIS, V183, P753, DOI 10.1086/318832; Reller ME, 2008, EPIDEMIOL INFECT, V136, P1109, DOI 10.1017/S0950268807009594; Scallan E, 2013, PEDIATR INFECT DIS J, V32, P217, DOI 10.1097/INF.0b013e31827ca763; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schikora A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002279; Sivapalasingam S, 2003, CLIN INFECT DIS, V37, P1585, DOI 10.1086/379710; SPIKA JS, 1987, NEW ENGL J MED, V316, P565, DOI 10.1056/NEJM198703053161001; Srikantiah P, 2004, EPIDEMIOL INFECT, V132, P273, DOI 10.1017/S0950268803001638; Steinmuller N, 2006, CLIN INFECT DIS, V43, P1596, DOI 10.1086/509576; STLOUIS ME, 1988, JAMA-J AM MED ASSOC, V259, P2103, DOI 10.1001/jama.259.14.2103; Uzzau S, 2000, EPIDEMIOL INFECT, V125, P229, DOI 10.1017/S0950268899004379; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578	41	57	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145416	10.1371/journal.pone.0145416	http://dx.doi.org/10.1371/journal.pone.0145416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701276	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092600077
J	Jablonski, KA; Amici, SA; Webb, LM; Ruiz-Rosado, JD; Popovich, PG; Partida-Sanchez, S; Guerau-de-Arellano, M				Jablonski, Kyle A.; Amici, Stephanie A.; Webb, Lindsay M.; Ruiz-Rosado, Juan de Dios; Popovich, Phillip G.; Partida-Sanchez, Santiago; Guerau-de-Arellano, Mireia			Novel Markers to Delineate Murine M1 and M2 Macrophages	PLOS ONE			English	Article							MICROGLIA/MACROPHAGE POLARIZATION DYNAMICS; ALTERNATIVE ACTIVATION; CYTOKINE PRODUCTION; HOST-DEFENSE; IFN-GAMMA; RECEPTOR; CD38; DIFFERENTIATION; MYCOBACTERIA; SALMONELLA	Classically (M1) and alternatively activated (M2) macrophages exhibit distinct phenotypes and functions. It has been difficult to dissect macrophage phenotypes in vivo, where a spectrum of macrophage phenotypes exists, and also in vitro, where low or non-selective M2 marker protein expression is observed. To provide a foundation for the complexity of in vivo macrophage phenotypes, we performed a comprehensive analysis of the transcriptional signature of murine M0, M1 and M2 macrophages and identified genes common or exclusive to either subset. We validated by real-time PCR an M1-exclusive pattern of expression for CD38, G-protein coupled receptor 18 (Gpr18) and Formyl peptide receptor 2 (Fpr2) whereas Early growth response protein 2 (Egr2) and c-Myc were M2-exclusive. We further confirmed these data by flow cytometry and show that M1 and M2 macrophages can be distinguished by their relative expression of CD38 and Egr2. Egr2 labeled more M2 macrophages (similar to 70%) than the canonical M2 macrophage marker Arginase-1, which labels 24% of M2 macrophages. Conversely, CD38 labeled most (71%) in vitro M1 macrophages. In vivo, a similar CD38(+) population greatly increased after LPS exposure. Overall, this work defines exclusive and common M1 and M2 signatures and provides novel and improved tools to distinguish M1 and M2 murine macrophages.	[Jablonski, Kyle A.; Amici, Stephanie A.; Webb, Lindsay M.; Guerau-de-Arellano, Mireia] Ohio State Univ, Med Lab Sci Div, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA; [Webb, Lindsay M.] Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Ruiz-Rosado, Juan de Dios; Partida-Sanchez, Santiago] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Res Inst, Columbus, OH USA; [Popovich, Phillip G.] Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Guerau-de-Arellano, M (corresponding author), Ohio State Univ, Med Lab Sci Div, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA.	mireia.guerau@osumc.edu	Partida-Sanchez, Santiago/B-7523-2008	Partida-Sanchez, Santiago/0000-0003-2996-9440; RUIZ-ROSADO, JUAN DE DIOS/0000-0002-6429-9086	International Foundation for Research on Paraplegia [P 129]; National Institutes of Health [NIH R21 R21NS081413, NIAID R01-AI092117]; Ray W. Poppleton Endowment; Ohio State University Mayer's Undergraduate Summer Research Fellowship; Systems and Integrative Biology Fellowship [NIH T32]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081413] Funding Source: NIH RePORTER	International Foundation for Research on Paraplegia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ray W. Poppleton Endowment; Ohio State University Mayer's Undergraduate Summer Research Fellowship; Systems and Integrative Biology Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funds from the International Foundation for Research on Paraplegia (P 129 to PP and MG), the National Institutes of Health (NIH R21 R21NS081413 to PP and MG and NIAID R01-AI092117 to SP-S), and the Ray W. Poppleton Endowment (PP). KJ was supported by the Ohio State University Mayer's Undergraduate Summer Research Fellowship and LW by the Systems and Integrative Biology Fellowship (NIH T32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2008, J IMMUNOL, V180, P5645, DOI 10.4049/jimmunol.180.8.5645; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Antonios JK, 2013, CELL MOL IMMUNOL, V10, P471, DOI 10.1038/cmi.2013.39; Arpa L, 2009, EUR J IMMUNOL, V39, P514, DOI 10.1002/eji.200838283; Bae YS, 2003, J IMMUNOL, V171, P6807, DOI 10.4049/jimmunol.171.12.6807; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bost KL, 1997, INFECT IMMUN, V65, P3186, DOI 10.1128/IAI.65.8.3186-3192.1997; Bronte V, 2015, NAT MED, V21, P117, DOI 10.1038/nm.3794; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Chamberlain LM, 2015, J BIOMED MATER RES A, V103, P2864, DOI 10.1002/jbm.a.35415; Dornand J, 2002, VET MICROBIOL, V90, P383, DOI 10.1016/S0378-1135(02)00223-7; El Chartouni C, 2010, IMMUNOBIOLOGY, V215, P780, DOI 10.1016/j.imbio.2010.05.032; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Gabet Y, 2010, BLOOD, V116, P3964, DOI 10.1182/blood-2010-01-263830; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gow DJ, 2010, J LEUKOCYTE BIOL, V88, P475, DOI 10.1189/jlb.0310158; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; Kahnert A, 2006, EUR J IMMUNOL, V36, P631, DOI 10.1002/eji.200535496; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kobayashi T, 2011, J IMMUNOL, V186, P4649, DOI 10.4049/jimmunol.1003888; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Link JM, 2015, BBA-GENE REGUL MECH, V1849, P554, DOI 10.1016/j.bbagrm.2014.04.004; Liu Y, 2013, CANCER RES, V73, P550, DOI 10.1158/0008-5472.CAN-12-2290; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mabbott NA, 2010, IMMUNOBIOLOGY, V215, P724, DOI 10.1016/j.imbio.2010.05.012; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Miller BH, 2004, INFECT IMMUN, V72, P2872, DOI 10.1128/IAI.72.5.2872-2878.2004; Mokarram N, 2014, ANN BIOMED ENG, V42, P338, DOI 10.1007/s10439-013-0941-0; Moreira AP, 2011, J INTERF CYTOK RES, V31, P485, DOI 10.1089/jir.2011.0027; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Musso T, 2001, J LEUKOCYTE BIOL, V69, P605; O'Carroll C, 2014, J IMMUNOL, V192, P427, DOI 10.4049/jimmunol.1301722; Ordway D, 2006, J IMMUNOL, V176, P4931, DOI 10.4049/jimmunol.176.8.4931; Oukka M, 2002, MOL CELL, V9, P121, DOI 10.1016/S1097-2765(01)00434-8; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Partida-Sanchez S, 2004, J IMMUNOL, V172, P1896, DOI 10.4049/jimmunol.172.3.1896; Partida-Sanchez S, 2003, MICROBES INFECT, V5, P49, DOI 10.1016/S1286-4579(02)00055-2; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; Schroder AJ, 2002, J IMMUNOL, V168, P996, DOI 10.4049/jimmunol.168.3.996; Scotton CJ, 2005, J IMMUNOL, V174, P834, DOI 10.4049/jimmunol.174.2.834; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Takenouchi R, 2012, BIOCHEM BIOPH RES CO, V418, P366, DOI 10.1016/j.bbrc.2012.01.027; Valledor AF, 2010, ADV IMMUNOL, V108, P1, DOI 10.1016/S0065-2776(10)08001_6; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Viegas MS, 2007, MICROBES INFECT, V9, P847, DOI 10.1016/j.micinf.2007.03.003; Vogel DYS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-35; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Weilemann A, 2015, BLOOD, V125, P124, DOI 10.1182/blood-2014-08-594507; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Zhang CY, 2013, CELL MOL IMMUNOL, V10, P84, DOI 10.1038/cmi.2012.57	69	518	536	12	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145342	10.1371/journal.pone.0145342	http://dx.doi.org/10.1371/journal.pone.0145342			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699615	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092600067
J	Jang, KI; Lee, SH; Huh, HJ; Chae, JH				Jang, Kuk-In; Lee, Seung-Hwan; Huh, Hyu Jung; Chae, Jeong-Ho			Influence of the 5-HT3A Receptor Gene Polymorphism and Childhood Sexual Trauma on Central Serotonin Activity	PLOS ONE			English	Article							AUDITORY-EVOKED-POTENTIALS; MAJOR DEPRESSIVE DISORDER; LOUDNESS DEPENDENCE; BIPOLAR DISORDER; EMOTIONAL BRAIN; HTR3A GENE; ABUSE; ASSOCIATION; DYSFUNCTION; LDAEP	Background Gene-environment interactions are important for understanding alterations in human brain function. The loudness dependence of auditory evoked potential (LDAEP) is known to reflect central serotonergic activity. Single nucleotide polymorphisms (SNPs) in the 5-HT3A serotonin receptor gene are associated with psychiatric disorders. This study aimed to investigate the effect between 5-HT3A receptor gene polymorphisms and childhood sexual trauma on the LDAEP as an electrophysiological marker in healthy subjects. Methods A total of 206 healthy subjects were recruited and evaluated using the childhood trauma questionnaire (CTQ) and hospital anxiety and depression scale (HADS). Peak-to-peak N1/P2 was measured at five stimulus intensities, and the LDAEP was calculated as the linear-regression slope. In addition, the rs1062613 SNPs of 5-HT3A (CC, CT, and TT) were analyzed in healthy subjects. Results There was a significant interaction between scores on the CTQ-sexual abuse subscale and 5-HT3A genotype on the LDAEP. Subjects with the CC polymorphism had a significantly higher LDEAP than T carriers in the sexually abused group. In addition, CC genotype subjects in the sexually abused group showed a significantly higher LDAEP compared with CC genotype subjects in the non-sexually abused group. Conclusions Our findings suggest that people with the CC polymorphism of the 5-HT3A gene have a greater risk of developing mental health problems if they have experienced childhood sexual abuse, possibly due to low central serotonin activity. Conversely, the T polymorphism may be protective against any central serotonergic changes following childhood sexual trauma.	[Jang, Kuk-In; Chae, Jeong-Ho] Catholic Univ Korea, Dept Biomed & Hlth Sci, Coll Med, Seoul, South Korea; [Lee, Seung-Hwan] Inje Univ, Clin Emot & Cognit Res Lab, Goyang, South Korea; [Jang, Kuk-In; Lee, Seung-Hwan] Inje Univ, Clin Emot & Cognit Res Lab, Goyang, South Korea; [Huh, Hyu Jung; Chae, Jeong-Ho] Catholic Univ Korea, Dept Psychiat, Coll Med, Seoul St Marys Hosp, Seoul, South Korea	Catholic University of Korea; Inje University; Inje University; Catholic University of Korea; Seoul St. Mary's Hospital	Chae, JH (corresponding author), Catholic Univ Korea, Dept Biomed & Hlth Sci, Coll Med, Seoul, South Korea.	alberto@catholic.ac.kr			Korea Health Technology R&D project through the Korea Health industry Development Institute (KHIDI) [HM15C1054]	Korea Health Technology R&D project through the Korea Health industry Development Institute (KHIDI)	This work was supported by the grant of the Korea Health Technology R&D project through the Korea Health industry Development Institute (KHIDI) (grant number: HM15C1054). The funders had no role on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington J, 2013, EARLY INTERV PSYCHIA, V7, P300, DOI 10.1111/eip.12020; Aguilera M, 2009, PSYCHOL MED, V39, P1425, DOI 10.1017/S0033291709005248; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; Bellani M, 2012, EPIDEMIOL PSYCH SCI, V21, P347, DOI 10.1017/S2045796012000418; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Bernstein DP, 1998, MANUAL CHILDHOOD TRA; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Blain LM, 2012, CHILD ABUSE NEGLECT, V36, P413, DOI 10.1016/j.chiabu.2012.03.003; Bublitz MH, 2012, PSYCHONEUROENDOCRINO, V37, P1425, DOI 10.1016/j.psyneuen.2012.01.009; Chen TJ, 2005, NEUROPSYCHOBIOLOGY, V52, P28, DOI 10.1159/000086175; Cicchetti D, 2007, DEV PSYCHOPATHOL, V19, P1161, DOI 10.1017/S0954579407000600; Coles J, 2015, J INTERPERS VIOLENCE, V30, P1929, DOI 10.1177/0886260514555270; Cummings M, 2012, CURR PSYCHIAT REP, V14, P599, DOI 10.1007/s11920-012-0316-5; Drueke B, 2013, EUR NEUROPSYCHOPHARM, V23, P830, DOI 10.1016/j.euroneuro.2013.05.005; Eagle DM, 2008, PSYCHOPHARMACOLOGY, V199, P439, DOI 10.1007/s00213-008-1127-6; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; First MB., 1997, USERS GUIDE STRUCTUR; Fisher HL, 2013, J AFFECT DISORDERS, V145, P136, DOI 10.1016/j.jad.2012.05.032; Gatt JM, 2010, BIOL PSYCHIAT, V68, P818, DOI 10.1016/j.biopsych.2010.06.025; Gatt JM, 2010, DEPRESS ANXIETY, V27, P752, DOI 10.1002/da.20726; Hammer C, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.30; HEGERL U, 1993, BIOL PSYCHIAT, V33, P173, DOI 10.1016/0006-3223(93)90137-3; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Heim C, 2009, ARCH GEN PSYCHIAT, V66, P72, DOI 10.1001/archgenpsychiatry.2008.508; Iidaka T, 2005, J NEUROSCI, V25, P6460, DOI 10.1523/JNEUROSCI.5261-04.2005; Irish L, 2010, J PEDIATR PSYCHOL, V35, P450, DOI 10.1093/jpepsy/jsp118; Isohookana R, 2013, EUR CHILD ADOLES PSY, V22, P13, DOI 10.1007/s00787-012-0311-8; Juckel G, 1997, BIOL PSYCHIAT, V41, P1181, DOI 10.1016/S0006-3223(96)00240-5; Kang SG, 2013, NORD J PSYCHIAT, V67, P214, DOI 10.3109/08039488.2012.732114; Kempke S, 2015, PSYCHONEUROENDOCRINO, V52, P14, DOI 10.1016/j.psyneuen.2014.10.027; Kilpatrick LA, 2011, GASTROENTEROLOGY, V140, P1943, DOI 10.1053/j.gastro.2011.03.011; Kim DH, 2013, J AFFECT DISORDERS, V148, P72, DOI 10.1016/j.jad.2012.11.051; Lau M, 2010, NORD J PSYCHIAT, V64, P4, DOI 10.3109/08039480903191205; Lee IH, 2011, PSYCHOPHARMACOLOGY, V214, P617, DOI 10.1007/s00213-010-2064-8; Lee KS, 2012, PSYCHIAT INVEST, V9, P298, DOI 10.4306/pi.2012.9.3.298; Lee SH, 2014, PROG NEURO-PSYCHOPH, V54, P7, DOI 10.1016/j.pnpbp.2014.05.010; Linka T, 2009, PSYCHIAT RES, V169, P139, DOI 10.1016/j.psychres.2008.06.009; Melke J, 2003, ARCH GEN PSYCHIAT, V60, P1017, DOI 10.1001/archpsyc.60.10.1017; Min JA, 2012, PSYCHIAT RES, V200, P374, DOI 10.1016/j.psychres.2012.06.038; Oliva JL, 2011, HUM PSYCHOPHARM CLIN, V26, P172, DOI 10.1002/hup.1187; Park YM, 2014, J AFFECT DISORDERS, V159, P62, DOI 10.1016/j.jad.2014.01.016; Park YM, 2013, PSYCHIAT INVEST, V10, P233, DOI 10.4306/pi.2013.10.3.233; Park YM, 2013, PSYCHIAT INVEST, V10, P143, DOI 10.4306/pi.2013.10.2.143; Park YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060340; Park YM, 2012, PSYCHIAT INVEST, V9, P80, DOI 10.4306/pi.2012.9.1.80; Park YM, 2011, PSYCHOPHARMACOLOGY, V213, P625, DOI 10.1007/s00213-010-2061-y; Park YM, 2010, PROG NEURO-PSYCHOPH, V34, P313, DOI 10.1016/j.pnpbp.2009.12.004; Scher CD, 2001, J TRAUMA STRESS, V14, P843, DOI 10.1023/A:1013058625719; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Sheffield JM, 2013, COMPR PSYCHIAT, V54, P1098, DOI 10.1016/j.comppsych.2013.05.013; Sigurdardotir S, 2014, SCAND J PUBLIC HEALT, V42, P278, DOI 10.1177/1403494813514645; Smith PN, 2012, J CLIN PSYCHOL, V68, P78, DOI 10.1002/jclp.20852; Spataro J, 2004, BRIT J PSYCHIAT, V184, P416, DOI 10.1192/bjp.184.5.416; Staples J, 2012, ARCH SEX BEHAV, V41, P341, DOI 10.1007/s10508-011-9773-x; Subica AM, 2013, J TRAUMA STRESS, V26, P588, DOI 10.1002/jts.21845; TERR LC, 1991, AM J PSYCHIAT, V148, P10; Uhl I, 2012, EUR ARCH PSY CLIN N, V262, P487, DOI 10.1007/s00406-012-0297-8; Wondie Y, 2011, J INTERPERS VIOLENCE, V26, P2025, DOI 10.1177/0886260510372937; Wyss C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068650; Yamada K, 2006, BIOL PSYCHIAT, V60, P192, DOI 10.1016/j.biopsych.2005.11.008	60	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145269	10.1371/journal.pone.0145269	http://dx.doi.org/10.1371/journal.pone.0145269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701104	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092600056
J	Karlsson, E; Magic, I; Bostner, J; Dyrager, C; Lysholm, F; Hallbeck, AL; Stal, O; Lundstrom, P				Karlsson, Elin; Magic, Ivana; Bostner, Josefine; Dyrager, Christine; Lysholm, Fredrik; Hallbeck, Anna-Lotta; Stal, Olle; Lundstrom, Patrik			Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis	PLOS ONE			English	Article							ENDOCRINE RESISTANCE; POOR-PROGNOSIS; GENE LISTS; KINASE; PHOSPHORYLATION; AMPLIFICATION; LOCALIZATION; MECHANISM; CLONING; PATHWAY	Background The AKT/mTORC1/S6K pathway is frequently overstimulated in breast cancer, constituting a promising therapeutic target. The benefit from mTOR inhibitors varies, likely as a consequence of tumour heterogeneity, and upregulation of several compensatory feed-back mechanisms. The mTORC1 downstream effectors S6K1, S6K2, and 4EBP1 are amplified and overexpressed in breast cancer, associated with a poor outcome and divergent endocrine treatment benefit. S6K1 and S6K2 share high sequence homology, but evidence of partly distinct biological functions is emerging. The aim of this work was to explore possible different roles and treatment target potentials of S6K1 and S6K2 in breast cancer. Materials and methods Whole-genome expression profiles were compared for breast tumours expressing high levels of S6K1, S6K2 or 4EBP1, using public datasets, as well as after in vitro siRNA downregulation of S6K1 and/or S6K2 in ZR751 breast cancer cells. In silico homology modelling of the S6K2 kinase domain was used to evaluate its possible structural divergences to S6K1. Results Genome expression profiles were highly different in S6K1 and S6K2 high tumours, whereas S6K2 and 4EBP1 profiles showed significant overlaps, both correlated to genes involved in cell cycle progression, among these the master regulator E2F1. S6K2 and 4EBP1 were inversely associated with IGF1 levels, and their prognostic value was shown to be restricted to tumours positive for IGFR and/or HER2. In vitro, S6K1 and S6K2 silencing resulted in upregulation of genes in the mTORC1 and mTORC2 complexes. Isoform-specific silencing also showed distinct patterns, e.g. S6K2 downregulation lead to upregulation of several cell cycle associated genes. Structural analyses of the S6K2 kinase domain showed unique structure patterns, deviating from those of S6K1, facilitating the development of isoform-specific inhibitors. Our data support emerging proposals of distinct biological features of S6K1 and S6K2, suggesting their importance as separate oncogenes and clinicalmarkers, where specific targeting in different breast cancer subtypes could facilitate further individualised therapies.	[Karlsson, Elin; Magic, Ivana; Bostner, Josefine; Hallbeck, Anna-Lotta; Stal, Olle] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden; [Karlsson, Elin; Magic, Ivana; Bostner, Josefine; Hallbeck, Anna-Lotta; Stal, Olle] Linkoping Univ, Dept Oncol, SE-58185 Linkoping, Sweden; [Magic, Ivana; Dyrager, Christine; Lundstrom, Patrik] Linkoping Univ, Dept Phys Chem & Biol, Div Chem, SE-58183 Linkoping, Sweden; [Lysholm, Fredrik] Linkoping Univ, Dept Phys Chem & Biol, Div Bioinformat, SE-58183 Linkoping, Sweden; [Lysholm, Fredrik] Linkoping Univ, Dept Phys Chem & Biol, SeRC, SE-58183 Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; Linkoping University; Linkoping University	Stal, O (corresponding author), Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden.	olle.stal@liu.se; patlu@ifm.liu.se			Swedish Research Council [2012-5136, 2007-3475]; Swedish Cancer Foundation; LiU Cancer; LiU Cancer Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; LiU Cancer; LiU Cancer Foundation	This study was supported by The Swedish Research Council (PL OS), Grant numbers: 2012-5136 and 2007-3475, URL: (vr.se); The Swedish Cancer Foundation (OS), LiU Cancer (ALH OS PL), No grant number available, URL: (https://www.liu.se/forskning/liu-cancer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from the Swedish Cancer Foundation (OS), the Swedish Research Council (OS and PL) and the LiU Cancer Foundation (ALH, OS, and PL)	Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Arnason T, 2013, CANCER BIOL THER, V14, P672, DOI 10.4161/cbt.25089; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; BLUNDELL TL, 1987, NATURE, V326, P347, DOI 10.1038/326347a0; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P8351, DOI 10.1073/pnas.95.14.8351; Couch FJ, 1999, CANCER RES, V59, P1408; Drury SC, 2011, ENDOCR-RELAT CANCER, V18, P565, DOI 10.1530/ERC-10-0046; Engelmann D, 2012, CANCER RES, V72, P571, DOI 10.1158/0008-5472.CAN-11-2575; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Fox EM, 2011, CANCER RES, V71, P6773, DOI 10.1158/0008-5472.CAN-11-1295; Goh ETH, 2010, J BIOL CHEM, V285, P17065, DOI 10.1074/jbc.M109.078782; Gout I, 1998, J BIOL CHEM, V273, P30061, DOI 10.1074/jbc.273.46.30061; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hengstschlager M, 2011, ONCOGENE; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Karlsson E, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3557; Karlsson E, 2011, GENE CHROMOSOME CANC, V50, P775, DOI 10.1002/gcc.20900; Kim EK, 2011, BREAST CANCER RES TR, V126, P93, DOI 10.1007/s10549-010-1315-z; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee-Fruman KK, 1999, ONCOGENE, V18, P5108, DOI 10.1038/sj.onc.1202894; Louie MC, 2010, MOL CANCER RES, V8, P343, DOI 10.1158/1541-7786.MCR-09-0395; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Meric-Bernstam F, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3343; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Pardo OE, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00191; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Perez-Tenorio G, 2011, BREAST CANCER RES TR, V128, P713, DOI 10.1007/s10549-010-1058-x; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Real S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016163; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Rong L, 2008, RNA, V14, P1318, DOI 10.1261/rna.950608; Rossi R, 2007, FEBS LETT, V581, P4058, DOI 10.1016/j.febslet.2007.07.047; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sridharan S, 2011, CANCER RES, V71, P2590, DOI 10.1158/0008-5472.CAN-10-3253; Sunami T, 2010, J BIOL CHEM, V285, P4587, DOI 10.1074/jbc.M109.040667; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang JC, 2013, BIOCHEM J, V454, P39, DOI 10.1042/BJ20121863; Williamson M. P., 2012, HOW PROTEINS WORK; Winder T, 2013, THE PHARMACOGENOMICS; Yamnik RL, 2009, J BIOL CHEM, V284, P6361, DOI 10.1074/jbc.M807532200; Yu ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062642; Zhou DJ, 2006, NUCLEIC ACIDS RES, V34, P5974, DOI 10.1093/nar/gkl764; Zhou W, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.110; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	56	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145013	10.1371/journal.pone.0145013	http://dx.doi.org/10.1371/journal.pone.0145013			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698305	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600042
J	Kuhn, J; Gripp, T; Flieder, T; Dittrich, M; Hendig, D; Busse, J; Knabbe, C; Birschmann, I				Kuhn, Joachim; Gripp, Tatjana; Flieder, Tobias; Dittrich, Marcus; Hendig, Doris; Busse, Jessica; Knabbe, Cornelius; Birschmann, Ingvild			UPLC-MRM Mass Spectrometry Method for Measurement of the Coagulation Inhibitors Dabigatran and Rivaroxaban in Human Plasma and Its Comparison with Functional Assays	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; FACTOR XA INHIBITOR; DIRECT ORAL ANTICOAGULANTS; DIRECT THROMBIN INHIBITOR; DIAGNOSTIC-ACCURACY; APIXABAN; MS/MS; QUANTIFICATION; VALIDATION; METABOLISM	Introduction The fast, precise, and accurate measurement of the new generation of oral anticoagulants such as dabigatran and rivaroxaban in patients' plasma my provide important information in different clinical circumstances such as in the case of suspicion of overdose, when patients switch from existing oral anticoagulant, in patients with hepatic or renal impairment, by concomitant use of interaction drugs, or to assess anticoagulant concentration in patients' blood before major surgery. Methods Here, we describe a quick and precise method to measure the coagulation inhibitors dabigatran and rivaroxaban using ultra-performance liquid chromatography electrospray ionization-tandem mass spectrometry in multiple reactions monitoring (MRM) mode (UPLC-MRM MS). Internal standards (ISs) were added to the sample and after protein precipitation; the sample was separated on a reverse phase column. After ionization of the analytes the ions were detected using electrospray ionization-tandem mass spectrometry. Run time was 2.5 minutes per injection. Ion suppression was characterized by means of post-column infusion. Results The calibration curves of dabigatran and rivaroxaban were linear over the working range between 0.8 and 800 mu g/L (r > 0.99). Limits of detection (LOD) in the plasma matrix were 0.21 mu g/L for dabigatran and 0.34 mu g/L for rivaroxaban, and lower limits of quantification (LLOQ) in the plasma matrix were 0.46 mu g/L for dabigatran and 0.54 mu g/L for rivaroxaban. The intraassay coefficients of variation (CVs) for dabigatran and rivaroxaban were < 4% and 6%; respectively, the interassay CVs were < 6% for dabigatran and < 9% for rivaroxaban. Inaccuracy was < 5% for both substances. The mean recovery was 104.5% (range 83.8-113.0%) for dabigatran and 87.0%(range 73.6-105.4%) for rivaroxaban. No significant ion suppressions were detected at the elution times of dabigatran or rivaroxaban. Both coagulation inhibitors were stable in citrate plasma at -20 degrees C, 4 degrees C and even at RT for at least one week. A method comparison between our UPLC-MRM MS method, the commercially available automated Direct Thrombin Inhibitor assay (DTI assay) for dabigatran measurement from CoaChrom Diagnostica, as well as the automated anti-Xa assay for rivaroxaban measurement from Chromogenix both performed by ACL-TOP showed a high degree of correlation. However, UPLC-MRM MS measurement of dabigatran and rivaroxaban has a much better selectivity than classical functional assays measuring activities of various coagulation factors which are susceptible to interference by other coagulant drugs. Conclusions Overall, we developed and validated a sensitive and specific UPLC-MRM MS assay for the quick and specific measurement of dabigatran and rivaroxaban in human plasma.	[Kuhn, Joachim; Gripp, Tatjana; Flieder, Tobias; Hendig, Doris; Busse, Jessica; Knabbe, Cornelius; Birschmann, Ingvild] Ruhr Univ Bochum, Heart & Diabet Ctr North Rhine Westphalia, Inst Lab & Transfus Med, Bad Oeynhausen, Germany; [Dittrich, Marcus] Univ Wurzburg, Dept Bioinformat, Bioctr, D-97070 Wurzburg, Germany	Ruhr University Bochum; University of Wurzburg	Kuhn, J (corresponding author), Ruhr Univ Bochum, Heart & Diabet Ctr North Rhine Westphalia, Inst Lab & Transfus Med, Bad Oeynhausen, Germany.	jkuhn@hdz-nrw.de	Hendig, Doris/F-1112-2013	Hendig, Doris/0000-0002-3660-6923				Aucella F, 2013, J PHARMACEUT BIOMED, V86, P123, DOI 10.1016/j.jpba.2013.08.001; Baglin T, 2013, J Thromb Haemost, DOI 10.1111/jth.12149; Blaich C, 2015, CLIN CHEM LAB MED, V53, P1981, DOI 10.1515/cclm-2014-1108; Bland JM, 2012, ANESTHESIOLOGY, V116, P182, DOI 10.1097/ALN.0b013e31823d7784; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blech S, 2008, DRUG METAB DISPOS, V36, P386, DOI 10.1124/dmd.107.019083; Boehringer Ingelheim Pharmaceuticals, 2020, PRAD DAB PACK INS; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Bossuyt PM, 2003, CLIN CHEM LAB MED, V41, P68, DOI 10.1515/CCLM.2003.012; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Ceglarek U, 2013, PROTEOM CLIN APPL, V7, P794, DOI 10.1002/prca.201300034; Chappell DL, 2012, BIOANALYSIS, V4, P2843, DOI [10.4155/BIO.12.268, 10.4155/bio.12.268]; Delavenne X, 2012, J PHARMACEUT BIOMED, V58, P152, DOI 10.1016/j.jpba.2011.09.018; Eby C, 2013, INT J LAB HEMATOL, V35, P262, DOI 10.1111/ijlh.12065; Eller T, 2014, CLIN CHEM LAB MED, V52, P835, DOI 10.1515/cclm-2013-0936; Ferrandis R, 2013, THROMB HAEMOSTASIS, V110, P515, DOI 10.1160/TH12-11-0868; Gous T, 2014, THER DRUG MONIT, V36, P597, DOI 10.1097/FTD.0000000000000059; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Hawes EM, 2013, J THROMB HAEMOST, V11, P1493, DOI 10.1111/jth.12308; Helin TA, 2013, CLIN CHEM, V59, P807, DOI 10.1373/clinchem.2012.198788; Hillarp A, 2014, J THROMB HAEMOST, V12, P1545, DOI 10.1111/jth.12649; Hillarp A, 2011, J THROMB HAEMOST, V9, P133, DOI 10.1111/j.1538-7836.2010.04098.x; Korostelev M, 2014, J PHARMACEUT BIOMED, V100, P230, DOI 10.1016/j.jpba.2014.08.011; Kuhn J, 2015, BIOCHEM BIOPH RES CO, V459, P469, DOI 10.1016/j.bbrc.2015.02.129; Kuhn J, 2013, TALANTA, V110, P71, DOI 10.1016/j.talanta.2013.02.010; Kuhn J, 2012, J PHARMACEUT BIOMED, V67-68, P137, DOI 10.1016/j.jpba.2012.04.036; Kuhn J, 2009, CLIN BIOCHEM, V42, P521, DOI 10.1016/j.clinbiochem.2008.12.009; Kuhn J, 2009, CLIN BIOCHEM, V42, P83, DOI 10.1016/j.clinbiochem.2008.10.004; Lang D, 2009, DRUG METAB DISPOS, V37, P1046, DOI 10.1124/dmd.108.025551; Lassen MR, 2007, J THROMB HAEMOST, V5, P2368, DOI 10.1111/j.1538-7836.2007.02764.x; Leung KSY, 2014, ANAL BIOANAL CHEM, V406, P2289, DOI 10.1007/s00216-013-7542-5; Li JY, 2014, J CHROMATOGR B, V973, P110, DOI 10.1016/j.jchromb.2014.09.025; Li YJ, 2014, CLIN CHEM, V60, P783, DOI 10.1373/clinchem.2013.219931; Mueck W, 2008, CLIN PHARMACOKINET, V47, P203, DOI 10.2165/00003088-200847030-00006; Raghavan N, 2009, DRUG METAB DISPOS, V37, P74, DOI 10.1124/dmd.108.023143; Schmitz EMH, 2014, J THROMB HAEMOST, V12, P1636, DOI 10.1111/jth.12702; Shah V P, 2000, Pharm Res, V17, P1551, DOI 10.1023/A:1007669411738; van den Ouweland JMW, 2012, J CHROMATOGR B, V883, P18, DOI 10.1016/j.jchromb.2011.11.044; Zander J, 2015, CLIN CHEM LAB MED, V53, P781, DOI 10.1515/cclm-2014-0746	39	33	34	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145478	10.1371/journal.pone.0145478	http://dx.doi.org/10.1371/journal.pone.0145478			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699714	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600088
J	Lyu, C; Hu, SY; Wei, LQ; Zhang, XM; Talhelm, T				Lyu, Chuang; Hu, Siyuan; Wei, Liuqing; Zhang, Xuemin; Talhelm, Thomas			Brain Activation of Identity Switching in Multiple Identity Tracking Task	PLOS ONE			English	Article							OBJECT TRACKING; WORKING-MEMORY; ATTENTIVE TRACKING; NEURAL MECHANISMS; PUZZLING FINDINGS; FMRI ACTIVATION; BINDING; INFORMATION; INHIBITION; DORSAL	When different objects switch identities in the multiple identity tracking (MIT) task, viewers need to rebind objects' identity and location, which requires attention. This rebinding helps people identify the regions targets are in (where they need to focus their attention) and inhibit unimportant regions (where distractors are). This study investigated the processing of attentional tracking after identity switching in an adapted MIT task. This experiment used three identity-switching conditions: a target-switching condition (where the target objects switched identities), a distractor-switching condition (where the distractor objects switched identities), and a no-switching condition. Compared to the distractor-switching condition, the target-switching condition elicited greater activation in the frontal eye fields (FEF), intraparietal sulcus (IPS), and visual cortex. Compared to the no-switching condition, the target-switching condition elicited greater activation in the FEF, inferior frontal gyrus (pars orbitalis) (IFG-Orb), IPS, visual cortex, middle temporal lobule, and anterior cingulate cortex. Finally, the distractor-switching condition showed greater activation in the IFG-Orb compared to the no-switching condition. These results suggest that, in the target-switching condition, the FEF and IPS (the dorsal attention network) might be involved in goal-driven attention to targets during attentional tracking. In addition, in the distractor-switching condition, the activation of the IFG-Orb may indicate salient change that pulls attention away automatically.	[Lyu, Chuang; Hu, Siyuan; Wei, Liuqing; Zhang, Xuemin] Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing 100875, Peoples R China; [Hu, Siyuan; Zhang, Xuemin] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Hu, Siyuan; Zhang, Xuemin] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Hu, Siyuan; Zhang, Xuemin] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China; [Talhelm, Thomas] Univ Chicago, Booth Sch Business, Chicago, IL 60637 USA	Beijing Normal University; Beijing Normal University; Beijing Normal University; Beijing Normal University; University of Chicago	Zhang, XM (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing 100875, Peoples R China.	xmzhang@bnu.edu.cn			National Natural Science Foundation of China [31271083]; National Basic Research Program of China [2011CB711001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was funded by the National Natural Science Foundation of China (31271083) (to XMZ) and the National Basic Research Program of China (2011CB711001) (to XMZ) (http://www.973.gov.cn/English/Index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2009, VIS COGN, V17, P141, DOI 10.1080/13506280802265496; Anderson BA, 2012, ATTEN PERCEPT PSYCHO, V74, P1183, DOI 10.3758/s13414-012-0325-9; Armstrong KM, 2009, J NEUROSCI, V29, P15621, DOI 10.1523/JNEUROSCI.4465-09.2009; Atmaca S, 2013, BRAIN BEHAV, V3, P683, DOI 10.1002/brb3.180; Battelli L, 2009, J COGNITIVE NEUROSCI, V21, P1946, DOI 10.1162/jocn.2008.21149; Campo P, 2010, NEUROIMAGE, V49, P2807, DOI 10.1016/j.neuroimage.2009.10.024; Cohen MA, 2011, ATTEN PERCEPT PSYCHO, V73, P1422, DOI 10.3758/s13414-011-0089-7; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; de Fockert JW, 2012, BRAIN COGNITION, V80, P367, DOI 10.1016/j.bandc.2012.07.006; de Lange FP, 2005, J COGNITIVE NEUROSCI, V17, P97, DOI 10.1162/0898929052880039; Doran MM, 2010, ATTEN PERCEPT PSYCHO, V72, P33, DOI 10.3758/APP.72.1.33; Drew T, 2009, PSYCHON B REV, V16, P411, DOI 10.3758/PBR.16.2.411; Farrant K, 2015, DEV COGN NEUROS-NETH, V12, P165, DOI 10.1016/j.dcn.2015.02.001; Giesbrecht B, 2003, NEUROIMAGE, V19, P496, DOI 10.1016/S1053-8119(03)00162-9; Greene CM, 2014, NEUROIMAGE, V84, P290, DOI 10.1016/j.neuroimage.2013.08.060; Hartwigsen G, 2010, P NATL ACAD SCI USA, V107, P16494, DOI 10.1073/pnas.1008121107; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Horowitz TS, 2007, PERCEPT PSYCHOPHYS, V69, P172, DOI 10.3758/BF03193740; Howe PD, 2009, J VISION, V9, DOI 10.1167/9.4.10; Howe PDL, 2015, COGNITIVE SCI, V39, P1622, DOI 10.1111/cogs.12204; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Jovicich J, 2001, J COGNITIVE NEUROSCI, V13, P1048, DOI 10.1162/089892901753294347; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Liu TW, 2012, VISION RES, V66, P31, DOI 10.1016/j.visres.2012.06.009; Liu TW, 2009, LECT NOTES ARTIF INT, V5639, P206; Makovski T, 2009, J EXP PSYCHOL HUMAN, V35, P1687, DOI 10.1037/a0016453; Makovski T, 2009, VIS COGN, V17, P180, DOI 10.1080/13506280802211334; Muggleton NG, 2010, CORTEX, V46, P178, DOI 10.1016/j.cortex.2009.01.011; Oksama L, 2008, COGNITIVE PSYCHOL, V56, P237, DOI 10.1016/j.cogpsych.2007.03.001; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Pinto Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042929; Pinto Y, 2010, J VISION, V10, DOI 10.1167/10.10.4; Poch C, 2010, NEUROPSYCHOLOGIA, V48, P3846, DOI 10.1016/j.neuropsychologia.2010.09.015; Postle BR, 2005, MEM COGNITION, V33, P203, DOI 10.3758/BF03195309; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Pylyshyn ZW, 2006, VIS COGN, V14, P175, DOI 10.1080/13506280544000200; Pylyshyn ZW, 2008, VIS COGN, V16, P1011, DOI 10.1080/13506280802247486; Pylyshyn ZW, 2004, VIS COGN, V11, P801, DOI 10.1080/13506280344000518; Ren DG, 2009, J VISION, V9, DOI 10.1167/9.5.18; Rosenberg-Lee M, 2011, NEUROPSYCHOLOGIA, V49, P2592, DOI 10.1016/j.neuropsychologia.2011.04.035; Salmi J, 2009, BRAIN RES, V1286, P155, DOI 10.1016/j.brainres.2009.06.083; Schafer RJ, 2007, NEURON, V56, P541, DOI 10.1016/j.neuron.2007.09.029; Sears CR, 2000, CAN J EXP PSYCHOL, V54, P1, DOI 10.1037/h0087326; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Spinks JA, 2004, NEUROIMAGE, V23, P517, DOI 10.1016/j.neuroimage.2004.06.025; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Thompson KG, 2005, J NEUROSCI, V25, P9479, DOI 10.1523/JNEUROSCI.0741-05.2005; Vogel SE, 2013, NEUROPSYCHOLOGIA, V51, P979, DOI 10.1016/j.neuropsychologia.2013.02.001; Weissman DH, 2012, NEUROIMAGE, V61, P798, DOI 10.1016/j.neuroimage.2012.03.032; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Yamasaki H, 2002, P NATL ACAD SCI USA, V99, P11447, DOI 10.1073/pnas.182176499	56	8	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145489	10.1371/journal.pone.0145489	http://dx.doi.org/10.1371/journal.pone.0145489			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26699865	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600089
J	Ghiasi, G; Lariviere, V; Sugimoto, CR				Ghiasi, Gita; Lariviere, Vincent; Sugimoto, Cassidy R.			On the Compliance of Women Engineers with a Gendered Scientific System	PLOS ONE			English	Article							PUBLICATION PRODUCTIVITY; RESEARCH COLLABORATION; RESEARCH PERFORMANCE; SCIENCE; CENTRALITY; NETWORK; IMPACT; EVOLUTION; OUTPUT	There has been considerable effort in the last decade to increase the participation of women in engineering through various policies. However, there has been little empirical research on gender disparities in engineering which help underpin the effective preparation, co-ordination, and implementation of the science and technology (S&T) policies. This article aims to present a comprehensive gendered analysis of engineering publications across different specialties and provide a cross-gender analysis of research output and scientific impact of engineering researchers in academic, governmental, and industrial sectors. For this purpose, 679,338 engineering articles published from 2008 to 2013 are extracted from the Web of Science database and 974,837 authorships are analyzed. The structures of co-authorship collaboration networks in different engineering disciplines are examined, highlighting the role of female scientists in the diffusion of knowledge. The findings reveal that men dominate 80% of all the scientific production in engineering. Women engineers publish their papers in journals with higher Impact Factors than their male peers, but their work receives lower recognition (fewer citations) from the scientific community. Engineers -regardless of their gender-contribute to the reproduction of the male-dominated scientific structures through forming and repeating their collaborations predominantly with men. The results of this study call for integration of data driven gender-related policies in existing S&T discourse.	[Ghiasi, Gita] Concordia Univ, Dept Mech & Ind Engn, Montreal, PQ H3G 1M8, Canada; [Lariviere, Vincent] Univ Montreal, Ecole Bibliothecon & Sci Informat, Montreal, PQ H3C 3J7, Canada; [Lariviere, Vincent] Univ Quebec, CIRST, OST, Montreal, PQ H3C 3P8, Canada; [Sugimoto, Cassidy R.] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA	Concordia University - Canada; Universite de Montreal; University of Quebec; University of Quebec Montreal; Indiana University System; Indiana University Bloomington	Ghiasi, G (corresponding author), Concordia Univ, Dept Mech & Ind Engn, 1455 De Maisonneuve Blvd, Montreal, PQ H3G 1M8, Canada.	g_ghia@encs.concordia.ca	Lariviere, Vincent/AAF-3179-2019; Sugimoto, Cassidy R/AAV-2705-2021	Sugimoto, Cassidy R/0000-0001-8608-3203; Ghiasi, Gita/0000-0001-8296-6674	Social Sciences and Humanities Research Council of Canada; Canada Research Chairs program	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canada Research Chairs program(Canada Research Chairs)	This research was funded by the Social Sciences and Humanities Research Council of Canada and the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2012, J INFORMETR, V6, P403, DOI 10.1016/j.joi.2012.01.002; Addis E, 2004, GENDER EXCELLENCE MA; [Anonymous], 2013, NATURE, V495, P5, DOI 10.1038/495005a; [Anonymous], 1996, KNOWL BAS EC; Badar K, 2013, SCIENTOMETRICS, V94, P755, DOI 10.1007/s11192-012-0764-z; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Bastian M, 2009, ICWSM; Bentley P, 2012, J SOCIOL, V48, P85, DOI 10.1177/1440783311411958; Berryman SE., 1983, WHO WILL DO SCI TREN; Borner K, 2005, COMPLEXITY, V10, P57, DOI 10.1002/cplx.20078; Borrego A, 2010, SCIENTOMETRICS, V83, P93, DOI 10.1007/s11192-009-0025-y; Bure C, 2007, STRATEG COMM PAP INN, V24; Burke R.J., 2007, WOMEN MINORITIES SCI; Cozzens SE, 2008, SCI ENG ETHICS, V14, P345, DOI 10.1007/s11948-008-9061-x; Dainty A., 2008, RES CULTURES SCI ENG; Ding WW, 2006, SCIENCE, V313, P665, DOI 10.1126/science.1124832; Dryburgh H, 1999, GENDER SOC, V13, P664, DOI 10.1177/089124399013005006; Duijn PAC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04238; Ellison SF, 2014, J ECON MANAGE STRAT, V23, P465, DOI 10.1111/jems.12051; Etzkowitz H., 2000, ATHENA UNBOUND ADV W; Evetts Julia., 1998, WOMEN MANAGEMENT REV, V13, P283, DOI [10.1108/09649429810243144, DOI 10.1108/09649429810243144]; Faulkner W, 2009, ENG STUD, V1, P169, DOI 10.1080/19378620903225059; Fox MF, 2005, SOC STUD SCI, V35, P131, DOI 10.1177/0306312705046630; Fraenkel B, 2004, CNRS SOCIOL; Frietsch R, 2009, RES POLICY, V38, P590, DOI 10.1016/j.respol.2009.01.019; Glanzel W, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P257; Godin B., 2006, J TECHNOLOGY TRANSFE, V31, P17, DOI DOI 10.1007/S10961-005-5010-X; Gupta N, 2004, GENDER EXCELLENCE MA; Hunter Laura., 2008, AM SOCIOL, V39, P290; Kaufman RR, 2011, PHYS THER, V91, P122, DOI 10.2522/ptj.20100106; Kyvik S, 1996, SCI TECHNOL HUM VAL, V21, P54, DOI 10.1177/016224399602100103; Lariviere, 2014, FEMMES SCI PREMIERES; Lariviere V, 2011, SCIENTOMETRICS, V87, P483, DOI 10.1007/s11192-011-0369-y; Leahey E, 2006, GENDER SOC, V20, P754, DOI 10.1177/0891243206293030; Liu XM, 2005, INFORM PROCESS MANAG, V41, P1462, DOI 10.1016/j.ipm.2005.03.012; LONG JS, 1992, SOC FORCES, V71, P159, DOI 10.2307/2579971; MANSFIELD E, 1972, SCIENCE, V175, P477, DOI 10.1126/science.175.4021.477; Miller DI, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00037; Milojevic S, 2010, J AM SOC INF SCI TEC, V61, P1410, DOI 10.1002/asi.21331; MOED HF, 1995, SCIENTOMETRICS, V33, P381, DOI 10.1007/BF02017338; Murray F, 2007, IND CORP CHANGE, V16, P657, DOI 10.1093/icc/dtm021; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Ozel B, 2014, SCIENTOMETRICS, V98, P703, DOI 10.1007/s11192-013-1145-y; Penas CS, 2006, J INF SCI, V32, P480, DOI 10.1177/0165551506066058; Prpic K, 2002, SCIENTOMETRICS, V55, P27, DOI 10.1023/A:1016046819457; ROSSITER MW, 1993, SOC STUD SCI, V23, P325, DOI 10.1177/030631293023002004; Sagebiel F., 2003, P GASAT 11 INT C MAU; Samson AES, 2006, GENDER SCI TECHNOLOG; Schumpeter J.A., 2017, THEORIE WIRTSCHAFTLI; Silim A, 2014, WOMEN IN ENG; SOLOW RM, 1956, Q J ECON, V70, P65, DOI 10.2307/1884513; Sreevalsan-Nair J, 2013, VISUALIZATION SMALL, P151; Sugimoto CR, 2013, NATURE, V504, P211, DOI 10.1038/504211a; Sugimoto CR, 2014, STI 2014 LEIDEN, P611; Sugimoto CR, SCI PUBLIC IN PRESS; Symonds MRE, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000127; Velden T, 2010, SCIENTOMETRICS, V85, P219, DOI 10.1007/s11192-010-0224-6; Wei W, 2011, HANDLING WEIGHTED AS; Whittington K., 2005, J TECHNOL TRANSFER, V30, P355, DOI DOI 10.1007/S10961-005-2581-5>; Whittington K.B., 2006, GENDER SCI DISSEMINA, P1; Xie Y, 1998, AM SOCIOL REV, V63, P847, DOI 10.2307/2657505; Yan EJ, 2009, J AM SOC INF SCI TEC, V60, P2107, DOI 10.1002/asi.21128; Zuckerman H, 1984, ADV MOTIV ACHIEV, V2; Zweig K., 2014, SOCIOINFORMATICS SOC	65	45	45	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145931	10.1371/journal.pone.0145931	http://dx.doi.org/10.1371/journal.pone.0145931			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716831	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500097
J	Ghosh, D; Ding, LL; Sivaprasad, U; Geh, E; Myers, JB; Bernstein, JA; Hershey, GKK; Mersha, TB				Ghosh, Debajyoti; Ding, Lili; Sivaprasad, Umasundari; Geh, Esmond; Myers, Jocelyn Biagini; Bernstein, Jonathan A.; Hershey, Gurjit K. Khurana; Mersha, Tesfaye B.			Multiple Transcriptome Data Analysis Reveals Biologically Relevant Atopic Dermatitis Signature Genes and Pathways	PLOS ONE			English	Article							NCBI GEO ARCHIVE; T-CELLS; STAPHYLOCOCCUS-AUREUS; MICROARRAY ANALYSIS; SKIN BARRIER; EXPRESSION; PSORIASIS; DISEASE; DIFFERENTIATION; ACTIVATION	Several studies have identified genes that are differentially expressed in atopic dermatitis (AD) compared to normal skin. However, there is also considerable variation in the list of differentially expressed genes (DEGs) reported by different groups and the exact cause of AD is still not fully understood. Using a rank-based approach, we analyzed gene expression data from five different microarray studies, comprising a total of 127 samples and more than 250,000 transcripts. A total of 89 AD gene expression signatures '89ADGES', including FLG gene, were identified to show dysregulation consistently across these studies. Using a Support Vector Machine, we showed that the '89ADGES' discriminates AD from normal skin with 98% predictive accuracy. Functional annotation of these genes implicated their roles in immune responses (e.g., betadefensin, microseminoprotein), keratinocyte differentiation/epidermal development (e.g., FLG, CORIN, AQP, LOR, KRT16), inflammation (e.g., IL37, IL27RA, CCL18) and lipid metabolism (e.g., AKR1B10, FAD7, FAR2). Subsequently, we validated a subset of signature genes using quantitative PCR in a mouse model. Using a bioinformatic approach, we identified keratinocyte pathway over-represented (P = < 0.0006) among the 89 signature genes. Keratinocytes are known to play a major role in barrier function due to their location in the epidermis. Our result suggests that besides immune-mediated pathway, skin barrier pathways such as the keratinocyte differentiation pathway play a key role in AD pathogenesis. A better understanding of the role of keratinocytes in AD will be important for developing novel "barrier therapy" for this disease.	[Ghosh, Debajyoti; Geh, Esmond; Bernstein, Jonathan A.] Univ Cincinnati, Dept Internal Med, Div Immunol Allergy & Rheumatol, Cincinnati, OH USA; [Ding, Lili] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH USA; [Sivaprasad, Umasundari; Myers, Jocelyn Biagini; Hershey, Gurjit K. Khurana; Mersha, Tesfaye B.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Mersha, TB (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45220 USA.	tesfaye.mersha@cchmc.org		Biagini, Jocelyn/0000-0002-4378-6133; Bernstein, Jonathan/0000-0002-3476-1196	National Institutes of Health [K01HL103165]; Diversity and Health Disparities Award of the Cincinnati Children's Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL103165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diversity and Health Disparities Award of the Cincinnati Children's Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant K01HL103165 and Diversity and Health Disparities Award of the Cincinnati Children's Research Foundation to TBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; Akdis CA, 2000, CURR OPIN IMMUNOL, V12, P641, DOI 10.1016/S0952-7915(00)00156-4; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Atamas SP, 2003, AM J RESP CELL MOL, V29, P743, DOI 10.1165/rcmb.2003-0078OC; Bantz Selene K, 2014, J Clin Cell Immunol, V5; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Behshad R, 2008, ARCH DERMATOL, V144, P84, DOI 10.1001/archdermatol.2007.22; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein DI, 2013, TOXICOL SCI, V131, P242, DOI 10.1093/toxsci/kfs272; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Bowcock AM, 2004, HUM MOL GENET, V13, pR43, DOI 10.1093/hmg/ddh094; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; CHRISTOPHERS E, 1987, ARCH DERMATOL RES, V279, pS48, DOI 10.1007/BF00585919; Darlenski R, 2014, CLIN DERMATOL, V32, P409, DOI 10.1016/j.clindermatol.2013.11.007; de Veer SJ, 2014, TRENDS MOL MED, V20, P166, DOI 10.1016/j.molmed.2013.11.005; Denby KS, 2012, CURR OPIN ALLERGY CL, V12, P421, DOI 10.1097/ACI.0b013e3283551da5; Ding LL, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-16; Dubrac S, 2011, DERM-ENDOCRINOL, V3, P23, DOI 10.4161/derm.3.1.14615; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esche C, 2004, CURR ALLERGY ASTHM R, V4, P276, DOI 10.1007/s11882-004-0071-8; Eyre S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3139; Febbo PG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-461; Garidel P, 2010, BIOPHYS CHEM, V150, P144, DOI 10.1016/j.bpc.2010.03.008; Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012; Glaser R, 2009, J INVEST DERMATOL, V129, P641, DOI 10.1038/jid.2008.268; GRICE K, 1975, J INVEST DERMATOL, V64, P313, DOI 10.1111/1523-1747.ep12512258; Gunther C, 2005, J IMMUNOL, V174, P1723, DOI 10.4049/jimmunol.174.3.1723; Guttman-Yassky E, 2013, EXPERT OPIN BIOL TH, V13, P549, DOI 10.1517/14712598.2013.758708; Guttman-Yassky E, 2009, J ALLERGY CLIN IMMUN, V124, P1235, DOI 10.1016/j.jaci.2009.09.031; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hatano Y, 2011, J INVEST DERMATOL, V131, P1845, DOI 10.1038/jid.2011.144; Hu YH, 2003, J PROTEOME RES, V2, P405, DOI 10.1021/pr0340227; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim JH, 2011, J CLIN IMMUNOL, V31, P112, DOI 10.1007/s10875-010-9462-x; Kodelja V, 1998, J IMMUNOL, V160, P1411; Kypriotou M, 2012, EXP DERMATOL, V21, P643, DOI 10.1111/j.1600-0625.2012.01472.x; Leung DYM, 2014, J ALLERGY CLIN IMMUN, V134, P769, DOI 10.1016/j.jaci.2014.08.008; Maeda M, 2011, MOL BIOL CELL, V22, P3840, DOI 10.1091/mbc.E11-04-0364; Mancini AJ, 2008, PEDIATR DERMATOL, V25, P1, DOI 10.1111/j.1525-1470.2007.00572.x; Mantel A, 2012, J INVEST DERMATOL, V132, P1103, DOI 10.1038/jid.2011.412; Mao-Qiang M, 2004, J INVEST DERMATOL, V123, P305, DOI 10.1111/j.0022-202X.2004.23235.x; Marenholz I, 1996, GENOMICS, V37, P295, DOI 10.1006/geno.1996.0563; Menzies BE, 2005, INFECT IMMUN, V73, P5241, DOI 10.1128/IAI.73.8.5241-5244.2005; Meyer-Hoffert U, 2009, ARCH IMMUNOL THER EX, V57, P345, DOI 10.1007/s00005-009-0045-6; Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262; Olsson M, 2006, ALLERGY, V61, P1132, DOI 10.1111/j.1398-9995.2006.01151.x; PICKER LJ, 1990, AM J PATHOL, V136, P1053; Plager DA, 2007, EXP DERMATOL, V16, P28, DOI 10.1111/j.1600-0625.2006.00504.x; Puya R, 2012, INT J DERMATOL, V51, P115, DOI 10.1111/j.1365-4632.2011.05195.x; Raponi M, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-56; Reginald K, 2011, CLIN EXP ALLERGY, V41, P357, DOI 10.1111/j.1365-2222.2010.03655.x; Rung J, 2013, NAT REV GENET, V14, P89, DOI 10.1038/nrg3394; Saaf AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004017; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Schutyser E, 2005, J LEUKOCYTE BIOL, V78, P14, DOI 10.1189/jlb.1204712; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Sertznig P, 2011, DERM-ENDOCRINOL, V3, P130, DOI [10.4161/derm.3.3.15025, 10.4161/derm.15025]; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soderhall C, 2001, HUM GENET, V109, P129, DOI 10.1007/s004390100556; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Suarez-Farinas M, 2011, J ALLERGY CLIN IMMUN, V127, P954, DOI 10.1016/j.jaci.2010.12.1124; Swindell WR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-527; Tan JQ, 1996, J INVEST DERMATOL, V107, P5, DOI 10.1111/1523-1747.ep12294284; Vapnik V., 1998, STAT LEARNING THEORY; Vogl T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5593; Xiao YF, 2014, BIOINFORMATICS, V30, P801, DOI 10.1093/bioinformatics/btr671; Yang LL, 2014, J INVEST DERMATOL, V134, P2105, DOI 10.1038/jid.2014.120; Zeeuwen PLJM, 2009, J INVEST DERMATOL, V129, P1327, DOI 10.1038/jid.2009.40; Zeller S, 2009, J ALLERGY CLIN IMMUN, V124, P278, DOI 10.1016/j.jaci.2009.05.015; Zhang ZH, 2014, J IMMUNOL, V192, P859, DOI 10.4049/jimmunol.1301062; Zheng T, 2011, ALLERGY ASTHMA IMMUN, V3, P67, DOI 10.4168/aair.2011.3.2.67	74	49	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0144316	10.1371/journal.pone.0144316	http://dx.doi.org/10.1371/journal.pone.0144316			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717000	gold, Green Submitted, Green Published			2022-12-27	WOS:000367510500010
J	Kanda, K; Pflug, JM; Sproul, JS; Dasenko, MA; Maddison, DR				Kanda, Kojun; Pflug, James M.; Sproul, John S.; Dasenko, Mark A.; Maddison, David R.			Successful Recovery of Nuclear Protein-Coding Genes from Small Insects in Museums Using Illumina Sequencing	PLOS ONE			English	Article							ANCIENT DNA; GENOME SIZE; COLEOPTERA; CARABIDAE; SPECIMENS; BEMBIDION; PRESERVATION; BEETLE; SUBGENUS; COLLECTIONS	In this paper we explore high-throughput Illumina sequencing of nuclear protein-coding, ribosomal, and mitochondrial genes in small, dried insects stored in natural history collections. We sequenced one tenebrionid beetle and 12 carabid beetles ranging in size from 3.7 to 9.7 mm in length that have been stored in various museums for 4 to 84 years. Although we chose a number of old, small specimens for which we expected low sequence recovery, we successfully recovered at least some low-copy nuclear protein-coding genes from all specimens. For example, in one 56-year-old beetle, 4.4 mm in length, our de novo assembly recovered about 63% of approximately 41,900 nucleotides in a target suite of 67 nuclear protein-coding gene fragments, and 70% using a reference-based assembly. Even in the least successfully sequenced carabid specimen, reference-based assembly yielded fragments that were at least 50% of the target length for 34 of 67 nuclear protein-coding gene fragments. Exploration of alternative references for reference-based assembly revealed few signs of bias created by the reference. For all specimens we recovered almost complete copies of ribosomal and mitochondrial genes. We verified the general accuracy of the sequences through comparisons with sequences obtained from PCR and Sanger sequencing, including of conspecific, fresh specimens, and through phylogenetic analysis that tested the placement of sequences in predicted regions. A few possible inaccuracies in the sequences were detected, but these rarely affected the phylogenetic placement of the samples. Although our sample sizes are low, an exploratory regression study suggests that the dominant factor in predicting success at recovering nuclear protein-coding genes is a high number of Illumina reads, with success at PCR of COI and killing by immersion in ethanol being secondary factors; in analyses of only high-read samples, the primary significant explanatory variable was body length, with small beetles being more successfully sequenced.	[Kanda, Kojun; Pflug, James M.; Sproul, John S.; Maddison, David R.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Dasenko, Mark A.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Kanda, K (corresponding author), Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA.	coniontis@gmail.com		Kanda, Kojun/0000-0001-5561-8471	Harold E. and Leona M. Rice Endowment Fund at Oregon State University; National Science Foundation [DEB-1258220]; Direct For Biological Sciences [1258220] Funding Source: National Science Foundation	Harold E. and Leona M. Rice Endowment Fund at Oregon State University; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded in part by the Harold E. and Leona M. Rice Endowment Fund at Oregon State University, as well as National Science Foundation grant DEB-1258220 to DRM.	Aleksandrova GN, 2008, STRATIGR GEO CORREL+, V16, P295, DOI 10.1134/S0869593808030052; Baker M, 2012, NAT METHODS, V9, P333, DOI 10.1038/nmeth.1935; Bakker FT, 2015, BIOL J LINNEAN SOC; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Besnard G, 2016, BIOL J LINN SOC, V117, P71, DOI 10.1111/bij.12494; Besnard G, 2014, J EXP BOT, V65, P6711, DOI 10.1093/jxb/eru395; Bi K, 2013, MOL ECOL, V22, P6018, DOI 10.1111/mec.12516; Bouchard P, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.88.807; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Burbano HA, 2010, SCIENCE, V328, P723, DOI 10.1126/science.1188046; Burrell AS, 2015, J HUM EVOL, V79, P35, DOI 10.1016/j.jhevol.2014.10.015; Cai GS, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S13-S5; Carpenter ML, 2013, AM J HUM GENET, V93, P852, DOI 10.1016/j.ajhg.2013.10.002; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; DARLINGTON P J JR, 1971, Bulletin of the Museum of Comparative Zoology, V142, P129; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dean MD, 2001, ENTOMOL EXP APPL, V98, P279, DOI 10.1023/A:1018963131302; Enk J, 2013, BIOTECHNIQUES, V55, P300, DOI 10.2144/000114114; Enk JM, 2014, MOL BIOL EVOL, V31, P1292, DOI 10.1093/molbev/msu074; Erwin TL, 1981, ENTOMOL SCAND, V15, P33; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gnerre S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r88; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Green P, 2002, PHRED VERSION 002042; Green P, 1999, PHRAP VERSION 099032; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guschanski K, 2013, SYST BIOL, V62, P539, DOI 10.1093/sysbio/syt018; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hanrahan SJ, 2011, CHROMOSOME RES, V19, P809, DOI 10.1007/s10577-011-9231-6; Haynes S, 2002, J ARCHAEOL SCI, V29, P585, DOI 10.1006/jasc.2001.0731; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heintzman PD, 2014, MOL ECOL RESOUR, V14, P606, DOI 10.1111/1755-0998.12205; Hofreiter M, 2015, BIOESSAYS, V37, P284, DOI 10.1002/bies.201400160; Hornett EA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-361; JUAN C, 1991, GENOME, V34, P169, DOI 10.1139/g91-026; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; King GA, 2009, J ARCHAEOL SCI, V36, P1179, DOI 10.1016/j.jas.2009.01.006; King JR, 2004, INSECT SOC, V51, P197, DOI 10.1007/s00040-003-0709-x; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Krehenwinkel H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136337; Kuraku S, 2013, NUCLEIC ACIDS RES, V41, pW22, DOI 10.1093/nar/gkt389; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LINDROTH C H, 1976, New Zealand Journal of Zoology, V3, P161; Maddison DR, 2008, ANN CARNEGIE MUS, V77, P147, DOI 10.2992/0097-4463-77.1.147; Maddison DR, 2014, ZOOL J LINN SOC-LOND, V172, P741, DOI 10.1111/zoj.12188; Maddison DR, 2013, ZOOTAXA, V3636, P547, DOI 10.11646/zootaxa.3636.4.3; Maddison DR, 2012, MOL PHYLOGENET EVOL, V63, P533, DOI 10.1016/j.ympev.2012.01.015; Maddison DR, 2010, ZOOKEYS, P15, DOI 10.3897/zookeys.43.390; MADDISON DR, 1985, GENETICA, V66, P93, DOI 10.1007/BF00139715; Maddison DR, 2014, CHROMASEQ A MESQUITE; Maddison WP, 2014, MESQUITE A MODULAR S; Marchant A, 2015, GENETICA, V143, P225, DOI 10.1007/s10709-014-9790-5; Marciniak S, 2015, J HUMAN EVOLUTION; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mason VC, 2011, GENOME RES, V21, P1695, DOI 10.1101/gr.120196.111; McCormack J, 2015, BIORXIV 020271; Millar CD, 2008, TRENDS ECOL EVOL, V23, P386, DOI 10.1016/j.tree.2008.04.002; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Mitchell KJ, 2014, SCIENCE, V344, P898, DOI 10.1126/science.1251981; Murienne J, 2015, MITOCHONDR DNA, P1; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Orlando L, 2011, GENOME RES, V21, P1705, DOI 10.1101/gr.122747.111; Ortuno VM, 2010, ANN SOC ENTOMOL FR, V46, P189, DOI 10.1080/00379271.2010.10697656; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Paijmans JL, 2015, MOL ECOLOGY RESOURCE; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Poinar HN, 1996, SCIENCE, V272, P864, DOI 10.1126/science.272.5263.864; POST RJ, 1993, BIOCHEM SYST ECOL, V21, P85, DOI 10.1016/0305-1978(93)90012-G; Price BW, 2015, PLOS ONE, V10; Pyke GH, 2010, BIOL REV, V85, P247, DOI 10.1111/j.1469-185X.2009.00098.x; Quail MA, 2012, BMC GENOMICS, V13; R Gore Team, 2014, R A LANGUAGE AND ENV; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; RITZKOWSKI S., 1997, METALLA BOCHUM, V66, P19; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rowe KC, 2011, MOL ECOL RESOUR, V11, P1082, DOI 10.1111/j.1755-0998.2011.03052.x; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Schubert M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-178; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Staats M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069189; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Tin MMY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096793; Wales N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045644; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Wang BA, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-180, 10.1186/1471-2164-15-467]; Watts PC, 2007, J INSECT CONSERV, V11, P195, DOI 10.1007/s10841-006-9024-y; Zedane L, 2016, BIOL J LINN SOC, V117, P44, DOI 10.1111/bij.12509	95	48	49	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0143929	10.1371/journal.pone.0143929	http://dx.doi.org/10.1371/journal.pone.0143929			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716693	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500008
J	Knight, GM; Gomez, GB; Dodd, PJ; Dowdy, D; Zwerling, A; Wells, WA; Cobelens, F; Vassall, A; White, RG				Knight, Gwenan M.; Gomez, Gabriela B.; Dodd, Peter J.; Dowdy, David; Zwerling, Alice; Wells, William A.; Cobelens, Frank; Vassall, Anna; White, Richard G.			The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; RESISTANT TUBERCULOSIS; HIV-INFECTION; TB TREATMENT; OUTCOMES; COUNTRIES; TRANSMISSION; CHEMOTHERAPY; PREVALENCE; REDUCTION	Background A 4-month first-line treatment regimen for tuberculosis disease (TB) is expected to have a direct impact on patient outcomes and societal costs, as well as an indirect impact on Mycobacterium tuberculosis transmission. We aimed to estimate this combined impact in a high TB-burden country: South Africa. Method An individual based M. tb transmission model was fitted to the TB burden of South Africa using a standard TB natural history framework. We measured the impact on TB burden from 2015-2035 of introduction of a non-inferior 4-month regimen replacing the standard 6-month regimen as first-line therapy. Impact was measured with respect to three separate baselines (Guidelines, Policy and Current), reflecting differences in adherence to TB and HIV treatment guidelines. Further scenario analyses considered the variation in treatment-related parameters and resistance levels. Impact was measured in terms of differences in TB burden and Disability Adjusted Life Years (DALYs) averted. We also examined the highest cost at which the new regimen would be cost-effective for several willingness-to-pay thresholds. Results It was estimated that a 4-month regimen would avert less than 1% of the predicted 6 million person years with TB disease in South Africa between 2015 and 2035. A similarly small impact was seen on deaths and DALYs averted. Despite this small impact, with the health systems and patient cost savings from regimen shortening, the 4-month regimen could be cost-effective at $436 [NA, 5983] (mean [range]) per month at a willingness-to-pay threshold of one GDP per capita ($6,618). Conclusion The introduction of a non-inferior 4-month first-line TB regimen into South Africa would have little impact on the TB burden. However, under several scenarios, it is likely that the averted societal costs would make such a regimen cost-effective in South Africa.	[Knight, Gwenan M.; White, Richard G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, TB Modeling Grp, Ctr Math Modelling Infect Dis,TB Ctr, London WC1, England; [Gomez, Gabriela B.; Cobelens, Frank] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Gomez, Gabriela B.; Cobelens, Frank] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Gomez, Gabriela B.; Vassall, Anna] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Dodd, Peter J.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Dowdy, David; Zwerling, Alice] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Wells, William A.] Global Alliance TB Drug Dev, New York, NY USA; [Cobelens, Frank] KNCV TB Fdn, The Hague, Netherlands	University of London; London School of Hygiene & Tropical Medicine; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of London; London School of Hygiene & Tropical Medicine; University of Sheffield; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; KNCV Tuberculosis Foundation	Knight, GM (corresponding author), Univ London Imperial Coll Sci Technol & Med, London, England.	g.knight@imperial.ac.uk	Knight, Gwen/AGE-2703-2022; Knight, Gwen/AAF-1176-2020; White, Richard G/D-5407-2009	White, Richard G/0000-0003-4410-6635; Vassall, Anna/0000-0002-2911-1375; Cobelens, Frank/0000-0002-4367-1133; Dodd, Pete/0000-0001-5825-9347; Knight, Gwenan/0000-0002-7263-9896	Global Alliance for TB Drug Development, New York, USA; Medical Research Council (UK) [MR/J005088/1]; Bill and Melinda Gates Foundation (TB Modelling and Analysis Consortium) [OPP1084276]; MRC [MR/J005088/1] Funding Source: UKRI; Medical Research Council [MR/J005088/1] Funding Source: researchfish	Global Alliance for TB Drug Development, New York, USA; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation (TB Modelling and Analysis Consortium); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Global Alliance for TB Drug Development, New York, USA (http://www.tballiance.org/). RGW is funded by the Medical Research Council (UK) (MR/J005088/1), and the Bill and Melinda Gates Foundation (TB Modelling and Analysis Consortium: OPP1084276). One of the co-authors, William Wells, was employed by the funders at the start of this work. He contributed to discussions as to the initial directions for the project, the available data and current understanding of TB regimen design. The funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Akksilp S, 2007, EMERG INFECT DIS, V13, P1001, DOI 10.3201/eid1307.061506; [Anonymous], 1986, Tubercle, V67, P5; [Anonymous], 2011, GLOB TUB CONTR; Ayles HM, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-63; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Churchyard G, 2013, COMMUNICATION; Cohen T, 2003, LANCET INFECT DIS, V3, P13, DOI 10.1016/S1473-3099(03)00483-3; Department of Health, 2011, MULT RES TUB POL FRA; Department of Health, 2014, NAT TUB MAN GUID 201; Department of Health, 2013, S AFR ANT TREATM GUI; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Fofana MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096389; Foster N, 2015, SOC SCI MED, V130, P42, DOI 10.1016/j.socscimed.2015.01.046; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; FOX W, 1986, AM REV RESPIR DIS, V133, P779; Global Alliance for TB drug development, 2015, INT PORTF REG; Gomez GB, 2015, POTENTIAL COST EFFEC; Gospodarevskaya E, 2014, INT J TUBERC LUNG D, V18, P810, DOI 10.5588/ijtld.13.0391; JAMISON DT, 1991, AM J PUBLIC HEALTH, V81, P15, DOI 10.2105/AJPH.81.1.15; Keeton C, 2013, B WORLD HEALTH ORGAN, V91, P163, DOI 10.2471/BLT.13.020313; Knight GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122514; Long L, 2010, AIDS, V24, P915, DOI 10.1097/QAD.0b013e3283360976; Marseille E, 2015, BULL WORLD HEALTH OR, V93; McNicol MW, 1995, CLINICAL FEATURES AN; Middelkoop K, 2015, J INFECT DIS, V211, P53, DOI 10.1093/infdis/jiu403; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Njeka N, 2013, ESTIMATED LEVELS; Owens JP, 2013, INT J TUBERC LUNG D, V17, P590, DOI 10.5588/ijtld.12.0776; PEPFAR CDC, 2012, SCAL UP IS PREV THER; Pretorius C, 2014, AIDS, V28, pS25, DOI 10.1097/QAD.0000000000000085; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; Salomon JA, 2006, PLOS MED, V3, P1302, DOI 10.1371/journal.pmed.0030273; Sepkowitz KA, 1996, CLIN INFECT DIS, V23, P954, DOI 10.1093/clinids/23.5.954; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; South African National AIDS Council (SANAC), 2012, NAT STRAT PLAN HIV S; Varma JK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-42; Vassall A, 2015, XPERT MTB RIF SCALEU; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO, 2013, TB DAT; World Health Organization, 2014, GLOB TUB REP; World Health Organization (WHO), 2014, THE STOP TB STRAT; 1984, AM REV RESP DIS, V130, P23	44	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145796	10.1371/journal.pone.0145796	http://dx.doi.org/10.1371/journal.pone.0145796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717007	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500074
J	Rosales, KR; Reid, MA; Yang, Y; Tran, TQ; Wang, WI; Lowman, X; Pan, M; Kong, M				Rosales, Kimberly Romero; Reid, Michael A.; Yang, Ying; Tran, Thai Q.; Wang, Wen-I; Lowman, Xazmin; Pan, Min; Kong, Mei			TIPRL Inhibits Protein Phosphatase 4 Activity and Promotes H2AX Phosphorylation in the DNA Damage Response	PLOS ONE			English	Article							DEPHOSPHORYLATES GAMMA-H2AX; SIGNALING PATHWAY; CATALYTIC SUBUNIT; COMPLEX; CHECKPOINT; REGULATOR; INTERACTS; RECOVERY; ALPHA-4; PP2A	Despite advances in our understanding of protein kinase regulation in the DNA damage response, the mechanism that controls protein phosphatase activity in this pathway is unclear. Unlike kinases, the activity and specificity of serine/threonine phosphatases is governed largely by their associated proteins. Here we show that Tip41-like protein (TIPRL), an evolutionarily conserved binding protein for PP2A-family phosphatases, is a negative regulator of protein phosphatase 4 (PP4). Knockdown of TIPRL resulted in increased PP4 phosphatase activity and formation of the active PP4-C/PP4R2 complex known to dephosphorylate gamma-H2AX. Thus, overexpression of TIPRL promotes phosphorylation of H2AX, and increases gamma-H2AX positive foci in response to DNA damage, whereas knockdown of TIPRL inhibits gamma-H2AX phosphorylation. In correlation with gamma-H2AX levels, we found that TIPRL overexpression promotes cell death in response to genotoxic stress, and knockdown of TIPRL protects cells from genotoxic agents. Taken together, these data demonstrate that TIPRL inhibits PP4 activity to allow for H2AX phosphorylation and the subsequent DNA damage response.	[Rosales, Kimberly Romero; Reid, Michael A.; Yang, Ying; Tran, Thai Q.; Wang, Wen-I; Lowman, Xazmin; Pan, Min; Kong, Mei] City Hope Canc Ctr, Dept Canc Biol, Beckman Res Inst, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Kong, M (corresponding author), City Hope Canc Ctr, Dept Canc Biol, Beckman Res Inst, Duarte, CA 91010 USA.	mekong@coh.org	Yang, Ying/I-8380-2019	Reid, Michael/0000-0001-6222-9538	City of Hope; NIH/NCI [P30CA33572]; National Science Foundation [DBI-1202818]; Ralph M. Parsons Foundation; NATIONAL CANCER INSTITUTE [P30CA033572, R01CA183989] Funding Source: NIH RePORTER	City of Hope; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); Ralph M. Parsons Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the City of Hope start-up to MK. Research reported here includes work carried out in Core Facilities, supported by the NIH/NCI under grant number P30CA33572. MK is a Pew Scholar in the Biomedical Sciences and V Scholar for Cancer Research. KR received a National Science Foundation Postdoctoral Fellowship in Biology (DBI-1202818). MR is supported by the Ralph M. Parsons Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREWIS ND, 1993, EMBO J, V12, P987, DOI 10.1002/j.1460-2075.1993.tb05739.x; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; McConnell JL, 2007, ONCOGENE, V26, P6021, DOI 10.1038/sj.onc.1210406; Moon SH, 2010, J BIOL CHEM, V285, P12935, DOI 10.1074/jbc.M109.071696; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Nakashima A, 2013, FEBS LETT, V587, P2924, DOI 10.1016/j.febslet.2013.07.027; RONNE H, 1991, MOL CELL BIOL, V11, P4876, DOI 10.1128/MCB.11.10.4876; Smetana JHC, 2007, FEBS J, V274, P5891, DOI 10.1111/j.1742-4658.2007.06112.x; Wang B, 2008, CELL RES, V18, P974, DOI 10.1038/cr.2008.274	16	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145938	10.1371/journal.pone.0145938	http://dx.doi.org/10.1371/journal.pone.0145938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717153	gold, Green Published, Green Submitted			2022-12-27	WOS:000367510500099
J	Shibata, M; Jintasakul, P; Azuma, Y; You, HL				Shibata, Masateru; Jintasakul, Pratueng; Azuma, Yoichi; You, Hai-Lu			A New Basal Hadrosauroid Dinosaur from the Lower Cretaceous Khok Kruat Formation in Nakhon Ratchasima Province, Northeastern Thailand	PLOS ONE			English	Article							ASIAN ORNITHOPODS DINOSAURIA; ORNITHISCHIA; DEPOSITS	A new basal hadrosauroid dinosaur from the Lower Cretaceous Khok Kruat Formation of Thailand, Sirindhoma khoratensis gen. et sp. nov is described. The new taxon is based on composite skull and mandible including premaxilla, maxilla, jugal, quadrate, braincases, predentary, dentaries, surangular, and maxillary and dentary teeth. It is diagnostic by such characters as, sagittal crest extending along entire dorsal surface of the parietal and reaching the frontoparietal suture (autapomorphy), transversely straight frontoparietal suture, caudodorsally faced supraoccipital, no participation of the supraoccipital in the foramen magnum, mesiodistally wide leaf-shaped dentary tooth with primary and secondary ridges on the lingual surface of the crown, perpendicularly-erected and large coronoid process of dentary, and nonvisible antorbital fossa of the maxilla in lateral view. Phylogenetic analysis revealed S. khoratensis as among the most basal hadrosauroids. Sirindhoma khoratensis is the best-preserved iguanodontian ornithopod in Southeast Asia and sheds new light to resolve the evolution of basal hadrosauriforms.	[Shibata, Masateru; Azuma, Yoichi] Fukui Prefectural Univ, Inst Dinosaur Res, Fukui 9101195, Japan; [Shibata, Masateru; Azuma, Yoichi] Fukui Prefectural Dinosaur Museum, Fukui 9118601, Japan; [Jintasakul, Pratueng] Nakhon Ratchasima Rajabhat Univ, Northeastern Res Inst Petrified Wood & Mineral Re, Nakhon Ratchasima 30000, Thailand; [You, Hai-Lu] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China	Fukui Prefectural University; Nakhon Ratchasima Rajabhat University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Shibata, M (corresponding author), Fukui Prefectural Univ, Inst Dinosaur Res, 4-1-1 Kenjojima,Eiheiji Cho, Fukui 9101195, Japan.	sdino@fpu.ac.jp		You, Hai-Lu/0000-0003-2203-6461	Fukui Prefectural Government, Japan; Nakhon Ratchasima Rajabhat University, Thailand	Fukui Prefectural Government, Japan; Nakhon Ratchasima Rajabhat University, Thailand	This work was supported by the Fukui Prefectural Government, Japan, and Nakhon Ratchasima Rajabhat University, Thailand.	Barrett PM, 2009, ACTA PALAEONTOL POL, V54, P35, DOI 10.4202/app.2009.0105; Brill Kathleen, 2007, P49; BUFFETAUT E, 1992, PALAEONTOLOGY, V35, P801; Buffetaut E, 2005, INT C GEOL GEOT MIN, P28; Buffetaut E, 2011, ANN PALEONTOL, V97, P51, DOI 10.1016/j.annpal.2011.08.001; Cappetta H., 1990, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1990, P659; DOLLO L, 1888, CR HEBD ACAD SCI, V106, P775; Edmund A. G., 1957, Contributions of the Royal Ontario Museum of Zoology, VNo. 48, P1; Godefroit P, 2005, CR PALEVOL, V4, P697, DOI 10.1016/j.crpv.2005.07.004; Godefroit P., 2012, BERNISSART DINOSAURS, P335; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hasegawa H, 2010, ISL ARC, V19, P605, DOI 10.1111/j.1440-1738.2010.00728.x; Kobayashi Y, 2003, J VERTEBR PALEONTOL, V23, P166, DOI 10.1671/0272-4634(2003)23[166:ANIDOF]2.0.CO;2; Kubota K, 2009, ACTA GEOL SIN-ENGL, V83, P39, DOI 10.1111/j.1755-6724.2009.00005.x; Lu Junchang, 1997, P27; Maddison W.P., MESQUITE MODULAR SYS; McDonal DAT, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0014075, DOI 10.1371/J0URNAL.P0NE.0014075]; Mcdonald AT, 2012, ZOOTAXA, P61; Meesook A, 2011, GEOLOGY OF THAILAND, P169; Norman D.B., 1986, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V56, P281; Norman DB, 2015, ZOOL J LINN SOC-LOND, V173, P92, DOI 10.1111/zoj.12193; Norman DB, 2002, ZOOL J LINN SOC-LOND, V136, P113, DOI 10.1046/j.1096-3642.2002.00027.x; Norman DB, 1998, ZOOL J LINN SOC-LOND, V122, P291; Norman DB., 1980, MEMOIRES I ROYAL SCI, V178, P1; OSTROM JOHN H., 1961, BULL AMER MUS NAT HIST, V122, P33; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Racey A, 2009, GEOL SOC SPEC PUBL, V315, P41, DOI 10.1144/SP315.5; Racey A, 2009, GEOL SOC SPEC PUBL, V315, P69, DOI 10.1144/SP315.6; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Sereno PC, 1997, ANN REV EARTH PLANET, P434; Sereno PC, 2005, STEM ARCHOSAURIA VER, P534; Shibata M, 2015, ZOOTAXA, V3914, P421, DOI 10.11646/zootaxa.3914.4.3; Shibata M, 2011, ACTA GEOL SIN-ENGL, V85, P969, DOI 10.1111/j.1755-6724.2011.00230.x; Sues HD, 2009, P R SOC B, V276, P2549, DOI 10.1098/rspb.2009.0229; Taquet Philippe, 1999, Annales de Paleontologie, V85, P85, DOI 10.1016/S0753-3969(99)80009-3; Taquet R, 1976, CHAPITRE, P57; Tsogtbaatar Khishigjav, 2014, P108; Wang RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077058; Wang XL, 2001, CHINESE SCI BULL, V46, P1669, DOI 10.1007/BF02900633; Wu W.H., 2012, BERNISSART DINOSAURS, P293; Xing H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098821; Xu X, 2000, VERTEBRAT PALASIATIC, V38, P186; You Hai-lu, 2014, P73; You HL, 2009, CAN J EARTH SCI, V46, P949, DOI 10.1139/E09-067; [You Hailu 尤海鲁], 2005, [地质通报, Geological Bulletin of China], V24, P785; You H, 2011, ACTA GEOL SIN-ENGL, V85, P51, DOI 10.1111/j.1755-6724.2011.00377.x; You HL, 2003, CRETACEOUS RES, V24, P347, DOI 10.1016/S0195-6671(03)00048-X; You HL, 2003, ACTA GEOL SIN-ENGL, V77, P148	50	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145904	10.1371/journal.pone.0145904	http://dx.doi.org/10.1371/journal.pone.0145904			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716981	Green Published, gold			2022-12-27	WOS:000367510500090
J	Belyy, A; Tabakova, I; Lang, AE; Jank, T; Belyi, Y; Aktories, K				Belyy, Alexander; Tabakova, Irina; Lang, Alexander E.; Jank, Thomas; Belyi, Yury; Aktories, Klaus			Roles of Asp179 and Glu270 in ADP-Ribosylation of Actin by Clostridium perfringens Iota Toxin	PLOS ONE			English	Article							YEAST ACTIN; SACCHAROMYCES-CEREVISIAE; ENZYMATIC COMPONENT; SHUTTLE VECTORS; CELLULAR UPTAKE; BINDING; RECOGNITION; RESIDUES; MUTATION; MUTANTS	Clostridium perfringens iota toxin is a binary toxin composed of the enzymatically active component Ia and receptor binding component Ib. Ia is an ADP-ribosyltransferase, which modifies Arg177 of actin. The previously determined crystal structure of the actin-Ia complex suggested involvement of Asp179 of actin in the ADP-ribosylation reaction. To gain more insights into the structural requirements of actin to serve as a substrate for toxin-catalyzed ADP-ribosylation, we engineered Saccharomyces cerevisiae strains, in which wild type actin was replaced by actin variants with substitutions in residues located on the Ia-actin interface. Expression of the actin mutant Arg177Lys resulted in complete resistance towards Ia. Actin mutation of Asp179 did not change Ia-induced ADP-ribosylation and growth inhibition of S. cerevisiae. By contrast, substitution of Glu270 of actin inhibited the toxic action of Ia and the ADP-ribosylation of actin. In vitro transcribed/translated human a-actin confirmed the crucial role of Glu270 in ADP-ribosylation of actin by Ia.	[Belyy, Alexander; Tabakova, Irina; Belyi, Yury] Gamaleya Res Inst, Moscow, Russia; [Belyy, Alexander] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Lang, Alexander E.; Jank, Thomas; Aktories, Klaus] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, D-79106 Freiburg, Germany; [Belyi, Yury; Aktories, Klaus] Univ Freiburg, Freiburg Inst Adv Studies FRIAS, D-79106 Freiburg, Germany; [Aktories, Klaus] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79106 Freiburg, Germany	Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; Lomonosov Moscow State University; University of Freiburg; University of Freiburg; University of Freiburg	Aktories, K (corresponding author), Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, Hugstetter Str 55, D-79106 Freiburg, Germany.	klaus.aktories@pharmakol.uni-freiburg.de	Jank, Thomas/R-9627-2017; Aktories, Klaus/CAJ-5682-2022; Belyi, Yury/AAU-8092-2020	Aktories, Klaus/0000-0002-5397-0436; Belyy, Alexander/0000-0003-3106-6574	German Research Foundation (DFG); Albert Ludwigs University Freiburg	German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Bartman T, 2004, PLOS BIOL, V2, P673, DOI 10.1371/journal.pbio.0020129; Belyi Y, 2012, J BIOL CHEM, V287, P26029, DOI 10.1074/jbc.M112.372672; Bennett TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056798; Blocker D, 2001, INFECT IMMUN, V69, P2980, DOI 10.1128/IAI.69.5.2980-2987.2001; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Bosis E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027698; Cavallius J, 1998, J BIOL CHEM, V273, P28752, DOI 10.1074/jbc.273.44.28752; CHEN X, 1995, J BIOL CHEM, V270, P11406, DOI 10.1074/jbc.270.19.11406; Conz C, 2007, J BIOL CHEM, V282, P33977, DOI 10.1074/jbc.M706737200; COOK RK, 1992, J BIOL CHEM, V267, P9430; Fang H, 2006, P NATL ACAD SCI USA, V103, P6958, DOI 10.1073/pnas.0510816103; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goode BL, 2002, METHOD ENZYMOL, V351, P433; Gulke I, 2001, INFECT IMMUN, V69, P6004, DOI 10.1128/IAI.69.10.6004-6011.2001; Heisler DB, 2015, SCIENCE, V349, P535, DOI 10.1126/science.aab4090; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; KRON SJ, 1992, P NATL ACAD SCI USA, V89, P4466, DOI 10.1073/pnas.89.10.4466; Kudryashova E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045721; Lang AE, 2010, SCIENCE, V327, P1139, DOI 10.1126/science.1184557; Margarit SM, 2006, STRUCTURE, V14, P1219, DOI 10.1016/j.str.2006.05.022; Marvaud JC, 2002, J BIOL CHEM, V277, P43659, DOI 10.1074/jbc.M207828200; Mateyak MK, 2013, J BIOL CHEM, V288, P24647, DOI 10.1074/jbc.M113.488783; Nagahama M, 2004, INFECT IMMUN, V72, P3267, DOI 10.1128/IAI.72.6.3267-3275.2004; Nagahama M, 2000, J BACTERIOL, V182, P2096, DOI 10.1128/JB.182.8.2096-2103.2000; Nagahama M, 2002, INFECT IMMUN, V70, P1909, DOI 10.1128/IAI.70.4.1909-1914.2002; NG R, 1980, P NATL ACAD SCI-BIOL, V77, P3912, DOI 10.1073/pnas.77.7.3912; Papatheodorou P, 2011, P NATL ACAD SCI USA, V108, P16422, DOI 10.1073/pnas.1109772108; Peisker K, 2008, MOL BIOL CELL, V19, P5279, DOI 10.1091/mbc.E08-06-0661; Perelle S, 1996, FEBS LETT, V395, P191, DOI 10.1016/0014-5793(96)01035-6; Satchell KJF, 2009, TOXINS, V1, P123, DOI 10.3390/toxins1020123; Schwan C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000626; SHERMAN F, 1964, GENETICS, V49, P39; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; SIKORSKI RS, 1989, GENETICS, V122, P19; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; Stiles BG, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00011; Stirling FR, 2006, MICROBIOL-SGM, V152, P2273, DOI 10.1099/mic.0.28831-0; Toda A, 2015, J BIOL CHEM, V290, P19423, DOI 10.1074/jbc.M115.653220; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Tsurumura T, 2013, P NATL ACAD SCI USA, V110, P4267, DOI 10.1073/pnas.1217227110; von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033; WEGNER A, 1988, J BIOL CHEM, V263, P13739; Wen KK, 2003, J BIOL CHEM, V278, P48386, DOI 10.1074/jbc.M308980200	47	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145708	10.1371/journal.pone.0145708	http://dx.doi.org/10.1371/journal.pone.0145708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713879	gold, Green Published, Green Submitted			2022-12-27	WOS:000367481900072
J	Boosalis, MS; Sangerman, JI; White, GL; Wolf, RF; Shen, L; Dai, Y; White, E; Makala, LH; Li, BR; Pace, BS; Nouraie, M; Faller, DV; Perrine, SP				Boosalis, Michael S.; Sangerman, Jose I.; White, Gary L.; Wolf, Roman F.; Shen, Ling; Dai, Yan; White, Emily; Makala, Levi H.; Li, Biaoru; Pace, Betty S.; Nouraie, Mehdi; Faller, Douglas V.; Perrine, Susan P.			Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice	PLOS ONE			English	Article							SICKLE-CELL-ANEMIA; GENE-EXPRESSION; BETA-THALASSEMIA; HEMOGLOBIN PRODUCTION; INDUCTION; BUTYRATE; TRIAL; ISOBUTYRAMIDE; HQK-1001; THERAPY	High-level fetal (gamma) globin expression ameliorates clinical severity of the beta (beta) hemoglobinopathies, and safe, orally-bioavailable gamma-globin inducing agents would benefit many patients. We adapted a LCR-gamma-globin promoter-GFP reporter assay to a high-throughput robotic system to evaluate five diverse chemical libraries for this activity. Multiple structurally- and functionally-diverse compounds were identified which activate the gamma-globin gene promoter at nanomolar concentrations, including some therapeutics approved for other conditions. Three candidates with established safety profiles were further evaluated in erythroid progenitors, anemic baboons and transgenic mice, with significant induction of gamma-globin expression observed in vivo. A lead candidate, Benserazide, emerged which demonstrated > 20-fold induction of gamma-globin mRNA expression in anemic baboons and increased F-cell proportions by 3.5-fold in transgenic mice. Benserazide has been used chronically to inhibit amino acid decarboxylase to enhance plasma levels of L-dopa. These studies confirm the utility of high-throughput screening and identify previously unrecognized fetal globin inducing candidates which can be developed expediently for treatment of hemoglobinopathies.	[Boosalis, Michael S.; Sangerman, Jose I.; Shen, Ling; Dai, Yan; Faller, Douglas V.; Perrine, Susan P.] Boston Univ, Sch Med, Ctr Canc, Boston, MA 02118 USA; [Boosalis, Michael S.; Sangerman, Jose I.; Shen, Ling; Dai, Yan; Faller, Douglas V.; Perrine, Susan P.] Boston Univ, Sch Med, Hemoglobinopathy Thalassemia Res Unit, Boston, MA 02118 USA; [White, Gary L.; Wolf, Roman F.; White, Emily] Univ Oklahoma, Hlth Sci Ctr, Dept Comparat Med, Oklahoma City, OK USA; [Faller, Douglas V.; Perrine, Susan P.] Phoenicia BioSci, Weston, MA USA; [Makala, Levi H.; Li, Biaoru; Pace, Betty S.] Georgia Regents Univ, Dept Pediat, Augusta, GA USA; [Nouraie, Mehdi] Howard Univ, Dept Med, Ctr Sickle Cell Dis, Washington, DC 20059 USA	Boston University; Boston University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University System of Georgia; Augusta University; Howard University	Perrine, SP (corresponding author), Boston Univ, Sch Med, Ctr Canc, Boston, MA 02118 USA.	sperrine@bu.edu	Nouraie, Seyed Mehdi/O-4071-2018	Nouraie, Seyed Mehdi/0000-0001-7465-0581; Li, Biaoru/0000-0002-5626-9557; Pace, Betty/0000-0002-1275-4112	National Institutes of Health [R01 DK-52962, R41 HL-105816, R42 HL-110727, 2 P40 ODO010988-16, UL1-TR000157]; Phoenicia BioSciences (through NIH);  [P50 HL-118006]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000157] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R42HL110727, P50HL118006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052962] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Phoenicia BioSciences (through NIH); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health, R01 DK-52962 (SPP, Boston University), R41 HL-105816 (SPP, Phoenicia BioSciences), and R42 HL-110727 (Phoenicia BioSciences), 2 P40 ODO010988-16 (GLW, University of Oklahoma) and UL1-TR000157 (RFW, University of Oklahoma). MN was supported by P50 HL-118006. The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript. Phoenicia BioSciences is a commercial organization, which provided partial funding for this work (through NIH grants), and did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials. The funder provided support in the form of partial salaries for authors [SPP, DVF] and experimental expenses, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions' section".; This work was supported by grants from the National Institutes of Health, R01 DK-52962, (SPP, Boston University), R41 HL-105816 (SPP, Phoenicia BioSciences), and R42 HL-110727 (Phoenicia BioSciences), 2 P40 ODO010988-16 (GLW, University of Oklahoma) and UL1-TR000157 (RFW, University of Oklahoma). SMN was supported by P50 HL-118006. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Atweh GF, 1999, BLOOD, V93, P1790; Bank A, 2006, BLOOD, V107, P435, DOI 10.1182/blood-2005-05-2113; Bauer DE, 2012, BLOOD, V120, P2945, DOI 10.1182/blood-2012-06-292078; Bohacek R, 2006, CHEM BIOL DRUG DES, V67, P318, DOI 10.1111/j.1747-0285.2006.00386.x; Boosalis MS, 2001, BLOOD, V97, P3259, DOI 10.1182/blood.V97.10.3259; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Cappellini MD, 2000, BLOOD CELL MOL DIS, V26, P105, DOI 10.1006/bcmd.2000.0283; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chen ZY, 2009, BLOOD CELL MOL DIS, V42, P144, DOI 10.1016/j.bcmd.2008.12.003; COLLINS AF, 1995, BLOOD, V85, P43, DOI 10.1182/blood.V85.1.43.bloodjournal85143; CONSTANTOULAKIS P, 1989, BLOOD, V74, P1963; Cui SY, 2015, BLOOD, V126, P386, DOI 10.1182/blood-2015-02-626259; Dai Y, 2007, MOL ENDOCRINOL, V21, P1807, DOI 10.1210/me.2006-0467; DESIMONE J, 1982, P NATL ACAD SCI-BIOL, V79, P4428, DOI 10.1073/pnas.79.14.4428; Fucharoen S, 2013, BRIT J HAEMATOL, V161, P587, DOI 10.1111/bjh.12304; Hoffman-La Roche Limited, PROD MON LEV BENS CO; Kutlar A, 2013, AM J HEMATOL, V88, pE255, DOI 10.1002/ajh.23533; LABIE D, 1985, P NATL ACAD SCI USA, V82, P2111, DOI 10.1073/pnas.82.7.2111; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Liu D, 2014, BLOOD, V124, P803, DOI 10.1182/blood-2014-03-561779; Mabaera R, 2008, EXP HEMATOL, V36, P1057, DOI 10.1016/j.exphem.2008.06.014; Mankidy R, 2006, BLOOD, V108, P3179, DOI 10.1182/blood-2005-12-010934; Manwani D, 2014, BLOOD, V124, P672, DOI 10.1182/blood-2014-05-576967; Nuinoon M, 2010, HUM GENET, V127, P303, DOI 10.1007/s00439-009-0770-2; Pace BS, 2002, BLOOD, V100, P4640, DOI 10.1182/blood-2002-02-0353; Patthamalai P, 2014, BLOOD, V123, P1956, DOI 10.1182/blood-2013-11-538470; PERRINE SP, 1994, BRIT J HAEMATOL, V88, P555, DOI 10.1111/j.1365-2141.1994.tb05073.x; PERRINE SP, 1993, NEW ENGL J MED, V328, P81, DOI 10.1056/NEJM199301143280202; Perrine SP, 2014, HEMATOL ONCOL CLIN N, V28, P233, DOI 10.1016/j.hoc.2013.11.009; Perrine SP, 2009, EUR J HAEMATOL, V82, P466, DOI 10.1111/j.1600-0609.2009.01234.x; Peterson KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107006; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Reich S, 2000, BLOOD, V96, P3357, DOI 10.1182/blood.V96.10.3357.h8003357_3357_3363; Resar LMS, 2002, J PEDIAT HEMATOL ONC, V24, P737, DOI 10.1097/00043426-200212000-00011; Saunthararajah Y, 2003, BLOOD, V102, P3865, DOI 10.1182/blood-2003-05-1738; Schaeffer EK, 2014, BLOOD CELL MOL DIS, V52, P214, DOI 10.1016/j.bcmd.2013.10.007; Schrier S L, 1997, Curr Opin Hematol, V4, P75; Sheehan VA, 2013, AM J HEMATOL, V88, P571, DOI 10.1002/ajh.23457; Spyrou P, 2010, BLOOD CELL MOL DIS, V44, P100, DOI 10.1016/j.bcmd.2009.10.008; Steinberg MH, 2010, AM J HEMATOL, V85, P403, DOI 10.1002/ajh.21699; Steinberg MH, 2001, MEDICINE, V80, P328, DOI 10.1097/00005792-200109000-00007; Taher AT, 2010, BLOOD, V115, P1886, DOI 10.1182/blood-2009-09-243154; Testa U, 2009, ANN HEMATOL, V88, P505, DOI 10.1007/s00277-008-0637-y; Thein SL, 2009, BRIT J HAEMATOL, V145, P455, DOI 10.1111/j.1365-2141.2009.07650.x; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Vichinsky EP, 2005, PEDIATRICS, V116, pE818, DOI 10.1542/peds.2005-0843; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348; Wilber A, 2011, BLOOD, V117, P3945, DOI 10.1182/blood-2010-11-316893	50	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144660	10.1371/journal.pone.0144660	http://dx.doi.org/10.1371/journal.pone.0144660			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713848	Green Submitted, gold, Green Published			2022-12-27	WOS:000367481900016
J	Findal, G; Stray-Pedersen, B; Holter, EK; Berge, T; Jenum, PA				Findal, Gry; Stray-Pedersen, Babill; Holter, Ellen K.; Berge, Tone; Jenum, Pal A.			Persistent Low Toxoplasma IgG Avidity Is Common in Pregnancy: Experience from Antenatal Testing in Norway	PLOS ONE			English	Article							IMMUNOGLOBULIN-G AVIDITY; GONDII INFECTION; WOMEN; DIAGNOSIS; MATURATION; SYSTEM	The parasite Toxoplasma gondii might harm the fetus if a woman is infected during pregnancy. IgG seroconversion and significant increase in IgG antibody amount in pregnancy indicates maternal infection. Presence of toxoplasma immunoglobulin M (IgM), immunoglobulin G (IgG) and low IgG avidity in a single serum sample indicates possible maternal infection, but positive toxoplasma IgM and low IgG avidity may persist for months and even years. We aimed to evaluate avidity development during pregnancy in a retrospective study. Serial blood samples from 176 pregnant women admitted to Oslo University Hospital 1993-2013 for amniocentesis because of suspected toxoplasma infection were included. Data were obtained from journals and laboratory records. The avidity method used was based on Platelia Toxo IgG assay. Mean maternal age at first serology was 29.9 years (SD 5.2, range 18-42). In 37 (21%) women only the avidity increased from low to high in < 3 months. In 139 (79%) the IgG avidity remained below the high threshold >= 3 months and within this group 74 (42%) women had stable low IgG avidity during the observation period. Median gestational age at first test was 10.6 weeks (range 4.6-28.7). Fetal infection was detected in four children, but none among children whose mother had stable low IgG avidity. The first antenatal toxoplasma serology should ideally be collected in early pregnancy and if stable values of toxoplasma IgM and low IgG-avidity are detected in a second sample after three to four weeks, the need for amniocentesis can be questioned.	[Findal, Gry; Stray-Pedersen, Babill; Jenum, Pal A.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Findal, Gry; Stray-Pedersen, Babill] Oslo Univ Hosp, Div Women & Children, Oslo, Norway; [Holter, Ellen K.; Berge, Tone] Oslo Univ Hosp, Dept Med Microbiol, Oslo, Norway; [Jenum, Pal A.] Vestre Viken Hlth Trust, Dept Med Microbiol, Drammen, Norway	University of Oslo; University of Oslo; University of Oslo	Findal, G (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	gryfi@medisin.uio.no		findal, gry/0000-0002-0766-6871				Alvarado-Esquivel C, 2011, EUR J MICROBIOL IMMU, V1, P249, DOI 10.1556/EuJMI.1.2011.3.9; [Anonymous], 2011, INFECT DIS FETUS NEW; Ashburn D, 1998, J CLIN PATHOL, V51, P312, DOI 10.1136/jcp.51.4.312; Cozon GJN, 1998, EUR J CLIN MICROBIOL, V17, P32, DOI 10.1007/BF01584360; Dunn D, 1999, LANCET, V353, P1829, DOI 10.1016/S0140-6736(98)08220-8; Eskild A, 2003, J MED SCREEN, V10, P172, DOI 10.1258/096914103771773258; Flori P, 2004, CLIN DIAGN LAB IMMUN, V11, P669, DOI 10.1128/CDLI.11.4.669-674.2004; Hareide Bodolf, 1997, Tidsskrift for den Norske Laegeforening, V117, P327; HEDMAN K, 1989, J INFECT DIS, V159, P736, DOI 10.1093/infdis/159.4.736; Jenum PA, 1997, J CLIN MICROBIOL, V35, P1972, DOI 10.1128/JCM.35.8.1972-1977.1997; Jenum PA, 1998, J CLIN MICROBIOL, V36, P2900, DOI 10.1128/JCM.36.10.2900-2906.1998; Jenum PA, 1995, FOREBYGGING MEDFODT; Khoshnood B, 2007, PRENATAL DIAG, V27, P395, DOI 10.1002/pd.1715; Lachaud L, 2009, DIAGN MICR INFEC DIS, V64, P267, DOI 10.1016/j.diagmicrobio.2009.02.014; Lebech M, 1996, EUR J CLIN MICROBIOL, V15, P799, DOI 10.1007/BF01701522; Lefevre-Pettazzoni M, 2006, EUR J CLIN MICROBIOL, V25, P687, DOI 10.1007/s10096-006-0204-1; Lefevre-Pettazzoni M, 2007, CLIN VACCINE IMMUNOL, V14, P239, DOI 10.1128/CVI.00311-06; Melby KK, 2012, NORSK REFERANSELABOR; Meroni V, 2009, CLIN VACCINE IMMUNOL, V16, P1517, DOI 10.1128/CVI.00253-09; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Murat JB, 2012, CLIN VACCINE IMMUNOL, V19, P1838, DOI 10.1128/CVI.00333-12; Norwegian Institute of Public Health, 2012, ARST MED FODS 2010; Paul M, 1999, CLIN DIAGN LAB IMMUN, V6, P514, DOI 10.1128/CDLI.6.4.514-518.1999; Petersen E, 2005, J CLIN MICROBIOL, V43, P1570, DOI 10.1128/JCM.43.4.1570-1574.2005; Sensini Alessandra, 1996, Clin Microbiol Infect, V2, P25, DOI 10.1111/j.1469-0691.1996.tb00196.x; WONG SY, 1994, CLIN INFECT DIS, V18, P853, DOI 10.1093/clinids/18.6.853	26	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145519	10.1371/journal.pone.0145519	http://dx.doi.org/10.1371/journal.pone.0145519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714282	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900051
J	Otoshi, T; Tanaka, T; Morimoto, K; Nakatani, T				Otoshi, Taiyo; Tanaka, Tomoaki; Morimoto, Kazuya; Nakatani, Tatsuya			Cytoplasmic Accumulation of Heterogeneous Nuclear Ribonucleoprotein K Strongly Promotes Tumor Invasion in Renal Cell Carcinoma Cells	PLOS ONE			English	Article							HNRNP-K; INTERFERON-ALPHA; POOR-PROGNOSIS; EXPRESSION; CANCER; IDENTIFICATION; APOPTOSIS; PATTERNS; TARGET; DOMAIN	Heterogeneous nuclear ribonucleoprotein (hnRNP) K is a part of the ribonucleoprotein complex which regulates diverse biological events. While overexpression of hnRNP K has been shown to be related to tumorigenesis in several cancers, both the expression patterns and biological mechanisms of hnRNP K in renal cell carcinoma (RCC) cells remain unclear. In this study, we showed that hnRNP K protein was strongly expressed in selected RCC cell lines (ACHN, A498, Caki-1, 786-0), and knock-down of hnRNP K expression by siRNA induced cell growth inhibition and apoptosis. Based on immunohistochemical (IHC) analysis of hnRNP K expression in human clear cell RCC specimens, we demonstrated that there was a significant positive correlation between hnRNP K staining score and tumor aggressiveness (e.g., Fuhrman grade, metastasis). Particularly, the rate of cytoplasmic localization of hnRNP K in primary RCC with distant metastasis was significantly higher than that in RCC without metastasis. Additionally, our results indicated that the cytoplasmic distribution of hnRNP K induced by TGF-beta stimulus mainly contributed to TGF-beta-triggered tumor cell invasion in RCC cells. Dominant cytoplasmic expression of ectopic hnRNP K markedly suppressed the inhibition of invasion by knock-down of endogenous hnRNP K. The expression level of matrix metalloproteinase protein-2 was decreased by endogenous hnRNP K knock-down, and restored by ectopic hnRNP K. Therefore, hnRNP K may be a key molecule involved in cell motility in RCC cells, and molecular mechanism associated with the subcellular localization of hnRNP K may be a novel target in the treatment of metastatic RCC.	[Otoshi, Taiyo; Tanaka, Tomoaki; Morimoto, Kazuya; Nakatani, Tatsuya] Osaka City Univ, Dept Urol, Grad Sch Med, Osaka 558, Japan	Osaka Metropolitan University	Tanaka, T (corresponding author), Osaka City Univ, Dept Urol, Grad Sch Med, Osaka 558, Japan.	tomoaki826@msic.med.osaka-cu.ac.jp	Tanaka, Tomoaki/H-7837-2019					Baber JL, 1999, J MOL BIOL, V289, P949, DOI 10.1006/jmbi.1999.2818; Barboro P, 2009, BRIT J CANCER, V100, P1608, DOI 10.1038/sj.bjc.6605057; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Carpenter B, 2006, BRIT J CANCER, V95, P921, DOI 10.1038/sj.bjc.6603349; Chen LC, 2008, CLIN CANCER RES, V14, P3807, DOI 10.1158/1078-0432.CCR-08-0155; Chung IC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-348; Enge M, 2009, CANCER CELL, V15, P171, DOI 10.1016/j.ccr.2009.01.019; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Escudier B, 2010, J CLIN ONCOL, V28, P2144, DOI 10.1200/JCO.2009.26.7849; Gao R, 2013, J BIOL CHEM, V288, P15046, DOI 10.1074/jbc.M113.466136; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Inoue A, 2007, P NATL ACAD SCI USA, V104, P8983, DOI 10.1073/pnas.0607595104; Jonasch E, 2014, CURR MED RES OPIN, V30, P2041, DOI 10.1185/03007995.2014.938730; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Klimek-Tomczak K, 2004, J MOL BIOL, V342, P1131, DOI 10.1016/j.jmb.2004.07.099; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lam JS, 2005, WORLD J UROL, V23, P202, DOI 10.1007/s00345-004-0466-0; Lynch M, 2005, MOL CELL BIOL, V25, P6436, DOI 10.1128/MCB.25.15.6436-6453.2005; Mandal M, 2001, J BIOL CHEM, V276, P9699, DOI 10.1074/jbc.M008514200; Matta A, 2009, INT J CANCER, V125, P1398, DOI 10.1002/ijc.24517; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Mikula M, 2006, PROTEOMICS, V6, P2395, DOI 10.1002/pmic.200500632; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pino I, 2003, LUNG CANCER-J IASLC, V41, P131, DOI 10.1016/S0169-5002(03)00193-4; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Ritchie SA, 2003, NUCLEIC ACIDS RES, V31, P1502, DOI 10.1093/nar/gkg246; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Tanaka T, 2003, J BIOL CHEM, V278, P32905, DOI 10.1074/jbc.M212057200; Wada H, 2000, J BIOL CHEM, V275, P17008, DOI 10.1074/jbc.275.22.17008; Wang F, 2012, MED ONCOL, V29, P1780, DOI 10.1007/s12032-011-0037-3; Wen FS, 2010, ANN SURG ONCOL, V17, P2619, DOI 10.1245/s10434-010-1121-1; Xiao ZW, 2013, CARCINOGENESIS, V34, P1458, DOI 10.1093/carcin/bgt085; Zhang YJ, 2012, CELL CYCLE, V11, P594, DOI 10.4161/cc.11.3.19096; Zhou RY, 2010, INT J CANCER, V126, P395, DOI 10.1002/ijc.24744	40	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145769	10.1371/journal.pone.0145769	http://dx.doi.org/10.1371/journal.pone.0145769			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713736	gold, Green Submitted, Green Published			2022-12-27	WOS:000367481900079
J	Ribitsch, W; Schneditz, D; Franssen, CFM; Schilcher, G; Stadlbauer, V; Horina, JH; Rosenkranz, AR				Ribitsch, Werner; Schneditz, Daniel; Franssen, Casper F. M.; Schilcher, Gernot; Stadlbauer, Vanessa; Horina, Joerg H.; Rosenkranz, Alexander R.			Increased Hepato-Splanchnic Vasoconstriction in Diabetics during Regular Hemodialysis	PLOS ONE			English	Article							AUTONOMIC NERVOUS-SYSTEM; CHRONIC KIDNEY-DISEASE; INDOCYANINE GREEN; DIALYSIS HYPOTENSION; ARGININE-VASOPRESSIN; BLOOD-VOLUME; INTRADIALYTIC HYPOTENSION; REFLEX CONTROL; DYSFUNCTION; FLOW	Background and Objectives Ultrafiltration (UF) of excess fluid activates numerous compensatory mechanisms during hemodialysis (HD). The increase of both total peripheral and splanchnic vascular resistance is considered essential in maintaining hemodynamic stability. The aim of this study was to evaluate the extent of UF-induced changes in hepato-splanchnic blood flow and resistance in a group of maintenance HD patients during regular dialysis. Design, Setting, Participants, & Measurements Hepato-splanchnic flow resistance index (RI) and hepato-splanchnic perfusion index (QI) were measured in 12 chronic HD patients using a modified, non-invasive Indocyaningreen (ICG) dilution method. During a midweek dialysis session we determined RI, QI, ICG disappearance rate (k(ICG)), plasma volume (V-p), hematocrit (Hct), mean arterial blood pressure (MAP) and heart rate (HR) at four times in hourly intervals (t(1) to t(4)). Dialysis settings were standardized and all patient studies were done in duplicate. Results In the whole study group mean UF volume was 1.86 +/- 0.46 L, V-p dropped from 3.65 +/- 0.77L at t(1) to 3.40 +/- 0.78L at t(4), and all patients remained hemodynamically stable. In all patients RI significantly increased from 12.40 +/- 4.21 mmHg.s.m(2)/mL at t1 to 14.94 +/- 6.36 mmHg.s.m(2)/mL at t(4) while QI significantly decreased from 0.61 +/- 0.22 at t1 to 0.52 +/- 0.20 L/min/m(2) at t(4), indicating active vasoconstriction. In diabetic subjects, however, RI was significantly larger than in non-diabetics at all time points. QI was lower in diabetic subjects. Conclusions In chronic HD-patients hepato-splanchnic blood flow substantially decreases during moderate UF as a result of an active splanchnic vasoconstriction. Our data indicate that diabetic HD-patients are particularly prone to splanchnic ischemia and might therefore have an increased risk for bacterial translocation, endotoxemia and systemic inflammation.	[Ribitsch, Werner; Schilcher, Gernot; Horina, Joerg H.; Rosenkranz, Alexander R.] Med Univ Graz, Clin Div Nephrol, Dept Internal Med, Graz, Austria; [Schneditz, Daniel] Med Univ Graz, Inst Physiol, Graz, Austria; [Franssen, Casper F. M.] Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, NL-9713 AV Groningen, Netherlands; [Stadlbauer, Vanessa] Med Univ Graz, Clin Div Gastroenterol & Hepatol, Dept Internal Med, Graz, Austria	Medical University of Graz; Medical University of Graz; University of Groningen; Medical University of Graz	Ribitsch, W (corresponding author), Med Univ Graz, Clin Div Nephrol, Dept Internal Med, Graz, Austria.	werner.ribitsch@medunigraz.at	Schneditz, Daniel/E-6580-2010	Schneditz, Daniel/0000-0002-0124-1012; Franssen, Casper/0000-0003-1004-9994; Stadlbauer, Vanessa/0000-0001-5508-8271	Austrian Science Fund (FWF) [P 23532] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		ABBOUD FM, 1990, BLOOD VESSELS, V27, P106; Agarwal R, 2012, CURR OPIN NEPHROL HY, V21, P593, DOI 10.1097/MNH.0b013e3283588f3c; Armengol NE, 1997, NEPHROL DIAL TRANSPL, V12, P939, DOI 10.1093/ndt/12.5.939; Burton JO, 2009, CLIN J AM SOC NEPHRO, V4, P914, DOI 10.2215/CJN.03900808; CAMPESE VM, 1981, KIDNEY INT, V20, P246, DOI 10.1038/ki.1981.127; Dasselaar JJ, 2007, CLIN J AM SOC NEPHRO, V2, P669, DOI 10.2215/CJN.00880207; Dasselaar JJ, 2009, NEPHROL DIAL TRANSPL, V24, P604, DOI 10.1093/ndt/gfn501; DAUZAT M, 1994, EUR J APPL PHYSIOL, V68, P373, DOI 10.1007/BF00843732; DIEBEL L, 1993, SURGERY, V113, P520; Dietrich CE, 2007, EUR J RADIOL, V64, P202, DOI 10.1016/j.ejrad.2007.06.034; Dorhout Mees EJ, 2010, CARDIOVASCULAR ASPEC; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Ettema EM, 2014, AM J NEPHROL, V39, P100, DOI 10.1159/000358203; Ettema EM, 2012, NEPHROL DIAL TRANSPL, V27, P3263, DOI 10.1093/ndt/gfr793; Franssen CMF, 2006, KIDNEY INT, V69, P789, DOI 10.1038/sj.ki.5000232; FRIESS U, 1995, NEPHROL DIAL TRANSPL, V10, P1421; Granger NS, 2009, MORGAN CLAYPOOL LIFE; HARVEY RF, 1980, LANCET, V1, P514; Hauser AB, 2011, NEPHRON CLIN PRACT, V118, pC165, DOI 10.1159/000321438; Hinghofer-Szalkay HG, 2008, AM J PHYSIOL-GASTR L, V295, pG332, DOI 10.1152/ajpgi.00042.2008; Imai E, 2006, KIDNEY INT, V69, P877, DOI 10.1038/sj.ki.5000088; Jakob SM, 2001, CRIT CARE MED, V29, P1393, DOI 10.1097/00003246-200107000-00015; Kimura S, 2001, CRIT CARE MED, V29, P1159, DOI 10.1097/00003246-200106000-00014; Knotzer H, 2005, AM J PHYSIOL-HEART C, V289, pH168, DOI 10.1152/ajpheart.01235.2004; KOOMAN JP, 1992, KIDNEY INT, V42, P718, DOI 10.1038/ki.1992.339; Korotinski S, 2005, AGE AGEING, V34, P10, DOI 10.1093/ageing/afh226; MARTINEZVEA A, 1985, CLIN NEPHROL, V24, P316; McIntyre CW, 2008, CLIN J AM SOC NEPHRO, V3, P19, DOI 10.2215/CJN.03170707; McIntyre CW, 2011, CLIN J AM SOC NEPHRO, V6, P133, DOI 10.2215/CJN.04610510; Mitra S, 2003, J AM SOC NEPHROL, V14, P2345, DOI 10.1097/01.ASN.0000082998.50730.FA; ROTHE CF, 1983, PHYSIOL REV, V63, P1281, DOI 10.1152/physrev.1983.63.4.1281; Rowell L., 1986, HUMAN CIRCULATION RE; SAAD CI, 1988, HYPERTENSION, V11, P217; Sakka SG, 2002, CHEST, V122, P1715, DOI 10.1378/chest.122.5.1715; Schneditz D, 2005, ASAIO J, V51, P376, DOI 10.1097/01.mat.0000169030.37228.82; SCHNEDITZ D, 1992, KIDNEY INT, V42, P1425, DOI 10.1038/ki.1992.437; Schneditz D, 2016, HEMODIAL INT, V20, P120, DOI 10.1111/hdi.12338; Schneditz D, 2014, ASAIO J, V60, P452, DOI 10.1097/MAT.0000000000000075; Shibagaki Y, 1998, CLIN NEPHROL, V49, P49; Silvan Delgado M, 1997, REV ESPANOLA ENFERME, V89, P677; van der Zee S, 2007, KIDNEY INT, V71, P318, DOI 10.1038/sj.ki.5001885; Vaziri ND, 2012, NEPHROL DIAL TRANSPL, V27, P2686, DOI 10.1093/ndt/gfr624; Wang FQ, 2012, NEPHROLOGY, V17, P733, DOI 10.1111/j.1440-1797.2012.01647.x; Yu AW, 1997, KIDNEY INT, V51, P1986, DOI 10.1038/ki.1997.270; ZOCCALI C, 1991, NEPHROL DIAL TRANSPL, V6, P631, DOI 10.1093/ndt/6.9.631	45	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145411	10.1371/journal.pone.0145411	http://dx.doi.org/10.1371/journal.pone.0145411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713734	gold, Green Submitted, Green Published			2022-12-27	WOS:000367481900039
J	Tuschen-Caffier, B; Bender, C; Caffier, D; Klenner, K; Braks, K; Svaldi, J				Tuschen-Caffier, Brunna; Bender, Caroline; Caffier, Detlef; Klenner, Katharina; Braks, Karsten; Svaldi, Jennifer			Selective Visual Attention during Mirror Exposure in Anorexia and Bulimia Nervosa	PLOS ONE			English	Article							BINGE-EATING DISORDER; BODY-IMAGE; EYE-TRACKING; SELF-REPORT; SHAPE; BIASES; DISSATISFACTION; INFORMATION; WEIGHT; WOMEN	Objective Cognitive theories suggest that body dissatisfaction results from the activation of maladaptive appearance schemata, which guide mental processes such as selective attention to shape and weight-related information. In line with this, the present study hypothesized that patients with anorexia nervosa (AN) and bulimia nervosa (BN) are characterized by increased visual attention for the most dissatisfying/ugly body part compared to their most satisfying/beautiful body part, while a more balanced viewing pattern was expected for controls without eating disorders (CG). Method Eye movements were recorded in a group of patients with AN (n = 16), BN (n = 16) and a CG (n = 16) in an ecologically valid setting, i.e., during a 3-min mirror exposure. Results Evidence was found that patients with AN and BN display longer and more frequent gazes towards the most dissatisfying relative to the most satisfying and towards their most ugly compared to their most beautiful body parts, whereas the CG showed a more balanced gaze pattern. Discussion The results converge with theoretical models that emphasize the role of information processing in the maintenance of body dissatisfaction. Given the etiological importance of body dissatisfaction in the development of eating disorders, future studies should focus on the modification of the reported patterns.	[Tuschen-Caffier, Brunna; Bender, Caroline; Caffier, Detlef] Univ Freiburg, Dept Psychol, D-79106 Freiburg, Germany; [Klenner, Katharina; Braks, Karsten] Klin Korso, Bad Oeynhausen, Germany; [Svaldi, Jennifer] Univ Tubingen, Dept Psychol, Tubingen, Germany	University of Freiburg; Eberhard Karls University of Tubingen	Tuschen-Caffier, B (corresponding author), Univ Freiburg, Dept Psychol, Hugstetter Str 55, D-79106 Freiburg, Germany.	tuschen@psychologie.uni-freiburg.de			German Research Foundation (DFG); Albert Ludwigs University Freiburg in the funding programme Open Access Publishing	German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg in the funding programme Open Access Publishing	The authors received no specific funding for this work. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing.	American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Aspen V, 2013, COGNITION EMOTION, V27, P820, DOI 10.1080/02699931.2012.749777; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Blechert J, 2010, J ABNORM PSYCHOL, V119, P575, DOI 10.1037/a0019531; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Cash TF, 1997, INT J EAT DISORDER, V22, P107, DOI 10.1002/(SICI)1098-108X(199709)22:2&lt;107::AID-EAT1&gt;3.0.CO;2-J; Cash Thomas F, 2004, Body Image, V1, P1, DOI 10.1016/S1740-1445(03)00011-1; Cho A, 2013, BODY IMAGE, V10, P95, DOI 10.1016/j.bodyim.2012.09.005; COOPER MJ, 1992, BEHAV RES THER, V30, P501, DOI 10.1016/0005-7967(92)90034-E; COOPER PJ, 1987, INT J EAT DISORDER, V6, P485, DOI 10.1002/1098-108X(198707)6:4<485::AID-EAT2260060405>3.0.CO;2-O; Dobson KS, 2004, CLIN PSYCHOL REV, V23, P1001, DOI 10.1016/j.cpr.2003.09.004; FAIRBURN CG, 1991, INT J EAT DISORDER, V10, P415, DOI 10.1002/1098-108X(199107)10:4<415::AID-EAT2260100406>3.0.CO;2-R; Fairburn CG, 2003, J CONSULT CLIN PSYCH, V71, P103, DOI 10.1037/0022-006X.71.1.103; Fairburn CG, 2003, BEHAV RES THER, V41, P509, DOI 10.1016/S0005-7967(02)00088-8; FAIRBURN CG, 1993, J CONSULT CLIN PSYCH, V61, P696, DOI 10.1037/0022-006X.61.4.696; Fairburn CG, 1999, BEHAV RES THER, V37, P1, DOI 10.1016/S0005-7967(98)00102-8; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Fairburn Christopher G., 1993, P317; Faunce Gavin J, 2002, Eat Disord, V10, P125; First MB, 2002, STRUCTURED CLIN INTE; Franke GH, 2002, SCL90R BELTZ TEST; FREEMAN R, 1991, INT J EAT DISORDER, V10, P709, DOI 10.1002/1098-108X(199111)10:6&lt;709::AID-EAT2260100609&gt;3.0.CO;2-N; FREEMAN RJ, 1985, J PSYCHIAT RES, V19, P349, DOI 10.1016/0022-3956(85)90039-1; Gao X, 2014, EAT BEHAV, V15, P540, DOI 10.1016/j.eatbeh.2014.08.001; [高笑 Gao Xiao], 2012, [心理学报, Acta Psychologica Sinica], V44, P498; Godart NT, 2007, J AFFECT DISORDERS, V97, P37, DOI 10.1016/j.jad.2006.06.023; Hautzinger M., 1995, BECK DEPRESSIONS INV; Hepworth R, 2010, APPETITE, V54, P134, DOI 10.1016/j.appet.2009.09.019; Herpertz S., 2011, S3 LEITLINIE DIAGNOS; Hewig J, 2008, PSYCHOSOM MED, V70, P729, DOI 10.1097/PSY.0b013e31817e41d3; Hilbert A, 2005, J SOC CLIN PSYCHOL, V24, P561, DOI 10.1521/jscp.2005.24.4.561; Hilbert A, 2004, DIAGNOSTICA, V50, P98, DOI 10.1026/0012-1924.50.2.98; Hilbert A, 2002, J PSYCHOSOM RES, V52, P137, DOI 10.1016/S0022-3999(01)00314-2; Hilbert A., 2006, EATING DISORDER EXAM; Horndasch S, 2012, PSYCHIAT RES, V198, P321, DOI 10.1016/j.psychres.2011.12.029; Jacobi C, 2004, PSYCHOL BULL, V130, P19, DOI 10.1037/0033-2909.130.1.19; Janelle C M, 2003, Eat Weight Disord, V8, P138; Jansen A, 2006, BRIT J CLIN PSYCHOL, V45, P123, DOI 10.1348/014466505X50167; Jansen A, 2005, BEHAV RES THER, V43, P183, DOI 10.1016/j.brat.2004.01.003; Killen JD, 1996, J CONSULT CLIN PSYCH, V64, P936, DOI 10.1037/0022-006X.64.5.936; Lee M, 2004, CLIN PSYCHOL REV, V24, P215, DOI 10.1016/j.cpr.2003.10.004; Lykins AD, 2014, BODY IMAGE, V11, P404, DOI 10.1016/j.bodyim.2014.05.003; Mond JM, 2004, BEHAV RES THER, V42, P551, DOI 10.1016/S0005-7967(03)00161-X; PATTON GC, 1990, PSYCHOL MED, V20, P383, DOI 10.1017/S0033291700017700; Pinhas L, 2014, PSYCHIAT RES, V220, P519, DOI 10.1016/j.psychres.2014.08.006; Roefs A, 2008, APPETITE, V51, P552, DOI 10.1016/j.appet.2008.04.008; Shafran R, 2004, INT J EAT DISORDER, V35, P93, DOI 10.1002/eat.10228; Skrzypek S, 2001, EUR CHILD ADOLES PSY, V10, P215, DOI 10.1007/s007870170010; SLADE PD, 1994, BEHAV RES THER, V32, P497, DOI 10.1016/0005-7967(94)90136-8; SLADE PD, 1988, BRIT J PSYCHIAT, V153, P20, DOI 10.1192/S0007125000298930; Smeets E, 2011, HEALTH PSYCHOL, V30, P360, DOI 10.1037/a0022095; Smith E, 2006, INT J EAT DISORDER, V39, P509, DOI 10.1002/eat.20291; Smith E, 2009, EUR EAT DISORD REV, V17, P169, DOI 10.1002/erv.921; Stice E, 2000, J ABNORM PSYCHOL, V109, P438, DOI 10.1037/0021-843X.109.3.438; Svaldi J, 2012, PSYCHOTHER PSYCHOSOM, V81, P52, DOI 10.1159/000329110; Svaldi J, 2011, PSYCHOTHER PSYCHOSOM, V80, P186, DOI 10.1159/000317538; TAYLOR MJ, 1992, BEHAV RES THER, V30, P53, DOI 10.1016/0005-7967(92)90096-Y; Thompson J. K., 1999, EXACTING BEAUTY THEO, DOI [10.1037/10312-000, DOI 10.1037/10312-000]; Trentowska M, 2013, BEHAV RES THER, V51, P1, DOI 10.1016/j.brat.2012.03.012; Tuschen-Caffier B, 2003, BEHAV RES THER, V41, P573, DOI 10.1016/S0005-7967(02)00030-X; Vocks S, 2007, J PSYCHOSOM RES, V62, P231, DOI 10.1016/j.jpsychores.2006.08.007; von Wietersheim J, 2012, PSYCHOSOM MED, V74, P107, DOI 10.1097/PSY.0b013e31823ba787; Waadt S., 1992, BULIMIE URSACHEN THE; Wilfley DE, 1997, BEHAV RES THER, V35, P1151, DOI 10.1016/S0005-7967(97)80010-1; Williams J.M.G., 1997, COGNITIVE PSYCHOL EM, V2nd ed.; Williamson DA, 2004, BEHAV MODIF, V28, P711, DOI 10.1177/0145445503259853; Williamson DA, 1999, BEHAV MODIF, V23, P556, DOI 10.1177/0145445599234003; Williamson DA, 1990, ASSESSMENT EATING DI; Williamson DA., 1996, EAT DISORD, V4, P47, DOI [10.1080/10640269608250075, DOI 10.1080/10640269608250075]; Wittchen H-U, 1997, STURKTURIERTES KLIN	70	47	48	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145886	10.1371/journal.pone.0145886	http://dx.doi.org/10.1371/journal.pone.0145886			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0IX	26714279	Green Submitted, Green Published, gold			2022-12-27	WOS:000367481900099
J	Abramson, DH; Fabius, AWM; Issa, R; Francis, JH; Marr, BP; Dunkel, IJ; Gobin, YP				Abramson, David H.; Fabius, Armida W. M.; Issa, Reda; Francis, Jasmine H.; Marr, Brian P.; Dunkel, Ira J.; Gobin, Y. Pierre			Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC	PLOS ONE			English	Article							INTRAARTERIAL CHEMOTHERAPY; INTRAOCULAR RETINOBLASTOMA; BILATERAL RETINOBLASTOMA; RETINAL-DETACHMENT; MANAGEMENT; RADIATION; MELPHALAN; RISK; RADIOTHERAPY	Purpose To report on the influence of ophthalmic artery chemosurgery (OAC) on enucleation rates, ocular and patient survival from metastasis and impact on practice patterns at Memorial Sloan Kettering for children with advanced intraocular unilateral retinoblastoma. Patients and Methods Single-center retrospective review of all unilateral retinoblastoma patients with advanced intraocular retinoblastoma treated at MSKCC between our introduction of OAC (May 2006) and December 2014. End points were ocular survival, patient survival from metastases and enucleation rates. Results 156 eyes of 156 retinoblastoma patients were included. Primary enucleation rates have progressively decreased from a rate of >95% before OAC to 66.7% in the first year of OAC use to the present rate of 7.4%. The percent of patients receiving OAC has progressively increased from 33.3% in 2006 to 92.6% in 2014. Overall, ocular survival was significantly better in eyes treated with OAC in the years 2010-2014 compared to 2006-2009 (p = 0.023, 92.7% vs 68.0% ocular survival at 48 months). There have been no metastatic deaths in the OAC group but two patients treated with primary enucleation have died of metastatic disease. Conclusion OAC was introduced in 2006 and its impact on patient management is profound. Enucleation rates have decreased from over 95% to less than 10%. Our ocular survival rate has also significantly and progressively improved since May 2006. Despite treating more advanced eyes rather then enucleating them patient survival has not been compromised (there have been no metastatic deaths in the OAC group). In our institution, enucleation is no longer the most common treatment for advanced unilateral retinoblastoma.	[Abramson, David H.; Fabius, Armida W. M.; Issa, Reda; Francis, Jasmine H.; Marr, Brian P.; Gobin, Y. Pierre] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Abramson, David H.; Francis, Jasmine H.] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA; [Dunkel, Ira J.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Dunkel, Ira J.] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Gobin, Y. Pierre] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Radiol, Intervent Neuroradiol, New York, NY USA; [Gobin, Y. Pierre] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Neurosurg, Intervent Neuroradiol, New York, NY USA; [Gobin, Y. Pierre] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Neurol, Intervent Neuroradiol, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital	Abramson, DH (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.	abramsod@mskcc.org		Francis, Jasmine/0000-0002-7637-3108; Dunkel, Ira/0000-0001-8091-6067	Fund for Ophthalmic Knowledge, Inc, N.Y.; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Fund for Ophthalmic Knowledge, Inc, N.Y.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Fund for Ophthalmic Knowledge, Inc, N.Y. awarded a philanthropic grant to the Ocular Oncology service at Memorial Sloan Kettering Cancer Center. This grant does not have grant number and the fund has no URL. DHA is President of the Fund for Ophthalmic Knowledge, Inc. The Fund is a 501c3 public charity. DHA receives no compensation for his position as President of the Fund.	Abramson DH, 2008, OPHTHALMOLOGY, V115, P1398, DOI 10.1016/j.ophtha.2007.12.014; Abramson DH, 2014, ANNU REV MED, V65, P171, DOI 10.1146/annurev-med-061312-123455; Abramson DH, 2011, ARCH OPHTHALMOL-CHIC, V129, P1492, DOI 10.1001/archophthalmol.2011.354; Abramson DH, 2010, ARCH OPHTHALMOL-CHIC, V128, P370, DOI 10.1001/archophthalmol.2010.7; Abramson DH, 1998, OPHTHALMOLOGY, V105, P573, DOI 10.1016/S0161-6420(98)94006-4; Abramson DH, 2004, ARCH OPHTHALMOL-CHIC, V122, P1316, DOI 10.1001/archopht.122.9.1316; ABRAMSON DH, 1976, T AM ACAD OPHTHALMOL, V81, pP454; ABRAMSON DH, 1981, ARCH OPHTHALMOL-CHIC, V99, P1761; Abramson DH, 1982, MANAGEMENT UNILATERA; Abramson DH, 1981, SIMULTANEOUS BILATER; Aziz HA, 2012, CLIN OPHTHALMOL, V6, P1601, DOI 10.2147/OPTH.S33094; Bracco S, 2013, BRIT J OPHTHALMOL, V97, P1219, DOI 10.1136/bjophthalmol-2013-303267; Dunkel IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108692; Francis JH, 2015, OPHTHALMOLOGY, V122, P1016, DOI 10.1016/j.ophtha.2014.11.029; Gobin YP, 2011, ARCH OPHTHALMOL-CHIC, V129, P732, DOI 10.1001/archophthalmol.2011.5; Gombos DS, 2007, OPHTHALMOLOGY, V114, P1378, DOI 10.1016/j.ophtha.2007.03.074; Grigorovski N, 2014, INT J OPHTHALMOL-CHI, V7, P726, DOI 10.3980/j.issn.2222-3959.2014.04.26; Hadjistilianou T, 2014, J PEDIAT OPHTH STRAB, V51, P32, DOI 10.3928/01913913-20131203-01; Muen WJ, 2012, OPHTHALMOLOGY, V119, P611, DOI 10.1016/j.ophtha.2011.08.045; Palioura S, 2012, PEDIATR BLOOD CANCER, V59, P859, DOI 10.1002/pbc.24170; REESE AB, 1958, ARCH OPHTHALMOL-CHIC, V60, P897; Reese AB, 2013, AM J OPHTHALMOL, V32, P175; Schaiquevich P, 2013, PEDIATR BLOOD CANCER, V60, P766, DOI 10.1002/pbc.24356; Schefler AC, 2008, CURR OPIN OPHTHALMOL; Shields CL, 2012, RETINA-J RET VIT DIS, V32, P799, DOI 10.1097/IAE.0b013e31823d8e1e; Shields JA, 2005, AM J OPHTHALMOL, V140, P505, DOI 10.1016/j.ajo.2005.04.047; Suzuki Shigenobu, 2004, Int J Clin Oncol, V9, P1, DOI 10.1007/s10147-003-0366-0; Thampi S, 2013, CLIN OPHTHALMOL, V7, P981, DOI 10.2147/OPTH.S43398; Wong FL, 1997, JAMA-J AM MED ASSOC, V278, P1262, DOI 10.1001/jama.278.15.1262; Wong JR, 2014, J CLIN ONCOL, V32, P3284, DOI 10.1200/JCO.2013.54.7844; Yannuzzi NA, 2015, JAMA OPHTHALMOL, V133, P1062, DOI 10.1001/jamaophthalmol.2015.2243	31	45	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145436	10.1371/journal.pone.0145436	http://dx.doi.org/10.1371/journal.pone.0145436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709699	Green Published, Green Submitted, gold			2022-12-27	WOS:000367451400046
J	Daly, SC; MacNeela, P; Sarma, KM				Daly, Siobhan C.; MacNeela, Padriag; Sarma, Kiran M.			When Parents Separate and One Parent 'Comes Out' as Lesbian, Gay or Bisexual: Sons and Daughters Engage with the Tension that Occurs When Their Family Unit Changes	PLOS ONE			English	Article							RELATIONSHIP QUALITY; CHILD ADJUSTMENT; GROUNDED THEORY; DIVORCE; PERCEPTIONS; RESILIENCE; DISSONANCE; HYPOCRISY; IDENTITY; SUPPORT	The experiences of Irish sons and daughters born into heterosexually-organised parental partnerships/unions whose parents have separated and one has come out as Lesbian, Gay or Bisexual (LGB) were explored through a grounded theory approach. 15 adult children (over the age of 18 years), who varied in age when their parents separated and one disclosed as LGB, were interviewed. The primary concern that emerged centred on participants having to adjust to their parents' being separated, as opposed to their parent being LGB. This involved engaging with the tension that arose from the loss of the parental union, which involved changes to the home environment and adapting to new parental partners and family units. Heightened reflection on sexual orientation and an increased sensitivity to societal LGB prejudice were specifically associated with a parent coming out as LGB. How parents negotiated disclosing the changes to others, the level of support available to parents, and how capable parents were at maintaining the parent-child relationship had an impact on the tension experienced by sons and daughters. Participants moved from initially avoiding and resisting the family changes that were occurring to gradual consonance with their altered family environments. Concluding directions for research and clinical considerations are suggested.	[Daly, Siobhan C.; MacNeela, Padriag; Sarma, Kiran M.] Natl Univ Ireland, Sch Psychol, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	Daly, SC (corresponding author), Natl Univ Ireland, Sch Psychol, Galway, Ireland.	s.daly14@nuigalway.ie						Afifi T.D., 2009, J FAMILY COMMUNICATI, V4, P65; Ahrons CR, 2007, FAM PROCESS, V46, P53, DOI 10.1111/j.1545-5300.2006.00191.x; Amato PR, 2006, J MARRIAGE FAM, V68, P222, DOI 10.1111/j.1741-3737.2006.00243.x; [Anonymous], 2013, SURVIVING THRIVING S; [Anonymous], 2007, BRAVE NEW STEPFAMILI; Bauserman R, 2002, J FAM PSYCHOL, V16, P91, DOI 10.1037/0893-3200.16.1.91; Berger R, 2008, FAMILIES SOC, V6, P504; Binger J.J., 2012, HDB LGBT AFFIRMATIVE; Bos HMW, 2007, AM J ORTHOPSYCHIAT, V77, P38, DOI 10.1037/0002-9432.77.1.38; Braithwaite DO, 2006, J APPL COMMUN RES, V34, P30, DOI 10.1080/00909880500420200; Brownell K.D., 2005, WEIGHT BIAS NATURE C; Cartwright C., 2006, J DIVORCE REMARRIAGE, V44, P125, DOI DOI 10.1300/J087; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; CROSBIEBURNETT M, 1993, FAM RELAT, V42, P256, DOI 10.2307/585554; Elizur Y, 2003, PERS RELATIONSHIP, V10, P411, DOI 10.1111/1475-6811.00057; Fassinger RE, 2005, J COUNS PSYCHOL, V52, P156, DOI 10.1037/0022-0167.52.2.156; Frable DES, 1998, J PERS SOC PSYCHOL, V74, P909, DOI 10.1037/0022-3514.74.4.909; Gershon TD, 1999, J ADOLESCENT HEALTH, V24, P437, DOI 10.1016/S1054-139X(98)00154-2; Glaser B. G., 2004, HIST SOCIAL RES S19, V5, P13, DOI [10.1016/j.clae.2007.06.001, DOI 10.1016/J.CLAE.2007.06.001]; Goldberg A. E., 2020, LGBTQ PARENT FAMILIE, V2nd; Heatherington L, 2008, J FAM PSYCHOL, V22, P329, DOI 10.1037/0893-3200.22.3.329; Herek G. M., 2003, STIGMA SEXUAL ORIENT; Jamison TB, 2014, FAM RELAT, V63, P411, DOI 10.1111/fare.12074; Kelly JB, 2003, FAM RELAT, V52, P352, DOI 10.1111/j.1741-3729.2003.00352.x; Kuvalanka K., 2013, J ADOLESCENT RES, V29, P1; Lansford JE, 2009, PERSPECT PSYCHOL SCI, V4, P140, DOI 10.1111/j.1745-6924.2009.01114.x; Lynch J.M., 2010, J HOMOSEXUAL, V40, P81; Malterud K, 2001, LANCET, V358, P397, DOI 10.1016/S0140-6736(01)05548-9; McConnell AR, 2010, J EXP SOC PSYCHOL, V46, P361, DOI 10.1016/j.jesp.2009.10.019; McKenzie, 2004, FAMILY COURT REV, V42, P85, DOI DOI 10.1111/J.174-1617.2004.TB00635.X; Meaney Gerardine, 2010, GENDER IRELAND CULTU; Menning CL, 2002, J FAM ISSUES, V23, P648, DOI 10.1177/0192513X02023005004; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Mohr JJ, 2006, PERS SOC PSYCHOL B, V32, P1085, DOI 10.1177/0146167206288281; Munhall P., 2012, NURSING RES QUALITAT; Patterson Charlotte J., 2005, LESBIAN GAY PARENTIN, P5; Rosenfeld MJ, 2010, DEMOGRAPHY, V47, P755, DOI 10.1353/dem.0.0112; Sasser A., 2006, IMPACT COMING OUT MI, V22, P18; Stone J, 2008, SOC PERSONAL PSYCHOL, V2, P1024, DOI 10.1111/j.1751-9004.2008.00088.x; Strauss A., 1990, BASICS QUALITATIVE R; Strauss A., 1998, BASICS QUALITATIVE R; Suddaby R, 2006, ACAD MANAGE J, V49, P633, DOI 10.5465/AMJ.2006.22083020; Sun YM, 2002, J MARRIAGE FAM, V64, P472, DOI 10.1111/j.1741-3737.2002.00472.x; Tasker F, 2005, J DEV BEHAV PEDIATR, V26, P224, DOI 10.1097/00004703-200506000-00012; van-Eeden-Moorefield B., 2012, EXPLAINING COUPLE CO, V33, P182; Wainright JL, 2006, J FAM PSYCHOL, V20, P526, DOI 10.1037/0893-3200.20.3.526; Willig C., 2008, INTRO QUALITATIVE RE, V(Second edition.)	47	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145491	10.1371/journal.pone.0145491	http://dx.doi.org/10.1371/journal.pone.0145491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ9XO	26710277	Green Submitted, gold, Green Published			2022-12-27	WOS:000367451400052
J	Saito, K; Pignon, P; Ayyoub, M; Valmori, D				Saito, Kanako; Pignon, Pascale; Ayyoub, Maha; Valmori, Danila			Modulation of Cytokine Secretion Allows CD4 T Cells Secreting IL-10 and IL-17 to Simultaneously Participate in Maintaining Tolerance and Immunity	PLOS ONE			English	Article							REGULATORY FUNCTION; IFN-GAMMA; IDENTIFICATION; INFLAMMATION; IL-1-BETA; BACTERIA; EXPRESS; TREGS; VIVO; TH17	CD4 T cells secreting IL-10 or IL-17 are frequent at mucosal sites, where their equilibrium is important for simultaneously maintaining tolerance and immunity to the resident microbiota. The mode of action of these cells, however, is as yet incompletely understood. In this study, we have combined ex vivo analysis of CD4 T cells producing IL-10 or/and IL-17 with assessment of clonal populations isolated ex vivo using a cytokine catch assay. We found that circulating CD4 T cells secreting IL-10 or/and IL-17 ex vivo include both conventional FOXP3(-)CD4 T cells and FOXP3(+) Helios-Treg. Upon assessment of clonal populations derived from single ex vivo isolated cytokine secreting cells, we found that IL-10 or/and IL-17 secreting cells prevalently secrete one or the other cytokine depending on the type of stimulation, the time after stimulation and the presence of microbial products. Namely, IL-10 secretion by clonal cells was prevalent at early time points after TCR mediated stimulation, was independent of co-stimulation and was increased in the presence of the microbial fermentation product butyrate. In contrast, IL-17 secretion was higher at later time points after TCR mediated stimulation and in the presence of co-stimulatory signals. Taken together, these results provide insights into the mechanisms that, through modulation of cytokine secretion depending on conditions, allow IL-10 and IL-17 producing CD4 T cells to contribute to maintain tolerance to microbes locally, while retaining the ability to participate in protective immune responses at distant sites.	[Saito, Kanako; Pignon, Pascale; Ayyoub, Maha; Valmori, Danila] Inst Cancerol Ouest, Inst Natl Sante & Rech Med, Equipe Labellisee Ligue Canc, Unite 1102, Nantes, France; [Valmori, Danila] Univ Nantes, Fac Med, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Nantes Universite	Valmori, D (corresponding author), Inst Cancerol Ouest, Inst Natl Sante & Rech Med, Equipe Labellisee Ligue Canc, Unite 1102, Nantes, France.	Danila.Valmori@univ-nantes.fr	Valmori, Danila/K-2439-2015; Ayyoub, Maha/A-2074-2017; Valmori, Danila/AAL-9766-2021	Ayyoub, Maha/0000-0003-2022-0898; 	Ludwig Institute for Cancer Research (USA); Cancer Research Institute (USA); Ligue contre le Cancer (France); LabeX IGO (France)	Ludwig Institute for Cancer Research (USA); Cancer Research Institute (USA); Ligue contre le Cancer (France); LabeX IGO (France)	This study was supported by the Ludwig Institute for Cancer Research (USA), the Cancer Research Institute (USA), Ligue contre le Cancer (France) and LabeX IGO (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia N, 2014, P NATL ACAD SCI USA, V111, P2058, DOI 10.1073/pnas.1323183111; Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Blaschitz C, 2010, J CLIN IMMUNOL, V30, P196, DOI 10.1007/s10875-010-9368-7; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Ganapathy V, 2013, CURR OPIN PHARMACOL, V13, P869, DOI 10.1016/j.coph.2013.08.006; Haringer B, 2009, J EXP MED, V206, P1009, DOI 10.1084/jem.20082238; Hamai A, 2012, CANCER RES, V72, P1059, DOI 10.1158/0008-5472.CAN-11-3432; Kole A, 2014, CURR TOP MICROBIOL, V380, P19, DOI 10.1007/978-3-662-43492-5_2; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Nutsch KM, 2012, CURR OPIN IMMUNOL, V24, P385, DOI 10.1016/j.coi.2012.04.009; Olsen I, 2013, J IMMUNOL METHODS, V390, P106, DOI 10.1016/j.jim.2013.01.015; Pot C, 2011, SEMIN IMMUNOL, V23, P202, DOI 10.1016/j.smim.2011.07.005; Raffin C, 2013, J IMMUNOL, V191, P4619, DOI 10.4049/jimmunol.1301378; Rivino L, 2010, J EXP MED, V207, P565, DOI 10.1084/jem.20091021; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Santarlasci V, 2012, IMMUNITY, V36, P201, DOI 10.1016/j.immuni.2011.12.013; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Zelante T, 2009, EUR J IMMUNOL, V39, P645, DOI 10.1002/eji.200839102; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	23	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145788	10.1371/journal.pone.0145788	http://dx.doi.org/10.1371/journal.pone.0145788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709703	gold, Green Published			2022-12-27	WOS:000367451400078
J	Headey, DD; Hoddinott, J				Headey, Derek D.; Hoddinott, John			Understanding the Rapid Reduction of Undernutrition in Nepal, 2001-2011	PLOS ONE			English	Article							NUTRITION; INTERVENTIONS; REGRESSION; HELP; BAD	South Asia has long been synonymous with unusually high rates of undernutrition. In the past decade, however, Nepal has arguably achieved the fastest recorded decline in child stunting in the world and has done so in the midst of civil war and post-conflict political instability. Given recent interest in reducing undernutrition-particularly the role of nutrition-sensitive policies-this paper aims to quantitatively understand this surprising success story by analyzing the 2001, 2006, and 2011 rounds of Nepal's Demographic Health Surveys. To do so, we construct models of the intermediate determinants of child and maternal nutritional change and then decompose predicted changes in nutrition outcomes over time. We identify four broad drivers of change: asset accumulation, health and nutrition interventions, maternal educational gains, and improvements in sanitation. Many of these changes were clearly influenced by policy decisions, including increased public investments in health and education and community-led health and sanitation campaigns. Other factors, such as rapid growth in migration-based remittances, are more a reflection of household responses to changing political and economic circumstances.	[Headey, Derek D.; Hoddinott, John] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA; [Hoddinott, John] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Hoddinott, John] Cornell Univ, Charles H Dyson Sch Appl Econ & Management, Ithaca, NY USA	CGIAR; International Food Policy Research Institute (IFPRI); Cornell University; Cornell University	Headey, DD (corresponding author), Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA.	D.Headey@cgiar.org			UK aid from the UK government; Department for International Development (DFID) [201448] Funding Source: researchfish	UK aid from the UK government(CGIAR); Department for International Development (DFID)	This paper is a product of the research consortium Transform Nutrition and is funded by UK aid from the UK government.	Acosta A., 2012, FIGHTING MATERNAL CH; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Deaton AS., 2008, ECON POLIT WEEKLY, DOI [DOI 10.2139/SSRN.1135253, 10.2139/ssrn.1135253]; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gertler P., 2015, 20997 NBER; Headey D, 2015, WORLD DEV, V66, P749, DOI 10.1016/j.worlddev.2014.09.022; Headey D, 2012, FOOD SECUR, V4, P87, DOI 10.1007/s12571-011-0161-0; Heaver R, 2002, INDIAS TAMIL NADU NU; Heaver R., 2002, THAILANDS NATL NUTR; HORTON S, 1988, ECON DEV CULT CHANGE, V36, P341, DOI 10.1086/451655; Jann B, 2008, STATA J, V8, P453, DOI 10.1177/1536867X0800800401; Jayachandran Seema, 2013, WHY ARE INDIAN CHILD; Nepal CBS (Central Bureau of Statistics), 2005, POV TRENDS NEP 1995; Nepal Ministry of Urban Development, 2013, S AS C SAN SAN ALL A; [New ERA ORC Macro Nepal MOHP], 1997, NEP DEM HLTH SURV 19; [New ERA ORC Macro Nepal MOHP], 2002, NEP DEM HLTH SURV 20; [New ERA ICF International Nepal MOHP (Ministry of Health and Population)], 2012, NEP DEM HLTH SURV 20; [New ERA ICF International Nepal MOHP (Ministry of Health and Population)], 2007, NEP DEM HLTH SURV 20; Nube M., 2007, WP0701 CTR WORLD FOO; Onyango AW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035320500494464; Pande RP, 2003, DEMOGRAPHY, V40, P395, DOI 10.1353/dem.2003.0029; Ramalingaswami V., 1997, PROGR NATIONS; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, P26; Shrimpton R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e75; Spears D., 2013, WORLD BANK POLICY RE; The World Bank, 2010, 55388NP WORLD BANK; [United Nations Nepal CBS], 2013, NEP MILL DEV GOALS P; WEINBERG CR, 1995, EPIDEMIOLOGY, V6, P345; World Bank, 2006, REP NUTR CENTR DEV S	32	55	55	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145738	10.1371/journal.pone.0145738	http://dx.doi.org/10.1371/journal.pone.0145738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26699135	Green Published, gold			2022-12-27	WOS:000367092600125
J	Hu, WG; Zhang, Q; Tian, T; Li, DY; Cheng, G; Mu, J; Wu, QB; Niu, FJ; Stegen, JC; An, LZ; Feng, HY				Hu, Weigang; Zhang, Qi; Tian, Tian; Li, Dingyao; Cheng, Gang; Mu, Jing; Wu, Qingbai; Niu, Fujun; Stegen, James C.; An, Lizhe; Feng, Huyuan			Relative Roles of Deterministic and Stochastic Processes in Driving the Vertical Distribution of Bacterial Communities in a Permafrost Core from the Qinghai-Tibet Plateau, China	PLOS ONE			English	Article							PHYLOGENETIC BETA DIVERSITY; MICROBIAL DIVERSITY; ECOLOGY; SOIL; BIODIVERSITY; PATTERNS; NICHE; BIOGEOGRAPHY; REVEALS; PROFILE	Understanding the processes that influence the structure of biotic communities is one of the major ecological topics, and both stochastic and deterministic processes are expected to be at work simultaneously in most communities. Here, we investigated the vertical distribution patterns of bacterial communities in a 10-m-long soil core taken within permafrost of the Qing-hai-Tibet Plateau. To get a better understanding of the forces that govern these patterns, we examined the diversity and structure of bacterial communities, and the change in community composition along the vertical distance (spatial turnover) from both taxonomic and phylogenetic perspectives. Measures of taxonomic and phylogenetic beta diversity revealed that bacterial community composition changed continuously along the soil core, and showed a vertical distance-decay relationship. Multiple stepwise regression analysis suggested that bacterial alpha diversity and phylogenetic structure were strongly correlated with soil conductivity and pH but weakly correlated with depth. There was evidence that deterministic and stochastic processes collectively drived bacterial vertically-structured pattern. Bacterial communities in five soil horizons (two originated from the active layer and three from permafrost) of the permafrost core were phylogenetically random, indicator of stochastic processes. However, we found a stronger effect of deterministic processes related to soil pH, conductivity, and organic carbon content that were structuring the bacterial communities. We therefore conclude that the vertical distribution of bacterial communities was governed primarily by deterministic ecological selection, although stochastic processes were also at work. Furthermore, the strong impact of environmental conditions ( for example, soil physicochemical parameters and seasonal freeze-thaw cycles) on these communities underlines the sensitivity of permafrost microorganisms to climate change and potentially subsequent permafrost thaw.	[Hu, Weigang; Zhang, Qi; Tian, Tian; Li, Dingyao; Cheng, Gang; Mu, Jing; An, Lizhe; Feng, Huyuan] Lanzhou Univ, Minist Educ, Key Lab Cell Activ & Stress Adaptat, Sch Life Sci, Lanzhou 730000, Peoples R China; [Wu, Qingbai; Niu, Fujun] Chinese Acad Sci, SKLFSE, CAREERI, Lanzhou, Peoples R China; [Stegen, James C.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA	Lanzhou University; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Wu, QB (corresponding author), Chinese Acad Sci, SKLFSE, CAREERI, Lanzhou, Peoples R China.	qbwu@lzb.ac.cn; fenghy@lzu.edu.cn	Stegen, James/Q-3078-2016; Hu, Weigang/CAH-3530-2022; Yang, Xiaoming/GRJ-9483-2022	Stegen, James/0000-0001-9135-7424; Hu, Weigang/0000-0003-1422-3726; Yang, Xiaoming/0000-0002-1792-6921	National Basic Research Program [2012CB026105]; National Natural Science Foundation [31170482, 31300445, 31370450]; PhD Programs Foundation of Ministry of Education [20130211120005]; Chinese Postdoctoral Science Foundation [2013M540780, 2014T70949]; Fundamental Research Funds for the Central Universities in China [LZUJBKY-2011-119]; State Key Laboratory of Frozen Soil Engineering, Chinese Academy of Sciences [SKLFSE200901]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); PhD Programs Foundation of Ministry of Education; Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities in China; State Key Laboratory of Frozen Soil Engineering, Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by funding from the National Basic Research Program (2012CB026105), National Natural Science Foundation (31170482, 31300445, 31370450), PhD Programs Foundation of Ministry of Education (20130211120005), the Chinese Postdoctoral Science Foundation (2013M540780, 2014T70949), Fundamental Research Funds for the Central Universities in China (LZUJBKY-2011-119) and State Key Laboratory of Frozen Soil Engineering, Chinese Academy of Sciences (SKLFSE200901).	Amaral-Zettler LA, 2011, ISME J, V5, P42, DOI 10.1038/ismej.2010.101; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Barberan Albert, 2014, Front Microbiol, V5, P203, DOI 10.3389/fmicb.2014.00203; Blaalid R, 2014, MOL ECOL, V23, P649, DOI 10.1111/mec.12622; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Caruso T, 2011, ISME J, V5, P1406, DOI 10.1038/ismej.2011.21; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Coolen MJL, 2011, ENVIRON MICROBIOL, V13, P2299, DOI 10.1111/j.1462-2920.2011.02489.x; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Cowan DA, 2010, POLAR MICROBIOLOGY: THE ECOLOGY, BIODIVERSITY AND BIOREMEDIATION POTENTIAL OF MICROORGANISMS IN EXTREMELY COLD ENVIRONMENTS, P1; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fox J., R COMPANION APPL REG, V3; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Gilichinsky DA, 2007, ASTROBIOLOGY, V7, P275, DOI 10.1089/ast.2006.0012; Gilichinsky DA, 2002, ENCY ENV MICROBIOLOG, P2367, DOI DOI 10.1128/JB.00395-07; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Helmus MR, 2010, ECOL LETT, V13, P162, DOI 10.1111/j.1461-0248.2009.01411.x; Horner-Devine MC, 2006, ECOLOGY, V87, pS100, DOI 10.1890/0012-9658(2006)87[100:PCAOIB]2.0.CO;2; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Hu WG, 2015, EXTREMOPHILES, V19, P693, DOI 10.1007/s00792-015-0749-y; Hu WG, 2014, J BASIC MICROB, V54, P1331, DOI 10.1002/jobm.201400232; Hubbell SP, 2004, ECOLOGY, V85, P3175, DOI 10.1890/04-0808; Hultman J, 2015, NATURE, V521, P208, DOI 10.1038/nature14238; Jansson JK, 2014, NAT REV MICROBIOL, V12, P414, DOI 10.1038/nrmicro3262; Johnson SS, 2007, P NATL ACAD SCI USA, V104, P14401, DOI 10.1073/pnas.0706787104; Jungblut AD, 2010, ISME J, V4, P191, DOI 10.1038/ismej.2009.113; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kim HM, 2014, FEMS MICROBIOL ECOL, V89, P465, DOI 10.1111/1574-6941.12362; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Koyama A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00516; Kraft NJB, 2015, FUNCT ECOL, V29, P592, DOI 10.1111/1365-2435.12345; Kubota Y, 2011, J BIOGEOGR, V38, P1006, DOI 10.1111/j.1365-2699.2011.02491.x; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre Pierre, 2007, Zhiwu Shengtai Xuebao, V31, P976; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; Margesin R, 2011, RES MICROBIOL, V162, P346, DOI 10.1016/j.resmic.2010.12.004; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; McCalley CK, 2014, NATURE, V514, P478, DOI 10.1038/nature13798; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Oksanen J., MULTIVARIATE ANAL EC; Ozerskaya Svetlana, 2009, V16, P85; Pommier T, 2012, BIOL LETTERS, V8, P562, DOI 10.1098/rsbl.2011.0990; Ren LJ, 2015, APPL ENVIRON MICROB, V81, P3104, DOI 10.1128/AEM.04042-14; Rominger AJ, 2009, OECOLOGIA, V161, P791, DOI 10.1007/s00442-009-1420-z; Sawicka JE, 2010, ISME J, V4, P585, DOI 10.1038/ismej.2009.140; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schuur EAG, 2015, NATURE, V520, P171, DOI 10.1038/nature14338; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; Shen CC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00582; Smith TW, 2010, ECOGRAPHY, V33, P648, DOI 10.1111/j.1600-0587.2009.06105.x; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Stegen JC, 2012, ISME J, V6, P1653, DOI 10.1038/ismej.2012.22; Stegen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020906; Steven B, 2008, ENVIRON MICROBIOL, V10, P3388, DOI 10.1111/j.1462-2920.2008.01746.x; Steven B, 2006, EXTREMOPHILES, V10, P259, DOI 10.1007/s00792-006-0506-3; Steven Blaire, 2009, V16, P59; Stomeo F, 2012, FEMS MICROBIOL ECOL, V82, P326, DOI 10.1111/j.1574-6941.2012.01360.x; Swenson NG, 2012, ECOLOGY, V93, pS112, DOI 10.1890/11-0402.1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tuomisto H, 2006, ECOLOGY, V87, P2697, DOI 10.1890/0012-9658(2006)87[2697:AOEBDU]2.0.CO;2; WANG BL, 1995, QUATERNARY SCI REV, V14, P255, DOI 10.1016/0277-3791(95)00006-B; Wang JJ, 2008, ENVIRON MICROBIOL, V10, P2537, DOI 10.1111/j.1462-2920.2008.01678.x; Wang JJ, 2013, ISME J, V7, P1310, DOI 10.1038/ismej.2013.30; Wang JJ, 2012, ENV MICROBIOL REP, V4, P217, DOI 10.1111/j.1758-2229.2011.00324.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Yang DQ, 2008, CAN J MICROBIOL, V54, P270, DOI [10.1139/W08-004, 10.1139/w08-004]; Yang Sienhung, 2012, Evid Based Complement Alternat Med, V2012, P521780, DOI 10.1155/2012/521780; Yergeau E, 2010, ISME J, V4, P1206, DOI 10.1038/ismej.2010.41; Yun JL, 2014, MICROB ECOL, V68, P360, DOI 10.1007/s00248-014-0415-4; Zhang XF, 2013, J APPL MICROBIOL, V114, P1054, DOI 10.1111/jam.12106	79	26	27	11	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145747	10.1371/journal.pone.0145747	http://dx.doi.org/10.1371/journal.pone.0145747			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699734	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600128
J	Ido, A; Nakayama, Y; Ishii, K; Iemitsu, M; Sato, K; Fujimoto, M; Kurihara, T; Hamaoka, T; Satoh-Asahara, N; Sanada, K				Ido, Ayumi; Nakayama, Yuki; Ishii, Kojiro; Iemitsu, Motoyuki; Sato, Koji; Fujimoto, Masahiro; Kurihara, Toshiyuki; Hamaoka, Takafumi; Satoh-Asahara, Noriko; Sanada, Kiyoshi			Ultrasound-Derived Abdominal Muscle Thickness Better Detects Metabolic Syndrome Risk in Obese Patients than Skeletal Muscle Index Measured by Dual-Energy X-Ray Absorptiometry	PLOS ONE			English	Article							REGIONAL ARTERIAL STIFFNESS; ARCHITECTURAL CHARACTERISTICS; SARCOPENIC OBESITY; PHYSICAL-ACTIVITY; JAPANESE ADULTS; WOMEN; AGE; MASS; MEN; STRENGTH	Sarcopenia has never been diagnosed based on site-specific muscle loss, and little is known about the relationship between site-specific muscle loss and metabolic syndrome (MetS) risk factors. To this end, this cross-sectional study aimed to investigate the relationship between site-specific muscle size and MetS risk factors. Subjects were 38 obese men and women aged 40-82 years. Total body fat and lean body mass were assessed by whole-body dual-energy X-ray absorptiometry (DXA) scan. Muscle thickness (MTH) was measured using B-mode ultrasound scanning in six body regions. Subjects were classified into general obesity (GO) and sarcopenic obesity (SO) groups using the threshold values of one standard deviation below the sex-specific means of either MTH or skeletal muscle index (SMI) measured by DXA. MetS risk score was acquired by standardizing and summing the following continuously distributed variables: visceral fat area, mean blood pressure, HbA1c, and serum triglyceride / high density lipoprotein cholesterol, to obtain the Z-score. Multiple regression analysis revealed that the MetS risk score was independently associated with abdominal MTH in all subjects, but not with MTH in other muscle regions, including the thigh. Although HbA1c and the number of MetS risk factors in the SO group were significantly higher than those in the GO group, there were no significant differences between GO and SO groups as defined by SMI. Ultrasound-derived abdominal MTH would allow a better assessment of sarcopenia in obese patients and can be used as an alternative to the conventionally-used SMI measured by DXA.	[Ido, Ayumi; Nakayama, Yuki; Iemitsu, Motoyuki; Sato, Koji; Fujimoto, Masahiro; Kurihara, Toshiyuki; Sanada, Kiyoshi] Ritsumeikan Univ, Coll Sport & Hlth Sci, Kusatsu, Shiga, Japan; [Ishii, Kojiro] Doshisha Univ, Fac Hlth & Sports Sci, Kyoto 602, Japan; [Hamaoka, Takafumi] Tokyo Med Univ, Dept Sports Med Hlth Promot, Tokyo 1608402, Japan; [Satoh-Asahara, Noriko] Natl Hosp Org Kyoto Med Ctr, Clin Res Inst, Div Diabet Res, Kyoto, Japan	Ritsumeikan University; Doshisha University; Tokyo Medical University	Sanada, K (corresponding author), Ritsumeikan Univ, Coll Sport & Hlth Sci, Kusatsu, Shiga, Japan.	ksanada@fc.ritsumei.ac.jp	Fujimoto, Masahiro/G-8876-2019	Fujimoto, Masahiro/0000-0003-2234-5029; Sanada, Kiyoshi/0000-0003-3703-4098	Ministry of Education, Culture, Sports, Science and Technology of Japan [24300239]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#24300239, Development of the taylor-made prevention programs for sarcopenia, K. Sanada) (https://kaken.nii.ac.jp/d/p/24300239.ja.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE T, 1994, AM J HUM BIOL, V6, P161, DOI 10.1002/ajhb.1310060204; Abe T, 2013, AGE DORDR; Abe T, 2014, AGE, V36, P813, DOI 10.1007/s11357-013-9600-5; Abe T, 2011, CLIN PHYSIOL FUNCT I, V31, P320, DOI 10.1111/j.1475-097X.2011.01021.x; ALEXANDER NB, 1995, J AM GERIATR SOC, V43, P338, DOI 10.1111/j.1532-5415.1995.tb05804.x; Anderson DE, 2013, J GERONTOL A-BIOL, V68, P317, DOI 10.1093/gerona/gls168; Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Chen Z, 2007, J NUTR, V137, P2775, DOI 10.1093/jn/137.12.2775; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157, DOI 10.1152/jappl.2001.90.6.2157; Heffernan KS, 2006, EUR J APPL PHYSIOL, V98, P185, DOI 10.1007/s00421-006-0259-9; Ichinose Y, 1998, EUR J APPL PHYSIOL O, V78, P109, DOI 10.1007/s004210050394; JUDGE JO, 1993, ARCH PHYS MED REHAB, V74, P400; Kanehisa H, 2004, EUR J APPL PHYSIOL, V91, P534, DOI 10.1007/s00421-003-1034-9; Kearns CF, 2000, EUR J APPL PHYSIOL, V83, P289, DOI 10.1007/s004210000298; Kearns CF, 2001, EUR J APPL PHYSIOL, V85, P240, DOI 10.1007/s004210100468; Kohara K, 2012, INT J CARDIOL, V158, P146, DOI 10.1016/j.ijcard.2012.04.033; KUAN JW, 1977, CLIN CHEM, V23, P1058; Kubo K, 2003, INT J SPORTS MED, V24, P125, DOI 10.1055/s-2003-38204; Lindstrom A, 2000, J EXP BIOL, V203, P913; Lu CW, 2013, OBES RES CLIN PRACT, V7, pE301, DOI 10.1016/j.orcp.2012.02.003; Ogawa M, 2012, CLIN PHYSIOL FUNCT I, V32, P89, DOI 10.1111/j.1475-097X.2011.01057.x; Reimers CD, 1998, J NEUROL SCI, V159, P60, DOI 10.1016/S0022-510X(98)00134-8; Rolland Y, 2004, AM J CLIN NUTR, V79, P552; Roubenoff R, 2004, OBES RES, V12, P887, DOI 10.1038/oby.2004.107; Sanada K, 2006, EUR J APPL PHYSIOL, V96, P24, DOI 10.1007/s00421-005-0061-0; Sanada K, 2007, EUR J APPL PHYSIOL, V99, P475, DOI 10.1007/s00421-006-0375-6; Scafoglieri A, 2013, EXP GERONTOL, V48, P985, DOI 10.1016/j.exger.2013.07.005; Schafer AL, 2010, J CLIN ENDOCR METAB, V95, pE368, DOI 10.1210/jc.2010-0780; Schrager MA, 2007, J APPL PHYSIOL, V102, P919, DOI 10.1152/japplphysiol.00627.2006; Starkey DB, 1996, MED SCI SPORT EXER, V28, P1311, DOI 10.1097/00005768-199610000-00016; Sugawara J, 2004, AM J PHYSIOL-HEART C, V287, pH2666, DOI 10.1152/ajpheart.00077.2004; Sugawara J, 2003, JPN J PHYSIOL, V53, P239, DOI 10.2170/jjphysiol.53.239; Sugawara J, 2005, J HUM HYPERTENS, V19, P401, DOI 10.1038/sj.jhh.1001838; Visser M, 1999, J APPL PHYSIOL, V87, P1513, DOI 10.1152/jappl.1999.87.4.1513; Walsh MC, 2006, OSTEOPOROSIS INT, V17, P61, DOI 10.1007/s00198-005-1900-x; WOLFSON L, 1995, J GERONTOL A-BIOL, V50, P64	38	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0143858	10.1371/journal.pone.0143858	http://dx.doi.org/10.1371/journal.pone.0143858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700167	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600011
J	Jasien, JV; Jonas, JB; de Moraes, CG; Ritch, R				Jasien, Jessica V.; Jonas, Jost B.; de Moraes, C. Gustavo; Ritch, Robert			Intraocular Pressure Rise in Subjects with and without Glaucoma during Four Common Yoga Positions	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; BODY POSITION; APPLANATION TONOMETRY; GRAVITY INVERSION; TENSION GLAUCOMA; POSTURAL CHANGE; PROGRESSION	Purpose To measure changes in intraocular pressure (IOP) in association with yoga exercises with a head-down position. Methods The single Center, prospective, observational study included 10 subjects with primary open-angle glaucoma and 10 normal individuals, who performed the yoga exercises of Adho Mukha Svanasana, Uttanasana, Halasana and Viparita Karani for two minutes each. IOP was measured by pneumatonometry at baseline and during and after the exercises. Results All yoga poses were associated with a significant (P<0.01) rise in IOP within one minute after assuming the yoga position. The highest IOP increase (P<0.01) was measured in the Adho Mukha Svanasana position (IOP increase from 17 +/- 3.2 mmHg to 28 +/- 3.8 mmHg in glaucoma patients; from 17 +/- 2.8 mmHg to 29 +/- 3.9 mmHg in normal individuals), followed by the Uttanasana position (17 +/- 3.9 mmHg to 27 +/- 3.4 mmHg (glaucoma patients) and from 18 +/- 2.5 mmHg to 26 +/- 3.6 mmHg normal individuals)), the Halasana position (18 +/- 2.8 mmHg to 24 +/- 3.5 mmHg (glaucoma patients); 18 +/- 2.7 mmHg to 22 +/- 3.4 mmHg (normal individuals)), and finally the Viparita Kirani position (17 +/- 4 mmHg to 21 +/- 3.6 mmHg (glaucoma patients); 17 +/- 2.8 to 21 +/- 2.4 mmHg (normal individuals)). IOP dropped back to baseline values within two minutes after returning to a sitting position. Overall, IOP rise was not significantly different between glaucoma and normal subjects (P = 0.813), all though glaucoma eyes tended to have measurements 2 mm Hg higher on average. Conclusions Yoga exercises with head-down positions were associated with a rapid rise in IOP in glaucoma and healthy eyes. IOP returned to baseline values within 2 minutes. Future studies are warranted addressing whether yoga exercise associated IOP changes are associated with similar changes in cerebrospinal fluid pressure and whether they increase the risk of glaucoma progression.	[Jasien, Jessica V.; Ritch, Robert] New York Ear Eye & Ear Infirm Mt Sinai, Einhom Clin Res Ctr, New York, NY 10003 USA; [Jonas, Jost B.] Heidelberg Univ, Seegartenklin Heidelberg, Med Fac Mannheim, Dept Ophthalmol, D-69115 Heidelberg, Germany; [de Moraes, C. Gustavo] Columbia Univ, Dept Ophthalmol, Med Ctr, New York, NY 10027 USA	New York Eye & Ear Infirmary of Mount Sinai; Ruprecht Karls University Heidelberg; Columbia University	Jasien, JV (corresponding author), New York Ear Eye & Ear Infirm Mt Sinai, Einhom Clin Res Ctr, New York, NY 10003 USA.	jjasien.ganyresearch@gmail.com			New York Glaucoma Research Institute, New York, NY	New York Glaucoma Research Institute, New York, NY	Supported by donations from Joseph M. Cohen to the New York Glaucoma Research Institute, New York, NY and New York Glaucoma Research Institute, New York, NY.	Almubrad TM, 2010, CLIN EXP OPTOM, V93, P77, DOI 10.1111/j.1444-0938.2010.00453.x; ANDERSON DR, 1973, INVEST OPHTH VISUAL, V12, P204; Baskaran M, 2006, OPHTHALMOLOGY, V113, P1327, DOI 10.1016/j.ophtha.2006.02.063; Bertschinger DR, 2007, BRIT J OPHTHALMOL, V91, P1413, DOI 10.1136/bjo.2007.114546; BUCHANAN RA, 1985, AM J OPTOM PHYS OPT, V62, P59; CARLSON KH, 1987, INVEST OPHTH VIS SCI, V28, P1346; Cramer H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075515; de Barros DSM, 2008, OPHTHAL SURG LAS IM, V39, P339; FRIBERG TR, 1985, ARCH OPHTHALMOL-CHIC, V103, P1687; Gallardo MJ, 2006, ADV THER, V23, P921, DOI 10.1007/BF02850214; Gaton DD, 2010, CURR EYE RES, V35, P475, DOI 10.3109/02713681003678824; Hirooka K, 2003, J GLAUCOMA, V12, P379, DOI 10.1097/00061198-200308000-00015; JAIN MR, 1976, BRIT J OPHTHALMOL, V60, P687, DOI 10.1136/bjo.60.10.687; Johannesson G, 2014, ACTA OPHTHALMOL, V92, P111, DOI 10.1111/aos.12058; Kiuchi T, 2006, OPHTHALMOLOGY, V113, P2150, DOI 10.1016/j.ophtha.2006.06.014; KLATZ RM, 1983, J AM OSTEOPATH ASSOC, V82, P853; LEMARR JD, 1984, AM J OPTOM PHYS OPT, V61, P679; LINDER BJ, 1988, INVEST OPHTH VIS SCI, V29, P1492; Mosaed S, 2005, AM J OPHTHALMOL, V139, P320, DOI 10.1016/j.ajo.2004.09.062; Pettinato Y, 2002, SIMPLY YOGA, P22; Prata TS, 2010, SURV OPHTHALMOL, V55, P445, DOI 10.1016/j.survophthal.2009.12.002; Saper RB, 2004, ALTERN THER HEALTH M, V10, P44; Sit AJ, 2008, INVEST OPHTH VIS SCI, V49, P1473, DOI 10.1167/iovs.07-1139; TARKKANEN A, 1967, ACTA OPHTHALMOL, V45, P569; TSUKAHARA S, 1984, BRIT J OPHTHALMOL, V68, P389, DOI 10.1136/bjo.68.6.389; WEBER AK, 1981, ANN OPHTHALMOL, V13, P323; WEINREB RN, 1984, AM J OPHTHALMOL, V98, P784, DOI 10.1016/0002-9394(84)90698-6; Wilensky J T, 1991, Trans Am Ophthalmol Soc, V89, P757	28	39	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144505	10.1371/journal.pone.0144505	http://dx.doi.org/10.1371/journal.pone.0144505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698309	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092600022
J	Snell, N; Kattner, F; Rokers, B; Green, CS				Snell, Nathaniel; Kattner, Florian; Rokers, Bas; Green, C. Shawn			Orientation Transfer in Vernier and Stereoacuity Training	PLOS ONE			English	Article							SPECIFICITY; PRECISION	Human performance on various visual tasks can be improved substantially via training. However, the enhancements are frequently specific to relatively low-level stimulus dimensions. While such specificity has often been thought to be indicative of a low-level neural locus of learning, recent research suggests that these same effects can be accounted for by changes in higher-level areas-in particular in the way higher-level areas read out information from lower-level areas in the service of highly practiced decisions. Here we contrast the degree of orientation transfer seen after training on two different tasks-vernier acuity and stereoacuity. Importantly, while the decision rule that could improve vernier acuity (i.e. a discriminant in the image plane) would not be transferable across orientations, the simplest rule that could be learned to solve the stereoacuity task (i.e. a discriminant in the depth plane) would be insensitive to changes in orientation. Thus, given a read-out hypothesis, more substantial transfer would be expected as a result of stereoacuity than vernier acuity training. To test this prediction, participants were trained (7500 total trials) on either a stereoacuity (N = 9) or vernier acuity (N = 7) task with the stimuli in either a vertical or horizontal configuration (balanced across participants). Following training, transfer to the untrained orientation was assessed. As predicted, evidence for relatively orientation specific learning was observed in vernier trained participants, while no evidence of specificity was observed in stereo trained participants. These results build upon the emerging view that perceptual learning (even very specific learning effects) may reflect changes in inferences made by high-level areas, rather than necessarily fully reflecting changes in the receptive field properties of low-level areas.	[Snell, Nathaniel; Kattner, Florian; Rokers, Bas; Green, C. Shawn] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Snell, Nathaniel] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	University of Wisconsin System; University of Wisconsin Madison; Brown University	Green, CS (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	csgreen2@wisc.edu	Kattner, Florian/H-8671-2019	Kattner, Florian/0000-0003-2124-2829; Snell, Nathaniel/0000-0002-8033-366X; Rokers, Bas/0000-0003-0573-5332				Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Ahissar M, 2009, PHILOS T R SOC B, V364, P285, DOI 10.1098/rstb.2008.0253; BALL K, 1982, SCIENCE, V218, P697, DOI 10.1126/science.7134968; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; FAHLE M, 1995, VISION RES, V35, P3003, DOI 10.1016/0042-6989(95)00044-Z; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Green CS, 2015, J VISION, V15, DOI 10.1167/15.10.5; Jeter PE, 2009, J VISION, V9, DOI 10.1167/9.3.1; Kahnt T, 2011, NEURON, V70, P549, DOI 10.1016/j.neuron.2011.02.054; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kleiner M, 2007, PERCEPTION, V36, P14; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Li S, 2009, NEURON, V62, P441, DOI 10.1016/j.neuron.2009.03.016; MCKEE SP, 1987, J OPT SOC AM A, V4, P1104, DOI 10.1364/JOSAA.4.001104; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; Saffell T, 2003, VISION RES, V43, P1365, DOI 10.1016/S0042-6989(03)00137-8; SAGI D, 1994, CURR OPIN NEUROBIOL, V4, P195, DOI 10.1016/0959-4388(94)90072-8; Sagi D, 2011, VISION RES, V51, P1552, DOI 10.1016/j.visres.2010.10.019; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; WESTHEIMER G, 1990, P ROY SOC B-BIOL SCI, V241, P42, DOI 10.1098/rspb.1990.0063; Xiao LQ, 2008, CURR BIOL, V18, P1922, DOI 10.1016/j.cub.2008.10.030; Zhang E, 2010, P NATL ACAD SCI USA, V107, P15969, DOI 10.1073/pnas.1003547107; Zhang JY, 2010, J NEUROSCI, V30, P12323, DOI 10.1523/JNEUROSCI.0704-10.2010; Zhang T, 2010, VISION RES, V50, P368, DOI 10.1016/j.visres.2009.08.024	27	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145770	10.1371/journal.pone.0145770	http://dx.doi.org/10.1371/journal.pone.0145770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700311	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600132
J	Llewellyn, A; Whittington, C; Stewart, G; Higgins, JPT; Meader, N				Llewellyn, Alexis; Whittington, Craig; Stewart, Gavin; Higgins, Julian P. T.; Meader, Nick			The Use of Bayesian Networks to Assess the Quality of Evidence from Research Synthesis: 2. Inter-Rater Reliability and Comparison with Standard GRADE Assessment	PLOS ONE			English	Article								Background The grades of recommendation, assessment, development and evaluation (GRADE) approach is widely implemented in systematic reviews, health technology assessment and guideline development organisations throughout the world. We have previously reported on the development of the Semi-Automated Quality Assessment Tool (SAQAT), which enables a semi-automated validity assessment based on GRADE criteria. The main advantage to our approach is the potential to improve inter-rater agreement of GRADE assessments particularly when used by less experienced researchers, because such judgements can be complex and challenging to apply without training. This is the first study examining the inter-rater agreement of the SAQAT. Methods We conducted two studies to compare: a) the inter-rater agreement of two researchers using the SAQAT independently on 28 meta-analyses and b) the inter-rater agreement between a researcher using the SAQAT (who had no experience of using GRADE) and an experienced member of the GRADE working group conducting a standard GRADE assessment on 15 meta-analyses. Results There was substantial agreement between independent researchers using the Quality Assessment Tool for all domains (for example, overall GRADE rating: weighted kappa 0.79; 95% CI 0.65 to 0.93). Comparison between the SAQAT and a standard GRADE assessment suggested that inconsistency was parameterised too conservatively by the SAQAT. Therefore the tool was amended. Following amendment we found fair-to-moderate agreement between the standard GRADE assessment and the SAQAT (for example, overall GRADE rating: weighted kappa 0.35; 95% CI 0.09 to 0.87). Conclusions Despite a need for further research, the SAQAT may aid consistent application of GRADE, particularly by less experienced researchers.	[Llewellyn, Alexis; Meader, Nick] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; [Whittington, Craig] UCL, Dept Clin Educ & Hlth Psychol, Ctr Outcomes Res & Effectiveness Res, London, England; [Stewart, Gavin] Newcastle Univ, Sch Agr Food & Rural Dev, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Higgins, Julian P. T.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of York - UK; University of London; University College London; Newcastle University - UK; University of Bristol	Stewart, G (corresponding author), Newcastle Univ, Sch Agr Food & Rural Dev, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	gavin.stewart@newcastle.ac.uk	Higgins, Julian PT/H-4008-2011; Whittington, Craig/B-1380-2008	Higgins, Julian PT/0000-0002-8323-2514; Meader, Nicholas/0000-0001-9332-6605; Whittington, Craig/0000-0002-1950-0334	National Institute for Health Research; Medical Research Council [MR/K025643/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10114] Funding Source: researchfish; MRC [MR/K025643/1] Funding Source: UKRI	National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the National Institute for Health Research.	Archer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006525.pub2; Baumeister H, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008381.pub2; Brozek J, 2008, GRADEPRO; Brozek J, 2011, J CLIN EPIDEMIOL; Cipriani A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006532.pub2; Cleary M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001088.pub2; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Depping AM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008120.pub2; Dieterich M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007906.pub2; Gillies D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007986.pub2; Guyatt GH, 2010, J CLIN EPIDEMIOL; Hartling L, 2012, PLOS ONE, V2012, P7, DOI DOI 10.1371/J0URNAL.P0NE.0034697; Higgins J., 2011, COCHRANE HDB SYST RE; James AC, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004690.pub3, 10.1002/14651858.CD004690.pub4]; Jensen F.V., 2001, BAYESIAN NETWORKS AN; Kisely SR, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004408.pub3; Matar HE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006352.pub2; Meader N, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-82; Mustafa RA, 2013, J CLIN EPIDEMIOL, V66, P736, DOI 10.1016/j.jclinepi.2013.02.004; Pani PP, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002950.pub3; Pourret O, 2008, BAYESIAN NETWORKS A; Rolinski M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006504.pub2; Shrier I, 2011, RES SYNTH METHODS, V2, P223, DOI 10.1002/jrsm.52; Soomro GM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001765.pub3; Stewart GB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114497; Thornton J, 2013, J CLIN EPIDEMIOL, V66, P124, DOI 10.1016/j.jclinepi.2011.12.007; Vernooij-Dassen M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005318.pub2; Williams ACD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007407.pub3	28	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0123511	10.1371/journal.pone.0123511	http://dx.doi.org/10.1371/journal.pone.0123511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716874	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500001
J	Agliari, E; Barra, A; Galluzzi, A; Javarone, MA; Pizzoferrato, A; Tantari, D				Agliari, Elena; Barra, Adriano; Galluzzi, Andrea; Javarone, Marco Alberto; Pizzoferrato, Andrea; Tantari, Daniele			Emerging Heterogeneities in Italian Customs and Comparison with Nearby Countries	PLOS ONE			English	Article							STATISTICAL-MECHANICS; ISING-MODEL; CHOICE	In this work we apply techniques and modus operandi typical of Statistical Mechanics to a large dataset about key social quantifiers and compare the resulting behaviors of five European nations, namely France, Germany, Italy, Spain and Switzerland. The social quantifiers considered are i. the evolution of the number of autochthonous marriages (i.e., between two natives) within a given territorial district and ii. the evolution of the number of mixed marriages (i.e., between a native and an immigrant) within a given territorial district. Our investigations are twofold. From a theoretical perspective, we develop novel techniques, complementary to classical methods (e.g., historical series and logistic regression), in order to detect possible collective features underlying the empirical behaviors; from an experimental perspective, we evidence a clear outline for the evolution of the social quantifiers considered. The comparison between experimental results and theoretical predictions is excellent and allows speculating that France, Italy and Spain display a certain degree of internal heterogeneity, that is not found in Germany and Switzerland; such heterogeneity, quite mild in France and in Spain, is not negligible in Italy and highlights quantitative differences in the habits of Northern and Southern regions. These findings may suggest the persistence of two culturally distinct communities, long-term lasting heritages of different and well-established customs. Also, we find qualitative differences between the evolution of autochthonous and of mixed marriages: for the former imitation in decisional mechanisms seems to play a key role (and this results in a square root relation between the number of autochthonous marriages versus the percentage of possible couples inside that country), while for the latter the emerging behavior can be recovered (in most cases) with elementary models with no interactions, suggesting weak imitation patterns between natives and migrants (and this translates in a linear growth for the number of mixed marriages versus the percentage of possible mixed couples in the country). However, the case of mixed marriages displays a more complex phenomenology, where further details (e.g., the provenance and the status of migrants, linguistic barriers, etc.) should also be accounted for.	[Agliari, Elena] Univ Roma La Sapienza, Dipartimento Matemat, I-00185 Rome, Italy; [Barra, Adriano; Galluzzi, Andrea] Univ Roma La Sapienza, Dipartimento Fis, Rome, Italy; [Javarone, Marco Alberto] Univ Cagliari, Dipartimento Matemat & Informat, Cagliari, Italy; [Javarone, Marco Alberto] Univ Sassari, Dipartimento Sci Umanist & Sociali, I-07100 Sassari, Italy; [Pizzoferrato, Andrea] Univ Warwick, Inst Math, Coventry CV4 7AL, W Midlands, England; [Tantari, Daniele] Scuola Normale Super Pisa, Ctr Ennio De Giorgi, Pisa, Italy	Sapienza University Rome; Sapienza University Rome; University of Cagliari; University of Sassari; University of Warwick; Scuola Normale Superiore di Pisa	Barra, A (corresponding author), Univ Roma La Sapienza, Dipartimento Fis, Rome, Italy.	Adriano.Barra@Roma1.infn.it	Javarone, Marco/AFU-9191-2022; Pizzoferrato, Andrea/AAK-2294-2020	Javarone, Marco/0000-0003-0514-9544; Pizzoferrato, Andrea/0000-0002-7334-0685; TANTARI, DANIELE/0000-0001-9982-5720	INdAM-GNFM (Progetto Giovani Agliari); EPSRC; LIFE group (Laboratories for Information, Food and Energy); Fondazione Banco di Sardegna; Engineering and Physical Sciences Research Council (EPSRC) [EP/L505110/1]; Engineering and Physical Sciences Research Council [1359571] Funding Source: researchfish	INdAM-GNFM (Progetto Giovani Agliari); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); LIFE group (Laboratories for Information, Food and Energy); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	INdAM-GNFM (Progetto Giovani Agliari2014), EPSRC support and Sapienza Universit'a di Roma are acknowledged. AB is grateful to LIFE group (Laboratories for Information, Food and Energy) for partial financial support through programma INNOVA, progetto MATCH. MAJ would like to thank Fondazione Banco di Sardegna for supporting his work. AP acknowledges support by the Engineering and Physical Sciences Research Council (EPSRC), Grant No. EP/L505110/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliari E, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/10002; Agliari E, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/103034; Agliari E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055017; [Anonymous], 2012, STAT YB; Axelrod R., 1997, COMPLEXITY COOPERATI, DOI [10.1515/9781400822300, DOI 10.1515/9781400822300]; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Barra A, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/68001; Barra A, 2008, J STAT PHYS, V132, P787, DOI 10.1007/s10955-008-9567-2; Barra A, 2014, EUR PHYS J B, V87, DOI 10.1140/epjb/e2014-40952-4; Barra A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04174; Barra A, 2012, PHYSICA A, V391, P3017, DOI 10.1016/j.physa.2012.01.007; Barrat A, 2000, EUR PHYS J B, V13, P547, DOI 10.1007/s100510050067; Bialek W, 2012, P NATL ACAD SCI USA, V109, P4786, DOI 10.1073/pnas.1118633109; Bianconi G, 2002, PHYS LETT A, V303, P166, DOI 10.1016/S0375-9601(02)01232-X; Brock W.A., 2001, HDB ECONOMETRICS, V5, P3297, DOI DOI 10.1016/S1573-4412(01)05007-3; Brock WA, 2001, REV ECON STUD, V68, P235, DOI 10.1111/1467-937X.00168; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Cimini G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113470; Cont R, 2003, SOCIAL DISTANCE HETE, V505; Contucci P, ARXIV14100501; Durlauf SN, 1999, P NATL ACAD SCI USA, V96, P10582, DOI 10.1073/pnas.96.19.10582; Ellis RS, 1985, LARGE DEVIATIONS STA; Fedele M, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/6/065001; Feng L, 2012, P NATL ACAD SCI USA, V109, P8388, DOI 10.1073/pnas.1205013109; FSO, 2014, SWITZ POP 2013; GALAM S, 1982, J MATH SOCIOL, V9, P1; Garzarelli F, 2001, SCI REP, V4, P4487; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Granovetter M., 1983, SOCIOLOGICAL THEORY, V1, P201, DOI [10.2307/202051, DOI 10.2307/202051]; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; INSEE, 2014, INSEE DOC TRAV; Istat, 2014, ANN STAT IT 2014; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Kalmijn M, 1998, ANNU REV SOCIOL, V24, P395, DOI 10.1146/annurev.soc.24.1.395; Le Bras H., 2008, NATURE DEMOGRAPHY; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; MCFADDEN D, 1980, J BUS, V53, pS13, DOI 10.1086/296093; Michard Q, 2001, EUROP PHYS J B, V47, P1; Mora T, 2010, P NATL ACAD SCI USA, V107, P5405, DOI 10.1073/pnas.1001705107; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Penninx R., 2008, MIGRATION INTEGRATIO; Sollich P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.238106; Van de Putte B, 2006, WORKING PAPER; Vinkovic D, 2006, P NATL ACAD SCI USA, V103, P19261, DOI 10.1073/pnas.0609371103; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020	47	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144643	10.1371/journal.pone.0144643	http://dx.doi.org/10.1371/journal.pone.0144643			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0IX	26713615	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900014
J	Bouras, G; Burns, EM; Howell, AM; Bottle, A; Athanasiou, T; Darzi, A				Bouras, George; Burns, Elaine Marie; Howell, Ann-Marie; Bottle, Alex; Athanasiou, Thanos; Darzi, Ara			Risk of Post-Discharge Venous Thromboembolism and Associated Mortality in General Surgery: A Population-Based Cohort Study Using Linked Hospital and Primary Care Data in England	PLOS ONE			English	Article							CANCER; IMPACT; COMPLICATIONS; PROPHYLAXIS; DURATION	Background Trends towards day case surgery and enhanced recovery mean that postoperative venous thromboembolism (VTE) may increasingly arise after hospital discharge. However, hospital data alone are unable to capture adverse events that occur outside of the hospital setting. The National Institute for Health and Care Excellence has suggested the use of primary care data to quantify hospital care-related VTE. Data in surgical patients using these resources is lacking. The aim of this study was to measure VTE risk and associated mortality in general surgery using linked primary care and hospital databases, to improve our understanding of harm from VTE that arises beyond hospital stay. Methods This was a longitudinal cohort study using nationally linked primary care (Clinical Practice Research Datalink, CPRD), hospital administrative (Hospital Episodes Statistics, HES), population statistics (Office of National Statistics, ONS) and National Cancer Intelligence Network databases. Routinely collected information was used to quantify 90-day in-hospital VTE, 90-day post-discharge VTE and 90-day mortality in adults undergoing one of twelve general surgical procedures between 1st April 1997 and 31st March 2012. The earliest postoperative recording of deep vein thrombosis or pulmonary embolism in CPRD, HES and ONS was counted in each patient. Covariates from multiple datasets were combined to derive detailed prediction models for VTE and mortality. Limitation included the capture of VTE presenting to healthcare only and the lack of information on adherence to pharmacological thromboprophylaxis as there was no data linkage to hospital pharmacy records. Results There were 981 VTE events captured within 90 days of surgery in 168005 procedures (23.7/1000 patient-years). Overall, primary care data increased the detection of postoperative VTE by a factor of 1.38 (981/710) when compared with using HES and ONS only. Total VTE rates ranged between 3.2/1000 patient-years in haemorrhoidectomy to 118.3/1000 patient-years in esophagogastric resection. Predictors of VTE included emergency surgery (OR = 1.91 95% CI 1.60-2.28, p<0.001), age (OR = 1.02 95% CI 1.02-1.03, p<0.001), body mass index (OR = 1.03 95% CI 1.01-1.04, p<0.001), previous VTE (OR = 8.07 95% CI 6.61-9.83, p<0.001), length of stay (OR = 1.00 95% CI 1.00-1.00, p = 0.007) and cancer stages II (OR = 1.38 95% CI 1.03-1.87, p = 0.033), III (OR = 1.50 95% CI 1.11-2.01, p = 0.008) and IV (OR = 1.63 95% CI 1.03-2.59, p = 0.038). Major organ resections had the greatest odds of VTE when adjusted for other risk factors including length of hospital stay. Post-discharge VTE accounted for 64.8% (636/981) of all recorded VTE. In-hospital VTE (165.4/1000 patient-years) was recorded more frequently than post-discharge VTE (16.2/1000 patient-years). Both in-hospital (OR = 2.07 95% CI 1.51-2.85, p<0.001) and post-discharge (OR = 4.03 95% CI 2.95-5.51, p<0.001) VTE independently predicted 90-day mortality. In patients who died and VTE was recorded on HES or CPRD (n = 56), VTE was one of the causes of death in 37.5% (21/56) of cases. Conclusions A large proportion of postoperative VTE was detected in primary care. Evaluation of linked databases was a useful way of measuring postoperative VTE at population level. These resources identified a significant association between post-discharge VTE and mortality in general surgery.	[Bouras, George; Burns, Elaine Marie; Howell, Ann-Marie; Athanasiou, Thanos; Darzi, Ara] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Surg & Canc, London W2 1NY, England; [Bottle, Alex] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Dept Epidemiol & Publ Hlth, London EC4Y 8EN, England	Imperial College London; Imperial College London	Bouras, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Surg & Canc, Praed St, London W2 1NY, England.	g.bouras@imperial.ac.uk	Burns, Elaine/V-5416-2019		Sowerby Foundation; National Institute for Health Research [NF-SI-0510-10186] Funding Source: researchfish	Sowerby Foundation; National Institute for Health Research(National Institute for Health Research (NIHR))	This project was supported by the Sowerby Foundation.	Agnelli G, 2004, CIRCULATION, V110, P4, DOI 10.1161/01.CIR.0000150639.98514.6c; Bergqvist D, 2002, NEW ENGL J MED, V346, P975, DOI 10.1056/NEJMoa012385; Bottle A., UNDERSTANDING HSMRS; Bouras G, 2014, ANN SURG; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Darzi A., 2008, HIGH QUALITY CARE AL; Dyer J, 2013, ANN ROY COLL SURG, V95, P65, DOI 10.1308/003588413X13511609956219; Eaton SC, 2008, PHARMACOEPIDEMIOL DR, V17; Gangireddy C, 2007, J VASC SURG, V45, P335, DOI 10.1016/j.jvs.2006.10.034; Huerta C, 2007, ARCH INTERN MED, V167, P935, DOI 10.1001/archinte.167.9.935; Jameson SS, 2010, J BONE JOINT SURG BR, V92B, P123, DOI 10.1302/0301-620X.92B1.22751; Kazaure HS, 2012, ARCH SURG-CHICAGO, V147, P1000, DOI 10.1001/2013.jamasurg.114; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Lester W, 2013, HEART, V99, P1734, DOI 10.1136/heartjnl-2013-304479; LOWE GDO, 1992, BMJ-BRIT MED J, V305, P567; Majeed Azeem, 2004, Health Stat Q, P5; Merkow RP, 2013, CANCER-AM CANCER SOC, V119, P1412, DOI 10.1002/cncr.27891; Merkow RP, 2011, ANN SURG, V254, P131, DOI 10.1097/SLA.0b013e31821b98da; Muntz J, 2010, AM J SURG, V200, P413, DOI 10.1016/j.amjsurg.2009.05.045; National Institute for Health and Care Excellence, 2010, VEN THROMB DEEP VEIN, V92; Pannucci CJ, 2012, ANN SURG, V255, P1093, DOI 10.1097/SLA.0b013e3182519ccf; Raftery J, 2005, HEALTH TECHNOL ASSES, V9, pIII; Reinke CE, 2012, SURGERY, V152, P186, DOI 10.1016/j.surg.2012.05.003; Seaman HE, 2007, BJU INT, V99, P1398, DOI 10.1111/j.1464-410X.2007.06859.x; Sobin L, 2009, TNM CLASSIFICATION M; Sultan AA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6099; Sutton PA, 2012, ANN ROY COLL SURG, V94, P481, DOI 10.1308/003588412X13171221592096; Sweetland S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4583; Tsang C, 2013, BRIT J GEN PRACT, V63, pE534, DOI 10.3399/bjgp13X670660; Vinogradova Y, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004499; Walker AJ, 2014, J THROMB HAEMOST, V12, P641, DOI 10.1111/jth.12533; Walker AJ, 2013, EUR J CANCER, V49, P1404, DOI 10.1016/j.ejca.2012.10.021; White RH, 2003, THROMB HAEMOSTASIS, V90, P446, DOI 10.1160/TH03-03-0152	34	30	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145759	10.1371/journal.pone.0145759	http://dx.doi.org/10.1371/journal.pone.0145759			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713434	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900077
J	Feng, XW; Zhang, N; Zheng, XG; Pan, DJ				Feng, Xiaowei; Zhang, Nong; Zheng, Xigui; Pan, Dongjiang			Strength Restoration of Cracked Sandstone and Coal under a Uniaxial Compression Test and Correlated Damage Source Location Based on Acoustic Emissions	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; BRITTLE-FRACTURE; ROCK; STRESS; PROPAGATION; VELOCITY; CONCRETE; BEHAVIOR; FAILURE; ENERGY	Underground rock masses have shown a general trend of natural balance over billions of years of ground movement. Nonetheless, man-made underground constructions disturb this balance and cause rock stability failure. Fractured rock masses are frequently encountered in underground constructions, and this study aims to restore the strength of rock masses that have experienced considerable fracturing under uniaxial compression. Coal and sandstone from a deep-buried coal mine were chosen as experimental subjects; they were crushed by uniaxial compression and then carefully restored by a chemical adhesive called MEYCO 364 with an innovative self-made device. Finally, the restored specimens were crushed once again by uniaxial compression. Axial stress, axial strain, circumferential strain, and volumetric strain data for the entire process were fully captured and are discussed here. An acoustic emission (AE) testing system was adopted to cooperate with the uniaxial compression system to provide better definitions for crack closure thresholds, crack initiation thresholds, crack damage thresholds, and three-dimensional damage source locations in intact and restored specimens. Several remarkable findings were obtained. The restoration effects of coal are considerably better than those of sandstone because the strength recovery coefficient of the former is 1.20, whereas that of the latter is 0.33, which indicates that MEYCO 364 is particularly valid for fractured rocks whose initial intact peak stress is less than that of MEYCO 364. Secondary cracked traces of restored sandstone almost follow the cracked traces of the initial intact sandstone, and the final failure is mainly caused by decoupling between the adhesive and the rock mass. However, cracked traces of restored coal only partially follow the traces of intact coal, with the final failure of the restored coal being caused by both bonding interface decoupling and self-breakage in coal. Three-dimensional damage source locations manifest such that AE events are highly correlated with a strength recovery coefficient; the AE events show a decreasing tendency when the coefficient is larger than 1, and vice versa. This study provides a feasible scheme for the reinforcement of fractured rock masses in underground constructions and reveals an internal mechanism of the crushing process for restored rock masses, which has certain instructive significance.	[Feng, Xiaowei; Zhang, Nong; Zheng, Xigui; Pan, Dongjiang] China Univ Min & Technol, Sch Mines, Key Lab Deep Coal Resource Min, Minist Educ, Xuzhou, Peoples R China	China University of Mining & Technology	Zhang, N (corresponding author), China Univ Min & Technol, Sch Mines, Key Lab Deep Coal Resource Min, Minist Educ, Xuzhou, Peoples R China.	zhangnong@126.com	Feng, Xiaowei/P-8126-2019; Pan, Dongjiang/ABD-4747-2021; Feng, Xiaowei/E-7039-2015	Pan, Dongjiang/0000-0003-4308-1210; Feng, Xiaowei/0000-0002-9348-9874; Zhang, Nong/0000-0001-6961-0729	Fundamental Research Funds for the Central Universities [2014XT01]; National Natural Science Foundation of China [51274193]; Program for Changjiang Scholars and Innovative Research Team in University [IRT_14R55]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by The Fundamental Research Funds for the Central Universities (NO. 2014XT01), received by NZ, the role of this funding is to provide financial support for our research in this manuscript, it also has data collection and analysis function. This work was also supported by the National Natural Science Foundation of China (51274193), received by NZ, the role of this funding is to provide financial support for possible publishing fees concerning the research, and it had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Lastly it was supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT_14R55), received by NZ, this funder provides supporting money for all members who joining the research, like transportation fees, accommodation fees, service fees, and the like, this funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge financial support for this project from the Fundamental Research Funds for the Central Universities (NO. 2014XT01), Project 51274193 supported by National Natural Science Foundation of China, and the Program for Changjiang Scholars and Innovative Research Team in University (IRT_14R55). We also appreciate the assistance and suggestions of Yuxin Zhao, an engineer from the BASF HOCK Mining Chemical Company Ltd. (China), Wanxin Song, a lab assistant from State Key Laboratory of Coal Resources and Safe Mining in China University of Mining and Technology, and Xianyang Yu from the Jiangsu Transportation Institute.	Abioye AV, 2015, INT J MIN SCI TECHNO, V25, P205, DOI 10.1016/j.ijmst.2015.02.007; Backblom G, 1999, TUNN UNDERGR SP TECH, V14, P377, DOI 10.1016/S0886-7798(99)00053-X; Bhasin R, 2002, NORTH AMERICAN TUNNELING 2002, P257; Bieniawski Z.T., 1967, INT J ROCK MECH MIN, V4, P425, DOI [DOI 10.1016/0148-9062(67)90032-0, DOI 10.1016/0148-9062(67)90030-7]; BRIDGMAN PW, 1949, J APPL PHYS, V20, P1241, DOI 10.1063/1.1698316; Cai W, 2014, J APPL GEOPHYS, V109, P140, DOI 10.1016/j.jappgeo.2014.07.021; Eberhardt E, 1998, CAN GEOTECH J, V35, P222, DOI 10.1139/cgj-35-2-222; Fairhurst CE, 1999, INT J ROCK MECH MIN, V36, P281; GERMANOVICH LN, 1994, PURE APPL GEOPHYS, V143, P117, DOI 10.1007/BF00874326; Goel RK, 2014, INT J MIN SCI TECHNO, V24, P783, DOI 10.1016/j.ijmst.2014.10.008; Griffith A.A., 1924, P 1 INT C APPL MECH, P55; HOEK E, 1965, INT J FRACT MECH, V1, P137; Huang BX, 2013, INT J ROCK MECH MIN, V61, P23, DOI 10.1016/j.ijrmms.2013.02.002; Kim JS, 2015, ROCK MECH ROCK ENG, V48, P495, DOI 10.1007/s00603-014-0590-0; Lau J, 1992, UNIAXIAL TRIAXIAL CO; Li LP, 2009, ROCK SOIL MECH, V30, P3642; Liu CY, 2015, MINE WATER ENVIRON, V34, P87, DOI 10.1007/s10230-014-0314-4; LOCKNER DA, 1991, NATURE, V350, P39, DOI 10.1038/350039a0; MARTIN CD, 1994, INT J ROCK MECH MIN, V31, P643, DOI 10.1016/0148-9062(94)90005-1; Michlmayr G, 2012, EARTH-SCI REV, V112, P97, DOI 10.1016/j.earscirev.2012.02.009; Paterson M.S., 2005, EXPT ROCK DEFORMATIO; Peng SS, 2015, INT J MIN SCI TECHNO, V25, P1, DOI 10.1016/j.ijmst.2014.12.006; Ranjith PG, 2008, MECH MATER, V40, P453, DOI 10.1016/j.mechmat.2007.11.002; Siren T, 2015, INT J ROCK MECH MIN, V73, P165, DOI 10.1016/j.ijrmms.2014.11.001; Su HZ, 2012, ULTRASONICS, V52, P890, DOI 10.1016/j.ultras.2012.02.011; Vilhelm J, 2008, INT J ROCK MECH MIN, V45, P1068, DOI 10.1016/j.ijrmms.2007.11.004; Villaescusa E, 2004, GROUND SUPPORT MININ; Wang CL, 2014, INT J ROCK MECH MIN, V71, P171, DOI 10.1016/j.ijrmms.2014.06.009; Wang HC, 2015, J APPL GEOPHYS, V117, P111, DOI 10.1016/j.jappgeo.2015.04.002; Wang SH, 2013, GEOTECH TEST J, V36, P903, DOI 10.1520/GTJ20120086; [王银梅 Wang Yinmei], 2005, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V24, P2554; Wasantha PLP, 2014, ULTRASONICS, V54, P217, DOI 10.1016/j.ultras.2013.06.015; Yan CL, 2015, ARAB J GEOSCI, V8, P2467, DOI 10.1007/s12517-014-1373-3; [于少峰 Yu Shaofeng], 2014, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V33, P2396; Zhao XG, 2013, INT J ROCK MECH MIN, V64, P258, DOI 10.1016/j.ijrmms.2013.09.003; [赵兴东 ZHAO Xingdong], 2008, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V27, P990; Zheng XG, 2015, ARAB J GEOSCI, V8, P6709, DOI 10.1007/s12517-014-1697-z; Zolfaghari A, 2015, INT J ROCK MECH MIN, V74, P38, DOI 10.1016/j.ijrmms.2014.12.004; Zong YJ, 2014, INT J MIN SCI TECHNO, V24, P165, DOI 10.1016/j.ijmst.2014.01.004	39	15	15	1	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145757	10.1371/journal.pone.0145757	http://dx.doi.org/10.1371/journal.pone.0145757			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714324	Green Submitted, gold, Green Published			2022-12-27	WOS:000367481900076
J	Pialoux, G; Marcelin, AG; Despiegel, N; Espinas, C; Cawston, H; Finkielsztejn, L; Laurisse, A; Aubin, C				Pialoux, Gilles; Marcelin, Anne-Genevieve; Despiegel, Nicolas; Espinas, Caroline; Cawston, Helene; Finkielsztejn, Laurent; Laurisse, Audrey; Aubin, Celine			Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Experienced (TE) Patients in France	PLOS ONE			English	Article							OPTIMIZED BACKGROUND THERAPY; ANTIRETROVIRAL-NAIVE ADULTS; ONCE-DAILY DOLUTEGRAVIR; DOUBLE-BLIND; RALTEGRAVIR; MARAVIROC; EFFICACY; SAFETY	Objectives To evaluate the cost-effectiveness of a new generation integrase inhibitor (INI), dolutegravir (DTG), in France, in treatment-experienced (TE) and INI-naive HIV-infected adults with at least two classes resistance compared to raltegravir (RAL), by adapting previously published Anti-Retroviral Analysis by Monte Carlo Individual Simulation (ARAMIS) model. Methods ARAMIS is a microsimulation Markov model with a lifetime time horizon and a monthly cycle length. Health states are defined as with or without opportunistic infection and death. In the initial cohort, efficacy and safety data were derived from a phase III study comparing DTG to RAL. Antiretroviral treatment algorithms, accounting for patient history, were based on French guidelines and experts opinion. Costs are mainly including treatment costs, routine HIV and opportunistic infection care, and death. Utilities depend on CD4+ cell count and the occurrence of opportunistic infections. Results The ARAMIS model indicates in the TE population that DTG compared to RAL over a life time is associated with 0.35 additional quality-adjusted life years (QALY; 10.75 versus 10.41) and additional costs of (sic)7,266 ((sic)390,001 versus (sic)382,735). DTG increased costs are mainly related to a 9.1-month increase in life expectancy for DTG compared with RAL, and consequently a longer time spent on ART. The incremental cost-effectiveness ratio (ICER) for DTG compared with RAL is (sic)21,048 per QALY gained. About 83% and 14% of total lifetime costs are associated with antiretroviral therapy and routine HIV care respectively. Univariate deterministic sensitivity analyses demonstrate the robustness of the model. Conclusion DTG is cost-effective in the management of TE INI naive patients in France, from a collective perspective. These results could be explained by the superior efficacy of DTG in this population and its higher genetic barrier to resistance compared to RAL. These data need to be confirmed with longer-term real life data.	[Pialoux, Gilles] Hop Tenon, AP HP, Serv Malad Infect & Trop, F-75970 Paris, France; [Marcelin, Anne-Genevieve] Univ Paris 06, INSERM, Sorbonne Univ, Hop Pitie Salpetriere,AP HP,Serv Virol,UMR S 1136, Paris, France; [Despiegel, Nicolas; Espinas, Caroline] Optum, Paris, France; [Cawston, Helene] Mapi Grp, Paris, France; [Finkielsztejn, Laurent; Laurisse, Audrey] ViiV, Marly Le Roi, France; [Aubin, Celine] GSK, Marly Le Roi, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; GlaxoSmithKline	Cawston, H (corresponding author), Mapi Grp, Paris, France.	hcawston@mapigroup.com	Marcelin, Anne-Genevieve/D-8272-2014	Marcelin, Anne-Genevieve/0000-0003-4808-8999	ViiV; GSK; Mapi Group; ViiV Healthcare	ViiV; GSK(GlaxoSmithKline); Mapi Group; ViiV Healthcare	The authors confirm that this study was funded by ViiV. Authors LF and AL are employed by Viiv. Author CA is employed by GSK. Authors ND and CE were employed by Optum (now Mapi Group) during the course of the study and author HC is employed by Mapi Group. Viiv, GSK and Mapi Group (formerly Optum) provided support in the form of salaries for authors LF, AL, CA, ND, CE and HC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The study was sponsored and funded by ViiV Healthcare.	[Anonymous], 2014, REMBOURSEMENT CONSUL; [Anonymous], 2013, BAS DONN BDM IND PRI; [Anonymous], 2012, TARIFS CONVENTIONNEL; [Anonymous], 2011, TARIFS CONVENTIONNEL; [Anonymous], 2014, BIOL MED NOMENCLATUR; [Anonymous], 2013, DOLUTEGRAVIR 50MG CO; [Anonymous], 2015, BASE MEDICAMENTS INF; [Anonymous], 2015, PHARM GUID WORLD INT; Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0; Chaudhary MA, 2011, EXPERT REV PHARM OUT, V11, P627, DOI [10.1586/erp.11.79, 10.1586/ERP.11.79]; Clotet B, 2014, LANCET, V383, P2222, DOI 10.1016/S0140-6736(14)60084-2; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; Costagliola D, 2012, LANCET INFECT DIS, V12, P119, DOI 10.1016/S1473-3099(11)70248-1; Despiegel N, ASSESSMENT REAL LIFE; Eron JJ, 2012, 19 INT AIDS C; European Medicines Agency ( EMA), 2013, EPAR SUMM PUBL TIV; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Hardy WD, 2010, JAIDS-J ACQ IMM DEF, V55, P558, DOI 10.1097/QAI.0b013e3181ee3d82; Haute Autorite de Sante, 2012, METH GUID CHOIC METH; Kauf TL, 2008, VALUE HEALTH, V11, P1144, DOI 10.1111/j.1524-4733.2008.00326.x; Kuhne FC, 2010, HIV CLIN TRIALS, V11, P80, DOI 10.1310/hct1102-80; Lohse N, 2007, J ANTIMICROB CHEMOTH, V60, P461, DOI 10.1093/jac/dkm241; Magoni M, 2011, HIV MED, V12, P129, DOI 10.1111/j.1468-1293.2010.00861.x; Mauskopf J, 2012, AIDS, V26, P355, DOI 10.1097/QAD.0b013e32834e87e6; Monforte AD, 2005, ARCH INTERN MED, V165, P416; Morlat P., PRISE CHARGE MED PER; Morlat P., 2013, PRISE CHARGE MED PER; Nelson M, 2005, JAIDS-J ACQ IMM DEF, V40, P404, DOI 10.1097/01.qai.0000185314.56556.c3; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paltiel AD, 1998, MED DECIS MAKING, V18, pS93, DOI 10.1177/0272989X9801800211; Raffi F, 2013, LANCET, V12; Raffi F, 2013, LANCET INFECT DIS, V13, P927, DOI 10.1016/S1473-3099(13)70257-3; Reekie J, 2011, HIV MED, V12, P259, DOI 10.1111/j.1468-1293.2010.00877.x; Schapiro JM, 2011, ANTIVIR THER, V16, P395, DOI 10.3851/IMP1759; Sloan CE, 2012, AIDS, V26, P45, DOI 10.1097/QAD.0b013e32834dce6e; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Steigbigel RT, 2010, CLIN INFECT DIS, V50, P605, DOI 10.1086/650002; van Sighem A, 2010, AIDS, V24, P1527, DOI 10.1097/QAD.0b013e32833a3946; Walmsley S, 2012, 52 INT C ANT AG CHEM	39	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145885	10.1371/journal.pone.0145885	http://dx.doi.org/10.1371/journal.pone.0145885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714188	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900098
J	Garcia-Escudero, JB; Trillos, PMH				Baselga Garcia-Escudero, Jaime; Hernandez Trillos, Pedro Miguel			Treatment of Osteoarthritis of the Knee with a Combination of Autologous Conditioned Serum and Physiotherapy: A Two-Year Observational Study	PLOS ONE			English	Article							MUSCLE INJURIES; ARTHROSCOPY; MANAGEMENT; PLACEBO	Background Autologous conditioned serum (ACS) is an autologous blood product that has shown efficacy against knee osteoarthritis (OA) in randomized controlled trials. However, there are few reports of its effectiveness in everyday practice. Here, we report clinical efficacy results from a two-year prospective observational study of patients with highly symptomatic knee OA who received ACS in conjunction with physiotherapy. Methods 118 patients with unilateral knee OA (Kellgren-Lawrence grades I-IV), who were candidates for surgery but instead chose conservative treatment, were treated with a combination of four intra-articular injections of ACS (2 mL each) once weekly over four weeks and subsequent physiotherapy applied 4 weeks after ACS injection. Main endpoints of the study were pain (Numeric Rating Scale [NRS]) assessed at 0, 3, 6, 12 and 24 months, and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) global score, assessed at 0 and 24 months. The effect size (Cohen's d) was calculated for pain and WOMAC outcomes, with effect sizes >0.8 considered large. Results By 3 months, there were significant improvements in pain (NRS) from baseline (-63.0%, p<0.001), which were maintained over 24 months. Mean WOMAC global score was reduced at 24 months compared to baseline (-56.9%, p<0.001), as were WOMAC sub-scores of pain (-86.0%, p<0.001) and function (-51.3%, p<0.001). Effect sizes for pain (>5) and WOMAC improvement (8.0-13.6) were very large. Only one patient received total knee joint replacement during the study. Clinical improvement did not correlate with gender, age, Kellgren-Lawrence grade, or body mass index. Conclusions Treatment with ACS and physiotherapy produced a rapid decline in pain, which was sustained for the entire two years of the study. This was accompanied by a large improvement in WOMAC scores at two years. These results confirm that ACS combined with physiotherapy is an effective treatment for OA of the knee.	[Baselga Garcia-Escudero, Jaime; Hernandez Trillos, Pedro Miguel] Hosp Ruber Int, Madrid, Spain		Garcia-Escudero, JB (corresponding author), Hosp Ruber Int, Madrid, Spain.	jbaselga@ruberinternacional.es			Orthogen	Orthogen	Costello Medical Consulting, UK, provided editorial assistance with this manuscript, which was funded by Orthogen (http://www.orthogen.ch/en/index.htm). Orthogen funded the statistical analysis for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Professor Christopher Evans for his critical review of this manuscript and Professor Sinclair Cleveland for carrying out the statistical analyses. We also acknowledge Costello Medical Consulting, UK, for editorial assistance with this manuscript, which was funded by Orthogen.	[Anonymous], 2013, TREATM OST KNEE; Baltzer AWA, 2009, OSTEOARTHR CARTILAGE, V17, P152, DOI 10.1016/j.joca.2008.06.014; Baltzer AW, 2013, ORTHOP REV, V5; Bellamy N, 2009, COCHRANE LIB; Bellamy N, 2008, COCHRANE DB SYST REV, P1; Campbell J, 2007, OSTEOARTHR CARTILAGE, V15, P1424, DOI 10.1016/j.joca.2007.01.022; Darabos N, 2014, KNEE SURG SPORT TR A, V24, P1; Darabos N, 2011, KNEE SURG SPORT TR A, V19, pS36, DOI 10.1007/s00167-011-1458-4; Dold AP, 2014, CLIN J SPORT MED, V24, P31, DOI 10.1097/01.jsm.0000432855.85143.e5; Evans CH, 2014, NAT REV RHEUMATOL, V10, P11, DOI 10.1038/nrrheum.2013.159; Felson DT, 2010, BEST PRACT RES CL RH, V24, P47, DOI 10.1016/j.berh.2009.08.002; Frisbie DD, 2007, AM J VET RES, V68, P290, DOI 10.2460/ajvr.68.3.290; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Goldring MB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2592; Karlsson J, 2002, RHEUMATOLOGY, V41, P1240, DOI 10.1093/rheumatology/41.11.1240; Katz JN, 2014, BEST PRACT RES CL RH, V28, P143, DOI 10.1016/j.berh.2014.01.008; Majewski M, 2009, AM J SPORT MED, V37, P2117, DOI 10.1177/0363546509348047; McConnell S, 2001, ARTHRIT RHEUM-ARTHR, V45, P453, DOI 10.1002/1529-0131(200110)45:5<453::AID-ART365>3.0.CO;2-W; Moraes VY, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010071.pub3; Rutjes AWS, 2012, ANN INTERN MED, V157, P180, DOI 10.7326/0003-4819-157-3-201208070-00473; Thorlund JB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2747; Wehling P, 2007, BIODRUGS, V21, P323, DOI 10.2165/00063030-200721050-00004; Wernecke C, 2015, J SPORTS MED, V3; Wright-Carpenter T, 2004, INT J SPORTS MED, V25, P582, DOI 10.1055/s-2004-821303; Wright-Carpenter T, 2004, INT J SPORTS MED, V25, P588, DOI 10.1055/s-2004-821304; Yang KGA, 2008, OSTEOARTHR CARTILAGE, V16, P498, DOI 10.1016/j.joca.2007.07.008	26	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145551	10.1371/journal.pone.0145551	http://dx.doi.org/10.1371/journal.pone.0145551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709697	Green Submitted, gold, Green Published			2022-12-27	WOS:000367451400062
J	Cui, YN; Ling, Y; Zhou, JH; Li, XJ				Cui, Yaning; Ling, Yu; Zhou, Junhui; Li, Xiaojuan			Interference of the Histone Deacetylase Inhibits Pollen Germination and Pollen Tube Growth in Picea wilsonii Mast	PLOS ONE			English	Article							CELL-WALL CONSTRUCTION; ACTIN-FILAMENTS; CYTOSOLIC CALCIUM; PINUS-BUNGEANA; TIP GROWTH; ARABIDOPSIS; ACETYLATION; CYTOSKELETON; EXPRESSION; RPD3	Histone deacetylase (HDAC) is a crucial component in the regulation of gene expression in various cellular processes in animal and plant cells. HDAC has been reported to play a role in embryogenesis. However, the effect of HDAC on androgamete development remains unclear, especially in gymnosperms. In this study, we used the HDAC inhibitors trichostatin A (TSA) and sodium butyrate (NaB) to examine the role of HDAC in Picea wilsonii pollen germination and pollen tube elongation. Measurements of the tip-focused Ca2+ gradient revealed that TSA and NaB influenced this gradient. Immunofluorescence showed that actin filaments were disrupted into disorganized fragments. As a result, the vesicle trafficking was disturbed, as determined by FM4-64 labeling. Moreover, the distribution of pectins and callose in cell walls was significantly altered in response to TSA and NaB. Our results suggest that HDAC affects pollen germination and polarized pollen tube growth in Picea wilsonii by affecting the intracellular Ca2+ concentration gradient, actin organization patterns, vesicle trafficking, as well as the deposition and configuration of cell wall components.	[Cui, Yaning; Ling, Yu; Zhou, Junhui; Li, Xiaojuan] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China; [Cui, Yaning; Ling, Yu; Zhou, Junhui; Li, Xiaojuan] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Li, XJ (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China.	lixj@bjfu.edu.cn			Fundamental Research Funds for the Central Universities [BLX2012039]; National Natural Science Foundation of China [31370212]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for the Central Universities (BLX2012039) and the National Natural Science Foundation of China (31370212).; This work was supported by the Fundamental Research Funds for the Central Universities (BLX2012039) and the National Natural Science Foundation of China (31370212). We thank Mr. Kai Song (Key Laboratory of Plant Resources, Institute of Botany, Chinese Academy of Sciences) for supplying the pollen. We also thank Meiqin Liu (Beijing Forest University) for her assistance with confocal laser scanning microscopy.	Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; Bhuja P, 2004, PLANT CELL PHYSIOL, V45, P543, DOI 10.1093/pcp/pch068; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Chen T, 2007, PLANT CELL PHYSIOL, V48, P19, DOI 10.1093/pcp/pcl036; Franklin-Tong VE, 1999, PLANT CELL, V11, P727, DOI 10.1105/tpc.11.4.727; Fu Y, 2010, J INTEGR PLANT BIOL, V52, P131, DOI 10.1111/j.1744-7909.2010.00922.x; Hao HQ, 2005, NEW PHYTOL, V165, P721, DOI 10.1111/j.1469-8137.2004.01290.x; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Nguyen HN, 2013, PLANT CELL REP, V32, P1625, DOI 10.1007/s00299-013-1474-6; HoldawayClarke TL, 1997, PLANT CELL, V9, P1999, DOI 10.1105/tpc.9.11.1999; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Justus CD, 2004, PLANTA, V219, P103, DOI 10.1007/s00425-003-1193-2; Kadosh D, 1998, GENE DEV, V12, P797, DOI 10.1101/gad.12.6.797; Krichevsky A, 2009, J MOL BIOL, V385, P45, DOI 10.1016/j.jmb.2008.09.040; Kuo MH, 2000, MOL CELL, V6, P1309, DOI 10.1016/S1097-2765(00)00129-5; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Li H, 2014, PLANT CELL, V26, P195, DOI 10.1105/tpc.113.116491; Ling Y, 2013, PLANTA, V238, P831, DOI 10.1007/s00425-013-1938-5; Lovy-Wheeler A, 2005, PLANTA, V221, P95, DOI 10.1007/s00425-004-1423-2; Marton ML, 2012, CURR BIOL, V22, P1194, DOI 10.1016/j.cub.2012.04.061; Michard E, 2009, INT J DEV BIOL, V53, P1609, DOI 10.1387/ijdb.072296em; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Munster PN, 2011, BRIT J CANCER, V104, P1828, DOI 10.1038/bjc.2011.156; Myers C, 2009, PLANT J, V59, P528, DOI 10.1111/j.1365-313X.2009.03894.x; Ou GS, 2002, PROTOPLASMA, V219, P168, DOI 10.1007/s007090200018; Parton RM, 2001, J CELL SCI, V114, P2685; Serrador JM, 2004, IMMUNITY, V20, P417, DOI 10.1016/S1074-7613(04)00078-0; Shi SQ, 2010, PLANT CELL ENVIRON, V33, P149, DOI 10.1111/j.1365-3040.2009.02065.x; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Suka N, 1998, COLD SPRING HARB SYM, V63, P391, DOI 10.1101/sqb.1998.63.391; Tian L, 2003, GENETICS, V165, P399; Tsuji H, 2006, PLANT CELL PHYSIOL, V47, P995, DOI 10.1093/pcp/pcj072; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Wang YH, 2009, NEW PHYTOL, V182, P851, DOI 10.1111/j.1469-8137.2009.02820.x; Wu KQ, 2000, PLANT MOL BIOL, V44, P167, DOI 10.1023/A:1006498413543; Xu CR, 2005, P NATL ACAD SCI USA, V102, P14469, DOI 10.1073/pnas.0503143102; Zhang WH, 1998, PLANT J, V15, P147, DOI 10.1046/j.1365-313X.1998.00188.x; Zhou CH, 2005, PLANT CELL, V17, P1196, DOI 10.1105/tpc.104.028514	42	6	8	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145661	10.1371/journal.pone.0145661	http://dx.doi.org/10.1371/journal.pone.0145661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710276	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400068
J	Dhanasekar, C; Kalaiselvan, S; Rasool, M				Dhanasekar, Chitra; Kalaiselvan, Sowmiya; Rasool, Mahaboobkhan			Morin, a Bioflavonoid Suppresses Monosodium Urate Crystal-Induced Inflammatory Immune Response in RAW 264.7 Macrophages through the Inhibition of Inflammatory Mediators, Intracellular ROS Levels and NF-kappa B Activation	PLOS ONE			English	Article							ACUTE GOUTY-ARTHRITIS; COLORIMETRIC ASSAY; NITRIC-OXIDE; IN-VITRO; CELLS; ACID; PHOSPHORYLATION; CHONDROCYTES; CYTOKINES; EFFICACY	Our previous studies had reported that morin, a bioflavanoid exhibited potent anti-inflammatory effect against adjuvant-induced arthritic rats. In this current study, we investigated the anti-inflammatory mechanism of morin against monosodium urate crystal (MSU)-induced inflammation in RAW 264.7 macrophage cells, an in vitro model for acute gouty arthritis. For comparison purpose, colchicine was used as a reference drug. We have observed that morin (100-300 mu M) treatment significantly suppressed the levels of inflammatory cytokines (TNF-alpha, IL-1 beta, IL-6, MCP-1 and VEGF), inflammatory mediators (NO and PEG(2)), and lysosomal enzymes (acid phosphatase, beta-galactosidase, N-acetyl glucosamindase and cathepsin D) in MSU-crystals stimulated macrophage cells. The mRNA expression of pro-inflammatory cytokines (TNF-alpha, IL-1 beta, IL-6, and MCP-1), inflammatory enzymes (iNOS and COX-2), and NF-kappa Bp65 was found downregulated in MSU crystal stimulated macrophage cells by morin treatment, however, the mRNA expression of hypoxanthine phospho ribosyl transferse (HPRT) was found to be increased. The flow cytometry analysis revealed that morin treatment decreased intracellular reactive oxygen species levels in MSU crystal stimulated macrophage cells. The western blot analysis clearly showed that morin mainly exerts its anti-inflammatory effects by inhibiting the MSU crystal-induced COX-2 and TNF-alpha protein expression through the inactivation of NF-kappa B signaling pathway in RAW264.7 macrophage cells similar to that of BAY 11-7082 (I kappa B kinase inhibitor). Our results collectively suggest that morin can be a potential therapeutic agent for inflammatory disorders like acute gouty arthritis.	[Dhanasekar, Chitra; Kalaiselvan, Sowmiya; Rasool, Mahaboobkhan] VIT Univ, Sch Biosci & Technol, Immunopathol Lab, Vellore 632014, Tamil Nadu, India	Vellore Institute of Technology	Rasool, M (corresponding author), VIT Univ, Sch Biosci & Technol, Immunopathol Lab, Vellore 632014, Tamil Nadu, India.	mkr474@gmail.com		Rasool, Mahaboobkhan/0000-0003-4980-5355; , DR. D. Chitra/0000-0002-2125-1082				Bartosikova L, 2003, ACTA VET BRNO, V72, P191, DOI 10.2754/avb200372020191; Chen LY, 2013, J ETHNOPHARMACOL, V150, P545, DOI 10.1016/j.jep.2013.08.063; Chen WP, 2012, INT IMMUNOPHARMACOL, V12, P447, DOI 10.1016/j.intimp.2011.12.024; Chen YC, 2006, CLIN CHIM ACTA, V369, P89, DOI 10.1016/j.cca.2006.01.018; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ETHERINGTON DJ, 1972, BIOCHEM J, V127, P685, DOI 10.1042/bj1270685; Ghaemi-Oskouie F, 2011, CURR RHEUMATOL REP, V13, P160, DOI 10.1007/s11926-011-0162-1; Jin HM, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4531; Kempuraj D, 2005, BRIT J PHARMACOL, V145, P934, DOI 10.1038/sj.bjp.0706246; Kim JM, 2010, FREE RADICAL RES, V44, P454, DOI 10.3109/10715761003610737; King J., 1965, PRACTICAL CLIN ENZYM, P83; Kodithuwakku ND, 2013, J ETHNOPHARMACOL, V150, P1071, DOI 10.1016/j.jep.2013.10.016; Kuo HM, 2007, ANTICANCER RES, V27, P395; Liu R, 2004, ARTHRITIS RHEUM, V50, P247, DOI 10.1002/art.11486; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKLUND S, 1974, European Journal of Biochemistry, V47, P469, DOI 10.1111/j.1432-1033.1974.tb03714.x; Martin WJ, 2009, ARTHRITIS RHEUM-US, V60, P281, DOI 10.1002/art.24185; MARUHN D, 1976, CLIN CHIM ACTA, V73, P453, DOI 10.1016/0009-8981(76)90147-9; Murunikkara V, 2014, CELL BIOCHEM FUNCT, V32, P106, DOI 10.1002/cbf.2979; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ottaviani S, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4303; Pope RM, 2007, ARTHRITIS RHEUM-US, V56, P3183, DOI 10.1002/art.22938; Rahim SS, 2005, IMMUNOLOGY, V114, P313, DOI 10.1111/j.1365-2567.2005.02107.x; RATTY AK, 1988, BIOCHEM PHARMACOL, V37, P989, DOI 10.1016/0006-2952(88)90499-6; ROSENBLI.PD, 1974, P SOC EXP BIOL MED, V145, P244; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Ru LB, 2005, ARTHRITIS RHEUM-US, V52, P2936, DOI 10.1002/art.21238; Sabina Evan Prince, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P128, DOI 10.1016/S2221-1691(11)60206-2; Sabina EP, 2011, INFLAMMATION, V34, P184, DOI 10.1007/s10753-010-9222-3; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Sultana F, 2015, CHEM-BIOL INTERACT, V230, P58, DOI 10.1016/j.cbi.2015.02.007; Vanltallie TB, 2010, METABOLISM, V59, pS32, DOI 10.1016/j.metabol.2010.07.009; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Yu ZF, 2007, DRUG METAB DISPOS, V35, P981, DOI 10.1124/dmd.106.012187; Zhang R, 2009, CHEM-BIOL INTERACT, V177, P21, DOI 10.1016/j.cbi.2008.08.009; Zhang ZT, 2010, ACTA PHARMACOL SIN, V31, P900, DOI 10.1038/aps.2010.77; Zhao ZZ, 2014, BIOCHEM PHARMACOL, V90, P73, DOI 10.1016/j.bcp.2014.04.015	40	49	52	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145093	10.1371/journal.pone.0145093	http://dx.doi.org/10.1371/journal.pone.0145093			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709520	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400021
J	Hector, S; Willard, K; Bauer, R; Mulako, I; Slabbert, E; Kossmann, J; George, GM				Hector, Stanton; Willard, Kyle; Bauer, Rolene; Mulako, Inonge; Slabbert, Etienne; Kossmann, Jens; George, Gavin M.			Diverse Exopolysaccharide Producing Bacteria Isolated from Milled Sugarcane: Implications for Cane Spoilage and Sucrose Yield	PLOS ONE			English	Article							NEIGHBOR-JOINING METHOD; MOLECULAR CHARACTERIZATION; LEUCONOSTOC-MESENTEROIDES; DEXTRAN; DETERIORATION; PHYLOGENIES; INDICATORS; PROSPECTS; STRAINS; JUICE	Bacterial deterioration of sugarcane during harvesting and processing is correlated with significant loss of sucrose yield and the accumulation of bacterial polysaccharides. Dextran, a homoglucan produced by Leuconostoc mesenteroides, has been cited as the primary polysaccharide associated with sugarcane deterioration. A culture-based approach was used to isolate extracellular polysaccharide (EPS) producing bacterial strains from milled sugarcane stalks. Ribosomal RNA sequencing analysis grouped 25 isolates into 4 genera. This study identified 2 bacterial genera not previously associated with EPS production or sucrose degradation. All isolates produced polysaccharide when grown in the presence of sucrose. Monosaccharide analysis of purified polymers by Gas Chromatography revealed 17 EPSs consisting solely of glucose (homoglucans), while the remainder contained traces of mannose or fructose. Dextranase treatment of polysaccharides yielded full digestion profiles for only 11 extracts. Incomplete hydrolysis profiles of the remaining polysaccharides suggest the release of longer oligosaccharides which may interfere with sucrose crystal formation.	[Hector, Stanton; Willard, Kyle; Mulako, Inonge; Kossmann, Jens; George, Gavin M.] Univ Stellenbosch, Dept Genet, Inst Plant Biotechnol, ZA-7602 Matieland, South Africa; [Bauer, Rolene] Univ Stellenbosch, LaunchLab, ZA-7602 Matieland, South Africa; [Slabbert, Etienne] Univ Stellenbosch, Dept Microbiol, ZA-7602 Matieland, South Africa; [Slabbert, Etienne] Univ Stellenbosch, Cent Analyt Facil, ZA-7602 Matieland, South Africa	Stellenbosch University; Stellenbosch University; Stellenbosch University; Stellenbosch University	George, GM (corresponding author), Swiss Fed Inst Technol, Inst Agr Sci, Univ Str 2, CH-8092 Zurich, Switzerland.	ggeorge@ethz.ch	George, Gavin/E-8578-2016; George, Gavin Mager/N-6205-2019	George, Gavin/0000-0001-7880-3952; George, Gavin Mager/0000-0001-7880-3952; Willard, Kyle/0000-0001-6137-5904; Kossmann, Jens/0000-0001-8895-894X; Hector, Stanton/0000-0001-8895-0710	South African National Research Foundation-Innovation Fund; Zurich-Basel Plant Science Centers' Plant Fellows program [GA-2010-267243]; South African National Research Foundation	South African National Research Foundation-Innovation Fund; Zurich-Basel Plant Science Centers' Plant Fellows program; South African National Research Foundation(National Research Foundation - South Africa)	Funding provided by South African National Research Foundation-Innovation Fund (http://www.nrf.ac.za/) and the Zurich-Basel Plant Science Centers' Plant Fellows program (Grant agreement no GA-2010-267243). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Dr Sandy Snyman and Dr Derek Watt of the South African Sugarcane Research Institute fro their advice (SASRI, Durban, South Africa). In addition we thank Dr Jan Bekker and Charl Marais for their contributions to this project. A final special thanks to Prof. Samuel C. Zeeman for his support as well as the Zurich-Basel Plant Science Centers' Plant Fellows program (Grant agreement no GA-2010-267243), as well as the South African National Research Foundation for their continuing contributions and support.	Abdel-Rahman EA, 2008, J FOOD ENG, V84, P501, DOI 10.1016/j.jfoodeng.2007.06.014; Aquino FWB, 2009, FOOD CHEM, V114, P1391, DOI 10.1016/j.foodchem.2008.11.019; Arrieta J, 1996, MICROBIOL-UK, V142, P1077, DOI 10.1099/13500872-142-5-1077; Babalola OO, 2010, BIOTECHNOL LETT, V32, P1559, DOI 10.1007/s10529-010-0347-0; Bauer R, 2009, INT J FOOD MICROBIOL, V131, P260, DOI 10.1016/j.ijfoodmicro.2009.02.020; Blanch M., 2006, Sugar Tech, V8, P224, DOI 10.1007/BF02943560; Chauhan MK, 2011, RENEW SUST ENERG REV, V15, P3445, DOI 10.1016/j.rser.2011.04.033; EGAN B. T., 1965, PROC QUEENSLAND SOC SUGAR CANE TECHNOL, V32, P21; Eggleston G, 2006, FOOD CHEM, V98, P366, DOI 10.1016/j.foodchem.2005.07.031; Eggleston G, 2005, PROCESS BIOCHEM, V40, P1881, DOI 10.1016/j.procbio.2004.06.025; Eggleston G, 2004, FOOD CHEM, V87, P119, DOI 10.1016/j.foodchem.2003.11.004; Eggleston G, 2002, FOOD CHEM, V78, P95, DOI 10.1016/S0308-8146(01)00390-9; Eggleston G., 2009, Sugar Tech, V11, P135, DOI 10.1007/s12355-009-0020-x; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goldemberg J, 2008, ENERG POLICY, V36, P2086, DOI 10.1016/j.enpol.2008.02.028; Kang HK, 2009, FEMS MICROBIOL LETT, V292, P33, DOI 10.1111/j.1574-6968.2008.01460.x; Katina K, 2009, FOOD MICROBIOL, V26, P734, DOI 10.1016/j.fm.2009.07.008; Kulkarni VM, 1987, 37 P DECC SUG TECHN, pM37; Leathers TD, 2011, BIOTECHNOL LETT, V33, P517, DOI 10.1007/s10529-010-0450-2; Lionnet G.R.E., 1986, P S AFR SUGAR TECHNO, V60, P52; MCINERNEY JO, 1995, APPL ENVIRON MICROB, V61, P1646, DOI 10.1128/AEM.61.4.1646-1648.1995; Morel du Boil PG, 1995, P S AFR SUG TECHNOL, V59, P146; Nwodo UU, 2012, INT J MOL SCI, V13, P14002, DOI 10.3390/ijms131114002; Promraksa A, 2009, J CRYST GROWTH, V311, P3667, DOI 10.1016/j.jcrysgro.2009.04.042; Purama RK, 2009, CARBOHYD POLYM, V76, P30, DOI 10.1016/j.carbpol.2008.09.018; Ravno A. B., 2005, Proceedings of the 79th Annual Congress of South African Sugar Technologists' Association, held at Kwa-Shukela, Mount Edgecombe, South Africa, 19-22 July 2005, P28; Rodriguez Jimenez E., 2009, Sugar Tech, V11, P124, DOI 10.1007/s12355-009-0019-3; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saxena P, 2010, AUST J CROP SCI, V4, P692; Soetaert W, 1995, PROGR BIOTECHNOL, V10, P351, DOI 10.1016/S0921-0423(06)80116-4; Solomon S., 2009, Sugar Tech, V11, P109, DOI 10.1007/s12355-009-0018-4; SUTHERLAND IW, 1979, TRENDS BIOCHEM SCI, V4, P55, DOI 10.1016/0968-0004(79)90262-7; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Watanabe K, 2001, J MICROBIOL METH, V44, P253, DOI 10.1016/S0167-7012(01)00220-2; Yusof S, 2000, FOOD CHEM, V68, P395, DOI 10.1016/S0308-8146(99)00180-6	37	13	15	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145487	10.1371/journal.pone.0145487	http://dx.doi.org/10.1371/journal.pone.0145487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710215	Green Submitted, gold, Green Published			2022-12-27	WOS:000367451400051
J	Marchowski, D; Neubauer, G; Lawicki, L; Wozniczka, A; Wysocki, D; Guentzel, S; Jarzemski, M				Marchowski, Dominik; Neubauer, Grzegorz; Lawicki, Lukasz; Wozniczka, Adam; Wysocki, Dariusz; Guentzel, Sebastian; Jarzemski, Maciej			The Importance of Non-Native Prey, the Zebra Mussel Dreissena polymorpha, for the Declining Greater Scaup Aythya marila: A Case Study at a Key European Staging and Wintering Site	PLOS ONE			English	Article							SZCZECIN LAGOON; COMMON EIDERS; DIVING DUCKS; FOOD; POPULATION; FULIGULA	The European population of Greater Scaup Aythya marila has experienced an alarming, similar to 60% decline in numbers over the last two decades. The brackish lagoons of the Odra River Estuary (ORE) in the south-western Baltic Sea, represent an important area for the species during the non-breeding season in Europe. The lagoons regularly support over 20 000 Scaup, with peaks exceeding 100 000 (38%-70% of the population wintering in NW Europe and the highest number recorded in April 2011-105 700). In the ORE, Scaup feed almost exclusively on the non-native Zebra Mussel Dreissena polymorpha. This mussel was present in the ORE already in the 19th century and continues to be superabundant. Using the results of 22 Scaup censuses (November to April 2002/2003 to 2013/2014) from the whole ORE (523 km(2) of water), we show that Scaup flocks follow areas with the greatest area of occurrence and biomass of the Zebra Mussel, while areas with low mussel densities are ignored. The numbers of Scaup in the ORE are primarily related to the area of Zebra Mussel occurrence on the lagoon's bottom (km(2)) in a non-linear fashion. Zebra Mussels were absolutely prevalent (97% of biomass) in the digestive tracts of birds unintentionally by-caught in fishing nets (n = 32). We estimate that Scaup alone consume an average of 5 400 tons of Zebra Mussels annually, which represents 5.6% of the total resources of the mussel in the ORE. Our results provide a clear picture of the strong dependence of the declining, migratory duck species on the non-native mussel, its primary food in the ORE. Our findings are particularly important as they can form the basis for the conservation action plan aimed at saving the north-western European populations of Scaup.	[Marchowski, Dominik; Wysocki, Dariusz] Univ Szczecin, Fac Biol, Dept Vertebrate Zool & Anthropol, PL-70453 Szczecin, Poland; [Marchowski, Dominik; Lawicki, Lukasz; Guentzel, Sebastian] West Pomeranian Nat Soc, Szczecin, Poland; [Neubauer, Grzegorz] Polish Acad Sci, Museum & Inst Zool, Ornithol Stn, Gdansk, Poland; [Wozniczka, Adam] Natl Marine Fisheries Res Inst, Res Stn Swinoujscie, Swinoujscie, Poland; [Jarzemski, Maciej] Linus Maciej Jarzemski, Szczecin, Poland	University of Szczecin; Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; National Marine Fisheries Research Institute	Marchowski, D (corresponding author), Univ Szczecin, Fac Biol, Dept Vertebrate Zool & Anthropol, PL-70453 Szczecin, Poland.	marchowskid@gmail.com	Marchowski, Dominik/ABC-7494-2021; Marchowski, Dominik/M-8184-2018	Lawicki, Lukasz/0000-0002-9829-0151; Marchowski, Dominik/0000-0001-7508-9466; Neubauer, Grzegorz/0000-0003-2123-0780; Wozniczka, Adam/0000-0001-5050-9145				[Anonymous], 2014, R LANG ENV STAT COMP; Araujo R., 2010, ZEBRA MUSSEL EUROPE, P183; Aunins A, 2013, HELCOM CORE INDICATO; Badzinski SS, 2006, WILDLIFE SOC B, V34, P664, DOI 10.2193/0091-7648(2006)34[664:DOLAGS]2.0.CO;2; Badzinski SS, 2009, ENVIRON POLLUT, V157, P1886, DOI 10.1016/j.envpol.2009.01.012; Beisel J.-N., 2010, ZEBRA MUSSEL EUROPE, P191; Bidwell J. R., 2010, ZEBRA MUSSEL EUROPE, P69; Bijleveld A. I., 2015, THESIS; Cervencl A, 2012, J SEA RES, V73, P41, DOI 10.1016/j.seares.2012.06.006; Czeraszkiewicz R, 2004, WATERBIRDS W POMERAN, P5; Czugala A, 2010, AQUAT INVASIONS, V5, pS61, DOI 10.3391/ai.2010.5.S1.014; De Leeuw JJ, 1999, ARDEA, V87, P15; FRYXELL JM, 1991, AM NAT, V138, P478, DOI 10.1086/285227; Grand JB, 2002, ENVIRON TOXICOL CHEM, V21, P1673, DOI 10.1897/1551-5028(2002)021<1673:COTEIE>2.0.CO;2; Guentzel S, 2012, IMPORTANT BIRD AREAS; Guillemette M, 1996, CAN J ZOOL, V74, P32; HASSELL MP, 1969, NATURE, V223, P1133, DOI 10.1038/2231133a0; HOLLING CS, 1961, ANNU REV ENTOMOL, V6, P163, DOI 10.1146/annurev.en.06.010161.001115; Hornman M, 2012, 3 PAN EUR DUCK S JIN; IZVEKOVA E I, 1972, Polskie Archiwum Hydrobiologii, V19, P203; Jakubas Dariusz, 2003, Ornis Svecica, V13, P75; Johnsgard PA, 1978, DUCKS GEESE SWANS WO; Kaliciuk J, 2003, WATERBIRDS W POMERAN, P14; Kalisinska E., 2005, FOLIA U AGR STETIN Z, V243, P71; Kalisinska E, 2007, OCHR SROD ZAS NAT, V31, P404; Kalisinska E., 2009, BIRDS ENV THREATS PR, P71; Kalisinska E, 2010, POL J ENVIRON STUD, V19, P1213; Kalisinska E, 2010, ECOTOXICOLOGY, V19, P1382, DOI 10.1007/s10646-010-0524-x; Keller I, 2009, J ORNITHOL, V150, P483, DOI 10.1007/s10336-008-0367-x; Kestenholz M., 1999, RING, V21, P26; Komdeur J, 1992, IWRB SPECIAL PUBLICA, V19; Lawicki Lukasz, 2008, Notatki Ornitolgiczne, V49, P235; LEIPE T, 1986, Mitteilungen aus dem Zoologischen Museum in Berlin, V62, P117; LEIPE T, 1989, Beitraege zur Vogelkunde, V35, P24; Marchowski D, 2011, PTAKI POMORZA, V2, P159; Marchowski D., 2012, PTAKI POMORZA, V3, P129; Marchowski D, 2013, PTAKI POMORZA, V4, P149; Marchowski D, 2015, AUK ORNITHOLOGI 1104, V4, P31, DOI [10.1642/AUK-15-62.1, DOI 10.1642/AUK-15-62.1]; Meissner W., 1992, IWRB SEADUCK B, V1, P21; Meissner W, 1994, IWRB SEADUCK RES GRO, V4, P26; Meissner Wlodzimierz, 2010, Ornis Polonica, V51, P275; Meissner Wlodzimierz, 1993, Ring, V15, P375; Mendel B., 2008, PROFILES SEABIRDS WA; Neubauer G., 2015, B MONITORINGU PRZYRO, V13, P1; NILSSON L, 1972, Ornis Scandinavica, V3, P55, DOI 10.2307/3676166; NILSSON L, 1970, OIKOS, V21, P145, DOI 10.2307/3543670; Petrie S, 2007, CONTAMINANT BURDENS, P54; Poulton VK, 2002, CONDOR, V104, P518, DOI 10.1650/0010-5422(2002)104[0518:CDASFB]2.0.CO;2; PREJS A, 1990, OECOLOGIA, V83, P378, DOI 10.1007/BF00317563; Radziejewska T., 2008, V197, P115, DOI 10.1007/978-3-540-73524-3_5; Skov H., 2011, WATERBIRD POPULATION; Stanczykowska A., 1983, Wiadomosci Ekologiczne, V29, P127; STANCZYKOWSKA A, 1993, HYDROBIOLOGIA, V251, P73, DOI 10.1007/BF00007167; Stanczykowska A, 2010, ZEBRA MUSSEL EUROPE, P119; Stempniewicz L., 1974, Acta Univ Nicolai Copernici (Limnol), V34, P83; Stempniewicz Lech, 1995, Ornis Svecica, V5, P133; Stempniewicz Lech, 1999, Ornis Svecica, V9, P143; Van Eerden M. R., 2010, ZEBRA MUSSEL EUROPE, P251; van Eerden M.R., 1997, THESIS U GRONINGEN V; Viksne J., 2010, ATLAS DUCK POPULATIO; Wetlands International, 2010, GUID WAT MON METH FI; Wiktor J, 1969, BIOL DREISSENA POLYM; WINFIELD IJ, 1994, FRESHWATER BIOL, V32, P467, DOI 10.1111/j.1365-2427.1994.tb01140.x; Wolnomiejski N, 2013, SZCZECIN LAGOON ECOSYSTEM: THE BIOTIC COMMUNITY OF THE GREAT LAGOON AND ITS FOOD WEB MODEL, P1, DOI 10.2478/9788376560502; Wolnomiejski Norbert, 2008, Ecological Questions, V9, P103, DOI 10.2478/v10090-009-0025-9; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wozniczka A, 2015, OCEANOLOGIA IN PRESS; Zuur A.F., 2013, BEGINNERS GUIDE GEN; Zuur AF, 1997, THESIS	69	13	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145496	10.1371/journal.pone.0145496	http://dx.doi.org/10.1371/journal.pone.0145496			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709707	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400054
J	Wu, L; Xue, L; Li, CL; Lv, X; Chen, ZL; Guo, MQ; Xie, Z				Wu, Liang; Xue, Lei; Li, Chaoling; Lv, Xia; Chen, Zhanlong; Guo, Mingqiang; Xie, Zhong			A Geospatial Information Grid Framework for Geological Survey	PLOS ONE			English	Article							SERVICE; MANAGEMENT; DISCOVERY; RESOURCES; PLATFORM	The use of digital information in geological fields is becoming very important. Thus, informatization in geological surveys should not stagnate as a result of the level of data accumulation. The integration and sharing of distributed, multi-source, heterogeneous geological information is an open problem in geological domains. Applications and services use geological spatial data with many features, including being cross-region and cross-domain and requiring real-time updating. As a result of these features, desktop and web-based geographic information systems (GISs) experience difficulties in meeting the demand for geological spatial information. To facilitate the real-time sharing of data and services in distributed environments, a GIS platform that is open, integrative, reconfigurable, reusable and elastic would represent an indispensable tool. The purpose of this paper is to develop a geological cloud-computing platform for integrating and sharing geological information based on a cloud architecture. Thus, the geological cloud-computing platform defines geological ontology semantics; designs a standard geological information framework and a standard resource integration model; builds a peer-to-peer node management mechanism; achieves the description, organization, discovery, computing and integration of the distributed resources; and provides the distributed spatial meta service, the spatial information catalog service, the multi-mode geological data service and the spatial data interoperation service. The geological survey information cloud-computing platform has been implemented, and based on the platform, some geological data services and geological processing services were developed. Furthermore, an iron mine resource forecast and an evaluation service is introduced in this paper.	[Wu, Liang; Xue, Lei; Chen, Zhanlong; Guo, Mingqiang; Xie, Zhong] China Univ Geosci, Sch Informat Engn, Wuhan 430074, Peoples R China; [Wu, Liang; Xie, Zhong] Natl Engn Res Ctr GIS, Wuhan, Peoples R China; [Li, Chaoling; Lv, Xia] China Geol Survey, Ctr Res & Dev, Beijing, Peoples R China	China University of Geosciences; China Geological Survey	Xie, Z (corresponding author), China Univ Geosci, Sch Informat Engn, Wuhan 430074, Peoples R China.	13317193026@189.cn			National Science Foundation of China [41401443]; Natural Science Foundation of Hubei Province [2015CFA012]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	National Science Foundation of China (Grant Nos. 41401443), Key Research Project supported by Natural Science Foundation of Hubei Province (Grant Nos. 2015CFA012).; This project was supported by the National Science Foundation of China (Grant Nos. 41401443) and the Key Research Project, supported by the Natural Science Foundation of Hubei Province (Grant Nos. 2015CFA012). The authors thank the Development and Research Center of China Geological Survey for providing technical support. We thank the NERCGIS (the National Engineering Research Center for Geographic Information System of China) for providing hardware support.	An Y, 2007, GEOONTOLOGY DESIGN C, P608; [Anonymous], 2015, PLOS ONE; Bildosola I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134563; Castella D, 2015, J GRID COMPUT, V13, P115, DOI 10.1007/s10723-014-9318-3; Chen YL, 2015, ORE GEOL REV, V71, P749, DOI 10.1016/j.oregeorev.2014.08.012; [揣媛媛 CHUAI Yuanyuan], 2007, [吉林大学学报. 地球科学版, Journal of Jilin University. Earth Science Edition], V37, P54; Devarakonda R, 2010, EARTH SCI INFORM, V3, P87, DOI 10.1007/s12145-010-0050-7; Dube N, 2013, INT J DIGIT EARTH, V6, P185, DOI 10.1080/17538947.2011.608814; Evangelidis K, 2014, COMPUT GEOSCI-UK, V63, P116, DOI 10.1016/j.cageo.2013.10.007; Ezaki Y, 2011, FUJITSU SCI TECH J, V47, P247; Gui ZP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105297; Gui ZP, 2013, INT J GEOGR INF SCI, V27, P1109, DOI 10.1080/13658816.2012.739692; Huang QY, 2013, COMPUT GEOSCI-UK, V59, P41, DOI 10.1016/j.cageo.2013.05.001; Ji X, 2010, 2010 18 INT C GEOINF; Kalabokidis K, 2014, INT J GEOGR INF SCI, V28, P541, DOI 10.1080/13658816.2013.858257; Kambayashi Y, 2007, LECT NOTES ARTIF INT, V4496, P364; Lee D, 2011, INT J GEOGR INF SCI, V25, P1283, DOI 10.1080/13658816.2011.558017; Li W, 2011, COMPUT GEOSCI-UK, V37, P1752, DOI 10.1016/j.cageo.2011.06.024; Li ZL, 2011, INT J GEOGR INF SCI, V25, P595, DOI 10.1080/13658816.2010.484811; Lin FC, 2013, INT CON ADV INFO NET, P621, DOI 10.1109/AINA.2013.94; Liu R, 2011, COMM COM INF SC, V238, P426; Liu xing, 2010, 2010 2nd Conference on Environmental Science and Information Application Technology (ESIAT 2010), P150, DOI 10.1109/ESIAT.2010.5567300; Liu Y, 2013, INT J DIGIT EARTH, V6, P313, DOI 10.1080/17538947.2012.687778; Moon J, 2008, LECT NOTES COMPUT SC, V5073, P360; Papagianni C, 2013, IEEE T COMPUT, V62, P1060, DOI 10.1109/TC.2013.31; Qinlu He, 2010, Proceedings 2010 International Conference on Computational and Information Sciences (ICCIS 2010), P1332, DOI 10.1109/ICCIS.2010.351; Schaffer B, 2010, LECT NOTES GEOINF CA, P399, DOI 10.1007/978-3-642-12326-9_21; Shao YZ, 2012, INT CONF AGRO-GEOINF, P286; Song MM, 2010, 2010 18TH INTERNATIONAL CONFERENCE ON GEOINFORMATICS; Vaccari L, 2009, INT J SPAT DATA INFR, V4, P24, DOI 10.2902/1725-0463.2009.04.art2; Wang J, 2010, DATA MINING MASS STO, P426; Wen YN, 2013, INT J DIGIT EARTH, V6, P356, DOI 10.1080/17538947.2012.716861; Xia JZ, 2015, INT J DIGIT EARTH, V8, P451, DOI 10.1080/17538947.2014.929750; Xu HM, 2012, 2012 INTERNATIONAL CONFERENCE ON QUALITY, RELIABILITY, RISK, MAINTENANCE, AND SAFETY ENGINEERING (ICQR2MSE), P1489, DOI 10.1109/ICQR2MSE.2012.6246507; Xu L, 2006, INT GEOSCI REMOTE SE, P899, DOI 10.1109/IGARSS.2006.231; Yang C, 2009, INT J GEOGR INF SCI, V23, P553, DOI 10.1080/13658810902733682; Yang CW, 2011, INT J DIGIT EARTH, V4, P305, DOI 10.1080/17538947.2011.587547; Yang CW, 2008, INT J DIGIT EARTH, V1, P259, DOI 10.1080/17538940802037954; Zhang HX, 2012, ADV INTEL SOFT COMPU, V143, P829; Zhang HJ, 2015, AER ADV ENG RES, V15, P1238; Zhang J, 2011, T NONFERR METAL SOC, V21, pS706, DOI 10.1016/S1003-6326(12)61666-5; [郑通科 Zheng Tongke], 2015, [合肥工业大学学报. 自然科学版, Journal of Hefei University of Technology. Natural Science], V38, P851; Zhong L, 2011, PROCEDIA ENVIRON SCI, V11, P77, DOI 10.1016/j.proenv.2011.12.013; Zhou J, 2010, IFIP ADV INF COMM TE, V340, P173, DOI 10.1007/978-3-642-16327-2_23	44	6	6	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145312	10.1371/journal.pone.0145312	http://dx.doi.org/10.1371/journal.pone.0145312			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710255	gold, Green Published, Green Submitted			2022-12-27	WOS:000367451400035
J	Yu, X; Jaatinen, A; Rintahaka, J; Hynonen, U; Lyytinen, O; Kant, R; Avall-Jaaskelainen, S; von Ossowski, I; Palva, A				Yu, Xia; Jaatinen, Annukka; Rintahaka, Johanna; Hynonen, Ulla; Lyytinen, Outi; Kant, Ravi; Avall-Jaaskelainen, Silja; von Ossowski, Ingemar; Palva, Airi			Human Gut-Commensalic Lactobacillus ruminis ATCC 25644 Displays Sortase-Assembled Surface Piliation: Phenotypic Characterization of Its Fimbrial Operon through In Silico Predictive Analysis and Recombinant Expression in Lactococcus lactis	PLOS ONE			English	Article							CONTROLLED GENE-EXPRESSION; GRAM-POSITIVE BACTERIA; GROUP-B STREPTOCOCCUS; RHAMNOSUS GG; FUNCTIONAL-ANALYSIS; PILI; ADHESION; PROTEIN; SEQUENCE; STRAINS	Sortase-dependent surface pili (or fimbriae) in Gram-positive bacteria are well documented as a key virulence factor for certain harmful opportunistic pathogens. However, it is only recently known that these multi-subunit protein appendages are also belonging to the "friendly" commensals and now, with this new perspective, they have come to be categorized as a niche-adaptation factor as well. In this regard, it was shown earlier that sortase-assembled piliation is a native fixture of two human intestinal commensalics (i.e., Lactobacillus rhamnosus and Bifidobacterium bifidum), and correspondingly where the pili involved have a significant role in cellular adhesion and immunomodulation processes. We now reveal that intestinal indigenous (or autochthonous) Lactobacillus ruminis is another surface-piliated commensal lactobacillar species. Heeding to in silico expectations, the predicted loci for the LrpCBA-called pili are organized tandemly in the L. ruminis genome as a canonical fimbrial operon, which then encodes for three pilin-proteins and a single C-type sortase enzyme. Through electron microscopic means, we showed that these pilus formations are a surface assemblage of tip, basal, and backbone pilin subunits (respectively named LrpC, LrpB, and LrpA) in L. ruminis, and also when expressed recombinantly in Lactococcus lactis. As well, by using the recombinant-piliated lactococci, we could define certain ecologically relevant phenotypic traits, such as the ability to adhere to extracellular matrix proteins and gut epithelial cells, but also to effectuate an induced dampening on Toll-like receptor 2 signaling and interleukin-8 responsiveness in immune-related cells. Within the context of the intestinal microcosm, by wielding such niche-advantageous cell-surface properties the LrpCBA pilus would undoubtedly have a requisite functional role in the colonization dynamics of L. ruminis indigeneity. Our study provides only the second description of a native-piliated Lactobacillus species, but at the same time also involves the structural and functional characterization of a third type of lactobacillar pilus.	[Yu, Xia; Jaatinen, Annukka; Rintahaka, Johanna; Hynonen, Ulla; Lyytinen, Outi; Kant, Ravi; Avall-Jaaskelainen, Silja; von Ossowski, Ingemar; Palva, Airi] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland	University of Helsinki	von Ossowski, I (corresponding author), Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland.	ingemar.von.ossowski@helsinki.fi; airi.palva@helsinki.fi	Kant, Ravi/AAF-8495-2021	Kant, Ravi/0000-0003-3878-9775; Pietikainen, Annukka/0000-0003-3554-0683; von Ossowski, Ingemar Eric/0000-0002-9899-671X; Hynonen, Ulla/0000-0002-2002-7804; Avall-Jaaskelainen, Silja Tuulia/0000-0002-9376-8566	Academy of Finland [118602, 141140, 277362]; China Scholarship Council (CSC); Finnish Veterinary Foundation; Finnish Foundation of Veterinary Research; University of Helsinki Applied Bioscience (ABS) Graduate School	Academy of Finland(Academy of Finland); China Scholarship Council (CSC)(China Scholarship Council); Finnish Veterinary Foundation; Finnish Foundation of Veterinary Research; University of Helsinki Applied Bioscience (ABS) Graduate School	Financing for this project (including operating costs and some salaries) was mainly through an Academy of Finland general research grant (No. 277362) (http://www.aka.fi) and the Academy of Finland-funded Center of Excellence in Microbial Food Safety (CoE-MiFoSa) research program (Grant Nos. 118602 and 141140). The China Scholarship Council (CSC), the Finnish Veterinary Foundation (http://www.etts.fi/), and the Finnish Foundation of Veterinary Research (http://www.sels.fi/index_eng.htm) provided personal salary funding to Xia Yu. The University of Helsinki Applied Bioscience (ABS) Graduate School (http://www.vetmed.helsinki.fi/abs/index.htm) supplied some salary support to Ravi Kant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Jassim RAM, 2003, LETT APPL MICROBIOL, V37, P213, DOI 10.1046/j.1472-765X.2003.01380.x; [Anonymous], 2012, ADV MICROBIOL-IRVINE, DOI DOI 10.4236/AIM.2012.23051; Ardita CS, 2014, APPL ENVIRON MICROB, V80, P5068, DOI 10.1128/AEM.01039-14; Basset A, 2013, J BIOL CHEM, V288, P2665, DOI 10.1074/jbc.M112.398875; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Brittan JL, 2015, MICROBES INFECT, V17, P360, DOI 10.1016/j.micinf.2014.12.013; Broadbent JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-533; Buccato S, 2006, J INFECT DIS, V194, P331, DOI 10.1086/505433; Chang Chungyu, 2013, Methods Mol Biol, V966, P77, DOI 10.1007/978-1-62703-245-2_5; Cheesman SE, 2007, RES MICROBIOL, V158, P2, DOI 10.1016/j.resmic.2006.10.005; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Danne C, 2012, RES MICROBIOL, V163, P645, DOI 10.1016/j.resmic.2012.10.012; deRuyter PGGA, 1996, J BACTERIOL, V178, P3434, DOI 10.1128/jb.178.12.3434-3439.1996; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Forde BM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S13; Ganguli K, 2015, PEDIATR RES, V77, P528, DOI 10.1038/pr.2015.5; Garcia CEV, 2015, APPL ENVIRON MICROB, V81, P2050, DOI 10.1128/AEM.03949-14; Gaspar AH, 2006, J BACTERIOL, V188, P1526, DOI 10.1128/JB.188.4.1526-1533.2006; Gorbach SL, 2000, AM J GASTROENTEROL, V95, pS2, DOI 10.1016/S0002-9270(99)00806-0; Harlow E., 1988, ANTIBODIES LAB MANUA; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kant R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102762; Krishnan V, 2015, IUBMB LIFE, V67, P533, DOI 10.1002/iub.1400; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Lebeer S, 2012, APPL ENVIRON MICROB, V78, P185, DOI 10.1128/AEM.06192-11; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Lee S, 2011, J BACTERIOL, V193, P5034, DOI 10.1128/JB.05601-11; Lerche M, 1961, ZENTRALBL BAKTERIOL, V180, P324; Maisey HC, 2008, FASEB J, V22, P1715, DOI 10.1096/fj.07-093963; Manetti AGO, 2014, ADV M C M, P151, DOI 10.1079/9781780642550.0151; Neville BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040592; Nishiyama K, 2016, ANIM SCI J, V87, P809, DOI 10.1111/asj.12491; O'Callaghan J, 2013, CURR TOP MICROBIOL, V358, P119, DOI 10.1007/82_2011_187; Oxaran V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050989; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PINTO M, 1983, BIOL CELL, V47, P323; Quigley BR, 2010, INFECT IMMUN, V78, P1294, DOI 10.1128/IAI.01037-09; Rakoff-Nahoum S, 2006, CURR TOP MICROBIOL, V308, P1; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reunanen J, 2012, APPL ENVIRON MICROB, V78, P2337, DOI 10.1128/AEM.07047-11; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Ribet D, 2015, MICROBES INFECT, V17, P173, DOI 10.1016/j.micinf.2015.01.004; Rintahaka J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113922; Rosini R, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00006; Savijoki K, 1992, HIGH LEVEL HETEROLOG, V186, P255; SHARPE ME, 1973, J GEN MICROBIOL, V77, P37, DOI 10.1099/00221287-77-1-37; Smokvina T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068731; Taweechotipatr M, 2009, FEMS MICROBIOL LETT, V293, P65, DOI 10.1111/j.1574-6968.2009.01506.x; Toh HS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075073, 10.1371/journal.pone.0064989]; Tripathi P, 2013, ACS NANO, V7, P3685, DOI 10.1021/nn400705u; Turroni F, 2013, P NATL ACAD SCI USA, V110, P11151, DOI 10.1073/pnas.1303897110; Varhimo E, 2011, VET MICROBIOL, V149, P381, DOI 10.1016/j.vetmic.2010.11.010; von Ossowski I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064416; von Ossowski I, 2011, APPL ENVIRON MICROB, V77, P4465, DOI 10.1128/AEM.02497-10; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09	58	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145718	10.1371/journal.pone.0145718	http://dx.doi.org/10.1371/journal.pone.0145718			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709916	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400072
J	Bryan, R; Aronson, JK; ten Hacken, P; Williams, A; Jordan, S				Bryan, Rachel; Aronson, Jeffrey K.; ten Hacken, Pius; Williams, Alison; Jordan, Sue			Patient Safety in Medication Nomenclature: Orthographic and Semantic Properties of International Nonproprietary Names	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; SOUND-ALIKE DRUGS; LOOK-ALIKE; DOUBLE-BLIND; ERRORS; MEDICINES; SIMILARITY; LENGTH	Background Confusion between look-alike and sound-alike (LASA) medication names (such as mercaptamine and mercaptopurine) accounts for up to one in four medication errors, threatening patient safety. Error reduction strategies include computerized physician order entry interventions, and 'Tall Man' lettering. The purpose of this study is to explore the medication name designation process, to elucidate properties that may prime the risk of confusion. Methods and Findings We analysed the formal and semantic properties of 7,987 International Non-proprietary Names (INNs), in relation to naming guidelines of the World Health Organization (WHO) INN programme, and have identified potential for errors. We explored: their linguistic properties, the underlying taxonomy of stems to indicate pharmacological interrelationships, and similarities between INNs. We used Microsoft Excel for analysis, including calculation of Levenshtein edit distance (LED). Compliance with WHO naming guidelines was inconsistent. Since the 1970s there has been a trend towards compliance in formal properties, such as word length, but longer names published in the 1950s and 1960s are still in use. The stems used to show pharmacological interrelationships are not spelled consistently and the guidelines do not impose an unequivocal order on them, making the meanings of INNs difficult to understand. Pairs of INNs sharing a stem (appropriately or not) often have high levels of similarity (< 5 LED), and thus have greater potential for confusion. Conclusions We have revealed a tension between WHO guidelines stipulating use of stems to denote meaning, and the aim of reducing similarities in nomenclature. To mitigate this tension and reduce the risk of confusion, the stem system should be made clear and well ordered, so as to avoid compounding the risk of confusion at the clinical level. The interplay between the different WHO INN naming principles should be further examined, to better understand their implications for the problem of LASA errors.	[Bryan, Rachel; Williams, Alison; Jordan, Sue] Swansea Univ, Swansea, W Glam, Wales; [Aronson, Jeffrey K.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [ten Hacken, Pius] Univ Innsbruck, Inst Translat Studies, A-6020 Innsbruck, Austria	Swansea University; University of Oxford; University of Innsbruck	Bryan, R (corresponding author), Swansea Univ, Swansea, W Glam, Wales.	r.bryan@swansea.ac.uk	jordan, sue/O-1297-2019; Bryan, Rachel/Q-9347-2016; Hacken, Pius ten/AAJ-2641-2021	jordan, sue/0000-0002-5691-2987; Bryan, Rachel/0000-0001-8617-3882; 	Arts and Humanities Research Council; AHRC	Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	The authors report no grants, no funding, no sponsors for the current work. R Bryan was funded by the Arts and Humanities Research Council between 2009 and 2012, for a Master's, during which time she developed an early incantation of this study and presented it in her thesis.; Rachel Bryan was funded by the Arts and Humanities Research Council (AHRC) between 2009 and 2012 to complete a Master's, during which she developed an early incantation of this study. The authors thank the AHRC for their support. We are particularly grateful for the critical remarks of Kent Vrana and an anonymous reviewer, whose suggestions enabled us to improve our paper considerably.	Aronson JK, 2009, QJM-INT J MED, V102, P513, DOI 10.1093/qjmed/hcp052; Bryan R, 2015, WORD FORMATION TRANS; Choi SH, 2002, J NEUROSCI RES, V67, P411, DOI 10.1002/jnr.10102; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; DAVE NK, 1990, ANN ALLERGY, V65, P298; Dogne Jean-Michel, 2002, Am J Respir Med, V1, P11; Emmerton LM, 2012, INT J CLIN PHARM-NET, V34, P4, DOI 10.1007/s11096-011-9595-x; Galanter WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101977; Garfield S., 2010, JUST MY TYPE BOOK FO; Ghaleb MA, 2010, ARCH DIS CHILD, V95, P113, DOI 10.1136/adc.2009.158485; Jordan S, 2014, J NURS MANAGE, V22, P271, DOI 10.1111/jonm.12238; Kaushal R, 2001, JAMA-J AM MED ASSOC, V285, P2114, DOI 10.1001/jama.285.16.2114; Kovacic Laurel, 2011, J Oncol Pharm Pract, V17, P104, DOI 10.1177/1078155209354135; Lambert BL, 2005, DRUG SAFETY, V28, P495, DOI 10.2165/00002018-200528060-00003; Lambert BL, 2003, SOC SCI MED, V57, P1939, DOI 10.1016/S0277-9536(03)00059-5; Lambert BL, 2001, DRUG INF J, V35, P163, DOI 10.1177/009286150103500119; Lambert BL, 1999, MED CARE, V37, P1214, DOI 10.1097/00005650-199912000-00005; Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3; [MHPRA Medicines and Healthcare Products Regulatory Agency], 2002, MERC MERC CONF DRUG; Moorman SM, 2008, GERONTOLOGIST, V48, P811, DOI 10.1093/geront/48.6.811; National Patient Safety Agency NPSA, 2006, GUID GRAPH DES MED P; National Reporting and Learning Service NRLS, 2009, SAF DOS IMPR US MED; New B, 2006, PSYCHON B REV, V13, P45, DOI 10.3758/BF03193811; Nute Christine, 2014, Nurs Stand, V29, P45, DOI 10.7748/ns.29.12.45.e9191; Ostini Remo, 2012, Int J Pharm Pract, V20, P349, DOI 10.1111/j.2042-7174.2012.00210.x; Rastle K, 1998, PSYCHON B REV, V5, P277, DOI 10.3758/BF03212951; Runciman WB, 2003, INT J QUAL HEALTH C, V15, pI49, DOI 10.1093/intqhc/mzg085; Sanders C, 2004, CAMBRIDGE COMPANION; Sauberan JB, 2010, AM J HEALTH-SYST PH, V67, P49, DOI 10.2146/ajhp090122; Tuohy N, 2005, J EMERG NURS, V31, P569, DOI 10.1016/j.jen.2005.07.012; WHO, 1997, GUID US INT NONPR NA; World Health Organization WHO, 2009, WHO STEMB 2009 US ST	32	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145431	10.1371/journal.pone.0145431	http://dx.doi.org/10.1371/journal.pone.0145431			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26701761	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600079
J	Cheng, X; Guan, WW; Sun, S; Li, BS; Li, HJ; Kang, FB; Kang, JW; Yang, DL; Nassal, M; Sun, DX				Cheng, Xin; Guan, Weiwei; Sun, Shuo; Li, Baosheng; Li, Haijun; Kang, Fubiao; Kang, Jiwen; Yang, Dongliang; Nassal, Michael; Sun, Dianxing			Stable Human Hepatoma Cell Lines for Efficient Regulated Expression of Nucleoside/Nucleotide Analog Resistant and Vaccine Escape Hepatitis B Virus Variants and Woolly Monkey Hepatitis B Virus	PLOS ONE			English	Article							PRIMARY TUPAIA HEPATOCYTES; SURFACE-ANTIGEN VARIANTS; CIRCULAR DNA FORMATION; ARGININE-RICH DOMAIN; DRUG-RESISTANT; HEPG2 CELLS; P-PROTEIN; RECOMBINANT BACULOVIRUS; REVERSE-TRANSCRIPTASE; COMMON STRUCTURE	Hepatitis B virus (HBV) causes acute and chronic hepatitis B (CHB). Due to its error-prone replication via reverse transcription, HBV can rapidly evolve variants that escape vaccination and/or become resistant to CHB treatment with nucleoside/nucleotide analogs (NAs). This is particularly problematic for the first generation NAs lamivudine and adefovir. Though now superseded by more potent NAs, both are still widely used. Furthermore, resistance against the older NAs can contribute to cross-resistance against more advanced NAs. For lack of feasible HBV infection systems, the biology of such variants is not well understood. From the recent discovery of Na+-taurocholate cotransporting polypeptide (NTCP) as an HBV receptor new in vitro infection systems are emerging, yet access to the required large amounts of virions, in particular variants, remains a limiting factor. Stably HBV producing cell lines address both issues by allowing to study intracellular viral replication and as a permanent source of defined virions. Accordingly, we generated a panel of new tetracycline regulated TetOFF HepG2 hepatoma cell lines which produce six lamivudine and adefovir resistance-associated and two vaccine escape variants of HBV as well as the model virus woolly monkey HBV (WMHBV). The cell line-borne viruses reproduced the expected NA resistance profiles and all were equally sensitive against a non-NA drug. The new cell lines should be valuable to investigate under standardized conditions HBV resistance and cross-resistance. With titers of secreted virions reaching >3x10(7) viral genome equivalents per ml they should also facilitate exploitation of the new in vitro infection systems.	[Cheng, Xin; Guan, Weiwei; Sun, Shuo; Li, Baosheng; Li, Haijun; Kang, Fubiao; Kang, Jiwen; Sun, Dianxing] Bethune Int Peace Hosp, Liver Dis Diag & Treatment Ctr PLA, Shijiazhuang, Peoples R China; [Sun, Shuo] Troop 66220 PLA, Xingtai, Xingtai Of Hebe, Peoples R China; [Yang, Dongliang] Huazhong Univ Sci & Technol, Dept Infect Dis, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Nassal, Michael] Univ Hosp Freiburg, Dept Internal Med Mol Biol 2, Freiburg, Germany	Huazhong University of Science & Technology; University of Freiburg	Nassal, M (corresponding author), Univ Hosp Freiburg, Dept Internal Med Mol Biol 2, Freiburg, Germany.	nassal2@ukl.uni-freiburg.de; sundianxing@hotmail.com	Nassal, Michael/U-4529-2019	Nassal, Michael/0000-0003-2204-9158	National Major Science and Technology Special Project for Infectious Diseases of China [2012ZX10004503-012, 2008ZX10002-011]; European Commission	National Major Science and Technology Special Project for Infectious Diseases of China; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the National Major Science and Technology Special Project for Infectious Diseases of China (2012ZX10004503-012, 2008ZX10002-011). Initial experiments were supported by the European Commission through project HepBvar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini-Bavil-Olyaee S, 2010, J VIROL, V84, P1026, DOI 10.1128/JVI.01796-09; Bartholomeusz A, 2004, ANTIVIR THER, V9, P149; Beck J, 2002, NUCLEIC ACIDS RES, V30, P1679, DOI 10.1093/nar/30.7.1679; Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; Beck J, 2011, J VIROL, V85, P7742, DOI 10.1128/JVI.00482-11; Bellecave P, 2009, HEPATOLOGY, V50, P46, DOI 10.1002/hep.22951; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; Brezillon N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025096; Brunelle MN, 2005, HEPATOLOGY, V41, P1391, DOI 10.1002/hep.20723; Carman WF, 1999, J HEPATOL, V31, P195, DOI 10.1016/S0168-8278(99)80213-X; Carman WF, 1997, J VIRAL HEPATITIS, V4, P11, DOI 10.1111/j.1365-2893.1997.tb00155.x; Chevaliez S, 2013, J HEPATOL, V58, P676, DOI 10.1016/j.jhep.2012.11.039; Chotiyaputta W, 2009, NAT REV GASTRO HEPAT, V6, P453, DOI 10.1038/nrgastro.2009.107; Christen V, 2007, J VIROL, V81, P159, DOI 10.1128/JVI.01292-06; Dallmeier K, 2008, ADV INFECT DIS; Das K, 2001, J VIROL, V75, P4771, DOI 10.1128/JVI.75.10.4771-4779.2001; Delaney WE, 1998, HEPATOLOGY, V28, P1134, DOI 10.1002/hep.510280432; Deres K, 2003, SCIENCE, V299, P893, DOI 10.1126/science.1077215; Gehring AJ, 2007, J VIROL, V81, P2940, DOI 10.1128/JVI.02415-06; Glebe D, 2005, GASTROENTEROLOGY, V129, P234, DOI 10.1053/j.gastro.2005.03.090; Guo H, 2007, J VIROL, V81, P12472, DOI 10.1128/JVI.01123-07; Ireland JH, 2000, HEPATOLOGY, V31, P1176, DOI 10.1053/he.2000.6407; Iwamoto M, 2014, BIOCHEM BIOPH RES CO, V443, P808, DOI 10.1016/j.bbrc.2013.12.052; Kamili S, 2009, HEPATOLOGY, V49, P1483, DOI 10.1002/hep.22796; Kock J, 2001, J VIROL, V75, P5084, DOI 10.1128/JVI.75.11.5084-5089.2001; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Ladner SK, 1998, ANTIVIR CHEM CHEMOTH, V9, P65; Lanford RE, 2003, J VIROL, V77, P7814, DOI 10.1128/JVI.77.14.7814-7819.2003; Le Pogam S, 2005, J VIROL, V79, P1871, DOI 10.1128/JVI.79.3.1871-1887.2005; Liu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053392; Lo AOS, 2014, EXPERT REV GASTROENT, V8, P607, DOI 10.1586/17474124.2014.909724; Locarnini SA, 2010, ANTIVIR THER, V15, P451, DOI 10.3851/IMP1499; Lucifora J, 2008, J GEN VIROL, V89, P1819, DOI 10.1099/vir.0.83659-0; Lucifora J, 2010, HEPATOLOGY, V51, P63, DOI 10.1002/hep.23230; Marion MJ, 2010, METHODS MOL BIOL, V640, P261, DOI 10.1007/978-1-60761-688-7_13; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Nassal M, 2015, GUT, V64, P1972, DOI 10.1136/gutjnl-2015-309809; Nassal M, 2009, FUTURE VIROL, V4, P55, DOI 10.2217/17460794.4.1.55; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; PASEK M, 1979, NATURE, V282, P575, DOI 10.1038/282575a0; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Prange R, 2012, MED MICROBIOL IMMUN, V201, P449, DOI 10.1007/s00430-012-0267-9; Protzer-Knolle U, 1998, HEPATOLOGY, V27, P254, DOI 10.1002/hep.510270138; Qi XP, 2007, ANTIVIR THER, V12, P355; Ren ST, 2001, J VIROL, V75, P1104, DOI 10.1128/JVI.75.3.1104-1116.2001; Rodgers MA, 2009, J AM CHEM SOC, V131, P5030, DOI 10.1021/ja809949r; Schonig K, 2010, METHOD ENZYMOL, V477, P429, DOI 10.1016/S0076-6879(10)77022-1; Seigneres B, 2002, HEPATOLOGY, V36, P710, DOI 10.1053/jhep.2002.35070; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; SERWER P, 1995, J CHROMATOGR A, V698, P251, DOI 10.1016/0021-9673(94)01259-H; Stray SJ, 2006, J MOL RECOGNIT, V19, P542, DOI 10.1002/jmr.801; Stuyver LJ, 2001, HEPATOLOGY, V33, P751, DOI 10.1053/jhep.2001.22166; Sun DX, 2006, J HEPATOL, V45, P636, DOI 10.1016/j.jhep.2006.05.019; Sun DX, 2010, J HEPATOL, V52, P817, DOI 10.1016/j.jhep.2009.10.038; Sureau C, 2013, HEPATOLOGY, V57, P985, DOI 10.1002/hep.26125; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; Villet S, 2008, J HEPATOL, V48, P747, DOI 10.1016/j.jhep.2008.01.027; Walker A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00005; Wang TZ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-231; Wang YX, 2012, J VIROL, V86, P6394, DOI 10.1128/JVI.00011-12; Wang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060306; Warner N, 2008, HEPATOLOGY, V48, P88, DOI 10.1002/hep.22295; Weinberger KM, 2000, J VIROL METHODS, V85, P75, DOI 10.1016/S0166-0934(99)00154-8; Xu CX, 2010, J VIROL, V84, P9332, DOI 10.1128/JVI.00918-10; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Zeisel M.B., 2015, GUT; Zhang MS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-292; Zhao R, 2011, WORLD J GASTROENTERO, V17, P1152, DOI 10.3748/wjg.v17.i9.1152; Zhong GC, 2013, J VIROL, V87, P7176, DOI 10.1128/JVI.03533-12; Zhu Y, 2007, J CLIN MICROBIOL, V45, P3335, DOI 10.1128/JCM.00272-07; Zidek Zdenek, 2005, Biomedical Papers (Olomouc), V149, P315; Zoulim F, 2015, COLD SPRING HARB PER, V5; Zoulim F, 2009, GASTROENTEROLOGY, V137, P1593, DOI 10.1053/j.gastro.2009.08.063	75	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145746	10.1371/journal.pone.0145746	http://dx.doi.org/10.1371/journal.pone.0145746			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699621	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600127
J	Dell'Anno, A; Carugati, L; Corinaldesi, C; Riccioni, G; Danovaro, R				Dell'Anno, Antonio; Carugati, Laura; Corinaldesi, Cinzia; Riccioni, Giulia; Danovaro, Roberto			Unveiling the Biodiversity of Deep-Sea Nematodes through Metabarcoding: Are We Ready to Bypass the Classical Taxonomy?	PLOS ONE			English	Article							FREE-LIVING MARINE; POPULATION GENETIC-STRUCTURE; DIVERSITY; MAGNITUDE; SEQUENCES; PATTERNS	Nematodes inhabiting benthic deep-sea ecosystems account for >90% of the total metazoan abundances and they have been hypothesised to be hyper-diverse, but their biodiversity is still largely unknown. Metabarcoding could facilitate the census of biodiversity, especially for those tiny metazoans for which morphological identification is difficult. We compared, for the first time, different DNA extraction procedures based on the use of two commercial kits and a previously published laboratory protocol and tested their suitability for sequencing analyses of 18S rDNA of marine nematodes. We also investigated the reliability of Roche 454 sequencing analyses for assessing the biodiversity of deep-sea nematode assemblages previously morphologically identified. Finally, intra-genomic variation in 18S rRNA gene repeats was investigated by Illumina MiSeq in different deep-sea nematode morphospecies to assess the influence of polymorphisms on nematode biodiversity estimates. Our results indicate that the two commercial kits should be preferred for the molecular analysis of biodiversity of deep-sea nematodes since they consistently provide amplifiable DNA suitable for sequencing. We report that the morphological identification of deep-sea nematodes matches the results obtained by metabarcoding analysis only at the order-family level and that a large portion of Operational Clustered Taxonomic Units (OCTUs) was not assigned. We also show that independently from the cut-off criteria and bioinformatic pipelines used, the number of OCTUs largely exceeds the number of individuals and that 18S rRNA gene of different morpho-species of nematodes displayed intragenomic polymorphisms. Our results indicate that metabarcoding is an important tool to explore the diversity of deep-sea nematodes, but still fails in identifying most of the species due to limited number of sequences deposited in the public databases, and in providing quantitative data on the species encountered. These aspects should be carefully taken into account before using metabarcoding in quantitative ecological research and monitoring programmes of marine biodiversity.	[Dell'Anno, Antonio; Carugati, Laura; Corinaldesi, Cinzia; Riccioni, Giulia; Danovaro, Roberto] Polytech Univ Marche, Dept Life & Environm Sci, I-60131 Ancona, Italy; [Danovaro, Roberto] Stn Zool Anton Dohrn, Naples, Italy	Marche Polytechnic University; Stazione Zoologica Anton Dohrn di Napoli	Danovaro, R (corresponding author), Polytech Univ Marche, Dept Life & Environm Sci, Via Brecce Bianche, I-60131 Ancona, Italy.	r.danovaro@univpm.it	Carugati, Laura/AAM-6614-2021; Dell'Anno, Antonio AD/G-9468-2012	Carugati, Laura/0000-0002-0921-6911; Dell'Anno, Antonio AD/0000-0002-4324-7834; Riccioni, Giulia/0000-0003-3934-8840	EU Project DEVOTES [308392]; EU Project MIDAS (Managing Impacts of Deep-seA reSource exploitation) [603418]; Italian Project RITMARE (MIUR); Italian Project EXPLODIVE (FIRB) [I31J10000060001]	EU Project DEVOTES; EU Project MIDAS (Managing Impacts of Deep-seA reSource exploitation); Italian Project RITMARE (MIUR); Italian Project EXPLODIVE (FIRB)	This research was financially supported by the EU Projects DEVOTES (grant agreement n. 308392), MIDAS (Managing Impacts of Deep-seA reSource exploitation; grant agreement n. 603418) and the Italian Projects RITMARE (MIUR, coordinated by CNR) and EXPLODIVE (FIRB 2008, contract no. I31J10000060001).	Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Bhadury P, 2008, MAR BIOL, V154, P509, DOI 10.1007/s00227-008-0945-8; Bhadury P, 2007, ZOOL SCR, V36, P93, DOI 10.1111/j.1463-6409.2006.00250.x; Bhadury P, 2006, MAR ECOL PROG SER, V320, P1, DOI 10.3354/meps320001; Bik HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078230; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Bik HM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-389; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Danovaro R, 2014, TRENDS ECOL EVOL, V29, P465, DOI 10.1016/j.tree.2014.06.002; De Ley P, 2005, PHILOS T R SOC B, V360, P1945, DOI 10.1098/rstb.2005.1726; De Ley P, 1999, NEMATOLOGY, V1, P591, DOI 10.1163/156854199508559; De Ley P, 2006, QUICK TOUR NEMATODE; Deprez T, 2005, WORLD WIDE WEB ELECT; Derycke S, 2007, MAR BIOL, V151, P1799, DOI 10.1007/s00227-007-0609-0; Derycke S, 2005, MAR ECOL PROG SER, V300, P91, DOI 10.3354/meps300091; Derycke S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013716; Derycke S, 2010, ZOOL SCR, V39, P276, DOI 10.1111/j.1463-6409.2009.00420.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Floyd RM, 2005, MOL ECOL NOTES, V5, P611, DOI 10.1111/j.1471-8286.2005.01009.x; Fonseca G, 2008, BIOL J LINN SOC, V94, P737, DOI 10.1111/j.1095-8312.2008.01015.x; Fonseca VG, 2014, GLOBAL ECOL BIOGEOGR, V23, P1293, DOI 10.1111/geb.12223; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Lambshead PJD, 2004, NEMATOLOGY: ADVANCES AND PERSPECTIVES, VOL 1: NEMATODE MORPHOLOGY, PHYSIOLOGY AND ECOLOGY, P438, DOI 10.1079/9780851996455.0438; Lecroq B, 2011, P NATL ACAD SCI USA, V108, P13177, DOI 10.1073/pnas.1018426108; Meldal BHM, 2007, MOL PHYLOGENET EVOL, V42, P622, DOI 10.1016/j.ympev.2006.08.025; Moens T, 1998, HELGOLANDER MEERESUN, V52, P115, DOI 10.1007/BF02908742; Platt H.M., 1983, SYNOPSES BRIT FAUNA, V28; PLATT HM, 1988, BRIT CHROMADORIDS 2; Porazinska DL, 2010, ZOOTAXA, P55, DOI 10.11646/zootaxa.2427.1.6; Porazinska DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044641; Porazinska DL, 2010, MOL ECOL, V19, P5521, DOI 10.1111/j.1365-294X.2010.04891.x; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shaw AK, 2008, ENVIRON MICROBIOL, V10, P2200, DOI 10.1111/j.1462-2920.2008.01626.x; Snelgrove PVR, 2014, TRENDS ECOL EVOL, V29, P398, DOI 10.1016/j.tree.2014.05.002; THOMAS WK, 2011, MARINE BENTHIC NEMAT, P22; VINCX M, 1994, ADV MAR BIOL, V30, P1, DOI 10.1016/S0065-2881(08)60061-9	49	51	51	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144928	10.1371/journal.pone.0144928	http://dx.doi.org/10.1371/journal.pone.0144928			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701112	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600036
J	Lussi, A; Carvalho, TS				Lussi, Adrian; Carvalho, Thiago Saads			Analyses of the Erosive Effect of Dietary Substances and Medications on Deciduous Teeth	PLOS ONE			English	Article							IN-VITRO; DENTAL EROSION; TOOTH WEAR; PERMANENT ENAMEL; CITRIC-ACID; SOFT DRINKS; PH; CALCIUM; DISSOLUTION; CHILDREN	This study aimed at analysing the erosive potential of 30 substances (drinks, candies, and medicaments) on deciduous enamel, and analyse the associated chemical factors with enamel dissolution. We analysed the initial pH, titratable acidity (TA) to pH 5.5, calcium (Ca), inorganic phosphate (P-i), and fluoride (F) concentration, and degree of saturation ((pK-pI)(HAP), (pK-pI)(FAP), and (pK-pI)(CaF2)) of all substances. Then, we randomly distributed 300 specimens of human deciduous enamel into 30 groups (n = 10 for each of the substances tested. We also prepared 20 specimens of permanent enamel for the sake of comparison between the two types of teeth, and we tested them in mineral water and Coca-Cola (R). In all specimens, we measured surface hardness (VHN: Vickers hardness numbers) and surface reflection intensity (SRI) at baseline (SHbaseline and SRIbaseline), after a total of 2 min (SH2min) and after 4 min (SH4min and SRI4min) erosive challenges (60 ml of substance for 6 enamel samples; 30 degrees C, under constant agitation at 95 rpm). There was no significant difference in SHbaseline between deciduous and permanent enamel. Comparing both teeth, we observed that after the first erosive challenge with Coca-Cola (R), a significantly greater hardness loss was seen in deciduous (-90.2 +/- 11.3 VHN) than in permanent enamel (-44.3 +/- 12.2 VHN; p = 0.007), but no differences between the two types of teeth were observed after two challenges (SH4min). After both erosive challenges, all substances except for mineral water caused a significant loss in relative surface reflectivity intensity, and most substances caused a significant loss in surface hardness. Multiple regression analyses showed that pH, TA and Ca concentration play a significant role in initial erosion of deciduous enamel. We conclude that drinks, foodstuffs and medications commonly consumed by children can cause erosion of deciduous teeth and erosion is mainly associated with pH, titratable acidity and calcium concentration in the solution.	[Lussi, Adrian; Carvalho, Thiago Saads] Univ Bern, Dept Prevent Restorat & Pediat Dent, Bern, Switzerland	University of Bern	Lussi, A (corresponding author), Univ Bern, Dept Prevent Restorat & Pediat Dent, Bern, Switzerland.	adrian.lussi@zmk.unibe.ch	Carvalho, Thiago/GWC-7662-2022; Carvalho, Thiago Saads/B-8945-2012	Carvalho, Thiago Saads/0000-0002-2435-1169	Deutsche Gesellschaft fur Zahnerhaltung (DGPZM-Wissenschaftsfonds)	Deutsche Gesellschaft fur Zahnerhaltung (DGPZM-Wissenschaftsfonds)	This study was funded by the Deutsche Gesellschaft fur Zahnerhaltung (DGPZM-Wissenschaftsfonds) to AL and TSC.; The present study was supported by the Deutsche Gesellschaft fur Zahnerhaltung (DGPZM-Wissenschaftsfonds). The authors show their gratitude towards G. Fischer and Prof. Hausler, Institute of Mathematical Statistics, University of Bern, for the statistical analyses, and to Brigitte Megert for her appreciated efforts in the laboratory. We also thank Dr. R.P. Shellis for his valuable comments on this manuscript.	Amaechi BT, 1999, J ORAL REHABIL, V26, P624, DOI 10.1046/j.1365-2842.1999.00433.x; Attin T, 2003, ARCH ORAL BIOL, V48, P753, DOI 10.1016/S0003-9969(03)00156-0; Barbour ME, 2003, EUR J ORAL SCI, V111, P428, DOI 10.1034/j.1600-0722.2003.00059.x; Brevik SC, 2013, J DENT, V41, P428, DOI 10.1016/j.jdent.2013.02.011; Carvalho TS, 2014, MONOGR ORAL SCI, V25, P262, DOI 10.1159/000360712; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Dawes Colin, 2003, J Can Dent Assoc, V69, P722; Dugmore CR, 2004, BRIT DENT J, V196, P283, DOI 10.1038/sj.bdj.4811041; Featherstone JDB, 2006, MG ORAL SCI, V20, P66, DOI 10.1159/000093351; Ganss C, 2001, COMMUNITY DENT ORAL, V29, P264, DOI 10.1034/j.1600-0528.2001.290405.x; Ganss C, 2014, MONOGR ORAL SCI, V25, P22, DOI 10.1159/000359935; Harding MA, 2010, COMMUNITY DENT HLTH, V27, P41, DOI 10.1922/CDH_2447Harding05; Hemingway C A, 2006, Br Dent J, V201, P447, DOI 10.1038/sj.bdj.4814073; Hughes JA, 1999, J DENT, V27, P285, DOI 10.1016/S0300-5712(98)00069-4; Hughes JA, 2000, J DENT, V28, P147, DOI 10.1016/S0300-5712(99)00060-3; Hunter L, 2009, INT J PAEDIATR DENT, V19, P325, DOI 10.1111/j.1365-263X.2009.00975.x; Hunter ML, 2008, INT J PAEDIATR DENT, V18, P251, DOI 10.1111/j.1365-263X.2008.00917.x; Hunter ML, 2000, J DENT, V28, P257, DOI 10.1016/S0300-5712(99)00079-2; Hunter ML, 2000, J DENT, V28, P265, DOI 10.1016/S0300-5712(99)00074-3; JARVINEN VK, 1991, J DENT RES, V70, P942, DOI 10.1177/00220345910700060601; Jensdottir T, 2005, J DENT, V33, P569, DOI 10.1016/j.jdent.2004.12.002; Johansson AK, 2004, EUR J ORAL SCI, V112, P484, DOI 10.1111/j.1600-0722.2004.00172.x; Johansson AK, 2001, J DENT, V29, P333, DOI 10.1016/S0300-5712(01)00029-X; Kreulen CM, 2010, CARIES RES, V44, P151, DOI 10.1159/000308567; LAGERLOF F, 1984, J DENT RES, V63, P618, DOI 10.1177/00220345840630050201; LARSEN MJ, 1986, ARCH ORAL BIOL, V31, P757, DOI 10.1016/0003-9969(86)90008-7; Larsen MJ, 1999, CARIES RES, V33, P81, DOI 10.1159/000016499; Lippert F, 2004, EUR J ORAL SCI, V112, P61, DOI 10.1111/j.0909-8836.2004.00095.x; LUSSI A, 1995, CARIES RES, V29, P349, DOI 10.1159/000262091; LUSSI A, 1993, CARIES RES, V27, P387, DOI 10.1159/000261569; Lussi A, 2011, CARIES RES, V45, P2, DOI 10.1159/000325915; Lussi A, 2014, MONOGR ORAL SCI, V25, P1, DOI 10.1159/000360380; Lussi A, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.9.097009; Lussi A, 2012, BRIT J NUTR, V107, P252, DOI 10.1017/S0007114511002820; Magalhaes AC, 2009, J APPL ORAL SCI, V17, P56, DOI 10.1590/S1678-77572009000100011; MCCANN HG, 1968, ARCH ORAL BIOL, V13, P987, DOI 10.1016/0003-9969(68)90014-9; MCDOWELL H, 1977, J RES NBS A PHYS CH, V81, P273, DOI 10.6028/jres.081A.017; O'Sullivan EA, 2000, J DENT CHILD, V67, P186; Radlanski RJ, 2001, EUR J ORAL SCI, V109, P409, DOI 10.1034/j.1600-0722.2001.00149.x; Rakhmatullina E, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.117009; Rakhmatullina E, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3631791; Rios Daniela, 2007, Oral Health Prev Dent, V5, P167; Shellis RP, 2013, CARIES RES, V47, P601, DOI 10.1159/000351641; Shellis RP, 2011, CARIES RES, V45, P69, DOI 10.1159/000325971; Shellis RP, 2014, MONOGR ORAL SCI, V25, P163, DOI 10.1159/000359943; SHELLIS RP, 1984, ARCH ORAL BIOL, V29, P697, DOI 10.1016/0003-9969(84)90175-4; Shellis RP, 2005, EUR J ORAL SCI, V113, P232, DOI 10.1111/j.1600-0722.2005.00210.x; Sonju Clasen A B, 1997, Adv Dent Res, V11, P523; STACK MV, 1953, BIOCHEM J, V54, pR15; STIEFEL DJ, 1976, J DENT RES, V55, P66, DOI 10.1177/00220345760550012601; TENCATE JM, 1995, EUR J ORAL SCI, V103, P362; Wetton S, 2006, CARIES RES, V40, P213, DOI 10.1159/000092228; WILSON PR, 1989, ARCH ORAL BIOL, V34, P85, DOI 10.1016/0003-9969(89)90130-1; ZERO DT, 1990, CARIES RES, V24, P181, DOI 10.1159/000261263	54	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0143957	10.1371/journal.pone.0143957	http://dx.doi.org/10.1371/journal.pone.0143957			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700481	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092600013
J	Menasria, R; Canivet, C; Piret, J; Boivin, G				Menasria, Rafik; Canivet, Coraline; Piret, Jocelyne; Boivin, Guy			Infiltration Pattern of Blood Monocytes into the Central Nervous System during Experimental Herpes Simplex Virus Encephalitis	PLOS ONE			English	Article							TICK-BORNE ENCEPHALITIS; INNATE IMMUNE-RESPONSE; MARROW-DERIVED CELLS; DENDRITIC CELLS; INFLAMMATORY MONOCYTES; TYPE-1 INFECTION; VIRAL MENINGITIS; TNF-ALPHA; MICROGLIA; BRAIN	The kinetics and distribution of infiltrating blood monocytes into the central nervous system and their involvement in the cerebral immune response together with resident macrophages, namely microglia, were evaluated in experimental herpes simplex virus 1 (HSV-1) encephalitis (HSE). To distinguish microglia from blood monocyte-derived macrophages, chimeras were generated by conditioning C57BL/6 recipient mice with chemotherapy regimen followed by transplantation of bone morrow-derived cells that expressed the green fluorescent protein. Mice were infected intranasally with a sub-lethal dose of HSV-1 (1.2x10(6) plaque forming units). Brains were harvested prior to and on days 4, 6, 8 and 10 post-infection for flow cytometry and immunohistochemistry analysis. The amounts of neutrophils (P<0.05) and "Ly6C(hi)" inflammatory monocytes (P<0.001) significantly increased in the CNS compared to non-infected controls on day 6 post-infection, which corresponded to more severe clinical signs of HSE. Levels decreased on day 8 for both leukocytes subpopulations (P<0.05 for inflammatory monocytes compared to non-infected controls) to reach baseline levels on day 10 following infection. The percentage of "Ly6Clow" patrolling monocytes significantly increased (P<0.01) at a later time point (day 8), which correlated with the resolution phase of HSE. Histological analysis demonstrated that blood leukocytes colonized mostly the olfactory bulb and the brainstem, which corresponded to regions where HSV-1 particles were detected. Furthermore, infiltrating cells from the monocytic lineage could differentiate into activated local tissue macrophages that express the microglia marker, ionized calcium-binding adaptor molecule 1. The lack of albumin detection in the brain parenchyma of infected mice showed that the infiltration of blood leukocytes was not necessarily related to a breakdown of the blood-brain barrier but could be the result of a functional recruitment. Thus, our findings suggest that blood monocyte-derived macrophages infiltrate the central nervous system and may contribute, with resident microglia, to the innate immune response seen during experimental HSE.	[Boivin, Guy] CHU Quebec, Res Ctr, Quebec City, PQ, Canada; Univ Laval, Quebec City, PQ, Canada	Laval University; Laval University	Boivin, G (corresponding author), CHU Quebec, Res Ctr, Quebec City, PQ, Canada.	Guy.Boivin@crchudequebec.ulaval.ca		Piret, Jocelyne/0000-0003-4102-0094; Boivin, Guy/0000-0003-3027-4662	Canadian Institutes of Health Research [MOP-89378]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Canadian Institutes of Health Research (grant MOP-89378 to GB). GB is the holder of the Canada research chair on emerging viruses and antiviral resistance. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Armien AG, 2010, BRAIN PATHOL, V20, P738, DOI 10.1111/j.1750-3639.2009.00354.x; Ashhurst TM, 2014, CELL IMMUNOL, V291, P49, DOI 10.1016/j.cellimm.2014.07.002; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bellavance MA, 2015, BRAIN STRUCT FUNCT, V220, P1759, DOI 10.1007/s00429-014-0759-z; Boivin N, 2013, ANTIVIR RES, V100, P649, DOI 10.1016/j.antiviral.2013.10.007; Boivin N, 2012, J GEN VIROL, V93, P1294, DOI 10.1099/vir.0.041046-0; Casano AM, 2015, DEV CELL, V32, P469, DOI 10.1016/j.devcel.2015.01.018; Chucair-Elliott AJ, 2014, GLIA, V62, P1418, DOI 10.1002/glia.22689; Conrady CD, 2013, J IMMUNOL, V190, P2807, DOI 10.4049/jimmunol.1203265; Conrady CD, 2010, J NEUROIMMUNOL, V220, P1, DOI 10.1016/j.jneuroim.2009.09.013; Daniels BP, 2015, CLIN PHARMACOL THER, V97, P372, DOI 10.1002/cpt.75; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gelpi E, 2005, J NEUROPATH EXP NEUR, V64, P506, DOI 10.1093/jnen/64.6.506; Gelpi E, 2006, J NEUROVIROL, V12, P322, DOI 10.1080/13550280600848746; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Getts DR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-246; Guo YJ, 2015, LIFE SCI, V127, P12, DOI 10.1016/j.lfs.2015.01.036; Hellwig S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00071; Howe CL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00545; Hu SX, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-123; Jennische E, 2015, J NEUROVIROL, V21, P129, DOI 10.1007/s13365-014-0312-0; Kang SS, 2010, J NEUROIMMUNE PHARM, V5, P370, DOI 10.1007/s11481-010-9208-9; Kastrukoff Lorne F, 2012, Herpesviridae, V3, P4, DOI 10.1186/2042-4280-3-4; Kastrukoff LF, 2010, VIROLOGY, V400, P248, DOI 10.1016/j.virol.2010.02.013; Kaushik DK, 2011, FRONT BIOSCI-LANDMRK, V16, P2187, DOI 10.2741/3847; Kennedy PGE, 2013, J NEUROVIROL, V19, P346, DOI 10.1007/s13365-013-0178-6; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Lampron A, 2013, J COMP NEUROL, V521, P3863, DOI 10.1002/cne.23363; Lampron A, 2012, CELL TRANSPLANT, V21, P1149, DOI 10.3727/096368911X593154; Lokensgard JR, 2001, J NEUROVIROL, V7, P208; Lundberg P, 2008, J VIROL, V82, P7078, DOI 10.1128/JVI.00619-08; Marques CP, 2008, J IMMUNOL, V181, P6417, DOI 10.4049/jimmunol.181.9.6417; Menasria R, 2013, J VIROL, V87, P7301, DOI 10.1128/JVI.00591-13; Michaud JP, 2014, J CEREBR BLOOD F MET, V34, P1253, DOI 10.1038/jcbfm.2014.80; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Piret J, 2015, REV MED VIROL, V25, P300, DOI 10.1002/rmv.1848; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Prinz M, 2010, J NEUROIMMUNOL, V224, P80, DOI 10.1016/j.jneuroim.2010.05.015; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Rozenberg Flore, 2011, Infectious Disorders - Drug Targets, V11, P235; Schachtele SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036216; Sellner J, 2006, BRAIN RES, V1125, P155, DOI 10.1016/j.brainres.2006.09.093; Sergerie Y, 2007, J INFECT DIS, V196, P853, DOI 10.1086/520094; Sergerie Y, 2007, J INFECT DIS, V195, P817, DOI 10.1086/511987; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shechter R, 2013, NAT REV IMMUNOL, V13, P206, DOI 10.1038/nri3391; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Steiner I, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0414-8; Terry RL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-270; Tuppeny M, 2013, CRIT CARE NURS CLIN, V25, P363, DOI 10.1016/j.ccell.2013.04.003; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; Wojtasiak M, 2010, J GEN VIROL, V91, P2158, DOI 10.1099/vir.0.021915-0; Wuest TR, 2008, FRONT BIOSCI-LANDMRK, V13, P4862, DOI 10.2741/3045; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zheng M, 2008, INVEST OPHTH VIS SCI, V49, P4018, DOI 10.1167/iovs.08-1914	60	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145773	10.1371/journal.pone.0145773	http://dx.doi.org/10.1371/journal.pone.0145773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700486	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600133
J	Sharma, A; Hoover, DR; Shi, QH; Gustafson, D; Plankey, MW; Hershow, RC; Tien, PC; Golub, ET; Anastos, K				Sharma, Anjali; Hoover, Donald R.; Shi, Qiuhu; Gustafson, Deborah; Plankey, Michael W.; Hershow, Ronald C.; Tien, Phyllis C.; Golub, Elizabeth T.; Anastos, Kathryn			Relationship between Body Mass Index and Mortality in HIV-Infected HAART Users in the Women's Interagency HIV Study	PLOS ONE			English	Article							STARTING ANTIRETROVIRAL THERAPY; ALL-CAUSE MORTALITY; IMMUNE CELL COUNTS; DISEASE PROGRESSION; NUTRITIONAL-STATUS; PROSPECTIVE COHORT; UNITED-STATES; OBESITY; IMPACT; OVERWEIGHT	Background Early HIV studies suggested protective associations of overweight against mortality, yet data are lacking for the era of potent highly active antiretroviral therapy (HAART). We evaluated associations of pre-HAART initiation body mass index (BMI) with mortality among HAART-using women. Methods Prospective study of time to death after HAART initiation among continuous HAART users in the Women's Interagency HIV Study. Unadjusted Kaplan-Meier and adjusted proportional hazards survival models assessed time to AIDS and non-AIDS death by last measured pre-HAART BMI. Results Of 1428 continuous HAART users 39 (2.7%) were underweight, 521 (36.5%) normal weight, 441 (30.9%) overweight, and 427 (29.9%) obese at time of HAART initiation. A total of 322 deaths occurred during median follow-up of 10.4 years (IQR 5.9-14.6). Censoring at non-AIDS death, the highest rate of AIDS death was observed among underweight women (p = 0.0003 for all 4 categories). In multivariate models, women underweight prior to HAART died from AIDS more than twice as rapidly vs. normal weight women (aHR 2.04, 95% CI 1.03, 4.04); but being overweight or obese (vs. normal weight) was not independently associated with AIDS death. Cumulative incidence of non-AIDS death was similar across all pre-HAART BMI categories. Conclusions Among continuous HAART-using women, being overweight prior to initiation was not associated with lower risk of AIDS or non-AIDS death. Being underweight prior to HAART was associated with over double the rate of AIDS death in adjusted analyses. Although overweight and obesity may be associated with many adverse health conditions, neither was predictive of mortality among the HAART-using women.	[Sharma, Anjali; Anastos, Kathryn] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Hoover, Donald R.] Rutgers State Univ, Dept Stat & Biostat, Piscataway, NJ USA; [Shi, Qiuhu] New York Med Coll, Dept Epidemiol & Community Hlth, Valhalla, NY 10595 USA; [Gustafson, Deborah] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Plankey, Michael W.] Georgetown Univ, Med Ctr, Dept Med, Div Infect Dis, Washington, DC 20007 USA; [Hershow, Ronald C.] Univ Illinois, Dept Epidemiol, Chicago, IL USA; [Tien, Phyllis C.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA; [Tien, Phyllis C.] San Francisco VA Med Ctr, San Francisco, CA USA; [Golub, Elizabeth T.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Rutgers State University New Brunswick; New York Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Georgetown University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sharma, A (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	anjali.sharma@einstein.yu.edu			National Institute of Allergy and Infectious Diseases [UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, UO1-AI-42590]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [UO1-HD-32632]; National Cancer Institute; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Center for Research Resources (UCSF-CTSI Grant) [UL1 RR024131]; National Institutes of Health [K23AR06199301]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI042590, U01AI031834, U01AI034989, U01AI034993, U01AI034994, U01AI035004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR061993] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Research Resources (UCSF-CTSI Grant); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The WIHS is funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, and UO1-AI-42590) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (UO1-HD-32632). The study is co-funded by the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute on Deafness and Other Communication Disorders. Funding is provided by the National Center for Research Resources (UCSF-CTSI Grant Number UL1 RR024131). Contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. This research was also supported by National Institutes of Health K23AR06199301 (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Al-Harthi L, 2006, J INFECT DIS, V193, P1202, DOI 10.1086/500843; Amorosa V, 2005, JAIDS-J ACQ IMM DEF, V39, P557; ANDRES R, 1985, ANN INTERN MED, V103, P1030, DOI 10.7326/0003-4819-103-6-1030; [Anonymous], 1992, MMWR RECOMM REP, V41, P1; Argemi X, 2012, AIDS, V26, P1161, DOI 10.1097/QAD.0b013e328353f363; Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005; Boggs DA, 2011, NEW ENGL J MED, V365, P901, DOI 10.1056/NEJMoa1104119; Boodram B, 2009, AIDS PATIENT CARE ST, V23, P1009, DOI 10.1089/apc.2009.0175; Buchacz K, 2013, ANTIVIR THER, V18, P65, DOI 10.3851/IMP2450; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; CALVELLI T, 1993, CYTOMETRY, V14, P702, DOI 10.1002/cyto.990140703; Centers for Disease Control and Prevention, 2011, BEH RISK FACT SURV S; CHLEBOWSKI RT, 1989, AM J GASTROENTEROL, V84, P1288; Cohen MH, 2002, AM J MED, V113, P91, DOI 10.1016/S0002-9343(02)01169-5; Cohen SS, 2012, AM J EPIDEMIOL, V176, P431, DOI 10.1093/aje/kws032; Crum-Cianflone N, 2008, AIDS PATIENT CARE ST, V22, P925, DOI 10.1089/apc.2008.0082; Crum-Cianflone NF, 2011, CLIN VACCINE IMMUNOL, V18, P940, DOI 10.1128/CVI.00020-11; Crum-Cianflone NF, 2010, AIDS, V24, P1069, DOI 10.1097/QAD.0b013e328337fe01; Department for Health and Human Services, GUIDELINES USE ANTIR; Ekali LG, 2013, DIABETES METAB, V39, P71, DOI 10.1016/j.diabet.2012.08.012; Flegal KM, 2014, AM J EPIDEMIOL, V180, P288, DOI 10.1093/aje/kwu111; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; French AL, 2009, JAIDS-J ACQ IMM DEF, V51, P399, DOI 10.1097/QAI.0b013e3181acb4e5; Grabowski DC, 2001, J AM GERIATR SOC, V49, P968, DOI 10.1046/j.1532-5415.2001.49189.x; GUENTER P, 1993, J ACQ IMMUN DEF SYND, V6, P1130; Hodgson LM, 2001, AIDS, V15, P2341, DOI 10.1097/00002030-200111230-00024; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; Jones CY, 2003, CLIN INFECT DIS, V37, pS69, DOI 10.1086/375889; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Koethe JR, 2011, CLIN INFECT DIS, V53, P952, DOI 10.1093/cid/cir606; Lakoski SG, 2011, J CLIN ENDOCR METAB, V96, P1805, DOI 10.1210/jc.2010-3055; Maskew M, 2013, J WOMENS HEALTH, V22, P113, DOI 10.1089/jwh.2012.3585; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Melchior JC, 1999, NUTRITION, V15, P865, DOI 10.1016/S0899-9007(99)00210-5; Murphy K, 2013, AIDS, V27, P2413, DOI 10.1097/01.aids.0000432537.92958.73; Park SY, 2012, EUR J EPIDEMIOL, V27, P489, DOI 10.1007/s10654-012-9695-5; Paton NI, 2006, HIV MED, V7, P323, DOI 10.1111/j.1468-1293.2006.00383.x; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reis JP, 2009, ANN EPIDEMIOL, V19, P134, DOI 10.1016/j.annepidem.2008.10.008; Seidell JC, 2000, EUR J CLIN NUTR, V54, pS33, DOI 10.1038/sj.ejcn.1601023; Shor-Posner G, 2000, J ACQ IMMUN DEF SYND, V23, P81; Shuter J, 2001, J ACQ IMMUN DEF SYND, V26, P291, DOI 10.1097/00126334-200103010-00013; Stevens J, 1998, OBES RES, V6, P268, DOI 10.1002/j.1550-8528.1998.tb00349.x; STEVENS J, 1992, ARCH INTERN MED, V152, P1257, DOI 10.1001/archinte.152.6.1257; SUTTMANN U, 1995, J ACQ IMMUN DEF SYND, V8, P239, DOI 10.1097/00042560-199503010-00004; Tedaldi EM, 2006, JAIDS-J ACQ IMM DEF, V43, P35, DOI 10.1097/01.qai.0000234084.11291.d4; Tien PC, 2012, JAIDS-J ACQ IMM DEF, V61, P334, DOI 10.1097/QAI.0b013e31826bfc32; Troiano RP, 1996, INT J OBESITY, V20, P63; Womack J, 2007, METABOLISM, V56, P998, DOI 10.1016/j.metabol.2007.03.008; Xiao Q, 2014, OBESITY, V22, P260, DOI 10.1002/oby.20412	54	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0143740	10.1371/journal.pone.0143740	http://dx.doi.org/10.1371/journal.pone.0143740			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699870	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600009
J	Winiarczyk, M; Winiarczyk, D; Banach, T; Adaszek, L; Madany, J; Mackiewicz, J; Pietras-Ozga, D; Winiarczyk, S				Winiarczyk, Mateusz; Winiarczyk, Dagmara; Banach, Tomasz; Adaszek, Lukasz; Madany, Jacek; Mackiewicz, Jerzy; Pietras-Ozga, Dorota; Winiarczyk, Stanislaw			Dog Tear Film Proteome In-Depth Analysis	PLOS ONE			English	Article							PROTEINS; FLUID; PROFILES; PATTERNS; HEALTHY; COW	In this study, mass spectrometry was used to explore the canine tear proteome. Tear samples were obtained from six healthy dogs, and one-dimensional sodium dodecyl sulphate polyacrylamide gel electrophoresis (1D SDS-PAGE) was used as a first step to separate intact proteins into 17 bands. Each fraction was then trypsin digested and analysed by matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry (MALDI-TOF-MS/MS) to characterize the protein components in each fraction. In total, 125 tear proteins were identified, with MCA (Major Canine Allergen), Serum albumin, UPF0557 protein C10orf119 homolog, Collagen alpha-2(I) chain, Tyrosine -protein kinase Fer, Keratine type II cytoskeletal, Beta-crystallin B2, Interleukin-6 and Desmin occuring as the most confident ones with the highest scores. The results showed that the proteomic strategy used in this study was successful in the analysis of the dog tear proteome. To the best of our knowledge, this study is the first to report the comprehensive proteome profile of tears from healthy dogs by 1D SDS PAGE and MALDI-TOF. Data are available via ProteomeX-change with identifier PXD003124.	[Winiarczyk, Mateusz; Mackiewicz, Jerzy] Med Univ Lublin, Dept Vitreoretinal Surg, PL-20079 Lublin, Poland; [Winiarczyk, Dagmara; Madany, Jacek] Univ Life Sci, Dept & Clin Anim Internal Dis, PL-20612 Lublin, Poland; [Banach, Tomasz; Adaszek, Lukasz; Pietras-Ozga, Dorota; Winiarczyk, Stanislaw] Univ Life Sci, Dept Epizootiol, PL-20612 Lublin, Poland; [Banach, Tomasz; Adaszek, Lukasz; Pietras-Ozga, Dorota; Winiarczyk, Stanislaw] Univ Life Sci, Clin Infect Dis, PL-20612 Lublin, Poland	Medical University of Lublin	Winiarczyk, S (corresponding author), Univ Life Sci, Dept Epizootiol, Gleboka 30, PL-20612 Lublin, Poland.	genp53@interia.pl	Winiarczyk, Mateusz/S-9712-2019	Adaszek, Lukasz/0000-0003-0261-2695; Winiarczyk, Dagmara/0000-0002-1257-869X; Winiarczyk, Mateusz/0000-0001-9704-3848; PIETRAS-OZGA, DOROTA/0000-0002-1580-9254; Banach, Tomasz/0000-0003-2567-5592				Adaszek L, 2014, PARASITOL RES, V113, P4293, DOI 10.1007/s00436-014-4124-1; Ananthi S, 2011, EXP EYE RES, V92, P454, DOI 10.1016/j.exer.2011.03.002; Banach T, 2013, POL J VET SCI, V16, P587, DOI 10.2478/pjvs-2013-0083; Bohm D, 2012, ONCOL REP, V28, P429, DOI 10.3892/or.2012.1849; Campos CD, 2008, RES VET SCI, V85, P349, DOI 10.1016/j.rvsc.2007.11.006; Chen ZY, 2011, MOL VIS, V17, P323; DAVIDSON HJ, 1994, ADV EXP MED BIOL, V350, P331; Evans V, 2001, CLIN EXP OPHTHALMOL, V29, P161, DOI 10.1046/j.1442-9071.2001.00408.x; Funke S, 2012, J PROTEOMICS, V75, P3177, DOI 10.1016/j.jprot.2012.03.018; Gonzalez N, 2012, MOL VIS, V18, P1572; Green-Church KB, 2008, MOL VIS, V14, P456; Grus FH, 2007, PROTEOM CLIN APPL, V1, P876, DOI 10.1002/prca.200700105; Hemsley S, 2000, RES VET SCI, V68, P207, DOI 10.1053/rvsc.1999.0358; Herber S, 2002, ADV EXP MED BIOL, V506, P623; Herber S, 2001, ELECTROPHORESIS, V22, P1838, DOI 10.1002/1522-2683(200105)22:9<1838::AID-ELPS1838>3.0.CO;2-7; Kim HJ, 2012, CLIN BIOCHEM, V45, P60, DOI 10.1016/j.clinbiochem.2011.10.006; Li N, 2005, J PROTEOME RES, V4, P2052, DOI 10.1021/pr0501970; Pong JCF, 2010, ANAL BIOCHEM, V404, P82, DOI 10.1016/j.ab.2010.04.036; Shamsi FA, 2011, INVEST OPHTH VIS SCI, V52, P9156, DOI 10.1167/iovs.11-8301; THORIG L, 1985, CURR EYE RES, V4, P913, DOI 10.3109/02713688509095259; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; You JJ, 2013, ADV CLIN CHEM, V62, P151, DOI 10.1016/B978-0-12-800096-0.00004-4; Zhao ZJ, 2010, EXP EYE RES, V90, P344, DOI 10.1016/j.exer.2009.11.013; Zhou L, 2006, ANN ACAD MED SINGAP, V35, P400; Zhou L, 2012, PROG RETIN EYE RES, V31, P527, DOI 10.1016/j.preteyeres.2012.06.002; Zhou L, 2012, J PROTEOMICS, V75, P3877, DOI 10.1016/j.jprot.2012.04.053	27	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144242	10.1371/journal.pone.0144242	http://dx.doi.org/10.1371/journal.pone.0144242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701646	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600018
J	Awad, SF; Sgaier, SK; Tambatamba, BC; Mohamoud, YA; Lau, FK; Reed, JB; Njeuhmeli, E; Abu-Raddad, LJ				Awad, Susanne F.; Sgaier, Sema K.; Tambatamba, Bushimbwa C.; Mohamoud, Yousra A.; Lau, Fiona K.; Reed, Jason B.; Njeuhmeli, Emmanuel; Abu-Raddad, Laith J.			Investigating Voluntary Medical Male Circumcision Program Efficiency Gains through Subpopulation Prioritization: Insights from Application to Zambia	PLOS ONE			English	Article							HIV PREVENTION; SEXUAL PARTNERSHIPS; TRANSMISSION; IMPACT; RISK; MEN; INFECTION; PATTERNS; BEHAVIOR; SPREAD	Background Countries in sub-Saharan Africa are scaling-up voluntary male medical circumcision (VMMC) as an HIV intervention. Emerging challenges in these programs call for increased focus on program efficiency (optimizing program impact while minimizing cost). A novel analytic approach was developed to determine how subpopulation prioritization can increase program efficiency using an illustrative application for Zambia. Methods and Findings A population-level mathematical model was constructed describing the heterosexual HIV epidemic and impact of VMMC programs (age-structured mathematical (ASM) model). The model stratified the population according to sex, circumcision status, age group, sexual-risk behavior, HIV status, and stage of infection. A three-level conceptual framework was also developed to determine maximum epidemic impact and program efficiency through subpopulation prioritization, based on age, geography, and risk profile. In the baseline scenario, achieving 80% VMMC coverage by 2017 among males 15-49 year old, 12 VMMCs were needed per HIV infection averted (effectiveness). The cost per infection averted (cost-effectiveness) was USD $1,089 and 306,000 infections were averted. Through age-group prioritization, effectiveness ranged from 11 (20-24 age-group) to 36 (45-49 age-group); cost-effectiveness ranged from $888 (20-24 age-group) to $3,300 (45-49 age-group). Circumcising 10-14, 15-19, or 20-24 year old achieved the largest incidence rate reduction; prioritizing 15-24, 15-29, or 15-34 year old achieved the greatest program efficiency. Through geographic prioritization, effectiveness ranged from 9-12. Prioritizing Lusaka achieved the highest effectiveness. Through risk-group prioritization, prioritizing the highest risk group achieved the highest effectiveness, with only one VMMC needed per infection averted; the lowest risk group required 80 times more VMMCs. Conclusion Epidemic impact and efficiency of VMMC programs can be improved by prioritizing young males (sexually active or just before sexual debut), geographic areas with higher HIV prevalence than the national, and high sexual-risk groups.	[Awad, Susanne F.; Mohamoud, Yousra A.; Abu-Raddad, Laith J.] Cornell Univ, Qatar Fdn, Weill Cornell Med Coll Qatar, Infect Dis Epidemiol Grp, Doha, Qatar; [Sgaier, Sema K.; Lau, Fiona K.] Bill & Melinda Gates Fdn, Global Dev Program, Integrated Delivery, Seattle, WA USA; [Sgaier, Sema K.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Tambatamba, Bushimbwa C.] Minist Community Dev & Mother & Child Hlth, Lusaka, Zambia; [Reed, Jason B.] Off US Global AIDS Coordinator, Washington, DC USA; [Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DC 20523 USA; [Abu-Raddad, Laith J.] Cornell Univ, Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY 10021 USA; [Abu-Raddad, Laith J.] Hamad bin Khalifa Univ, Qatar Fdn, Coll Publ Hlth, Doha, Qatar	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Bill & Melinda Gates Foundation; University of Washington; University of Washington Seattle; United States Agency for International Development (USAID); Cornell University; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar	Abu-Raddad, LJ (corresponding author), Cornell Univ, Qatar Fdn, Weill Cornell Med Coll Qatar, Infect Dis Epidemiol Grp, Doha, Qatar.	lja2002@qatar-med.cornell.edu	Abu-Raddad, Laith J/AAY-1441-2020	Abu-Raddad, Laith J/0000-0003-0790-0506	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This publication is based on research funded by the Bill & Melinda Gates Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2008, AIDS, V22, P1055, DOI 10.1097/QAD.0b013e3282f8af84; Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Alsallaq RA, 2009, EPIDEMICS-NETH, V1, P139, DOI 10.1016/j.epidem.2009.08.001; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Awad S, 2012, INT J INFECT DIS, V16, pE180, DOI 10.1016/j.ijid.2012.05.737; Awad SF, 2015, MATHEMATICAL MODELIN; Awad SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140818; Awad SF, 2014, EPIDEMICS-NETH, V8, P9, DOI 10.1016/j.epidem.2014.06.001; Baeten JM, 2010, AIDS, V24, P737, DOI 10.1097/QAD.0b013e32833616e0; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Barabasi A., 2003, LINKED HOW EVERYTHIN; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Chemaitelly H, 2014, EPIDEMICS-NETH, V6, P1, DOI 10.1016/j.epidem.2013.11.001; Chemaitelly H, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18765; Chemaitelly H, 2012, SEX TRANSM INFECT, V88, P51, DOI 10.1136/sextrans-2011-050114; Cleland J, 2004, SEX TRANSM INFECT, V80, P1, DOI 10.1136/sti.2004.013151; Cuadros DF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-216; Drummond M, 1999, METHODS FOR THE ECON; GARNETT GP, 1993, PHILOS T R SOC B, V342, P137, DOI 10.1098/rstb.1993.0143; GARNETT GP, 1994, IMA J MATH APPL MED, V11, P161; Gray RH, 2007, AIDS, V21, P845, DOI 10.1097/QAD.0b013e3280187544; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Grund JM, 2012, AIDS CARE, V24, P245, DOI 10.1080/09540121.2011.596516; Haddix A, 1996, PREVENTION EFFECTIVE; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hallett TB, 2011, SEX TRANSM INFECT, V87, P88, DOI 10.1136/sti.2010.043372; Hamilton DT, 2008, SEX TRANSM DIS, V35, P30, DOI 10.1097/OLQ.0b013e3181453a84; Handcock MS, 2004, THEOR POPUL BIOL, V65, P413, DOI 10.1016/j.tpb.2003.09.006; HOGAN DR, 2005, BRIT MED J, V331, P1431, DOI DOI 10.1136/BMJ.38643.368692.68; [Joint United Nations Programme on HIV/AIDS (UNAIDS) WHO], 2007, WHO UNAIDS TECHNICAL; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Nagelkerke NJD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-16; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Republic of Zambia Ministry of Health, 2012, COUNTRY OPERATIONAL; Rosario IJ, 2013, CURR UROL REP, V14, P285, DOI 10.1007/s11934-013-0343-8; Sgaier SK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001641; Sgaier SK, 2014, PERFORMED VOLUNTARY; The MathWorks Inc., 2015, MATLAB THE LANGUAGE; UNAIDS, 2011, POLITICAL DECLARATIO; UNAIDS, 2012, GLOBAL AIDS RESPONSE; UNAIDS, 2012, ANNUAL UNAIDS REPORT; UNAIDS, 2014, ENDING THE AIDS EPID; UNAIDS, 2013, EPIDEMIOLOGICAL DATA; United Nations Department of Economic and Social Affairs, 2012, WORLD POPULATION PRO; [University of Zambia Lusaka Zambia Tropical Diseases Research Centre Ndola Zambia and Macro International Inc.Calverton Maryland Central Statistical Office MoH], 2009, 2007 FINAL REPORT; Vandament L., 2013, COUNTRY LEVEL DATA; Vandament L., 2013, PROGRAM CIRCUMCISION; Vandament L., 2013, VOLUNTARY MEDICAL MA; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Weiss HA, 2009, LANCET INFECT DIS, V9, P669, DOI 10.1016/S1473-3099(09)70235-X; Westercamp N, 2014, AIDS BEHAV, V18, P1764, DOI 10.1007/s10461-014-0846-4; White RG, 2008, AIDS, V22, P1841, DOI 10.1097/QAD.0b013e32830e0137; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; World Health Organization, 2013, GLOBAL UPDATE ON HIV; World Health Organization (WHO), 2011, JOINT STRATEGIC ACTI	60	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145729	10.1371/journal.pone.0145729	http://dx.doi.org/10.1371/journal.pone.0145729			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716442	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500063
J	Cao, L; Yao, GY; Liu, MF; Chen, LJ; Hu, XL; Ye, CS				Cao, Li; Yao, Guang-yu; Liu, Min-feng; Chen, Lu-jia; Hu, Xiao-lei; Ye, Chang-sheng			Neoadjuvant Bevacizumab plus Chemotherapy versus Chemotherapy Alone to Treat Non-Metastatic Breast Cancer: A Meta-Analysis of Randomised Controlled Trials	PLOS ONE			English	Article							PATHOLOGICAL COMPLETE RESPONSE; SYSTEMIC TREATMENT; OPEN-LABEL; PHASE-3 TRIAL; DOCETAXEL; SURVIVAL; CYCLOPHOSPHAMIDE; ASSOCIATION; MASTECTOMY; THERAPY	Purpose Results from previous randomised controlled trials (RCTs) investigating whether the addition of bevacizumab to neoadjuvant chemotherapy (NAC) could statistically significantly increase the pathological complete response (pCR) and to identify which subgroup would benefit most from such regimens have produced conflicting results. This meta-analysis was designed to assess the efficacy and safety of bevacizumab plus chemotherapy compared with chemotherapy alone in the neoadjuvant setting. Methods A literature search of MEDLINE, EMBASE, Web of Science, and the Cochrane library was performed to identify eligible studies. The primary endpoint of interest was pCR. The secondary endpoints were clinical complete rate (cCR), surgery rate, breast-conserving surgery (BCS) rate, and toxicity. The meta-analysis was performed using Review Manager software version 5.3. Results Nine RCTs matched the selection criteria, yielding a total of 4967 patients (bevacizumab plus chemotherapy: 50.1%, chemotherapy alone: 49.9%). The results of this meta-analysis demonstrated that the addition of bevacizumab to NAC significantly increased the pCR rate (odds ratio [OR] = 1.34 [1.18-1.54]; P < 0.0001) compared with chemotherapy alone. Subgroup analysis showed that the effect of bevacizumab was more pronounced in patients with HER2-negative cancer (OR = 1.34 [1.17-1.54]; P < 0.0001) compared with HER2-positive cancer (OR = 1.69 [0.90-3.20]; P = 0.11). Similarly, in patients with HER2-negative cancer, the effect of bevacizumab was also more pronounced in patients with HR-negative cancer (OR = 1.38 [1.09-1.74]; P = 0.007) compared with HR-positive cancer (OR = 1.36 [0.78-2.35]; P = 0.27). No significant differences were observed between the groups with respect to cCR, surgery rate, or BCS rate. Additionally bevacizumab was associated with a higher incidence of neutropenia, febrile neutropenia, and hand-foot syndrome. Conclusions Higher proportions of patients achieved pCR when bevacizumab was added to NAC compared with when they received chemotherapy alone; acceptable toxicities were also found. Subgroup analysis demonstrated that patients with histologically confirmed HER2-negative and HR-negative breast cancer benefited the most.	[Cao, Li; Yao, Guang-yu; Liu, Min-feng; Chen, Lu-jia; Hu, Xiao-lei; Ye, Chang-sheng] Southern Med Univ, Nanfang Hosp, Breast Ctr, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Ye, CS (corresponding author), Southern Med Univ, Nanfang Hosp, Breast Ctr, Guangzhou, Guangdong, Peoples R China.	yechangsheng2015@126.com			President Foundation of Nanfang Hospital, Southern Medical University [2014B017]	President Foundation of Nanfang Hospital, Southern Medical University	The President Foundation of Nanfang Hospital, Southern Medical University (No. 2014B017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkisson CD, 2012, ANN SURG ONCOL, V19, P1129, DOI 10.1245/s10434-011-2080-x; Alvarez RH, 2011, ONCOLOGIST, V16, P1684, DOI 10.1634/theoncologist.2011-0113; Bear HD, 2012, NEW ENGL J MED, V366, P310, DOI 10.1056/NEJMoa1111097; Bear HD, 2003, J CLIN ONCOL, V21, P4165, DOI 10.1200/JCO.2003.12.005; Berruti A, 2014, J CLIN ONCOL, V32, P3883, DOI 10.1200/JCO.2014.55.2836; Berruti A, 2008, ONCOLOGIST, V13, P1137, DOI 10.1634/theoncologist.2008-0162; Brouwers B, 2008, TUMOR BIOL, V29, P211, DOI 10.1159/000152938; Brufsky AM, 2011, J CLIN ONCOL, V29, P4286, DOI 10.1200/JCO.2010.34.1255; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chia S, 2008, J CLIN ONCOL, V26, P786, DOI 10.1200/JCO.2008.15.0243; Colleoni M, 2004, CLIN CANCER RES, V10, P6622, DOI 10.1158/1078-0432.CCR-04-0380; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Coudert B, 2014, LANCET ONCOL, V15, P1493, DOI 10.1016/S1470-2045(14)70475-9; de Azambuja E, 2014, LANCET ONCOL, V15, P1137, DOI 10.1016/S1470-2045(14)70320-1; Earl HM, 2015, LANCET ONCOL, V16, P656, DOI 10.1016/S1470-2045(15)70137-3; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Engebraaten O, 2015, CANC RES, V75; Gerber B, 2013, ANN ONCOL, V24, P2978, DOI 10.1093/annonc/mdt361; Golshan M, 2015, ANN SURG, V262, P434, DOI 10.1097/SLA.0000000000001417; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Houssami N, 2012, EUR J CANCER, V48, P3342, DOI 10.1016/j.ejca.2012.05.023; Hurvitz SA, 2012, CANC RES, V72; Jebbink M, 2015, BREAST CANCER RES TR, V153, P145, DOI 10.1007/s10549-015-3510-4; Kaufmann M, 2006, J CLIN ONCOL, V24, P1940, DOI 10.1200/JCO.2005.02.6187; Killelea BK, 2015, J AM COLL SURGEONS, V220, P1063, DOI 10.1016/j.jamcollsurg.2015.02.011; Lohmann AE, 2012, CURR TREAT OPTION ON, V13, P249, DOI 10.1007/s11864-012-0181-9; Luangdilok S, 2014, J BREAST CANCER, V17, P376, DOI 10.4048/jbc.2014.17.4.376; Makris A, 1998, ANN ONCOL, V9, P1179, DOI 10.1023/A:1008400706949; Mauri D, 2005, JNCI-J NATL CANCER I, V97, P188, DOI 10.1093/jnci/dji021; Metcalfe KA, 2008, J CLIN ONCOL, V26, P1093, DOI 10.1200/JCO.2007.12.6078; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Nahleh ZA, 2015, CANC RES, V75; Ring AE, 2004, BRIT J CANCER, V91, P2012, DOI 10.1038/sj.bjc.6602235; Robert NJ, 2011, J CLIN ONCOL, V29, P1252, DOI 10.1200/JCO.2010.28.0982; Sikov WM, 2015, J CLIN ONCOL, V33, P13, DOI 10.1200/JCO.2014.57.0572; Steger GG, 2015, CANC RES, V75; Valachis A, 2014, BREAST CANCER RES TR, V144, P443, DOI 10.1007/s10549-014-2890-1; van der Hage JA, 2001, J CLIN ONCOL, V19, P4224, DOI 10.1200/JCO.2001.19.22.4224; von Minckwitz G, 2014, ANN ONCOL, V25, P2363, DOI 10.1093/annonc/mdu455; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; von Minckwitz G, 2012, NEW ENGL J MED, V366, P299, DOI 10.1056/NEJMoa1111065; Wang-Lopez Q, 2015, CRIT REV ONCOL HEMAT, V95, P88, DOI 10.1016/j.critrevonc.2015.02.011	43	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145442	10.1371/journal.pone.0145442	http://dx.doi.org/10.1371/journal.pone.0145442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717149	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500035
J	Bekal, S; Domier, LL; Gonfa, B; Lakhssassi, N; Meksem, K; Lambert, KN				Bekal, Sadia; Domier, Leslie L.; Gonfa, Biruk; Lakhssassi, Naoufal; Meksem, Khalid; Lambert, Kris N.			A SNARE-Like Protein and Biotin Are Implicated in Soybean Cyst Nematode Virulence	PLOS ONE			English	Article							HETERODERA-GLYCINES; EFFECTOR PROTEIN; GLOBODERA-ROSTOCHIENSIS; MELOIDOGYNE-JAVANICA; CHORISMATE MUTASE; PLANT-RESISTANCE; MEMBRANE-FUSION; HOST-DEFENSE; PARASITISM; EXPRESSION	Phytoparasitic nematodes that are able to infect and reproduce on plants that are considered resistant are referred to as virulent. The mechanism(s) that virulent nematodes employ to evade or suppress host plant defenses are not well understood. Here we report the use of a genetic strategy (allelic imbalance analysis) to associate single nucleotide polymorphisms (SNPs) with nematode virulence genes in Heterodera glycines, the soybean cyst nematode (SCN). To accomplish this analysis, a custom SCN SNP array was developed and used to genotype SCN F3-derived populations grown on resistant and susceptible soybean plants. Three SNPs reproducibly showed allele imbalances between nematodes grown on resistant and susceptible plants. Two candidate SCN virulence genes that were tightly linked to the SNPs were identified. One SCN gene encoded biotin synthase (HgBioB), and the other encoded a bacterial-like protein containing a putative SNARE domain (HgSLP-1). The two genes mapped to two different linkage groups. HgBioB contained sequence polymorphisms between avirulent and virulent nematodes. However, the gene encoding HgSLP-1 had reduced copy number in virulent nematode populations and appears to produce multiple forms of the protein via intron retention and alternative splicing. We show that HgSLP-1 is an esophageal-gland protein that is secreted by the nematode during plant parasitism. Furthermore, in bacterial co-expression experiments, HgSLP-1 co-purified with the SCN resistance protein Rhg1 alpha-SNAP, suggesting that these two proteins physically interact. Collectively our data suggest that multiple SCN genes are involved in SCN virulence, and that HgSLP-1 may function as an avirulence protein and when absent it helps SCN evade host defenses.	[Domier, Leslie L.; Gonfa, Biruk; Lambert, Kris N.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Bekal, Sadia; Lakhssassi, Naoufal; Meksem, Khalid] So Illinois Univ, Dept Plant Soil & Agr Syst, Carbondale, IL 62901 USA	University of Illinois System; University of Illinois Urbana-Champaign; Southern Illinois University System; Southern Illinois University	Lambert, KN (corresponding author), Univ Illinois, Dept Crop Sci, 1102 S Goodwin Ave, Urbana, IL 61801 USA.	knlamber@illinois.edu	Meksem, Khalid/AAD-3101-2022; Lakhssassi, Naoufal/AAH-4641-2019	Lakhssassi, Naoufal/0000-0002-8255-9419; Meksem, Khalid/0000-0002-9469-9718	United Soybean Board [1420-532-5620]; North Central Soybean Research Program [NCSRP 2010-07360]; Illinois Soybean Association [09ISA354291]; United Stated Department of Agriculture, National Institute of Food and Agriculture, Agricultural and Food Research Initiative [2008-04061]; ARS [ARS-0422909] Funding Source: Federal RePORTER	United Soybean Board; North Central Soybean Research Program; Illinois Soybean Association; United Stated Department of Agriculture, National Institute of Food and Agriculture, Agricultural and Food Research Initiative; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported by the United Soybean Board (Proposal Number: 1420-532-5620, PI: KNL) (http://unitedsoybean.org/); North Central Soybean Research Program (Proposal Number: NCSRP 2010-07360, PI: KNL) (http://www.ncsrp.com); Illinois Soybean Association (Proposal Number: 09ISA354291, PI KNL) (http://www.ilsoy.org/); United Stated Department of Agriculture, National Institute of Food and Agriculture, Agricultural and Food Research Initiative (Proposal Number: 2008-04061, PI: KNL) (http://nifa.usda.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2010, ADV BOT RES, V53, P147, DOI 10.1016/S0065-2296(10)53005-2; Atibalentja N, 2005, MOL GENET GENOMICS, V273, P273, DOI 10.1007/s00438-005-1125-x; Barnard RJO, 1996, MOL BIOL CELL, V7, P693, DOI 10.1091/mbc.7.5.693; Bekal S, 2003, MOL PLANT MICROBE IN, V16, P439, DOI 10.1094/MPMI.2003.16.5.439; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Carlson CS, 2006, HUM MOL GENET, V15, P1931, DOI 10.1093/hmg/ddl115; Castagnone-Sereno P, 2009, MOL GENET GENOMICS, V282, P547, DOI 10.1007/s00438-009-0487-x; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Concibido VC, 2004, CROP SCI, V44, P1121, DOI 10.2135/cropsci2004.1121; Cook D, 2014, PLANT PHYSL; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; Craig JP, 2008, MOL BIOL EVOL, V25, P2085, DOI 10.1093/molbev/msn141; Craig JP, 2009, J NEMATOL, V41, P281; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; Dong K, 1997, GENETICS, V146, P1311; Doyle EA, 2003, MOL PLANT MICROBE IN, V16, P123, DOI 10.1094/MPMI.2003.16.2.123; DROPKIN VH, 1969, ANNU REV PHYTOPATHOL, V7, P101, DOI 10.1146/annurev.py.07.090169.000533; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; ENDO BY, 1963, PHYTOPATHOLOGY, V53, P622; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Feng YJ, 2014, MOL MICROBIOL, V91, P300, DOI 10.1111/mmi.12460; Gleason CA, 2008, MOL PLANT MICROBE IN, V21, P576, DOI 10.1094/MPMI-21-5-0576; Hamamouch N, 2012, J EXP BOT, V63, P3683, DOI 10.1093/jxb/ers058; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; Hewezi T, 2010, PLANT PHYSIOL, V152, P968, DOI 10.1104/pp.109.150557; Hyten DL, 2009, CROP SCI, V49, P265, DOI 10.2135/cropsci2008.08.0511; Jaouannet M, 2013, MOL PLANT MICROBE IN, V26, P97, DOI 10.1094/MPMI-05-12-0130-R; Jones JT, 2004, GENE, V324, P47, DOI 10.1016/j.gene.2003.09.051; Kalde M, 2007, P NATL ACAD SCI USA, V104, P11850, DOI 10.1073/pnas.0701083104; Kim H, 2014, PLANT J, V79, P835, DOI 10.1111/tpj.12591; Lambert KN, 1999, MOL PLANT MICROBE IN, V12, P328, DOI 10.1094/MPMI.1999.12.4.328; Lambert KN, 2005, MOL PLANT MICROBE IN, V18, P593, DOI 10.1094/MPMI-18-0593; Liu Ren-Hu, 2003, Yichuan, V25, P317; Liu SM, 2012, NATURE, V492, P256, DOI 10.1038/nature11651; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozano-Torres JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004569; Lozano-Torres JL, 2012, P NATL ACAD SCI USA, V109, P10119, DOI 10.1073/pnas.1202867109; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Matsye PD, 2012, PLANT MOL BIOL, V80, P131, DOI 10.1007/s11103-012-9932-z; Mitchum MG, 2013, NEW PHYTOL, V199, P879, DOI 10.1111/nph.12323; NIBLACK TL, 1993, J NEMATOL, V25, P880; Pant SR, 2014, PLANT MOL BIOL; Patel N, 2010, J EXP BOT, V61, P235, DOI 10.1093/jxb/erp293; Paumet F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007375; Prior A, 2001, BIOCHEM J, V356, P387, DOI 10.1042/0264-6021:3560387; Quentin M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00053; Rehman S, 2009, MOL PLANT MICROBE IN, V22, P330, DOI 10.1094/MPMI-22-3-0330; Rodriguez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021925; Sacco MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000564; Schmitt DP, 2004, BIOL MANAGEMENT SOYB, Vxi; Semblat JP, 2001, MOL PLANT MICROBE IN, V14, P72, DOI 10.1094/MPMI.2001.14.1.72; Smant G, 1998, P NATL ACAD SCI USA, V95, P4906, DOI 10.1073/pnas.95.9.4906; Smant G, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P273, DOI 10.1007/978-94-007-0434-3_13; Vivona S, 2013, J BIOL CHEM, V288, P24984, DOI 10.1074/jbc.M113.489807; Wesolowski J, 2010, VIRULENCE, V1, P319, DOI 10.4161/viru.1.4.12195; Williamson VM, 2006, TRENDS GENET, V22, P396, DOI 10.1016/j.tig.2006.05.003; Wong KK, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh072; Wrather JA, 2006, J NEMATOL, V38, P173; Wu Y, 2007, EFFICIENT ACCURATE C, P395; Zempleni J, 2009, BIOFACTORS, V35, P36, DOI 10.1002/biof.8	62	36	39	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145601	10.1371/journal.pone.0145601	http://dx.doi.org/10.1371/journal.pone.0145601			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714307	Green Submitted, Green Published, gold			2022-12-27	WOS:000367481900060
J	Coscia, M; Hausmann, R				Coscia, Michele; Hausmann, Ricardo			Evidence That Calls-Based and Mobility Networks Are Isomorphic	PLOS ONE			English	Article							SPILLOVERS; TRADE	Social relations involve both face-to-face interaction as well as telecommunications. We can observe the geography of phone calls and of the mobility of cell phones in space. These two phenomena can be described as networks of connections between different points in space. We use a dataset that includes billions of phone calls made in Colombia during a six-month period. We draw the two networks and find that the call-based network resembles a higher order aggregation of the mobility network and that both are isomorphic except for a higher spatial decay coefficient of the mobility network relative to the call-based network: when we discount distance effects on the call connections with the same decay observed for mobility connections, the two networks are virtually indistinguishable.	[Coscia, Michele; Hausmann, Ricardo] Harvard Univ, Ctr Int Dev, Cambridge, MA 02138 USA	Harvard University	Coscia, M (corresponding author), Harvard Univ, Ctr Int Dev, Cambridge, MA 02138 USA.	michele_coscia@hks.harvard.edu	Coscia, Michele/AGJ-5531-2022	Coscia, Michele/0000-0001-5984-5137				Amini A, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds31; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; BERGSTRAND JH, 1985, REV ECON STAT, V67, P474, DOI 10.2307/1925976; Berry B.J.L., 1961, CENTRAL PLACE STUDIE; Bottazzi L, 2003, EUR ECON REV, V47, P687, DOI 10.1016/S0014-2921(02)00307-0; Branstetter LG, 2001, J INT ECON, V53, P53, DOI 10.1016/S0022-1996(00)00068-4; Cha M, P 18 INT C WORLD WID, P721, DOI DOI 10.1145/1526709.1526806; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; Coscia Michele, 2011, Statistical Analysis and Data Mining, V4, P514, DOI 10.1002/sam.10133; De Domenico M, 2013, PERVASIVE MOB COMPUT, V9, P798, DOI 10.1016/j.pmcj.2013.07.008; Duranton G, 2013, DELINEATING METROPOL; Halloran ME, 2014, SCIENCE, V346, P433, DOI 10.1126/science.346.6208.433-a; HOLM S, 1979, SCAND J STAT, V6, P65; Jaffe A. B., 1992, GEOGRAPHIC LOCALIZAT; Keller W, 2002, J ECON GROWTH, V7, P5, DOI 10.1023/A:1013461025733; Keller W, 2009, REV ECON STAT, V91, P821, DOI 10.1162/rest.91.4.821; Kleinert J, 2010, REV INT ECON, V18, P1, DOI 10.1111/j.1467-9396.2009.00869.x; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lambiotte R, 2008, PHYSICA A, V387, P5317, DOI 10.1016/j.physa.2008.05.014; Llorente A, 2014, ARXIV14113140; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Miritello G., 2013, TEMPORAL NETWORKS, P175, DOI DOI 10.1007/978-3-642-36461-7_9; Musolesi M., 2007, ACM SIGMOBILE MOB CO, V11, P59, DOI DOI 10.1145/1317425.1317433; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Pennacchioli Diego, 2013, 2013 IEEE International Conference on Big Data, P648, DOI 10.1109/BigData.2013.6691634; Ratti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014248; Rinzivillo S, 2012, KUNSTL INTELL, V26, P253, DOI 10.1007/s13218-012-0181-8; Rosvall M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018209; Santi P, 2014, P NATL ACAD SCI USA, V111, P13290, DOI 10.1073/pnas.1403657111; Scellato Salvatore, 2010, WOSN; Schneider CM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0246; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Shmueli Erez, 2015, Social Computing, Behavioral-Cultural Modeling and Prediction. 8th International Conference, SBP 2015. Proceedings: LNCS 9021, P434, DOI 10.1007/978-3-319-16268-3_55; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; Takhteyev Y, 2012, SOC NETWORKS, V34, P73, DOI 10.1016/j.socnet.2011.05.006; Thiemann C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015422; Toole JL, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1128; Toole JL, 2014, ARXIV14030636; Toole JL, 2015, ARXIV150506791; Wang D., 2011, P 17 ACM SIGKDD INT, P1100, DOI DOI 10.1145/2020408.2020581	41	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145091	10.1371/journal.pone.0145091	http://dx.doi.org/10.1371/journal.pone.0145091			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0IX	26713730	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900031
J	Moy, K; Li, WY; Tran, HP; Simonis, V; Story, E; Brandon, C; Furst, J; Raicu, D; Kim, H				Moy, Kyle; Li, Weiyu; Tran, Huu Phuoc; Simonis, Valerie; Story, Evan; Brandon, Christopher; Furst, Jacob; Raicu, Daniela; Kim, Hongkyun			Computational Methods for Tracking, Quantitative Assessment, and Visualization of C-elegans Locomotory Behavior	PLOS ONE			English	Article							LEVY; MOVEMENT; SEROTONIN; SYSTEM; DOPAMINE; PATTERNS; CIRCUIT; SUCCESS; NEURONS	The nematode Caenorhabditis elegans provides a unique opportunity to interrogate the neural basis of behavior at single neuron resolution. In C. elegans, neural circuits that control behaviors can be formulated based on its complete neural connection map, and easily assessed by applying advanced genetic tools that allow for modulation in the activity of specific neurons. Importantly, C. elegans exhibits several elaborate behaviors that can be empirically quantified and analyzed, thus providing a means to assess the contribution of specific neural circuits to behavioral output. Particularly, locomotory behavior can be recorded and analyzed with computational and mathematical tools. Here, we describe a robust single worm-tracking system, which is based on the open-source Python programming language, and an analysis system, which implements path-related algorithms. Our tracking system was designed to accommodate worms that explore a large area with frequent turns and reversals at high speeds. As a proof of principle, we used our tracker to record the movements of wild-type animals that were freshly removed from abundant bacterial food, and determined how wild-type animals change locomotory behavior over a long period of time. Consistent with previous findings, we observed that wild-type animals show a transition from area-restricted local search to global search over time. Intriguingly, we found that wild-type animals initially exhibit short, random movements interrupted by infrequent long trajectories. This movement pattern often coincides with local/global search behavior, and visually resembles Levy flight search, a search behavior conserved across species. Our mathematical analysis showed that while most of the animals exhibited Brownian walks, approximately 20% of the animals exhibited Levy flights, indicating that C. elegans can use Levy flights for efficient food search. In summary, our tracker and analysis software will help analyze the neural basis of the alteration and transition of C. elegans locomotory behavior in a food-deprived condition.	[Moy, Kyle; Li, Weiyu; Tran, Huu Phuoc; Simonis, Valerie; Story, Evan; Furst, Jacob; Raicu, Daniela] Depaul Univ, Sch Comp, Coll Comp & Digital Media, Chicago, IL 60604 USA; [Brandon, Christopher; Kim, Hongkyun] Rosalind Franklin Univ, Dept Cell Biol & Anat, Chicago Med Sch, N Chicago, IL USA	DePaul University; Chicago Medical School; Rosalind Franklin University Medical & Science	Raicu, D (corresponding author), Depaul Univ, Sch Comp, Coll Comp & Digital Media, Chicago, IL 60604 USA.	draicu@cdm.depaul.edu; hongkyun.kim@rosalindfranklin.edu	Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526; Kim, Hongkyun/0000-0002-4879-7122				Abraham LS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001077; Ben Arous J, 2010, J NEUROSCI METH, V187, P229, DOI 10.1016/j.jneumeth.2010.01.011; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Brown AEX, 2013, P NATL ACAD SCI USA, V110, P791, DOI 10.1073/pnas.1211447110; Calhoun AJ, 2015, NEURON, V86, P428, DOI 10.1016/j.neuron.2015.03.026; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Codling EA, 2011, THEOR ECOL-NETH, V4, P397, DOI 10.1007/s12080-010-0086-9; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; Dray S, 2010, ECOL RES, V25, P673, DOI 10.1007/s11284-010-0701-7; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Faumont S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024666; Feng ZY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-115; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Humphries NE, 2014, J THEOR BIOL, V358, P179, DOI 10.1016/j.jtbi.2014.05.032; Humphries NE, 2012, P NATL ACAD SCI USA, V109, P7169, DOI 10.1073/pnas.1121201109; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Husson Steven J, 2013, WormBook, P1, DOI 10.1895/wormbook.1.156.1; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; Luo LJ, 2014, NEURON, V82, P1115, DOI 10.1016/j.neuron.2014.05.010; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; Nonet ML, 1998, J NEUROSCI, V18, P70; Peliti Margherita, 2013, PLoS One, V8, pe78535, DOI 10.1371/journal.pone.0078535; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Reynolds A, 2015, PHYS LIFE REV; Reynolds AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000354; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; TRENT C, 1983, GENETICS, V104, P619; Viswanathan G, 1996, INDIAN J BIOCHEM BIO, V33, P311; Viswanathan GM, 2010, NATURE, V465, P1018, DOI 10.1038/4651018a; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yemini E, 2013, NAT METHODS, V10, P877, DOI [10.1038/NMETH.2560, 10.1038/nmeth.2560]; Zhang M, 2008, CURR BIOL, V18, P1445, DOI 10.1016/j.cub.2008.08.047; Zhao K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1158; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	47	8	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145870	10.1371/journal.pone.0145870	http://dx.doi.org/10.1371/journal.pone.0145870			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713869	Green Submitted, Green Published, gold			2022-12-27	WOS:000367481900096
J	Okwechime, IO; Roberson, S; Odoi, A				Okwechime, Ifechukwude Obiamaka; Roberson, Shamarial; Odoi, Agricola			Prevalence and Predictors of Pre-Diabetes and Diabetes among Adults 18 Years or Older in Florida: A Multinomial Logistic Modeling Approach	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; PHYSICAL-ACTIVITY; RISK-FACTORS; INSULIN-RESISTANCE; HEALTH; HBA(1C); DISPARITIES; CARE; US; TOLERANCE	Background Individuals with pre-diabetes and diabetes have increased risks of developing macro-vascular complications including heart disease and stroke; which are the leading causes of death globally. The objective of this study was to estimate the prevalence of pre-diabetes and diabetes, and to investigate their predictors among adults >= 18 years in Florida. Methods Data covering the time period January-December 2013, were obtained from Florida's Behavioral Risk Factor Surveillance System (BRFSS). Survey design of the study was declared using SVYSET statement of STATA 13.1. Descriptive analyses were performed to estimate the prevalence of pre-diabetes and diabetes. Predictors of pre-diabetes and diabetes were investigated using multinomial logistic regression model. Model goodness-of-fit was evaluated using both the multinomial goodness-of-fit test proposed by Fagerland, Hosmer, and Bofin, as well as, the Hosmer-Lemeshow's goodness of fit test. Results There were approximately 2,983 (7.3%) and 5,189 (12.1%) adults in Florida diagnosed with pre-diabetes and diabetes, respectively. Over half of the study respondents were white, married and over the age of 45 years while 36.4% reported being physically inactive, overweight (36.4%) or obese (26.4%), hypertensive (34.6%), hypercholesteremic (40.3%), and 26% were arthritic. Based on the final multivariable multinomial model, only being overweight (Relative Risk Ratio [RRR] = 1.85, 95% Confidence Interval [95% CI] = 1.41, 2.42), obese (RRR = 3.41, 95% CI = 2.61, 4.45), hypertensive (RRR = 1.69, 95% CI = 1.33, 2.15), hypercholesterolemic (RRR = 1.94, 95% CI = 1.55, 2.43), and arthritic (RRR = 1.24, 95% CI = 1.00, 1.55) had significant associations with pre-diabetes. However, more predictors had significant associations with diabetes and the strengths of associations tended to be higher than for the association with pre-diabetes. For instance, the relative risk ratios for the association between diabetes and being overweight (RRR = 2.00, 95% CI = 1.55, 2.57), or obese (RRR = 4.04, 95% CI = 3.22, 5.07), hypertensive (RRR = 2.66, 95% CI = 2.08, 3.41), hypercholesterolemic (RRR = 1.98, 95% CI = 1.61, 2.45) and arthritic (RRR = 1.28, 95% CI = 1.04, 1.58) were all further away from the null than their associations with pre-diabetes. Moreover, a number of variables such as age, income level, sex, and level of physical activity had significant association with diabetes but not pre-diabetes. The risk of diabetes increased with increasing age, lower income, in males, and with physical inactivity. Insufficient physical activity had no significant association with the risk of diabetes or prediabetes. Conclusions There is evidence of differences in the strength of association of the predictors across levels of diabetes status (pre-diabetes and diabetes) among adults >= 18 years in Florida. It is important to monitor populations at high risk for pre-diabetes and diabetes, so as to help guide health programming decisions and resource allocations to control the condition.	[Okwechime, Ifechukwude Obiamaka; Odoi, Agricola] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA; [Roberson, Shamarial] Bur Chron Dis Prevent, Florida Dept Hlth, Tallahassee, FL USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Florida Department of Health	Odoi, A (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA.	aodoi@utk.edu	Odoi, Agricola/I-9532-2019	Odoi, Agricola/0000-0001-5050-6737				Abraham TM, 2013, DIABETES CARE, V36, P2139, DOI 10.2337/dc13-0792; Akter S, 2014, DIABETES CARE, V37, pE9, DOI 10.2337/dc13-1647; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], DIAGN DIAB LEARN PRE; Bardenheier BH, 2013, DIABETES CARE, V36, P2655, DOI 10.2337/dc12-2608; Barker LE, 2011, AM J PREV MED, V40, P434, DOI 10.1016/j.amepre.2010.12.019; Bowlin SJ, 1996, J CLIN EPIDEMIOL, V49, P511, DOI 10.1016/0895-4356(96)00010-8; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Brazeau AS, 2012, DIABETIC MED, V29, pE402, DOI 10.1111/j.1464-5491.2012.03757.x; Centers for Disease Control, 2020, NATL DIABETES STAT R; Centers for Disease Control and Prevention, 2015, ALL STAT PRED NUMB 1; Chasens ER, 2012, CLIN NURS RES, V21, P294, DOI 10.1177/1054773811411295; Chatterjee R, 2013, DIABETES CARE, V36, P1981, DOI 10.2337/dc12-1752; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Diaz-Redondo A, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-014-0216-3; Dinca-Panaitescu M, 2012, MATURITAS, V72, P229, DOI 10.1016/j.maturitas.2012.03.017; Dinca-Panaitescu S, 2011, HEALTH POLICY, V99, P116, DOI 10.1016/j.healthpol.2010.07.018; Dubowitz N, 2014, DIABETIC MED, V31, P927, DOI 10.1111/dme.12459; Fagerland MW, 2012, STATA J, V12, P447, DOI 10.1177/1536867X1201200307; Farni K, 2014, PEERJ, V2, DOI 10.7717/peerj.499; Farr JN, 2012, MED SCI SPORT EXER, V44, P1375, DOI 10.1249/MSS.0b013e31824749b2; Ferguson JF, 2015, METABOLISM, V64, P513, DOI 10.1016/j.metabol.2014.12.007; Gaskin DJ, 2014, AM J PUBLIC HEALTH, V104, P2147, DOI 10.2105/AJPH.2013.301420; Glechner A, 2015, DIABETOLOGIA, V58, P242, DOI 10.1007/s00125-014-3439-x; Graham E, 2015, PREV MED, V77, P74, DOI 10.1016/j.ypmed.2015.05.004; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Harada ND, 2001, MED SCI SPORT EXER, V33, P962, DOI 10.1097/00005768-200106000-00016; Hsu CC, 2012, DIABETES CARE, V35, P2286, DOI 10.2337/dc11-2052; Hu G, 2004, ARCH INTERN MED, V164, P892, DOI 10.1001/archinte.164.8.892; Hu Y, 2014, OBESITY, V22, P2267, DOI 10.1002/oby.20851; International-Diabetes-Federation, IDF DIAB ATL UPD POS; Islam FMA, 2016, J DIABETES, V8, P260, DOI 10.1111/1753-0407.12294; Lee LT, 2014, PREV MED, V63, P43, DOI 10.1016/j.ypmed.2014.02.013; Lipska KJ, 2013, DIABETES CARE, V36, P3923, DOI 10.2337/dc12-2631; Livingood WC, 2010, PREV CHRONIC DIS, V7; Logan H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-906; Mengesha Addisu Y, 2007, Afr Health Sci, V7, P244; Nelson KM, 2005, HEALTH SERV RES, V40, P361, DOI 10.1111/j.1475-6773.2005.0d362.x; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P673, DOI 10.2215/CJN.07891109; RaviKumar P, 2011, DIABETIC MED, V28, P590, DOI 10.1111/j.1464-5491.2011.03242.x; Rhee MK, 2006, DIABETIC MED, V23, P1174, DOI 10.1111/j.1464-5491.2006.01956.x; Ridic Goran, 2012, Mater Sociomed, V24, P112, DOI 10.5455/msm.2012.24.112-120; Saltevo JT, 2011, DIABETES RES CLIN PR, V93, P344, DOI 10.1016/j.diabres.2011.05.006; Solomon DH, 2010, ANN RHEUM DIS, V69, P2114, DOI 10.1136/ard.2009.125476; StataCorp, 2013, STATA STAT SOFTW REL; STEIN AD, 1995, AM J EPIDEMIOL, V141, P1097, DOI 10.1093/oxfordjournals.aje.a117375; Stryhn H., 2012, METHODS EPIDEMIOLOGI; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tester J, 2013, DIABETES METAB SYND, V7, P161, DOI 10.1016/j.dsx.2013.06.002; US Census Bureau, 2010, 2010 CENS INT POP SE; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028962; Woolf SH, 2011, HEALTH AFFAIR, V30, P1852, DOI 10.1377/hlthaff.2011.0685; Xu F, 2014, MMWR SURVEILL SUMM, V63, P1	55	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145781	10.1371/journal.pone.0145781	http://dx.doi.org/10.1371/journal.pone.0145781			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0IX	26714019	Green Published, gold			2022-12-27	WOS:000367481900081
J	Usta, M; Wein, LM				Usta, Mericcan; Wein, Lawrence M.			Assessing Risk-Based Policies for Pretrial Release and Split Sentencing in Los Angeles County Jails	PLOS ONE			English	Article								Court-mandated downsizing of the CA prison system has led to a redistribution of detainees from prisons to CA county jails, and subsequent jail overcrowding. Using data that is representative of the LA County jail system, we build a mathematical model that tracks the flow of individuals during arraignment, pretrial release or detention, case disposition, jail sentence, and possible recidivism during pretrial release, after a failure to appear in court, during non-felony probation and during felony supervision. We assess 64 joint pretrial release and splitsentencing (where low-level felon sentences are split between jail time and mandatory supervision) policies that are based on the type of charge (felony or non-felony) and the risk category as determined by the CA Static Risk Assessment tool, and compare their performance to that of the policy LA County used in early 2014, before split sentencing was in use. In our model, policies that offer split sentences to all low-level felons optimize the key tradeoff between public safety and jail congestion by, e.g., simultaneously reducing the rearrest rate by 7% and the mean jail population by 20% relative to the policy LA County used in 2014. The effectiveness of split sentencing is due to two facts: (i) convicted felony offenders comprised approximate to 45% of LA County's jail population in 2014, and (ii) compared to pretrial release, split sentencing exposes offenders to much less time under recidivism risk per saved jail day.	[Usta, Mericcan] Stanford Univ, Management Sci & Engn Dept, Stanford, CA 94305 USA; [Wein, Lawrence M.] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA	Stanford University; Stanford University	Wein, LM (corresponding author), Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA.	lwein@stanford.edu	Usta, Mericcan/K-6083-2017	Usta, Mericcan/0000-0001-6709-3983				American Civil Liberties Union of Southern California, 2013, LOS ANG COUNT JAIL P; Austin J. A., 2012, EVALUATION CURRENT F; Barton-Bellessa S. M., 2012, COMMUNITY BASED CORR; Beard J., 2014, 2013 OUTCOME EVALUAT; Berk Richard, 2014, USING REGRESSION KER; Blomberg T., 2010, VALIDATION COMPAS RI; Board of State and Community Corrections California, JAIL POP DASHB; CA Department of Corrections and Rehabilitation, 2015, COMPAS ASS TOOL LAUN; California State Department of Finance, 2015, 1468 AB CAL STAT DEP; Chalfin Aaron, 2013, ARE US CITIES UNDERP; CHUNG CF, 1991, J QUANTITATIVE CRIMI, V0007; Delgado M, 2013, PUBLIC SAFETY REALIG; Delgado M., 2012, PUBLIC SAFETY REALIG; Farabee D., 2010, COMPAS VALIDATION ST; Frazier C. E., 1985, J CRIM LAW CRIM, V1132, P1139; Freedman A. E., 2013, SANTA CLARA COUNTY A; Golden M., 2006, COST BENEFIT ANAL; Greene J. A, 2012, COST RESPONDING IMMI; Gross D., 1985, FUNDAMENTALS QUEUEIN; Hickert A. O., 2013, PRETRIAL RELEASE RIS; Jahr S., 2014, COURT REALIGNMENT DA; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Kelly F. P., 1991, ANN APPL PROBAB, V1, P319; LA County Sheriff's Department, 2013, YEAR IN REV 2012; Landes W. M., 1974, J LEGAL STUD, V287, P333; Lofstrom Magnus, 2015, INCARCERATION CRIME; Lowenkamp C. T., 2008, FED PROBAT, V72, P2; Petersilia Joan., 2014, HARVARD LAW POLICY R, V8; Powers J. E., 2015, PUBLIC SAFETY REALIG; Public Safety Realignment Team, 2013, PUBL SAF REAL YEAR 2; Public Safety Realignment Team, 2015, PUBL SAF REAL YEAR 3; SCHMIDT P, 1989, J ECONOMETRICS, V40, P141, DOI 10.1016/0304-4076(89)90034-1; Sharkey J., 2013, PUBLIC SAFETY REALIG; Shouse California Law Group, FEL PROB WORKS CAL; Shouse California Law Group, MISD SUMM PROB CAL; Tonry M, 2014, CRIMINOL PUBLIC POL, V13, P503, DOI 10.1111/1745-9133.12097; Turner S., 2009, DEV CALIFORNIA STATI; VanNostrand M., 2009, PRETRIAL RISK ASSESS; Vera Institute of Justice, 2011, LOS ANG COUNT JAIL O; Wen Hefei, 2014, 20537 NAT BUR EC RES; Wooldredge J, 2015, CRIMINOL PUBLIC POL, V14, P187, DOI 10.1111/1745-9133.12124; Yang M, 2010, PSYCHOL BULL, V136, P740, DOI 10.1037/a0020473	42	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144967	10.1371/journal.pone.0144967	http://dx.doi.org/10.1371/journal.pone.0144967			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0IX	26714283	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900027
J	Laming, SR; Szafranski, KM; Rodrigues, CF; Gaudron, SM; Cunha, MR; Hilario, A; Le Bris, N; Duperron, S				Laming, Sven R.; Szafranski, Kamil M.; Rodrigues, Clara F.; Gaudron, Sylvie M.; Cunha, Marina R.; Hilario, Ana; Le Bris, Nadine; Duperron, Sebastien			Fickle or Faithful: The Roles of Host and Environmental Context in Determining Symbiont Composition in Two Bathymodioline Mussels	PLOS ONE			English	Article							DEEP-SEA; COLD SEEPS; BIVALVIA; COLONIZATION; MYTILIDAE; DIVERSITY; ATLANTIC; GILLS; COOCCURRENCE; CARBONATES	The Mediterranean Sea and adjoining East Atlantic Ocean host a diverse array of small-sized mussels that predominantly live on sunken, decomposing organic remains. At least two of these, Idas modiolaeformis and Idas simpsoni, are known to engage in gill-associated symbioses; however, the composition, diversity and variability of these symbioses with changing habitat and location is poorly defined. The current study presents bacterial symbiont assemblage data, derived from 454 pyrosequencing carried out on replicate specimens of these two host species, collected across seven sample sites found in three oceanographic regions in the Mediterranean and East Atlantic. The presence of several bacterial OTUs in both the Mediterranean Sea and eastern Atlantic suggests that similar symbiont candidates occur on both sides of the Strait of Gibraltar. The results reveal markedly different symbiotic modes in the two species. Idas modiolaeformis displays high symbiont diversity and flexibility, with strong variation in symbiont composition from the East Mediterranean to the East Atlantic. Idas simpsoni displays low symbiont diversity but high symbiont fidelity, with a single dominant OTU occurring in all specimens analysed. These differences are argued to be a function of the host species, where subtle differences in host evolution, life-history and behaviour could partially explain the observed patterns. The variability in symbiont compositions, particularly in Idas modiolaeformis, is thought to be a function of the nature, context and location of the habitat from which symbiont candidates are sourced.	[Laming, Sven R.; Szafranski, Kamil M.; Rodrigues, Clara F.; Gaudron, Sylvie M.; Duperron, Sebastien] Univ Paris 06, Sorbonne Univ, Lab Biol Organismes & Ecosyst Aquat, UMR7208,UPMC,CNRS,MNHM,IRD,CAEN, Paris, France; [Laming, Sven R.; Rodrigues, Clara F.; Cunha, Marina R.; Hilario, Ana] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Laming, Sven R.; Rodrigues, Clara F.; Cunha, Marina R.; Hilario, Ana] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Le Bris, Nadine] Sorbonne Univ, UPMC Banyuls, Stn Marine Banyuls,Observ Oceanol, UMR8222,Lab Ecogeochim Environm Benth UPMC CNRS, Banyuls Sur Mer, France; [Duperron, Sebastien] Inst Univ France, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universidade de Aveiro; Universidade de Aveiro; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut Universitaire de France	Duperron, S (corresponding author), Univ Paris 06, Sorbonne Univ, Lab Biol Organismes & Ecosyst Aquat, UMR7208,UPMC,CNRS,MNHM,IRD,CAEN, 7 Quai St Bernard, Paris, France.	sebastien.duperron@upmc.fr	Cunha, Marina R/B-7644-2008; Hilário, Ana/C-1260-2008; Laming, Sven/Q-3470-2019; Rodrigues, Clara F./A-4536-2009; Le Bris, Nadine/E-1381-2014	Cunha, Marina R/0000-0001-8833-6980; Hilário, Ana/0000-0001-8287-1528; Laming, Sven/0000-0002-1316-486X; Rodrigues, Clara F./0000-0002-3426-8342; Le Bris, Nadine/0000-0002-0142-4847; Gaudron, Sylvie/0000-0001-6189-3824; duperron, sebastien/0000-0002-6422-6821	CARCACE project (Fundacao para a Ciencia e a Tecnologia, FCT) [PTDC/MAR/099656/2008]; European Regional Development Fund through COMPETE [FCOMP-01-0124-FEDER-010569]; European Commission Seventh Framework Programme (FP7) under the HERMIONE project [226354]; French ANR DeepOases; GDRE-DIWOOD; CHEMECO ESF EURODEEP [EURODEEP/0001/2007]; ITN SYMBIOMICS; UPMC (University Pierre and Marie Currie); Foundation TOTAL; Institut Universitaire de France; MARES Joint Doctorate programme [FPA 2011-0016]; Marie Curie Actions Initial Training Network (ITN) SYMBIOMICS [264774]; FCT (Portugal) [SFRH/BPD/64154/2009]; FCT [SFRH/BPD/64154/2009, PEst-C/MAR/LA0017/2013, UID/AMB/50017/2013]; European Network GDRE-DIWOOD (CNRS)	CARCACE project (Fundacao para a Ciencia e a Tecnologia, FCT); European Regional Development Fund through COMPETE; European Commission Seventh Framework Programme (FP7) under the HERMIONE project; French ANR DeepOases(French National Research Agency (ANR)); GDRE-DIWOOD; CHEMECO ESF EURODEEP; ITN SYMBIOMICS; UPMC (University Pierre and Marie Currie); Foundation TOTAL; Institut Universitaire de France; MARES Joint Doctorate programme; Marie Curie Actions Initial Training Network (ITN) SYMBIOMICS; FCT (Portugal)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Network GDRE-DIWOOD (CNRS)	Sample collection and analyses were supported by the CARCACE project (PTDC/MAR/099656 /2008, co-financed by Fundacao para a Ciencia e a Tecnologia, FCT); the European Regional Development Fund through COMPETE (FCOMP-01-0124-FEDER-010569); the European Commission Seventh Framework Programme (FP7/2007-2013) under the HERMIONE project contract 226354; the French ANR DeepOases; GDRE-DIWOOD; CHEMECO ESF EURODEEP (EURODEEP/0001/2007); ITN SYMBIOMICS; UPMC (University Pierre and Marie Currie), Foundation TOTAL and the Institut Universitaire de France. SRL was also supported by a PhD grant from the MARES Joint Doctorate programme selected under Erasmus Mundus coordinated by Ghent University (FPA 2011-0016), KS was funded through a PhD grant from the Marie Curie Actions Initial Training Network (ITN) SYMBIOMICS (contract number 264774), and CFR was supported by a postdoctoral fellowship (SFRH/BPD/64154/2009) from FCT (Portugal).; We thank the captains, crew, ROVs operators and scientists (including JP. Henriet, A. Boetius, F. Wenzhofer, C. Pierre, L. Corbari, J. Thubaut and C. Borowski) involved in sample collection and fixation during following cruises: MERIAN (RV Maria S Merian), MEDECO (RV Pourquoi Pas?), JC10 (RV James Cook), 64PE284 (RV Pelagia), B09-14b (RV Belgica), Nautilus Expedition NA017 (EV Nautilus), Banyuls LD4-5 (RV Minibex, COMEX) and CARCACE (NRP Almirante Gago Coutinho / RV Belgica). We thank the anonymous reviewers for helpful comments. Sample collection and analyses were supported by the CARCACE project (PTDC/MAR/099656 /2008, co-financed by Fundacao para a Ciencia e a Tecnologia, FCT); the European Regional Development Fund through COMPETE (FCOMP-01-0124-FEDER-010569); the projects PEst-C/MAR/LA0017/2013 and UID/AMB/50017/2013 (FCT); the European Commission Seventh Framework Programme (FP7/2007-2013) under the HERMIONE project contract 226354; the French ANR DeepOases; European Network GDRE-DIWOOD (CNRS); CHEMECO ESF EURODEEP (EURODEEP/0001/2007); ITN SYMBIOMICS; UPMC (University Pierre and Marie Currie), Foundation TOTAL (Chair Biodiversity, extreme marine environment and global change, NLB) and the Institut Universitaire de France. SRL was supported by a PhD grant from the MARES Joint Doctorate programme selected under Erasmus Mundus coordinated by Ghent University (FPA 2011-0016), KS was funded through a PhD grant from the Marie Curie Actions Initial Training Network (ITN) SYMBIOMICS (contract number 264774), and CFR was supported by a postdoctoral fellowship (SFRH/BPD/64154/2009) from FCT.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Bolotin J, 2005, J MAR BIOL ASSOC UK, V85, P977, DOI 10.1017/S0025315405011975; Chevalier N, 2011, MAR GEOL, V288, P112, DOI 10.1016/j.margeo.2011.08.005; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cruaud P, 2014, APPL ENVIRON MICROB, V80, P4626, DOI 10.1128/AEM.00592-14; Cunha MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076688; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Duperron S, 2013, BIOGEOSCIENCES, V10, P3241, DOI 10.5194/bg-10-3241-2013; Duperron S, 2008, FEMS MICROBIOL ECOL, V63, P338, DOI 10.1111/j.1574-6941.2008.00438.x; Duperron S, 2008, ENVIRON MICROBIOL, V10, P433, DOI 10.1111/j.1462-2920.2007.01465.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gasperini L, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004190; Gaudron SM, 2010, MAR ENVIRON RES, V70, P1, DOI 10.1016/j.marenvres.2010.02.002; Gaudron SM, 2012, BIOL BULL-US, V222, P6, DOI 10.1086/BBLv222n1p6; Genio L, 2015, MAR ECOL-EVOL PERSP, V36, P71, DOI 10.1111/maec.12217; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Kautz S, 2013, APPL ENVIRON MICROB, V79, P525, DOI 10.1128/AEM.03107-12; Kiel S, 2006, J PALEONTOL, V80, P121, DOI 10.1666/0022-3360(2006)080[0121:NRASOM]2.0.CO;2; Kiel S, 2010, ZOOTAXA, P26, DOI 10.11646/zootaxa.2390.1.2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Laming SR, 2015, MAR ENV RES; Laming SR, 2014, THESIS; Laming SR, 2014, MAR BIOL, V161, P1319, DOI 10.1007/s00227-014-2421-y; Laurent MCZ, 2009, MAR ENVIRON RES, V67, P83, DOI 10.1016/j.marenvres.2008.11.006; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lorion J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1243; Lorion J, 2012, CAH BIOL MAR, V53, P77; LUTZ RA, 1980, MAR BIOL, V57, P127, DOI 10.1007/BF00387378; Olu-Le Roy K, 2004, DEEP-SEA RES PT I, V51, P1915, DOI 10.1016/j.dsr.2004.07.004; Omoregie EO, 2009, MAR GEOL, V261, P114, DOI 10.1016/j.margeo.2009.02.001; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Quero J-C, 1973, ANN SOC SCI NAT CHAR, V55, P319; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R Core Team, 2021, R LANGUAGE ENV STAT; Ritt B, 2012, DEEP-SEA RES PT I, V67, P121, DOI 10.1016/j.dsr.2012.05.009; Ritt B, 2011, MAR BIOL, V158, P1187, DOI 10.1007/s00227-011-1679-6; Rodrigues CF, 2015, BIOL J LINN SOC, V114, P398, DOI 10.1111/bij.12431; Rodrigues CF, 2013, NATURWISSENSCHAFTEN, V100, P21, DOI 10.1007/s00114-012-0985-2; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Southward EC, 2008, J SHELLFISH RES, V27, P139, DOI 10.2983/0730-8000(2008)27[139:TMOBSI]2.0.CO;2; Stewart FJ, 2009, ENVIRON MICROBIOL, V11, P2136, DOI 10.1111/j.1462-2920.2009.01933.x; Szafranski KM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00162; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thubaut J, 2012, THESIS; Thubaut J, 2013, ECOL EVOL, V3, P4748, DOI 10.1002/ece3.749; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Won YJ, 2008, J SHELLFISH RES, V27, P129, DOI 10.2983/0730-8000(2008)27[129:AOCBDM]2.0.CO;2; Yucel M, 2013, CHEMOSPHERE, V90, P403, DOI 10.1016/j.chemosphere.2012.07.036	51	8	8	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144307	10.1371/journal.pone.0144307	http://dx.doi.org/10.1371/journal.pone.0144307			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710314	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400004
J	Wang, BW; Han, YN; Li, Y; Li, YY; Wang, XY				Wang, Biwen; Han, Yaning; Li, Ye; Li, Yanyan; Wang, Xiaoyuan			Immuno-Stimulatory Activity of Escherichia coli Mutants Producing Kdo(2)-Monophosphoryl-Lipid A or Kdo(2)-Pentaacyl-Monophosphoryl-Lipid A	PLOS ONE			English	Article							OUTER-MEMBRANE PERMEABILITY; MONOPHOSPHORYL-LIPID-A; ANTIBIOTIC-RESISTANCE; STRUCTURAL BASIS; LIPOPOLYSACCHARIDE; ENDOTOXIN; PURIFICATION; MACROPHAGES; KDO(2)-LIPID-A; CONSTRUCTION	Lipid A is the active center of lipopolysaccharide which also known as endotoxin. Monophosphoryl-lipid A (MPLA) has less toxicity but retains potent immunoadjuvant activity; therefore, it can be developed as adjuvant for improving the strength and duration of the immune response to antigens. However, MPLA cannot be chemically synthesized and can only be obtained by hydrolyzing lipopolysaccharide (LPS) purified from Gram-negative bacteria. Purifying LPS is difficult and time-consuming and can damage the structure of MPLA. In this study, Escherichia coli mutant strains HWB01 and HWB02 were constructed by deleting several genes and integrating Francisella novicida gene lpxE into the chromosome of E. coli wild type strain W3110. Compared with W3110, HWB01 and HWB02 synthesized very short LPS, Kdo(2)-monophosphoryl-lipid A (Kdo(2)-MPLA) and Kdo(2)-pentaacyl-monophosphoryl-lipid A (Kdo(2)-pentaacyl-MPLA), respectively. Structural changes of LPS in the outer membranes of HWB01 and HWB02 increased their membrane permeability, surface hydrophobicity, auto-aggregation ability and sensitivity to some antibiotics, but the abilities of these strains to activate the TLR4/MD-2 receptor of HKE-Blue hTLR4 cells were deceased. Importantly, purified Kdo(2)-MPLA and Kdo(2)-pentaacyl-MPLA differed from wild type LPS in their ability to stimulate the mammalian cell lines THP-1 and RAW264.7. The purification of Kdo(2)-MPLA and Kdo(2)-pentaacyl-MPLA from HWB01 and HWB02, respectively, is much easier than the purification of LPS from W3110, and these lipid A derivatives could be important tools for developing future vaccine adjuvants.	[Wang, Biwen; Han, Yaning; Li, Ye; Li, Yanyan; Wang, Xiaoyuan] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Peoples R China; [Wang, Biwen] Jiangnan Univ, Sch Food Sci & Technol, Wuxi 214122, Peoples R China; [Wang, Xiaoyuan] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi 214122, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Wang, XY (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Peoples R China.	xwang@jiangnan.edu.cn			National Natural Science Foundation of China [31170069]; National Key Basic Research Program of China [2012CB725202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (31170069) and National Key Basic Research Program of China (2012CB725202) to XW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (31170069) and the National Key Basic Research Program of China (2012CB725202).	Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; BAKER PJ, 1992, INFECT IMMUN, V60, P2694, DOI 10.1128/IAI.60.7.2694-2701.1992; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bohannon JK, 2013, SHOCK, V40, P451, DOI 10.1097/SHK.0000000000000042; Brabetz W, 1997, EUR J BIOCHEM, V247, P716, DOI 10.1111/j.1432-1033.1997.00716.x; Chen JZ, 2011, BIOTECHNOL LETT, V33, P1013, DOI 10.1007/s10529-011-0521-z; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Cullen TW, 2013, INFECT IMMUN, V81, P430, DOI 10.1128/IAI.01046-12; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Desjardins P, 2010, J VIS EXP; DESJARDINS P, 2009, CURR PROTOC PROTEIN, pCH3; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaekwad J, 2010, J BIOL CHEM, V285, P29375, DOI 10.1074/jbc.M110.115204; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Garcon N, 2010, METHODS MOL BIOL, V626, P15, DOI 10.1007/978-1-60761-585-9_2; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; Han YN, 2013, MAR DRUGS, V11, P363, DOI 10.3390/md11020363; Hankins JV, 2011, MOL MICROBIOL, V81, P1313, DOI 10.1111/j.1365-2958.2011.07765.x; Helander IM, 2000, J APPL MICROBIOL, V88, P213, DOI 10.1046/j.1365-2672.2000.00971.x; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Janusch H, 2002, J ENDOTOXIN RES, V8, P343, DOI 10.1179/096805102125000678; Li YY, 2013, MAR DRUGS, V11, P3197, DOI 10.3390/md11093197; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Murphy RC, 2005, PROSTAG OTH LIPID M, V77, P131, DOI 10.1016/j.prostaglandins.2004.09.004; Needham BD, 2013, P NATL ACAD SCI USA, V110, P1464, DOI 10.1073/pnas.1218080110; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nweze EI, 2012, J ANTIMICROB CHEMOTH, V67, P149, DOI 10.1093/jac/dkr429; Oblak A, 2015, MOL IMMUNOL, V63, P134, DOI 10.1016/j.molimm.2014.06.034; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rahman MM, 2008, ANAEROBE, V14, P73, DOI 10.1016/j.anaerobe.2008.01.002; Reynolds CM, 2009, BIOCHEMISTRY-US, V48, P9627, DOI 10.1021/bi901391g; Sasaki H, 2008, BIOPHYS J, V95, P986, DOI 10.1529/biophysj.108.129197; Thompson BS, 2005, J LEUKOCYTE BIOL, V78, P1273, DOI 10.1189/jlb.0305172; Wang JL, 2014, MAR DRUGS, V12, P1495, DOI 10.3390/md12031495; Wang L, 2012, J APPL MICROBIOL, V112, P985, DOI 10.1111/j.1365-2672.2012.05263.x; Wang XY, 2015, BIOL REV, V90, P408, DOI 10.1111/brv.12114; Wang XY, 2010, SUBCELL BIOCHEM, V53, P27, DOI 10.1007/978-90-481-9078-2_2; Wang XY, 2010, SUBCELL BIOCHEM, V53, P3, DOI 10.1007/978-90-481-9078-2_1; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002; Wang XY, 2004, J BIOL CHEM, V279, P49470, DOI 10.1074/jbc.M409078200; Wang Z, 2015, MAR DRUGS, V13, P3325, DOI 10.3390/md13063325; WEINSTEIN SL, 1993, J IMMUNOL, V151, P3829; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600	51	8	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144714	10.1371/journal.pone.0144714	http://dx.doi.org/10.1371/journal.pone.0144714			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710252	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400011
J	Yan, XC; Yan, MF; Guo, YH; Singh, G; Chen, YH; Yu, M; Wang, DM; Hillery, CA; Chan, AM				Yan, Xiaocai; Yan, Mingfei; Guo, Yihe; Singh, Gobind; Chen, Yuhong; Yu, Mei; Wang, Demin; Hillery, Cheryl A.; Chan, Andrew M.			R-Ras Regulates Murine T Cell Migration and Intercellular Adhesion Molecule-1 Binding	PLOS ONE			English	Article							INTEGRIN ACTIVATION; PHOSPHATIDYLINOSITOL-3-OH KINASE; LYMPH-NODES; H-RAS; RAP1; TRANSFORMATION; REGENERATION; INFLAMMATION; MEMBRANE; PATHWAYS	The trafficking of T-lymphocytes to peripheral draining lymph nodes is crucial for mounting an adaptive immune response. The role of chemokines in the activation of integrins via Ras-related small GTPases has been well established. R-Ras is a member of the Ras-subfamily of small guanosine-5'-triphosphate-binding proteins and its role in T cell trafficking has been investigated in R-Ras null mice (Rras(-/-)). An examination of the lymphoid organs of Rras(-/-) mice revealed a 40% reduction in the cellularity of the peripheral lymph nodes. Morphologically, the high endothelial venules of Rras(-/-) mice were more disorganized and less mature than those of wild-type mice. Furthermore, CD4(+) and CD8(+) T cells from Rras(-/-) mice had approximately 42% lower surface expression of L-selectin/CD62L. These aberrant peripheral lymph node phenotypes were associated with proliferative and trafficking defects in Rras(-/-) T cells. Furthermore, R-Ras could be activated by the chemokine, CCL21. Indeed, Rras(-/-) T cells had approximately 14.5% attenuation in binding to intercellular adhesion molecule 1 upon CCL21 stimulation. Finally, in a graft-versus host disease model, recipient mice that were transfused with Rras(-/-) T cells showed a significant reduction in disease severity when compared with mice transplanted with wild-type T cells. These findings implicate a role for R-Ras in T cell trafficking in the high endothelial venules during an effective immune response.	[Yan, Xiaocai; Hillery, Cheryl A.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Yan, Mingfei; Chan, Andrew M.] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Guo, Yihe; Chen, Yuhong; Yu, Mei; Wang, Demin; Hillery, Cheryl A.] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI USA; [Singh, Gobind] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA	Medical College of Wisconsin; Chinese University of Hong Kong; Versiti Blood Center of Wisconsin; Icahn School of Medicine at Mount Sinai	Chan, AM (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	andrewmchan@cuhk.edu.hk	Chan, Andrew/AAC-1145-2020; Yu, Mei/K-2206-2017; Yan, Mingfei/AAQ-9265-2021; Chan, Andrew Man-Lok/J-9497-2013; Wang, Demin/AAX-4449-2020	Chan, Andrew/0000-0001-9923-5464; Yan, Mingfei/0000-0002-2054-5986; Chan, Andrew Man-Lok/0000-0001-9923-5464; Wang, Demin/0000-0001-5549-3795	US National Institutes of Health [HL44612, AI079087, HL090503, HL102836, NS070711, CA78509, MH59771]; Midwest Athletes Against Childhood Cancer Funds; National Cancer Institute [T32CA078207]; Hong Kong PhD Fellowship Scheme [PF12-13584]; Lo Kwee-Seong Seed Fund; NIH [HL44612, AI079087, HL090503, HL102836, CA78509, MH59771, NS00711]; NATIONAL CANCER INSTITUTE [T32CA078207, R29CA078509] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044612, U54HL090503, R01HL102836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059771] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Midwest Athletes Against Childhood Cancer Funds; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hong Kong PhD Fellowship Scheme; Lo Kwee-Seong Seed Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the US National Institutes of Health HL44612 (DW), AI079087 (DW), HL090503 (CAH), HL102836 (CAH), NS070711 (CAH), CA78509 (AMC), MH59771 (AMC), and Midwest Athletes Against Childhood Cancer Funds (AMC and CAH). GS was supported by a National Cancer Institute pre-doctoral training grant, T32CA078207, MY was supported by Hong Kong PhD Fellowship Scheme (PF12-13584) and AMC was supported by the Lo Kwee-Seong Seed Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Drs. Yu Huang, Li Wang, Shu-Hsia Chen and Miriam Merad for their helpful advice; and Colin Kennedy, Hong Guan, and Penelope Or for technical support. This work was supported by NIH HL44612 (DW), AI079087 (DW), HL090503 (CAH), HL102836 (CAH), NS00711 (CAH), CA78509 (AMC), MH59771 (AMC), and Midwest Athletes Against Childhood Cancer Funds (AMC and CAH). GS was supported by a National Cancer Institute pre-doctoral training grant, T32CA078207, MY was supported by Hong Kong PhD Fellowship Scheme (PF12-13584) and AMC was supported by the Lo Kwee-Seong Seed Fund.	Ada-Nguema AS, 2006, J CELL SCI, V119, P1307, DOI 10.1242/jcs.02835; Alon R, 2011, EXP CELL RES, V317, P632, DOI 10.1016/j.yexcr.2010.12.007; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; COX AD, 1994, ONCOGENE, V9, P3281; Delgado P, 2009, NAT IMMUNOL, V10, P880, DOI 10.1038/ni.1749; Gawecka JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011269; Goldfinger LE, 2006, J CELL BIOL, V174, P877, DOI 10.1083/jcb.200603111; Griffiths GS, 2011, J CELL PHYSIOL, V226, P2287, DOI 10.1002/jcp.22565; Hodkinson PS, 2007, J BIOL CHEM, V282, P28991, DOI 10.1074/jbc.M703601200; Holly SP, 2005, MOL BIOL CELL, V16, P2458, DOI 10.1091/mbc.E03-12-0917; Hughes PE, 2001, METHOD ENZYMOL, V333, P163; Iborra S, 2011, BLOOD, V117, P5102, DOI 10.1182/blood-2010-10-315770; Iwasawa N, 2012, MOL BIOL CELL, V23, P2793, DOI 10.1091/mbc.E12-02-0103; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Komatsu M, 2005, NAT MED, V11, P1346, DOI 10.1038/nm1324; Koopman WJH, 2003, J BIOL CHEM, V278, P13672, DOI 10.1074/jbc.M211256200; Li Y, 2007, J IMMUNOL, V179, P8322, DOI 10.4049/jimmunol.179.12.8322; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Mor A, 2009, MOL CELL BIOL, V29, P3297, DOI 10.1128/MCB.00366-09; Mory A, 2008, BLOOD, V112, P2591, DOI 10.1182/blood-2008-06-163162; Moussion C, 2011, NATURE, V479, P542, DOI 10.1038/nature10540; OCONNELL KA, 1990, J IMMUNOL, V144, P521; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Osada M, 1999, MOL CELL BIOL, V19, P6333; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; SAEZ R, 1994, ONCOGENE, V9, P2977; Sawada J, 2012, CANCER CELL, V22, P235, DOI 10.1016/j.ccr.2012.06.013; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Self AJ, 2001, J CELL SCI, V114, P1357; Shang X, 2011, J BIOL CHEM, V286, P24068, DOI 10.1074/jbc.M111.226951; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Singh G, 2012, BLOOD, V119, P1693, DOI 10.1182/blood-2011-05-357319; Takaya A, 2007, MOL BIOL CELL, V18, P1850, DOI 10.1091/mbc.E06-08-0765; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wurtzel Jeremy G T, 2012, Small GTPases, V3, P139, DOI 10.4161/sgtp.21084; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	39	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145218	10.1371/journal.pone.0145218	http://dx.doi.org/10.1371/journal.pone.0145218			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710069	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400025
J	Zhang, LC; Lv, HC; Zheng, HL; Li, M; Yin, PB; Peng, Y; Gao, Y; Zhang, LH; Tang, PF				Zhang, Licheng; Lv, Houchen; Zheng, Hailiang; Li, Ming; Yin, Pengbin; Peng, Ye; Gao, Yuan; Zhang, Lihai; Tang, Peifu			Correlation between Parameters of Calcaneal Quantitative Ultrasound and Hip Structural Analysis in Osteoporotic Fracture Patients	PLOS ONE			English	Article							BONE-MINERAL DENSITY; ELDERLY-WOMEN; POSTMENOPAUSAL WOMEN; SUBSEQUENT FRACTURE; EUROPEAN GUIDANCE; TRABECULAR BONE; RISK; MEN; DIAGNOSIS; HEEL	Background Calcaneal quantitative ultrasound (QUS), which is used in the evaluation of osteoporosis, is believed to be intimately associated with the characteristics of the proximal femur. However, the specific associations of calcaneal QUS with characteristics of the hip sub-regions remain unclear. Design A cross-sectional assessment of 53 osteoporotic patients was performed for the skeletal status of the heel and hip. Methods We prospectively enrolled 53 female osteoporotic patients with femoral fractures. Calcaneal QUS, dual energy X-ray absorptiometry (DXA), and hip structural analysis (HSA) were performed for each patient. Femoral heads were obtained during the surgery, and principal compressive trabeculae (PCT) were extracted by a three-dimensional printing technique-assisted method. Pearson's correlation between QUS measurement with DXA, HSA-derived parameters and Young's modulus were calculated in order to evaluate the specific association of QUS with the parameters for the hip sub-regions, including the femoral neck, trochanteric and Ward's areas, and the femoral shaft, respectively. Results Significant correlations were found between estimated BMD (Est. BMD) and BMD of different sub-regions of proximal femur. However, the correlation coefficient of trochanteric area (r = 0.356, p = 0.009) was higher than that of the neck area (r = 0.297, p = 0.031) and total proximal femur (r = 0.291, p = 0.034). Furthermore, the quantitative ultrasound index (QUI) was significantly correlated with the HSA-derived parameters of the trochanteric area (r value: 0.315-0.356, all p<0.05) as well as with the Young's modulus of PCT from the femoral head (r = 0.589, p<0.001). Conclusion The calcaneal bone had an intimate association with the trochanteric cancellous bone. To a certain extent, the parameters of the calcaneal QUS can reflect the characteristics of the trochanteric area of the proximal hip, although not specifically reflective of those of the femoral neck or shaft.	[Zhang, Licheng; Lv, Houchen; Li, Ming; Yin, Pengbin; Peng, Ye; Gao, Yuan; Zhang, Lihai; Tang, Peifu] Chinese PLA, Gen Hosp, Dept Orthoped, Beijing, Peoples R China; [Zheng, Hailiang] Capital Med Univ, Beijing Shijitan Hosp, Dept Bioengn, Beijing, Peoples R China	Capital Medical University	Zhang, LH (corresponding author), Chinese PLA, Gen Hosp, Dept Orthoped, Beijing, Peoples R China.	zhanglihai301@gmail.com; pftang301@126.com		Yin, Pengbin/0000-0002-5391-4477; Tang, Peifu/0000-0003-4279-1704	National Natural Science Foundation of China (NSFC) [31370947]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (NSFC) (No.31370947, Lihai Zhang).	Ackerman KE, 2013, J CLIN ENDOCR METAB, V98, P1742, DOI 10.1210/jc.2013-1006; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Bonnick SL, 2007, BONE, V41, pS9, DOI 10.1016/j.bone.2007.03.007; Bouxsein ML, 1999, BONE, V25, P49, DOI 10.1016/S8756-3282(99)00093-9; Center JR, 2007, JAMA-J AM MED ASSOC, V297, P387, DOI 10.1001/jama.297.4.387; Chan MY, 2012, CALCIFIED TISSUE INT, V90, P128, DOI 10.1007/s00223-011-9556-3; Chiba K, 2013, BONE, V56, P139, DOI 10.1016/j.bone.2013.05.019; Eckstein F, 2002, J BONE MINER RES, V17, P162, DOI 10.1359/jbmr.2002.17.1.162; Emaus N, 2014, J BONE MINER RES, V29, P2080, DOI 10.1002/jbmr.2232; FROST HM, 1994, ANGLE ORTHOD, V64, P175; Frost ML, 2000, OSTEOPOROSIS INT, V11, P321, DOI 10.1007/s001980070121; Hans D, 1996, LANCET, V348, P511, DOI 10.1016/S0140-6736(95)11456-4; Huopio J, 2004, Osteoporos Int, V15, P190; Ikeda Y, 2004, J BONE MINER METAB, V22, P248, DOI 10.1007/s00774-003-0475-x; Ikeda Y, 2002, CALCIFIED TISSUE INT, V71, P1, DOI 10.1007/S00223-001-2079-6; Jorgensen HL, 2001, CLIN PHYSIOL, V21, P51, DOI 10.1046/j.1365-2281.2001.00298.x; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2013, OSTEOPOROSIS INT, V24, P23, DOI 10.1007/s00198-012-2074-y; Keaveny TM, 1997, J ORTHOPAED RES, V15, P101, DOI 10.1002/jor.1100150115; Khaw KT, 2004, LANCET, V363, P197, DOI 10.1016/S0140-6736(03)15325-1; Krieg MA, 2003, J BONE MINER RES, V18, P1261, DOI 10.1359/jbmr.2003.18.7.1261; Kwok T, 2012, OSTEOPOROSIS INT, V23, P1001, DOI 10.1007/s00198-011-1634-x; Langton C M, 1984, Eng Med, V13, P89, DOI 10.1243/EMED_JOUR_1984_013_022_02; Lochmuller EM, 1999, ULTRASOUND OBST GYN, V14, P125, DOI 10.1046/j.1469-0705.1999.14020125.x; Lv H, 2015, OSTEOPOROSIS INT, V26, P1791, DOI 10.1007/s00198-015-3058-5; Maeda Y, 2011, CLIN ORTHOP RELAT R, V469, P884, DOI 10.1007/s11999-010-1529-8; Marin F, 2006, J BONE MINER RES, V21, P1126, DOI 10.1359/JBMR.060417; Misra M, 2013, J CLIN ENDOCR METAB, V98, P2952, DOI 10.1210/jc.2013-1457; Moayyeri A, 2012, OSTEOPOROSIS INT, V23, P143, DOI 10.1007/s00198-011-1817-5; Morin S, 2011, OSTEOPOROSIS INT, V22, P2439, DOI 10.1007/s00198-010-1480-2; Nguyen ND, 2007, J BONE MINER RES, V22, P781, DOI 10.1359/JBMR.070315; Schott AM, 1998, OSTEOPOROSIS INT, V8, P247, DOI 10.1007/s001980050061; Trimpou P, 2010, EUR J RADIOL, V73, P360, DOI 10.1016/j.ejrad.2008.11.024; Turunen MJ, 2013, BONE, V54, P118, DOI 10.1016/j.bone.2013.01.045; Varenna M, 2005, OSTEOPOROSIS INT, V16, P1749, DOI 10.1007/s00198-005-1914-4; Wilsgaard T, 2009, AM J EPIDEMIOL, V169, P877, DOI 10.1093/aje/kwn407; Wuster C, 2005, Technol Health Care, V13, P497	37	11	11	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145879	10.1371/journal.pone.0145879	http://dx.doi.org/10.1371/journal.pone.0145879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710123	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400090
J	Ard, R; Mulatz, K; Pomoransky, JL; Parks, RJ; Trinkle-Mulcahy, L; Bell, JC; Gee, SH				Ard, Ryan; Mulatz, Kirk; Pomoransky, Julia L.; Parks, Robin J.; Trinkle-Mulcahy, Laura; Bell, John C.; Gee, Stephen H.			Regulation of Macropinocytosis by Diacylglycerol Kinase zeta	PLOS ONE			English	Article							DENDRITIC CELLS; RAC ACTIVATION; PROTEIN; PHOSPHORYLATION; LOCALIZATION; DISSOCIATION; SALMONELLA; RECEPTOR; FAMILY; ENTRY	Macropinosomes arise from the closure of plasma membrane ruffles to bring about the nonselective uptake of nutrients and solutes into cells. The morphological changes underlying ruffle formation and macropinosome biogenesis are driven by actin cytoskeleton rearrangements under the control of the Rho GTPase Rac1. We showed previously that Rac1 is activated by diacylglycerol kinase zeta (DGK zeta), which phosphorylates diacylglycerol to yield phosphatidic acid. Here, we show DGK zeta is required for optimal macropinocytosis induced by growth factor stimulation of mouse embryonic fibroblasts. Time-lapse imaging of live cells and quantitative analysis revealed DGK zeta was associated with membrane ruffles and nascent macropinosomes. Macropinocytosis was attenuated in DGK zeta-null cells, as determined by live imaging and vaccinia virus uptake experiments. Moreover, macropinosomes that did form in DGK zeta-null cells were smaller than those found in wild type cells. Rescue of this defect required DGK zeta catalytic activity, consistent with it also being required for Rac1 activation. A constitutively membrane bound DGK zeta mutant substantially increased the size of macropinosomes and potentiated the effect of a constitutively active Rac1 mutant on macropinocytosis. Collectively, our results suggest DGK zeta functions in concert with Rac1 to regulate macropinocytosis.	[Ard, Ryan; Mulatz, Kirk; Trinkle-Mulcahy, Laura; Gee, Stephen H.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Ard, Ryan; Mulatz, Kirk; Parks, Robin J.; Gee, Stephen H.] Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON, Canada; [Pomoransky, Julia L.; Bell, John C.] Ottawa Hosp Res Inst, Ctr Innovat Canc Res, Ottawa, ON K1H 1C4, Canada; [Pomoransky, Julia L.; Parks, Robin J.; Bell, John C.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Parks, Robin J.] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada; [Trinkle-Mulcahy, Laura] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Gee, SH (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	stevegee@uottawa.ca			Canadian Institutes of Health Research; Ontario Institute for Cancer Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Institute for Cancer Research	This work was supported by grants from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) to SHG, LT-M and RJP. JB is supported by the Ontario Institute for Cancer Research (http://oicr.on.ca/).	Abramovici H, 2003, MOL BIOL CELL, V14, P4499, DOI 10.1091/mbc.E03-03-0190; Abramovici H, 2007, CELL MOTIL CYTOSKEL, V64, P549, DOI 10.1002/cm.20204; Abramovici H, 2009, MOL BIOL CELL, V20, P2049, DOI 10.1091/mbc.E07-12-1248; Akhtar N, 2000, CELL ADHES COMMUN, V7, P465, DOI 10.3109/15419060009040304; ALPUCHEARANDA CM, 1994, J EXP MED, V179, P601, DOI 10.1084/jem.179.2.601; Amstutz B, 2008, EMBO J, V27, P956, DOI 10.1038/emboj.2008.38; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Bohdanowicz M, 2013, MOL BIOL CELL, V24, P1700, DOI 10.1091/mbc.E12-11-0789; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Cai JJ, 2009, BBA-MOL CELL BIOL L, V1791, P942, DOI 10.1016/j.bbalip.2009.02.010; Carter GC, 2005, J GEN VIROL, V86, P1279, DOI 10.1099/vir.0.80831-0; Charles-Whitbeck J, 2009, VIROLOGY, V385, P383, DOI 10.1016/j.virol.2008.12.029; Chianale F, 2007, MOL BIOL CELL, V18, P4859, DOI 10.1091/mbc.E07-02-0177; Chianale F, 2010, P NATL ACAD SCI USA, V107, P4182, DOI 10.1073/pnas.0908326107; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; FRANCIS CL, 1993, NATURE, V364, P639, DOI 10.1038/364639a0; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Law M, 2006, P NATL ACAD SCI USA, V103, P5989, DOI 10.1073/pnas.0601025103; Liberali P, 2008, EMBO J, V27, P970, DOI 10.1038/emboj.2008.59; Luo B, 2003, J BIOL CHEM, V278, P39542, DOI 10.1074/jbc.M307153200; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; McCart JA, 2001, CANCER RES, V61, P8751; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5; RACOOSIN EL, 1993, J CELL BIOL, V121, P1011, DOI 10.1083/jcb.121.5.1011; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sandgren KJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000866; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; STEINMAN RM, 1972, J CELL BIOL, V55, P186, DOI 10.1083/jcb.55.1.186; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; Wang JTH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013763; Watarai M, 2001, J EXP MED, V194, P1081, DOI 10.1084/jem.194.8.1081; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Yakubchyk Y, 2005, MOL CELL BIOL, V25, P7289, DOI 10.1128/MCB.25.16.7289-7302.2005; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	43	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144942	10.1371/journal.pone.0144942	http://dx.doi.org/10.1371/journal.pone.0144942			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701304	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092600037
J	Friggens, MM; Finch, DM				Friggens, Megan M.; Finch, Deborah M.			Implications of Climate Change for Bird Conservation in the Southwestern US under Three Alternative Futures	PLOS ONE			English	Article							LAND-USE; MODELS; NICHE; DISTRIBUTIONS; VARIABILITY; PREDICTION; VEGETATION; ABUNDANCE; IMPACTS	Future expected changes in climate and human activity threaten many riparian habitats, particularly in the southwestern U.S. Using Maximum Entropy (MaxEnt3.3.3) modeling, we characterized habitat relationships and generated spatial predictions of habitat suitability for the Lucy's warbler (Oreothlypis luciae), the Southwestern willow flycatcher (Empidonax traillii extimus) and the Western yellow-billed cuckoo (Coccyzus americanus). Our goal was to provide site- and species-specific information that can be used by managers to identify areas for habitat conservation and/or restoration along the Rio Grande in New Mexico. We created models of suitable habitat for each species based on collection and survey samples and climate, biophysical, and vegetation data. We projected habitat suitability under future climates by applying these models to conditions generated from three climate models for 2030, 2060 and 2090. By comparing current and future distributions, we identified how habitats are likely to change as a result of changing climate and the consequences of those changes for these bird species. We also examined whether land ownership of high value sites shifts under changing climate conditions. Habitat suitability models performed well. Biophysical characteristics were more important that climate conditions for predicting habitat suitability with distance to water being the single most important predictor. Climate, though less important, was still influential and led to declines of suitable habitat of more than 60% by 2090. For all species, suitable habitat tended to shrink over time within the study area leaving a few core areas of high importance. Overall, climate changes will increase habitat fragmentation and reduce breeding habitat patch size. The best strategy for conserving bird species within the Rio Grande will include measures to maintain and restore critical habitat refugia. This study provides an example of a presence-only habitat model that can be used to inform the management of species at intermediate scales.	[Friggens, Megan M.; Finch, Deborah M.] US Forest Serv, Rocky Mt Res Stn, Albuquerque, NM USA	United States Department of Agriculture (USDA); United States Forest Service	Friggens, MM (corresponding author), Albuquerque Forestry Sci Lab, 333 Broadway SE,Suite 115, Albuquerque, NM 87102 USA.	meganfriggens@fs.fed.us			Southern Rockies Landscape Conservation Cooperative [11221632-006]; Desert Landscape Conservation Cooperative [11221632-006]	Southern Rockies Landscape Conservation Cooperative; Desert Landscape Conservation Cooperative	The work being used in this study was jointly funded (IA#11221632-006) by the Southern Rockies Landscape Conservation Cooperative (http://southernrockieslcc.org/) and the Desert Landscape Conservation Cooperative (http://www.usbr.gov/dlcc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders AD, 2006, J ANIM ECOL, V75, P221, DOI 10.1111/j.1365-2656.2006.01034.x; [Anonymous], 1999, YELL BILL CUCK COCC; [Anonymous], 2012, NEW MEX RAP WAT ASS; Araujo MB, 2009, P NATL ACAD SCI USA, V106, pE45, DOI 10.1073/pnas.0813294106; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Beale CM, 2008, P NATL ACAD SCI USA, V105, P14908, DOI 10.1073/pnas.0803506105; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Cloern JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024465; Cole JC, 2002, GROUND WATER RESOURC; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Entling MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045875; Finch D, 2007, ACCOMPLISHING APPL N, P32; Finch DM, 2000, STUD AVIAN BIOL-SER, P88; Finch DM, 2006, MONITORING BIRD POPU; Finch DM, 2000, STATUS ECOLOGY CONSE; Fish NMDoGa, 2006, COMPR WILDL CONS STR; Foldi SE, 2014, SOUTHWEST NAT, V59, P337, DOI 10.1894/F02-JEM-03.1; Friedlaender AS, 2011, DEEP-SEA RES PT II, V58, P1729, DOI 10.1016/j.dsr2.2010.11.018; Friggens M, 2013, RMRSGTR306 US DEP AG, DOI http://dx.doi.org/10.3996/052013-JFWM-039S1; Fullerton W., 2003, ALLIANCE RIO GRANDE; GAINES D, 1974, CONDOR, V76, P204, DOI 10.2307/1366731; Gallardo B, 2013, BIOL CONSERV, V160, P225, DOI 10.1016/j.biocon.2013.02.001; Ganguly AR, 2009, P NATL ACAD SCI USA, V106, P15555, DOI 10.1073/pnas.0904495106; Girvetz EH, 2009, LANDSCAPE ECOL, V24, P1315, DOI 10.1007/s10980-009-9384-2; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; Howe WH, 1986, STATUS OF THE YELLOW; Huntley B, 2006, IBIS, V148, P8, DOI 10.1111/j.1474-919X.2006.00523.x; Huntly N, 2011, PLANT ECOL, V212, P1549, DOI 10.1007/s11258-011-9930-2; Jackson ST, 2009, P NATL ACAD SCI USA, V106, P19685, DOI 10.1073/pnas.0901644106; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Johnson M, 2012, DEV GIS BASED MODEL; Johnson MJ, 2007, ANN REPORT; Kirkpatrick C, 2009, SURFACE WATER UNPUB; LAYMON SA, 1989, US FOR SERV T R PSW, V110, P272; Levings GW, 1998, WATER QUALITY RIO GR, P1162; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lucys Warbler (Vermivoraluciae), 1997, LUC WARBL VERM LUC; MATTHEWS S, 2004, ATLAS CLIMATE CHANGE; Matthews SN, 2011, ECOGRAPHY, V34, P933, DOI 10.1111/j.1600-0587.2011.06803.x; Mcrae BH, 2008, ECOL MODEL, V219, P77, DOI 10.1016/j.ecolmodel.2008.08.001; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; O'Donnell M.S., 2012, US GEOLOGICAL SURVEY, V691, P10, DOI [DOI 10.3133/DS691, 10.1016/j.mimet.2011.04.001]; Opdam P, 2004, BIOL CONSERV, V117, P285, DOI 10.1016/j.biocon.2003.12.008; Palmer MA, 2009, ENVIRON MANAGE, V44, P1053, DOI 10.1007/s00267-009-9329-1; Parcher J. W, 2010, J TRANSBOUNDARY WATE, V1, P159; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Poole A, 2014, BIRDS N AM ONLINE; Pruitt GST, 2011, W WIDE CLIMATE RISK; Pruitt T., 2011, EOS T AGU, V92, P441, DOI [10.1029/2011EO480001, DOI 10.1029/2011EO480001]; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Rehfeldt GE, 2006, INT J PLANT SCI, V167, P1123, DOI 10.1086/507711; Rehfeldt GE, 2012, ECOL APPL, V22, P119, DOI 10.1890/11-0495.1; Roberts L, 2005, MIDDLE RIO GRANDE EC; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Service USFaW, 2013, FED REGISTER, V78, P344; Shah JJF, 2007, RESTOR ECOL, V15, P550, DOI 10.1111/j.1526-100X.2007.00250.x; Skagen SK, 2005, CONDOR, V107, P212, DOI 10.1650/7807; Smith DM, 2006, ENVIRON ENTOMOL, V35, P1525, DOI 10.1603/0046-225X(2006)35[1525:IODAVO]2.0.CO;2; Smith DM, 2006, WILDFIRE EXOTIC VEGE; Sogge M.K., 1997, NPSNAUCPRSNRTR9712 U; Sohl TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112251; Stoleson Scott H., 2000, Western Birds, V31, P235; Thorne LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043167; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Toews MW, 2009, J HYDROL, V374, P265, DOI 10.1016/j.jhydrol.2009.06.022; U.S. Army Corps of Engineers AD, 2011, ENV ASS MIDDL RIO GR; U.S. Fish and Wildlife Service, 1995, FED REGISTER, V60, P10694; van Riper III C, 2014, PROJECTING CLIMATE E; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Webb RH, 2007, RIBBON GREEN CHANGE; Williams KK, 2008, ENVIRON ENTOMOL, V37, P94, DOI 10.1603/0046-225X(2008)37[94:IOEOBB]2.0.CO;2; Wong C. M., 2007, WORLDS TOP 10 RIVERS; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004	76	14	14	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144089	10.1371/journal.pone.0144089	http://dx.doi.org/10.1371/journal.pone.0144089			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700871	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092600015
J	Ma, FY; Han, YJ; Nikolic-Paterson, DJ; Kolkhof, P; Tesch, GH				Ma, Frank Y.; Han, Yingjie; Nikolic-Paterson, David J.; Kolkhof, Peter; Tesch, Greg H.			Suppression of Rapidly Progressive Mouse Glomerulonephritis with the Non-Steroidal Mineralocorticoid Receptor Antagonist BR-4628	PLOS ONE			English	Article							COLLAGEN GENE-EXPRESSION; RENAL INJURY; DIABETIC-NEPHROPATHY; MESANGIAL CELLS; KIDNEY-DISEASE; ACTIVATION; SPIRONOLACTONE; RATS; PROLIFERATION; INFLAMMATION	Background/Aim Steroidal mineralocorticoid receptor antagonists (MRAs) are effective in the treatment of kidney disease; however, the side effect of hyperkalaemia, particularly in the context of renal impairment, is a major limitation to their clinical use. Recently developed non-steroidal MRAs have distinct characteristics suggesting that they may be superior to steroidal MRAs. Therefore, we explored the benefits of a non-steroidal MRA in a model of rapidly progressive glomerulonephritis. Methods Accelerated anti-glomerular basement membrane (GBM) glomerulonephritis was induced in groups of C57BL/6J mice which received no treatment, vehicle or a non-steroidal MRA (BR-4628, 5mg/kg/bid) from day 0 until being killed on day 15 of disease. Mice were examined for renal injury. Results Mice with anti-GBM glomerulonephritis which received no treatment or vehicle developed similar disease with severe albuminuria, impaired renal function, glomerular tuft damage and crescents in 40% of glomeruli. In comparison, mice which received BR-4628 displayed similar albuminuria, but had improved renal function, reduced severity of glomerular tuft lesions and a 50% reduction in crescents. The protection seen in BR-4628 treated mice was associated with a marked reduction in glomerular macrophages and T-cells and reduced kidney gene expression of proinflammatory (CCL2, TNF-alpha, IFN-gamma) and profibrotic molecules (collagen I, fibronectin). In addition, treatment with BR-4626 did not cause hyperkalaemia or increase urine Na+/K+ excretion (a marker of tubular dysfunction). Conclusions The non-steroidal MRA (BR-4628) provided substantial suppression of mouse crescentic glomerulonephritis without causing tubular dysfunction. This finding warrants further investigation of non-steroidal MRAs as a therapy for inflammatory kidney diseases.	[Ma, Frank Y.; Han, Yingjie; Nikolic-Paterson, David J.; Tesch, Greg H.] Monash Med Ctr, Dept Nephrol, Clayton, Vic 3168, Australia; [Ma, Frank Y.; Han, Yingjie; Nikolic-Paterson, David J.; Tesch, Greg H.] Monash Univ, Dept Med, Clayton, Vic, Australia; [Kolkhof, Peter] Bayer HealthCare, Dept Cardiol Res, Global Drug Discovery, Wuppertal, Germany	Monash University; Monash University; Bayer AG; Bayer Healthcare Pharmaceuticals	Tesch, GH (corresponding author), Monash Med Ctr, Dept Nephrol, 246 Clayton Rd, Clayton, Vic 3168, Australia.	greg.tesch@monash.edu	Tesch, Greg/I-1444-2013	Tesch, Greg/0000-0002-6137-3092; Nikolic-Paterson, David/0000-0001-5734-2931	Bayer Healthcare	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals)	GHT received funding from Bayer Healthcare to perform the study. PK is an employee of Bayer Healthcare and played a role in study design and manuscript preparation.	Barfacker L, 2012, CHEMMEDCHEM, V7, P1385, DOI 10.1002/cmdc.201200081; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Bertocchio JP, 2011, KIDNEY INT, V79, P1051, DOI 10.1038/ki.2011.48; Bianchi S, 2010, AM J KIDNEY DIS, V55, P671, DOI 10.1053/j.ajkd.2009.11.006; Blasi ER, 2003, KIDNEY INT, V63, P1791, DOI 10.1046/j.1523-1755.2003.00929.x; Boesby L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026904; Chen D, 2013, GENE, V531, P23, DOI 10.1016/j.gene.2013.08.047; Danjuma MI, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-013-0414-8; Diah S, 2008, EXP CELL RES, V314, P3654, DOI 10.1016/j.yexcr.2008.09.018; Fagart J, 2010, J BIOL CHEM, V285, P29932, DOI 10.1074/jbc.M110.131342; Guo C, 2006, ENDOCRINOLOGY, V147, P5363, DOI 10.1210/en.2006-0944; Han SY, 2006, J AM SOC NEPHROL, V17, P1362, DOI 10.1681/ASN.2005111196; Huang LL, 2012, NEPHRON EXP NEPHROL, V120, pE115, DOI 10.1159/000339500; Huang LL, 2014, J AM SOC NEPHROL, V25, P2231, DOI 10.1681/ASN.2012111094; Huang SM, 2009, AM J PHYSIOL-RENAL, V296, pF1323, DOI 10.1152/ajprenal.90428.2008; Kerr PG, 2007, DIS KIDNEY URINARY T, P1511; Lai L, 2006, BIOCHEM BIOPH RES CO, V348, P70, DOI 10.1016/j.bbrc.2006.07.057; Lian M, 2012, NEPHROL DIAL TRANSPL, V27, P906, DOI 10.1093/ndt/gfr495; Monrad SU, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2353; Nagai Y, 2005, HYPERTENSION, V46, P1039, DOI 10.1161/01.HYP.0000174593.88899.68; Nariai T, 2012, PHARMACOLOGY, V89, P44, DOI 10.1159/000335559; Orena S, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00115; Qin DP, 2013, J NEPHROL, V26, P199, DOI 10.5301/jn.5000125; Rossing K, 2005, DIABETES CARE, V28, P2106, DOI 10.2337/diacare.28.9.2106; Schupp N, 2011, FASEB J, V25, P968, DOI 10.1096/fj.10-173286; Shibata H, 2012, AM J HYPERTENS, V25, P514, DOI 10.1038/ajh.2011.245; Suganami T, 2001, J AM SOC NEPHROL, V12, P2652, DOI 10.1681/ASN.V12122652; Tesch G, 2014, DIABETOLOGIA, V57, P1977, DOI 10.1007/s00125-014-3291-z; Zitt E, 2011, INT J CLIN EXP PATHO, V4, P606	29	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145666	10.1371/journal.pone.0145666	http://dx.doi.org/10.1371/journal.pone.0145666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700873	Green Published, gold			2022-12-27	WOS:000367092600115
J	Phillips, AC; Carroll, D; Drayson, MT; Der, G				Phillips, Anna C.; Carroll, Douglas; Drayson, Mark T.; Der, Geoff			Salivary Immunoglobulin A Secretion Rate Is Negatively Associated with Cancer Mortality: The West of Scotland Twenty-07 Study	PLOS ONE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; IGA DEFICIENCY; MUCOSAL IMMUNITY; RISK; HEALTH; COHORT; RESPONSES; SYMPTOMS; EXERCISE; DISEASE	Immunoglobulins are essential for combating infectious disease although very high levels can indicate underlying pathology. The present study examined associations between secretory immunoglobulin A (sIgA) in saliva and mortality rates in the general population. Participants were 639 adults from the eldest cohort of the West of Scotland Twenty-07 Study aged 63 years at the time of saliva sampling in 1995. From unstimulated 2-minute saliva samples, saliva volume and S-IgA concentration were measured, and S-IgA secretion rate determined as their product. Mortality data were tracked for 19 years. Cox proportional hazard models were applied to compute hazard ratios (HR) for all-cause mortality from sIgA secretion rate. Associations were adjusted for gender, assay batch, household occupational group, smoking, medication usage, and self-reported health. There was a negative association between log sIgA secretion rate and all-cause mortality, HR = 0.81, 95% CI = 0.73-0.91, p <.001. Further analysis of specific causes of mortality revealed that the all-cause association was due to an underlying association with cancer mortality and in particular with cancers other than lung cancer. The HR for non-lung cancer was 0.68 (95% CI = 0.54 to 0.85) implying a 32% reduction in mortality risk per standard deviation rise in log sIgA secretion rate. Effects were stronger for men than women. For deaths from respiratory diseases, sIgA secretion had a non-linear relationship with mortality risk whereby only the very lowest levels of secretion were associated with elevated risk. SIgA concentration revealed a similar but weaker pattern of association. In the present study, higher secretion rates of sIgA were associated with a decreased risk of death from cancer, specifically non- lung cancer, as well as from respiratory disease. Thus, it appears that sIgA plays a protective role among older adults, and could serve as a marker of mortality risk, specifically cancer mortality.	[Phillips, Anna C.; Carroll, Douglas] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England; [Drayson, Mark T.] Univ Birmingham, Coll Med & Dent, Clin Immunol Serv, Birmingham, W Midlands, England; [Der, Geoff] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland	University of Birmingham; University of Birmingham; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Phillips, AC (corresponding author), Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England.	A.C.Phillips@bham.ac.uk	Whittaker, Anna C./A-3577-2013	Whittaker, Anna C./0000-0002-5461-0598; Der, Geoff/0000-0002-8677-073X; Drayson, Mark/0000-0002-1528-7564	Medical Research Council [MC_UU_12017/5]; ESRC [ES/H043772/1] Funding Source: UKRI; MRC [MC_UU_12017/5, MC_UU_12017/13] Funding Source: UKRI; Economic and Social Research Council [ES/H043772/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The work was supported by Medical Research Council (grant number MC_UU_12017/5), http://2007study.sphsu.mrc.ac.uk/. No additional funding was received by AP, the main author. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The West of Scotland Twenty-07 Study data were originally collected by the MRC Social and Public Health Sciences Unit (MC_A540_53462). We are grateful to all of the participants in the Study, and to the survey staff and research nurses who carried it out. The data are employed here with the permission of the Twenty-07 Steering Group. Further information about the data and free access to it can be found at http://2007study.sphsu.mrc.ac.uk/. GD is funded by the Medical Research Council [grant number MC_UU_12017/5].	Ahmadiafshar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122757; Bathman LM, 2013, BRAIN BEHAV IMMUN, V33, P74, DOI 10.1016/j.bbi.2013.05.010; Benzeval M, 2009, INT J EPIDEMIOL, V38, P1215, DOI 10.1093/ije/dyn213; Bosch JA, 2004, PSYCHOSOM MED, V66, P625, DOI 10.1097/01.psy.0000133254.46947.ac; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Brandtzaeg P, 2010, CURR OPIN GASTROEN, V26, P554, DOI 10.1097/MOG.0b013e32833dccf8; Carroll D, 1996, INT J BEHAV MED, V3, P266, DOI 10.1207/s15327558ijbm0303_6; Challacombe S J, 2006, Adv Dent Res, V19, P29; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Cunningham-Rundles C, 2012, HEMATOL-AM SOC HEMAT, P301, DOI 10.1182/asheducation-2012.1.301; Der G, 1998, 60 MRC MED SOC UN; Ecob R, 1987, 6 MRC MED SOC UN; Eliasson L, 2006, EUR J ORAL SCI, V114, P494, DOI 10.1111/j.1600-0722.2006.00413.x; FORD G, 1994, SOC SCI MED, V39, P1037, DOI 10.1016/0277-9536(94)90375-1; Gallagher S, 2008, BRAIN BEHAV IMMUN, V22, P565, DOI 10.1016/j.bbi.2007.11.007; Gleeson M, 2000, EXERC IMMUNOL REV, V6, P5; He CS, 2014, EXERC IMMUNOL REV, V20, P8; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hood LE, 1978, IMMUNOLOGY; Hurme M, 2005, MECH AGEING DEV, V126, P829, DOI 10.1016/j.mad.2005.02.005; Janeway C., 2005, IMMUNOBIOLOGY IMMUNE; Janket S, 2010, J DENT RES, V89, P389, DOI 10.1177/0022034509359884; Jorgensen GH, 2013, J CLIN IMMUNOL, V33, P742, DOI 10.1007/s10875-012-9858-x; Ludvigsson JF, 2013, J CLIN IMMUNOL, V33, P1317, DOI 10.1007/s10875-013-9948-4; Ludvigsson JF, 2014, J CLIN IMMUNOL, V34, P444, DOI 10.1007/s10875-014-0009-4; Macintyre S, 1987, 7 MRC MED SOC UN; Mellemkjaer L, 2002, CLIN EXP IMMUNOL, V130, P495, DOI 10.1046/j.1365-2249.2002.02004.x; MESTECKY J, 1993, ANN NY ACAD SCI, V694, P184, DOI 10.1111/j.1749-6632.1993.tb18352.x; Mikulska M, 2009, BONE MARROW TRANSPL, V44, P361, DOI 10.1038/bmt.2009.39; Miletic ID, 1996, PHYSIOL BEHAV, V60, P243, DOI 10.1016/0031-9384(95)02161-2; Ng V, 2004, Int J Immunopathol Pharmacol, V17, P49; Office of Population Censuses and Surveys (OPCS), 1980, CLASS OCC; Oikawa J, 2015, J EPIDEMIOL, V25, P470, DOI 10.2188/jea.JE20140088; Papista C, 2011, CELL MOL IMMUNOL, V8, P126, DOI 10.1038/cmi.2010.69; Phillips AC, 2006, BRAIN BEHAV IMMUN, V20, P191, DOI 10.1016/j.bbi.2005.06.006; Phillips AC, 2015, J EPIDEMIOL COMMUN H, V69, P129, DOI 10.1136/jech-2014-204345; Provinciali M, 2005, CANCER IMMUNOL IMMUN, V54, P93, DOI 10.1007/s00262-004-0539-3; Rashkova Maya P, 2010, Folia Med (Plovdiv), V52, P48; Senpuku H, 2010, CLIN LAB, V56, P505; Shimizu K, 2007, EXERC IMMUNOL REV, V13, P55; Teeuw W, 2004, BIOL CHEM, V385, P1137, DOI 10.1515/BC.2004.147; Thoreux K, 2000, IMMUNOLOGY, V101, P161, DOI 10.1046/j.1365-2567.2000.00095.x; Torisu T, 2009, GERONTOLOGY, V55, P179, DOI 10.1159/000162260; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P6; Wang N, 2011, MOL MED, V17, P1383, DOI 10.2119/molmed.2011.00195; Zeier H, 1996, BIOL PSYCHOL, V42, P413, DOI 10.1016/0301-0511(95)05170-8	47	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145083	10.1371/journal.pone.0145083	http://dx.doi.org/10.1371/journal.pone.0145083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699127	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000367092600045
J	Tan, AX; Kapiga, S; Khoshnood, K; Bruce, RD				Tan, Annabel Xulin; Kapiga, Saidi; Khoshnood, Kaveh; Bruce, R. Douglas			Epidemiology of Drug Use and HIV-Related Risk Behaviors among People Who Inject Drugs in Mwanza, Tanzania	PLOS ONE			English	Article							PREVENTION; PREVALENCE; INFECTION; POPULATIONS; RUSSIA; HEROIN; COHORT; SEX; IDU	Heroin trafficking and consumption has increased steadily over the past decade in Tanzania, but limited information regarding HIV and drug use exists for the city of Mwanza. Our study investigates the epidemiology of drug use, and HIV risk behaviors among drug users in the northwestern city of Mwanza. Using a combination of targeted sampling and participant referral, we recruited 480 participants in Mwanza between June and August 2014. The sample was 92% male. Seventy-nine (16.4%) participants reported injecting heroin, while 434 (90.4%) reported smoking heroin. Unstable housing and cohabitation status were the only socioeconomic characteristics significantly associated with heroin injection. More than half of heroin injectors left syringes in common locations, and half reported sharing needles and syringes. Other risk behaviors such as lack of condom use during sex, and the use of illicit drugs during sex was widely reported as well. Among the study sample, there was poor awareness of health risks posed by needle/syringe sharing and drug use. Our results show that heroin use and HIV risk related behaviors are pressing problems that should not be ignored in Mwanza. Harm reduction programs are urgently needed in this population.	[Tan, Annabel Xulin; Khoshnood, Kaveh] Yale Univ, Sch Publ Hlth, New Haven, CT 06511 USA; [Kapiga, Saidi] Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Bruce, R. Douglas] Cornell Scott Hill Hlth Ctr, New Haven, CT USA; [Bruce, R. Douglas] Yale Univ, Sch Med, New Haven, CT USA	Yale University; Yale University	Tan, AX (corresponding author), Yale Univ, Sch Publ Hlth, New Haven, CT 06511 USA.	xulin.tan@yale.edu	Khoshnood, Kaveh/AAX-1402-2020	Khoshnood, Kaveh/0000-0003-2795-0447; Kapiga, Saidi/0000-0003-1753-4060; Bruce, Robert/0000-0003-4184-8748	Yale Global Health Initiative Field Experience Award; MRC [G0901756] Funding Source: UKRI	Yale Global Health Initiative Field Experience Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Yale Global Health Initiative Field Experience Award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, CONSENSUS ESTIMATES; BOOTH RE, 1993, AM J PUBLIC HEALTH, V83, P1144, DOI 10.2105/AJPH.83.8.1144; Bruce RD, 2014, COMMUNICATION; Burchell AN, 2008, SEX TRANSM DIS, V35, P807, DOI 10.1097/OLQ.0b013e3181728a9e; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Corneil TA, 2006, HEALTH PLACE, V12, P79, DOI 10.1016/j.healthplace.2004.10.004; Dahoma MJU, 2006, AFRICAN J DRUG ALCOH, P5; Doyle AM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000287; Genereux M, 2010, INT J DRUG POLICY, V21, P49, DOI 10.1016/j.drugpo.2009.01.004; Gillies M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-721; GLEGHORN AA, 1994, J ACQ IMMUN DEF SYND, V7, P767; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Hammett TM, 2006, AIDS EDUC PREV, V18, P97, DOI 10.1521/aeap.2006.18.2.97; Jolley E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001465; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Kelley MS, 2004, SOC SCI MED, V58, P2083, DOI 10.1016/j.socscimed.2003.08.006; Kerr T, 2007, DRUG ALCOHOL DEPEN, V87, P39, DOI 10.1016/j.drugalcdep.2006.07.009; Lambdin BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067062; Maas B, 2007, HEALTH PLACE, V13, P432, DOI 10.1016/j.healthplace.2006.05.005; Mary J., 2014, INT J RES HEAL SCI, V2, P740; Mbatia J, 2009, INT J ENV RES PUB HE, V6, P1991, DOI 10.3390/ijerph6071991; McCurdy SA, 2005, AIDS CARE, V17, pS65, DOI 10.1080/09540120500120930; McCurdy SA, 2006, DRUG ALCOHOL DEPEN, V82, pS23, DOI 10.1016/S0376-8716(06)80004-9; McCurdy SA, 2010, ADDICTION, V105, P1062, DOI 10.1111/j.1360-0443.2010.02908.x; MCELRATH K, 1994, AM J PUBLIC HEALTH, V84, P1965, DOI 10.2105/AJPH.84.12.1965; Mongi AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084447; Obasi AI, 2001, TROP MED INT HEALTH, V6, P517, DOI 10.1046/j.1365-3156.2001.00738.x; Qian H, 2006, HARM REDUCT J, P3; Ratliff E. A, 2013, ADV PREV MED, V2013; Rhodes T, 2005, BMJ-BRIT MED J, V331, P220, DOI 10.1136/bmj.331.7510.220; Ross DA, 2007, AIDS, V21, P1943, DOI 10.1097/QAD.0b013e3282ed3cf5; Senyimba C, 2005, BMJ-BRIT MED J, V331, P778, DOI 10.1136/bmj.331.7519.778-b; Strathdee Steffanie A, 2010, Curr HIV/AIDS Rep, V7, P99, DOI 10.1007/s11904-010-0043-7; Timpson S, 2006, AFRICAN J DRUG ALCOH, V5, P157; United Nations Office of Drug and Crime, 2011, GLOB AFGH OP TRAD; Wall M, 2011, INT J DRUG POLICY, V22, P133, DOI 10.1016/j.drugpo.2010.10.001; WATTERS JK, 1989, SOC PROBL, V36, P416, DOI 10.1525/sp.1989.36.4.03a00070; Williams ML, 2007, AIDS BEHAV, V11, P137, DOI 10.1007/s10461-006-9102-x; [Zanzibar AIDS Commission National Bureau of Statistics Statistician O of the CG Zanzibar International I Tanzania Commission for AIDS], 2011, HIV AIDS MAL IND SUR	39	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145578	10.1371/journal.pone.0145578	http://dx.doi.org/10.1371/journal.pone.0145578			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26701616	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000367092600098
J	Barman, RK; Jana, T; Das, S; Saha, S				Barman, Ranjan Kumar; Jana, Tanmoy; Das, Santasabuj; Saha, Sudipto			Prediction of Intra-Species Protein-Protein Interactions in Enteropathogens Facilitating Systems Biology Study	PLOS ONE			English	Article							ESCHERICHIA-COLI; INTERACTION NETWORKS; SEQUENCES	Protein-protein interactions in Escherichia coli (E. coli) has been studied extensively using high throughput methods such as tandem affinity purification followed by mass spectrometry and yeast two-hybrid method. This can in turn be used to understand the mechanisms of bacterial cellular processes. However, experimental characterization of such huge amount of interactions data is not available for other important enteropathogens. Here, we propose a support vector machine (SVM)-based prediction model using the known PPIs data of E. coli that can be used to predict PPIs in other enteropathogens, such as Vibrio cholerae, Salmonella Typhi, Shigella flexneri and Yersinia entrocolitica. Different features such as domain-domain association (DDA), network topology, and sequence information were used in developing the SVM model. The proposed model using DDA, degree and amino acid composition features has achieved an accuracy of 82% and 62% on 5-fold cross validation and blind E. coli datasets, respectively. The predicted interactions were validated by Gene Ontology (GO) semantic similarity measure and String PPIs database (experimental PPIs only). Finally, we have developed a user-friendly webserver named EnPPIpred to predict intra-species PPIs in enteropathogens, which will be of great help for the experimental biologists. The webserver EnPPIpred is freely available at http://bicresources.jcbose.ac.in/ssaha4/EnPPIpred/.	[Barman, Ranjan Kumar; Das, Santasabuj] Natl Inst Cholera & Enter Dis, Biomed Informat Ctr, Kolkata, W Bengal, India; [Jana, Tanmoy; Saha, Sudipto] Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India; [Das, Santasabuj] Natl Inst Cholera & Enter Dis, Div Clin Med, Kolkata, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Department of Science & Technology (India); Bose Institute; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Das, S (corresponding author), Natl Inst Cholera & Enter Dis, Biomed Informat Ctr, Kolkata, W Bengal, India.	dasss@icmr.org.in; ssaha4@jcbose.ac.in	Saha, Sudipto/AAF-1034-2020; Barman, Ranjan Kumar/GXZ-8073-2022	Barman, Ranjan Kumar/0000-0001-9901-3108; Saha, Sudipto/0000-0001-9433-8894; Jana, Tanmoy/0000-0003-1321-2240	Department of Biotechnology [BT/RLF/Re-entry/11/2011]; Indian Council of Medical Research [2013-1551G]	Department of Biotechnology; Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This project was supported by Department of Biotechnology for Ramalingaswami fellowship (BT/RLF/Re-entry/11/2011). RKB and SD thank Indian Council of Medical Research [extramural project (IRIS ID: 2013-1551G)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Barman RK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0112034, DOI 10.1371/J0URNAL.P0NE.0112034]; Ben-Hur A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S2; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Chou KC, 2006, J PROTEOME RES, V5, P316, DOI 10.1021/pr050331g; Du ZD, 2009, NUCLEIC ACIDS RES, V37, pW345, DOI 10.1093/nar/gkp463; Guo YZ, 2008, NUCLEIC ACIDS RES, V36, P3025, DOI 10.1093/nar/gkn159; Guo Yanzhi, 2010, BMC Res Notes, V3, P145, DOI 10.1186/1756-0500-3-145; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Joachims T Thorsten, 2002, LEARNING CLASSIFY TE; Memisevic V, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-154; Rajagopala SV, 2014, NAT BIOTECHNOL, V32, P285, DOI 10.1038/nbt.2831; Rashid M, 2010, CURR PROTEIN PEPT SC, V11, P589, DOI 10.2174/138920310794109120; Rathaur VK, 2014, J CLIN DIAGN RES, V8, pPC1, DOI 10.7860/JCDR/2014/6677.4319; Roy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007813; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Skrabanek L, 2008, MOL BIOTECHNOL, V38, P1, DOI 10.1007/s12033-007-0069-2; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Soltan-Dallal M.M., 2001, ARCH IRAN MED, V4, P201, DOI [10.1023/a:1017472726251, DOI 10.1023/A:1017472726251]; Sprinzak E, 2001, J MOL BIOL, V311, P681, DOI 10.1006/jmbi.2001.4920; Su C, 2008, NUCLEIC ACIDS RES, V36, pD632, DOI 10.1093/nar/gkm807; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003	25	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145648	10.1371/journal.pone.0145648	http://dx.doi.org/10.1371/journal.pone.0145648			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717407	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500052
J	Conway, MJ				Conway, Michael J.			Identification of a Flavivirus Sequence in a Marine Arthropod	PLOS ONE			English	Article							EVOLUTION; PHYLOGENY; ARBOVIRUS; POLY(A); VIRUS; TRANSMISSION; GENOME	Phylogenetic analysis has yet to uncover the early origins of flaviviruses. In this study, I mined a database of expressed sequence tags in order to discover novel flavivirus sequences. Flavivirus sequences were identified in a pool of mRNA extracted from the sea spider Endeis spinosa (Pycnogonida, Pantopoda). Reconstruction of the translated sequences and BLAST analysis matched the sequence to the flavivirus NS5 gene. Additional sequences corresponding to envelope and the NS5 MTase domain were also identified. Phylogenetic analysis of homologous NS5 sequences revealed that Endeis spinosa NS5 (ESNS5) is likely related to classical insect-specific flaviviruses. It is unclear if ESNS5 represents genetic material from an active viral infection or an integrated viral genome. These data raise the possibility that classical insect-specific flaviviruses and perhaps medically relevant flaviviruses, evolved from progenitors that infected marine arthropods.	[Conway, Michael J.] Cent Michigan Univ, Coll Med, Foundat Sci, Mt Pleasant, MI 48859 USA	Central Michigan University	Conway, MJ (corresponding author), Cent Michigan Univ, Coll Med, Foundat Sci, Mt Pleasant, MI 48859 USA.	michael.conway@cmich.edu			Central Michigan University College of Medicine	Central Michigan University College of Medicine	This work was supported by Start-up funds from Central Michigan University College of Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango CP, 2007, CLADISTICS, V23, P255, DOI 10.1111/j.1096-0031.2007.00143.x; Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927; Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016; Calzolari M, 2016, INFECT GENET EVOL, V40, P381, DOI 10.1016/j.meegid.2015.07.032; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105; Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0; Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0; Forrester NL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002897; Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867; Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X; Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0; Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534; Holmes EC, 2003, J VIROL, V77, P3893, DOI 10.1128/JVI.77.7.3893-3897.2003; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; MANDL CW, 1991, J VIROL, V65, P4070, DOI 10.1128/JVI.65.8.4070-4077.1991; MARIN MS, 1995, VIROLOGY, V206, P1133, DOI 10.1006/viro.1995.1038; Nam DK, 2002, P NATL ACAD SCI USA, V99, P6152, DOI 10.1073/pnas.092140899; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pettersson JHO, 2014, J GEN VIROL, V95, P1969, DOI 10.1099/vir.0.065227-0; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Stock JH, EXPT FOOD PREFERENCE; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turpaeva EP, DEEP SEA PYCNOGONIDS; Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467; WALLNER G, 1995, VIROLOGY, V213, P169, DOI 10.1006/viro.1995.1557; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003	30	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146037	10.1371/journal.pone.0146037	http://dx.doi.org/10.1371/journal.pone.0146037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717191	Green Submitted, gold, Green Published			2022-12-27	WOS:000367510500123
J	Lo, CI; Fall, B; Sambe-Ba, B; Diawara, S; Gueye, MW; Mediannikov, O; Sokhna, C; Faye, N; Dieme, Y; Wade, B; Raoult, D; Fenollar, F				Lo, Cheikh I.; Fall, Becaye; Sambe-Ba, Bissoume; Diawara, Silman; Gueye, Mamadou W.; Mediannikov, Oleg; Sokhna, Cheikh; Faye, Ngor; Dieme, Yaya; Wade, Boubacar; Raoult, Didier; Fenollar, Florence			MALDI-TOF Mass Spectrometry: A Powerful Tool for Clinical Microbiology at Hopital Principal de Dakar, Senegal (West Africa)	PLOS ONE			English	Article							DESORPTION-IONIZATION-TIME; SEQUENCE-BASED IDENTIFICATION; BACILLUS-CEREUS GROUP; RIBOSOMAL-RNA GENE; ROUTINE IDENTIFICATION; ONGOING REVOLUTION; MS SYSTEM; VITEK MS; BACTERIA; DNA	Our team in Europe has developed the routine clinical laboratory identification of microorganisms by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry (MS). To evaluate the utility of MALDI-TOF MS in tropical Africa in collaboration with local teams, we installed an apparatus in the Hopital Principal de Dakar (Senegal), performed routine identification of isolates, and confirmed or completed their identification in France. In the case of discordance or a lack of identification, molecular biology was performed. Overall, 153/191(80.1%) and 174/191(91.1%) isolates yielded an accurate and concordant identification for the species and genus, respectively, with the 2 different MALDI-TOF MSs in Dakar and Marseille. The 10 most common bacteria, representing 94.2% of all bacteria routinely identified in the laboratory in Dakar (Escherichia coli, Klebsiella pneumoniae, Streptococcus agalactiae, Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Staphylococcus haemolyticus, Enterobacter cloacae, Enterococcus faecalis, and Staphylococcus epidermidis) were accurately identified with the MALDI-TOF MS in Dakar. The most frequent misidentification in Dakar was at the species level for Achromobacter xylosoxidans, which was inaccurately identified as Achromobacter denitrificans, and the bacteria absent from the database, such as Exiguobacterium aurientacum or Kytococcus schroeteri, could not be identified. A few difficulties were observed with MALDI-TOF MS for Bacillus sp. or oral streptococci. 16S rRNA sequencing identified a novel bacterium, "Necropsobacter massiliensis." The robust identification of microorganisms by MALDI-TOF MS in Dakar and Marseille demonstrates that MALDI-TOF MS can be used as a first-line tool in clinical microbiology laboratories in tropical countries.	[Lo, Cheikh I.; Mediannikov, Oleg; Sokhna, Cheikh; Raoult, Didier; Fenollar, Florence] Aix Marseille Univ, Inst Hosp Univ Mediterranee Infect, INSERM,U1095,UM63,CNRS7278,IRD198, Unit Rech Malad Infectieuses & Trop Emergentes, Marseille, France; [Lo, Cheikh I.; Mediannikov, Oleg; Sokhna, Cheikh; Raoult, Didier; Fenollar, Florence] Aix Marseille Univ, Inst Hosp Univ Mediterranee Infect, INSERM,U1095,UM63,CNRS7278,IRD198, Unit Rech Malad Infectieuses & Trop Emergentes, Dakar, Senegal; [Fall, Becaye; Sambe-Ba, Bissoume; Diawara, Silman; Gueye, Mamadou W.; Dieme, Yaya; Wade, Boubacar] Hop Principal Dakar, Dakar, Senegal; [Faye, Ngor] Univ Cheikh Anta Diop, Dakar, Senegal	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University Cheikh Anta Diop Dakar	Fenollar, F (corresponding author), Aix Marseille Univ, Inst Hosp Univ Mediterranee Infect, INSERM,U1095,UM63,CNRS7278,IRD198, Unit Rech Malad Infectieuses & Trop Emergentes, Marseille, France.	florence.fenollar@univ-amu.fr	RAOULT, Didier/A-8434-2008; Mediannikov, Oleg/H-4018-2015	RAOULT, Didier/0000-0002-0633-5974; Mediannikov, Oleg/0000-0001-6039-2008; Boubacar, WADE/0000-0003-1663-799X	Institut Hospitalo-Universitaire (IHU) Mediterranee Infection	Institut Hospitalo-Universitaire (IHU) Mediterranee Infection	The Institut Hospitalo-Universitaire (IHU) Mediterranee Infection has financially supported the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2009, TRENDS MICROBIOL, V17, P37, DOI 10.1016/j.tim.2008.09.008; Al Masalma M, 2009, CLIN INFECT DIS, V48, P1169, DOI 10.1086/597578; Bizzini A, 2010, J CLIN MICROBIOL, V48, P1549, DOI 10.1128/JCM.01794-09; Castanha ER, 2006, J MICROBIOL METH, V67, P230, DOI 10.1016/j.mimet.2006.03.024; Cheng A, 2013, J MICROBIOL IMMUNOL, V46, P187, DOI 10.1016/j.jmii.2012.05.005; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; Crapart S, 2007, INT J SYST EVOL MICR, V57, P287, DOI 10.1099/ijs.0.64639-0; Deak E, 2015, DIAGN MICR INFEC DIS, V81, P27, DOI 10.1016/j.diagmicrobio.2014.09.018; Drancourt M, 2001, INT J SYST EVOL MICR, V51, P925, DOI 10.1099/00207713-51-3-925; Drancourt M, 2002, J CLIN MICROBIOL, V40, P1333, DOI 10.1128/JCM.40.4.1333-1338.2002; Drancourt M, 2004, J CLIN MICROBIOL, V42, P497, DOI 10.1128/JCM.42.2.497-504.2004; Drancourt M, 2004, J CLIN MICROBIOL, V42, P2197, DOI 10.1128/JCM.42.5.2197-2202.2004; Dridi B, 2012, APMIS, V120, P85, DOI 10.1111/j.1600-0463.2011.02833.x; Fall B, 2015, AM J TROP MED HYG, V92, P641, DOI 10.4269/ajtmh.14-0406; Fenollar F, 2006, J CLIN MICROBIOL, V44, P1018, DOI 10.1128/JCM.44.3.1018-1028.2006; Gutzmer R, 2004, J MED MICROBIOL, V53, P1207, DOI 10.1099/jmm.0.45779-0; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Khamis A, 2004, J CLIN MICROBIOL, V42, P3925, DOI 10.1128/JCM.42.9.3925-3931.2004; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Ling HZ, 2014, J CLIN MICROBIOL, V52, P2573, DOI 10.1128/JCM.00700-14; Lo C. I., 2015, New Microbes and New Infections, V8, P41, DOI 10.1016/j.nmni.2015.09.007; Logan NA, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P455; Manji R, 2014, EUR J CLIN MICROBIOL, V33, P337, DOI 10.1007/s10096-013-1961-2; Patel R, 2015, CLIN CHEM, V61, P100, DOI 10.1373/clinchem.2014.221770; Patel R, 2013, CLIN INFECT DIS, V57, P564, DOI 10.1093/cid/cit247; Pitt TL, 2007, CLIN MICROBIOL INFEC, V13, P946, DOI 10.1111/j.1469-0691.2007.01779.x; Renvoise A, 2008, INT J INFECT DIS, V12, P223, DOI 10.1016/j.ijid.2007.06.011; Richter S, 2013, EUR J CLIN MICROBIOL, V32, P1571, DOI 10.1007/s10096-013-1912-y; Ryzhov V, 2000, APPL ENVIRON MICROB, V66, P3828, DOI 10.1128/AEM.66.9.3828-3834.2000; Seng P, 2013, J CLIN MICROBIOL, V51, P2182, DOI 10.1128/JCM.00492-13; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Suzuki T, 2007, J CLIN MICROBIOL, V45, P3833, DOI 10.1128/JCM.01212-07; Tan KE, 2012, J CLIN MICROBIOL, V50, P3301, DOI 10.1128/JCM.01405-12; van Veen SQ, 2010, J CLIN MICROBIOL, V48, P900, DOI 10.1128/JCM.02071-09; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	37	37	48	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145889	10.1371/journal.pone.0145889	http://dx.doi.org/10.1371/journal.pone.0145889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716681	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500088
J	Chen, B; Xu, T; Zhou, CL; Wang, LY; Yang, N; Wang, Z; Dong, HM; Yang, Z; Zang, YF; Zuo, XN; Weng, XC				Chen, Bing; Xu, Ting; Zhou, Changle; Wang, Luoyu; Yang, Ning; Wang, Ze; Dong, Hao-Ming; Yang, Zhi; Zang, Yu-Feng; Zuo, Xi-Nian; Weng, Xu-Chu			Individual Variability and Test-Retest Reliability Revealed by Ten Repeated Resting-State Brain Scans over One Month	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; FUNCTIONAL CONNECTIVITY; TOPOLOGICAL ORGANIZATION; NETWORK STRUCTURE; FMRI; CONNECTOME; CORTEX; SEGMENTATION; FLEXIBILITY; HOMOGENEITY	Individual differences in mind and behavior are believed to reflect the functional variability of the human brain. Due to the lack of a large-scale longitudinal dataset, the full landscape of variability within and between individual functional connectomes is largely unknown. We collected 300 resting-state functional magnetic resonance imaging (rfMRI) datasets from 30 healthy participants who were scanned every three days for one month. With these data, both intra-and inter-individual variability of six common rfMRI metrics, as well as their test-retest reliability, were estimated across multiple spatial scales. Global metrics were more dynamic than local regional metrics. Cognitive components involving working memory, inhibition, attention, language and related neural networks exhibited high intra-individual variability. In contrast, inter-individual variability demonstrated a more complex picture across the multiple scales of metrics. Limbic, default, frontoparietal and visual networks and their related cognitive components were more differentiable than somatomotor and attention networks across the participants. Analyzing both intra-and inter-individual variability revealed a set of high-resolution maps on test-retest reliability of the multi-scale connectomic metrics. These findings represent the first collection of individual differences in multi-scale and multimetric characterization of the human functional connectomes in-vivo, serving as normal references for the field to guide the use of common functional metrics in rfMRI-based applications.	[Chen, Bing; Zhou, Changle; Weng, Xu-Chu] Xiamen Univ, Sch Informat Sci & Engn, Fujian Prov Key Lab Brain Like Intelligent Syst, Xiamen 361005, Fujian, Peoples R China; [Chen, Bing; Wang, Luoyu; Wang, Ze; Zang, Yu-Feng; Weng, Xu-Chu] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou 311121, Zhejiang, Peoples R China; [Xu, Ting; Yang, Ning; Dong, Hao-Ming; Yang, Zhi; Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Xu, Ting; Yang, Ning; Dong, Hao-Ming; Yang, Zhi; Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Magnet Resonance Imaging Res Ctr, Beijing 100101, Peoples R China; [Yang, Ning; Dong, Hao-Ming] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Yang, Ning; Dong, Hao-Ming; Yang, Zhi; Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Lab Funct Connectome & Dev, Beijing 100101, Peoples R China; [Zuo, Xi-Nian] Southwest Univ, Fac Psychol, Chongqing 400715, Peoples R China; [Zuo, Xi-Nian] Guangxi Teachers Educ Univ, Sch Educ Sci, Dept Psychol, Nanning 530001, Guangxi, Peoples R China	Xiamen University; Hangzhou Normal University; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; Southwest University - China; Nanning Normal University	Zuo, XN (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	zuoxn@psych.ac.cn; wengxc@psych.ac.cn	Yang, Zhi/W-6459-2019; Zuo, Xi-Nian/A-7273-2009	Yang, Zhi/0000-0002-2222-2312; Zuo, Xi-Nian/0000-0001-9110-585X	National Key Basic Research and Development (973) Program [2015CB351702]; Major Joint Fund for International Cooperation and Exchange of the National Natural Science Foundation [81220108014]; Hundred Talents Program; Chinese Academy of Sciences [KSZD-EW-TZ-002]; Natural Science Foundation of China [31070905, 31371134, 81171409, 81471740]; National Social Science Foundation of China [11AZD119]	National Key Basic Research and Development (973) Program(National Basic Research Program of China); Major Joint Fund for International Cooperation and Exchange of the National Natural Science Foundation; Hundred Talents Program(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation of China	This work was partially supported by the National Key Basic Research and Development (973) Program (2015CB351702, X-NZ), the Major Joint Fund for International Cooperation and Exchange of the National Natural Science Foundation (81220108014, X-NZ), the Hundred Talents Program and the Key Research Program (KSZD-EW-TZ-002, X-NZ) of the Chinese Academy of Sciences, the Natural Science Foundation of China (31070905, 31371134, 81171409 and 81471740) and the National Social Science Foundation of China (11AZD119).; This work was partially supported by the National Key Basic Research and Development (973) Program (2015CB351702, X-NZ), the Major Joint Fund for International Cooperation and Exchange of the National Natural Science Foundation (81220108014, X-NZ), the Hundred Talents Program and the Key Research Program (KSZD-EW-TZ-002, X-NZ) of the Chinese Academy of Sciences, the Natural Science Foundation of China (31070905, 31371134, 81171409 and 81471740) and the National Social Science Foundation of China (11AZD119). The computations were performed on the Dell Blade Cluster System at the Institute of Psychology, Chinese Academy of Sciences. We thank Dr. B.T. Thomas Yeo for discussions about the use of the cognitive ontology and Dr. Richard F. Betzel for proof-reading of the final version of the manuscript.	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Anderson JS, 2014, HUM BRAIN MAPP, V35, P1273, DOI 10.1002/hbm.22251; Anderson ML, 2014, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00918; Baker AP, 2014, ELIFE, V3, DOI 10.7554/eLife.01867; Barttfeld P, 2015, P NATL ACAD SCI USA, V112, P887, DOI 10.1073/pnas.1418031112; Bassett DS, 2011, TRENDS COGN SCI, V15, P200, DOI 10.1016/j.tics.2011.03.006; Betzel RF, 2016, NEUROIMAGE, V127, P287, DOI 10.1016/j.neuroimage.2015.12.001; Betzel RF, 2016, NEUROIMAGE, V124, P1054, DOI 10.1016/j.neuroimage.2015.09.041; Betzel RF, 2014, NEUROIMAGE, V102, P345, DOI 10.1016/j.neuroimage.2014.07.067; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2012, NEUROIMAGE, V62, P938, DOI 10.1016/j.neuroimage.2012.01.090; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blautzik J, 2013, J ALZHEIMERS DIS, V34, P741, DOI 10.3233/JAD-111970; Buckner RL, 2013, NAT NEUROSCI, V16, P832, DOI 10.1038/nn.3423; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Calhoun VD, 2014, NEURON, V84, P262, DOI 10.1016/j.neuron.2014.10.015; Cao M, 2014, DEV COGN NEUROS-NETH, V7, P76, DOI 10.1016/j.dcn.2013.11.004; Carp J, 2013, NEUROIMAGE, V76, P436, DOI 10.1016/j.neuroimage.2011.12.061; Chan MY, 2014, P NATL ACAD SCI USA, V111, pE4997, DOI 10.1073/pnas.1415122111; Choe AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140134; Cox RW, 2012, NEUROIMAGE, V62, P743, DOI 10.1016/j.neuroimage.2011.08.056; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Deco G, 2014, J NEUROSCI, V34, P7910, DOI 10.1523/JNEUROSCI.4423-13.2014; Deco G, 2013, J NEUROSCI, V33, P11239, DOI 10.1523/JNEUROSCI.1091-13.2013; Di Martino A, 2014, Mol Psychiatry, V19, P659, DOI 10.1038/mp.2013.78; Du HX, 2015, CNS NEUROSCI THER, V21, P802, DOI 10.1111/cns.12431; Fukushima M, 2015, ARXIV151106427V1; Gao W, 2014, J NEUROSCI, V34, P11288, DOI 10.1523/JNEUROSCI.5072-13.2014; Gonzalez-Castillo J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00138; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Gu S, 2015, P NATL ACAD SCI USA, V112, P13681, DOI 10.1073/pnas.1502829112; Guo CC, 2012, NEUROIMAGE, V61, P1471, DOI 10.1016/j.neuroimage.2012.03.027; He Y, 2016, HUM BRAIN M IN PRESS; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hellyer PJ, 2015, J NEUROSCI, V35, P9050, DOI 10.1523/JNEUROSCI.4648-14.2015; Holmes AJ, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.31; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jiang L, 2015, NEUROSCENTI IN PRESS; Jiang LL, 2015, BRAIN STRUCT FUNCT, V220, P2485, DOI 10.1007/s00429-014-0795-8; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Keilholz SD, 2014, BRAIN CONNECT, V4, P769, DOI 10.1089/brain.2014.0250; Kelly C, 2012, TRENDS COGN SCI, V16, P181, DOI 10.1016/j.tics.2012.02.001; Kraemer HC, 2014, ANNU REV CLIN PSYCHO, V10, P111, DOI 10.1146/annurev-clinpsy-032813-153739; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laumann TO, 2015, NEURON, V87, P657, DOI 10.1016/j.neuron.2015.06.037; Li ZJ, 2012, J MAGN RESON IMAGING, V36, P344, DOI 10.1002/jmri.23670; Liao XH, 2013, NEUROIMAGE, V83, P969, DOI 10.1016/j.neuroimage.2013.07.058; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; Messe A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003530; Mueller S, 2015, HUM BRAIN MAPP, V36, P4664, DOI 10.1002/hbm.22947; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Murphy K, 2013, NEUROIMAGE, V80, P349, DOI 10.1016/j.neuroimage.2013.04.001; Orban P, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.43; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Poldrack RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9885; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Saad ZS, 2013, BRAIN CONNECT, V3, P339, DOI 10.1089/brain.2013.0156; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Schaefer A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00195; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shen K, 2015, J NEUROSCI, V35, P5579, DOI 10.1523/JNEUROSCI.4903-14.2015; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith DV, 2014, NEUROIMAGE, V95, P1, DOI 10.1016/j.neuroimage.2014.03.042; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Somandepalli K, 2015, DEV COGN NEUROS-NETH, V15, P83, DOI 10.1016/j.dcn.2015.08.003; Song J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049847; Thomason ME, 2011, NEUROIMAGE, V55, P165, DOI 10.1016/j.neuroimage.2010.11.080; Wang DH, 2015, NAT NEUROSCI, V18, P1853, DOI 10.1038/nn.4164; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wink AM, 2012, BRAIN CONNECT, V2, P265, DOI 10.1089/brain.2012.0087; Xing XX, 2011, MAGN RESON IMAGING, V29, P731, DOI 10.1016/j.mri.2011.02.007; Xu T, 2015, SCI BULL, V60, P86, DOI 10.1007/s11434-014-0698-3; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Yang Z, 2014, NEUROIMAGE, V89, P45, DOI 10.1016/j.neuroimage.2013.10.039; Yeo BTT, 2015, CEREB CORTEX, V25, P3654, DOI 10.1093/cercor/bhu217; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zalesky A, 2014, P NATL ACAD SCI USA, V111, P10341, DOI 10.1073/pnas.1400181111; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhao TD, 2015, HUM BRAIN MAPP, V36, P3777, DOI 10.1002/hbm.22877; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.49; Zuo XN, 2014, NEUROSCI BIOBEHAV R, V45, P100, DOI 10.1016/j.neubiorev.2014.05.009; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269; Zuo XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026703; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	99	74	75	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144963	10.1371/journal.pone.0144963	http://dx.doi.org/10.1371/journal.pone.0144963			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714192	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900026
J	Haesevoets, T; Folmer, CR; Van Hiel, A				Haesevoets, Tessa; Folmer, Chris Reinders; Van Hiel, Alain			Is Trust for Sale? The Effectiveness of Financial Compensation for Repairing Competence- versus Integrity-Based Trust Violations	PLOS ONE			English	Article							ORGANIZATIONAL TRUST; OBSERVER DIFFERENCES; COOPERATION; MONEY; OVERCOMPENSATION; ATTRIBUTIONS; ANTECEDENTS; FORGIVENESS; PSYCHOLOGY; APOLOGIES	Despite the popularity of financial compensation as a means for addressing trust violations, the question whether (more) money can indeed buy trust back remains largely unexplored. In the present research, we focus on the role of violation type and compensation size. The results of a scenario study and a laboratory experiment show that financial compensation can effectively promote the restoration of trust for transgressions that indicate a lack of competence. Conversely, for transgressions which signal a lack of integrity, financial compensation is not an effective tool to repair trust. Moreover, our findings indicate that for both violation types, overcompensation has no positive effects on top of the impact of equal compensation. These findings therefore show that when it comes to trust, money cannot buy everything.	[Haesevoets, Tessa; Folmer, Chris Reinders; Van Hiel, Alain] Univ Ghent, Dept Dev Personal & Social Psychol, B-9000 Ghent, Belgium; [Folmer, Chris Reinders] Erasmus Univ, Erasmus Sch Law, Rotterdam, Netherlands	Ghent University; Erasmus University Rotterdam	Haesevoets, T (corresponding author), Univ Ghent, Dept Dev Personal & Social Psychol, B-9000 Ghent, Belgium.	Tessa.Haesevoets@UGent.be	Folmer, Chris Reinders/AAL-2334-2021; Haesevoets, Tessa/ABC-3486-2020	Folmer, Chris Reinders/0000-0003-1340-2300; Haesevoets, Tessa/0000-0001-7167-1299	National Fund for Scientific Research-Flanders (FWO) [G095912N]	National Fund for Scientific Research-Flanders (FWO)(FWO)	This work was funded by National Fund for Scientific Research-Flanders (FWO) Grant number: G095912N. Website: http://www.fwo.be. Role: The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin W, 1976, ADV EXPT SOCIAL PSYC, P163, DOI DOI 10.1016/S0065-2601(08)60061-1; Barber B, 1983, LOGIC LIMITS TRUST; BLOUNT S, 1995, ORGAN BEHAV HUM DEC, V63, P131, DOI 10.1006/obhd.1995.1068; Bottom WP, 2002, ORGAN SCI, V13, P497, DOI 10.1287/orsc.13.5.497.7816; BRICKMAN P, 1977, J SOC ISSUES, V33, P140, DOI 10.1111/j.1540-4560.1977.tb01873.x; BUTLER JK, 1984, PSYCHOL REP, V55, P19, DOI 10.2466/pr0.1984.55.1.19; Castelfranchi C, 2005, OPEN AGENT SOC NORMA, P58; Castelfranchi C, 2006, LECT NOTES COMPUT SC, V3986, P19; Costigan RD, 2012, J APPL SOC PSYCHOL, V42, P1123, DOI 10.1111/j.1559-1816.2011.00880.x; Darley JM, 2003, PERS SOC PSYCHOL REV, V7, P324, DOI 10.1207/S15327957PSPR0704_05; Davidow M., 2003, J SERV RES-US, V5, P225, DOI DOI 10.1177/1094670502238917; De Cremer D, 2005, ADV EXP SOC PSYCHOL, V37, P151, DOI 10.1016/S0065-2601(05)37003-1; De Cremer D, 2012, RESTORING TRUST CHAL, P241; DECARUFEL A, 1981, J APPL SOC PSYCHOL, V11, P445, DOI 10.1111/j.1559-1816.1981.tb00835.x; Desmet PTM, 2011, PERS INDIV DIFFER, V51, P267, DOI 10.1016/j.paid.2010.05.027; Desmet PTM, 2010, J BUS ETHICS, V95, P105, DOI 10.1007/s10551-011-0791-3; Desmet PTM, 2011, ORGAN BEHAV HUM DEC, V114, P75, DOI 10.1016/j.obhdp.2010.10.006; Dirks KT, 2001, ORGAN SCI, V12, P450, DOI 10.1287/orsc.12.4.450.10640; Dirks KT, 2002, J APPL PSYCHOL, V87, P611, DOI 10.1037/0021-9010.87.4.611; Dirks KT, 2011, ORGAN BEHAV HUM DEC, V114, P87, DOI 10.1016/j.obhdp.2010.10.003; Dirks KT, 2009, ACAD MANAGE REV, V34, P68, DOI 10.5465/AMR.2009.35713285; Falcone R, 2001, TRUST AND DECEPTION IN VIRTUAL SOCIETIES, P55; Falcone R., 2001, TRUST CYBER SOC INTE, P1; Ferrin DL, 2007, J APPL PSYCHOL, V92, P893, DOI 10.1037/0021-9010.92.4.893; Haden SC, 2006, J SOC PERS RELAT, V23, P101, DOI 10.1177/0265407506060181; Haesevoets T, 2014, PSYCHOL BELG, V54, P389, DOI 10.5334/pb.ay; Haesevoets T, 2014, J ECON PSYCHOL, V42, P83, DOI 10.1016/j.joep.2014.02.001; Haesevoets T, 2013, J ECON PSYCHOL, V35, P95, DOI 10.1016/j.joep.2013.02.003; Hewstone M., 2012, INTRO SOCIAL PSYCHOL, V5th ed., P237; Janowicz-Panjaitan M, 2009, J MANAGE STUD, V46, P245, DOI 10.1111/j.1467-6486.2008.00798.x; Joskowicz-Jabloner L, 2013, J APPL SOC PSYCHOL, V43, P1799, DOI 10.1111/jasp.12130; Kim PH, 2009, ACAD MANAGE REV, V34, P401, DOI 10.5465/AMR.2009.40631887; Kim PH, 2006, ORGAN BEHAV HUM DEC, V99, P49, DOI 10.1016/j.obhdp.2005.07.002; Kim PH, 2004, J APPL PSYCHOL, V89, P104, DOI 10.1037/0021-9010.89.1.104; Kramer R.M., 1996, TRUST ORG FRONTIERS; Kramer RM, 2010, ACAD MANAG ANN, V4, P245, DOI 10.1080/19416520.2010.487403; Lee D, 2011, J APPL SOC PSYCHOL, V41, P1603, DOI 10.1111/j.1559-1816.2011.00776.x; Lewicki RJ, 2005, HANDBOOK OF ORGANIZATIONAL JUSTICE, P247; Marzo F, 2013, ORG CHANGE INFORM SY, P167; Mazar N, 2008, J MARKETING RES, V45, P633, DOI 10.1509/jmkr.45.6.633; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; REEDER GD, 1979, PSYCHOL REV, V86, P61, DOI 10.1037/0033-295X.86.1.61; REMPEL JK, 1985, J PERS SOC PSYCHOL, V49, P95, DOI 10.1037/0022-3514.49.1.95; Risen JL, 2007, J PERS SOC PSYCHOL, V92, P418, DOI 10.1037/0022-3514.92.3.418; Rousseau DM, 1998, ACAD MANAGE REV, V23, P393, DOI 10.5465/AMR.1998.926617; Schoorman FD, 2007, ACAD MANAGE REV, V32, P344, DOI 10.5465/AMR.2007.24348410; Schweitzer ME, 2006, ORGAN BEHAV HUM DEC, V101, P1, DOI 10.1016/j.obhdp.2006.05.005; Sousa-Lima M, 2013, J APPL SOC PSYCHOL, V43, P418, DOI 10.1111/j.1559-1816.2013.01012.x; Tomlinson EC, 2004, J MANAGE, V30, P165, DOI 10.1016/j.jm.2003.01.003; Tyler T. R., 1997, SOCIAL JUSTICE RES D; Van Hiel A, 2013, SOCIALE PSYCHOL; Van Vugt M, 2004, J PERS SOC PSYCHOL, V86, P585, DOI 10.1037/0022-3514.86.4.585; Worsfold K, 2007, J APPL SOC PSYCHOL, V37, P2496, DOI 10.1111/j.1559-1816.2007.00267.x; Xie Y, 2009, PSYCHOL MARKET, V26, P572, DOI 10.1002/mar.20289	54	2	2	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145952	10.1371/journal.pone.0145952	http://dx.doi.org/10.1371/journal.pone.0145952			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0IX	26714025	gold, Green Submitted, Green Published			2022-12-27	WOS:000367481900105
J	Nayar, R; Schutten, E; Jangalwe, S; Durost, PA; Kenney, LL; Conley, JM; Daniels, K; Brehm, MA; Welsh, RM; Berg, LJ				Nayar, Ribhu; Schutten, Elizabeth; Jangalwe, Sonal; Durost, Philip A.; Kenney, Laurie L.; Conley, James M.; Daniels, Keith; Brehm, Michael A.; Welsh, Raymond M.; Berg, Leslie J.			IRF4 Regulates the Ratio of T-Bet to Eomesodermin in CD8(+) T Cells Responding to Persistent LCMV Infection	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; TRANSCRIPTION FACTOR IRF4; INHIBITORY RECEPTOR PD-1; EFFECTOR FUNCTION; TCR AFFINITY; MEMORY; DIFFERENTIATION; RESPONSES; EXHAUSTION; ANTIGEN	CD8(+) T cell exhaustion commonly occurs in chronic infections and cancers. During T cell exhaustion there is a progressive and hierarchical loss of effector cytokine production, upregulation of inhibitory co-stimulatory molecules, and eventual deletion of antigen specific cells by apoptosis. A key factor that regulates T cell exhaustion is persistent TCR stimulation. Loss of this interaction results in restoration of CD8(+) T cell effector functions in previously exhausted CD8(+) T cells. TCR stimulation is also important for the differentiation of Eomes(hi) anti-viral CD8(+) effector T cells from T-bet(hi) precursors, both of which are required for optimal viral control. However, the molecular mechanisms regulating the differentiation of these two cell subsets and the relative ratios required for viral clearance have not been described. We show that TCR signal strength regulates the relative expression of T-bet and Eomes in antigen-specific CD8(+) T cells by modulating levels of IRF4. Reduced IRF4 expression results in skewing of this ratio in the favor of Eomes, leading to lower proportions and numbers of T-bet(+) Eomes(-) precursors and poor control of LCMV-clone 13 infection. Manipulation of this ratio in the favor of T-bet restores the differentiation of T-bet(+) Eomes(-) precursors and the protective balance of T-bet to Eomes required for efficient viral control. These data highlight a critical role for IRF4 in regulating protective anti-viral CD8(+) T cell responses by ensuring a balanced ratio of T-bet to Eomes, leading to the ultimate control of this chronic viral infection.	[Nayar, Ribhu; Schutten, Elizabeth; Kenney, Laurie L.; Conley, James M.; Daniels, Keith; Welsh, Raymond M.; Berg, Leslie J.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Jangalwe, Sonal; Durost, Philip A.; Brehm, Michael A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Berg, LJ (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.	Leslie.Berg@umassmed.edu	Jangalwe, Sonal/Y-9319-2019	Jangalwe, Sonal/0000-0002-2464-4711; Conley, James/0000-0001-8901-4713; Brehm, Michael/0000-0001-6813-3262	National Institutes of Health [AI084987, AI106833, AI046629, AI017672, AI081678]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI046629, R01AI101048, P01AI081678, R01AI017672, T32AI007349, R01AI084987, R37AI017672, R01AI106833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health AI084987 (LJB), National Institutes of Health AI106833 (LJB), National Institutes of Health AI046629 (MAB), National Institutes of Health AI017672 (RMW), and National Institutes of Health AI081678 (RMW).	[Anonymous], 2003, VIRAL PERSISTENCE AL, V77, P4911, DOI [10.1128/JVI.77.8.4911-4927.2003, DOI 10.1128/JVI.77.8.4911-4927.2003]; Aubert RD, 2011, P NATL ACAD SCI USA, V108, P21182, DOI 10.1073/pnas.1118450109; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bergthaler A, 2009, PLOS BIOL, V7, P789, DOI 10.1371/journal.pbio.1000080; Brooks DG, 2006, J CLIN INVEST, V116, P1675, DOI 10.1172/JCI26856; Cornberg M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00475; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Gronski MA, 2004, NAT MED, V10, P1234, DOI 10.1038/nm1114; Grusdat M, 2014, CELL DEATH DIFFER, V21, P1050, DOI 10.1038/cdd.2014.19; Huber M, 2014, EUR J IMMUNOL, V44, P1886, DOI 10.1002/eji.201344279; Huber M, 2013, J CLIN INVEST, V123, P247, DOI 10.1172/JCI63681; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Nayar R, 2014, J IMMUNOL, V192, P5881, DOI 10.4049/jimmunol.1303187; Nayar R, 2012, P NATL ACAD SCI USA, V109, pE2794, DOI 10.1073/pnas.1205742109; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Popescu I, 2014, J IMMUNOL, V193, P5709, DOI 10.4049/jimmunol.1401436; Raczkowski F, 2013, P NATL ACAD SCI USA, V110, P15019, DOI 10.1073/pnas.1309378110; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Thomsen AR, 1996, J IMMUNOL, V157, P3074; Welsh RM, 2005, LYMPHOCYTIC CHORIOME, DOI [10.1002/9780471729259.mc15a01s8, DOI 10.1002/9780471729259.MC15A01S8]; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhu YB, 2010, J IMMUNOL, V185, P3174, DOI 10.4049/jimmunol.1000749	39	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144826	10.1371/journal.pone.0144826	http://dx.doi.org/10.1371/journal.pone.0144826			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714260	gold, Green Published, Green Submitted			2022-12-27	WOS:000367481900019
J	Tabisz, L; Tukibayeva, A; Pankiewicz, R; Dobielska, M; Leska, B				Tabisz, Lukasz; Tukibayeva, Ainur; Pankiewicz, Radoslaw; Dobielska, Marta; Leska, Boguslawa			Disiloxanes and Functionalized Silica Gels: One Route, Two Complementary Outcomes-Guanidinium and Pyridinium Ion-Exchangers	PLOS ONE			English	Article							ANION; IMMOBILIZATION; EXTRACTION; RECEPTORS; COMPLEXES; SILOXANES; CATALYSTS; BINDING	Five novel disiloxane compounds comprising guanidinium and pyridinium moieties were obtained with high yields and purity. The verified synthetic pathways were then applied for modification of pre-functionalized silica gel, producing materials with the analogous organic side-chains. These halide-containing compounds and materials were then compared as to their ion-exchange properties: two disiloxanes proved to be effective in leaching different anions (nitrate, benzoate and ascorbate) from solid to organic phase, and pyridinium-functionalized silica gels showed selectivity towards perchlorate ion, removing it from methanolic solutions with preference to other singly charged anions. The results presented demonstrate that both compounds and materials containing silicon-carbon bonds can be produced using the same methodology, but offer strikingly different application opportunities. Comparison of their properties provides additional insight into the binding mode of different anions and hints at how the transition from a flexible siloxane bridge to immobilization on solid surface influences anion-binding selectivity. Additionally, one of the siloxane dipodands was found to form a crystalline and poorly soluble nitrate salt (1.316 g/L, water), although it was miscible with a wide range of solvents as a hydrochloride. A possible explanation is given with the help of semi-empirical calculations. A simple, time-and cost-efficient automated potentiometric titration methodology was used as a viable analytical tool for studying ion-exchange processes for both compounds and materials, in addition to standard NMR, FT-IR and ESI-MS methods.	[Tabisz, Lukasz; Pankiewicz, Radoslaw; Dobielska, Marta; Leska, Boguslawa] Adam Mickiewicz Univ, Fac Chem, PL-61614 Poznan, Poland; [Tukibayeva, Ainur] M Auezov South Kazakhstan State Univ, Dept Chem, Shymkent 160012, Kazakhstan	Adam Mickiewicz University; M. Auezov South Kazakhstan State University	Leska, B (corresponding author), Adam Mickiewicz Univ, Fac Chem, Umultowska 89b, PL-61614 Poznan, Poland.	bogunial@amu.edu.pl	Tabisz, Łukasz/AAW-3738-2020; Sabirov, Vakhobjan/K-4761-2015; Tukibayeva, Ainur S/N-8994-2017	Tabisz, Łukasz/0000-0002-5281-3826; Leska, Boguslawa/0000-0002-9504-5265; Pankiewicz, Radoslaw/0000-0002-0929-6018	Kazakh Committee of Science MES [68-35]	Kazakh Committee of Science MES(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	Financial support was given under Grant No. 68-35, realized from 12.02.2015, by the Kazakh Committee of Science MES, http://control.edu.gov.kz/en, AT. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belcher WJ, 2006, ORG BIOMOL CHEM, V4, P781, DOI 10.1039/b516027h; COLVIN EW, 1978, CHEM SOC REV, V7, P15, DOI 10.1039/cs9780700015; Cypryk M, 2002, ORGANOMETALLICS, V21, P2165, DOI 10.1021/om011055s; Houk RJT, 2005, TOP CURR CHEM, V255, P199, DOI 10.1007/b101167; Ibrahim I.A.M., 2010, J AM SCI, V6, P985, DOI 10.7537/marsjas061110.133; Ikem VO, 2008, ANGEW CHEM INT EDIT, V47, P8277, DOI 10.1002/anie.200802244; Jal PK, 2004, TALANTA, V62, P1005, DOI 10.1016/j.talanta.2003.10.028; Kittappa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130253; Kubota LT, 1996, ELECTROCHIM ACTA, V41, P1465, DOI 10.1016/0013-4686(95)00395-9; Maia A, 2003, TETRAHEDRON LETT, V44, P4149, DOI 10.1016/S0040-4039(03)00838-4; Maiga DT, 2014, PHYS CHEM EARTH, V72-75, P83, DOI 10.1016/j.pce.2014.09.012; Pankiewicz R, 2007, J MOL STRUCT, V829, P120, DOI 10.1016/j.molstruc.2006.06.013; Patai S, 2001, CHEM ORGANIC SILICON, V3; Pu QS, 1998, ANALYST, V123, P239, DOI 10.1039/a706135h; Rosciszewski P, 2004, WLASCIWOSCI ZASTOSOW; Seo Y, 2015, MICROPOR MESOPOR MAT, V207, P156, DOI 10.1016/j.micromeso.2015.01.021; Shu XZ, 2015, J AM CHEM SOC, V137, P7083, DOI 10.1021/jacs.5b04294; Soroceanu A, 2013, EUR J INORG CHEM, P1458, DOI 10.1002/ejic.201201080; Tabisz L, 2015, TETRAHEDRON, V71, P2267, DOI 10.1016/j.tet.2015.02.056; Tabisz L, 2014, TETRAHEDRON LETT, V55, P6416, DOI 10.1016/j.tetlet.2014.09.117; Van der Voort P, 2013, CHEM SOC REV, V42, P3913, DOI 10.1039/c2cs35222b; Vlad A, 2012, EUR J INORG CHEM, P5078, DOI 10.1002/ejic.201200612; Wang N, 2015, RSC ADV, V5, P15500, DOI 10.1039/c4ra13861a; Weinhold F, 2013, J AM CHEM SOC, V135, P5762, DOI 10.1021/ja312222k; Zaltariov MF, 2014, EUR J INORG CHEM, P4946, DOI 10.1002/ejic.201402578	25	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145680	10.1371/journal.pone.0145680	http://dx.doi.org/10.1371/journal.pone.0145680			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714187	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900066
J	Zuo, YC; Lv, Y; Wei, ZY; Yang, L; Li, GP; Fan, GL				Zuo, Yongchun; Lv, Yang; Wei, Zhuying; Yang, Lei; Li, Guangpeng; Fan, Guoliang			iDPF-PseRAAAC: A Web-Server for Identifying the Defensin Peptide Family and Subfamily Using Pseudo Reduced Amino Acid Alphabet Composition	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; SUBCELLULAR-LOCALIZATION; MEMBRANE-PROTEINS; PREDICTION; INNATE; SEQUENCE; DIVERSITY; COMPONENT; DISTANCE; FEATURES	Defensins as one of the most abundant classes of antimicrobial peptides are an essential part of the innate immunity that has evolved in most living organisms from lower organisms to humans. To identify specific defensins as interesting antifungal leads, in this study, we constructed a more rigorous benchmark dataset and the iDPF-PseRAAAC server was developed to predict the defensin family and subfamily. Using reduced dipeptide compositions were used, the overall accuracy of proposed method increased to 95.10% for the defensin family, and 98.39% for the vertebrate subfamily, which is higher than the accuracy from other methods. The jackknife test shows that more than 4% improvement was obtained comparing with the previous method. A free online server was further established for the convenience of most experimental scientists at http://wlxy.imu.edu.cn/college/biostation/fuwu/iDPF-PseRAAAC/index.asp. A friendly guide is provided to describe how to use the web server. We anticipate that iDPF-PseRAAAC may become a useful high-throughput tool for both basic research and drug design.	[Zuo, Yongchun; Lv, Yang; Wei, Zhuying; Li, Guangpeng] Inner Mongolia Univ, Key Lab Mammalian Reprod Biol & Biotechnol, Minist Educ, Coll Life Sci, Hohhot, Peoples R China; [Yang, Lei] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Fan, Guoliang] Inner Mongolia Univ, Sch Phys Sci & Technol, Lab Theoret Biophys, Hohhot, Peoples R China	Inner Mongolia University; Harbin Medical University; Inner Mongolia University	Zuo, YC (corresponding author), Inner Mongolia Univ, Key Lab Mammalian Reprod Biol & Biotechnol, Minist Educ, Coll Life Sci, Hohhot, Peoples R China.	yczuo@imu.edu.cn; eeguoliangfan@sina.com	Zuo, Yongchun/J-2703-2014	Zuo, Yongchun/0000-0002-6065-7835	National Nature Scientific Foundation of China [11447201, 61561036]; Specialized Research Fund for the Doctoral Program of Higher Education [20131501120009]; Natural Science Foundation of Inner Mongolia Autonomous Region [2013MS0503]	National Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Inner Mongolia Autonomous Region	This work was supported by The National Nature Scientific Foundation of China (No: 11447201, 61561036), the Specialized Research Fund for the Doctoral Program of Higher Education (20131501120009) and the Natural Science Foundation of Inner Mongolia Autonomous Region (No: 2013MS0503).	Aerts AM, 2008, CELL MOL LIFE SCI, V65, P2069, DOI 10.1007/s00018-008-8035-0; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen W, 2009, J MICROBIOL METH, V78, P94, DOI 10.1016/j.mimet.2009.03.013; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2013, MOL BIOSYST, V9, P1092, DOI 10.1039/c3mb25555g; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; de Brevern Alexandre G., 2005, In Silico Biology, V5, P283; de Medeiros LN, 2010, BBA-BIOMEMBRANES, V1798, P105, DOI 10.1016/j.bbamem.2009.07.013; Ding C, 2012, J PROTEOMICS, V77, P321, DOI 10.1016/j.jprot.2012.09.006; Du PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086879; Du PF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/263829; Du PF, 2012, J THEOR BIOL, V313, P61, DOI 10.1016/j.jtbi.2012.08.016; Etchebest C, 2007, EUR BIOPHYS J BIOPHY, V36, P1059, DOI 10.1007/s00249-007-0188-5; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Jarczak J, 2013, HUM IMMUNOL, V74, P1069, DOI 10.1016/j.humimm.2013.05.008; Kumari SR, 2012, PROTEIN PEPTIDE LETT, V19, P1318; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Li DY, 2014, MOL BIOL REP, V41, P3859, DOI 10.1007/s11033-014-3253-z; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin H, 2011, J THEOR BIOL, V269, P64, DOI 10.1016/j.jtbi.2010.10.019; Lin HH, 2006, PROTEINS, V62, P218, DOI 10.1002/prot.20605; Liu B, 2015, MOL GENET GENOMICS, V290, P1919, DOI 10.1007/s00438-015-1044-4; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Martin J, 2008, PROTEINS, V71, P92, DOI 10.1002/prot.21659; Menendez A, 2007, CURR OPIN IMMUNOL, V19, P385, DOI 10.1016/j.coi.2007.06.008; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; Oppenheim JJ, 2003, ANN RHEUM DIS, V62, P17, DOI 10.1136/ard.62.suppl_2.ii17; Palma M, 2011, AMINO ACIDS, V40, P1, DOI 10.1007/s00726-010-0726-9; Seebah S, 2007, NUCLEIC ACIDS RES, V35, pD265, DOI 10.1093/nar/gkl866; Thomas PD, 1996, P NATL ACAD SCI USA, V93, P11628, DOI 10.1073/pnas.93.21.11628; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Tyagi M, 2008, PROTEINS, V71, P920, DOI 10.1002/prot.21776; Tyagi M, 2006, NUCLEIC ACIDS RES, V34, pW119, DOI 10.1093/nar/gkl199; Xiao X, 2013, ANAL BIOCHEM, V436, P168, DOI 10.1016/j.ab.2013.01.019; Xiao X, 2011, CURR PROTEIN PEPT SC, V12, P508, DOI 10.2174/138920311796957720; Zhao XM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-57; Zhao XM, 2008, PROTEINS, V70, P1125, DOI 10.1002/prot.21870; Zhao XM, 2006, INT J PATTERN RECOGN, V20, P271, DOI 10.1142/S021800140600465X; Zhao XM, 2005, NEURAL NETWORKS, V18, P1019, DOI 10.1016/j.neunet.2005.07.002; Zuo YC, 2014, ANAL BIOCHEM, V458, P14, DOI 10.1016/j.ab.2014.04.032; Zuo YC, 2013, AMINO ACIDS, V44, P573, DOI 10.1007/s00726-012-1374-z; Zuo YC, 2010, AMINO ACIDS, V38, P859, DOI 10.1007/s00726-009-0292-1; Zuo YC, 2009, PEPTIDES, V30, P1788, DOI 10.1016/j.peptides.2009.06.032	45	37	38	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145541	10.1371/journal.pone.0145541	http://dx.doi.org/10.1371/journal.pone.0145541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713618	Green Submitted, gold, Green Published			2022-12-27	WOS:000367481900054
J	Chang, YC; Reddy, MV; Umemoto, H; Sato, Y; Kang, MH; Yajima, Y; Kikuchi, S				Chang, Young-Cheol; Reddy, M. Venkateswar; Umemoto, Honoka; Sato, Yuki; Kang, Mi-Hye; Yajima, Yuka; Kikuchi, Shintaro			Bio-Augmentation of Cupriavidus sp CY-1 into 2,4-D Contaminated Soil: Microbial Community Analysis by Culture Dependent and Independent Techniques	PLOS ONE			English	Article							2,4-DICHLOROPHENOXYACETIC ACID DEGRADATION; RIBOSOMAL-RNA GENES; BACTERIAL COMMUNITY; DIVERSITY; BIOAUGMENTATION; REMEDIATION; HERBICIDES; STRATEGY; IMPACTS; REGION	In the present study, a 2,4-dichlorophenoxyacetic acid (2,4-D) degrading bacterial strain CY-1 was isolated from the forest soil. Based on physiological, biochemical and 16S rRNA gene sequence analysis it was identified as Cupriavidus sp. CY-1. Further 2,4-D degradation experiments at different concentrations (200 to 800 mg l(-1)) were carried out using CY-1. Effect of NaCl and KNO3 on 2,4-D degradation was also evaluated. Degradation of 2,4-D and the metabolites produced during degradation process were analyzed using high pressure liquid chromatography (HPLC) and GC-MS respectively. The amount of chloride ions produced during the 2,4-D degradation were analyzed by Ion chromatography (IC) and it is stoichiometric with 2,4-D dechlorination. Furthermore two different types of soils collected from two different sources were used for 2,4-D degradation studies. The isolated strain CY1 was bio-augmented into 2,4-D contaminated soils to analyze its degradation ability. Culture independent methods like denaturing gradient gel electrophoresis (DGGE) and terminal restriction fragment length polymorphism (T-RFLP), and culture dependent methods like colony forming units (CFU) and most probable number (MPN) were used to analyze the survivability of strain CY-1 in contaminated soil. Results of T-RFLP were coincident with the DGGE analysis. From the DGGE, T-RFLP, MPN and HPLC results it was concluded that strain CY-1 effectively degraded 2,4-D without disturbing the ecosystem of soil indigenous microorganisms.	[Chang, Young-Cheol; Reddy, M. Venkateswar; Umemoto, Honoka; Sato, Yuki; Kikuchi, Shintaro] Muroran Inst Technol, Div Sustainable & Environm Engn, Coll Environm Technol, Course Chem & Biol Engn, Muroran, Hokkaido 0508585, Japan; [Kang, Mi-Hye] Seoul Metropolitan Govt Res Inst Publ Hlth & Envi, Seoul 137893, South Korea; [Yajima, Yuka] Kyoto Univ, Grad Sch Med, Kyoto, Kyoto 6068501, Japan	Muroran Institute of Technology; Kyoto University	Chang, YC (corresponding author), Muroran Inst Technol, Div Sustainable & Environm Engn, Coll Environm Technol, Course Chem & Biol Engn, 27-1 Mizumoto, Muroran, Hokkaido 0508585, Japan.	ychang@mmm.muroran-it.ac.jp	Chang, Young-Cheol/U-4910-2017; Reddy, M Venkateswar/E-5535-2012; Motakatla, Venkateswer Reddy/AAT-4203-2021	Chang, Young-Cheol/0000-0002-6197-5974; Motakatla, Venkateswer Reddy/0000-0001-5944-5395	Ministry of Education, Culture, Sports, Science and Technology of Japan [26340067]; Muroran Institute Technology, Japan; Grants-in-Aid for Scientific Research [15F15352] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Muroran Institute Technology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (No. 26340067) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Research fund of Muroran Institute Technology, Japan.	Alexander M., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P815; Barreto DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110128; Bouseba B, 2009, PEST MANAG SCI, V65, P1021, DOI 10.1002/ps.1789; Celis E, 2008, WATER RES, V42, P3218, DOI 10.1016/j.watres.2008.04.008; Chang YC, 2011, J IND MICROBIOL BIOT, V38, P1667, DOI 10.1007/s10295-011-0956-1; Chen WM, 2008, J HAZARD MATER, V151, P364, DOI 10.1016/j.jhazmat.2007.05.082; Cheng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113253; Cupples AM, 2007, SOIL BIOL BIOCHEM, V39, P232, DOI 10.1016/j.soilbio.2006.07.011; de Morais MG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/967814; Dunbar J, 1997, APPL ENVIRON MICROB, V63, P1326, DOI 10.1128/AEM.63.4.1326-1331.1997; Dunbar J, 2001, APPL ENVIRON MICROB, V67, P190, DOI 10.1128/AEM.67.1.190-197.2001; FUKUMORI F, 1993, J BIOL CHEM, V268, P24311; Gauri SS, 2012, BIORESOURCE TECHNOL, V126, P350, DOI 10.1016/j.biortech.2012.09.097; Gonod LV, 2006, FEMS MICROBIOL ECOL, V58, P529, DOI 10.1111/j.1574-6941.2006.00159.x; GREER CW, 1990, ARCH MICROBIOL, V154, P317, DOI 10.1007/BF00276525; Han LZ, 2014, WORLD J MICROB BIOT, V30, P2567, DOI 10.1007/s11274-014-1680-6; Heuer H, 2012, FEMS MICROBIOL REV, V36, P1083, DOI 10.1111/j.1574-6976.2012.00337.x; Inoue D, 2012, BIODEGRADATION, V23, P263, DOI 10.1007/s10532-011-9505-x; Itoh K, 2004, APPL ENVIRON MICROB, V70, P2110, DOI 10.1128/AEM.70.4.2110-2118.2004; Kitagawa W, 2002, J BACTERIOL, V184, P509, DOI 10.1128/JB.184.2.509-518.2002; Lee EH, 2011, J ENVIRON SCI HEAL A, V46, P281, DOI 10.1080/10934529.2011.535435; Lee TH, 2005, MICROB ECOL, V49, P151, DOI 10.1007/s00248-003-1035-6; Macur RE, 2007, MICROBIOL RES, V162, P37, DOI 10.1016/j.micres.2006.05.007; Manzano M, 2007, ANTON LEEUW INT J G, V91, P115, DOI 10.1007/s10482-006-9101-y; Martin-Laurent F, 2001, APPL ENVIRON MICROB, V67, P2354, DOI 10.1128/AEM.67.5.2354-2359.2001; Martinez-Alonso M, 2010, INT MICROBIOL, V13, P123, DOI 10.2436/20.1501.01.117; Merini LJ, 2007, CHEMOSPHERE, V68, P259, DOI 10.1016/j.chemosphere.2007.01.012; Mohan SV, 2010, BIORESOURCE TECHNOL, V101, P9382, DOI 10.1016/j.biortech.2010.06.109; Newby DT, 2000, APPL ENVIRON MICROB, V66, P3399, DOI 10.1128/AEM.66.8.3399-3407.2000; Nunan N, 2005, APPL ENVIRON MICROB, V71, P6784, DOI 10.1128/AEM.71.11.6784-6792.2005; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Reddy MV, 2015, GREEN CHEM, V17, P4560, DOI [10.1039/C5GC01156F, 10.1039/c5gc01156f]; Reddy MV, 2015, BIORESOURCE TECHNOL, V192, P711, DOI 10.1016/j.biortech.2015.06.043; Reddy MV, 2011, J HAZARD MATER, V197, P80, DOI 10.1016/j.jhazmat.2011.09.061; Roane TM, 2001, APPL ENVIRON MICROB, V67, P3208, DOI 10.1128/AEM.67.7.3208-3215.2001; Sakai Y, 2007, MICROBES ENVIRON, V22, P145, DOI 10.1264/jsme2.22.145; Shimojo M, 2009, J BIOSCI BIOENG, V108, P56, DOI 10.1016/j.jbiosc.2009.02.018; Shiozaki A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111374; Singh BK, 2006, APPL ENVIRON MICROB, V72, P7278, DOI 10.1128/AEM.00510-06; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Top EM, 2002, FEMS MICROBIOL ECOL, V42, P199, DOI 10.1111/j.1574-6941.2002.tb01009.x; Zabaloy MC, 2008, APPL SOIL ECOL, V40, P1, DOI 10.1016/j.apsoil.2008.02.004	43	8	8	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145057	10.1371/journal.pone.0145057	http://dx.doi.org/10.1371/journal.pone.0145057			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710231	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400019
J	Fortin, E; Platt, RW; Fontela, PS; Buckeridge, DL; Quach, C				Fortin, Elise; Platt, Robert W.; Fontela, Patricia S.; Buckeridge, David L.; Quach, Caroline			Predicting Antimicrobial Resistance Prevalence and Incidence from Indicators of Antimicrobial Use: What Is the Most Accurate Indicator for Surveillance in Intensive Care Units?	PLOS ONE			English	Article							ANTIBIOTIC USE; PATIENT-DAYS; DRUG-USE; HOSPITALS; ASSOCIATION; QUALITY	Objective The optimal way to measure antimicrobial use in hospital populations, as a complement to surveillance of resistance is still unclear. Using respiratory isolates and antimicrobial prescriptions of nine intensive care units (ICUs), this study aimed to identify the indicator of antimicrobial use that predicted prevalence and incidence rates of resistance with the best accuracy. Methods Retrospective cohort study including all patients admitted to three neonatal (NICU), two pediatric (PICU) and four adult ICUs between April 2006 and March 2010. Ten different resistance / antimicrobial use combinations were studied. After adjustment for ICU type, indicators of antimicrobial use were successively tested in regression models, to predict resistance prevalence and incidence rates, per 4-week time period, per ICU. Binomial regression and Poisson regression were used to model prevalence and incidence rates, respectively. Multiplicative and additive models were tested, as well as no time lag and a one 4-week-period time lag. For each model, the mean absolute error (MAE) in prediction of resistance was computed. The most accurate indicator was compared to other indicators using t-tests. Results Results for all indicators were equivalent, except for 1/20 scenarios studied. In this scenario, where prevalence of carbapenem-resistant Pseudomonas sp. was predicted with carbapenem use, recommended daily doses per 100 admissions were less accurate than courses per 100 patient-days (p = 0.0006). Conclusions A single best indicator to predict antimicrobial resistance might not exist. Feasibility considerations such as ease of computation or potential external comparisons could be decisive in the choice of an indicator for surveillance of healthcare antimicrobial use.	[Fortin, Elise; Platt, Robert W.; Fontela, Patricia S.; Buckeridge, David L.; Quach, Caroline] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Fortin, Elise; Quach, Caroline] Inst Natl Sante Publ Quebec, Direct Risques Biol & Sante Travail, Quebec City, PQ, Canada; [Fortin, Elise; Quach, Caroline] Inst Natl Sante Publ Quebec, Direct Risques Biol & Sante Travail, Montreal, PQ, Canada; [Fontela, Patricia S.; Quach, Caroline] McGill Univ, Montreal Childrens Hosp, Dept Pediat, Montreal, PQ H3H 1P3, Canada	McGill University; Institut national de sante publique du Quebec (INSPQ); Institut national de sante publique du Quebec (INSPQ); McGill University	Quach, C (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	caroline.quach@mcgill.ca	Quach, Caroline/AAT-6987-2021; Fontela, Patricia/S-6455-2019	Quach, Caroline/0000-0002-1170-9475; 	Fonds de recherche du Quebec - Sante	Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec)	This work was funded by Fonds de recherche du Quebec - Sante: www.frqs.gouv.qc.ca/le-frqs. No grant number. CQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Berrington A, 2010, J ANTIMICROB CHEMOTH, V65, P163, DOI 10.1093/jac/dkp399; Cohen AL, 2008, INFECT CONT HOSP EP, V29, P901, DOI 10.1086/591741; Committee I, 2012, RED BOOK 2012 REPORT; de With K, 2006, INFECTION, V34, P91, DOI 10.1007/s15010-006-5085-9; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Filius PMG, 2005, J ANTIMICROB CHEMOTH, V55, P805, DOI 10.1093/jac/dki093; Fortin E, 2014, J ANTIMICROB CHEMOTH, V69, P1447, DOI 10.1093/jac/dku003; Fortin E, 2015, AM J INFECT CONTROL, V43, P174, DOI 10.1016/j.ajic.2014.10.024; Gilbert DN, 2008, SANFORD GUIDE ANTIMI; Gilca R, 2010, INFECT CONT HOSP EP, V31, P939, DOI 10.1086/655463; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Haug JB, 2013, J ANTIMICROB CHEMOTH, V68, P2940, DOI 10.1093/jac/dkt268; HOLM S, 1979, SCAND J STAT, V6, P65; Hyndman R.J., 2006, FORESIGHT INT J APPL, V4, P43; Ibrahim OM, 2012, EXPERT REV ANTI-INFE, V10, P445, DOI 10.1586/eri.12.18; Kern WV, 2005, INFECTION, V33, P333, DOI 10.1007/s15010-005-5059-3; La Salle M, 2004, MONTREAL CHILDRENS H; Li H, 2012, INT J MED MICROBIOL, V302, P63, DOI 10.1016/j.ijmm.2011.10.001; Lipsitch M, 2001, CLIN INFECT DIS, V32, P1044, DOI 10.1086/319604; MALDONADO G, 1994, EPIDEMIOLOGY, V5, P171, DOI 10.1097/00001648-199403000-00007; Monnet DL, 2007, CLIN INFECT DIS, V44, P671, DOI 10.1086/511649; National Healthcare Safety Network (NHSN), 2014, ANT US RES AUR MOD; Nelson JD., 2012, 2012 2013 NELSONS PE, V19th; Polk RE, 2007, CLIN INFECT DIS, V44, P664, DOI 10.1086/511640; Ruef C, 2006, INFECTION, V34, P53, DOI 10.1007/s15010-006-7206-x; Schechner V, 2013, CLIN MICROBIOL REV, V26, P289, DOI 10.1128/CMR.00001-13; Steinke D, 2001, CLIN INFECT DIS, V33, pS193, DOI 10.1086/321848; WHO, 2001, WHO GLOB STRAT CONT; WHO Collaborating Centre for Drug Statistics Methodology; Norwegian Institute of Public Health, 2014, ATC DDD IND 2014; World Health Organisation Collaborating Center for Drug Statistics Methodology, 2011, GUID ATC CLASS DDD A; Zarb P, 2011, J ANTIMICROB CHEMOTH, V66, P443, DOI 10.1093/jac/dkq430	32	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145088	10.1371/journal.pone.0145088	http://dx.doi.org/10.1371/journal.pone.0145088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710322	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400020
J	Gurdziel, K; Lorberbaum, DS; Udager, AM; Song, JY; Richards, N; Parker, DS; Johnson, LA; Allen, BL; Barolo, S; Gumucio, DL				Gurdziel, Katherine; Lorberbaum, David S.; Udager, Aaron M.; Song, Jane Y.; Richards, Neil; Parker, David S.; Johnson, Lisa A.; Allen, Benjamin L.; Barolo, Scott; Gumucio, Deborah L.			Identification and Validation of Novel Hedgehog-Responsive Enhancers Predicted by Computational Analysis of Ci/Gli Binding Site Density	PLOS ONE			English	Article							CIS-REGULATORY MODULES; NEURAL-TUBE; PATTERN-FORMATION; GENE-EXPRESSION; DROSOPHILA; TRANSCRIPTION; ELEMENTS; PATHWAY; SEQUENCES; WINGLESS	The Hedgehog (Hh) signaling pathway directs a multitude of cellular responses during embryogenesis and adult tissue homeostasis. Stimulation of the pathway results in activation of Hh target genes by the transcription factor Ci/Gli, which binds to specific motifs in genomic enhancers. In Drosophila, only a few enhancers (patched, decapentaplegic, wingless, stripe, knot, hairy, orthodenticle) have been shown by in vivo functional assays to depend on direct Ci/Gli regulation. All but one (orthodenticle) contain more than one Ci/Gli site, prompting us to directly test whether homotypic clustering of Ci/Gli binding sites is sufficient to define a Hh-regulated enhancer. We therefore developed a computational algorithm to identify Ci/Gli clusters that are enriched over random expectation, within a given region of the genome. Candidate genomic regions containing Ci/Gli clusters were functionally tested in chicken neural tube electroporation assays and in transgenic flies. Of the 22 Ci/Gli clusters tested, seven novel enhancers (and the previously known patched enhancer) were identified as Hh-responsive and Ci/Gli-dependent in one or both of these assays, including: Cuticular protein 100A (Cpr100A); invected (inv), which encodes an engrailed-related transcription factor expressed at the anterior/posterior wing disc boundary; roadkill (rdx), the fly homolog of vertebrate Spop; the segment polarity gene gooseberry (gsb); and two previously untested regions of the Hh receptor-encoding patched (ptc) gene. We conclude that homotypic Ci/Gli clustering is not sufficient information to ensure Hh-responsiveness; however, it can provide a clue for enhancer recognition within putative Hedgehog target gene loci.	[Gurdziel, Katherine; Lorberbaum, David S.; Udager, Aaron M.; Song, Jane Y.; Richards, Neil; Parker, David S.; Johnson, Lisa A.; Allen, Benjamin L.; Barolo, Scott; Gumucio, Deborah L.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Gurdziel, Katherine] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Lorberbaum, David S.; Song, Jane Y.] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Allen, BL (corresponding author), Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	benallen@umich.edu; sbarolo@umich.edu; dgumucio@umich.edu			University of Michigan Center for Organogenesis; NIH [R01-DK65850, P01-DK062041, T32 DK094775, F30DK082144, GM076509, R21 CA167122, R01 DC014428]; Training Program in Bioinformatics [NIH T32 GM070499]; Medical Scientist Training Program [NIH T32GM007863]; Cellular and Molecular Biology Training Grant [NIH T32-GM007315]; Center for Organogenesis predoctoral fellowship [NIH T32-HD007505]; NSF [MCB-1157800]; AHA scientist development grant [11SDG6380000]; NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA167122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK082144, P30DK034933, R01DK065850, P01DK062041, T32DK094775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863, T32GM007315, R01GM076509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014428] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1157800] Funding Source: National Science Foundation	University of Michigan Center for Organogenesis(University of Michigan System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Program in Bioinformatics; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular and Molecular Biology Training Grant; Center for Organogenesis predoctoral fellowship; NSF(National Science Foundation (NSF)); AHA scientist development grant(American Heart Association); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	DLG, SB and BLA were funded by a Research Team Grant from The University of Michigan Center for Organogenesis. DLG is grateful for support from NIH R01-DK65850 and NIH P01-DK062041. KG was supported by NIH T32 DK094775 and the Training Program in Bioinformatics (NIH T32 GM070499). AMU was supported by NIH F30DK082144 and the Medical Scientist Training Program (NIH T32GM007863). DSL was supported by the Cellular and Molecular Biology Training Grant (NIH T32-GM007315) and a Center for Organogenesis predoctoral fellowship (NIH T32-HD007505); the Barolo lab was supported by NIH grant GM076509 and NSF grant MCB-1157800. Work in the Allen lab is supported by an AHA scientist development grant (11SDG6380000) and by NIH R21 CA167122 and NIH R01 DC014428.; The NKX6.1 antibody was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA. Confocal microscopy was performed in the Microscopy and Image Analysis Laboratory at the University of Michigan. Sequencing of enhancer constructs was performed at the University of Michigan Sequencing Core. The authors would like to thank Dr. Mark Rebeiz for generously sharing scripts and Dr. William J. Zacharias for helpful discussions.	Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Biehs B, 2010, DEV CAMBRIDGE ENGLAN, V137, P1; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Blanco J, 2009, DEV BIOL, V329, P104, DOI 10.1016/j.ydbio.2009.02.027; Bouchard M, 2000, DEV BIOL, V222, P135, DOI 10.1006/dbio.2000.9702; Boy AL, 2010, GENESIS, V48, P452, DOI 10.1002/dvg.20637; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Celniker SE, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0079; Coward E, 1999, BIOINFORMATICS, V15, P1058, DOI 10.1093/bioinformatics/15.12.1058; de Sauvage F, 2007, Bull Mem Acad R Med Belg, V162, P219; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; FITCH WM, 1983, J MOL BIOL, V163, P171, DOI 10.1016/0022-2836(83)90002-5; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Halfon MS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-578; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hammonds AS, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r140; Hersh BM, 2005, DEVELOPMENT, V132, P1567, DOI 10.1242/dev.01737; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; Jeong JH, 2005, DEVELOPMENT, V132, P143, DOI 10.1242/dev.01566; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jory A, 2012, CELL REP, V2, P1014, DOI 10.1016/j.celrep.2012.09.010; Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109; Kent D, 2006, DEVELOPMENT, V133, P2001, DOI 10.1242/dev.02370; Lang M, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-11; Lee EY, 2010, P NATL ACAD SCI USA, V107, P9736, DOI 10.1073/pnas.1004602107; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; LI XL, 1993, EMBO J, V12, P4499, DOI 10.1002/j.1460-2075.1993.tb06139.x; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Lipinski RJ, 2010, BIRTH DEFECTS RES A, V88, P232, DOI 10.1002/bdra.20656; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; McKay DJ, 2013, DEV CELL, V27, P306, DOI 10.1016/j.devcel.2013.10.009; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Megason SG, 2002, DEVELOPMENT, V129, P2087; Michel M, 2012, DEVELOPMENT, V139, P2663, DOI 10.1242/dev.075242; Muller B, 2000, DEV CAMBRIDGE ENGLAN, V127, P1; Murdoch JN, 2010, BIRTH DEFECTS RES A, V88, P633, DOI 10.1002/bdra.20686; Ngan ESW, 2013, MOL SYNDROMOL, V4, P32, DOI 10.1159/000345725; Nishi Y, 2015, DEVELOPMENT, V142, P3286, DOI 10.1242/dev.124636; Ohlen T, 1997, MECH DEVELOP, V68, P1; Oosterveen T, 2012, DEV CELL, V23, P1006, DOI 10.1016/j.devcel.2012.09.015; Peterson KA, 2012, GENE DEV, V26, P2802, DOI 10.1101/gad.207142.112; Piepenburg O, 2000, MOL CELL, V6, P203, DOI 10.1016/S1097-2765(00)00022-8; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Ramos AI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0018; Rebeiz M, 2002, P NATL ACAD SCI USA, V99, P9888, DOI 10.1073/pnas.152320899; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sawaya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054710; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Schachter KA, 2008, CURR TOP DEV BIOL, V84, P139, DOI 10.1016/S0070-2153(08)00603-0; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Suryamohan K, 2014, WILEY INTERDISCIPLIN; Swanson CI, 2008, GENE, V408, P180, DOI 10.1016/j.gene.2007.11.003; Swanson CI, 2010, DEV CELL, V18, P359, DOI 10.1016/j.devcel.2009.12.026; Taher L, 2015, COLD SPRING HARB PRO, V2015; Tang JY, 2012, NEW ENGL J MED, V366, P2180, DOI 10.1056/NEJMoa1113538; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Timmer J, 2001, GENESIS, V29, P123, DOI 10.1002/gene.1015; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Vadasz S, 2013, DEVELOPMENT, V140, P3691, DOI 10.1242/dev.088328; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; VonOhlen T, 1997, P NATL ACAD SCI USA, V94, P2404, DOI 10.1073/pnas.94.6.2404; Wang H, 2011, DEVELOPMENT, V138, P3711, DOI 10.1242/dev.068270; Winklmayr M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-2; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	75	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145225	10.1371/journal.pone.0145225	http://dx.doi.org/10.1371/journal.pone.0145225			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710299	gold, Green Published, Green Submitted			2022-12-27	WOS:000367451400028
J	Massett, MP; Avila, JJ; Kim, SK				Massett, Michael P.; Avila, Joshua J.; Kim, Seung Kyum			Exercise Capacity and Response to Training Quantitative Trait Loci in a NZW X 129S1 Intercross and Combined Cross Analysis of Inbred Mouse Strains	PLOS ONE			English	Article							MITOCHONDRIAL INTERMEDIATE PEPTIDASE; ENDURANCE EXERCISE; SPINOCEREBELLAR ATAXIA; PHYSICAL-FITNESS; AEROBIC CAPACITY; SKELETAL-MUSCLE; OXYGEN-UPTAKE; QTL; MORTALITY; TDP1	Genetic factors determining exercise capacity and the magnitude of the response to exercise training are poorly understood. The aim of this study was to identify quantitative trait loci (QTL) associated with exercise training in mice. Based on marked differences in training responses in inbred NZW (-0.65 +/- 1.73 min) and 129S1 (6.18 +/- 3.81 min) mice, a reciprocal intercross breeding scheme was used to generate 285 F-2 mice. All F-2 mice completed an exercise performance test before and after a 4-week treadmill running program, resulting in an increase in exercise capacity of 1.54 +/- 3.69 min (range = -10 to + 12 min). Genome-wide linkage scans were performed for pre-training, post-training, and change in run time. For pre-training exercise time, suggestive QTL were identified on Chromosomes 5 (57.4 cM, 2.5 LOD) and 6 (47.8 cM, 2.9 LOD). A significant QTL for post-training exercise capacity was identified on Chromosome 5 (43.4 cM, 4.1 LOD) and a suggestive QTL on Chromosomes 1 (55.7 cM, 2.3 LOD) and 8 (66.1 cM, 2.2 LOD). A suggestive QTL for the change in run time was identified on Chromosome 6 (37.8 cM, 2.7 LOD). To identify shared QTL, this data set was combined with data from a previous F-2 cross between B6 and FVB strains. In the combined cross analysis, significant novel QTL for pre-training exercise time and change in exercise time were identified on Chromosome 12 (54.0 cM, 3.6 LOD) and Chromosome 6 (28.0 cM, 3.7 LOD), respectively. Collectively, these data suggest that combined cross analysis can be used to identify novel QTL and narrow the confidence interval of QTL for exercise capacity and responses to training. Furthermore, these data support the use of larger and more diverse mapping populations to identify the genetic basis for exercise capacity and responses to training.	[Massett, Michael P.; Avila, Joshua J.; Kim, Seung Kyum] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station	Massett, MP (corresponding author), Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA.	mmassett@hlkn.tamu.edu	Kim, Seung/ABC-8404-2020	Kim, Seung/0000-0002-1708-9393; Massett, Michael/0000-0001-5356-4959	National Institutes of Health [R01 HL085918]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by National Institutes of Health grant R01 HL085918 (M.P.M.). No individuals employed or contracted by the funders played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert-Bicknell CL, 2012, BONE, V50, P1188, DOI 10.1016/j.bone.2012.01.011; Al-Jarrah M, 2007, NEUROSCIENCE, V149, P28, DOI 10.1016/j.neuroscience.2007.07.038; Barlow CE, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001354; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Bouchard C, 2000, J APPL PHYSIOL, V88, P551, DOI 10.1152/jappl.2000.88.2.551; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Broman KW, 2001, LAB ANIMAL, V30, P44; Chaillou T, 2015, J APPL PHYSIOL, V118, P86, DOI 10.1152/japplphysiol.00351.2014; Cheverud JM, 2012, HEREDITY, V108, P441, DOI 10.1038/hdy.2011.94; Chew A, 1997, GENOMICS, V40, P493, DOI 10.1006/geno.1996.4586; Chew A, 2000, GENOMICS, V65, P104, DOI 10.1006/geno.2000.6162; CHURCHILL GA, 1994, GENETICS, V138, P963; Courtney Sean M, 2014, F1000Res, V3, P9, DOI 10.12688/f1000research.3-9.v1; Courtney SM, 2012, PHYSIOL GENOMICS, V44, P948, DOI 10.1152/physiolgenomics.00051.2012; CRYSTAL RG, 1990, J CLIN INVEST, V85, P1343, DOI 10.1172/JCI114578; Das BB, 2010, P NATL ACAD SCI USA, V107, P19790, DOI 10.1073/pnas.1009814107; De Angelis K, 2004, J APPL PHYSIOL, V96, P2174, DOI 10.1152/japplphysiol.00870.2003; Dias RG, 2015, PHYSIOL GENOMICS, V47, P13, DOI 10.1152/physiolgenomics.00072.2014; Dunn-Lewis C, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-90; Erikssen G, 1998, LANCET, V352, P759, DOI 10.1016/S0140-6736(98)02268-5; Farber CR, 2007, GENETICS, V175, P349, DOI 10.1534/genetics.106.063693; Green DJ, 2014, J APPL PHYSIOL, V117, P345, DOI 10.1152/japplphysiol.00354.2014; Hagberg JM, 2011, MED SCI SPORT EXER, V43, P743, DOI 10.1249/MSS.0b013e3182155d21; Heit C, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-22; Hirano R, 2007, EMBO J, V26, P4732, DOI 10.1038/sj.emboj.7601885; Jagodic M, 2006, GENOMICS, V88, P737, DOI 10.1016/j.ygeno.2006.08.013; Koch LG, 2005, AM J PHYSIOL-REG I, V288, pR466, DOI 10.1152/ajpregu.00621.2004; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; Kokkinos P, 2010, CIRCULATION, V122, P790, DOI 10.1161/CIRCULATIONAHA.110.938852; Korstanje R, 2004, J LIPID RES, V45, P881, DOI 10.1194/jlr.M300460-JLR200; Li RH, 2005, GENETICS, V169, P1699, DOI 10.1534/genetics.104.033993; Lightfoot JT, 2007, J APPL PHYSIOL, V103, P105, DOI 10.1152/japplphysiol.01328.2006; Lightfoot JT, 2010, J APPL PHYSIOL, V109, P623, DOI 10.1152/japplphysiol.00525.2010; LORTIE G, 1984, INT J SPORTS MED, V5, P232, DOI 10.1055/s-2008-1025911; Martin-Sanchez FJ, 2011, J SPORT SCI MED, V10, P45; Massett MP, 2009, PHYSIOL GENOMICS, V40, P15, DOI 10.1152/physiolgenomics.00116.2009; Massett MP, 2005, AM J PHYSIOL-REG I, V288, pR1006, DOI 10.1152/ajpregu.00476.2004; Meier P, 2013, CELL BIOCHEM FUNCT, V31, P51, DOI 10.1002/cbf.2859; Nehrenberg DL, 2010, J HERED, V101, P42, DOI 10.1093/jhered/esp066; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Petkov PM, 2004, GENOMICS, V83, P902, DOI 10.1016/j.ygeno.2003.11.007; Rampersaud E, 2013, ANN HUM GENET, V77, P147, DOI 10.1111/ahg.12006; Rice TK, 2012, EUR J APPL PHYSIOL, V112, P2969, DOI 10.1007/s00421-011-2274-8; Rico-Sanz J, 2004, PHYSIOL GENOMICS, V16, P256, DOI 10.1152/physiolgenomics.00035.2003; Savage KJ, 2010, MUSCLE NERVE, V42, P355, DOI 10.1002/mus.21688; Semple SJ, 2006, BRIT J SPORT MED, V40, P124, DOI 10.1136/bjsm.2005.019489; Sisson SB, 2009, MED SCI SPORT EXER, V41, P539, DOI 10.1249/MSS.0b013e3181896c4e; Solberg LC, 2004, MAMM GENOME, V15, P648, DOI 10.1007/s00335-004-2326-z; Su ZG, 2009, J LIPID RES, V50, P2083, DOI 10.1194/jlr.M900076-JLR200; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009; Vollaard NBJ, 2009, J APPL PHYSIOL, V106, P1479, DOI 10.1152/japplphysiol.91453.2008; Ways JA, 2002, GENOMICS, V80, P13, DOI 10.1006/geno.2002.6797; Wergedal JE, 2007, J LIPID RES, V48, P1724, DOI 10.1194/jlr.M700015-JLR200; Wu CL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000070; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	59	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145741	10.1371/journal.pone.0145741	http://dx.doi.org/10.1371/journal.pone.0145741			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710100	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400074
J	Belle-van Meerkerk, G; de Jong, PA; de Valk, HW; Neefjes, T; Pameijer, FA; Kwakkel-van Erp, JM; van de Graaf, EA				Belle-van Meerkerk, Gerdien; de Jong, Pim A.; de Valk, Harold W.; Neefjes, Tim; Pameijer, Frank A.; Kwakkel-van Erp, Johanna M.; van de Graaf, Ed A.			Pretransplant HRCT Characteristics Are Associated with Worse Outcome of Lung Transplantation for Cystic Fibrosis Patients	PLOS ONE			English	Article							DIABETES-MELLITUS; EXACERBATION; CT	Objectives Peri-and postoperative complications diminish the outcome of lung transplantation (LTx) in patients with cystic fibrosis (CF). We hypothesized that the degree of pathological findings on pre-LTx high resolution computed tomography (HRCT) is associated with higher morbidity and mortality in CF. Methods All our CF patients undergoing LTx between 2001 and 2011 were included. HRCT examinations were evaluated according to a scoring system for pulmonary disease in CF patients, the Severe Advanced Lung Disease (SALD) score and for pleural involvement. Results Fifty-three patients were included. Dominant infectious/inflammatory disease according to the SALD score was observed in 10 patients (19%). Five (50%) of those patients died within one week after LTx, compared to 2 (5%) patients without dominant infectious/inflammatory disease (p<0.001). This difference in survival percentage remained also significant in multivariate analysis. Patients with infectious/inflammatory disease received more packed red blood cells; 26 versus 8 in the first week (p<0.001). Pleural thickening was associated with higher requirement (10 units) for blood transfusion during LTx, compared to patients with normal pleura (4 units). Conclusions The analysis of HRCT in CF patients according to the SALD score showed that dominant infectious/inflammatory disease is associated with a higher mortality after LTx. If confirmed in other studies, HRCT might aid estimation of surgical risk in some adult CF patients.	[Belle-van Meerkerk, Gerdien; Kwakkel-van Erp, Johanna M.; van de Graaf, Ed A.] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands; [Belle-van Meerkerk, Gerdien; de Valk, Harold W.] Univ Med Ctr Utrecht, Dept Internal Med, Utrecht, Netherlands; [de Jong, Pim A.; Neefjes, Tim; Pameijer, Frank A.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Belle-van Meerkerk, G (corresponding author), Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands.	G.vanMeerkerk@umcutrecht.nl						Aratari MT, 2008, TRANSPL P, V40, P2001, DOI 10.1016/j.transproceed.2008.05.029; Belle-van Meerkerk G, 2012, DIABETIC MED, V29, pE159, DOI 10.1111/j.1464-5491.2012.03676.x; Bradbury RA, 2009, INTERN MED J, V39, P384, DOI 10.1111/j.1445-5994.2008.01786.x; Bremner RM, 2001, AM SURGEON, V67, P1136; Christie JD, 2011, J HEART LUNG TRANSPL, V30, P1104, DOI 10.1016/j.healun.2011.08.004; Dosanjh A, 1998, Pediatr Transplant, V2, P283; Ferkol T, 2006, J PEDIATR-US, V148, P259, DOI 10.1016/j.jpeds.2005.10.019; Hackman KL, 2014, AM J TRANSPLANT, V14, P438, DOI 10.1111/ajt.12561; Hofer M, 2012, J CYST FIBROS, V11, P131, DOI 10.1016/j.jcf.2011.10.005; Kelly A, 2013, J CYST FIBROS, V12, P318, DOI 10.1016/j.jcf.2013.02.008; Loeve M, 2009, THORAX, V64, P876, DOI 10.1136/thx.2008.110908; Loeve M, 2012, AM J RESP CRIT CARE, V185, P1096, DOI 10.1164/rccm.201111-2065OC; Marom EM, 1999, RADIOLOGY, V213, P283, DOI 10.1148/radiology.213.1.r99oc12283; Meachery G, 2008, THORAX, V63, P725, DOI 10.1136/thx.2007.092056; Moran A, 2010, DIABETES CARE, V33, P2697, DOI 10.2337/dc10-1768; Moran A, 2009, DIABETES CARE, V32, P1626, DOI 10.2337/dc09-0586; Moreno P, 2016, EUR J CARDIO-THORAC, V49, P1334, DOI 10.1093/ejcts/ezv377; Parkins MD, 2012, CHEST, V141, P485, DOI 10.1378/chest.11-0917; Quattrucci Serena, 2005, J Cyst Fibros, V4, P107, DOI 10.1016/j.jcf.2005.01.003; Shah RM, 1997, AM J ROENTGENOL, V169, P375, DOI 10.2214/ajr.169.2.9242738	20	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145597	10.1371/journal.pone.0145597	http://dx.doi.org/10.1371/journal.pone.0145597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698308	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600102
J	He, YM; Makovicky, PJ; Wang, KB; Chen, SQ; Sullivan, C; Han, FL; Xu, X				He, Yiming; Makovicky, Peter J.; Wang, Kebai; Chen, Shuqing; Sullivan, Corwin; Han, Fenglu; Xu, Xing			A New Leptoceratopsid (Ornithischia, Ceratopsia) with a Unique Ischium from the Upper Cretaceous of Shandong Province, China	PLOS ONE			English	Article							DINOSAUR; PHYLOGENY; MUSCULATURE; ANATOMY; PARVUS	The partial skeleton of a leptoceratopsid dinosaur, Ischioceratops zhuchengensis gen. et sp. nov., was excavated from the bone-beds of the Upper Cretaceous Wangshi Group of Zhucheng, Shandong Province, China. This fossil represents the second leptoceratopsid dinosaur specimen recovered from the Kugou locality, a highly productive site in Zhucheng. The ischium of the new taxon is morphologically unique among known Dinosauria, flaring gradually to form an obturator process in its middle portion and resembling the shaft of a recurve bow. An elliptical fenestra perforates the obturator process, and the distal end of the shaft forms an axehead-shaped expansion. The discovery of Ischioceratops increases the known taxonomic diversity and morphological disparity of the Leptoceratopsidae.	[He, Yiming; Sullivan, Corwin; Xu, Xing] Chinese Acad Sci, Inst Vertebrate Palaeontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Makovicky, Peter J.] Field Museum, Dept Geol, Chicago, IL USA; [Wang, Kebai; Chen, Shuqing] Zhucheng Dinosaur Museum, Zhucheng, Shandong, Peoples R China; [Han, Fenglu] China Univ Geosci, Sch Earth Sci, Wuhan 430074, Peoples R China; [He, Yiming] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Field Museum of Natural History (Chicago); China University of Geosciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, YM (corresponding author), Chinese Acad Sci, Inst Vertebrate Palaeontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.	15210674219@126.com		Sullivan, Corwin/0000-0002-5488-6797	National Natural Science Foundation of China [41120124002]; 973 program [2012CB821900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China)	This research was supported by grants from the National Natural Science Foundation of China (grant number: 41120124002) and 973 program (2012CB821900, http://www.cas.cn/).	Adams JS, 2005, J VERTEBR PALEONTOL, V25, P614, DOI 10.1671/0272-4634(2005)025[0614:HDOOPA]2.0.CO;2; [Anonymous], 1923, FORTSCHRITTE GEOLOGI; Averianov AO, 2006, J SYST PALAEONTOL, V4, P359, DOI 10.1017/S1477201906001933; Barrett PM, 2005, J VERTEBR PALEONTOL, V25, P823, DOI 10.1671/0272-4634(2005)025[0823:SODFTM]2.0.CO;2; Brett-Surman Michael K., 2007, P135; Brochu CA, 2003, J VERTEBR PALEONTOL, V22; Broom R, 1913, RECORDS ALBANY MUSEU, V2, P394; Brown B, 1914, B AM MUS NAT HIST, V33, P567; Brown B., 1940, Annals of the New York Academy of Sciences, V40, P133; Brown B, 1916, B AM MUS NAT HIST, V35, P709; Brown B, 1937, AM MUS NOVIT, V955, P1; Brown Barnum, 1942, AMER MUS NOVITATES, V1169, P1; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Butler RJ, 2011, PALAEONTOLOGY, V54, P667, DOI 10.1111/j.1475-4983.2011.01046.x; Butler RJ, 2010, ZOOL J LINN SOC-LOND, V160, P648, DOI 10.1111/j.1096-3642.2009.00631.x; Butler RJ, 2005, ZOOL J LINN SOC-LOND, V145, P175, DOI 10.1111/j.1096-3642.2005.00182.x; Butler RJ, 2007, P ROYAL SOC B, P2041; Cai KJ, 1984, ORNITHOPOD DINOSAURS, V1, P71; Carpenter Kenneth, 2001, P90; Chinnery B, 2004, J VERTEBR PALEONTOL, V24, P572, DOI 10.1671/0272-4634(2004)024[0572:DOPPGE]2.0.CO;2; Chinnery BJ, 1998, J VERTEBR PALEONTOL, V18, P569, DOI 10.1080/02724634.1998.10011085; Chinnery BJ, 2007, J VERTEBR PALEONTOL, V27, P625, DOI 10.1671/0272-4634(2007)27[625:ANNDLN]2.0.CO;2; Coria RA, 1996, J VERTEBR PALEONTOL, V16, P445, DOI 10.1080/02724634.1996.10011333; Dodson P., 1996, THE HORNED DINOSAURS; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Dong Zhiming, 1997, P68; EWER RF, 1965, PHILOS T ROY SOC B, V248, P379, DOI 10.1098/rstb.1965.0003; Farke AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112055; Forster C.A., 1990, Journal of Vertebrate Paleontology, V10, P273; GALTON P M, 1981, Palaeontologische Zeitschrift, V55, P271; Galton PM., 1974, B BRIT MUS NAT HIS A, V25, P1; Gilmore CW, 1909, OSTEOLOGY JURASSIC R, P197; Godefroit P, 2012, NEW SAUROLOPHINE DIN, V7; Goloboff P, 2008, CLADISTICS, V24, P91; Granger W., 1923, American Museum Novitates, VNo. 72, P1; Guenther MF, 2009, ANAT REC, V292, P1427, DOI 10.1002/ar.20988; Han FL, 2012, J VERTEBR PALEONTOL, V32, P1370, DOI 10.1080/02724634.2012.694385; Hatcher J. B., 1907, MONOGRAPHS US GEOLOG, VXLIX, DOI DOI 10.5962/BHL.TITLE.60500; Hone DWE, 2011, CRETACEOUS RES, V32, P495, DOI 10.1016/j.cretres.2011.03.005; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Hu C.Z., 1973, ACTA GEOL SINICA, V2, P179; Hu CZ, 2001, SHANTUNGOSAURUS GIGA, P139; Huxley T.H., 1869, ABSTRACTS P GEOLOGIC, V204, P3; KURZANOV SM, 1992, PALEONTOL ZH, P81; Lee YN, 2011, NATURWISSENSCHAFTEN, V98, P39, DOI 10.1007/s00114-010-0739-y; Lehman T.M., 1989, Journal of Vertebrate Paleontology, V9, P137; Lindgren J, 2007, PALAEONTOLOGY, V50, P929, DOI 10.1111/j.1475-4983.2007.00690.x; Liu J, 2004, J VERTEBR PALEONTOL, V24, p84A; [柳永清 Liu Yongqing], 2010, [地质论评, Geological Review], V56, P457; Lull R.S., 1942, GEOLOGICAL SOC AM SP, V40, P242; Maidment SCR, 2011, J VERTEBR PALEONTOL, V31, P1265, DOI 10.1080/02724634.2011.606857; Makovicky PJ, 2011, J VERTEBR PALEONTOL, V31, P626, DOI 10.1080/02724634.2011.557114; Makovicky Peter J., 2010, P68; Makovicky PJ, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3530[1:YDANPC]2.0.CO;2; Makovicky Peter J., 2001, P243; Makovicky PJ, 2002, TAXONOMIC REVISION P, P297; Marsh O.C., 1890, AM J SCI, V39, P418, DOI DOI 10.2475/AJS.S3-39.233.418; MARYANSKA T, 1985, Acta Palaeontologica Polonica, V30, P137; Maryanska T, 1974, Palaeontologia Polonica, VNo. 30, P45; MARYANSKA T, 1975, Palaeontologia Polonica, V33, P133; Morschhauser EM, 2012, THESIS; Nesov L.A., 1989, T 33 SESSII VSESOYUZ, P144; Norman D.B., 1986, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V56, P281; Norman D.B., 1990, P510; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P393; NORMAN DB, 1980, I ROYAL SCI NATURELL, V178, P1; PARKS WA, 1920, U TORONTO STUDIES GE, V11, P1; Peng Guangzhao, 1992, Vertebrata Palasiatica, V30, P39; Rozhdestvensky AK, 1966, PALEONTOL ZH, V1966, P103; Russell DA, 1996, CAN J EARTH SCI, V33, P637, DOI 10.1139/e96-047; RUSSELL DA, 1970, CAN J EARTH SCI, V7, P181, DOI 10.1139/e70-014; Ryan MJ, 2012, CRETACEOUS RES, V35, P69, DOI 10.1016/j.cretres.2011.11.018; Santa Luca A. P., 1980, ANN S AFR MUS, V79, P159, DOI DOI 10.1038/264324A0; Seeley H.G., 1888, REPORT BRIT ASS ADV, V57, P698; Sereno P.C., 1990, P579; Sereno Paul C., 2000, P480; Sereno PC, 2012, ZOOKEYS, P1, DOI [10.3897/zookeys.226.2840, 10.3897/zookeys.223.2840]; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Sternberg CM, 1951, NATIONAL MUSEUM CANA, V123, P225; THULBORN R A, 1972, Palaeontology (Oxford), V15, P29; Weishampel D.B., 1992, Historical Biology, V6, P159; Xu X, 2006, P ROY SOC B-BIOL SCI, V273, P2135, DOI 10.1098/rspb.2006.3566; Xu X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013835; Xu X, 2010, CHINESE SCI BULL, V55, P1631, DOI 10.1007/s11434-009-3614-5; You Hailu, 2004, P478	86	14	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144148	10.1371/journal.pone.0144148	http://dx.doi.org/10.1371/journal.pone.0144148			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701114	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600016
J	Isingrini, M; Angel, L; Fay, S; Taconnat, L; Lemaire, P; Bouazzaoui, B				Isingrini, Michel; Angel, Lucie; Fay, Severine; Taconnat, Laurence; Lemaire, Patrick; Bouazzaoui, Badiaa			Age-Related Differences in the Reliance on Executive Control in Working Memory: Role of Task Demand	PLOS ONE			English	Article							OLDER-ADULTS; PREFRONTAL CORTEX; EPISODIC MEMORY; CAPACITY; REPRESENTATION; INVOLVEMENT; PERFORMANCE; ATTENTION; YOUNG	We examined the hypothesis that age-related differences in the reliance on executive control may be better explained by variations of task demand than by a mechanism specifically linked to aging. To this end, we compared the relationship between the performance of young and older adults on two executive functioning tests and an updating working-memory task with different load levels. The results revealed a significant interaction between age, task demand, and individual executive capacities, indicating that executive resources were only involved at lower loads in older adults, and only at higher loads in young adults. Overall, the results are not consistent with the proposition that cognition places greater demand on executive control in older adults. However, they support the view that how much young and older adults rely on executive control to accomplish cognitive tasks depends on task demand. Finally, interestingly these results are consistent with the CRUNCH model accounting for age-related differences in brain activations.	[Isingrini, Michel; Angel, Lucie; Fay, Severine; Taconnat, Laurence; Bouazzaoui, Badiaa] Univ Tours, Ctr Rech Cognit & Apprentissage, Tours, France; [Isingrini, Michel; Angel, Lucie; Fay, Severine; Taconnat, Laurence; Lemaire, Patrick; Bouazzaoui, Badiaa] CNRS, Poitiers, France; [Isingrini, Michel; Angel, Lucie; Fay, Severine; Taconnat, Laurence; Lemaire, Patrick; Bouazzaoui, Badiaa] CNRS, Tours, France; [Lemaire, Patrick] Aix Marseille Univ, Lab Psychol Cognit, Marseille, France; [Lemaire, Patrick] Inst Univ France, Paris, France	Universite de Tours; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Institut Universitaire de France	Isingrini, M (corresponding author), Univ Tours, Ctr Rech Cognit & Apprentissage, Tours, France.	isingrini@univ-tours.fr	Lemaire, Patrick/ABB-9890-2021	Lemaire, Patrick/0000-0002-3321-7244	French National Research Agency [ANR-2010-Blan-1912-01]	French National Research Agency(French National Research Agency (ANR))	This research was funded by the French National Research Agency Grant number: ANR-2010-Blan-1912-01 to MI.	Angel L, 2011, J COGNITIVE NEUROSCI, V23, P3767, DOI 10.1162/jocn_a_00104; ARNETT PA, 1994, NEUROLOGY, V44, P420, DOI 10.1212/WNL.44.3_Part_1.420; Bennett IJ, 2013, NEUROIMAGE, V72, P20, DOI 10.1016/j.neuroimage.2013.01.030; Bouazzaoui B, 2014, CAN J EXP PSYCHOL, V68, P59, DOI 10.1037/cep0000005; Bouazzaoui B, 2013, CAN J EXP PSYCHOL, V67, P100, DOI 10.1037/a0028517; Cabeza, 2012, PRINCIPLES FRONTAL L, P628, DOI DOI 10.1093/ACPROF:OSO/9780195134971.001.0001; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cappell KA, 2010, CORTEX, V46, P462, DOI 10.1016/j.cortex.2009.11.009; Carp J, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00217; Craik FIM, 2012, NEUROSCI BIOBEHAV R, V36, P1729, DOI 10.1016/j.neubiorev.2011.11.007; Deltour J. J., 1993, ADAPTATION FRANCAISE; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRITH CD, 1991, P ROY SOC B-BIOL SCI, V244, P241, DOI 10.1098/rspb.1991.0077; Glisky EL, 2008, J EXP PSYCHOL LEARN, V34, P809, DOI 10.1037/0278-7393.34.4.809; Greenwood PM, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00150; Gutchess AH, 2005, J COGNITIVE NEUROSCI, V17, P84, DOI 10.1162/0898929052880048; Hodzik S, 2011, ACTA PSYCHOL, V137, P335, DOI 10.1016/j.actpsy.2011.04.002; Isingrini M, 1997, INT J AGING HUM DEV, V45, P99, DOI 10.2190/WHWX-YNVB-079V-2L74; Jeantin A, 2006, ANN PSYCHOL, V106, P213; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Manenti R, 2011, BEHAV BRAIN RES, V216, P153, DOI 10.1016/j.bbr.2010.07.027; Mattay VS, 2006, NEUROSCI LETT, V392, P32, DOI 10.1016/j.neulet.2005.09.025; McCabe DP, 2010, NEUROPSYCHOLOGY, V24, P222, DOI 10.1037/a0017619; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; Nagel IE, 2011, J COGNITIVE NEUROSCI, V23, P2030, DOI 10.1162/jocn.2010.21560; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; PARKIN AJ, 1991, PSYCHOBIOLOGY, V19, P175; POLLACK I, 1959, J EXP PSYCHOL, V57, P137, DOI 10.1037/h0046137; Raz N, 1998, NEUROPSYCHOLOGY, V12, P95, DOI 10.1037/0894-4105.12.1.95; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Reuter-Lorenz PA, 2014, NEUROPSYCHOL REV, V24, P355, DOI 10.1007/s11065-014-9270-9; Schneider-Garces NJ, 2010, J COGNITIVE NEUROSCI, V22, P655, DOI 10.1162/jocn.2009.21230; Souchay C, 2000, NEUROPSYCHOLOGY, V14, P299, DOI 10.1037/0894-4105.14.2.299; Stuss D.T., 1986, FRONTAL LOBES; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; VANDERLINDEN M, 1994, BRIT J PSYCHOL, V85, P145; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272	40	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145361	10.1371/journal.pone.0145361	http://dx.doi.org/10.1371/journal.pone.0145361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26700019	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092600070
J	Kang, S; Ma, WJ; Li, FY; Zhang, Q; Niu, JM; Ding, Y; Han, F; Sun, XL				Kang, Saruul; Ma, Wenjing; Li, Frank Yonghong; Zhang, Qing; Niu, Jianming; Ding, Yong; Han, Fang; Sun, Xiaoli			Functional Redundancy Instead of Species Redundancy Determines Community Stability in a Typical Steppe of Inner Mongolia	PLOS ONE			English	Article							ECOSYSTEM STABILITY; RESPONSE DIVERSITY; BIODIVERSITY; PRODUCTIVITY; POPULATIONS; VEGETATION; PATTERNS	Background The redundancy hypothesis predicts that the species redundancy in a plant community enhances community stability. However, numerous studies in recent years questioned the positive correlation between redundancy and stability. Methodology We explored the relationship between the species redundancy, functional redundancy and community stability in typical steppe grassland in Northern China by sampling grassland vegetation along a gradient of resource availability caused by micro-topography. We aimed to test whether community redundancy enhanced community stability, and to quantify the relative importance of species redundancy and functional redundancy in maintaining community stability. Results Our results showed that the spatial stability of plant community production increases with increased supply of soil resources, and the functional redundancy instead of species diversity or species redundancy is correlated with the community stability. Our results supported the redundancy hypothesis and have implications for sustainable grassland management.	[Kang, Saruul; Ma, Wenjing; Li, Frank Yonghong; Zhang, Qing; Niu, Jianming; Sun, Xiaoli] Inner Mongolia Univ, Sch Life Sci, Ecol, Hohhot, Peoples R China; [Niu, Jianming] Inner Mongolia Univ, SinoUS Ctr Conservat Energy & Sustainabil Sci, Hohhot, Peoples R China; [Ding, Yong] Chinese Acad Agr Sci, Grassland Res Inst, Hohhot, Peoples R China; [Han, Fang] Inner Mongolian Meteorol Bur, Hohhot, Peoples R China	Inner Mongolia University; Inner Mongolia University; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS	Zhang, Q (corresponding author), Inner Mongolia Univ, Sch Life Sci, Ecol, Hohhot, Peoples R China.	qzhang82@163.com	Niu, Jianming/K-3597-2019; Li, Frank Yonghong/AAN-3093-2020	Li, Frank Yonghong/0000-0002-5137-8017	National Basic Research Programme of China [31200414]; State Key Basic Research Development Programme of China [2014CB138802]; Specialized Research Fund for the Doctoral Programme of Higher Education of China [20121501120006]	National Basic Research Programme of China(National Basic Research Program of China); State Key Basic Research Development Programme of China; Specialized Research Fund for the Doctoral Programme of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The National Basic Research Programme of China (Grant no. 31200414); State Key Basic Research Development Programme of China (Grant nos. 2014CB138802); The Specialized Research Fund for the Doctoral Programme of Higher Education of China (Grant no. 20121501120006). All sources of funding that have supported this work. The funders also contributed in study design (QZ) and data collection (YD).	Arno S.F., 1977, METHOD DETERMINING F; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2007, J APPL ECOL, V44, P1023, DOI 10.1111/j.1365-2664.2007.01351.x; Bengtsson J, 1998, APPL SOIL ECOL, V10, P191, DOI 10.1016/S0929-1393(98)00120-6; Chollet S, 2014, ECOLOGY, V95, P737, DOI 10.1890/13-0751.1; de Bello F, 2007, COMMUNITY ECOL, V8, P163, DOI 10.1556/ComEc.8.2007.2.3; Diaz S, 2001, J APPL ECOL, V38, P497, DOI 10.1046/j.1365-2664.2001.00635.x; Dovciak M, 2010, ECOL LETT, V13, P1300, DOI 10.1111/j.1461-0248.2010.01524.x; Ehrlich AH, 1981, EXTINCTION, P384; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Elton C.S., 2000, ECOLOGY INVASIONS AN; Fang JY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024231; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Fonseca CR, 2001, J ECOL, V89, P118, DOI 10.1046/j.1365-2745.2001.00528.x; Godron M., 1971, STAT ECOL, V3, P397; Gonzalez A, 2009, ANNU REV ECOL EVOL S, V40, P393, DOI 10.1146/annurev.ecolsys.39.110707.173349; Griffin JN, 2009, OIKOS, V118, P37, DOI 10.1111/j.1600-0706.2008.16960.x; Heinselman ML, 1981, FOREST SUCCESSION, P374, DOI [10.1007/978-1-4612-5950-3_23, DOI 10.1007/978-1-4612-5950-3_23]; Hooper DU, 1994, BIOL DIVERSITY TERRE; Johnson KH, 1996, TRENDS ECOL EVOL, V11, P372, DOI 10.1016/0169-5347(96)10040-9; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; LAWTON JH, 1994, OIKOS, V71, P367, DOI 10.2307/3545824; Lawton JH, 1994, REDUNDANCY ECOSYSTEM; Leps J, 2006, PRESLIA, V78, P481; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; MCNAUGHTON SJ, 1977, AM NAT, V111, P515, DOI 10.1086/283181; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Mori AS, 2013, BIOL REV, V88, P349, DOI 10.1111/brv.12004; Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529; Naeem S, 1998, CONSERV BIOL, V12, P39, DOI 10.1046/j.1523-1739.1998.96379.x; Ochoa-Ochoa LM, 2014, BIOL J LINN SOC, V111, P305, DOI 10.1111/bij.12201; Petchey OL, 2007, J ANIM ECOL, V76, P977, DOI 10.1111/j.1365-2656.2007.01271.x; Piao SL, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002274; Pillar VD, 2013, J VEG SCI, V24, P963, DOI 10.1111/jvs.12047; Qiao S., 2012, EXPT INSTRUCTION SOI; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Sala O. E., 1996, Functional roles of biodiversity: a global perspective., P129; Santoro FR, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0119826, DOI 10.1371/J0URNAL.P0NE.0119826]; Schulze E, 1994, BIODIVERSITY ECOSYST; Sternberg M, 2000, J APPL ECOL, V37, P224, DOI 10.1046/j.1365-2664.2000.00491.x; Thibaut LM, 2012, ECOLOGY, V93, P891, DOI 10.1890/11-1753.1; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Zhang J.T., 2004, QUANTITATIVE ECOLOGY, V2nd ed.	46	35	40	11	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145605	10.1371/journal.pone.0145605	http://dx.doi.org/10.1371/journal.pone.0145605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699133	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600105
J	Pedrosa, AM; Martins, CDS; Goncalves, LP; Costa, MGC				Pedrosa, Andresa Muniz; Santos Martins, Cristina de Paula; Goncalves, Luana Pereira; Cardoso Costa, Marcio Gilberto			Late Embryogenesis Abundant (LEA) Constitutes a Large and Diverse Family of Proteins Involved in Development and Abiotic Stress Responses in Sweet Orange (Citrus sinensis L. Osb.)	PLOS ONE			English	Article							COTTONSEED EMBRYOGENESIS; DEHYDRATION TOLERANCE; ADAPTIVE RESPONSE; GENE FAMILY; MAIZE DHN1; BINDING; EXPRESSION; DEHYDRIN; REVEALS; DROUGHT	Late Embryogenesis Abundant (LEA) proteins are an ubiquitous group of polypeptides that were first described to accumulate during plant seed dehydration, at the later stages of embryogenesis. Since then they have also been recorded in vegetative plant tissues experiencing water limitation and in anhydrobiotic bacteria and invertebrates and, thereby, correlated with the acquisition of desiccation tolerance. This study provides the first comprehensive study about the LEA gene family in sweet orange (Citrus sinensis L. Osb.), the most important and widely grown fruit crop around the world. A surprisingly high number (72) of genes encoding C. sinensis LEAs (CsLEAs) were identified and classified into seven groups (LEA_1, LEA_2, LEA_3 and LEA_4, LEA_5, DEHYDRIN and SMP) based on their predicted amino acid sequences and also on their phylogenetic relationships with the complete set of Arabidopsis thaliana LEA proteins (AtLEAs). Approximately 60% of the CsLEAs identified in this study belongs to the unusual LEA_2 group of more hydrophobic LEA proteins, while the other LEA groups contained a relatively small number of members typically hydrophilic. A correlation between gene structure and motif composition was observed within each LEA group. Investigation of their chromosomal localizations revealed that the CsLEAs were non-randomly distributed across all nine chromosomes and that 33% of all CsLEAs are segmentally or tandemly duplicated genes. Analysis of the upstream sequences required for transcription revealed the presence of various stress-responsive cis-acting regulatory elements in the promoter regions of CsLEAs, including ABRE, DRE/CRT, MYBS and LTRE. Expression analysis using both RNA-seq data and quantitative real-time RT-PCR (qPCR) revealed that the CsLEA genes are widely expressed in various tissues, and that many genes containing the ABRE promoter sequence are induced by drought, salt and PEG. These results provide a useful reference for further exploration of the CsLEAs functions and applications on crop improvement.	[Pedrosa, Andresa Muniz; Santos Martins, Cristina de Paula; Goncalves, Luana Pereira; Cardoso Costa, Marcio Gilberto] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ctr Biotecnol & Genet, Ilheus, BA, Brazil	Universidade Estadual de Santa Cruz	Costa, MGC (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Ctr Biotecnol & Genet, Ilheus, BA, Brazil.	marciogc.costa@gmail.com	martins, cristina/AFV-5571-2022; Costa, Marcio/AAG-3285-2020	Costa, Marcio/0000-0002-4358-5489	CNPq (Brasilia, Brazil); CAPES (Brasilia, Brazil); FAPESP (Sao Paulo, Brazil)	CNPq (Brasilia, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Brasilia, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP (Sao Paulo, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported in part by research grants from CNPq (Brasilia, Brazil), CAPES (Brasilia, Brazil) and FAPESP (Sao Paulo, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu RC, 2004, PLANT SCI, V166, P855, DOI 10.1016/j.plantsci.2003.11.023; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cao J, 2015, PLANTA, V241, P757, DOI 10.1007/s00425-014-2215-y; Chakrabortee S, 2007, P NATL ACAD SCI USA, V104, P18073, DOI 10.1073/pnas.0706964104; Charfeddine S, 2015, MOL BIOL REP, V42, P1163, DOI 10.1007/s11033-015-3853-2; Checker VG, 2012, TRANSGENIC RES, V21, P939, DOI 10.1007/s11248-011-9577-8; Covarrubias AA, 2013, FRONT PLANT SCI, P25; Cuming AC, 1999, SEED PROTEINS, P753; de Oliveira TM, 2011, TREE GENET GENOMES, V7, P1123, DOI 10.1007/s11295-011-0400-8; Du DL, 2013, MOL BIOL REP, V40, P1937, DOI 10.1007/s11033-012-2250-3; Duan JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045117; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; DURE L, 1981, PLANT PHYSIOL, V68, P187, DOI 10.1104/pp.68.1.187; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gong XQ, 2013, PLANT CELL TISS ORG, V113, P137, DOI 10.1007/s11240-012-0267-x; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; Hara M, 2005, J EXP BOT, V56, P2695, DOI 10.1093/jxb/eri262; Hara M, 2003, PLANTA, V217, P290, DOI 10.1007/s00425-003-0986-7; Hara M, 1999, BIOSCI BIOTECH BIOCH, V63, P433, DOI 10.1271/bbb.63.433; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Ismail AM, 1999, PLANT PHYSIOL, V120, P237, DOI 10.1104/pp.120.1.237; Jeffares DC, 2008, TRENDS GENET, V24, P375, DOI 10.1016/j.tig.2008.05.006; Kim HS, 2005, GENE, V344, P115, DOI 10.1016/j.gene.2004.09.012; Koag MC, 2003, PLANT PHYSIOL, V131, P309, DOI 10.1104/pp.011171; Koag MC, 2009, PLANT PHYSIOL, V150, P1503, DOI 10.1104/pp.109.136697; Kosova K, 2007, BIOL PLANTARUM, V51, P601, DOI 10.1007/s10535-007-0133-6; Lan T, 2013, TREE GENET GENOMES, V9, P253, DOI 10.1007/s11295-012-0551-2; Li CN, 2015, ENVIRON EXP BOT, V114, P80, DOI 10.1016/j.envexpbot.2014.06.014; Liu GB, 2011, PLANT CELL PHYSIOL, V52, P994, DOI 10.1093/pcp/pcr052; Liu Y, 2013, PLANT CELL PHYSIOL, V54, P944, DOI 10.1093/pcp/pct047; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mizoi Junya, 2013, Methods Mol Biol, V956, P269, DOI 10.1007/978-1-62703-194-3_20; NAOT D, 1995, PLANT MOL BIOL, V27, P619, DOI 10.1007/BF00019327; Olvera-Carrillo Y, 2011, PLANT SIGNAL BEHAV, V6, P586, DOI 10.4161/psb.6.4.15042; Olvera-Carrillo Y, 2010, PLANT PHYSIOL, V154, P373, DOI 10.1104/pp.110.158964; Reddy PS, 2012, MOL BIOL REP, V39, P7163, DOI 10.1007/s11033-012-1548-5; Reyes JL, 2005, PLANT CELL ENVIRON, V28, P709, DOI 10.1111/j.1365-3040.2005.01317.x; Reyes JL, 2008, PLANT CELL ENVIRON, V31, P1781, DOI 10.1111/j.1365-3040.2008.01879.x; Rorat T, 2006, CELL MOL BIOL LETT, V11, P536, DOI 10.2478/s11658-006-0044-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez-Ballesta MT, 2004, J AGR FOOD CHEM, V52, P1950, DOI 10.1021/jf035216+; Shao HB, 2005, COLLOID SURFACE B, V45, P131, DOI 10.1016/j.colsurfb.2005.07.017; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Wang XS, 2007, PLANT SCI, V172, P414, DOI 10.1016/j.plantsci.2006.10.004; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012	59	64	68	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145785	10.1371/journal.pone.0145785	http://dx.doi.org/10.1371/journal.pone.0145785			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700652	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092600134
J	Vivarelli, M; Vincenzi, P; Montalti, R; Fava, G; Tavio, M; Coletta, M; Vecchi, A; Nicolini, D; Agostini, A; Ahmed, EA; Giovagnoni, A; Mocchegiani, F				Vivarelli, Marco; Vincenzi, Paolo; Montalti, Roberto; Fava, Giammarco; Tavio, Marcello; Coletta, Martina; Vecchi, Andrea; Nicolini, Daniele; Agostini, Andrea; Ahmed, Emad Ali; Giovagnoni, Andrea; Mocchegiani, Federico			ALPPS Procedure for Extended Liver Resections: A Single Centre Experience and a Systematic Review	PLOS ONE			English	Article							PORTAL-VEIN LIGATION; STAGED HEPATECTOMY ALPPS; HEPATOCELLULAR-CARCINOMA; COLORECTAL METASTASES; FUTURE PERSPECTIVES; HEPATIC RESECTION; PARTITION; HYPERTROPHY; EMBOLIZATION; GROWTH	Aim To report a single-centre experience with the novel Associating Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS) technique and systematically review the related literature. Methods Since January 2013, patients with extended primary or secondary liver tumors whose future liver remnant (FLR) was considered too small to allow hepatic resection were prospectively assessed for the ALPPS procedure. A systematic literature search was performed using PubMed, Scopus and the Cochrane Library Central. Results Until July 2014 ALPPS was completed in 9 patients whose mean age was 60 +/- 8 years. Indications for surgical resection were metastases from colorectal cancer in 3 cases, perihilar cholangiocarcinoma in 3 cases, intrahepatic cholangiocarcinoma in 2 cases and hepatocellular carcinoma without chronic liver disease in 1 case. The calculated FLR volume was 289 +/- 122 mL (21.1 +/- 5.5%) before ALPPS-1 and 528 +/- 121 mL (32.2 +/- 5.7%) before ALLPS-2 (p<0.001). The increase in FLR between the two procedures was 96 +/- 47% (range: 24-160%, p<0.001). Additional interventions were performed in 4 cases: 3 patients underwent Roux-en-Y hepaticojejunostomy, and one case underwent wedge resection of a residual tumor in the FLR. The average time between the first and second step of the procedure was 10.8 +/- 2.9 days. The average hospital stay was 24.1 +/- 13.3 days. There was 1 postoperative death due to hepatic failure in the oldest patient of this series who had a perihilar cholangiocarcinoma and concomitant liver fibrosis; 11 complications occurred in 6 patients, 4 of whom had grade III or above disease. After a mean follow-up of 17.1 +/- 8.5 months, the overall survival was 89% at 3-6 and 12 months. The recurrence-free survival was 100%, 87.5% and 75% at 3-6-12 months respectively. The literature search yielded 148 articles, of which 22 articles published between 2012 and 2015 were included in this systematic review. Conclusion The ALPPS technique effectively increased the resectability of otherwise inoperable liver tumors. The postoperative morbidity in our series was high in accordance with the data from the systematic review. Age, liver fibrosis and presence of biliary stenting were predisposing factors for postoperative morbidity and mortality.	[Vivarelli, Marco; Vincenzi, Paolo; Montalti, Roberto; Coletta, Martina; Vecchi, Andrea; Nicolini, Daniele; Ahmed, Emad Ali; Mocchegiani, Federico] Polytech Univ Marche, Dept Expt & Clin Med, Hepatobiliary & Abdominal Transplantat Surg, Ancona, Italy; [Fava, Giammarco; Ahmed, Emad Ali] Polytech Univ Marche, Dept Gastroenterol, Ancona, Italy; [Tavio, Marcello; Ahmed, Emad Ali] Polytech Univ Marche, Dept Gastroenterol & Transplantat, Unit Emerging & Immunosuppressed Infect Dis, Ancona, Italy; [Agostini, Andrea; Ahmed, Emad Ali; Giovagnoni, Andrea] Polytech Univ Marche, Dept Radiol, Unit Gen & Paediat Radiol, Ancona, Italy; [Ahmed, Emad Ali] Sohag Univ, Fac Med, Dept Gen Surg, Hepatobiliary & Pancreat Surg Unit, Sohag, Egypt	Marche Polytechnic University; Marche Polytechnic University; Marche Polytechnic University; Marche Polytechnic University; Egyptian Knowledge Bank (EKB); Sohag University	Montalti, R (corresponding author), Polytech Univ Marche, Dept Expt & Clin Med, Hepatobiliary & Abdominal Transplantat Surg, Ancona, Italy.	robertomontalti@yahoo.it	ALI, EMAD ALI AHMED/O-1366-2017; NICOLINI, DANIELE/AAD-8241-2020; Montalti, Roberto/AAF-5627-2019; Nicolini, Daniele/AAK-3717-2020	ALI, EMAD ALI AHMED/0000-0003-4384-0934; NICOLINI, DANIELE/0000-0002-5477-3346; MOCCHEGIANI, FEDERICO/0000-0002-8833-5360; VIVARELLI, MARCO/0000-0003-0500-9461; Montalti, Roberto/0000-0002-3915-3851; Fava, Giammarco/0000-0001-6757-1420				Adams RB, 2013, HPB, V15, P91, DOI 10.1111/j.1477-2574.2012.00557.x; Alvarez FA, 2013, J GASTROINTEST SURG, V17, P814, DOI 10.1007/s11605-012-2092-2; Aussilhou B, 2008, J GASTROINTEST SURG, V12, P297, DOI 10.1007/s11605-007-0410-x; Balzan S, 2005, ANN SURG, V242, P824, DOI 10.1097/01.sla.0000189131.90876.9e; Bjornsson B, 2013, CASE REP SURG, V2013, DOI 10.1155/2013/238675; Brustia R, 2013, J AM COLL SURGEONS, V217, pE51, DOI 10.1016/j.jamcollsurg.2013.08.020; Cavaness KM, 2013, J GASTROINTEST SURG, V17, P207, DOI 10.1007/s11605-012-2029-9; Chan A, 2014, WORLD J GASTROENTERO, V20, P10208, DOI 10.3748/wjg.v20.i29.10208; Croome KP, 2015, HPB, V17, P477, DOI 10.1111/hpb.12386; De Carlis L, 2014, HEPATO-GASTROENTEROL, V61, P1712; de Santibanes E, 2012, WORLD J SURG, V36, P125, DOI 10.1007/s00268-011-1331-0; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Ding XZ, 2013, SEMIN LIVER DIS, V33, P293, DOI 10.1055/s-0033-1351786; Donati M, 2015, FUTURE ONCOL, V11, P2255, DOI 10.2217/fon.15.145; Farges O, 2003, ANN SURG, V237, P208, DOI 10.1097/00000658-200302000-00010; Gauzolino R, 2013, UPDATES SURG, V65, P141, DOI 10.1007/s13304-013-0214-3; Herman Paulo, 2015, J Gastrointest Cancer, V46, P190, DOI 10.1007/s12029-015-9691-6; Hernandez-Alejandro R, 2015, SURGERY, V157, P194, DOI 10.1016/j.surg.2014.08.041; Higuchi R, 2014, J HEPATO-BIL-PAN SCI, V21, P542, DOI 10.1002/jhbp.77; Ielpo B, 2014, UPDATES SURG-ITALY, V66, P159, DOI 10.1007/s13304-014-0249-0; Ielpo B, 2013, HEPATO-GASTROENTEROL, V60, P2069, DOI 10.5754/hge.13583; Jackson T, 2014, CASE REP SURG, V2014, DOI 10.1155/2014/487852; Jacobson BF, 2013, SAMJ S AFR MED J, V103, P261, DOI [10.7196/samj.6706, 10.7196/SAMJ.6706]; Kilburn DJ, 2014, ANZ J SURG; Knoefel WT, 2013, BRIT J SURG, V100, P388, DOI 10.1002/bjs.8955; Kokudo N, 2001, HEPATOLOGY, V34, P267, DOI 10.1053/jhep.2001.26513; Li J, 2013, J GASTROINTEST SURG, V17, P956, DOI 10.1007/s11605-012-2132-y; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu H, 2009, AM J SURG, V197, P686, DOI [10.1016/j.amjsurg.2008.04.006, 10.1016/j.amjsurg.2008.04.022]; Machado MAC, 2012, ANN SURG, V256, pE13, DOI 10.1097/SLA.0b013e318265ff2e; Torres OJM, 2013, ABCD-ARQ BRAS CIR DI, V26, P40, DOI 10.1590/S0102-67202013000100009; Torres OJM, 2012, ABCD-ARQ BRAS CIR DI, V25, P290, DOI 10.1590/S0102-67202012000400015; Nadalin S, 2014, Z GASTROENTEROL, V52, P35, DOI 10.1055/s-0033-1356364; Oldhafer KJ, 2014, WORLD J SURG, V38, P1504, DOI 10.1007/s00268-013-2401-2; Petrowsky H, 2015, ANN SURG, V261, pE90, DOI 10.1097/SLA.0000000000001087; Ratti F, 2014, UPDATES SURG, V66, P41, DOI 10.1007/s13304-013-0243-y; Reiner CS, 2009, J COMPUT ASSIST TOMO, V33, P390, DOI 10.1097/RCT.0b013e3181806c29; Campos RR, 2013, CIR ESPAN, V91, P633, DOI 10.1016/j.ciresp.2013.09.004; Robles R, 2014, BRIT J SURG, V101, P1129, DOI 10.1002/bjs.9547; Sala S, 2012, UPDATES SURG-ITALY, V64, P167, DOI 10.1007/s13304-012-0175-y; Schadde E, 2015, ANN SURG ONCOL, V22, P3109, DOI 10.1245/s10434-014-4213-5; Schadde E, 2014, ANN SURG, V260, P829, DOI 10.1097/SLA.0000000000000947; Schadde E, 2014, WORLD J SURG, V38, P1510, DOI 10.1007/s00268-014-2513-3; Schindl MJ, 2005, GUT, V54, P289, DOI 10.1136/gut.2004.046524; Schnitzbauer AA, 2012, ANN SURG, V255, P405, DOI 10.1097/SLA.0b013e31824856f5; Tanaka K, 2015, EJSO-EUR J SURG ONC, V41, P506, DOI 10.1016/j.ejso.2015.01.031; Troja A, 2014, INT J SURG, V12, P1020, DOI 10.1016/j.ijsu.2014.07.006; Truant S, 2015, EJSO-EUR J SURG ONC, V41, P674, DOI 10.1016/j.ejso.2015.01.004; Tschuor C, 2013, EJSO-EUR J SURG ONC, V39, P1230, DOI 10.1016/j.ejso.2013.08.009; Ulla M, 2013, HEPATO-GASTROENTEROL, V60, P337, DOI 10.5754/hge12717; Vennarecci G, 2014, EJSO-EUR J SURG ONC, V40, P982, DOI 10.1016/j.ejso.2014.04.002; Vennarecci G, 2014, WORLD J SURG, V38, P1498, DOI 10.1007/s00268-013-2296-y; Vyas Soumil J, 2014, J Gastrointest Cancer, V45 Suppl 1, P233, DOI 10.1007/s12029-014-9643-6; Zappa M, 2009, RADIOLOGY, V252, P426, DOI [10.1148/radiol.2523080922, 10.1148/radiol.2522080922]; Zhang GQ, 2014, INT J SURG, V12, P437, DOI 10.1016/j.ijsu.2014.03.009	55	32	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144019	10.1371/journal.pone.0144019	http://dx.doi.org/10.1371/journal.pone.0144019			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700646	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600014
J	Zhao, GY; Jiang, YT; Qiu, HJ; Gao, TT; Zeng, Y; Guo, Y; Yu, H; Li, JF; Kou, ZH; Du, LY; Tan, WJ; Jiang, SB; Sun, SH; Zhou, YS				Zhao, Guangyu; Jiang, Yuting; Qiu, Hongjie; Gao, Tongtong; Zeng, Yang; Guo, Yan; Yu, Hong; Li, Junfeng; Kou, Zhihua; Du, Lanying; Tan, Wenjie; Jiang, Shibo; Sun, Shihui; Zhou, Yusen			Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus	PLOS ONE			English	Article							MOUSE MODEL; CLINICAL-FEATURES; PATHOGENESIS; RECEPTOR; GENERATION; PNEUMONIA; PATHOLOGY; OUTBREAK; PROTEIN; INNATE	The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) causes severe acute respiratory failure and considerable extrapumonary organ dysfuction with substantial high mortality. For the limited number of autopsy reports, small animal models are urgently needed to study the mechanisms of MERS-CoV infection and pathogenesis of the disease and to evaluate the efficacy of therapeutics against MERS-CoV infection. In this study, we developed a transgenic mouse model globally expressing codon-optimized human dipeptidyl peptidase 4 (hDPP4), the receptor for MERS-CoV. After intranasal inoculation with MERS-CoV, the mice rapidly developed severe pneumonia and multi-organ damage, with viral replication being detected in the lungs on day 5 and in the lungs, kidneys and brains on day 9 post-infection. In addition, the mice exhibited systemic inflammation with mild to severe pneumonia accompanied by the injury of liver, kidney and spleen with neutrophil and macrophage infiltration. Importantly, the mice exhibited symptoms of paralysis with high viral burden and viral positive neurons on day 9. Taken together, this study characterizes the tropism of MERS-CoV upon infection. Importantly, this hDPP4-expressing transgenic mouse model will be applicable for studying the pathogenesis of MERS-CoV infection and investigating the efficacy of vaccines and antiviral agents designed to combat MERS-CoV infection.	[Zhao, Guangyu; Jiang, Yuting; Qiu, Hongjie; Gao, Tongtong; Zeng, Yang; Guo, Yan; Yu, Hong; Li, Junfeng; Kou, Zhihua; Sun, Shihui; Zhou, Yusen] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Du, Lanying; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Educ, Shanghai 200433, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Hlth, Shanghai 200433, Peoples R China; [Tan, Wenjie] China CDC, Key Lab Med Virol, Minist Hlth, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China	Beijing Institute of Microbiology & Epidemiology; New York Blood Center; Fudan University; Fudan University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Sun, SH (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.	sunsh01@163.com; yszhou@bmi.ac.cn	Jiang, Shibo/L-4500-2014	Jiang, Shibo/0000-0001-8283-7135	National Project of Infectious Disease [2014ZX10004001004, 2012ZX10004502]; Basic Research 973 Project [2011CB504706]; National Natural Science Foundation of China [81371805]	National Project of Infectious Disease; Basic Research 973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Project of Infectious Disease (2014ZX10004001004, 2012ZX10004502), the Basic Research 973 Project (2011CB504706), and the National Natural Science Foundation of China (81371805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AS, 2015, J VIROL, V89, P3659, DOI 10.1128/JVI.03427-14; Al-Abdallat MM, 2014, CLIN INFECT DIS, V59, P1225, DOI 10.1093/cid/ciu359; Arabi YM, 2015, INFECTION, V43, P495, DOI 10.1007/s15010-015-0720-y; Arabi YM, 2014, ANN INTERN MED, V160, P389, DOI 10.7326/M13-2486; Arden KE, 2015, VIRUS RES; Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07; Cao B, 2013, EXPERT REV ANTI-INFE, V11, P1123, DOI 10.1586/14787210.2013.847787; Coleman CM, 2014, J GEN VIROL, V95, P408, DOI 10.1099/vir.0.060640-0; Corman VM, 2012, EUROSURVEILLANCE, V17, P3; de Wit E, 2013, P NATL ACAD SCI USA, V110, P16598, DOI 10.1073/pnas.1310744110; de Wit E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069127; Drosten C, 2013, LANCET INFECT DIS, V13, P745, DOI 10.1016/S1473-3099(13)70154-3; Du LY, 2014, J VIROL, V88, P7045, DOI 10.1128/JVI.00433-14; Eckerle I, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-359; Falzarano D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004250; Falzarano D, 2013, NAT MED, V19, P1313, DOI 10.1038/nm.3362; Gralinski LE, 2015, J PATHOL, V235, P185, DOI 10.1002/path.4454; Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828; Gu J, 2007, AM J PATHOL, V170, P1136, DOI 10.2353/ajpath.2007.061088; Guery B, 2013, LANCET, V381, P2265, DOI 10.1016/S0140-6736(13)60982-4; Lau KK, 2004, EMERG INFECT DIS, V10, P342, DOI 10.3201/eid1002.030638; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu XY, 2014, J CLIN MICROBIOL, V52, P67, DOI 10.1128/JCM.02533-13; Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729; Pascal KE, 2015, P NATL ACAD SCI USA, V112, P8738, DOI 10.1073/pnas.1510830112; Pollack MP, 2013, INT J INFECT DIS, V17, pE143, DOI 10.1016/j.ijid.2012.12.001; Raj VS, 2014, J VIROL, V88, P1834, DOI 10.1128/JVI.02935-13; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110; Sun SH, 2013, AM J RESP CELL MOL, V49, P221, DOI 10.1165/rcmb.2012-0428OC; van den Brand JMA, 2015, J PATHOL, V235, P175, DOI 10.1002/path.4458; van Doremalen N, 2014, J VIROL, V88, P9220, DOI 10.1128/JVI.00676-14; Who Mers-Cov Research Group, 2013, PLoS Curr, V5, DOI 10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8; Wong GWK, 2003, PEDIATR PULM, V36, P261, DOI 10.1002/ppul.10367; Xu J, 2005, CLIN INFECT DIS, V41, P1089, DOI 10.1086/444461; Yamashita M, 2005, BIOCHEM BIOPH RES CO, V334, P79, DOI 10.1016/j.bbrc.2005.06.061; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111	42	54	56	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145561	10.1371/journal.pone.0145561	http://dx.doi.org/10.1371/journal.pone.0145561			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701103	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600096
J	Martinez-Skinner, AL; Arainga, MA; Puligujja, P; Palandri, DL; Baldridge, HM; Edagwa, BJ; McMillan, JM; Mosley, RL; Gendelman, HE				Martinez-Skinner, Andrea L.; Arainga, Mariluz A.; Puligujja, Pavan; Palandri, Diana L.; Baldridge, Hannah M.; Edagwa, Benson J.; McMillan, JoEllyn M.; Mosley, R. Lee; Gendelman, Howard E.			Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy	PLOS ONE			English	Article							HIV-1-INFECTED HUMANIZED MICE; MONOCYTE-DERIVED MACROPHAGES; DRUG-DELIVERY; HIV-1 INFECTION; IN-VIVO; SUBCAPSULAR SINUS; LYMPH-NODE; NANOPARTICLES; PHARMACOKINETICS; PHARMACODYNAMICS	Long-acting nanoformulated antiretroviral therapy (nanoART) induces a range of innate immune migratory, phagocytic and secretory cell functions that perpetuate drug depots. While recycling endosomes serve as the macrophage subcellular depots, little is known of the dynamics of nanoART-cell interactions. To this end, we assessed temporal leukocyte responses, drug uptake and distribution following both intraperitoneal and intramuscular injection of nanoformulated atazanavir (nanoATV). Local inflammatory responses heralded drug distribution to peritoneal cell populations, regional lymph nodes, spleen and liver. This proceeded for three days in male Balb/c mice. NanoATV-induced changes in myeloid populations were assessed by fluorescence-activated cell sorting (FACS) with CD45, CD3, CD11b, F4180, and GR-1 antibodies. The localization of nanoATV within leukocyte cell subsets was determined by confocal microscopy. Combined FACS and ultra-performance liquid chromatography tandem mass-spectrometry assays determined nanoATV carriages by cell-based vehicles. A robust granulocyte, but not peritoneal macrophage nanoATV response paralleled zymosan A treatment. ATV levels were highest at sites of injection in peritoneal or muscle macrophages, dependent on the injection site. The spleen and liver served as nanoATV tissue depots while drug levels in lymph nodes were higher than those recorded in plasma. Dual polymer and cell labeling demonstrated a nearly exclusive drug reservoir in macrophages within the liver and spleen. Overall, nanoART induces innate immune responses coincident with rapid tissue macrophage distribution. Taken together, these works provide avenues for therapeutic development designed towards chemical eradication of human immunodeficiency viral infection.	[Martinez-Skinner, Andrea L.; Arainga, Mariluz A.; Puligujja, Pavan; Palandri, Diana L.; Baldridge, Hannah M.; Edagwa, Benson J.; McMillan, JoEllyn M.; Mosley, R. Lee; Gendelman, Howard E.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Gendelman, Howard E.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	McMillan, JM (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.	jmmcmillan@unmc.edu			University of Nebraska Foundation; Vice Chancellor's office of the University of Nebraska Medical Center; ViiV Healthcare; National Institutes of Health [P01 DA028555, R01 NS36126, P01 NS31492, 2R01 NS034239, P01 MH64570, P01 NS43985, P30 MH062261, R01 AG043540]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261, P01MH064570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS031492, R01NS034239, P01NS043985, R01NS036126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA028555] Funding Source: NIH RePORTER	University of Nebraska Foundation; Vice Chancellor's office of the University of Nebraska Medical Center; ViiV Healthcare; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the University of Nebraska Foundation (https://nufoundation.org) which includes individual donations from Carol Swarts and Frances and Louie Blumkin; the Vice Chancellor's office of the University of Nebraska Medical Center; ViiV Healthcare; and National Institutes of Health grants P01 DA028555, R01 NS36126, P01 NS31492, 2R01 NS034239, P01 MH64570, P01 NS43985, P30 MH062261 and R01 AG043540.	Adams JL, 2012, CURR OPIN HIV AIDS, V7, P390, DOI 10.1097/COH.0b013e328356e91c; Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; Allers K, 2014, J INFECT DIS, V209, P739, DOI 10.1093/infdis/jit547; [Anonymous], 2003, Proj Inf Perspect, P7; Azzam R, 2006, JAIDS-J ACQ IMM DEF, V42, P19; Balkundi S, 2011, INT J NANOMED, V6, P3393, DOI 10.2147/IJN.S27830; Balkundi Shantanu, 2010, J Vis Exp, DOI 10.3791/2460; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bogdan C, 2008, CELL MICROBIOL, V10, P1221, DOI 10.1111/j.1462-5822.2008.01146.x; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Bressani RF, 2011, NANOTOXICOLOGY, V5, P592, DOI 10.3109/17435390.2010.541292; Carter CA, 2008, ANNU REV MICROBIOL, V62, P425, DOI 10.1146/annurev.micro.62.081307.162758; Cash JL, 2009, METHOD ENZYMOL, V461, P379, DOI 10.1016/S0076-6879(09)05417-2; Chen RY, 2002, AIDS RES HUM RETROV, V18, P909, DOI 10.1089/088922202760265588; Chulamokha L, 2005, J NEUROVIROL, V11, P76, DOI 10.1080/13550280590931270; Dash PK, 2012, AIDS, V26, P2135, DOI 10.1097/QAD.0b013e328357f5ad; Dou HY, 2007, VIROLOGY, V358, P148, DOI 10.1016/j.virol.2006.08.012; Dou H, 2006, BLOOD, V108, P2827, DOI 10.1182/blood-2006-03-012534; Dou HY, 2009, J IMMUNOL, V183, P661, DOI 10.4049/jimmunol.0900274; Edagwa BJ, 2014, FASEB J, V28, P5071, DOI 10.1096/fj.14-255786; Edagwa BJ, 2014, CURR MED CHEM, V21, P4186, DOI 10.2174/0929867321666140826114135; Fellay J, 2001, LANCET, V358, P1322, DOI 10.1016/S0140-6736(01)06413-3; Fujiwara M, 1996, BBA-BIOMEMBRANES, V1278, P59, DOI 10.1016/0005-2736(95)00183-2; Gautam N, 2014, ANTIMICROB AGENTS CH, V58, P7510, DOI 10.1128/AAC.04108-14; Gautam N, 2013, ANTIMICROB AGENTS CH, V57, P3110, DOI 10.1128/AAC.00267-13; Gent YYJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4191; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Hawkins T, 2006, AIDS PATIENT CARE ST, V20, P6, DOI 10.1089/apc.2006.20.6; Huang JG, 2011, J CHROMATOGR B, V879, P2332, DOI 10.1016/j.jchromb.2011.06.032; Kadiu I, 2011, J NEUROIMMUNE PHARM, V6, P658, DOI 10.1007/s11481-011-9298-z; Kadiu I, 2011, NANOMEDICINE-UK, V6, P975, DOI [10.2217/NNM.11.27, 10.2217/nnm.11.27]; Kamaly N, 2013, P NATL ACAD SCI USA, V110, P6506, DOI 10.1073/pnas.1303377110; Kanmogne GD, 2012, INT J NANOMED, V7, P2373, DOI 10.2147/IJN.S29454; Kovarova M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005075; Lieberman-Blum SS, 2008, CLIN THER, V30, P1228, DOI 10.1016/S0149-2918(08)80048-3; Lu J, 2012, NANOMED-NANOTECHNOL, V8, P212, DOI 10.1016/j.nano.2011.06.002; Martinez-Skinner AL, 2013, J PROTEOME RES, V12, P2282, DOI 10.1021/pr400185w; Nowacek A, 2009, NANOMEDICINE-UK, V4, P557, DOI 10.2217/nnm.09.38; Nowacek AS, 2011, J CONTROL RELEASE, V150, P204, DOI 10.1016/j.jconrel.2010.11.019; Nowacek AS, 2010, J NEUROIMMUNE PHARM, V5, P592, DOI 10.1007/s11481-010-9198-7; Nowacek AS, 2009, NANOMEDICINE-UK, V4, P903, DOI [10.2217/nnm.09.71, 10.2217/NNM.09.71]; Nukolova NV, 2011, BIOMATERIALS, V32, P5417, DOI 10.1016/j.biomaterials.2011.04.006; Orenstein JM, 2007, ULTRASTRUCT PATHOL, V31, P151, DOI 10.1080/01913120701344343; Parboosing R, 2012, VIRUSES-BASEL, V4, P488, DOI 10.3390/v4040488; Puligujja P, 2015, ANTIVIR RES, V120, P85, DOI 10.1016/j.antiviral.2015.05.009; Puligujja P, 2015, BIOMATERIALS, V41, P141, DOI 10.1016/j.biomaterials.2014.11.012; Puligujja P, 2013, NANOMED-NANOTECHNOL, V9, P1263, DOI 10.1016/j.nano.2013.05.003; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Roy U, 2012, J INFECT DIS, V206, P1577, DOI 10.1093/infdis/jis395; SAINTEMARIE G, 1985, CELL TISSUE RES, V239, P31, DOI 10.1007/BF00214899; Shehu-Xhilaga M, 2005, CURR MED CHEM, V12, P1705, DOI 10.2174/0929867054367211; Spreen W, 2014, JAIDS-J ACQ IMM DEF, V67, P481, DOI 10.1097/QAI.0000000000000301; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541; Wang X, 2009, ACS NANO, V3, P3165, DOI 10.1021/nn900649v; Wegzyn CM, 2012, CURR OPIN PHARMACOL, V12, P556, DOI 10.1016/j.coph.2012.06.005; Zhao YL, 2011, NANOMEDICINE-UK, V6, P25, DOI [10.2217/nnm.10.129, 10.2217/NNM.10.129]	60	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145966	10.1371/journal.pone.0145966	http://dx.doi.org/10.1371/journal.pone.0145966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716700	gold, Green Submitted, Green Published			2022-12-27	WOS:000367510500104
J	He, J; Zhu, JJ; Gong, CG; Qi, JM; Xiao, H; Jiang, B; Zhao, YL				He, Jing; Zhu, Jianjun; Gong, Changguo; Qi, Jiming; Xiao, Han; Jiang, Bin; Zhao, Yulan			Label-Free Direct Detection of miRNAs with Poly-Silicon Nanowire Biosensors	PLOS ONE			English	Article							FIELD-EFFECT TRANSISTOR; SILICON NANOWIRES; MICRORNAS; EXPRESSION; CANCER; BIOMARKERS; DNA	Background The diagnostic and prognostic value of microRNAs (miRNAs) in a variety of diseases is promising. The novel silicon nanowire (SiNW) biosensors have advantages in molecular detection because of their high sensitivity and fast response. In this study, poly-crystalline silicon nanowire field-effect transistor (poly-SiNW FET) device was developed to achieve specific and ultrasensitive detection of miRNAs without labeling and amplification. Methods The poly-SiNW FET was fabricated by a top-down Complementary Metal Oxide Semiconductor (CMOS) wafer fabrication based technique. Single strand DNA (ssDNA) probe was bind to the surface of the poly-SiNW device which was silanated and aldehyde-modified. By comparing the difference of resistance value before and after ssDNA and miRNA hybridization, poly-SiNW device can be used to detect standard and real miRNA samples. Results Poly-SiNW device with different structures (different line width and different pitch) was applied to detect standard Let-7b sample with a detection limitation of 1 fM. One-base mismatched sequence could be distinguished meanwhile. Furthermore, these poly-SiNW arrays can detect snRNA U6 in total RNA samples extracted from HepG2 cells with a detection limitation of 0.2 mu g/mL. In general, structures with pitch showed better results than those without pitch in detection of both Let-7b and snRNA U6. Moreover, structures with smaller pitch showed better detection efficacy. Conclusion Our findings suggest that poly-SiNW arrays could detect standard and real miRNA sample without labeling or amplification. Poly-SiNW biosensor device is promising for miRNA detection.	[He, Jing; Gong, Changguo; Zhao, Yulan] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Zhu, Jianjun; Qi, Jiming; Jiang, Bin] Shanghai Integrated Circuit Res & Dev Ctr, Shanghai, Peoples R China; [He, Jing] Zhejiang Univ, Ocean Res Ctr Zhoushan, Hangzhou, Zhejiang, Peoples R China; [Xiao, Han] Wuhan Med & Hlth Ctr Women & Children, Wuhan, Hubei, Peoples R China	East China Normal University; Zhejiang University	Jiang, B (corresponding author), Shanghai Integrated Circuit Res & Dev Ctr, Shanghai, Peoples R China.	bjiang@icrd.com.cn; ylzhao@imet.ecnu.edu.cn			National Natural Science Foundation of China [NSFC 30800401, 81201604]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (NSFC 30800401 and 81201604, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Bunimovich YL, 2006, J AM CHEM SOC, V128, P16323, DOI 10.1021/ja065923u; Chen XY, 2014, CLIN CANCER RES, V20, P2617, DOI 10.1158/1078-0432.CCR-13-3224; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; de Planell-Saguer M, 2013, CLIN BIOCHEM, V46, P869, DOI 10.1016/j.clinbiochem.2013.02.017; Dorvel BR, 2012, ACS NANO, V6, P6150, DOI 10.1021/nn301495k; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gao AR, 2012, NANO LETT, V12, P5262, DOI 10.1021/nl302476h; Guo DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091354; Huber F, 2013, NAT NANOTECHNOL, V8, P125, DOI [10.1038/nnano.2012.263, 10.1038/NNANO.2012.263]; Ingebrandt S, 2011, ECS TRANSACTIONS, V35, P3, DOI 10.1149/1.3571972; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Johnson BN, 2014, ANALYST, V139, P1576, DOI 10.1039/c3an01677c; Lin CH, 2009, BIOSENS BIOELECTRON, V24, P3019, DOI 10.1016/j.bios.2009.03.014; Liu CG, 2008, NAT PROTOC, V3, P563, DOI 10.1038/nprot.2008.14; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Ramnani P, 2013, ANAL CHEM, V85, P8061, DOI 10.1021/ac4018346; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Yao Xiaozhen, 2012, Methods Mol Biol, V883, P143, DOI 10.1007/978-1-61779-839-9_11; Zhang GJ, 2011, METHODS MOL BIOL, V676, P111, DOI 10.1007/978-1-60761-863-8_9; Zhang GJ, 2009, BIOSENS BIOELECTRON, V24, P2504, DOI 10.1016/j.bios.2008.12.035	25	9	11	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145160	10.1371/journal.pone.0145160	http://dx.doi.org/10.1371/journal.pone.0145160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709827	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400023
J	Wullink, B; Pas, HH; Van der Worp, RJ; Kuijer, R; Los, LI				Wullink, Bart; Pas, Hendri H.; Van der Worp, Roelofje J.; Kuijer, Roel; Los, Leonoor I.			Type VII Collagen Expression in the Human Vitreoretinal Interface, Corpora Amylacea and Inner Retinal Layers	PLOS ONE			English	Article							DERMAL-EPIDERMAL JUNCTION; ANCHORING FIBRILS; BASEMENT-MEMBRANE; IN-VITRO; EPIRETINAL MEMBRANES; CONNECTIVE-TISSUE; BASAL LAMINA; OPTIC-NERVE; COMPONENTS; CELLS	Type VII collagen, as a major component of anchoring fibrils found at basement membrane zones, is crucial in anchoring epithelial tissue layers to their underlying stroma. Recently, type VII collagen was discovered in the inner human retina by means of immunohistochemistry, while proteomic investigations demonstrated type VII collagen at the vitreoretinal interface of chicken. Because of its potential anchoring function at the vitreoretinal interface, we further assessed the presence of type VII collagen at this site. We evaluated the vitreoretinal interface of human donor eyes by means of immunohistochemistry, confocal microscopy, immunoelectron microscopy, and Western blotting. Firstly, type VII collagen was detected alongside vitreous fibers6 at the vitreoretinal interface. Because of its known anchoring function, it is likely that type VII collagen is involved in vitreoretinal attachment. Secondly, type VII collagen was found within cytoplasmic vesicles of inner retinal cells. These cells resided most frequently in the ganglion cell layer and inner plexiform layer. Thirdly, type VII collagen was found in astrocytic cytoplasmic inclusions, known as corpora amylacea. The intraretinal presence of type VII collagen was confirmed by Western blotting of homogenized retinal preparations. These data add to the understanding of vitreoretinal attachment, which is important for a better comprehension of common vitreoretinal attachment pathologies.	[Wullink, Bart; Van der Worp, Roelofje J.; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Wullink, Bart; Van der Worp, Roelofje J.; Kuijer, Roel; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, WJ Kolff Inst, Groningen, Netherlands; [Pas, Hendri H.] Univ Groningen, Univ Med Ctr Groningen, Dept Dermatol, Groningen, Netherlands; [Van der Worp, Roelofje J.; Kuijer, Roel] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Wullink, B (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	b.wullink@umcg.nl	Pas, Hendri H/G-9749-2011; Kuijer, Roel/A-6690-2015	Pas, Hendri H/0000-0001-8823-2591; Wullink, Bart/0000-0001-5047-3939; Kuijer, Roel/0000-0002-7637-4944				BACHINGER HP, 1990, J BIOL CHEM, V265, P10095; BAKER KS, 1993, INVEST OPHTH VIS SCI, V34, P137; Balasubramani M, 2010, MATRIX BIOL, V29, P471, DOI 10.1016/j.matbio.2010.04.002; BRIGGAMAN RA, 1971, J CELL BIOL, V51, P384, DOI 10.1083/jcb.51.2.384; BRODY I, 1959, J ULTRA MOL STRUCT R, V2, P482, DOI 10.1016/S0022-5320(59)90007-3; Bruckner Tuderman L, 1987, EUR J BIOCHEM, V165, P607; Bu SC, 2014, RETINA-J RET VIT DIS, V34, P897, DOI 10.1097/IAE.0000000000000013; GIPSON IK, 1987, INVEST OPHTH VIS SCI, V28, P212; GIPSON IK, 1988, DEV BIOL, V126, P253, DOI 10.1016/0012-1606(88)90136-4; Johnson MW, 2013, AM J OPHTHALMOL, V155, P203, DOI 10.1016/j.ajo.2012.10.016; KAHL FR, 1967, J INVEST DERMATOL, V49, P616, DOI 10.1038/jid.1967.189; Kaur C, 2007, J PATHOL, V212, P429, DOI 10.1002/path.2195; KAWANAMI O, 1978, AM J PATHOL, V92, P389; KEENE DR, 1987, J CELL BIOL, V104, P611, DOI 10.1083/jcb.104.3.611; Kenyon K R, 1979, Int Ophthalmol Clin, V19, P169; KONIG A, 1991, J INVEST DERMATOL, V96, P803, DOI 10.1111/1523-1747.ep12474424; KUBOTA T, 1993, GRAEF ARCH CLIN EXP, V231, P249, DOI 10.1007/BF00919099; KUBOTA T, 1993, GRAEF ARCH CLIN EXP, V231, P7, DOI 10.1007/BF01681693; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGUENS R, 1972, J ULTRA MOL STRUCT R, V41, P202, DOI 10.1016/S0022-5320(72)90064-0; LEIGH IM, 1987, EPITHELIA, V1, P17; McMillan JR, 2003, J DERMATOL SCI, V31, P169, DOI 10.1016/S0923-1811(03)00045-8; Meng H, 2009, NEUROPATHOLOGY, V29, P664, DOI 10.1111/j.1440-1789.2009.01024.x; Oberstein SYL, 2008, BRIT J OPHTHALMOL, V92, P981, DOI 10.1136/bjo.2007.132332; Ockleford CD, 2013, PLACENTA, V34, P727, DOI 10.1016/j.placenta.2013.06.002; PALADE GE, 1965, J CELL BIOL, V27, P215, DOI 10.1083/jcb.27.1.215; Pas HH, 1997, J INVEST DERMATOL, V108, P423, DOI 10.1111/1523-1747.ep12289703; PAULUS W, 1995, VIRCHOWS ARCH, V426, P199; Ponsioen TL, 2008, INVEST OPHTH VIS SCI, V49, P4089, DOI 10.1167/iovs.07-1456; Ponsioen TL, 2008, MOL VIS, V14, P652; Purkinje J, 1906, VIRCHOWS ARCH PATHOL, V184, P454; RAMIREZ JM, 1994, VISION RES, V34, P1935, DOI 10.1016/0042-6989(94)90024-8; ROBITAILLE Y, 1980, BRAIN, V103, P315, DOI 10.1093/brain/103.2.315; SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577; Selmaj K, 2008, ACTA BIOCHIM POL, V55, P43, DOI 10.18388/abp.2008_3199; SINGHRAO SK, 1993, NEUROPATH APPL NEURO, V19, P269, DOI 10.1111/j.1365-2990.1993.tb00437.x; SINGHRAO SK, 1995, NEURODEGENERATION, V4, P335, DOI 10.1016/1055-8330(95)90024-1; SINGHRAO SK, 1994, NEUROPATH APPL NEURO, V20, P66, DOI 10.1111/j.1365-2990.1994.tb00958.x; SMITH LT, 1988, J INVEST DERMATOL, V90, P480, DOI 10.1111/1523-1747.ep12460951; Song W, 2014, EXP NEUROL, V254, P78, DOI 10.1016/j.expneurol.2014.01.006; STEELE HD, 1952, AMA ARCH PATHOL, V54, P94; TIDMAN MJ, 1984, J INVEST DERMATOL, V83, P448, DOI 10.1111/1523-1747.ep12273562; TISDALE AS, 1988, INVEST OPHTH VIS SCI, V29, P727; Trivino A, 2000, J ANAT, V196, P61, DOI 10.1046/j.1469-7580.2000.19610061.x; Tuori A, 1996, CORNEA, V15, P286, DOI 10.1097/00003226-199605000-00010; Villone D, 2008, J BIOL CHEM, V283, P24506, DOI 10.1074/jbc.M802415200; WASANO K, 1985, CELL TISSUE RES, V239, P485; WETZELS RHW, 1991, AM J PATHOL, V139, P451; WOODFORD B, 1980, AM J OPHTHALMOL, V90, P492, DOI 10.1016/S0002-9394(14)75018-4; WOODLEY DT, 1988, J CLIN INVEST, V81, P683, DOI 10.1172/JCI113373	50	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145502	10.1371/journal.pone.0145502	http://dx.doi.org/10.1371/journal.pone.0145502			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709927	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400056
J	Lerario, MP; Gialdini, G; Lapidus, DM; Shaw, MM; Navi, BB; Merkler, AE; Lip, GYH; Healey, JS; Kamel, H				Lerario, Michael P.; Gialdini, Gino; Lapidus, Daniel M.; Shaw, Mesha M.; Navi, Babak B.; Merkler, Alexander E.; Lip, Gregory Y. H.; Healey, Jeff S.; Kamel, Hooman			Risk of Ischemic Stroke after Intracranial Hemorrhage in Patients with Atrial Fibrillation	PLOS ONE			English	Article							INTRACEREBRAL HEMORRHAGE; ANTICOAGULATION; WARFARIN; DISCONTINUATION; THROMBOEMBOLISM; RESUMPTION; PROGNOSIS; SAFETY; IMPACT	Background We aimed to estimate the risk of ischemic stroke after intracranial hemorrhage in patients with atrial fibrillation. Materials and Methods Using discharge data from all nonfederal acute care hospitals and emergency departments in California, Florida, and New York from 2005 to 2012, we identified patients at the time of a first-recorded encounter with a diagnosis of atrial fibrillation. Ischemic stroke and intracranial hemorrhage were identified using validated diagnosis codes. Kaplan-Meier survival statistics and Cox proportional hazard analyses were used to evaluate cumulative rates of ischemic stroke and the relationship between incident intracranial hemorrhage and subsequent stroke. Results Among 2,084,735 patients with atrial fibrillation, 50,468 (2.4%) developed intracranial hemorrhage and 89,594 (4.3%) developed ischemic stroke during a mean follow-up period of 3.2 years. The 1-year cumulative rate of stroke was 8.1% (95% CI, 7.5-8.7%) after intracerebral hemorrhage, 3.9% (95% CI, 3.5-4.3%) after subdural hemorrhage, and 2.0% (95% CI, 2.0-2.1%) in those without intracranial hemorrhage. After adjustment for the CHA(2)DS(2)-VASc score, stroke risk was elevated after both intracerebral hemorrhage (hazard ratio [HR], 2.8; 95% CI, 2.6-2.9) and subdural hemorrhage (HR, 1.6; 95% CI, 1.5-1.7). Cumulative 1-year rates of stroke ranged from 0.9% in those with subdural hemorrhage and a CHA(2)DS(2)-VASc score of 0, to 33.3% in those with intracerebral hemorrhage and a CHA(2)DS(2)-VASc score of 9. Conclusions In a large, heterogeneous cohort, patients with atrial fibrillation faced a substantially heightened risk of ischemic stroke after intracranial hemorrhage. The risk was most marked in those with intracerebral hemorrhage and high CHA(2)DS(2)-VASc scores.	[Lerario, Michael P.; Lapidus, Daniel M.; Shaw, Mesha M.; Navi, Babak B.; Merkler, Alexander E.; Kamel, Hooman] Weill Cornell Med Coll, Dept Neurol, New York, NY 10021 USA; [Gialdini, Gino; Navi, Babak B.; Kamel, Hooman] Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY USA; [Lip, Gregory Y. H.] Univ Birmingham, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Lip, Gregory Y. H.] Aalborg Univ, Thrombosis Res Unit, Aalborg, Denmark; [Healey, Jeff S.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada	Cornell University; Cornell University; University of Birmingham; Aalborg University; McMaster University; Population Health Research Institute	Lerario, MP (corresponding author), Weill Cornell Med Coll, Dept Neurol, New York, NY 10021 USA.	mpl9005@med.cornell.edu	Kamel, Hooman/AGG-9071-2022; Lerario, Mackenzie P/ABB-4338-2021; Lerario, Mackenzie/ABC-3517-2021	Lerario, Mackenzie/0000-0003-0806-9670; Navi, Babak/0000-0001-8424-6128	National Institute of Neurological Disorders and Stroke [K23NS082367]; Michael Goldberg Stroke Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS082367] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael Goldberg Stroke Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grant K23NS082367 from the National Institute of Neurological Disorders and Stroke and a grant from the Michael Goldberg Stroke Research Fund (HK). The sponsors had no role in the design of the study, the collection and analysis of the data, the preparation of the manuscript, or the decision to publish.	Agency for Healthcare Research and Quality, HCUP METH SER METH I; Aguilar MI, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006186.pub2; Broderick JP, 2011, STROKE, V42, P2509, DOI 10.1161/STROKEAHA.110.611905; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Dowlatshahi D, 2012, STROKE, V43, P1812, DOI 10.1161/STROKEAHA.112.652065; Eckman MH, 2003, STROKE, V34, P1710, DOI 10.1161/01.STR.0000078311.18928.16; Goldstein JN, 2009, NEUROCRIT CARE, V10, P28, DOI 10.1007/s12028-008-9134-3; Jung HS, 2014, J KOREAN NEUROSURG S, V55, P69, DOI 10.3340/jkns.2014.55.2.69; Kuramatsu JB, 2015, JAMA-J AM MED ASSOC, V313, P824, DOI 10.1001/jama.2015.0846; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Majeed A, 2010, STROKE, V41, P2860, DOI 10.1161/STROKEAHA.110.593087; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Nielsen PB, 2015, CIRCULATION, V132, P517, DOI 10.1161/CIRCULATIONAHA.115.015735; Nielsen PB, 2015, CHEST, V147, P1651, DOI 10.1378/chest.14-2099; Pennlert J, 2015, STROKE, V46, P2094, DOI 10.1161/STROKEAHA.115.009087; Phan TG, 2000, ARCH NEUROL-CHICAGO, V57, P1710, DOI 10.1001/archneur.57.12.1710; Poon MTC, 2014, J NEUROL NEUROSUR PS, V85, P660, DOI 10.1136/jnnp-2013-306476; Reddy VY, 2014, JAMA-J AM MED ASSOC, V312, P1988, DOI 10.1001/jama.2014.15192; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973	21	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145579	10.1371/journal.pone.0145579	http://dx.doi.org/10.1371/journal.pone.0145579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701759	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092600099
J	Mair, G; von Kummer, R; Lindley, RI; Sandercock, PAG; Wardlaw, JM				Mair, Grant; von Kummer, Ruediger; Lindley, Richard I.; Sandercock, Peter A. G.; Wardlaw, Joanna M.		IST-3 Collaborative Grp	Effect of X-Ray Attenuation of Arterial Obstructions on Intravenous Thrombolysis and Outcome after Ischemic Stroke	PLOS ONE			English	Article							PREDICTS SUCCESSFUL RECANALIZATION; TISSUE-PLASMINOGEN ACTIVATOR; THROMBUS ATTENUATION; COMPUTED-TOMOGRAPHY; TRIAL IST-3; CT; THROMBECTOMY; DENSITY; VESSEL; SIGN	Objective To assess whether the x-ray attenuation of intra-arterial obstruction measured on non-contrast CT in ischemic stroke can predict response to thrombolysis and subsequent functional outcome. Methods The Third International Stroke Trial (IST-3) was a multicenter randomized-controlled trial of intravenous thrombolysis (rt-PA) given within six hours of ischemic stroke. Ethical approval and informed consent were obtained. In a subgroup of 109 IST-3 patients (38 men, median age 82 years), a single reader, masked to all clinical and other imaging data, manually measured x-ray attenuation (Hounsfield Units, HU) on non-contrast CT at the location of angiographically-proven intra-arterial obstructions, pre-randomization and at 24-48 hour follow-up. We calculated change in attenuation between scans. We assessed the impact of pre-randomization arterial obstruction attenuation on six-month functional outcome. Results Most arterial obstructions (64/109, 59%) were hyperattenuating (mean 51.0 HU). Compared with control, treatment with rt-PA was associated with a greater, but non-significant, reduction in obstruction attenuation at follow-up (-8.0 HU versus -1.4 HU in patients allocated control, p = 0.117). In multivariable ordinal regression analysis controlled for patient age, stroke severity, location and extent of obstruction, time from stroke onset to baseline scan and rt-PA treatment allocation, the attenuation of pre-randomization arterial obstruction was not independently associated with six-month outcome (odds ratio = 0.99, 95% confidence interval = 0.94-1.03, p = 0.516). Conclusions In ischemic stroke, the x-ray attenuation of the arterial obstruction may decline more rapidly from baseline to 24-48 hours following treatment with thrombolysis but we found no evidence that baseline arterial obstruction attenuation predicts six-month outcome.	[Mair, Grant; Wardlaw, Joanna M.] Univ Edinburgh, Western Gen Hosp, Div Neuroimaging Sci, Edinburgh, Midlothian, Scotland; [von Kummer, Ruediger] Dresden Univ, Stroke Ctr, Univ Hosp, Dept Neuroradiol, Dresden, Germany; [Lindley, Richard I.] Univ Sydney, Westmead Hosp, Sch Clin, Sydney, NSW 2006, Australia; [Lindley, Richard I.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Sandercock, Peter A. G.] Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh, Midlothian, Scotland	University of Edinburgh; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Sydney; George Institute for Global Health; University of Sydney; University of Edinburgh	Wardlaw, JM (corresponding author), Univ Edinburgh, Western Gen Hosp, Div Neuroimaging Sci, Edinburgh, Midlothian, Scotland.	joanna.wardlaw@ed.ac.uk	Hankey, Graeme J/H-4968-2014; von Kummer, Rüdiger/AAA-4478-2019; Lueck, Christian Joseph/O-4031-2016; Mair, Grant/M-9071-2016; Lindley, Richard/B-8148-2013; Hernandez, María/GYU-3543-2022; Wardlaw, Joanna M/Y-3456-2019; Zini, Andrea/K-1136-2014	Hankey, Graeme J/0000-0002-6044-7328; von Kummer, Rüdiger/0000-0003-0119-4604; Lueck, Christian Joseph/0000-0003-1537-7612; Mair, Grant/0000-0003-2189-443X; Lindley, Richard/0000-0002-0104-5679; Wardlaw, Joanna M/0000-0002-9812-6642; Zini, Andrea/0000-0003-1486-4507; Engelter, Stefan/0000-0003-3855-6234	Stroke Association, UK [TSA 04/99]; Health Foundation UK [2268/1282]; Chest, Heart & Stroke Scotland [R100/7]; UK Medical Research Council (MRC) [G0400069, EME 09-800-15]; Research Council of Norway; Arbetsmarknadens Partners Forsakringsbolag (AFA) Insurances Sweden; Swedish Heart Lung Fund; Foundation of Marianne and Marcus Wallenberg, Stockholm County Council; Karolinska Institute Joint ALF-project grants Sweden; Polish Ministry of Science and Education [2PO5B10928]; Australian Heart Foundation; Australian National Health and Medical Research Council (NHMRC); Swiss National Research Foundation; Swiss Heart Foundation; Foundation for Health and Cardio-/Neurovascular Research, Basel, Switzerland; Assessorato alla Sanita, Regione dell'Umbria, Italy; Danube University, Krems, Austria; Scottish Funding Council (SFC); Chief Scientist Office of the Scottish Executive (CSO); Chest Heart and Stroke Scotland; DesAcc; University of Edinburgh; Danderyd Hospital RD Department; Karolinska Institutet; Oslo University Hospital; Dalhousie University Internal Medicine Research Fund; National Institute for Health Research Efficacy and Mechanisms Evaluation Panel [EME 08-43-52]; MRC [MC_G1002455, G0400069] Funding Source: UKRI; Medical Research Council [MC_G1002455, G0400069] Funding Source: researchfish	Stroke Association, UK; Health Foundation UK; Chest, Heart & Stroke Scotland; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research Council of Norway(Research Council of Norway); Arbetsmarknadens Partners Forsakringsbolag (AFA) Insurances Sweden; Swedish Heart Lung Fund(Swedish Heart-Lung Foundation); Foundation of Marianne and Marcus Wallenberg, Stockholm County Council; Karolinska Institute Joint ALF-project grants Sweden; Polish Ministry of Science and Education(Ministry of Science and Higher Education, Poland); Australian Heart Foundation; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Swiss Heart Foundation; Foundation for Health and Cardio-/Neurovascular Research, Basel, Switzerland; Assessorato alla Sanita, Regione dell'Umbria, Italy; Danube University, Krems, Austria; Scottish Funding Council (SFC); Chief Scientist Office of the Scottish Executive (CSO); Chest Heart and Stroke Scotland; DesAcc; University of Edinburgh; Danderyd Hospital RD Department; Karolinska Institutet(Karolinska Institutet); Oslo University Hospital; Dalhousie University Internal Medicine Research Fund; National Institute for Health Research Efficacy and Mechanisms Evaluation Panel; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The start-up phase of IST-3 was supported by a grant from the Stroke Association, UK (TSA 04/99, www.stroke.org.uk). The expansion phase was funded by the Health Foundation UK (2268/1282, www.health.org.uk). The scan reading development was funded by Chest, Heart & Stroke Scotland (R100/7, www.chss.org.uk). The main phase of the trial was funded by: UK Medical Research Council (MRC) (grant numbers G0400069 and EME 09-800-15, www.mrc.ac.uk) and managed by the National Institute for Health Research (NIHR) on behalf of the MRC-NIHR partnership; the Research Council of Norway; Arbetsmarknadens Partners Forsakringsbolag (AFA) Insurances Sweden; the Swedish Heart Lung Fund; The Foundation of Marianne and Marcus Wallenberg, Stockholm County Council; Karolinska Institute Joint ALF-project grants Sweden, the Polish Ministry of Science and Education (grant number 2PO5B10928, www.nauka.gov.pl); the Australian Heart Foundation; Australian National Health and Medical Research Council (NHMRC); the Swiss National Research Foundation; the Swiss Heart Foundation; the Foundation for Health and Cardio-/Neurovascular Research, Basel, Switzerland; the Assessorato alla Sanita, Regione dell'Umbria, Italy; and, Danube University, Krems, Austria. Boehringer-Ingelheim GmbH donated drug and placebo for the 300 patients in the double-blind phase, but thereafter had no role whatsoever in the trial. The UK Stroke Research Network (SRN study ID 2135, www.uksrn.ac.uk) adopted the trial in 01/05/2006, supported the initiation of new UK sites, and in some centres, and, after that date, data collection was undertaken by staff funded by the network or working for associated NHS organizations. IST-3 gratefully acknowledges the extensive support of the NIHR Stroke Research Network, NHS Research Scotland (NRS), through the Scottish Stroke Research Network, and the National Institute for Social Care and Health Research Clinical Research Centre (NISCHR CRC). The central imaging work was undertaken at the Brain Imaging Research Centre, a member of the Scottish Imaging Network A Platform for Scientific Excellence (SINAPSE) collaboration, at the Division of Clinical Neurosciences, University of Edinburgh. SINAPSE is funded by the Scottish Funding Council (SFC) and the Chief Scientist Office of the Scottish Executive (CSO). Additional support was received from Chest Heart and Stroke Scotland, DesAcc, University of Edinburgh, Danderyd Hospital R&D Department, Karolinska Institutet, Oslo University Hospital, and the Dalhousie University Internal Medicine Research Fund. The IST-3 angiography substudy was funded by the National Institute for Health Research Efficacy and Mechanisms Evaluation Panel (EME 08-43-52, www.nets.nihr.ac.uk/programmes/eme). The views are those of the authors and not the funders. The funders played no role in study design, data analysis, decision to publish or preparation of the manuscript.	BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Froehler MT, 2013, J NEUROINTERV SURG, V5, P289, DOI 10.1136/neurintsurg-2012-010313; Nam HS, 2012, THROMB HAEMOSTASIS, V107, P786, DOI 10.1160/TH11-08-0585; Kirchhof K, 2003, RADIOLOGY, V228, P126, DOI 10.1148/radiol.2273020530; Liebeskind DS, 2011, STROKE, V42, P1237, DOI 10.1161/STROKEAHA.110.605576; Mair G, 2015, NEUROLOGY IN PRESS; Mair G, 2015, NEURORADIOLOGY, V57, P1, DOI 10.1007/s00234-014-1441-0; Mair G, 2015, STROKE, V46, P102, DOI 10.1161/STROKEAHA.114.007036; Moftakhar P, 2013, STROKE, V44, P243, DOI 10.1161/STROKEAHA.112.674127; Mokin M, 2015, J NEUROINTERV SURG, V7, P104, DOI 10.1136/neurintsurg-2013-011017; Niesten JM, 2014, CEREBROVASC DIS, V37, P116, DOI 10.1159/000357420; Niesten JM, 2013, NEURORADIOLOGY, V55, P1071, DOI 10.1007/s00234-013-1217-y; Niesten JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088882; Novotna J, 2014, J STROKE CEREBROVASC, V23, P2533, DOI 10.1016/j.jstrokecerebrovasdis.2014.04.034; Puig J, 2012, AM J NEURORADIOL, V33, P90, DOI 10.3174/ajnr.A2878; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Sandercock P, 2012, INT J STROKE, V7, P186, DOI 10.1111/j.1747-4949.2012.00782.x; Sandercock P, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-37; Spiotta AM, 2014, J NEUROINTERV SURG, V6, P423, DOI 10.1136/neurintsurg-2013-010765; Topcuoglu MA, 2014, J STROKE CEREBROVASC, V23, pE85, DOI 10.1016/j.jstrokecerebrovasdis.2013.08.026; Wardlaw JM, 2015, INT J STROKE, V10, P956, DOI 10.1111/j.1747-4949.2012.00946.x; Yilmaz U, 2013, AM J NEURORADIOL, V34, P2184, DOI 10.3174/ajnr.A3565; Zhu GM, 2015, INT J STROKE, V10, P28, DOI 10.1111/ijs.12312	24	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145683	10.1371/journal.pone.0145683	http://dx.doi.org/10.1371/journal.pone.0145683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701648	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600118
J	Krausch-Hofmann, S; Bogaerts, K; Hofmann, M; Mello, JD; Moreira, NCF; Lesaffre, E; Declerck, D; Declercq, A; Duyck, J				Krausch-Hofmann, Stefanie; Bogaerts, Kris; Hofmann, Michael; Mello, Johanna de Almeida; Moreira, Nadia Cristina Favaro; Lesaffre, Emmanuel; Declerck, Dominique; Declercq, Anja; Duyck, Joke			Missing Oral Health-Related Data in the interRAI-HC - Associations with Selected Variables of General Health and the Effect of Multiple Imputation on the Relationship between Oral and General Health	PLOS ONE			English	Article							MINIMUM DATA SET; COGNITIVE PERFORMANCE SCALE; DEPRESSION RATING-SCALE; NURSING-HOME RESIDENTS; CHEWING PROBLEMS; CARE; ABILITY; ADULTS; PART; NEED	Background Missing data within the comprehensive geriatric assessment of the interRAI suite of assessment instruments potentially imply the under-detection of conditions that require care as well as the risk of biased statistical results. Impaired oral health in older individuals has to be registered accurately as it causes pain and discomfort and is related to the general health status. Objective This study was based on interRAI-Home Care (HC) baseline data from 7590 subjects (mean age 81.2 years, SD 6.9) in Belgium. It was investigated if missingness of the oral health-related items was associated with selected variables of general health. It was also determined if multiple imputation of missing data affected the associations between oral and general health. Materials and Methods Multivariable logistic regression was used to determine if the prevalence of missingness in the oral health-related variables was associated with activities of daily life (ADLH), cognitive performance (CPS2) and depression (DRS). Associations between oral health and ADLH, CPS2 and DRS were determined, with missing data treated by 1. the complete-case technique and 2. by multiple imputation, and results were compared. Results The individual oral health-related variables had a similar proportion of missing values, ranging from 16.3% to 17.2%. The prevalence of missing data in all oral health-related variables was significantly associated with symptoms of depression dental prosthesis use OR 1.66, CI 1.41-1.95; damaged teeth OR 1.74, CI 1.48-2.04; chewing problems OR 1.74, CI 1.47-2.05; dry mouth OR 1.65, CI 1.40-1.94). Missingness in damaged teeth OR 1.27, CI 1.08-1.48), chewing problems OR 1.22, CI 1.04-1.44) and dry mouth OR 1.23, CI 1.05-1.44) occurred more frequently in cognitively impaired subjects. ADLH was not associated with the prevalence of missing data. When comparing the complete-case technique with the multiple imputation approach, nearly identical odds ratios characterized the associations between oral and general health. Conclusion Cognitively impaired and depressive individuals had a higher risk of missing oral health-related information. Associations between oral health and ADLH, CPS2 and DRS were not influenced by multiple imputation of missing data. Further research should concentrate on the mechanisms that mediate the occurrence of missingness to develop preventative strategies.	[Krausch-Hofmann, Stefanie; Declerck, Dominique] Katholieke Univ Leuven, Populat Studies Oral Hlth, Dept Oral Hlth Sci, Leuven, Belgium; [Bogaerts, Kris; Lesaffre, Emmanuel] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Leuven, Belgium; [Bogaerts, Kris; Lesaffre, Emmanuel] Katholieke Univ Leuven, Hasselt Univ I BioStat, Leuven, Belgium; [Hofmann, Michael] Katholieke Univ Leuven, Res Grp Expt Otorhinolaryngol, Dept Neurosci, Leuven, Belgium; [Mello, Johanna de Almeida; Declercq, Anja] Katholieke Univ Leuven, Ctr Care Res & Consultancy, LUCAS, Leuven, Belgium; [Moreira, Nadia Cristina Favaro; Duyck, Joke] Katholieke Univ Leuven, Biomat, Dept Oral Hlth Sci, Leuven, Belgium	KU Leuven; KU Leuven; Hasselt University; KU Leuven; KU Leuven; KU Leuven; KU Leuven	Duyck, J (corresponding author), Katholieke Univ Leuven, Biomat, Dept Oral Hlth Sci, Leuven, Belgium.	joke.duyck@med.kuleuven.be	Declercq, Anja/AGS-7441-2022; Declercq, Anja G./G-8014-2011	Declercq, Anja/0000-0003-3136-124X; Declercq, Anja G./0000-0003-3136-124X; Favaro Moreira, Nadia Cristina/0000-0003-0142-8079; De Almeida Mello, Johanna/0000-0002-1262-318X; Bogaerts, Kris/0000-0003-0188-8665	Belgian National Institute for Health and Disability Insurance [49574]	Belgian National Institute for Health and Disability Insurance	The present study used data from the Protocol 3 project that was financed by the Belgian National Institute for Health and Disability Insurance (Protocol 3 M.B. 16/07/2009 - 49574). This federal non-commercial institution is responsible for the organization and supervision of the compulsory health insurance in Belgium. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burrows AB, 2000, AGE AGEING, V29, P165, DOI 10.1093/ageing/29.2.165; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Eekhout I, 2012, EPIDEMIOLOGY, V23, P729, DOI 10.1097/EDE.0b013e3182576cdb; Folse G J, 2001, Spec Care Dentist, V21, P37, DOI 10.1111/j.1754-4505.2001.tb00222.x; Furuta M, 2013, COMMUNITY DENT ORAL, V41, P173, DOI 10.1111/cdoe.12000; HARTMAIER SL, 1995, J GERONTOL A-BIOL, V50, pM128, DOI 10.1093/gerona/50A.2.M128; Hawkley LC, 2014, J GERONTOL B-PSYCHOL, P1; Hirdes JP, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-277; Huang YC, 2011, AGING MENT HEALTH, V15, P1045, DOI 10.1080/13607863.2011.583626; Johnson CL., 2013, ANAL GUIDELINES 1999; Kimura Y, 2013, GERIATR GERONTOL INT, V13, P718, DOI 10.1111/ggi.12006; Laudisio A, 2014, INT J GERIATR PSYCH, V29, P236, DOI 10.1002/gps.3995; Laudisio A, 2010, J CLIN PERIODONTOL, V37, P113, DOI 10.1111/j.1600-051X.2009.01518.x; Mello JD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-615; Meurman Jukka H, 2006, Gerodontology, V23, P3, DOI 10.1111/j.1741-2358.2006.00102.x; Moriya S, 2012, J ORAL REHABIL, V39, P568, DOI 10.1111/j.1365-2842.2012.02302.x; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Muller T, 2007, CLIN ORAL IMPLAN RES, V18, P2, DOI 10.1111/j.1600-0501.2007.01459.x; Nordenram G, 2002, ORAL DIS, V8, P296, DOI 10.1034/j.1601-0825.2002.01788.x; Onder G, 2007, J AM GERIATR SOC, V55, P1961, DOI 10.1111/j.1532-5415.2007.01453.x; Paquay L, 2007, INT J GERIATR PSYCH, V22, P286, DOI 10.1002/gps.1671; Polzer I, 2010, INT DENT J, V60, P143, DOI 10.1922/IDJ_2184Polzer13; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Vanneste D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123760; Wellens NIH, 2011, AGING CLIN EXP RES, V23, P476, DOI 10.1007/BF03325244	26	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146065	10.1371/journal.pone.0146065	http://dx.doi.org/10.1371/journal.pone.0146065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716689	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500128
J	Panova, N; Zbornikova, E; Simak, O; Pohl, R; Kolar, M; Bogdanova, K; Vecerova, R; Seydlova, G; Fiser, R; Hadravova, R; Sanderova, H; Viovska, D; Sikova, M; Latal, T; Lovecka, P; Barvik, I; Krasny, L; Rejman, D				Panova, Natalya; Zbornikova, Eva; Simak, Ondrej; Pohl, Radek; Kolar, Milan; Bogdanova, Katerina; Vecerova, Renata; Seydlova, Gabriela; Fiser, Radovan; Hadravova, Romana; Sanderova, Hana; Viovska, Dragana; Sikova, Michaela; Latal, Tomas; Lovecka, Petra; Barvik, Ivan; Krasny, Libor; Rejman, Dominik			Insights into the Mechanism of Action of Bactericidal Lipophosphonoxins	PLOS ONE			English	Article							CATIONIC STEROID ANTIBIOTICS; BACILLUS-SUBTILIS; ANTIBACTERIAL PROPERTIES; ESCHERICHIA-COLI; GENE-EXPRESSION; BROAD-SPECTRUM; MEMBRANE; RESISTANCE; ACID; INFECTIONS	The advantages offered by established antibiotics in the treatment of infectious diseases are endangered due to the increase in the number of antibiotic-resistant bacterial strains. This leads to a need for new antibacterial compounds. Recently, we discovered a series of compounds termed lipophosphonoxins (LPPOs) that exhibit selective cytotoxicity towards Gram-positive bacteria that include pathogens and resistant strains. For further development of these compounds, it was necessary to identify the mechanism of their action and characterize their interaction with eukaryotic cells/organisms in more detail. Here, we show that at their bactericidal concentrations LPPOs localize to the plasmatic membrane in bacteria but not in eukaryotes. In an in vitro system we demonstrate that LPPOs create pores in the membrane. This provides an explanation of their action in vivo where they cause serious damage of the cellular membrane, efflux of the cytosol, and cell disintegration. Further, we show that (i) LPPOs are not genotoxic as determined by the Ames test, (ii) do not cross a monolayer of Caco-2 cells, suggesting they are unable of transepithelial transport, (iii) are well tolerated by living mice when administered orally but not peritoneally, and (iv) are stable at low pH, indicating they could survive the acidic environment in the stomach. Finally, using one of the most potent LPPOs, we attempted and failed to select resistant strains against this compound while we were able to readily select resistant strains against a known antibiotic, rifampicin. In summary, LPPOs represent a new class of compounds with a potential for development as antibacterial agents for topical applications and perhaps also for treatment of gastrointestinal infections.	[Panova, Natalya; Zbornikova, Eva; Simak, Ondrej; Pohl, Radek; Hadravova, Romana; Rejman, Dominik] Czech Acad Sci Vvi, Inst Organ Chem & Biochem, Prague 16610 6, Czech Republic; [Panova, Natalya; Sanderova, Hana; Viovska, Dragana; Sikova, Michaela; Krasny, Libor] Czech Acad Sci Vvi, Inst Microbiol, Prague 14220 4, Czech Republic; [Kolar, Milan; Bogdanova, Katerina; Vecerova, Renata] Palacky Univ, Fac Med & Dent, Dept Microbiol, Olomouc 77515, Czech Republic; [Seydlova, Gabriela; Fiser, Radovan] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague 12843 2, Czech Republic; [Latal, Tomas] TRIOS Ltd, Prague 14900 4, Czech Republic; [Lovecka, Petra] Univ Chem & Technol, Tech 5, Prague 16628, Czech Republic; [Barvik, Ivan] Charles Univ Prague, Inst Phys, Div Biomol Phys, Fac Math & Phys, Prague 12116 2, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Palacky University Olomouc; Charles University Prague; University of Chemistry & Technology, Prague; Charles University Prague	Krasny, L (corresponding author), Czech Acad Sci Vvi, Inst Microbiol, Videnska 1083, Prague 14220 4, Czech Republic.	rejman@uochb.cas.cz; krasny@biomed.cas.cz	Krasny, Libor/H-2429-2014; Simak, Ondrej/G-5583-2014; Sanderova, Hana/I-1731-2014; Fiser, Radovan/E-4908-2012; Seydlová, Gabriela/H-2050-2014; Pohl, Radek/G-5295-2014; Zbornikova, Eva/I-5786-2014; KOLÁŘ, Milan/ACL-9884-2022; Kolář, Milan/AAB-4423-2021; Rejman, Dominik/D-6901-2011; Barvik, Ivan/G-8906-2014; Sikova, Michaela/T-3439-2017	Krasny, Libor/0000-0002-4120-4347; Fiser, Radovan/0000-0003-4516-0086; Seydlová, Gabriela/0000-0001-8424-9249; Zbornikova, Eva/0000-0002-7510-220X; KOLÁŘ, Milan/0000-0003-4621-8868; Kolář, Milan/0000-0003-4621-8868; Rejman, Dominik/0000-0001-5977-5001; Pohl, Radek/0000-0001-7898-946X; Sikova, Michaela/0000-0001-9244-2604; Bogdanova, Katerina/0000-0003-3014-2213; Sanderova, Hana/0000-0002-5436-7583; Vecerova, Renata/0000-0002-7546-530X; Simak, Ondrej/0000-0002-9506-7085	Technological Agency of the Czech Republic [TA02010035]; Czech Science Foundation [P305/12/G034, 13-18051P]; TRIOS Ltd	Technological Agency of the Czech Republic; Czech Science Foundation(Grant Agency of the Czech Republic); TRIOS Ltd	This work was supported by Technological Agency of the Czech Republic, www.tacr.cz, TA02010035 DR; Czech Science Foundation, www.gacr.cz, P305/12/G034 LK; Czech Science Foundation, www.gacr.cz, 13-18051P GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder TRIOS Ltd provided support in the form of salaries for authors [TL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ashrafuzzaman M, 2008, BBA-BIOMEMBRANES, V1778, P2814, DOI 10.1016/j.bbamem.2008.08.017; BISSCHOP A, 1976, EUR J BIOCHEM, V67, P357, DOI 10.1111/j.1432-1033.1976.tb10699.x; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; Ding B, 2002, J MED CHEM, V45, P663, DOI 10.1021/jm0105070; EDWARDS DI, 1980, BRIT J VENER DIS, V56, P285; Epand RF, 2007, BBA-BIOMEMBRANES, V1768, P2500, DOI 10.1016/j.bbamem.2007.05.023; Eun YJ, 2012, J AM CHEM SOC, V134, P11322, DOI 10.1021/ja302542j; Fujitani S, 2011, AM J INFECT CONTROL, V39, P188, DOI 10.1016/j.ajic.2010.10.024; GLECKMAN R, 1981, PHARMACOTHERAPY, V1, P14; GOLDBERG I, 1973, ANTIMICROB AGENTS CH, V3, P549, DOI 10.1128/AAC.3.5.549; Goldstein BP, 2014, J ANTIBIOT, V67, P625, DOI 10.1038/ja.2014.107; HAHN F. E., 1955, J BACT, V69, P215; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HARRIS WJ, 1973, BIOCHEM J, V135, P315, DOI 10.1042/bj1350315; Henry RJ, 1943, BACTERIOL REV, V7, P175, DOI 10.1128/MMBR.7.4.175-262.1943; Hurdle JG, 2014, ANTIBIOTICS TARGETS; Kanoh S, 2010, CLIN MICROBIOL REV, V23, P590, DOI 10.1128/CMR.00078-09; Kesselheim AS, 2010, HEALTH AFFAIR, V29, P1689, DOI 10.1377/hlthaff.2009.0439; Kevin DA, 2009, EXPERT OPIN DRUG DIS, V4, P109, DOI 10.1517/17460440802661443; Koh JJ, 2015, J MED CHEM, V58, P739, DOI 10.1021/jm501285x; Konai MM, 2014, J MED CHEM, V57, P9409, DOI 10.1021/jm5013566; Konopasek I, 2004, CHEM PHYS LIPIDS, V130, P135, DOI 10.1016/j.chemphyslip.2004.02.005; Kovacs F, 1999, P NATL ACAD SCI USA, V96, P7910, DOI 10.1073/pnas.96.14.7910; Krasny L, 2008, MOL MICROBIOL, V69, P42, DOI 10.1111/j.1365-2958.2008.06256.x; Liu DH, 2004, ANGEW CHEM INT EDIT, V43, P1158, DOI 10.1002/anie.200352791; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; MANDELSTAM J, 1968, BIOCHEM J, V109, P793, DOI 10.1042/bj1090793; Marcolongo JP, 2011, J CHEM EDUC, V88, P629, DOI 10.1021/ed900019u; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; Masin J, 2013, INFECT IMMUN, V81, P4571, DOI 10.1128/IAI.00711-13; Mensa B, 2011, ANTIMICROB AGENTS CH, V55, P5043, DOI 10.1128/AAC.05009-11; Morar M, 2009, STRUCTURE, V17, P1649, DOI 10.1016/j.str.2009.10.013; Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Raghuraman H, 2007, BIOSCIENCE REP, V27, P189, DOI 10.1007/s10540-006-9030-z; Randall CP, 2013, ANTIMICROB AGENTS CH, V57, P637, DOI 10.1128/AAC.02005-12; Savage PB, 2002, FEMS MICROBIOL LETT, V217, P1; Seaton RA, 2008, J ANTIMICROB CHEMOTH, V62, P15, DOI 10.1093/jac/dkn368; SMITH JT, 1986, INFECTION, V14, pS3, DOI 10.1007/BF01645191; Sojka L, 2011, NUCLEIC ACIDS RES, V39, P4598, DOI 10.1093/nar/gkr032; Tan LKK, 2014, CURR OPIN INFECT DIS, V27, P155, DOI 10.1097/QCO.0000000000000047; TUOMANEN E, 1986, J BACTERIOL, V167, P535, DOI 10.1128/jb.167.2.535-543.1986; U. S. Environmental Protection Agency WD, 1983, INT PROC COND SALM M; Van Bambeke F, 2008, TRENDS PHARMACOL SCI, V29, P124, DOI 10.1016/j.tips.2007.12.004; WILLE W, 1975, ANTIMICROB AGENTS CH, V8, P231, DOI 10.1128/AAC.8.3.231; YOCUM RR, 1980, J BIOL CHEM, V255, P3977; YOTSUJI A, 1988, ANTIMICROB AGENTS CH, V32, P1848, DOI 10.1128/AAC.32.12.1848; Zhanel GG, 2010, DRUGS, V70, P859, DOI 10.2165/11534440-000000000-00000	52	10	11	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145918	10.1371/journal.pone.0145918	http://dx.doi.org/10.1371/journal.pone.0145918			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716439	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500095
J	Paul, D; Chanda, DD; Maurya, AP; Mishra, S; Chakravarty, A; Sharma, GD; Bhattacharjee, A				Paul, Deepjyoti; Chanda, Debadatta Dhar; Maurya, Anand Prakash; Mishra, Shweta; Chakravarty, Atanu; Sharma, Gauri Dutt; Bhattacharjee, Amitabha			Co-Carriage of bla(KPC-2) and bla(NDM-1) in Clinical Isolates of Pseudomonas aeruginosa Associated with Hospital Infections from India	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; IDENTIFICATION; GENE; PCR	Global spread of KPC poses to be a serious threat complicating treatment options in hospital settings. The present study investigates the genetic environment of bla(KPC-2) among clinical isolates of Pseudomonas aeruginosa from a tertiary referral hospital of India. The study isolates were collected from different wards and clinics of Silchar Medical College and Hospital, India, from 2012-2013. The presence of bla(KPC) was confirmed by genotypic characterization followed by sequencing. Cloning of the bla(KPC-2) gene was performed and the genetic environment of this gene was characterized as well. Transferability of the resistance gene was determined by transformation assay and Southern hybridization. Additionally, restriction mapping was also carried out. Two isolates of P. aeruginosa were found to harbor bla(KPC-2), were resistant towards aminoglycosides, quinolone and beta-lactam-beta-lactamase inhibitor combination. In both the isolates, the resistance determinant was associated with class 1 integron and horizontally transferable. Both the isolates were co-harboring bla(NDM-1). The first detection of this integron mediated bla(KPC-2) coexisting with bla(NDM-1) in P. aeruginosa from India is worrisome, and further investigation is required to track the gene cassette mediated bla(KPC-2) in terms of infection control and to prevent the spread of this gene in hospitals as well as in the community.	[Paul, Deepjyoti; Maurya, Anand Prakash; Bhattacharjee, Amitabha] Assam Univ, Dept Microbiol, Silchar, India; [Chanda, Debadatta Dhar; Chakravarty, Atanu] Silchar Med Coll & Hosp, Dept Microbiol, Silchar, India; [Mishra, Shweta] Banaras Hindu Univ, Dept Microbiol, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Sharma, Gauri Dutt] Assam Univ, Dept Life Sci & Bioinformat, Silchar, India	Assam University; Banaras Hindu University (BHU); Assam University	Bhattacharjee, A (corresponding author), Assam Univ, Dept Microbiol, Silchar, India.	ab0404@gmail.com		Paul, Deepjyoti/0000-0002-6078-9408; Maurya, Anand Prakash/0000-0001-5231-8174	Department of Bio-technology (DBT-NER, Twinning Scheme), Government of India; CSIR [37 (1632)/14/EMR-II]	Department of Bio-technology (DBT-NER, Twinning Scheme), Government of India; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by the Department of Bio-technology (DBT-NER, Twinning Scheme), Government of India, and CSIR (grant number 37 (1632)/14/EMR-II). Deepjyoti Paul received a CSIR Senior Research Fellowship under the grant number 37(1632)/14/EMR-II.	Almeida ACS, 2012, ANTIMICROB AGENTS CH, V56, P2205, DOI 10.1128/AAC.05268-11; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Clinical and Laboratory Standard Institute, 2011, M100S21 CLSI, V31; Ge CR, 2011, J ANTIMICROB CHEMOTH, V66, P1184, DOI 10.1093/jac/dkr060; Jh Y., 2002, J ANTIMICROB CHEMOTH, V49, P837; Koeleman JGM, 2001, J CLIN MICROBIOL, V39, P8, DOI 10.1128/JCM.39.1.8-13.2001; Kumarasamy K, 2012, J ANTIMICROB CHEMOTH, V67, P243, DOI 10.1093/jac/dkr431; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Liu Y, 2012, CAN J MICROBIOL, V58, P1167, DOI [10.1139/W2012-094, 10.1139/w2012-094]; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; NAAS T, 1994, ANTIMICROB AGENTS CH, V38, P1262, DOI 10.1128/AAC.38.6.1262; Naas T, 2008, ANTIMICROB AGENTS CH, V52, P1257, DOI 10.1128/AAC.01451-07; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Potron A, 2012, J ANTIMICROB CHEMOTH, V67, P242, DOI 10.1093/jac/dkr426; Rasmussen BA, 1996, ANTIMICROB AGENTS CH, V40, P2080, DOI 10.1128/AAC.40.9.2080; Stokes HW, 2001, APPL ENVIRON MICROB, V67, P5240, DOI 10.1128/AEM.67.11.5240-5246.2001; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09	18	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145823	10.1371/journal.pone.0145823	http://dx.doi.org/10.1371/journal.pone.0145823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714034	gold, Green Published, Green Submitted			2022-12-27	WOS:000367481900089
J	Rohrlack, T; Haande, S; Molversmyr, A; Kyle, M				Rohrlack, Thomas; Haande, Sigrid; Molversmyr, Age; Kyle, Marcia			Environmental Conditions Determine the Course and Outcome of Phytoplankton Chytridiomycosis	PLOS ONE			English	Article							DIATOM ASTERIONELLA; PLANKTOTHRIX-RUBESCENS; ANNUAL CYCLE; CYANOBACTERIA; DIVERSITY; EPIDEMICS; HOST; POPULATIONS; CHEMOTYPES; INFECTION	Chytrid fungi are highly potent parasites of phytoplankton. They are thought to force phytoplankton organisms into an evolutionary arms race with high population diversity as the outcome. The underlying selection regime is known as Red Queen dynamics. However, our study suggests a more complex picture for chytrid parasitism in the cyanobacterium Planktothrix. Laboratory experiments identified a "cold thermal refuge", inside which Planktothrix can grow without chytrid infection. A field study in two Norwegian lakes underlined the ecological significance of this finding. The study utilized sediment DNA as a biological archive in combination with existing monitoring data. In one lake, temperature and light conditions forced Planktothrix outside the thermal refuge for most of the growing season. This probably resulted in Red Queen dynamics as suggested by a high parasitic pressure exerted by chytrids, an increase in Planktothrix genotype diversity over time, and a correlation between Planktothrix genotype diversity and duration of bloom events. In the second lake, a colder climate allowed Planktothrix to largely stay inside the thermal refuge. The parasitic pressure exerted by chytrids and Planktothrix genotype diversity remained low, indicating that Planktothrix successfully evaded the Red Queen dynamics. Episodic Planktothrix blooms were observed during spring and autumn circulation, in the metalimnion or under the ice. Interestingly, both lakes were dominated by the same or related Planktothrix genotypes. Taken together, our data suggest that, depending on environmental conditions, chytrid parasitism can impose distinct selection regimes on conspecific phytoplankton populations with similar genotype composition, causing these populations to behave and perhaps to evolve differently.	[Rohrlack, Thomas; Kyle, Marcia] Norwegian Univ Life Sci, Inst Environm Studies, NO-1432 As, Norway; [Haande, Sigrid] Norwegian Inst Water Res, NO-0349 Oslo, Norway; [Molversmyr, Age] Int Res Inst Stavanger, NO-4021 Stavanger, Norway	Norwegian University of Life Sciences; Norwegian Institute for Water Research (NIVA)	Rohrlack, T (corresponding author), Norwegian Univ Life Sci, Inst Environm Studies, Postbox 5003, NO-1432 As, Norway.	Thomas.Rohrlack@nmbu.no		Molversmyr, Age/0000-0003-2774-0503	Norwegian University of Life Sciences	Norwegian University of Life Sciences	The study was supported by a Norwegian University of Life Sciences grant to TR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to express their gratitude to all persons who contributed to the monitoring projects in Lakes Kolbotnvannet and Halandsvatnet. We are particularly thankful to Pal Brettum, Robert Ptacnik and Oyvind Lovstad, who counted phytoplankton samples for these projects and to Anne Charlotte Kinn, who helped with field work. Monitoring projects in Lakes Kolbotnvannet and Halandsvatnet where financed by local authorities. The paleolimnological work in both lakes was supported by a Norwegian University of Life Sciences grant to T.R.	BRUNING K, 1991, J PLANKTON RES, V13, P103, DOI 10.1093/plankt/13.1.103; BRUNING K, 1991, FRESHWATER BIOL, V25, P409, DOI 10.1111/j.1365-2427.1991.tb01385.x; BRUNING K, 1991, J PLANKTON RES, V13, P119, DOI 10.1093/plankt/13.1.119; Davis PA, 2003, FRESHWATER BIOL, V48, P852, DOI 10.1046/j.1365-2427.2003.01055.x; De Bruin A, 2004, J PHYCOL, V40, P823, DOI 10.1111/j.1529-8817.2004.04006.x; De Bruin A, 2008, J EUKARYOT MICROBIOL, V55, P69, DOI 10.1111/j.1550-7408.2008.00306.x; Gerphagnon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060894; Gsell AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071737; Gsell AS, 2013, ISME J, V7, P2057, DOI 10.1038/ismej.2013.73; Haande S, 2014, OVERVAKING GJERSJOEN; Ibelings BW, 2011, FRESHWATER BIOL, V56, P754, DOI 10.1111/j.1365-2427.2010.02565.x; Ibelings BW, 2004, J PHYCOL, V40, P437, DOI 10.1111/j.1529-8817.2004.03117.x; Kagami M, 2007, HYDROBIOLOGIA, V578, P113, DOI 10.1007/s10750-006-0438-z; Kagami M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00166; Kurmayer R, 2006, MOL ECOL, V15, P3849, DOI 10.1111/j.1365-294X.2006.03044.x; Kyle M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118738; Kyle M, 2015, J PALEOLIMNOL, V53, P61, DOI 10.1007/s10933-014-9807-1; Lefevre E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002324; Luhtala H, 2013, ISPRS INT J GEO-INF, V2, P1153, DOI 10.3390/ijgi2041153; Molversmyr A, 2014, OVERVAKING JAERVASSD; Molversmyr A, 2006, UNDERSOKELSERI HALAN; Molversmyr A, 2009, UNDERSOKELSERI HALAN; Monchy S, 2011, ENVIRON MICROBIOL, V13, P1433, DOI 10.1111/j.1462-2920.2011.02444.x; REYNOLDS CS, 1981, PHILOS T ROY SOC B, V293, P419, DOI 10.1098/rstb.1981.0081; Reynolds CS, 2002, J PLANKTON RES, V24, P417, DOI 10.1093/plankt/24.5.417; Rohrlack T, 2008, LIMNOL OCEANOGR, V53, P1279, DOI 10.4319/lo.2008.53.4.1279; Rohrlack T, 2013, APPL ENVIRON MICROB, V79, P2642, DOI 10.1128/AEM.03499-12; Rohrlack T, 2009, J PHYCOL, V45, P1259, DOI 10.1111/j.1529-8817.2009.00757.x; Savichtcheva O, 2015, FRESHWATER BIOL, V60, P31, DOI 10.1111/fwb.12465; Sime-Ngando T, 2012, FRONTIERS MICROBIOLO, V3, P13; Sogge H, 2013, STUDIES PLANKTOTHRIX; Sogge H, 2013, APPL ENVIRON MICROB, V79, P508, DOI 10.1128/AEM.02417-12; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Sonstebo JH, 2011, APPL ENVIRON MICROB, V77, P1344, DOI 10.1128/AEM.02153-10; Tooming-Klunderud A, 2013, APPL ENVIRON MICROB, V79, P6803, DOI 10.1128/AEM.01455-13; Walsby AE, 2005, NEW PHYTOL, V168, P365, DOI 10.1111/j.1469-8137.2005.01508.x; Welker M, 2004, ARCH MICROBIOL, V182, P288, DOI 10.1007/s00203-004-0711-3	37	15	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145559	10.1371/journal.pone.0145559	http://dx.doi.org/10.1371/journal.pone.0145559			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714010	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900057
J	Schartl, M; Shen, YJ; Maurus, K; Walter, R; Tomlinson, C; Wilson, RK; Postlethwait, J; Warren, WC				Schartl, Manfred; Shen, Yingjia; Maurus, Katja; Walter, Ron; Tomlinson, Chad; Wilson, Richard K.; Postlethwait, John; Warren, Wesley C.			Whole Body Melanoma Transcriptome Response in Medaka	PLOS ONE			English	Article							STAGE-III; EXPRESSION; GENE; MELANOGENESIS; CONTRIBUTES; CELLS; STIMULATION; ZEBRAFISH; TYROSINE; MODEL	The incidence of malignant melanoma continues to increase each year with poor prognosis for survival in many relapse cases. To reverse this trend, whole body response measures are needed to discover collaborative paths to primary and secondary malignancy. Several species of fish provide excellent melanoma models because fish and human melanocytes both appear in the epidermis, and fish and human pigment cell tumors share conserved gene expression signatures. For the first time, we have examined the whole body transcriptome response to invasive melanoma as a prelude to using transcriptome profiling to screen for drugs in a medaka (Oryzias latipes) model. We generated RNA-seq data from whole body RNA isolates for controls and melanoma fish. After testing for differential expression, 396 genes had significantly different expression (adjusted p-value <0.02) in the whole body transcriptome between melanoma and control fish; 379 of these genes were matched to human orthologs with 233 having annotated human gene symbols and 14 matched genes that contain putative deleterious variants in human melanoma at varying levels of recurrence. A detailed canonical pathway evaluation for significant enrichment showed the top scoring pathway to be antigen presentation but also included the expected melanocyte development and pigmentation signaling pathway. Results revealed a profound down-regulation of genes involved in the immune response, especially the innate immune system. We hypothesize that the developing melanoma actively suppresses the immune system responses of the body in reacting to the invasive malignancy, and that this mal-adaptive response contributes to disease progression, a result that suggests our whole-body transcriptomic approach merits further use. In these findings, we also observed novel genes not yet identified in human melanoma expression studies and uncovered known and new candidate drug targets for further testing in this malignant melanoma medaka model.	[Schartl, Manfred; Maurus, Katja] Univ Wurzburg, Physiol Chem, Biozentrum, D-97074 Wurzburg, Germany; [Schartl, Manfred] Univ Clin Wurzburg, Ctr Comprehens Canc, D-97074 Wurzburg, Germany; [Shen, Yingjia; Walter, Ron] Texas State Univ, Dept Chem & Biochem, San Marcos, TX 78666 USA; [Tomlinson, Chad; Wilson, Richard K.; Warren, Wesley C.] Washington Univ, McDonnell Genome Inst, St Louis, MO 63108 USA; [Postlethwait, John] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Wurzburg; University of Wurzburg; Texas State University System; Texas State University San Marcos; Washington University (WUSTL); University of Oregon	Schartl, M (corresponding author), Univ Wurzburg, Physiol Chem, Biozentrum, D-97074 Wurzburg, Germany.	phch1@biozentrum.uni-wuerzburg.de; wwarren@genome.wustl.edu	Wilson, Richard K./AAF-4139-2019	Wilson, Richard K./0000-0002-1992-1358; Schartl, Manfred/0000-0001-9882-5948	NIH [R24 RR032658-01, 1R24OD018555]; Deutsche Forschungsgemeinschaft [GRK1048, TR17]; Deutsche Krebshilfe through the Melanomverbund; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR032658] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011198, R24OD018555] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe through the Melanomverbund(Deutsche Krebshilfe); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant R24 RR032658-01 to WCW and Deutsche Forschungsgemeinschaft through GRK1048 and TR17 and the Deutsche Krebshilfe through the Melanomverbund to MS and 1R24OD018555 to JHP, MS, RW, and WW.; This work was supported by NIH grant R24 RR032658-01 to WCW and 1R24OD018555 to JHP, MS, RW, and WCW and Deutsche Forschungsgemeinschaft through GRK1048 and TR17 and the Deutsche Krebshilfe through the Melanomverbund to MS.	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Chan J, 2001, MOL CARCINOGEN, V31, P16, DOI 10.1002/mc.1033; Coca S, 1997, CANCER-AM CANCER SOC, V79, P2320, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P; D'Angelillo A, 2015, CURRENT MOL PHARM; Ding L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111153; Dovey M, 2009, ZEBRAFISH, V6, P397, DOI 10.1089/zeb.2009.0606; Eggermont AMM, 2008, LANCET, V372, P117, DOI 10.1016/S0140-6736(08)61033-8; Fijneman RJA, 2005, CELL ONCOL, V27, P281; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Geissinger E, 2002, CANCER RES, V62, P4820; Giacomotto J, 2010, BRIT J PHARMACOL, V160, P204, DOI 10.1111/j.1476-5381.2010.00725.x; Griffith M, 2013, NAT METHODS, V10, P1209, DOI [10.1038/NMETH.2689, 10.1038/nmeth.2689]; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kluger HM, 2011, CLIN CANCER RES, V17, P2417, DOI 10.1158/1078-0432.CCR-10-2402; Koludrovic D, 2013, FUTURE ONCOL, V9, P235, DOI [10.2217/fon.12.177, 10.2217/FON.12.177]; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Laisney JAGC, 2013, ONCOGENE, V32, P2403, DOI 10.1038/onc.2012.267; Liu QZ, 2014, J CLIN INVEST, V124, P2147, DOI 10.1172/JCI69611; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MARESH GA, 1994, DNA CELL BIOL, V13, P87, DOI 10.1089/dna.1994.13.87; Meierjohann S, 2006, TRENDS GENET, V22, P654, DOI 10.1016/j.tig.2006.09.013; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Mione MC, 2010, DIS MODEL MECH, V3, P517, DOI 10.1242/dmm.004747; Morcinek JC, 2002, ONCOGENE, V21, P1668, DOI 10.1038/sj.onc.1205148; Natarajan VT, 2014, P NATL ACAD SCI USA, V111, P2301, DOI 10.1073/pnas.1304988111; Ngiow SF, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23036; Panelli MC, 2000, J IMMUNOL, V164, P495, DOI 10.4049/jimmunol.164.1.495; Patton EE, 2010, PIGM CELL MELANOMA R, V23, P314, DOI 10.1111/j.1755-148X.2010.00693.x; Plonka PM, 2003, EXP DERMATOL, V12, P356, DOI 10.1034/j.1600-0625.2002.120401.x; Rigel DS, 2008, J AM ACAD DERMATOL, V58, pS129, DOI 10.1016/j.jaad.2007.04.034; Schaafhausen MK, 2013, J CELL SCI, V126, P3862, DOI 10.1242/jcs.125021; Schartl M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037880; Schartl M, 2010, J INVEST DERMATOL, V130, P249, DOI 10.1038/jid.2009.213; Shimanovsky A, 2013, EXPERT OPIN BIOL TH, V13, P1413, DOI 10.1517/14712598.2013.827658; Slominski A, 1998, ANTICANCER RES, V18, P3709; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tucci M, 2014, EXPERT REV CLIN IMMU, V10, P1395, DOI 10.1586/1744666X.2014.955851; Wellbrock C, 2005, CURR BIOL, V15, P1629, DOI 10.1016/j.cub.2005.08.036; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; WITTBRODT J, 1989, NATURE, V341, P415, DOI 10.1038/341415a0; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Yen J, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r113; Zhao H, 2014, GENE, V548, P234, DOI 10.1016/j.gene.2014.07.038	53	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0143057	10.1371/journal.pone.0143057	http://dx.doi.org/10.1371/journal.pone.0143057			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714172	Green Submitted, Green Published, gold			2022-12-27	WOS:000367481900002
J	Eiselein, L; Nyunt, T; Lame, MW; Ng, KF; Wilson, DW; Rutledge, JC; Aung, HH				Eiselein, Larissa; Nyunt, Tun; Lame, Michael W.; Ng, Kit F.; Wilson, Dennis W.; Rutledge, John C.; Aung, Hnin H.			TGRL Lipolysis Products Induce Stress Protein ATF3 via the TGF-beta Receptor Pathway in Human Aortic Endothelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; NECROSIS-FACTOR-ALPHA; TRIGLYCERIDE-RICH LIPOPROTEINS; LOW-DENSITY-LIPOPROTEIN; TRANSCRIPTIONAL REPRESSOR ATF3/LRF1; CEREBELLAR GRANULE NEURONS; EPITHELIAL-CELLS; GENE-EXPRESSION; TRANSFORMING GROWTH-FACTOR-BETA-1; C-JUN	Studies have suggested a link between the transforming growth factor beta 1 (TGF-beta 1) signaling cascade and the stress-inducible activating transcription factor 3 (ATF3). We have demonstrated that triglyceride-rich lipoproteins (TGRL) lipolysis products activate MAP kinase stress associated JNK/c-Jun pathways resulting in up-regulation of ATF3, pro-inflammatory genes and induction of apoptosis in human aortic endothelial cells. Here we demonstrate increased release of active TGF-beta at 15 min, phosphorylation of Smad2 and translocation of co-Smad4 from cytosol to nucleus after a 1.5 h treatment with lipolysis products. Activation and translocation of Smad2 and 4 was blocked by addition of SB431542 (10 mu M), a specific inhibitor of TGF-beta-activin receptor ALKs 4, 5, 7. Both ALK receptor inhibition and anti TGF-beta 1 antibody prevented lipolysis product induced up-regulation of ATF3 mRNA and protein. ALK inhibition prevented lipolysis product-induced nuclear accumulation of ATF3. ALKs 4, 5, 7 inhibition also prevented phosphorylation of c-Jun and TGRL lipolysis product-induced p53 and caspase-3 protein expression. These findings demonstrate that TGRL lipolysis products cause release of active TGF-beta and lipolysis product-induced apoptosis is dependent on TGF-beta signaling. Furthermore, signaling through the stress associated JNK/c-Jun pathway is dependent on TGF-beta signaling suggesting that TGF-beta signaling is necessary for nuclear accumulation of the ATF3/cJun transcription complex and induction of pro-inflammatory responses.	[Eiselein, Larissa; Nyunt, Tun; Ng, Kit F.; Rutledge, John C.; Aung, Hnin H.] Univ Calif Davis, Sch Med, Dept Internal Med, Div Cardiovasc Med, Davis, CA 95616 USA; [Lame, Michael W.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Wilson, Dennis W.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Aung, HH (corresponding author), Univ Calif Davis, Sch Med, Dept Internal Med, Div Cardiovasc Med, Davis, CA 95616 USA.	mhaung@ucdavis.edu			National Institutes of Health [HL55667, AG039094]; Richard A. and Nora Eccles Harrison Endowed Chair in Diabetes Research Fund; UCD Humanities Graduate Research Award; UCD Dissertation Year Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG039094, R01AG045541] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard A. and Nora Eccles Harrison Endowed Chair in Diabetes Research Fund; UCD Humanities Graduate Research Award; UCD Dissertation Year Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by National Institutes of Health HL55667 and AG039094: JCR, Richard A. and Nora Eccles Harrison Endowed Chair in Diabetes Research Fund: JCR and the UCD Humanities Graduate Research Award and the UCD Dissertation Year Fellowship: LE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram A, 2010, AM J RESP CRIT CARE, V182, P489, DOI 10.1164/rccm.200906-0925OC; Aung HH, 2013, ARTERIOSCL THROM VAS, V33, P2088, DOI 10.1161/ATVBAHA.113.301375; Birukova AA, 2005, FEBS LETT, V579, P4031, DOI 10.1016/j.febslet.2005.06.018; Bombeli T, 1997, BLOOD, V89, P2429, DOI 10.1182/blood.V89.7.2429; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; Chen CC, 1996, CYTOKINE, V8, P58, DOI 10.1006/cyto.1995.0008; Chiarugi V, 1997, PHARMACOL RES, V35, P257, DOI 10.1006/phrs.1997.0140; Choy JC, 2001, J MOL CELL CARDIOL, V33, P1673, DOI 10.1006/jmcc.2001.1419; Clements RT, 2005, AM J PHYSIOL-LUNG C, V288, pL294, DOI 10.1152/ajplung.00213.2004; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Dimmeler S, 1997, CIRCULATION, V95, P1760; Ding GH, 1997, KIDNEY INT, V51, P147, DOI 10.1038/ki.1997.18; Dmitrieva N, 2000, J BIOL CHEM, V275, P18243, DOI 10.1074/jbc.M000522200; Donato NJ, 1998, J BIOL CHEM, V273, P5067, DOI 10.1074/jbc.273.9.5067; Du XL, 1998, DIABETOLOGIA, V41, P249, DOI 10.1007/s001250050900; Dupont S, 2004, CANCER LETT, V213, P129, DOI 10.1016/j.canlet.2004.06.008; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; Eiselein L, 2007, AM J PHYSIOL-HEART C, V292, pH2745, DOI 10.1152/ajpheart.00686.2006; Feng JP, 2013, INT J CLIN EXP PATHO, V6, P2064; Francis JM, 2000, J BIOL CHEM, V275, P39137, DOI 10.1074/jbc.M007212200; GENG YJ, 1995, AM J PATHOL, V147, P251; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; GOTLIEB WH, 1994, AM J OBSTET GYNECOL, V170, P1121, DOI 10.1016/S0002-9378(94)70106-7; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hainaut P, 2000, ADV CANCER RES, V77, P81; HAN DKM, 1995, AM J PATHOL, V147, P267; Hong HK, 2006, TRANSL RES, V148, P171, DOI 10.1016/j.trsl.2006.07.005; HSU JC, 1992, MOL CELL BIOL, V12, P4654, DOI 10.1128/MCB.12.10.4654; Huber J, 2002, ARTERIOSCL THROM VAS, V22, P101, DOI 10.1161/hq0102.101525; Hyman KM, 2002, SURGERY, V132, P173, DOI 10.1067/msy.2002.125304; Inoue K, 2004, GENES CELLS, V9, P59, DOI 10.1111/j.1356-9597.2004.00707.x; ISNER JM, 1995, CIRCULATION, V91, P2703, DOI 10.1161/01.CIR.91.11.2703; Jack GD, 2007, CELL SIGNAL, V19, P772, DOI 10.1016/j.cellsig.2006.10.005; Jin MH, 2008, TOXICOL LETT, V178, P202, DOI 10.1016/j.toxlet.2008.03.015; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; KASTAN MB, 1991, CANCER RES, V51, P4279; Ladiwala U, 1999, J NEUROCHEM, V73, P605, DOI 10.1046/j.1471-4159.1999.0730605.x; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; LENZ ML, 1990, J LIPID RES, V31, P1043; Li DY, 1998, AM J PHYSIOL-HEART C, V275, pH568, DOI 10.1152/ajpheart.1998.275.2.H568; Liang GS, 1996, J BIOL CHEM, V271, P1695, DOI 10.1074/jbc.271.3.1695; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long X, 2007, MOL CELL BIOCHEM, V303, P167, DOI 10.1007/s11010-007-9470-1; Lu DM, 2007, APOPTOSIS, V12, P1893, DOI 10.1007/s10495-007-0111-7; Lu Q, 2006, J APPL PHYSIOL, V101, P375, DOI 10.1152/japplphysiol.01515.2005; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; McLaughlin R, 2001, IRISH J MED SCI, V170, P132, DOI 10.1007/BF03168827; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Mei Y, 2008, NEUROSCIENCE, V151, P771, DOI 10.1016/j.neuroscience.2007.10.057; MORLEY N, 1972, J BIOL CHEM, V247, P6389; Napoli C, 2000, FASEB J, V14, P1996, DOI 10.1096/fj.99-0986com; Nawa T, 2000, BIOCHEM BIOPH RES CO, V275, P406, DOI 10.1006/bbrc.2000.3332; Nawa T, 2002, ATHEROSCLEROSIS, V161, P281, DOI 10.1016/S0021-9150(01)00639-6; NIKOL S, 1992, J CLIN INVEST, V90, P1582, DOI 10.1172/JCI116027; NILSSONE.P, 1973, J BIOL CHEM, V248, P6734; Norata GD, 2006, J MOL CELL CARDIOL, V40, P484, DOI 10.1016/j.yjmcc.2006.01.022; Norata GD, 2007, ATHEROSCLEROSIS, V193, P321, DOI 10.1016/j.atherosclerosis.2006.09.015; Pollman MJ, 1999, CIRCULATION, V99, P2019, DOI 10.1161/01.CIR.99.15.2019; ROBERTS AB, 1993, GROWTH FACTORS, V8, P1; Rorke EA, 2000, EXP CELL RES, V259, P149, DOI 10.1006/excr.2000.4953; Sata M, 1998, J CLIN INVEST, V102, P1682, DOI 10.1172/JCI3531; Schmidt-Ott KM, 2000, REGUL PEPTIDES, V93, P65, DOI 10.1016/S0167-0115(00)00178-6; SELVAKUMARAN M, 1994, ONCOGENE, V9, P1791; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Silverstein Roy L, 2010, Trans Am Clin Climatol Assoc, V121, P206; Simeonova PP, 2001, TOXICOL APPL PHARM, V177, P112, DOI 10.1006/taap.2001.9304; Singh NN, 2006, CYTOKINE GROWTH F R, V17, P487, DOI 10.1016/j.cytogfr.2006.09.002; Smith WB, 1996, J IMMUNOL, V157, P360; Sola S, 2004, BIOCHEMISTRY-US, V43, P8429, DOI 10.1021/bi049781x; Song CY, 2005, KIDNEY INT, V67, P1743, DOI 10.1111/j.1523-1755.2005.00271.x; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Teramoto T, 1998, BIOCHEM BIOPH RES CO, V251, P56, DOI 10.1006/bbrc.1998.9411; Ting HJ, 2007, CIRC RES, V100, P381, DOI 10.1161/01.RES.0000258023.76515.a3; Wang LM, 2008, AM J PHYSIOL-HEART C, V295, pH237, DOI 10.1152/ajpheart.01366.2007; Wang LM, 2009, J LIPID RES, V50, P204, DOI 10.1194/jlr.M700505-JLR200; Wang MY, 2006, ARTERIOSCL THROM VAS, V26, P1503, DOI 10.1161/01.ATV.0000225777.58488.f2; Wang SZE, 2007, J BIOL CHEM, V282, P5661, DOI 10.1074/jbc.M608499200; Watson A, 1998, J NEUROSCI, V18, P751; Weiss JM, 1999, ENDOTHELIUM-NEW YORK, V6, P291, DOI 10.3109/10623329909078496; Xie SQ, 2001, J BIOL CHEM, V276, P36194, DOI 10.1074/jbc.M104157200; Zhang C, 2001, BIOCHEM BIOPH RES CO, V289, P718, DOI 10.1006/bbrc.2001.6044; Zhang ST, 2006, CELL CYCLE, V5, P2787, DOI 10.4161/cc.5.23.3523	85	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145523	10.1371/journal.pone.0145523	http://dx.doi.org/10.1371/journal.pone.0145523			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709509	Green Submitted, gold, Green Published			2022-12-27	WOS:000367451400061
J	Khaliq, W; Aamar, A; Wright, SM				Khaliq, Waseem; Aamar, Ali; Wright, Scott M.			Predictors of Non-Adherence to Breast Cancer Screening among Hospitalized Women	PLOS ONE			English	Article							UNITED-STATES; MAMMOGRAPHY; RISK; VALIDATION; BENEFITS; SERVICES	Objective Disparities in screening mammography use persists among low income women, even those who are insured, despite the proven mortality benefit. A recent study reported that more than a third of hospitalized women were non-adherent with breast cancer screening. The current study explores prevalence of socio-demographic and clinical variables associated with non-adherence to screening mammography recommendations among hospitalized women. Patients and Methods A cross sectional bedside survey was conducted to collect socio-demographic and clinical comorbidity data thought to effect breast cancer screening adherence of hospitalized women aged 50-75 years. Logistic regression models were used to assess the association between these factors and non-adherence to screening mammography. Results Of 250 enrolled women, 61% were of low income, and 42% reported non-adherence to screening guidelines. After adjustment for socio-demographic and clinical predictors, three variables were found to be independently associated with non-adherence to breast cancer screening: low income (OR = 3.81, 95% CI; 1.84-7.89), current or ex-smoker (OR = 2.29, 95% CI; 1.12-4.67), and history of stroke (OR = 2.83, 95% CI; 1.21-6.60). By contrast, hospitalized women with diabetes were more likely to be compliant with breast cancer screening (OR = 2.70, 95% CI 1.35-5.34). Conclusion Because hospitalization creates the scenario wherein patients are in close proximity to healthcare resources, at a time when they may be reflecting upon their health status, strategies could be employed to counsel, educate, and motivate these patients towards health maintenance. Capitalizing on this opportunity would involve offering screening during hospitalization for those who are overdue, particularly for those who are at higher risk of disease.	[Khaliq, Waseem; Wright, Scott M.] Johns Hopkins Univ, Sch Med, Dept Med, Johns Hopkins Bayview Med Ctr, Baltimore, MD 21205 USA; [Aamar, Ali] Yale Univ, Sch Med, Yale Waterbury Hosp, Dept Internal Med, Waterbury, CT USA	Johns Hopkins University; Johns Hopkins Medicine; Yale University	Khaliq, W (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Johns Hopkins Bayview Med Ctr, Baltimore, MD 21205 USA.	wkhaliq1@jhmi.edu			Hopkins Center for Innovative Medicine; Maryland Cigarette Restitution Fund Research Grant at Johns Hopkins	Hopkins Center for Innovative Medicine; Maryland Cigarette Restitution Fund Research Grant at Johns Hopkins	Dr. Wright is a Miller-Coulson Family Scholar supported by Hopkins Center for Innovative Medicine.; This work was made possible in part by the Maryland Cigarette Restitution Fund Research Grant at Johns Hopkins. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achat H, 2005, PREV MED, V41, P312, DOI 10.1016/j.ypmed.2004.11.016; American Cancer Society, 2013, BREAST CANC FACTS FI; [Anonymous], 2014, WHO POSITION PAPER O; Blackwell DL, 2008, WOMEN HEALTH ISS, V18, P85, DOI 10.1016/j.whi.2007.10.006; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Borrayo EA, 2009, J WOMENS HEALTH, V18, P1585, DOI 10.1089/jwh.2008.1009; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Cosgrove DM, 2013, HEALTH AFFAIR, V32, P321, DOI 10.1377/hlthaff.2012.1074; Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541; Elmore JG, 2005, JAMA-J AM MED ASSOC, V293, P1245, DOI 10.1001/jama.293.10.1245; Ferrante JM, 2007, AM J PREV MED, V32, P525, DOI 10.1016/j.amepre.2007.02.004; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 1999, J NATL CANCER I, V91, P1829, DOI 10.1093/jnci/91.21.1829; Gail MH, 2007, J NATL CANCER I, V99, P1782, DOI 10.1093/jnci/djm223; Hendrick RE, 2011, AM J ROENTGENOL, V196, pW112, DOI 10.2214/AJR.10.5609; Kempe Karin L, 2013, Perm J, V17, P38, DOI 10.7812/TPP/12-068; Khaliq W, 2014, ANN FAM MED, V12, P556, DOI 10.1370/afm.1694; Khaliq W, 2013, J WOMENS HEALTH, V22, P637, DOI 10.1089/jwh.2012.4083; Kim Jaeyoung, 2008, J Prev Med Public Health, V41, P186; Kisuule F, 2007, J HOSP MED, V2, P93, DOI 10.1002/jhm.185; Loberg M, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0525-z; Ludman EJ, 2010, AM J PREV MED, V38, P303, DOI 10.1016/j.amepre.2009.10.039; Maruthur NM, 2009, J GEN INTERN MED, V24, P665, DOI 10.1007/s11606-009-0939-3; Matsuno RK, 2011, J NATL CANCER I, V103, P951, DOI 10.1093/jnci/djr154; Miller Jacqueline W, 2012, MMWR Suppl, V61, P46; Ogedegbe G, 2005, J NATL MED ASSOC, V97, P162; Phillips Kathryn A, 2006, Prev Chronic Dis, V3, pA75; Ramirez A, 2005, AM J PUBLIC HEALTH, V95, P2057, DOI 10.2105/AJPH.2005.066118; Rattanawatkul K, 2011, U MARYLAND MCNAIR SC, V3, P10; Rauscher GH, 2012, J WOMENS HEALTH, V21, P154, DOI 10.1089/jwh.2010.2415; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; Selvin E, 2003, AM J PUBLIC HEALTH, V93, P618, DOI 10.2105/AJPH.93.4.618; Shah M, 2007, J WOMENS HEALTH, V16, P526, DOI 10.1089/jwh.2006.0108; Smith EC, 2013, JAMA SURG, V148, P516, DOI 10.1001/jamasurg.2013.1680	34	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145492	10.1371/journal.pone.0145492	http://dx.doi.org/10.1371/journal.pone.0145492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ9XO	26709510	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400053
J	Khor, WC; Puah, SM; Tan, JAMA; Puthucheary, SD; Chua, KH				Khor, Wei Ching; Puah, Suat Moi; Tan, Jin Ai Mary Anne; Puthucheary, S. D.; Chua, Kek Heng			Phenotypic and Genetic Diversity of Aeromonas Species Isolated from Fresh Water Lakes in Malaysia	PLOS ONE			English	Article							III SECRETION SYSTEM; VIRULENCE FACTORS; GENUS AEROMONAS; CLINICAL ISOLATE; HEALTHY CONTROLS; HYDROPHILA; IDENTIFICATION; ENTEROTOXINS; SEQUENCES; PCR	Gram-negative bacilli of the genus Aeromonas are primarily inhabitants of the aquatic environment. Humans acquire this organism from a wide range of food and water sources as well as during aquatic recreational activities. In the present study, the diversity and distribution of Aeromonas species from freshwater lakes in Malaysia was investigated using glycerophospholipid-cholesterol acyltransferase (GCAT) and RNA polymerase sigma-factor (rpoD) genes for speciation. A total of 122 possible Aeromonas strains were isolated and confirmed to genus level using the API20E system. The clonality of the isolates was investigated using ERIC-PCR and 20 duplicate isolates were excluded from the study. The specific GCAT-PCR identified all isolates as belonging to the genus Aeromonas, in agreement with the biochemical identification. A phylogenetic tree was constructed using the rpoD gene sequence and all 102 isolates were identified as: A. veronii 43%, A. jandaei 37%, A. hydrophila 6%, A. caviae 4%, A. salmonicida 2%, A. media 2%, A. allosaccharophila 1%, A. dhakensis 1% and Aeromonas spp. 4%. Twelve virulence genes were present in the following proportions-exu 96%, ser 93%, aer 87%, fla 83%, enolase 70%, ela 62%, act 54%, aexT 33%, lip 16%, dam 16%, alt 8% and ast 4%, and at least 2 of these genes were present in all 102 strains. The ascV, aexU and hlyA genes were not detected among the isolates. A. hydrophila was the main species containing virulence genes alt and ast either present alone or in combination. It is possible that different mechanisms may be used by each genospecies to demonstrate virulence. In summary, with the use of GCAT and rpoD genes, unambiguous identification of Aeromonas species is possible and provides valuable data on the phylogenetic diversity of the organism.	[Khor, Wei Ching; Puah, Suat Moi; Tan, Jin Ai Mary Anne; Chua, Kek Heng] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia; [Puthucheary, S. D.] Duke NUS Med Sch Singapore, Dept Med Educ Res & Evaluat, Singapore, Singapore	Universiti Malaya; National University of Singapore	Chua, KH (corresponding author), Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia.	khchua@um.edu.my	Puah, Suat Moi/J-6296-2016; TAN, JIN AI MARY ANNE/B-8950-2010; CHUA, KEK HENG/B-5261-2010	Puah, Suat Moi/0000-0003-1346-3787; CHUA, KEK HENG/0000-0002-0452-9994; Khor, Wei Ching/0000-0003-3931-0682	University of Malaya [RP039A-15HTM, PG082-2014B]	University of Malaya(Universiti Malaya)	This study was funded by the University of Malaya Research Grant RP039A-15HTM and Postgraduate Research Grant PG082-2014B.	Abbott SL, 2003, J CLIN MICROBIOL, V41, P2348, DOI 10.1128/JCM.41.6.2348-2357.2003; Aguilera-Arreola MG, 2005, FEMS MICROBIOL LETT, V242, P231, DOI 10.1016/j.femsle.2004.11.011; Albert MJ, 2000, J CLIN MICROBIOL, V38, P3785, DOI 10.1128/JCM.38.10.3785-3790.2000; ALTWEGG M, 1990, J CLIN MICROBIOL, V28, P258, DOI 10.1128/JCM.28.2.258-264.1990; Beaz-Hidalgo R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115813; Beaz-Hidalgo R, 2010, SYST APPL MICROBIOL, V33, P149, DOI 10.1016/j.syapm.2010.02.002; Bin Kingombe CI, 1999, APPL ENVIRON MICROB, V65, P5293; Bossi-Kupfer M, 2007, J MED MICROBIOL, V56, P1563, DOI 10.1099/jmm.0.47202-0; Chacon MR, 2003, ANTON LEEUW INT J G, V84, P269, DOI 10.1023/A:1026042125243; Chacon MR, 2002, DIAGN MICR INFEC DIS, V44, P221, DOI 10.1016/S0732-8893(02)00455-8; Chopra AK, 1999, MICROBES INFECT, V1, P1129, DOI 10.1016/S1286-4579(99)00202-6; Corry JEL, 2003, HDB CULTURE MEDIA FO; Erova TE, 2007, FEMS MICROBIOL LETT, V275, P301, DOI 10.1111/j.1574-6968.2007.00895.x; Erova TE, 2006, INFECT IMMUN, V74, P410, DOI 10.1128/IAI.74.1.410-424.2006; Esteve C, 2003, INT J SYST EVOL MICR, V53, P1411, DOI 10.1099/ijs.0.02504-0; Faisal M, 2007, J WILDLIFE DIS, V43, P618, DOI 10.7589/0090-3558-43.4.618; Figueras MJ, 2005, REV MED MICROBIOL, V16, P145; Grim CJ, 2013, MBIO, V4, DOI 10.1128/mBio.00064-13; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HAVELAAR AH, 1988, LETT APPL MICROBIOL, V7, P169, DOI 10.1111/j.1472-765X.1988.tb01271.x; Hossain MJ, 2014, MBIO, V5, DOI 10.1128/mBio.00848-14; Hu M, 2012, LETT APPL MICROBIOL, V55, P224, DOI 10.1111/j.1472-765X.2012.03281.x; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Janda JM, 1998, CLIN INFECT DIS, V27, P332, DOI 10.1086/514652; Khajanchi BK, 2010, APPL ENVIRON MICROB, V76, P2313, DOI 10.1128/AEM.02535-09; Lamy B, 2010, DIAGN MICR INFEC DIS, V67, P9, DOI 10.1016/j.diagmicrobio.2009.12.012; Lee W. S., 2001, SMJ Singapore Medical Journal, V42, P057; Nam IY, 2007, J MICROBIOL, V45, P297; Nawaz M, 2010, FOOD MICROBIOL, V27, P327, DOI 10.1016/j.fm.2009.11.007; Nordmann P, 2002, CLIN MICROBIOL INFEC, V8, P321, DOI 10.1046/j.1469-0691.2002.00401.x; Pemberton JM, 1997, FEMS MICROBIOL LETT, V152, P1, DOI 10.1016/S0378-1097(97)00186-9; Pillai L, 2006, INFECT IMMUN, V74, P3742, DOI 10.1128/IAI.00402-06; Puthucheary SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030205; RHODES MW, 1994, WATER RES, V28, P2241, DOI 10.1016/0043-1354(94)90039-6; Sen K, 2004, J APPL MICROBIOL, V97, P1077, DOI 10.1111/j.1365-2672.2004.02398.x; Sha J, 2005, INFECT IMMUN, V73, P6446, DOI 10.1128/IAI.73.10.6446-6457.2005; Sha J, 2003, MICROB PATHOGENESIS, V34, P195, DOI 10.1016/S0882-4010(03)00028-7; Sha J, 2002, INFECT IMMUN, V70, P1924, DOI 10.1128/IAI.70.4.1924-1935.2002; Sha J, 2007, MICROB PATHOGENESIS, V43, P127, DOI 10.1016/j.micpath.2007.05.002; Sreedharan K, 2013, ANTON LEEUW INT J G, V103, P53, DOI 10.1007/s10482-012-9786-z; Szczuka E, 2004, J CLIN MICROBIOL, V42, P220, DOI 10.1128/JCM.42.1.220-228.2004; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Vilches S, 2008, MICROB PATHOGENESIS, V44, P1, DOI 10.1016/j.micpath.2007.06.004; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385; Yousr A, 2007, ASEAN FOOD J, V14, P115	46	35	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145933	10.1371/journal.pone.0145933	http://dx.doi.org/10.1371/journal.pone.0145933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710336	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400092
J	Siette, J; Gulea, C; Priebe, S				Siette, Joyce; Gulea, Claudia; Priebe, Stefan			Assessing Social Networks in Patients with Psychotic Disorders: A Systematic Review of Instruments	PLOS ONE			English	Article							COMMUNITY; PEOPLE; LIFE	Background Evidence suggests that social networks of patients with psychotic disorders influence symptoms, quality of life and treatment outcomes. It is therefore important to assess social networks for which appropriate and preferably established instruments should be used. Aims To identify instruments assessing social networks in studies of patients with psychotic disorders and explore their properties. Method A systematic search of electronic databases was conducted to identify studies that used a measure of social networks in patients with psychotic disorders. Results Eight instruments were identified, all of which had been developed before 1991. They have been used in 65 studies (total N of patients = 8,522). They assess one or more aspects of social networks such as their size, structure, dimensionality and quality. Most instruments have various shortcomings, including questionable inter-rater and test-retest reliability. Conclusions The assessment of social networks in patients with psychotic disorders is characterized by a variety of approaches which may reflect the complexity of the construct. Further research on social networks in patients with psychotic disorders would benefit from advanced and more precise instruments using comparable definitions of and timescales for social networks across studies.	[Siette, Joyce; Gulea, Claudia; Priebe, Stefan] Queen Mary Univ London, Newham Ctr Mental Hlth, Unit Social & Community Psychiat, WHO Collaborating Ctr Mental Hlth Serv Dev, London E3 8SP, England	University of London; Queen Mary University London; World Health Organization	Gulea, C (corresponding author), Queen Mary Univ London, Newham Ctr Mental Hlth, Unit Social & Community Psychiat, WHO Collaborating Ctr Mental Hlth Serv Dev, London E3 8SP, England.	c.gulea@qmul.ac.uk	Siette, Joyce/O-4208-2018	Siette, Joyce/0000-0001-9568-5847; Gulea, Claudia/0000-0001-9607-5901; Priebe, Stefan/0000-0001-9864-3394	National Institute for Health Research [RP-PG-0611-20002] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Albert M, 1998, INT J SOC PSYCHIATR, V44, P248, DOI 10.1177/002076409804400402; [Anonymous], [No title captured]; BARRERA M, 1992, J ABNORM CHILD PSYCH, V20, P1, DOI 10.1007/BF00927113; Barrera M., 1981, SOCIAL NETWORKS SOCI, P69; Becker T, 1998, SOC PSYCH PSYCH EPID, V33, P299, DOI 10.1007/s001270050058; Becker T, 1998, BRIT J PSYCHIAT, V173, P404, DOI 10.1192/bjp.173.5.404; Bengtsson-Tops A, 2004, J Psychiatr Ment Health Nurs, V11, P298, DOI 10.1111/j.1365-2850.2003.00718.x; Bengtsson-Tops A, 2001, INT J SOC PSYCHIATR, V47, P67, DOI 10.1177/002076400104700307; Bengtsson-Tops A, 2001, J ADV NURS, V33, P432, DOI 10.1046/j.1365-2648.2001.01692.x; BOISSEVAIN J, 1979, CURR ANTHROPOL, V20, P392, DOI 10.1086/202277; COHEN CI, 1978, SCHIZOPHRENIA BULL, V4, P546, DOI 10.1093/schbul/4.4.546; COHEN CI, 1989, COMMUNITY MENT HLT J, V25, P197, DOI 10.1007/BF00754437; DUNN M, 1990, BRIT J PSYCHIAT, V157, P842, DOI 10.1192/bjp.157.6.842; Eassom E, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006108; Eklund M, 2007, INT J SOC PSYCHIATR, V53, P293, DOI 10.1177/0020764006074540; Epstein A.L., 1961, RHODES LIVINGSTONE J, V29, P29; HENDERSON S, 1980, PSYCHOL MED, V10, P723, DOI 10.1017/S003329170005501X; Jackson HJ, 1992, SCHIZOPHRENIA OVERVI, P275; Jeppesen P, 2008, PSYCHOL MED, V38, P1157, DOI 10.1017/S0033291708003449; Lovell A. M., 1984, COMMUNICATION; MacDonald E.M, 2000, SCHIZOPHR RES, V25, P39; MacDonald E.M, 1996, SCHIZOOPHRENIA RES, V29, P275; MCFARLANE AH, 1981, SCHIZOPHRENIA BULL, V7, P90, DOI 10.1093/schbul/7.1.90; Mitchell J.C., 1969, SOC NETWORKS URBAN, P51; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; PATTISON EM, 1981, SCHIZOPHRENIA BULL, V7, P135, DOI 10.1093/schbul/7.1.135; Randolph ET, HDB SOCIAL FUNCTIONI, P238; SOKOLOVSKY J, 1981, SCHIZOPHRENIA BULL, V7, P109, DOI 10.1093/schbul/7.1.109; STEIN CH, 1995, COMMUNITY MENT HLT J, V31, P351, DOI 10.1007/BF02207521; WHO, 2018, INT STAT CLASS DIS R	30	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145250	10.1371/journal.pone.0145250	http://dx.doi.org/10.1371/journal.pone.0145250			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ9XO	26709513	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400029
J	Joseph, JV; van Roosmalen, IAM; Busschers, E; Tomar, T; Conroy, S; Eggens-Meijer, E; Fajardo, NP; Pore, MM; Balasubramanyian, V; Wagemakers, M; Copray, S; den Dunnen, WFA; Kruyt, FAE				Joseph, Justin V.; van Roosmalen, Ingrid A. M.; Busschers, Ellen; Tomar, Tushar; Conroy, Siobhan; Eggens-Meijer, Ellie; Fajardo, Natalia Penaranda; Pore, Milind M.; Balasubramanyian, Veerakumar; Wagemakers, Michiel; Copray, Sjef; den Dunnen, Wilfred F. A.; Kruyt, Frank A. E.			Serum-Induced Differentiation of Glioblastoma Neurospheres Leads to Enhanced Migration/Invasion Capacity That Is Associated with Increased MMP9	PLOS ONE			English	Article							CANCER STEM-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN BRAIN; MATRIX METALLOPROTEINASES; INVASION; GLIOMAS; TRANSDIFFERENTIATION; IDENTIFICATION; ASTROCYTES; RESISTANCE	Glioblastoma (GBM) is a highly infiltrative brain tumor in which cells with properties of stem cells, called glioblastoma stem cells (GSCs), have been identified. In general, the dominant view is that GSCs are responsible for the initiation, progression, invasion and recurrence of this tumor. In this study, we addressed the question whether the differentiation status of GBM cells is associated with their invasive capacity. For this, several primary GBM cell lines were used, cultured either as neurospheres known to enrich for GSCs or in medium supplemented with 10% FCS that promotes differentiation. The differentiation state of the cells was confirmed by determining the expression of stem cell and differentiation markers. The migration/invasion potential of these cells was tested using in vitro assays and intracranial mouse models. Interestingly, we found that serum-induced differentiation enhanced the invasive potential of GBM cells, which was associated with enhanced MMP9 expression. Chemical inhibition of MMP9 significantly reduced the invasive potential of differentiated cells in vitro. Furthermore, the serum-differentiated cells could revert back to an undifferentiated/stem cell state that were able to form neurospheres, although with a reduced efficiency as compared to non-differentiated counterparts. We propose a model in which activation of the differentiation program in GBM cells enhances their infiltrative potential and that depending on microenvironmental cues a significant portion of these cells are able to revert back to an undifferentiated state with enhanced tumorigenic potential. Thus, effective therapy should target both GSCs and differentiated offspring and targeting of differentiation-associated pathways may offer therapeutic opportunities to reduce invasive growth of GBM.	[Joseph, Justin V.; van Roosmalen, Ingrid A. M.; Busschers, Ellen; Fajardo, Natalia Penaranda; Pore, Milind M.; Kruyt, Frank A. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [van Roosmalen, Ingrid A. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pharm, Groningen, Netherlands; [Tomar, Tushar] Univ Groningen, Univ Med Ctr Groningen, Dept Gynecol Oncol, Groningen, Netherlands; [Conroy, Siobhan; den Dunnen, Wilfred F. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands; [Eggens-Meijer, Ellie; Balasubramanyian, Veerakumar; Copray, Sjef] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Wagemakers, Michiel] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosurg, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Kruyt, FAE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands.	f.a.e.kruyt@umcg.nl	Tomar, Tushar/AAJ-3952-2021; Tomar, Tushar/AAK-1012-2020	Tomar, Tushar/0000-0002-3344-7605; den Dunnen, Wilfred/0000-0002-4168-1207; Kruyt, Frank/0000-0002-2445-9380	Dutch Cancer Society [RUG2011-5150]; Graduate School of Medical Sciences; GUIDE-CRCG; Jan Kornelis de Cock Foundation	Dutch Cancer Society(KWF Kankerbestrijding); Graduate School of Medical Sciences; GUIDE-CRCG; Jan Kornelis de Cock Foundation	This work was supported by grant RUG2011-5150 from the Dutch Cancer Society, the Graduate School of Medical Sciences, GUIDE-CRCG and the Jan Kornelis de Cock Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brabletz T, 2012, CANCER CELL, V22, P699, DOI 10.1016/j.ccr.2012.11.009; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Cheng L, 2011, BIOCHEM BIOPH RES CO, V406, P643, DOI 10.1016/j.bbrc.2011.02.123; Cheng L, 2010, BIOCHEM PHARMACOL, V80, P654, DOI 10.1016/j.bcp.2010.04.035; Dandy WE, 1928, J AMER MED ASSOC, V90, P823, DOI 10.1001/jama.1928.02690380007003; Das G, 2011, MOL CARCINOGEN, V50, P412, DOI 10.1002/mc.20723; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Eichenbaum KD, 2005, BIOTECHNIQUES, V39, P487, DOI 10.2144/000112003; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gardner WJ, 1933, JAMA-J AM MED ASSOC, V12, P154; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Gritti A, 1996, J NEUROSCI, V16, P1091; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Joseph JV, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.395; Laks DR, 2009, STEM CELLS, V27, P980, DOI 10.1002/stem.15; Lang B, 2004, NEUROSCIENCE, V128, P775, DOI 10.1016/j.neuroscience.2004.06.033; Lathia JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024807; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liu LP, 2010, CANCER RES, V70, P3750, DOI 10.1158/0008-5472.CAN-09-3838; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Miao H, 2014, ONCOGENE, DOI [10.1038/onc.2013.590, DOI 10.1038/onc.2013.590]; Nakada M, 2003, FRONT BIOSCI, V8, pE261, DOI 10.2741/1016; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Rath BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054752; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rohde LE, 1999, CIRCULATION, V99, P3063, DOI 10.1161/01.CIR.99.23.3063; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; van Strien ME, 2011, CELL RES, V21, P1523, DOI 10.1038/cr.2011.101; Vescovi AL, 2001, BIOMED PHARMACOTHER, V55, P201, DOI 10.1016/S0753-3322(01)00056-7; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wang Maode, 2003, Brain Tumor Pathol, V20, P65, DOI 10.1007/BF02483449; Weber K, 2010, J NEUROPATH EXP NEUR, V69, P623, DOI 10.1097/NEN.0b013e3181e04739; Weller M, 2014, LANCET ONCOL, V15, pE395, DOI 10.1016/S1470-2045(14)70011-7; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Wick W, 2008, NEURO-ONCOLOGY, V10, P1019, DOI 10.1215/15228517-2008-058; Xie Q, 2014, NEURO-ONCOLOGY, V16, P1575, DOI 10.1093/neuonc/nou147; Yang H, 2009, CELL MOL NEUROBIOL, V29, P455, DOI 10.1007/s10571-008-9337-3; Yang TQ, 2014, CANCER SCI, V105, P265, DOI 10.1111/cas.12351; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311	47	25	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145393	10.1371/journal.pone.0145393	http://dx.doi.org/10.1371/journal.pone.0145393			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700636	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600074
J	Rad, SK; Kanthimathi, MS; Abd Malek, SN; Lee, GS; Looi, CY; Wong, WF				Rad, Sima Kianpour; Kanthimathi, M. S.; Abd Malek, Sri Nurestri; Lee, Guan Serm; Looi, Chung Yeng; Wong, Won Fen			Cinnamomum cassia Suppresses Caspase-9 through Stimulation of AKT1 in MCF-7 Cells but Not in MDA-MB-231 Cells	PLOS ONE			English	Article							INDUCED APOPTOSIS; GLUTATHIONE-PEROXIDASE; MITOCHONDRIAL DAMAGE; SUPEROXIDE-DISMUTASE; ANTIOXIDANT ACTIVITY; CANCER; BARK; P53; INHIBITORS; INDUCTION	Background Cinnamomum cassia bark is a popular culinary spice used for flavoring and in traditional medicine. C. cassia extract (CE) induces apoptosis in many cell lines. In the present study, particular differences in the mechanism of the anti-proliferative property of C. cassia on two breast cancer cell lines, MCF-7 and MDA-MB-231, were elucidated. Methodology/Principal Findings The hexane extract of C. cassia demonstrated high anti-proliferative activity against MCF-7 and MDA-MB-231 cells (IC50, 34 +/- 3.52 and 32.42 +/- 0.37 mu g/ml, respectively). Oxidative stress due to disruption of antioxidant enzyme (SOD, GPx and CAT) activity is suggested as the probable cause for apoptosis initiation. Though the main apoptosis pathway in both cell lines was found to be through caspase-8 activation, caspase-9 was also activated in MDA-MB-231 cells but suppressed in MCF-7 cells. Gene expression studies revealed that AKT1, the caspase-9 suppressor, was up-regulated in MCF-7 cells while down-regulated in MDA-MB-231 cells. Although, AKT1 protein expression in both cell lines was down-regulated, a steady increase in MCF-7 cells was observed after a sharp decrease of suppression of AKT1. Trans-cinnamaldehyde and coumarin were isolated and identified and found to be mainly responsible for the observed anti-proliferative activity of CE (Cinnamomum cassia). Conclusion Activation of caspase-8 is reported for the first time to be involved as the main apoptosis pathway in breast cancer cell lines upon treatment with C. cassia. The double effects of C. cassia on AKT1 gene expression in MCF-7 cells is reported for the first time in this study.	[Rad, Sima Kianpour; Kanthimathi, M. S.] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Kanthimathi, M. S.] Univ Malaya, Fac Med, UMCPR, Ctr Prote Res, Kuala Lumpur, Malaysia; [Abd Malek, Sri Nurestri; Lee, Guan Serm] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Looi, Chung Yeng] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Wong, Won Fen] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Kanthimathi, MS (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.	kanthi@ummc.edu.my	Malek, Sri Nurestri Abd/B-9834-2010; Kianpour Rad, Sima/AAC-5642-2022; Wong, Won Fen/D-3087-2012; Malek, Sri Nurestri/W-8556-2019; LEE, GUAN SERM/B-8833-2010	Malek, Sri Nurestri Abd/0000-0001-6278-8559; Wong, Won Fen/0000-0003-1082-1956; Malek, Sri Nurestri/0000-0001-6278-8559; LEE, GUAN SERM/0000-0002-8386-4976	University of Malaya Research University [UMRG RG290-14AFR, RP027A-14HTM]; University of Malaya	University of Malaya Research University; University of Malaya(Universiti Malaya)	This research was supported by University of Malaya Research University grants, UMRG RG290-14AFR and RP027A-14HTM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the University of Malaya for financial support.	Almeida RD, 2004, BBA-REV CANCER, V1704, P59, DOI 10.1016/j.bbcan.2004.05.003; Amaral JD, 2010, DISCOV MED, V9, P145; Angeloni SV, 2004, J ENDOCRINOL, V180, P497, DOI 10.1677/joe.0.1800497; Araujo JR, 2011, NUTR RES, V31, P77, DOI 10.1016/j.nutres.2011.01.006; Arbab IA, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/856029; Assadollahi V, 2013, ADV BIOMEDICAL RES, P2; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Blanc C, 2000, CANCER RES, V60, P4386; Cardo-Vila M, 2003, MOL CELL, V11, P1151, DOI 10.1016/S1097-2765(03)00138-2; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chuang JY, 2007, IN VIVO, V21, P1003; Ciapetti G, 2002, BIOMATERIALS, V23, P617, DOI 10.1016/S0142-9612(01)00149-1; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; D'Archivio M, 2008, INT J MOL SCI, V9, P213, DOI 10.3390/ijms9030213; de Fatima A, 2006, BIOORGAN MED CHEM, V14, P622, DOI 10.1016/j.bmc.2005.08.036; Dejean LM, 2006, CELL DEATH DIFFER, V13, P1387, DOI 10.1038/sj.cdd.4401949; Downward J, 2004, SEMINARS CELL DEV BI; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Evens AM, 2005, BLOOD, V105, P1265, DOI 10.1182/blood-2004-03-0964; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Fesik SW, 2001, SCIENCE, V294, P1477, DOI 10.1126/science.1062236; Franco-Molina MA, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-148; Frydman-Marom A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016564; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gerhauser C, 2003, MUTAT RES-FUND MOL M, V523, P163, DOI 10.1016/S0027-5107(02)00332-9; GONZALES R, 1984, CANCER RES, V44, P4137; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Huang HL, 2003, ONCOGENE, V22, P8168, DOI 10.1038/sj.onc.1206979; Kim IG, 2008, ENVIRON TOXICOL PHAR, V25, P75, DOI 10.1016/j.etap.2007.09.002; Koppikar SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-210; Kuete V, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00123; Lahiry L, 2008, APOPTOSIS, V13, P771, DOI 10.1007/s10495-008-0213-x; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lee KH, 2006, PHYTOTHER RES, V20, P952, DOI 10.1002/ptr.1984; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lopez-Gonzalez JS, 2004, LUNG CANCER-J IASLC, V43, P275, DOI 10.1016/j.lungcan.2003.09.005; Lopez-Lazaro M, 2007, CANCER LETT, V252, P1, DOI 10.1016/j.canlet.2006.10.029; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKLUND SL, 1982, CANCER RES, V42, P1955; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; O'Mahony R, 2005, WORLD J GASTROENTERO, V11, P7499, DOI 10.3748/wjg.v11.i47.7499; Peter K. V, 2006, HDB HERBS SPICES, V3; Rashad AE, 2010, ARCH PHARM, V343, P440, DOI 10.1002/ardp.201000002; Rasul A, 2011, ASIAN PAC J CANCER P, V12, P1219; Riveiro ME, 2008, BIOORGAN MED CHEM, V16, P2665, DOI 10.1016/j.bmc.2007.11.038; Rosato RR, 2003, MOL CANCER THER, V2, P1273; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Shklyar B, 2013, MOL CELL BIOL, V33, P3191, DOI 10.1128/MCB.00233-13; Tang ELH, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-347; Tomaino A, 2005, FOOD CHEM, V89, P549, DOI 10.1016/j.foodchem.2004.03.011; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tsuji-Naito K, 2008, BIOORGAN MED CHEM, V16, P9176, DOI 10.1016/j.bmc.2008.09.036; Watanabe Y, 2013, J ALLERGY CLIN IMMUN, V132, P648, DOI 10.1016/j.jaci.2013.03.046; Wondrak GT, 2010, MOLECULES, V15, P3338, DOI 10.3390/molecules15053338; Wu SJ, 2007, FOOD CHEM TOXICOL, V45, P2446, DOI 10.1016/j.fct.2007.05.032; Yang PM, 2012, INT J ONCOL, V40, P469, DOI 10.3892/ijo.2011.1203; Yu YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009339; Zhang JH, 2010, ACTA PHARMACOL SIN, V31, P861, DOI 10.1038/aps.2010.76; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zu YG, 2010, MOLECULES, V15, P3200, DOI 10.3390/molecules15053200	60	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145216	10.1371/journal.pone.0145216	http://dx.doi.org/10.1371/journal.pone.0145216			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700476	Green Published, gold			2022-12-27	WOS:000367092600053
J	Rhee, SY; Jordan, MR; Raizes, E; Chua, A; Parkin, N; Kantor, R; Van Zyl, GU; Mukui, I; Hosseinipour, MC; Frenkel, LM; Ndembi, N; Hamers, RL; de Wit, TFR; Wallis, CL; Gupta, RK; Fokam, J; Zeh, C; Schapiro, JM; Carmona, S; Katzenstein, D; Tang, M; Aghokeng, AF; De Oliveira, T; Wensing, AMJ; Gallant, JE; Wainberg, MA; Richman, DD; Fitzgibbon, JE; Schito, M; Bertagnolio, S; Yang, CF; Shafer, RW				Rhee, Soo-Yon; Jordan, Michael R.; Raizes, Elliot; Chua, Arlene; Parkin, Neil; Kantor, Rami; Van Zyl, Gert U.; Mukui, Irene; Hosseinipour, Mina C.; Frenkel, Lisa M.; Ndembi, Nicaise; Hamers, Raph L.; de Wit, Tobias F. Rinke; Wallis, Carole L.; Gupta, Ravindra K.; Fokam, Joseph; Zeh, Clement; Schapiro, Jonathan M.; Carmona, Sergio; Katzenstein, David; Tang, Michele; Aghokeng, Avelin F.; De Oliveira, Tulio; Wensing, Annemarie M. J.; Gallant, Joel E.; Wainberg, Mark A.; Richman, Douglas D.; Fitzgibbon, Joseph E.; Schito, Marco; Bertagnolio, Silvia; Yang, Chunfu; Shafer, Robert W.			HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; ACTIVE ANTIRETROVIRAL THERAPY; SUB-SAHARAN AFRICA; VIROLOGICAL FAILURE; PROTEASE INHIBITOR; SOUTH-AFRICA; HIV-1-INFECTED PATIENTS; TREATMENT PROGRAMS; NAIVE INDIVIDUALS; ATAZANAVIR	The increasing prevalence of acquired and transmitted HIV-1 drug resistance is an obstacle to successful antiretroviral therapy (ART) in the low- and middle-income countries (LMICs) hardest hit by the HIV-1 pandemic. Genotypic drug resistance testing could facilitate the choice of initial ART in areas with rising transmitted drug resistance (TDR) and enable care-providers to determine which individuals with virological failure (VF) on a first-or second-line ART regimen require a change in treatment. An inexpensive near point-of-care (POC) genotypic resistance test would be useful in settings where the resources, capacity, and infrastructure to perform standard genotypic drug resistance testing are limited. Such a test would be particularly useful in conjunction with the POC HIV-1 viral load tests that are currently being introduced in LMICs. A POC genotypic resistance test is likely to involve the use of allele-specific point mutation assays for detecting drug-resistance mutations (DRMs). This study proposes that two major nucleoside reverse transcriptase inhibitor (NRTI)-associated DRMs (M184V and K65R) and four major NNRTI-associated DRMs (K103N, Y181C, G190A, and V106M) would be the most useful for POC genotypic resistance testing in LMIC settings. One or more of these six DRMs was present in 61.2% of analyzed virus sequences from ART-naive individuals with intermediate or high-level TDR and 98.8% of analyzed virus sequences from individuals on a first-line NRTI/NNRTI-containing regimen with intermediate or high-level acquired drug resistance. The detection of one or more of these DRMs in an ART-naive individual or in a individual with VF on a first-line NRTI/NNRTI-containing regimen may be considered an indication for a protease inhibitor (PI)-containing regimen or closer virological monitoring based on cost-effectiveness or country policy.	[Rhee, Soo-Yon; Katzenstein, David; Tang, Michele; Shafer, Robert W.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Jordan, Michael R.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Raizes, Elliot; Yang, Chunfu] Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA USA; [Chua, Arlene] Access Campaign, Med Sans Frontieres, Geneva, Switzerland; [Chua, Arlene] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore; [Parkin, Neil] Data First Consulting, Belmont, MA USA; [Kantor, Rami] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Van Zyl, Gert U.] Natl Hlth Lab Serv, Tygerberg, Coastal Branch, South Africa; [Van Zyl, Gert U.] Univ Stellenbosch, Div Med Virol, Parow, South Africa; [Mukui, Irene] Natl AIDS & Sexually Transmitted Infect STI Contr, Minist Hlth, Nairobi, Kenya; [Hosseinipour, Mina C.] UNC Project, Lilongwe, Malawi; [Frenkel, Lisa M.] Univ Washington, Seattle, WA 98195 USA; [Frenkel, Lisa M.] Seattle Childrens Res Inst, Seattle, WA USA; [Ndembi, Nicaise] Inst Human Virol, Abuja, Nigeria; [Hamers, Raph L.; de Wit, Tobias F. Rinke] Univ Amsterdam, Acad Med Ctr, AIGHD, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Wallis, Carole L.] Lancet Labs & BARC SA, Johannesburg, South Africa; [Gupta, Ravindra K.] UCL, Dept Infect, London, England; [Fokam, Joseph] Chantal BIYA Int Reference Ctr Res HIV AIDS Preve, Yaounde, Cameroon; [Fokam, Joseph] Univ Yaounde I, FMBS, Yaounde, Cameroon; [Zeh, Clement] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; [Schapiro, Jonathan M.] Natl Hemophilia Ctr, Tel Hashomer, Israel; [Carmona, Sergio] Univ Witwatersrand, Dept Haematol & Mol Med, Johannesburg, South Africa; [Carmona, Sergio] Natl Hlth Lab Serv, Johannesburg, South Africa; [Aghokeng, Avelin F.] Virol Lab CREMER IMPM, Yaounde, Cameroon; [De Oliveira, Tulio] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Sch Lab Med & Med Sci, Durban, South Africa; [Wensing, Annemarie M. J.] Univ Med Ctr Utrecht, Dept Med Microbiol, Virol, Utrecht, Netherlands; [Gallant, Joel E.] Southwest CARE Ctr, Santa Fe, NM USA; [Wainberg, Mark A.] McGill Univ, Jewish Gen Hosp, AIDS Ctr, Montreal, PQ H3T 1E2, Canada; [Richman, Douglas D.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Richman, Douglas D.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Fitzgibbon, Joseph E.] NIAID, NIH, Drug Dev & Clin Sci Branch, Div Aids, Bethesda, MD 20892 USA; [Schito, Marco] Adv Mil Med Inc, Henry M Jackson Fdn, HJF DAIDS Div, Bethesda, MD USA; [Bertagnolio, Silvia] WHO, HIV Dept, CH-1211 Geneva, Switzerland	Stanford University; Tufts University; Centers for Disease Control & Prevention - USA; Doctors Without Borders; Tan Tock Seng Hospital; Brown University; Stellenbosch University; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London; University of Yaounde I; Centers for Disease Control & Prevention - USA; University of Witwatersrand; National Health Laboratory Service; University of Kwazulu Natal; Utrecht University; Utrecht University Medical Center; McGill University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; World Health Organization	Rhee, SY (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.	syrhee@stanford.edu	van Zyl, Gert/I-7357-2019; NDEMBI, Nicaise/AAE-4383-2020; Mukui, Irene/GYE-0151-2022; Parkin, Neil/P-2724-2019; Gupta, Ravindra/G-5529-2015	van Zyl, Gert/0000-0003-3021-5101; katzenstein, david/0000-0002-8593-4560; Carmona, Sergio/0000-0002-6792-4748; Hamers, Raph/0000-0002-5007-7896; Gupta, Ravindra/0000-0001-9751-1808; Rhee, Soo-Yon/0000-0002-1231-6542; Chua, Arlene/0000-0001-6428-9083; AGHOKENG FOBANG, Avelin/0000-0002-1414-0237; Mukui, Irene/0000-0002-3699-1841; Wallis, Carole/0000-0001-8408-8772	Bill and Melinda Gates Foundation; NIH [AI068581]; CFAR [1P30A142853]; Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068581, R56AI068581] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CFAR; Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RWS and SYR were supported in part by a grant from the Bill and Melinda Gates Foundation and from the NIH (AI068581). NP was supported by a grant from the Bill and Melinda Gates Foundation. MRJ was supported in part by CFAR 1P30A142853. This project has been supported in part by the Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC). Data First Consulting provided support in the form of salaries for authors NP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghokeng AF, 2014, CLIN INFECT DIS, V58, P99, DOI 10.1093/cid/cit627; Aitken SC, 2013, J CLIN MICROBIOL, V51, P1757, DOI 10.1128/JCM.00118-13; Barber TJ, 2012, J ANTIMICROB CHEMOTH, V67, P995, DOI 10.1093/jac/dkr569; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bertagnolio S, 2013, J INFECT DIS, V207, pS45, DOI 10.1093/infdis/jit121; Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Bronze M, 2013, J VIROL METHODS, DOI [10.1016/j.jviromet.2013.08.015, DOI 10.1016/J.JVIR0MET.2013.08.015]; Castagna A, 2014, AIDS, V28, P2269, DOI [10.1097/QAD.000000, 10.1097/QAD.0000000000000407]; Chi BH, 2013, CURR OPIN HIV AIDS, V8, P498, DOI 10.1097/COH.0b013e3283637f7a; Chung MH, 2014, JAIDS-J ACQ IMM DEF, V67, P246, DOI 10.1097/QAI.0000000000000312; Clutter DS, 2015, PLOS ONE; Dolling DI, 2013, J ANTIMICROB CHEMOTH, V68, P2339, DOI 10.1093/jac/dkt199; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Frentz D, 2012, AIDS REV, V14, P17; Fun A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-63; Guiguet M, 2012, AIDS, V26, P2345, DOI 10.1097/QAD.0b013e32835646e0; Gupta RK, 2014, CLIN INFECT DIS, V58, P1023, DOI 10.1093/cid/cit933; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hamers RL, 2010, JAIDS-J ACQ IMM DEF, V55, P95, DOI 10.1097/QAI.0b013e3181e544e0; HIV/AIDS Programme World Health Organization, 2012, WHO HIV DRUG RES REP; HIV/ AIDS Programme World Health Organization, 2013, CONGUID UANT DRU; Hoffmann CJ, 2014, TROP MED INT HEALTH, V19, P236, DOI 10.1111/tmi.12237; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Holmes CB, 2010, JAMA-J AM MED ASSOC, V304, P313, DOI 10.1001/jama.2010.993; Johnston V, 2012, JAIDS-J ACQ IMM DEF, V61, P370, DOI 10.1097/QAI.0b013e318266ee3f; Karlstrom O, 2007, JAIDS-J ACQ IMM DEF, V44, P417, DOI 10.1097/QAI.0b013e31802e2940; Lapointe HR, 2015, ANTIMICROB AGENTS CH, V59, P6824, DOI 10.1128/AAC.01490-15; Llibre JM, 2013, AIDS REV, V15, P112; MacLeod I, 2014, C RETR OPP INF; Malan D R Niel, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P34, DOI 10.1177/1545109709355828; McMahon JH, 2013, B WORLD HEALTH ORGAN, V91, P377, DOI 10.2471/BLT.12.112946; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; Mollan K, 2012, J INFECT DIS, V206, P1920, DOI 10.1093/infdis/jis613; Murtagh M, 2014, HIV AIDS DIAGNOSTIC; Malan DR, 2008, JAIDS-J ACQ IMM DEF, V47, P161, DOI 10.1097/QAI.0b013e31815ace6a; Rabi SA, 2013, J CLIN INVEST, V123, P3848, DOI 10.1172/JCI67399; Rhee SY, 2010, ANTIMICROB AGENTS CH, V54, P4253, DOI 10.1128/AAC.00574-10; Rhee SY, 2015, PLOS MED IN PRESS; Rimsky L, 2012, JAIDS-J ACQ IMM DEF, V59, P39, DOI 10.1097/QAI.0b013e31823df4da; Ritchie AV, 2014, J CLIN MICROBIOL, V52, P3377, DOI 10.1128/JCM.00593-14; Rivadeneira E, 2014, INT WORKSH ANT DRUG; Rosenbloom DIS, 2012, NAT MED, V18, P1378, DOI 10.1038/nm.2892; Rowley CF, 2014, CLIN INFECT DIS, V58, P407, DOI 10.1093/cid/cit733; Scott L, 2015, J CLIN MICROBIOL, V53, P1616, DOI 10.1128/JCM.03325-14; Servais J, 2001, J CLIN MICROBIOL, V39, P454, DOI 10.1128/JCM.39.2.454-459.2001; Shelton JD, 2015, GLOBAL HLTH SCI PRAC; Siliciano JD, 2013, CURR OPIN VIROL, V3, P487, DOI 10.1016/j.coviro.2013.08.007; Stadeli KM, 2013, ANTIVIR THER, V18, P115, DOI 10.3851/IMP2437; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; The H. I. V. Causal Collaboration, 2015, CLIN INFECT DIS, DOI [10.1093/cid/ciu1167, DOI 10.1093/CID/CIU1167]; Vahey M, 1999, J CLIN MICROBIOL, V37, P2533, DOI 10.1128/JCM.37.8.2533-2537.1999; Van Zyl GU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067188; Weinheimer S, 2005, ANTIMICROB AGENTS CH, V49, P3816, DOI 10.1128/AAC.49.9.3816-3824.2005; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642; World Health Organization HIV/AIDS Programme, 2013, CONGUID UANT DRU; Zhang GQ, 2013, J CLIN MICROBIOL, V51, P3666, DOI 10.1128/JCM.01669-13; Zheng Y, 2014, CLIN INFECT DIS, V59, P888, DOI 10.1093/cid/ciu367	60	49	52	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145772	10.1371/journal.pone.0145772	http://dx.doi.org/10.1371/journal.pone.0145772			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717411	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500068
J	Rybalko, V; Hsieh, PL; Merscham-Banda, M; Suggs, LJ; Farrar, RP				Rybalko, Viktoriya; Hsieh, Pei-Ling; Merscham-Banda, Melissa; Suggs, Laura J.; Farrar, Roger P.			The Development of Macrophage-Mediated Cell Therapy to Improve Skeletal Muscle Function after Injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ISOMETRIC CONTRACTILE FUNCTION; GROWTH-FACTOR-I; TISSUE-REPAIR; TOURNIQUET ISCHEMIA; GENE-EXPRESSION; REGENERATION; MICE; MONOCYTES; RECOVERY	Skeletal muscle regeneration following acute injury is a multi-step process involving complex changes in tissue microenvironment. Macrophages (MPs) are one of the key cell types involved in orchestration and modulation of the repair process. Multiple studies highlight the essential role of MPs in the control of the myogenic program and inflammatory response during skeletal muscle regeneration. A variety of MP phenotypes have been identified and characterized in vitro as well as in vivo. As such, MPs hold great promise for cell-based therapies in the field of regenerative medicine. In this study we used bone-marrow derived in vitro LPS/IFN-y-induced M1 MPs to enhance functional muscle recovery after tourniquet-induced ischemia/reperfusion injury (TK-I/R). We detected a 15% improvement in specific tension and force normalized to mass after M1 (LPS/IFN-gamma) MP transplantation 24 hours post-reperfusion. Interestingly, we found that M0 bone marrow-derived unpolarized MPs significantly impaired muscle function highlighting the complexity of temporally coordinated skeletal muscle regenerative program. Furthermore, we show that delivery of M1 (LPS/IFN-gamma) MPs early in regeneration accelerates myofiber repair, decreases fibrotic tissue deposition and increases whole muscle IGF-I expression.	[Rybalko, Viktoriya; Hsieh, Pei-Ling; Merscham-Banda, Melissa; Farrar, Roger P.] Univ Texas Austin, Dept Kinesiol, Austin, TX 78712 USA; [Suggs, Laura J.] Univ Texas Austin, Cockrell Sch Engn, Biomed Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Farrar, RP (corresponding author), Univ Texas Austin, Dept Kinesiol, 1 Univ Stn D3700, Austin, TX 78712 USA.	rfarrar@austin.utexas.edu		/0000-0002-1419-8017	National Institutes of Health [R01EB015007]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB015007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by external non-Federal funding sources and the National Institutes of Health grant #R01EB015007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bencze M, 2012, MOL THER, V20, P2168, DOI 10.1038/mt.2012.189; Bi W, 2010, J MED CHEM, V53, P6763, DOI 10.1021/jm100529e; Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; Chazaud B, 2014, IMMUNOBIOLOGY, V219, P172, DOI 10.1016/j.imbio.2013.09.001; Chazaud B, 2009, EXERC SPORT SCI REV, V37, P18, DOI 10.1097/JES.0b013e318190ebdb; Chen XYK, 2011, J SURG RES, V170, pE65, DOI 10.1016/j.jss.2011.05.061; Cowled RA, 2008, J INVEST SURG, V21, P119, DOI 10.1080/08941930802046501; DANON D, 1989, P NATL ACAD SCI USA, V86, P2018, DOI 10.1073/pnas.86.6.2018; Danon D, 1998, J Wound Care, V7, P281; Deune EG, 1996, PLAST RECONSTR SURG, V98, P711, DOI 10.1097/00006534-199609001-00018; Dillon JP, 2006, ACTA ORTHOP, V77, P27, DOI 10.1080/17453670610045669; FISH JS, 1989, J SURG RES, V47, P365, DOI 10.1016/0022-4804(89)90149-2; FISH JS, 1993, J HAND SURG-AM, V18A, P210, DOI 10.1016/0363-5023(93)90348-7; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Hamer PW, 2002, J ANAT, V200, P69, DOI 10.1046/j.0021-8782.2001.00008.x; Hammers DW, 2008, J APPL PHYSIOL, V105, P1274, DOI 10.1152/japplphysiol.90418.2008; Hammers DW, 2012, BIOTECHNOL BIOENG, V109, P1051, DOI 10.1002/bit.24382; Hammers DW, 1985, J APPL PHYSIOL, V2015, DOI [10.1152/japplphysiol.00313.2014, DOI 10.1152/JAPPLPHYSI0L.00313.2014]; Hardin BJ, 2008, J APPL PHYSIOL, V104, P694, DOI 10.1152/japplphysiol.00898.2007; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Jetten N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068811; Keeling S, 2013, BIOL RES NURS, V15, P62, DOI 10.1177/1099800411414871; Koh TJ, 2005, AM J PHYSIOL-CELL PH, V289, pC217, DOI 10.1152/ajpcell.00555.2004; Lu HY, 2011, FASEB J, V25, P3344, DOI 10.1096/fj.10-178939; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; McEwen PKIM, 2004, NATO RTO MP HFM PROC, V109, P1; Merritt EK, 2010, TISSUE ENG PT A, V16, P1395, DOI [10.1089/ten.tea.2009.0226, 10.1089/ten.TEA.2009.0226]; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815; Novak ML, 2014, J PATHOL, V232, P344, DOI 10.1002/path.4301; Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512; Novak ML, 2011, J IMMUNOL, V187, P1448, DOI 10.4049/jimmunol.1004091; Ochoa O, 2007, AM J PHYSIOL-REG I, V293, pR651, DOI 10.1152/ajpregu.00069.2007; Patel H, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/121237; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; Perdiguero E, 2012, CELL CYCLE, V11, P877, DOI 10.4161/cc.11.5.19374; Perdiguero E, 2011, J CELL BIOL, V195, P307, DOI 10.1083/jcb.201104053; Sachdev U, 2013, J VASC SURG, V58, P460, DOI 10.1016/j.jvs.2012.11.071; Saclier M, 2013, FEBS J, V280, P4118, DOI 10.1111/febs.12166; Saclier M, 2013, STEM CELLS, V31, P384, DOI 10.1002/stem.1288; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Shen W, 2005, AM J PATHOL, V167, P1105, DOI 10.1016/S0002-9440(10)61199-6; Sisson TH, 2009, BLOOD, V114, P5052, DOI 10.1182/blood-2008-12-196212; Smith C, 2008, SPORTS MED, V38, P947, DOI 10.2165/00007256-200838110-00005; Summan M, 2006, AM J PHYSIOL-REG I, V290, pR1488, DOI 10.1152/ajpregu.00465.2005; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265; Tidball JG, 2011, COMPR PHYSIOL, V1, P2029, DOI 10.1002/cphy.c100092; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Tonkin J, 2015, MOL THER, V23, P1189, DOI 10.1038/mt.2015.66; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Vignaud A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/724914; Wang HZ, 2014, AM J PATHOL, V184, P1167, DOI 10.1016/j.ajpath.2013.12.020	59	44	45	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145550	10.1371/journal.pone.0145550	http://dx.doi.org/10.1371/journal.pone.0145550			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717325	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500044
J	Halley, YA; Oldeschulte, DL; Bhattarai, EK; Hill, J; Metz, RP; Johnson, CD; Presley, SM; Ruzicka, RE; Rollins, D; Peterson, MJ; Murphy, WJ; Seabury, CM				Halley, Yvette A.; Oldeschulte, David L.; Bhattarai, Eric K.; Hill, Joshua; Metz, Richard P.; Johnson, Charles D.; Presley, Steven M.; Ruzicka, Rebekah E.; Rollins, Dale; Peterson, Markus J.; Murphy, William J.; Seabury, Christopher M.			Northern Bobwhite (Colinus virginianus) Mitochondrial Population Genomics Reveals Structure, Divergence, and Evidence for Heteroplasmy	PLOS ONE			English	Article							ADAPTIVE PROTEIN EVOLUTION; OXYSPIRURA-PETROWI; QUAIL ABUNDANCE; PAIRWISE COMPARISONS; COMPLETE SEQUENCE; CONTROL REGION; DNA SEQUENCES; GENE FLOW; MUTATIONS; PHYLOGENY	Herein, we evaluated the concordance of population inferences and conclusions resulting from the analysis of short mitochondrial fragments (i.e., partial or complete D-Loop nucleotide sequences) versus complete mitogenome sequences for 53 bobwhites representing six ecoregions across TX and OK (USA). Median joining (MJ) haplotype networks demonstrated that analyses performed using small mitochondrial fragments were insufficient for estimating the true (i.e., complete) mitogenome haplotype structure, corresponding levels of divergence, and maternal population history of our samples. Notably, discordant demographic inferences were observed when mismatch distributions of partial (i.e., partial D-Loop) versus complete mitogenome sequences were compared, with the reduction in mitochondrial genomic information content observed to encourage spurious inferences in our samples. A probabilistic approach to variant prediction for the complete bobwhite mitogenomes revealed 344 segregating sites corresponding to 347 total mutations, including 49 putative nonsynonymous single nucleotide variants (SNVs) distributed across 12 protein coding genes. Evidence of gross heteroplasmy was observed for 13 bobwhites, with 10 of the 13 heteroplasmies involving one moderate to high frequency SNV. Haplotype network and phylogenetic analyses for the complete bobwhite mitogenome sequences revealed two divergent maternal lineages (d(XY) = 0.00731; F-ST = 0.849; P < 0.05), thereby supporting the potential for two putative subspecies. However, the diverged lineage (n = 103 variants) almost exclusively involved bobwhites geographically classified as Colinus virginianus texanus, which is discordant with the expectations of previous geographic subspecies designations. Tests of adaptive evolution for functional divergence (MKT), frequency distribution tests (D, F-S) and phylogenetic analyses (RAxML) provide no evidence for positive selection or hybridization with the sympatric scaled quail (Callipepla squamata) as being explanatory factors for the two bobwhite maternal lineages observed. Instead, our analyses support the supposition that two diverged maternal lineages have survived from pre-expansion to post-expansion population(s), with the segregation of some slightly deleterious non-synonymous mutations.	[Halley, Yvette A.; Oldeschulte, David L.; Bhattarai, Eric K.; Seabury, Christopher M.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Hill, Joshua; Metz, Richard P.; Johnson, Charles D.] Texas A&M AgriLife Res, Genom & Bioinformat Core, College Stn, TX USA; [Presley, Steven M.] Texas Tech Univ, Dept Environm Toxicol, Inst Environm & Human Hlth, Lubbock, TX 79409 USA; [Ruzicka, Rebekah E.] Texas A&M AgriLife Extens Serv, Dallas, TX USA; [Rollins, Dale] Rolling Plains Quail Res Ranch, Rotan, TX USA; [Peterson, Markus J.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Murphy, William J.] Texas A&M Univ, Coll Vet Med, Dept Vet Integrat Biosci, \, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Texas Tech University System; Texas Tech University; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; University of Texas System; University of Texas El Paso; Texas A&M University System; Texas A&M University College Station	Seabury, CM (corresponding author), Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA.	cseabury@cvm.tamu.edu	Peterson, Markus J/C-3303-2008	Peterson, Markus J/0000-0001-6145-0134; Presley, Steven/0000-0002-6652-2835; Metz, Richard/0000-0002-9876-3385; Johnson, Charles/0000-0003-3892-7082	Reversing the Quail Decline in Texas Initiative; Texas Parks and Wildlife Department; Texas A&M AgriLife Extension Service	Reversing the Quail Decline in Texas Initiative; Texas Parks and Wildlife Department; Texas A&M AgriLife Extension Service	Funding was provided through the Reversing the Quail Decline in Texas Initiative and the Upland Game Bird Stamp Fund based on a collaborative effort between Texas Parks and Wildlife Department and Texas A&M AgriLife Extension Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CR, 2000, J AGR URBAN ENTOMOL, V17, P43; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baumgartner F. M., 1944, JOUR WILDLIFE MANAGEMENT, V8, P112, DOI 10.2307/3796443; Berkman LK, 2013, CONSERV GENET, V14, P323, DOI 10.1007/s10592-013-0471-1; Brady S.J., 1998, Gibier Faune Sauvage, V15, P413; BRENNAN LA, 1991, WILDLIFE SOC B, V19, P544; Bridges AS, 2001, J WILDLIFE MANAGE, V65, P10, DOI 10.2307/3803270; Bruno A, 2015, J PARASITOL, V101, P364, DOI 10.1645/14-526.1; BUECHNER HK, 1950, J WILDLIFE MANAGE, V14, P363, DOI 10.2307/3797265; Chen B, 2011, HEREDITY, V106, P241, DOI 10.1038/hdy.2010.58; Church K. E., 1993, P NATL QUAIL S, V3, P44; Cibois A, 2014, MOL PHYLOGENET EVOL, V70, P442, DOI 10.1016/j.ympev.2013.08.019; del Hoyo J, 1994, HDB BIRDS WORLD, V2, P412; DEVOS T, 1995, WILDLIFE SOC B, V23, P267; Droege S, 1990, PERDIX, P2; Dudu A, 2014, GENET MOL BIOL, V37, P587, DOI 10.1590/S1415-47572014000400016; Dunham NR, 2014, J WILDLIFE DIS, V50, P711, DOI 10.7589/2013-11-313; Dunham NR, 2014, J WILDLIFE DIS, V50, P552, DOI 10.7589/2013-10-275; Egea R, 2008, NUCLEIC ACIDS RES, V36, pW157, DOI 10.1093/nar/gkn337; Evans KO, 2012, P NATL QUAIL S, V7, P244; Evans KO, 2006, GAMEBIRD, P121; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Eyre-Walker A, 2002, GENETICS, V162, P2017; Ferrando A, 2015, ANIM GENET, V46, P452, DOI 10.1111/age.12302; Fu YX, 1997, GENETICS, V147, P915; Garcia-Trejo EA, 2009, CONDOR, V111, P442, DOI 10.1525/cond.2009.080017; Gibb GC, 2007, MOL BIOL EVOL, V24, P269, DOI 10.1093/molbev/msl158; Goto H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r59; Guan X, 2009, ANIM GENET, V40, P134, DOI 10.1111/j.1365-2052.2008.01810.x; Guthery FS, 2000, NATL QUAIL S P, P198; Hailer F, 2015, MOL PHYLOGENET EVOL, V83, P40, DOI 10.1016/j.ympev.2014.11.005; Halley YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090240; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; He XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066324; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Heikkinen ME, 2015, ANIM GENET, V46, P485, DOI 10.1111/age.12319; Hernandez F, 2005, WILDLIFE SOC B, V33, P1071, DOI 10.2193/0091-7648(2005)33[1071:IOPODO]2.0.CO;2; Hernandez F, 2007, TEXAS QUAILS BOOK, P40; Hernandez F, 2013, WILDLIFE SOC B, V37, P177, DOI 10.1002/wsb.223; Horne JB, 2008, MOL PHYLOGENET EVOL, V49, P629, DOI 10.1016/j.ympev.2008.08.023; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Inoue K, 2014, HEREDITY, V112, P282, DOI 10.1038/hdy.2013.104; JOHNSGARD P A, 1970, Condor, V72, P85, DOI 10.2307/1366478; Kitulagodage M, 2011, CHEMOSPHERE, V83, P524, DOI 10.1016/j.chemosphere.2010.12.057; Kvist L, 2003, MOL BIOL EVOL, V20, P243, DOI 10.1093/molbev/msg025; Labuschagne C, 2014, GENE, V534, P113, DOI 10.1016/j.gene.2013.09.057; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133; Lopes IF, 2011, GENET MOL RES, V10, P1910, DOI 10.4238/vol10-3gmr1217; Lusk JJ, 2002, J WILDLIFE MANAGE, V66, P1040, DOI 10.2307/3802936; Malago Wilson Jr, 2002, BMC Biotechnol, V2, P19, DOI 10.1186/1472-6750-2-19; MARJORAM P, 1994, GENETICS, V136, P673; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Meikejohn KA, 2014, MOL PHYLOGENET EVOL, V78, P314, DOI 10.1016/j.ympev.2014.06.003; Mindell DP, 1998, MOL BIOL EVOL, V15, P1568, DOI 10.1093/oxfordjournals.molbev.a025884; Mueller JM, 1999, J WILDLIFE MANAGE, V63, P1291, DOI 10.2307/3802847; Mundy NI, 1996, J HERED, V87, P21, DOI 10.1093/oxfordjournals.jhered.a022948; Nei M., 1987, MOL EVOLUTIONARY GEN; Nishibori M, 2001, ANIM GENET, V32, P380, DOI 10.1046/j.1365-2052.2001.00795.x; Nishibori Masahide, 2003, Animal Science Journal, V74, P437, DOI 10.1046/j.1344-3941.2003.00136.x; Ottinger MA, 2005, DOMEST ANIM ENDOCRIN, V29, P411, DOI 10.1016/j.domaniend.2005.02.038; Pereira SL, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-17; Peterson MJ, 2001, J WILDLIFE MANAGE, V65, P828, DOI 10.2307/3803032; Peterson MJ, 2002, P NATL QUAIL S, V5, P35; Peterson MJ, 2000, P NATL QUAIL S, V4, P85, DOI DOI 10.2307/3803032; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Reyna KS, 2012, POULTRY SCI, V91, P41, DOI 10.3382/ps.2011-01676; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Royston SR, 2014, MITOCHONDR DNA, V26, P1; Sammler S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-35; Sauer JR, 2005, J WILDLIFE MANAGE, V69, P1321, DOI 10.2193/0022-541X(2005)69[1321:UTNABB]2.0.CO;2; Sauer JR, 2012, N AM BREEDING BIRD S; Scott JL, 2013, WILDLIFE SOC B, V37, P168, DOI 10.1002/wsb.239; SHUPE TE, 1990, WILSON BULL, V102, P352; Slack KE, 2003, GENE, V302, P43, DOI 10.1016/S0378111902010533; SLATKIN M, 1991, GENETICS, V129, P555; Smigrodzki RM, 2005, REJUV RES, V8, P172, DOI 10.1089/rej.2005.8.172; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TAJIMA F, 1993, GENETICS, V135, P599; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terhune TM, 2010, ECOL APPL, V20, P1040, DOI 10.1890/09-1106.1; Vinas J, 2004, MOL PHYLOGENET EVOL, V33, P32, DOI 10.1016/j.ympev.2004.04.009; Wang N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064312; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weckstein JD, 2002, CONDOR, V104, P432, DOI 10.1650/0010-5422(2002)104[0432:HAPSWA]2.0.CO;2; Williams CK, 2004, J WILDLIFE MANAGE, V68, P94, DOI 10.2193/0022-541X(2004)068[0094:WSAAHI]2.0.CO;2; Williams CK, 2001, WILDLIFE SOC B, V32, P861; Williford D, 2014, J WILDLIFE MANAGE, V78, P914, DOI 10.1002/jwmg.733; Xiang LX, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-233	96	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144913	10.1371/journal.pone.0144913	http://dx.doi.org/10.1371/journal.pone.0144913			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713762	Green Submitted, gold, Green Published			2022-12-27	WOS:000367481900023
J	Munoz-Rivas, N; Mendez-Bailon, M; Hernandez-Barrera, V; de Miguel-Yanes, JM; Jimenez-Garcia, R; Esteban-Hernandez, J; Jimenez-Trujillo, I; Alvaro-Meca, A; Carrasco-Garrido, P; de Miguel-Diez, J; Lopez-de-Andres, A				Munoz-Rivas, Nuria; Mendez-Bailon, Manuel; Hernandez-Barrera, Valentin; Ma de Miguel-Yanes, Jose; Jimenez-Garcia, Rodrigo; Esteban-Hernandez, Jesus; Jimenez-Trujillo, Isabel; Alvaro-Meca, Alejandro; Carrasco-Garrido, Pilar; de Miguel-Diez, Javier; Lopez-de-Andres, Ana			Time Trends in Ischemic Stroke among Type 2 Diabetic and Non-Diabetic Patients: Analysis of the Spanish National Hospital Discharge Data (2003-2012)	PLOS ONE			English	Article							RISK-FACTORS; CASE-FATALITY; CEREBROVASCULAR-DISEASE; SEX-DIFFERENCES; EPIDEMIOLOGY; MELLITUS; MORTALITY; SPAIN; METAANALYSIS; WOMEN	Background Type 2 Diabetes (T2DM) is the most rapidly increasing risk factor for ischemic stroke. We aimed to compare trends in outcomes for ischemic stroke in people with or without diabetes in Spain between 2003 and 2012. Methods We selected all patients hospitalized for ischemic stroke using national hospital discharge data. We evaluated annual incident rates stratified by T2DM status. We analyzed trends in the use of diagnostic and therapeutic procedures, patient comorbidities, and in-hospital outcomes. We calculated in-hospital mortality (IHM), length of hospital stay (LOHS) and readmission rate in one month after discharge. Time trend on the incidence of hospitalization was estimated fitting Poisson regression models by sex and diabetes variables. In-hospital mortality was analyzed using logistic regression models separate for men and women. LOHS were compared with ANOVA or Kruskal-Wallis when necessary. Results We identified a total of 423,475 discharges of patients (221,418 men and 202,057 women) admitted with ischemic stroke as primary diagnosis. Patients with T2DM accounted for 30.9% of total. The estimated incidence rates of discharges increased significantly in all groups. The incidence of hospitalization due to stroke (with ICD9 codes for stroke as main diagnosis at discharge) was higher among those with than those without diabetes in all the years studied. T2DM was positively associated with ischemic stroke with an adjusted incidence rate ratio (IRR) of 2.27 (95% CI 2.24-2.29) for men and 2.15 (95% CI 2.13-2.17) for women. Over the 10 year period LOHS decreased significantly in men and women with and without diabetes. Readmission rate remained stable in diabetic and non diabetic men (around 5%) while slightly increased in women with and without diabetes. We observed a significant increase in the use of fibrinolysis from 2002-2013. IHM was positively associated with older age in all groups, with Charlson Comorbidity Index > 3 and atrial fibrillation as risk factors. The IHM did not change significantly over time among T2DM men and women ranging from 9.25% to 10.56% and from 13.21% to 14.86%, respectively; neither did among non-diabetic women. However, in men without T2DM IHM decreased significantly over time. Diabetes was associated to higher IHM only in women (OR 1.07; 95% CI, 1.05-1.11). Conclusions Our national data show that incidence rate of ischemic stroke hospitalization increased significantly during the period of study (2003-2012). People with T2DM have more than double the risk of ischemic stroke after adjusting for other risk factors. Women with T2DM had poorer outcomes-IHM and readmission rates-than diabetic men. Diabetes was an independent factor for IHM only in women.	[Munoz-Rivas, Nuria] Hosp Univ Infanta Leonor, Dept Med, Madrid, Spain; [Mendez-Bailon, Manuel] Hosp Clin San Carlos, Dept Med, Madrid, Comunidad De Ma, Spain; [Hernandez-Barrera, Valentin; Jimenez-Garcia, Rodrigo; Esteban-Hernandez, Jesus; Jimenez-Trujillo, Isabel; Alvaro-Meca, Alejandro; Carrasco-Garrido, Pilar; Lopez-de-Andres, Ana] Rey Juan Carlos Univ, Fac Hlth Sci, Prevent Med & Publ Hlth Teaching & Res Unit, Alcorcon, Comunidad De Ma, Spain; [Ma de Miguel-Yanes, Jose] Hosp Gregorio Maranon, Dept Med, Comunidad De Madrid, Spain; [de Miguel-Diez, Javier] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Dept Pneumol, Madrid, Spain	Hospital Universitario Infanta Leonor; Hospital Clinico San Carlos; Universidad Rey Juan Carlos; General University Gregorio Maranon Hospital; Complutense University of Madrid; General University Gregorio Maranon Hospital	Munoz-Rivas, N (corresponding author), Hosp Univ Infanta Leonor, Dept Med, Madrid, Spain.	nmunozr@salud.madrid.org	Jimenez-Trujillo, Isabel/AAP-7746-2021; Lopez-de-Andres, Ana/D-4498-2019; Jimenez-Garcia, Rodrigo/D-4953-2019; Lopez-de-Andres, Ana/AAD-8703-2019; Esteban-Hernandez, Jesus/B-6816-2009; Esteban-Hernández, Jesús/ABG-4660-2020	Jimenez-Trujillo, Isabel/0000-0002-9394-6799; Lopez-de-Andres, Ana/0000-0001-5551-5181; Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; Lopez-de-Andres, Ana/0000-0001-5551-5181; Esteban-Hernández, Jesús/0000-0002-6013-1091; Hernandez-Barrera, Valentin/0000-0001-5790-1959; de Miguel-Yanes, Jose M./0000-0003-2802-033X; de Miguel-Diez, Javier/0000-0003-4543-573X; Alvaro-Meca, Alejandro/0000-0003-1315-4386	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III) [PI13/00118]; Grupo de Excelencia Investigadora URJC-Banco Santander [30VCPIGI03]	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III); Grupo de Excelencia Investigadora URJC-Banco Santander	This study forms part of research funded by the FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, grant no. PI13/00118, Instituto de Salud Carlos III) and partly funded by the Grupo de Excelencia Investigadora URJC-Banco Santander No30VCPIGI03: Investigacion traslacional en el proceso de salud - enfermedad (ITPSE). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; This study forms part of research funded by the FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, grant no. PI13/00118, Instituto de Salud Carlos III) and by the Grupo de Excelencia Investigadora URJC-Banco Santander No30VCPIGI03: Investigacion traslacional en el proceso de salud-enfermedad (ITPSE).	Aleman JA, 2011, MED CLIN-BARCELONA, V136, P329, DOI 10.1016/j.medcli.2010.04.035; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; [Anonymous], SERV SOC LGUALD ENC; Arboix A, 2014, CLIN NEUROL NEUROSUR, V127, P19, DOI 10.1016/j.clineuro.2014.09.024; Banerjee C, 2012, STROKE, V43, P1212, DOI 10.1161/STROKEAHA.111.641381; Basterra-Gortari FJ, 2007, MED CLIN-BARCELONA, V129, P405; Bejot Y, 2007, J NEUROL SCI, V262, P85, DOI 10.1016/j.jns.2007.06.025; Brea A, 2013, CLIN INVEST ARTERIOS, V25, P211, DOI 10.1016/j.arteri.2013.10.006; Cayuela A, ANALISIS TENDENCIAS; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Diaz-Guzman J, 2008, REV NEUROLOGIA, V47, P617, DOI 10.33588/rn.4712.2008576; Diaz-Guzman J, 2012, CEREBROVASC DIS, V34, P272, DOI 10.1159/000342652; Eriksson M, 2012, CEREBROVASC DIS, V34, P153, DOI 10.1159/000339763; EVANS RW, 1994, METABOLISM, V43, P1196, DOI 10.1016/0026-0495(94)90065-5; Feigin VL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134609; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Giampaoli S, 2015, EUR J PREV CARDIOL, V22, P9, DOI 10.1177/2047487315589011; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Grysiewicz RA, 2008, NEUROL CLIN, V26, P871, DOI 10.1016/j.ncl.2008.07.003; Howard BV, 1998, DIABETES CARE, V21, P1258, DOI 10.2337/diacare.21.8.1258; Icks A, 2012, DIABETES CARE, V35, P1868, DOI 10.2337/dc11-2159; Idris I, 2006, INT J CLIN PRACT, V60, P48, DOI 10.1111/j.1368-5031.2006.00682.x; Instituto Nacional de Estadistica, 2004, DEF SEG CAUS MUERT 2; Caballero PEJ, 2013, J STROKE CEREBROVASC, V22, pE214, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.014; Khalessi AA, 2011, JACC-CARDIOVASC INTE, V4, P261, DOI 10.1016/j.jcin.2010.11.015; Lindley RI, 2015, STROKE, V46, P746, DOI 10.1161/STROKEAHA.114.006573; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lopez-De-Andres A, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-3; Luitse MJA, 2012, LANCET NEUROL, V11, P261, DOI 10.1016/S1474-4422(12)70005-4; Mansfield MW, 1996, ARTERIOSCL THROM VAS, V16, P160, DOI 10.1161/01.ATV.16.1.160; Marini C, 2003, STROKE, V34, pE13, DOI 10.1161/01.STR.0000065429.56621.6E; Marrugat J, 2007, REV ESP CARDIOL, V60, P573, DOI 10.1157/13107113; Nwaneri C., 2013, BRIT J DIABETES VASC, V13, P192, DOI [10.1177/1474651413495703, DOI 10.1177/1474651413495703]; Palacio S, 2014, STROKE, V45, P2689, DOI 10.1161/STROKEAHA.114.005018; Peters SAE, 2014, LANCET, V383, P1973, DOI 10.1016/S0140-6736(14)60040-4; Ramalle-Gomara E, 2013, J STROKE CEREBROVASC, V22, pE441, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.039; Rodriguez T, 2006, HEART, V92, P453, DOI 10.1136/hrt.2004.059295; Sandercock P, 2013, LANCET NEUROL, V12, P768, DOI 10.1016/S1474-4422(13)70130-3; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Shah AD, 2015, LANCET DIABETES ENDO, V3, P105, DOI 10.1016/S2213-8587(14)70219-0; Soriguer F, 2012, DIABETOLOGIA, V55, P88, DOI 10.1007/s00125-011-2336-9; Steinberg HO, 2000, CIRCULATION, V101, P2040, DOI 10.1161/01.CIR.101.17.2040; Stevens R, 2004, DIABETES CARE, V27, P201, DOI 10.2337/diacare.27.1.201; Strbian D, 2011, NEUROLOGY, V77, P341, DOI 10.1212/WNL.0b013e3182267b8c; Garcia JT, 2010, AV DIABETOL, V26, P397; Thomsen Reimar Wernich, 2012, Clin Epidemiol, V4, P43, DOI 10.2147/CLEP.S30083; Vasiliadis AV, 2014, NEUROL NEUROCHIR POL, V48, P449, DOI 10.1016/j.pjnns.2014.11.001; Vega T, 2009, J STROKE CEREBROVASC, V18, P11, DOI 10.1016/j.jstrokecerebrovasdis.2008.06.010; Wannamethee SG, 2012, DIABETOLOGIA, V55, P80, DOI 10.1007/s00125-011-2284-4; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2; Whiteley WN, 2012, STROKE, V43, P2904, DOI 10.1161/STROKEAHA.112.665331; Zhang PL, 2015, EUR REV MED PHARMACO, V19, P1001	52	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145535	10.1371/journal.pone.0145535	http://dx.doi.org/10.1371/journal.pone.0145535			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713435	gold, Green Published, Green Submitted			2022-12-27	WOS:000367481900053
J	Salam, MT; Lin, PC; Eckel, SP; Gauderman, WJ; Gilliland, FD				Salam, Muhammad T.; Lin, Pi-Chu; Eckel, Sandrah P.; Gauderman, W. James; Gilliland, Frank D.			Inducible Nitric Oxide Synthase Promoter Haplotypes and Residential Traffic-Related Air Pollution Jointly Influence Exhaled Nitric Oxide Level in Children	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; RESPIRATORY SYMPTOMS; CHILDHOOD ASTHMA; HEALTH; SCHOOLCHILDREN; INFLAMMATION; SUSCEPTIBILITY; EXPOSURES; INFERENCE; MARKERS	Background Exhaled nitric oxide (FeNO), a biomarker of airway inflammation, predicts asthma risk in children. We previously found that the promoter haplotypes in inducible nitric oxide synthase (NOS2) and exposure to residential traffic independently influence FeNO level. Because NOS2 is inducible by environmental exposures such as traffic-related exposure, we tested the hypothesis that common NOS2 promoter haplotypes modulate the relationship between residential traffic-related exposure and FeNO level in children. Methods In a cross-sectional population-based study, subjects (N = 2,457; 7-11 year-old) were Hispanic and non-Hispanic white children who participated in the Southern California Children's Health Study and had FeNO measurements. For residential traffic, lengths of local roads within circular buffers (50m, 100m and 200m radii around homes) around the subjects' homes were estimated using geographic information system (GIS) methods. We interrogated the two most common NOS2 promoter haplotypes that were found to affect FeNO level. Results The relationship between local road lengths within 100m and 200m circular buffers and FeNO level varied significantly by one of the NOS2 promoter haplotypes (P-values for interaction between road length and NOS2 promoter haplotype = 0.02 and 0.03, respectively). In children who had <= 250m of local road lengths within 100m buffer around their homes, those with two copies of the haplotype had significantly lower FeNO (adjusted geometric mean = 11.74ppb; 95% confidence intervals (CI): 9.99 to 13.80) than those with no copies (adjusted geometric mean = 15.28ppb; 95% CI: 14.04 to 16.63) with statistically significant trend of lower FeNO level with increasing number of haplotype copy (P-value for trend = 0.002). In contrast, among children who had >250m of local road lengths within 100m buffer, FeNO level did not significantly differ by the haplotype copy-number (P-value for trend = 0.34). Similar interactive effects of this haplotype and local road lengths within 200m buffer on FeNO were also observed. Conclusions Higher exposure from residential traffic nullifies the protective effect of one common NOS2 promoter haplotype on FeNO level. Regulation of traffic-related pollution may protect children's respiratory health.	[Salam, Muhammad T.; Eckel, Sandrah P.; Gauderman, W. James; Gilliland, Frank D.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Salam, Muhammad T.] Kern Med Ctr, Dept Psychiat, Bakersfield, CA USA; [Lin, Pi-Chu] Siemens HealthCare Diagnost, Mol Tech Operat, East Walpole, MA USA	University of Southern California; Siemens AG	Salam, MT (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	msalam@usc.edu			National Heart, Lung and Blood Institute [5R01HL61768, 5R01HL76647]; Southern California Environmental Health Sciences Center - National Institute of Environmental Health Sciences [5P30ES007048]; Children's Environmental Health Center - National Institute of Environmental Health Sciences [5P01ES009581, R826708-01, RD831861-01]; United States Environmental Protection Agency; National Institute of Environmental Health Sciences [5P01ES011627]; Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061768, R01HL076647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048, P01ES009581] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Southern California Environmental Health Sciences Center - National Institute of Environmental Health Sciences; Children's Environmental Health Center - National Institute of Environmental Health Sciences; United States Environmental Protection Agency(United States Environmental Protection Agency); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Heart, Lung and Blood Institute (grants 5R01HL61768 and 5R01HL76647; URL http://www.nhlbi.nih.gov/); the Southern California Environmental Health Sciences Center (grant 5P30ES007048) funded by the National Institute of Environmental Health Sciences; the Children's Environmental Health Center (grants 5P01ES009581, R826708-01, and RD831861-01) funded by the National Institute of Environmental Health Sciences (URL: http://www.niehs.nih.gov/) and the United States Environmental Protection Agency (URL: http://www.epa.gov/); the National Institute of Environmental Health Sciences (grants 5P01ES011627; URL: http://www.niehs.nih.gov); and the Hastings Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the authors [PL] was a graduate student at University of Southern California when she was involved in data analysis and manuscript preparation. She is now employed by Siemens HealthCare Diagnostics, but the company did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 1999, AM J RESP CRIT CARE, V160, P2104, DOI DOI 10.1164/AJRCCM.160.6.ATS8-99; Baldauf R, 2009, AIR QUAL ATMOS HLTH, V2, P1, DOI 10.1007/s11869-009-0028-0; Barath S, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-36; Bastain TM, 2011, EUR RESPIR J, V37, P523, DOI 10.1183/09031936.00021210; Berhane K, 2011, EUR RESPIR J, V37, P1029, DOI 10.1183/09031936.00081410; Dales R, 2008, ENVIRON HEALTH PERSP, V116, P1423, DOI 10.1289/ehp.10943; Eckel SP, 2011, ENVIRON HEALTH PERSP, V119, P1472, DOI 10.1289/ehp.1103516; Falush D, 2003, GENETICS, V164, P1567; Fleming L, 2013, AM J RESP CRIT CARE, V188, P400, DOI 10.1164/rccm.201212-2156LE; Gasser M, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-30; Holguin F, 2007, AM J RESP CRIT CARE, V176, P1236, DOI 10.1164/rccm.200611-1616OC; Islam T, 2010, THORAX, V65, P139, DOI 10.1136/thx.2009.114355; Lane C, 2004, THORAX, V59, P757, DOI 10.1136/thx.2003.014894; Linn WS, 2009, J EXPO SCI ENV EPID, V19, P674, DOI 10.1038/jes.2008.64; Linn WS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-28; Liu L, 2009, ENVIRON HEALTH PERSP, V117, P668, DOI 10.1289/ehp11813; Malinovschi A, 2013, J ALLERGY CLIN IMMUN, V132, P821, DOI 10.1016/j.jaci.2013.06.007; Manzo ND, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-43; McConnell R, 2006, ENVIRON HEALTH PERSP, V114, P766, DOI 10.1289/ehp.8594; Nordling E, 2008, EPIDEMIOLOGY, V19, P401, DOI 10.1097/EDE.0b013e31816a1ce3; Olin AC, 2010, AM J RESP CRIT CARE, V181, P324, DOI 10.1164/rccm.200907-1079OC; Patelis A, 2012, J ALLERGY CLIN IMMUN, V130, P397, DOI 10.1016/j.jaci.2012.03.046; Pritchard JK, 2000, GENETICS, V155, P945; Ricciardolo FLM, 2006, EUR J PHARMACOL, V533, P240, DOI 10.1016/j.ejphar.2005.12.057; Saito J, 2004, J ALLERGY CLIN IMMUN, V114, P512, DOI 10.1016/j.jaci.2004.05.033; Salam MT, 2011, ALLERGY, V66, P412, DOI 10.1111/j.1398-9995.2010.02492.x; Salam MT, 2007, AM J RESP CRIT CARE, V176, P1192, DOI 10.1164/rccm.200704-561OC; Scott M, 2010, THORAX, V65, P258, DOI 10.1136/thx.2009.125443; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Sheffield M, 2006, PEDIATRICS, V118, P1056, DOI 10.1542/peds.2006-0195; Shtir CJ, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-71; Singer F, 2013, ALLERGY, V68, P531, DOI 10.1111/all.12127; Steerenberg PA, 2001, ARCH ENVIRON HEALTH, V56, P167, DOI 10.1080/00039890109604069; Strunk RC, 2003, J ALLERGY CLIN IMMUN, V112, P883, DOI 10.1016/j.jaci.2003.08.014; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, pS9, DOI 10.1016/j.jaci.2011.12.979	35	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145363	10.1371/journal.pone.0145363	http://dx.doi.org/10.1371/journal.pone.0145363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714306	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900036
J	Cao, J; Yang, JC; Ramachandran, V; Arumugam, T; Deng, DF; Li, ZS; Xu, LM; Logsdon, CD				Cao, Jia; Yang, Jiachun; Ramachandran, Vijaya; Arumugam, Thiruvengadam; Deng, Defeng; Li, Zhaoshen; Xu, Leiming; Logsdon, Craig D.			TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo	PLOS ONE			English	Article							CHIMERIC L6 ANTIBODY; MULTIDRUG-RESISTANCE; MESENCHYMAL TRANSITION; DRUG-RESISTANCE; CELLS; EXPRESSION; SURVIVAL; RECEPTOR; BREAST; RADIOIMMUNOTHERAPY	Background TM4SF1 is overexpressed in pancreatic ductal adenocarcinoma (PDAC) and affects the development of this cancer. Also, multidrug resistance (MDR) is generally associated with tumor chemoresistance in pancreatic cancer. However, the correlation between TM4SF1 and MDR remains unknown. This research aims to investigate the effect of TM4SF1 on gemcitabine resistance in PDAC and explore the possible molecular mechanism between TM4SF1 and MDR. Methods The expression of TM4SF1 was evaluated in pancreatic cancer cell lines and human pancreatic duct epithelial (HPDE) cell lines by quantitative RT-PCR. TM4SF1 siRNA transfection was carried out using Hiperfect transfection reagent to knock down TM4SF1. The transcripts were analyzed by quantitative RT-PCR, RT-PCR and western blotting for further study. The cell proliferation and apoptosis were obtained to investigate the sensitivity to gemcitabine of pancreatic cancer cells after silencing TM4SF1 in vitro. We demonstrated that cell signaling of TM4SF1 mediated chemoresistance in cancer cells by assessing the expression of multidrug resistance (MDR) genes using quantitative RT-PCR. In vivo, we used orthotopic pancreatic tumor models to investigate the effect of proliferation after silencing TM4SF1 by a lentivirus-mediated shRNA in MIA PaCa-2 cell lines. Results The mRNA expression of TM4SF1 was higher in seven pancreatic cancer cell lines than in HPDE cell lines. In three gemcitabine-sensitive cell lines (L3.6pl, BxPC-3, SU86.86), the expression of TM4SF1 was lower than that in four gemcitabine-resistant cell lines (MIA PaCa-2, PANC-1, Hs766T, AsPC-1). We evaluated that TM4SF1 was a putative target for gemcitabine resistance in pancreatic cancer cells. Using AsPC-1, MIA PaCa-2 and PANC-we investigated that TM4SF1 silencing affected cell proliferation and increased the percentages of cell apoptosis mediated by treatment with gemcitabine compared with cells which were treated with negative control. This resistance was associated with the expression of multidrug resistance genes including ABCB1 and ABCC1. In vivo, silencing of TM4SF1 in MIA PaCa-2 cell lines increased the effectiveness of gemcitabine-based treatment in orthotopic pancreatic tumor models evaluated using noninvasive bioluminescent imaging. Conclusion These findings suggest that TM4SF1 is a surface membrane antigen that is highly expressed in pancreatic cancer cells and increases the chemoresistance to gemcitabine. Thus, TM4SF1 may be a promising target to overcome the chemoresistance of pancreatic cancer.	[Cao, Jia; Yang, Jiachun; Xu, Leiming] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gastroenterol, Shanghai 200030, Peoples R China; [Ramachandran, Vijaya; Arumugam, Thiruvengadam; Deng, Defeng; Logsdon, Craig D.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Li, Zhaoshen] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center; Naval Medical University	Xu, LM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gastroenterol, Shanghai 200030, Peoples R China.	leiming.xu@aliyun.com; clogsdon@mdanderson.org			Cancer Center Support Core grant [CA016672]; Lockton Endowment; National Natural Science Foundation of China [81301826];  [NIH-DK05207]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Cancer Center Support Core grant; Lockton Endowment; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by NIH-DK05207 (to C.D. Logsdon), Cancer Center Support Core grant CA016672 (to UT M.D. Anderson Cancer Center), the Lockton Endowment (to C.D. Logsdon), and National Natural Science Foundation of China, 81301826 (to Jia Cao).	Allioli N, 2011, PROSTATE, V71, P1239, DOI 10.1002/pros.21340; Arumugam T, 2005, CLIN CANCER RES, V11, P5356, DOI 10.1158/1078-0432.CCR-05-0092; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Brenner H, 2007, J CLIN ONCOL, V25, P3274, DOI 10.1200/JCO.2007.11.3431; Cao J, 2009, PANCREAS, V38, P986; Cavalcante LD, 2014, EUR J PHARMACOL, V741, P8, DOI [10.1010/j.ejphar.2014.07.041, 10.1016/j.ejphar.2014.07.041]; DeNardo SJ, 1997, P NATL ACAD SCI USA, V94, P4000, DOI 10.1073/pnas.94.8.4000; GOODMAN GE, 1990, J CLIN ONCOL, V8, P1083, DOI 10.1200/JCO.1990.8.6.1083; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; HELLSTROM I, 1986, CANCER RES, V46, P3917; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Jager W, 2009, INT J CLIN PHARM TH, V47, P46; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jones SM, 2006, NAT REV CANCER, V6, P175, DOI 10.1038/nrc1817; Kim H, 2012, CANCER LETT, V314, P198, DOI 10.1016/j.canlet.2011.09.030; Kim H, 2010, BBA-MOL CELL RES, V1803, P975, DOI 10.1016/j.bbamcr.2010.04.001; Konig J, 2005, INT J CANCER, V115, P359, DOI 10.1002/ijc.20831; Langley RR, 2004, CANCER RES, V64, P3727, DOI 10.1158/0008-5472.CAN-03-3863; Lee MS, 2012, BBA-MOL CELL RES, V1823, P514, DOI 10.1016/j.bbamcr.2011.11.017; Lee SA, 2008, J CLIN INVEST, V118, P1354, DOI 10.1172/JCI33768; Lekishvili T, 2008, J CELL SCI, V121, P685, DOI 10.1242/jcs.020347; Lin CI, 2014, ANGIOGENESIS, V17, P897, DOI 10.1007/s10456-014-9437-2; Logsdon CD, 2003, CANCER RES, V63, P2649; Lu Z, 2000, PANCREAS, V21, P240, DOI 10.1097/00006676-200010000-00004; Nath S, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.16; O'Driscoll L, 2007, ANTICANCER RES, V27, P2115; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Ramachandran V, 2007, CANCER RES, V67, P2666, DOI 10.1158/0008-5472.CAN-06-3362; RICHMAN CM, 1995, CANCER RES, V55, pS5916; Shi S, 2012, CANCER LETT, V317, P127, DOI 10.1016/j.canlet.2011.11.029; Shih SC, 2009, CANCER RES, V69, P3272, DOI 10.1158/0008-5472.CAN-08-4886; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Visintin A, 2015, MOL CANCER THER, V14, P1868, DOI 10.1158/1535-7163.MCT-15-0188; Wright MD, 2000, PROTEIN SCI, V9, P1594, DOI 10.1110/ps.9.8.1594; Xiao Z, 2012, ANAT REC, V295, P2122, DOI 10.1002/ar.22552; Xu LJ, 2014, INT J ONCOL, V44, P459, DOI 10.3892/ijo.2013.2189; Zhang W, 2013, INT J ONCOL, V42, P1189, DOI 10.3892/ijo.2013.1839; Yu-Pei Z, 2007, CHINESE MED J-PEKING, V120, P1743, DOI 10.1097/00029330-200710020-00003	38	16	20	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144969	10.1371/journal.pone.0144969	http://dx.doi.org/10.1371/journal.pone.0144969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709920	Green Published, Green Submitted, gold			2022-12-27	WOS:000367451400016
J	Hernandez-Avila, I; Cambon-Bonavita, MA; Pradillon, F				Hernandez-Avila, Ivan; Cambon-Bonavita, Marie-Anne; Pradillon, Florence			Morphology of First Zoeal Stage of Four Genera of Alvinocaridid Shrimps from Hydrothermal Vents and Cold Seeps: Implications for Ecology, Larval Biology and Phylogeny	PLOS ONE			English	Article							REPRODUCTIVE-BIOLOGY; MIROCARIS-FORTUNATA; DECAPODA; CARIDEA; CRUSTACEA; DISPERSAL; PINNOTHERIDAE; ACCURACY; WILLIAMS; ANIMALS	Alvinocaridid shrimps are endemic species inhabiting hydrothermal vents and/or cold seeps. Although indirect evidences (genetic and lipid markers) suggest that their larval stages disperse widely and support large scale connectivity, larval life and mechanisms underlying dispersal are unknown in alvinocaridids. Here we provide for the first time detailed descriptions of the first larval stage (zoea I) of four alvinocaridid species: Rimicaris exoculata and Mirocaris fortunata from the Mid-Atlantic Ridge, Alvinocaris muricola from the Congo Basin and Nautilocaris saintlaurentae from the Western Pacific. The larvae were obtained from onboard hatching of brooding females (either at atmospheric pressure or at habitat pressure in hyperbaric chambers) and from the water column near adult habitats, sampled with plankton pumps or sediment traps. Major characteristics of the alvinocaridid larvae include undeveloped mandible and almost complete absence of setation in the inner margin of the mouth parts and maxillipeds. Although the larvae are very similar between the four species studied, some morphological features could be used for species identification. In addition, undeveloped mouthparts and the large amount of lipid reserves strongly support the occurrence of primary lecithotrophy in the early stage of alvinocaridids. Although lecithotrophy in decapod crustaceans is usually associated with abbreviated larval development, as a mechanism of larval retention, morphological and physiological evidences suggest the occurrence of an extended and lecithotrophic larval stage in the Alvinocarididae. These traits permit the colonization of widely dispersed and fragmented environments of hydrothermal vents and cold seeps. Distribution of larval traits along the phylogenetic reconstruction of the Alvinocarididae and related families suggest that lecithotrophy/planktotrophy and extended/abbreviated development have evolved independently along related families in all potential combinations. However, the Alvinocarididae is the only taxa with a combination of lecithotrophy and extended larval development.	[Hernandez-Avila, Ivan; Pradillon, Florence] IFREMER, Lab Environm Profond, CS 10070, F-29280 Plouzane, France; [Hernandez-Avila, Ivan] Univ Oriente, Dept Ciencias, Unidad Cursos Basicos, Margarita Isl, Venezuela; [Cambon-Bonavita, Marie-Anne] IFREMER, CNRS, Lab Microbiol Environm Extremes, UMR6197,UBO, F-29280 Plouzane, France	Ifremer; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Hernandez-Avila, I (corresponding author), IFREMER, Lab Environm Profond, CS 10070, F-29280 Plouzane, France.	ivan.hernandez@ifremer.fr; florence.pradillon@ifremer.fr	Avila, Ivan IHA Hernandez/F-8715-2014; Pradillon, Florence/AAM-2992-2020	Pradillon, Florence/0000-0002-6473-6290; Cambon-Bonavita, Marie-Anne/0000-0002-4076-0472; Hernandez, Ivan/0000-0002-6722-5226	European Union Seventh Framework Programme (FP7) under the MIDAS project [603418]; French Agence Nationale de la Recherche (ANR) [CARN 018-01 EDROME, 11 BS 56 030 02]; European Community [FP6-GOCE-CT-2003-505342]; ANR grant [BALIST ANR-08-BLAN-0252]; University Pierre et Marie Curie, under the BQR UPMC; Eramet company (Futuna cruise); Technip company (Futuna cruise); Fundacion Gran Mariscal de Ayacucho [E-223-85-2012-2]; Campus France [796045K]	European Union Seventh Framework Programme (FP7) under the MIDAS project; French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); European Community(European Commission); ANR grant(French National Research Agency (ANR)); University Pierre et Marie Curie, under the BQR UPMC; Eramet company (Futuna cruise); Technip company (Futuna cruise); Fundacion Gran Mariscal de Ayacucho; Campus France	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under the MIDAS project, grant agreement no 603418, and from the French Agence Nationale de la Recherche (ANR) under the CARNOT Programme, grant CARN 018-01 EDROME, and under the CONGOLOBE project, grant no 11 BS 56 030 02. Pressure equipments used in this study were funded by a European Community program EXOCET/D (FP6-GOCE-CT-2003-505342), by an ANR grant, BALIST ANR-08-BLAN-0252, and by the University Pierre et Marie Curie, under the BQR UPMC 2008. Financial support was also provided by the Eramet and Technip companies (Futuna cruise). IHA received PhD funding from the Fundacion Gran Mariscal de Ayacucho (www.fundayacucho.gob.ve), PhD grant E-223-85-2012-2, and from Campus France (http://www.campusfrance.org), grant 796045K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGER K, 1992, COMP BIOCHEM PHYS A, V103, P507, DOI 10.1016/0300-9629(92)90280-4; Anger K., 2001, BIOL DECAPOD CRUSTAC; Aznar-Cormano L, 2015, GENETICA, V143, P195, DOI 10.1007/s10709-014-9807-0; Bauer RT., 2004, REMARKABLE SHRIMPS A; Beedessee G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081570; BENZIE JAH, 1983, J CRUSTACEAN BIOL, V3, P117, DOI 10.2307/1547857; Bolanos J, 2004, SCI MAR, V68, P373, DOI 10.3989/scimar.2004.68n3373; Bracken Heather D., 2009, Crustacean Issues, V18, P281; Campos E, 2010, ZOOTAXA, P41; CHACE F A JR, 1978, Smithsonian Contributions to Zoology, P1; Chan TY, 2010, INVERTEBR SYST, V24, P172, DOI 10.1071/IS09049; Clark PF, 2008, RAFFLES B ZOOL, V56, P85; Clark PF, 1998, INVERTEBR REPROD DEV, V33, P127, DOI 10.1080/07924259.1998.9652627; Copley JTP, 2006, MAR ECOL PROG SER, V315, P199, DOI 10.3354/meps315199; Cowen JP, 2001, DEEP-SEA RES PT I, V48, P1093, DOI 10.1016/S0967-0637(00)00070-4; De Grave S, 2009, RAFFLES B ZOOL, P1; Desbruyeres D, 2000, HYDROBIOLOGIA, V440, P201, DOI 10.1023/A:1004175211848; Dixon DR, 1998, CAH BIOL MAR, V39, P383; Dobkin S, 1967, B MAR SCI, V15, P450; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duffy JE, 1996, NATURE, V381, P512, DOI 10.1038/381512a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fouquet Y, 2015, MINERAL RESOURCES IN A SUSTAINABLE WORLD, VOLS 1-5, P1223; Gebruk AV, 1997, ADV MAR BIOL, V32, P93; Giribet G, 1996, MOL BIOL EVOL, V13, P76, DOI 10.1093/oxfordjournals.molbev.a025573; Guri M, 2012, ISME J, V6, P597, DOI 10.1038/ismej.2011.133; Gurney R., 1941, Journal of the Linnean Society London Zoology, V41, P89; Gurney R., 1942, RAY SOC, V129, P1; Hendrickx M, 2007, CONTRIBUTIONS STUDY, V4, P31; Herring PJ, 1998, CAH BIOL MAR, V39, P387; Herring PJ, 1998, DEEP-SEA RES PT I, V45, P2105, DOI 10.1016/S0967-0637(98)00050-8; HONG SY, 1988, J NAT HIST, V22, P1041, DOI 10.1080/00222938800770651; Gonzalez-Gordillo JI, 2010, J CRUSTACEAN BIOL, V30, P101, DOI 10.1651/08-3110.1; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; KNOWLTON RE, 1973, J NAT HIST, V7, P273, DOI 10.1080/00222937300770231; Komai T, 2005, J NAT HIST, V39, P1111, DOI 10.1080/00222930400002499; Komai T, 2003, CAH BIOL MAR, V44, P199; Komai T, 2008, J SHELLFISH RES, V27, P21, DOI 10.2983/0730-8000(2008)27[21:TROTHV]2.0.CO;2; Konishi Kooichi, 2000, Crustacean Research, V29, P65; Koyama S, 2005, MAR BIOTECHNOL, V7, P272, DOI 10.1007/s10126-004-3050-0; Li CP, 2011, ZOOL ANZ, V250, P270, DOI 10.1016/j.jcz.2011.04.003; MARTIN JW, 1986, CRUSTACEANA, V51, P299, DOI 10.1163/156854086X00476; McLaughlin PA, 2008, ZOOTAXA, P52, DOI 10.11646/zootaxa.1911.1.3; Metaxas A, 2004, LIMNOL OCEANOGR, V49, P1949, DOI 10.4319/lo.2004.49.6.1949; Miyake H, 2007, MAR ECOL-EVOL PERSP, V28, P86, DOI 10.1111/j.1439-0485.2006.00115.x; Miyake H, 2010, CAH BIOL MAR, V51, P441; Mullineaux LS, 2010, P NATL ACAD SCI USA, V107, P7829, DOI 10.1073/pnas.0913187107; Nanjo Nobuaki, 2009, Crustacean Research, V38, P77; Nye V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060319; Olu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011967; Plouviez S, 2015, DEEP-SEA RES PT I, V97, P124, DOI 10.1016/j.dsr.2014.11.011; POHLE G, 1981, B MAR SCI, V31, P753; Pond DW, 2000, DEEP-SEA RES PT I, V47, P121, DOI 10.1016/S0967-0637(99)00050-3; Pond DW, 1997, MAR ECOL PROG SER, V157, P221, DOI 10.3354/meps157221; Ponsard J, 2013, ISME J, V7, P96, DOI 10.1038/ismej.2012.87; Pradillon F, 2004, HIGH PRESSURE RES, V24, P237, DOI 10.1080/08957950410001699818; Pradillon F, 2007, MAR ECOL PROG SER, V333, P103, DOI 10.3354/meps333103; Rabalais N.N., 1985, Crustacean Issues, V2, P67; Ramirez-Llodra E, 2006, J MAR BIOL ASSOC UK, V86, P1347, DOI 10.1017/S0025315406014378; Ramirez-Llodra R, 2000, J MAR BIOL ASSOC UK, V80, P473, DOI [10.1017/S0025315400002174, DOI 10.1017/S0025315400002174]; Ravaux J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064074; Saito T, 2002, CRUSTACEANA, V75, P621, DOI 10.1163/156854002760095642; SEGONZAC M, 1993, CAH BIOL MAR, V34, P535; Shank TM, 1999, MOL PHYLOGENET EVOL, V13, P244, DOI 10.1006/mpev.1999.0642; Shillito B, 2008, DEEP-SEA RES PT I, V55, P881, DOI 10.1016/j.dsr.2008.03.010; Teixeira S, 2013, MOL ECOL, V22, P4663, DOI 10.1111/mec.12419; Teixeira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038521; Terossi M, 2010, ZOOTAXA, P49; Thaler AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101345; Thatje S, 2004, J EXP MAR BIOL ECOL, V301, P15, DOI 10.1016/j.jembe.2003.09.010; Thatje S, 2001, J CRUSTACEAN BIOL, V21, P492, DOI 10.1651/0278-0372(2001)021[0492:DAKTTZ]2.0.CO;2; Thatje S, 2000, CRUSTACEANA, V73, P609, DOI 10.1163/156854000504697; Thatje S., 2015, SEXUALITY EARLY DEV, V1, P109, DOI [DOI 10.3354/SEDAO00011, 10.3354/sedao00011]; Tokuda G, 2006, BIOL LETTERS, V2, P257, DOI 10.1098/rsbl.2005.0420; Tyler PA, 2000, J MAR BIOL ASSOC UK, V80, P739, DOI 10.1017/S0025315400002605; Van Dover C.L., 1995, BULL BIOL SOC WASH, V6, P223; Vereshchaka AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129975; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; WILLIAMSON D. I., 1960, CRUSTACEANA, V1, P331, DOI 10.1163/156854060X00339; Zelnio KA, 2009, P BIOL SOC WASH, V122, P52, DOI 10.2988/07-28.1	82	16	16	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144657	10.1371/journal.pone.0144657	http://dx.doi.org/10.1371/journal.pone.0144657			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710075	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400009
J	Moon, J; Choi, Y; Jung, J; Won, D				Moon, Jongho; Choi, Younsung; Jung, Jaewook; Won, Dongho			An Improvement of Robust Biometrics-Based Authentication and Key Agreement Scheme for Multi-Server Environments Using Smart Cards	PLOS ONE			English	Article							SECURITY; ANONYMITY; EXCHANGE	In multi-server environments, user authentication is a very important issue because it provides the authorization that enables users to access their data and services; furthermore, remote user authentication schemes for multi-server environments have solved the problem that has arisen from user's management of different identities and passwords. For this reason, numerous user authentication schemes that are designed for multi-server environments have been proposed over recent years. In 2015, Lu et al. improved upon Mishra et al.'s scheme, claiming that their remote user authentication scheme is more secure and practical; however, we found that Lu et al.' s scheme is still insecure and incorrect. In this paper, we demonstrate that Lu et al.'s scheme is vulnerable to outsider attack and user impersonation attack, and we propose a new biometrics-based scheme for authentication and key agreement that can be used in multi-server environments; then, we show that our proposed scheme is more secure and supports the required security properties.	[Moon, Jongho; Choi, Younsung; Jung, Jaewook; Won, Dongho] Sungkyunkwan Univ, Dept Comp Engn, Suwon 16419, Gyeonggido, South Korea	Sungkyunkwan University (SKKU)	Won, D (corresponding author), Sungkyunkwan Univ, Dept Comp Engn, Suwon 16419, Gyeonggido, South Korea.	dhwon@security.re.kr		Choi, Younsung/0000-0002-3185-8670	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2014R1A1A2002775]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning(National Research Foundation of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (2014R1A1A2002775) (http://www.nrf.re.kr/nrf_eng_cms/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURROWS M, 1990, ACM T COMPUT SYST, V8, P18, DOI [10.1145/77648.77649, 10.1145/74851.74852]; Canetti R, 2001, LECT NOTES COMPUT SC, V2045, P453; Choi Y, 2014, SCI WORLD J, DOI 10.1155/2014/281305; Chuang MC, 2014, EXPERT SYST APPL, V41, P1411, DOI 10.1016/j.eswa.2013.08.040; Das AK., 2013, NETWORKING SCI, V2, P12, DOI DOI 10.1007/S13119-012-0009-8; Das AK, 2012, INFORM SCIENCES, V209, P80, DOI 10.1016/j.ins.2012.04.036; Jeon W, 2012, IEICE T COMMUN, VE95B, P2505, DOI 10.1587/transcom.E95.B.2505; Kim J, 2014, SENSORS-BASEL, V14, P6443, DOI 10.3390/s140406443; LAMPORT L, 1981, COMMUN ACM, V24, P770, DOI 10.1145/358790.358797; Lee CC, 2011, EXPERT SYST APPL, V38, P13863, DOI 10.1016/j.eswa.2011.04.190; Li X, 2013, MATH COMPUT MODEL, V58, P85, DOI 10.1016/j.mcm.2012.06.033; Liao YP, 2009, COMPUT STAND INTER, V31, P24, DOI 10.1016/j.csi.2007.10.007; Lu RX, 2012, IEEE T PARALL DISTR, V23, P32, DOI 10.1109/TPDS.2011.95; Lu YR, 2015, INT J DISTRIB SENS N, DOI [10.1109/ISSNIP.2015.7106965, 10.1007/s10766-015-0386-1, 10.1155/2015/635890]; Lu YR, 2015, SECUR COMMUN NETW, V8, P3219, DOI 10.1002/sec.1246; Lu YR, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0229-z; Lu YR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126323; Lu YR, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/894549; Lu YR, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0221-7; Messerges TS, 2002, IEEE T COMPUT, V51, P541, DOI 10.1109/TC.2002.1004593; Mishra D, 2014, EXPERT SYST APPL, V41, P8129, DOI 10.1016/j.eswa.2014.07.004; Nam J, 2015, IEICE T FUND ELECTR, VE98A, P424, DOI 10.1587/transfun.E98.A.424; Nam J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116709; Nam J, 2014, SCI WORLD J, DOI 10.1155/2014/825072; Odelu V, 2015, IEEE T INF FOREN SEC, V10, P1953, DOI 10.1109/TIFS.2015.2439964; Son K, 2015, IEICE T COMMUN, VE98B, P160, DOI 10.1587/transcom.E98.B.160; Sun DZ, 2009, IEEE T IND ELECTRON, V56, P2284, DOI 10.1109/TIE.2009.2016508; Tsai JL, 2008, COMPUT SECUR, V27, P115, DOI 10.1016/j.cose.2008.04.001; Xue KP, 2014, J COMPUT SYST SCI, V80, P195, DOI 10.1016/j.jcss.2013.07.004; Xue KP, 2012, COMMUN NONLINEAR SCI, V17, P2969, DOI 10.1016/j.cnsns.2011.11.025; Zhao DW, 2014, WIRELESS PERS COMMUN, V78, P247, DOI 10.1007/s11277-014-1750-y	31	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145263	10.1371/journal.pone.0145263	http://dx.doi.org/10.1371/journal.pone.0145263			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709702	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400030
J	Griffiths, M; Goldring, S; Griffiths, C; Shaheen, SO; Martineau, A; Cross, L; Robinson, S; Warner, JO; Devine, A; Boyle, RJ				Griffiths, Megan; Goldring, Stephen; Griffiths, Chris; Shaheen, Seif O.; Martineau, Adrian; Cross, Louise; Robinson, Stephen; Warner, John O.; Devine, Angela; Boyle, Robert J.			Effects of Pre-Natal Vitamin D Supplementation with Partial Correction of Vitamin D Deficiency on Early Life Healthcare Utilisation: A Randomised Controlled Trial	PLOS ONE			English	Article							MATERNAL 25-HYDROXYVITAMIN D; GENERAL-PRACTICE; SOCIOECONOMIC DIFFERENCES; RESPIRATORY-INFECTION; SERVICE UTILIZATION; LUNG-FUNCTION; PREGNANCY; ASTHMA; CHILDREN; MORBIDITY	Background Some observational studies have suggested that higher prenatal Vitamin D intake may be associated with improved health outcomes in childhood. However there have been mixed results in this area with some negative studies, especially for effects on atopic and respiratory outcomes. We examined the effect of prenatal Vitamin D on healthcare utilisation in the first three years of life. Methods In an ethnically stratified randomised controlled trial conducted at St Mary's Hospital London, 180 women at 27 weeks gestation were allocated to no Vitamin D, 800 IU ergocalciferol daily until delivery, or a single oral bolus of 200,000 IU cholecalciferol. Participants were randomised in blocks of 15 using computer-generated numbers and investigators were blinded to group assignment. Supplementation increased maternal and cord blood 25 (OH) vitamin D concentrations, but levels remained lower than current recommendations. Primary health economic outcome was overall cost of unscheduled healthcare utilisation in the first three years of life as documented in the child's electronic health record. Secondary outcomes included cost attributable to: primary and secondary healthcare visits, respiratory and atopic complaints, cost in years 1, 2 and 3 of life and cost and frequency of prescribed medication. All costs were calculated as pounds sterling. Differences between groups were analysed using unpaired t-test or Mann-Whitney U test, and analysis of variance for adjusted analyses. Results We assessed 99/180 (55%) complete electronic health records, control (n = 31), daily (n = 36) and bolus (n = 32). We found no difference in total healthcare utilisation costs between the control and daily (mean difference in costs in pounds sterling 1.02, 95%CI -1.60, 1.65; adjusted 1.07, 95%CI -1.62, 1.86) or control and bolus groups (mean difference -1.58, 95%CI -2.63, 1.06; adjusted -1.40, 95%CI -2.45, 1.24). There were no adverse effects of supplementation reported during the trial. Conclusions We found no evidence that prenatal vitamin D supplementation from 27 weeks gestation to delivery, at doses which failed to completely correct maternal vitamin D deficiency, influence overall healthcare utilisation in children in the first 3 years.	[Griffiths, Megan; Goldring, Stephen; Warner, John O.; Boyle, Robert J.] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London, England; [Griffiths, Chris; Shaheen, Seif O.; Martineau, Adrian; Cross, Louise; Devine, Angela] Queen Mary Univ London, Blizard Inst, Ctr Primary Care & Publ Hlth, London, England; [Robinson, Stephen] Univ London Imperial Coll Sci Technol & Med, Dept Endocrinol, London, England	Imperial College London; University of London; Queen Mary University London; Imperial College London	Boyle, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London, England.	r.boyle@imperial.ac.uk	Warner, John/AAF-9587-2020; Martineau, Adrian R/A-3083-2010; Devine, Angela/A-6295-2012	Devine, Angela/0000-0002-3321-8706; Boyle, Robert/0000-0002-4913-7580	Asthma UK grant [09/36]; Medical Research Council [G1000758B] Funding Source: researchfish; Asthma UK [09/036] Funding Source: researchfish	Asthma UK grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	Funded by Asthma UK grant number 09/36. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ANT CAR ROUT CAR HLT; Baiz N, 2014, J ALLERGY CLIN IMMUN, V133, P147, DOI 10.1016/j.jaci.2013.05.017; Belderbos ME, 2011, PEDIATRICS, V127, pE1513, DOI 10.1542/peds.2010-3054; Berra S, 2009, MED CARE, V47, P161, DOI 10.1097/MLR.0b013e3181844e09; Bisgaard H, 2014, VITAMIN D SUPPLEMENT; BNFC, 2010, BRIT NAT FORM CHILDR; Boomla K, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7648; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Cremers E, 2011, THORAX, V66, P474, DOI 10.1136/thx.2010.151985; Curtis L., 2009, UNIT COSTS HLTH SOCI; DuranTauleria E, 1996, BRIT MED J, V313, P148, DOI 10.1136/bmj.313.7050.148; Erkkola M, 2009, CLIN EXP ALLERGY, V39, P875, DOI 10.1111/j.1365-2222.2009.03234.x; Excellence NlfC, 2015, INT ADV DIET WOM WHO; Goldring ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066627; Grant CC, 2015, ACTA PAEDIATR, V104, P396, DOI 10.1111/apa.12819; Groholt EK, 2003, EUR J PUBLIC HEALTH, V13, P30, DOI 10.1093/eurpub/13.1.30; Gupta R, 2004, CLIN EXP ALLERGY, V34, P520, DOI 10.1111/j.1365-2222.2004.1935.x; Gynaecology RCoOa, 2014, HLTH EAT VIT SUPPL P; Hansen S, 2015, J ALLERGY CLIN IMMUN, V136, P169, DOI 10.1016/j.jaci.2014.12.1924; Harvey NC, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18450; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Iluiu NAO, 2006, PROVISION OUT HOURS; Jordan K, 2004, FAM PRACT, V21, P396, DOI 10.1093/fampra/cmh409; Litonjua AA, 2014, CONTEMP CLIN TRIALS, V38, P37, DOI 10.1016/j.cct.2014.02.006; Majeed A, 2008, FAM PRACT, V25, P213, DOI 10.1093/fampra/cmn047; McDermid LHaS, 2010, UNIT COSTS HLTH SOCI; Morales E, 2012, EPIDEMIOLOGY, V23, P64, DOI 10.1097/EDE.0b013e31823a44d3; Netuveli G, 2005, LANCET, V365, P312, DOI 10.1016/S0140-6736(05)17785-X; NEWACHECK PW, 1992, MED CARE, V30, P30, DOI 10.1097/00005650-199201000-00003; Office NA, 2006, PROVISION OUT HOURS; Partridge MR, 2000, THORAX, V55, P175, DOI 10.1136/thorax.55.3.175; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Petrou S, 2005, J EPIDEMIOL COMMUN H, V59, P591, DOI 10.1136/jech.2004.025395; Pike KC, 2012, THORAX, V67, P950, DOI 10.1136/thoraxjnl-2012-201888; RILEY AW, 1993, MED CARE, V31, P767, DOI 10.1097/00005650-199309000-00002; Ross AC, 2011, PUBLIC HEALTH NUTR, V14, P938, DOI 10.1017/S1368980011000565; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Saxena S, 1999, BRIT MED J, V318, P642, DOI 10.1136/bmj.318.7184.642; Scragg R, 2008, AM J EPIDEMIOL, V168, P577, DOI 10.1093/aje/kwn163; STARFIELD B, 1985, PEDIATRICS, V75, P241; Thiru K, 2003, BMJ-BRIT MED J, V326, P1070, DOI 10.1136/bmj.326.7398.1070; Wang SS, 2014, PEDIAT ALLERG IMM-UK, V25, P30, DOI 10.1111/pai.12167; Ward A, 1996, AUST NZ J PUBL HEAL, V20, P309, DOI 10.1111/j.1467-842X.1996.tb01034.x; Wayse V, 2004, EUR J CLIN NUTR, V58, P563, DOI 10.1038/sj.ejcn.1601845; Weissman MM, 1997, ARCH GEN PSYCHIAT, V54, P932; Wills AK, 2013, CLIN EXP ALLERGY, V43, P1180, DOI 10.1111/cea.12172; WOODWARD CA, 1988, PEDIATRICS, V82, P425; Yu CKH, 2009, CLIN ENDOCRINOL, V70, P685, DOI 10.1111/j.1365-2265.2008.03403.x	50	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145303	10.1371/journal.pone.0145303	http://dx.doi.org/10.1371/journal.pone.0145303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26698303	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600062
J	Jamet, S; Slama, N; Domingues, J; Laval, F; Texier, P; Eynard, N; Quemard, A; Peixoto, A; Lemassu, A; Daffe, M; Cam, K				Jamet, Stevie; Slama, Nawel; Domingues, Joana; Laval, Francoise; Texier, Pauline; Eynard, Nathalie; Quemard, Annaik; Peixoto, Antonio; Lemassu, Anne; Daffe, Mamadou; Cam, Kaymeuang			The Non-Essential Mycolic Acid Biosynthesis Genes hadA and hadC Contribute to the Physiology and Fitness of Mycobacterium smegmatis	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; CELL-WALL; DEHYDRATASE COMPONENT; MULTIDRUG-RESISTANT; SLIDING MOTILITY; PERMEABILITY; INHIBITION; ISOXYL; VIRULENCE; MECHANISM	Gram positive mycobacteria with a high GC content, such as the etiological agent of tuberculosis Mycobacterium tuberculosis, possess an outer membrane mainly composed of mycolic acids (MAs), the so-called mycomembrane, which is essential for the cell. About thirty genes are involved in the biosynthesis of MAs, which include the hadA, hadB and hadC genes that encode the dehydratases Fatty Acid Synthase type II (FAS-II) known to function as the heterodimers HadA-HadB and HadB-HadC. The present study shows that M. smegmatis cells remain viable in the absence of either HadA and HadC or both. Inactivation of HadC has a dramatic effect on the physiology and fitness of the mutant strains whereas that of HadA exacerbates the phenotype of a hadC deletion. The hadC mutants exhibit a novel MA profile, display a distinct colony morphology, are less aggregated, are impaired for sliding motility and biofilm development and are more resistant to detergent. Conversely, the hadC mutants are significantly more susceptible to low-and high-temperature and to selective toxic compounds, including several current anti-tubercular drugs.	[Jamet, Stevie; Slama, Nawel; Domingues, Joana; Laval, Francoise; Texier, Pauline; Eynard, Nathalie; Quemard, Annaik; Peixoto, Antonio; Lemassu, Anne; Daffe, Mamadou; Cam, Kaymeuang] CNRS, IPBS, UMR 5089, F-31077 Toulouse, France; [Jamet, Stevie; Slama, Nawel; Domingues, Joana; Laval, Francoise; Texier, Pauline; Eynard, Nathalie; Quemard, Annaik; Peixoto, Antonio; Lemassu, Anne; Daffe, Mamadou; Cam, Kaymeuang] Univ Toulouse, UPS, F-31000 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Cam, K (corresponding author), CNRS, IPBS, UMR 5089, F-31077 Toulouse, France.	kaymeuang.cam@ipbs.fr	LAUZERAL-VIZCAINO, Françoise/W-8898-2019	LAUZERAL-VIZCAINO, Françoise/0000-0002-9741-3252; Quemard, Annaik/0000-0002-5545-3424; Lemassu, Anne/0000-0002-9323-2497; Peixoto, Antonio/0000-0001-9493-1954	Ministere de l'Enseignement Superieur et de la Recherche; European Respiratory Society/Marie Curie Fellowship; Marie Curie International Incoming Fellowship; Centre National de la Recherche Scientifique	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); European Respiratory Society/Marie Curie Fellowship; Marie Curie International Incoming Fellowship(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	SJ Ministere de l'Enseignement Superieur et de la Recherche, JD a European Respiratory Society/Marie Curie Fellowship, AP a Marie Curie International Incoming Fellowship. This work was supported by institutional grants from the Centre National de la Recherche Scientifique.	Alibaud L, 2010, J BIOL CHEM, V285, P21698, DOI 10.1074/jbc.M110.125724; BABA T, 1989, J BIOCHEM-TOKYO, V106, P81, DOI 10.1093/oxfordjournals.jbchem.a122825; Balaban NQ, 2013, NAT REV MICROBIOL, V11, P587, DOI 10.1038/nrmicro3076; BELISLE JT, 1989, J BACTERIOL, V171, P3465, DOI 10.1128/jb.171.6.3465-3470.1989; Bercovier H, 2001, REV SCI TECH OIE, V20, P265, DOI 10.20506/rst.20.1.1269; Biswas R, 2015, BIOCHEM BIOPH RES CO, V458, P369, DOI 10.1016/j.bbrc.2015.01.119; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brown AK, 2007, MICROBIOL-SGM, V153, P4166, DOI 10.1099/mic.0.2007/012419-0; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Cantaloube S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029564; Carrere-Kremer S, 2015, MOL MICROBIOL, V96, P1085, DOI 10.1111/mmi.12992; Catherinot E, 2007, INFECT IMMUN, V75, P1055, DOI 10.1128/IAI.00835-06; Coxon GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053162; DAFFE M, 1983, ANN INST PASTEUR MIC, VB134, P241, DOI 10.1016/S0769-2609(83)80037-4; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Daffe M, 2015, TUBERCULOSIS; Dahl JL, 2011, FEMS MICROBIOL LETT, V319, P153, DOI 10.1111/j.1574-6968.2011.02278.x; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P3127, DOI 10.1128/AAC.00239-08; Falzon D, 2013, LANCET INFECT DIS, V13, P690, DOI 10.1016/S1473-3099(13)70130-0; Fattorini L, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.072; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Grzegorzewicz AE, 2015, ACS INFECT DIS, V1, P91, DOI 10.1021/id500032q; Grzegorzewicz AE, 2012, J BIOL CHEM, V287, P38434, DOI 10.1074/jbc.M112.400994; Gutierrez MC, 2009, GENOME DYNAM, V6, P198, DOI 10.1159/000235772; Healy VL, 2000, CHEM BIOL, V7, pR109, DOI 10.1016/S1074-5521(00)00116-2; Islam MS, 2012, EXPERT REV ANTI-INFE, V10, P1055, DOI [10.1586/eri.12.88, 10.1586/ERI.12.88]; Jamet S, 2015, J BACTERIOL, V197, P3797, DOI 10.1128/JB.00433-15; JARLIER V, 1990, J BACTERIOL, V172, P1418, DOI 10.1128/jb.172.3.1418-1423.1990; Kansal RG, 1998, MICROB PATHOGENESIS, V25, P203, DOI 10.1006/mpat.1998.0227; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Kulka K, 2012, JOVE-J VIS EXP, DOI 10.3791/3820; Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181; Laval F, 2008, J BIOL CHEM, V283, P1419, DOI 10.1074/jbc.M708859200; Lechartier B, 2014, EMBO MOL MED, V6, P158, DOI 10.1002/emmm.201201772; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Liu J, 1999, P NATL ACAD SCI USA, V96, P4011, DOI 10.1073/pnas.96.7.4011; Liu J, 1996, J BIOL CHEM, V271, P29545, DOI 10.1074/jbc.271.47.29545; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; Martinez A, 1999, J BACTERIOL, V181, P7331; Migliori GB, 2013, EUR RESPIR J, V42, P169, DOI 10.1183/09031936.00136312; Mitchison DA, 1998, INT J TUBERC LUNG D, V2, P10; Nguyen L, 2009, ANNU REV PHARMACOL, V49, P427, DOI 10.1146/annurev-pharmtox-061008-103123; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Phetsuksiri B, 1999, ANTIMICROB AGENTS CH, V43, P1042, DOI 10.1128/AAC.43.5.1042; Recht J, 2000, J BACTERIOL, V182, P4348, DOI 10.1128/JB.182.15.4348-4351.2000; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Sambandan D, 2013, MBIO, V4, DOI 10.1128/mBio.00222-13; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shahab FM, 2010, XENOBIOTICA, V40, P225, DOI 10.3109/00498250903461411; Slama N, 2015, MOL MICROBIOLOGY; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Stahl C, 2001, MOL MICROBIOL, V40, P451, DOI 10.1046/j.1365-2958.2001.02394.x; Stratton HM, 2003, SYST APPL MICROBIOL, V26, P165, DOI 10.1078/072320203322345994; TAKAYAMA K, 1989, ANTIMICROB AGENTS CH, V33, P1493, DOI 10.1128/AAC.33.9.1493; TRIAS J, 1994, MOL MICROBIOL, V14, P283, DOI 10.1111/j.1365-2958.1994.tb01289.x; URBANCIK B, 1970, ANTIBIOT CHEMOTHER, V16, P117; van der Woude AD, 2012, J BIOL CHEM, V287, P20417, DOI 10.1074/jbc.M111.336461; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; WALLACE RJ, 1988, J INFECT DIS, V158, P52, DOI 10.1093/infdis/158.1.52; Weiss LA, 2013, J BACTERIOL, V195, P5629, DOI 10.1128/JB.00759-13; WHO, 2014, GLOB TUB REP 2013; Willand N, 2009, NAT MED, V15, P537, DOI 10.1038/nm.1950; Xu WX, 2014, BIOCHEM BIOPH RES CO, V448, P255, DOI 10.1016/j.bbrc.2014.04.116; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005; Zhang YJJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002946; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	75	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145883	10.1371/journal.pone.0145883	http://dx.doi.org/10.1371/journal.pone.0145883			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701652	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600138
J	Long, R; Heffernan, C; Gao, ZW; Egedahl, ML; Talbot, J				Long, Richard; Heffernan, Courtney; Gao, Zhiwei; Egedahl, Mary Lou; Talbot, James			Do "Virtual" and "Outpatient" Public Health Tuberculosis Clinics Perform Equally Well? A Program-Wide Evaluation in Alberta, Canada	PLOS ONE			English	Article							FOREIGN-BORN; PEDIATRIC TUBERCULOSIS; ABORIGINAL PEOPLES; EPIDEMIOLOGY; POPULATION; TRANSMISSION; EXPERIENCE	Background Meeting the challenge of tuberculosis (TB) elimination will require adopting new models of delivering patient-centered care customized to diverse settings and contexts. In areas of low incidence with cases spread out across jurisdictions and large geographic areas, a "virtual" model is attractive. However, whether "virtual" clinics and telemedicine deliver the same outcomes as face-to-face encounters in general and within the sphere of public health in particular, is unknown. This evidence is generated here by analyzing outcomes between the "virtual" and "outpatient" public health TB clinics in Alberta, a province of Western Canada with a large geographic area and relatively small population. Methods In response to the challenge of delivering equitable TB services over long distances and to hard to reach communities, Alberta established three public health clinics for the delivery of its program: two outpatient serving major metropolitan areas, and one virtual serving mainly rural areas. The virtual clinic receives paper-based or electronic referrals and generates directives which are acted upon by local providers. Clinics are staffed by dedicated public health nurses and university-based TB physicians. Performance of the two types of clinics is compared between the years 2008 and 2012 using 16 case management and treatment outcome indicators and 12 contact management indicators. Findings In the outpatient and virtual clinics, respectively, 691 and 150 cases and their contacts were managed. Individually and together both types of clinics met most performance targets. Compared to outpatient clinics, virtual clinic performance was comparable, superior and inferior in 22, 3, and 3 indicators, respectively. Conclusions Outpatient and virtual public health TB clinics perform equally well. In low incidence settings a combination of the two clinic types has the potential to address issues around equitable service delivery and declining expertise.	[Long, Richard; Heffernan, Courtney; Egedahl, Mary Lou] Univ Alberta, Dept Med, Fac Med & Dent, Edmonton, AB, Canada; [Long, Richard; Talbot, James] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Gao, Zhiwei] Mem Univ Newfoundland, Dept Med, Clin Epidemiol Unit, St John, NF, Canada; [Talbot, James] Alberta Hlth Prov Alberta, Edmonton, AB, Canada	University of Alberta; University of Alberta; Memorial University Newfoundland; Alberta Health Services (AHS)	Long, R (corresponding author), Univ Alberta, Dept Med, Fac Med & Dent, Edmonton, AB, Canada.	richard.long@ualberta.ca	Heffernan, Courtney E/G-5296-2016					Alberta Health and Wellness, 2010, TUB PREV CONTR GUID; ALLEN E. A., 1964, CAN J PUBLIC HEALTH, V55, P323; Binkin NJ, 1999, INT J TUBERC LUNG D, V3, P663; Boland P, 1974, Bull Int Union Tuberc, V49 suppl 1, P84; BYRD RB, 1977, ANN INTERN MED, V86, P799, DOI 10.7326/0003-4819-86-6-799; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; Canadian Tuberculosis Committee, 2007, CAN COMMUN DIS REP, V33, P1; CANETTI G, 1962, Tubercle, V43, P301; Centers for Disease Control and Prevention, NAT TB PROGR OBJ PER; CURRY FJ, 1968, NEW ENGL J MED, V279, P1262, DOI 10.1056/NEJM196812052792305; CURRY FJ, 1964, DIS CHEST, V46, P524, DOI 10.1378/chest.46.5.524; [Education and Welfare Public Health Service US Department of Health], 1960, US DEP HLTH PUBL; Erkens CGM, 2010, EUR RESPIR J, V36, P925, DOI 10.1183/09031936.00201609; ETKIND SC, 1993, MED CLIN N AM, V77, P1303, DOI 10.1016/S0025-7125(16)30195-X; Gao Z, 2015, INT J TUBERC LUNG D, V19, P772, DOI 10.5588/ijtld.14.0753; GAUDETTE LA, 1993, TUBERCLE LUNG DIS, V74, P244, DOI 10.1016/0962-8479(93)90050-8; Government of Canada SC, CANSIM 051 0006 IMM; Government of Canada SC, CANSIM 051 0011 INT; GRZYBOWSKI S, 1978, Bulletin of the International Union Against Tuberculosis, V53, P70; Health Canada: First Nations and Inuit Health Branch, STRAT TUB 1 NAT ON R; Henderson DA, 1998, INT J TUBERC LUNG D, V2, pS4; Jensen M, 2012, INT J TUBERC LUNG D, V16, P43, DOI 10.5588/ijtld.11.0374; Jereb J, 2004, SEMIN RESP CRIT CARE, V25, P255, DOI 10.1055/s-2004-829521; Khan K, 2006, CAN MED ASSOC J, V175, P749, DOI 10.1503/cmaj.060124; Kunimoto D, 2004, INT J TUBERC LUNG D, V8, P1213; Langlois-Klassen D, 2011, EUR RESPIR J, V38, P895, DOI 10.1183/09031936.00196610; Long R, 2004, CAN J PUBLIC HEALTH, V95, P249, DOI 10.1007/BF03405124; Long R, 2002, CAN J PUBLIC HEALTH, V93, P264, DOI 10.1007/BF03405013; Long R, 2001, AM J EPIDEMIOL, V153, P903, DOI 10.1093/aje/153.9.903; Long R, 2006, CAN MED ASSOC J, V175, P759, DOI 10.1503/cmaj.060752; Long R, 2013, CAN RESPIR J, V20, P223, DOI 10.1155/2013/429496; Loudon R G, 1966, Bull Natl Tuberc Assoc, V52, P2; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Menzies D, 2013, CAN RESP J SA, V20, p1A; MOULDING T, 1966, AM J PUBLIC HEALTH N, V56, P416, DOI 10.2105/AJPH.56.3.416; Pan-Canadian Public Health Network, GUID TUB PREV CONTR; Parhar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117036; Public Health Agency of Canada, 2015, TUB CAN 2012; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; Reichler MR, 2002, JAMA-J AM MED ASSOC, V287, P991, DOI 10.1001/jama.287.8.991; SBARBARO JA, 1970, AM REV RESPIR DIS, V101, P463; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; The Canadian Tuberculosis Committee of the Centre for Infectious Disease Prevention and Control Population and Public Health Branch Health Canada, 2002, CCDR, V28, P1; Thombley M, 2011, TUBERCULOSIS AND NONTUBERCULOUS MYCOBACTERIAL INFECTIONS, 6TH EDITION, P224; WERHANE MJ, 1989, CHEST, V96, P815, DOI 10.1378/chest.96.4.815; World Health Organization, 2008, GLOB TUB CONTR SURV; Yip D, 2007, CAN J PUBLIC HEALTH, V98, P276, DOI 10.1007/BF03405402	47	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144784	10.1371/journal.pone.0144784	http://dx.doi.org/10.1371/journal.pone.0144784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26700163	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600031
J	Senthilkumaran, B; Sreenivasulu, G; Wang, DS; Sudhakumari, CC; Kobayashi, T; Nagahama, Y				Senthilkumaran, Balasubramanian; Sreenivasulu, Gunti; Wang, De-Shou; Sudhakumari, Cheni-Chery; Kobayashi, Tohru; Nagahama, Yoshitaka			Expression Patterns of CREBs in Oocyte Growth and Maturation of Fish	PLOS ONE			English	Article							20-BETA-HYDROXYSTEROID DEHYDROGENASE; OVARIAN-FOLLICLES; AROMATASE GENE; NILE TILAPIA; CYCLIC-AMP; OREOCHROMIS-NILOTICUS; MEIOTIC MATURATION; POTENTIAL ROLE; MESSENGER-RNA; PROMOTER	In fish, oocyte meiotic maturation is regulated by 17 alpha, 20 beta-dihydroxy-progesterone through cAMP. To study the role of cAMP response element binding protein (CREB) in meiotic maturation, we cloned and characterized the expression pattern of CREBs from two fish models, the Nile tilapia and catfish. In the Nile tilapia three different CREBs were identified where in CREB1 was found in many tissues including gonads with abundant expression in testis. CREB2, few amino acids shorter than CREB1, was expressed in several tissues with abundant expression in ovary. In addition, a 3'UTR variant form, CREB3 was exclusively found in ovary. During natural 14-day ovarian cycle of the Nile tilapia, CREB1 expression was stable throughout vitellogenesis with a sharp decrease on the day of spawning. In contrast, CREB2 remain unchanged throughout the ovarian cycle, however elevated in 11-day full-grown immature ovarian follicle and after hCG-induction. Interestingly, CREB3 expression was induced three folds on the day of spawning as well as during hCG-induced oocyte maturation. Based on the synergistic expression pattern, CREB1 is likely to control oocyte growth, whereas CREB 2 and 3 contribute to oocyte maturation in tilapia and the latter seems to be critical. In catfish, a single form of CREB showed a maximum expression during spawning phase and hCG-induced maturation both in vivo and in vitro augmented CREB expression. These results suggest that spatial and temporal expression of CREBs seems to be important for final oocyte maturation and may also regulate oocyte growth in fish.	[Senthilkumaran, Balasubramanian; Sreenivasulu, Gunti; Sudhakumari, Cheni-Chery] Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Hyderabad 500046, Telangana, India; [Senthilkumaran, Balasubramanian; Wang, De-Shou; Sudhakumari, Cheni-Chery; Kobayashi, Tohru; Nagahama, Yoshitaka] Natl Inst Nat Sci, Natl Inst Basic Biol, Reprod Biol Lab, Okazaki, Aichi 4448585, Japan	University of Hyderabad; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Senthilkumaran, B (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Biol, PO Cent Univ, Hyderabad 500046, Telangana, India.	bsksl@uohyd.ernet.in	Wang, Deshou/ABD-6014-2021	Wang, Deshou/0000-0002-4967-524X	CREST (Core Research for Evolutional Science and Technology), JST (Japan Science and Technology Corporation), Research for the Future [JSPS-RFTF 96L00401]; Ministry of Education, Science, Culture, and Sports, Japan [07283104, 14042267]; Ministry of Agriculture, Forestry and Fisheries, Japan; Department of Science and Technology (DST), India [SP/SO/AS-49/2003]; DST-FIST of the Department of Animal Biology and School of Life Sciences; Council of Scientific and Industrial Research, India; TATA innovation fellowship, Department of Biotechnology, Government of India	CREST (Core Research for Evolutional Science and Technology), JST (Japan Science and Technology Corporation), Research for the Future; Ministry of Education, Science, Culture, and Sports, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry and Fisheries, Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Department of Science and Technology (DST), India(Department of Science & Technology (India)); DST-FIST of the Department of Animal Biology and School of Life Sciences; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); TATA innovation fellowship, Department of Biotechnology, Government of India	Grants-in-aid for Research from CREST (Core Research for Evolutional Science and Technology), JST (Japan Science and Technology Corporation), Research for the Future (JSPS-RFTF 96L00401) and Priority Areas (07283104 and 14042267) from the Ministry of Education, Science, Culture, and Sports, Japan, and Bio Design Program from the Ministry of Agriculture, Forestry and Fisheries, Japan to YN is acknowledged. A Grant-in-aid (SP/SO/AS-49/2003) from the Department of Science and Technology (DST), India, to BS is acknowledged. BS and CCS are the recipients of the Japan Society for the Promotion of Science, which is acknowledged. The authors also thank the support from DST-FIST of the Department of Animal Biology and School of Life Sciences. GS acknowledges junior and senior research fellowships from Council of Scientific and Industrial Research, India. BS is a recipient of TATA innovation fellowship, Department of Biotechnology, Government of India, which is duly acknowledged.; BS and CCS are the recipients of the Japan Society for the Promotion of Science, which is acknowledged. We also thank the support from DST-FIST of the Department of Animal Biology and School of Life Sciences. GS acknowledges junior and senior research fellowships from Council of Scientific and Industrial Research, India. BS is a recipient of TATA innovation fellowship, Department of Biotechnology, Government of India, which is duly acknowledged.	Carlone DL, 1997, J STEROID BIOCHEM, V61, P223, DOI 10.1016/S0960-0760(97)80016-7; Fitzpatrick SL, 1997, STEROIDS, V62, P197, DOI 10.1016/S0039-128X(96)00181-X; Gen K, 2000, BIOL REPROD, V63, P308, DOI 10.1095/biolreprod63.1.308; Guan GJ, 1999, BIOCHEM BIOPH RES CO, V255, P123, DOI 10.1006/bbrc.1998.0127; Haider S, 2003, COMP BIOCHEM PHYS A, V134, P267, DOI 10.1016/S1095-6433(02)00261-1; Huang W, 2009, MOL CELL ENDOCRINOL, V307, P224, DOI 10.1016/j.mce.2009.04.003; KANAMORI A, 1988, GEN COMP ENDOCR, V72, P39, DOI 10.1016/0016-6480(88)90178-5; KOIDE Y, 1992, GEN COMP ENDOCR, V87, P327, DOI 10.1016/0016-6480(92)90039-M; Kwon JY, 2001, MOL REPROD DEV, V59, P359, DOI 10.1002/mrd.1042; Nagahama Y, 1997, STEROIDS, V62, P190, DOI 10.1016/S0039-128X(96)00180-8; Nagahama Y, 2008, DEV GROWTH DIFFER, V50, pS195, DOI 10.1111/j.1440-169X.2008.01019.x; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Senthilkumaran B, 2004, MOL CELL ENDOCRINOL, V215, P11, DOI 10.1016/j.mce.2003.11.012; Senthilkumaran B, 2002, BIOL REPROD, V67, P1080, DOI 10.1095/biolreprod67.4.1080; Senthilkumaran B, 2001, J ENDOCRINOL, V168, P239, DOI 10.1677/joe.0.1680239; Senthilkumaran B, 2011, FRONT BIOSCI-LANDMRK, V16, P1898, DOI 10.2741/3829; Sreenivasulu G, 2012, GENE, V509, P68, DOI 10.1016/j.gene.2012.07.017; Sreenivasulu G, 2009, GEN COMP ENDOCR, V163, P259, DOI 10.1016/j.ygcen.2009.04.022; Tanaka M, 2002, BIOL REPROD, V66, P1498, DOI 10.1095/biolreprod66.5.1498; Wang DS, 2007, MOL ENDOCRINOL, V21, P712, DOI 10.1210/me.2006-0248; Watanabe M, 1999, MOL CELL ENDOCRINOL, V149, P221, DOI 10.1016/S0303-7207(99)00006-4; Yoshiura Y, 2003, BIOL REPROD, V68, P1545, DOI 10.1095/biolreprod.102.010843; Young M, 1998, ENDOCRINOLOGY, V139, P5082, DOI 10.1210/en.139.12.5082	23	6	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145182	10.1371/journal.pone.0145182	http://dx.doi.org/10.1371/journal.pone.0145182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700177	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600051
J	Zhu, ZD; Fan, XT; Lv, YH; Zhang, N; Fan, CN; Zhang, PF; Zeng, WX				Zhu, Zhendong; Fan, Xiaoteng; Lv, Yinghua; Zhang, Nan; Fan, Chuning; Zhang, Pengfei; Zeng, Wenxian			Vitamin E Analogue Improves Rabbit Sperm Quality during the Process of Cryopreservation through Its Antioxidative Action	PLOS ONE			English	Article							ALPHA-TOCOPHEROL SUPPLEMENTATION; LIPID-PEROXIDATION; BOAR SPERMATOZOA; SEMEN CRYOPRESERVATION; DIFFERENT FRACTIONS; OXIDATIVE STRESS; PARAMETERS; EXTENDER; MOTILITY; FROZEN	The process of cryopreservation results in high concentration of reactive oxygen species which is detrimental to spermatozoa. The aim of this study was to investigate whether addition of vitamin E analogue to freezing extender can facilitate the cryosurvival of spermatozoa in rabbits, and how vitamin E protects spermatozoa against damages during the process of preservation. Freshly ejaculated semen was diluted with Tris-citrate-glucose extender supplemented with different concentrations of Trolox (a vitamin E analogue). The level of radical oxygen species (ROS) in spermatozoa that was exposed to Trolox was significantly lower than that of the control during each step of the process of preservation. The percentage of frozen-thawed spermatozoa with lipid peroxidation in the Trolox treatments was significantly lower than that of the control. The motility, intact acrosome, membrane integrity and mitochondrial potentials of the frozen-thawed spermatozoa in the treatment of 200 mu M Trolox were significantly higher than those of the control. These observations suggest that addition of vitamin E to a freezing extender leads to higher integrity of acrosome, plasma membrane and mitochondrial membrane potential as well as higher motility. Vitamin E protects spermatozoa through its capacity to quench ROS accumulation and lipid peroxidation during the process of preservation. Addition of Trolox is recommended to facilitate the improvement of semen preservation for the rabbit breeding industry.	[Zhu, Zhendong; Fan, Xiaoteng; Lv, Yinghua; Zhang, Nan; Fan, Chuning; Zhang, Pengfei; Zeng, Wenxian] Northwest A&F Univ, Coll Anim Sci & Technol, Xian 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Zeng, WX (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Xian 712100, Shaanxi, Peoples R China.	zengwnxian@hotmail.com	Zeng, Wen/GPS-8058-2022	zhu, zhendong/0000-0001-7002-7119; Fan, Xiaoteng/0000-0002-6405-8135	National Natural Science Foundation of China [31072029, 31272439, 31230048]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 31072029, No. 31272439 and No. 31230048) for W Zeng (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported in part by the National Natural Science Foundation of China (Grant No. 31072029, No. 31272439 and No. 31230048). We thank Dr. Lawrence M. Liao at Hiroshima University, Japan for reviewing and editing the manuscript.	Agarwal A, 2005, BJU INT, V95, P503, DOI 10.1111/j.1464-410X.2005.05328.x; Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)04948-8; ALVAREZ JG, 1984, BIOL REPROD, V30, P323, DOI 10.1095/biolreprod30.2.323; Anel-Lopez L, 2012, ANIM REPROD SCI, V135, P37, DOI 10.1016/j.anireprosci.2012.09.001; Apel-Paz M, 2003, BIOCHEM BIOPH RES CO, V309, P724, DOI 10.1016/j.bbrc.2003.08.065; da Silva CMB, 2011, J PINEAL RES, V51, P172, DOI 10.1111/j.1600-079X.2011.00873.x; Bansal Amrit Kaur, 2010, Vet Med Int, V2010, DOI 10.4061/2011/686137; Bansal AK, 2009, ANIM SCI PAP REP, V27, P5; Beheshti R., 2011, The Journal of American Science, V7, P227; Bergmann AR, 1997, J LIPID RES, V38, P2580; Bilodeau JF, 2000, MOL REPROD DEV, V55, P282, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;282::AID-MRD6&gt;3.0.CO;2-7; Breininger E, 2005, THERIOGENOLOGY, V63, P2126, DOI 10.1016/j.theriogenology.2004.08.016; Bucak MN, 2008, SMALL RUMINANT RES, V75, P128, DOI 10.1016/j.smallrumres.2007.09.002; Chatterjee S, 2001, MOL REPROD DEV, V59, P451, DOI 10.1002/mrd.1052; Foote RH, 2000, J ANDROL, V21, P664; GARNER DL, 1995, BIOL REPROD, V53, P276, DOI 10.1095/biolreprod53.2.276; Holt WV, 1997, REPROD FERT DEVELOP, V9, P309, DOI 10.1071/R96082; Holt WV, 2000, ANIM REPROD SCI, V62, P3, DOI 10.1016/S0378-4320(00)00152-4; Hu JH, 2011, ANIMAL, V5, P107, DOI 10.1017/S1751731110001679; Jeong YJ, 2009, CRYOBIOLOGY, V58, P181, DOI 10.1016/j.cryobiol.2008.12.004; JONES R, 1977, J REPROD FERTIL, V50, P261, DOI 10.1530/jrf.0.0500261; Kalthur G, 2011, FERTIL STERIL, V95, P1149, DOI 10.1016/j.fertnstert.2010.10.005; Luo HL, 2004, CHINESE J ANIM SCI, V40, P0007; Ma HM, 2010, ANIM REPROD SCI, V121, P106, DOI 10.1016/j.anireprosci.2010.05.005; Maia MD, 2009, SMALL RUMINANT RES, V85, P85, DOI 10.1016/j.smallrumres.2009.07.001; Moce E, 2009, ANIM REPROD SCI, V110, P1, DOI 10.1016/j.anireprosci.2008.08.015; Mourvaki E, 2008, ANDROLOGIA, V40, P282, DOI 10.1111/j.1439-0272.2008.00854.x; Mourvaki E, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-16; Nasiri AH, 2012, ANDROLOGIA, V44, P550, DOI 10.1111/j.1439-0272.2011.01225.x; Pant N, 2008, TOXICOL APPL PHARM, V231, P112, DOI 10.1016/j.taap.2008.04.001; Pena FJ, 2004, ZYGOTE, V12, P117, DOI 10.1017/S096719940400262X; Pena FJ, 2003, ANIM REPROD SCI, V78, P85, DOI 10.1016/S0378-4320(03)00049-6; Penitente JM, 2014, SCI WORLD J, DOI 10.1155/2014/964172; Satorre MM, 2007, THERIOGENOLOGY, V68, P958, DOI 10.1016/j.theriogenology.2007.06.021; Sicherle CC, 2011, SMALL RUMINANT RES, V95, P144, DOI 10.1016/j.smallrumres.2010.10.011; Sikka Suresh C., 1996, Frontiers in Bioscience (online), V1, pE78; Silva SV, 2013, ANIM REPROD SCI, V137, P37, DOI 10.1016/j.anireprosci.2012.12.002; Surai P, 1998, BIOL TRACE ELEM RES, V64, P119, DOI 10.1007/BF02783329; Taylor K, 2009, REPROD BIOMED ONLINE, V18, P184, DOI 10.1016/S1472-6483(10)60254-4; Thuwanut P, 2009, REPROD DOMEST ANIM, V44, P373, DOI 10.1111/j.1439-0531.2009.01453.x; Towhidi A, 2012, J ASSIST REPROD GEN, V29, P1051, DOI 10.1007/s10815-012-9834-7; Zeng WX, 2001, THERIOGENOLOGY, V56, P447, DOI 10.1016/S0093-691X(01)00576-3; Zeng WX, 2000, REPROD FERT DEVELOP, V12, P223, DOI 10.1071/RD00058	43	38	43	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145383	10.1371/journal.pone.0145383	http://dx.doi.org/10.1371/journal.pone.0145383			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700473	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600073
J	Christie, AE; Chi, M; Lameyer, TJ; Pascual, MG; Shea, DN; Stanhope, ME; Schulz, DJ; Dickinson, PS				Christie, Andrew E.; Chi, Megan; Lameyer, Tess J.; Pascual, Micah G.; Shea, Devlin N.; Stanhope, Meredith E.; Schulz, David J.; Dickinson, Patsy S.			Neuropeptidergic Signaling in the American Lobster Homarus americanus: New Insights from High-Throughput Nucleotide Sequencing	PLOS ONE			English	Article							STOMATOGASTRIC NERVOUS-SYSTEM; CARDIAC NEUROMUSCULAR SYSTEM; NOVO ASSEMBLED TRANSCRIPTOME; INTEGRATED DOCUMENTATION RESOURCE; CRUSTACEAN CALANUS-FINMARCHICUS; CRAYFISH PROCAMBARUS-CLARKII; TRANSFORM MASS-SPECTROMETRY; IN-SILICO CHARACTERIZATION; ALLATOSTATIN-LIKE PEPTIDE; SILKWORM BOMBYX-MORI	Peptides are the largest and most diverse class of molecules used for neurochemical communication, playing key roles in the control of essentially all aspects of physiology and behavior. The American lobster, Homarus americanus, is a crustacean of commercial and biomedical importance; lobster growth and reproduction are under neuropeptidergic control, and portions of the lobster nervous system serve as models for understanding the general principles underlying rhythmic motor behavior (including peptidergic neuromodulation). While a number of neuropeptides have been identified from H. americanus, and the effects of some have been investigated at the cellular/systems levels, little is currently known about the molecular components of neuropeptidergic signaling in the lobster. Here, a H. americanus neural transcriptome was generated and mined for sequences encoding putative peptide precursors and receptors; 35 precursor- and 41 receptor-encoding transcripts were identified. We predicted 194 distinct neuropeptides from the deduced precursor proteins, including members of the adipokinetic hormone-corazonin-like peptide, allatostatin A, allatostatin C, bursicon, CCHamide, corazonin, crustacean cardioactive peptide, crustacean hyperglycemic hormone (CHH), CHH precursor-related peptide, diuretic hormone 31, diuretic hormone 44, eclosion hormone, FLRFamide, GSEFLamide, insulin-like peptide, intocin, leucokinin, myosuppressin, neuroparsin, neuropeptide F, orcokinin, pigment dispersing hormone, proctolin, pyrokinin, SIFamide, sulfakinin and tachykinin-related peptide families. While some of the predicted peptides are known H. americanus isoforms, most are novel identifications, more than doubling the extant lobster neuropeptidome. The deduced receptor proteins are the first descriptions of H. americanus neuropeptide receptors, and include ones for most of the peptide groups mentioned earlier, as well as those for ecdysis-triggering hormone, red pigment concentrating hormone and short neuropeptide F. Multiple receptors were identified for most peptide families. These data represent the most complete description of the molecular underpinnings of peptidergic signaling in H. americanus, and will serve as a foundation for future gene-based studies of neuropeptidergic control in the lobster.	[Christie, Andrew E.; Chi, Megan; Pascual, Micah G.] Univ Hawaii Manoa, Bekesy Lab Neurobiol, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; [Christie, Andrew E.; Chi, Megan; Pascual, Micah G.] Univ Hawaii Manoa, Technol, Honolulu, HI 96822 USA; [Lameyer, Tess J.; Shea, Devlin N.; Stanhope, Meredith E.; Dickinson, Patsy S.] Bowdoin Coll, Dept Biol, Brunswick, ME 04672 USA; [Schulz, David J.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Bowdoin College; University of Missouri System; University of Missouri Columbia	Christie, AE (corresponding author), Univ Hawaii Manoa, Bekesy Lab Neurobiol, Pacific Biosci Res Ctr, 6500 Coll Stn,1993 East West Rd, Honolulu, HI 96822 USA.	crabman@pbrc.hawaii.edu		Stanhope, Meredith/0000-0002-6358-4141; Shea, Devlin/0000-0002-5058-6770; Schulz, David/0000-0003-4532-5362	National Science Foundation [IOS-1353023, IOS-1354567]; National Institutes of Health (Maine IDeA Networks of Biomedical Research Excellence (INBRE) from NIGMS) [P20GM0103423]; Doherty Fund of Bowdoin College; American Physiological Society; Cades Foundation of Honolulu, Hawaii; National Institutes of Health [MH46742]; Direct For Biological Sciences [1354567] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH046742, R01MH046742] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (Maine IDeA Networks of Biomedical Research Excellence (INBRE) from NIGMS); Doherty Fund of Bowdoin College; American Physiological Society; Cades Foundation of Honolulu, Hawaii; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Financial support for this study was provided by the National Science Foundation (IOS-1353023 to A.E.C and IOS-1354567 to P.S.D), the National Institutes of Health (Maine IDeA Networks of Biomedical Research Excellence (INBRE) [P20GM0103423 from NIGMS to Dr. Patricia Hand, Mount Desert Island Biological Laboratory]), the Doherty Fund of Bowdoin College (to D.N.S.), the American Physiological Society (to M.E.S.), and the Cades Foundation of Honolulu, Hawaii (to A.E.C). The cost of transcriptome sequencing was supported by the National Institutes of Health (MH46742 to Eve Marder, Brandeis University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aikins MJ, 2008, INSECT BIOCHEM MOLEC, V38, P740, DOI 10.1016/j.ibmb.2008.04.006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2000, BIOINFORMATICS, V16, P1145, DOI 10.1093/bioinformatics/16.12.1145; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Auerswald L, 2001, BIOCHEM BIOPH RES CO, V282, P904, DOI 10.1006/bbrc.2001.4659; Blitz DM, 2011, CURR OPIN NEUROBIOL, V21, P544, DOI 10.1016/j.conb.2011.05.019; Cape SS, 2008, J NEUROCHEM, V105, P690, DOI 10.1111/j.1471-4159.2007.05154.x; CHANG ES, 1990, BIOCHEM BIOPH RES CO, V171, P818, DOI 10.1016/0006-291X(90)91219-I; Chen RB, 2010, J PROTEOME RES, V9, P818, DOI 10.1021/pr900736t; Christie AE, 2010, J EXP BIOL, V213, P118, DOI 10.1242/jeb.037077; Christie AE, 2006, J COMP NEUROL, V496, P406, DOI 10.1002/cne.20932; Christie AE, 2015, GEN COMP EN IN PRESS; Christie AE, 2008, PEPTIDES, V29, P1909, DOI 10.1016/j.peptides.2008.07.010; Christie AE, 2008, GEN COMP ENDOCR, V159, P67, DOI 10.1016/j.ygcen.2008.07.022; Christie AE, 2008, GEN COMP ENDOCR, V157, P174, DOI 10.1016/j.ygcen.2008.03.027; Christie AE, 2008, GEN COMP ENDOCR, V156, P246, DOI 10.1016/j.ygcen.2008.01.018; Christie AE, 2015, GEN COMP ENDOCR, V213, P90, DOI 10.1016/j.ygcen.2015.02.003; Christie AE, 2015, GEN COMP ENDOCR, V211, P92, DOI 10.1016/j.ygcen.2014.11.002; Christie AE, 2015, GEN COMP ENDOCR, V210, P63, DOI 10.1016/j.ygcen.2014.10.005; Christie AE, 2014, GEN COMP ENDOCR, V206, P96, DOI 10.1016/j.ygcen.2014.07.010; Christie AE, 2014, GEN COMP ENDOCR, V206, P235, DOI 10.1016/j.ygcen.2014.04.015; Christie AE, 2014, GEN COMP ENDOCR, V204, P248, DOI 10.1016/j.ygcen.2014.05.031; Christie AE, 2014, GEN COMP ENDOCR, V204, P114, DOI 10.1016/j.ygcen.2014.05.004; Christie AE, 2014, GEN COMP ENDOCR, V202, P76, DOI 10.1016/j.ygcen.2014.04.003; Christie AE, 2014, GEN COMP ENDOCR, V201, P74, DOI 10.1016/j.ygcen.2014.01.017; Christie AE, 2014, GEN COMP ENDOCR, V201, P87, DOI 10.1016/j.ygcen.2014.02.015; Christie AE, 2014, GEN COMP ENDOCR, V195, P28, DOI 10.1016/j.ygcen.2013.10.003; Christie AE, 2013, COMP BIOCHEM PHYS D, V8, P165, DOI 10.1016/j.cbd.2013.04.002; Christie AE, 2013, GEN COMP ENDOCR, V187, P117, DOI 10.1016/j.ygcen.2013.03.018; Christie AE, 2011, CELL TISSUE RES, V345, P41, DOI 10.1007/s00441-011-1183-9; Christie AE, 2011, GEN COMP ENDOCR, V171, P131, DOI 10.1016/j.ygcen.2011.01.002; Christie AE, 2011, GEN COMP ENDOCR, V170, P144, DOI 10.1016/j.ygcen.2010.09.018; Christie AE, 2011, GEN COMP ENDOCR, V170, P480, DOI 10.1016/j.ygcen.2010.11.002; Christie AE, 2010, CELL MOL LIFE SCI, V67, P4135, DOI 10.1007/s00018-010-0482-8; Christie AE, 2010, GEN COMP ENDOCR, V167, P164, DOI 10.1016/j.ygcen.2010.01.005; Chung JS, 2006, J EXP BIOL, V209, P3862, DOI 10.1242/jeb.02425; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Cooke IM, 2002, BIOL BULL-US, V202, P108, DOI 10.2307/1543649; DEKLEIJN DPV, 1995, BBA-GENE STRUCT EXPR, V1260, P62, DOI 10.1016/0167-4781(94)00173-Z; DEKLEIJN DPV, 1994, FEBS LETT, V353, P255, DOI 10.1016/0014-5793(94)01055-2; DEKLEIJN DPV, 1993, FEBS LETT, V321, P251, DOI 10.1016/0014-5793(93)80119-F; Dickinson PS, 2008, GEN COMP ENDOCR, V156, P347, DOI 10.1016/j.ygcen.2008.01.011; Dickinson PS, 2007, J EXP BIOL, V210, P2278, DOI 10.1242/jeb.004770; Dickinson PS, 2015, J EXP BIOL, V218, P2892, DOI 10.1242/jeb.124800; Dickinson PS, 2015, J EXP BIOL, V218, P2905, DOI 10.1242/jeb.124818; Dickinson PS, 2009, J EXP BIOL, V212, P1140, DOI 10.1242/jeb.028621; Dickinson PS, 2009, PEPTIDES, V30, P297, DOI 10.1016/j.peptides.2008.10.009; Dircksen H, 2011, J PROTEOME RES, V10, P4478, DOI 10.1021/pr200284e; dos Santos G, 2015, NUCLEIC ACIDS RES, V43, pD690, DOI 10.1093/nar/gku1099; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; Fu Q, 2005, BIOCHEM BIOPH RES CO, V337, P765, DOI 10.1016/j.bbrc.2005.09.111; Gard AL, 2009, GEN COMP ENDOCR, V160, P271, DOI 10.1016/j.ygcen.2008.12.014; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; Hansen KK, 2010, J BIOL CHEM, V285, P10736, DOI 10.1074/jbc.M109.045369; Hooper SL, 2004, NEUROSIGNALS, V13, P50, DOI 10.1159/000076158; Horodyski FM, 2011, INSECT BIOCHEM MOLEC, V41, P804, DOI 10.1016/j.ibmb.2011.06.002; Hui LM, 2012, PEPTIDES, V36, P230, DOI 10.1016/j.peptides.2012.05.007; Jiang XY, 2012, ACS CHEM NEUROSCI, V3, P439, DOI 10.1021/cn200107v; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Li LJ, 2002, J COMP NEUROL, V444, P227, DOI 10.1002/cne.10139; Ma MM, 2008, GEN COMP ENDOCR, V156, P395, DOI 10.1016/j.ygcen.2008.01.009; Ma MM, 2010, PEPTIDES, V31, P27, DOI 10.1016/j.peptides.2009.10.007; Ma MM, 2009, PEPTIDES, V30, P1660, DOI 10.1016/j.peptides.2009.05.023; Ma MM, 2009, GEN COMP ENDOCR, V161, P320, DOI 10.1016/j.ygcen.2009.01.015; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Martinez-Perez F, 2007, PEPTIDES, V28, P76, DOI 10.1016/j.peptides.2006.09.021; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Nagai C, 2014, J BIOL CHEM, V289, P32166, DOI 10.1074/jbc.M114.590646; Nesbit KT, 2014, COMP BIOCHEM PHYS D, V12, P16, DOI 10.1016/j.cbd.2014.09.002; Nusbaum MP, 2001, TRENDS NEUROSCI, V24, P146, DOI 10.1016/S0166-2236(00)01723-9; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poels J, 2005, PEPTIDES, V26, P109, DOI 10.1016/j.peptides.2004.07.015; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Saideman SR, 2007, J NEUROPHYSIOL, V97, P579, DOI 10.1152/jn.00772.2006; SCHWARZ TL, 1984, J NEUROSCI, V4, P1300; Selverston AI, 2006, BIOL CYBERN, V95, P537, DOI 10.1007/s00422-006-0125-1; Sharp JH, 2010, GEN COMP ENDOCR, V169, P65, DOI 10.1016/j.ygcen.2010.07.006; Skiebe P, 2001, J EXP BIOL, V204, P2035; Stein W, 2009, J COMP PHYSIOL A, V195, P989, DOI 10.1007/s00359-009-0483-y; Stemmler EA, 2006, J MASS SPECTROM, V41, P295, DOI 10.1002/jms.989; Stemmler EA, 2005, ANAL CHEM, V77, P3594, DOI 10.1021/ac0502347; Stemmler EA, 2007, PEPTIDES, V28, P2104, DOI 10.1016/j.peptides.2007.08.019; Stemmler EA, 2007, GEN COMP ENDOCR, V154, P184, DOI 10.1016/j.ygcen.2007.06.025; Stemmler EA, 2010, GEN COMP ENDOCR, V165, P1, DOI 10.1016/j.ygcen.2009.05.010; Stepanyan R, 2006, PHYSIOL GENOMICS, V25, P224, DOI 10.1152/physiolgenomics.00276.2005; Stevens JS, 2009, J EXP BIOL, V212, P3961, DOI 10.1242/jeb.035741; TENSEN CP, 1991, EUR J BIOCHEM, V200, P103, DOI 10.1111/j.1432-1033.1991.tb21054.x; Torfs P, 2001, EUR J BIOCHEM, V268, P149, DOI 10.1046/j.1432-1327.2001.01858.x; Toullec JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071609; Towle DW, 2006, INTEGR COMP BIOL, V46, P912, DOI 10.1093/icb/icl002; TRIMMER BA, 1987, J COMP NEUROL, V266, P16, DOI 10.1002/cne.902660103; Veenstra JA, 2000, ARCH INSECT BIOCHEM, V43, P49, DOI 10.1002/(SICI)1520-6327(200002)43:2&lt;49::AID-ARCH1&gt;3.0.CO;2-M; Veenstra JA, 2012, INSECT BIOCHEM MOLEC, V42, P277, DOI 10.1016/j.ibmb.2011.12.009; Ventura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097323; Williams AH, 2013, J NEUROSCI, V33, P16565, DOI 10.1523/JNEUROSCI.2903-13.2013; Wiwatpanit T, 2012, J EXP BIOL, V215, P2308, DOI 10.1242/jeb.069989; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046513; Yasuda-Kamatani Y, 2006, J COMP NEUROL, V496, P135, DOI 10.1002/cne.20903	101	65	65	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145964	10.1371/journal.pone.0145964	http://dx.doi.org/10.1371/journal.pone.0145964			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716450	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500103
J	Ji, HB; Zhuang, SY; Zhu, ZL; Zhong, ZK				Ji, Haibao; Zhuang, Shunyao; Zhu, Zhaoliang; Zhong, Zheke			Soil Organic Carbon Pool and Its Chemical Composition in Phyllostachy pubescens Forests at Two Altitudes in Jian-ou City, China	PLOS ONE			English	Article							LAND-USE CHANGE; ELEVATION GRADIENT; HUMUS FORMS; TEMPERATURE-DEPENDENCE; MATTER DECOMPOSITION; NMR-SPECTROSCOPY; HUMIC SUBSTANCES; PADDY SOIL; STOCKS; STORAGE	Phyllostachys pubescens forests play an important role in soil organic carbon (SOC) sequestration in terrestrial ecosystems. However, the estimation and mechanism of SOC sequestration by P. pubescens forests remain unclear. In this study, the effect of P. pubescens forest distribution with elevation was investigated at two altitude sites in Jian-ou City, Southeast China. SOC storage was estimated and its chemical composition was obtained via C-13-nuclear magnetic resonance (NMR), chemical classification, and spectral analysis. Results showed that the SOC contents and stocks were significantly higher at the high-altitude site than at the low-altitude site in the entire soil profile (0-60 cm). The C contents of the three combined humus forms exhibited similar responses to the elevation change, and all of these forms were higher at the high-altitude site than at the low-altitude site regardless of soil layer. However, the proportions of the three combined humus C showed no significant differences between the two altitudes. The results of C-13-NMR showed that the SOC chemical composition did not significantly vary with elevation as well. This finding was consistent with the E-465/E-665 of the loosely combined humus. Overall, the results suggested that altitude should be considered during regional SOC estimation and that altitude affected the quantity rather than the quality of the SOC under the same P. pubescens vegetation.	[Ji, Haibao; Zhuang, Shunyao; Zhu, Zhaoliang] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Ji, Haibao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhong, Zheke] Chinese Acad Forestry, China Bamboo Res Ctr, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Forestry; China National Bamboo Research Center, CAF	Zhuang, SY (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	syzhuang@issas.ac.cn			Special Project for Basic Work in Science and Technology of China [2012FY111800]; Chinese Nonprofit Industry Research Project [201504407]	Special Project for Basic Work in Science and Technology of China; Chinese Nonprofit Industry Research Project	The authors would like to thank the Special Project for Basic Work in Science and Technology of China (2012FY111800) and the Chinese Nonprofit Industry Research Project (201504407) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreetta A, 2011, BIOL FERT SOILS, V47, P31, DOI 10.1007/s00374-010-0499-z; Baldock JA, 1997, AUST J SOIL RES, V35, P1061, DOI 10.1071/S97004; Beniston M, 2003, CLIMATIC CHANGE, V59, P5, DOI 10.1023/A:1024458411589; Bonifacio E, 2011, BIOL FERT SOILS, V47, P555, DOI 10.1007/s00374-011-0568-y; Bonito GM, 2003, FOREST ECOL MANAG, V176, P563, DOI 10.1016/S0378-1127(02)00234-7; Britton AJ, 2011, PLANT SOIL, V345, P287, DOI 10.1007/s11104-011-0781-3; Chen H, 2006, B ENG GEOL ENVIRON, V65, P445, DOI 10.1007/s10064-005-0030-1; Chen XG, 2009, FOREST ECOL MANAG, V258, P1489, DOI 10.1016/j.foreco.2009.06.051; Chin YP, 1997, ENVIRON SCI TECHNOL, V31, P1630, DOI 10.1021/es960404k; Couteaux MM, 2002, SOIL BIOL BIOCHEM, V34, P69, DOI 10.1016/S0038-0717(01)00155-9; Dahlgren RA, 1997, GEODERMA, V78, P207, DOI 10.1016/S0016-7061(97)00034-7; Dai KH, 2001, BIOGEOCHEMISTRY, V54, P51, DOI 10.1023/A:1010697518227; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Djukic I, 2010, J PLANT NUTR SOIL SC, V173, P30, DOI 10.1002/jpln.200900027; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; Du BM, 2014, ECOL RES, V29, P433, DOI 10.1007/s11284-014-1135-4; Fu J., 2001, BAMBOO, V22, P5; Fu J., 2000, AM BAMBOO SOC MAG, V21, P12; Fu WJ, 2014, J SOIL SEDIMENT, V14, P320, DOI 10.1007/s11368-013-0665-7; Garten CT, 2006, GEODERMA, V136, P342, DOI 10.1016/j.geoderma.2006.03.049; Garten CT, 1999, BIOGEOCHEMISTRY, V45, P115, DOI 10.1007/BF01106778; Garten CT, 2004, SOIL BIOL BIOCHEM, V36, P1491, DOI 10.1016/j.soilbio.2004.04.019; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Gupta M. K., 2013, APPL ECOLOGY ENV SCI, V1, P7, DOI DOI 10.12691/AEES-1-1-2; Guru Charan, 2012, African Journal of Agricultural Research, V7, P6313; Hoffmann U, 2014, GEODERMA, V232, P270, DOI 10.1016/j.geoderma.2014.04.038; Hontoria C, 1999, SOIL SCI SOC AM J, V63, P614, DOI 10.2136/sssaj1999.03615995006300030026x; Huan ZQ, 2008, FOREST ECOL MANAG, V254, P46, DOI 10.1016/j.foreco.2007.07.021; Huang CY, 2014, J SOIL SEDIMENT, V14, P1061, DOI 10.1007/s11368-014-0870-z; Jien SH, 2011, J FOREST RES-JPN, V16, P275, DOI 10.1007/s10310-010-0231-8; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Johnson DW, 2001, FOREST ECOL MANAG, V140, P227, DOI 10.1016/S0378-1127(00)00282-6; Katterer T, 1998, BIOL FERT SOILS, V27, P258, DOI 10.1007/s003740050430; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; KONONOVA M. M., 1966, Soil Organic Matter. Its Nature, its Role in Soil Formation and in Soil Fertility.; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Leifeld J, 2009, GLOBAL CHANGE BIOL, V15, P668, DOI 10.1111/j.1365-2486.2008.01782.x; Lemenih M, 2004, GEODERMA, V123, P177, DOI 10.1016/j.geoderma.2004.02.004; Li YF, 2010, J SOIL SEDIMENT, V10, P739, DOI 10.1007/s11368-010-0188-4; Liu ShuXia, 2002, Journal of Jilin Agricultural University, V24, P72; Lu RK, 2000, ANALYTICAL METHODS O; Ma Li, 2008, Yingyong Shengtai Xuebao, V19, P1951; MacDonald NW, 1999, SOIL SCI SOC AM J, V63, P211, DOI 10.2136/sssaj1999.03615995006300010030x; Martin-Neto L, 1998, GEODERMA, V81, P305, DOI 10.1016/S0016-7061(97)00089-X; Mathers NJ, 2000, AUST J SOIL RES, V38, P769, DOI 10.1071/SR99074; Mathers NJ, 2003, GEODERMA, V114, P19, DOI 10.1016/S0016-7061(02)00339-7; Mathers NJ, 2002, AUST J SOIL RES, V40, P655, DOI 10.1071/SR01073; Matus F, 2008, GEODERMA, V148, P180, DOI 10.1016/j.geoderma.2008.10.004; Niklinska M, 2007, BIOL FERT SOILS, V43, P511, DOI 10.1007/s00374-006-0129-y; Ohrnberger D, 1999, THE BAMBOOS OF THE W; Ponge JF, 2003, SOIL BIOL BIOCHEM, V35, P935, DOI 10.1016/S0038-0717(03)00149-4; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Rasmussen C, 2005, SOIL SCI SOC AM J, V69, P1711, DOI 10.2136/sssaj2005.0040; Rumpel C, 2010, NUTR CYCL AGROECOSYS, V88, P173, DOI 10.1007/s10705-009-9333-0; Schnitzer M, 2001, CAN J SOIL SCI, V81, P249, DOI 10.4141/S00-064; Schoening I, 2006, SOIL BIOL BIOCHEM, V38, P2411, DOI 10.1016/j.soilbio.2006.03.005; Senesi N, 2003, GEODERMA, V116, P325, DOI 10.1016/S0016-7061(03)00107-1; Shrestha BM, 2008, SOIL SCI SOC AM J, V72, P1563, DOI 10.2136/sssaj2007.0375; Smith JL, 2002, SOIL BIOL BIOCHEM, V34, P1749, DOI 10.1016/S0038-0717(02)00162-1; Spielvogel S, 2008, EUR J SOIL SCI, V59, P674, DOI 10.1111/j.1365-2389.2008.01030.x; State Forestry Administration P. R. China (SFAPRC), 2005, STATISTICS OF FOREST; State Soil Survey Service of China, 1998, SOILS OF CHINA; STEVENSON IL, 1982, SOIL SCI, V133, P179, DOI 10.1097/00010694-198203000-00007; Tewksbury CE, 2007, CAN J FOREST RES, V37, P1161, DOI 10.1139/X06-317; Trumbore SE, 1996, SCIENCE, V272, P393, DOI 10.1126/science.272.5260.393; Uyguner CS, 2004, ANAL BIOANAL CHEM, V378, P1579, DOI 10.1007/s00216-003-2451-7; Wang B, 2013, J TROP FOR SCI, V25, P137; Wang SL, 2004, ENVIRON MANAGE, V33, pS200, DOI 10.1007/s00267-003-9130-5; Wei YW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072201, 10.1371/journal.pone.0060044]; World Reference Base for Soil Resources (WRB), 2006, 103 FAO WORLD REF BA, P103; Xu XJ, 2011, INT J REMOTE SENS, V32, P1431, DOI 10.1080/01431160903551389; Zech W, 1997, GEODERMA, V79, P117, DOI 10.1016/S0016-7061(97)00040-2; [张彩华 Zhang Caihua], 2011, [光谱实验室, Chinese Journal of Spectroscopy laboratory], V28, P693; Zhang HX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119175; [张厚喜 Zhang Houxi], 2014, [土壤, Soils], V46, P413; Zhang M, 2011, PEDOSPHERE, V21, P615, DOI 10.1016/S1002-0160(11)60163-X; Zhang T, 2013, PLANT SOIL, V367, P249, DOI 10.1007/s11104-012-1551-6; Zhou GuoMo, 2004, Scientia Silvae Sinicae, V40, P20; Zhou P, 2010, EUR J SOIL SCI, V61, P231, DOI 10.1111/j.1365-2389.2009.01223.x; Zhu BA, 2010, J PLANT RES, V123, P439, DOI 10.1007/s10265-009-0301-1; Zhuang SY, 2015, TROP ECOL, V56, P383	82	6	9	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146029	10.1371/journal.pone.0146029	http://dx.doi.org/10.1371/journal.pone.0146029			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716688	gold, Green Published, Green Submitted			2022-12-27	WOS:000367510500120
J	Rasmussen, CH; Petersen, DR; Moeller, JB; Hansson, M; Dufva, M				Rasmussen, Camilla Holzmann; Petersen, Dorthe Roenn; Moeller, Jonas Bech; Hansson, Mattias; Dufva, Martin			Collagen Type I Improves the Differentiation of Human Embryonic Stem Cells towards Definitive Endoderm	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; MOUSE; GENE; FIBRONECTIN; TRANSCRIPTION; MESODERM; CATENIN; CANCER; NANOG	Human embryonic stem cells have the ability to generate all cell types in the body and can potentially provide an unlimited source of cells for cell replacement therapy to treat degenerative diseases such as diabetes. Current differentiation protocols of human embryonic stem cells towards insulin producing beta cells focus on soluble molecules whereas the impact of cell-matrix interactions has been mainly unattended. In this study almost 500 different extracellular matrix protein combinations were screened to systemically identify extracellular matrix proteins that influence differentiation of human embryonic stem cells to the definitive endoderm lineage. The percentage of definitive endoderm cells after differentiation on collagen I and fibronectin was >85% and 65%, respectively. The cells on collagen I substrates displayed different morphology and gene expression during differentiation as assessed by time lapse studies compared to cells on the other tested substrates. Global gene expression analysis showed that cells differentiated on collagen I were largely similar to cells on fibronectin after completed differentiation. Collectively, the data suggest that collagen I induces a more rapid and consistent differentiation of stem cells to definitive endoderm. The results shed light on the importance of extracellular matrix proteins for differentiation and also points to a cost effective and easy method to improve differentiation.	[Rasmussen, Camilla Holzmann; Petersen, Dorthe Roenn; Moeller, Jonas Bech; Hansson, Mattias] Novo Nordisk AS, Malov, Denmark; [Rasmussen, Camilla Holzmann; Dufva, Martin] Tech Univ Denmark, DTU Nanotech, DK-2800 Lyngby, Denmark	Novo Nordisk; Technical University of Denmark	Hansson, M (corresponding author), Novo Nordisk AS, Malov, Denmark.	mshs@novonordisk.com; Martin.dufva@nanotech.dtu.dk	Dufva, Martin/V-9469-2019; Dufva, Martin/D-1873-2012	Dufva, Martin/0000-0001-5449-0189	Innovation Fund Denmark; Novo Nordisk A/S	Innovation Fund Denmark; Novo Nordisk A/S(Novo Nordisk)	This work was supported by a grant from Innovation Fund Denmark and Novo Nordisk A/S. The funders provided support in the form of salary for author CHR and research materials. Novo Nordisk A/S also provided support in the form of salaries for authors DRP, JBM and MH, but the funding entities did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ameri J, 2010, STEM CELLS, V28, P45, DOI 10.1002/stem.249; Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Brafman DA, 2013, CELL DEATH DIFFER, V20, P369, DOI 10.1038/cdd.2012.138; Carthy JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019809; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Cicchini C, 2008, EXP CELL RES, V314, P143, DOI 10.1016/j.yexcr.2007.09.005; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Darribere T, 2000, MECH DEVELOP, V92, P239, DOI 10.1016/S0925-4773(00)00245-8; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Evans AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033346; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Fox IJ, 2014, SCIENCE, V345, P889, DOI 10.1126/science.1247391; Gersdorff N, 2005, DEV DYNAM, V233, P1140, DOI 10.1002/dvdy.20425; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Harburger DS, 2009, J CELL SCI, V122, P1472, DOI 10.1242/jcs.052910; Higuchi Y, 2010, J CELL SCI, V123, P2733, DOI 10.1242/jcs.066886; Holster T, 2007, J BIOL CHEM, V282, P2512, DOI 10.1074/jbc.M606608200; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kelder T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006447; Koenig A, 2006, CANCER RES, V66, P4662, DOI 10.1158/0008-5472.CAN-05-2804; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Lee LH, 2009, STEM CELL RES, V2, P155, DOI 10.1016/j.scr.2008.11.004; LOHLER J, 1984, CELL, V38, P597, DOI 10.1016/0092-8674(84)90514-2; Madsen OD, 2006, NAT BIOTECHNOL, V24, P1481, DOI 10.1038/nbt1206-1481; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Parsons MJ, 2002, DEVELOPMENT, V129, P3137; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Prowse ABJ, 2011, STEM CELL RES, V6, P1, DOI 10.1016/j.scr.2010.09.005; Rasmussen CH, 2016, ADV FUNCT MATER, V26, P815, DOI 10.1002/adfm.201504204; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; SASAKI H, 1993, DEVELOPMENT, V118, P47; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; SMITH AG, 2001, ANN REV CELL DEV BIO; Stover DA, 2011, MOL BIOL EVOL, V28, P533, DOI 10.1093/molbev/msq221; Switzer CH, 2012, MOL CANCER RES, V10, P1203, DOI 10.1158/1541-7786.MCR-12-0124; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Taylor-Weiner H, 2013, STEM CELLS, V31, P2084, DOI 10.1002/stem.1453; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vazin T, 2010, RESTOR NEUROL NEUROS, V28, P589, DOI 10.3233/RNN-2010-0543; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Wong JCY, 2010, CELL ADHES MIGR, V4, P39, DOI 10.4161/cam.4.1.10627; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Zagris N, 2001, MICRON, V32, P427, DOI 10.1016/S0968-4328(00)00011-1; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	58	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145389	10.1371/journal.pone.0145389	http://dx.doi.org/10.1371/journal.pone.0145389			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713616	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900038
J	Zhang, HF; Cannell, MB; Kim, SJ; Watson, JJ; Norman, R; Calaghan, SC; Orchard, CH; James, AF				Zhang, Haifei; Cannell, Mark B.; Kim, Shang Jin; Watson, Judy J.; Norman, Ruth; Calaghan, Sarah C.; Orchard, Clive H.; James, Andrew F.			Cellular Hypertrophy and Increased Susceptibility to Spontaneous Calcium-Release of Rat Left Atrial Myocytes Due to Elevated Afterload	PLOS ONE			English	Article							RETICULUM CA2+ LEAK; SARCOPLASMIC-RETICULUM; VENTRICULAR MYOCYTES; CARDIAC MYOCYTES; HEART-FAILURE; INTRACELLULAR CALCIUM; HYPERTENSIVE-RATS; OVINE MODEL; FIBRILLATION; MECHANISMS	Atrial remodeling due to elevated arterial pressure predisposes the heart to atrial fibrillation (AF). Although abnormal sarcoplasmic reticulum (SR) function has been associated with AF, there is little information on the effects of elevated afterload on atrial Ca2+-handling. We investigated the effects of ascending aortic banding (AoB) on Ca2+-handling in rat isolated atrial myocytes in comparison to age-matched sham-operated animals (Sham). Myocytes were either labelled for ryanodine receptor (RyR) or loaded with fluo-3-AM and imaged by confocal microscopy. AoB myocytes were hypertrophied in comparison to Sham controls (P< 0.0001). RyR labeling was localized to the z-lines and to the cell edge. There were no differences between AoB and Sham in the intensity or pattern of RyR-staining. In both AoB and Sham, electrical stimulation evoked robust SR Ca2+-release at the cell edge whereas Ca2+ transients at the cell center were much smaller. Western blotting showed a decreased L-type Ca channel expression but no significant changes in RyR or RyR phosphorylation or in expression of Na+/Ca2+ exchanger, SR Ca2+ ATPase or phospholamban. Mathematical modeling indicated that [Ca2+](i) transients at the cell center were accounted for by simple centripetal diffusion of Ca2+ released at the cell edge. In contrast, caffeine (10 mM) induced Ca2+ release was uniform across the cell. The caffeine-induced transient was smaller in AoB than in Sham, suggesting a reduced SR Ca2+-load in hypertrophied cells. There were no significant differences between AoB and Sham cells in the rate of Ca2+ extrusion during recovery of electrically-stimulated or caffeine-induced transients. The incidence and frequency of spontaneous Ca2+-transients following rapid-pacing (4 Hz) was greater in AoB than in Sham myocytes. In conclusion, elevated afterload causes cellular hypertrophy and remodeling of atrial SR Ca2+-release.	[Zhang, Haifei; Cannell, Mark B.; Kim, Shang Jin; Watson, Judy J.; Orchard, Clive H.; James, Andrew F.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Cardiovasc Res Labs, Bristol BS8 1TD, Avon, England; [Norman, Ruth; Calaghan, Sarah C.] Univ Leeds, Sch Biomed Sci, Garstang, Leeds LS2 9JT, W Yorkshire, England	University of Bristol; University of Leeds	James, AF (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Cardiovasc Res Labs, Bristol BS8 1TD, Avon, England.	a.james@bristol.ac.uk		Calaghan, Sarah/0000-0002-9145-2576	British Heart Foundation (GB) [PG/07/101, RG/12/10]; British Heart Foundation [RG/12/10/29802] Funding Source: researchfish	British Heart Foundation (GB); British Heart Foundation(British Heart Foundation)	This work was supported by grant funding from the British Heart Foundation (GB) (http://www.bhf.org.uk/) (PG/07/101 AFJ CHO) (RG/12/10 CHO AFJ MBC).	BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; BERLIN JR, 1989, CIRC RES, V65, P115, DOI 10.1161/01.RES.65.1.115; BerrebiBertrand I, 1997, EUR J BIOCHEM, V247, P801, DOI 10.1111/j.1432-1033.1997.t01-1-00801.x; Bosch RF, 1999, CARDIOVASC RES, V44, P121, DOI 10.1016/S0008-6363(99)00178-9; Brette F, 2002, AM J PHYSIOL-HEART C, V283, pH1720, DOI 10.1152/ajpheart.00347.2002; CANNELL MB, 1994, BIOPHYS J, V67, P1942, DOI 10.1016/S0006-3495(94)80677-0; CARL SL, 1995, J CELL BIOL, V129, P672; CHEN Q, 1992, CAN J PHYSIOL PHARM, V70, P509, DOI 10.1139/y92-066; Chen-Izu Y, 2006, BIOPHYS J, V91, P1, DOI 10.1529/biophysj.105.077180; Choisy SCM, 2007, HYPERTENSION, V49, P498, DOI 10.1161/01.HYP.0000257123.95372.ab; Christ T, 2004, CIRCULATION, V110, P2651, DOI 10.1161/01.CIR.0000145659.80212.6A; Clarke JD, 2015, J MOL CELL CARDIOL, V79, P169, DOI 10.1016/j.yjmcc.2014.11.017; Dibb KM, 2004, J MOL CELL CARDIOL, V37, P1171, DOI 10.1016/j.yjmcc.2004.09.005; Diness JG, 2011, HYPERTENSION, V57, P1129, DOI 10.1161/HYPERTENSIONAHA.111.170613; Fischer TH, 2013, CIRCULATION, V128, P970, DOI 10.1161/CIRCULATIONAHA.113.001746; Grammer JB, 2001, BASIC RES CARDIOL, V96, P82, DOI 10.1007/s003950170081; Hove-Madsen L, 2004, CIRCULATION, V110, P1358, DOI 10.1161/01.CIR.0000141296.59876.87; ISENBERG G, 1982, PFLUG ARCH EUR J PHY, V395, P6, DOI 10.1007/BF00584963; Kim SJ, 2011, CIRC-ARRHYTHMIA ELEC, V4, P761, DOI 10.1161/CIRCEP.111.964783; Kirk MM, 2003, J PHYSIOL-LONDON, V547, P441, DOI 10.1113/jphysiol.2002.034355; Kistler PM, 2006, EUR HEART J, V27, P3045, DOI 10.1093/eurheartj/ehl360; Kockskamper J, 2001, BIOPHYS J, V81, P2590, DOI 10.1016/S0006-3495(01)75903-6; Kong CHT, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002931; Lau DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072416; Lenaerts I, 2009, CIRC RES, V105, P876, DOI 10.1161/CIRCRESAHA.109.206276; Li DS, 2000, CIRCULATION, V101, P2631, DOI 10.1161/01.CIR.101.22.2631; Mackenzie L, 2001, J PHYSIOL-LONDON, V530, P417, DOI 10.1111/j.1469-7793.2001.0417k.x; Neef S, 2010, CIRC RES, V106, P1134, DOI 10.1161/CIRCRESAHA.109.203836; NEGRETTI N, 1993, CARDIOVASC RES, V27, P1826, DOI 10.1093/cvr/27.10.1826; O'Neill SC, 2004, J PHYSIOL-LONDON, V559, P121, DOI 10.1113/jphysiol.2003.058917; Pluteanu F, 2015, CARDIOVASC RES, V106, P87, DOI 10.1093/cvr/cvv045; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Shan J, 2010, J CLIN INVEST, V120, P4388, DOI 10.1172/JCI32726; Soeller C, 1997, BIOPHYS J, V73, P97, DOI 10.1016/S0006-3495(97)78051-2; Stange M, 2003, J BIOL CHEM, V278, P51693, DOI 10.1074/jbc.M310406200; TAKAMATSU T, 1990, FASEB J, V4, P1519, DOI 10.1096/fasebj.4.5.2307330; Vagaonescu TD, 2008, HYPERTENSION, V51, P1552, DOI 10.1161/HYPERTENSIONAHA.108.110775; van Oort RJ, 2010, CIRCULATION, V122, P2669, DOI 10.1161/CIRCULATIONAHA.110.982298; Vest JA, 2005, CIRCULATION, V111, P2025, DOI 10.1161/01.CIR.0000162461.67140.4C; Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Walden AP, 2009, J MOL CELL CARDIOL, V46, P463, DOI 10.1016/j.yjmcc.2008.11.003; Woo SH, 2005, J PHYSIOL-LONDON, V567, P905, DOI 10.1113/jphysiol.2005.092270; Workman AJ, 2001, CARDIOVASC RES, V52, P226, DOI 10.1016/S0008-6363(01)00380-7; Yamasaki Y, 1997, ANAT REC, V248, P70; Yeh YH, 2008, CIRC-ARRHYTHMIA ELEC, V1, P93, DOI 10.1161/CIRCEP.107.754788; Zima AV, 2010, J PHYSIOL-LONDON, V588, P4743, DOI 10.1113/jphysiol.2010.197913	48	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144309	10.1371/journal.pone.0144309	http://dx.doi.org/10.1371/journal.pone.0144309			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713852	gold, Green Published, Green Submitted			2022-12-27	WOS:000367481900008
J	Cross-Villasana, F; Gropel, P; Doppelmayr, M; Beckmann, J				Cross-Villasana, Fernando; Groepel, Peter; Doppelmayr, Michael; Beckmann, Juergen			Unilateral Left-Hand Contractions Produce Widespread Depression of Cortical Activity after Their Execution	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR-EVOKED-POTENTIALS; EEG ALPHA; FUNCTIONAL-SIGNIFICANCE; MUSCLE-CONTRACTIONS; SKILL FAILURE; WHITE-MATTER; ASYMMETRY; RHYTHMS; POWER	The execution of unilateral hand contractions before performance has been reported to produce behavioral aftereffects in various tasks. These effects have been regularly attributed to an induced shift in activation asymmetry to the contralateral hemisphere produced by the contractions. An alternative explanation proposes a generalized state of reduced bilateral cortical activity following unilateral hand contractions. The current experiment contrasted the above explanation models and tested the state of cortical activity after the termination of unilateral hand contractions. Twenty right-handed participants performed hand contractions in two blocks, one for each hand. Using electroencephalogram (EEG), the broad alpha band and its asymmetry between hemispheres before, during, and after hand contractions were analyzed. During contractions, significant bilateral decrease in alpha amplitudes (indicating cortical activation) emerged for both hands around sensory-motor regions. After contractions, alpha amplitudes increased significantly over the whole scalp when compared to baseline, but only for the left hand. No modulation of hemispheric asymmetry was observed at any phase. The results suggest that unilateral hand contractions produce a state of reduced cortical activity after their termination, which is more pronounced if the left hand was used. Consequently, we propose that the reduced cortical activity (and not the persistent activation asymmetry) may facilitate engagement in subsequent behavior, probably due to preventing interference from other, nonessential cortical regions.	[Cross-Villasana, Fernando; Groepel, Peter; Beckmann, Juergen] Tech Univ Munich, Chair Sport Psychol, D-80290 Munich, Germany; [Doppelmayr, Michael] Johannes Gutenberg Univ Mainz, Inst Sport Sci, D-55122 Mainz, Germany	Technical University of Munich; Johannes Gutenberg University of Mainz	Cross-Villasana, F (corresponding author), Tech Univ Munich, Chair Sport Psychol, D-80290 Munich, Germany.	fernando.cross@tum.de	Beckmann, Juergen/G-7271-2011; Doppelmayr, Michael/GRF-5286-2022	Beckmann, Juergen/0000-0001-7238-4646; Gropel, Peter/0000-0001-8765-176X				ALARCON G, 1994, J NEUROL NEUROSUR PS, V57, P435, DOI 10.1136/jnnp.57.4.435; Allen JS, 2003, NEUROIMAGE, V18, P880, DOI 10.1016/S1053-8119(03)00034-X; [Anonymous], 1994, J Clin Neurophysiol, V11, P111; Baumer T, 2002, EXP BRAIN RES, V146, P467, DOI 10.1007/s00221-002-1202-x; Beam W, 2009, BRAIN STIMUL, V2, P50, DOI 10.1016/j.brs.2008.09.006; Beckmann J, 2013, J EXP PSYCHOL GEN, V142, P679, DOI 10.1037/a0029852; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; Bonato C, 1996, NEUROSCI LETT, V216, P97; BRASILNETO J, 1993, EXP BRAIN RES, V93, P181; Chen YQ, 2003, EXP BRAIN RES, V148, P105, DOI 10.1007/s00221-002-1244-0; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; COLLINS D, 1990, J SPORT EXERCISE PSY, V12, P223, DOI 10.1123/jsep.12.3.223; Craig AD, 2005, TRENDS COGN SCI, V9, P566, DOI 10.1016/j.tics.2005.10.005; Davidson RJ, 2004, PHILOS T R SOC B, V359, P1395, DOI 10.1098/rstb.2004.1510; DAVIDSON RJ, 1988, INT J NEUROSCI, V39, P71, DOI 10.3109/00207458808985694; Deiber MP, 2001, CLIN NEUROPHYSIOL, V112, P1419, DOI 10.1016/S1388-2457(01)00536-3; Del Percio C, 2009, HUM BRAIN MAPP, V30, P3527, DOI 10.1002/hbm.20776; Derambure P, 1997, EPILEPSIA, V38, P655, DOI 10.1111/j.1528-1157.1997.tb01234.x; Dettmers C, 1996, J APPL PHYSIOL, V81, P596, DOI 10.1152/jappl.1996.81.2.596; Doppelmayr MM, 1998, BRAIN TOPOGR, V11, P133, DOI 10.1023/A:1022206622348; Gable PA, 2013, BRAIN COGNITION, V83, P337, DOI 10.1016/j.bandc.2013.09.012; Goldstein A, 2010, PSYCHON B REV, V17, P895, DOI 10.3758/PBR.17.6.895; GUR RC, 1980, SCIENCE, V207, P1226, DOI 10.1126/science.7355287; Harmon-Jones E, 2006, PSYCHOPHYSIOLOGY, V43, P598, DOI 10.1111/j.1469-8986.2006.00465.x; Hatfield BD, 2004, J CLIN NEUROPHYSIOL, V21, P144, DOI 10.1097/00004691-200405000-00003; Haufler AJ, 2000, BIOL PSYCHOL, V53, P131, DOI 10.1016/S0301-0511(00)00047-8; Helfrich RF, 2014, CURR BIOL, V24, P333, DOI 10.1016/j.cub.2013.12.041; Hellige J. B., 1993, HEMISPHERIC ASYMMETR; Hummel F, 2002, BRAIN, V125, P404, DOI 10.1093/brain/awf030; Iturria-Medina Y, 2011, CEREB CORTEX, V21, P56, DOI 10.1093/cercor/bhq058; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Johnson KA, 2013, BRAIN STIMUL, V6, P108, DOI 10.1016/j.brs.2012.02.003; Kapur N, 1996, BRAIN 5, V119; Kayser J, 2015, INT J PSYCHOPHYSIOL, V97, P189, DOI 10.1016/j.ijpsycho.2015.04.012; Klimesch W, 2003, EUR J NEUROSCI, V17, P1129, DOI 10.1046/j.1460-9568.2003.02517.x; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Liu JZ, 2003, J NEUROPHYSIOL, V90, P300, DOI 10.1152/jn.00821.2002; Makeig S, 1996, ADV NEUR IN, V8, P145; McGilchrist Iain, 2010, Dialogues Clin Neurosci, V12, P503; Milton JG, 2004, J CLIN NEUROPHYSIOL, V21, P134, DOI 10.1097/00004691-200405000-00002; Nunez PL, 2014, BRAIN RES, V1542, P138, DOI 10.1016/j.brainres.2013.10.036; Nunez PL, 1999, CLIN NEUROPHYSIOL, V110, P469, DOI 10.1016/S1388-2457(98)00043-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Peterson CK, 2008, PSYCHOPHYSIOLOGY, V45, P86, DOI 10.1111/j.1469-8986.2007.00597.x; Pfurtscheller G, 1997, ELECTROEN CLIN NEURO, V102, P316, DOI 10.1016/S0013-4694(96)96612-2; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Pollatos O, 2004, PSYCHOPHYSIOLOGY, V41, P476, DOI 10.1111/1469-8986.2004.00170.x; Propper RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062474; Romei V, 2008, CEREB CORTEX, V18, P2010, DOI 10.1093/cercor/bhm229; Romei V, 2008, NEUROREPORT, V19, P203, DOI 10.1097/WNR.0b013e3282f454c4; Salenius S, 1997, NEUROIMAGE, V5, P221, DOI 10.1006/nimg.1997.0261; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Sauseng P, 2009, NEUROPSYCHOLOGIA, V47, P284, DOI 10.1016/j.neuropsychologia.2008.07.021; Schevon CA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2056; Schiff BB, 1998, NEUROPSYCHOLOGY, V12, P526, DOI 10.1037/0894-4105.12.4.526; Sohn YH, 2004, EXP BRAIN RES, V158, P397, DOI 10.1007/s00221-004-1909-y; Stancak A, 1997, J CLIN NEUROPHYSIOL, V14, P419, DOI 10.1097/00004691-199709000-00008; Takahashi T, 1993, ELECTROENCEPHALOGRAP, P252; Tenke CE, 2005, CLIN NEUROPHYSIOL, V116, P2826, DOI 10.1016/j.clinph.2005.08.007; Thut G, 2009, TRENDS COGN SCI, V13, P182, DOI 10.1016/j.tics.2009.01.004; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Trevelyan AJ, 2006, J NEUROSCI, V26, P12447, DOI 10.1523/JNEUROSCI.2787-06.2006; TUCKER DM, 1986, ELECTROEN CLIN NEURO, V63, P242, DOI 10.1016/0013-4694(86)90092-1; Widmann A, 2015, J NEUROSCI METH, V250, P34, DOI 10.1016/j.jneumeth.2014.08.002; Wolf S, 2015, BIOL PSYCHOL, V105, P95, DOI 10.1016/j.biopsycho.2015.01.007; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766; ZANETTE G, 1995, EXP BRAIN RES, V107, P80; Zarkowski P, 2006, CLIN EEG NEUROSCI, V37, P247, DOI 10.1177/155005940603700316	73	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145867	10.1371/journal.pone.0145867	http://dx.doi.org/10.1371/journal.pone.0145867			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709832	Green Published, Green Submitted, gold			2022-12-27	WOS:000367451400087
J	Kato, K; Konno, D; Berry, M; Matsuzaki, F; Logan, A; Hidalgo, A				Kato, Kentaro; Konno, Daijiro; Berry, Martin; Matsuzaki, Fumio; Logan, Ann; Hidalgo, Alicia			Prox1 Inhibits Proliferation and Is Required for Differentiation of the Oligodendrocyte Cell Lineage in the Mouse	PLOS ONE			English	Article							SPINAL-CORD; GLIAL-CELLS; IN-VITRO; CNS; REMYELINATION; MACROPHAGES; DEMYELINATION; ACTIVATION; PROGENITORS; INJECTIONS	Central nervous system injury induces a regenerative response in ensheathing glial cells comprising cell proliferation, spontaneous axonal remyelination, and limited functional recovery, but the molecular mechanisms are not fully understood. In Drosophila, this involves the genes prospero and Notch controlling the balance between glial proliferation and differentiation, and manipulating their levels in glia can switch the response to injury from prevention to promotion of repair. In the mouse, Notch1 maintains NG2 oligodendrocyte progenitor cells (OPCs) in a progenitor state, but what factor may enable oligodendrocyte (OL) differentiation and functional remyelination is not understood. Here, we asked whether the mammalian homologue of prospero, Prox1, is involved. Our data show that Prox1 is distributed in NG2+ OPCs and in OLs in primary cultured cells, and in the mouse spinal cord in vivo. siRNA prox1 knockdown in primary OPCs increased cell proliferation, increased NG2+ OPC cell number and decreased CC1+ OL number. Prox1 conditional knockout in the OL cell lineage in mice increased NG2+ OPC cell number, and decreased CC1+ OL number. Lysolecithin-induced demyelination injury caused a reduction in CC1+ OLs in homozygous Prox1-/- conditional knockout mice compared to controls. Remarkably, Prox1-/- conditional knockout mice had smaller lesions than controls. Altogether, these data show that Prox1 is required to inhibit OPC proliferation and for OL differentiation, and could be a relevant component of the regenerative glial response. Therapeutic uses of glia and stem cells to promote regeneration and repair after central nervous system injury would benefit from manipulating Prox1.	[Kato, Kentaro; Hidalgo, Alicia] Univ Birmingham, Sch Biosci, NeuroDev Grp, Birmingham, W Midlands, England; [Kato, Kentaro; Berry, Martin; Logan, Ann] Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Birmingham, W Midlands, England; [Kato, Kentaro; Konno, Daijiro; Matsuzaki, Fumio] RIKEN Ctr Dev Biol, Lab Cell Asymmetry, Chuo Ku, Kobe, Hyogo, Japan	University of Birmingham; University of Birmingham; RIKEN	Hidalgo, A (corresponding author), Univ Birmingham, Sch Biosci, NeuroDev Grp, Birmingham, W Midlands, England.	a.hidalgo@bham.ac.uk	Hidalgo, Alicia/F-5930-2015	Hidalgo, Alicia/0000-0001-8041-5764; Matsuzaki, Fumio/0000-0001-7902-4520; Logan, Ann/0000-0003-3215-5042	BBSRC [BB/L008343/1, BB/K02146X/1]; Royal Society [IE121357]; BBSRC [BB/H002278/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H002278/1, BB/K02146X/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by BBSRC Project Grant BB/L008343/1 to AH and AL, and BBSRC ISIS BB/K02146X/1 and The Royal Society International Exchanges Scheme IE121357 Travel Grants to AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbik F, 2012, EXP NEUROL, V235, P43, DOI 10.1016/j.expneurol.2011.06.006; Birgbauer E, 2004, J NEUROSCI RES, V78, P157, DOI 10.1002/jnr.20248; Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193; BLAKEMORE WF, 1977, J NEUROL SCI, V33, P31, DOI 10.1016/0022-510X(77)90179-4; Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Chari DM, 2002, GLIA, V37, P307, DOI 10.1002/glia.10038; Chekenya M, 2002, J NEUROCYTOL, V31, P507, DOI 10.1023/A:1025795715377; Dimou L, 2014, PHYSIOL REV, V94, P709, DOI 10.1152/physrev.00036.2013; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Elsir T, 2012, CANCER METAST REV, V31, P793, DOI 10.1007/s10555-012-9390-8; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; FFRENCHCONSTANT C, 1986, NATURE, V323, P335, DOI 10.1038/323335a0; Fitch MT, 1999, J NEUROSCI, V19, P8182; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Genoud S, 2002, J CELL BIOL, V158, P709, DOI 10.1083/jcb.200202002; Ghasemlou N, 2007, GLIA, V55, P294, DOI 10.1002/glia.20449; Granger N, 2014, NEUROSCIENTIST, V20, P623, DOI 10.1177/1073858413514635; Griffiths RL, 2004, EMBO J, V23, P2440, DOI 10.1038/sj.emboj.7600258; HALL SM, 1972, J CELL SCI, V10, P535; Hesp ZC, 2015, J NEUROSCI, V35, P1274, DOI 10.1523/JNEUROSCI.2568-14.2015; Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008; Islam MS, 2009, NEUROCHEM INT, V54, P192, DOI 10.1016/j.neuint.2008.10.011; Iwano T, 2012, DEVELOPMENT, V139, P3051, DOI 10.1242/dev.080002; Kaltezioti V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000565; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kato K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001133; Keough MB, 2015, JOVE-J VIS EXP, DOI 10.3791/52679; Kotter MR, 2001, GLIA, V35, P204, DOI 10.1002/glia.1085; Kucharova K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-158; Kukley M, 2008, FASEB J, V22, P2957, DOI 10.1096/fj.07-090985; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; O'Meara RW, 2011, JOVE-J VIS EXP, DOI 10.3791/3324; Ousman SS, 2000, GLIA, V30, P92, DOI 10.1002/(SICI)1098-1136(200003)30:1<92::AID-GLIA10>3.0.CO;2-W; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Rubin AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077339; Seifert T, 2007, ACTA NEUROPATHOL, V113, P195, DOI 10.1007/s00401-006-0170-9; Sharma K, 2012, EXP NEUROL, V237, P370, DOI 10.1016/j.expneurol.2012.07.009; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Stidworthy MF, 2004, BRAIN, V127, P1928, DOI 10.1093/brain/awh217; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tripathi R, 2007, GLIA, V55, P698, DOI 10.1002/glia.20491; TROTTER J, 1986, NEUROCHEM RES, V11, P349, DOI 10.1007/BF00965009; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; WELTZIEN HU, 1979, BIOCHIM BIOPHYS ACTA, V559, P259, DOI 10.1016/0304-4157(79)90004-2; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yang ZS, 2005, J NEUROSCI METH, V149, P50, DOI 10.1016/j.jneumeth.2005.05.003	50	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145334	10.1371/journal.pone.0145334	http://dx.doi.org/10.1371/journal.pone.0145334			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709696	Green Published, gold			2022-12-27	WOS:000367451400038
J	Marks, J; de la Haye, K; Barnett, LM; Allender, S				Marks, Jennifer; de la Haye, Kayla; Barnett, Lisa M.; Allender, Steven			Friendship Network Characteristics Are Associated with Physical Activity and Sedentary Behavior in Early Adolescence	PLOS ONE			English	Article							ACCELEROMETER DATA REDUCTION; PEER INFLUENCE; SCHOOL; CHILDRENS; YOUTH; TRANSITION; CHILDHOOD; VALIDITY; WEIGHT	Introduction There is limited understanding of the association between peer social networks and physical activity (PA), sedentary and screen-related behaviors. This study reports on associations between personal network characteristics and these important health behaviors for early adolescents. Methods Participants were 310 students, aged 11-13 years, from fifteen randomly selected Victorian primary schools (43% response rate). PA and sedentary behaviors were collected via accelerometer and self-report questionnaire, and anthropometric measures via trained researchers. Participants nominated up to fifteen friends, and described the frequency of interaction and perceived activity intensity of these friends. Personal network predictors were examined using regression modelling for PA and sedentary/screen behavior. Results Perceived activity levels of friends, and friendships with very frequent interaction were associated with outside-of-school PA and/or sedentary/screen time. Differences according to sex were also observed in the association between network characteristics and PA and sedentary time. A higher number of friends and greater proportion of same sex friends were associated with boys engaging in more moderate-to-vigorous PA outside of school hours. PA intensity during school-day breaks was positively associated with having a greater proportion of friends who played sports for girls, and a greater proportion of male friends for boys. Conclusion Friendship network characteristics are associated with PA and sedentary/screen time in late childhood/early adolescence, and these associations differ by sex. The positive influence of very active peers may be a promising avenue to strengthen traditional interventions for the promotion of PA and reduction in screen time.	[Marks, Jennifer; Allender, Steven] Deakin Univ, WHO Collaborating Ctr Obes Prevent, Geelong, Vic 3217, Australia; [Marks, Jennifer; Barnett, Lisa M.; Allender, Steven] Deakin Univ, Sch Hlth & Social Dev, Burwood, Australia; [de la Haye, Kayla] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA	Deakin University; World Health Organization; Deakin University; University of Southern California	Marks, J (corresponding author), Deakin Univ, WHO Collaborating Ctr Obes Prevent, Geelong, Vic 3217, Australia.	jennifer.marks@deakin.edu.au	Barnett, Lisa/C-9997-2014; Allender, Steven/G-9881-2011	Barnett, Lisa/0000-0002-9731-625X; Marks, Jennifer/0000-0002-4551-7332; Allender, Steven/0000-0002-4842-3294	Alfred Deakin postdoctoral fellowship; Australian National Health and Medical Research Council/ Australian National Heart Foundation Career Development Fellowship [APP1045836]; US National Institutes of Health [1R01HL115485-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115485] Funding Source: NIH RePORTER	Alfred Deakin postdoctoral fellowship; Australian National Health and Medical Research Council/ Australian National Heart Foundation Career Development Fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	LMB is supported by an Alfred Deakin postdoctoral fellowship. SA is supported by funding from an Australian National Health and Medical Research Council/ Australian National Heart Foundation Career Development Fellowship (APP1045836). SA is a researcher on the US National Institutes of Health grant titled Systems Science to Guide Whole-of-Community Childhood Obesity Interventions (1R01HL115485-01A1). SA is a researcher within a NHMRC Centre for Research Excellence in Obesity Policy and Food Systems (APP1041020).; We acknowledge the support of the Department of Education and Early Childhood Development, Victorian Catholic Education Diocese, participating schools and students, and data collectors who made this research possible. LMB is supported by an Alfred Deakin postdoctoral fellowship. SA is supported by funding from an Australian National Health and Medical Research Council/ Australian National Heart Foundation Career Development Fellowship (APP1045836). SA is a researcher on the US National Institutes of Health grant titled Systems Science to Guide Whole-of-Community Childhood Obesity Interventions (1R01HL115485-01A1). SA is a researcher within a NHMRC Centre for Research Excellence in Obesity Policy and Food Systems (APP1041020).	Ali MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016183; Aronson E, 2005, SOZIALPSYCHOLOGIE; Arundell L, 2013, HEALTH PROMOT J AUST, V24, P65, DOI 10.1071/HE12910; Bandura Albert, 1977, SOCIAL LEARNING THEO; Berten H, 2011, SOCIOL PERSPECT, V54, P183, DOI 10.1525/sop.2011.54.2.183; Biddle SJH, 2010, PREV MED, V51, P345, DOI 10.1016/j.ypmed.2010.07.018; Borraccino A, 2009, MED SCI SPORT EXER, V41, P749, DOI 10.1249/MSS.0b013e3181917722; Brechwald WA, 2011, J RES ADOLESCENCE, V21, P166, DOI 10.1111/j.1532-7795.2010.00721.x; Brown B.B., 2004, ADOLESCENTS RELATION; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; Davies P.S.W., 2001, STANDARD METHODS COL; de la Haye K, 2011, J ADOLESCENT HEALTH, V49, P421, DOI 10.1016/j.jadohealth.2011.02.008; de la Haye K, 2011, SOC SCI MED, V73, P719, DOI 10.1016/j.socscimed.2011.06.023; de la Haye K, 2010, SOC NETWORKS, V32, P161, DOI 10.1016/j.socnet.2009.09.001; De Meester F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-261; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; De Vries SI, 2009, MED SCI SPORT EXER, V41, P818, DOI 10.1249/MSS.0b013e31818e5819; Department of Health and Ageing, 2007, AUSTR NAT CHILDR NUT; Dumith SC, 2011, INT J EPIDEMIOL, V40, P685, DOI 10.1093/ije/dyq272; Fitzgerald A, 2012, J ADOLESCENCE, V35, P941, DOI 10.1016/j.adolescence.2012.01.002; Gesell SB, 2012, PEDIATRICS, V129, P1064, DOI 10.1542/peds.2011-2567; Jago R, 2012, MED SCI SPORT EXER, V44, P111, DOI 10.1249/MSS.0b013e318229df6e; Jago R, 2011, MED SCI SPORT EXER, V43, P259, DOI 10.1249/MSS.0b013e3181edefaa; Kowalski KC, 2004, PHYS ACTIVITY QUESTI; Leech RM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-4; Macdonald-Wallis K, 2012, AM J PREV MED, V43, P636, DOI 10.1016/j.amepre.2012.08.021; Macdonald-Wallis K, 2011, SOC SCI MED, V73, P6, DOI 10.1016/j.socscimed.2011.04.018; de Rezende LFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105620; Marks J, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0218-0; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Prinstein M.J., 2008, UNDERSTANDING PEER I; Rimal RN, 2005, COMMUN RES, V32, P389, DOI 10.1177/0093650205275385; Salvy SJ, 2012, PHYSIOL BEHAV, V106, P369, DOI 10.1016/j.physbeh.2012.03.022; Sawka KJ, 2014, J OBES, V2014, DOI 10.1155/2014/632689; Sawka KJ, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-130; Shoham DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039795; Sirard JR, 2013, AM J PREV MED, V44, P48, DOI 10.1016/j.amepre.2012.09.054; Sisson SB, 2009, INT J PEDIATR OBES, V4, P353, DOI 10.3109/17477160902934777; Strauss RS, 2003, ARCH PEDIAT ADOL MED, V157, P746, DOI 10.1001/archpedi.157.8.746; Telford A, 2004, PEDIATR EXERC SCI, V16, P64, DOI 10.1123/pes.16.1.64; Toftager M, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-140; Triplett N., 1898, AM J PSYCHOL, V9, P507, DOI [10.2307/1412188, DOI 10.2307/1412188]; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wilkinson RB, 2010, J ADOLESCENCE, V33, P709, DOI 10.1016/j.adolescence.2009.10.013	49	33	36	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145344	10.1371/journal.pone.0145344	http://dx.doi.org/10.1371/journal.pone.0145344			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ9XO	26709924	Green Submitted, gold, Green Published			2022-12-27	WOS:000367451400040
J	Murugan, D; Lau, YS; Lau, WC; Mustafa, MR; Huang, Y				Murugan, Dharmani; Lau, Yeh Siang; Lau, Wai Chi; Mustafa, Mohd Rais; Huang, Yu			Angiotensin 1-7 Protects against Angiotensin II-Induced Endoplasmic Reticulum Stress and Endothelial Dysfunction via Mas Receptor	PLOS ONE			English	Article							OXIDATIVE STRESS; INDUCED APOPTOSIS; INHIBITION; ANTAGONIST; OLMESARTAN; CELLS; MICE	Angiotensin 1-7 (Ang 1-7) counter-regulates the cardiovascular actions of angiotensin II (Ang II). The present study investigated the protective effect of Ang 1-7 against Ang II-induced endoplasmic reticulum (ER) stress and endothelial dysfunction. Ex vivo treatment with Ang II (0.5 mu M, 24 hours) impaired endothelium-dependent relaxation in mouse aortas; this harmful effect of Ang II was reversed by co-treatment with ER stress inhibitors, l4-phenylbutyric acid (PBA) and tauroursodeoxycholic acid (TUDCA) as well as Ang 1-7. The Mas receptor antagonist, A779, antagonized the effect of Ang 1-7. The elevated mRNA expression of CHOP, Grp78 and ATF4 or protein expression of p-eIF2 alpha and ATF6 (ER stress markers) in Ang II-treated human umbilical vein endothelial cells (HUVECs) and mouse aortas were blunted by co-treatment with Ang 1-7 and the latter effect was reversed by A779. Furthermore, Ang II-induced reduction in both eNOS phosphorylation and NO production was inhibited by Ang 1-7. In addition, Ang 1-7 decreased the levels of ER stress markers and augmented NO production in HUVECs treated with ER stress inducer, tunicamycin. The present study provides new evidence for functional antagonism between the two arms of the renin-angiotensin system in endothelial cells by demonstrating that Ang 1-7 ameliorates Ang II-stimulated ER stress to raise NO bioavailability, and subsequently preserves endothelial function.	[Murugan, Dharmani; Lau, Yeh Siang; Mustafa, Mohd Rais] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Lau, Wai Chi; Huang, Yu] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	Universiti Malaya; Chinese University of Hong Kong	Murugan, D (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia.	dharmani79@um.edu.my; yu-huang@cuhk.edu.hk	Lau, Yee Ling/C-6996-2009; Huang, Yu/K-2866-2017; MURUGAN, DHARMANI DEVI/B-8436-2010; Mustafa, Mohamed R/B-1647-2009; Lau, Yeh Siang/D-2136-2016	Lau, Yee Ling/0000-0002-2037-2165; Huang, Yu/0000-0002-1277-6784; MURUGAN, DHARMANI DEVI/0000-0002-1345-0292; Mustafa, Mohamed R/0000-0002-7864-5189; Lau, Yeh Siang/0000-0002-1770-3058	Ministry of Education High Impact Research, Malaysia [H-20001-00-E000055]; Natural Science Foundation of China [91339117]; Hong Kong Research Grants Council [CUHK2/CRF/12G, CUHK465611, T12/402/13N]	Ministry of Education High Impact Research, Malaysia; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported by grants from Ministry of Education High Impact Research Grant H-20001-00-E000055, Malaysia, Natural Science Foundation of China (91339117) and Hong Kong Research Grants Council (CUHK2/CRF/12G, CUHK465611, T12/402/13N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chao YM, 2013, HYPERTENSION, V61, P1270, DOI 10.1161/HYPERTENSIONAHA.111.00469; Cheang WS, 2014, ARTERIOSCL THROM VAS, V34, P830, DOI 10.1161/ATVBAHA.113.301938; Chen ZY, 1999, EUR J PHARMACOL, V374, P41, DOI 10.1016/S0014-2999(99)00291-5; Christiakov DA, 2014, BIOMED RES INT, V2014; Dong JH, 2012, EUR HEART J, V33, P2980, DOI 10.1093/eurheartj/ehr459; Galan M, 2014, BBA-MOL CELL RES, V1843, P1063, DOI 10.1016/j.bbamcr.2014.02.009; Isodono K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009746; Kadowaki H, 2013, GENES-BASEL, V4, P306, DOI 10.3390/genes4030306; Kassan M, 2012, ARTERIOSCL THROM VAS, V32, P1652, DOI 10.1161/ATVBAHA.112.249318; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Lakshmanan AP, 2011, EUR J PHARM SCI, V44, P627, DOI 10.1016/j.ejps.2011.10.009; Lau YS, 2013, BRIT J PHARMACOL, V170, P1190, DOI 10.1111/bph.12350; Li G, 2010, J CELL BIOL, V191, P1113, DOI 10.1083/jcb.201006121; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; NAKAMOTO H, 1995, HYPERTENSION, V25, P796, DOI 10.1161/01.HYP.25.4.796; Rabelo LA, 2011, HYPERTENS RES, V34, P154, DOI 10.1038/hr.2010.235; Sampaio WO, 2007, HYPERTENSION, V50, P1093, DOI 10.1161/HYPERTENSIONAHA.106.084848; Santos CXC, 2014, ANTIOXID REDOX SIGN, V20, P121, DOI 10.1089/ars.2013.5262; Santos RA, 2014, HYPERTENSION, V63, P1138, DOI 10.1161/HYPERTENSIONAHA.113.01274; Spitler KM, 2014, HYPERTENSION, V63, pE40, DOI 10.1161/HYPERTENSIONAHA.113.02558; Sukumaran V, 2011, INT J BIOL SCI, V7, P154, DOI 10.7150/ijbs.7.154; Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018; Uhal BD, 2013, AM J PHYSIOL-LUNG C, V305, pL33, DOI 10.1152/ajplung.00001.2013; Wong WT, 2010, ANTIOXID REDOX SIGN, V13, P757, DOI 10.1089/ars.2009.2831; Wu TT, 2011, EUR J PHARM SCI, V42, P496, DOI 10.1016/j.ejps.2011.02.005; Xu P, 2008, HYPERTENSION, V51, P574, DOI 10.1161/HYPERTENSIONAHA.107.102764; Zhang Y, 2015, ANTIOXID REDOX SIGN, V23, P880, DOI 10.1089/ars.2014.6070; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005; Zou XJ, 2012, EXP BIOL MED, V237, P1341, DOI 10.1258/ebm.2012.012041	29	38	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145413	10.1371/journal.pone.0145413	http://dx.doi.org/10.1371/journal.pone.0145413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709511	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400045
J	Santos, E; Faria, D; Pesquita, C; Couto, FM				Santos, Emanuel; Faria, Daniel; Pesquita, Catia; Couto, Francisco M.			Ontology Alignment Repair through Modularization and Confidence-Based Heuristics	PLOS ONE			English	Article								Ontology Matching aims at identifying a set of semantic correspondences, called an alignment, between related ontologies. In recent years, there has been a growing interest in efficient and effective matching methods for large ontologies. However, alignments produced for large ontologies are often logically incoherent. It was only recently that the use of repair techniques to improve the coherence of ontology alignments began to be explored. This paper presents a novel modularization technique for ontology alignment repair which extracts fragments of the input ontologies that only contain the necessary classes and relations to resolve all detectable incoherences. The paper presents also an alignment repair algorithm that uses a global repair strategy to minimize both the degree of incoherence and the number of mappings removed from the alignment, while overcoming the scalability problem by employing the proposed modularization technique. Our evaluation shows that our modularization technique produces significantly small fragments of the ontologies and that our repair algorithm produces more complete alignments than other current alignment repair systems, while obtaining an equivalent degree of incoherence. Additionally, we also present a variant of our repair algorithm that makes use of the confidence values of the mappings to improve alignment repair. Our repair algorithm was implemented as part of AgreementMakerLight, a free and open-source ontology matching system.	[Santos, Emanuel; Pesquita, Catia; Couto, Francisco M.] Univ Lisbon, Fac Ciencias, Dept Informat, P-1699 Lisbon, Portugal; [Faria, Daniel; Pesquita, Catia; Couto, Francisco M.] Univ Lisbon, Fac Ciencias, LASIGE, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Santos, E (corresponding author), Univ Lisbon, Fac Ciencias, Dept Informat, P-1699 Lisbon, Portugal.	esantos@di.fc.ul.pt	Couto, Francisco M/A-4066-2010; Pesquita, Catia/O-8883-2015	Couto, Francisco M/0000-0003-0627-1496; Pesquita, Catia/0000-0002-1847-9393; Faria, Daniel/0000-0003-1511-277X	Portuguese FCT through the SOMER project [PTDC/EIA-EIA/119119/2010]; Portuguese FCT through the LaSIGE Strategic Project [PEst-OE/EEI/UI0408/2013]	Portuguese FCT through the SOMER project; Portuguese FCT through the LaSIGE Strategic Project	ES, DF, CP and FMC were funded by the Portuguese FCT through the SOMER project (PTDC/EIA-EIA/119119/2010) and LaSIGE Strategic Project (ref. PEst-OE/EEI/UI0408/2013).; The authors are grateful to Isabel F. Cruz and Ernesto Jimenez-Ruiz for providing valuable comments and suggestions. ES, DF, CP and FMC were funded by the Portuguese FCT through the SOMER project (PTDC/EIA-EIA/119119/2010) and LaSIGE Strategic Project (ref. PEst-OE/EEI/UI0408/2014).	[Anonymous], 2012, ORE; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Cruz Isabel F., 2012, The Semantic Web: Research and Applications. Proceedings 9th Extended Semantic Web Conference (ESWC 2012), P179, DOI 10.1007/978-3-642-30284-8_19; Cruz IF, 2009, PROC VLDB ENDOW, V2, P1586, DOI 10.14778/1687553.1687598; David J, 2006, CIKM, V2006, P830, DOI DOI 10.1145/1183614.1183752; Doran Paul, 2007, P 16 ACM C CONFERENC, P61, DOI DOI 10.1145/1321440.1321451; Duchateau F., 2009, CIKM ACM, P2079; Euzenat J., 2007, ONTOLOGY MATCHING; Faria D., SEMANTIC WEB ISWC 20, P17; Faria D., MOV MEAN INT SYST OT, P527; Faria D., 2013, P 8 INT C ONT MATCH, P101; Foto N.A., 2009, P INT C DAT THEOR IC, P31; Grau B. C., 2007, CEUR WORKSHOP P, V258; Grau B.C., 2013, P 8 ISWC WORKSH ONT, P61; Horridge M, 2008, LECT NOTES COMPUT SC, V5318, P323, DOI 10.1007/978-3-540-88564-1_21; Jimenez Ruiz E, 2013, P 26 INT WORKSH DESC, V13, P246; Jimenez-Ruiz E, 2012, FRONT ARTIF INTEL AP, V242, P444, DOI 10.3233/978-1-61499-098-7-444; Jimenez-Ruiz E, 2011, LECT NOTES COMPUT SC, V7031, P273, DOI 10.1007/978-3-642-25073-6_18; Kalyanpur A, 2007, LECT NOTES COMPUT SC, V4825, P267; Lopatenko A., 2007, EFFICIENT APPROXIMAT, P216; Meilicke C, 2011, ALIGNMENT INCOHERENC; Noy Natalya F., 2009, NUCL ACIDS RES, V37; Parsia B., 2004, 3 INT SEM WEB C, V18; Pesquita C., 2013, P 8 INT WORKSHOP ONT, V1111, P13; Sabou M., 2008, J DATA SEMANTICS, V11, P156, DOI DOI 10.1007/978-3-540-92148-66; Salvadores M, 2013, SEMANT WEB, V4, P277, DOI 10.3233/SW-2012-0086; Santos E, 2013, ARXIV13075322; Schlobach S, 2007, J AUTOM REASONING, V39, P317, DOI 10.1007/s10817-007-9076-z; Shvaiko P, 2013, IEEE T KNOWL DATA EN, V25, P158, DOI 10.1109/TKDE.2011.253; Stuckenschmidt H, 2007, DATA KNOWL ENG, V63, P200, DOI 10.1016/j.datak.2007.02.001; Suntisrivaraporn B, 2008, LECT NOTES COMPUT SC, V5367, P1, DOI 10.1007/978-3-540-89704-0_1	31	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144807	10.1371/journal.pone.0144807	http://dx.doi.org/10.1371/journal.pone.0144807			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710335	gold, Green Published, Green Submitted			2022-12-27	WOS:000367451400012
J	Vaillancourt, K; LeBel, G; Frenette, M; Fittipaldi, N; Gottschalk, M; Grenier, D				Vaillancourt, Katy; LeBel, Genevieve; Frenette, Michel; Fittipaldi, Nahuel; Gottschalk, Marcelo; Grenier, Daniel			Purification and Characterization of Suicin 65, a Novel Class I Type B Lantibiotic Produced by Streptococcus suis	PLOS ONE			English	Article							SWINE PATHOGEN; SEQUENCE; BIOSYNTHESIS; INFECTION; VIRULENCE; STRAINS; SYSTEMS	Bacteriocins are antimicrobial peptides of bacterial origin that are considered as a promising alternative to the use of conventional antibiotics. Recently, our laboratory reported the purification and characterization of two lantibiotics, suicin 90-1330 and suicin 3908, produced by the swine pathogen and zoonotic agent Streptococcus suis (serotype 2). In this study, a novel bacteriocin produced by S. suis has been identified and characterized. The producing strain S. suis 65 (serotype 2) was found to belong to the sequence type 28, that includes strains known to be weakly or avirulent in a mouse model. The bacteriocin, whose production was only possible following growth on solid culture medium, was purified to homogeneity by cationic exchange and reversed-phase high-pressure liquid chromatography. The bacteriocin, named suicin 65, was heat, pH and protease resistant. Suicin 65 was active against all S. suis isolates tested, including antibiotic resistant strains. Amino acid sequencing of the purified bacteriocin by Edman degradation revealed the presence of modified amino acids suggesting a lantibiotic. Using the partial sequence obtained, a blast was performed against published genomes of S. suis and allowed to identify a putative lantibiotic locus in the genome of S. suis 89-1591. From this genome, primers were designed and the gene cluster involved in the production of suicin 65 by S. suis 65 was amplified by PCR. Sequence analysis revealed the presence of ten open reading frames, including a duplicate of the structural gene. The structural genes (sssA and sssA') of suicin 65 encodes a 25-amino acid residue leader peptide and a 26-amino acid residue mature peptide yielding an active bacteriocin with a deducted-molecular mass of 3,005 Da. Mature suicin 65 showed a high degree of identity with class I type B lantibiotics (globular structure) produced by Streptococcus pyogenes (streptococcin FF22; 84.6%), Streptococcus macedonicus (macedocin ACA-DC 198; 84.6%), and Lactococcus lactis subsp. lactis (lacticin 481; 74.1%). Further studies will evaluate the ability of suicin 65 or the producing strain to prevent experimental S. suis infections in pigs.	[Vaillancourt, Katy; LeBel, Genevieve; Frenette, Michel; Grenier, Daniel] Univ Laval, Fac Med Dent, GREB, Quebec City, PQ, Canada; [Frenette, Michel; Gottschalk, Marcelo; Grenier, Daniel] Fonds Rech Quebec Nat & Technol FQRNT, CRIPA, St Hyacinthe, PQ, Canada; [Fittipaldi, Nahuel] Univ Toronto, Fac Med, Publ Hlth Ontario, Toronto, ON, Canada; [Fittipaldi, Nahuel] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Gottschalk, Marcelo] Univ Montreal, Fac Med Vet, Grp Rech Malad Infect Porc GREMIP, St Hyacinthe, PQ J2S 7C6, Canada	Laval University; University of Toronto; University of Toronto; Universite de Montreal	Grenier, D (corresponding author), Univ Laval, Fac Med Dent, GREB, Quebec City, PQ, Canada.	Daniel.Grenier@greb.ulaval.ca	Gottschalk, Marcelo/I-8116-2012	Fittipaldi, Nahuel/0000-0001-9553-3798	Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec [811326]	Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec	This research was supported by Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec, Grant #811326, to DG MF MG. This study made use of the Streptococcus suis Multilocus Sequence Typing Database hosted at Imperial College and whose development is funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur TD, 2014, FUTURE MICROBIOL, V9, P235, DOI 10.2217/fmb.13.148; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Baums Christoph Georg, 2009, Animal Health Research Reviews, V10, P65, DOI 10.1017/S146625230999003X; Berthelot-Herault F, 2001, CAN J VET RES, V65, P196; Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Callens BF, 2013, MICROB DRUG RESIST, V19, P146, DOI 10.1089/mdr.2012.0131; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Cromwell GL, 2002, ANIM BIOTECHNOL, V13, P7, DOI 10.1081/ABIO-120005767; de Arauz LJ, 2009, TRENDS FOOD SCI TECH, V20, P146, DOI 10.1016/j.tifs.2009.01.056; Dufour A, 2003, RECENT RES DEV BACTE, V1, P219; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Fittipaldi N, 2011, EMERG INFECT DIS, V17, P2239, DOI 10.3201/eid1712.110609; Food and Drug Administration, 2010, CVM UPD CVM REP ANT; Gottschalk M., 2012, DIS SWINE, P841; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; Khadthasrima N, 2007, HUMAN STREPTOCOCCUS, V1, P4; LeBel G, 2014, APPL ENVIRON MICROB, V80, P5484, DOI 10.1128/AEM.01055-14; Lin J, 2009, FOODBORNE PATHOG DIS, V6, P755, DOI 10.1089/fpd.2008.0247; Maldonado-Barragan A, 2009, INT J FOOD MICROBIOL, V130, P35, DOI 10.1016/j.ijfoodmicro.2008.12.033; McLaughlin RE, 1999, FEMS MICROBIOL LETT, V175, P171, DOI 10.1111/j.1574-6968.1999.tb13616.x; Melancon D, 2003, APPL ENVIRON MICROB, V69, P4482, DOI 10.1128/AEM.69.8.4482-4488.2003; MEYER HE, 1994, ANAL BIOCHEM, V223, P185, DOI 10.1006/abio.1994.1571; Nicolas GG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-69; Papadelli M, 2007, FEMS MICROBIOL LETT, V272, P75, DOI 10.1111/j.1574-6968.2007.00740.x; Segura M, 2015, EXPERT REV VACCINES, V14, P1587, DOI 10.1586/14760584.2015.1101349; Vaillancourt K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117245; Varela NP, 2013, ANIM HEALTH RES REV, V20, P1	28	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145854	10.1371/journal.pone.0145854	http://dx.doi.org/10.1371/journal.pone.0145854			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709705	gold, Green Published, Green Submitted			2022-12-27	WOS:000367451400086
J	Burnecki, K; Wylomanska, A; Chechkin, A				Burnecki, Krzysztof; Wylomanska, Agnieszka; Chechkin, Aleksei			Discriminating between Light- and Heavy-Tailed Distributions with Limit Theorem	PLOS ONE			English	Article							LEVY FLIGHT; STATISTICAL-ANALYSIS; FRACTIONAL DYNAMICS; STOCHASTIC-PROCESS; EDGE TURBULENCE; SCALING LAWS; STABLE LAWS; POWER-LAW; CONVERGENCE; FLUCTUATIONS	In this paper we propose an algorithm to distinguish between light- and heavy-tailed probability laws underlying random datasets. The idea of the algorithm, which is visual and easy to implement, is to check whether the underlying law belongs to the domain of attraction of the Gaussian or non-Gaussian stable distribution by examining its rate of convergence. The method allows to discriminate between stable and various non-stable distributions. The test allows to differentiate between distributions, which appear the same according to standard Kolmogorov-Smirnov test. In particular, it helps to distinguish between stable and Student's t probability laws as well as between the stable and tempered stable, the cases which are considered in the literature as very cumbersome. Finally, we illustrate the procedure on plasma data to identify cases with so-called L-H transition.	[Burnecki, Krzysztof; Wylomanska, Agnieszka] Wroclaw Univ Technol, Hugo Steinhaus Ctr, Dept Math, PL-50370 Wroclaw, Poland; [Chechkin, Aleksei] Kharkov Inst Phys & Technol, Akhiezer Inst Theoret Phys, Natl Sci Ctr, Kharkov, Ukraine; [Chechkin, Aleksei] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Chechkin, Aleksei] Univ Potsdam, Inst Phys & Astron, Potsdam, Germany	Wroclaw University of Science & Technology; Kharkov Institute of Physics & Technology; Max Planck Society; University of Potsdam	Burnecki, K (corresponding author), Wroclaw Univ Technol, Hugo Steinhaus Ctr, Dept Math, PL-50370 Wroclaw, Poland.	krzysztof.burnecki@pwr.edu.pl	Chechkin, Aleksei/AAC-3605-2020	Chechkin, Aleksei/0000-0002-3803-1174; Burnecki, Krzysztof/0000-0002-1754-4472; Wylomanska, Agnieszka/0000-0001-9750-1351	NCN Maestro [2012/06/A/ST1/00258]; NCN [UMO-2012/07/B/ST8/03031]	NCN Maestro; NCN	KB would like to acknowledge the support of NCN Maestro Grant No. 2012/06/A/ST1/00258. AW would like to acknowledge the support of NCN Grant No. UMO-2012/07/B/ST8/03031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; Anderson TW, 1957, ANN MATH STAT, V28, P823; Bartelmus W, 2009, MECH SYST SIGNAL PR, V23, P1528, DOI 10.1016/j.ymssp.2009.01.014; Barthelemy P, 2008, NATURE, V453, P495, DOI 10.1038/nature06948; Batanov GM, 2002, PLASMA PHYS REP+, V28, P111, DOI 10.1134/1.1450675; Beletskii AA, 2009, PLASMA PHYS REP+, V35, P818, DOI 10.1134/S1063780X0910002X; BENJAMINI Y, 1988, AM STAT, V42, P257, DOI 10.2307/2685133; Borak S, 2011, STATISTICAL TOOLS FOR FINANCE AND INSURANCE, SECOND EDITION, P21; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Brcich RF, 2005, IEEE T SIGNAL PROCES, V53, P977, DOI 10.1109/TSP.2004.842192; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Burnecki K, 2000, PHYSICA A, V287, P269, DOI 10.1016/S0378-4371(00)00453-2; Burnecki K, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056711; Burnecki K, 2011, STATISTICAL TOOLS FOR FINANCE AND INSURANCE, SECOND EDITION, P293; Burnecki K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021130; BUTZER PL, 1978, J MULTIVARIATE ANAL, V8, P202, DOI 10.1016/0047-259X(78)90072-6; Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1; Chechkin A. V., 2008, ANOMALOUS TRANSPORT, P129, DOI [10.1002/9783527622979, DOI 10.1002/9783527622979, DOI 10.1002/9783527622979.CH5]; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cont R, 1997, SCALE INVARIANCE, P75; DAgostino RB, 1986, GOODNESS OF FIT TECH; Davison A.C., 1999, CAMBRIDGE SERIES STA; Ditlevsen PD, 1999, PHYS REV E, V60, P172, DOI 10.1103/PhysRevE.60.172; Ditlevsen PD, 1999, GEOPHYS RES LETT, V26, P1441, DOI 10.1029/1999GL900252; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Gnedenko B. V., 1954, LIMIT DISTRIBUTIONS; Gonchar VY, 2003, PLASMA PHYS REP+, V29, P380, DOI 10.1134/1.1575308; Huelsenbeck JP, 1996, SYST BIOL, V45, P546, DOI 10.2307/2413530; Humphries NE, 2012, P NATL ACAD SCI USA, V109, P7169, DOI 10.1073/pnas.1121201109; Janic-Wroblewska A, 2000, SCAND J STAT, V27, P281, DOI 10.1111/1467-9469.00189; Jansen VAA, 2012, SCIENCE, V335, DOI 10.1126/science.1215747; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Jha R, 2003, PHYS PLASMAS, V10, P699, DOI 10.1063/1.1541607; Johnson O., 2004, INFORM THEORY CENTRA; Kim YS, 2010, J BANK FINANC, V34, P2096, DOI 10.1016/j.jbankfin.2010.01.015; Klenke A, 2014, PROBABILITY THEORY C, V2nd; KOPONEN I, 1995, PHYS REV E, V52, P1197, DOI 10.1103/PhysRevE.52.1197; KOUTROUVELIS IA, 1980, J AM STAT ASSOC, V75, P918, DOI 10.2307/2287182; KOUTROUVELIS IA, 1981, COMMUN STAT B-SIMUL, V10, P17, DOI 10.1080/03610918108812189; Kuske R, 2000, SIAM J APPL MATH, V61, P1308; LEPAGE R, 1981, ANN PROBAB, V9, P624, DOI 10.1214/aop/1176994367; Levy PP, 1925, 1925 THEORIE DEL ADD; Lomholt MA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.260603; MANDELBROT B, 1963, J BUS, V36, P394, DOI 10.1086/294632; Mantegna R. N., 2000, INTRO ECONOPHYSICS; MANTEGNA RN, 1994, PHYS REV LETT, V73, P2946, DOI 10.1103/PhysRevLett.73.2946; Mashanova A, 2010, J R SOC INTERFACE, V7, P199, DOI 10.1098/rsif.2009.0121; Mercadier N, 2009, NAT PHYS, V5, P602, DOI 10.1038/NPHYS1286; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Metzler R, 2004, J PHYS A-MATH GEN, V37, pR161, DOI 10.1088/0305-4470/37/31/R01; Metzler R., 2009, ENCY COMPLEXITY SYST, P1724; Mizuuchi T, 2005, J NUCL MATER, V337, P332, DOI 10.1016/j.jnucmat.2004.10.010; Neyman J, 1933, PHILOS T R SOC LOND, V231, P289, DOI 10.1098/rsta.1933.0009; Nikias C. L., 1995, SIGNAL PROCESSING WI; Nolan J, 2007, MODELS FOR HEAVY TAI; Obuchowski J, 2014, MECH SYST SIGNAL PR, V48, P138, DOI 10.1016/j.ymssp.2014.03.011; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Petrovskii S, 2011, P NATL ACAD SCI USA, V108, P8704, DOI 10.1073/pnas.1015208108; Rachev S., 2000, STABLE PARETIAN MODE; Rachev ST, 2003, HANDBOOK OF HEAVY TA; Romao X, 2010, J STAT COMPUT SIM, V80, P545, DOI 10.1080/00949650902740824; Rosinski J, 2007, STOCH PROC APPL, V117, P677, DOI 10.1016/j.spa.2006.10.003; Ross S.M., 2002, SIMULATION; Rychlik Z, 1993, PROBAB MATH STAT-POL, V14, P63; Samorodnitsky G., 1994, STABLE NONGAUSSIAN R; Sandberg I, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.165001; Sidak Z., 1967, THEORY RANK TESTS; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sokolov IM, 1997, PHYS REV LETT, V79, P857, DOI 10.1103/PhysRevLett.79.857; Tankov P, 2003, FINANCIAL MODELLING; TSUI HYW, 1993, PHYS FLUIDS B-PLASMA, V5, P2491, DOI 10.1063/1.860734; Viswanathan G. M., 2011, PHYS FORAGING; Wagner F, 2007, PLASMA PHYS CONTR F, V49, pB1, DOI 10.1088/0741-3335/49/12B/S01; Weron R, 2004, HANDBOOK OF COMPUTATIONAL STATISTICS: CONCEPTS AND METHODS, P911; Zaid IM, 2011, J R SOC INTERFACE, V8, P1314, DOI 10.1098/rsif.2010.0545	75	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145604	10.1371/journal.pone.0145604	http://dx.doi.org/10.1371/journal.pone.0145604			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698863	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600104
J	Parra, MJ; Acuna, KI; Sierra-Almeida, A; Sanfuentes, C; Saldana, A; Corcuera, LJ; Bravo, LA				Jose Parra, Maria; Acuna, Karina I.; Sierra-Almeida, Angela; Sanfuentes, Camila; Saldana, Alfredo; Corcuera, Luis J.; Bravo, Leon A.			Photosynthetic Light Responses May Explain Vertical Distribution of Hymenophyllaceae Species in a Temperate Rainforest of Southern Chile	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; PHOTOSYSTEM-I; REDOX STATE; FILMY FERNS; PLANTS; SUN; BRYOPHYTES; POIKILOHYDRY; ACCLIMATION; DISSIPATION	Some epiphytic Hymenophyllaceae are restricted to lower parts of the host (<60 cm; 10-100 mu mol photons m(-2) s(-1)) in a secondary forest of Southern Chile; other species occupy the whole host height (>= 10 m; max PPFD > 1000 mu mol photons m(-2) s(-1)). Our aim was to study the photosynthetic light responses of two Hymenophyllaceae species in relation to their contrasting distribution. We determined light tolerance of Hymenoglossum cruentum and Hymenophyllum dentatum by measuring gas exchange, PSI and PSII light energy partitioning, NPQ components, and pigment contents. H. dentatum showed lower maximum photosynthesis rates (A(max)) than H. cruentum, but the former species kept its net rates (A(n)) near A(max) across a wide light range. In contrast, in the latter one, A(n) declined at PPFDs > 60 mu mol photons m(-2) s(-1). H. cruentum, the shadiest plant, showed higher chlorophyll contents than H. dentatum. Differences in energy partitioning at PSI and PSII were consistent with gas exchange results. H. dentatum exhibited a higher light compensation point of the partitioning of absorbed energy between photochemical Y(PSII) and non-photochemical Y(NPQ) processes. Hence, both species allocated energy mainly toward photochemistry instead of heat dissipation at their light saturation points. Above saturation, H. cruentum had higher heat dissipation than H. dentatum. PSI yield (YPSI) remained higher in H. dentatum than H. cruentum in a wider light range. In both species, the main cause of heat dissipation at PSI was a donor side limitation. An early dynamic photo-inhibition of PSII may have caused an over reduction of the Qa(+) pool decreasing the efficiency of electron donation to PSI. In H. dentatum, a slight increase in heat dissipation due to acceptor side limitation of PSI was observed above 300 mu mol photons m(-2)s(-1). Differences in photosynthetic responses to light suggest that light tolerance and species plasticity could explain their contrasting vertical distribution.	[Jose Parra, Maria] Univ San Sebastian, Fac Ciencia, Dept Ciencias Biol & Quim, Concepcion, Chile; [Acuna, Karina I.; Sierra-Almeida, Angela; Saldana, Alfredo; Corcuera, Luis J.] Univ Concepcion, Dept Bot, Fac Ciencias Nat & Oceanog, Concepcion, Chile; [Sierra-Almeida, Angela; Sanfuentes, Camila] IEB, Santiago, Chile; [Sanfuentes, Camila] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Las Palmeras 3425, Chile; [Acuna, Karina I.; Bravo, Leon A.] Univ La Frontera, Lab Fisiol & Biol Mol Vegetal, Dept Ciencias Agron & Recursos Nat, Fac Ciencias Agr & Forestales, Temuco, Chile; [Acuna, Karina I.; Bravo, Leon A.] Univ La Frontera, Sci & Technol Bioresource Nucleus, Ctr Plant Soil Interact & Nat Resources Biotechno, Temuco, Chile	Universidad San Sebastian; Universidad de Concepcion; Universidad de Chile; Universidad de La Frontera; Universidad de La Frontera	Sierra-Almeida, A (corresponding author), Univ Concepcion, Dept Bot, Fac Ciencias Nat & Oceanog, Casilla 160-C, Concepcion, Chile.	angelasierra@udec.cl	Saldaña, Alfredo/C-8826-2011; Bravo, Leon/H-9251-2018; Sierra-Almeida, Angela/F-8409-2014; Bravo, León/AAO-8437-2020	Bravo, Leon/0000-0003-4705-4842; Sierra-Almeida, Angela/0000-0002-4207-0950; Bravo, León/0000-0003-4705-4842; Saldana, Alfredo/0000-0001-5161-5150	AS-A Programa de Atraccion e Insercion de capital humano avanzado [PAI-CONICYT 791100040]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 1090397, FONDECYT 1120964]; Beca de Doctorado Nacional de la Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)	AS-A Programa de Atraccion e Insercion de capital humano avanzado; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Beca de Doctorado Nacional de la Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was funded by AS-A Programa de Atraccion e Insercion de capital humano avanzado PAI-CONICYT 791100040 [http://www.conicyt.cl/pai/sobre-pai/que-es-pai/] to LAB; Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT 1090397 and FONDECYT 1120964 [http://www.conicyt.cl/fondecyt/category/concursos/fondecytregular/] to MJP; Beca de Doctorado Nacional de la Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [http://www.conicyt.cl/becas-conicyt/2014/08/beca-doctorado-nacional-2015/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade J. L., 2004, FISIOLOGIA ECOLOGICA, P139; Bailey S, 2001, PLANTA, V213, P794, DOI 10.1007/s004250100556; BJORKMAN O, 1968, PHYSIOL PLANTARUM, V21, P1, DOI 10.1111/j.1399-3054.1968.tb07225.x; BOARDMAN NK, 1977, ANNU REV PLANT PHYS, V28, P355, DOI 10.1146/annurev.pp.28.060177.002035; BRADBURY M, 1981, BIOCHIM BIOPHYS ACTA, V635, P542, DOI 10.1016/0005-2728(81)90113-4; Clement Joel P., 2001, Selbyana, V22, P76; de Bianchi S, 2010, BIOCHEM SOC T, V38, P651, DOI 10.1042/BST0380651; Demmig-Adams B, 1998, PLANT CELL PHYSIOL, V39, P474, DOI 10.1093/oxfordjournals.pcp.a029394; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Dubuisson JY, 2003, BOT J LINN SOC, V142, P41, DOI 10.1046/j.1095-8339.2003.00165.x; DYTHAM C, 2005, CHOOSING USING STAT; Evans GB, 1964, THESIS; EVANS JR, 1988, AUST J PLANT PHYSIOL, V15, P93, DOI 10.1071/PP9880093; Fuller GD, 1925, BOT GAZ, V79, P232; Garcia-Plazaola JI, 1999, PHYTOCHEM ANALYSIS, V10, P307, DOI 10.1002/(SICI)1099-1565(199911/12)10:6&lt;307::AID-PCA477&gt;3.0.CO;2-L; Gessner F, 1940, PROTOPLASMA, V34, P102; Hajek E, 1975, BIOCLIMATOLOGIA CHIL; Hernandez-Rosas J, 1999, ECOTROPICOS, V12, P33; HORTON P, 1988, BIOCHIM BIOPHYS ACTA, V932, P107, DOI 10.1016/0005-2728(88)90144-2; Johnson GN, 2000, NEW PHYTOL, V148, P423, DOI 10.1046/j.1469-8137.2000.00772.x; Klughammer C., 2008, PAM APP NOTES, V1, P11, DOI DOI 10.1007/S00415-017-8571-3; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Lambers H., 2008, PLANT PHYSL ECOLOGY; Marschall M, 2004, ANN BOT-LONDON, V94, P593, DOI 10.1093/aob/mch178; Matsubara S, 2009, FUNCT PLANT BIOL, V36, P20, DOI 10.1071/FP08214; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; NASRULHAQBOYCE A, 1987, NEW PHYTOL, V105, P81, DOI 10.1111/j.1469-8137.1987.tb00112.x; Osmond CB, 1993, PHOTOINHIBITION PHOT, P1; Parra MJ, 2009, J VEG SCI, V20, P588, DOI 10.1111/j.1654-1103.2009.01078.x; Parra MJ, 2012, THESIS; PEARCY RW, 1990, ANNU REV PLANT PHYS, V41, P421, DOI 10.1146/annurev.pp.41.060190.002225; Proctor MCF, 2005, J BRYOL, V27, P221, DOI 10.1179/174328205X69968; Proctor MCF, 2003, ANN BOT-LONDON, V91, P717, DOI 10.1093/aob/mcg077; Proctor MCF, 2002, NEW PHYTOL, V156, P327, DOI 10.1046/j.1469-8137.2002.00526.x; Proctor MCF, 2014, ADV PHOTOSYNTH RESP, V37, P59, DOI 10.1007/978-94-007-6988-5_4; Proctor MCF, 2012, ANN BOT-LONDON, V109, P1019, DOI 10.1093/aob/mcs012; Proctor MCF, 2011, PHYSIOL PLANTARUM, V141, P130, DOI 10.1111/j.1399-3054.2010.01424.x; Rice SK, 1996, PLANT CELL ENVIRON, V19, P118, DOI 10.1111/j.1365-3040.1996.tb00233.x; RICHARDS PW, 1972, J ECOL, V60, P245, DOI 10.2307/2258054; Rodriguez R., 1995, FLORA CHILE, V1, P119, DOI DOI 10.1007/S12228-009-9078-8; Saez PL, 2013, PLANT SCI, V201, P12, DOI 10.1016/j.plantsci.2012.11.008; Saldana A, 2014, PLANT SPEC BIOL, V29, P253, DOI 10.1111/1442-1984.12020; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Trebst A, 2003, Z NATURFORSCH C, V58, P609; Tryon RM, 1982, FERN ALLIED PLANTS S; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Walters RG, 2005, J EXP BOT, V56, P435, DOI 10.1093/jxb/eri060; WALTERS RG, 1991, PHOTOSYNTH RES, V27, P121, DOI 10.1007/BF00033251; Wang YL, 2004, BIOPHYS J, V86, P3097, DOI 10.1016/S0006-3495(04)74358-1; Zotz Gerhard, 2000, Ecotropica (Bonn), V6, P203	52	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145475	10.1371/journal.pone.0145475	http://dx.doi.org/10.1371/journal.pone.0145475			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699612	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092600087
J	Martinez-Martin, P; Rodriguez-Blazquez, C; Paz, S; Forjaz, MJ; Frades-Payo, B; Cubo, E; de Pedro-Cuesta, J; Lizan, L				Martinez-Martin, Pablo; Rodriguez-Blazquez, Carmen; Paz, Silvia; Joao Forjaz, Maria; Frades-Payo, Belen; Cubo, Esther; de Pedro-Cuesta, Jesus; Lizan, Luis		ELEP Grp	Parkinson Symptoms and Health Related Quality of Life as Predictors of Costs: A Longitudinal Observational Study with Linear Mixed Model Analysis	PLOS ONE			English	Article							ECONOMIC BURDEN; DISEASE; IMPACT; IMPAIRMENT; DIAGNOSIS; SEVERITY; PAIN	Objective To estimate the magnitude in which Parkinson's disease (PD) symptoms and health-related quality of life (HRQoL) determined PD costs over a 4-year period. Materials and Methods Data collected during 3-month, each year, for 4 years, from the ELEP study, included socio-demographic, clinical and use of resources information. Costs were calculated yearly, as mean 3-month costs/patient and updated to Spanish (sic), 2012. Mixed linear models were performed to analyze total, direct and indirect costs based on symptoms and HRQoL. Results One-hundred and seventy four patients were included. Mean (SD) age: 63 (11) years, mean (SD) disease duration: 8 (6) years. Ninety-three percent were HY I, II or III (mild or moderate disease). Forty-nine percent remained in the same stage during the study period. Clinical evaluation and HRQoL scales showed relatively slight changes over time, demonstrating a stable group overall. Mean (SD) PD total costs augmented 92.5%, from (sic)2,082.17 ((sic)2,889.86) in year 1 to (sic)4,008.6 ((sic)7,757.35) in year 4. Total, direct and indirect cost incremented 45.96%, 35.63%, and 69.69% for mild disease, respectively, whereas increased 166.52% for total, 55.68% for direct and 347.85% for indirect cost in patients with moderate PD. For severe patients, cost remained almost the same throughout the study. For each additional point in the SCOPA-Motor scale total costs increased (sic)75.72 (p = 0.0174); for each additional point on SCOPA-Motor and the SCOPA-COG, direct costs incremented (sic)49.21 (p = 0.0094) and (sic)44.81 (p = 0.0404), respectively; and for each extra point on the pain scale, indirect costs increased (sic)16.31 (p = 0.0228). Conclusions PD is an expensive disease in Spain. Disease progression and severity as well as motor and cognitive dysfunctions are major drivers of costs increments. Therapeutic measures aimed at controlling progression and symptoms could help contain disease expenses.	[Martinez-Martin, Pablo; Rodriguez-Blazquez, Carmen; de Pedro-Cuesta, Jesus] Carlos III Inst Hlth, Natl Ctr Epidemiol, Madrid, Spain; [Martinez-Martin, Pablo; Rodriguez-Blazquez, Carmen; de Pedro-Cuesta, Jesus] Carlos III Inst Hlth, CIBERNED, Madrid, Spain; [Paz, Silvia; Lizan, Luis] Jaume I Univ, Outcomes 10, Castellon De La Plana, Castellon, Spain; [Joao Forjaz, Maria] Carlos III Inst Hlth, Natl Sch Publ Hlth, Madrid, Spain; [Joao Forjaz, Maria] Carlos III Inst Hlth, REDISSEC, Madrid, Spain; [Frades-Payo, Belen] Carlos III Inst Hlth, Reina Sofia Fdn, Alzheimer Ctr, Res Unit, Madrid, Spain; [Cubo, Esther] Complejo Asistencial Univ Burgos, Burgos, Spain	Instituto de Salud Carlos III; CIBERNED; Instituto de Salud Carlos III; Universitat Jaume I; Instituto de Salud Carlos III; Instituto de Salud Carlos III; Instituto de Salud Carlos III	Paz, S (corresponding author), Jaume I Univ, Outcomes 10, Castellon De La Plana, Castellon, Spain.	spaz@outcomes10.com	lizan, luis/AAF-1953-2020; Castrillo, Juan Carlos Martinez/F-3119-2013; Forjaz, Maria João/AAI-3797-2020; Martinez-Martin, Pablo/N-9909-2019; Blázquez Estrada, Marta/AAG-2988-2021; Garcia Ruiz, Pedro J/G-8660-2013	Castrillo, Juan Carlos Martinez/0000-0001-7744-6850; Forjaz, Maria João/0000-0003-3935-962X; Martinez-Martin, Pablo/0000-0003-0837-5280; Blázquez Estrada, Marta/0000-0003-3348-9992; Vela-Desojo, Lydia/0000-0001-6663-395X; Garcia Ruiz, Pedro J/0000-0001-6194-672X	Abbvie Pharmaceuticals	Abbvie Pharmaceuticals(AbbVie)	Abbvie Pharmaceuticals has solely funded the publication of this study; however, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armananzas R, 2013, ARTIF INTELL MED, V58, P195, DOI 10.1016/j.artmed.2013.04.002; Bach JP, 2012, J NEUROL SCI, V314, P41, DOI 10.1016/j.jns.2011.11.002; Bloem BR, 2012, EUR J NEUROL, V19, P402, DOI 10.1111/j.1468-1331.2011.03532.x; Boland DF, 2012, AM J MANAG CARE, V18, pS168; Breivik H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1229; Chaudhuri KR, 2011, HDB NONMOTOR SYMPTOM; Chen JJ, 2010, AM J MANAG CARE, V16, pS87; Cubo E, 2009, NEUROLOGIA, V21, P15; Dodel R., 2011, EUR NEUROL REV, V6, P13; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; ELEP group, 2006, REV NEUROL, V42, P360; Findley LJ, 2007, PARKINSONISM RELAT D, V13, pS8, DOI 10.1016/j.parkreldis.2007.06.003; Ford B, 2010, MOVEMENT DISORD, V25, pS98, DOI 10.1002/mds.22716; Garcia Ramos R, 2013, NEUROLOGIA, DOI [10.1016/j.nrl.2013.04.008, DOI 10.1016/J.NRL.2013.04.008]; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Keranen T, 2003, PARKINSONISM RELAT D, V9, P163, DOI 10.1016/S1353-8020(02)00097-4; Mateus C., 2013, EUR NEUROL REV, V8, P6, DOI [DOI 10.17925/ENR.2013.08.016, 10.17925/ENR.2013.08.01.6, DOI 10.17925/ENR.2013.08.01.6]; Olivia J, 2007, PHARMACOECON SPANISH, V4, P83; Penas Domingo E, 2015, LIBRO BLANCO PARKINS; Pinheiro J, 2020, R PACKAGE VERSION 31; R Core Team, 2012, R LANG ENV STAT COMP; Reese JP, 2011, REV NEUROLOGIA, V52, P264, DOI 10.33588/rn.5205.2010492; Richy FF, 2013, APPL HEALTH ECON HEA, V11, P395, DOI 10.1007/s40258-013-0033-1; Schenkman M, 2001, PARKINSONISM RELAT D, V8, P41, DOI 10.1016/S1353-8020(00)00079-1; von Campenhausen S, 2011, EUR NEUROPSYCHOPHARM, V21, P180, DOI 10.1016/j.euroneuro.2010.08.002; Vossius C, 2011, MOVEMENT DISORD, V26, P1541, DOI 10.1002/mds.23661; Weintraub D, 2008, AM J MANAG CARE, V14, pS40; Weintraub D, 2008, AM J MANAG CARE, V14, pS49; Wen Hong-Bo, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS222, DOI 10.1016/S1353-8020(11)70068-2; Winter Y, 2010, J NEUROL SCI, V294, P18, DOI 10.1016/j.jns.2010.04.011	31	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145310	10.1371/journal.pone.0145310	http://dx.doi.org/10.1371/journal.pone.0145310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698860	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600064
J	Cen, H; Tan, XH; Guo, BP				Cen, Hong; Tan, Xiaohong; Guo, Baoping			A20 Mutation Is Not a Prognostic Marker for Activated B-Cell-Like Diffuse Large B-Cell Lymphoma	PLOS ONE			English	Article							NF-KAPPA-B; HODGKIN-LYMPHOMA; TNFAIP3 A20; GENE; RECEPTOR; SUBGROUPS; DELETIONS; RESPONSES; CARMA1; FAMILY	Background Constitutive activation of nuclear factor kappa B (NF-kappa B) is a hallmark of activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL). Mutations in the A20 gene activate NF-kappa B, but the prognostic value of A20 mutations in ABC-DLBLC is unclear. Purpose To investigate the prognostic value of A20 mutation in ABC-DLBCL patients. Methods The somatic mutation of A20 was investigated in 68 de novo ABC-DLBCLs by PCR/sequencing. The Kaplan-Meier method was used to estimate median overall survival (OS) and progression-free survival (PFS). Results The A20 mutation rate in ABC-DLBCL patients was 29.4%. Complete remission rates were 35% and 45.8% in patients with and without A20 mutations, respectively (P = 0.410). In patients with and without A20 mutations, the median OS was 24.0 and 30.6 months, respectively (P = 0.58), and the median PFS was 15 and 17.4 months, respectively (P = 0.52). None of the differences between the patient groups were significant. Conclusions Our findings suggested that the A20 mutation is a frequent event in ABC-DLBCLs. However, there was no significant difference in PFS and OS in patients with or without A20 mutations. Further study is required to completely exclude A20 somatic mutation as a prognostic marker in the ABC subtype of DLBLC.	[Cen, Hong; Tan, Xiaohong; Guo, Baoping] Guangxi Med Univ, Tumor Hosp, Dept Chemotherapy, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Cen, H (corresponding author), Guangxi Med Univ, Tumor Hosp, Dept Chemotherapy, Nanning, Guangxi, Peoples R China.	cen_hong@163.com			National Natural Science Foundation of China [81160298]; Health Department of Guangxi Province [2011077]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Department of Guangxi Province	This work was supported by the National Natural Science Foundation of China (81160298) and Key Grant of Health Department of Guangxi Province (2011077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Berglund M, 2005, MODERN PATHOL, V18, P1113, DOI 10.1038/modpathol.3800396; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Dong GH, 2011, CLIN CANCER RES, V17, P1440, DOI 10.1158/1078-0432.CCR-10-1859; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; GAIDANO G, 1992, BLOOD, V80, P1781, DOI 10.1182/blood.V80.7.1781.bloodjournal8071781; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Honma K, 2008, GENE CHROMOSOME CANC, V47, P1, DOI 10.1002/gcc.20499; Honma K, 2009, BLOOD, V114, P2467, DOI 10.1182/blood-2008-12-194852; Johnson AD, 2005, PHARMACOL THERAPEUT, V106, P19, DOI 10.1016/j.pharmthera.2004.11.001; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Lam LT, 2005, CLIN CANCER RES, V11, P28; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lepper ER, 2005, PHARMACOGENOMICS, V6, P115, DOI 10.1517/14622416.6.2.115; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Novak U, 2009, BLOOD, V113, P4918, DOI 10.1182/blood-2008-08-174110; Paik JH, 2013, LEUKEMIA LYMPHOMA, V54, P1934, DOI 10.3109/10428194.2012.762511; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; van Imhoff GW, 2006, J CLIN ONCOL, V24, P4135, DOI 10.1200/JCO.2006.05.5897; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X	34	2	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145037	10.1371/journal.pone.0145037	http://dx.doi.org/10.1371/journal.pone.0145037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716984	gold, Green Submitted, Green Published			2022-12-27	WOS:000367510500018
J	Hopkins, KD; Shepherd, CCJ; Taylor, CL; Zubrick, SR				Hopkins, Katrina D.; Shepherd, Carrington C. J.; Taylor, Catherine L.; Zubrick, Stephen R.			Relationships between Psychosocial Resilience and Physical Health Status of Western Australian Urban Aboriginal Youth	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; ALLOSTATIC LOAD; INDIGENOUS AUSTRALIANS; RESERVE CAPACITY; CHRONIC DISEASE; EARLY-CHILDHOOD; STRESS; ASTHMA; DISPARITIES; CHILDREN	Background Psychosocial processes are implicated as mediators of racial/ethnic health disparities via dysregulation of physiological responses to stress. Our aim was to investigate the extent to which factors previously documented as buffering the impact of high-risk family environments on Aboriginal youths' psychosocial functioning were similarly beneficial for their physical health status. Method and Results We examined the relationship between psychosocial resilience and physical health of urban Aboriginal youth (12-17 years, n = 677) drawn from a representative survey of Western Australian Aboriginal children and their families. A composite variable of psychosocial resilient status, derived by cross-classifying youth by high/low family risk exposure and normal/abnormal psychosocial functioning, resulted in four groups-Resilient, Less Resilient, Expected Good and Vulnerable. Separate logistic regression modeling for high and low risk exposed youth revealed that Resilient youth were significantly more likely to have lower self-reported asthma symptoms (OR 3.48, p<.001) and carer reported lifetime health problems (OR 1.76, p<.04) than Less Resilient youth. Conclusion The findings are consistent with biopsychosocial models and provide a more nuanced understanding of the patterns of risks, resources and adaptation that impact on the physical health of Aboriginal youth. The results support the posited biological pathways between chronic stress and physical health, and identify the protective role of social connections impacting not only psychosocial function but also physical health. Using a resilience framework may identify potent protective factors otherwise undetected in aggregated analyses, offering important insights to augment general public health prevention strategies.	[Hopkins, Katrina D.; Shepherd, Carrington C. J.; Taylor, Catherine L.; Zubrick, Stephen R.] Univ Western Australia, Telethon Kids Inst, Crawley, WA, Australia	Telethon Kids Institute; University of Western Australia	Hopkins, KD (corresponding author), Telethon Kids Inst, Roberts Rd, Subiaco, WA, Australia.	Katrina.Hopkins@telethonkids.org.au	Zubrick, Stephen R/CAI-1970-2022	Zubrick, Stephen R/0000-0002-6369-1713; Shepherd, Carrington C.J./0000-0003-0043-7053	Australian Research Council [CE140100027]; Australian National Health and Medical Research Council [1074146]	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	SZ is supported by a grant from the Australian Research Council (CE140100027). CCJS is supported by a grant from the Australian National Health and Medical Research Council (1074146).	Adler N, 2012, P NATL ACAD SCI USA, V109, P17154, DOI 10.1073/pnas.1121399109; Andersson Neil, 2008, Pimatisiwin, V6, P65; Australian Institute of Health and Welfare, 2013, ASTHM HOSP AUSTR 201; Azzopardi PS, 2013, MED J AUSTRALIA, V199, P57, DOI 10.5694/mja12.11141; Bersamin M, 2005, PREV SCI, V6, P127, DOI 10.1007/s11121-005-3411-6; Blair C, 2011, DEV PSYCHOPATHOL, V23, P845, DOI 10.1017/S0954579411000344; Brady SS, 2002, J PEDIATR PSYCHOL, V27, P575, DOI 10.1093/jpepsy/27.7.575; Brondolo E, 2011, AM J HYPERTENS, V24, P518, DOI 10.1038/ajh.2011.9; Burgess CP, 2005, AUST NZ J PUBL HEAL, V29, P117, DOI 10.1111/j.1467-842X.2005.tb00060.x; Campbell D, 2011, HEALTH POLICY, V99, P83, DOI 10.1016/j.healthpol.2010.07.009; Center on the Developing Child at Harvard University, 2014, SUPP REL ACT SKILL B; Chandler MJ, 2009, MENTAL HLTH CANADIAN; Chen E, 2012, ROLE MODELS PSYCHOL; Chen E, 2011, J ALLERGY CLIN IMMUN, V128, P970, DOI 10.1016/j.jaci.2011.06.040; Cicchetti D., 2006, DEV PSYCHOPATHOLOGY, V3; Clarke C, 1999, ABORIG ISL HLTH WORK, V23, P6; Commission P, 2013, OV IND DIS KEY IND 2; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Daniel M, 2011, ANNU REV PUBL HEALTH, V32, P327, DOI 10.1146/annurev.publhealth.012809.103557; Dawson A P, 2004, Rural Remote Health, V4, P238; Day A, 2013, ANGER INDIGENOUS MEN; De Maio JA, 2013, W AUSTR ABORIGINAL C; Drake KA, 2008, PHARMACOGENOMICS, V9, P453, DOI 10.2217/14622416.9.4.453; Dudgeon P, 2010, WORKING TOGETHER ABO; Essex MJ, 2011, DEV PSYCHOPATHOL, V23, P1039, DOI 10.1017/S0954579411000484; Evans GW, 2004, AM PSYCHOL, V59, P77, DOI 10.1037/0003-066X.59.2.77; Gallo LC, 2003, PSYCHOL BULL, V129, P10, DOI 10.1037//0033-2909.129.1.10; Gallo LC, 2009, APPL PSYCHOL-HLTH WE, V1, P62, DOI 10.1111/j.1758-0854.2008.01000.x; Gallo LC, 2009, CURR DIR PSYCHOL SCI, V18, P269, DOI 10.1111/j.1467-8721.2009.01650.x; Garnett S., 2007, SUSTAINABLE NO LANDS; Geva R, 2006, PEDIATRICS, V118, P91, DOI 10.1542/peds.2005-2343; Gold DR, 2005, ANNU REV PUBL HEALTH, V26, P89, DOI 10.1146/annurev.publhealth.26.021304.144528; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605; Hallett D, 2007, COGNITIVE DEV, V22, P392, DOI 10.1016/j.cogdev.2007.02.001; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Hopkins KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102820; Hopkins KD, 2013, AM J ORTHOPSYCHIAT, V83, P459, DOI 10.1111/ajop.12052; Hopkins KD, 2012, HDB THEORY PRACTICE; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Huston AC, 2010, ANNU REV PSYCHOL, V61, P411, DOI 10.1146/annurev.psych.093008.100442; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Kubzansky LD, 2012, PSYCHOL BULL; Lincoln R, 2013, REPORT TO CRIMINOLOG; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; Masten AS, 1999, DEV PSYCHOPATHOL, V11, P143, DOI 10.1017/S0954579499001996; Matthews KA, 2011, ANNU REV PSYCHOL, V62, P501, DOI 10.1146/annurev.psych.031809.130711; Matthews KA, 2010, ANN NY ACAD SCI, V1186, P146, DOI 10.1111/j.1749-6632.2009.05332.x; Miller GE, 2012, ANN REV CLIN PSYCHOL, V9; Miller G, 2009, ANNU REV PSYCHOL, V60, P501, DOI 10.1146/annurev.psych.60.110707.163551; Myers HF, 2009, J BEHAV MED, V32, P9, DOI 10.1007/s10865-008-9181-4; O'Shane P., 1995, AUSTRALAS PSYCHIATRY, V3, P149; Paradies Y, 2006, ETHNIC DIS, V16, P295; Paradies Y, 2006, INT J EPIDEMIOL, V35, P888, DOI 10.1093/ije/dyl056; Paradies Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138511; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Priest N, 2009, AUST NZ J PUBL HEAL, V33, P55, DOI 10.1111/j.1753-6405.2009.00339.x; Priest N, 2012, HEALTH SOCIOL REV, V21, P180, DOI 10.5172/hesr.2012.21.2.180; Rivas-Drake D, 2009, J RES ADOLESCENCE, V19, P558, DOI 10.1111/j.1532-7795.2009.00607.x; Rutter M, 2012, SOCIAL ECOLOGY OF RESILIENCE: A HANDBOOK OF THEORY AND PRACTICE, P33, DOI 10.1007/978-1-4614-0586-3_3; Sawyer PJ, 2012, AM J PUBLIC HEALTH, V102, P1020, DOI 10.2105/AJPH.2011.300620; Schreier HMC, 2013, PSYCHOL BULL, V139, P606, DOI 10.1037/a0029416; Schwab R, 2012, 852012 CAEPR AUSTR N; Schwab RG, 2013, 2812006 CAEPR AUSTR; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Shepherd CCJ, 2012, ETHNIC HEALTH, V17, P439, DOI 10.1080/13557858.2012.654768; Shepherd CCJ, 2012, AM J PUBLIC HEALTH, V102, P107, DOI 10.2105/AJPH.2011.300354; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Silburn SR, 2013, W AUSTR CHILD HLTH S; Tabachnick B. G., 2013, USING MULTIVARIATE S; WALLACE JM, 2002, J PRIMARY PREVENTION, V0022; Walter M, 2015, AUSTR J SOCIAL ISSUE, V50; Weil CM, 1999, PEDIATRICS, V104, P1274, DOI 10.1542/peds.104.6.1274; Williams DR, 2009, PEDIATRICS, V123, pS174, DOI 10.1542/peds.2008-2233H; Wright RJ, 1998, THORAX, V53, P1066, DOI 10.1136/thx.53.12.1066; Wright RJ, 2013, AM J RESP CRIT CARE, V187, P115, DOI 10.1164/rccm.201210-1816ED; Wright RJ, 2011, IMMUNOL ALLERGY CLIN, V31, P19, DOI 10.1016/j.iac.2010.09.011; Zubrick SR, 2000, DEV MED CHILD NEUROL, V42, P14, DOI 10.1017/S0012162200000049; Zubrick SR, 2013, W AUSTR ABORIGINAL C; Zubrick SR, 2013, TESTING RELIABILITY	81	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145382	10.1371/journal.pone.0145382	http://dx.doi.org/10.1371/journal.pone.0145382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716829	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500033
J	Keino, L; Baijukya, F; Ng'etich, W; Otinga, AN; Okalebo, JR; Njoroge, R; Mukalama, J				Keino, Ludy; Baijukya, Frederick; Ng'etich, Wilson; Otinga, Abigael N.; Okalebo, John R.; Njoroge, Ruth; Mukalama, John			Nutrients Limiting Soybean (glycine max l) Growth in Acrisols and Ferralsols of Western Kenya	PLOS ONE			English	Article							SYSTEMS	Low soybean yields in western Kenya have been attributed to low soil fertility despite much work done on nitrogen (N) and phosphorus (P) nutrition leading to suspicion of other nutrient limitations. To investigate this, a nutrient omission trial was set up in the greenhouse at the University of Eldoret-Kenya to diagnose the nutrients limiting soybean production in Acrisols from Masaba central and Butere sub-Counties, and Ferralsols from Kakamega (Shikhulu and Khwisero sub-locations) and Butula sub-Counties and to assess the effect of liming on soil pH and soybean growth. The experiment was laid out in a completely randomized design with ten treatments viz; positive control (complete), negative control (distilled water), complete with lime, complete with N, minus macronutrients P, potassium (K), calcium (Ca), magnesium (Mg) and sulphur (S) and with, micro-nutrients boron (B), molybdenum (Mo), manganese (Mn), copper (Cu) and zinc (Zn) omitted. Visual deficiency symptoms observed included interveinal leaf yellowing in Mg omission and N addition and dark green leaves in P omission. Nutrients omission resulted in their significantly low concentration in plant tissues than the complete treatment. Significantly (P <= 0.05) lower shoot dry weights (SDWs) than the complete treatment were obtained in different treatments; omission of K and Mg in Masaba and Shikhulu, Mg in Khwisero, K in Butere and, P, Mg and K in Butula. Nitrogen significantly improved SDWs in soils from Kakamega and Butula. Liming significantly raised soil pH by 9, 13 and 11% from 4.65, 4.91 and 4.99 in soils from Masaba, Butere and Butula respectively and soybean SDWs in soils from Butere. The results show that, poor soybean growth was due to K, Mg and P limitation and low pH in some soils. The results also signify necessity of application of small quantities of N for initial soybean use.	[Keino, Ludy; Ng'etich, Wilson; Otinga, Abigael N.; Okalebo, John R.; Njoroge, Ruth] Univ Eldoret, Dept Soil Sci, Eldoret, Kenya; [Baijukya, Frederick] Int Inst Trop Agr, Dar Es Salaam, Tanzania; [Mukalama, John] Ctr Int Agr Trop, Nairobi, Kenya	Alliance; International Center for Tropical Agriculture - CIAT	Keino, L (corresponding author), Univ Eldoret, Dept Soil Sci, Eldoret, Kenya.	ludykeino@yahoo.com	Ng'etich, Wilson/AAI-4541-2021	Ng'etich, Wilson/0000-0002-2650-3648; Otinga, Abigael/0000-0003-1624-2648	N2Africa [OPP1020032(13-1947)]	N2Africa	This study was funded by N2Africa, grant number OPP1020032(13-1947) (http://www.N2Africa.org).	Adekunle, 2013, EFFECT NITROGEN NUTR, V5, P79; Anderson N.P., 2013, STATE U EXT SERV, pEM 9061; Andric L, 2012, TURK J AGRIC FOR, V36, P415, DOI 10.3906/tar-1107-23; Baijukya F., 2010, RES DISSEMINATION MO; Chianu J.N., 2009, J SUSTAINABLE DEV AF, V10, P1520; Dumas J. B. A, 1831, ANN CHIM PHYS, V2, P198; Foli S, 2012, THESIS; FOX R L, 1970, Soil Science Society of America Proceedings, V34, P902; Giller K.E., 2001, NITROGEN FIXATION TR, V2nd ed., DOI [DOI 10.1079/9780851994178.0000, 10.1079/9780851994178.0000]; Hoagland D. R., 1950, CALIFORNIA AGR EXPT, P1; Husnjak S, 2002, ROST VYROBA, V48, P249; Jaetzold R, 2005, FARMMANAGEMENT HDB K, V2; Janssen B.H., 1974, TROP AGR, V51, P160; JANSSEN BH, 1990, DEV PLANT SOIL SCI, V41, P759; Kanyanjua S.M., 2002, 11 KARI; Kiplagat J.K., 2010, 2 RUF BIENN M 20 24; Kiplagat K.J., 2013, THESIS; Kisinyo P. O., 2013, Sustainable Agriculture Research, V2, P116; Mahasi J.M., 2011, AFRICAN CROP SCI C P, V10, P111; Malavolta E., 2007, Better Crops with Plant Food, V91, P26; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Marschner P, 2011, SOIL BIOL BIOCHEM, V43, P883, DOI 10.1016/j.soilbio.2011.01.005; Mauyo Lianda Wanyonyi, 2010, Journal of Service Science and Management, V3, P501, DOI 10.4236/jssm.2010.34057; Mburu M.W., 2011, AFR CROP SCI P, V10, P1; Moore A, 2014, AGRON J, V106, P73, DOI 10.2134/agronj2013.0345; Myaka F. A., 2005, P 1 NAT SOYB STAK WO; Nanthi S.B., 2003, SOIL ACIDIFICATION L; Ohyama T., 2011, EFFECT NITRATE NODUL; Okalebo J. R., 2002, LOB METHODS SOIL PLA; Otieno P. E., 2009, Journal of Biological Sciences, V9, P326, DOI 10.3923/jbs.2009.326.332; Paradiso R, 2012, ADV SPACE RES, V50, P1501, DOI 10.1016/j.asr.2012.07.025; Robert L.M., 2004, BALANCED CROP NUTRIT; Roy R.N., 2006, PLANT NUTR FOOD SECU, DOI [10.1017/S0014479706394537, DOI 10.1017/S0014479706394537]; Ruiz Diaz D.A., 2011, DIAGNOSING NUTRIENT; Rutgers, 2013, COMM VEG PROD REC NE; Sabbe W. E., 2011, SO COOP SER B, V394, P33; Salvagiotti F., 2008, NITROGEN UPTAKE FIXA; Sanginga N, 2003, PLANT SOIL, V252, P25, DOI 10.1023/A:1024192604607; Saud H.M., 2012, INT J LIFE SCI BIOTE, V1, P2250; Seitz T., 2013, THESIS; Shavrukov Y, 2012, HYDROPONICS STANDARD; Slaton N., 2011, ARKANSAS SOYBEAN PRO; Stevens G., 2002, CROP NUTRIENT DEFICI; Thuita M., 2012, J BIOL FERTILITY SOI, V48, P78; Uchida R., 2000, PLANT NUTR MANAGEMEN, P31; Vanlauwe B., 2003, AFR CROP SCI C P, V6, P58; Verde B., 2013, INT J AGR SCI RES, V2, P283; Wietske V., 2012, THESIS; Workneh Bekere, 2013, International Journal of Soil Science, V8, P25	49	16	17	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145202	10.1371/journal.pone.0145202	http://dx.doi.org/10.1371/journal.pone.0145202			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716825	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500025
J	Le, TD; Zhang, JP; Liu, L; Liu, HW; Li, JY				Le, Thuc Duy; Zhang, Junpeng; Liu, Lin; Liu, Huawen; Li, Jiuyong			miRLAB: An R Based Dry Lab for Exploring miRNA-mRNA Regulatory Relationships	PLOS ONE			English	Article							INFERRING MICRORNA; PROTEIN; CANCER; REGULARIZATION; NETWORKS; RESOURCE; TARGETS; SYSTEMS; MODELS	microRNAs (miRNAs) are important gene regulators at post-transcriptional level, and inferring miRNA-mRNA regulatory relationships is a crucial problem. Consequently, several computational methods of predicting miRNA targets have been proposed using expression data with or without sequence based miRNA target information. A typical procedure for applying and evaluating such a method is i) collecting matched miRNA and mRNA expression profiles in a specific condition, e.g. a cancer dataset from The Cancer Genome Atlas (TCGA), ii) applying the new computational method to the selected dataset, iii) validating the predictions against knowledge from literature and third-party databases, and comparing the performance of the method with some existing methods. This procedure is time consuming given the time elapsed when collecting and processing data, repeating the work from existing methods, searching for knowledge from literature and third-party databases to validate the results, and comparing the results from different methods. The time consuming procedure prevents researchers from quickly testing new computational models, analysing new datasets, and selecting suitable methods for assisting with the experiment design. Here, we present an R package, miRLAB, for automating the procedure of inferring and validating miRNA-mRNA regulatory relationships. The package provides a complete set of pipelines for testing new methods and analysing new datasets. miRLAB includes a pipeline to obtain matched miRNA and mRNA expression datasets directly from TCGA, 12 benchmark computational methods for inferring miRNA-mRNA regulatory relationships, the functions for validating the predictions using experimentally validated miRNA target data and miRNA perturbation data, and the tools for comparing the results from different computational methods.	[Le, Thuc Duy; Liu, Lin; Li, Jiuyong] Univ S Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia; [Zhang, Junpeng] Dali Univ, Fac Engn, Dali, Peoples R China; [Liu, Huawen] Zhejiang Normal Univ, Dept Comp Sci, Jinhua, Peoples R China	University of South Australia; Dali University; Zhejiang Normal University	Le, TD (corresponding author), Univ S Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia.	thuc.le@unisa.edu.au; jiuyong.li@unisa.edu.au	Le, Thuc Duy D/G-8444-2019; Zhang, Junpeng/E-4737-2013; Liu, Lin/ABD-1224-2020; Li, Jiuyong/AAY-2706-2020; Li, Jiuyong/A-8134-2008	Le, Thuc Duy D/0000-0002-9732-4313; Zhang, Junpeng/0000-0001-6127-9701; Liu, Lin/0000-0003-2843-5738; Li, Jiuyong/0000-0002-9023-1878; Li, Jiuyong/0000-0002-9023-1878	Australian Research Council [DP130104090]; Applied Basic Research Foundation of Science and Technology of Yunnan Province [2013FD038]	Australian Research Council(Australian Research Council); Applied Basic Research Foundation of Science and Technology of Yunnan Province	This work has been partially supported by Australian Research Council Discovery Project DP130104090, (JL and LL), and the Applied Basic Research Foundation of Science and Technology of Yunnan Province, No. 2013FD038 (JZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Cheng WY, 2013, ARXIV PREPRINT ARXIV; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; HOEFFDING W, 1948, ANN MATH STAT, V19, P546, DOI 10.1214/aoms/1177730150; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141; Le TD, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-92; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li Y, 2013, BIOINFORMATICS; Li Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku182; Liu B, 2014, BRIEF BIOINFORM, V15, P1, DOI 10.1093/bib/bbs075; Liu B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-408; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Lopez-Paz D., 2013, ADV NEURAL INFORM PR, V26, P1, DOI DOI 10.1214/A0S/1176345528; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu YM, 2011, BIOINFORMATICS, V27, P2406, DOI 10.1093/bioinformatics/btr410; Maathuis MH, 2010, NAT METHODS, V7, P247, DOI 10.1038/nmeth0410-247; Maathuis MH, 2009, ANN STAT, V37, P3133, DOI 10.1214/09-AOS685; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; MOON YI, 1995, PHYS REV E, V52, P2318, DOI 10.1103/PhysRevE.52.2318; Muniategui A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030766; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Pearson K, 1920, BIOMETRIKA, V13, P25, DOI 10.1093/biomet/13.1.25; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sokilde R, 2011, MOL CANCER THER, V10, P375, DOI 10.1158/1535-7163.MCT-10-0605; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Speed T, 2011, SCIENCE, V334, P1502, DOI 10.1126/science.1215894; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Le TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131627; Le TD, 2015, BRIEF BIOINFORM, V16, P475, DOI 10.1093/bib/bbu023; Le TD, 2013, BIOINFORMATICS, V29, P765, DOI 10.1093/bioinformatics/btt048; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yu K, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S17-S6; Zhang JP, 2014, J BIOMED INFORM, V52, P438, DOI 10.1016/j.jbi.2014.08.005; Zhu YT, 2014, NAT METHODS, V11, P599, DOI 10.1038/nmeth.2956; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	49	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145386	10.1371/journal.pone.0145386	http://dx.doi.org/10.1371/journal.pone.0145386			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716983	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500034
J	Tyrka, M; Tyrka, D; Wedzony, M				Tyrka, Miroslaw; Tyrka, Dorota; Wedzony, Maria			Genetic Map of Triticale Integrating Microsatellite, DArT and SNP Markers	PLOS ONE			English	Article							ARRAYS TECHNOLOGY DART; WINTER TRITICALE; LINKAGE MAP; SEGREGATION DISTORTION; DIVERSITY ARRAYS; COMBINING ABILITY; AGRONOMIC TRAITS; WHEAT; GENOME; IDENTIFICATION	Triticale (xTriticosecale Wittm) is an economically important crop for fodder and biomass production. To facilitate the identification of markers for agronomically important traits and for genetic and genomic characteristics of this species, a new high-density genetic linkage map of triticale was constructed using doubled haploid (DH) population derived from a cross between cultivars 'Hewo' and 'Magnat'. The map consists of 1615 bin markers, that represent 50 simple sequence repeat (SSR), 842 diversity array technology (DArT), and 16888 DArTseq markers mapped onto 20 linkage groups assigned to the A, B, and R genomes of triticale. No markers specific to chromosome 7R were found, instead mosaic linkage group composed of 1880 highly distorted markers (116 bins) from 10 wheat chromosomes was identified. The genetic map covers 4907 cM with a mean distance between two bins of 3.0 cM. Comparative analysis in respect to published maps of wheat, rye and triticale revealed possible deletions in chromosomes 4B, 5A, and 6A, as well as inversion in chromosome 7B. The number of bin markers in each chromosome varied from 24 in chromosome 3R to 147 in chromosome 6R. The length of individual chromosomes ranged between 50.7 cM for chromosome 2R and 386.2 cM for chromosome 7B. A total of 512 (31.7%) bin markers showed significant (P < 0.05) segregation distortion across all chromosomes. The number of 8 the segregation distorted regions (SDRs) were identified on 1A, 7A, 1B, 2B, 7B (2 SDRs), 5R and 6R chromosomes. The high-density genetic map of triticale will facilitate fine mapping of quantitative trait loci, the identification of candidate genes and map-based cloning.	[Tyrka, Miroslaw; Tyrka, Dorota] Rzeszow Univ Technol, Fac Chem, Dept Biochem & Biotechnol, Rzeszow, Poland; [Wedzony, Maria] Pedag Univ Krakow, Fac Geog & Biol, Inst Biol, Krakow, Poland; [Wedzony, Maria] Polish Acad Sci, Inst Plant Physiol, Krakow, Poland	Rzeszow University of Technology; Pedagogical University of Cracow; Polish Academy of Sciences; Franciszek Gorski Institute of Plant Physiology Polish Academy of Sciences	Tyrka, M (corresponding author), Rzeszow Univ Technol, Fac Chem, Dept Biochem & Biotechnol, Rzeszow, Poland.	mtyrka@prz.edu.pl		Tyrka, Miroslaw/0000-0002-6051-5079; Wedzony, Maria/0000-0001-5911-2208	Ministry of Science and Higher Education [PBZ-MNiSW-2/3/2006/20]; National Centre for Research and Development [PBS1/A8/1/2012]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Centre for Research and Development(National Centre for Research & Development, Poland)	This work was supported by grant number PBZ-MNiSW-2/3/2006/20, Ministry of Science and Higher Education, http://www.nauka.gov.pl/en/ (MW) grant number PBS1/A8/1/2012, The National Centre for Research and Development (MT)	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Alheit KV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-380; Apolinarska B, 1996, DEV PLANT BREED, V5, P189; Badea A, 2011, THEOR APPL GENET, V122, P1547, DOI 10.1007/s00122-011-1554-3; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bartos J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-95; Bolibok-Bragoszewska H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-578; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; Chu CG, 2008, MOL BREEDING, V22, P251, DOI 10.1007/s11032-008-9171-9; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Cui F, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-57; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fiust A, 2015, J APPL GENET, V56, P299, DOI 10.1007/s13353-015-0273-x; Fu Y, 2010, PLANT J, V62, P898, DOI 10.1111/j.1365-313X.2010.04196.x; Gonzalez JM, 2005, GENOME, V48, P999, DOI [10.1139/G05-064, 10.1139/g05-064]; Goral H, 2002, CEREAL RES COMMUN, V30, P31; GRANER A, 1991, THEOR APPL GENET, V83, P250, DOI 10.1007/BF00226259; Hackauf B, 2009, THEOR APPL GENET, V118, P371, DOI 10.1007/s00122-008-0906-0; Hackauf B, 2002, PLANT BREEDING, V121, P17, DOI 10.1046/j.1439-0523.2002.00649.x; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Jones RN, 1995, NEW PHYTOL, V131, P411, DOI 10.1111/j.1469-8137.1995.tb03079.x; Korzun V, 2001, THEOR APPL GENET, V102, P709, DOI 10.1007/s001220051701; Korzun V, 1998, THEOR APPL GENET, V96, P203, DOI 10.1007/s001220050728; Li HH, 2008, THEOR APPL GENET, V116, P243, DOI 10.1007/s00122-007-0663-5; Loarce Y, 1996, THEOR APPL GENET, V93, P1112, DOI 10.1007/BF00230133; Lukaszewski AJ, 2003, CROP SCI, V43, P2316, DOI 10.2135/cropsci2003.2316; Manninen OM, 2000, THEOR APPL GENET, V100, P57, DOI 10.1007/s001220050008; Martis MM, 2012, P NATL ACAD SCI USA, V109, P13343, DOI 10.1073/pnas.1204237109; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Milligan B. G., 1992, Molecular genetic analysis of populations: a practical approach., P59; NARANJO T, 1982, HEREDITY, V48, P57, DOI 10.1038/hdy.1982.6; Niedziela A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-67; Oettler G, 2005, CROP SCI, V45, P1476, DOI 10.2135/cropsci2004.0462; Oettler G, 2003, PLANT BREEDING, V122, P318, DOI 10.1046/j.1439-0523.2003.00877.x; Paillard S, 2003, THEOR APPL GENET, V107, P1235, DOI 10.1007/s00122-003-1361-6; Pestsova E, 2000, GENOME, V43, P689, DOI 10.1139/gen-43-4-689; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pronyk C, 2011, BIORESOURCE TECHNOL, V102, P2016, DOI 10.1016/j.biortech.2010.09.064; Puertas MJ, 1998, HEREDITY, V80, P209, DOI 10.1046/j.1365-2540.1998.00293.x; Raman H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101673; Ren RS, 2015, MOL GENET GENOMICS, V290, P1457, DOI 10.1007/s00438-015-0997-7; Roder MS, 1998, GENETICS, V149, P2007; Saal B, 1999, GENOME, V42, P964, DOI 10.1139/gen-42-5-964; Saintenac C, 2013, G3-GENES GENOM GENET, V3, P1105, DOI 10.1534/g3.113.005819; Saintenac C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r88; Semagn K, 2006, GENOME, V49, P545, DOI 10.1139/G06-002; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Stojalowski S, 2013, J APPL GENET, V54, P179, DOI 10.1007/s13353-013-0144-2; Szechynska-Hebda M, 2013, PLANT PATHOL, V62, P867, DOI 10.1111/ppa.12001; Taketa S, 1993, P 8 INT WHEAT GEN S, P287; Tams SH, 2006, PLANT BREEDING, V125, P331, DOI 10.1111/j.1439-0523.2006.01218.x; TARKOWSKI C, 1992, HEREDITAS, V116, P281, DOI 10.1111/j.1601-5223.1992.tb00155.x; Trebbi D, 2011, THEOR APPL GENET, V123, P555, DOI 10.1007/s00122-011-1607-7; Tyrka M, 2011, GENOME, V54, P391, DOI [10.1139/g11-009, 10.1139/G11-009]; Tyrka Miroslaw, 2004, Journal of Applied Genetics, V45, P283; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; Van Os H, 2005, THEOR APPL GENET, V112, P30, DOI 10.1007/s00122-005-0097-x; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; van Poecke RMP, 2013, PLANT BIOTECHNOL J, V11, P809, DOI 10.1111/pbi.12072; Wedzony M, 1998, PLANT BREEDING, V117, P211, DOI 10.1111/j.1439-0523.1998.tb01928.x; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Winfield MO, 2012, PLANT BIOTECHNOL J, V10, P733, DOI 10.1111/j.1467-7652.2012.00713.x; Zhang L, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-69; ZIVY M, 1992, THEOR APPL GENET, V83, P919, DOI 10.1007/BF00226716	66	19	20	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145714	10.1371/journal.pone.0145714	http://dx.doi.org/10.1371/journal.pone.0145714			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717308	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500060
J	Viola, V; Tosoni, A; Brizi, A; Salvato, I; Kruglanski, AW; Galati, G; Mannetti, L				Viola, Vanda; Tosoni, Annalisa; Brizi, Ambra; Salvato, Ilaria; Kruglanski, Arie W.; Galati, Gaspare; Mannetti, Lucia			Need for Cognitive Closure Modulates How Perceptual Decisions Are Affected by Task Difficulty and Outcome Relevance	PLOS ONE			English	Article							CARDIOVASCULAR-RESPONSE; INDIVIDUAL-DIFFERENCES; VISUAL-MOTION; SELF; AREA; PERFORMANCE; MOTIVATION; DEPLETION; STRIATUM; ACCURACY	The aim of this study was to assess the extent to which Need for Cognitive Closure (NCC), an individual-level epistemic motivation, can explain inter-individual variability in the cognitive effort invested on a perceptual decision making task (the random motion task). High levels of NCC are manifested in a preference for clarity, order and structure and a desire for firm and stable knowledge. The study evaluated how NCC moderates the impact of two variables known to increase the amount of cognitive effort invested on a task, namely task ambiguity (i.e., the difficulty of the perceptual discrimination) and outcome relevance (i.e., the monetary gain associated with a correct discrimination). Based on previous work and current design, we assumed that reaction times (RTs) on our motion discrimination task represent a valid index of effort investment. Task ambiguity was associated with increased cognitive effort in participants with low or medium NCC but, interestingly, it did not affect the RTs of participants with high NCC. A different pattern of association was observed for outcome relevance; high outcome relevance increased cognitive effort in participants with moderate or high NCC, but did not affect the performance of low NCC participants. In summary, the performance of individuals with low NCC was affected by task difficulty but not by outcome relevance, whereas individuals with high NCC were influenced by outcome relevance but not by task difficulty; only participants with medium NCC were affected by both task difficulty and outcome relevance. These results suggest that perceptual decision making is influenced by the interaction between context and NCC.	[Viola, Vanda; Salvato, Ilaria; Galati, Gaspare] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy; [Viola, Vanda; Galati, Gaspare] Fdn Santa Lucia, Neuropsychol Lab, Rome, Italy; [Tosoni, Annalisa] Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Tosoni, Annalisa] Fdn G DAnnunzio, Inst Adv Biomed Technol, Chieti, Italy; [Brizi, Ambra; Mannetti, Lucia] Univ Roma La Sapienza, Dept Dev & Social Psychol, I-00185 Rome, Italy; [Kruglanski, Arie W.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA	Sapienza University Rome; IRCCS Santa Lucia; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Sapienza University Rome; University System of Maryland; University of Maryland College Park	Viola, V (corresponding author), Univ Roma La Sapienza, Dept Psychol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	vanda.viola@uniroma1.it	Galati, Gaspare/F-3277-2011; Tosoni, Annalisa/J-7410-2016	Galati, Gaspare/0000-0002-0640-4247; Tosoni, Annalisa/0000-0001-9004-2623; Brizi, Ambra/0000-0001-6462-5059	Italian Ministry of Health; Sapienza University of Rome [C26A137J9F]	Italian Ministry of Health(Ministry of Health, Italy); Sapienza University of Rome	RC block grants by the Italian Ministry of Health to Fondazione Santa Lucia and by C26A137J9F grant by Sapienza University of Rome to the last author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ach N., 1935, HDB BIOLOGISCHEN ARB; BALL K, 1982, SCIENCE, V218, P697, DOI 10.1126/science.7134968; Bijleveld E, 2010, COGNITION, V115, P330, DOI 10.1016/j.cognition.2009.12.012; BREHM JW, 1983, J EXP SOC PSYCHOL, V19, P21, DOI 10.1016/0022-1031(83)90003-3; BREHM JW, 1989, ANNU REV PSYCHOL, V40, P109, DOI 10.1146/annurev.ps.40.020189.000545; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; CACIOPPO JT, 1982, J PERS SOC PSYCHOL, V42, P116, DOI 10.1037/0022-3514.42.1.116; CACIOPPO JT, 1984, J PERS ASSESS, V48, P306, DOI 10.1207/s15327752jpa4803_13; CACIOPPO JT, 1983, J PERS SOC PSYCHOL, V45, P805, DOI 10.1037/0022-3514.45.4.805; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; DECI EL, 1985, J RES PERS, V19, P109, DOI 10.1016/0092-6566(85)90023-6; Eubanks L, 2002, MOTIV EMOTION, V26, P139, DOI 10.1023/A:1019863318803; Finney D.J., 1971, PROBIT ANAL; Fiske SusanT., 1991, SOCIAL COGNITION 2; Forster J, 2003, ORGAN BEHAV HUM DEC, V90, P148, DOI 10.1016/S0749-5978(02)00509-5; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Gendolla GHE, 2010, REV GEN PSYCHOL, V14, P212, DOI 10.1037/a0019742; Grant M., 2014, CVX MATLAB SOFTWARE; Hillgruber A, 1912, UNTERSUCHUNGEN PSYCH, V1, P6; Ho CS, 2009, VISION RES, V49, P2891, DOI 10.1016/j.visres.2009.07.012; JUST MA, 1980, PSYCHOL REV, V87, P329, DOI 10.1037/0033-295X.87.4.329; Kossowska M, 2014, NEUROSCI LETT, V570, P38, DOI 10.1016/j.neulet.2014.04.002; Kruglanski A. W, 1989, LAY EPISTEMICS HUMAN; Kruglanski AW, 2012, PSYCHOL REV, V119, P1, DOI 10.1037/a0025488; Kruglanski Arie W., 2004, PSYCHOL CLOSED MINDE; Kruglanski AW, 1996, PSYCHOL REV, V103, P263, DOI 10.1037/0033-295X.103.2.263; Marcora SM, 2008, AM J PHYSIOL-REG I, V294, pR874, DOI 10.1152/ajpregu.00678.2007; MCKEE SP, 1985, PERCEPT PSYCHOPHYS, V37, P286, DOI 10.3758/BF03211350; Mulder MJ, 2013, ATTEN PERCEPT PSYCHO, V75, P1048, DOI 10.3758/s13414-013-0447-8; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Niwa M, 2008, J NEUROSCI, V28, P4435, DOI 10.1523/JNEUROSCI.5564-07.2008; Pierro A., 2005, REVISED NEED C UNPUB; Pilly PK, 2009, VISION RES, V49, P1599, DOI 10.1016/j.visres.2009.03.019; Richter M, 2008, PSYCHOPHYSIOLOGY, V45, P869, DOI 10.1111/j.1469-8986.2008.00688.x; Richter M, 2009, PSYCHOPHYSIOLOGY, V46, P451, DOI 10.1111/j.1469-8986.2009.00795.x; Robertson BD, 2015, NEUROIMAGE, V114, P170, DOI 10.1016/j.neuroimage.2015.03.082; Robinson LJ, 2012, ACTA PSYCHOL, V141, P243, DOI 10.1016/j.actpsy.2012.05.012; Roets A, 2008, PERS SOC PSYCHOL B, V34, P779, DOI 10.1177/0146167208315554; Roitman JD, 2002, J NEUROSCI, V22, P9475; Romaya J, 2000, COGENT 2000 VERSION; SALZMAN CD, 1994, SCIENCE, V264, P231, DOI 10.1126/science.8146653; Schmeichel BJ, 2010, J PERS SOC PSYCHOL, V99, P162, DOI 10.1037/a0019797; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Storey PL, 1996, J PSYCHOPHYSIOL, V10, P228; Thompson-Schill SL, 2002, COGN AFFECT BEHAV NE, V2, P109, DOI 10.3758/CABN.2.2.109; van Maanen L, 2011, J NEUROSCI, V31, P17488, DOI 10.1523/JNEUROSCI.2924-11.2011; Viola V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098010; Vonk W, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P291, DOI 10.1016/B978-044451020-4/50017-7; Wagner DD, 2013, SOC COGN AFFECT NEUR, V8, P410, DOI 10.1093/scan/nss082; WEBSTER DM, 1994, J PERS SOC PSYCHOL, V67, P1049, DOI 10.1037/0022-3514.67.6.1049; Westbrook A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068210; Wright RA, 2003, PSYCHOPHYSIOLOGY, V40, P98, DOI 10.1111/1469-8986.00010; WRIGHT RA, 1989, BASIC APPL SOC PSYCH, V10, P161, DOI 10.1207/s15324834basp1002_6	54	12	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146002	10.1371/journal.pone.0146002	http://dx.doi.org/10.1371/journal.pone.0146002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716987	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500114
J	Tillotson, BJ; Goulatis, LI; Parenti, I; Duxbury, E; Shusta, EV				Tillotson, Benjamin J.; Goulatis, Loukas I.; Parenti, Isabelle; Duxbury, Elizabeth; Shusta, Eric V.			Engineering an Anti-Transferrin Receptor ScFv for pH-Sensitive Binding Leads to Increased Intracellular Accumulation	PLOS ONE			English	Article							PROTEIN-SYNTHESIS INHIBITION; YEAST SURFACE DISPLAY; NEONATAL FC-RECEPTOR; IONIZATION MASS-SPECTROMETRY; HUMAN SERUM TRANSFERRIN; IRON RELEASE; IN-VIVO; SACCHAROMYCES-CEREVISIAE; QUANTITATIVE-ANALYSIS; ANTIBODY LIBRARIES	The equilibrium binding affinity of receptor-ligand or antibody-antigen pairs may be modulated by protonation of histidine side-chains, and such pH-dependent mechanisms play important roles in biological systems, affecting molecular uptake and trafficking. Here, we aimed to manipulate cellular transport of single-chain antibodies (scFvs) against the transferrin receptor (TfR) by engineering pH-dependent antigen binding. An anti-TfR scFv was subjected to histidine saturation mutagenesis of a single CDR. By employing yeast surface display with a pH-dependent screening pressure, scFvs having markedly increased dissociation from TfR at pH 5.5 were identified. The pH-sensitivity generally resulted from a central cluster of histidine residues in CDRH1. When soluble, pH-sensitive, scFv clone M16 was dosed onto live cells, the internalized fraction was 2.6-fold greater than scFvs that lacked pH-sensitive binding and the increase was dependent on endosomal acidification. Differences in the intracellular distribution of M16 were also observed consistent with an intracellular decoupling of the scFv M16-TfR complex. Engineered pH-sensitive TfR binding could prove important for increasing the effectiveness of TfR-targeted antibodies seeking to exploit endocytosis or transcytosis for drug delivery purposes.	[Tillotson, Benjamin J.; Goulatis, Loukas I.; Parenti, Isabelle; Duxbury, Elizabeth; Shusta, Eric V.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Shusta, EV (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53705 USA.	eshusta@wisc.edu			UWCCC from the National Institutes of Health [P30 CA014520]; Defense Threat Reduction Agency [HDTRA1-15-1-0012]; National Science Foundation [CBET-0966014]; National Institutes of Health [NS071513]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071513] Funding Source: NIH RePORTER	UWCCC from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant NS071513, Defense Threat Reduction Agency grant HDTRA1-15-1-0012 and National Science Foundation grant CBET-0966014. Additionally, the UW-Madison Comprehensive Cancer Center (UWCCC) flow cytometry facility, is funded by UWCCC Support Grant P30 CA014520 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwal JK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002254; Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Chaparro-Riggers J, 2012, J BIOL CHEM, V287, P11090, DOI 10.1074/jbc.M111.319764; CHITAMBAR CR, 1989, BLOOD, V74, P602; CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171, DOI 10.4049/jimmunol.169.9.5171; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Daniels TR, 2006, CLIN IMMUNOL, V121, P159, DOI 10.1016/j.clim.2006.06.006; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Eckenroth BE, 2011, P NATL ACAD SCI USA, V108, P13089, DOI 10.1073/pnas.1105786108; Edgcomb SP, 2002, PROTEINS, V49, P1, DOI 10.1002/prot.10177; Gera N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048928; Giannetti AM, 2005, STRUCTURE, V13, P1613, DOI 10.1016/j.str.2005.07.016; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gumerov DR, 2003, BIOCHEMISTRY-US, V42, P5421, DOI 10.1021/bi020660b; Hackel BJ, 2006, PHARM RES-DORDR, V23, P790, DOI 10.1007/s11095-006-9778-7; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kulkarni MV, 2010, J BIOL CHEM, V285, P38524, DOI 10.1074/jbc.M110.172072; Lao BJ, 2007, J CONTROL RELEASE, V117, P403, DOI 10.1016/j.jconrel.2006.12.001; Leverence R, 2010, P NATL ACAD SCI USA, V107, P8123, DOI 10.1073/pnas.0914898107; Luck AN, 2013, ADV DRUG DELIVER REV, V65, P1012, DOI 10.1016/j.addr.2012.11.001; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Mayle KM, 2012, BBA-GEN SUBJECTS, V1820, P264, DOI 10.1016/j.bbagen.2011.09.009; Murtaugh ML, 2011, PROTEIN SCI, V20, P1619, DOI 10.1002/pro.696; Nga BL, 2014, J EXP MED, V211, P233, DOI 10.1084/jem.20131660; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Oganesyan V, 2009, MOL IMMUNOL, V46, P1750, DOI 10.1016/j.molimm.2009.01.026; Piatesi A, 2006, PROTEIN EXPRES PURIF, V48, P232, DOI 10.1016/j.pep.2006.01.026; Poul MA, 2000, J MOL BIOL, V301, P1149, DOI 10.1006/jmbi.2000.4026; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sade H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096340; Sarkar CA, 2002, NAT BIOTECHNOL, V20, P908, DOI 10.1038/nbt725; Schroter C, 2014, MABS, V7, P138; Shusta EV, 1998, NAT BIOTECHNOL, V16, P773, DOI 10.1038/nbt0898-773; Sun HZ, 1998, FEBS LETT, V422, P315, DOI 10.1016/S0014-5793(98)00034-9; Swers JS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh030; Tillotson BJ, 2013, PROTEIN ENG DES SEL, V26, P101, DOI 10.1093/protein/gzs077; Traxlmayr MW, 2014, BIOTECHNOL J, V9, P1013, DOI 10.1002/biot.201300483; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; VanAntwerp JJ, 2000, BIOTECHNOL PROGR, V16, P31, DOI 10.1021/bp990133s; Wally J, 2006, J BIOL CHEM, V281, P24934, DOI 10.1074/jbc.M604592200; Wang XX, 2007, NAT METHODS, V4, P143, DOI 10.1038/nmeth993; Wenning LA, 1998, BIOTECHNOL BIOENG, V57, P484, DOI 10.1002/(SICI)1097-0290(19980220)57:4<484::AID-BIT13>3.0.CO;2-C; Wentz AE, 2007, APPL ENVIRON MICROB, V73, P1189, DOI 10.1128/AEM.02427-06; YAZDI PT, 1995, CANCER RES, V55, P3763; YAZDI PT, 1994, CANCER RES, V54, P6387; Yoon DJ, 2009, J CONTROL RELEASE, V133, P178, DOI 10.1016/j.jconrel.2008.10.006; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230	52	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145820	10.1371/journal.pone.0145820	http://dx.doi.org/10.1371/journal.pone.0145820			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713870	Green Submitted, Green Published, gold			2022-12-27	WOS:000367481900088
J	Yan, H; Ajuwon, KM				Yan, Hui; Ajuwon, Kolapo M.			Mechanism of Butyrate Stimulation of Triglyceride Storage and Adipokine Expression during Adipogenic Differentiation of Porcine Stromovascular Cells	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; PEROXISOMAL BETA-OXIDATION; ADIPOSE-TISSUE; INSULIN-RESISTANCE; GUT MICROBIOTA; INHIBITION; RECEPTOR; IDENTIFICATION; TRANSCRIPTION; PROPIONATE	Short chain fatty acids (SCFA), products of microbial fermentation of dietary fiber, exert multiple metabolic effects in cells. Previously, we had demonstrated that soluble fiber influenced fat mass accumulation, gut microbial community structure and SCFA production in pigs. The current study was designed to identify effects of SCFA treatment during adipogenic differentiation of porcine stromovascular cells on lipid metabolism and adipokine expression. Differentiating cells were treated with varying concentrations of butyrate. Results show that butyrate treatment enhanced adipogenesis and lipid accumulation, perhaps through upregulation of glucose uptake and de novo lipogenesis and other mechanisms that include induction of SREBP-1c, C/EBP alpha/beta, GLUT4, LPL, PPAR., GPAT4, DGAT1 and DGAT2 expression. In addition, butyrate induced adiponectin expression, resulting in activation of downstream target genes, such as AMPK and AKT. Activation of AMPK by butyrate led to phosphorylation of ACC. Although increased ACO gene expression was seen with butyrate treatment, experiments with the peroxisomal fatty acid inhibitor, thioridazine, suggest that butyrate may have an inhibitory effect on peroxisomal fatty acid oxidation. Our studies also provide evidence that butyrate may inhibit lipolysis, perhaps in an FFAR3-dependent manner. Therefore, this study presents a novel paradigm for butyrate action in adipocytes and shows that adipocytes are capable of utilizing butyrate, leading to increased expression of adiponectin for enhanced glucose uptake and improved insulin sensitivity.	[Yan, Hui; Ajuwon, Kolapo M.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ajuwon, KM (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	kajuwon@purdue.edu						Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Giri S, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-31; Griesel BA, 2010, DIABETES, V59, P800, DOI 10.2337/db09-1542; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Hu GX, 2010, MED HYPOTHESES, V74, P123, DOI 10.1016/j.mehy.2009.07.022; Kelly M, 2006, FOOD NUTR RES, V50, P7, DOI [10.3402/fnr.v50i0.1581, DOI 10.3402/FNR.V50I0.1581]; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Li GL, 2014, J NUTR, V144, P1887, DOI 10.3945/jn.114.198531; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Pang XY, 2007, ISME J, V1, P156, DOI 10.1038/ismej.2007.23; Papathanasopoulos A, 2010, GASTROENTEROLOGY, V138, P65, DOI 10.1053/j.gastro.2009.11.045; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Shi RL, 2012, NEUROSCI LETT, V528, P6, DOI 10.1016/j.neulet.2012.08.086; Steliou K, 2012, BIORESEARCH OPEN ACC, V1, P192, DOI 10.1089/biores.2012.0223; Topping DL, 2001, SHORT CHAIN FATTY AC; Valet P, 2002, J LIPID RES, V43, P835; VANDENBRANDEN C, 1990, GLIA, V3, P458, DOI 10.1002/glia.440030604; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059581; Yoo EJ, 2006, J BIOL CHEM, V281, P6608, DOI 10.1074/jbc.M508982200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	39	47	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145940	10.1371/journal.pone.0145940	http://dx.doi.org/10.1371/journal.pone.0145940			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713737	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900103
J	Fu, YG; Ge, YT; Sun, Y; Liang, JH; Wan, L; Wu, XJ; Xu, AL				Fu, Yonggui; Ge, Yutong; Sun, Yu; Liang, Jiahui; Wan, Liang; Wu, Xiaojian; Xu, Anlong			IVT-SAPAS: Low-Input and Rapid Method for Sequencing Alternative Polyadenylation Sites	PLOS ONE			English	Article							3' UNTRANSLATED REGIONS; 2 MESSENGER-RNAS; CANCER; GENOME; CELLS; LANDSCAPE; CLEAVAGE; 3'UTRS; GENE; ENDS	Gene transcribing with alternative polyadenylation (APA) sites leads to mRNA isoforms, which may encode different proteins or harbor different 3'UTRs. APA plays an important role in regulating gene expression network among various physiological processes, such as development, immune responses and cancer. Several methods of library construction for APA study have been developed to apply high-throughput sequencing. However, the requirement of high-input RNA and time-consuming nature of the current methods limited the studies of APA for the samples difficult to obtain. Here, we describe a new method based on our SAPAS in combining in vitro transcription (IVT) and magnetic beads purification. The new IVT-SAPAS provides a rapid and high-parallel procedure for APA library construction with low-input sample, which may be a new robust approach for studying APA.	[Fu, Yonggui] Sun Yat Sen Univ, Res Inst, Shenzhen Res Ctr, State Key Lab Biocontrol, Shenzhen 518057, Peoples R China; [Fu, Yonggui; Ge, Yutong; Sun, Yu; Liang, Jiahui; Wan, Liang; Xu, Anlong] Sun Yat Sen Univ, Higher Educ Mega Ctr, Guangdong Prov Key Lab Pharmaceut Funct Genes, Dept Biochem,Sch Life Sci,State Key Lab Biocontro, Guangzhou 510006, Guangdong, Peoples R China; [Wu, Xiaojian] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou 510655, Guangdong, Peoples R China; [Xu, Anlong] Beijing Univ Chinese Med, Beijing 100029, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Beijing University of Chinese Medicine	Xu, AL (corresponding author), Sun Yat Sen Univ, Higher Educ Mega Ctr, Guangdong Prov Key Lab Pharmaceut Funct Genes, Dept Biochem,Sch Life Sci,State Key Lab Biocontro, Guangzhou 510006, Guangdong, Peoples R China.	lssxal@mail.sysu.edu.cn		Fu, Yonggui/0000-0001-6469-3430; Xu, Anlong/0000-0002-1419-3494	National High-tech R&D Program of China (863 Program) [2012AA02A520]; National Natural Science Foundation of China [30730089, 91331113]; Committee of Science and Technology Innovation of Shenzhen [JCYJ20120831173744342]; National Natural Science Foundation	National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology Innovation of Shenzhen; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National High-tech R&D Program of China (863 Program) (No. 2012AA02A520 to W.X.), National Natural Science Foundation of China (No. 30730089 to A.X. and No. 91331113 to Y.F.), and Committee of Science and Technology Innovation of Shenzhen ( No. JCYJ20120831173744342 to Y.F.). A.X. is the recipient of an "Outstanding Young Scientist Award" from the National Natural Science Foundation.; The authors are grateful to Dr. Jingde Zhu and Xueqin Wang for their suggestions. This work was supported by National High-tech R&D Program of China (863 Program) (No. 2012AA02A520 to W.X.), National Natural Science Foundation of China (No. 30730089 to A.X. and No. 91331113 to Y.F.), and Committee of Science and Technology Innovation of Shenzhen (No. JCYJ20120831173744342 to Y.F.). A.X. is the recipient of an "Outstanding Young Scientist Award" from the National Natural Science Foundation.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; ALT FW, 1980, CELL, V20, P293, DOI 10.1016/0092-8674(80)90615-7; EARLY P, 1980, CELL, V20, P313, DOI 10.1016/0092-8674(80)90617-0; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Hoque M, 2013, NAT METHODS, V10, P133, DOI [10.1038/NMETH.2288, 10.1038/nmeth.2288]; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li YX, 2012, GENOME RES, V22, P1899, DOI 10.1101/gr.128488.111; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; ROGERS J, 1980, CELL, V20, P303, DOI 10.1016/0092-8674(80)90616-9; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sawasaki T, 2004, TUMOR BIOL, V25, P141, DOI 10.1159/000079146; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Wallrapp C, 2000, CANCER RES, V60, P2602	19	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145477	10.1371/journal.pone.0145477	http://dx.doi.org/10.1371/journal.pone.0145477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710068	Green Submitted, gold, Green Published			2022-12-27	WOS:000367451400049
J	Greene, JA; Portillo, JAC; Corcino, YL; Subauste, CS				Greene, Jennifer A.; Portillo, Jose-Andres C.; Corcino, Yalitza Lopez; Subauste, Carlos S.			CD40-TRAF Signaling Upregulates CX3CL1 and TNF-alpha in Human Aortic Endothelial Cells but Not in Retinal Endothelial Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RECEPTOR-ASSOCIATED FACTOR-2; EARLY DIABETIC-RETINOPATHY; TRAF BINDING-SITES; FRACTALKINE CX3CL1; ATHEROSCLEROTIC LESIONS; ANTIMICROBIAL ACTIVITY; IMMUNE-RESPONSE; B-LYMPHOCYTES; IN-VIVO	CD40, CX3CL1 and TNF-alpha promote atheroma and neointima formation. CD40 and TNF-alpha are also central to the development of diabetic retinopathy while CX3CL1 may play a role in the pathogenesis of this retinopathy. The purpose of this study was to examine whether CD40 ligation increases CX3CL1 and TNF-alpha protein expression in human endothelial cells from the aorta and retina. CD154 (CD40 ligand) upregulated membrane-bound and soluble CX3CL1 in human aortic endothelial cells. CD154 triggered TNF-alpha production by human aortic endothelial cells. TNF Receptor Associated Factors (TRAF) are key mediators of CD40 signaling. Compared to human aortic endothelial cells that express wt CD40, cells that express CD40 with a mutation that prevents TRAF2,3 recruitment, or CD40 with a mutation that prevents TRAF6 recruitment exhibited a profound inhibition of CD154-driven upregulation of membrane bound and soluble CX3CL1 as well as of TNF-alpha secretion. While both CD154 and TNF-alpha upregulated CX3CL1 in human aortic endothelial cells, these stimuli could act independently of each other. In contrast to human aortic endothelial cells, human retinal endothelial cells did not increase membrane bound or soluble CX3CL1 expression or secrete TNF-alpha in response to CD154 even though CD40 ligation upregulated ICAM-1 and CCL2 in these cells. Moreover, TNF-alpha did not upregulate CX3CL1 in retinal endothelial cells. In conclusion, CD40 ligation increases CX3CL1 protein levels and induces TNF-alpha production in endothelial cells. However, endothelial cells are heterogeneous in regards to these responses. Human aortic but not retinal endothelial cells upregulated CX3CL1 and TNF-alpha in response to CD40 ligation, as well as upregulated CX3CL1 in response to TNF-alpha. These dissimilarities may contribute to differences in regulation of inflammation in large vessels versus the retina.	[Greene, Jennifer A.; Portillo, Jose-Andres C.; Corcino, Yalitza Lopez; Subauste, Carlos S.] Case Western Reserve Univ, Dept Med, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Subauste, Carlos S.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Subauste, Carlos S.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Subauste, CS (corresponding author), Case Western Reserve Univ, Dept Med, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA.	carlos.subauste@case.edu			NIH Grant [EY019250]; Flow Cytometry Core Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland [P30 CA43703]; Postbaccalaureate Research Education Program at CWRU; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019250] Funding Source: NIH RePORTER	NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flow Cytometry Core Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland; Postbaccalaureate Research Education Program at CWRU; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH Grant EY019250 (CSS) as well as by the Flow Cytometry Core Facility of the Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland (P30 CA43703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH Grant EY019250, (C.S.S) as well as by the Flow Cytometry Core Facility of the Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland (P30 CA43703). YLC was supported by the Postbaccalaureate Research Education Program at CWRU. We thank Dr. James Jacobberger (Case Western Reserve University) for assistance with flow cytometry analysis.	Ahn SY, 2004, AM J PATHOL, V164, P1663, DOI 10.1016/S0002-9440(10)63725-X; Ahonen CL, 2002, NAT IMMUNOL, V3, P451, DOI 10.1038/ni792; Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Andrade RM, 2005, J IMMUNOL, V175, P6014, DOI 10.4049/jimmunol.175.9.6014; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Asgeirsdottir SA, 2012, AM J PHYSIOL-RENAL, V302, pF1630, DOI 10.1152/ajprenal.00400.2011; Baccam M, 1999, EUR J IMMUNOL, V29, P3855, DOI 10.1002/(SICI)1521-4141(199912)29:12<3855::AID-IMMU3855>3.0.CO;2-S; BARATH P, 1990, AM J CARDIOL, V65, P297, DOI 10.1016/0002-9149(90)90291-8; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Beck GC, 2006, CLIN EXP IMMUNOL, V143, P523, DOI 10.1111/j.1365-2249.2006.03005.x; Behl Y, 2008, AM J PATHOL, V172, P1411, DOI 10.2353/ajpath.2008.071070; Bishop GA, 2002, J LEUKOCYTE BIOL, V72, P19; Boumpas DT, 2003, ARTHRITIS RHEUM-US, V48, P719, DOI 10.1002/art.10856; CAPETANDES A, 1990, INVEST OPHTH VIS SCI, V31, P1738; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Davis B, 2005, CIRCULATION, V112, P2184, DOI 10.1161/CIRCULATIONAHA.105.553206; Donners MMPC, 2008, BLOOD, V111, P4596, DOI 10.1182/blood-2007-05-088906; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Fraticelli P, 2001, J CLIN INVEST, V107, P1173, DOI 10.1172/JCI11517; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Greene JA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-47; Hakkinen T, 2000, VIRCHOWS ARCH, V437, P396, DOI 10.1007/s004280000239; HANSSON GK, 1989, ARTERIOSCLEROSIS, V9, P567, DOI 10.1161/01.ATV.9.5.567; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Haskell CA, 2000, J BIOL CHEM, V275, P34183, DOI 10.1074/jbc.M005731200; Haxhinasto SA, 2002, J IMMUNOL, V169, P1145, DOI 10.4049/jimmunol.169.3.1145; Hsing Y, 1997, J IMMUNOL, V159, P4898; Huang H, 2011, INVEST OPHTH VIS SCI, V52, P1336, DOI 10.1167/iovs.10-5768; Jabara HH, 2002, IMMUNITY, V17, P265, DOI 10.1016/S1074-7613(02)00394-1; Jalukar SV, 2000, J IMMUNOL, V164, P623, DOI 10.4049/jimmunol.164.2.623; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; KARMANN K, 1995, P NATL ACAD SCI USA, V92, P4342, DOI 10.1073/pnas.92.10.4342; Lambert CM, 2010, AM J PHYSIOL-HEART C, V299, pH995, DOI 10.1152/ajpheart.00562.2010; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Limb GA, 1996, BRIT J OPHTHALMOL, V80, P168, DOI 10.1136/bjo.80.2.168; Lu LF, 2003, J BIOL CHEM, V278, P45414, DOI 10.1074/jbc.M309601200; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Mackey MF, 2003, EUR J IMMUNOL, V33, P779, DOI 10.1002/eji.200323729; Miller DL, 1998, J LEUKOCYTE BIOL, V63, P373, DOI 10.1002/jlb.63.3.373; Minami T, 2005, TRENDS CARDIOVAS MED, V15, P174, DOI 10.1016/j.tcm.2005.06.002; Mukundan L, 2005, J IMMUNOL, V174, P1081, DOI 10.4049/jimmunol.174.2.1081; Ohta H, 2005, ATHEROSCLEROSIS, V180, P11, DOI 10.1016/j.atherosclerosis.2004.11.016; Portillo JAC, 2014, INVEST OPHTH VIS SCI, V55, P8590, DOI 10.1167/iovs.14-15340; Portillo JAC, 2015, IMMUNOLOGY, V144, P21, DOI 10.1111/imm.12361; Portillo JAC, 2014, DIABETOLOGIA, V57, P2222, DOI 10.1007/s00125-014-3321-x; Portillo JAC, 2012, IMMUNOLOGY, V135, P140, DOI 10.1111/j.1365-2567.2011.03519.x; Portillo JAC, 2008, J IMMUNOL, V181, P8719, DOI 10.4049/jimmunol.181.12.8719; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; Schonbeck U, 1999, J EXP MED, V189, P843, DOI 10.1084/jem.189.5.843; Schulz C, 2007, CIRCULATION, V116, P764, DOI 10.1161/CIRCULATIONAHA.107.695189; Serra AM, 2012, AM J PATHOL, V181, P719, DOI 10.1016/j.ajpath.2012.04.009; Silverman MD, 2003, INVEST OPHTH VIS SCI, V44, P1608, DOI 10.1167/iovs.02-0233; Song ZF, 2012, ARTERIOSCL THROM VAS, V32, P50, DOI 10.1161/ATVBAHA.111.238329; Subauste CS, 2007, AUTOPHAGY, V3, P245, DOI 10.4161/auto.3717; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Tei N, 2013, J NEUROSCI RES, V91, P681, DOI 10.1002/jnr.23202; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Tsou CL, 2001, J BIOL CHEM, V276, P44622, DOI 10.1074/jbc.M107327200; Wong BWC, 2002, CARDIOVASC PATHOL, V11, P332, DOI 10.1016/S1054-8807(02)00111-4; You JJ, 2007, INVEST OPHTH VIS SCI, V48, P5290, DOI 10.1167/iovs.07-0187; Zhang HR, 2009, CLIN SCI, V116, P219, DOI 10.1042/CS20080196; Zieger M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106562	63	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144133	10.1371/journal.pone.0144133	http://dx.doi.org/10.1371/journal.pone.0144133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710229	gold, Green Submitted, Green Published			2022-12-27	WOS:000367451400003
J	Marchildon, F; Lamarche, E; Lala-Tabbert, N; St-Louis, C; Wiper-Bergeron, N				Marchildon, Francois; Lamarche, Emilie; Lala-Tabbert, Neena; St-Louis, Catherine; Wiper-Bergeron, Nadine			Expression of CCAAT/Enhancer Binding Protein Beta in Muscle Satellite Cells Inhibits Myogenesis in Cancer Cachexia	PLOS ONE			English	Article							NF-KAPPA-B; C/EBP-BETA; PREADIPOCYTE DIFFERENTIATION; UBIQUITIN LIGASES; GENE-EXPRESSION; INTERLEUKIN-6; TRANSCRIPTION; MECHANISMS; CYTOKINES; DELTA	Cancer cachexia is a paraneoplastic syndrome that causes profound weight loss and muscle mass atrophy and is estimated to be the cause of up to 30% of cancer deaths. Though the exact cause is unknown, patients with cancer cachexia have increased muscle protein catabolism. In healthy muscle, injury activates skeletal muscle stem cells, called satellite cells, to differentiate and promote regeneration. Here, we provide evidence that this mechanism is inhibited in cancer cachexia due to persistent expression of CCAAT/Enhancer Binding Protein beta (C/EBP beta) in muscle myoblasts. C/EBP beta is a bzip transcription factor that is expressed in muscle satellite cells and is normally downregulated upon differentiation. However, in myoblasts exposed to a cachectic milieu, C/EBP beta expression remains elevated, despite activation to differentiate, resulting in the inhibition of myogenin expression and myogenesis. In vivo, cancer cachexia results in increased number of Pax7+ cells that also express C/EBP beta and the inhibition of normal repair mechanisms. Loss of C/EBP beta expression in primary myoblasts rescues differentiation under cachectic conditions without restoring myotube size, indicating that C/EBP beta is an important inhibitor of myogenesis in cancer cachexia.	[Marchildon, Francois; Lamarche, Emilie; Lala-Tabbert, Neena] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Grad Program Cellular & Mol Med, Ottawa, ON, Canada; [St-Louis, Catherine; Wiper-Bergeron, Nadine] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada	University of Ottawa; University of Ottawa	Wiper-Bergeron, N (corresponding author), Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada.	Nadine.WiperBergeron@uottawa.ca	Wiper-Bergeron, Nadine/AAO-4370-2021	Wiper-Bergeron, Nadine/0000-0001-8448-3246; Marchildon, Francois/0000-0002-4846-3149	Canadian Institutes of Health Research; Cancer Research Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research Society	This work was funded by grants to NWB from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) and the Cancer Research Society (https://www.crs-src.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Argiles JM, 2005, INT J BIOCHEM CELL B, V37, P1084, DOI 10.1016/j.biocel.2004.10.003; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bruera E, 2000, Lancet Oncol, V1, P138, DOI 10.1016/S1470-2045(00)00033-4; Bruera E, 1997, BRIT MED J, V315, P1219, DOI 10.1136/bmj.315.7117.1219; Buck M, 2003, HEPATOLOGY, V37, P731, DOI 10.1053/jhep.2003.50155; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.0.CO;2-I; Coletti D, 2006, BASIC APPL MYOL, V16, P131; Deans C, 2005, CURR OPIN CLIN NUTR, V8, P265, DOI 10.1097/01.mco.0000165004.93707.88; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Fu DC, 2015, J BIOL CHEM, V290, P10200, DOI 10.1074/jbc.M115.638577; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Grimm SL, 2003, J MAMMARY GLAND BIOL, V8, P191, DOI 10.1023/A:1025900908026; GUTTRIDGE DC, 2000, SCIENCE, V289, P2363, DOI [10.1126/sci-ence.289.5488.2363, DOI 10.1126/SCI-ENCE.289.5488.2363, DOI 10.1126/science.289.5488.2363, DOI 10.1126/SCIENCE.289.5488.2363]; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Jiang ZL, 2006, FASEB J, V20, P2570, DOI 10.1096/fj.06-6347fje; Kuroda K, 2007, UROLOGY, V69, P113, DOI 10.1016/j.urology.2006.09.039; Li YP, 2000, AM J PHYSIOL-REG I, V279, pR1165, DOI 10.1152/ajpregu.2000.279.4.R1165; Liu Y, 2013, MOL CELL BIOL, V33, P4606, DOI 10.1128/MCB.00723-13; Loell I, 2011, J INTERN MED, V269, P243, DOI 10.1111/j.1365-2796.2010.02334.x; Marchildon F, 2012, STEM CELLS, V30, P2619, DOI 10.1002/stem.1248; MATTHYS P, 1991, INT J CANCER, V49, P77, DOI 10.1002/ijc.2910490115; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Mitchell PO, 2004, AM J PHYSIOL-CELL PH, V287, pC1753, DOI 10.1152/ajpcell.00292.2004; OLIFF A, 1987, CELL, V50, P555, DOI 10.1016/0092-8674(87)90028-6; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Ramos EJB, 2004, CURR OPIN CLIN NUTR, V7, P427, DOI 10.1097/01.mco.0000134363.53782.cb; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rosen ED, 2000, GENE DEV, V14, P1293; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Saini A, 2006, CYTOKINE GROWTH F R, V17, P475, DOI 10.1016/j.cytogfr.2006.09.006; SCHULTZ E, 1985, MUSCLE NERVE, V8, P217, DOI 10.1002/mus.880080307; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Sharples AP, 2015, BIOGERONTOLOGY; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; STRASSMANN G, 1992, J CLIN INVEST, V89, P1681, DOI 10.1172/JCI115767; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tsujinaka T, 1996, J CLIN INVEST, V97, P244, DOI 10.1172/JCI118398; Tsutsui T, 2013, J BIOL CHEM, V288, P20955, DOI 10.1074/jbc.M113.486746; Tuca A, 2013, CRIT REV ONCOL HEMAT, V88, P625, DOI 10.1016/j.critrevonc.2013.07.015; VANEYS J, 1985, ANNU REV NUTR, V5, P435, DOI 10.1146/annurev.nu.05.070185.002251; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P1, DOI 10.1007/s13539-010-0002-6; Wagatsuma A, 2007, MOL CELL BIOCHEM, V304, P25, DOI 10.1007/s11010-007-9482-x; Wiper-Bergeron N, 2003, EMBO J, V22, P2135, DOI 10.1093/emboj/cdg218; Wiper-Bergeron N, 2007, MOL ENDOCRINOL, V21, P2124, DOI 10.1210/me.2006-0452; Wiper-Bergeron N, 2007, P NATL ACAD SCI USA, V104, P2703, DOI 10.1073/pnas.0607378104; Wray CJ, 2003, INT J BIOCHEM CELL B, V35, P698, DOI 10.1016/S1357-2725(02)00341-2; Yang HM, 2005, J CELL PHYSIOL, V204, P219, DOI 10.1002/jcp.20278; YASUMOTO K, 1995, CANCER RES, V55, P921; Zhang GH, 2011, EMBO J, V30, P4323, DOI 10.1038/emboj.2011.292; Zhou W, 2003, WORLD J GASTROENTERO, V9, P1567, DOI 10.3748/wjg.v9.i7.1567; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	65	19	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145583	10.1371/journal.pone.0145583	http://dx.doi.org/10.1371/journal.pone.0145583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709824	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400063
J	Mowery, P; Ames, P; Reiser, RH; Parkinson, JS				Mowery, Patricia; Ames, Peter; Reiser, Rebecca H.; Parkinson, John S.			Chemotactic Signaling by Single-Chain Chemoreceptors	PLOS ONE			English	Article							ESCHERICHIA-COLI; LIGAND-BINDING; IN-VIVO; SENSORY ADAPTATION; BACTERIAL CHEMORECEPTORS; CYTOPLASMIC DOMAIN; HAMP DOMAINS; LAC OPERATOR; RECEPTOR; TSR	Bacterial chemoreceptors of the methyl-accepting chemotaxis protein (MCP) family operate in commingled clusters that enable cells to detect and track environmental chemical gradients with high sensitivity and precision. MCP homodimers of different detection specificities form mixed trimers of dimers that facilitate inter-receptor communication in core signaling complexes, which in turn assemble into a large signaling network. The two subunits of each homodimeric receptor molecule occupy different locations in the core complexes. One subunit participates in trimer-stabilizing interactions at the trimer axis, the other lies on the periphery of the trimer, where it can interact with two cytoplasmic proteins: CheA, a signaling autokinase, and CheW, which couples CheA activity to receptor control. As a possible tool for independently manipulating receptor subunits in these two structural environments, we constructed and characterized fused genes for the E. coli serine chemoreceptor Tsr that encoded single-chain receptor molecules in which the C-terminus of the first Tsr subunit was covalently connected to the N-terminus of the second with a polypeptide linker. We showed with soft agar assays and with a FRET-based in vivo CheA kinase assay that single-chain Tsr similar to Tsr molecules could promote serine sensing and chemotaxis responses. The length of the connection between the joined subunits was critical. Linkers nine residues or shorter locked the receptor in a kinase-on state, most likely by distorting the native structure of the receptor HAMP domain. Linkers 22 or more residues in length permitted near-normal Tsr function. Few single-chain molecules were found as monomer-sized proteolytic fragments in cells, indicating that covalently joined receptor subunits were responsible for mediating the signaling responses we observed. However, cysteine-directed crosslinking, spoiling by dominant-negative Tsr subunits, and rearrangement of ligand-binding site lesions revealed subunit swapping interactions that will need to be taken into account in experimental applications of single-chain chemoreceptors.	[Mowery, Patricia; Ames, Peter; Reiser, Rebecca H.; Parkinson, John S.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Mowery, Patricia] Hobart Coll, Geneva, NY USA; [Mowery, Patricia] William Smith Coll, Geneva, NY USA	Utah System of Higher Education; University of Utah	Mowery, P (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	mowery@hws.edu			National Institute of General Medical Sciences [GM19559]; Ruth L. Kirschstein National Institutes of Health fellowship [5F32GM072406]; National Cancer Institute [CA42014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019559, F32GM072406, R01GM019559] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ruth L. Kirschstein National Institutes of Health fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by the National Institute of General Medical Sciences #GM19559 to JSP (http://www.nigms.nih.gov) and the Ruth L. Kirschstein National Institutes of Health fellowship #5F32GM072406 to PM (https://researchtraining.nih.gov). The Protein-DNA Core Facility at the University of Utah receives support from National Cancer Institute grant #CA42014 (http://www.cancer.gov) to the Huntsman Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames P, 2002, P NATL ACAD SCI USA, V99, P7060, DOI 10.1073/pnas.092071899; AMES P, 1994, J BACTERIOL, V176, P6340, DOI 10.1128/jb.176.20.6340-6348.1994; Ames P, 2006, P NATL ACAD SCI USA, V103, P9292, DOI 10.1073/pnas.0602135103; Ames P, 2014, MOL MICROBIOL, V91, P875, DOI 10.1111/mmi.12443; Vu A, 2012, J MOL BIOL, V415, P759, DOI 10.1016/j.jmb.2011.11.043; Barnakov AN, 1999, P NATL ACAD SCI USA, V96, P10667, DOI 10.1073/pnas.96.19.10667; BERG HC, 1984, J GEN MICROBIOL, V130, P2915; Berleman JE, 2005, MOL MICROBIOL, V55, P1390, DOI 10.1111/j.1365-2958.2005.04489.x; Bhatnagar J, 2010, BIOCHEMISTRY-US, V49, P3824, DOI 10.1021/bi100055m; Bibikov SI, 1997, J BACTERIOL, V179, P4075, DOI 10.1128/jb.179.12.4075-4079.1997; Bjorkman AM, 2001, J BIOL CHEM, V276, P2808, DOI 10.1074/jbc.M009593200; Feng XH, 1999, J BACTERIOL, V181, P3164, DOI 10.1128/JB.181.10.3164-3171.1999; Feng XH, 1997, J BACTERIOL, V179, P6714, DOI 10.1128/jb.179.21.6714-6720.1997; Francis NR, 2004, P NATL ACAD SCI USA, V101, P17480, DOI 10.1073/pnas.0407826101; Gardina PJ, 1996, SCIENCE, V274, P425, DOI 10.1126/science.274.5286.425; Greenswag AR, 2015, BIOCHEMISTRY-US, V54, P3454, DOI 10.1021/bi501570n; Han XS, 2014, J BACTERIOL, V196, P641, DOI 10.1128/JB.01164-13; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; IWAMA T, 1995, J BACTERIOL, V177, P2218, DOI 10.1128/jb.177.8.2218-2221.1995; JEFFERY CJ, 1993, PROTEIN SCI, V2, P559; Khursigara CM, 2008, P NATL ACAD SCI USA, V105, P16555, DOI 10.1073/pnas.0806401105; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai RZ, 2014, J MOL BIOL, V426, P3642, DOI 10.1016/j.jmb.2014.08.003; LeMoual H, 1996, J MOL BIOL, V261, P568, DOI 10.1006/jmbi.1996.0483; Li JY, 1997, BIOCHEMISTRY-US, V36, P11851, DOI 10.1021/bi971510h; Li MS, 2011, P NATL ACAD SCI USA, V108, P9390, DOI 10.1073/pnas.1104824108; Li MS, 2005, MOL MICROBIOL, V56, P1617, DOI 10.1111/j.1365-2958.2005.04641.x; Li XX, 2013, BIOCHEMISTRY-US, V52, P3852, DOI 10.1021/bi400383e; Miller AS, 2006, BIOCHEMISTRY-US, V45, P8699, DOI 10.1021/bi060580y; Mowery P, 2008, J BACTERIOL, V190, P8065, DOI 10.1128/JB.01121-08; Muppirala UK, 2009, PROTEIN SCI, V18, P1702, DOI 10.1002/pro.170; Nikaido H, 2009, BBA-PROTEINS PROTEOM, V1794, P769, DOI 10.1016/j.bbapap.2008.10.004; OOSAWA K, 1988, J BACTERIOL, V170, P2521, DOI 10.1128/jb.170.6.2521-2526.1988; Park SY, 2006, NAT STRUCT MOL BIOL, V13, P400, DOI 10.1038/nsmb1085; Parkinson JS, 2015, TRENDS MICROBIOL, V23, P257, DOI 10.1016/j.tim.2015.03.003; Parkinson JS, 2010, ANNU REV MICROBIOL, V64, P101, DOI 10.1146/annurev.micro.112408.134215; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; PARKINSON JS, 1976, J BACTERIOL, V126, P758, DOI 10.1128/JB.126.2.758-770.1976; SADLER JR, 1983, P NATL ACAD SCI-BIOL, V80, P6785, DOI 10.1073/pnas.80.22.6785; SIMONS A, 1984, P NATL ACAD SCI-BIOL, V81, P1624, DOI 10.1073/pnas.81.6.1624; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P12669, DOI 10.1073/pnas.192463199; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Sourjik V, 2007, METHOD ENZYMOL, V423, P365, DOI 10.1016/S0076-6879(07)23017-4; Sourjik V, 2010, EMBO J, V29, P2724, DOI 10.1038/emboj.2010.178; Studdert CA, 2005, P NATL ACAD SCI USA, V102, P15623, DOI 10.1073/pnas.0506040102; Studdert CA, 2004, P NATL ACAD SCI USA, V101, P2117, DOI 10.1073/pnas.0308622100; Studdert CA, 2007, METHOD ENZYMOL, V423, P414, DOI 10.1016/S0076-6879(07)23019-8; Tajima H, 2011, J BIOL CHEM, V286, P42200, DOI 10.1074/jbc.M111.221887; Wang XQ, 2012, J MOL BIOL, V422, P282, DOI 10.1016/j.jmb.2012.05.023; Wu JG, 1996, BIOCHEMISTRY-US, V35, P4984, DOI 10.1021/bi9530189; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; YANG Y, 1993, J MOL BIOL, V232, P493, DOI 10.1006/jmbi.1993.1405; Yu DQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08640; Zhou Q, 2011, MOL MICROBIOL, V80, P596, DOI 10.1111/j.1365-2958.2011.07577.x; Zhou Q, 2009, MOL MICROBIOL, V73, P801, DOI 10.1111/j.1365-2958.2009.06819.x; Zhulin IB, 2001, ADV MICROB PHYSIOL, V45, P157, DOI 10.1016/S0065-2911(01)45004-1	58	4	4	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145267	10.1371/journal.pone.0145267	http://dx.doi.org/10.1371/journal.pone.0145267			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709829	Green Submitted, gold, Green Published			2022-12-27	WOS:000367451400031
J	Onelli, E; Ghiani, A; Gentili, R; Serra, S; Musacchi, S; Citterio, S				Onelli, E.; Ghiani, A.; Gentili, R.; Serra, S.; Musacchi, S.; Citterio, S.			Specific Changes of Exocarp and Mesocarp Occurring during Softening Differently Affect Firmness in Melting (MF) and Non Melting Flesh (NMF) Fruits	PLOS ONE			English	Article							CELL-WALL METABOLISM; RHEOLOGICAL PROPERTIES; PHENOLIC-COMPOUNDS; PRUNUS-PERSICA; FERULIC ACID; PEACH FRUIT; CUTICLE; PECTIN; BIOMECHANICS; REVEALS	Melting (MF) and non melting flesh (NMF) peaches differ in their final texture and firmness. Their specific characteristics are achieved by softening process and directly dictate fruit shelf life and quality. Softening is influenced by various mechanisms including cell wall reorganization and water loss. In this work, the biomechanical properties of MF Spring Crest's and NMF Oro A's exocarp and mesocarp along with the amount and localization of hydroxycinnamic acids and flavonoids were investigated during fruit ripening and post-harvest. The objective was to better understand the role played by water loss and cell wall reorganization in peach softening. Results showed that in ripe Spring Crest, where both cell turgor loss and cell wall dismantling occurred, mesocarp had a little role in the fruit reaction to compression and probe penetration response was almost exclusively ascribed to the epidermis which functioned as a mechanical support to the pulp. In ripe Oro A's fruit, where cell wall disassembly did not occur and the loss of cell turgor was observed only in mesocarp, the contribution of exocarp to fruit firmness was consistent but relatively lower than that of mesocarp, suggesting that in addition to cell turgor, the integrity of cell wall played a key role in maintaining NMF fruit firmness. The analysis of phenols suggested that permeability and firmness of epidermis were associated with the presence of flavonoids and hydroxycinnamic acids.	[Onelli, E.] Univ Milan, Dept Biosci, I-20133 Milan, Italy; [Ghiani, A.; Gentili, R.; Citterio, S.] Univ Milano Bicocca, Dept Earth & Environm Sci, I-20126 Milan, Italy; [Serra, S.; Musacchi, S.] Washington State Univ, Dept Hort, TFREC, Wenatchee, WA 98801 USA	University of Milan; University of Milano-Bicocca; Washington State University	Citterio, S (corresponding author), Univ Milano Bicocca, Dept Earth & Environm Sci, Piazza Sci 1, I-20126 Milan, Italy.	sandra.citterio@unimib.it	Musacchi, Stefano/H-8663-2019; Gentili, Rodolfo/I-5613-2016; ONELLI, ELISABETTA/B-1164-2017	Musacchi, Stefano/0000-0001-8618-6202; Gentili, Rodolfo/0000-0002-9332-7963; serra, sara/0000-0002-4117-2875; ONELLI, ELISABETTA/0000-0003-3724-4116	Italian MIUR PRIN-COFIN Project "The determination of nutraceutical and organoleptic features of peach fruit: role of the metabolism of phenylpropanoids and phenolic compounds" [2009SRZRE9]	Italian MIUR PRIN-COFIN Project "The determination of nutraceutical and organoleptic features of peach fruit: role of the metabolism of phenylpropanoids and phenolic compounds"	This research was funded by the Italian MIUR PRIN-COFIN Project "The determination of nutraceutical and organoleptic features of peach fruit: role of the metabolism of phenylpropanoids and phenolic compounds", project number: 2009SRZRE9.	Bargel H, 2004, J PLANT GROWTH REGUL, V23, P61, DOI 10.1007/s00344-004-0036-0; Bonghi C, 1999, POSTHARVEST BIOL TEC, V16, P213, DOI 10.1016/S0925-5214(99)00028-9; Bonora E, 2013, INT J AGRON, V2013, DOI 10.1155/2013/242461; Braybrook SA, 2012, PLANT SIGNAL BEHAV, V7, P1037, DOI 10.4161/psb.20768; Brovelli EA, 1999, J SCI FOOD AGR, V79, P707, DOI [10.1002/(SICI)1097-0010(199904)79:5<707::AID-JSFA241>3.0.CO;2-#, 10.1002/(SICI)1097-0010(199904)79:5&lt;707::AID-JSFA241&gt;3.0.CO;2-#]; Brummell DA, 2004, J EXP BOT, V55, P2029, DOI 10.1093/jxb/erh227; Buschmann C, 2000, PHOTOSYNTHETICA, V38, P483, DOI 10.1023/A:1012440903014; Cacao SMB, 2012, GENET MOL RES, V11, P3186, DOI 10.4238/2012.September.3.7; Dominguez E, 2011, PLANT SCI, V181, P77, DOI 10.1016/j.plantsci.2011.04.016; Dominguez E, 2009, FUNCT PLANT BIOL, V36, P613, DOI 10.1071/FP09039; Duan YX, 2013, ACTA PHYSIOL PLANT, V35, P707, DOI 10.1007/s11738-012-1111-y; Edelmann HG, 2005, J PLANT GROWTH REGUL, V24, P116, DOI 10.1007/s00344-004-0015-5; Espana L, 2014, PLANT PHYSIOL, V166, P1371, DOI 10.1104/pp.114.246405; Espana L, 2014, NEW PHYTOL, V202, P790, DOI 10.1111/nph.12727; Fernandez V, 2011, PLANT PHYSIOL, V156, P2098, DOI 10.1104/pp.111.176305; Fry Stephen C., 2004, Phytochemistry Reviews, V3, P97, DOI 10.1023/B:PHYT.0000047808.74647.43; Ghiani A, 2011, J EXP BOT, V62, P4043, DOI 10.1093/jxb/err109; Goulao L. F., 2010, Stewart Postharvest Review, V6, P7, DOI 10.2212/spr.2010.1.7; HARRIS PJ, 1976, NATURE, V259, P508, DOI 10.1038/259508a0; Heredia A, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1019979; Hutzler P, 1998, J EXP BOT, V49, P953, DOI 10.1093/jexbot/49.323.953; Isaacson T, 2009, PLANT J, V60, P363, DOI 10.1111/j.1365-313X.2009.03969.x; Ishii T, 1997, PLANT SCI, V127, P111, DOI 10.1016/S0168-9452(97)00130-1; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kerstiens G, 2006, J EXP BOT, V57, P2547, DOI 10.1093/jxb/erl015; Klepacka J, 2006, CRIT REV FOOD SCI, V46, P639, DOI 10.1080/10408390500511821; Knoche M, 2004, PHYSIOL PLANTARUM, V120, P667, DOI 10.1111/j.0031-9317.2004.0285.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lara I, 2014, POSTHARVEST BIOL TEC, V87, P103, DOI 10.1016/j.postharvbio.2013.08.012; Leide J, 2007, PLANT PHYSIOL, V144, P1667, DOI 10.1104/pp.107.099481; LESTER DR, 1994, PLANT PHYSIOL, V105, P225, DOI 10.1104/pp.105.1.225; Liakopoulos G, 2001, ANN BOT-LONDON, V87, P641, DOI 10.1006/anbo.2001.1387; Lopez-Casado G, 2007, J EXP BOT, V58, P3875, DOI 10.1093/jxb/erm233; Lunn D, 2013, PLANT PHYSIOL BIOCH, V66, P91, DOI 10.1016/j.plaphy.2013.02.005; LUQUE P, 1995, ARCH BIOCHEM BIOPHYS, V317, P417, DOI 10.1006/abbi.1995.1183; Meyer S, 2003, J EXP BOT, V54, P757, DOI 10.1093/jxb/erg063; MIYAMOTO K, 1994, PHYSIOL PLANTARUM, V92, P350, DOI 10.1111/j.1399-3054.1994.tb05347.x; Palin R, 2012, BIOSYSTEMS, V109, P397, DOI 10.1016/j.biosystems.2012.04.006; Pan XQ, 2014, J PROTEOME RES, V13, P1979, DOI 10.1021/pr401091n; PETRACEK PD, 1995, PLANT PHYSIOL, V109, P675, DOI 10.1104/pp.109.2.675; Prasanna V, 2007, CRIT REV FOOD SCI, V47, P1, DOI 10.1080/10408390600976841; RILEY RG, 1975, PLANT PHYSIOL, V56, P650, DOI 10.1104/pp.56.5.650; Saladie M, 2007, PLANT PHYSIOL, V144, P1012, DOI 10.1104/pp.107.097477; TAN KS, 1992, J PLANT PHYSIOL, V140, P460, DOI 10.1016/S0176-1617(11)80825-4; Trainotti L, 2003, J EXP BOT, V54, P1821, DOI 10.1093/jxb/erg198; Vicente AR, 2007, J SCI FOOD AGR, V87, P1435, DOI 10.1002/jsfa.2837; Zdunek A, 2013, SENSORS-BASEL, V13, P12175, DOI 10.3390/s130912175; Ziosi V, 2008, POSTHARVEST BIOL TEC, V49, P319, DOI 10.1016/j.postharvbio.2008.01.017	48	10	10	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145341	10.1371/journal.pone.0145341	http://dx.doi.org/10.1371/journal.pone.0145341			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709823	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400039
J	Joscelyne, A; Knuckey, S; Satterthwaite, ML; Bryant, RA; Li, M; Qian, M; Brown, AD				Joscelyne, Amy; Knuckey, Sarah; Satterthwaite, Margaret L.; Bryant, Richard A.; Li, Meng; Qian, Meng; Brown, Adam D.			Mental Health Functioning in the Human Rights Field: Findings from an International Internet-Based Survey	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SELF-EFFICACY; SYMPTOMS; TRAUMA; WAR; TRANSFORMATIONS; PERFECTIONISM; AFGHANISTAN; PREDICTORS; APPRAISALS	Human rights advocates play a critical role in promoting respect for human rights worldwide, and engage in a broad range of strategies, including documentation of rights violations, monitoring, press work and report-writing, advocacy, and litigation. However, little is known about the impact of human rights work on the mental health of human rights advocates. This study examined the mental health profile of human rights advocates and risk factors associated with their psychological functioning. 346 individuals currently or previously working in the field of human rights completed an internet-based survey regarding trauma exposure, depression, posttraumatic stress disorder (PTSD), resilience and occupational burnout. PTSD was measured with the Posttraumatic Stress Disorder Checklist-Civilian Version (PCL-C) and depression was measured with the Patient History Questionnaire-9 (PHQ-9). These findings revealed that among human rights advocates that completed the survey, 19.4% met criteria for PTSD, 18.8% met criteria for subthreshold PTSD, and 14.7% met criteria for depression. Multiple linear regressions revealed that after controlling for symptoms of depression, PTSD symptom severity was predicted by human rights-related trauma exposure, perfectionism and negative self-appraisals about human rights work. In addition, after controlling for symptoms of PTSD, depressive symptoms were predicted by perfectionism and lower levels of self-efficacy. Survey responses also suggested high levels of resilience: 43% of responders reported minimal symptoms of PTSD. Although survey responses suggest that many human rights workers are resilient, they also suggest that human rights work is associated with elevated rates of PTSD and depression. The field of human rights would benefit from further empirical research, as well as additional education and training programs in the workplace about enhancing resilience in the context of human rights work.	[Joscelyne, Amy] NYU, Sch Med, Program Survivors Torture, Dept Psychiat,Bellevue Hosp Ctr, New York, NY USA; [Knuckey, Sarah] Columbia Law Sch, Human Rights Inst, New York, NY USA; [Satterthwaite, Margaret L.] NYU, Sch Law New York, Ctr Human Rights & Global Justice, New York, NY USA; [Bryant, Richard A.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Li, Meng; Qian, Meng; Brown, Adam D.] NYU, Sch Med, Dept Psychiat, Steven & Alexandra Cohen Vet Ctr, New York, NY 11201 USA; [Brown, Adam D.] Sarah Lawrence Coll, Dept Psychol, Bronxville, NY 10708 USA	Bellevue Hospital Center; New York University; Columbia University; New York University; University of New South Wales Sydney; New York University; Sarah Lawrence College	Brown, AD (corresponding author), NYU, Sch Med, Dept Psychiat, Steven & Alexandra Cohen Vet Ctr, New York, NY 11201 USA.	abrown@sarahlawrence.edu	Satterthwaite, Margaret/FVD-1665-2022; Bryant, Richard/AAA-6479-2019	Satterthwaite, Margaret/0000-0001-7683-5619; Bryant, Richard/0000-0002-9607-819X				Benight CC, 2004, BEHAV RES THER, V42, P1129, DOI 10.1016/j.brat.2003.08.008; Berger W, 2012, SOC PSYCH PSYCH EPID, V47, P1001, DOI 10.1007/s00127-011-0408-2; Berntsen D, 2007, APPL COGNITIVE PSYCH, V21, P417, DOI 10.1002/acp.1290; Berntsen D, 2012, PSYCHOL SCI, V23, P1557, DOI 10.1177/0956797612457389; Blackburn L, 2015, J CLIN PSYCHOL, V71, P219, DOI 10.1002/jclp.22133; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Connorton E, 2012, EPIDEMIOL REV, V34, P145, DOI 10.1093/epirev/mxr026; Dunmore E, 1999, BEHAV RES THER, V37, P809, DOI 10.1016/S0005-7967(98)00181-8; Feinstein A, 2002, AM J PSYCHIAT, V159, P1570, DOI 10.1176/appi.ajp.159.9.1570; Field EL, 2008, BEHAV RES THER, V46, P62, DOI 10.1016/j.brat.2007.10.006; FROST RO, 1990, COGNITIVE THER RES, V14, P449, DOI 10.1007/BF01172967; Galatzer-Levy IR, 2011, J TRAUMA STRESS, V24, P557, DOI 10.1002/jts.20684; Holtz TH, 2002, J TRAUMA STRESS, V15, P389, DOI 10.1023/A:1020133308188; Kia-Keating Maryam, 2007, Clin Child Psychol Psychiatry, V12, P29, DOI 10.1177/1359104507071052; Marmar CR, 2006, ANN NY ACAD SCI, V1071, P1, DOI 10.1196/annals.1364.001; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mayou R, 2001, AM J PSYCHIAT, V158, P1231, DOI 10.1176/appi.ajp.158.8.1231; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Read J. P., 2009, TRAUMATOLOGY, V15, P94, DOI [10.1177/1534765608325121, DOI 10.1177/1534765608325121]; Sattler DN, 2014, STRESS HEALTH, V30, P356, DOI 10.1002/smi.2608; SCHMIDT NB, 1995, COGNITIVE THER RES, V19, P295, DOI 10.1007/BF02230402; Schwarzer R, 1997, MICROSCOPY ANAL, P35; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Skogstad M, 2013, OCCUP MED-OXFORD, V63, P175, DOI 10.1093/occmed/kqt003; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stoeber J, 2008, ANXIETY STRESS COPIN, V21, P37, DOI 10.1080/10615800701742461; Tsai J, 2015, DEPRESS ANXIETY; Weathers F.W., 1994, PTSD CHECKLIST CIVIL; Yeo IK, 2000, BIOMETRIKA, V87, P954, DOI 10.1093/biomet/87.4.954	30	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145188	10.1371/journal.pone.0145188	http://dx.doi.org/10.1371/journal.pone.0145188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26700305	Green Published, gold			2022-12-27	WOS:000367092600052
J	Bronsema, J; Brouwer, S; de Boer, MR; Groothoff, JW				Bronsema, Jan; Brouwer, Sandra; de Boer, Michiel R.; Groothoff, Johan W.			The Added Value of Medical Testing in Underwriting Life Insurance	PLOS ONE			English	Article							BODY-MASS INDEX; CORONARY-HEART-DISEASE; TERM-FOLLOW-UP; FAMILY-HISTORY; MORTALITY; ADULTS; RISK; PREVALENCE; DEATH; MEN	Background In present-day life-insurance medical underwriting practice the risk assessment starts with a standard health declaration (SHD). Indication for additional medical screening depends predominantly on age and amount of insured capital. From a medical perspective it is questionable whether there is an association between the level of insured capital and medical risk in terms of mortality. The aim of the study is to examine the prognostic value of parameters from the health declaration and application form on extra mortality based on results from additional medical testing. Methods A history register-based cohort study was conducted including about 15.000 application files accepted between 2007 and 2010. Blood pressure, lipids, cotinine and glucose levels were used as dependent variables in logistic regression models. Resampling validation was applied using 250 bootstrap samples to calculate area under the curves (AUC's). The AUC was used to discriminate between persons with and without at least 25% extra mortality. Results BMI and the overall assessment of the health declaration by an insurance physician or medical underwriter showed the strongest discrimination in multivariable analysis. Including all variables at minimum cut-off levels resulted in an AUC of 0.710 while by using a model with BMI, the assessment of the health declaration and gender, the AUC was 0.708. Including all variables at maximum cut-off levels lead to an AUC of 0.743 while a model with BMI, the assessment of the health declaration and age resulted in an AUC of 0.741. Conclusions The outcome of this study shows that BMI and the overall assessment of the health declaration were the dominant variables to discriminate between applicants for life-insurance with and without at least 25 percent extra mortality. The variable insured capital set by insurers as factor for additional medical testing could not be established in this study population. The indication for additional medical testing at underwriting life-insurance can possibly be done on limited variables instead of the obligatory medical testing based on age and the amount of insured capital.	[Bronsema, Jan] Legal & Gen, Hilversum, Netherlands; [Bronsema, Jan; Brouwer, Sandra; de Boer, Michiel R.; Groothoff, Johan W.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Div Community & Occupat Med, Groningen, Netherlands; [Bronsema, Jan; Brouwer, Sandra; Groothoff, Johan W.] Univ Groningen, Univ Med Ctr Groningen, Acad Ctr Private Insurance Med, Groningen, Netherlands; [de Boer, Michiel R.] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands	University of Groningen; University of Groningen; Vrije Universiteit Amsterdam	Bronsema, J (corresponding author), Legal & Gen, Hilversum, Netherlands.	jan.bronsema@online.nl	Brouwer, Sandra/AAH-3182-2020	de Boer, Michiel/0000-0001-9240-0199	Legal General	Legal General	The authors received no funding for this work. The authors declare that Legal & General provided (partly) support in the form of salary for author JB. Majority of time involved was on own expense of author JB. Legal & General did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of author JB is articulated in the 'author contributions' section.	[Anonymous], 2003, WHO INT DIAB FED M S; [Anonymous], 2013, AG SPEC MORT RAT SEX; [Anonymous], 2003, REP SOC ACT; [Anonymous], 2010, LIF EXP PROJ TABL 20; Bachmann JM, 2012, CIRCULATION, V125, P3092, DOI 10.1161/CIRCULATIONAHA.111.065490; Bays HE, 2007, INT J CLIN PRACT, V61, P737, DOI 10.1111/j.1742-1241.2007.01336.x; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Brackenridge RDC., 2006, MED SELECTION LIFE R; Caracciolo di Torella E, 2012, GENDER EQUALITY TEST, DOI [10.1007/s12027-012-0248-x, DOI 10.1007/S12027-012-0248-X]; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Centers for Disease Control and Prevention (CDC), NAT VIT STAT SYST MO; Clarke MG, 2009, EUR J INTERN MED, V20, P640, DOI 10.1016/j.ejim.2009.06.009; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2018; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Jureidini R, 2000, J HIST SOCIOL, V13, P190, DOI 10.1111/1467-6443.00113; KINOSIAN B, 1994, ANN INTERN MED, V121, P641, DOI 10.7326/0003-4819-121-9-199411010-00002; Krogsboll LT, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7191; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Nabholz C., 2011, FAIR RISK ASSESSMENT; Ranthe MF, 2012, J AM COLL CARDIOL, V60, P814, DOI 10.1016/j.jacc.2012.06.018; Rothstein MA, 2004, GENETICS LIFE INSURA, P87; Sijbrands EJG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005457; Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419; Strulovici-Barel Y, 2010, AM J RESP CRIT CARE, V182, P1524, DOI 10.1164/rccm.201002-0294OC; *TRANS REINS, 2009, ARCH MAT CAUS DEATH; van Baal PH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-163; Vistisen D, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001602; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	29	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145891	10.1371/journal.pone.0145891	http://dx.doi.org/10.1371/journal.pone.0145891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716827	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500089
J	Favaro, VM; Yonamine, M; Soares, JCK; Oliveira, MGM				Favaro, Vanessa Manchim; Yonamine, Mauricio; Kramer Soares, Juliana Carlota; Menezes Oliveira, Maria Gabriela			Effects of Long-Term Ayahuasca Administration on Memory and Anxiety in Rats	PLOS ONE			English	Article							N,N-DIMETHYLTRYPTAMINE; ALKALOIDS; LESIONS; MAZE	Ayahuasca is a hallucinogenic beverage that combines the action of the 5-HT2A/2C agonist N,N-dimethyltryptamine (DMT) from Psychotria viridis with the monoamine oxidase inhibitors (MAOIs) induced by beta-carbonyls from Banisteriopsis caapi. Previous investigations have highlighted the involvement of ayahuasca with the activation of brain regions known to be involved with episodic memory, contextual associations and emotional processing after ayahuasca ingestion. Moreover long term users show better performance in neuropsychological tests when tested in off-drug condition. This study evaluated the effects of long-term administration of ayahuasca on Morris water maze (MWM), fear conditioning and elevated plus maze (EPM) performance in rats. Behavior tests started 48h after the end of treatment. Freeze-dried ayahuasca doses of 120, 240 and 480 mg/kg were used, with water as the control. Long-term administration consisted of a daily oral dose for 30 days by gavage. The behavioral data indicated that long-term ayahuasca administration did not affect the performance of animals in MWM and EPM tasks. However the dose of 120 mg/kg increased the contextual conditioned fear response for both background and foreground fear conditioning. The tone conditioned response was not affected after long-term administration. In addition, the increase in the contextual fear response was maintained during the repeated sessions several weeks after training. Taken together, these data showed that long-term ayahuasca administration in rats can interfere with the contextual association of emotional events, which is in agreement with the fact that the beverage activates brain areas related to these processes.	[Favaro, Vanessa Manchim; Kramer Soares, Juliana Carlota; Menezes Oliveira, Maria Gabriela] Univ Fed Sao Paulo UNIFESP, Dept Psicobiol, Sao Paulo, SP, Brazil; [Yonamine, Mauricio] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Oliveira, MGM (corresponding author), Univ Fed Sao Paulo UNIFESP, Dept Psicobiol, Sao Paulo, SP, Brazil.	gabi.oliveira@gmail.com	Soares, Juliana Carlota Kramer/M-6110-2014; Yonamine, Mauricio/C-6316-2012	Soares, Juliana Carlota Kramer/0000-0003-3464-6208; Yonamine, Mauricio/0000-0002-4615-1088	Sao Paulo Research Foundation (FAPESP) [2011/03791-3]; Research Incentive Fund Association (AFIP); Coordination for the Improvement of Higher Education Personnel (CAPES); National Council of Scientific and Technological Development (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Research Incentive Fund Association (AFIP); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was financially supported by a grant #2011/03791-3 by Sao Paulo Research Foundation (FAPESP), by the Research Incentive Fund Association (AFIP), by the Coordination for the Improvement of Higher Education Personnel (CAPES) and by the National Council of Scientific and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRITZKY W, 1989, J PSYCHOACTIVE DRUGS, V21, P77, DOI 10.1080/02791072.1989.10472145; Callaway JC, 1996, J ANAL TOXICOL, V20, P492, DOI 10.1093/jat/20.6.492; Bouso JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042421; de Araujo DB, 2012, HUM BRAIN MAPP, V33, P2550, DOI 10.1002/hbm.21381; de Castro-Neto Eduardo Ferreira, 2013, World J Biol Chem, V4, P141, DOI 10.4331/wjbc.v4.i4.141; Grob CS, 1996, J NERV MENT DIS, V184, P86, DOI 10.1097/00005053-199602000-00004; Halpern JH, 2004, PHARMACOL THERAPEUT, V102, P131, DOI 10.1016/j.pharmthera.2004.03.003; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lowry CA, 2005, STRESS, V8, P233, DOI 10.1080/10253890500492787; McKenna D, 1998, REV PSYCHEDELIC RES; McKenna DJ, 2004, PHARMACOL THERAPEUT, V102, P111, DOI 10.1016/j.pharmathera.2004.03.002; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; PACKARD MG, 1992, BEHAV NEUROSCI, V106, P439, DOI 10.1037/0735-7044.106.3.439; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Riba J, 2006, PSYCHOPHARMACOLOGY, V186, P93, DOI 10.1007/s00213-006-0358-7; Pires APS, 2009, PHYTOCHEM ANALYSIS, V20, P149, DOI 10.1002/pca.1110; Shreve-Neiger AK, 2004, CLIN PSYCHOL REV, V24, P379, DOI 10.1016/j.cpr.2004.02.003; Smith RL, 1998, PHARMACOL BIOCHEM BE, V61, P323, DOI 10.1016/S0091-3057(98)00110-5; Tupper KW, 2008, INT J DRUG POLICY, V19, P297, DOI 10.1016/j.drugpo.2006.11.001	23	15	16	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145840	10.1371/journal.pone.0145840	http://dx.doi.org/10.1371/journal.pone.0145840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716991	gold, Green Published, Green Submitted			2022-12-27	WOS:000367510500082
J	Ferreira, JCP; Fujihara, CJ; Fruhvald, E; Trevisol, E; Destro, FC; Teixeira, CR; Pantoja, JCF; Schmidt, EMS; Palme, R				Ferreira, Joao C. P.; Fujihara, Caroline J.; Fruhvald, Erika; Trevisol, Eduardo; Destro, Flavia C.; Teixeira, Carlos R.; Pantoja, Jose C. F.; Schmidt, Elizabeth M. S.; Palme, Rupert			Non-Invasive Measurement of Adrenocortical Activity in Blue-Fronted Parrots (Amazona aestiva, Linnaeus, 1758)	PLOS ONE			English	Article							FECAL GLUCOCORTICOID METABOLITES; STRESS-INDUCED CORTICOSTERONE; ACTH STIMULATION; PSITTACINE BIRDS; TETRAO-UROGALLUS; ADRENAL-FUNCTION; COPING STYLES; FECES; EXCRETION; DROPPINGS	Parrots kept in zoos and private households often develop psychological and behavioural disorders. Despite knowing that such disorders have a multifactorial aetiology and that chronic stress is involved, little is known about their development mainly due to a poor understanding of the parrots' physiology and the lack of validated methods to measure stress in these species. In birds, blood corticosterone concentrations provide information about adrenocortical activity. However, blood sampling techniques are difficult, highly invasive and inappropriate to investigate stressful situations and welfare conditions. Thus, a non-invasive method to measure steroid hormones is critically needed. Aiming to perform a physiological validation of a cortisone enzyme immunoassay (EIA) to measure glucocorticoid metabolites (GCM) in droppings of 24 Blue-fronted parrots (Amazona aestiva), two experiments were designed. During the experiments all droppings were collected at 3-h intervals. Initially, birds were sampled for 24 h (experiment 1) and one week later assigned to four different treatments (experiment 2): Control (undisturbed), Saline (0.2 mL of 0.9% NaCl IM), Dexamethasone (1 mg/kg IM) and Adrenocorticotropic hormone (ACTH; 25 IU IM). Treatments (always one week apart) were applied to all animals in a cross-over study design. A daily rhythm pattern in GCM excretion was detected but there were no sex differences (first experiment). Saline and dexamethasone treatments had no effect on GCM (not different from control concentrations). Following ACTH injection, GCM concentration increased about 13.1-fold (median) at the peak (after 3-9 h), and then dropped to pre-treatment concentrations. By a successful physiological validation, we demonstrated the suitability of the cortisone EIA to non-invasively monitor increased adrenocortical activity, and thus, stress in the Blue-fronted parrot. This method opens up new perspectives for investigating the connection between behavioural disorders and stress in this bird species, and could also help in their captive management.	[Ferreira, Joao C. P.; Fujihara, Caroline J.; Fruhvald, Erika; Trevisol, Eduardo; Destro, Flavia C.] Unesp Univ Estadual Paulista, Dept Anim Reprod & Vet Radiol, Sch Vet Med & Anim Sci, BR-18618970 Botucatu, SP, Brazil; [Teixeira, Carlos R.] Unesp Univ Estadual Paulista, Dept Vet Surg, Sch Vet Med & Anim Sci, BR-18618970 Botucatu, SP, Brazil; [Pantoja, Jose C. F.] UNESP Univ Estadual Paulista, Dept Vet Hyg & Publ Hlth, Sch Vet Med & Anim Sci, BR-18618970 Botucatu, SP, Brazil; [Schmidt, Elizabeth M. S.] Unesp Univ Estadual Paulista, Dept Vet Clin, Sch Vet Med & Anim Sci, BR-18618970 Botucatu, SP, Brazil; [Palme, Rupert] Univ Vet Med, Unit Physiol Pathophysiol & Expt Endocrinol, Dept Biomed Sci, A-2210 Vienna, Austria	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; University of Veterinary Medicine Vienna	Ferreira, JCP (corresponding author), Unesp Univ Estadual Paulista, Dept Anim Reprod & Vet Radiol, Sch Vet Med & Anim Sci, Rubiao Jr S-N, BR-18618970 Botucatu, SP, Brazil.	jcferreira@fmvz.unesp.br	Moreira dos Santos Schmidt, Elizabeth/AHC-8353-2022; Ferreira, Joao C P/G-1153-2012; Pantoja, José Carlos Figueiredo/K-6640-2012; Ferreira, João Carlos Pinheiro/V-4281-2019; Palme, Rupert/A-3499-2008; de Figueiredo Pantoja, José Carlos/N-1515-2019	Pantoja, José Carlos Figueiredo/0000-0002-1648-9360; Ferreira, João Carlos Pinheiro/0000-0002-7742-8254; Palme, Rupert/0000-0001-9466-3662; de Figueiredo Pantoja, José Carlos/0000-0002-1648-9360; Schmidt, Elizabeth/0000-0001-8297-6979	FAPESP (Sao Paulo Research Foundation - FAPESP) [2009/05864-8]; PROPG (Pro-Reitoria de Pos-Graduacao) - Unesp	FAPESP (Sao Paulo Research Foundation - FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PROPG (Pro-Reitoria de Pos-Graduacao) - Unesp	This work was supported by FAPESP (Grant 2009/05864-8, Sao Paulo Research Foundation - FAPESP) and PROPG (Pro-Reitoria de Pos-Graduacao) - Unesp.	Arias N, 2013, ANIM WELFARE, V22, P25, DOI 10.7120/09627286.22.1.025; ASTHEIMER LB, 1994, GEN COMP ENDOCR, V94, P33, DOI 10.1006/gcen.1994.1057; Baltic M, 2005, ANN NY ACAD SCI, V1046, P81, DOI 10.1196/annals.1343.008; Breuner CW, 1999, J EXP ZOOL, V284, P334, DOI 10.1002/(SICI)1097-010X(19990801)284:3<334::AID-JEZ11>3.3.CO;2-R; Busso JM, 2013, DOMEST ANIM ENDOCRIN, V44, P151, DOI 10.1016/j.domaniend.2013.01.001; Carere C, 2003, HORM BEHAV, V43, P540, DOI 10.1016/S0018-506X(03)00065-5; Carvalho PP, 2004, ALTERACOES PATOLOGIC; Chelini MOM, 2010, J COMP PHYSIOL B, V180, P919, DOI 10.1007/s00360-010-0467-9; Collette JC, 2000, APPL ANIM BEHAV SCI, V66, P335, DOI 10.1016/S0168-1591(99)00098-2; Cussen VA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126170; Cussen VA, 2014, ANIM BEHAV, V89, P123, DOI 10.1016/j.anbehav.2013.12.022; Dantzer B, 2013, SCIENCE, V340, P1215, DOI 10.1126/science.1235765; Dehnhard M, 2003, GEN COMP ENDOCR, V131, P345, DOI 10.1016/S0016-6480(03)00033-9; Dickens MJ, 2009, GEN COMP ENDOCR, V160, P76, DOI 10.1016/j.ygcen.2008.10.023; Fujihara Caroline Junko, 2014, Ciênc. anim. bras., V15, P277, DOI 10.1590/1809-6891v15i34450; Gaskins LA, 2011, J AVIAN MED SURG, V25, P111, DOI 10.1647/2010-027.1; Giovanini D, 2002, 1 RELATORIO NACL TRA; Hirschenhauser K, 2005, ANN NY ACAD SCI, V1046, P138, DOI 10.1196/annals.1343.011; Hofer H, 1998, ADV STUD BEHAV, V27, P405; Johnstone CP, 2012, J COMP PHYSIOL B, V182, P861, DOI 10.1007/s00360-012-0656-9; Keckeis K, 2012, J COMP PHYSIOL B, V182, P985, DOI 10.1007/s00360-012-0674-7; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Lepschy M, 2007, LAB ANIM-UK, V41, P372, DOI 10.1258/002367707781282730; LOTHROP CD, 1985, J AM VET MED ASSOC, V187, P1113; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; McMillan MC, 1994, AVIAN MED PRINCIPLES, P256; Meehan CL, 2004, DEV PSYCHOBIOL, V44, P209, DOI 10.1002/dev.20007; Mormede P, 2007, PHYSIOL BEHAV, V92, P317, DOI 10.1016/j.physbeh.2006.12.003; Mostl E, 1999, J VET MED A, V46, P621, DOI 10.1046/j.1439-0442.1999.00256.x; Mostl E, 2005, ANN NY ACAD SCI, V1046, P17, DOI 10.1196/annals.1343.004; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; Moura SG, 2012, ENCICLOPEDIA BIOSFER, V8, P1748; Pagano Isales Santos de Alexandria, 2009, Ornithologia, V3, P132; Palme R, 1999, WIEN TIERARZTL MONAT, V86, P237; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Palme R, 2005, ANN NY ACAD SCI, V1046, P75, DOI 10.1196/annals.1343.007; Palme R, 2013, WIEN TIERARZTL MONAT, V100, P238; Palme R, 2012, ANIM WELFARE, V21, P331, DOI 10.7120/09627286.21.3.331; de Freitas ACP, 2015, CIENC RURAL, V45, P163, DOI 10.1590/0103-8478cr20131212; Popp LG, 2008, J COMP PHYSIOL B, V178, P487, DOI 10.1007/s00360-007-0241-9; Reece WO, 2015, DUKES PHYSL DOMESTIC, P532; Rettenbacher S, 2004, BRIT POULTRY SCI, V45, P704, DOI 10.1080/00071660400006156; Rich EL, 2001, J COMP PHYSIOL B, V171, P543; Romero LM, 2000, GEN COMP ENDOCR, V119, P52, DOI 10.1006/gcen.2000.7491; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Ruis MAW, 2000, APPL ANIM BEHAV SCI, V66, P31, DOI 10.1016/S0168-1591(99)00070-2; Schmidt KL, 2012, HORM BEHAV, V61, P652, DOI 10.1016/j.yhbeh.2012.02.027; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Stead SK, 2000, J S AFR VET ASSOC, V71, P192; Thiel D, 2005, ANN NY ACAD SCI, V1046, P96, DOI 10.1196/annals.1343.009; Thiel D, 2011, IBIS, V153, P122, DOI 10.1111/j.1474-919X.2010.01083.x; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; van Hoek Caroline S., 1998, Journal of Applied Animal Welfare Science, V1, P51, DOI 10.1207/s15327604jaws0101_5; van Zeeland YRA, 2013, APPL ANIM BEHAV SCI, V148, P218, DOI 10.1016/j.applanim.2013.08.004; van Zeeland YRA, 2009, APPL ANIM BEHAV SCI, V121, P75, DOI 10.1016/j.applanim.2009.09.006; Walker D., 2005, Scottish Birds, V25, P24; WALSH MT, 1985, AM J VET RES, V46, P1584; Wasser SK, 1997, CONSERV BIOL, V11, P1019, DOI 10.1046/j.1523-1739.1997.96240.x; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; Westerhof I, 1996, AVIAN DIS, V40, P312, DOI 10.2307/1592226; Westerhof I, 1998, J AVIAN MED SURG; Whittow, 1999, STURKIES AVIAN PHYSL, P489; Young AM, 2013, ZOO BIOL, V32, P112, DOI 10.1002/zoo.21041; ZENOBLE RD, 1985, J AM VET MED ASSOC, V187, P1116	66	11	12	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145909	10.1371/journal.pone.0145909	http://dx.doi.org/10.1371/journal.pone.0145909			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717147	gold, Green Published, Green Submitted			2022-12-27	WOS:000367510500091
J	Herrmann, S; Kluess, D; Kaehler, M; Grawe, R; Rachholz, R; Souffrant, R; Zierath, J; Bader, R; Woernle, C				Herrmann, Sven; Kluess, Daniel; Kaehler, Michael; Grawe, Robert; Rachholz, Roman; Souffrant, Robert; Zierath, Janos; Bader, Rainer; Woernle, Christoph			A Novel Approach for Dynamic Testing of Total Hip Dislocation under Physiological Conditions	PLOS ONE			English	Article							HUMAN JOINT MOTION; CERAMIC ACETABULAR CUPS; FINITE-ELEMENT-ANALYSIS; CLOSED-LOOP PROBLEMS; ISB RECOMMENDATION; CONTACT FORCES; LOWER-LIMB; COORDINATE SYSTEMS; MUSCLE FORCES; HEAD SIZE	Constant high rates of dislocation-related complications of total hip replacements (THRs) show that contributing factors like implant position and design, soft tissue condition and dynamics of physiological motions have not yet been fully understood. As in vivo measurements of excessive motions are not possible due to ethical objections, a comprehensive approach is proposed which is capable of testing THR stability under dynamic, reproducible and physiological conditions. The approach is based on a hardware-in-the-loop (HiL) simulation where a robotic physical setup interacts with a computational musculoskeletal model based on inverse dynamics. A major objective of this work was the validation of the HiL test system against in vivo data derived from patients with instrumented THRs. Moreover, the impact of certain test conditions, such as joint lubrication, implant position, load level in terms of body mass and removal of muscle structures, was evaluated within several HiL simulations. The outcomes for a normal sitting down and standing up maneuver revealed good agreement in trend and magnitude compared with in vivo measured hip joint forces. For a deep maneuver with femoral adduction, lubrication was shown to cause less friction torques than under dry conditions. Similarly, it could be demonstrated that less cup anteversion and inclination lead to earlier impingement in flexion motion including pelvic tilt for selected combinations of cup and stem positions. Reducing body mass did not influence impingement-free range of motion and dislocation behavior; however, higher resisting torques were observed under higher loads. Muscle removal emulating a posterior surgical approach indicated alterations in THR loading and the instability process in contrast to a reference case with intact musculature. Based on the presented data, it can be concluded that the HiL test system is able to reproduce comparable joint dynamics as present in THR patients.	[Herrmann, Sven; Kluess, Daniel; Souffrant, Robert; Bader, Rainer] Univ Med Rostock, Dept Orthopaed, Rostock, Germany; [Kaehler, Michael; Grawe, Robert; Rachholz, Roman; Zierath, Janos; Woernle, Christoph] Univ Rostock, Fac Mech Engn & Marine Technol, Chair Tech Dynam, D-18055 Rostock, Germany	University of Rostock; University of Rostock	Woernle, C (corresponding author), Univ Rostock, Fac Mech Engn & Marine Technol, Chair Tech Dynam, D-18055 Rostock, Germany.	woernle@uni-rostock.de	Herrmann, Sven/AAD-4384-2019	Herrmann, Sven/0000-0001-5287-0751; Zierath, Janos/0000-0001-5185-9649; Kluess, Daniel/0000-0003-1244-6360	Deutsche Forschungsgemeinschaft [WO 452/8-1, WO 452/8-2, BA 3347/3-1, BA 3347/3-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/), Grant numbers WO 452/8-1, WO 452/8-2 for CW and BA 3347/3-1, BA 3347/3-2 for RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN KN, 1989, J BIOMECH, V22, P1249, DOI 10.1016/0021-9290(89)90227-3; Anderson FC, 2001, J BIOMECH, V34, P153, DOI 10.1016/S0021-9290(00)00155-X; Bader R, 2004, BIOMED TECH, V49, P137, DOI 10.1515/BMT.2004.027; Bader R, 1999, BIOMED TECH, V44, P212, DOI 10.1515/bmte.1999.44.7-8.212; Bader R, 1999, BIOMED TECH, V44, P345, DOI 10.1515/bmte.1999.44.12.345; Baker R, 2003, J BIOMECH, V36, P300, DOI 10.1016/S0021-9290(02)00336-6; Bartz RL, 2000, J BONE JOINT SURG AM, V82A, P1300, DOI 10.2106/00004623-200009000-00010; Bauer R, 1994, ORTHOPADISCHE OPERAT, V2; Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; Bergmann G, 2001, BIOMED TECH, V46, P168, DOI 10.1515/bmte.2001.46.6.168; Bishop NE, 2013, J ORTHOP RES, V31, P807, DOI 10.1002/jor.22255; BLANKEVOORT L, 1988, J BIOMECH, V21, P705, DOI 10.1016/0021-9290(88)90280-1; Boge T, 2011, IEEE INT CONF ROBOT; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155; Brand R A, 1994, J Arthroplasty, V9, P45, DOI 10.1016/0883-5403(94)90136-8; Burroughs BR, 2005, J ARTHROPLASTY, V20, P11, DOI 10.1016/j.arth.2004.07.008; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Carbone V, 2012, J BIOMECH, V45, P2476, DOI 10.1016/j.jbiomech.2012.06.026; COLLINS JJ, 1995, J BIOMECH, V28, P251, DOI 10.1016/0021-9290(94)00072-C; D'Lima DD, 2000, J BONE JOINT SURG AM, V82A, P315, DOI 10.2106/00004623-200003000-00003; DELP SL, 1994, J ORTHOP RES, V12, P860, DOI 10.1002/jor.1100120614; Elkins JM, 2015, CLIN ORTHOP RELAT R, V473, P441, DOI 10.1007/s11999-014-3818-0; Elkins JM, 2014, CLIN ORTHOP RELAT R, V472, P529, DOI 10.1007/s11999-013-3244-8; Elkins JM, 2013, CLIN ORTHOP RELAT R, V471, P971, DOI 10.1007/s11999-012-2512-3; Elkins JM, 2012, J ORTHOP RES, V30, P169, DOI 10.1002/jor.21524; Elkins JM, 2011, J ORTHOP RES, V29, P1642, DOI 10.1002/jor.21435; Fabry C, 2014, MED ENG PHYS, V36, P65, DOI 10.1016/j.medengphy.2013.09.007; Garellick G, 2012, ANN REP 2011; Heller MO, 2001, CLIN BIOMECH, V16, P644, DOI 10.1016/S0268-0033(01)00053-5; Heller MO, 2001, J BIOMECH, V34, P883, DOI 10.1016/S0021-9290(01)00039-2; Herrmann S, 2015, MECH MACH SCI, V24, P659, DOI 10.1007/978-3-319-09411-3_70; Herrmann S, 2012, ORTHOPADE, V41, P252, DOI 10.1007/s00132-011-1851-1; Herrmann S., 2015, THESIS; Herrmann S, 2012, MULTIBODY SYST DYN, V28, P55, DOI 10.1007/s11044-011-9283-6; Herrmann S, 2012, COMPUT METH PROG BIO, V105, P109, DOI 10.1016/j.cmpb.2011.07.012; HERZOG W, 1993, MATH BIOSCI, V118, P83, DOI 10.1016/0025-5564(93)90034-8; Hewitt J, 2001, J ORTHOPAED RES, V19, P359, DOI 10.1016/S0736-0266(00)00035-8; Higa M, 2011, J BIOMECH, V44, P1810, DOI 10.1016/j.jbiomech.2011.04.002; Horsman MDK, 2007, CLIN BIOMECH, V22, P239, DOI 10.1016/j.clinbiomech.2006.10.003; Kahler M, 2009, COMPUTATIONAL KINEMATICS, PROCEEDINGS, P159, DOI 10.1007/978-3-642-01947-0_20; Kiguchi Kazuo, 2008, 2008 International Conference on Control, Automation and Systems (ICCAS), P1942, DOI 10.1109/ICCAS.2008.4694415; Kliewe C, 2010, BIOMED TECH, V55, P47, DOI 10.1515/BMT.2010.005; Kluess D, 2007, MED ENG PHYS, V29, P465, DOI 10.1016/j.medengphy.2006.07.001; Kluess D, 2009, COMPUT METH PROG BIO, V95, P23, DOI 10.1016/j.cmpb.2009.01.004; Krenn R, 1999, ESA SP PUBL, V440, P681; Kwon MS, 2006, CLIN ORTHOP RELAT R, P34, DOI 10.1097/01.blo.0000218746.84494.df; Lamontagne M, 2012, J ORTHOP RES, V30, P1611, DOI 10.1002/jor.22127; Lehmann T, 2009, MIQL FORTRAN CODE CO; Lenaerts G, 2008, J BIOMECH, V41, P1243, DOI 10.1016/j.jbiomech.2008.01.014; Lenaerts G, 2009, J BIOMECH, V42, P1246, DOI 10.1016/j.jbiomech.2009.03.037; LEWINNEK GE, 1978, J BONE JOINT SURG AM, V60, P217, DOI 10.2106/00004623-197860020-00014; Lu TW, 1999, J BIOMECH, V32, P129, DOI 10.1016/S0021-9290(98)00158-4; Martelli S, 2011, J BIOMECH, V44, P1716, DOI 10.1016/j.jbiomech.2011.03.039; Mihalko WM, 2004, CLIN ORTHOP RELAT R, P194, DOI 10.1097/01.blo.0000126221.38764.cc; Modenese L, 2013, J BIOMECH, V46, P1193, DOI 10.1016/j.jbiomech.2012.11.045; Modenese L, 2011, J BIOMECH, V44, P2185, DOI 10.1016/j.jbiomech.2011.06.019; MURRAY DW, 1993, J BONE JOINT SURG BR, V75, P228, DOI 10.1302/0301-620X.75B2.8444942; Nadzadi ME, 2003, J BIOMECH, V36, P577, DOI 10.1016/S0021-9290(02)00232-4; NICHOLAS RM, 1990, J BONE JOINT SURG BR, V72, P418, DOI 10.1302/0301-620X.72B3.2341440; PATRIARCO AG, 1981, J BIOMECH, V14, P513, DOI 10.1016/0021-9290(81)90001-4; Pedersen DR, 2005, MED ENG PHYS, V27, P323, DOI 10.1016/j.medengphy.2004.09.004; PEDERSEN DR, 1987, J BIOMECH ENG-T ASME, V109, P192, DOI 10.1115/1.3138669; Pellicci PM, 1998, CLIN ORTHOP RELAT R, P224; PENROD DD, 1974, J BIOMECH, V7, P123, DOI 10.1016/0021-9290(74)90050-5; Raikova R, 1999, J BIOMECH, V32, P689, DOI 10.1016/S0021-9290(99)00037-8; Raikova RT, 2001, J BIOMECH, V34, P1243, DOI 10.1016/S0021-9290(01)00097-5; Schuenke M, 2005, THIEME ATLAS ANATOMY; Scifert CF, 2001, ORTHOP CLIN N AM, V32, P553, DOI 10.1016/S0030-5898(05)70226-1; Scifert CF, 1998, CLIN ORTHOP RELAT R, P152, DOI 10.1097/00003086-199810000-00016; SEIREG A, 1973, J BIOMECH, V6, P313, DOI 10.1016/0021-9290(73)90053-5; Siciliano B, 2009, ADV TXB CONTR SIG PR, P1; Sioen W, 2002, J BONE JOINT SURG AM, V84A, P1793, DOI 10.2106/00004623-200210000-00009; Spitzer V, 1996, J AM MED INFORM ASSN, V3, P118, DOI 10.1136/jamia.1996.96236280; Stewart KJ, 2002, J BIOMECH, V35, P1491, DOI 10.1016/S0021-9290(02)00091-X; van Arkel RJ, 2015, BONE JOINT J, V97B, P484, DOI 10.1302/0301-620X.97B4.34638; van Arkel RJ, 2013, J ORTHOP RES, V31, P1172, DOI 10.1002/jor.22364; VANDENBOGERT AJ, 1994, J BIOMECH, V27, P1477, DOI 10.1016/0021-9290(94)90197-X; VAUGHAN CL, 1982, J BIOMECH, V15, P197, DOI 10.1016/0021-9290(82)90252-4; VAUGHAN CL, 1982, J BIOMECH, V15, P201, DOI 10.1016/0021-9290(82)90253-6; VRAHAS MS, 1990, J BIOMECH, V23, P357, DOI 10.1016/0021-9290(90)90065-B; Ward SR, 2009, CLIN ORTHOP RELAT R, V467, P1074, DOI 10.1007/s11999-008-0594-8; White RE, 2001, CLIN ORTHOP RELAT R, P163; Widmer KH, 2005, CLIN BIOMECH, V20, P723, DOI 10.1016/j.clinbiomech.2005.04.003; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; WU G, 1995, J BIOMECH, V28, P1257, DOI 10.1016/0021-9290(95)00017-C; Yoshimine F, 2005, J BIOMECH, V38, P125, DOI 10.1016/j.jbiomech.2004.03.012; Yoshimine F, 2006, J BIOMECH, V39, P1315, DOI 10.1016/j.jbiomech.2005.03.008; Zierath J, 2009, MULTIBODY DYNAMICS 2	91	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145798	10.1371/journal.pone.0145798	http://dx.doi.org/10.1371/journal.pone.0145798			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717236	gold, Green Published, Green Submitted			2022-12-27	WOS:000367510500075
J	Hong, C; Hwang, J; Cho, KH; Shin, I				Hong, Changki; Hwang, Jeewon; Cho, Kwang-Hyun; Shin, Insik			An Efficient Steady-State Analysis Method for Large Boolean Networks with High Maximum Node Connectivity	PLOS ONE			English	Article							SINGLETON ATTRACTOR; REGULATORY NETWORKS; MODEL; SYSTEMS; SIMULATION; GENERATION; REDUCTION; STABILITY; ALGORITHM; PREDICTS	Boolean networks have been widely used to model biological processes lacking detailed kinetic information. Despite their simplicity, Boolean network dynamics can still capture some important features of biological systems such as stable cell phenotypes represented by steady states. For small models, steady states can be determined through exhaustive enumeration of all state transitions. As the number of nodes increases, however, the state space grows exponentially thus making it difficult to find steady states. Over the last several decades, many studies have addressed how to handle such a state space explosion. Recently, increasing attention has been paid to a satisfiability solving algorithm due to its potential scalability to handle large networks. Meanwhile, there still lies a problem in the case of large models with high maximum node connectivity where the satisfiability solving algorithm is known to be computationally intractable. To address the problem, this paper presents a new partitioning-based method that breaks down a given network into smaller subnetworks. Steady states of each subnetworks are identified by independently applying the satisfiability solving algorithm. Then, they are combined to construct the steady states of the overall network. To efficiently apply the satisfiability solving algorithm to each subnetwork, it is crucial to find the best partition of the network. In this paper, we propose a method that divides each subnetwork to be smallest in size and lowest in maximum node connectivity. This minimizes the total cost of finding all steady states in entire subnetworks. The proposed algorithm is compared with others for steady states identification through a number of simulations on both published small models and randomly generated large models with differing maximum node connectivities. The simulation results show that our method can scale up to several hundreds of nodes even for Boolean networks with high maximum node connectivity. The algorithm is implemented and available at http://cps.kaist.ac.kr/similar to ckhong/tools/download/PAD.tar.gz.	[Hong, Changki; Hwang, Jeewon; Shin, Insik] Korea Adv Inst Sci & Technol, Sch Comp, Daejeon, South Korea; [Cho, Kwang-Hyun] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Shin, I (corresponding author), Korea Adv Inst Sci & Technol, Sch Comp, Daejeon, South Korea.	insik.shin@cs.kaist.ac.kr	Shin, Insik/C-1706-2011; Cho, Kwang-Hyun/C-1684-2011		IITP [B0101-15-0557]; NRF - Korea Government, the Ministry of Science, ICT & Future Planning [2013M3A9A7046303, 2014R1A2A1A10052404, 2015M3A9A7067220]	IITP(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of Korea); NRF - Korea Government, the Ministry of Science, ICT & Future Planning(National Research Foundation of Korea)	This work was supported in part by IITP (B0101-15-0557) and NRF funded by the Korea Government, the Ministry of Science, ICT & Future Planning (2013M3A9A7046303, 2014R1A2A1A10052404 and 2015M3A9A7067220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 1998, SYSTEM IDENTIFYING G; Akutsu T, 2012, INFORM PROCESS LETT, V112, P35, DOI 10.1016/j.ipl.2011.10.002; Akutsu T, 2011, J COMPUT BIOL, V18, P1275, DOI 10.1089/cmb.2010.0281; Akutsu T, 2009, IEEE DECIS CONTR P, P5610, DOI 10.1109/CDC.2009.5400017; Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Albert R, 2007, PLANT CELL, V19, P3327, DOI 10.1105/tpc.107.054700; Aldana M, 2003, PHYSICA D, V185, P45, DOI 10.1016/S0167-2789(03)00174-X; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Berntenis N, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-361; Bilke S, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.016129; Chatain T, 2014, LECT NOTES COMPUT SC, V8859, P129, DOI 10.1007/978-3-319-12982-2_10; Choi M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003363; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; De Jong H, 2008, IEEE ACM T COMPUT BI, V5, P208, DOI [10.1109/TCBB.2007.70254, 10.1109/TCBB.2008.70254]; Devloo V, 2003, B MATH BIOL, V65, P1025, DOI 10.1016/S0092-8240(03)00061-2; Di Cara A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-462; Dubrova E, 2005, P IEEE ACM INT C COM; Dubrova E, 2011, IEEE ACM T COMPUT BI, V8, P1393, DOI 10.1109/TCBB.2010.20; Een N, 2004, LECT NOTES COMPUT SC, V2919, P502, DOI 10.1007/978-3-540-24605-3_37; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Garg A, 2007, LECT NOTES COMPUT SC, V4453, P62; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; Guo WS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094258; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Helikar T, 2008, P NATL ACAD SCI USA, V105, P1913, DOI 10.1073/pnas.0705088105; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Ma HW, 2003, BIOINFORMATICS, V19, P1423, DOI 10.1093/bioinformatics/btg177; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Mussel C, 2010, BIOINFORMATICS, V26, P1378, DOI 10.1093/bioinformatics/btq124; Naldi Aurelien, 2012, Computational Methods in Systems Biology. Proceedings of the 10th International Conference, CMSB 2012, P288, DOI 10.1007/978-3-642-33636-2_17; Naldi A, 2007, LECT NOTES COMPUT SC, V4695, P233; Naldi A, 2011, THEOR COMPUT SCI, V412, P2207, DOI 10.1016/j.tcs.2010.10.021; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; R Core Team, 2018, R LANG ENV STAT COMP; Richardson KA, 2005, ADV COMPLEX SYST, V8, P365, DOI 10.1142/S0219525905000518; Saadatpour A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002267; Schaefer T.J., 1978, P 10 ANN ACM S THEOR, DOI DOI 10.1145/800133.804350; Somogyi R, 1996, COMPLEXITY, V1, P45, DOI DOI 10.1002/CPLX.6130010612; Tamura T, 2007, LECT NOTES COMPUT SC, V4639, P494; Veliz-Cuba A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-221; Veliz-Cuba A, 2011, J THEOR BIOL, V289, P167, DOI 10.1016/j.jtbi.2011.08.042; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Zanudo JGT, 2013, CHAOS, V23, DOI 10.1063/1.4809777; Zhang SQ, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/20180; Zhao Y, 2013, IEEE T AUTOMAT CONTR, V58, P1976, DOI 10.1109/TAC.2013.2251819; Zheng DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060593	55	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145734	10.1371/journal.pone.0145734	http://dx.doi.org/10.1371/journal.pone.0145734			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716694	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500064
J	Bahamonde, MI; Serra, SA; Drechsel, O; Rahman, R; Marce-Grau, A; Prieto, M; Ossowski, S; Macaya, A; Fernandez-Fernandez, JM				Isabel Bahamonde, Maria; Angelica Serra, Selma; Drechsel, Oliver; Rahman, Rubayte; Marce-Grau, Anna; Prieto, Marta; Ossowski, Stephan; Macaya, Alfons; Fernandez-Fernandez, Jose M.			A Single Amino Acid Deletion (Delta F1502) in the S6 Segment of Ca(V)2.1 Domain III Associated with Congenital Ataxia Increases Channel Activity and Promotes Ca2+ Influx	PLOS ONE			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; ENHANCED EXCITATORY TRANSMISSION; ANHYDRASE-RELATED PROTEIN; DELAYED CEREBRAL EDEMA; P/Q CALCIUM-CHANNEL; EPISODIC ATAXIA; CEREBELLAR-ATAXIA; MOUSE MODEL; CACNA1A MUTATION; SPREADING DEPRESSION	Mutations in the CACNA1A gene, encoding the pore-forming Ca(V)2.1 (P/Q-type) channel alpha(1A) subunit, result in heterogeneous human neurological disorders, including familial and sporadic hemiplegic migraine along with episodic and progressive forms of ataxia. Hemiplegic Migraine (HM) mutations induce gain-of-channel function, mainly by shifting channel activation to lower voltages, whereas ataxia mutations mostly produce loss-of-channel function. However, some HM-linked gain-of-function mutations are also associated to congenital ataxia and/or cerebellar atrophy, including the deletion of a highly conserved phenylalanine located at the S6 pore region of alpha(1A) domain III (Delta F1502). Functional studies of Delta F1502 Ca(V)2.1 channels, expressed in Xenopus oocytes, using the non-physiological Ba2+ as the charge carrier have only revealed discrete alterations in channel function of unclear pathophysiological relevance. Here, we report a second case of congenital ataxia linked to the Delta F1502 alpha(1A) mutation, detected by whole-exome sequencing, and analyze its functional consequences on Ca(V)2.1 human channels heterologously expressed in mammalian tsA-201 HEK cells, using the physiological permeant ion Ca2+. Delta F1502 strongly decreases the voltage threshold for channel activation (by similar to 21 mV), allowing significantly higher Ca2+ current densities in a range of depolarized voltages with physiological relevance in neurons, even though maximal Ca2+ current density through Delta F1502 Ca(V)2.1 channels is 60% lower than through wild-type channels. Delta F1502 accelerates activation kinetics and slows deactivation kinetics of Ca(V)2.1 within a wide range of voltage depolarization. Delta F1502 also slowed Ca(V)2.1 inactivation kinetic and shifted the inactivation curve to hyperpolarized potentials (by similar to 28 mV). Delta F1502 effects on Ca(V)2.1 activation and deactivation properties seem to be of high physiological relevance. Thus, Delta F1502 strongly promotes Ca2+ influx in response to either single or trains of action potential-like waveforms of different durations. Our observations support a causative role of gain-of-function Ca(V)2.1 mutations in congenital ataxia, a neurodevelopmental disorder at the severe-most end of CACNA1A-associated phenotypic spectrum.	[Isabel Bahamonde, Maria; Angelica Serra, Selma; Prieto, Marta; Fernandez-Fernandez, Jose M.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Lab Fisiol Mol & Canalopaties, Barcelona, Spain; [Drechsel, Oliver; Rahman, Rubayte; Ossowski, Stephan] Barcelona Inst Sci & Technol, CRG, Genom & Epigen Variat Dis Grp, Barcelona, Spain; [Drechsel, Oliver; Rahman, Rubayte; Ossowski, Stephan] Univ Pompeu Fabra, Barcelona, Spain; [Marce-Grau, Anna; Macaya, Alfons] Univ Autonoma Barcelona, Vall dHebron Res Inst, Pediat Neurol Res Grp, E-08193 Barcelona, Spain	Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Autonomous University of Barcelona	Fernandez-Fernandez, JM (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Lab Fisiol Mol & Canalopaties, Barcelona, Spain.	jmanuel.fernandez@upf.edu	Serra, Selma A./Q-5360-2018; Fernández-Fernández, José Manuel M/M-8157-2015	Serra, Selma A./0000-0002-2242-7713; Fernández-Fernández, José Manuel M/0000-0003-2330-8449; Marce-Grau, Anna/0000-0001-5762-4023; Macaya Ruiz, Alfons/0000-0001-7998-4185	Spanish Ministry of Economy and Competitiveness [5AF2012-31089, SEV-2012-0208, MDM-2014-0370]; FEDER Funds, Fondo de Investigacion Sanitaria, Institut Carlos III, Spain [RIC RD12/0042/0014, PI12/1005]; Vail d'Hebron Institut de Recerca, Barcelona, Spain; FEDER Funds, Fondo de Investigacion Sanitaria, Institut Carlos III, Spain (Red HERACLES)	Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER Funds, Fondo de Investigacion Sanitaria, Institut Carlos III, Spain; Vail d'Hebron Institut de Recerca, Barcelona, Spain; FEDER Funds, Fondo de Investigacion Sanitaria, Institut Carlos III, Spain (Red HERACLES)	This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (5AF2012-31089 to JMF-F; SEV-2012-0208 to Centre for Genomic Regulation, "Centro de Excelencia Severo Ochoa 2013-2017"; and MDM-2014-0370 through the "Maria de Maeztu" Programme for Units of Excellence in R&D to "Departament de Ciencies Experimentals i de la Salut"), FEDER Funds, Fondo de Investigacion Sanitaria, Institut Carlos III, Spain (RIC RD12/0042/0014, Red HERACLES, and Grant PI12/1005 to AM). AM-G is a predoctoral fellow supported by Vail d'Hebron Institut de Recerca, Barcelona, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aspatwar A, 2013, HUM MOL GENET, V22, P417, DOI 10.1093/hmg/dds438; Blumkin L, 2010, J CHILD NEUROL, V25, P892, DOI 10.1177/0883073809351316; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Bravin M, 1999, P NATL ACAD SCI USA, V96, P1704, DOI 10.1073/pnas.96.4.1704; Carreno O, 2013, MOL GENET GENOM MED, V1, P206, DOI 10.1002/mgg3.24; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Cricchi F, 2007, J NEUROL SCI, V254, P69, DOI 10.1016/j.jns.2007.01.008; Cuenca-Leon E, 2009, J NEUROL SCI, V280, P10, DOI 10.1016/j.jns.2009.01.005; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Di Guilmi MN, 2014, J NEUROSCI, V34, P7047, DOI 10.1523/JNEUROSCI.2526-13.2014; Ducros A, 1999, AM J HUM GENET, V64, P89, DOI 10.1086/302192; Eilers J, 1996, CELL CALCIUM, V20, P215, DOI 10.1016/S0143-4160(96)90108-6; Fioretti B, 2011, J PHYSIOL-LONDON, V589, P5879, DOI 10.1113/jphysiol.2011.220533; FITZSIMONS RB, 1985, BRAIN, V108, P555, DOI 10.1093/brain/108.3.555-a; Fletcher CF, 2001, FASEB J, V15, P1288, DOI 10.1096/fj.00-0562fje; Gao ZY, 2012, J NEUROSCI, V32, P15533, DOI 10.1523/JNEUROSCI.2454-12.2012; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hirasawa M, 2007, MOL CELL NEUROSCI, V35, P161, DOI 10.1016/j.mcn.2007.02.013; Hirota J, 2003, BIOCHEM J, V372, P435, DOI 10.1042/BJ20030110; Imbrici P, 2005, NEUROLOGY, V65, P944, DOI 10.1212/01.wnl.0000176069.64200.28; Imbrici P, 2004, BRAIN, V127, P2682, DOI 10.1093/brain/awh301; Inagaki A, 2014, NEURON, V81, P91, DOI 10.1016/j.neuron.2013.10.056; Jiao Y, 2005, GENETICS, V171, P1239, DOI 10.1534/genetics.105.044487; Kaplan JC, 2013, NEUROMUSCULAR DISORD, V23, P1081, DOI 10.1016/j.nmd.2013.10.006; Kasumu A, 2012, CEREBELLUM, V11, P630, DOI 10.1007/s12311-010-0182-9; Kaya N, 2011, AM J MED GENET B, V156B, P826, DOI 10.1002/ajmg.b.31227; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Knierim E, 2011, STROKE, V42, pE14, DOI 10.1161/STROKEAHA.110.600023; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; Kraus RL, 1998, J BIOL CHEM, V273, P5586, DOI 10.1074/jbc.273.10.5586; Kraus RL, 2000, J BIOL CHEM, V275, P9239, DOI 10.1074/jbc.275.13.9239; Li H., 2013, 13033997V2 ARXIV, V1303, P1; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Miki T, 2008, NEUROSCIENCE, V155, P31, DOI 10.1016/j.neuroscience.2008.05.028; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Mori Y, 2000, J NEUROSCI, V20, P5654, DOI 10.1523/JNEUROSCI.20-15-05654.2000; Naik S, 2011, PEDIATR NEUROL, V45, P328, DOI 10.1016/j.pediatrneurol.2011.08.002; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Oelstrom K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4420; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Pattillo JM, 1999, J PHYSIOL-LONDON, V514, P719, DOI 10.1111/j.1469-7793.1999.719ad.x; Pelzer N, 2013, CURR TREAT OPTION NE, V15, P13, DOI 10.1007/s11940-012-0208-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pietrobon D, 2003, NAT REV NEUROSCI, V4, P386, DOI 10.1038/nrn1102; Pietrobon D, 2007, NEUROTHERAPEUTICS, V4, P274, DOI 10.1016/j.nurt.2007.01.008; Pietrobon D, 2013, ANNU REV PHYSIOL, V75, P365, DOI 10.1146/annurev-physiol-030212-183717; Pietrobon D, 2010, PFLUG ARCH EUR J PHY, V460, P375, DOI 10.1007/s00424-010-0802-8; Pineda JC, 1998, J NEUROPHYSIOL, V79, P2522, DOI 10.1152/jn.1998.79.5.2522; Rajakulendran S, 2010, J PHYSIOL-LONDON, V588, P1905, DOI 10.1113/jphysiol.2009.186437; Rose SJ, 2014, EXP NEUROL, V261, P553, DOI 10.1016/j.expneurol.2014.08.001; Scoggan KA, 2006, CAN J NEUROL SCI, V33, P68, DOI 10.1017/S0317167100004728; Segarra NG, 2014, J NEUROL SCI, V342, P69, DOI 10.1016/j.jns.2014.04.027; Serra SA, 2010, P NATL ACAD SCI USA, V107, P1672, DOI 10.1073/pnas.0908359107; Serra SA, 2009, PFLUG ARCH EUR J PHY, V458, P489, DOI 10.1007/s00424-009-0637-3; SOTELO C, 1975, BRAIN RES, V98, P574, DOI 10.1016/0006-8993(75)90374-1; Spacey SD, 2004, ANN NEUROL, V56, P213, DOI 10.1002/ana.20169; Strupp M, 2007, NEUROTHERAPEUTICS, V4, P267, DOI 10.1016/j.nurt.2007.01.014; Sutton KG, 1999, NATURE, V401, P800, DOI 10.1038/44586; Terwindt GM, 1998, NEUROLOGY, V50, P1105, DOI 10.1212/WNL.50.4.1105; Tottene A, 2005, J BIOL CHEM, V280, P17678, DOI 10.1074/jbc.M501110200; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Turkmen S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000487; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; van den Maagdenberg AMJM, 2010, ANN NEUROL, V67, P85, DOI 10.1002/ana.21815; Vecchia D, 2014, NEUROBIOL DIS, V69, P225, DOI 10.1016/j.nbd.2014.05.035; Vila-Pueyo M, 2014, EUR J PAEDIATR NEURO, V18, P430, DOI 10.1016/j.ejpn.2013.12.011; Wada T, 2002, PEDIATR NEUROL, V26, P47, DOI 10.1016/S0887-8994(01)00371-X; Wan J, 2005, NEUROLOGY, V64, P2090, DOI 10.1212/01.WNL.0000167409.59089.C0; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wappl E, 2002, J BIOL CHEM, V277, P6960, DOI 10.1074/jbc.M110948200; Watase K, 2008, P NATL ACAD SCI USA, V105, P11987, DOI 10.1073/pnas.0804350105; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; Womack MD, 2004, J NEUROSCI, V24, P8818, DOI 10.1523/JNEUROSCI.2915-04.2004; Zanni G, 2012, P NATL ACAD SCI USA, V109, P14514, DOI 10.1073/pnas.1207488109; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	79	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146035	10.1371/journal.pone.0146035	http://dx.doi.org/10.1371/journal.pone.0146035			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716990	gold, Green Published			2022-12-27	WOS:000367510500122
J	Wang, JX; Zhang, PP; Liu, N; Wang, Q; Luo, JX; Wang, L				Wang, Jinxiang; Zhang, Pingping; Liu, Na; Wang, Qian; Luo, Jixian; Wang, Lan			Cadmium Induces Apoptosis in Freshwater Crab Sinopotamon henanense through Activating Calcium Signal Transduction Pathway	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH; MITOCHONDRIAL PATHWAY; DEPENDENT APOPTOSIS; MEDIATED ACTIVATION; OXIDATIVE STRESS; DNA-REPAIR; CALMODULIN; YANGTSEKIENSE; TOXICITY	Calcium ion (Ca2+) is one of the key intracellular signals, which is implicated in the regulation of cell functions such as impregnation, cell proliferation, differentiation and death. Cadmium (Cd) is a toxic environmental pollutant that can disturb cell functions and even lead to cell death. Recently, we have found that Cd induced apoptosis in gill cells of the freshwater crab Sinopotamon henanense via caspase activation. In the present study, we further investigated the role of calcium signaling in the Cd-induced apoptosis in the animals. Our data showed that Cd triggered gill cell apoptosis which is evidenced by apoptotic DNA fragmentation, activations of caspases-3, -8 and -9 and the presence of apoptotic morphological features. Moreover, Cd elevated the intracellular concentration of Ca2+, the protein concentration of calmodulin (CaM) and the activity of Ca2+-ATPase in the gill cells of the crabs. Pretreatment of the animals with ethylene glycol-bis-(b-aminoethyl ether)-N, N, N', N'-tetraacetic acid (EGTA), Ca2+ chelator, inhibited Cd-induced activation of caspases-3, -8 and -9 as well as blocked the Cd-triggered apoptotic DNA fragmentation. The apoptotic morphological features were no longer observed in gill cells pretreated with the Ca2+ signaling inhibitors before Cd treatment. Our results indicate that Cd evokes gill cell apoptosis through activating Ca2+-CaM signaling transduction pathway.	[Wang, Jinxiang; Zhang, Pingping; Liu, Na; Wang, Qian; Luo, Jixian; Wang, Lan] Shanxi Univ, Sch Life Sci, Taiyuan 030006, Peoples R China; [Wang, Jinxiang] Shanxi Datong Univ, Sch Life Sci, Datong 037009, Peoples R China	Shanxi University; Shanxi Datong University	Wang, L (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan 030006, Peoples R China.	lanwang.sxu@qq.com			National Natural Science Foundation of China [31272319]; China Postdoctoral Science Foundatio [2012M510774]; Basic Research Programs foundation of Datong city of Shanxi Province [2014105-6]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundatio; Basic Research Programs foundation of Datong city of Shanxi Province	This work was supported by National Natural Science Foundation of China (No. 31272319), China Postdoctoral Science Foundation (No. 2012M510774) and Basic Research Programs foundation of Datong city of Shanxi Province (No. 2014105-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016100; Andosch A, 2012, J PLANT PHYSIOL, V169, P1489, DOI 10.1016/j.jplph.2012.06.002; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Biagioli M, 2008, CELL CALCIUM, V43, P184, DOI 10.1016/j.ceca.2007.05.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchholz M, 2007, CELL CYCLE, V6, P16, DOI 10.4161/cc.6.1.3650; Chen SJ, 2011, J NEUROCHEM, V119, P1108, DOI 10.1111/j.1471-4159.2011.07493.x; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Crabtree GR, 2009, CELL, V138, DOI 10.1016/j.cell.2009.06.026; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; Fiekers JF, 2001, LIFE SCI, V70, P681, DOI 10.1016/S0024-3205(01)01443-6; FINN BE, 1995, STRUCTURE, V3, P7, DOI 10.1016/S0969-2126(01)00130-7; Francois F, 2000, FEBS LETT, V486, P281, DOI 10.1016/S0014-5793(00)02316-4; Giaginis C, 2006, TOXICOL APPL PHARM, V213, P282, DOI 10.1016/j.taap.2006.03.008; Giorgi C, 2008, CURR MOL MED, V8, P119; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; HOCKENBERY D, 1995, AM J PATHOL, V146, P16; Hu XL, 2007, NEW PHYTOL, V173, P27, DOI 10.1111/j.1469-8137.2006.01888.x; Impey S, 2001, Sci STKE, V2001, ppe1; Ishido M, 2002, ENVIRON HEALTH PERSP, V110, P37, DOI 10.1289/ehp.0211037; Iwai-Kanai E, 2004, MOL CELL BIOCHEM, V259, P163, DOI 10.1023/B:MCBI.0000021368.80389.b9; Kim J, 2004, TOXICOL SCI, V81, P518, DOI 10.1093/toxsci/kfh221; Kim MS, 2000, TOXICOLOGY, V145, P27, DOI 10.1016/S0300-483X(99)00176-6; Kondoh M, 2002, TOXICOLOGY, V170, P111, DOI 10.1016/S0300-483X(01)00536-4; Kursula P, 2007, ACTA CRYSTALLOGR F, V63, P653, DOI 10.1107/S1744309107034525; Lee WK, 2006, AM J PHYSIOL-RENAL, V291, pF823, DOI 10.1152/ajprenal.00276.2005; Lemarie A, 2004, FREE RADICAL BIO MED, V36, P1517, DOI 10.1016/j.freeradbiomed.2004.03.020; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li RJ, 2011, ECOTOX ENVIRON SAFE, V74, P1164, DOI 10.1016/j.ecoenv.2011.02.018; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045711; Liu DM, 2011, AQUAT TOXICOL, V105, P394, DOI 10.1016/j.aquatox.2011.07.013; Liu J S, 1985, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V7, P453; Liu Y, 2007, FEBS LETT, V581, P1481, DOI 10.1016/j.febslet.2007.03.003; Liu ZM, 2007, CELL MOL LIFE SCI, V64, P1428, DOI 10.1007/s00018-007-7107-x; Ma WL, 2008, ENVIRON TOXICOL, V23, P393, DOI 10.1002/tox.20339; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Misra UK, 2002, CELL SIGNAL, V14, P327, DOI 10.1016/S0898-6568(01)00268-6; Oh SH, 2004, BIOCHEM PHARMACOL, V68, P1845, DOI 10.1016/j.bcp.2004.06.021; Park JD, 2001, TOXICOLOGY, V163, P93, DOI 10.1016/S0300-483X(01)00375-4; Petersen OH, 2005, CELL CALCIUM, V38, P161, DOI 10.1016/j.ceca.2005.06.023; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Qin Q, 2012, AQUAT TOXICOL, V106, P140, DOI 10.1016/j.aquatox.2011.08.013; REUTER H, 1983, NATURE, V301, P569, DOI 10.1038/301569a0; Risso-de Faverney C, 2004, AQUAT TOXICOL, V69, P247, DOI 10.1016/j.aquatox.2004.05.011; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shen HM, 2001, TOXICOL APPL PHARM, V171, P12, DOI 10.1006/taap.2000.9092; SUZUKI Y, 1985, ARCH TOXICOL, V57, P205, DOI 10.1007/BF00290889; Szuster-Ciesielska A, 2000, TOXICOLOGY, V145, P159, DOI 10.1016/S0300-483X(00)00144-X; Templeton DM, 2010, CHEM-BIOL INTERACT, V188, P267, DOI 10.1016/j.cbi.2010.03.040; THASTRUP O, 1990, AGENTS ACTIONS, V29, P8, DOI 10.1007/BF01964706; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Wang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064020; Wang JX, 2012, COMP BIOCHEM PHYS C, V156, P195, DOI 10.1016/j.cbpc.2012.05.006; Wang L, 2008, CHEMOSPHERE, V74, P51, DOI 10.1016/j.chemosphere.2008.09.025; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027853; Wang SH, 2008, CELL MOL LIFE SCI, V65, P3640, DOI 10.1007/s00018-008-8383-9; Wang SH, 2009, CHEM-BIOL INTERACT, V181, P45, DOI 10.1016/j.cbi.2009.05.004; Watjen W, 2002, ENVIRON HEALTH PERSP, V110, P865, DOI 10.1289/ehp.110-1241262; Wu H, 2014, ECOTOXICOLOGY, V23, P65, DOI 10.1007/s10646-013-1152-z; Xu BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019052; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xuan RJ, 2014, ENVIRON SCI POLLUT R, V21, P1738, DOI 10.1007/s11356-013-2068-0; Yang QL, 2012, COMP BIOCHEM PHYS C, V155, P190, DOI 10.1016/j.cbpc.2011.08.003; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yeh JH, 2009, BASIC CLIN PHARMACOL, V104, P345, DOI 10.1111/j.1742-7843.2009.00391.x	70	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144392	10.1371/journal.pone.0144392	http://dx.doi.org/10.1371/journal.pone.0144392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714174	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900010
J	Yang, J; Chen, XR; Zhu, CL; Peng, XS; He, XP; Fu, JR; Ouyang, LJ; Bian, JM; Hu, LF; Sun, XT; Xu, J; He, HH				Yang, Jun; Chen, Xiaorong; Zhu, Changlan; Peng, Xiaosong; He, Xiaopeng; Fu, Junru; Ouyang, Linjuan; Bian, Jianmin; Hu, Lifang; Sun, Xiaotang; Xu, Jie; He, Haohua			Using RNA-seq to Profile Gene Expression of Spikelet Development in Response to Temperature and Nitrogen during Meiosis in Rice (Oryza sativa L.)	PLOS ONE			English	Article							POLLEN GERMINATION; ANTHER DEHISCENCE; MALE-STERILITY; ARABIDOPSIS; FERTILITY; PROTEIN; TOOL; TRANSCRIPTOME; NITRATE; PLANTS	Rice reproductive development is sensitive to high temperature and soil nitrogen supply, both of which are predicted to be increased threats to rice crop yield. Rice spikelet development is a critical process that determines yield, yet little is known about the transcriptional regulation of rice spikelet development in response to the combination of heat stress and low nitrogen availability. Here, we profiled gene expression of rice spikelet development during meiosis under heat stress and different nitrogen levels using RNA-seq. We subjected plants to four treatments: 1) NN: normal nitrogen level (165 kg ha(-1)) with normal temperature (30 degrees C); 2) HH: high nitrogen level (264 kg ha(-1)) with high temperature (37 degrees C); 3) NH: normal nitrogen level and high temperature; and 4) HN: high nitrogen level and normal temperature. The de novo transcriptome assembly resulted in 52,250,482 clean reads aligned with 76,103 unigenes, which were then used to compare differentially expressed genes (DEGs) in the different treatments. Comparing gene expression in samples with the same nitrogen levels but different temperatures, we identified 70 temperature-responsive DEGs in normal nitrogen levels (NN vs NH) and 135 DEGs in high nitrogen levels (HN vs HH), with 27 overlapping DEGs. We identified 17 and seven nitrogen-responsive DEGs by comparing changes in nitrogen levels in lower temperature (NN vs HN) and higher temperature (NH vs HH), with one common DEG. The temperature-responsive genes were principally associated with cytochrome, heat shock protein, peroxidase, and ubiquitin, while the nitrogen-responsive genes were mainly involved in glutamine synthetase, amino acid transporter, pollen development, and plant hormone. Rice spikelet fertility was significantly reduced under high temperature, but less reduced under high-nitrogen treatment. In the high temperature treatments, we observed downregulation of genes involved in spikelet development, such as pollen tube growth, pollen maturation, especially sporopollenin biosynthetic process, and pollen exine formation. Moreover, we observed higher expression levels of the co-expressed DEGs in HN vs HH compared to NN vs NH. These included the six downregulated genes (one pollen maturation and five pollen exine formation genes), as well as the four upregulated DEGs in response to heat. This suggests that high-nitrogen treatment may enhance the gene expression levels to mitigate aspects of heat-stress. The spikelet genes identified in this study may play important roles in response to the combined effects of high temperature and high nitrogen, and may serve as candidates for crop improvement.	[Yang, Jun; Chen, Xiaorong; Zhu, Changlan; Peng, Xiaosong; He, Xiaopeng; Fu, Junru; Ouyang, Linjuan; Bian, Jianmin; Hu, Lifang; Sun, Xiaotang; Xu, Jie; He, Haohua] Jiangxi Agr Univ, Coll Agron, Key Lab Crop Physiol Ecol & Genet Breeding, Minist Educ, Nanchang 330045, Peoples R China; [Chen, Xiaorong; Zhu, Changlan; Peng, Xiaosong; He, Xiaopeng; Fu, Junru; Ouyang, Linjuan; Bian, Jianmin; Hu, Lifang; Sun, Xiaotang; He, Haohua] Hunan Agr Univ, Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha 410128, Hunan, Peoples R China	Jiangxi Agricultural University; Hunan Agricultural University	He, HH (corresponding author), Jiangxi Agr Univ, Coll Agron, Key Lab Crop Physiol Ecol & Genet Breeding, Minist Educ, Nanchang 330045, Peoples R China.	hhhua64@163.com		Yang, Jun/0000-0003-3420-2543	Special Scientific Research Foundation of Meteorological Public Welfare Industry of China [GYHY201406025]; Special Scientific Research Foundation of Agricultural Public Welfare Industry of China [201403002]	Special Scientific Research Foundation of Meteorological Public Welfare Industry of China; Special Scientific Research Foundation of Agricultural Public Welfare Industry of China	HH was supported by grant GYHY201406025 from the Special Scientific Research Foundation of Meteorological Public Welfare Industry of China (http://www.hymof.net.cn/SystemFrame/wdt_login.aspx), and grant 201403002 from the Special Scientific Research Foundation of Agricultural Public Welfare Industry of China (http://www.hymof.net.cn/SystemFrame/wdt_login.aspx).	Ata-Ul-Karim ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104540; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Castaings L, 2011, J EXP BOT, V62, P1391, DOI 10.1093/jxb/erq375; Chen S, 2013, SCI WORLD J, DOI 10.1155/2013/649326; Chhun T, 2007, PLANT CELL, V19, P3876, DOI 10.1105/tpc.107.054759; Chueasiri C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106386; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CRAWFORD NM, 1995, PLANT CELL, V7, P859, DOI 10.1105/tpc.7.7.859; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Endo M, 2009, PLANT CELL PHYSIOL, V50, P1911, DOI 10.1093/pcp/pcp135; FAO, 2002, WORLD AGR 2015 2030; Frink CR, 1999, P NATL ACAD SCI USA, V96, P1175, DOI 10.1073/pnas.96.4.1175; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guan JC, 2010, J EXP BOT, V61, P4249, DOI 10.1093/jxb/erq230; Harke MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069834; Hayashi T., 2011, Bulletin of the National Agricultural Research Center for Tohoku Region, P67; Higashitani A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00047; Hirano K, 2008, PLANT CELL PHYSIOL, V49, P1429, DOI 10.1093/pcp/pcn123; Huang JY, 2013, J EXP BOT, V64, P3351, DOI 10.1093/jxb/ert173; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jagadish SVK, 2007, J EXP BOT, V58, P1627, DOI 10.1093/jxb/erm003; Jagadish SVK, 2010, J EXP BOT, V61, P143, DOI 10.1093/jxb/erp289; Jung KH, 2013, FUNCT INTEGR GENOMIC, V13, P391, DOI 10.1007/s10142-013-0331-6; Jungkunz I, 2011, PLANT J, V66, P983, DOI 10.1111/j.1365-313X.2011.04558.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kant S, 2011, J EXP BOT, V62, P1499, DOI 10.1093/jxb/erq297; Kim HY, 2013, GLOBAL CHANGE BIOL, V19, P548, DOI 10.1111/gcb.12047; Ko SS, 2014, PLANT CELL, V26, P2486, DOI 10.1105/tpc.114.126292; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3793; Lian XM, 2006, PLANT MOL BIOL, V60, P617, DOI 10.1007/s11103-005-5441-7; Liao CS, 2012, J EXP BOT, V63, P5275, DOI 10.1093/jxb/ers187; Lin MY, 2014, PLANT PHYSIOL, V164, P2045, DOI 10.1104/pp.113.229609; Ling S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1305-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Madan P, 2012, J EXP BOT, V63, P3843, DOI 10.1093/jxb/ers077; Matsui T, 2002, ANN BOT-LONDON, V89, P683, DOI 10.1093/aob/mcf112; Mohammed AR, 2009, AGR FOREST METEOROL, V149, P999, DOI 10.1016/j.agrformet.2008.12.003; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Park HC, 2010, PLANT CELL ENVIRON, V33, P1923, DOI 10.1111/j.1365-3040.2010.02195.x; Peng MS, 2007, PLANT MOL BIOL, V65, P775, DOI 10.1007/s11103-007-9241-0; Prasad PVV, 2006, FIELD CROP RES, V95, P398, DOI 10.1016/j.fcr.2005.04.008; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Sakata T, 2014, PLANT PHYSIOL, V164, P2011, DOI 10.1104/pp.113.234401; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sarkar NK, 2014, PLANT MOL BIOL, V84, P125, DOI 10.1007/s11103-013-0123-3; SATAKE T, 1987, JPN J CROP SCI, V56, P404; Scafaro AP, 2010, J EXP BOT, V61, P191, DOI 10.1093/jxb/erp294; Shi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059721; Shi WJ, 2013, NEW PHYTOL, V197, P825, DOI 10.1111/nph.12088; Stitt M, 1999, CURR OPIN PLANT BIOL, V2, P178, DOI 10.1016/S1369-5266(99)80033-8; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; Tang XA, 2010, PLANT PHYSIOL, V154, P1855, DOI 10.1104/pp.110.161661; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thangasamy S, 2011, NEW PHYTOL, V189, P869, DOI 10.1111/j.1469-8137.2010.03538.x; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Waters ER, 2013, J EXP BOT, V64, P391, DOI 10.1093/jxb/ers355; WENG JH, 1987, PHOTOSYNTH RES, V14, P171, DOI 10.1007/BF00032321; Wu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098481; Wu LN, 2014, PLANT CELL REP, V33, P1881, DOI 10.1007/s00299-014-1666-8; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049652; Zhou SR, 2011, PLANT CELL, V23, P111, DOI 10.1105/tpc.109.073692	70	7	7	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145532	10.1371/journal.pone.0145532	http://dx.doi.org/10.1371/journal.pone.0145532			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714321	gold, Green Submitted, Green Published			2022-12-27	WOS:000367481900052
J	Zhu, YJ; Chen, K; Mi, XF; Chen, TX; Ali, J; Ye, GY; Xu, JL; Li, ZK				Zhu, Yajun; Chen, Kai; Mi, Xuefei; Chen, Tianxiao; Ali, Jauhar; Ye, Guoyou; Xu, Jianlong; Li, Zhikang			Identification and Fine Mapping of a Stably Expressed QTL for Cold Tolerance at the Booting Stage Using an Interconnected Breeding Population in Rice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GENOME-WIDE ASSOCIATION; SOUTHERN LEAF-BLIGHT; GENETIC ARCHITECTURE; INTROGRESSION LINES; COMPLEX TRAITS; RESISTANCE; YIELD; METABOLISM; STRESS	Cold stress is one of the major abiotic stresses that impede rice production. A interconnected breeding (IB) population consisted of 497 advanced lines developed using HHZ as the recurrent parent and eight diverse elite indica lines as the donors were used to identify stably expressed QTLs for CT at the booting stage. A total of 41,754 high-quality SNPs were obtained through re-sequencing of the IB population. Phenotyping was conducted under field conditions in two years and three locations. Association analysis identified six QTLs for CT on the chromosomes 3, 4 and 12. QTL qCT-3-2 that showed stable CT across years and locations was fine-mapped to an approximately 192.9 kb region. Our results suggested that GWAS applied to an IB population allows better integration of gene discovery and breeding. QTLs can be mapped in high resolution and quickly utilized in breeding.	[Zhu, Yajun; Chen, Kai; Chen, Tianxiao; Xu, Jianlong; Li, Zhikang] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Zhu, Yajun; Chen, Kai; Mi, Xuefei; Xu, Jianlong] Chinese Acad Agr Sci, Agr Genom Inst, Shenzhen 518120, Peoples R China; [Zhu, Yajun; Chen, Kai; Xu, Jianlong; Li, Zhikang] Chinese Acad Agr Sci, Shenzhen Inst Breeding & Innovat, Shenzhen 518120, Peoples R China; [Ali, Jauhar; Ye, Guoyou] Int Rice Res Inst, Manila, Philippines	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Chinese Academy of Agricultural Sciences; CGIAR; International Rice Research Institute (IRRI)	Xu, JL (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	xujlcaas@126.com; zhkli1953@126.com	Ali, Jauhar Ali or A. Jauhar/E-4432-2012; Xu, Jianlong/AAI-8310-2020	Ali, Jauhar Ali or A. Jauhar/0000-0002-3177-2607; Ye, Guoyou/0000-0002-9943-4815	Shenzhen Technology Research Development [JSGG20121026152117750]; Chinese Ministry of Science Technology [2014AA10A601]; Shenzhen Peacock Plan [20130415095710361]; CAAS Innovative Team Award; China Postdoctoral Science Foundation [2015M571176]	Shenzhen Technology Research Development; Chinese Ministry of Science Technology(Ministry of Science and Technology, China); Shenzhen Peacock Plan; CAAS Innovative Team Award; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was funded by Shenzhen Technology Research & Development (http://www.szsti.gov.cn/) (#: JSGG20121026152117750, Recipient: JLX); the "863" Key Project to JLX (2014AA10A601) from the Chinese Ministry of Science & Technology (http://www.863.gov.cn/); the Shenzhen Peacock Plan (http://www.szsti.gov.cn/) (#: 20130415095710361, Recipient: ZKL); the CAAS Innovative Team Award to JL Xu's team (http://www.caas.net.cn/); and the China Postdoctoral Science Foundation (http://res.chinapostdoctor.org.cn/BshWeb/index.shtml) (#: 2015M571176, Recipient: YJZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AJ, 2006, FIELD CROP RES, V97, P66, DOI 10.1016/j.fcr.2005.08.016; Andaya VC, 2006, THEOR APPL GENET, V113, P467, DOI 10.1007/s00122-006-0311-5; Andaya VC, 2007, MOL BREEDING, V20, P349, DOI 10.1007/s11032-007-9096-8; Auguie B, 2017, GRIDEXTRA MISCELLANE; Blanc G, 2006, THEOR APPL GENET, V113, P206, DOI 10.1007/s00122-006-0287-1; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Campbell MT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120385; Cheng LR, 2012, GENOME, V55, P45, DOI [10.1139/G11-075, 10.1139/g11-075]; Coles ND, 2010, GENETICS, V184, P799, DOI 10.1534/genetics.109.110304; Cook JP, 2012, PLANT PHYSIOL, V158, P824, DOI 10.1104/pp.111.185033; Fujino K, 2008, P NATL ACAD SCI USA, V105, P12623, DOI 10.1073/pnas.0805303105; GRAMENE, 2011, GRAMENE DAT VERS 33; Guan YS, 2010, J EXP BOT, V61, P4145, DOI 10.1093/jxb/erq212; He YX, 2010, PLANT BREEDING, V129, P167, DOI 10.1111/j.1439-0523.2009.01683.x; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Jena KK, 2012, CROP SCI, V52, P517, DOI 10.2135/cropsci2010.12.0733; Jiang L, 2008, J CEREAL SCI, V48, P173, DOI 10.1016/j.jcs.2007.08.013; Jordan DR, 2011, CROP SCI, V51, P1444, DOI 10.2135/cropsci2010.06.0326; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Kuroki M, 2007, THEOR APPL GENET, V115, P593, DOI 10.1007/s00122-007-0589-y; Li LF, 2013, THEOR APPL GENET, V126, P2313, DOI 10.1007/s00122-013-2137-2; Li TG, 1993, RICE GERMPLASM RESOU, P71; Li ZK, 2013, CURR OPIN PLANT BIOL, V16, P261, DOI 10.1016/j.pbi.2013.03.008; Li ZK, 2005, PLANT MOL BIOL, V59, P33, DOI 10.1007/s11103-005-8519-3; Liu Z., 2009, CHIN AGRI SCI B, V25, P45; Mao DH, 2015, THEOR APPL GENET, V128, P1359, DOI 10.1007/s00122-015-2511-3; Matthus E, 2015, THEOR APPL GENET, V128, P2085, DOI 10.1007/s00122-015-2569-y; Maurer A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1459-7; Meng LJ, 2013, PLANT BREEDING, V132, P604, DOI 10.1111/pbr.12097; Negeri AT, 2011, CROP SCI, V51, P1571, DOI 10.2135/cropsci2010.12.0672; Ogut F, 2015, HEREDITY, V114, P552, DOI 10.1038/hdy.2014.123; Peiffer JA, 2014, GENETICS, V196, P1337, DOI 10.1534/genetics.113.159152; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Saito K, 2010, PLANT SCI, V179, P97, DOI 10.1016/j.plantsci.2010.04.004; Schnaithmann F, 2014, THEOR APPL GENET, V127, P1513, DOI 10.1007/s00122-014-2315-x; Semagn K, 2010, ELECT J BIOTECHNOLOG; Shirasawa S, 2012, THEOR APPL GENET, V124, P937, DOI 10.1007/s00122-011-1758-6; Steinhoff J, 2011, CROP SCI, V51, P2505, DOI 10.2135/cropsci2011.03.0181; Suh JP, 2010, THEOR APPL GENET, V120, P985, DOI 10.1007/s00122-009-1226-8; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Wang HY, 2012, CROP SCI, V52, P1767, DOI 10.2135/cropsci2011.06.0323; Wang Y, 2013, CROP J, V1, P134, DOI 10.1016/j.cj.2013.07.006; Wissuwa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124215; Xu JL, 2005, THEOR APPL GENET, V111, P1642, DOI 10.1007/s00122-005-0099-8; Xu LM, 2008, PLANT SCI, V174, P340, DOI 10.1016/j.plantsci.2007.12.003; [杨梯丰 Yang Tifeng], 2015, [分子植物育种, Molecular Plant Breeding], V13, P1; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zeng YW, 2009, GENES GENOM, V31, P143, DOI 10.1007/BF03191147; Zhang F, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-55; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014541; Zhang NY, 2015, PLANT PHYSIOL, V168, P575, DOI 10.1104/pp.15.00025; Zhang QN, 2014, J INEQUAL APPL, DOI 10.1186/1029-242X-2014-221; Zhang SH, 2014, EUPHYTICA, V195, P95, DOI 10.1007/s10681-013-0977-0; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhou L, 2010, THEOR APPL GENET, V121, P895, DOI 10.1007/s00122-010-1358-x; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010; Zhu YJ, 2014, PLANT DIS, V98, P1112, DOI 10.1094/PDIS-10-13-1095-RE	58	43	44	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145704	10.1371/journal.pone.0145704	http://dx.doi.org/10.1371/journal.pone.0145704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713764	gold, Green Published, Green Submitted			2022-12-27	WOS:000367481900071
J	Deschemin, JC; Allouche, S; Brouillard, F; Vaulont, S				Deschemin, Jean-Christophe; Allouche, Sarah; Brouillard, Franck; Vaulont, Sophie			Iron Homeostasis and Inflammatory Status in Mice Deficient for the Cystic Fibrosis Transmembrane Regulator	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; BOWEL-DISEASE; LUNG-DISEASE; MACROPHAGES; PROTEINS; METABOLISM; ABSORPTION; EXPRESSION; FERRITIN; MATRIPTASE-2	Background Cystic Fibrosis (CF) is a frequent and lethal autosomal recessive disease caused by mutations in the gene encoding the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). Patients with CF suffer from chronic infections and severe inflammation, which lead to progressive pulmonary and gut diseases. Recently, an expanding body of evidence has suggested that iron homeostasis was abnormal in CF with, in particular, systemic iron deficiency and iron sequestration in the epithelium airway. The molecular mechanisms responsible for iron dysregulation and the relationship with inflammation in CF are unknown. Methods and Results We assessed the impact of CFTR deficiency on systemic and tissue iron homeostasis as well as inflammation in wildtype and CFTR knockout (KO) mice. First, in contrast to the systemic and intestinal inflammation we observed in the CFTR KO mice, we reported the absence of lung phenotype with regards to both inflammation and iron status. Second, we showed a significant decrease of plasma ferritin levels in the KO mice, as in CF patients, likely caused by a decrease in spleen ferritin levels. However, we measured unchanged plasma iron levels in the KO mice that may be explained by increased intestinal iron absorption. Conclusion These results indicate that in CF, the lung do not predominantly contributes to the systemic ferritin deficiency and we propose the spleen as the major organ responsible for hypoferritinemia in the KO mouse. These results should provide a better understanding of iron dysregulation in CF patients where treating or not iron deficiency remains a challenging question.	[Deschemin, Jean-Christophe; Allouche, Sarah; Vaulont, Sophie] INSERM, Inst Cochin, U1016, Paris, France; [Deschemin, Jean-Christophe; Allouche, Sarah; Vaulont, Sophie] CNRS, UMR8104, Paris, France; [Deschemin, Jean-Christophe; Allouche, Sarah; Brouillard, Franck; Vaulont, Sophie] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Deschemin, Jean-Christophe; Allouche, Sarah; Vaulont, Sophie] Lab Excellence GR Ex, Paris, France; [Brouillard, Franck] CNRS, Inst Chim Subst Nat, UPR2301, Gif Sur Yvette, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Vaulont, S (corresponding author), INSERM, Inst Cochin, U1016, Paris, France.	sophie.vaulont@inserm.fr	Vaulont, Sophie/O-6732-2017	Deschemin, Jean-Christophe/0000-0002-1256-8459	Vaincre la Mucoviscidose [RF20120600684]; Laboratory of Excellence GR-Ex - "Investissements d'avenir" program of the French National Research Agency [ANR-11-LABX-0051]	Vaincre la Mucoviscidose; Laboratory of Excellence GR-Ex - "Investissements d'avenir" program of the French National Research Agency(French National Research Agency (ANR))	This work was supported by grants from the Laboratory of Excellence GR-Ex (ANR-11-LABX-0051), which is funded by the "Investissements d'avenir" program of the French National Research Agency (ANR-11-IDEX-0005-02) and Vaincre la Mucoviscidose (grant RF20120600684). These funding organizations did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and do not provided financial support in the form of salaries.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; Andoh A, 2008, WORLD J GASTROENTERO, V14, P5154, DOI 10.3748/wjg.14.5154; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Canonne-Hergaux F, 2006, AM J PHYSIOL-GASTR L, V290, pG156, DOI 10.1152/ajpgi.00227.2005; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Chillappagari S, 2014, AM J PHYSIOL-LUNG C, V307, pL791, DOI 10.1152/ajplung.00167.2014; Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; Delaby C, 2005, EXP CELL RES, V310, P43, DOI 10.1016/j.yexcr.2005.07.002; Deschemin JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061050; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dowdle WE, 2014, NAT CELL BIOL, V16, P1069, DOI 10.1038/ncb3053; Feng Q, 2012, AM J PHYSIOL-GASTR L, V302, pG1397, DOI 10.1152/ajpgi.00020.2012; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Galy B, 2013, CELL REP, V3, P844, DOI 10.1016/j.celrep.2013.02.026; Gammella E, 2014, METALLOMICS, V6, P1336, DOI 10.1039/c4mt00104d; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Ghio AJ, 2013, J CYST FIBROS, V12, P390, DOI 10.1016/j.jcf.2012.10.010; Gulec S, 2014, ANNU REV NUTR, V34, P95, DOI 10.1146/annurev-nutr-071812-161215; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Kreda SM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009589; Lane DJR, 2015, NUTRIENTS, V7, P2274, DOI 10.3390/nu7042274; Lenoir A, 2011, BLOOD, V117, P647, DOI 10.1182/blood-2010-07-295147; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Mastrogiannaki M, 2013, BLOOD, V122, P885, DOI 10.1182/blood-2012-11-427765; Moreau-Marquis S, 2008, AM J PHYSIOL-LUNG C, V295, pL25, DOI 10.1152/ajplung.00391.2007; Neurath MF, 2008, MUCOSAL IMMUNOL, V1, pS28, DOI 10.1038/mi.2008.45; Norkina O, 2004, AM J PHYSIOL-GASTR L, V286, pG1032, DOI 10.1152/ajpgi.00473.2003; Poussier P, 2000, GASTROENTEROLOGY, V118, P880, DOI 10.1016/S0016-5085(00)70174-0; Reid DW, 2002, CHEST, V121, P48, DOI 10.1378/chest.121.1.48; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sharp P, 2007, WORLD J GASTROENTERO, V13, P4716, DOI 10.3748/wjg.v13.i35.4716; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Sterling KM, 2004, J CELL BIOCHEM, V91, P1174, DOI 10.1002/jcb.20017; Stites SW, 1999, AM J RESP CRIT CARE, V160, P796, DOI 10.1164/ajrccm.160.3.9811018; Sukumaran A, 2014, BRIT J NUTR, V111, P1059, DOI 10.1017/S0007114513003334; Uijterschout L, 2014, PEDIATR PULM, V49, P458, DOI 10.1002/ppul.22857; Verkman AS, 2013, CURR PHARM DESIGN, V19, P3529, DOI 10.2174/13816128113199990321; Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804; White C, 2013, CELL METAB, V17, P261, DOI 10.1016/j.cmet.2013.01.005; Wilke M, 2011, J CYST FIBROS, V10, pS152, DOI 10.1016/S1569-1993(11)60020-9; Willemetz A, 2014, BLOOD, V124, P441, DOI 10.1182/blood-2014-01-551150	46	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145685	10.1371/journal.pone.0145685	http://dx.doi.org/10.1371/journal.pone.0145685			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709821	Green Published, Green Submitted, gold			2022-12-27	WOS:000367451400071
J	Mitra, S; Wewers, MD; Sarkar, A				Mitra, Srabani; Wewers, Mark D.; Sarkar, Anasuya			Mononuclear Phagocyte-Derived Microparticulate Caspase-1 Induces Pulmonary Vascular Endothelial Cell Injury	PLOS ONE			English	Article							IL-1-BETA-CONVERTING ENZYME; ACUTE LUNG; MEMBRANE MICROPARTICLES; EPITHELIAL-CELLS; FAS-LIGAND; APOPTOSIS; ACTIVATION; DEATH; IL-1-BETA; INFLAMMASOME	Lung endothelial cell apoptosis and injury occurs throughout all stages of acute lung injury (ALI/ARDS) and impacts disease progression. Lung endothelial injury has traditionally been focused on the role of neutrophil trafficking to lung vascular integrin receptors induced by proinflammatory cytokine expression. Although much is known about the pathogenesis of cell injury and death in ALI/ARDS, gaps remain in our knowledge; as a result of which there is currently no effective pharmacologic therapy. Enzymes known as caspases are essential for completion of the apoptotic program and secretion of pro-inflammatory cytokines. We hypothesized that caspase-1 may serve as a key regulator of human pulmonary microvascular endothelial cell (HPMVEC) apoptosis in ALI/ARDS. Our recent experiments confirm that microparticles released from stimulated monocytic cells (THP1) induce lung endothelial cell apoptosis. Microparticles pretreated with the caspase-1 inhibitor, YVAD, or pan-caspase inhibitor, ZVAD, were unable to induce cell death of HPMVEC, suggesting the role of caspase-1 or its substrate in the induction of HPMVEC cell death. Neither un-induced microparticles (control) nor direct treatment with LPS induced apoptosis of HPMVEC. Further experiments showed that caspase-1 uptake into HPMVEC and the induction of HPMVEC apoptosis was facilitated by caspase-1 interactions with microparticulate vesicles. Altering vesicle integrity completely abrogated apoptosis of HPMVEC suggesting an encapsulation requirement for target cell uptake of active caspase-1. Taken together, we confirm that microparticle centered caspase-1 can play a regulator role in endothelial cell injury.	[Mitra, Srabani; Wewers, Mark D.; Sarkar, Anasuya] Ohio State Univ, Dept Internal Med, Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Sarkar, A (corresponding author), Ohio State Univ, Dept Internal Med, Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA.	anasuya.sarkar@osumc.edu	Wewers, Mark/AAB-6202-2021		NHLBI [RO1-HL076278, R21-HL102629]; AAT Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL102629, R01HL076278, R01HL124325] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AAT Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI RO1-HL076278 to MDW; NHLBI R21-HL102629 and AAT Foundation grant to AS.	Aoki N, 2007, ENDOCRINOLOGY, V148, P3850, DOI 10.1210/en.2006-1479; Baroni M, 2007, FASEB J, V21, P1926, DOI 10.1096/fj.06-7238com; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Braddock M, 2004, NAT REV DRUG DISCOV, V3, P1, DOI 10.1038/nrd1342; Cacquevel M, 2004, CURR DRUG TARGETS, V5, P529, DOI 10.2174/1389450043345308; Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126; Diamant M, 2004, EUR J CLIN INVEST, V34, P392, DOI 10.1111/j.1365-2362.2004.01355.x; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Dinarello CA, 2001, ANN RHEUM DIS, V60, pIII18; Distler JHW, 2005, APOPTOSIS, V10, P731, DOI 10.1007/s10495-005-2941-5; Distler JHW, 2006, AUTOIMMUNITY, V39, P683, DOI 10.1080/08916930601061538; Exline MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090968; Fahy RJ, 2008, AM J RESP CRIT CARE, V177, P983, DOI 10.1164/rccm.200703-418OC; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Hamacher J, 2002, AM J RESP CRIT CARE, V166, P651, DOI 10.1164/rccm.2109004; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Huber LC, 2007, APOPTOSIS, V12, P363, DOI 10.1007/s10495-006-0622-7; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Imanishi T, 2002, ATHEROSCLEROSIS, V161, P143, DOI 10.1016/S0021-9150(01)00631-1; Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793; Kahlenberg JM, 2004, J LEUKOCYTE BIOL, V76, P676, DOI 10.1189/jlb.0404221; Kim HJ, 2004, J IMMUNOL, V172, P4948, DOI 10.4049/jimmunol.172.8.4948; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kurtovic Jelica, 2004, Trop Gastroenterol, V25, P9; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mallat Z, 2000, BRIT J PHARMACOL, V130, P947, DOI 10.1038/sj.bjp.0703407; Mangan DF, 1991, J IMMUNOL, V163, P1755; Martin S, 2004, CIRCULATION, V109, P1653, DOI 10.1161/01.CIR.0000124065.31211.6E; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matute-Bello G, 2005, J IMMUNOL, V175, P4069, DOI 10.4049/jimmunol.175.6.4069; Matute-Bello G, 2003, CRIT CARE, V7, P355, DOI 10.1186/cc1861; McKechnie NM, 2006, EXP EYE RES, V83, P304, DOI 10.1016/j.exer.2005.11.028; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Nakamura M, 2004, AM J PATHOL, V164, P1949, DOI 10.1016/S0002-9440(10)63755-8; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Santos RL, 2001, INFECT IMMUN, V69, P2293, DOI 10.1128/IAI.69.4.2293-2301.2001; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; Sarkar A, 2006, J IMMUNOL, V176, P4979, DOI 10.4049/jimmunol.176.8.4979; Sarkar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007140; Sue W, 2006, AM J CLIN NUTR, V83, p470S; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Tiwary R, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3063; van der Velden AWM, 2003, J IMMUNOL, V171, P6742, DOI 10.4049/jimmunol.171.12.6742; Wang J, 2000, J CELL SCI, V113, P753; Watanabe JJ, 2003, J BIOL CHEM, V278, P33161, DOI 10.1074/jbc.M305321200; Wewers MD, 2004, P NATL ACAD SCI USA, V101, P10241, DOI 10.1073/pnas.0403971101; WIENERKRONISH JP, 1991, J CLIN INVEST, V88, P864, DOI 10.1172/JCI115388; Wilson HL, 2004, J IMMUNOL, V173, P1202, DOI 10.4049/jimmunol.173.2.1202; Zimmerman GA, 1999, CHEST, V116, p18S, DOI 10.1378/chest.116.suppl_1.18S	54	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145607	10.1371/journal.pone.0145607	http://dx.doi.org/10.1371/journal.pone.0145607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710067	Green Published, Green Submitted, gold			2022-12-27	WOS:000367451400065
J	Niu, EL; Shang, XG; Cheng, CZ; Bao, JH; Zeng, YD; Cai, CP; Du, XM; Guo, WZ				Niu, Erli; Shang, Xiaoguang; Cheng, Chaoze; Bao, Jianghao; Zeng, Yanda; Cai, Caiping; Du, Xiongming; Guo, Wangzhen			Comprehensive Analysis of the COBRA-Like (COBL) Gene Family in Gossypium Identifies Two COBLs Potentially Associated with Fiber Quality	PLOS ONE			English	Article							CELL-WALL; COTTON FIBER; ANCHORED PROTEIN; TRANSCRIPTION FACTOR; CELLULOSE SYNTHESIS; UPLAND COTTON; SYNTHASE-A; ARABIDOPSIS; EXPRESSION; ELONGATION	COBRA-Like (COBL) genes, which encode a plant-specific glycosylphosphatidylinositol (GPI) anchored protein, have been proven to be key regulators in the orientation of cell expansion and cellulose crystallinity status. Genome-wide analysis has been performed in A. thaliana, O. sativa, Z. mays and S. lycopersicum, but little in Gossypium. Here we identified 19, 18 and 33 candidate COBL genes from three sequenced cotton species, diploid cotton G. raimondii, G. arboreum and tetraploid cotton G. hirsutum acc. TM-1, respectively. These COBL members were anchored onto 10 chromosomes in G. raimondii and could be divided into two subgroups. Expression patterns of COBL genes showed highly developmental and spatial regulation in G. hirsutum acc. TM-1. Of them, GhCOBL9 and GhCOBL13 were preferentially expressed at the secondary cell wall stage of fiber development and had significantly co-upregulated expression with cellulose synthase genes GhCESA4, GhCESA7 and GhCESA8. Besides, GhCOBL9 D-t and GhCOBL13 D-t were co-localized with previously reported cotton fiber quality quantitative trait loci (QTLs) and the favorable allele types of GhCOBL9 D-t had significantly positive correlations with fiber quality traits, indicating that these two genes might play an important role in fiber development.	[Niu, Erli; Shang, Xiaoguang; Cheng, Chaoze; Bao, Jianghao; Zeng, Yanda; Cai, Caiping; Guo, Wangzhen] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Minist Educ, Hybrid Cotton R&D Engn Res Ctr, Nanjing, Jiangsu, Peoples R China; [Du, Xiongming] Chinese Acad Agr Sci, Cotton Res Inst, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Guo, WZ (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Minist Educ, Hybrid Cotton R&D Engn Res Ctr, Nanjing, Jiangsu, Peoples R China.	moelab@njau.edu.cn	Shang, Xiaoguang/GQA-8937-2022; Du, Xiongming/AAI-9999-2020; Shang, Xiaoguang/AAT-7979-2021		National Natural Science Foundation of China [31471539]; National High Technology Research and Development Program of China (863 Program) [2012AA101108-04-04]; Key R & D program in Jiangsu Province [BE2015360]; Priority Academic Program Development of Jiangsu Higher Education Institutions [010-809001]; Jiangsu Collaborative Innovation Center for Modern Crop Production [10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Key R & D program in Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Collaborative Innovation Center for Modern Crop Production	This program was financially supported in part by the National Natural Science Foundation of China (31471539), the National High Technology Research and Development Program of China (863 Program) (2012AA101108-04-04), Key R & D program in Jiangsu Province (BE2015360), the Priority Academic Program Development of Jiangsu Higher Education Institutions (010-809001) and Jiangsu Collaborative Innovation Center for Modern Crop Production (No. 10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpat AB, 2004, PLANT MOL BIOL, V54, P911, DOI 10.1007/s11103-004-0392-y; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; Beeckman T, 2002, PLANT PHYSIOL, V130, P1883, DOI 10.1104/pp.102.010603; BENFEY PN, 1993, DEVELOPMENT, V119, P57; Betancur L, 2010, J INTEGR PLANT BIOL, V52, P205, DOI 10.1111/j.1744-7909.2010.00934.x; Brady SM, 2007, PLANT PHYSIOL, V143, P172, DOI 10.1104/pp.106.087262; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Cai CP, 2014, CROP J, V2, P87, DOI 10.1016/j.cj.2014.03.001; Cao Y, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-211; Chen H, 2009, THEOR APPL GENET, V119, P605, DOI 10.1007/s00122-009-1070-x; Ching A, 2006, PLANTA, V224, P1174, DOI 10.1007/s00425-006-0299-8; Comai L, 2004, PLANT J, V37, P778, DOI 10.1111/j.0960-7412.2003.01999.x; Dai XX, 2011, PLANT MOL BIOL, V75, P333, DOI 10.1007/s11103-011-9730-z; Dai XX, 2009, PLANT MOL BIOL, V71, P469, DOI 10.1007/s11103-009-9537-3; Drenkard E, 2000, PLANT PHYSIOL, V124, P1483, DOI 10.1104/pp.124.4.1483; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Ellis C, 2002, PLANT CELL, V14, P1557, DOI 10.1105/tpc.002022; Endler A, 2011, MOL PLANT, V4, P199, DOI 10.1093/mp/ssq079; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Haigler CH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00104; HAUSER MT, 1995, DEVELOPMENT, V121, P1237; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hochholdinger F, 2008, PLANT J, V54, P888, DOI 10.1111/j.1365-313X.2008.03459.x; [蒋建雄 Jiang Jianxiong], 2003, [棉花学报, Cotton Science], V15, P166; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li YH, 2003, PLANT CELL, V15, P2020, DOI 10.1105/tpc.011775; Liang Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-539; Liu LF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003704; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XX, 2008, J GENET GENOMICS, V35, P751, DOI 10.1016/S1673-8527(08)60231-3; MacMillan CP, 2010, PLANT J, V62, P689, DOI 10.1111/j.1365-313X.2010.04181.x; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Qin YongSheng, 2009, Scientia Agricultura Sinica, V42, P4145; Renny-Byfield S, 2014, GENOME BIOL EVOL, V6, P559, DOI 10.1093/gbe/evu037; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732; Roudier F, 2002, PLANT PHYSIOL, V130, P538, DOI 10.1104/pp.007468; Sanchez-Rodriguez C, 2009, MOL PLANT MICROBE IN, V22, P953, DOI 10.1094/MPMI-22-8-0953; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; SCHUBERT AM, 1973, CROP SCI, V13, P704, DOI 10.2135/cropsci1973.0011183X001300060035x; Shen XL, 2005, MOL BREEDING, V15, P169, DOI 10.1007/s11032-004-4731-0; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Taylor NG, 2000, PLANT CELL, V12, P2529, DOI 10.1105/tpc.12.12.2529; Wang BH, 2007, CROP SCI, V47, P1384, DOI 10.2135/cropsci2006.10.0647; Wang BH, 2006, EUPHYTICA, V152, P367, DOI 10.1007/s10681-006-9224-2; Wang P, 2012, THEOR APPL GENET, V124, P1415, DOI 10.1007/s00122-012-1797-7; Xu YH, 2004, PLANT PHYSIOL, V135, P507, DOI 10.1104/pp.104.038612; Yang C, 2007, MOL PLANT BREED, V5, P797; Zeng CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047284; Zhang HB, 2008, INT J PLANT GENOMICS, V2008, DOI [10.1155/2008/742304, DOI 10.1155/2008/742304]; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057220; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678	63	26	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145725	10.1371/journal.pone.0145725	http://dx.doi.org/10.1371/journal.pone.0145725			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710066	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400073
J	Akinrinade, O; Koskenvuo, JW; Alastalo, TP				Akinrinade, Oyediran; Koskenvuo, Juha W.; Alastalo, Tero-Pekka			Prevalence of Titin Truncating Variants in General Population	PLOS ONE			English	Article							TIBIAL MUSCULAR-DYSTROPHY; MUSCLE FILAMENT TITIN; C-TERMINAL TITIN; GENETIC-VARIATION; MUTATIONS; CARDIOMYOPATHY; TTN; MYOPATHY; 5-METHYLCYTOSINE; IDENTIFICATION	Background Truncating titin (TTN) mutations, especially in A-band region, represent the most common cause of dilated cardiomyopathy (DCM). Clinical interpretation of these variants can be challenging, as these variants are also present in reference populations. We carried out systematic analyses of TTN truncating variants (TTNtv) in publicly available reference populations, including, for the first time, data from Exome Aggregation Consortium (ExAC). The goal was to establish more accurate estimate of prevalence of different TTNtv to allow better clinical interpretation of these findings. Methods and Results Using data from 1000 Genomes Project, Exome Sequencing Project (ESP) and ExAC, we estimated the prevalence of TTNtv in the population. In the three population datasets, 52-54% of TTNtv were not affecting all TTN transcripts. The frequency of truncations affecting all transcripts in ExAC was 0.36% (0.32% - 0.41%, 95% CI) and 0.19% (0.16% - 0.23%, 95% CI) for those affecting the A-band. In the A-band region, the prevalences of frameshift, nonsense and essential splice site variants were 0.057%, 0.090%, and 0.047% respectively. Cga/Tga (arginine/nonsense-R/*) transitional change at CpG mutation hotspots was the most frequent type of TTN nonsense mutation accounting for 91.3% (21/23) of arginine residue nonsense mutation (R/*) at TTN A-band region. Non-essential splice-site variants had significantly lower proportion of private variants and higher proportion of low-frequency variants compared to essential splice-site variants (P = 0.01; P = 5.1 X 10(-4), respectively). Conclusion A-band TTNtv are more rare in the general population than previously reported. Based on this analysis, one in 500 carries a truncation in TTN A-band suggesting the penetrance of these potentially harmful variants is still poorly understood, and some of these variants do not manifest as autosomal dominant DCM. This calls for caution when interpreting TTNtv in individuals and families with no history of DCM. Considering the size of TTN, expertise in DNA library preparation, high coverage NGS strategies, validated bioinformatics approach, accurate variant assessment strategy, and confirmatory sequencing are prerequisites for reliable evaluation of TTN in clinical settings, and ideally with the inclusion of mRNA and/or protein level assessment for a definite diagnosis.	[Akinrinade, Oyediran; Alastalo, Tero-Pekka] Univ Helsinki, Inst Clin Med, Childrens Hosp Helsinki, Helsinki, Finland; [Akinrinade, Oyediran; Alastalo, Tero-Pekka] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Koskenvuo, Juha W.; Alastalo, Tero-Pekka] Blueprint Genet, Helsinki, Finland; [Koskenvuo, Juha W.] Univ Helsinki, Cent Hosp, Dept Clin Physiol & Nucl Med, HUS Med Imaging Ctr, Helsinki, Finland; [Koskenvuo, Juha W.] Univ Helsinki, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Alastalo, TP (corresponding author), Univ Helsinki, Inst Clin Med, Childrens Hosp Helsinki, Helsinki, Finland.	tero-pekka.alastalo@helsinki.fi	Akinrinade, Oyediran/AAX-3795-2020	Akinrinade, Oyediran/0000-0002-6797-6353	Sigrid Juselius Foundation; Finnish Foundation for Pediatric Research; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation [00150083]; Ida Montin Foundation	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Pediatric Research; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Ida Montin Foundation	This work was supported by grants from the Sigrid Juselius Foundation; the Finnish Foundation for Pediatric Research; the Finnish Foundation for Cardiovascular Research; the Finnish Cultural Foundation (00150083:OA); and the Ida Montin Foundation (OA). The funders Blueprint Genetics had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors [OA, JWK and TPA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akinrinade O, 2015, GENETICS GE IN PRESS; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Carmignac V, 2007, ANN NEUROL, V61, P340, DOI 10.1002/ana.21089; Ceyhan-Birsoy O, 2013, NEUROLOGY, V81, P1205, DOI 10.1212/WNL.0b013e3182a6ca62; Chauveau C, 2014, HUM MOL GENET, V23, P980, DOI 10.1093/hmg/ddt494; Cooper David N, 2010, Hum Genomics, V4, P406; Dewey FE, 2014, JAMA-J AM MED ASSOC, V311, P1035, DOI 10.1001/jama.2014.1717; Evila A, 2014, ANN NEUROL, V75, P230, DOI 10.1002/ana.24102; Gerull B, 2006, J MOL MED-JMM, V84, P478, DOI 10.1007/s00109-006-0060-6; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Golbus JR, 2012, CIRC-CARDIOVASC GENE, V5, P391, DOI 10.1161/CIRCGENETICS.112.962928; Haas J, 2015, EUR HEART J, V36, P1123, DOI 10.1093/eurheartj/ehu301; Haas J, 2013, EMBO MOL MED, V5, P413, DOI 10.1002/emmm.201201553; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; Hackman P, 2008, NEUROMUSCULAR DISORD, V18, P922, DOI 10.1016/j.nmd.2008.07.010; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Itoh-Satoh M, 2002, BIOCHEM BIOPH RES CO, V291, P385, DOI 10.1006/bbrc.2002.6448; Krawczak M, 1996, HUM MUTAT, V8, P23; Matsumoto Y, 2005, J MUSCLE RES CELL M, V26, P367, DOI 10.1007/s10974-005-9018-5; Meurs KM, 2011, ENVIRON MOL MUTAGEN, V52, P161, DOI 10.1002/em.20596; Movassagh M, 2011, CIRCULATION, V124, P2411, DOI 10.1161/CIRCULATIONAHA.111.040071; NHLBI, EX VAR SERV NHLBI EX; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Pan S, 2012, CIRC-CARDIOVASC GENE, V5, P602, DOI 10.1161/CIRCGENETICS.112.963421; Patricia Arscott M, 2014, HEART RHYTHM    0509; Pugh TJ, 2014, GENET MED, V16, P601, DOI 10.1038/gim.2013.204; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; Roberts AM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010134; Satoh M, 1999, BIOCHEM BIOPH RES CO, V262, P411, DOI 10.1006/bbrc.1999.1221; Strom SP, 2014, GENET MED, V16, P510, DOI 10.1038/gim.2013.183; Taylor M, 2011, CIRCULATION, V124, P876, DOI 10.1161/CIRCULATIONAHA.110.005405; Udd B, 2005, NEUROLOGY, V64, P636, DOI 10.1212/01.WNL.0000151853.50144.82; van Spaendonck-Zwarts KY, 2014, EUR HEART J, V35, P2165, DOI 10.1093/eurheartj/ehu050; Yoskovitz G, 2012, AM J CARDIOL, V109, P1644, DOI 10.1016/j.amjcard.2012.01.392	36	57	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145284	10.1371/journal.pone.0145284	http://dx.doi.org/10.1371/journal.pone.0145284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701604	Green Published, gold			2022-12-27	WOS:000367092600058
J	Azevedo, MDS; Rosa, PS; Soares, CT; Fachin, LRV; Baptista, IMFD; Woods, WJ; Garlet, GP; Trombone, APF; Belone, ADF				Azevedo, Michelle de C. S.; Rosa, Patricia S.; Soares, Cleverson T.; Fachin, Luciana R. V.; Baptista, Ida Maria F. D.; Woods, William J.; Garlet, Gustavo P.; Trombone, Ana Paula F.; Belone, Andrea de F. F.			Analysis of Immune Response Markers in Jorge Lobo's Disease Lesions Suggests the Occurrence of Mixed T Helper Responses with the Dominance of Regulatory T Cell Activity	PLOS ONE			English	Article							IL-17; BETA; LOBOMYCOSIS; LACAZIOSIS; INFECTION; CYTOKINES; PATHOGEN; T(H)17; GROWTH; SKIN	Jorge Lobo's disease (JLD) is a chronic infection that affects the skin and subcutaneous tissues. Its etiologic agent is the fungus Lacazia loboi. Lesions are classified as localized, multifocal, or disseminated, depending on their location. Early diagnosis and the surgical removal of lesions are the best therapeutic options currently available for JLD. The few studies that evaluate the immunological response of JLD patients show a predominance of Th2 response, as well as a high frequency of TGF-beta and IL-10 positive cells in the lesions; however, the overall immunological status of the lesions in terms of their T cell phenotype has yet to be determined. Therefore, the objective of this study was to evaluate the pattern of Th1, Th2, Th17 and regulatory T cell (Treg) markers mRNA in JLD patients by means of real-time PCR. Biopsies of JLD lesions (N = 102) were classified according to their clinical and histopathological features and then analyzed using real-time PCR in order to determine the expression levels of TGF-beta 1, FoxP3, CTLA4, IKZF2, IL-10, T-bet, IFN-gamma, GATA3, IL-4, IL-5, IL-13, IL-33, RORC, IL-17A, IL-17F, and IL-22 and to compare these levels to those of healthy control skin (N = 12). The results showed an increased expression of FoxP3, CTLA4, TGF-beta 1, IL-10, T-bet, IL-17F, and IL-17A in lesions, while GATA3 and IL-4 levels were found to be lower in diseased skin than in the control group. When the clinical forms were compared, TGF-beta 1 was found to be highly expressed in patients with a single localized lesion while IL-5 and IL-17A levels were higher in patients with multiple/disseminated lesions. These results demonstrate the occurrence of mixed T helper responses and suggest the dominance of regulatory T cell activity, which could inhibit Th-dependent protective responses to intracellular fungi such as L. loboi. Therefore, Tregs may play a key role in JLD pathogenesis.	[Azevedo, Michelle de C. S.] Univ Estadual Paulista, Fac Med Botucatu, Dept Doencas Trop, Botucatu, SP, Brazil; [Azevedo, Michelle de C. S.; Rosa, Patricia S.; Soares, Cleverson T.; Fachin, Luciana R. V.; Belone, Andrea de F. F.] Inst Lauro Souza Lima, Dept Patol, Sao Paulo, Brazil; [Baptista, Ida Maria F. D.] Inst Lauro Souza Lima, Dept Microbiol, Sao Paulo, Brazil; [Woods, William J.] Hosp Clin Acre, Serv Especializado Dermatol, Sao Paulo, Brazil; [Garlet, Gustavo P.] Univ Sao Paulo, Fac Odontol Bauru, Dept Ciencias Biol, Sao Paulo, Brazil; [Trombone, Ana Paula F.] Univ Sagrado Coracao, Dept Ciencias Saude, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade do Sagrado Coracao	Trombone, APF (corresponding author), Univ Sagrado Coracao, Dept Ciencias Saude, Sao Paulo, Brazil.	tromboneap@yahoo.com.br; abelone@ilsl.br	Baptista, Ida Maria F D/G-8736-2012; de Campos Soriani Azevedo, Michelle/Y-8096-2018; Garlet, Ana Paula Trombone/N-9346-2013; Garlet, Gustavo Pompermaier/E-6762-2012; Azevedo, Michelle de Campos Soriani/GOJ-9716-2022	Baptista, Ida Maria F D/0000-0002-1574-9490; de Campos Soriani Azevedo, Michelle/0000-0001-5777-1138; Garlet, Ana Paula Trombone/0000-0002-8102-6098; Garlet, Gustavo Pompermaier/0000-0002-5071-8382; Azevedo, Michelle de Campos Soriani/0000-0001-5777-1138				Abbas A.K., 2012, IMUNOLOGIA CELULAR M, V8th; Arju R, 2014, THER ADV INFECT DIS, V2, P91, DOI 10.1177/2049936114559919; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Borghi M, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00506; Bourgeois C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00142; Brito Arival Cardoso de, 2007, An. Bras. Dermatol., V82, P461, DOI 10.1590/S0365-05962007000500010; Burns RA, 2000, J CLIN MICROBIOL, V38, P1283, DOI 10.1128/JCM.38.3.1283-1285.2000; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Campbell DJ, 2011, NAT MED, V17, P929, DOI 10.1038/nm.2433; Cavassani KA, 2006, J IMMUNOL, V177, P5811, DOI 10.4049/jimmunol.177.9.5811; Chen X, 2014, TH17 CELLS TREGS UNL; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; Costa TA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002512; Silva AAD, 2013, MICROB PATHOGENESIS, V65, P36, DOI 10.1016/j.micpath.2013.09.004; De Luca A, 2007, J IMMUNOL, V179, P5999, DOI 10.4049/jimmunol.179.9.5999; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Espinosa V, 2012, CYTOKINE, V58, P100, DOI 10.1016/j.cyto.2011.11.005; Felonato M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051071; Ferreira MC, 2010, INFECT IMMUN, V78, P4392, DOI 10.1128/IAI.00487-10; Gaffen SL, 2014, IMMUNITY, V10; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Herr RA, 2001, J CLIN MICROBIOL, V39, P309, DOI 10.1128/JCM.39.1.309-314.2001; Holmer SM, 2014, INFECT IMMUN, V82, P683, DOI 10.1128/IAI.00855-13; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Hube B, 2009, CURR OPIN MICROBIOL, V12, P347, DOI 10.1016/j.mib.2009.06.009; Jarvinen TAH, 2013, ADV WOUND CARE, V2, P50, DOI 10.1089/wound.2011.0299; Jin W, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.58; Kanashiro-Galo L, 2015, MED MYCOL; Kennedy J, 1996, J INTERF CYTOK RES, V16, P611, DOI 10.1089/jir.1996.16.611; Kimizuka Y, 2012, INFECT IMMUN, V80, P1121, DOI 10.1128/IAI.05544-11; Koguchi Yoshinobu, 2002, Int Rev Immunol, V21, P423, DOI 10.1080/08830180213274; Koh AY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040035; Lacaz C.S., 1986, DOENCA JORGE LOBO, P1; MacCallum DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006420; Marcos EVC, 2005, REV SOC BRAS MED TRO, V38, P399, DOI 10.1590/S0037-86822005000500007; MATSUMOTO K, 1990, J CELL PHYSIOL, V145, P95, DOI 10.1002/jcp.1041450114; McCormick LL, 1999, J IMMUNOL, V163, P5693; McNamee KE, 2011, PAIN, V152, P1838, DOI 10.1016/j.pain.2011.03.035; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Miranda MFR, 2010, AN BRAS DERMATOL, V85, P39, DOI 10.1590/S0365-05962010000100005; Tubilla LHM, 2008, AN BRAS DERMATOL, V83, P261, DOI 10.1590/S0365-05962008000300011; Moreira AP, 2008, J IMMUNOL, V180, P3049, DOI 10.4049/jimmunol.180.5.3049; Muraille E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00603; Opromolla D. V. A., 2000, Anais Brasileiros de Dermatologia, V75, P425; Opromolla D. V. A., 1999, Anais Brasileiros de Dermatologia, V74, P135; Paniz-Mondolfi A, 2012, MYCOSES, V55, P298, DOI 10.1111/j.1439-0507.2012.02184.x; Paniz-Mondolfi AE, 2007, INT J DERMATOL, V46, P180, DOI 10.1111/j.1365-4632.2007.02937.x; Papadavid E, 2012, J DERMATOL CASE REP, V6, P65, DOI 10.3315/jdcr.2012.1104; Piehler D, 2011, AM J PATHOL, V179, P733, DOI 10.1016/j.ajpath.2011.04.025; RESTREPO A, 1994, J AM ACAD DERMATOL, V31, pS91, DOI 10.1016/S0190-9622(08)81277-7; RODRIGUEZTORO G, 1993, INT J DERMATOL, V32, P324, DOI 10.1111/j.1365-4362.1993.tb01466.x; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Rosa Patricia Sammarco, 2009, J Med Case Rep, V3, P67, DOI 10.1186/1752-1947-3-67; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; Talhari S, 2012, CLIN DERMATOL, V30, P420, DOI 10.1016/j.clindermatol.2011.09.014; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; Ulges A, 2015, NAT IMMUNOL, V16, P267, DOI 10.1038/ni.3083; Verma A, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a019612; Vilani-Moreno Fatima Regina, 2005, Revista Iberoamericana de Micologia, V22, P44, DOI 10.1016/S1130-1406(05)70006-1; Vilani-Moreno FR, 2004, MYCOPATHOLOGIA, V158, P17, DOI 10.1023/B:MYCO.0000038433.76437.ec; Vilani-Moreno FR, 2011, MED MYCOL, P1; Vinh DC, 2011, LANCET INFECT DIS, V11, P780, DOI 10.1016/S1473-3099(11)70217-1; WIERSEMA JP, 1965, TROP GEOGR MED, V17, P89; Woods WJ, 2010, REV INST MED TROP SP, V52, P273, DOI 10.1590/S0036-46652010000500010; Xavier MB, 2006, EMERG INFECT DIS, V12, P526, DOI 10.3201/eid1203.051426; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409	67	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145814	10.1371/journal.pone.0145814	http://dx.doi.org/10.1371/journal.pone.0145814			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700881	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600135
J	Holodinsky, JK; Hebert, MA; Zygun, DA; Rigal, R; Berthelot, S; Cook, DJ; Stelfox, HT				Holodinsky, Jessalyn K.; Hebert, Marilynne A.; Zygun, David A.; Rigal, Romain; Berthelot, Simon; Cook, Deborah J.; Stelfox, Henry T.			A Survey of Rounding Practices in Canadian Adult Intensive Care Units	PLOS ONE			English	Article							FAMILY-CENTERED ROUNDS; QUALITY IMPROVEMENT; MULTIDISCIPLINARY ROUNDS; IMPROVING COMMUNICATION; MEASURABLE OUTCOMES; CLINICAL PHARMACIST; IMPACT; TEAM; PARTICIPATION; PERCEPTIONS	Objective To describe rounding practices in Canadian adult Intensive Care Units (ICU) and identify opportunities for improvement. Design Mixed methods design. Cross sectional survey of Canadian Adult ICUs (n = 180) with purposefully sampled follow-up interviews (n = 7). Measurements and Main Results Medical directors representing 111 ICUs (62%) participated in the survey. Rounding practices varied across ICUs with the majority reporting the use of interprofessional rounds (81%) that employed an open (94%) and collaborative (86%) approach, occurred at the patient's bedside (82%), and started at a standard time (79%) and standard location (56%). Most participants reported that patients (83%) and family members (67%) were welcome to attend rounds. Approximately half of ICUs (48%) used tools to facilitate rounds. Interruptions during rounds were reported to be common (i.e., >= 1 interruption for >= 50% of patients) in 46% of ICUs. Four themes were identified from qualitative analysis of participant responses to open-ended survey questions and interviews: multidisciplinarity, patient and family involvement, factors influencing productivity, and teaching and learning. Conclusions There is considerable variation in current rounding practices in Canadian medical/surgical ICUs. Opportunities exist to improve ICU rounds including ensuring the engagement of essential participants, clearly defining participant roles, establishing a standardized approach to the rounding process, minimizing interruptions, modifying the role of teaching, utilizing a structured rounding tool, and developing a metric for measuring rounding quality.	[Holodinsky, Jessalyn K.; Hebert, Marilynne A.; Stelfox, Henry T.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Zygun, David A.] Univ Alberta, Div Crit Care Med, Edmonton, AB, Canada; [Rigal, Romain] Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Berthelot, Simon] CHU Quebec, Dept Med Urgence, Quebec City, PQ, Canada; [Cook, Deborah J.] McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada; [Stelfox, Henry T.] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Stelfox, Henry T.] Alberta Hlth Serv, Calgary, AB, Canada	University of Calgary; University of Alberta; Universite de Montreal; Laval University; McMaster University; University of Calgary; Alberta Health Services (AHS); University of Calgary	Stelfox, HT (corresponding author), Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada.	tstelfox@ucalgary.ca	Holodinsky, Jessalyn/A-1287-2018	Holodinsky, Jessalyn/0000-0003-1748-5211; Stelfox, Henry/0000-0003-1231-1490	Alberta Innovates - Health Solutions; Alberta Innovates [201201137] Funding Source: researchfish	Alberta Innovates - Health Solutions; Alberta Innovates	The project was supported by an establishment grant from Alberta Innovates - Health Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, J CRIT CARE, V23, P227, DOI 10.1016/j.jcrc.2007.07.001; Al-Jazairi AS, 2008, SAUDI MED J, V29, P277; Alvarez G, 2005, INT J MED INFORM, V74, P791, DOI 10.1016/j.ijmedinf.2005.03.017; [Anonymous], 2012, FAMILY PRESENCE ROUN, V31, P53, DOI [10.1097/DCC.0b013e31824246dd, DOI 10.1097/DCC.0B013E31824246DD]; [Anonymous], 2003, EXPLICIT APPROACH TO, V29, P1584, DOI [10.1007/s00134-013-3002-0, DOI 10.1007/S00134-003-1815-Y]; Aronson PL, 2009, PEDIATRICS, V124, P1119, DOI 10.1542/peds.2009-0369; Baggs JG, 1999, CRIT CARE MED, V27, P1991, DOI 10.1097/00003246-199909000-00045; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cameron MA, 2009, J PEDIATR-US, V155, P522, DOI 10.1016/j.jpeds.2009.03.035; Centofanti JE, 2014, CRIT CARE MED, V42, P1797, DOI 10.1097/CCM.0000000000000331; Collins SA, 2011, J AM MED INFORM ASSN, V18, P45, DOI 10.1136/jamia.2010.006437; Coombs Maureen, 2003, Intensive Crit Care Nurs, V19, P125, DOI 10.1016/S0964-3397(03)00040-5; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; DuBose JJ, 2008, J TRAUMA, V64, P22, DOI 10.1097/TA.0b013e318161b0c8; FRIESDORF W, 1994, J CLIN MONITOR, V10, P201, DOI 10.1007/BF02908862; Hales B, 2008, INT J QUAL HEALTH C, V20, P22, DOI 10.1093/intqhc/mzm062; Have Ten ECM, 2013, QUALITY IMPROVEMENT, V39, P1800, DOI [10.1007/s00134-013-3002-0, DOI 10.1007/S00134-013-3002-0]; Hewson KM, 2006, ANAESTH INTENS CARE, V34, P322, DOI 10.1177/0310057X0603400222; Hill Karen, 2003, Nurs Crit Care, V8, P231, DOI 10.1111/j.1362-1017.2003.00038.x; Holodinsky JK, 2016, CURRENT CONCEPTS ADU; Ingram TC, 2014, J CRIT CARE, V29, P915, DOI 10.1016/j.jcrc.2014.07.015; Institute of Medicine (US) Committee, 2001, CROSSING QUALITY CHA, P1, DOI [DOI 10.17226/10027, 10.17226/10027]; Joint Nature Conservation Committee, 2007, 2 REP UK ART 17 IMPL, P1; Kim MM, 2010, ARCH INTERN MED, V170, P369, DOI 10.1001/archinternmed.2009.521; Knoderer HM, 2009, ACAD MED, V84, P1576, DOI 10.1097/ACM.0b013e3181bb2bed; Knoll M, 2008, PFLEGE, V21, P339, DOI 10.1024/1012-5302.21.5.339; Kuzin JK, 2007, PEDIATRICS, V120, pe895, DOI 10.1542/peds.2006-2943; Landry MA, 2007, PEDIATRICS, V120, P275, DOI 10.1542/peds.2007-0107; Lane D, 2013, CRIT CARE MED, V41, P2015, DOI 10.1097/CCM.0b013e31828a435f; Latta LC, 2008, ACAD MED, V83, P292, DOI 10.1097/ACM.0b013e3181637e21; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; Lyons MN, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2008.028977; Manias E, 2001, J CLIN NURS, V10, P442, DOI 10.1046/j.1365-2702.2001.00504.x; Miller A, 2009, HUM FACTORS, V51, P339, DOI 10.1177/0018720809338188; Narasimhan M, 2006, AM J CRIT CARE, V15, P217, DOI 10.4037/ajcc2006.15.2.217; Newkirk M, 2012, J TRAUMA ACUTE CARE, V73, pS75, DOI 10.1097/TA.0b013e3182606239; Patel NP, 2006, J BURN CARE RES, V27, P310, DOI 10.1097/01.BCR.0000216287.98801.96; Phipps LM, 2007, PEDIATR CRIT CARE ME, V8, P220, DOI 10.1097/01.PCC.0000262798.84416.C5; Phipps Lorri M, 2007, Intensive Crit Care Nurs, V23, P264, DOI 10.1016/j.iccn.2007.02.001; Pronovost P, 2003, J CRIT CARE, V18, P71, DOI 10.1053/jcrc.2003.50008; Rappaport DI, 2010, CLIN PEDIATR, V49, P228, DOI 10.1177/0009922809346568; Rivkin A, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.04.014; Rosen P, 2009, PEDIATRICS, V123, pE603, DOI 10.1542/peds.2008-2238; Rotman-Pikielny P, 2007, PATIENT EDUC COUNS, V65, P166, DOI 10.1016/j.pec.2006.07.003; Santiago C, 2014, INTENS CRIT CARE NUR, V30, P13, DOI 10.1016/j.iccn.2013.06.003; Schiller William R, 2003, J Trauma Nurs, V10, P93; Stockwell DC, 2007, PEDIATR CRIT CARE ME, V8, P540, DOI 10.1097/01.PCC.0000288709.15113.8A; Stone ME, 2011, SURG INFECT, V12, P373, DOI 10.1089/sur.2010.067; Teixeira PGR, 2013, J TRAUMA ACUTE CARE, V75, P717, DOI 10.1097/TA.0b013e31829d27b6; Ten Have ECM, 2013, J CRIT CARE, V28, P476, DOI 10.1016/j.jcrc.2012.12.007; Ten Have ECM, 2014, J INTENSIVE CARE MED, V29, P292, DOI 10.1177/0885066613486596; Vats A, 2012, CRIT CARE MED, V40, P608, DOI 10.1097/CCM.0b013e318232e2fc; Vats A, 2011, PEDIATR CRIT CARE ME, V12, P415, DOI 10.1097/PCC.0b013e3181fe2e3c; Ventura Ribal M R, 2002, Enferm Intensiva, V13, P68; Walden M, 2009, NEWBORN INFANT NURS, V9, P169, DOI 10.1053/j.nainr.2009.07.001; Weant KA, 2009, NEUROSURGERY, V65, P946, DOI 10.1227/01.NEU.0000347090.22818.35; Weiss CH, 2011, AM J RESP CRIT CARE, V184, P680, DOI 10.1164/rccm.201101-0037OC; White C. M., 1998, HOSP PHARM, V33, P419; Williams M, 2010, J AM COLL SURGEONS, V210, P17, DOI 10.1016/j.jamcollsurg.2009.09.025; Wright S, 1996, Nurs Crit Care, V1, P241; Wysham NG, 2014, J CRIT CARE, V29, P450, DOI 10.1016/j.jcrc.2013.12.006; Young MP, 1998, INT J QUAL HEALTH C, V10, P15, DOI 10.1093/intqhc/10.1.15; Zhang Y., 2014, COMP STAT MODELS	63	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145408	10.1371/journal.pone.0145408	http://dx.doi.org/10.1371/journal.pone.0145408			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26700860	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600075
J	Izumi, K; Kaneko, Y; Hashizume, M; Yoshimoto, K; Takeuchi, T				Izumi, Keisuke; Kaneko, Yuko; Hashizume, Misato; Yoshimoto, Keiko; Takeuchi, Tsutomu			Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naive Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study)	PLOS ONE			English	Article							INTERLEUKIN-6; REMISSION; JOINTS	Objective To explore the baseline predictors of clinical effectiveness after tocilizumab or infliximab treatment in biologic-naive rheumatoid arthritis patients. Methods Consecutive biologic-naive patients with rheumatoid arthritis initiating infliximab (n = 57) or tocilizumab (n = 70) treatment were included in our prospective cohort study. Our cohort started in February 2010, and the patients observed for at least 1 year as of April 2013 were analysed. We assessed baseline variables including patients' characteristics (age, sex, disease duration, prednisolone dose, methotrexate dose, other disease-modifying antirheumatic drug use, Clinical Disease Activity Index [CDAI]) and serum biomarker levels (C-reactive protein, immunoglobulin M-rheumatoid factor, anti-cyclic citrullinated protein/peptide antibodies, interferon-gamma, interleukin (IL)-1 beta, IL-2, IL-6, IL-8, IL-10, IL-17, tumor necrosis factor-alpha, soluble intercellular adhesion molecule-1, bone alkaline phosphatase, osteonectin, osteopontin) to extract factors associated with clinical remission (CDAI <= 2.8) at 1 year using univariate analyses, and the extracted factors were entered into a multivariate logistic regression model. Similar analyses were also performed for Simplified Disease Activity Index (SDAI) remission (<= 3.3) and Disease Activity Score with 28 joint counts, erythrocyte sedimentation rate (DAS28-ESR) remission (< 2.6). Results There were no significant differences in the baseline characteristics except for methotrexate use between the groups. In the multivariate analyses, the low baseline osteopontin levels (OR 0.9145, 95% CI 0.8399-0.9857) were identified as predictors of CDAI remission in the tocilizumab group, whereas no predictors of CDAI remission were found in the infliximab group. Similar results were obtained when using SDAI and DAS28-ESR remission criteria. Conclusion Baseline low serum osteopontin levels predict clinical remission 1 year after tocilizumab treatment and not infliximab treatment in biologic-naive patients with rheumatoid arthritis. Our prediction model provided insights into how to optimize the choice of biologics and warrants external validation in other cohorts.	[Izumi, Keisuke; Kaneko, Yuko; Yoshimoto, Keiko; Takeuchi, Tsutomu] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan; [Izumi, Keisuke] Natl Tokyo Med Ctr, Dept Connect Tissue Dis, Tokyo, Japan; [Hashizume, Misato] Chugai Pharmaceut Co Ltd, Fuji Gotemba Res Labs, Prod Res Dept, Gotemba, Japan	Keio University; Chugai Pharmaceutical Co., Ltd.; Roche Holding	Izumi, K (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan.	izz@keio.jp	Kaneko, Yuko/L-2897-2013; Takeuchi, Tsutomu/AFM-8316-2022; Takeuchi, Tsutomu/L-2327-2013	Takeuchi, Tsutomu/0000-0003-1111-8218	Astellas Pharma Inc; Bristol-Myers KK; Chugai Pharmaceutical Co, Ltd; Daiichi Sankyo Co, Ltd; Eisai Co, Ltd; Mitsubishi Tanabe Pharma Corp; Pfizer Japan; Santen Pharmaceutical Co, Ltd; Takeda Pharmaceutical Co, Ltd; Teijin Pharma Ltd; AbbVie GK; Asahi Kasei Pharma Corp; Taisho Toyama Pharmaceutical Co, Ltd; SymBio Pharmaceuticals Ltd; Janssen Pharmaceutical KK; Pfizer Japan Inc; Astra Zeneca KK; Eli Lilly Japan KK; Novartis Pharma KK; Asahi Kasei Medical Co, Ltd; Grants-in-Aid for Scientific Research [15K21368] Funding Source: KAKEN	Astellas Pharma Inc(Astellas Pharmaceuticals); Bristol-Myers KK; Chugai Pharmaceutical Co, Ltd; Daiichi Sankyo Co, Ltd(Daiichi Sankyo Company Limited); Eisai Co, Ltd(Eisai Co Ltd); Mitsubishi Tanabe Pharma Corp; Pfizer Japan(Pfizer); Santen Pharmaceutical Co, Ltd; Takeda Pharmaceutical Co, Ltd(Takeda Pharmaceutical Company Ltd); Teijin Pharma Ltd; AbbVie GK(AbbVie); Asahi Kasei Pharma Corp; Taisho Toyama Pharmaceutical Co, Ltd; SymBio Pharmaceuticals Ltd; Janssen Pharmaceutical KK; Pfizer Japan Inc(Pfizer); Astra Zeneca KK(AstraZeneca); Eli Lilly Japan KK(Eli Lilly); Novartis Pharma KK(Novartis); Asahi Kasei Medical Co, Ltd; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	KI, KY, and YK declare that they have no competing interests. MH is an employee of Chugai Pharmaceutical Co, Ltd. TT has received grants from Astellas Pharma Inc, Bristol-Myers KK, Chugai Pharmaceutical Co, Ltd, Daiichi Sankyo Co, Ltd, Eisai Co, Ltd, Mitsubishi Tanabe Pharma Corp, Pfizer Japan, Santen Pharmaceutical Co, Ltd, Takeda Pharmaceutical Co, Ltd, Teijin Pharma Ltd, AbbVie GK, Asahi Kasei Pharma Corp, Taisho Toyama Pharmaceutical Co, Ltd, and SymBio Pharmaceuticals Ltd; speaking fees from AbbVie GK, Bristol-Myers KK, Chugai Pharmaceutical Co, Ltd, Eisai Co, Ltd, Janssen Pharmaceutical KK, Mitsubishi Tanabe Pharma Corp, Pfizer Japan Inc, Takeda Pharmaceutical Co, Ltd, Astellas Pharma Inc, and Daiichi Sankyo Co, Ltd; and consultant fees from Astra Zeneca KK, Eli Lilly Japan KK, Novartis Pharma KK, Mitsubishi Tanabe Pharma Corp, Asahi Kasei Medical Co, Ltd, AbbVie GK, Daiichi Sankyo Co, Ltd, and Bristol-Myers KK. All of the authors declare that they have no non-financial conflicts of interest. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Gazal S, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204581; Hashizume M, 2009, RHEUMATOL INT, V29, P1449, DOI 10.1007/s00296-009-0885-8; Izumi K, 2015, MOD RHEUMATOL, V25, P31, DOI 10.3109/14397595.2014.897793; Katchamart W, 2010, ARTHRIT CARE RES, V62, P1128, DOI 10.1002/acr.20188; Kawashiri S, 2011, MOD RHEUMATOL, V21, P370, DOI 10.1007/s10165-010-0409-0; Kojima T, 2013, MOD RHEUMATOL, V23, P977, DOI [10.1007/s10165-012-0782-y, 10.3109/s10165-012-0782-y]; Maneiro RJ, 2013, SEMIN ARTHRITIS RHEU, V43, P9, DOI 10.1016/j.semarthrit.2012.11.007; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Nishina N, 2014, ANN RHEUM DIS, V73, P945, DOI 10.1136/annrheumdis-2013-204137; Ohshima S, 2002, J RHEUMATOL, V29, P2061; Take Y, 2009, ARTHRITIS RHEUM-US, V60, P3591, DOI 10.1002/art.25020; Todd DJ, 2011, ARTHRITIS RHEUM-US, V63, P894, DOI 10.1002/art.30213; Xu GW, 2005, J CLIN INVEST, V115, P1060; Yumoto K, 2002, P NATL ACAD SCI USA, V99, P4556, DOI 10.1073/pnas.052523599	17	12	12	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145468	10.1371/journal.pone.0145468	http://dx.doi.org/10.1371/journal.pone.0145468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698858	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600084
J	Pletneva, NV; Pletnev, VZ; Sarkisyan, KS; Gorbachev, DA; Egorov, ES; Mishin, AS; Lukyanov, KA; Dauter, Z; Pletnev, S				Pletneva, Nadya V.; Pletnev, Vladimir Z.; Sarkisyan, Karen S.; Gorbachev, Dmitry A.; Egorov, Evgeny S.; Mishin, Alexander S.; Lukyanov, Konstantin A.; Dauter, Zbigniew; Pletnev, Sergei			Crystal Structure of Phototoxic Orange Fluorescent Proteins with a Tryptophan-Based Chromophore	PLOS ONE			English	Article							ELECTRON-TRANSFER; RED; INACTIVATION; PATHWAYS; OXYGEN	Phototoxic fluorescent proteins represent a sparse group of genetically encoded photosensitizers that could be used for precise light-induced inactivation of target proteins, DNA damage, and cell killing. Only two such GFP-based fluorescent proteins (FPs), KillerRed and its monomeric variant SuperNova, were described up to date. Here, we present a crystallographic study of their two orange successors, dimeric KillerOrange and monomeric mKiller-Orange, at 1.81 and 1.57 angstrom resolution, respectively. They are the first orange-emitting protein photosensitizers with a tryptophan-based chromophore (Gln65-Trp66-Gly67). Same as their red progenitors, both orange photosensitizers have a water-filled channel connecting the chromophore to the beta-barrel exterior and enabling transport of ROS. In both proteins, Trp66 of the chromophore adopts an unusual trans-cis conformation stabilized by H- bond with the nearby Gln159. This trans-cis conformation along with the water channel was shown to be a key structural feature providing bright orange emission and phototoxicity of both examined orange photosensitizers.	[Pletneva, Nadya V.; Pletnev, Vladimir Z.; Sarkisyan, Karen S.; Gorbachev, Dmitry A.; Egorov, Evgeny S.; Mishin, Alexander S.; Lukyanov, Konstantin A.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Gorbachev, Dmitry A.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Mishin, Alexander S.; Lukyanov, Konstantin A.] Nizhny Novgorod State Med Acad, Nizhnii Novgorod, Russia; [Dauter, Zbigniew; Pletnev, Sergei] NCI, Synchrotron Radiat Res Sect, Macromol Crystallog Lab, Argonne, IL 60439 USA; [Pletnev, Sergei] Leidos Biomed Res Inc, Basic Res Program, Argonne, IL USA	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lomonosov Moscow State University; Privolzhsky Research Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pletnev, S (corresponding author), NCI, Synchrotron Radiat Res Sect, Macromol Crystallog Lab, Argonne, IL 60439 USA.	vzpletnev@gmail.com; pletnevs@mail.nih.gov	Pletneva, Nadya/F-7839-2014; Sarkisyan, Karen S/M-6821-2015; Sarkisyan, Karen/AAA-5784-2021; Pletnev, Vladimir/Q-6151-2016; Mishin, Alexander/L-9420-2014; Lukyanov, Konstantin A/D-4030-2013	Sarkisyan, Karen S/0000-0002-5375-6341; Sarkisyan, Karen/0000-0002-5375-6341; Mishin, Alexander/0000-0002-4935-7030; Lukyanov, Konstantin A/0000-0001-9845-2088; Gorbachev, Dmitry/0000-0001-6124-2511; Pletneva, Nadya/0000-0001-9681-4022	Russian Science Foundation (RSF) [14-14-00281]; Russian Science Foundation [14-25-00129]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.; NATIONAL CANCER INSTITUTE [ZIABC010378] Funding Source: NIH RePORTER	Russian Science Foundation (RSF)(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been supported with a federal grant from the Russian Science Foundation (RSF) No 14-14-00281. Mutagenesis work has been supported by Russian Science Foundation grant 14-25-00129. Experiments were partially carried out using the equipment provided by the IBCH core facility (CKP IBCH). Diffraction experiments were carried out at beamline 22-ID of the Southeast Regional Collaborative Access Team (SER-CAT), located at the Advanced Photon Source, Argonne National Laboratory, USA. Use of the APS was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. W-31-109-Eng-38. The project has been supported in part with federal funds from the National Cancer Institute, National Institutes of Health under contract no. HHSN261200800001E, by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. SP is employed by Leidos Biomedical Research, Inc. The specific contributions of this author can be found in the Author Contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JH, 2003, J MOL BIOL, V328, P1071, DOI 10.1016/S0022-2836(03)00364-4; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Carpentier P, 2009, FEBS LETT, V583, P2839, DOI 10.1016/j.febslet.2009.07.041; DeLano WL, 2002, THE PYMOL MOLECULAR; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evdokimov AG, 2006, EMBO REP, V7, P1006, DOI 10.1038/sj.embor.7400787; Ivashchenko O, 2011, MOL BIOL CELL, V22, P1440, DOI 10.1091/mbc.E10-11-0919; Kuznetsova DS, 2015, J BIOPHOTONICS, V8, P952, DOI 10.1002/jbio.201400130; Lelimousin M, 2009, BIOCHEMISTRY-US, V48, P10038, DOI 10.1021/bi901093w; Lin JY, 2013, NEURON, V79, P241, DOI 10.1016/j.neuron.2013.05.022; Lin JP, 2005, SCIENCE, V310, P1311, DOI 10.1126/science.1118316; Lukyanov KA, 2010, PHOTOCH PHOTOBIO SCI, V9, P1301, DOI 10.1039/c0pp00114g; Malo GD, 2007, BIOCHEMISTRY-US, V46, P9865, DOI 10.1021/bi602664c; Matsumoto A, 2011, BIOTECHNIQUES, V51, P55, DOI 10.2144/000113705; Miyashita O, 2005, P NATL ACAD SCI USA, V102, P3558, DOI 10.1073/pnas.0409600102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pletnev S, 2009, J BIOL CHEM, V284, P32028, DOI 10.1074/jbc.M109.054973; Pletnev VZ, 2015, ACTA CRYSTALLOGR D, V71, P1699, DOI 10.1107/S1399004715010159; Pletneva NV, 2007, RUSS J BIOORG CHEM+, V33, P390, DOI 10.1134/S1068162007040048; Pletneva N, 2007, ACTA CRYSTALLOGR D, V63, P1082, DOI 10.1107/S0907444907042461; Pletneva NV, 2011, PROTEIN SCI, V20, P1265, DOI 10.1002/pro.654; Roy A, 2010, PHOTOCH PHOTOBIO SCI, V9, P1342, DOI 10.1039/c0pp00141d; Ryumina AP, 2013, BBA-GEN SUBJECTS, V1830, P5059, DOI 10.1016/j.bbagen.2013.07.015; Sano Y, 2014, J CELL SCI, V127, P1621, DOI 10.1242/jcs.144527; Sarkisyan KS, 2015, PLOS ONE FORTHCOMING; Serebrovskaya EO, 2011, BIOCHEM J, V435, P65, DOI 10.1042/BJ20101217; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Takemoto K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02629; Torra J, 2015, PHOTOCH PHOTOBIO SCI, V14, P280, DOI 10.1039/c4pp00338a; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vegh RB, 2014, J PHYS CHEM B, V118, P4527, DOI 10.1021/jp500919a; Vegh RB, 2011, CHEM COMMUN, V47, P4887, DOI 10.1039/c0cc05713d; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Williams DC, 2013, CELL REP, V5, P553, DOI 10.1016/j.celrep.2013.09.023; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	38	20	27	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145740	10.1371/journal.pone.0145740	http://dx.doi.org/10.1371/journal.pone.0145740			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699366	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092600126
J	Sriram, N; Mills, J; Lang, E; Dickson, HK; Hamann, HA; Nosek, BA; Schiller, JH				Sriram, N.; Mills, Jennifer; Lang, Edward; Dickson, Holli K.; Hamann, Heidi A.; Nosek, Brian A.; Schiller, Joan H.			Attitudes and Stereotypes in Lung Cancer versus Breast Cancer	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; STIGMA; PERCEPTIONS; COGNITION	Societal perceptions may factor into the high rates of nontreatment in patients with lung cancer. To determine whether bias exists toward lung cancer, a study using the Implicit Association Test method of inferring subconscious attitudes and stereotypes from participant reaction times to visual cues was initiated. Participants were primarily recruited from an online survey panel based on US census data. Explicit attitudes regarding lung and breast cancer were derived from participants' ratings (n = 1778) regarding what they thought patients experienced in terms of guilt, shame, and hope (descriptive statements) and from participants' opinions regarding whether patients ought to experience such feelings (normative statements). Participants' responses to descriptive and normative statements about lung cancer were compared with responses to statements about breast cancer. Analyses of responses revealed that the participants were more likely to agree with negative descriptive and normative statements about lung cancer than breast cancer (P<0.001). Furthermore, participants had significantly stronger implicit negative associations with lung cancer compared with breast cancer; mean response times in the lung cancer/negative conditions were significantly shorter than in the lung cancer/positive conditions (P<0.001). Patients, caregivers, healthcare providers, and members of the general public had comparable levels of negative implicit attitudes toward lung cancer. These results show that lung cancer was stigmatized by patients, caregivers, healthcare professionals, and the general public. Further research is needed to investigate whether implicit and explicit attitudes and stereotypes affect patient care.	[Sriram, N.; Nosek, Brian A.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA; [Mills, Jennifer; Lang, Edward; Dickson, Holli K.] Genentech Inc, San Francisco, CA 94080 USA; [Hamann, Heidi A.; Schiller, Joan H.] Univ Texas Southwestern, Div Hematol, Dallas, TX 75390 USA; [Hamann, Heidi A.; Schiller, Joan H.] Univ Texas Southwestern, Div Oncol, Dallas, TX USA; [Hamann, Heidi A.] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA	University of Virginia; Roche Holding; Genentech; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Arizona	Schiller, JH (corresponding author), Univ Texas Southwestern, Div Hematol, Dallas, TX 75390 USA.	Joan.Schiller@utsouthwestern.edu		Nosek, Brian/0000-0001-6797-5476	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	The study sponsor (Genentech, Inc.) provided support in the form of salaries for authors JM, EL, and HD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; N. Sriram had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The study was sponsored by Genentech, Inc.; the sponsor provided support in the form of salaries for authors JM, EL, and HD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Third-party writing assistance for this manuscript was provided by Christopher M. Brown, PhD of CodonMedical, an Ashfield Company, and was funded by Genentech, Inc.	Cataldo JK, 2013, ONCOLOGY-BASEL, V85, P33, DOI 10.1159/000350834; Chapple A, 2004, BMJ-BRIT MED J, V328, P1470, DOI 10.1136/bmj.38111.639734.7C; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Hamann HA, 2014, PSYCHO-ONCOLOGY, V23, P81, DOI 10.1002/pon.3371; Hamann HA, 2013, J THORAC ONCOL, V8, P1474, DOI 10.1097/01.JTO.0000437501.83763.5d; Hume D., 2009, TREATISE HUMAN NATUR; Lai CK, 2014, J EXP PSYCHOL GEN, V143, P1765, DOI 10.1037/a0036260; Lai CK, 2013, SOC PERSONAL PSYCHOL, V7, P315, DOI 10.1111/spc3.12023; LoConte NK, 2008, CLIN LUNG CANCER, V9, P171, DOI 10.3816/CLC.2008.n.026; Marini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083543; Nosek B. A., 2007, AUTOMATIC PROCESSES, P265, DOI DOI 10.1080/10463280701489053; Nosek BA, 2011, TRENDS COGN SCI, V15, P152, DOI 10.1016/j.tics.2011.01.005; Nosek BA, 2009, P NATL ACAD SCI USA, V106, P10593, DOI 10.1073/pnas.0809921106; PETERSGOLDEN H, 1982, SOC SCI MED, V16, P483, DOI 10.1016/0277-9536(82)90057-0; Rusch N, 2010, J NERV MENT DIS, V198, P150, DOI 10.1097/NMD.0b013e3181cc43b5; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Small AC, 2012, CANCER-AM CANCER SOC, V118, P5947, DOI 10.1002/cncr.27658; VILLENEUVE PJ, 1994, CAN J PUBLIC HEALTH, V85, P385	21	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145715	10.1371/journal.pone.0145715	http://dx.doi.org/10.1371/journal.pone.0145715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26698307	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600122
J	Wang, MTM; Bolland, MJ; Gamble, G; Grey, A				Wang, Michael T. M.; Bolland, Mark J.; Gamble, Greg; Grey, Andrew			Media Coverage, Journal Press Releases and Editorials Associated with Randomized and Observational Studies in High-Impact Medical Journals: A Cohort Study	PLOS ONE			English	Article							RELIABLE ASSESSMENT; MAJOR MORBIDITY; LIMITATIONS; MORTALITY	Background Publication of clinical research findings in prominent journals influences health beliefs and medical practice, in part by engendering news coverage. Randomized controlled trials (RCTs) should be most influential in guiding clinical practice. We determined whether study design of clinical research published in high-impact journals influences media coverage. Methods and Findings We compared the incidence and amount of media coverage of RCTs with that of observational studies published in the top 7 medical journals between 1 January 2013 and 31 March 2013. We specifically assessed media coverage of the most rigorous RCTs, those with > 1000 participants that reported 'hard' outcomes. There was no difference between RCTs and observational studies in coverage by major newspapers or news agencies, or in total number of news stories generated (all P>0.63). Large RCTs reporting 'hard' outcomes did not generate more news coverage than small RCTs that reported surrogate outcomes and observational studies (all P>0.32). RCTs were more likely than observational studies to attract a journal editorial (70% vs 46%, P = 0.003), but less likely to be the subject of a journal press release (17% vs 50%, P<0.001). Large RCTs that reported 'hard' outcomes did not attract an editorial more frequently than other studies (61% vs 58%, P>0.99), nor were they more likely to be the subject of a journal press release (14% vs 38%, P = 0.14). Conclusions The design of clinical studies whose results are published in high-impact medical journals is not associated with the likelihood or amount of ensuing news coverage.	[Wang, Michael T. M.; Bolland, Mark J.; Gamble, Greg; Grey, Andrew] Univ Auckland, Dept Med, Auckland, New Zealand	University of Auckland	Grey, A (corresponding author), Univ Auckland, Dept Med, Private Bag 92019, Auckland, New Zealand.	a.grey@auckland.ac.nz	Wang, Michael T. M./X-4197-2019; Bolland, Mark J/A-7554-2008	Wang, Michael T. M./0000-0001-8334-3911; Bolland, Mark J/0000-0003-0465-2674	Health Research Council of New Zealand; University of Auckland	Health Research Council of New Zealand(Health Research Council of New Zealand); University of Auckland	Funding support from the Health Research Council of New Zealand and the University of Auckland. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Collins R, 2001, LANCET, V357, P373, DOI 10.1016/S0140-6736(00)03651-5; Institute of Medicine, 2010, EVALUATION BIOMARKER; Ioannidis JPA, 2007, J CLIN EPIDEMIOL, V60, P324, DOI 10.1016/j.jclinepi.2006.09.011; MacMahon S, 2001, LANCET, V357, P455, DOI 10.1016/S0140-6736(00)04017-4; PHILLIPS DP, 1991, NEW ENGL J MED, V325, P1180, DOI 10.1056/NEJM199110173251620; Prasad V, 2013, J CLIN EPIDEMIOL, V66, P361, DOI 10.1016/j.jclinepi.2012.11.005; Prasad V, 2012, JAMA-J AM MED ASSOC, V307, P37, DOI 10.1001/jama.2011.1960; Schwartz LM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8164; Schwartz LM, 2004, ANN INTERN MED, V140, P226, DOI 10.7326/0003-4819-140-3-200402030-00015; Schwitzer G, 2005, PLOS MED, V2, P576, DOI 10.1371/journal.pmed.0020215; Selvaraj S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085355; Sumner P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7015; Wang MTM, 2015, JAMA INTERN MED, V175, P1571, DOI 10.1001/jamainternmed.2015.2147; Wang MTM, 2015, JAMA INTERN MED, V175, P845, DOI 10.1001/jamainternmed.2015.0153; Yavchitz A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001308; Yudkin JS, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7995	16	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145294	10.1371/journal.pone.0145294	http://dx.doi.org/10.1371/journal.pone.0145294			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701758	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600059
J	Wiegand, SB; Heidrich, B; Susser, S; Rogalska-Taranta, M; Petersen, J; Boker, KHW; Grigorian, N; Link, R; Naumann, U; John, C; Lueth, S; Malfertheiner, P; Manns, MP; Wedemeyer, H; Sarrazin, C; Cornberg, M				Wiegand, Steffen B.; Heidrich, Benjamin; Susser, Simone; Rogalska-Taranta, Magdalena; Petersen, Joerg; Boeker, Klaus H. W.; Grigorian, Natalia; Link, Ralph; Naumann, Uwe; John, Christine; Lueth, Stefan; Malfertheiner, Peter; Manns, Michael P.; Wedemeyer, Heiner; Sarrazin, Christoph; Cornberg, Markus			Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting	PLOS ONE			English	Article							VIROLOGICAL RESPONSE; THERAPY; RIBAVIRIN; POLYMORPHISMS; FIBROSIS	Background SNPs near the interferon lambda (IFNL) 3 gene are predictors for sustained virological response (SVR) in patients with chronic hepatitis C genotype (GT) 1. In addition, a dinucleotide frame shift in ss469415590 was described, which generates IFNL4. In this study, we compared the role of IFNL4 variants with IFNL3-(rs12979860) and IFNL3-(rs8099917) on response to pegylated (PEG)-IFN and Ribavirin (RBV) in patients with chronic hepatitis C GT2/3. Methods We recruited 1006 patients with chronic hepatitis C and GT2/3 in a large German registry. A treatment with PEG-IFN and Ribavirin was started by 959 patients. We performed genotyping of IFNL3 (rs12979860, n = 726; rs8099917, n = 687) and of IFNL4 (ss469415590; n = 631). Results Both preferable IFNL3 genotypes were associated with RVR (both p<0.0001) rather than with SVR (rs12979860: p = 0.251; rs8099917: p = 0.447). Only RVR was linked to SVR in univariate and multivariate analyzes (both p<0.001). Concordance of genotyping in patients with available serum samples and EDTA blood samples (n = 259) was more than 96% for both IFNL3 SNPs. IFNL3-(rs12979860) correlated with IFNL4: 99.2% of patients with IFNL3-(rs12979860)-CC were IFNL4-(ss469415590)-TT/TT. IFNL3-(rs12979860)-CT was linked with IFNL4-(ss469415590)-TT/Delta G (98.0%) and IFNL3-(rs12979860)-TT was associated with IFNL4-(ss469415590)-Delta G/Delta G (97.6%). Conclusion IFNL3 genotyping from serum was highly efficient and can be used as an alternative if EDTA whole blood is not available. In Caucasian GT2/3 patients genotyping for INFL4(ss469415590) does not lead to additional information for the decision-making process. Importantly, IFNL3 SNPs were not associated with SVR but with RVR. Even in the era of new direct acting antiviral (DAA) therapies, IFNL3 testing may therefore still be considered for naive GT2/3 patients to decide if dual Peg-IFN/RBV therapy is an option in resource limited regions.	[Wiegand, Steffen B.; Heidrich, Benjamin; Rogalska-Taranta, Magdalena; Manns, Michael P.; Wedemeyer, Heiner; Cornberg, Markus] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Wiegand, Steffen B.; Heidrich, Benjamin; Manns, Michael P.; Wedemeyer, Heiner; Sarrazin, Christoph; Cornberg, Markus] German Liver Fdn, Hannover, Germany; [Wiegand, Steffen B.; Heidrich, Benjamin; Manns, Michael P.; Wedemeyer, Heiner; Sarrazin, Christoph; Cornberg, Markus] German Liver Fdn, Frankfurt, Germany; [Susser, Simone; Sarrazin, Christoph] Goethe Univ Frankfurt, Dept Internal Med 1, D-60054 Frankfurt, Germany; [Wiegand, Steffen B.; Heidrich, Benjamin; Manns, Michael P.; Wedemeyer, Heiner; Sarrazin, Christoph; Cornberg, Markus] German Ctr Infect Diesease DZIF, Hannover, Germany; German Ctr Infect Diesease DZIF, Hannover, Germany; [Petersen, Joerg] IFI Inst Interdisciplinary Med, Asklepios Klin St Georg, Hamburg, Germany; [Grigorian, Natalia] Univ Saarland, Dept Internal Med 2, Saarland, Germany; [Link, Ralph] St Josefs Hosp, Dept Internal Med, Clin Internal Med, Offenburg, Germany; [Naumann, Uwe] Praxiszentrum Kaiserdamm, Ctr Addict Med Hepatol & HIV, Berlin, Germany; [Lueth, Stefan] Univ Hamburg, Dept Internal Med, Hamburg, Germany; [Malfertheiner, Peter] Univ Magdeburg, Dept Gastroenterol Hepatol & Endocrinol, D-39106 Magdeburg, Germany	Hannover Medical School; Goethe University Frankfurt; German Center for Infection Research; German Center for Infection Research; Asklepios Klinik St. Georg; Saarland University; University of Hamburg; Otto von Guericke University	Cornberg, M (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.	Cornberg.Markus@mh-hannover.de	Rogalska-Taranta, Magdalena/W-5799-2019; Cornberg, Markus/AAN-6939-2021	Rogalska-Taranta, Magdalena/0000-0003-3539-3679; Cornberg, Markus/0000-0002-9141-8001; Luth, Stefan/0000-0001-9946-0960; Malfertheiner, Peter/0000-0001-8439-9036	MSD Sharp Dohme; German Liver Foundation	MSD Sharp Dohme; German Liver Foundation	This study was supported financially by MSD Sharp & Dohme (www.msd.de) and the German Liver Foundation (http://www.deutsche-leberstiftung.de). MSD had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The HepNet Study House of the German Liver Foundation was used for sample storage and data collection and had no role in study	Bochud PY, 2009, J HEPATOL, V51, P655, DOI 10.1016/j.jhep.2009.05.016; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Cornberg M, 2003, Z GASTROENTEROL, V41, P517, DOI 10.1055/s-2003-39649; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; DERITIS F, 1972, LANCET, V1, P685; Eslam M, 2014, J HEPATOL, V61, P235, DOI 10.1016/j.jhep.2014.03.039; Ferenci P, 2012, BEST PRACT RES CL GA, V26, P463, DOI 10.1016/j.bpg.2012.09.002; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Heidrich B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108751; Hiraga N, 2005, J MED VIROL, V75, P240, DOI 10.1002/jmv.20263; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Mangia A, 2010, GASTROENTEROLOGY, V139, P821, DOI 10.1053/j.gastro.2010.05.079; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Manns MP, 2013, NAT REV DRUG DISCOV, V12, P595, DOI 10.1038/nrd4050; Moghaddam A, 2011, HEPATOLOGY, V53, P746, DOI 10.1002/hep.24154; Munir S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-296; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rangnekar AS, 2013, J VIRAL HEPATITIS, V20, P377, DOI 10.1111/jvh.12039; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Sarrazin C, 2010, Z GASTROENTEROL, V48, P289, DOI 10.1055/s-0028-1110008; Sarrazin C, 2011, J HEPATOL, V54, P415, DOI 10.1016/j.jhep.2010.07.041; Sarrazin C, 2010, J HEPATOL, V52, P832, DOI 10.1016/j.jhep.2010.01.030; Stattermayer AF, 2011, CLIN GASTROENTEROL H, V9, P344, DOI 10.1016/j.cgh.2010.07.019; Stenkvist J, 2013, J VIRAL HEPATITIS, V20, P193, DOI 10.1111/j.1365-2893.2012.01645.x; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Susser S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112592; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013	30	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145622	10.1371/journal.pone.0145622	http://dx.doi.org/10.1371/journal.pone.0145622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699619	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092600107
J	Birla, BS; Chou, HH				Birla, Bhagyashree S.; Chou, Hui-Hsien			Rational Design of High-Number dsDNA Fragments Based on Thermodynamics for the Construction of Full-Length Genes in a Single Reaction	PLOS ONE			English	Article							MYCOPLASMA-GENITALIUM GENOME; CHEMICAL-SYNTHESIS; DNA-MOLECULES; PCR; EXPRESSION; SEQUENCES; YEAST; MICROARRAY	Gene synthesis is frequently used in modern molecular biology research either to create novel genes or to obtain natural genes when the synthesis approach is more flexible and reliable than cloning. DNA chemical synthesis has limits on both its length and yield, thus full-length genes have to be hierarchically constructed from synthesized DNA fragments. Gibson Assembly and its derivatives are the simplest methods to assemble multiple double-stranded DNA fragments. Currently, up to 12 dsDNA fragments can be assembled at once with Gibson Assembly according to its vendor. In practice, the number of dsDNA fragments that can be assembled in a single reaction are much lower. We have developed a rational design method for gene construction that allows high-number dsDNA fragments to be assembled into full-length genes in a single reaction. Using this new design method and a modified version of the Gibson Assembly protocol, we have assembled 3 different genes from up to 45 dsDNA fragments at once. Our design method uses the thermodynamic analysis software PICKY that identifies all unique junctions in a gene where consecutive DNA fragments are specifically made to connect to each other. Our novel method is generally applicable to most gene sequences, and can improve both the efficiency and cost of gene assembly.	[Birla, Bhagyashree S.; Chou, Hui-Hsien] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Chou, Hui-Hsien] Iowa State Univ, Dept Comp Sci, Ames, IA USA	Iowa State University; Iowa State University	Chou, HH (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	hhchou@iastate.edu			National Science Foundation [DBI-0850195]; Iowa State University Plant Sciences Institute Scholar Award	National Science Foundation(National Science Foundation (NSF)); Iowa State University Plant Sciences Institute Scholar Award	This study was supported by the National Science Foundation Grant DBI-0850195 < http://www.nsf.gov/awardsearch/showAward?AWD_ID=0850195 > and the Iowa State University Plant Sciences Institute Scholar Award < http://plantsciences.iastate.edu >. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Chou HH, 2004, BIOINFORMATICS, V20, P2893, DOI 10.1093/bioinformatics/bth347; Chou HH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-196; Chou HH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-347; CICCARELLI RB, 1991, NUCLEIC ACIDS RES, V19, P6007, DOI 10.1093/nar/19.21.6007; de Kok S, 2014, ACS SYNTH BIOL, V3, P97, DOI 10.1021/sb4001992; Dormitzer PR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006368; EDGE MD, 1983, NUCLEIC ACIDS RES, V11, P6419, DOI 10.1093/nar/11.18.6419; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2014, NATURE, V509, P168, DOI 10.1038/509168a; Gibson DG, 2010, NAT METHODS, V7, P901, DOI 10.1038/nmeth.1515; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jung KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003337; Kuijpers NGA, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-47; Ma SY, 2012, TRENDS BIOTECHNOL, V30, P147, DOI 10.1016/j.tibtech.2011.10.002; MANDECKI W, 1988, GENE, V68, P101, DOI 10.1016/0378-1119(88)90603-8; Seo YS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-99; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; SPROAT BS, 1985, NUCLEIC ACIDS RES, V13, P2959, DOI 10.1093/nar/13.8.2959; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Sutton Dennis W., 1992, Transgenic Research, V1, P228, DOI 10.1007/BF02524753; URDEA MS, 1983, P NATL ACAD SCI-BIOL, V80, P7461, DOI 10.1073/pnas.80.24.7461; Xiong AS, 2006, NAT PROTOC, V1, P791, DOI 10.1038/nprot.2006.103; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Young L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh058	29	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145682	10.1371/journal.pone.0145682	http://dx.doi.org/10.1371/journal.pone.0145682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716828	gold, Green Published			2022-12-27	WOS:000367510500057
J	Iannaccone, A; Giorgianni, F; New, DD; Hollingsworth, TJ; Umfress, A; Alhatem, AH; Neeli, I; Lenchik, NI; Jennings, BJ; Calzada, JI; Satterfield, S; Mathews, D; Diaz, RI; Harris, T; Johnson, KC; Charles, S; Kritchevsky, SB; Gerling, IC; Beranova-Giorgianni, S; Radic, MZ				Iannaccone, Alessandro; Giorgianni, Francesco; New, David D.; Hollingsworth, T. J.; Umfress, Allison; Alhatem, Albert H.; Neeli, Indira; Lenchik, Nataliya I.; Jennings, Barbara J.; Calzada, Jorge I.; Satterfield, Suzanne; Mathews, Dennis; Diaz, Rocio I.; Harris, Tamara; Johnson, Karen C.; Charles, Steve; Kritchevsky, Stephen B.; Gerling, Ivan C.; Beranova-Giorgianni, Sarka; Radic, Marko Z.		Hlth ABC Study	Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and Apoptosis	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; SUBRETINAL DRUSENOID DEPOSITS; CANCER-ASSOCIATED RETINOPATHY; ALPHA-ENOLASE AUTOANTIBODIES; FACTOR-H POLYMORPHISM; HEAT-SHOCK-RESPONSE; BRUCHS MEMBRANE; OPTICAL-DENSITY; EYE DISEASE; CHOROIDAL NEOVASCULARIZATION	Background We investigated sera from elderly subjects with and without age-related macular degeneration (AMD) for presence of autoantibodies (AAbs) against human macular antigens and characterized their identity. Methods Sera were collected from participants in the Age-Related Maculopathy Ancillary (ARMA) Study, a cross-sectional investigation ancillary to the Health ABC Study, enriched with participants from the general population. The resulting sample (mean age: 79.2 +/- 3.9 years old) included subjects with early to advanced AMD (n = 131) and controls (n = 231). Sera were tested by Western blots for immunoreactive bands against human donor macular tissue homogenates. Immunoreactive bands were identified and graded, and odds ratios (OR) calculated. Based on these findings, sera were immunoprecipitated, and subjected to 2D gel electrophoresis (GE). Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used to identify the targets recognized by circulating AAbs seen on 2D-GE, followed by ELI-SAs with recombinant proteins to confirm LC-MS/MS results, and quantify autoreactivities. Results In AMD, 11 immunoreactive bands were significantly more frequent and 13 were significantly stronger than in controls. Nine of the more frequent bands also showed stronger reactivity. OR estimates ranged between 4.06 and 1.93, and all clearly excluded the null value. Following immunoprecipitation, 2D-GE and LC-MS/MS, five of the possible autoreactivity targets were conclusively identified: two members of the heat shock protein 70 (HSP70) family, HSPA8 and HSPA9; another member of the HSP family, HSPB4, also known as alpha-crystallin A chain (CRYAA); Annexin A5 (ANXA5); and Protein S100-A9, also known as calgranulin B that, when complexed with S100A8, forms calprotectin. ELISA testing with recombinant proteins confirmed, on average, significantly higher reactivities against all targets in AMD samples compared to controls. Conclusions Consistent with other evidence supporting the role of inflammation and the immune system in AMD pathogenesis, AAbs were identified in AMD sera, including early-stage disease. Identified targets may be mechanistically linked to AMD pathogenesis because the identified proteins are implicated in autophagy, immunomodulation, and protection from oxidative stress and apoptosis. In particular, a role in autophagy activation is shared by all five autoantigens, raising the possibility that the detected AAbs may play a role in AMD via autophagy compromise and downstream activation of the inflammasome. Thus, we propose that the detected AAbs provide further insight into AMD pathogenesis and have the potential to contribute to disease biogenesis and progression.	[Iannaccone, Alessandro; New, David D.; Hollingsworth, T. J.; Umfress, Allison; Alhatem, Albert H.; Neeli, Indira; Lenchik, Nataliya I.; Jennings, Barbara J.; Calzada, Jorge I.; Diaz, Rocio I.; Charles, Steve] Univ Tennessee, Ctr Hlth Sci, Hamilton Eye Inst, Dept Ophthalmol, Memphis, TN 38163 USA; [Giorgianni, Francesco; Beranova-Giorgianni, Sarka] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Neeli, Indira; Radic, Marko Z.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Lenchik, Nataliya I.; Gerling, Ivan C.] Univ Tennessee, Ctr Hlth Sci, Dept Internal Med Endocrinol, Memphis, TN 38163 USA; [Calzada, Jorge I.; Diaz, Rocio I.; Charles, Steve] Charles Retina Inst, Memphis, TN USA; [Satterfield, Suzanne; Johnson, Karen C.; Kritchevsky, Stephen B.] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA; [Mathews, Dennis] Eye Specialty Grp, Memphis, TN USA; [Mathews, Dennis] Southern Coll Optometry, Memphis, TN USA; [Harris, Tamara] NIA, NIH, Bethesda, MD 20892 USA; [Kritchevsky, Stephen B.] Wake Forest Univ, Sticht Ctr Aging, Winston Salem, NC 27109 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Wake Forest University	Iannaccone, A (corresponding author), Univ Tennessee, Ctr Hlth Sci, Hamilton Eye Inst, Dept Ophthalmol, Memphis, TN 38163 USA.	aiannacc@yahoo.com	Hollingsworth, T.J./AAD-2814-2022	Alhatem, Albert/0000-0003-1826-6854; Radic, Marko/0000-0002-8004-282X; Iannaccone, Alessandro/0000-0001-5737-8424; Hollingsworth, T.J./0000-0002-2119-521X	National Institutes of Health/National Eye Institute [K23 EY000409, R21 EY018416, R01 EY022706]; International Retinal Research Foundation; Research to Prevent Blindness, Inc. New York, NY; University of Tennessee Health Science Center College of Pharmacy; University of Tennessee Health Science Center, Neuroscience Undergraduate Merit Fellowship Award; National Institutes of Health/National Institute on Aging, Intramural Research Program; National Institutes of Health/National Institute on AgingH [N01 AG-62101, N01 AG-62103, N01-AG-62106]; NATIONAL EYE INSTITUTE [R21EY018416, K23EY000409, R01EY022706] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); International Retinal Research Foundation; Research to Prevent Blindness, Inc. New York, NY(Research to Prevent Blindness (RPB)); University of Tennessee Health Science Center College of Pharmacy; University of Tennessee Health Science Center, Neuroscience Undergraduate Merit Fellowship Award; National Institutes of Health/National Institute on Aging, Intramural Research Program; National Institutes of Health/National Institute on AgingH; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by: National Institutes of Health/National Eye Institute grants K23 EY000409 (AI), R21 EY018416 (AI, PI; ICG and MRZ, co-investigators) and R01 EY022706 (AI, PI; MRZ, FG, ICG, and SBG, co-investigators) (https://nei.nih.gov); International Retinal Research Foundation (AI) (http://www.irrfonline.org); Research to Prevent Blindness, Inc. New York, NY (Career Development Award and Physician Scientist Award to AI and unrestricted grant to the UTHSC Hamilton Eye Institute, Memphis, TN, USA) (https://www.rpbusa.org/rpb/?); University of Tennessee Health Science Center College of Pharmacy, Intramural grant (FG and SBG) (http://www.uthsc.edu/pharmacy/); University of Tennessee Health Science Center, Neuroscience Undergraduate Merit Fellowship Award (AU) (http://www.uthsc.edu/neuroscience/); National Institutes of Health/National Institute on Aging, Intramural Research Program (TH) (https://www.nia.nih.gov). The Health ABC study was supported by: National Institutes of Health/National Institute on AgingH Contracts N01 AG-62101 (SBK, PI: SS and KCJ, co-investigators), N01 AG-62103 (SBK, PI: SS and KCJ, co-investigators), and N01-AG-62106 (Health ABC Coordinating Center) (https://www.nia.nih.gov). The Health ABC Publications Committee and the National Institute on Aging reviewed and approved the manuscript for publication before submission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamus G, 1998, J AUTOIMMUN, V11, P523, DOI 10.1006/jaut.1998.0221; Adamus G, 1997, INVEST OPHTH VIS SCI, V38, P283; Adamus G, 1998, J AUTOIMMUN, V11, P671, DOI 10.1006/jaut.1998.0239; Adamus G, 2003, AUTOIMMUN REV, V2, P63, DOI 10.1016/S1568-9972(02)00127-1; Adamus Grazyna, 2004, BMC Ophthalmol, V4, P5, DOI 10.1186/1471-2415-4-5; Adamus G, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-154; Adamus G, 2011, J OPHTHALMIC INFLAMM, V1, P111, DOI 10.1007/s12348-011-0028-8; Adamus G, 2009, J AUTOIMMUN, V32, P133, DOI 10.1016/j.jaut.2009.02.001; Adamus G, 2009, AUTOIMMUN REV, V8, P410, DOI 10.1016/j.autrev.2009.01.002; Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668; Alessandri C, 2011, AUTOIMMUN REV, V10, P609, DOI 10.1016/j.autrev.2011.04.011; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Baird PN, 2008, HUM MOL GENET, V17, P1299, DOI 10.1093/hmg/ddn018; Bakar F, 2014, J CLIN ENDOCR METAB, V99, P932, DOI 10.1210/jc.2013-2592; BERBERIAN PA, 1990, AM J PATHOL, V136, P71; Bernstein SL, 2000, INVEST OPHTH VIS SCI, V41, P2857; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Bok D, 2005, P NATL ACAD SCI USA, V102, P7053, DOI 10.1073/pnas.0502819102; Borges TJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00095; Casola C, 2015, J MOL NEUROSCI, V56, P228, DOI 10.1007/s12031-014-0485-2; Cederholm A, 2005, IMMUNOBIOLOGY, V210, P761, DOI 10.1016/j.imbio.2005.10.007; Celkova L, 2015, J CLIN MED, V4, P172, DOI 10.3390/jcm4010172; Cesaro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045478; Cherepanoff S, 2006, CLIN EXP OPHTHALMOL, V34, P590, DOI 10.1111/j.1442-9071.2006.01281.x; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Curcio CA, 2013, RETINA-J RET VIT DIS, V33, P265, DOI 10.1097/IAE.0b013e31827e25e0; Danis RP, 2013, INVEST OPHTH VIS SCI, V54, P4548, DOI 10.1167/iovs.13-11804; Davis MD, 2005, ARCH OPHTHALMOL-CHIC, V123, P1484; Decanini A, 2007, AM J OPHTHALMOL, V143, P607, DOI 10.1016/j.ajo.2006.12.006; Dhas D. B. B., 2012, Current Pediatric Research, V16, P83; Dokladny K, 2015, AUTOPHAGY, V11, P200, DOI 10.1080/15548627.2015.1009776; Dokladny K, 2013, J BIOL CHEM, V288, P14959, DOI 10.1074/jbc.M113.462408; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Ebrahem Q, 2006, P NATL ACAD SCI USA, V103, P13480, DOI 10.1073/pnas.0601552103; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ethen CM, 2007, FEBS LETT, V581, P885, DOI 10.1016/j.febslet.2007.01.061; Ferrington D., 2015, PROG RETIN EYE RES; Ferris FL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1570; FOUQUERAY B, 1992, EUR J IMMUNOL, V22, P2983, DOI 10.1002/eji.1830221133; Francis PJ, 2009, J MED GENET, V46, P300, DOI 10.1136/jmg.2008.062737; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Gallaher KT, 2007, VISION RES, V47, P1253, DOI 10.1016/j.visres.2007.01.013; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Gehrs KM, 2010, ARCH OPHTHALMOL-CHIC, V128, P349, DOI 10.1001/archophthalmol.2010.18; Ghavami S, 2010, CELL RES, V20, P314, DOI 10.1038/cr.2009.129; Ghislat G, 2012, J CELL SCI, V125, P92, DOI 10.1242/jcs.086728; Giorgianni F, 2004, ANAL CHEM, V76, P7028, DOI 10.1021/ac0493368; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Grassmann F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037979; Grus FH, 2004, MOL VIS, V10, P132; Gu JY, 2010, ADV EXP MED BIOL, V664, P411, DOI 10.1007/978-1-4419-1399-9_47; Gu JY, 2009, MOL CELL PROTEOMICS, V8, P1338, DOI 10.1074/mcp.M800453-MCP200; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Hageman Gregory S., 2011, Human Genomics, V5, P420; Hageman GS, 1999, MOL VIS, V5; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hashizume K, 2008, AM J PATHOL, V172, P1325, DOI 10.2353/ajpath.2008.070730; Hawkins BS, 1999, MOL VIS, V5; Hollyfield JG, 2003, ADV EXP MED BIOL, V533, P83; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hollyfield JG, 2010, MOL NEUROBIOL, V41, P290, DOI 10.1007/s12035-010-8110-z; Hughes AE, 2006, NAT GENET; Iaccarino L, 2011, AUTOIMMUN REV, V10, P553, DOI 10.1016/j.autrev.2011.04.007; Iannaccone A, 2007, INVEST OPHTH VIS SCI, V48, P1458, DOI 10.1167/iovs.06-0438; Iannaccone A, 2012, ADV EXP MED BIOL, V723, P11, DOI 10.1007/978-1-4614-0631-0_2; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Jablonski MM, 2001, EXP EYE RES, V72, P573, DOI 10.1006/exer.2001.0987; Jablonski MM, 2007, INVEST OPHTH VIS SCI, V48, P479, DOI 10.1167/iovs.06-0972; Jia J, 2014, CELL, V159, P623, DOI 10.1016/j.cell.2014.09.032; Joachim SC, 2007, CURR EYE RES, V32, P501, DOI 10.1080/02713680701375183; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Kaarniranta K, 2009, J MOL MED, V87, P117, DOI 10.1007/s00109-008-0418-z; Kaarniranta K, 2013, AUTOPHAGY, V9, P973, DOI 10.4161/auto.24546; Kaarniranta K, 2009, AGEING RES REV, V8, P128, DOI 10.1016/j.arr.2009.01.001; Kannan R, 2015, BIOCH BIOPHYS ACTA; Kannan R, 2012, PROG RETIN EYE RES, V31, P576, DOI 10.1016/j.preteyeres.2012.06.001; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Koike A, 2012, INFLAMMATION, V35, P409, DOI 10.1007/s10753-011-9330-8; Lechanteur YTE, 2015, JAMA OPHTHALMOL, V133, P533, DOI 10.1001/jamaophthalmol.2015.18; Lederman M, 2010, INVEST OPHTH VIS SCI, V51, P53, DOI 10.1167/iovs.08-3019; Li CS, 2009, BIOCHEM J, V422, P363, DOI 10.1042/BJ20090465; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Liu MM, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-13; Louie JL, 2002, EXP EYE RES, V75, P271, DOI 10.1006/exer.2002.2022; Magrys A, 2007, J CLIN IMMUNOL, V27, P181, DOI 10.1007/s10875-006-9065-8; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Marx J, 2006, SCIENCE, V311, P1704, DOI 10.1126/science.311.5768.1704; Matsumura Y, 2013, J BIOL CHEM, V288, P31069, DOI 10.1074/jbc.M113.479345; McGeer EG, 2005, NEUROBIOL AGING, V26, pS94, DOI 10.1016/j.neurobiolaging.2005.08.008; McGeer Patrick L, 2002, Sci Aging Knowledge Environ, V2002, pre3, DOI 10.1126/sageke.2002.29.re3; McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007; Meyers KJ, 2014, INVEST OPHTH VIS SCI, V55, P587, DOI 10.1167/iovs.13-13216; Minoia M, 2014, MOL CELL BIOL, V34, P3570, DOI 10.1128/MCB.00698-14; Morohoshi K, 2012, EXP MOL PATHOL, V93, P193, DOI 10.1016/j.yexmp.2012.03.007; Morohoshi K, 2012, EXP MOL PATHOL, V92, P64, DOI 10.1016/j.yexmp.2011.09.017; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Nakata K, 2005, EXP EYE RES, V80, P821, DOI 10.1016/j.exer.2004.12.011; Nakatani Y, 2005, MEDIAT INFLAMM, P280, DOI 10.1155/MI.2005.280; Nussenblatt RB, 2007, AM J OPHTHALMOL, V144, P618, DOI 10.1016/j.ajo.2007.06.025; Nussenblatt RB, 2009, CURR OPIN INVEST DR, V10, P434; Ohguro H, 1999, INVEST OPHTH VIS SCI, V40, P3160; Pabst MJ, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-13; Patel M, 2008, SEMIN IMMUNOPATHOL, V30, P97, DOI 10.1007/s00281-008-0112-9; Patel N, 2005, IMMUNOLOGY, V115, P422, DOI 10.1111/j.1365-2567.2005.02173.x; PENFOLD P, 1984, AUST J OPHTHALMOL, V12, P23; PENFOLD PL, 1987, GRAEF ARCH CLIN EXP, V225, P70, DOI 10.1007/BF02155808; PENFOLD PL, 1986, INVEST OPHTH VIS SCI, V27, P364; PENFOLD PL, 1985, GRAEF ARCH CLIN EXP, V223, P69, DOI 10.1007/BF02150948; PENFOLD PL, 1990, GRAEF ARCH CLIN EXP, V228, P270, DOI 10.1007/BF00920033; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Petrukhin K, 2007, EXPERT OPIN THER TAR, V11, P625, DOI 10.1517/14728222.11.5.625; Philip LP, 2004, JAMA-J AM MED ASSOC, V292, P43, DOI 10.1001/jama.292.1.43-a; Postel EA, 2006, OPHTHALMOLOGY, V113, P1504, DOI 10.1016/j.ophtha.2006.02.049; Rayborn ME, 2006, ADV EXP MED BIOL, V572, P75; Ren GY, 2004, J AUTOIMMUN, V23, P161, DOI 10.1016/j.jaut.2004.06.003; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; Rudolf M, 2008, EXP EYE RES, V87, P402, DOI 10.1016/j.exer.2008.07.010; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Ryhanen T, 2009, J CELL MOL MED, V13, P3616, DOI 10.1111/j.1582-4934.2008.00577.x; Saraswathy S, 2010, INVEST OPHTH VIS SCI, V51, P3680, DOI 10.1167/iovs.09-4575; Schaumberg DA, 2014, JAMA OPHTHALMOL, V132, P84, DOI 10.1001/jamaophthalmol.2013.5506; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; Sepp T, 2006, INVEST OPHTH VIS SCI, V47, P536, DOI 10.1167/iovs.05-1143; Shiraga S, 2002, J NEUROIMMUNOL, V132, P72, DOI 10.1016/S0165-5728(02)00314-4; Simard JC, 2011, J IMMUNOL, V186, P3622, DOI 10.4049/jimmunol.1002956; Skeie JM, 2014, JAMA OPHTHALMOL, V132, P1271, DOI 10.1001/jamaophthalmol.2014.2065; Spencer KL, 2008, HUM MOL GENET, V17, P1821, DOI 10.1093/hmg/ddn075; Spencer KL, 2008, HUM MOL GENET, V17, P971, DOI 10.1093/hmg/ddm369; Spencer KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017784; Sreekumar PG, 2013, INVEST OPHTH VIS SCI, V54, P2787, DOI 10.1167/iovs.12-11571; Stone EM, 2015, JAMA OPHTHALMOL, V133, P598, DOI 10.1001/jamaophthalmol.2015.0369; Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212; Tahiri F, 2008, HEPATOLOGY, V47, P937, DOI 10.1002/hep.22149; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Thanos S, 2014, PROG RETIN EYE RES, V42, P145, DOI 10.1016/j.preteyeres.2014.06.004; Tulapurkar ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118010; Tuo JS, 2012, OCUL IMMUNOL INFLAMM, V20, P27, DOI 10.3109/09273948.2011.628432; Umeda S, 2005, FASEB J, V19, P1683, DOI 10.1096/fj.04-3525fje; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Vishwanathan R, 2014, AGE AGEING, V43, P271, DOI 10.1093/ageing/aft210; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Yao JY, 2015, AUTOPHAGY, V11, P939, DOI 10.1080/15548627.2015.1041699; Yaung J, 2007, MOL VIS, V13, P566; Yu Y, 2012, INVEST OPHTH VIS SCI, V53, P1548, DOI 10.1167/iovs.11-8657; Yuan XL, 2010, MOL CELL PROTEOMICS, V9, P1031, DOI 10.1074/mcp.M900523-MCP200; Zetterstrom P, 2011, J BIOL CHEM, V286, P20130, DOI 10.1074/jbc.M111.218842; Zigler JS, 2011, J CELL SCI, V124, P523, DOI 10.1242/jcs.078790; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P303, DOI 10.1016/j.ophtha.2009.07.014	155	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145323	10.1371/journal.pone.0145323	http://dx.doi.org/10.1371/journal.pone.0145323			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717306	Green Submitted, gold, Green Published			2022-12-27	WOS:000367510500028
J	Maeda, M; Shimada, T; Ishihama, A				Maeda, Michihisa; Shimada, Tomohiro; Ishihama, Akira			Strength and Regulation of Seven rRNA Promoters in Escherichia coli	PLOS ONE			English	Article							POLYMERASE ALPHA-SUBUNIT; AMINO-ACID-SEQUENCE; NUCLEOTIDE-SEQUENCE; DNA-BINDING; TRANSCRIPTION; UPSTREAM; GROWTH; MODULATION; ACTIVATION; EXPRESSION	The model prokaryote Escherichia coli contains seven copies of the rRNA operon in the genome. The presence of multiple rRNA operons is an advantage for increasing the level of ribosome, the key apparatus of translation, in response to environmental conditions. The complete sequence of E. coli genome, however, indicated the micro heterogeneity between seven rRNA operons, raising the possibility in functional heterogeneity and/or differential mode of expression. The aim of this research is to determine the strength and regulation of the promoter of each rRNA operon in E. coli. For this purpose, we used the double-fluorescent protein reporter pBRP system that was developed for accurate and precise determination of the promoter strength of protein-coding genes. For application of this promoter assay vector for measurement of the rRNA operon promoters devoid of the signal for translation, a synthetic SD sequence was added at the initiation codon of the reporter GFP gene, and then approximately 500 bp-sequence upstream each 16S rRNA was inserted in front of this SD sequence. Using this modified pGRS system, the promoter activity of each rrn operon was determined by measuring the rrn promoter-directed GFP and the reference promoter-directed RFP fluorescence, both encoded by a single and the same vector. Results indicated that: the promoter activity was the highest for the rrnE promoter under all growth conditions analyzed, including different growth phases of wild-type E. coli grown in various media; but the promoter strength of other six rrn promoters was various depending on the culture conditions. These findings altogether indicate that seven rRNA operons are different with respect to the regulation mode of expression, conferring an advantage to E. coli through a more fine-tuned control of ribosome formation in a wide range of environmental situations. Possible difference in the functional role of each rRNA operon is also discussed.	[Maeda, Michihisa] Meiji Univ, Fac Agr Chem, Kawasaki, Kanagawa 2148571, Japan; [Shimada, Tomohiro] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan; [Shimada, Tomohiro; Ishihama, Akira] Hosei Univ, Res Ctr Micronano Technol, Koganei, Tokyo 1848584, Japan	Meiji University; Tokyo Institute of Technology; Hosei University	Ishihama, A (corresponding author), Hosei Univ, Res Ctr Micronano Technol, Koganei, Tokyo 1848584, Japan.	aishiham@hosei.ac.jp	Shimada, Tomohiro/E-7660-2014	Shimada, Tomohiro/0000-0002-8361-0730	MEXT [21241047, 18310133, 25430173, 24710214, 208-2012 (S0801037)]; Research Fund from IFO (Institute for Fermentation, Osaka); MEXT Cooperative Research Program of Network Joint Research Center for Materials and Devices	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Fund from IFO (Institute for Fermentation, Osaka); MEXT Cooperative Research Program of Network Joint Research Center for Materials and Devices	This work was supported by the MEXT Grants-in-Aid for Scientific Research (A) (21241047), (B) (18310133) and (C) (25430173) to AI, MEXT Grant-in-Aid for Young Scientists (B) (24710214) to TS, Research Fund from IFO (Institute for Fermentation, Osaka) to TS, MEXT Cooperative Research Program of Network Joint Research Center for Materials and Devices to TS and AI, MEXT-Supported Program for the Strategic Research Foundation at Private Universities 208-2012 (S0801037) to AI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; ARAI K, 1980, P NATL ACAD SCI-BIOL, V77, P1326, DOI 10.1073/pnas.77.3.1326; Asai T, 1999, J BACTERIOL, V181, P3803, DOI 10.1128/JB.181.12.3803-3809.1999; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bokal AJ, 1997, EMBO J, V16, P154, DOI 10.1093/emboj/16.1.154; BRADSHAW RA, 1981, P NATL ACAD SCI-BIOL, V78, P3473, DOI 10.1073/pnas.78.6.3473; Bremer H, 1996, ESCHERICHIA COLI SAL; CARBON P, 1979, EUR J BIOCHEM, V100, P399, DOI 10.1111/j.1432-1033.1979.tb04183.x; CASHEL M, 1970, J BIOL CHEM, V245, P2309; CONDON C, 1995, J BACTERIOL, V177, P4152, DOI 10.1128/jb.177.14.4152-4156.1995; CONDON C, 1993, EMBO J, V12, P4305, DOI 10.1002/j.1460-2075.1993.tb06115.x; CONDON C, 1992, EMBO J, V11, P4175, DOI 10.1002/j.1460-2075.1992.tb05511.x; Dennis PP, 2004, MICROBIOL MOL BIOL R, V68, P639, DOI 10.1128/MMBR.68.4.639-668.2004; ELLWOOD M, 1982, J BACTERIOL, V149, P458, DOI 10.1128/JB.149.2.458-468.1982; FURANO AV, 1975, P NATL ACAD SCI USA, V72, P4780, DOI 10.1073/pnas.72.12.4780; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; GOSINK KK, 1993, J BACTERIOL, V175, P1580, DOI 10.1128/JB.175.6.1580-1589.1993; Gourse RL, 1996, ANNU REV MICROBIOL, V50, P645, DOI 10.1146/annurev.micro.50.1.645; Gralla JD, 2005, MOL MICROBIOL, V55, P973, DOI 10.1111/j.1365-2958.2004.04455.x; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; Gyorfy Z, 2015, NUCLEIC ACIDS RES, V43, P1783, DOI 10.1093/nar/gkv040; HARVEY S, 1988, J BACTERIOL, V170, P1235, DOI 10.1128/jb.170.3.1235-1238.1988; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Hillebrand A, 2005, BIOL CHEM, V386, P523, DOI 10.1515/BC.2005.062; Hirvonen CA, 2001, J BACTERIOL, V183, P6305, DOI 10.1128/JB.183.21.6305-6314.2001; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Ishihama A, 1999, GENES CELLS, V4, P135, DOI 10.1046/j.1365-2443.1999.00247.x; Ishihama A, 1999, J BIOL CHEM, V274, P33105, DOI DOI 10.1074/JBC.274.46; Ishihama A, 2009, ECOSAL ESCNERICNIA C; Ishihama A, 2014, J BACTERIOL, V196, P2718, DOI 10.1128/JB.01579-14; Jain V, 2006, J MICROBIOL, V44, P1; Jin DJ, 2012, FEMS MICROBIOL REV, V36, P269, DOI 10.1111/j.1574-6976.2011.00279.x; Jinks-Robertson S., 1987, ESCHERICHIA COLI SAL, P1358; Jishage M, 1997, J BACTERIOL, V179, P959, DOI 10.1128/jb.179.3.959-963.1997; Keener J, 1996, ESCHERICHIA COLI SAL, V2, P1417; KELLEY PM, 1973, BIOCHEMISTRY-US, V12, P3499, DOI 10.1021/bi00742a023; KJELDGAARD NO, 1958, J GEN MICROBIOL, V19, P607, DOI 10.1099/00221287-19-3-607; Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4; LEIRMO S, 1991, J MOL BIOL, V220, P555, DOI 10.1016/0022-2836(91)90100-K; Liang ST, 1999, J MOL BIOL, V292, P19, DOI 10.1006/jmbi.1999.3056; Murakami K, 1997, P NATL ACAD SCI USA, V94, P1709, DOI 10.1073/pnas.94.5.1709; Murakami K, 1996, EMBO J, V15, P4358, DOI 10.1002/j.1460-2075.1996.tb00809.x; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; NOMURA M, 1977, ANNU REV GENET, V11, P297, DOI 10.1146/annurev.ge.11.120177.001501; Ogasawara H, 2007, J BACTERIOL, V189, P4791, DOI 10.1128/JB.00319-07; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; Paul BJ, 2004, ANNU REV GENET, V38, P749, DOI 10.1146/annurev.genet.38.072902.091347; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; PLASKON RR, 1987, NUCLEIC ACIDS RES, V15, P785, DOI 10.1093/nar/15.2.785; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; Ross W, 2001, GENE DEV, V15, P491, DOI 10.1101/gad.870001; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; SHEN WF, 1982, NUCLEIC ACIDS RES, V10, P3303, DOI 10.1093/nar/10.10.3303; Shimada T, 2005, GENES CELLS, V10, P907, DOI 10.1111/j.1365-2443.2005.00888.x; Shimada T, 2004, J BACTERIOL, V186, P7112, DOI 10.1128/JB.186.21.7112-7122.2004; Shimada T, 2011, MOL MICROBIOL, V82, P378, DOI 10.1111/j.1365-2958.2011.07818.x; Toulokhonov II, 2001, J BIOL CHEM, V276, P1220, DOI 10.1074/jbc.M007184200; Wada A, 1998, GENES CELLS, V3, P203, DOI 10.1046/j.1365-2443.1998.00187.x; Wilson DN, 2007, CRIT REV BIOCHEM MOL, V42, P187, DOI 10.1080/10409230701360843; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Yasuno K, 2001, J MOL BIOL, V306, P213, DOI 10.1006/jmbi.2000.4369; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	64	26	29	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0144697	10.1371/journal.pone.0144697	http://dx.doi.org/10.1371/journal.pone.0144697			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717514	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500013
J	Nijman, V; Spaan, D; Nekaris, KAI				Nijman, Vincent; Spaan, Denise; Nekaris, K. Anne-Isola			Large-Scale Trade in Legally Protected Marine Mollusc Shells from Java and Bali, Indonesia	PLOS ONE			English	Article							INTERNATIONAL-TRADE; GROWTH	Background Tropical marine molluscs are traded globally. Larger species with slow life histories are under threat from over-exploitation. We report on the trade in protected marine mollusc shells in and from Java and Bali, Indonesia. Since 1987 twelve species of marine molluscs are protected under Indonesian law to shield them from overexploitation. Despite this protection they are traded openly in large volumes. Methodology/Principal Findings We collected data on species composition, origins, volumes and prices at two large open markets (2013), collected data from wholesale traders (2013), and compiled seizure data by the Indonesian authorities (2008-2013). All twelve protected species were observed in trade. Smaller species were traded for <USD1.00 whereas prices of larger species were USD15.00-40.00 with clear price-size relationships. Some shells were collected locally in Java and Bali, but the trade involves networks stretching hundreds of kilometres throughout Indonesia. Wholesale traders offer protected marine mollusc shells for the export market by the container or by the metric ton. Data from 20 confiscated shipments show an on-going trade in these molluscs. Over 42,000 shells were seized over a 5-year period, with a retail value of USD700,000 within Indonesia; horned helmet (Cassis cornuta) (>32,000 shells valued at USD500,000), chambered nautilus (Nautilus pompilius) (>3,000 shells, USD60,000) and giant clams (Tridacna spp.) (>2,000 shells, USD45,000) were traded in largest volumes. Two-thirds of this trade was destined for international markets, including in the USA and Asia-Pacific region. Conclusions/Significance We demonstrated that the trade in protected marine mollusc shells in Indonesia is not controlled nor monitored, that it involves large volumes, and that networks of shell collectors, traders, middlemen and exporters span the globe. This impedes protection of these species on the ground and calls into question the effectiveness of protected species management in Indonesia; solutions are unlikely to be found only in Indonesia and must involve the cooperation of importing countries.	[Nijman, Vincent; Spaan, Denise; Nekaris, K. Anne-Isola] Oxford Brookes Univ, Oxford Wildlife Trade Res Grp, Oxford OX3 0BP, England; [Spaan, Denise] Univ Veracruz, Inst Neuroethol, Xalapa, Veracruz, Mexico	Oxford Brookes University; Universidad Veracruzana	Nijman, V (corresponding author), Oxford Brookes Univ, Oxford Wildlife Trade Res Grp, Oxford OX3 0BP, England.	vnijman@brookes.ac.uk	Spaan, Denise/AAH-5727-2021; Nijman, Vincent/AHD-8685-2022	Spaan, Denise/0000-0002-6876-1194; Nijman, Vincent/0000-0002-5600-4276	Leverhulme Trust [RPG-084]; Cleveland Zoo Asian Seed Fund; Dierenpark Amersfoort; Mohamed bin Zayed Species Conservation Fund	Leverhulme Trust(Leverhulme Trust); Cleveland Zoo Asian Seed Fund; Dierenpark Amersfoort; Mohamed bin Zayed Species Conservation Fund	Funding provided by Leverhulme Trust (RPG-084, http://www.leverhulme.ac.uk/), the Cleveland Zoo Asian Seed Fund (http://www.clemetzoo.com/conservation/grants/), Dierenpark Amersfoort (http://www.dierenparkamersfoort.nl/), and Mohamed bin Zayed Species Conservation Fund (http://www.speciesconservation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, SURABAYA PAGI   0314; [Anonymous], 2008, BKSDA SITA RATUSAN K; [Anonymous], 2008, KENDARI POS     0130; [Anonymous], 2009, POLHUT BANDARA NGURA; [Anonymous], 2005, ANTARA NEWS     0801; [Anonymous], 2012, SURABAYA TRIBUN 0619; [Anonymous], 2009, ELSHINTA        0428; [Anonymous], 2011, SURABAYA PAGI   0702; [Anonymous], 2009, BAUNGCAMP; [Anonymous], 2013, SURBAYA TRIBUNE 0808; Arifin Z, 1998, P N PAC S INV STOCK, P401; Barord GJ., 2014, CEPHALOPOD CULTURE, Veds, P165; BECKVAR N, 1981, AQUACULTURE, V24, P21, DOI 10.1016/0044-8486(81)90040-5; Bostock J, 2010, PHILOS T R SOC B, V365, P2897, DOI 10.1098/rstb.2010.0170; Burhanuddin, 1997, ACIAR PROC, P14; Butcher John., 2004, CLOSING FRONTIER HIS; CITES, 1994, INCL GIANT TRIT CHAR; CITES, 2005, NOT 2005 035; CITES, 2006, 102 CITES AC22; Claassen C., 1998, SHELLS; De Angelis P, 2012, GEOBIOS-LYON, V45, P5, DOI 10.1016/j.geobios.2011.11.005; Dianti T, 2010, JURNAL NASIONAL 1213; Dias TLP, 2011, BIODIVERS CONSERV, V20, P2393, DOI 10.1007/s10531-011-9991-5; Dunstan A, 2010, FISH RES, V106, P239, DOI 10.1016/j.fishres.2010.06.015; Dunstan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016716; Dunstan AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016312; Faidi, 2009, WARTA BEA CUKAI, V420, P27; Floren A.S., 2003, PHILIPPINE SHELL IND; Gibbons E., 2011, CURIO TRADE SW MADAG; Gossling S, 2004, BIODIVERS CONSERV, V13, P2623, DOI 10.1007/s10531-004-2139-0; Istanto, 2009, STAT BALAI KONSERVAS; Istanto, 2010, STAT BALAI KONSERVAS; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Lee CL, 1997, ACIAR PROC, P38; Nijman V., 2012, TRAFFIC B, V24, P49; Nijman Vincent, 2014, Traffic Bulletin, V26, P31; Noerjito M., 2001, JENIS JENIS HAYATI Y; Panggabean L.J.G.L., 2006, MARINE RES INDONESIA, V31, P13, DOI [10.14203/mri.v31i0.425, DOI 10.14203/MRI.V31I0.425]; Phelps J, 2010, SCIENCE, V330, P1752, DOI 10.1126/science.1195558; Rustam, 2009, KABAR INDONESIA 0129; Salamanca A.M., 1996, Traffic Bulletin, V16, P61; Shepherd C.R., 2007, OVERVIEW REGULATION; Sinaga A, 2013, RADIO REPUBLIK  0613; Soehartono T, 2002, CITES IMPLEMENTATION; Taylor John D., 2003, P217; USFWS, 2013, NAUT; Wabnitz C., 2003, OCEAN AQUARIUM GLOBA; Ward PD, 1997, J PALEONTOL, V71, P1054, DOI 10.1017/S0022336000036039; Wells S.M., 1983, IUCN INVERTEBRATE RE, P97; WELLS SM, 1991, COAST MANAGE, V19, P135, DOI 10.1080/08920759109362135; Whitten Tony., 1996, ECOLOGY JAVA BALI; Wibowo KS, 2007, TEMPO; Wibowo S., 1990, FAO Fisheries Report, P214; YAMAGUCHI M, 1975, OECOLOGIA, V20, P321, DOI 10.1007/BF00345522	54	17	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0140593	10.1371/journal.pone.0140593	http://dx.doi.org/10.1371/journal.pone.0140593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717021	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500002
J	Ruiz, M; Bottle, A; Long, S; Aylin, P				Ruiz, Milagros; Bottle, Alex; Long, Susannah; Aylin, Paul			Multi-Morbidity in Hospitalised Older Patients: Who Are the Complex Elderly?	PLOS ONE			English	Article							UNITED-STATES; CARE; PREVALENCE; MULTIMORBIDITY; OUTCOMES; FRAILTY	Background No formal definition for the "complex elderly" exists; moreover, these older patients with high levels of multi-morbidity are not readily identified as such at point of hospitalisation, thus missing a valuable opportunity to manage the older patient appropriately within the hospital setting. Objectives To empirically identify the complex elderly patient based on degree of multi-morbidity. Design Retrospective observational study using administrative data. Setting English hospitals during the financial year 2012-13. Subjects All admitted patients aged 65 years and over. Methods By using exploratory analysis (correspondence analysis) we identify multi-morbidity groups based on 20 target conditions whose hospital prevalence was >= 1%. Results We examined a total of 2788900 hospital admissions. Multi-morbidity was highly prevalent, 62.8% had 2 or more of the targeted conditions while 4.7% had six or more. Multi-morbidity increased with age from 56% (65-69yr age-groups) up to 67% (80-84yr age-group). The average multi-morbidity was 3.2 +/- 1.2 (SD). Correspondence analysis revealed 3 distinct groups of older patients. Group 1 (multi-morbidity <= 2), associated with cancer and/or metastasis; Group 2 (multi-morbidity of 3, 4 or 5), associated with chronic pulmonary disease, lung disease, rheumatism and osteoporosis; finally Group 3 with the highest level of multi-morbidity (>= 6) and associated with heart failure, cerebrovascular accident, diabetes, hypertension and myocardial infarction. Conclusions By using widely available hospital administrative data, we propose patients in Groups 2 and 3 to be identified as the complex elderly. Identification of multi-morbidity patterns can help to predict the needs of the older patient and improve resource provision.	[Ruiz, Milagros; Bottle, Alex; Aylin, Paul] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, Dr Foster Unit Imperial, London W6 6RP, England; [Long, Susannah] Univ London Imperial Coll Sci Technol & Med, Dept Med Elderly, London W2 1NY, England	Imperial College London; Imperial College London	Ruiz, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, Dr Foster Unit Imperial, Reynolds Bldg,St Dunstans Rd, London W6 6RP, England.	m.ruiz@imperial.ac.uk		Aylin, Paul/0000-0003-4589-1743; Ruiz, Milagros/0000-0003-2265-2889	NIHR Biomedical Research Centre; Dr Foster Intelligence (an independent health service research organisation)	NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Dr Foster Intelligence (an independent health service research organisation)	The Dr Foster Unit at Imperial is affiliated with the National Institute for Health Research (NIHR) Imperial Patient Safety Translational Research Centre. The NIHR Imperial Patient Safety Translational Research Centre is a partnership between the Imperial College Healthcare NHS Trust and Imperial College London. The Dr Foster Unit at Imperial is grateful for support from the NIHR Biomedical Research Centre funding scheme. The Unit is largely funded by a research grant from Dr Foster Intelligence (an independent health service research organisation).	Bates C, 1 NATL FRAILTY WORKS; Bottle A, 2013, HEALTH SERV RES, V48, P2081, DOI 10.1111/1475-6773.12074; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Cornwell J., CONTINUITY CARE OLDE; de Jonge P, 2006, MED CLIN N AM, V90, P679, DOI 10.1016/j.mcna.2006.04.005; DeCoster C, 1997, CAN MED ASSOC J, V157, P889; Fortin M, 2006, QUAL LIFE RES, V15, P83, DOI 10.1007/s11136-005-8661-z; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Garcia-Olmos L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032141; Goodwin N., 2013, COORDINATED CARE PEO; Heath H, 2009, INT J OLDER PEOPLE N, V4, P120, DOI 10.1111/j.1748-3743.2009.00165.x; Huyse FJ, 2001, PSYCHOSOMATICS, V42, P222, DOI 10.1176/appi.psy.42.3.222; Ko DT, 2007, CIRCULATION, V115, P196, DOI 10.1161/CIRCULATIONAHA.106.657601; Luck J, 2007, J GEN INTERN MED, V22, P396, DOI 10.1007/s11606-007-0293-2; Mazzella F, 2010, ARCH GERONTOL GERIAT, V51, P323, DOI 10.1016/j.archger.2010.01.011; Oliver D., MAKING OUR HLTH CARE; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Safford MM, 2007, J GEN INTERN MED, V22, P382, DOI 10.1007/s11606-007-0307-0; Schafer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014060; Schneider KM, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-82; Schram MT, 2008, J CLIN EPIDEMIOL, V61, P1104, DOI 10.1016/j.jclinepi.2007.11.021; Stiefel FC, 2006, MED CLIN N AM, V90, P713, DOI 10.1016/j.mcna.2006.05.006; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Vance Jenny, 2005, Emerg Med Australas, V17, P382, DOI 10.1111/j.1742-6723.2005.00761.x; Winstone K, 2015, LATER LIFE UK; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; World Health Organization, AGEING	30	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145372	10.1371/journal.pone.0145372	http://dx.doi.org/10.1371/journal.pone.0145372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716440	gold, Green Submitted, Green Published			2022-12-27	WOS:000367510500031
J	Monteiro, JGD; Torres, DDC; da Silva, MCFC; Ramos, TMD; Alves, ML; Nunes, WJ; Damasceno, EP; Brunet, AF; Bittencourt, MS; Pedrosa, RP; Sobral, DC				de Moura Monteiro Junior, Jose Gildo; Cipriano Torres, Dilenia de Oliveira; Freire Clementino da Silva, Maria Cleide; de Brito Ramos, Tadzia Maria; Alves, Marilene Leite; Nunes Filho, Wellington Jorge; Damasceno, Edgar Paulo; Brunet, Antonio Fernandes; Bittencourt, Marcio Sommer; Pedrosa, Rodrigo Pinto; Sobral Filho, Dario Celestino			Nucleated Red Blood Cells as Predictors of All-Cause Mortality in Cardiac Intensive Care Unit Patients: A Prospective Cohort Study	PLOS ONE			English	Article							ASSOCIATION	Background The presence of nucleated red blood cells (NRBCs) in the peripheral blood of critically ill patients is associated with a poorer prognosis, though data on cardiovascular critical care patients is lacking. The aim of the present study was to assess the role of NRBCs as a predictor of intensive care unit (ICU) and in hospital all-cause mortality among cardiologic patients. Methods NRBCs were measured daily in consecutive cardiac ICU patients, including individuals with both coronary and non-coronary acute cardiac care. We excluded patients younger than 18 years, with cancer or hematological disease, on glucocorticoid therapy, those that were readmitted after hospital discharge and patients who died in the first 24 hours after admission. We performed a multiple logistic analysis to identify independent predictors of mortality. Results We included 152 patients (60.6 +/- 16.8 years, 51.8% female, median ICU stay of 7 [4-11] days). The prevalence of NRBCs was 54.6%(83/152). The presence of NRBC was associated with a higher ICU mortality (49.4% vs 21.7%, P<0.001) as well as in-hospital mortality (61.4% vs 33.3%, p = 0.001). NRBC were equally associated with mortality among coronary disease (64.71% vs 32.5%[OR 3.80; 95% CI: 1.45-10.0; p = 0.007]) and non-coronary disease patients (61.45% vs 33.3% [OR 3.19; 95% CI: 1.63-6.21; p<0.001]). In a multivariable model, the inclusion of NRBC to the APACHE II score resulted in a significant improvement in the discrimination (p = 0.01). Conclusions NRBC are predictors of all-cause in-hospital mortality in patients admitted to a cardiac ICU. This predictive value is independent and complementary to the well validated APACHE II score.	[de Moura Monteiro Junior, Jose Gildo; Nunes Filho, Wellington Jorge; Damasceno, Edgar Paulo; Brunet, Antonio Fernandes; Pedrosa, Rodrigo Pinto; Sobral Filho, Dario Celestino] Univ Pernambuco UPE, PROCAPE Pernambuco Cardiac Emergency Hosp, Coronary Care Unit, Recife, PE, Brazil; [Cipriano Torres, Dilenia de Oliveira; Freire Clementino da Silva, Maria Cleide; de Brito Ramos, Tadzia Maria; Alves, Marilene Leite] Univ Pernambuco, Lab PROCAPE, Recife, PE, Brazil; [Bittencourt, Marcio Sommer] Univ Sao Paulo, Ctr Clin & Epidemiol Res, Sao Paulo, Brazil	Universidade de Pernambuco (UPE); Universidade de Pernambuco (UPE); Universidade de Sao Paulo	Monteiro, JGD (corresponding author), Univ Pernambuco UPE, PROCAPE Pernambuco Cardiac Emergency Hosp, Coronary Care Unit, Recife, PE, Brazil.	jgildojunior@uol.com.br	Bittencourt, Marcio Sommer/C-1444-2011; Filho, Dario Sobral/H-8624-2019; Pedrosa, Rodrigo P/G-4593-2013; de Moura Monteiro Júnior, José Gildo/R-3977-2017	Bittencourt, Marcio Sommer/0000-0002-3711-1754; Filho, Dario Sobral/0000-0002-5301-7741; de Moura Monteiro Júnior, José Gildo/0000-0002-8983-8744				Azab B, 2010, AM J CARDIOL, V106, P470, DOI 10.1016/j.amjcard.2010.03.062; Danise P, 2012, CLIN CHEM LAB MED, V50, P357, DOI 10.1515/CCLM.2011.766; De Labriolle A, 2010, EUR HEART J, V31, P1079, DOI 10.1093/eurheartj/ehp594; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Desai S, 2012, SURG INFECT, V13, P360, DOI 10.1089/sur.2011.089; Fraker TD, 2007, J AM COLL CARDIOL, V50, P2264, DOI [10.1016/j.jacc.2007.08.002, 10.1161/CIRCULATIONAHA.107.187930]; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kuert S, 2011, CLIN CHEM LAB MED, V49, P257, DOI 10.1515/CCLM.2011.041; Nakul-Aquaronne D, 2003, J CLIN LAB ANAL, V17, P113, DOI 10.1002/jcla.10083; Nunez J, 2010, CORONARY ARTERY DIS, V21, P1, DOI 10.1097/MCA.0b013e328332ee15; Pipitone S, 2012, CLIN CHEM LAB MED, V50, P1857, DOI 10.1515/cclm-2012-0148; Rogers HM, 2008, EXP HEMATOL, V36, P17, DOI 10.1016/j.exphem.2007.08.014; Shah R, 2012, AM J SURG, V203, P343, DOI 10.1016/j.amjsurg.2011.10.002; Stachon A, 2005, SHOCK, V24, P34, DOI 10.1097/01.shk.0000164693.11649.91; Stachon A, 2004, CLIN CHEM LAB MED, V42, P933, DOI 10.1515/CCLM.2004.151; Stachon A, 2007, CRIT CARE, V11, DOI 10.1186/cc5932; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	18	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144259	10.1371/journal.pone.0144259	http://dx.doi.org/10.1371/journal.pone.0144259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713613	gold, Green Published, Green Submitted			2022-12-27	WOS:000367481900006
J	Lu, YH; Li, XP; Mesfioui, R; Bauer, JE; Chambers, RM; Canuel, EA; Hatcher, PG				Lu, YueHan; Li, Xiaping; Mesfioui, Rajaa; Bauer, James E.; Chambers, R. M.; Canuel, Elizabeth A.; Hatcher, Patrick G.			Use of ESI-FTICR-MS to Characterize Dissolved Organic Matter in Headwater Streams Draining Forest-Dominated and Pasture-Dominated Watersheds	PLOS ONE			English	Article							RESOLUTION MASS-SPECTROMETRY; BLACK CARBON; LAND-USE; MOLECULAR CHARACTERIZATION; PHOTOCHEMICAL DEGRADATION; ELECTROSPRAY; BIOAVAILABILITY; SOILS; SPECTRA; MARINE	Electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry (ESI-FTICR-MS) has proven to be a powerful technique revealing complexity and diversity of natural DOM molecules, but its application to DOM analysis in grazing-impacted agricultural systems remains scarce. In the present study, we presented a case study of using ESI-FTICR-MS in analyzing DOM from four headwater streams draining forest-or pasture-dominated watersheds in Virginia, USA. In all samples, most formulas were CHO compounds (71.8-87.9%), with other molecular series (CHOS, CHON, CHONS, and CHOP (N, S)) accounting for only minor fractions. All samples were dominated by molecules falling in the lignin-like region (H/C = 0.7-1.5, O/C = 0.1-0.67), suggesting the predominance of allochthonous, terrestrial plant-derived DOM. Relative to the two pasture streams, DOM formulas in the two forest streams were more similar, based on Jaccard similarity coefficients and nonmetric multidimensional scaling calculated from Bray-Curtis distance. Formulas from the pasture streams were characterized by lower proportions of aromatic formulas and lower unsaturation, suggesting that the allochthonous versus autochthonous contributions of organic matter to streams were modified by pasture land use. The number of condensed aromatic structures (CAS) was higher for the forest streams, which is possibly due to the controlled burning in the forest-dominated watersheds and suggests that black carbon was mobilized from soils to streams. During 15-day biodegradation experiments, DOM from the two pasture streams was altered to a greater extent than DOM from the forest streams, with formulas with H/C and O/C ranges similar to protein (H/C = 1.5-2.2, O/C = 0.3-0.67), lipid (H/C = 1.5-2.0, O/C = 0-0.3), and unsaturated hydrocarbon (H/C = 0.7-1.5, O/C = 0-0.1) being the most bioreactive groups. Aromatic compound formulas including CAS were preferentially removed during combined light+bacterial incubations, supporting the contention that black carbon is labile to light alterations. Collectively, our data demonstrate that head-water DOM composition contains integrative information on watershed sources and processes, and the application of ESI-FTICR-MS technique offers additional insights into compound composition and reactivity unrevealed by fluorescence and stable carbon isotopic measurements.	[Lu, YueHan; Li, Xiaping] Univ Alabama, Dept Geol Sci, Tuscaloosa, AL 35401 USA; [Mesfioui, Rajaa; Hatcher, Patrick G.] Old Dominion Univ, Dept Chem & Biochem, Norfolk, VA USA; [Bauer, James E.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Aquat Biogeochem Lab, Columbus, OH 43210 USA; [Chambers, R. M.] Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA; [Canuel, Elizabeth A.] Virginia Inst Marine Sci, Dept Phys Sci, Gloucester Point, VA 23062 USA	University of Alabama System; University of Alabama Tuscaloosa; Old Dominion University; University System of Ohio; Ohio State University; William & Mary; William & Mary; Virginia Institute of Marine Science	Lu, YH (corresponding author), Univ Alabama, Dept Geol Sci, Tuscaloosa, AL 35401 USA.	yuehan.lu@ua.edu		Lu, Yuehan/0000-0002-0536-532X	Department of Geological Science at the University of Alabama; Mellon Foundation Postdoctoral Fellow Grant from the College of William and Mary; Department of Geological Sciences, the University of Alabama; HOOK's research fund; Division Of Ocean Sciences [0961860] Funding Source: National Science Foundation	Department of Geological Science at the University of Alabama; Mellon Foundation Postdoctoral Fellow Grant from the College of William and Mary; Department of Geological Sciences, the University of Alabama; HOOK's research fund; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by a start-up analytical fund to YL from the Department of Geological Science at the University of Alabama and a Mellon Foundation Postdoctoral Fellow Grant from the College of William and Mary. The authors also acknowledge the HOOK's research fund and the Johnson travel fund from the Department of Geological Sciences, the University of Alabama, for providing student research and travel funds.; We thank Dr. B. Zhang for providing support for statistical analysis. This work was supported by a start-up analytical fund to Y. L. from the Department of Geological Science at the University of Alabama, in collaboration with a Mellon Foundation Postdoctoral Fellow Grant from the College of William and Mary. We also acknowledge the HOOK's research fund and the Johnson travel fund from the Department of Geological Sciences, the University of Alabama, for providing student research and travel funds.	Balcarczyk KL, 2009, BIOGEOCHEMISTRY, V94, P255, DOI 10.1007/s10533-009-9324-x; Baldock JA, 2002, ORG GEOCHEM, V33, P1093, DOI 10.1016/S0146-6380(02)00062-1; Baldock JA, 2004, MAR CHEM, V92, P39, DOI 10.1016/j.marchem.2004.06.016; Bianchi T.S., 2011, CHEM BIOMARKERS AQUA; Cope M.J., 1980, PHYS CHEM EARTH, V12, P663; Cory RM, 2005, ENVIRON SCI TECHNOL, V39, P8142, DOI 10.1021/es0506962; Dalzell BJ, 2009, ORG GEOCHEM, V40, P243, DOI 10.1016/j.orggeochem.2008.10.003; Fellman JB, 2009, BIOGEOCHEMISTRY, V95, P277, DOI 10.1007/s10533-009-9336-6; Fellman JB, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000790; Findlay S.E.G., 2003, AQUATIC ECOSYSTEMS I, P25, DOI [10.1016/b978-012256371-3/50003-2, DOI 10.1016/B978-012256371-3/50003-2]; Glaser B, 1998, ORG GEOCHEM, V29, P811, DOI 10.1016/S0146-6380(98)00194-6; Goldberg E.D., 1985, BLACK CARBON ENV PRO; Harvey HR, 1997, ORG GEOCHEM, V27, P129, DOI 10.1016/S0146-6380(97)00077-6; Herlemann DPR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093945; Hockaday WC, 2006, ORG GEOCHEM, V37, P501, DOI 10.1016/j.orggeochem.2005.11.003; Hockaday WC, 2007, GEOCHIM COSMOCHIM AC, V71, P3432, DOI 10.1016/j.gca.2007.02.023; Hockaday WC, 2009, LIMNOL OCEANOGR-METH, V7, P81, DOI 10.4319/lom.2009.7.81; Hosen JD, 2014, ENVIRON SCI TECHNOL, V48, P7817, DOI 10.1021/es501422z; Jaffe R, 2012, GEOCHIM COSMOCHIM AC, V94, P95, DOI 10.1016/j.gca.2012.06.031; Jaffe R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000683; Jaffe R, 2014, ADV PHYSICOCHEMICAL, P29; Jaffe R, 2013, SCIENCE, V340, P345, DOI 10.1126/science.1231476; Kalbitz K, 2006, EUR J SOIL SCI, V57, P504, DOI 10.1111/j.1365-2389.2006.00797.x; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Kalbitz K, 2003, GEODERMA, V113, P273, DOI 10.1016/S0016-7061(02)00365-8; Kim S, 2003, ANAL CHEM, V75, P5336, DOI 10.1021/ac034415p; Kim S, 2003, ORG GEOCHEM, V34, P1325, DOI 10.1016/S0146-6380(03)00101-3; Kim SW, 2004, MAR CHEM, V92, P225, DOI 10.1016/j.marchem.2004.06.042; Kirchman DL, 2003, AQUATIC ECOSYSTEMS I, P121; Koch BP, 2007, ANAL CHEM, V79, P1758, DOI 10.1021/ac061949s; Koch BP, 2006, RAPID COMMUN MASS SP, V20, P926, DOI 10.1002/rcm.2386; Koch BP, 2005, GEOCHIM COSMOCHIM AC, V69, P3299, DOI 10.1016/j.gca.2005.02.027; Kujawinski EB, 2004, MAR CHEM, V92, P23, DOI 10.1016/j.marchem.2004.06.038; Kujawinski EB, 2006, ANAL CHEM, V78, P4363, DOI 10.1021/ac0600306; Kujawinski EB, 2009, GEOCHIM COSMOCHIM AC, V73, P4384, DOI 10.1016/j.gca.2009.04.033; Leifer Asa, 1988, KINETICS ENV AQUATIC; Lu YH, 2014, AQUAT SCI, V76, P419, DOI 10.1007/s00027-014-0344-9; Lu YH, 2014, BIOGEOCHEMISTRY, V119, P275, DOI 10.1007/s10533-014-9965-2; Lu YH, 2013, J GEOPHYS RES-BIOGEO, V118, P566, DOI 10.1002/jgrg.20048; Maie N, 2007, WATER RES, V41, P563, DOI 10.1016/j.watres.2006.11.006; Major J, 2010, GLOBAL CHANGE BIOL, V16, P1366, DOI 10.1111/j.1365-2486.2009.02044.x; McKnight DM., 2003, AQUATIC ECOSYSTEMS, P71, DOI 10.1016/B978-012256371-3/50004-4; Mopper K, 2007, CHEM REV, V107, P419, DOI 10.1021/cr050359b; Mosher JJ, 2010, ORG GEOCHEM, V41, P1177, DOI 10.1016/j.orggeochem.2010.08.004; Nebbioso A, 2013, ANAL BIOANAL CHEM, V405, P109, DOI 10.1007/s00216-012-6363-2; Ohno T, 2010, ENVIRON SCI TECHNOL, V44, P8594, DOI 10.1021/es101089t; Parr TB, 2015, LIMNOL OCEANOGR, V60, P885, DOI 10.1002/lno.10060; Roth VN, 2014, VADOSE ZONE J, V13, DOI 10.2136/vzj2013.09.0162; Schmitt-Kopplin P, 1998, ENVIRON SCI TECHNOL, V32, P2531, DOI 10.1021/es970636z; Skjemstad JO, 1996, AUST J SOIL RES, V34, P251, DOI 10.1071/SR9960251; Sleighter RL, 2008, MAR CHEM, V110, P140, DOI 10.1016/j.marchem.2008.04.008; Sleighter RL, 2008, LIMNOL OCEANOGR-METH, V6, P246, DOI 10.4319/lom.2008.6.246; Sleighter RL, 2007, J MASS SPECTROM, V42, P559, DOI 10.1002/jms.1221; Sleighter RL, 2012, ANAL CHEM, V84, P9184, DOI 10.1021/ac3018026; Stubbins A, 2014, ENVIRON SCI TECHNOL, V48, P10598, DOI 10.1021/es502086e; Stubbins A, 2010, LIMNOL OCEANOGR, V55, P1467, DOI 10.4319/lo.2010.55.4.1467; Sulzberger B, 2009, AQUAT SCI, V71, P104, DOI 10.1007/s00027-008-8082-5; Sun L, 1997, LIMNOL OCEANOGR, V42, P714, DOI 10.4319/lo.1997.42.4.0714; Williams CJ, 2010, LIMNOL OCEANOGR, V55, P1159, DOI 10.4319/lo.2010.55.3.1159; Willoughby AS, 2014, ATMOS CHEM PHYS, V14, P10299, DOI 10.5194/acp-14-10299-2014; Wilson HF, 2013, ECOSYSTEMS, V16, P604, DOI 10.1007/s10021-013-9635-6; Wilson HF, 2009, NAT GEOSCI, V2, P37, DOI 10.1038/NGEO391; Zhong JY, 2011, ORG GEOCHEM, V42, P903, DOI 10.1016/j.orggeochem.2011.04.007	63	47	51	18	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145639	10.1371/journal.pone.0145639	http://dx.doi.org/10.1371/journal.pone.0145639			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713621	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900062
J	Malqvist, M; Hoa, DPT; Persson, LA; Selling, KE				Malqvist, Mats; Dinh Phuong Thi Hoa; Persson, Lars-Ake; Selling, Katarina Ekholm			Effect of Facilitation of Local Stakeholder Groups on Equity in Neonatal Survival; Results from the NeoKIP Trial in Northern Vietnam	PLOS ONE			English	Article							QUANG NINH PROVINCE; CHILD HEALTH; MORTALITY; KNOWLEDGE; COUNTRIES; PROGRESS; POVERTY; NEWBORN	Background To operationalize the post-MDG agenda, there is a need to evaluate the effects of health interventions on equity. The aim of this study is to evaluate the effect on equity in neonatal survival of the NeoKIP trial (ISRCTN44599712), a population-based, cluster-randomized intervention trial with facilitated local stakeholder groups for improved neonatal survival in Quang Ninh province in northern Vietnam. Methods Semi-structured interviews were conducted with all mothers experiencing neonatal mortality and a random sample of 6% of all mothers with a live birth in the study area during the study period (July 2008-June 2011). Multilevel regression analyses were performed, stratifying mothers according to household wealth, maternal education and mother's ethnicity in order to assess impact on equity in neonatal survival. Findings In the last year of study the risk of neonatal death was reduced by 69% among poor mothers in the intervention area as compared to poor mothers in the control area (OR 0.31, 95% CI 0.15-0.66). This pattern was not evident among mothers from non-poor households. Mothers with higher education had a 50% lower risk of neonatal mortality if living in the intervention area during the same time period (OR 0.50, 95% CI 0.28-0.90), whereas no significant effect was detected among mothers with low education. Interpretation The NeoKIP intervention promoted equity in neonatal survival based on wealth but increased inequity based on maternal education.	[Malqvist, Mats; Persson, Lars-Ake; Selling, Katarina Ekholm] Uppsala Univ, Dept Womens & Childrens Hlth, Int Maternal & Child Hlth, Uppsala, Sweden; [Dinh Phuong Thi Hoa] Hanoi Sch Publ Hlth, Hanoi, Vietnam	Uppsala University; Hanoi University of Public Health	Malqvist, M (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Int Maternal & Child Hlth, Uppsala, Sweden.	mats.malqvist@kbh.uu.se	Målqvist, Mats/Q-1274-2019; Målqvist, Mats/G-6748-2017	Målqvist, Mats/0000-0002-8184-3530; Målqvist, Mats/0000-0002-8184-3530; Persson, Lars Ake/0000-0003-0710-7954	Swedish International Development Cooperation Agency (Sida), Sweden	Swedish International Development Cooperation Agency (Sida), Sweden	The NeoKIP project was financially supported by grants from the Swedish International Development Cooperation Agency (Sida), Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2014, J STAT SOFTW, V1, P1; Bhutta ZA, 2013, NEW ENGL J MED, V369, P2226, DOI 10.1056/NEJMra1111853; Booysen F, 2008, WORLD DEV, V36, P1113, DOI 10.1016/j.worlddev.2007.10.008; Bryce J, 2013, LANCET, V382, P1049, DOI 10.1016/S0140-6736(13)61753-5; CALDWELL JC, 1979, POP STUD-J DEMOG, V33, P395, DOI 10.2307/2173888; CLELAND JG, 1988, SOC SCI MED, V27, P1357, DOI 10.1016/0277-9536(88)90201-8; Eriksson L, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-234; Houweling TAJ, 2013, INT J EPIDEMIOL, V42, P520, DOI 10.1093/ije/dyt012; Kang W, 2012, J ASIAN ECON, V23, P527, DOI 10.1016/j.asieco.2012.04.004; Vu L, 2011, ASIA-PAC J PUBLIC HE, V23, P996, DOI 10.1177/1010539510361638; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Malqvist M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066453; Malqvist M, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19803; Malqvist M, 2011, ACTA PAEDIATR, V100, P340, DOI 10.1111/j.1651-2227.2010.02065.x; McKinnon B, 2014, LANCET GLOB HEALTH, V2, pE165, DOI 10.1016/S2214-109X(14)70008-7; Nonyane BA, 2015, EQUITY IMPROVEMENTS; Paudel D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1239; Persson LA, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001445; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Scott SD, 2010, WORLDV EVID-BASED NU, V7, P226, DOI 10.1111/j.1741-6787.2010.00197.x; Sen A, 2002, HEALTH ECON, V11, P659, DOI 10.1002/hec.762; Solar O, 2010, CONCEPTUAL FRAMEWORK; Thomsen S, 2011, REPROD HEALTH MATTER, V19, P176, DOI 10.1016/S0968-8080(11)38586-2; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Wallin L, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-239	25	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145510	10.1371/journal.pone.0145510	http://dx.doi.org/10.1371/journal.pone.0145510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713871	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000367481900048
J	Qiu, XJ; Pang, YL; Yuan, ZH; Xing, DY; Xu, JL; Dingkuhn, M; Li, ZK; Ye, GY				Qiu, Xianjin; Pang, Yunlong; Yuan, Zhihua; Xing, Danying; Xu, Jianlong; Dingkuhn, Michael; Li, Zhikang; Ye, Guoyou			Genome-Wide Association Study of Grain Appearance and Milling Quality in a Worldwide Collection of Indica Rice Germplasm	PLOS ONE			English	Article							ORYZA-SATIVA L.; QUANTITATIVE TRAIT LOCUS; NEAR-ISOGENIC LINES; LINKAGE DISEQUILIBRIUM; NATURAL VARIATION; COMPLEX TRAITS; GENETIC BASES; SEED SIZE; YIELD; WEIGHT	Grain appearance quality and milling quality are the main determinants of market value of rice. Breeding for improved grain quality is a major objective of rice breeding worldwide. Identification of genes/QTL controlling quality traits is the prerequisite for increasing breeding efficiency through marker-assisted selection. Here, we reported a genome-wide association study in indica rice to identify QTL associated with 10 appearance and milling quality related traits, including grain length, grain width, grain length to width ratio, grain thickness, thousand grain weight, degree of endosperm chalkiness, percentage of grains with chalkiness, brown rice rate, milled rice rate and head milled rice rate. A diversity panel consisting of 272 indica accessions collected worldwide was evaluated in four locations including Hangzhou, Jingzhou, Sanya and Shenzhen representing indica rice production environments in China and genotyped using genotyping-by-sequencing and Diversity Arrays Technology based on next-generation sequencing technique called DArTseq (TM). A wide range of variation was observed for all traits in all environments. A total of 16 different association analysis models were compared to determine the best model for each trait-environment combination. Association mapping based on 18,824 high quality markers yielded 38 QTL for the 10 traits. Five of the detected QTL corresponded to known genes or fine mapped QTL. Among the 33 novel QTL identified, qDEC1.1 (qGLWR1.1), qBRR2.2 (qGL2.1), qTGW2.1 (qGL2.2), qGW11.1 (qMRR11.1) and qGL7.1 affected multiple traits with relatively large effects and/or were detected in multiple environments. The research provided an insight of the genetic architecture of rice grain quality and important information for mining genes/QTL with large effects within indica accessions for rice breeding.	[Qiu, Xianjin; Yuan, Zhihua; Xing, Danying] Yangtze Univ, Engn Res Ctr Ecol & Agr Use Wetland, Minist Educ, Coll Agr, Jingzhou 434025, Peoples R China; [Pang, Yunlong; Xu, Jianlong; Li, Zhikang] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100081, Peoples R China; [Xu, Jianlong] Chinese Acad Agr Sci, Shenzhen Inst Breeding & Innovat, Shenzhen 518120, Peoples R China; [Dingkuhn, Michael; Ye, Guoyou] Int Rice Res Inst, Manila, Philippines; [Dingkuhn, Michael] CIRAD, UMR AGAP, F-34398 Montpellier, France	Yangtze University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; CGIAR; International Rice Research Institute (IRRI); CIRAD; Universite de Montpellier	Xu, JL (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100081, Peoples R China.	xujlcaas@126.com; g.ye@irri.org	Xu, Jianlong/AAI-8310-2020	Xing, Danying/0000-0002-3768-5424	Global Rice Science Partnership (GRiSP); National 863 High Technology Research and Development Program from the Ministry of Science and Technology of China [2014AA10A601]; Shenzhen Peacock Plan, the Natural Science Foundation of China [31461143014, 31261140369]; Hubei Collaborative Innovation Center for Grain Industry	Global Rice Science Partnership (GRiSP); National 863 High Technology Research and Development Program from the Ministry of Science and Technology of China; Shenzhen Peacock Plan, the Natural Science Foundation of China; Hubei Collaborative Innovation Center for Grain Industry	This research was granted by Global Rice Science Partnership (GRiSP), National 863 High Technology Research and Development Program from the Ministry of Science and Technology of China (2014AA10A601), Shenzhen Peacock Plan, the Natural Science Foundation of China (31461143014, 31261140369), and Hubei Collaborative Innovation Center for Grain Industry.	Abe Y, 2010, GENES GENET SYST, V85, P327, DOI 10.1266/ggs.85.327; Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Bai XF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-16; Begum H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119873; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cheng FM, 2005, FOOD CHEM, V90, P39, DOI 10.1016/j.foodchem.2004.03.018; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Borba TCD, 2010, GENET MOL BIOL, V33, P515, DOI 10.1590/S1415-47572010005000065; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Gao XY, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-34; Guo LB, 2014, RICE SCI, V21, P65, DOI 10.1016/S1672-6308(13)60174-2; Guo LB, 2009, J INTEGR PLANT BIOL, V51, P45, DOI 10.1111/j.1744-7909.2008.00793.x; Huang RY, 2013, TRENDS PLANT SCI, V18, P218, DOI 10.1016/j.tplants.2012.11.001; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Ishimaru K, 2013, NAT GENET, V45, P707, DOI 10.1038/ng.2612; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; Jombart T, 2011, ADEGENET 1 3 1 NEW T; Jr FEH, 2015, HMISC HARRELL MISCEL; Kato T, 2011, BREEDING SCI, V61, P269, DOI 10.1270/jsbbs.61.269; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li YB, 2014, NAT GENET, V46, P398, DOI 10.1038/ng.2923; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Phung NTP, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0371-7; Oh JM, 2011, GENES GENOM, V33, P259, DOI 10.1007/s13258-011-0038-9; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Pritchard JK, 2000, GENETICS, V155, P945; Qi P, 2012, CELL RES, V22, P1666, DOI 10.1038/cr.2012.151; R Core Team, 2013, R LANG ENV STAT COMP; Risterucci AM, 2000, THEOR APPL GENET, V101, P948, DOI 10.1007/s001220051566; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Singh R, 2012, J PLANT BIOCHEM BIOT, V21, P157, DOI 10.1007/s13562-011-0080-3; Song XJ, 2015, P NATL ACAD SCI USA, V112, P76, DOI 10.1073/pnas.1421127112; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Stich B, 2008, GENETICS, V178, P1745, DOI 10.1534/genetics.107.079707; Tan YF, 2000, THEOR APPL GENET, V101, P823, DOI 10.1007/s001220051549; Unnevehr L. J., 1992, CONSUMER DEMAND RICE; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wang SK, 2015, NAT GENET, V47, P949, DOI 10.1038/ng.3352; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wang YX, 2015, NAT GENET, V47, P944, DOI 10.1038/ng.3346; Xie XB, 2008, THEOR APPL GENET, V116, P613, DOI 10.1007/s00122-007-0695-x; Xie XB, 2006, THEOR APPL GENET, V113, P885, DOI 10.1007/s00122-006-0348-5; Xu FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122206; Yan S, 2011, THEOR APPL GENET, V123, P1173, DOI 10.1007/s00122-011-1657-x; Yang WN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6087; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yu SW, 2008, CHINESE SCI BULL, V53, P2326, DOI 10.1007/s11434-008-0281-x; Zhang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111508; Zhang WH, 2013, CROP J, V1, P160, DOI 10.1016/j.cj.2013.10.003; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao XQ, 2015, RICE, V8, DOI 10.1186/s12284-015-0064-3; Zheng TQ, 2007, PLANT BREEDING, V126, P158, DOI 10.1111/j.1439-0523.2007.01357.x; Zhou JiangBo, 2012, African Journal of Biotechnology, V11, P2957; Zhou LJ, 2009, THEOR APPL GENET, V118, P581, DOI 10.1007/s00122-008-0922-0	65	29	39	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145577	10.1371/journal.pone.0145577	http://dx.doi.org/10.1371/journal.pone.0145577			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714258	gold, Green Published, Green Submitted			2022-12-27	WOS:000367481900059
J	Tampubolon, G				Tampubolon, Gindo			Cognitive Ageing in Great Britain in the New Century: Cohort Differences in Episodic Memory	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LATE-LIFE; OLDER-PEOPLE; AGE; TRAJECTORIES; ATTRITION; DEMENTIA; DECLINE; POPULATION; IMPAIRMENT	Background Dementias in high income countries are set to be the third major burden of disease even as older people are increasingly required to think for themselves how to provide for their lives in retirement. Meanwhile the period of older age continues to extend with increase in life expectancy. This challenge demands an understanding of how cognition changes over an extended period in later life. But studying cognitive ageing in the population faces a difficulty from the fact that older respondents are liable to leave (attrite) before study completion. This study tested three hypotheses: trajectories of cognitive ageing in Britain show an improvement beyond the age of 50; and they are lifted by secular improvement in cognition across cohorts; lastly they are susceptible to distortion due to attrition. Methods and Findings Using the English Longitudinal Study of Ageing, this paper studied trajectories of episodic memory of Britons aged 50-89 from 2002 to 2013 (N = 5931). Using joint models the analysis found that levels of episodic memory follow a curvilinear shape, not a steady decline, in later life. The findings also revealed secular improvement in cognitive ageing such that as a cohort is being replaced episodic memory levels in the population improve. The analysis lastly demonstrated that failure to simultaneously model attrition can produce distorted pictures of cognitive ageing. Conclusion Old age in this century is not necessarily a period dominated by cognitive decline. In identifying behavioural factors associated with better cognitive ageing, such as social connections of traditional and online kinds, the paper raises possibilities of mustering an adequate response to the cognition challenge.	[Tampubolon, Gindo] Univ Manchester, Cathie Marsh Inst Social Res, Manchester, Lancs, England	University of Manchester	Tampubolon, G (corresponding author), Univ Manchester, Cathie Marsh Inst Social Res, Manchester, Lancs, England.	tampubolon@manchester.ac.uk		Tampubolon, Gindo/0000-0002-9081-2349	Medical Research Council; Medical Research Council [G1001375] Funding Source: researchfish; MRC [G1001375] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	GT is funded by the Medical Research Council, GB (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baars MAE, 2009, DEMENT GERIATR COGN, V27, P173, DOI 10.1159/000200465; Banks J, 2005, PREPARED RETIREMENT; Banks J, 2008, LIVING 21 CENTURY OL; Banks J, 2010, FINANCIAL CIRCUMSTAN; Banks J., 2006, RETIREMENT HLTH RELA; Banks J, 2012, DYNAMICS AGEING EVID; Banks J, 2014, DYNAMICS AGEING EVID; Banks J, 2006, FISC STUD, V27, P281, DOI 10.1111/j.1467-8578.2006.00036.x; Banks J, 2011, LONGITUD LIFE COURSE, V2, P101, DOI 10.14301/llcs.v2i2.115; Brayne C, 2011, ALZHEIMERS DEMENT, V7, P3, DOI 10.1016/j.jalz.2010.12.003; Craik FIM, 2006, TRENDS COGN SCI, V10, P131, DOI 10.1016/j.tics.2006.01.007; Dodge HH, 2014, J GERONTOL A-BIOL, V69, P687, DOI 10.1093/gerona/glt181; Dodge HH, 2011, NEUROLOGY, V77, P722, DOI 10.1212/WNL.0b013e31822b0068; Dregan A, 2013, PSYCHOL MED, V43, P2447, DOI 10.1017/S0033291713000305; Fenge R, 2005, SOCIAL SECURITY EARL; Flynn JR, 2012, ARE WE GETTING SMARTER?: RISING IQ IN THE TWENTY-FIRST CENTURY, P1, DOI 10.1017/CBO9781139235679; Gale CR, 2012, PSYCHOL MED, V42, P2057, DOI 10.1017/S0033291712000402; Graham PL, 2011, J R STAT SOC C-APPL, V60, P221, DOI 10.1111/j.1467-9876.2010.00737.x; Grodstein F, 2007, ALZHEIMERS DEMENT, V3, pS16, DOI 10.1016/j.jalz.2007.01.001; Huppert F.A., 2006, RETIREMENT HLTH RELA, P217; Karlamangla AS, 2009, AM J EPIDEMIOL, V170, P331, DOI 10.1093/aje/kwp154; Lima TAS, 2014, AGE AGEING, V43, P289, DOI 10.1093/ageing/aft193; Marmot M, 2003, HLTH WEALTH LIFESTYL; Marshall A, 2015, J EPIDEMIOL COMMUN H, V69, P316, DOI 10.1136/jech-2014-204655; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matthews FE, 2007, PLOS MED, V4, P1615, DOI 10.1371/journal.pmed.0040304; McArdle JJ, 2009, COGNITION EC OUTCOME, P4269; McArdle JJ, 2007, PSYCHOL AGING, V22, P525, DOI 10.1037/0882-7974.22.3.525; Nordlund A, 2015, J CARD FAIL, V21, P702, DOI 10.1016/j.cardfail.2015.04.006; Rabbitt P, 2004, J GERONTOL B-PSYCHOL, V59, pP84, DOI 10.1093/geronb/59.2.P84; Rabbitt P, 2001, NEUROPSYCHOLOGIA, V39, P532, DOI 10.1016/S0028-3932(00)00099-3; Rabbitt P, 2005, CAMBRIDGE HDB AGE AG, P190; Richard E, 2014, NAT REV NEUROL, V10, P130, DOI 10.1038/nrneurol.2014.23; Rodgers WL, 2003, J GERONTOL B-PSYCHOL, V58, pS338, DOI 10.1093/geronb/58.6.S338; Rose D, 2003, RES GUIDE NATL STAT; Salthouse TA, 2013, DEV PSYCHOL, V49, P2172, DOI 10.1037/a0032019; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Schaie KW, 2004, AGING NEUROPSYCHOL C, V11, P304, DOI 10.1080/13825580490511134; Silverman JM, 2012, NEUROLOGY, V79, P1116, DOI 10.1212/WNL.0b013e3182698c89; Silverman JM, 2009, AGE AGEING, V38, P237, DOI 10.1093/ageing/afn278; Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622; Skirbekk V, 2012, P NATL ACAD SCI USA, V109, P770, DOI 10.1073/pnas.1112173109; Small ML, 2012, NEIGHBOURHOOD EFFECT, P57, DOI [10.1007/978- 94-007-2309-2_3, DOI 10.1007/978-94-007-2309-2_3, DOI 10.1007/978-94-007-2309-2]; Sotaniemi M, 2012, ACTA NEUROL SCAND, V125, P16, DOI 10.1111/j.1600-0404.2010.01459.x; Staff RT, 2014, INTELLIGENCE, V47, P194, DOI 10.1016/j.intell.2014.09.013; Steel N., 2002, HLTH WEALTH LIFESTYL, P249; Steptoe A, 2012, DYNAMICS AGEING EVID, P98; Suthers Kristen, 2003, J Gerontol B Psychol Sci Soc Sci, V58, pS179; Tampubolon G, 2015, AGING MENT HEALTH, V19, P576, DOI 10.1080/13607863.2014.1003279; The Marmot Review, 2010, MARM REV FAIR SOC HL; Uswatte G, 2010, NEW FRONTIERS RESILI, P104; Vermunt JK, 2013, LG SYNTAX USERS GUID; Weuve J, 2012, EPIDEMIOLOGY, V23, P119, DOI 10.1097/EDE.0b013e318230e861; Whalley L, 2001, THE AGEING BRAIN; WHO Commission on Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Willis SL, 2009, HDB THEORIES AGING, P295; Wise DA, 2009, DEV EC AGING; Wise DA, 2012, INVESTIGATIONS EC AG; Wise DA, 2005, ANAL EC AGING; Yaffe K, 2013, CHRONIC MED DIS COGN; Yang Y, 2007, J HEALTH SOC BEHAV, V48, P16, DOI 10.1177/002214650704800102	61	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144907	10.1371/journal.pone.0144907	http://dx.doi.org/10.1371/journal.pone.0144907			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0IX	26713627	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900022
J	Wang, L; Yu, CP; Guo, L; Lin, HR; Meng, ZN				Wang, Le; Yu, Cuiping; Guo, Liang; Lin, Haoran; Meng, Zining			In Silico Comparative Transcriptome Analysis of Two Color Morphs of the Common Coral Trout (Plectropomus Leopardus)	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; REEF FISH; ECOLOGICAL SPECIATION; SPAWNING AGGREGATIONS; ARABIDOPSIS-THALIANA; ONCORHYNCHUS-MYKISS; GENE-EXPRESSION; MARINE FISH; SERRANIDAE; TOOL	The common coral trout is one species of major importance in commercial fisheries and aquaculture. Recently, two different color morphs of Plectropomus leopardus were discovered and the biological importance of the color difference is unknown. Since coral trout species are poorly characterized at the molecular level, we undertook the transcriptomic characterization of the two color morphs, one black and one red coral trout, using Illumina next generation sequencing technologies. The study produced 55162966 and 54588952 paired-end reads, for black and red trout, respectively. De novo transcriptome assembly generated 95367 and 99424 unique sequences in black and red trout, respectively, with 88813 sequences shared between them. Approximately 50% of both trancriptomes were functionally annotated by BLAST searches against protein databases. The two trancriptomes were enriched into 25 functional categories and showed similar profiles of Gene Ontology category compositions. 34110 unigenes were grouped into 259 KEGG pathways. Moreover, we identified 14649 simple sequence repeats (SSRs) and designed primers for potential application. We also discovered 130524 putative single nucleotide polymorphisms (SNPs) in the two transcriptomes, supplying potential genomic resources for the coral trout species. In addition, we identified 936 fast-evolving genes and 165 candidate genes under positive selection between the two color morphs. Finally, 38 candidate genes underlying the mechanism of color and pigmentation were also isolated. This study presents the first transcriptome resources for the common coral trout and provides basic information for the development of genomic tools for the identification, conservation, and understanding of the speciation and local adaptation of coral reef fish species.	[Wang, Le; Yu, Cuiping; Guo, Liang; Lin, Haoran; Meng, Zining] Sun Yat Sen Univ, State Key Lab Biocontrol, Inst Aquat Econ Anim, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Le; Yu, Cuiping; Guo, Liang; Lin, Haoran; Meng, Zining] Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Aquat Econ Anim, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Meng, ZN (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Inst Aquat Econ Anim, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	mengzn@sysu.edu.cn	lin, haoran/GXH-3030-2022		National High Technology R & D Program 863 of China [2012AA10A414]; National Natural Science Foundation of China [31370047]	National High Technology R & D Program 863 of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology R & D Program 863 of China (2012AA10A414) and the National Natural Science Foundation of China (grant 31370047).; This work was supported by the National High Technology R & D Program 863 of China (2012AA10A414) and the National Natural Science Foundation of China (grant 31370047).	Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Brawand D, 2014, NATURE; Cai XP, 2013, ACTA OCEANOL SIN, V32, P40, DOI 10.1007/s13131-013-0304-6; COLLIN SP, 1989, J COMP NEUROL, V281, P143, DOI 10.1002/cne.902810112; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fox SE, 2014, MAR GENOM, V15, P13, DOI 10.1016/j.margen.2013.12.001; Frisch A, 2005, COMP BIOCHEM PHYS A, V140, P317, DOI 10.1016/j.cbpb.2005.01.014; Frisch AJ, 2000, FISH PHYSIOL BIOCHEM, V23, P23, DOI 10.1023/A:1007811302002; GALZIN R, 1994, CORAL REEFS, V13, P175, DOI 10.1007/BF00301196; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Howe K., 2013, NATURE, V496, P498, DOI DOI 10.1038/NATURE12111; Huang MS, 2009, MOL PLANT, V2, P773, DOI 10.1093/mp/ssp029; Huang YH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-556; Iseli C, 1999, ESTSCAN PROGRAM DETE; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Krasnov A, 2005, AQUAT TOXICOL, V74, P70, DOI 10.1016/j.aquatox.2005.04.009; Lamanna F, 2014, MOL ECOL RESOUR, V14, P1222, DOI 10.1111/1755-0998.12260; Leis JM, 1999, MAR BIOL, V134, P51, DOI 10.1007/s002270050524; Leskinen PK, 2012, MOL ECOL, V21, P5762, DOI 10.1111/mec.12073; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lieske E., 2001, CORAL REEF FISHES IN; Light PR, 1997, CORAL REEFS, V16, P117, DOI 10.1007/s003380050065; Limborg MT, 2012, MOL ECOL, V21, P3686, DOI 10.1111/j.1365-294X.2012.05639.x; Lu MW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-651; Momen AZMR, 1998, J CHEM SOC PERK T 1, P3087; Morris AV, 2000, BIODIVERS CONSERV, V9, P919, DOI 10.1023/A:1008996002822; Nishiyama T, 2003, P NATL ACAD SCI USA, V100, P8007, DOI 10.1073/pnas.0932694100; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nuckels RJ, 2009, INVEST OPHTH VIS SCI, V50, P893, DOI 10.1167/iovs.08-2743; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; Sadovy Yvonne J., 2002, P391, DOI 10.1016/B978-012615185-5/50023-2; SALE PF, 1977, AM NAT, V111, P337, DOI 10.1086/283164; Samoilys MA, 1997, MAR ECOL PROG SER, V160, P149, DOI 10.3354/meps160149; Schluter D, 2009, P NATL ACAD SCI USA, V106, P9955, DOI 10.1073/pnas.0901264106; Schunter C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-167; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; STODDART DR, 1969, BIOL REV, V44, P433, DOI 10.1111/j.1469-185X.1969.tb00609.x; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Szovenyi P, 2015, MOL ECOL RESOUR, V15, P203, DOI 10.1111/1755-0998.12284; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tiffin P, 2002, J MOL EVOL, V54, P746, DOI 10.1007/s0023901-0074-1; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van Herwerden L, 2006, MOL PHYLOGENET EVOL, V41, P420, DOI 10.1016/j.ympev.2006.04.024; Via S, 2012, PHILOS T R SOC B, V367, P451, DOI 10.1098/rstb.2011.0260; Victor B., 2014, MANY CORAL REEF FISH; Wang CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090074; Wang DH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1023; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xie Z, 2014, MITOCHONDR DNA, P1; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yue JX, 2014, GENOME BIOL EVOL, V6, P2681, DOI 10.1093/gbe/evu212; Zeller DC, 1998, MAR ECOL PROG SER, V162, P253, DOI 10.3354/meps162253; Zeller DC, 1997, MAR ECOL PROG SER, V154, P65, DOI 10.3354/meps154065; Zhang JB, 2010, CONSERV GENET RESOUR, V2, P101, DOI 10.1007/s12686-010-9210-9; Zhuang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073561; Zou M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131504	67	11	11	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145868	10.1371/journal.pone.0145868	http://dx.doi.org/10.1371/journal.pone.0145868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713756	Green Submitted, Green Published, gold			2022-12-27	WOS:000367481900095
J	Anttila, J; Kaitala, V; Laakso, J; Ruokolainen, L				Anttila, Jani; Kaitala, Veijo; Laakso, Jouni; Ruokolainen, Lasse			Environmental Variation Generates Environmental Opportunist Pathogen Outbreaks	PLOS ONE			English	Article							BIOFILM FORMATION; POPULATION-DYNAMICS; INFECTIOUS-DISEASES; HOPF-BIFURCATION; IMMUNITY; CHOLERA; MODEL; SEASONALITY; REINFECTION; EVOLUTION	Many socio-economically important pathogens persist and grow in the outside host environment and opportunistically invade host individuals. The environmental growth and opportunistic nature of these pathogens has received only little attention in epidemiology. Environmental reservoirs are, however, an important source of novel diseases. Thus, attempts to control these diseases require different approaches than in traditional epidemiology focusing on obligatory parasites. Conditions in the outside-host environment are prone to fluctuate over time. This variation is a potentially important driver of epidemiological dynamics and affect the evolution of novel diseases. Using a modelling approach combining the traditional SIRS models to environmental opportunist pathogens and environmental variability, we show that epidemiological dynamics of opportunist diseases are profoundly driven by the quality of environmental variability, such as the long-term predictability and magnitude of fluctuations. When comparing periodic and stochastic environmental factors, for a given variance, stochastic variation is more likely to cause outbreaks than periodic variation. This is due to the extreme values being further away from the mean. Moreover, the effects of variability depend on the underlying biology of the epidemiological system, and which part of the system is being affected. Variation in host susceptibility leads to more severe pathogen outbreaks than variation in pathogen growth rate in the environment. Positive correlation in variation on both targets can cancel the effect of variation altogether. Moreover, the severity of outbreaks is significantly reduced by increase in the duration of immunity. Uncovering these issues helps in understanding and controlling diseases caused by environmental pathogens.	[Anttila, Jani; Kaitala, Veijo; Laakso, Jouni; Ruokolainen, Lasse] Univ Helsinki, Dept Biosci, Integrat Ecol Unit, FI-00014 Helsinki, Finland	University of Helsinki	Anttila, J (corresponding author), Univ Helsinki, Dept Biosci, Integrat Ecol Unit, FI-00014 Helsinki, Finland.	jani.anttila@helsinki.fi	; Laakso, Jouni/I-7794-2013	Ruokolainen, Lasse/0000-0003-0951-9100; Laakso, Jouni/0000-0001-8245-9912	Academy of Finland [1255572, 1267541]	Academy of Finland(Academy of Finland)	This work was funded by Academy of Finland (http://www.aka.fi/) grants #1255572 for JL and #1267541 for VK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Anttila J, 2016, OIKOS, V125, P1144, DOI 10.1111/oik.02913; Anttila J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071621; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boldin B, 2012, EVOLUTION, V66, P2514, DOI 10.1111/j.1558-5646.2012.01613.x; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Codeco CT, 2001, BMC INFECT DIS, V1, DOI 10.1186/1471-2334-1-1; Cohen AE, 1998, P ROY SOC B-BIOL SCI, V265, P11, DOI 10.1098/rspb.1998.0257; Cohen JE, 1999, CIRC SYST SIGNAL PR, V18, P431, DOI 10.1007/BF01200792; Edenhofer O., 2014, CONTRIBUTION WORKING; Fowler MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055855; Godfray HCJ, 1999, P ROY SOC B-BIOL SCI, V266, P233, DOI 10.1098/rspb.1999.0627; Gomes MGM, 2004, J THEOR BIOL, V228, P539, DOI 10.1016/j.jtbi.2004.02.015; Greenhalgh D, 1997, MATH COMPUT MODEL, V25, P85, DOI 10.1016/S0895-7177(97)00009-5; Greenhalgh D, 2004, MATH COMPUT MODEL, V39, P1261, DOI 10.1016/j.mcm.2004.06.007; Greenman J, 2004, PHYSICA D, V190, P136, DOI 10.1016/j.physd.2003.08.008; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; Halley JM, 1996, TRENDS ECOL EVOL, V11, P33, DOI 10.1016/0169-5347(96)81067-6; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Joh RI, 2009, B MATH BIOL, V71, P845, DOI 10.1007/s11538-008-9384-4; Kaitala V, 1997, P ROY SOC B-BIOL SCI, V264, P943, DOI 10.1098/rspb.1997.0130; Koelle K, 2005, NATURE, V436, P696, DOI 10.1038/nature03820; KRUGMAN S, 1965, J PEDIATR-US, V66, P471, DOI 10.1016/S0022-3476(65)80112-3; Kunttu HMT, 2012, ENV MICROBIOL REP, V4, P398, DOI 10.1111/j.1758-2229.2012.00342.x; Merikanto I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050158; Nisbet RM, 1982, MODELLING FLUCTUATIN; Pelosse P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070830; Ranta Esa, 2006, P1; Regoes RR, 2002, P ROY SOC B-BIOL SCI, V269, P271, DOI 10.1098/rspb.2001.1816; Rohani P, 2002, AM NAT, V159, P469, DOI 10.1086/339467; ROUGHGARDEN J, 1975, AM NAT, V109, P713, DOI 10.1086/283039; Ruiz-Moreno D, 2007, ECOHEALTH, V4, P52, DOI 10.1007/s10393-006-0079-8; Ruokolainen L, 2013, J THEOR BIOL, V339, P36, DOI 10.1016/j.jtbi.2013.08.021; Ruokolainen L, 2009, TRENDS ECOL EVOL, V24, P555, DOI 10.1016/j.tree.2009.04.009; SNIESZKO SF, 1974, J FISH BIOL, V6, P197, DOI 10.1111/j.1095-8649.1974.tb04537.x; Suomalainen LR, 2006, DIS AQUAT ORGAN, V70, P55, DOI 10.3354/dao070055; Suomalainen LR, 2005, J FISH DIS, V28, P271, DOI 10.1111/j.1365-2761.2005.00631.x; Turner WC, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00245.1; van Boven M, 2000, MATH BIOSCI, V164, P161, DOI 10.1016/S0025-5564(00)00009-2; Vasseur DA, 2004, ECOLOGY, V85, P1146, DOI 10.1890/02-3122; Vasseur DA, 2007, THEOR POPUL BIOL, V72, P186, DOI 10.1016/j.tpb.2007.06.002; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Wearing HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000647; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41	47	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145511	10.1371/journal.pone.0145511	http://dx.doi.org/10.1371/journal.pone.0145511			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710238	Green Published, Green Submitted, gold			2022-12-27	WOS:000367451400059
J	Yu, BL; Zhou, H; Liu, M; Zheng, T; Jiang, L; Zhao, M; Xu, XX; Huang, ZF				Yu, Bolan; Zhou, Hua; Liu, Min; Zheng, Ting; Jiang, Lu; Zhao, Mei; Xu, Xiaoxie; Huang, Zhaofeng			Epigenetic Alterations in Density Selected Human Spermatozoa for Assisted Reproduction	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; BECKWITH-WIEDEMANN-SYNDROME; ABERRANT DNA METHYLATION; LARGE GENE LISTS; SPERM DNA; EJACULATED SPERMATOZOA; INFERTILE MEN; PROTAMINE; CHROMATIN; RATIO	Epidemiological evidence indicates that assisted reproductive technologies (ART) may be associated with several epigenetic diseases such as Beckwith-Wiedemann syndrome (BWS) or Silver-Russell syndrome (SRS). Selection of sperm by density-gradients in ART has improved DNA integrity and sperm quality; however, epigenetic alterations associated with this approach are largely unknown. In the present study, we investigated DNA methylation and histone retention profiles in raw sperm and selected sperm derived from the same individual and separated by using density-gradients. Results from a study group consisting of 93 males demonstrated that both global DNA methylation and histone retention levels decreased in density selected sperm. Compared to unselected raw sperm, histone transition rates decreased by an average of 27.2% in selected sperm, and the global methylation rate was 3.8% in unselected sperm and 3.3% in the selected sperm. DNA methylation and histone retention location profiling analyses suggested that these alterations displayed specific location patterns in the human genome. Changes in the pattern of hypomethylation largely occurred in transcriptional factor gene families such as HOX, FOX, and GATA. Histone retention increased in 67 genes, whereas it was significantly clustered in neural development-related gene families, particularly the olfactory sensor gene family. Although a causative relationship could not be established, the results of the present study suggest the possibility that sperm with good density also possess unique epigenetic profiles, particularly for genes involved in neural and olfactory development. As increasing evidence demonstrates that epigenetics plays a key role in embryonic development and offspring growth characteristics, the specific epigenetic alterations we observed in selected sperm may influence the transcriptional process and neural development in embryos.	[Yu, Bolan; Zhou, Hua; Liu, Min; Zheng, Ting; Jiang, Lu] Guangzhou Med Univ, Affiliated Hosp 3, Guangdong Higher Educ Inst, Key Lab Reprod & Genet, Guangzhou 510150, Guangdong, Peoples R China; [Yu, Bolan; Zhou, Hua; Liu, Min; Zheng, Ting; Jiang, Lu] Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Major Obstetr Dis Guangdong Prov, Guangzhou 510150, Guangdong, Peoples R China; [Zhao, Mei; Xu, Xiaoxie; Huang, Zhaofeng] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510080, Guangdong, Peoples R China; [Zhao, Mei; Xu, Xiaoxie; Huang, Zhaofeng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510080, Guangdong, Peoples R China; [Zhao, Mei; Xu, Xiaoxie; Huang, Zhaofeng] Sun Yat Sen Univ, Minist Educ China, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University; Ministry of Education, China; Sun Yat Sen University	Yu, BL (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Guangdong Higher Educ Inst, Key Lab Reprod & Genet, Guangzhou 510150, Guangdong, Peoples R China.	yubolan-q@qq.com; hzhaof@mail.sysu.edu.cn			Natural Science Foundation of China [81370751, 31170831]; Guangdong Natural Science Foundation [2014A030313502, 2015A030302016]; Guangzhou City Science and Technology Administration [201510010014]; Guangdong Recruitment Program of Creative Research Group [2009010058]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangzhou City Science and Technology Administration; Guangdong Recruitment Program of Creative Research Group	The work was supported by the Natural Science Foundation of China (81370751 and 31170831), Guangdong Natural Science Foundation (2014A030313502 and 2015A030302016), Guangzhou City Science and Technology Administration (201510010014), and the Guangdong Recruitment Program of Creative Research Group (No. 2009010058).	Ankolkar M, 2012, FERTIL STERIL, V98, P1186, DOI 10.1016/j.fertnstert.2012.07.1143; Aoki VW, 2006, FERTIL STERIL, V86, P1408, DOI 10.1016/j.fertnstert.2006.04.024; Bench GS, 1996, CYTOMETRY, V23, P263, DOI 10.1002/(SICI)1097-0320(19960401)23:4<263::AID-CYTO1>3.3.CO;2-9; Benchaib M, 2005, HUM REPROD, V20, P768, DOI 10.1093/humrep/deh684; Benchaib M, 2006, Gynecol Obstet Fertil, V34, P836, DOI 10.1016/j.gyobfe.2006.07.036; Brewer LR, 1999, SCIENCE, V286, P120, DOI 10.1126/science.286.5437.120; Carrell DT, 2007, HUM REPROD UPDATE, V13, P313, DOI 10.1093/humupd/dml057; Carrell DT, 2008, INT J ANDROL, V31, P537, DOI 10.1111/j.1365-2605.2008.00872.x; Carrell DT, 2001, J ANDROL, V22, P604; Dale RK, 2011, BIOINFORMATICS, V27, P3423, DOI 10.1093/bioinformatics/btr539; de Mateo S, 2009, FERTIL STERIL, V91, P715, DOI 10.1016/j.fertnstert.2007.12.047; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; El Hajj N, 2011, SEX DEV, V5, P60, DOI 10.1159/000323806; Erkek S, 2013, NAT STRUCT MOL BIOL, V20, P868, DOI 10.1038/nsmb.2599; Gandini L, 2004, HUM REPROD, V19, P1409, DOI 10.1093/humrep/deh233; Gicquel C, 2003, AM J HUM GENET, V72, P1338, DOI 10.1086/374824; Hammadeh ME, 2010, HUM REPROD, V25, P2708, DOI 10.1093/humrep/deq226; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hisano M, 2013, NAT PROTOC, V8, P2449, DOI 10.1038/nprot.2013.145; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jackson RE, 2010, FERTIL STERIL, V94, P2626, DOI 10.1016/j.fertnstert.2010.04.049; Jenkins TG, 2015, MOL HUM REPROD, V21, P313, DOI 10.1093/molehr/gau115; Jenkins TG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004458; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kagami M, 2007, J ASSIST REPROD GEN, V24, P131, DOI 10.1007/s10815-006-9096-3; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Lachaud C, 2004, HUM REPROD, V19, P607, DOI 10.1093/humrep/deh130; Lambrot R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3889; Larson KL, 1999, HUM REPROD, V14, P2015, DOI 10.1093/humrep/14.8.2015; Liang F, 2014, NEUROPHARMACOLOGY, V81, P126, DOI 10.1016/j.neuropharm.2014.01.025; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Luke L, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3359; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Morrell JM, 2004, J ASSIST REPROD GEN, V21, P217, DOI 10.1023/B:JARG.0000040237.47026.0f; Nasr-Esfahani MH, 2004, ANDROLOGIA, V36, P95, DOI 10.1111/j.1439-0272.2004.00612.x; Oliva R, 2006, HUM REPROD UPDATE, V12, P417, DOI 10.1093/humupd/dml009; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Qureshi IA, 2010, CELL CYCLE, V9, P4477, DOI 10.4161/cc.9.22.13973; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Steger K, 2008, HUM REPROD, V23, P11, DOI 10.1093/humrep/dem363; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tunc O, 2009, J ASSIST REPROD GEN, V26, P537, DOI 10.1007/s10815-009-9346-2; Urdinguio RG, 2015, HUM REPROD, V30, P1014, DOI 10.1093/humrep/dev053; Wei YC, 2014, P NATL ACAD SCI USA, V111, P1873, DOI 10.1073/pnas.1321195111; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Yu BL, 2014, FERTIL STERIL, V101, P51, DOI 10.1016/j.fertnstert.2013.09.001; Zhang XY, 2006, J ANDROL, V27, P414, DOI 10.2164/jandrol.05171; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141	53	12	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145585	10.1371/journal.pone.0145585	http://dx.doi.org/10.1371/journal.pone.0145585			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709917	Green Submitted, gold, Green Published			2022-12-27	WOS:000367451400064
J	Huang, JF; Zeng, DZ; Duan, GJ; Shi, Y; Deng, GH; Xia, H; Xu, HQ; Zhao, N; Fu, WL; Huang, Q				Huang, Jun-Fu; Zeng, Dong-Zhu; Duan, Guang-Jie; Shi, Yan; Deng, Guo-Hong; Xia, Han; Xu, Han-Qing; Zhao, Na; Fu, Wei-Ling; Huang, Qing			Single-Tubed Wild-Type Blocking Quantitative PCR Detection Assay for the Sensitive Detection of Codon 12 and 13 KRAS Mutations	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; GROWTH-FACTOR RECEPTOR; PEPTIDE NUCLEIC-ACID; K-RAS MUTATIONS; CELL-FREE DNA; PICODROPLET DIGITAL PCR; MELTING CURVE ANALYSIS; ANTI-EGFR THERAPY; MONOCLONAL-ANTIBODY; ACQUIRED-RESISTANCE	The high degree of intra-tumor heterogeneity has meant that it is important to develop sensitive and selective assays to detect low-abundance KRAS mutations in metastatic colorectal carcinoma (mCRC) patients. As a major potential source of tumor DNA in the aforementioned genotyping assays, it was necessary to conduct an analysis on both the quality and quantity of DNA extracted from formalin-fixed paraffin-embedded (FFPE). Therefore, four commercial FFPE DNA extraction kits were initially compared with respect to their ability to facilitate extraction of amplifiable DNA. The results showed that TrimGen kits showed the greatest performance in relation to the quality and quantity of extracted FFPE DNA solutions. Using DNA extracted by TrimGen kits as a template for tumor genotyping, a real-time wild-type blocking PCR (WTB-PCR) assay was subsequently developed to detect the aforementioned KRAS mutations in mCRC patients. The results showed that WTB-PCR facilitated the detection of mutated alleles at a ratio of 1:10,000 (i.e. 0.01%) wild-type alleles. When the assay was subsequently used to test 49 mCRC patients, the results showed that the mutation detection levels of the WTB-PCR assay (61.8%; 30/49) were significantly higher than that of traditional PCR (38.8%; 19/49). Following the use of the real-time WTB-PCR assay, the Delta Cq method was used to quantitatively analyze the mutation levels associated with KRAS in each FFPE sample. The results showed that the mutant levels ranged from 53.74 to 0.12% in the patients analyzed. In conclusion, the current real-time WTB-PCR is a rapid, simple, and low-cost method that permits the detection of trace amounts of the mutated KRAS gene.	[Huang, Jun-Fu; Xia, Han; Xu, Han-Qing; Zhao, Na; Fu, Wei-Ling; Huang, Qing] Third Mil Med Univ, Southwest Hosp, Dept Lab Med, Chongqing 400038, Peoples R China; [Zeng, Dong-Zhu; Shi, Yan] Third Mil Med Univ, Southwest Hosp, Dept Gen Surg, Chongqing 400038, Peoples R China; [Duan, Guang-Jie] Third Mil Med Univ, Inst Pathol, Southwest Hosp, Chongqing 400038, Peoples R China; [Duan, Guang-Jie] Third Mil Med Univ, Southwest Canc Ctr, Southwest Hosp, Chongqing 400038, Peoples R China; [Deng, Guo-Hong] Third Mil Med Univ, Southwest Hosp, Dept Infect Dis, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University; Army Medical University	Fu, WL (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Lab Med, Chongqing 400038, Peoples R China.	weilingfu@yahoo.com; Q.Huang@gmail.com	fu, weiling/AAX-3286-2021; Huang, Qing/E-1872-2017	fu, weiling/0000-0002-5768-6563; Huang, Qing/0000-0002-0140-8978	National 863 Program of China [2011AA02A121, 2013AA020204]; Scientific Foundation of Chongqing [CSTC2014YYKFA110029, CSTC2015JCSF0105]	National 863 Program of China; Scientific Foundation of Chongqing	This work was supported in part by grants from the National 863 Program of China (No. 2011AA02A121 and 2013AA020204), and the Scientific Foundation of Chongqing (No. CSTC2014YYKFA110029; CSTC2015JCSF0105).	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Baker M, 2012, NAT METHODS, V9, P541, DOI 10.1038/nmeth.2027; Bando H, 2011, BRIT J CANCER, V105, P403, DOI 10.1038/bjc.2011.247; Beau-Faller M, 2009, BRIT J CANCER, V100, P985, DOI 10.1038/sj.bjc.6604925; Bonin S, 2010, VIRCHOWS ARCH, V457, P309, DOI 10.1007/s00428-010-0917-5; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen D, 2014, ANAL BIOANAL CHEM, V406, P2477, DOI 10.1007/s00216-014-7618-x; Chretien AS, 2013, CANCER MED-US, V2, P11, DOI 10.1002/cam4.47; Cremolini C, 2015, ANN ONCOL, V26, P2092, DOI 10.1093/annonc/mdv290; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Custodio A, 2013, CRIT REV ONCOL HEMAT, V85, P45, DOI 10.1016/j.critrevonc.2012.05.001; Dabritz J, 2005, BRIT J CANCER, V92, P405, DOI 10.1038/sj.bjc.6602319; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Didelot A, 2013, CLIN CHEM, V59, P815, DOI 10.1373/clinchem.2012.193409; Dominguez PL, 2005, ONCOGENE, V24, P6830, DOI 10.1038/sj.onc.1208832; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Fox JC, 1998, BRIT J CANCER, V77, P1267, DOI 10.1038/bjc.1998.212; Franklin WA, 2010, J MOL DIAGN, V12, P43, DOI 10.2353/jmoldx.2010.080131; Gilje B, 2008, J MOL DIAGN, V10, P325, DOI 10.2353/jmoldx.2008.070183; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Hamilton SC, 2001, BIOTECHNIQUES, V31, P370, DOI 10.2144/01312rv01; Harle A, 2013, VIRCHOWS ARCH, V462, P329, DOI 10.1007/s00428-013-1380-x; Hecht JR, 2015, CANCER TREAT REV, V41, P653, DOI 10.1016/j.ctrv.2015.05.008; Hu YC, 2014, ASIAN PAC J CANCER P, V15, P2733, DOI 10.7314/APJCP.2014.15.6.2733; Huang Q, 2006, MOL CELL PROBE, V20, P250, DOI 10.1016/j.mcp.2006.01.005; Huang Q, 2010, MOL CELL PROBE, V24, P376, DOI 10.1016/j.mcp.2010.07.010; Igloi GL, 1998, P NATL ACAD SCI USA, V95, P8562, DOI 10.1073/pnas.95.15.8562; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kimura T, 2012, ONCOLOGY-BASEL, V82, P298, DOI 10.1159/000336792; Kopetz S, 2015, CLIN COLORECTAL CANC; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Laurent-Puig P, 2015, CLIN CANCER RES, V21, P1087, DOI 10.1158/1078-0432.CCR-14-0983; Lee S, 2012, VIRCHOWS ARCH, V460, P141, DOI 10.1007/s00428-011-1180-0; Li M, 2006, NAT METHODS, V3, P95, DOI 10.1038/NMETH850; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Luo JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj008; Mackay John, 2007, Methods Mol Biol, V353, P237; Messersmith WA, 2008, NEW ENGL J MED, V359, P1834, DOI 10.1056/NEJMe0806778; Milbury CA, 2009, CLIN CHEM, V55, P632, DOI 10.1373/clinchem.2008.113035; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Mitani Y, 2007, NAT METHODS, V4, P257, DOI 10.1038/NMETH1007; Miyamae Y, 2010, J MOL DIAGN, V12, P257, DOI 10.2353/jmoldx.2010.090105; Molinari F, 2011, CLIN CANCER RES, V17, P4901, DOI 10.1158/1078-0432.CCR-10-3137; Mouliere F, 2014, MOL ONCOL, V8, P927, DOI 10.1016/j.molonc.2014.02.005; Mouliere F, 2013, TRANSL ONCOL, V6, P319, DOI 10.1593/tlo.12445; Oh JE, 2010, J MOL DIAGN, V12, P418, DOI 10.2353/jmoldx.2010.090146; Okello JBA, 2010, ANAL BIOCHEM, V400, P110, DOI 10.1016/j.ab.2010.01.014; Oldenburg RP, 2008, J INVEST DERMATOL, V128, P398, DOI 10.1038/sj.jid.5700920; ORUM H, 1993, NUCLEIC ACIDS RES, V21, P5332, DOI 10.1093/nar/21.23.5332; Pekin D, 2011, LAB CHIP, V11, P2156, DOI 10.1039/c1lc20128j; Pinto P, 2011, CANCER GENET-NY, V204, P439, DOI 10.1016/j.cancergen.2011.07.003; Radstrom P, 2004, MOL BIOTECHNOL, V26, P133, DOI 10.1385/MB:26:2:133; Spindler KLG, 2014, INT J CANCER, V135, P2215, DOI 10.1002/ijc.28863; Suzuki M, 2000, J BIOL CHEM, V275, P32728, DOI 10.1074/jbc.M000097200; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; Thiede C, 1996, NUCLEIC ACIDS RES, V24, P983, DOI 10.1093/nar/24.5.983; Thierry AR, 2014, NAT MED, V20, P430, DOI 10.1038/nm.3511; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Tougeron D, 2013, ANN ONCOL, V24, P1267, DOI 10.1093/annonc/mds620; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; Van Cutsem E, 2014, ANN ONCOL, V25, P1, DOI 10.1093/annonc/mdu260; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Yang XD, 1999, CANCER RES, V59, P1236; You Y, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl175; Zheng G, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1811-y	70	4	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145698	10.1371/journal.pone.0145698	http://dx.doi.org/10.1371/journal.pone.0145698			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701781	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600119
J	Lim, SY; Chan, CEZ; Lisowska, MM; Hanson, BJ; MacAry, PA				Lim, She Yah; Chan, Conrad E. Z.; Lisowska, Malgorzata M.; Hanson, Brendon J.; MacAry, Paul A.			The Molecular Engineering of an Anti-Idiotypic Antibody for Pharmacokinetic Analysis of a Fully Human Anti-Infective	PLOS ONE			English	Article							DISPLAY	Anti-idiotype monoclonal antibodies represent a class of reagents that are potentially optimal for analyzing the pharmacokinetics of fully human, anti-infective antibodies that have been developed as therapeutic candidates. This is particularly important where direct pathogen binding assays are complicated by requirements for biosafety level III or IV for pathogen handling. In this study, we describe the development of a recombinant, anti-idiotype monoclonal antibody termed E1 for the detection of a fully human, serotype-specific, therapeutic antibody candidate for the BSLIII pathogen Dengue virus termed 14c10 hG1. E1 was generated by naive human Fab phage library panning technology and subsequently engineered as a monoclonal antibody. We show that E1 is highly specific for the fully-folded form of 14c10 hG1 and can be employed for the detection of this antibody in healthy human subjects' serum by enzyme linked immunosorbent assay. In addition, we show that E1 is capable of blocking the binding of 14c10 hG1 to dengue virus serotype 1. Finally, we show that E1 can detect 14c10 hG1 in mouse serum after the administration of the therapeutic antibody in vivo. E1 represents an important new form of ancillary reagent that can be utilized in the clinical development of a therapeutic human antibody candidate.	[Lim, She Yah; Lisowska, Malgorzata M.; Hanson, Brendon J.; MacAry, Paul A.] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore; [Lim, She Yah; Lisowska, Malgorzata M.; MacAry, Paul A.] Natl Univ Singapore, Ctr Life Sci, Program Immunol, Singapore 117548, Singapore; [Lim, She Yah] NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore; [Chan, Conrad E. Z.; Hanson, Brendon J.] DSO Natl Labs, Def Med & Environm Res Inst, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Hanson, BJ (corresponding author), Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore.	hbrendon@dso.org.sg; paul_macary@nuhs.edu.sg		Lisowska, Malgorzata/0000-0003-4858-9312; MacAry, Paul/0000-0002-1139-8996	Biomedical Research Council-Science and Engineering Research Council [R-182-000-206-305]; National Research Foundation, Singapore [R-182-005-172-281]; National University of Singapore [R-182-000-192-133]; National Medical Research Council (STOP-Dengue TCR) [R-182-003-220-275]	Biomedical Research Council-Science and Engineering Research Council; National Research Foundation, Singapore(National Research Foundation, Singapore); National University of Singapore(National University of Singapore); National Medical Research Council (STOP-Dengue TCR)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Biomedical Research Council-Science and Engineering Research Council Grant number R-182-000-206-305 (http://www.a-star.edu.sg/About-A-STAR/Science-and-Engineering-Research-Council.aspx), National Research Foundation, Singapore Grant number R-182-005-172-281 (http://www.nrf.gov.sg/funding-grants), National University of Singapore Grant number R-182-000-192-133 (http://www.nus.edu.sg/dpr/#), and National Medical Research Council (STOP-Dengue TCR) Grant number R-182-003-220-275 (http://www.nmrc.gov.sg/content/nmrc_internet/home/grant/compgrants/tcrinfec.html). PAM received all the above funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bradbury ARM, 2004, J IMMUNOL METHODS, V290, P29, DOI 10.1016/j.jim.2004.04.007; Chan AHY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033451; de Haard HJ, 1999, J BIOL CHEM, V274, P18218, DOI 10.1074/jbc.274.26.18218; Dubel S, 2010, HDB THERAPEUTIC ANTI; FUJII K, 1989, J IMMUNOL METHODS, V124, P63; Gonzalez-Quintela A, 2008, CLIN EXP IMMUNOL, V151, P42, DOI 10.1111/j.1365-2249.2007.03545.x; Hoogenboom HR, METHODS MOL BIOL, V178; Mahmood I, 2005, CLIN PHARMACOKINET, V44, P331, DOI 10.2165/00003088-200544040-00001; Mire-Sluis AR, 2004, J IMMUNOL METHODS, V289, P1, DOI 10.1016/j.jim.2004.06.002; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Pieper R, 2003, PROTEOMICS, V3, P1345, DOI 10.1002/pmic.200300449; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888; Trang JM, 1992, PROTEIN PHARMACKINET; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; World Health Organization, 2009, DENGUE GUIDELINES DI	17	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145381	10.1371/journal.pone.0145381	http://dx.doi.org/10.1371/journal.pone.0145381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700297	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600072
J	Oonincx, DGAB; van Broekhoven, S; van Huis, A; van Loon, JJA				Oonincx, Dennis G. A. B.; van Broekhoven, Sarah; van Huis, Arnold; van Loon, Joop J. A.			Feed Conversion, Survival and Development, and Composition of Four Insect Species on Diets Composed of Food By-Products	PLOS ONE			English	Article							BLACK SOLDIER FLY; ACHETA-DOMESTICUS ORTHOPTERA; FATTY-ACID-COMPOSITION; MOLITOR L COLEOPTERA; HOUSE CRICKET; LINOLEIC-ACID; NUTRIENT COMPOSITION; 2 STRAINS; GROWTH; PHOSPHORUS	A large part of the environmental impact of animal production systems is due to the production of feed. Insects are suggested to efficiently convert feed to body mass and might therefore form a more sustainable food and/or feed source. Four diets were composed from by-products of food manufacturing and formulated such as to vary in protein and fat content. These were offered to newly hatched Argentinean cockroaches, black soldier flies, yellow mealworms, and house crickets. The first two species are potentially interesting as a feed ingredient, while the latter two are considered edible for humans. Feed conversion efficiency, survival, development time, as well as chemical composition (nitrogen, phosphorus, and fatty acids), were determined. The Argentinean cockroaches and the black soldier flies converted feed more efficiently than yellow mealworms, and house crickets. The first two were also more efficient than conventional production animals. On three of the four diets yellow mealworms and house crickets had a feed conversion efficiency similar to pigs. Furthermore, on the most suitable diet, they converted their feed as efficiently as poultry, when corrected for edible portion. All four species had a higher nitrogen-efficiency than conventional production animals, when corrected for edible portion. Offering carrots to yellow mealworms increased dry matter- and nitrogen-efficiency and decreased development time. Diet affected survival in all species but black soldier flies, and development time was strongly influenced in all four species. The chemical composition of Argentinean cockroaches was highly variable between diets, for black soldier flies it remained similar. The investigated species can be considered efficient production animals when suitable diets are provided. Hence, they could form a sustainable alternative to conventional production animals as a source of feed or food.	[Oonincx, Dennis G. A. B.; van Broekhoven, Sarah; van Huis, Arnold; van Loon, Joop J. A.] Wageningen Univ, Plant Sci Grp, Entomol Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	Oonincx, DGAB (corresponding author), Wageningen Univ, Plant Sci Grp, Entomol Lab, NL-6700 AP Wageningen, Netherlands.	dennisoonincx@gmail.com	; van Loon, Joop J.A./B-3744-2009	Oonincx, Dennis/0000-0002-6728-4859; van Loon, Joop J.A./0000-0002-4260-0501	Wageningen University, Wageningen, The Netherlands as part of a PhD program	Wageningen University, Wageningen, The Netherlands as part of a PhD program	This study was directly funded by Wageningen University, Wageningen, The Netherlands (www.wur.nl) as part of a PhD program. Wageningen University had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, than can be expected with the academic supervision of a PhD candidate.	Allen ME, 1997, NUTR ADVISORY GROUP, V1997; Barker D, 1998, ZOO BIOL, V17, P123, DOI 10.1002/(SICI)1098-2361(1998)17:2&lt;123::AID-ZOO7&gt;3.0.CO;2-B; BLOMQUIST GJ, 1991, INSECT BIOCHEM, V21, P99, DOI 10.1016/0020-1790(91)90069-Q; BONDARI K, 1981, AQUACULTURE, V24, P103, DOI 10.1016/0044-8486(81)90047-8; Bosch G, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.23; CLIFFORD CW, 1990, J APPL ENTOMOL, V109, P1, DOI 10.1111/j.1439-0418.1990.tb00012.x; Cohen A. C., 2003, INSECT DIETS SCI TEC; Collavo Alberto, 2005, P519; CRIPPS C, 1986, BIOCHIM BIOPHYS ACTA, V876, P572, DOI 10.1016/0005-2760(86)90046-9; de Vries M, 2010, LIVEST SCI, V128, P1, DOI 10.1016/j.livsci.2009.11.007; DERENOBALES M, 1987, TRENDS BIOCHEM SCI, V12, P364, DOI 10.1016/0968-0004(87)90167-8; Diener S, 2009, WASTE MANAGE RES, V27, P603, DOI 10.1177/0734242X09103838; Dierenfeld Ellen S., 2008, Journal of Herpetological Medicine and Surgery, V18, P100; Fast P.G., 1970, PROGR CHEM FATS OTHE, V11, P181; Finke M.D., 2013, MASS PRODUCTION BENE; Finke MD, 2002, ZOO BIOL, V21, P269, DOI 10.1002/zoo.10031; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRAENKEL G, 1950, PHYSIOL ZOOL, V23, P92, DOI 10.1086/physzool.23.2.30152067; FRIEND WG, 1958, ANNU REV ENTOMOL, V3, P57, DOI 10.1146/annurev.en.03.010158.000421; Frost PC, 2002, ECOL LETT, V5, P232, DOI 10.1046/j.1461-0248.2002.00307.x; FURMAN DP, 1959, J ECON ENTOMOL, V52, P917, DOI 10.1093/jee/52.5.917; Ghaly A.E., 2009, American Journal of Agricultural and Biological Sciences, V4, P319; Gobbi P, 2013, EUR J ENTOMOL, V110, P461, DOI 10.14411/eje.2013.061; HACKSTEIN JHP, 1994, P NATL ACAD SCI USA, V91, P5441, DOI 10.1073/pnas.91.12.5441; HALE O M, 1973, Journal of the Georgia Entomological Society, V8, P16; Hanboonsong Y., 2013, 6 LEGGED LIVESTOCK E; Herrero M, 2013, P NATL ACAD SCI USA, V110, P20878, DOI 10.1073/pnas.1321844111; Herrero M, 2013, P NATL ACAD SCI USA, V110, P20888, DOI 10.1073/pnas.1308149110; HOUSE HL, 1961, ANNU REV ENTOMOL, V6, P13, DOI 10.1146/annurev.en.06.010161.000305; Howard RW, 1996, COMP BIOCHEM PHYS B, V115, P429, DOI 10.1016/S0305-0491(96)00161-7; Kouba M, 2011, BIOCHIMIE, V93, P13, DOI 10.1016/j.biochi.2010.02.027; Li Q, 2011, WASTE MANAGE, V31, P1316, DOI 10.1016/j.wasman.2011.01.005; Liu KY, 2011, J VIROL, V85, P10069, DOI 10.1128/JVI.00625-11; Lundy ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118785; McFARLANE J. E., 1959, CANADIAN JOUR ZOOL, V37, P913, DOI 10.1139/z59-088; MCFARLANE JE, 1962, CAN J ZOOLOG, V40, P559, DOI 10.1139/z62-048; MULLINS DE, 1975, COMP BIOCHEM PHYSIOL, V50, P489, DOI 10.1016/0300-9629(75)90306-0; MURRAY DRP, 1960, J INSECT PHYSIOL, V4, P80, DOI 10.1016/0022-1910(60)90069-X; NAKAGAKI BJ, 1991, J ECON ENTOMOL, V84, P891, DOI 10.1093/jee/84.3.891; NAKAGAKI BJ, 1987, POULTRY SCI, V66, P1367, DOI 10.3382/ps.0661367; Newton G. L, 2005, BLACK SOLDIER FLY HE; Newton G.L., 2005, USING BLACK SOLDIER; NEWTON GL, 1977, J ANIM SCI, V44, P395, DOI 10.2527/jas1977.443395x; NOVOZAMSKY I, 1984, NETH J AGR SCI, V32, P322; Oonincx D, 2015, J INSECTS FOOD FEED, P1; Oonincx DGAB, 2011, ZOO BIOL, V30, P9, DOI 10.1002/zoo.20308; Oonincx DGAB, 2010, COMP BIOCHEM PHYS B, V156, P122, DOI 10.1016/j.cbpb.2010.02.008; Oonincx DGAB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051145; Oonincx DGAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014445; Patton C.J., 2003, METHODS ANAL US GEOL; PATTON RL, 1978, ANN ENTOMOL SOC AM, V71, P40, DOI 10.1093/aesa/71.1.40; PATTON RL, 1967, ANN ENTOMOL SOC AM, V60, P1238, DOI 10.1093/aesa/60.6.1238; Perkins MC, 2004, ARCH INSECT BIOCHEM, V55, P153, DOI 10.1002/arch.10133; Pham HT, 2013, GENOME ANNOUNCEMENTS, V1, DOI [10.1128/genomeA.00914-13, DOI 10.1128/GEN0MEA.00914-13]; Raes K, 2001, ANIM SCI, V73, P253, DOI 10.1017/S1357729800058227; Ramos-Elorduy J, 2008, ECOL FOOD NUTR, V47, P280, DOI 10.1080/03670240701805074; Rowland AP, 1997, J ENVIRON QUAL, V26, P410, DOI 10.2134/jeq1997.00472425002600020011x; SCRIBER JM, 1981, ANNU REV ENTOMOL, V26, P183, DOI 10.1146/annurev.en.26.010181.001151; Sealey WM, 2011, J WORLD AQUACULT SOC, V42, P34, DOI 10.1111/j.1749-7345.2010.00441.x; SHEPPARD DC, 1994, BIORESOURCE TECHNOL, V50, P275, DOI 10.1016/0960-8524(94)90102-3; St-Hilaire S, 2007, J WORLD AQUACULT SOC, V38, P309, DOI 10.1111/j.1749-7345.2007.00101.x; Steinfeld H., 2006, Livestock's long shadow: environmental issues and options; Steinfeld H., 2012, EXPL WORKSH SUST PRO; Szelei J, 2011, J INVERTEBR PATHOL, V106, P394, DOI 10.1016/j.jip.2010.12.009; Tzompa-Sosa DA, 2014, FOOD RES INT, V62, P1087, DOI 10.1016/j.foodres.2014.05.052; URS KCD, 1973, J STORED PROD RES, V8, P291, DOI 10.1016/0022-474X(73)90045-3; URS KCD, 1973, J STORED PROD RES, V8, P299, DOI 10.1016/0022-474X(73)90046-5; van Broekhoven S, 2015, J INSECT PHYSIOL, V73, P1, DOI 10.1016/j.jinsphys.2014.12.005; Visanuvimol L, 2010, ECOL ENTOMOL, V35, P386, DOI 10.1111/j.1365-2311.2010.01195.x; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1; Wilkinson JM, 2011, ANIMAL, V5, P1014, DOI 10.1017/S175173111100005X; WOODRING JP, 1977, J INSECT PHYSIOL, V23, P207, DOI 10.1016/0022-1910(77)90031-2; WOODRING JP, 1979, J INSECT PHYSIOL, V25, P903, DOI 10.1016/0022-1910(79)90102-1; Yi LY, 2013, FOOD CHEM, V141, P3341, DOI 10.1016/j.foodchem.2013.05.115	74	394	399	16	285	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144601	10.1371/journal.pone.0144601	http://dx.doi.org/10.1371/journal.pone.0144601			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699129	Green Published, gold			2022-12-27	WOS:000367092600025
J	Ferrara, TFD; Schneider, VK; Kishi, LT; Carmona, AK; Alves, MFM; Belasque, J; Rosa, JC; Hunter, WB; Henrique-Silva, F; Soares-Costa, A				da Silva Ferrara, Taise Fernanda; Schneider, Vanessa Karine; Kishi, Luciano Takeshi; Carmona, Adriana Karaoglanovic; Madureira Alves, Marcio Fernando; Belasque-Junior, Jose; Rosa, Jose Cesar; Hunter, Wayne Brian; Henrique-Silva, Flavio; Soares-Costa, Andrea			Characterization of a Recombinant Cathepsin B-Like Cysteine Peptidase from Diaphorina citri Kuwayama (Hemiptera: Liviidae): A Putative Target for Control of Citrus Huanglongbing	PLOS ONE			English	Article							CANDIDATUS-LIBERIBACTER-ASIATICUS; L-LIKE PROTEINASES; SAO-PAULO-STATE; MOLECULAR-CLONING; GREENING DISEASE; 1ST REPORT; FAT-BODY; EXPRESSION; AMERICANUS; CYSTATIN	Huanglonbing (HLB) is one of the most destructive disease affecting citrus plants. The causal agent is associated with the phloem-limited bacterium Candidatus Liberibacter asiaticus (CLas) and the psyllid Diaphorina citri, vector of disease, that transmits the bacterium associated with HLB. The control of disease can be achieved by suppressing either the bacterium or the vector. Among the control strategies for HLB disease, one of the widely used consists in controlling the enzymes of the disease vector, Diaphorina citri. The insect Diaphorina citri belongs to the order Hemiptera, which frequently have cysteine peptidases in the gut. The importance of this class of enzymes led us to search for enzymes in the D. citri transcriptome for the establishment of alternatives strategies for HLB control. In this study, we reported the identification and characterization of a cathepsin B-like cysteine peptidase from D. citri (DCcathB). DCcathB was recombinantly expressed in Pichia pastoris, presenting a molecular mass of approximately 50 kDa. The enzyme hydrolyzed the fluorogenic substrate Z-F-R-AMC (K-m = 23.5 mu M) and the selective substrate for cathepsin B,Z-R-R-AMC (K-m = 6.13 mu M). The recombinant enzyme was inhibited by the cysteine protease inhibitors E64 (IC50 = 0.014 mu M) and CaneCPI-4 (Ki = 0.05 nM) and by the selective cathepsin B inhibitor CA-074 (IC50 = 0.095 nM). RT-qPCR analysis revealed that the expression of the DCcathB in nymph and adult was approximately 9-fold greater than in egg. Moreover, the expression of this enzyme in the gut was 175-fold and 3333-fold higher than in the remaining tissues and in the head, respectively, suggesting that DCcathB can be a target for HLB control.	[da Silva Ferrara, Taise Fernanda; Schneider, Vanessa Karine; Kishi, Luciano Takeshi; Henrique-Silva, Flavio; Soares-Costa, Andrea] Univ Fed Sao Carlos, Dept Genet & Evolut, Mol Biol Lab, BR-13560 Sao Carlos, SP, Brazil; [Carmona, Adriana Karaoglanovic; Madureira Alves, Marcio Fernando] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, SP, Brazil; [Belasque-Junior, Jose] Univ Sao Paulo, Dept Phytopathol & Nematol, Sao Paulo, SP, Brazil; [Rosa, Jose Cesar] ARS, USDA, Ft Pierce, FL USA; [Hunter, Wayne Brian] Univ Sao Paulo, Ribeirao Preto Med Sch, Prot Chem Ctr, BR-14049 Ribeirao Preto, SP, Brazil; [Hunter, Wayne Brian] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Mol & Cellular Biol & Pathogen Bioagents, BR-14049 Ribeirao Preto, SP, Brazil	Universidade Federal de Sao Carlos; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; United States Department of Agriculture (USDA); Universidade de Sao Paulo; Universidade de Sao Paulo	Soares-Costa, A (corresponding author), Univ Fed Sao Carlos, Dept Genet & Evolut, Mol Biol Lab, BR-13560 Sao Carlos, SP, Brazil.	andreasc@ufscar.br	Carmona, Adriana K/D-2240-2012; hunter, wayne/AAB-9096-2020; Rosa, Jose C/A-1966-2013; Schneider, Vanessa Karine/C-7456-2013; Kishi, Luciano T/O-3982-2014; Belasque, José/B-7753-2015; Henrique-Silva, Flavio/A-1937-2013; Soares-Costa, Andrea/D-8270-2012	Carmona, Adriana K/0000-0003-3311-5456; hunter, wayne/0000-0001-8603-3337; Rosa, Jose C/0000-0002-6917-0230; Kishi, Luciano T/0000-0003-0449-4274; Belasque, José/0000-0001-6059-2173; Henrique-Silva, Flavio/0000-0003-3329-4597	Brazilian fostering agencies Fapesp [2012124278-5]; Fundo de Defesa da Citricultura; Capes; Fapesp	Brazilian fostering agencies Fapesp; Fundo de Defesa da Citricultura; Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Research was supported by the Brazilian fostering agencies Fapesp (Proc. 2012124278-5) and Fundo de Defesa da Citricultura. T.F.S.F. received a grant from Capes, V.K.S. received a grant from Fapesp.	ABRAHAMSON M, 1994, METHOD ENZYMOL, V244, P685; Akada R, 2000, BIOTECHNIQUES, V28, P668, DOI 10.2144/00284st02; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANASTASI A, 1983, BIOCHEM J, V211, P129, DOI 10.1042/bj2110129; Avery PB, 2009, FLA ENTOMOL, V92, P608, DOI 10.1653/024.092.0413; Barrett A. J., 1998, HDB PROTEOLYTIC ENZY; BARRETT AJ, 1987, TRENDS BIOCHEM SCI, V12, P193, DOI 10.1016/0968-0004(87)90092-2; BARRETT AJ, 1981, ACTA BIOL MED GER, V40, P1513; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boina DR, 2009, PEST MANAG SCI, V65, P870, DOI 10.1002/ps.1767; Bove JM, 2006, J PLANT PATHOL, V88, P7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; Carrillo L, 2011, TRANSGENIC RES, V20, P305, DOI 10.1007/s11248-010-9417-2; Cho WL, 1999, J BIOL CHEM, V274, P13311, DOI 10.1074/jbc.274.19.13311; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cimerman N, 1999, J ENZYM INHIB, V14, P167, DOI 10.3109/14756369909036552; Cocco A, 2008, FLA ENTOMOL, V91, P610; Coletta HD, 2004, PLANT DIS, V88, P1382, DOI 10.1094/PDIS.2004.88.12.1382C; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cregg JM, 2007, PICHIA PROTOCOLS; Cristofoletti PT, 2005, INSECT BIOCHEM MOLEC, V35, P883, DOI 10.1016/j.ibmb.2005.03.006; Donmez D, 2013, SCI WORLD J, DOI 10.1155/2013/491207; Dutt M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137134; El-Shesheny I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065392; Falco MC, 2003, PLANT PHYSIOL BIOCH, V41, P761, DOI 10.1016/S0981-9428(03)00100-1; FAO, 2013, STAT YB; Fonseca FPP, 2012, INSECT BIOCHEM MOLEC, V42, P58, DOI 10.1016/j.ibmb.2011.10.008; Gianotti A, 2008, BIOL CHEM, V389, P447, DOI 10.1515/BC.2008.035; Gottwald TR, 2007, PLANT HLTH PROGRESS; Gupta R, 2004, NETNGLYC 1 0; Hajeri S, 2014, J BIOTECHNOL, V176, P42, DOI 10.1016/j.jbiotec.2014.02.010; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Halbert SE., 2005, PROC 2 INT CITRUS CA, pH3; HASNAIN S, 1993, J BIOL CHEM, V268, P235; HOUSEMAN JG, 1984, CAN ENTOMOL, V116, P1393, DOI 10.4039/Ent1161393-10; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; IZUMI S, 1994, J INSECT PHYSIOL, V40, P735, DOI 10.1016/0022-1910(94)90001-9; Killiny N, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0110536, DOI 10.1371/J0URNAL.P0NE.0110536]; Kutsukake M, 2004, P NATL ACAD SCI USA, V101, P11338, DOI 10.1073/pnas.0402462101; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leatherbarrow R.J., 2001, GRAFIT VERSION 5; Lecardonnel A, 1999, PLANT SCI, V140, P71, DOI 10.1016/S0168-9452(98)00197-6; Lee KS, 2009, COMP BIOCHEM PHYS B, V154, P188, DOI 10.1016/j.cbpb.2009.06.002; LIN K. -H., 1956, Acta Phytopathologica Sinica, V2, P1; Liu SH, 2010, INSECT BIOCHEM MOLEC, V40, P666, DOI 10.1016/j.ibmb.2010.06.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes SA, 2009, PLANT DIS, V93, P257, DOI 10.1094/PDIS-93-3-0257; Lopes SA, 2009, PHYTOPATHOLOGY, V99, P301, DOI 10.1094/PHYTO-99-3-0301; Luis M, 2009, J PLANT PATHOL, V91, P709; Manjunath KL, 2010, PLANT DIS, V94, P781, DOI 10.1094/PDIS-94-6-0781A; Martinez M, 2005, J EXP BOT, V56, P1821, DOI 10.1093/jxb/eri172; Martinez Y, 2009, PLANT PATHOL, V58, P389, DOI 10.1111/j.1365-3059.2008.01997.x; Marutani-Hert M, 2010, FLA ENTOMOL, V93, P519, DOI 10.1653/024.093.0408; Matos L, 2009, PLANT DIS, V93, P668, DOI 10.1094/PDIS-93-6-0668B; MEDINA M, 1988, ARCH BIOCHEM BIOPHYS, V263, P355, DOI 10.1016/0003-9861(88)90646-7; MURATA M, 1991, FEBS LETT, V280, P307, DOI 10.1016/0014-5793(91)80318-W; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; Nagase, 2001, PRACTICAL APPROACH, P131; Noda H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-117; Ohtsubo S, 2005, J AGR FOOD CHEM, V53, P5218, DOI 10.1021/jf050348j; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Reese Justin, 2014, J Genomics, V2, P54; Reinking OA, 1919, PHILIPPINE AGR, V8, P109; Reis EM, 2001, GENET MOL BIOL, V24, P291, DOI 10.1590/S1415-47572001000100038; Ribeiro JMC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002594; Rispe C, 2008, MOL BIOL EVOL, V25, P5, DOI 10.1093/molbev/msm222; Rozen S, 2000, Methods Mol Biol, V132, P365; Sako Y, 2011, EXP PARASITOL, V127, P693, DOI 10.1016/j.exppara.2010.11.005; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shiba HJ, 2001, ARCH BIOCHEM BIOPHYS, V390, P28, DOI 10.1006/abbi.2001.2343; TAKAHASHI N, 1993, FEBS LETT, V334, P153, DOI 10.1016/0014-5793(93)81702-2; Teixeira DD, 2005, INT J SYST EVOL MICR, V55, P1857, DOI 10.1099/ijs.0.63677-0; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; TERRA WR, 1988, INSECT BIOCHEM, V18, P423, DOI 10.1016/0020-1790(88)90058-3; Texeira DC, 2005, PLANT DIS, V89, P107, DOI 10.1094/PD-89-0107A; Tiwari S, 2011, INSECT MOL BIOL, V20, P733, DOI 10.1111/j.1365-2583.2011.01103.x; Tsai JH, 2000, J ECON ENTOMOL, V93, P1721, DOI 10.1603/0022-0493-93.6.1721; Valadares NF, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-30; VERNET T, 1991, J BIOL CHEM, V266, P21451; Vyas M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130328; Wulff NA, 2014, MOL PLANT MICROBE IN, V27, P163, DOI 10.1094/MPMI-09-13-0292-R; Wuriyanghan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027736; Xu CF, 1998, P 10 C INT ORG CRTR; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhao XF, 2002, INSECT MOL BIOL, V11, P567, DOI 10.1046/j.1365-2583.2002.00366.x	91	11	12	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145132	10.1371/journal.pone.0145132	http://dx.doi.org/10.1371/journal.pone.0145132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717484	gold, Green Submitted, Green Published			2022-12-27	WOS:000367510500021
J	Efsen, AMW; Schultze, A; Post, FA; Panteleev, A; Furrer, H; Miller, RF; Losso, MH; Toibaro, J; Skrahin, A; Miro, JM; Cayla, JA; Girardi, E; Bruyand, M; Obel, N; Podlekareva, DN; Lundgren, JD; Mocroft, A; Kirk, O				Efsen, Anne Marie W.; Schultze, Anna; Post, Frank A.; Panteleev, Alexander; Furrer, Hansjakob; Miller, Robert F.; Losso, Marcelo H.; Toibaro, Javier; Skrahin, Aliaksandr; Miro, Jose M.; Cayla, Joan A.; Girardi, Enrico; Bruyand, Mathias; Obel, Niels; Podlekareva, Daria N.; Lundgren, Jens D.; Mocroft, Amanda; Kirk, Ole		TB HIV Study Grp EuroCoord	Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; RISK-FACTORS; HIV; CARE; PREVENTION; PEOPLE	Objectives Rates of TB/HIV coinfection and multi-drug resistant (MDR)-TB are increasing in Eastern Europe (EE). We aimed to study clinical characteristics, factors associated with MDR-TB and predicted activity of empiric anti-TB treatment at time of TB diagnosis among TB/HIV coinfected patients in EE, Western Europe (WE) and Latin America (LA). Design and Methods Between January 1, 2011, and December 31, 2013, 1413 TB/HIV patients (62 clinics in 19 countries in EE, WE, Southern Europe (SE), and LA) were enrolled. Results Significant differences were observed between EE (N = 844), WE (N = 152), SE (N = 164), and LA (N = 253) in the proportion of patients with a definite TB diagnosis (47%, 71%, 72% and 40%, p<0.0001), MDR-TB (40%, 5%, 3% and 15%, p<0.0001), and use of combination antiretroviral therapy (cART) (17%, 40%, 44% and 35%, p<0.0001). Injecting drug use (adjusted OR (aOR) = 2.03 (95% CI 1.00-4.09), prior anti-TB treatment (3.42 (1.88-6.22)), and living in EE (7.19 (3.28-15.78)) were associated with MDR-TB. Among 585 patients with drug susceptibility test (DST) results, the empiric (i.e. without knowledge of the DST results) anti-TB treatment included >= 3 active drugs in 66% of participants in EE compared with 90-96% in other regions (p<0.0001). Conclusions In EE, TB/HIV patients were less likely to receive a definite TB diagnosis, more likely to house MDR-TB and commonly received empiric anti-TB treatment with reduced activity. Improved management of TB/HIV patients in EE requires better access to TB diagnostics including DSTs, empiric anti-TB therapy directed at both susceptible and MDR-TB, and more widespread use of cART.	[Efsen, Anne Marie W.; Lundgren, Jens D.; Kirk, Ole] Univ Copenhagen, Rigshosp, Ctr Hlth & Infect Dis Res CHIP, Dept Infect Dis & Rheumatol,Finsencentret, DK-2100 Copenhagen, Denmark; [Schultze, Anna; Mocroft, Amanda] UCL, Sch Med, Dept Infect & Populat Hlth, London W1N 8AA, England; [Post, Frank A.] Kings Coll Hosp London, Dept Sexual Hlth, Caldecot Ctr, London, England; [Efsen, Anne Marie W.] TB Hosp 2, Dept HIV TB, St Petersburg, Russia; [Furrer, Hansjakob] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland; [Furrer, Hansjakob] Univ Bern, Bern, Switzerland; [Miller, Robert F.] UCL, Ctr Sexual Hlth & HIV Res, Mortimer Market Ctr, London, England; [Losso, Marcelo H.; Toibaro, Javier] Hosp JM Ramos Mejia, Dept Immunocompromised, Buenos Aires, DF, Argentina; [Skrahin, Aliaksandr] Republican Res & Pract Ctr Pulmonol & TB, Clin Dept, Minsk, BELARUS; [Miro, Jose M.] Univ Barcelona, Hosp Clin, IDIBAPS, Infect Dis Serv, Barcelona, Spain; [Cayla, Joan A.] Agcy Salud Publ, Barcelona, Spain; [Cayla, Joan A.] SEPAR, PII TB, CIBERESP, Barcelona, Spain; [Girardi, Enrico] Osped L Spallanzani, Dept Infect Dis INMI L Spallanzani, Rome, Italy; [Bruyand, Mathias] INSERM, ISPED, Ctr Inserm Epidemiol Biostat U897, Bordeaux, France; [Obel, Niels] Univ Copenhagen, Rigshosp, Dept Infect Dis & Rheumatol, Finsencentret, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of London; University College London; UCL Medical School; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Bern; University Hospital of Bern; University of Bern; University of London; University College London; Hospital Ramos Mejia; University of Buenos Aires; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; IRCCS Lazzaro Spallanzani; Institut National de la Sante et de la Recherche Medicale (Inserm); Rigshospitalet; University of Copenhagen	Efsen, AMW (corresponding author), Univ Copenhagen, Rigshosp, Ctr Hlth & Infect Dis Res CHIP, Dept Infect Dis & Rheumatol,Finsencentret, DK-2100 Copenhagen, Denmark.	anne.marie.werlinrud.efsen@regionh.dk	Bruyand, Mathias/AAP-6177-2020; Furrer, Hansjakob/G-6768-2013; Podlekareva, Daria/ABE-5024-2021; kirk, ole/ABB-4746-2021; Alcaide, Fernando/B-4124-2015; Lundgren, Jens/AAE-6876-2019	Furrer, Hansjakob/0000-0002-1375-3146; Alcaide, Fernando/0000-0002-4097-1499; Schultze, Anna/0000-0002-1637-837X; Cayla, Joan A./0000-0003-3891-111X; Podlekareva, Daria/0000-0003-3187-0597; Obel, Niels/0000-0002-5031-0045; Miller, Robert/0000-0003-2067-4291; Girardi, Enrico/0000-0001-8182-5896; Skrahin, Alaksandr/0000-0002-7028-3785	European Union [260694]; Danish Council for Independent Research (DFF); Research Council, Copenhagen University Hospital, Rigshospitalet	European Union(European Commission); Danish Council for Independent Research (DFF)(Det Frie Forskningsrad (DFF)); Research Council, Copenhagen University Hospital, Rigshospitalet	This study was funded by the European Union 7th Framework (FP7/2007-2013, EuroCoord no 260694) programme and The Danish Council for Independent Research (DFF); Research Council, Copenhagen University Hospital, Rigshospitalet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar I, 2013, LANCET INFECT DIS, V13, P529, DOI 10.1016/S1473-3099(13)70030-6; Andrews JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015735; BHIVA, BRIT HIV ASS GUID TR; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; CDC, TREATM TB 2003; Dalton T, 2012, LANCET, V380, P1406, DOI 10.1016/S0140-6736(12)60734-X; DeHovitz J, 2014, CURR HIV-AIDS REP, V11, P168, DOI 10.1007/s11904-014-0202-3; Dheda K, 2014, LANCET RESP MED, V2, P321, DOI 10.1016/S2213-2600(14)70031-1; Efsen AM, 2014, J INT AIDS SOC, V17, P12, DOI 10.7448/IAS.17.4.19505; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; Keshavjee S, 2008, ANN NY ACAD SCI, V1136, P1, DOI 10.1196/annals.1425.009; Kim HR, 2007, CLIN INFECT DIS, V45, P1290, DOI 10.1086/522537; Leimane V, 2010, EUR RESPIR J, V36, P584, DOI 10.1183/09031936.00003710; Mansfeld M, 2015, HIV MED, V16, P544, DOI 10.1111/hiv.12256; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Morozova Olga, 2013, Int J Drug Policy, V24, pe91, DOI 10.1016/j.drugpo.2013.09.001; Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076; Organization WH, 2011, AUT REAL TIM NUCL AC; Podlekareva DN, 2009, AIDS, V23, P2485, DOI 10.1097/QAD.0b013e3283326879; Post FA, 2014, J INFECTION, V68, P259, DOI 10.1016/j.jinf.2013.09.034; Skrahina A, 2012, EUR RESPIR J, V39, P1425, DOI 10.1183/09031936.00145411; Spire B, 2007, INT J DRUG POLICY, V18, P262, DOI 10.1016/j.drugpo.2006.12.014; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; UNAIDS, UNAIDS REP GLOB AIDS; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organisation, 2008, POL GUID COLL TB HIV; World Health Organization, MULT EXT DRUG RES TB; World Health Organization, GLOB TUB REP 2013; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	33	20	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145380	10.1371/journal.pone.0145380	http://dx.doi.org/10.1371/journal.pone.0145380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716686	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500032
J	Suntharasamai, P; Martin, M; Choopanya, K; Vanichseni, S; Sangkum, U; Tararut, P; Leelawiwat, W; Anekvorapong, R; Mock, PA; Cherdtrakulkiat, T; Leethochawalit, M; Chiamwongpaet, S; Gvetadze, RJ; McNicholl, JM; Paxton, LA; Kittimunkong, S; Curlin, ME				Suntharasamai, Pravan; Martin, Michael; Choopanya, Kachit; Vanichseni, Suphak; Sangkum, Udomsak; Tararut, Pairote; Leelawiwat, Wanna; Anekvorapong, Rapeepan; Mock, Philip A.; Cherdtrakulkiat, Thitima; Leethochawalit, Manoj; Chiamwongpaet, Sithisat; Gvetadze, Roman J.; McNicholl, Janet M.; Paxton, Lynn A.; Kittimunkong, Somyot; Curlin, Marcel E.			Assessment of Oral Fluid HIV Test Performance in an HIV Pre-Exposure Prophylaxis Trial in Bangkok, Thailand	PLOS ONE			English	Article							INFECTION; DIAGNOSIS	Background Rapid easy-to-use HIV tests offer opportunities to increase HIV testing among populations at risk of infection. We used the OraQuick Rapid HIV-1/2 antibody test (OraQuick) in the Bangkok Tenofovir Study, an HIV pre-exposure prophylaxis trial among people who inject drugs. Methods The Bangkok Tenofovir Study was a randomized, double-blind, placebo-controlled trial. We tested participants' oral fluid for HIV using OraQuick monthly and blood using a nucleic-acid amplification test (NAAT) every 3 months. We used Kaplan-Meier methods to estimate the duration from a positive HIV NAAT until the mid-point between the last non-reactive and first reactive oral fluid test and proportional hazards to examine factors associated with the time until the test was reactive. Results We screened 3678 people for HIV using OraQuick. Among 447 with reactive results, 436 (97.5%) were confirmed HIV-infected, 10 (2.2%) HIV-uninfected, and one (0.2%) had indeterminate results. Two participants with non-reactive OraQuick results were, in fact, HIV-infected at screening yielding 99.5% sensitivity, 99.7% specificity, a 97.8% positive predictive value, and a 99.9% negative predictive value. Participants receiving tenofovir took longer to develop a reactive OraQuick (191.8 days) than participants receiving placebo (16.8 days) (p = 0.02) and participants infected with HIV CRF01_AE developed a reactive OraQuick earlier than participants infected with other subtypes (p = 0.04). Discussion The oral fluid HIV test performed well at screening, suggesting it can be used when rapid results and non-invasive tools are preferred. However, participants receiving tenofovir took longer to develop a reactive oral fluid test result than those receiving placebo. Thus, among people using pre-exposure prophylaxis, a blood-based HIV test may be an appropriate choice.	[Suntharasamai, Pravan; Choopanya, Kachit; Vanichseni, Suphak; Sangkum, Udomsak] Bangkok Tenofovir Study Grp, Bangkok, Thailand; [Martin, Michael; Tararut, Pairote; Leelawiwat, Wanna; Mock, Philip A.; Cherdtrakulkiat, Thitima; Curlin, Marcel E.] Thailand MOPH US CDC Collaborat, Nonthaburi, Thailand; [Martin, Michael; Gvetadze, Roman J.; McNicholl, Janet M.; Paxton, Lynn A.; Curlin, Marcel E.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Anekvorapong, Rapeepan; Leethochawalit, Manoj; Chiamwongpaet, Sithisat] Bangkok Metropolitan Adm, Bangkok, Thailand; [Kittimunkong, Somyot] Thailand Minist Publ Hlth, Nonthaburi, Thailand	Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand	Martin, M (corresponding author), Thailand MOPH US CDC Collaborat, Nonthaburi, Thailand.	Znd9@cdc.gov		Cherdtrakulkiat, Thitima/0000-0001-5006-6145	US Centers for Disease Control and Prevention (CDC); Bangkok Metropolitan Administration (BMA)	US Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bangkok Metropolitan Administration (BMA)	The US Centers for Disease Control and Prevention (CDC) sponsored the trial in collaboration with the Bangkok Metropolitan Administration (BMA). CDC and BMA staff participated in study design, data collection, analysis, and interpretation of the results. The corresponding author had access to all the data and decided to submit the manuscript for publication. Study drug was donated by Gilead Sciences.	Armitage P, 2001, STAT METHODS MED RES, V4th; Branson BM, 2007, CLIN INFECT DIS, V45, pS221, DOI 10.1086/522541; *CDC, 2003, MMWR-MORBID MORTAL W, V52, P329; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Delaney KP, 2006, AIDS, V20, P1655, DOI 10.1097/01.aids.0000238412.75324.82; [Department of Disease Control Thailand Ministry of Public Health], 2013, GUID HIV COUNS TEST; [Department of Medical Sciences Thailand Ministry of Public Health], 2014, DIAGN HIV TESTS AV T; FDA, 2012, ORAQUICK IN HOM HIV; Hu DJ, 2001, AIDS, V15, P683, DOI 10.1097/00002030-200104130-00003; Martin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025127; O'Connell RJ, 2003, J CLIN MICROBIOL, V41, P2153, DOI 10.1128/JCM.41.5.2153-2155.2003; OraSure Technologies, ORAQUICK RAP HIV 1 2; OraSure Technologies, 2004, ORAQUICK ADV RAP HIV; Owen SM, 2008, J CLIN MICROBIOL, V46, P1588, DOI 10.1128/JCM.02196-07; Patel P, 2012, J CLIN VIROL, V54, P42, DOI 10.1016/j.jcv.2012.01.022; Pavie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011581; Pilcher CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080629; Thailand Food and Drug Administration, 1990, MED DEV CONTR THAIL; UNAIDS, 2014, 90 90 90 AMB TREATM; van Elteren PH, 1960, B INT STAT I, V37, P351; Wesolowski LG, 2006, AIDS, V20, P1661, DOI 10.1097/01.aids.0000238413.13442.ed; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization, 2012, SERV DEL APPR HIV TE	23	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145859	10.1371/journal.pone.0145859	http://dx.doi.org/10.1371/journal.pone.0145859			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717405	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500084
J	Bouchard, DS; Seridan, B; Saraoui, T; Rault, L; Germon, P; Gonzalez-Moreno, C; Nader-Macias, FME; Baud, D; Francois, P; Chuat, V; Chain, F; Langella, P; Nicoli, J; Le Loir, Y; Even, S				Bouchard, Damien S.; Seridan, Bianca; Saraoui, Taous; Rault, Lucie; Germon, Pierre; Gonzalez-Moreno, Candelaria; Nader-Macias, Fatima M. E.; Baud, Damien; Francois, Patrice; Chuat, Victoria; Chain, Florian; Langella, Philippe; Nicoli, Jacques; Le Loir, Yves; Even, Sergine			Lactic Acid Bacteria Isolated from Bovine Mammary Microbiota: Potential Allies against Bovine Mastitis	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; LACTOCOCCUS-LACTIS; GENOME SEQUENCE; DNA; INHIBITION; PRODUCTS; PROTEINS; MILK	Bovine mastitis is a costly disease in dairy cattle worldwide. As of yet, the control of bovine mastitis is mostly based on prevention by thorough hygienic procedures during milking. Additional strategies include vaccination and utilization of antibiotics. Despite these measures, mastitis is not fully under control, thus prompting the need for alternative strategies. The goal of this study was to isolate autochthonous lactic acid bacteria (LAB) from bovine mammary microbiota that exhibit beneficial properties that could be used for mastitis prevention and/or treatment. Sampling of the teat canal led to the isolation of 165 isolates, among which a selection of ten non-redundant LAB strains belonging to the genera Lactobacillus and Lactococcus were further characterized with regard to several properties: surface properties (hydrophobicity, autoaggregation); inhibition potential of three main mastitis pathogens, Staphylococcus aureus, Escherichia coli and Streptococcus uberis; colonization capacities of bovine mammary epithelial cells (bMEC); and immunomodulation properties. Three strains, Lactobacillus brevis 1595 and 1597 and Lactobacillus plantarum 1610, showed high colonization capacities and a medium surface hydrophobicity. These strains are good candidates to compete with pathogens for mammary gland colonization. Moreover, nine strains exhibited anti-inflammatory properties, as illustrated by the lower IL-8 secretion by E. coli-stimulated bMEC in the presence of these LAB. Full genome sequencing of five candidate strains allowed to check for undesirable genetic elements such as antibiotic resistance genes and to identify potential bacterial determinants involved in the beneficial properties. This large screening of beneficial properties while checking for undesirable genetic markers allowed the selection of promising candidate LAB strains from bovine mammary microbiota for the prevention and/or treatment of bovine mastitis.	[Bouchard, Damien S.; Seridan, Bianca; Saraoui, Taous; Rault, Lucie; Chuat, Victoria; Le Loir, Yves; Even, Sergine] INRA, UMR STLO 1253, F-35042 Rennes, France; [Bouchard, Damien S.; Seridan, Bianca; Saraoui, Taous; Rault, Lucie; Chuat, Victoria; Le Loir, Yves; Even, Sergine] Agrocampus Ouest, STLO UMR1253, Rennes, France; [Seridan, Bianca; Nicoli, Jacques] Univ Fed Minas Gerais, ICB, Dept Microbiol, Belo Horizonte, MG, Brazil; [Germon, Pierre] INRA, UMR Infectiol & Sante Publ 1282, F-37380 Nouzilly, France; [Gonzalez-Moreno, Candelaria; Nader-Macias, Fatima M. E.] Consejo Nacl Invest Cient & Tecn, Ctr Referencia Lactobacillus, CERELA, San Miguel De Tucuman, Tucuman, Argentina; [Baud, Damien; Francois, Patrice] Univ Hosp Geneva, Genom Res Lab, Geneva, Switzerland; [Chain, Florian; Langella, Philippe] INRA MICALIS, Jouy En Josas, France	INRAE; Institut Agro; Agrocampus Ouest; Universidade Federal de Minas Gerais; INRAE; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Geneva; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Even, S (corresponding author), INRA, UMR STLO 1253, F-35042 Rennes, France.	sergine.even@rennes.inra.fr	Langella, Philippe/N-8368-2017; GERMON, Pierre/AAC-9111-2019; francois, patrice/AAL-5583-2020; GERMON, Pierre/M-5264-2019; LE LOIR, Yves/AAD-1879-2021; Nicoli, Jacques R/K-4807-2015	Langella, Philippe/0000-0001-5960-4341; GERMON, Pierre/0000-0003-3078-876X; Nicoli, Jacques R/0000-0003-2390-2608; Gonzalez Moreno, Candelaria/0000-0003-4317-6172; Chain, Florian/0000-0001-8787-3311; Le Loir, Yves/0000-0002-0355-1065; francois, patrice/0000-0002-0540-750X	French Ministry of Research and Higher Education; CAPES-COFECUB fellowship (CAPES/Brazil); French government [748798C]; French National Institute of Agricultural Research (INRA/France); INRA-funded GISA project (Ruminflame); ECOS SUD project [A12B01]	French Ministry of Research and Higher Education; CAPES-COFECUB fellowship (CAPES/Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); French government; French National Institute of Agricultural Research (INRA/France); INRA-funded GISA project (Ruminflame); ECOS SUD project	DSB was the recipient of a fellowship from the French Ministry of Research and Higher Education. BS was the recipient of a CAPES-COFECUB fellowship (CAPES/Brazil) and of an Excellence Eiffel fellowship (No748798C; Campus France) from the French government. This research was supported by the French National Institute of Agricultural Research (INRA/France). Part of this work was financially supported by the INRA-funded GISA project (Ruminflame) and part was done within the framework of an ECOS SUD project (A12B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSES, 2014, ASS RISKS EM ANT RES; Arroyo R, 2010, CLIN INFECT DIS, V50, P1551, DOI 10.1086/652763; Barinov A, 2009, PROTEOMICS, V9, P61, DOI 10.1002/pmic.200800195; Behnsen J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010074; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; Bouchard D, 2012, J BACTERIOL, V194, P6292, DOI 10.1128/JB.01188-12; Bouchard DS, 2013, APPL ENVIRON MICROB, V79, P877, DOI 10.1128/AEM.03323-12; Espeche MC, 2012, ANAEROBE, V18, P103, DOI 10.1016/j.anaerobe.2012.01.002; Espeche MC, 2009, VET MICROBIOL, V135, P346, DOI 10.1016/j.vetmic.2008.09.078; Charlier C, 2009, INT J FOOD MICROBIOL, V131, P30, DOI 10.1016/j.ijfoodmicro.2008.06.032; Contreras GA, 2011, J MAMMARY GLAND BIOL, V16, P339, DOI 10.1007/s10911-011-9234-0; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Deplanche M, 2015, FASEB J, V29, P1950, DOI 10.1096/fj.14-260513; Dogan B, 2006, VET MICROBIOL, V116, P270, DOI 10.1016/j.vetmic.2006.04.023; Even S, 2014, INTERACTIVE PROBIOTICS, P52; Nader-Macias MEF, 2008, J IND MICROBIOL BIOT, V35, P1387, DOI 10.1007/s10295-008-0438-2; Frola ID, 2013, J DAIRY RES, V80, P28, DOI 10.1017/S0022029912000581; Frola ID, 2012, J DAIRY RES, V79, P84, DOI 10.1017/S0022029911000835; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Innocentin S, 2009, APPL ENVIRON MICROB, V75, P4870, DOI 10.1128/AEM.00825-09; Kechaou N, 2013, APPL ENVIRON MICROB, V79, P1491, DOI 10.1128/AEM.03075-12; Klostermann K, 2008, J DAIRY RES, V75, P365, DOI 10.1017/S0022029908003373; Le Marechal C, 2011, DAIRY SCI TECHNOL, V91, P247, DOI 10.1007/s13594-011-0009-6; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Lortal S, 1997, CURR MICROBIOL, V34, P180, DOI 10.1007/s002849900165; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Maze A, 2010, J BACTERIOL, V192, P2647, DOI 10.1128/JB.00076-10; Otero MC, 2006, LETT APPL MICROBIOL, V43, P91, DOI 10.1111/j.1472-765X.2006.01914.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reid G, 2006, FEMS IMMUNOL MED MIC, V46, P149, DOI 10.1111/j.1574-695X.2005.00026.x; Riollet C, 2000, CLIN DIAGN LAB IMMUN, V7, P161, DOI 10.1128/CDLI.7.2.161-167.2000; Roussel P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0201-4; Sengupta R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/237921; SMITH CL, 1987, METHOD ENZYMOL, V155, P449; Suojala L, 2013, J VET PHARMACOL THER, V36, P521, DOI 10.1111/jvp.12057; Suojala L, 2010, J DAIRY SCI, V93, P1960, DOI 10.3168/jds.2009-2462; Tomas MSJ, 2003, J MED MICROBIOL, V52, P1117, DOI 10.1099/jmm.0.05155-0; Turpin W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038034; VANDEVOORDE L, 1992, J APPL BACTERIOL, V72, P214, DOI 10.1111/j.1365-2672.1992.tb01826.x; Younes JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036917; Zuily S, 2011, ARCH CARDIOVASC DIS, V104, P138, DOI 10.1016/j.acvd.2010.05.005	42	67	70	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144831	10.1371/journal.pone.0144831	http://dx.doi.org/10.1371/journal.pone.0144831			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713450	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900021
J	Hestand, MS; Zeng, Z; Coleman, SJ; Liu, JZ; MacLeod, JN				Hestand, Matthew S.; Zeng, Zheng; Coleman, Stephen J.; Liu, Jinze; MacLeod, James N.			Tissue Restricted Splice Junctions Originate Not Only from Tissue-Specific Gene Loci, but Gene Loci with a Broad Pattern of Expression	PLOS ONE			English	Article							HUMAN TRANSCRIPTOME; GENOME BROWSER; NUCLEOTIDE	Cellular mechanisms that achieve protein diversity in eukaryotes are multifaceted, including transcriptional components such as RNA splicing. Through alternative splicing, a single protein-coding gene can generate multiple mRNA transcripts and protein isoforms, some of which are tissue-specific. We have conducted qualitative and quantitative analyses of the Bodymap 2.0 messenger RNA-sequencing data from 16 human tissue samples and identified 209,363 splice junctions. Of these, 22,231 (10.6%) were not previously annotated and 21,650 (10.3%) were expressed in a tissue-restricted pattern. Tissue-restricted alternative splicing was found to be widespread, with approximately 65% of expressed multi-exon genes containing at least one tissue-specific splice junction. Interestingly, we observed many tissue-specific splice junctions not only in genes expressed in one or a few tissues, but also from gene loci with a broad pattern of expression.	[Hestand, Matthew S.; Coleman, Stephen J.; MacLeod, James N.] Univ Kentucky, Dept Vet Sci, Gluck Equine Res Ctr, Lexington, KY 40506 USA; [Zeng, Zheng; Liu, Jinze] Univ Kentucky, Dept Comp Sci, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky	MacLeod, JN (corresponding author), Univ Kentucky, Dept Vet Sci, Gluck Equine Res Ctr, Lexington, KY 40506 USA.	jnmacleod@uky.edu		Coleman, Stephen/0000-0001-7686-4866	National Science Foundation [Crosscut-EF-0850237, 1054631]; Kentucky Infrastructure for Biomedical Research Excellence award (KY-INBRE) from the National Institutes of Health [5P20RR016481-09]; Lourie Foundation; Gluck Equine Research Center, University of Kentucky; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006272] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1054631] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Kentucky Infrastructure for Biomedical Research Excellence award (KY-INBRE) from the National Institutes of Health; Lourie Foundation; Gluck Equine Research Center, University of Kentucky; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by the National Science Foundation (Crosscut-EF-0850237 to J.L. and J.N.M. and 1054631 to J.L.) and a Kentucky Infrastructure for Biomedical Research Excellence award (KY-INBRE, 5P20RR016481-09) from the National Institutes of Health. Additional financial support was received from the Lourie Foundation and through endowments at the Gluck Equine Research Center, University of Kentucky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the Liu laboratory for assistance using MapSplice. This work was supported by the National Science Foundation (Crosscut-EF-0850237 to J.L. and J.N.M. and 1054631 to J.L.) and a Kentucky Infrastructure for Biomedical Research Excellence award (KY-INBRE, 5P20RR016481-09) from the National Institutes of Health. Additional financial support was received from the Lourie Foundation and through endowments at the Gluck Equine Research Center, University of Kentucky.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Camon Evelyn, 2004, In Silico Biology, V4, P5; de la Grange P, 2010, NUCLEIC ACIDS RES, V38, P2825, DOI 10.1093/nar/gkq008; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Fagerberg L, 2013, J PROTEOME RES, V12, P2439, DOI 10.1021/pr300924j; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Florea Liliana, 2013, F1000Res, V2, P188, DOI 10.12688/f1000research.2-188.v1; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gonzalez-Porta M, 2012, GENOME RES, V22, P528, DOI 10.1101/gr.121947.111; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Hoffman JD, 1998, AM J MED GENET, V80, P140, DOI 10.1002/(SICI)1096-8628(19981102)80:2<140::AID-AJMG10>3.0.CO;2-L; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KURAHASHI H, 1995, CANCER RES, V55, P5007; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neklason Deborah W, 2004, Fam Cancer, V3, P35; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Song L, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S14; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Thomas S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094650; Tilgner H, 2014, P NATL ACAD SCI USA, V111, P9869, DOI 10.1073/pnas.1400447111; Venables JP, 2012, NUCLEIC ACIDS RES, V40, P1, DOI 10.1093/nar/gkr648; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144302	10.1371/journal.pone.0144302	http://dx.doi.org/10.1371/journal.pone.0144302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713731	gold, Green Published, Green Submitted			2022-12-27	WOS:000367481900007
J	Huang, Y; Xiong, YY; Lin, ZH; Feng, XY; Jiang, X; Zhou, SY; Huang, JJ				Huang, Yan; Xiong, Yuanyan; Lin, Zhuoheng; Feng, Xuyang; Jiang, Xue; Zhou Songyang; Huang, Junjiu			Specific Tandem 3 ' UTR Patterns and Gene Expression Profiles in Mouse Thy1(+) Germline Stem Cells	PLOS ONE			English	Article							3' UNTRANSLATED REGIONS; MESSENGER-RNA POLYADENYLATION; ALTERNATIVE POLYADENYLATION; ZEBRAFISH DEVELOPMENT; SELF-RENEWAL; SPERMATOGENESIS; IDENTIFICATION; INFERTILITY; CLEAVAGE; DEFECTS	A recently developed strategy of sequencing alternative polyadenylation (APA) sites (SAPAS) with second-generation sequencing technology can be used to explore complete genome-wide patterns of tandem APA sites and global gene expression profiles. spermatogonial stem cells (SSCs) maintain long-term reproductive abilities in male mammals. The detailed mechanisms by which SSCs self-renew and generate mature spermatozoa are not clear. To understand the specific alternative polyadenylation pattern and global gene expression profile of male germline stem cells (GSCs, mainly referred to SSCs here), we isolated and purified mouse Thy1(+) cells from testis by magnetic-activated cell sorting (MACS) and then used the SAPAS method for analysis, using pluripotent embryonic stem cells (ESCs) and differentiated mouse embryonic fibroblast cells (MEFs) as controls. As a result, we obtained 99,944 poly(A) sites, approximately 40% of which were newly detected in our experiments. These poly(A) sites originated from three mouse cell types and covered 17,499 genes, including 831 long non-coding RNA (lncRNA) genes. We observed that GSCs tend to have shorter 3'UTR lengths while MEFs tend towards longer 3'UTR lengths. We also identified 1337 genes that were highly expressed in GSCs, and these genes were highly consistent with the functional characteristics of GSCs. Our detailed bioinformatics analysis identified APA site-switching events at 3'UTRs and many new specifically expressed genes in GSCs, which we experimentally confirmed. Furthermore, qRT-PCR was performed to validate several events of the 334 genes with distal-to-proximal poly(A) switch in GSCs. Consistently APA reporter assay confirmed the total 3'UTR shortening in GSCs compared to MEFs. We also analyzed the cis elements around the proximal poly(A) site preferentially used in GSCs and found C-rich elements may contribute to this regulation. Overall, our results identified the expression level and polyadenylation site profiles and these data provide new insights into the processes potentially involved in the GSC life cycle and spermatogenesis.	[Huang, Yan; Xiong, Yuanyan; Lin, Zhuoheng; Feng, Xuyang; Jiang, Xue; Zhou Songyang; Huang, Junjiu] Sun Yat Sen Univ, Affiliated Hosp 1, Key Lab Reprod Med Guangdong Prov, Guangzhou 51000, Guangdong, Peoples R China; [Huang, Yan; Xiong, Yuanyan; Lin, Zhuoheng; Feng, Xuyang; Jiang, Xue; Zhou Songyang; Huang, Junjiu] Sun Yat Sen Univ, Sch Life Sci, Minist Educ, Key Lab Gene Engn, Guangzhou 51000, Guangdong, Peoples R China; [Xiong, Yuanyan] SYSU CMU Shunde Int Joint Res Inst, Shunde, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Huang, JJ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Key Lab Reprod Med Guangdong Prov, Guangzhou 51000, Guangdong, Peoples R China.	hjunjiu@mail.sysu.edu.cn			Natural Science Foundation of Guangdong Province [2014A030312011]; Science and Technology Planning Project of Guangdong Province [2015B020228002, 2015A020212010]; National Natural Science Foundation [31371508, 31401223, 31301085, 81330055, J1310025]; Program of International ST Cooperation [2014DFB30020]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program of International ST Cooperation	This study was supported by the Natural Science Foundation of Guangdong Province (2014A030312011), the Science and Technology Planning Project of Guangdong Province (2015B020228002, 2015A020212010), the National Natural Science Foundation (31371508, 31401223, 31301085, 81330055 and J1310025) and the Program of International S&T Cooperation (2014DFB30020).; This study was supported by the Natural Science Foundation of Guangdong Province (2014A030312011), the Science and Technology Planning Project of Guangdong Province (2015B020228002, 2015A020212010), the National Natural Science Foundation (31371508, 31401223, 31301085, 81330055 and J1310025) and the Program of International S&T Cooperation (2014DFB30020). We would like to thank Dr. Bin Tian for kindly providing the APA reporter plasmids 77S.AD and 77S.AE. We also thank Dr. Yuwen Qiu and Zhini Zhang for their helpful suggestions in animal experimental design.	Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Dass B, 2007, P NATL ACAD SCI USA, V104, P20374, DOI 10.1073/pnas.0707589104; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Hammoud SS, 2014, CELL STEM CELL, V15, P239, DOI 10.1016/j.stem.2014.04.006; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hockert KJ, 2011, J REPROD IMMUNOL, V89, P26, DOI 10.1016/j.jri.2011.01.018; Hoque M, 2013, NAT METHODS, V10, P133, DOI [10.1038/NMETH.2288, 10.1038/nmeth.2288]; Huang JJ, 2011, CELL RES, V21, P779, DOI 10.1038/cr.2011.16; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Ji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008419; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kogo H, 2010, J HUM GENET, V55, P293, DOI 10.1038/jhg.2010.26; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Lefevre C, 2008, DEV DYNAM, V237, P1082, DOI 10.1002/dvdy.21482; Li WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048373; Li YX, 2012, GENOME RES, V22, P1899, DOI 10.1101/gr.128488.111; Lianoglou S, 2013, GENE DEV, V27, P2380, DOI 10.1101/gad.229328.113; Liu DL, 2007, NUCLEIC ACIDS RES, V35, P234, DOI 10.1093/nar/gkl919; MacDonald CC, 2002, MOL CELL ENDOCRINOL, V190, P1, DOI 10.1016/S0303-7207(02)00044-8; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Masamha CP, 2014, NATURE, V510, P412, DOI 10.1038/nature13261; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Oatley JM, 2009, DEVELOPMENT, V136, P1191, DOI 10.1242/dev.032243; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Smibert P, 2012, CELL REP, V1, P277, DOI 10.1016/j.celrep.2012.01.001; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Xiao SJ, 2010, BIOINFORMATICS, V26, P1273, DOI 10.1093/bioinformatics/btq109; Yang LL, 2013, GENESIS, V51, P83, DOI 10.1002/dvg.22358; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	35	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145417	10.1371/journal.pone.0145417	http://dx.doi.org/10.1371/journal.pone.0145417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713853	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900040
J	Liu, JD; He, ZH; Wu, L; Bai, B; Wen, WE; Xie, CJ; Xia, XC				Liu, Jindong; He, Zhonghu; Wu, Ling; Bai, Bin; Wen, Weie; Xie, Chaojie; Xia, Xianchun			Genome-Wide Linkage Mapping of QTL for Adult-Plant Resistance to Stripe Rust in a Chinese Wheat Population Linmai 2 x Zhong 892	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LEAF RUST; HIGH-TEMPERATURE; DURABLE RESISTANCE; POWDERY MILDEW; PUCCINIA-STRIIFORMIS; GENETIC-LINKAGE; DISEASE RESISTANCE; MAP; CULTIVAR	Stripe rust is one of the most devastating diseases of wheat (Triticum aestivum) worldwide. Adult-plant resistance (APR) is an efficient approach to provide long-term protection of wheat from the disease. The Chinese winter wheat cultivar Zhong 892 has a moderate level of APR to stripe rust in the field. To determine the inheritance of the APR resistance in this cultivar, 273 F-6 recombinant inbred lines (RILs) were developed from a cross between Linmai 2 and Zhong 892. The RILs were evaluated for maximum disease severity (MDS) in two sites during the 2011-2012, 2012-2013 and 2013-2014 cropping seasons, providing data for five environments. Illumina 90k SNP (single nucleotide polymorphism) chips were used to genotype the RILs and their parents. Composite interval mapping (CIM) detected eight QTL, namely QYr.caas-2AL, QYr.caas-2BL.3, QYr.caas-3AS, QYr.caas-3BS, QYr.caas-5DL, QYr.caas-6AL, QYr.caas-7AL and QYr.caas-7DS. 1, respectively. All except QYr.caas-2BL. 3 resistance alleles were contributed by Zhong 892. QYr.caas-3AS and QYr.caas-3BS conferred stable resistance to stripe rust in all environments, explaining 6.2-17.4% and 5.0-11.5% of the phenotypic variances, respectively. The genome scan of SNP sequences tightly linked to QTL for APR against annotated proteins in wheat and related cereals genomes identified two candidate genes (autophagy-related gene and disease resistance gene RGA1), significantly associated with stripe rust resistance. These QTL and their closely linked SNP markers, in combination with kompetitive allele specific PCR (KASP) technology, are potentially useful for improving stripe rust resistances in wheat breeding.	[Liu, Jindong; He, Zhonghu; Xia, Xianchun] Chinese Acad Agr Sci, Natl Wheat Improvement Ctr, Inst Crop Sci, Beijing 100193, Peoples R China; [Liu, Jindong] China Agr Univ, State Key Lab Agrobiotechnol, Dept Plant Genet & Breeding, Beijing 100094, Peoples R China; [He, Zhonghu] Chinese Acad Agr Sci, Int Maize & Wheat Improvement Ctr CIMMYT China Of, Beijing 100193, Peoples R China; [Wu, Ling] Sichuan Acad Agr Sci, Crop Res Inst, Chengdu, Sichuan, Peoples R China; [Bai, Bin] Gansu Acad Agr Sci, Wheat Res Inst, Lanzhou, Gansu, Peoples R China; [Wen, Weie] Xinjiang Agr Univ, Coll Agron, Urumqi, Xinjiang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; China Agricultural University; Chinese Academy of Agricultural Sciences; Sichuan Academy of Agricultural Sciences (SAAS); Xinjiang Agricultural University	Xia, XC (corresponding author), Chinese Acad Agr Sci, Natl Wheat Improvement Ctr, Inst Crop Sci, Beijing 100193, Peoples R China.	xiaxianchun@caas.cn	; Liu, Jindong/C-8422-2017	Bai, Bin/0000-0001-9904-9987; He, Zhonghu/0000-0003-1384-3712; Liu, Jindong/0000-0002-5927-4845	National Key Basic Research Program of China [2013CB127700]; National Natural Science Foundation of China [31261140370]; Ministry of Science and Technology [2011DFG32990, 2013DFG30530]; Ministry of Agriculture [2011-G3]; National 863 Project [2012AA101105]; China Agricultural Research System [CARS-3-1-3]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); National 863 Project(National High Technology Research and Development Program of China); China Agricultural Research System	This study was supported by the National Key Basic Research Program of China (2013CB127700), National Natural Science Foundation of China (31261140370), International Collaboration Projects from the Ministry of Science and Technology (2011DFG32990, 2013DFG30530) and Ministry of Agriculture (2011-G3), National 863 Project (2012AA101105), and the China Agricultural Research System (CARS-3-1-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Prof. R. A. McIntosh, Plant Breeding Institute, University of Sydney, for critical review of this manuscript. This study was supported by the National Key Basic Research Program of China (2013CB127700), National Natural Science Foundation of China (31261140370), International Collaboration Projects from the Ministry of Science and Technology (2011DFG32990, 2013DFG30530) and Ministry of Agriculture (2011-G3), National 863 Project (2012AA101105), and the China Agricultural Research System (CARS-3-1-3).	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Avni R, 2014, MOL BREEDING, V34, P1549, DOI 10.1007/s11032-014-0176-2; Bariana HS, 2001, AUST J AGR RES, V52, P1247, DOI 10.1071/AR01040; Basnet BR, 2014, MOL BREEDING, V33, P385, DOI 10.1007/s11032-013-9957-2; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Boukhatem N, 2002, THEOR APPL GENET, V104, P111, DOI 10.1007/s001220200013; Carter AH, 2009, THEOR APPL GENET, V119, P1119, DOI 10.1007/s00122-009-1114-2; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P567, DOI 10.1094/Phyto-85-567; Colasuonno P, 2014, MOL BREEDING, V34, P1563, DOI 10.1007/s11032-014-0183-3; Cuthbert PA, 2006, THEOR APPL GENET, V112, P1465, DOI 10.1007/s00122-006-0249-7; Dedryver F, 2009, PHYTOPATHOLOGY, V99, P968, DOI 10.1094/PHYTO-99-8-0968; DEVOS KM, 1993, THEOR APPL GENET, V85, P784, DOI 10.1007/BF00225020; DYCK PL, 1987, GENOME, V29, P467, DOI 10.1139/g87-081; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Hao YF, 2011, THEOR APPL GENET, V123, P1401, DOI 10.1007/s00122-011-1675-8; HARE RA, 1979, Z PFLANZENZUCHT, V83, P350; He ZhongHu, 2011, Scientia Agricultura Sinica, V44, P2193; Herrera-Foessel SA, 2011, THEOR APPL GENET, V122, P239, DOI 10.1007/s00122-010-1439-x; Imtiaz M, 2004, PLANT BREEDING, V123, P401, DOI 10.1111/j.1439-0523.2004.01002.x; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; JOHNSON R, 1981, PHYTOPATHOLOGY, V71, P567, DOI 10.1094/Phyto-71-567; JOHNSON R, 1984, ANNU REV PHYTOPATHOL, V22, P309, DOI 10.1146/annurev.py.22.090184.001521; JOHNSON R, 1992, EUPHYTICA, V63, P3, DOI 10.1007/BF00023908; Khlestkina EK, 2007, EUPHYTICA, V153, P1, DOI 10.1007/s10681-006-9182-8; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Lagudah ES, 2006, THEOR APPL GENET, V114, P21, DOI 10.1007/s00122-006-0406-z; Lagudah ES, 2011, EUPHYTICA, V179, P81, DOI 10.1007/s10681-010-0336-3; Lan CX, 2015, THEOR APPL GENET, V128, P549, DOI 10.1007/s00122-015-2454-8; Li ZF, 2014, CROP SCI, V54, P1907, DOI 10.2135/cropsci2014.02.0162; Lillemo M, 2008, THEOR APPL GENET, V116, P1155, DOI 10.1007/s00122-008-0743-1; Lin F, 2007, THEOR APPL GENET, V114, P1277, DOI 10.1007/s00122-007-0518-0; Lowe I, 2011, THEOR APPL GENET, V123, P143, DOI 10.1007/s00122-011-1573-0; Lu YM, 2009, THEOR APPL GENET, V119, P1349, DOI 10.1007/s00122-009-1139-6; Lu Y, 2014, THEOR APPL GENET, V127, P1449, DOI 10.1007/s00122-014-2312-0; Mago R, 2011, THEOR APPL GENET, V123, P615, DOI 10.1007/s00122-011-1611-y; Mcintosh R.A., 2014, CATALOGUE GENE SYMBO; MCINTOSH RA, 1992, PLANT PATHOL, V41, P523, DOI 10.1111/j.1365-3059.1992.tb02450.x; Mclntosh RA, 2011, CATALOGUE GENE SYM S; National Agro-technical Extension and Service Center (NAESC), 2014, CHINA PLANT PROT, V33, P47; National Agro-technical Extension and Service Center (NAESC), 2013, CHINA PLANT PROT, V33, P35; Navabi A, 2005, GENOME, V48, P97, DOI [10.1139/g04-100, 10.1139/G04-100]; Pei D, 2014, PLANT CELL REP, V33, P1697, DOI 10.1007/s00299-014-1648-x; Quan W, 2013, EUR J PLANT PATHOL, V136, P715, DOI 10.1007/s10658-013-0201-z; Ramburan VP, 2004, THEOR APPL GENET, V108, P1426, DOI 10.1007/s00122-003-1567-7; Ren J, 2013, INT J MOL SCI, V14, P7061, DOI 10.3390/ijms14047061; Ren RS, 2012, THEOR APPL GENET, V125, P847, DOI 10.1007/s00122-012-1877-8; Ren Y, 2012, THEOR APPL GENET, V125, P1253, DOI 10.1007/s00122-012-1910-y; Ren Y, 2012, THEOR APPL GENET, V125, P1211, DOI 10.1007/s00122-012-1907-6; Roder MS, 1998, GENETICS, V149, P2007; Rosewarne GM, 2013, THEOR APPL GENET, V126, P2427, DOI 10.1007/s00122-013-2159-9; Rosewarne GM, 2012, THEOR APPL GENET, V124, P1283, DOI 10.1007/s00122-012-1786-x; Rosewarne GM, 2006, THEOR APPL GENET, V112, P500, DOI 10.1007/s00122-005-0153-6; Russo MA, 2014, MOL BREEDING, V34, P1579, DOI 10.1007/s11032-014-0181-5; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Singh R. P., 2000, Acta Phytopathologica et Entomologica Hungarica, V35, P133; Singh RP, 2011, EUPHYTICA, V179, P175, DOI 10.1007/s10681-010-0322-9; Singh Ravi Prakash, 2005, Turkish Journal of Agriculture and Forestry, V29, P121; Singh RP, 2014, J INTEGR AGR, V13, P255, DOI 10.1016/S2095-3119(13)60649-8; SINGH RP, 1992, PHYTOPATHOLOGY, V82, P835, DOI 10.1094/Phyto-82-835; Singh RP, 2000, CROP SCI, V40, P1148, DOI 10.2135/cropsci2000.4041148x; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Spielmeyer W, 2003, CROP SCI, V43, P333, DOI 10.2135/cropsci2003.0333; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Stubbs R. W., 1985, CEREAL RUSTS, V2, P61, DOI 10.1016/B978-0-12-148402-6.50011-0; Suenaga K, 2003, PHYTOPATHOLOGY, V93, P881, DOI 10.1094/PHYTO.2003.93.7.881; Uauy C, 2005, THEOR APPL GENET, V112, P97, DOI 10.1007/s00122-005-0109-x; Vazquez MD, 2012, THEOR APPL GENET, V124, P1, DOI 10.1007/s00122-011-1681-x; Velappan N, 2001, DIAGN MICR INFEC DIS, V39, P77, DOI 10.1016/S0732-8893(00)00235-2; Veldboom LR, 1996, CROP SCI, V36, P1310, DOI 10.2135/cropsci1996.0011183X003600050040x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wan AM, 2007, AUST J AGR RES, V58, P605, DOI 10.1071/AR06142; Wang S, 2012, WINDOWS QTL CARTOGRA; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wang ZL, 2005, PLANT DIS, V89, P457, DOI 10.1094/PD-89-0457; Wellings CR, 2011, EUPHYTICA, V179, P129, DOI 10.1007/s10681-011-0360-y; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; William HM, 2006, GENOME, V49, P977, DOI 10.1139/G06-052; Zhou XL, 2014, THEOR APPL GENET, V127, P935, DOI 10.1007/s00122-014-2269-z; Zwart RS, 2010, MOL BREEDING, V26, P107, DOI 10.1007/s11032-009-9381-9	82	19	20	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145462	10.1371/journal.pone.0145462	http://dx.doi.org/10.1371/journal.pone.0145462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714310	gold, Green Submitted, Green Published			2022-12-27	WOS:000367481900044
J	Moll, K; Palmkvist, M; Ch'ng, J; Kiwuwa, MS; Wahlgren, M				Moll, Kirsten; Palmkvist, Mia; Ch'ng, Junhong; Kiwuwa, Mpungu Steven; Wahlgren, Mats			Evasion of Immunity to Plasmodium falciparum: Rosettes of Blood Group A Impair Recognition of PfEMP1	PLOS ONE			English	Article							HUMAN CEREBRAL MALARIA; INFECTED ERYTHROCYTES; MULTIPLICATION RATE; IN-VIVO; ASSOCIATION; PROTECTION; PARASITES; CELLS; SUSCEPTIBILITY; SURFACE	The ABO blood group antigens are expressed on erythrocytes but also on endothelial cells, platelets and serum proteins. Notably, the ABO blood group of a malaria patient determines the development of the disease given that blood group O reduces the probability to succumb in severe malaria, compared to individuals of groups A, B or AB. P. falciparum rosetting and sequestration are mediated by PfEMP1, RIFIN and STEVOR, expressed at the surface of the parasitized red blood cell (pRBC). Antibodies to these antigens consequently modify the course of a malaria infection by preventing sequestration and promoting phagocytosis of pRBC. Here we have studied rosetting P. falciparum and present evidence of an immune evasion mechanismnot previously recognized. We find the accessibility of antibodies to PfEMP1 at the surface of the pRBC to be reduced when P. falciparum forms rosettes in blood group A RBC, as compared to group O RBC. The pRBC surrounds itself with tightly bound normal RBC that makes PfEMP1 inaccessible to antibodies and clearance by the immune system. Accordingly, pRBC of in vitro cloned P. falciparum devoid of ABO blood group dependent rosetting were equally well detected by anti-PfEMP1 antibodies, independent of the blood group utilized for their propagation. The pathogenic mechanisms underlying the severe forms of malaria may in patients of blood group A depend on the ability of the parasite to mask PfEMP1 from antibody recognition, in so doing evading immune clearance.	[Moll, Kirsten; Palmkvist, Mia; Ch'ng, Junhong; Wahlgren, Mats] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, SE-17177 Stockholm, Sweden; [Kiwuwa, Mpungu Steven] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Pediat, Kampala, Uganda; [Kiwuwa, Mpungu Steven] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Biochem, Kampala, Uganda	Karolinska Institutet; Makerere University; Makerere University	Moll, K (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Box 280,Nobels Vag 16, SE-17177 Stockholm, Sweden.	kirsten.moll@ki.se; mats.wahlgren@ki.se	Ch'ng, Jun Hong/V-7150-2019					Albrecht L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-17; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; ALYAMAN F, 1995, T ROY SOC TROP MED H, V89, P55, DOI 10.1016/0035-9203(95)90658-4; Angeletti D., 2013, PLOS ONE, V7; Angeletti D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118898; Angeletti D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-32; Band G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003509; Barfod L, 2011, P NATL ACAD SCI USA, V108, P12485, DOI 10.1073/pnas.1103708108; Barragan A, 2000, INFECT IMMUN, V68, P2971, DOI 10.1128/IAI.68.5.2971-2975.2000; Beiguelman B, 2003, MEM I OSWALDO CRUZ, V98, P455, DOI 10.1590/S0074-02762003000400004; Burman N, 1998, INFECT IMMUN, V66, P815, DOI 10.1128/IAI.66.2.815-819.1998; CARLSON J, 1992, J EXP MED, V176, P1311, DOI 10.1084/jem.176.5.1311; CARLSON J, 1994, BLOOD, V84, P3909, DOI 10.1182/blood.V84.11.3909.bloodjournal84113909; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; CELADA A, 1982, CLIN EXP IMMUNOL, V47, P635; Chotivanich K, 2000, J INFECT DIS, V181, P1206, DOI 10.1086/315353; Clough B, 1998, EXP PARASITOL, V89, P129, DOI 10.1006/expr.1998.4275; Clough B, 1998, BRIT J HAEMATOL, V100, P99, DOI 10.1046/j.1365-2141.1998.00534.x; Cooling L, 2015, CLIN MICROBIOL REV, V28, P801, DOI 10.1128/CMR.00109-14; Cserti CM, 2007, BLOOD, V110, P2250, DOI 10.1182/blood-2007-03-077602; Deans AM, 2006, AM J TROP MED HYG, V74, P554, DOI 10.4269/ajtmh.2006.74.554; Deepa, 2011, J VECTOR DIS, V48, P7; Fairhurst RM, 2003, BLOOD, V101, P3309, DOI 10.1182/blood-2002-10-3105; FANDEUR T, 1995, J EXP MED, V181, P283, DOI 10.1084/jem.181.1.283; Fischer PR, 1998, AM J TROP MED HYG, V58, P122, DOI 10.4269/ajtmh.1998.58.122; FRATTALI A, 1997, MOL BIOL EVOLUTION B, P268; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; Ghumra A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016414; Goel S, 2015, NAT MED, V21, P314, DOI 10.1038/nm.3812; KAUL DK, 1991, BLOOD, V78, P812; Kiwuwa MS, 2013, PARASITOL RES, V112, P1691, DOI 10.1007/s00436-013-3325-3; Le Scanf C, 2008, MICROBES INFECT, V10, P447, DOI 10.1016/j.micinf.2007.12.012; Lee WC, 2014, BLOOD; Lell B, 1999, CLIN INFECT DIS, V28, P794, DOI 10.1086/515193; Loscertales MP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-72; Lowe BS, 1998, T ROY SOC TROP MED H, V92, P526, DOI 10.1016/S0035-9203(98)90901-4; Marin-Menendez A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002155; Migot-Nabias F, 2000, GENES IMMUN, V1, P435, DOI 10.1038/sj.gene.6363703; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mok BW, 2007, MOL BIOCHEM PARASIT, V151, P184, DOI 10.1016/j.molbiopara.2006.11.006; Moll K, 2014, METHODS MALARIA RES; Moulds JM, 2000, TRANSFUS MED REV, V14, P302, DOI 10.1053/tmrv.2000.16227; Pathirana SL, 2005, ANN TROP MED PARASIT, V99, P119, DOI 10.1179/136485905X19946; Ribacke U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069781; Rockett KA, 2014, NAT GENET, V46, P1197, DOI 10.1038/ng.3107; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; Rowe JA, 2002, AM J TROP MED HYG, V66, P692, DOI 10.4269/ajtmh.2002.66.692; Rowe JA, 2002, AM J TROP MED HYG, V66, P458, DOI 10.4269/ajtmh.2002.66.458; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Scholander C, 1996, NAT MED, V2, P204, DOI 10.1038/nm0296-204; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; Thakur A., 1992, Indian Journal of Malariology, V29, P241; Treutiger CJ, 1999, EXP PARASITOL, V93, P215, DOI 10.1006/expr.1999.4454; TREUTIGER CJ, 1992, AM J TROP MED HYG, V46, P503, DOI 10.4269/ajtmh.1992.46.503; UDOMSANGPETCH R, 1993, AM J TROP MED HYG, V48, P149, DOI 10.4269/ajtmh.1993.48.149; UDOMSANGPETCH R, 1993, BLOOD, V82, P3752; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; Vigan-Womas I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002781; Vogt AM, 2003, BLOOD, V101, P2405, DOI 10.1182/blood-2002-07-2016; Vogt AM, 2006, PLOS PATHOG, V2, P853, DOI 10.1371/journal.ppat.0020100; WAHLGREN M, 1989, PARASITOL TODAY, V5, P183, DOI 10.1016/0169-4758(89)90141-5; Wolofsky KT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002942	63	29	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145120	10.1371/journal.pone.0145120	http://dx.doi.org/10.1371/journal.pone.0145120			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714011	Green Published, gold			2022-12-27	WOS:000367481900033
J	Luo, M; Li, JX; Sun, XS; Lai, R; Wang, YF; Xu, XW; Sheng, WL				Luo, Man; Li, Jiaoxing; Sun, Xunsha; Lai, Rong; Wang, Yufang; Xu, Xiaowei; Sheng, Wenli			Interactions among Candidate Genes Selected by Meta-Analyses Resulting in Higher Risk of Ischemic Stroke in a Chinese Population	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; INSERTION DELETION POLYMORPHISM; ATHEROSCLEROSIS; CONFERS; ASSOCIATION; GENOTYPES	Ischemic stroke (IS) is a multifactorial disorder caused by both genetic and environmental factors. The combined effects of multiple susceptibility genes might result in a higher risk for IS than a single gene. Therefore, we investigated whether interactions among multiple susceptibility genes were associated with an increased risk of IS by evaluating gene polymorphisms identified in previous meta-analyses, including methylenetetrahydrofolate reductase (MTHFR) C677T, beta fibrinogen (FGB, beta-FG) A455G and T148C, apolipoprotein E (APOE) epsilon 2-4, angiotensin-converting enzyme (ACE) insertion/deletion (I/D), and endothelial nitric oxide synthase (eNOS) G894T. In order to examine these interactions, 712 patients with IS and 774 controls in a Chinese Han population were genotyped using the SNaPshot method, and multifactor dimensionality reduction analysis was used to detect potential interactions among the candidate genes. The results of this study found that ACE I/D and beta-FG T148C were significant synergistic contributors to IS. In particular, the ACE DD + beta-FG 148CC, ACE DD + beta-FG 148CT, and ACE ID + beta-FG 148CC genotype combinations resulted in higher risk of IS. After adjusting for potential confounding IS risk factors (age, gender, family history of IS, hypertension history and history of diabetes mellitus) using a logistic analysis, a significant correlation between the genotype combinations and IS patients persisted (overall stroke: adjusted odds ratio [OR] = 1.57, 95% confidence interval [CI]: 1.22-2.02, P < 0.001, large artery atherosclerosis subtype: adjusted OR = 1.50, 95% CI: 1.08-2.07, P = 0.016, small-artery occlusion subtype: adjusted OR = 2.04, 95% CI: 1.43-2.91, P < 0.001). The results of this study indicate that the ACE I/D and beta-FG T148C combination may result in significantly higher risk of IS in this Chinese population.	[Luo, Man; Li, Jiaoxing; Sun, Xunsha; Lai, Rong; Wang, Yufang; Sheng, Wenli] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Xiaowei] Weifang Peoples Hosp, Dept Neurol, Weifang, Shandong, Peoples R China	Sun Yat Sen University	Xu, XW (corresponding author), Weifang Peoples Hosp, Dept Neurol, Weifang, Shandong, Peoples R China.	qyeileen@163.com; shengwl@mail.sysu.edu.cn		Sheng, Wenli/0000-0001-6867-371X; Luo, Man/0000-0002-0543-9763	National Natural Science Foundation of China [81070912]; Guangxi Natural Science Foundation [2013GXNSFBA019131, 2015GXNSFAA139171]; Self-financing Science Foundation of Guangxi Health Bureau [Z2012096]; Shandong Province Excellent Young Scientist Research Award Fund [BS2012YY035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Self-financing Science Foundation of Guangxi Health Bureau; Shandong Province Excellent Young Scientist Research Award Fund	This work was supported by National Natural Science Foundation of China (81070912, http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list), Guangxi Natural Science Foundation (2013GXNSFBA019131) and (2015GXNSFAA139171), Self-financing Science Foundation of Guangxi Health Bureau (#Z2012096), and Shandong Province Excellent Young Scientist Research Award Fund (#BS2012YY035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; DANSER AHJ, 1995, CIRCULATION, V92, P1387, DOI 10.1161/01.CIR.92.6.1387; Fish RJ, 2012, THROMB HAEMOSTASIS, V108, P419, DOI 10.1160/TH12-04-0273; Flossmann E, 2004, STROKE, V35, P212, DOI 10.1161/01.STR.0000107187.84390.AA; Gao XG, 2006, NEUROSCI LETT, V398, P172, DOI 10.1016/j.neulet.2005.12.078; Green D, 2009, ATHEROSCLEROSIS, V202, P623, DOI 10.1016/j.atherosclerosis.2008.05.039; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hassan A, 2000, BRAIN, V123, P1784, DOI 10.1093/brain/123.9.1784; HUMPHRIES SE, 1987, LANCET, V1, P1452, DOI 10.1016/S0140-6736(87)92205-7; Juo SHH, 2009, FRONT BIOSCI-LANDMRK, V14, P4525, DOI 10.2741/3545; Kardys I, 2007, THROMB HAEMOSTASIS, V97, P288, DOI 10.1160/TH06-10-0554; Li W, 2012, CNS NEUROSCI THER, V18, P558, DOI 10.1111/j.1755-5949.2012.00322.x; Luo M, 2014, CNS NEUROSCI THER, V20, P893, DOI 10.1111/cns.12298; Luo M, 2014, J CLIN NEUROSCI, V21, P1740, DOI 10.1016/j.jocn.2013.12.034; Pezzini A, 2005, STROKE, V36, P533, DOI 10.1161/01.STR.0000155741.31499.c2; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Sharma P, 1996, J HYPERTENS, V14, P277, DOI 10.1097/00004872-199603000-00002; Shen CD, 2007, ANN HUM GENET, V71, P620, DOI 10.1111/j.1469-1809.2007.00364.x; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; Wang MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060472; Wang YT, 2013, ATHEROSCLEROSIS, V226, P3, DOI 10.1016/j.atherosclerosis.2012.08.018; Xu XW, 2008, CEREBROVASC DIS, V26, P48, DOI 10.1159/000135653	25	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145399	10.1371/journal.pone.0145399	http://dx.doi.org/10.1371/journal.pone.0145399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710338	Green Submitted, gold, Green Published			2022-12-27	WOS:000367451400044
J	Wang, B; Swaminathan, S; Bhattacharyya, MK				Wang, Bing; Swaminathan, Sivakumar; Bhattacharyya, Madan K.			Identification of Fusarium virguliforme FvTox1-Interacting Synthetic Peptides for Enhancing Foliar Sudden Death Syndrome Resistance in Soybean	PLOS ONE			English	Article							ANTHRAX TOXIN; PROTECTION; INHIBITORS; PATHOGEN; ANTIBODY; SOLANI; PLANTS	Soybean is one of the most important crops grown across the globe. In the United States, approximately 15% of the soybean yield is suppressed due to various pathogen and pests attack. Sudden death syndrome (SDS) is an emerging fungal disease caused by Fusarium virguliforme. Although growing SDS resistant soybean cultivars has been the main method of controlling this disease, SDS resistance is partial and controlled by a large number of quantitative trait loci (QTL). A proteinacious toxin, FvTox1, produced by the pathogen, causes foliar SDS. Earlier, we demonstrated that expression of an anti-FvTox1 single chain variable fragment antibody resulted in reduced foliar SDS development in transgenic soybean plants. Here, we investigated if synthetic FvTox1-interacting peptides, displayed on M13 phage particles, can be identified for enhancing foliar SDS resistance in soybean. We screened three phage-display peptide libraries and discovered four classes of M13 phage clones displaying FvTox1-interacting peptides. In vitro pull-down assays and in vivo interaction assays in yeast were conducted to confirm the interaction of FvTox1 with these four synthetic peptides and their fusion-combinations. One of these peptides was able to partially neutralize the toxic effect of FvTox1 in vitro. Possible application of the synthetic peptides in engineering SDS resistance soybean cultivars is discussed.	[Wang, Bing; Swaminathan, Sivakumar; Bhattacharyya, Madan K.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA	Iowa State University	Bhattacharyya, MK (corresponding author), Iowa State Univ, Dept Agron, Ames, IA 50011 USA.	mbhattac@iastate.edu	bing, wang/ABG-9255-2020	Swaminathan, Sivakumar/0000-0003-3931-275X	National Institute of Food and Agriculture (NIFA), United States Department of Agriculture [2013-68004-20374]	National Institute of Food and Agriculture (NIFA), United States Department of Agriculture	This work was supported by the National Institute of Food and Agriculture (NIFA), United States Department of Agriculture (Grant no. 2013-68004-20374).; We thank Jordan L Baumbach for reviewing the manuscript. This work was supported by the National Institute of Food and Agriculture (NIFA), United States Department of Agriculture (Grant no. 2013-68004-20374).	Abdeen SJ, 2010, ACS CHEM BIOL, V5, P1097, DOI 10.1021/cb100209b; Abeysekara NS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093667; Bashat S, 2006, P NATL ACAD SCI USA, V103, P13509, DOI 10.1073/pnas.0509870103; Bishop-Hurley SL, 2002, APPL ENVIRON MICROB, V68, P3315, DOI 10.1128/AEM.68.7.3315-3320.2002; Brar HK, 2012, MOL PLANT MICROBE IN, V25, P817, DOI 10.1094/MPMI-12-11-0317; Brar HK, 2011, MOL PLANT MICROBE IN, V24, P1179, DOI 10.1094/MPMI-12-10-0285; Fang ZWD, 2010, PHYTOPATHOLOGY, V100, P1111, DOI 10.1094/PHYTO-12-09-0365; Fang ZD, 2006, P NATL ACAD SCI USA, V103, P18444, DOI 10.1073/pnas.0605542103; Hartman GL, 2015, CROP PROT, V73, P60, DOI 10.1016/j.cropro.2015.01.017; Hirrel M. C., 1987, AM SEED TRAD ASS 16, P95; Ji J, 2006, PLANT BIOLOGY, V8, P597, DOI 10.1055/s-2006-924175; Jin H, 1996, PHYTOPATHOLOGY, V86, P277, DOI 10.1094/Phyto-86-277; Kushwaha R, 2013, COMPUT MATH METHODS, V2013; Li S, 1999, PLANT CELL REP, V18, P375, DOI 10.1007/s002990050589; Liu B, 2005, PLANT BIOTECHNOL J, V3, P487, DOI 10.1111/j.1467-7652.2005.00139.x; Marcos JF, 2008, ANNU REV PHYTOPATHOL, V46, P273, DOI 10.1146/annurev.phyto.121307.094843; Morin H, 2007, J BIOTECHNOL, V128, P423, DOI 10.1016/j.jbiotec.2006.10.013; Mourez M, 2001, NAT BIOTECHNOL, V19, P958, DOI 10.1038/nbt1001-958; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Park HY, 2009, J MICROBIOL METH, V78, P54, DOI 10.1016/j.mimet.2009.04.006; Peschen D, 2004, NAT BIOTECHNOL, V22, P732, DOI 10.1038/nbt970; Petsalaki E, 2008, CURR OPIN BIOTECH, V19, P344, DOI 10.1016/j.copbio.2008.06.004; Pudake RN, 2013, CURR GENET, V59, P107, DOI 10.1007/s00294-013-0392-z; Rao SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056081; Rebollar A, 2013, MOL PLANT MICROBE IN, V26, P1407, DOI 10.1094/MPMI-04-13-0110-R; Sambrook J, 2001, MOL CLONING LAB MANU; Sidhu SS, 2001, BIOMOL ENG, V18, P57, DOI 10.1016/S1389-0344(01)00087-9; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Vanhee P, 2011, TRENDS BIOTECHNOL, V29, P231, DOI 10.1016/j.tibtech.2011.01.004; Westphal A, 2008, PLANT HEAL INSTR; Wrather JA, 2011, SOYBEAN DIS LOSS EST	31	10	11	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145156	10.1371/journal.pone.0145156	http://dx.doi.org/10.1371/journal.pone.0145156			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709700	gold, Green Published			2022-12-27	WOS:000367451400022
J	Jong, J; Whitehouse, H; Kavanagh, C; Lane, J				Jong, Jonathan; Whitehouse, Harvey; Kavanagh, Christopher; Lane, Justin			Shared Negative Experiences Lead to Identity Fusion via Personal Reflection	PLOS ONE			English	Article							SELF; MODEL	Across three studies, we examined the role of shared negative experiences in the formation of strong social bonds-identity fusion-previously associated with individuals' willingness to self-sacrifice for the sake of their groups. Studies 1 and 2 were correlational studies conducted on two different populations. In Study 1, we found that the extent to which Northern Irish Republicans and Unionists experienced shared negative experiences was associated with levels of identity fusion, and that this relationship was mediated by their reflection on these experiences. In Study 2, we replicated this finding among Bostonians, looking at their experiences of the 2013 Boston Marathon Bombings. These correlational studies provide initial evidence for the plausibility of our causal model; however, an experiment was required for a more direct test. Thus, in Study 3, we experimentally manipulated the salience of the Boston Marathon Bombings, and found that this increased state levels of identity fusion among those who experienced it negatively. Taken together, these three studies provide evidence that shared negative experience leads to identity fusion, and that this process involves personal reflection.	[Jong, Jonathan] Coventry Univ, Coventry, W Midlands, England; [Jong, Jonathan; Whitehouse, Harvey; Kavanagh, Christopher; Lane, Justin] Univ Oxford, Inst Cognit & Evolutionary Anthropol, Oxford, England	Coventry University; University of Oxford	Jong, J (corresponding author), Coventry Univ, Coventry, W Midlands, England.	jonathan.jong@coventry.ac.uk	Kavanagh, Christopher/AAD-4993-2019; Lane, Justin/AAX-4285-2021	Kavanagh, Christopher/0000-0001-7545-8137; Lane, Justin/0000-0002-8875-8232; Jong, Jonathan/0000-0002-8039-9298; Whitehouse, Harvey/0000-0001-6935-6724	John Templeton Foundation [37624]; ESRC [ES/I005455/1] Funding Source: UKRI; Economic and Social Research Council [ES/I005455/1] Funding Source: researchfish	John Templeton Foundation; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supposed by a John Templeton Foundation grant (#37624) awarded to HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blagov PS, 2004, J PERS, V72, P481, DOI 10.1111/j.0022-3506.2004.00270.x; Brown SD, 2014, MEM STUD, V7, P328, DOI 10.1177/1750698014530622; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Conway MA, 2004, SOC COGNITION, V22, P491, DOI 10.1521/soco.22.5.491.50768; Gomez A, 2011, J PERS SOC PSYCHOL, V100, P918, DOI 10.1037/a0022642; Hayes A.F., PROCESS VERSATILE CO; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Jimenez J, 2015, SOC SCI COMPUT REV, DOI [10.1177/0894439314566178, DOI 10.1177/0894439314566178]; McAdams D.P., 2001, REV GEN PSYCHOL, V5, P100, DOI [10.1037/1089-2680.5.2.100, DOI 10.1037/1089-2680.5.2.100]; McLean KC, 2006, DEV PSYCHOL, V42, P714, DOI 10.1037/0012-1649.42.4.714; Mehrabian A., 1974, AN APPROACH TO ENVIR; Pals JL, 2006, J PERS, V74, P1079, DOI 10.1111/j.1467-6494.2006.00403.x; Pals JL, 2004, PSYCHOL INQ, V15, P65; Pillemer D.B., 2009, MOMENTOUS EVENTS VIV, DOI 10.1037/1089-2680.5.2.123; Pillemer DB., 2001, REV GEN PSYCHOL, V5, P123, DOI [10.1037/1089-2680.5.2.123, DOI 10.1037/1089-2680.5.2.123]; Postmes T, 1998, PSYCHOL BULL, V123, P238; Reicher S. D., 1995, EUROPEAN REV SOCIAL, V6, P161, DOI [10.1080/14792779443000049, DOI 10.1080/14792779443000049]; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Singer J.A., 1993, REMEMBERED SELF EMOT; Swann WB, 2012, PSYCHOL REV, V119, P441, DOI 10.1037/a0028589; Swann WB, 2009, J PERS SOC PSYCHOL, V96, P995, DOI 10.1037/a0013668; Thorne A, 2003, AUTOBIOGRAPHICAL MEMORY AND THE CONSTRUCTION OF A NARRATIVE SELF: DEVELOPMENTAL AND CULTURAL PERSPECTIVES, P169; Trapnell PD, 1999, J PERS SOC PSYCHOL, V76, P284, DOI 10.1037/0022-3514.76.2.284; Whitehouse H., 2000, ARGUMENTS ICONS DIVE; Whitehouse H, 2014, P NATL ACAD SCI USA, V111, P17783, DOI 10.1073/pnas.1416284111; Whitehouse H, 2014, CURR ANTHROPOL, V55, P674, DOI 10.1086/678698; Whitehouse Harvey, 1995, INSIDE CULT RELIG IN; Whitehouse Harvey, 2004, MODES RELIGIOSITY CO; Wilson AE, 2003, MEMORY, V11, P137, DOI 10.1080/741938210; Xygalatas D, 2013, PSYCHOL SCI, V24, P1602, DOI 10.1177/0956797612472910	31	55	56	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145611	10.1371/journal.pone.0145611	http://dx.doi.org/10.1371/journal.pone.0145611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26699364	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600106
J	Kirkham, AJ; Hayes, AE; Pawling, R; Tipper, SP				Kirkham, Alexander J.; Hayes, Amy E.; Pawling, Ralph; Tipper, Steven P.			Facial Mimicry and Emotion Consistency: Influences of Memory and Context	PLOS ONE			English	Article							EXPRESSIONS; RESPONSES; CONSEQUENCES; PERCEPTION; IMPACT; FACES	This study investigates whether mimicry of facial emotions is a stable response or can instead be modulated and influenced by memory of the context in which the emotion was initially observed, and therefore the meaning of the expression. The study manipulated emotion consistency implicitly, where a face expressing smiles or frowns was irrelevant and to be ignored while participants categorised target scenes. Some face identities always expressed emotions consistent with the scene (e.g., smiling with a positive scene), whilst others were always inconsistent (e.g., frowning with a positive scene). During this implicit learning of face identity and emotion consistency there was evidence for encoding of face-scene emotion consistency, with slower RTs, a reduction in trust, and inhibited facial EMG for faces expressing incompatible emotions. However, in a later task where the faces were subsequently viewed expressing emotions with no additional context, there was no evidence for retrieval of prior emotion consistency, as mimicry of emotion was similar for consistent and inconsistent individuals. We conclude that facial mimicry can be influenced by current emotion context, but there is little evidence of learning, as subsequent mimicry of emotionally consistent and inconsistent faces is similar.	[Kirkham, Alexander J.; Tipper, Steven P.] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Hayes, Amy E.] Bangor Univ, Sch Sport Hlth & Exercise Sci, Bangor LL57 2PZ, Gwynedd, Wales; [Pawling, Ralph] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 3AF, Merseyside, England	University of York - UK; Bangor University; Liverpool John Moores University	Tipper, SP (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	steven.tipper@york.ac.uk	Pawling, Ralph/V-6370-2019		Economic and Social Research Council [ES/K000012/1]; ESRC [ES/K000012/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Economic and Social Research Council (http://www.esrc.ac.uk/) under Grant ES/K000012/1 awarded to SPT and AEH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey PE, 2009, PSYCHOL AGING, V24, P995, DOI 10.1037/a0015789; Bayliss AP, 2012, PSYCHOPHYSIOLOGY, V49, P1571, DOI 10.1111/j.1469-8986.2012.01481.x; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; BROWN SL, 1980, BIOL PSYCHOL, V11, P49, DOI 10.1016/0301-0511(80)90026-5; Cannon PR, 2009, COGNITION EMOTION, V23, P918, DOI 10.1080/02699930802234864; Chartrand TL, 2013, ANNU REV PSYCHOL, V64, P285, DOI 10.1146/annurev-psych-113011-143754; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; Dimberg U, 2002, COGNITION EMOTION, V16, P449, DOI 10.1080/02699930143000356; Fischer AH., 2008, HDB EMOTIONS, P456, DOI DOI 10.2307/2076468; Fridlund A. J., 1986, J PSYCHOPHYSIOL, V23, P567, DOI DOI 10.1111/J.1469-8986.1986.TB00676.X; Halberstadt J, 2009, PSYCHOL SCI, V20, P1254, DOI 10.1111/j.1467-9280.2009.02432.x; Hess U, 2001, EMOTIONS QUALIA CONS, P397; Hess U, 2014, COLLECTIVE EMOTIONS; Hofman D, 2012, P ROY SOC B-BIOL SCI, V279, P3535, DOI 10.1098/rspb.2012.0694; Korb S, 2010, BIOL PSYCHOL, V85, P347, DOI 10.1016/j.biopsycho.2010.07.012; Lakin J. L., 2006, SAGE HDB NONVERBAL C, P59, DOI [10.4135/9781412976152.n4, DOI 10.4135/9781412976152.N4]; Lang P.J., 2008, A8 U FLOR; LANZETTA JT, 1989, J PERS SOC PSYCHOL, V56, P543, DOI 10.1037/0022-3514.56.4.543; Larsen JT, 2003, PSYCHOPHYSIOLOGY, V40, P776, DOI 10.1111/1469-8986.00078; Likowski KU, 2008, J EXP SOC PSYCHOL, V44, P1065, DOI 10.1016/j.jesp.2007.10.007; Lundqvist D., 1998, KAROLINSKA DIRECTED; Moody EJ, 2007, EMOTION, V7, P447, DOI 10.1037/1528-3542.7.2.447; Reber AS, 1999, NATURE COGNITION; RINN WE, 1984, PSYCHOL BULL, V95, P52, DOI 10.1037/0033-2909.95.1.52; Schneider W., 2002, E PRIME USERS GUIDE; Sonnby-Borgstrom M, 2002, SCAND J PSYCHOL, V43, P433, DOI 10.1111/1467-9450.00312; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; van Boxtel A, 2010, P MEAS BEH 2010 AUG; van der Schalk J, 2011, EMOTION, V11, P286, DOI 10.1037/a0022582; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	32	3	3	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145731	10.1371/journal.pone.0145731	http://dx.doi.org/10.1371/journal.pone.0145731			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26698864	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000367092600124
J	Mantwill, S; Monestel-Umana, S; Schulz, PJ				Mantwill, Sarah; Monestel-Umana, Silvia; Schulz, Peter J.			The Relationship between Health Literacy and Health Disparities: A Systematic Review	PLOS ONE			English	Article							SELF-RATED HEALTH; LIMITED ENGLISH PROFICIENCY; ALTERNATIVE MEDICINE USE; SOCIOECONOMIC-STATUS; INFORMATION-SEEKING; RACIAL DISPARITIES; OVERLOOKED FACTOR; PRIMARY-CARE; RACE; NUMERACY	Objectives Health literacy is commonly associated with many of the antecedents of health disparities. Yet the precise nature of the relationship between health literacy and disparities remains unclear. A systematic review was conducted to better understand in how far the relationship between health literacy and health disparities has been systematically studied and which potential relationships and pathways have been identified. Methods Five databases, including PubMed/MEDLINE and CINAHL, were searched for peer-reviewed studies. Publications were included in the review when they (1) included a valid measure of health literacy, (2) explicitly conceived a health disparity as related to a social disparity, such as race/ethnicity or education and (3) when results were presented by comparing two or more groups afflicted by a social disparity investigating the effect of health literacy on health outcomes. Two reviewers evaluated each study for inclusion and abstracted relevant information. Findings were ordered according to the disparities identified and the role of health literacy in explaining them. Results 36 studies were included in the final synthesis. Most of the studies investigated racial/ethnic disparities, followed by some few studies that systematically investigated educational disparities. Some evidence was found on the mediating function of health literacy on self-rated health status across racial/ethnic and educational disparities, as well as on the potential effect of health literacy and numeracy on reducing racial/ethnic disparities in medication adherence and understanding of medication intake. Conclusion Overall the evidence on the relationship between health literacy and disparities is still mixed and fairly limited. Studies largely varied with regard to health(-related) outcomes under investigation and the health literacy assessments used. Further, many studies lacked a specific description of the nature of the disparity that was explored and a clear account of possible pathways tested.	[Mantwill, Sarah; Monestel-Umana, Silvia; Schulz, Peter J.] Univ Lugano, Inst Commun & Hlth, Lugano, Switzerland	Universita della Svizzera Italiana	Mantwill, S (corresponding author), Univ Lugano, Inst Commun & Hlth, Lugano, Switzerland.	Sarah.Mantwill@usi.ch	Schulz, Peter/AAM-9816-2020; Schulz, Peter/GQQ-1290-2022	Schulz, Peter/0000-0003-4281-489X; Schulz, Peter/0000-0003-4281-489X				Bailey SC, 2009, FAM MED, V41, P715; Bains SS, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-138; Baker DW, 1999, PATIENT EDUC COUNS, V38, P33, DOI 10.1016/S0738-3991(98)00116-5; Baker DW, 2002, AM J PUBLIC HEALTH, V92, P1278, DOI 10.2105/AJPH.92.8.1278; Baker DW, 1999, J GEN INTERN MED, V14, P315, DOI 10.1046/j.1525-1497.1999.00342.x; Bakker JP, 2011, SLEEP, V34, P1595, DOI 10.5665/sleep.1404; Bennett CL, 1998, J CLIN ONCOL, V16, P3101, DOI 10.1200/JCO.1998.16.9.3101; Bennett IM, 2009, ANN FAM MED, V7, P204, DOI 10.1370/afm.940; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Braveman P, 2006, ANNU REV PUBL HEALTH, V27, P167, DOI 10.1146/annurev.publhealth.27.021405.102103; Braveman P, 2014, PUBLIC HEALTH REP, V129, P5, DOI 10.1177/00333549141291S203; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Brega AG, 2012, PATIENT EDUC COUNS, V88, P61, DOI 10.1016/j.pec.2012.03.008; Chakkalakal RJ, 2014, DIABETES CARE, V37, pE53, DOI 10.2337/dc13-1984; Chaudhry SI, 2011, J CARD FAIL, V17, P122, DOI 10.1016/j.cardfail.2010.09.016; Chen YX, 2014, HEALTH COMMUN, V29, P843, DOI 10.1080/10410236.2013.807904; Chew LD, 2008, J GEN INTERN MED, V23, P561, DOI 10.1007/s11606-008-0520-5; Curtis LM, 2012, J ASTHMA, V49, P178, DOI 10.3109/02770903.2011.648297; Davis T C, 1993, Fam Med, V25, P391; Freedman RA, 2015, CANCER-AM CANCER SOC, V121, P724, DOI 10.1002/cncr.28977; Gardiner P, 2013, J HEALTH COMMUN, V18, P290, DOI 10.1080/10810730.2013.830663; Hovick SR, 2014, HEALTH COMMUN, V29, P656, DOI 10.1080/10410236.2012.763204; Howard DH, 2006, J GEN INTERN MED, V21, P857, DOI 10.1111/j.1525-1497.2006.00530.x; Kaphingst KA, 2015, HEALTH PSYCHOL, V34, P101, DOI 10.1037/hea0000177; Kawachi I, 2005, HEALTH AFFAIR, V24, P343, DOI 10.1377/hlthaff.24.2.343; Kennedy BP, 1998, BRIT MED J, V317, P917; Keppel Kenneth, 2005, Vital Health Stat 2, P1; Kindig DA, 2004, HLTH LITERACY PRESCR; Koh HK, 2012, HEALTH AFFAIR, V31, P434, DOI 10.1377/hlthaff.2011.1169; Kutner M., 2006, HLTH LITERACY AM ADU; Langford AT, 2012, J GENET COUNS, V21, P440, DOI 10.1007/s10897-011-9478-2; Lee HY, 2015, J GEN INTERN MED, V30, P1118, DOI 10.1007/s11606-015-3217-6; Lindau ST, 2002, AM J OBSTET GYNECOL, V186, P938, DOI 10.1067/mob.2002.122091; Matsuyama RK, 2011, PATIENT EDUC COUNS, V85, pE229, DOI 10.1016/j.pec.2011.03.022; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mottus R, 2014, HEALTH PSYCHOL, V33, P164, DOI 10.1037/a0031439; National Institutes of Health, 2009, NIH HLTH DISP STRAT; Nutbeam D, 2009, INT J PUBLIC HEALTH, V54, P303, DOI 10.1007/s00038-009-0050-x; Omariba DWR, 2015, INT J PUBLIC HEALTH, V63, P389, DOI 10.1007/s00038-014-0640-0; Omariba DWR, 2011, CAN J PUBLIC HEALTH, V102, P281, DOI 10.1007/BF03404049; Osborn CY, 2007, AM J PREV MED, V33, P374, DOI 10.1016/j.amepre.2007.07.022; Osborn CY, 2011, J HEALTH COMMUN, V16, P268, DOI 10.1080/10810730.2011.604388; Osborn CY, 2011, AM J HEALTH BEHAV, V35, P118; Osborn CY, 2009, DIABETES CARE, V32, P1614, DOI 10.2337/dc09-0425; Pandit AU, 2009, PATIENT EDUC COUNS, V75, P381, DOI 10.1016/j.pec.2009.04.006; Rothman RL, 2008, J HEALTH COMMUN, V13, P583, DOI 10.1080/10810730802281791; Rudd RE, 2007, AM J HEALTH BEHAV, V31, pS8; Sarkar U, 2010, J HEALTH COMMUN, V15, P183, DOI 10.1080/10810730.2010.499988; Schillinger D, 2006, PUBLIC HEALTH REP, V121, P245, DOI 10.1177/003335490612100305; Schulz PJ, 2013, PATIENT EDUC COUNS, V90, P4, DOI 10.1016/j.pec.2012.09.006; Sentell T, 2013, J HEALTH COMMUN, V18, P242, DOI 10.1080/10810730.2013.825669; Sentell T, 2012, J HEALTH COMMUN, V17, P82, DOI 10.1080/10810730.2012.712621; Sentell T, 2011, J HEALTH COMMUN, V16, P279, DOI 10.1080/10810730.2011.604390; Shieh C, 2010, WOMEN HEALTH, V50, P426, DOI 10.1080/03630242.2010.506152; Smith PC, 2012, J NATL MED ASSOC, V104, P521, DOI 10.1016/S0027-9684(15)30218-2; Song LX, 2014, PATIENT EDUC COUNS, V97, P339, DOI 10.1016/j.pec.2014.08.019; Sperber NR, 2013, HEALTH EDUC RES, V28, P502, DOI 10.1093/her/cyt043; Sudore RL, 2006, J AM GERIATR SOC, V54, P770, DOI 10.1111/j.1532-5415.2006.00691.x; Sudore RL, 2010, J HEALTH COMMUN, V15, P159, DOI 10.1080/10810730.2010.499982; U.S. Department of Health and Human Services, 2010, HEALTHY PEOPLE 2020; van der Heide I, 2013, J HEALTH COMMUN, V18, P172, DOI 10.1080/10810730.2013.825668; Volandes AE, 2008, J PALLIAT MED, V11, P754, DOI 10.1089/jpm.2007.0224; von Wagner C, 2007, J EPIDEMIOL COMMUN H, V61, P1086, DOI 10.1136/jech.2006.053967; Waite KR, 2013, J AM GERIATR SOC, V61, P403, DOI 10.1111/jgs.12134; Waldrop-Valverde D, 2010, AIDS BEHAV, V14, P799, DOI 10.1007/s10461-009-9604-4; Waldrop-Valverde D, 2009, AIDS BEHAV, V13, P46, DOI 10.1007/s10461-008-9425-x; Wang CL, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-153; Weiss BD, 2005, ANN FAM MED, V3, P514, DOI 10.1370/afm.405; Wolf MS, 2007, PATIENT EDUC COUNS, V65, P253, DOI 10.1016/j.pec.2006.08.006; Wolf MS, 2006, UROLOGY, V68, P89, DOI 10.1016/j.urology.2006.01.064; Wolf MS, 2005, ARCH INTERN MED, V165, P1946, DOI 10.1001/archinte.165.17.1946; Yin H Shonna, 2009, Pediatrics, V124 Suppl 3, pS289, DOI 10.1542/peds.2009-1162E	72	159	164	6	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145455	10.1371/journal.pone.0145455	http://dx.doi.org/10.1371/journal.pone.0145455			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26698310	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600082
J	Robinson, KJ; Twiss, SD; Hazon, N; Pomeroy, PP				Robinson, Kelly J.; Twiss, Sean D.; Hazon, Neil; Pomeroy, Patrick P.			Maternal Oxytocin Is Linked to Close Mother-Infant Proximity in Grey Seals (Halichoerus grypus)	PLOS ONE			English	Article							PLASMA OXYTOCIN; REPRODUCTIVE SUCCESS; NORTH RONA; BEHAVIOR; VASOPRESSIN; RELEASE; BRAIN; DEPRESSION; LACTATION; SHEEP	Maternal behaviour is a crucial component of reproduction in all mammals; however the quality of care that mothers give to infants can vary greatly. It is vital to document variation in maternal behaviour caused by the physiological processes controlling its expression. This underlying physiology should be conserved throughout reproductive events and should be replicated across all individuals of a species; therefore, any correlates to maternal care quality may be present across many individuals or contexts. Oxytocin modulates the initiation and expression of maternal behaviour in mammals; therefore we tested whether maternal plasma oxytocin concentrations correlated to key maternal behaviours in wild grey seals (Halichoerus grypus). Plasma oxytocin concentrations in non-breeding individuals (4.3 +/- 0.5 pg/ml) were significantly lower than those in mothers with dependent pups in both early (8.2 +/- 0.8 pg/ml) and late (6.9 +/- 0.7 pg/ml) lactation. Maternal plasma oxytocin concentrations were not correlated to the amount of nursing prior to sampling, or a mother's nursing intensity throughout the dependant period. Mothers with high plasma oxytocin concentrations stayed closer to their pups, reducing the likelihood of mother-pup separation during lactation which is credited with causing starvation, the largest cause of pup mortality in grey seals. This is the first study to link endogenous oxytocin concentrations in wild mammalian mothers with any type of maternal behaviour. Oxytocin's structure and function is widely conserved across mammalian mothers, including humans. Defining the impact the oxytocin system has on maternal behaviour highlights relationships that may occur across many individuals or species, and such behaviours heavily influence infant development and an individual's lifetime reproductive success.	[Robinson, Kelly J.; Pomeroy, Patrick P.] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Twiss, Sean D.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Hazon, Neil] Univ St Andrews, Scottish Oceans Inst, St Andrews KY16 9AJ, Fife, Scotland	University of St Andrews; Durham University; University of St Andrews	Robinson, KJ (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland.	kjr33@st-andrews.ac.uk		Robinson, Kelly/0000-0002-6212-9710; pomeroy, patrick/0000-0003-1603-5630; Twiss, Sean/0000-0002-1923-8874	UK's Natural Environmental Research Council; NERC [NE/G008930/1]; UK Natural Environment Research Council [NE/H524930/1]; SMRU Marine, St Andrews, UK; Natural Environment Research Council [NE/G008930/1, smru10001] Funding Source: researchfish	UK's Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); SMRU Marine, St Andrews, UK; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The UK's Natural Environmental Research Council (http://www.nerc.ac.uk/) funded the long term program of research on grey seals at North Rona and the Isle of May. PPP and SDT were in receipt of NERC grant NE/G008930/1 during the work. This paper formed part of KJR's PhD funded by the UK Natural Environment Research Council grant NE/H524930/1 and by SMRU Marine (http://www.smru.st-andrews.ac.uk/), St Andrews, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER G, 1986, APPL ANIM BEHAV SCI, V16, P295, DOI 10.1016/0168-1591(86)90122-X; ANDERSON SS, 1979, J ZOOL, V189, P407, DOI 10.1111/j.1469-7998.1979.tb03972.x; Atzil S, 2011, NEUROPSYCHOPHARMACOL, V36, P2603, DOI 10.1038/npp.2011.172; BAKER JR, 1988, J ZOOL, V216, P529, DOI 10.1111/j.1469-7998.1988.tb02449.x; Bales KL, 2007, HORM BEHAV, V52, P274, DOI 10.1016/j.yhbeh.2007.05.004; Baskerville TA, 2010, CNS NEUROSCI THER, V16, pe92, DOI 10.1111/j.1755-5949.2010.00154.x; Boness DJ, 1996, BIOSCIENCE, V46, P645, DOI 10.2307/1312894; BOYD JM, 1971, J ZOOL, V164, P469, DOI 10.1111/j.1469-7998.1971.tb01331.x; Broad KD, 2006, PHILOS T R SOC B, V361, P2199, DOI 10.1098/rstb.2006.1940; BURTON RW, 1975, J ZOOL, V177, P197, DOI 10.1111/j.1469-7998.1975.tb05978.x; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Conradt L, 1999, OECOLOGIA, V120, P218, DOI 10.1007/s004420050851; Culloch R., 2012, THESIS; DaCosta APC, 1996, J NEUROENDOCRINOL, V8, P163, DOI 10.1046/j.1365-2826.1996.04411.x; DAWOOD MY, 1981, J CLIN ENDOCR METAB, V52, P678, DOI 10.1210/jcem-52-4-678; Degabriel JL, 2009, ECOLOGY, V90, P711, DOI 10.1890/08-0940.1; DREWETT RF, 1982, HORM BEHAV, V16, P245, DOI 10.1016/0018-506X(82)90023-X; Dwyer CM, 2008, J NEUROENDOCRINOL, V20, P526, DOI 10.1111/j.1365-2826.2008.01657.x; Dwyer CM, 2005, APPL ANIM BEHAV SCI, V92, P235, DOI 10.1016/j.applanim.2005.05.010; ELMASRY N, 2010, CURRENT PSYCHIAT, V17, P31; Everett-Hincks JM, 2005, LIVEST PROD SCI, V93, P51, DOI 10.1016/j.livprodsci.2004.11.006; Fairbanks LA., 1996, ADV STUDY BEHAV VOL, V25, P579, DOI [10.1016/S0065-3454(08)60343-5, DOI 10.1016/S0065-3454(08)60343-5]; FEDAK MA, 1982, J ZOOL, V198, P473, DOI 10.1111/jzo.1982.198.4.473; Feldman R, 2007, PSYCHOL SCI, V18, P965, DOI 10.1111/j.1467-9280.2007.02010.x; Feldman R, 2010, PSYCHONEUROENDOCRINO, V35, P1133, DOI 10.1016/j.psyneuen.2010.01.013; FOGDEN SCL, 1971, J ZOOL, V164, P61; Galbally M, 2011, HARVARD REV PSYCHIAT, V19, P1, DOI 10.3109/10673229.2011.549771; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gossen A, 2012, NEUROPEPTIDES, V46, P211, DOI 10.1016/j.npep.2012.07.001; Haaland P, 2011, CALIBFIT STAT MODEL; Hall AJ, 2001, J ANIM ECOL, V70, P138; Haller MA, 1996, CAN J ZOOL, V74, P1531, DOI 10.1139/z96-167; Heinrichs M, 2008, PROG BRAIN RES, V170, P337, DOI 10.1016/S0079-6123(08)00428-7; Hiby L., 1990, Reports of the International Whaling Commission Special Issue, P57; HIGUCHI T, 1985, J ENDOCRINOL, V105, P339, DOI 10.1677/joe.0.1050339; Hoge EA, 2012, DEPRESS ANXIETY, V29, P924, DOI 10.1002/da.21973; Holt-Lunstad J, 2011, PSYCHONEUROENDOCRINO, V36, P1249, DOI 10.1016/j.psyneuen.2011.03.007; Houpt KA, 2002, APPL ANIM BEHAV SCI, V78, P319, DOI 10.1016/S0168-1591(02)00111-9; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; IVERSON SJ, 1993, PHYSIOL ZOOL, V66, P61, DOI 10.1086/physzool.66.1.30158287; Kendrick KM, 2000, EXP PHYSIOL, V85, p111S, DOI 10.1111/j.1469-445X.2000.tb00014.x; KOVACS KM, 1987, J ZOOL, V213, P697, DOI 10.1111/j.1469-7998.1987.tb03735.x; Kunkele J, 1997, PHYSIOL ZOOL, V70, P571; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Leuine A, 2007, PEPTIDES, V28, P1162, DOI 10.1016/j.peptides.2007.04.016; LEVY F, 1995, BRAIN RES, V669, P197, DOI 10.1016/0006-8993(94)01236-B; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Madden JR, 2011, P ROY SOC B-BIOL SCI, V278, P1189, DOI 10.1098/rspb.2010.1675; Maestripieri D, 2009, PHYSIOL BEHAV, V96, P613, DOI 10.1016/j.physbeh.2008.12.016; McCulloch S, 1999, CAN J ZOOL, V77, P716, DOI 10.1139/cjz-77-5-716; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Modahl C, 1998, BIOL PSYCHIAT, V43, P270, DOI 10.1016/S0006-3223(97)00439-3; Nelson RJ, 2000, INTRO BEHAV ENDOCRIN, P337; Neumann ID, 2012, TRENDS NEUROSCI, V35, P649, DOI 10.1016/j.tins.2012.08.004; Newberry RC, APPL ANIM BEHAV SCI; Olsson IAS, 2003, APPL ANIM BEHAV SCI, V81, P245, DOI 10.1016/S0168-1591(02)00285-X; Otero-Garcia M, 2015, BRAIN STRUCT FUNCT, P1; Perry EA, 1998, MOL ECOL, V7, P81, DOI 10.1046/j.1365-294x.1998.00313.x; Poland VF, 2008, MAR MAMMAL SCI, V24, P371, DOI 10.1111/j.1748-7692.2008.00191.x; Pomeroy PP, 1999, J ANIM ECOL, V68, P235, DOI 10.1046/j.1365-2656.1999.00281.x; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Redman P., 2002, THESIS; Robinson KJ, 2014, J NEUROSCI METH, V226, P73, DOI 10.1016/j.jneumeth.2014.01.019; RYDEN G, 1969, ACTA ENDOCRINOL-COP, V61, P425, DOI 10.1530/acta.0.0610425; Scantamburlo G, 2007, PSYCHONEUROENDOCRINO, V32, P407, DOI 10.1016/j.psyneuen.2007.01.009; Skrundz M, 2011, NEUROPSYCHOPHARMACOL, V36, P1886, DOI 10.1038/npp.2011.74; Smout S, 2011, ENVIRON ECOL STAT, V18, P331, DOI 10.1007/s10651-010-0135-y; Strathearn L, 2009, NEUROPSYCHOPHARMACOL, V34, P2655, DOI 10.1038/npp.2009.103; Szeto A, 2011, PSYCHOSOM MED, V73, P393, DOI 10.1097/PSY.0b013e31821df0c2; Trillmich F, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P267, DOI 10.1007/978-3-642-02624-9_10; Tsuneoka Y, 2013, J COMP NEUROL, V521, P1633, DOI 10.1002/cne.23251; Turner RA, 1999, PSYCHIATRY, V62, P97, DOI 10.1080/00332747.1999.11024859; Twiss SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049598; Twiss SD, 2012, MAR MAMMAL SCI, V28, pE280, DOI 10.1111/j.1748-7692.2011.00523.x; Wood S., 2012, MGCV MIXED GAM COMPU; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2006, BIOMETRICS, V62, P1025, DOI 10.1111/j.1541-0420.2006.00574.x; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	79	13	13	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144577	10.1371/journal.pone.0144577	http://dx.doi.org/10.1371/journal.pone.0144577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698856	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000367092600024
J	Cattoni, DI; Chara, O; Kaufman, SB; Flecha, FLG				Cattoni, Diego I.; Chara, Osvaldo; Kaufman, Sergio B.; Luis Gonzalez Flecha, F.			Cooperativity in Binding Processes: New Insights from Phenomenological Modeling	PLOS ONE			English	Article							PROTEIN INTERACTIONS; NEGATIVE COOPERATIVITY; HILL COEFFICIENT; HEMOGLOBIN	Cooperative binding is one of the most interesting and not fully understood phenomena involved in control and regulation of biological processes. Here we analyze the simplest phenomenological model that can account for cooperativity (i. e. ligand binding to a macromolecule with two binding sites) by generating equilibrium binding isotherms from deterministically simulated binding time courses. We show that the Hill coefficients determined for cooperative binding, provide a good measure of the Gibbs free energy of interaction among binding sites, and that their values are independent of the free energy of association for empty sites. We also conclude that although negative cooperativity and different classes of binding sites cannot be distinguished at equilibrium, they can be kinetically differentiated. This feature highlights the usefulness of pre-equilibrium time-resolved strategies to explore binding models as a key complement of equilibrium experiments. Furthermore, our analysis shows that under conditions of strong negative cooperativity, the existence of some binding sites can be overlooked, and experiments at very high ligand concentrations can be a valuable tool to unmask such sites.	[Cattoni, Diego I.; Kaufman, Sergio B.; Luis Gonzalez Flecha, F.] Univ Buenos Aires, CONICET, Inst Quim & Fis Quim Biol, Lab Biofis Mol, Buenos Aires, DF, Argentina; [Cattoni, Diego I.] Univ Montpellier 1 & 2, Ctr Biochim Struct, Montpellier, France; [Chara, Osvaldo] Univ Nacl La Plata, Inst Phys Liquids & Biol Syst IFLYSIB, RA-1900 La Plata, Buenos Aires, Argentina; [Chara, Osvaldo] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, D-01062 Dresden, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universite de Montpellier; National University of La Plata; Technische Universitat Dresden	Chara, O (corresponding author), Univ Nacl La Plata, Inst Phys Liquids & Biol Syst IFLYSIB, RA-1900 La Plata, Buenos Aires, Argentina.	ochara@iflysib.unlp.edu.ar; lgf@qb.ffyb.uba.ar	Chara, Osvaldo/T-2798-2019; González Flecha, F Luis/J-7060-2014	González Flecha, F Luis/0000-0003-2828-7907; Kaufman, Sergio Benjamin/0000-0002-8763-4086; Chara, Osvaldo/0000-0002-0868-2507; Cattoni, Diego I./0000-0002-0048-8531	Agencia Nacional de Promocion ANPCyT [PICT2013-1691]; UBACyT [20020100100048]	Agencia Nacional de Promocion ANPCyT(ANPCyT); UBACyT	This work was supported by Agencia Nacional de Promocion ANPCyT (PICT2013-1691) and UBACyT (20020100100048).	Abeliovich H, 2005, BIOPHYS J, V89, P76, DOI 10.1529/biophysj.105.060194; Adair GS, 1925, J BIOL CHEM, V63, P529; Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; Barcroft J, 1910, J PHYSIOL-LONDON, V39, P411; Bujalowski W, 2014, J MOL STRUCT, V1077, P40, DOI 10.1016/j.molstruc.2014.04.041; Cattoni DI, 2009, BBA-PROTEINS PROTEOM, V1794, P1700, DOI 10.1016/j.bbapap.2009.08.007; Traian MMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039255; Edelstein SJ, 2013, J MOL BIOL, V425, P1424, DOI 10.1016/j.jmb.2013.03.011; Freiburger L, 2014, NAT CHEM BIOL, V10, P937, DOI [10.1038/NCHEMBIO.1626, 10.1038/nchembio.1626]; Garbett NC, 2008, METHOD CELL BIOL, V84, P3, DOI 10.1016/S0091-679X(07)84001-5; Gutfreund H., 1995, KINETICS LIFE SCI RE; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Hargrove Mark S., 2005, V305, P323; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Hillier BJ, 1998, FOLD DES, V3, P87, DOI 10.1016/S1359-0278(98)00014-5; Holt JM, 2009, METHOD ENZYMOL, V455, P193, DOI 10.1016/S0076-6879(08)04207-9; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; KLOTZ IM, 1974, ACCOUNTS CHEM RES, V7, P162, DOI 10.1021/ar50077a006; Koshland DE, 2002, J BIOL CHEM, V277, P46841, DOI 10.1074/jbc.R200014200; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Levi V, 2002, BIOPHYS J, V82, P437, DOI 10.1016/S0006-3495(02)75408-8; Levi V, 2008, BIOCHEM J, V416, P145, DOI 10.1042/BJ20080618; Pollard TD, 2013, MOL BIOL CELL, V24, P1103, DOI 10.1091/mbc.E13-01-0030; Ruscio JZ, 2008, P NATL ACAD SCI USA, V105, P9204, DOI 10.1073/pnas.0710825105; Ruzicka FJ, 2010, J PHYS CHEM B, V114, P16118, DOI 10.1021/jp103856m; Sakaguchi M, 2006, P NATL ACAD SCI USA, V103, P7112, DOI 10.1073/pnas.0508793103; Shcheynikov N, 2015, P NATL ACAD SCI USA, V112, pE329, DOI 10.1073/pnas.1415673112; WALDER JA, 1984, J BIOL CHEM, V259, P238; Wang ZX, 1996, FEBS LETT, V388, P73, DOI 10.1016/0014-5793(96)00498-X; Weber G., 1992, PROTEIN INTERACTIONS; WEBER GREGORIO, 1965, BIOCHEMISTRY, V4, P1942, DOI 10.1021/bi00886a006; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4	33	30	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146043	10.1371/journal.pone.0146043	http://dx.doi.org/10.1371/journal.pone.0146043			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717487	Green Submitted, gold, Green Published			2022-12-27	WOS:000367510500125
J	Fraser, LE; Makooie, B; Harris, LR				Fraser, Lindsey E.; Makooie, Bobbak; Harris, Laurence R.			The Subjective Visual Vertical and the Subjective Haptic Vertical Access Different Gravity Estimates	PLOS ONE			English	Article							GALVANIC VESTIBULAR STIMULATION; BODY-TILT; HEAD ORIENTATION; PERCEPTION; ROLL; HUMANS; NECK; REPRESENTATION; DISSOCIATION; INFORMATION	The subjective visual vertical (SVV) and the subjective haptic vertical (SHV) both claim to probe the underlying perception of gravity. However, when the body is roll tilted these two measures evoke different patterns of errors with SVV generally becoming biased towards the body (A-effect, named for its discoverer, Hermann Rudolph Aubert) and SHV remaining accurate or becoming biased away from the body (E-effect, short for Entgegengesetzt-effect, meaning "opposite", i.e., opposite to the A-effect). We compared the two methods in a series of five experiments and provide evidence that the two measures access two different but related estimates of gravitational vertical. Experiment 1 compared SVV and SHV across three levels of whole-body tilt and found that SVV showed an A-effect at larger tilts while SHV was accurate. Experiment 2 found that tilting either the head or the trunk independently produced an A-effect in SVV while SHV remained accurate when the head was tilted on an upright body but showed an A-effect when the body was tilted below an upright head. Experiment 3 repeated these head/body configurations in the presence of vestibular noise induced by using disruptive galvanic vestibular stimulation (dGVS). dGVS abolished both SVV and SHV A-effects while evoking a massive E-effect in the SHV head tilt condition. Experiments 4 and 5 show that SVV and SHV do not combine in an optimally statistical fashion, but when vibration is applied to the dorsal neck muscles, integration becomes optimal. Overall our results suggest that SVV and SHV access distinct underlying gravity percepts based primarily on head and body position information respectively, consistent with a model proposed by Clemens and colleagues.	[Fraser, Lindsey E.; Makooie, Bobbak; Harris, Laurence R.] York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada	York University - Canada	Fraser, LE (corresponding author), York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada.	lfraser4@yorku.ca	Harris, Laurence/AAT-9549-2021	Harris, Laurence/0000-0002-7154-8757	Natural Sciences and Engineering Research Council (NSERC) of Canada; NSERC Alexander Graham Bell Scholarship; NSERC CREATE grant	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Alexander Graham Bell Scholarship; NSERC CREATE grant	This research was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada to LRH. LEF is supported by an NSERC Alexander Graham Bell Scholarship and an NSERC CREATE grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasopoulos D, 1997, NEUROSCI LETT, V233, P151, DOI 10.1016/S0304-3940(97)00639-3; Aubert H., 1861, ARCH PATHOL ANAT, V20, P381, DOI DOI 10.1007/BF02355256; Baccini M, 2014, ATTEN PERCEPT PSYCHO, V76, P112, DOI 10.3758/s13414-013-0551-9; Barra J, 2010, BRAIN, V133, P3552, DOI 10.1093/brain/awq311; BAUERMEISTER M, 1964, AM J PSYCHOL, V77, P451, DOI 10.2307/1421016; Betts GA, 1998, VISION RES, V38, P1989, DOI 10.1016/S0042-6989(97)00401-X; Bortolami SB, 2006, EXP BRAIN RES, V173, P364, DOI 10.1007/s00221-006-0385-y; Braem B, 2014, NEUROPHYSIOL CLIN, V44, P41, DOI 10.1016/j.neucli.2013.10.137; Bresciani JP, 2002, NEUROSCI LETT, V318, P34, DOI 10.1016/S0304-3940(01)02462-4; Bronstein AM, 2003, NEUROLOGY, V61, P1260, DOI 10.1212/01.WNL.0000086815.22816.DC; Cauquil AS, 2003, EXP BRAIN RES, V148, P414, DOI 10.1007/s00221-002-1326-z; Ceyte H, 2009, NEUROSCI LETT, V462, P85, DOI 10.1016/j.neulet.2009.06.048; Clemens IAH, 2011, J NEUROSCI, V31, P5365, DOI 10.1523/JNEUROSCI.6472-10.2011; Cribbie RA, 2004, J CLIN PSYCHOL, V60, P1, DOI 10.1002/jclp.10217; de Graaf B, 1992, J Vestib Res, V2, P15; De Vrijer M, 2009, J VISION, V9, DOI 10.1167/9.2.9; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2012, NEW HDB MULTISENSORY, P527; Ferre ER, 2011, EUR J NEUROSCI, V34, P1337, DOI 10.1111/j.1460-9568.2011.07859.x; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; FRIEDMANN G, 1970, BRAIN, V93, P313, DOI 10.1093/brain/93.2.313; Gueguen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034380; Guerraz M, 1998, PERCEPT MOTOR SKILL, V87, P643, DOI 10.2466/pms.1998.87.2.643; Guerraz M, 2003, EXP BRAIN RES, V150, P40, DOI 10.1007/s00221-003-1411-y; Howard I. P., 1982, HUMAN VISUAL ORIENTA; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; Lopez C, 2012, NEUROPSYCHOLOGIA, V50, P1830, DOI 10.1016/j.neuropsychologia.2012.04.008; Luyat M, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-28; MacDougall HG, 2006, EXP BRAIN RES, V172, P208, DOI 10.1007/s00221-005-0329-y; MacNeilage PR, 2007, EXP BRAIN RES, V179, P263, DOI 10.1007/s00221-006-0792-0; Mars F, 2003, EXP BRAIN RES, V150, P515, DOI 10.1007/s00221-003-1485-6; Mast FW, 2000, SWISS J PSYCHOL, V59, P89, DOI 10.1024//1421-0185.59.2.89; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; MayouxBenhamou MA, 1997, EXP BRAIN RES, V113, P353, DOI 10.1007/BF02450333; McKenna GJ, 2004, JARO-J ASSOC RES OTO, V5, P25, DOI 10.1007/s10162-003-4005-2; Mittelstaedt H, 1996, BIOL PSYCHOL, V42, P53, DOI 10.1016/0301-0511(95)05146-5; MITTELSTAEDT H, 1983, NATURWISSENSCHAFTEN, V70, P272, DOI 10.1007/BF00404833; Moore ST, 2006, EXP BRAIN RES, V174, P647, DOI 10.1007/s00221-006-0528-1; Muller G., 1916, Z SINNESPHYSIOL, V49, P109; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; ROCK I, 1957, AM J PSYCHOL, V70, P493, DOI 10.2307/1419441; Schneider E, 2002, J NEUROPHYSIOL, V87, P2064, DOI 10.1152/jn.00558.2001; Schuler JR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-83; Tarnutzer AA, 2010, J NEUROPHYSIOL, V103, P934, DOI 10.1152/jn.00407.2009; Tarnutzer AA, 2009, J NEUROPHYSIOL, V102, P1657, DOI 10.1152/jn.00007.2008; Tarnutzer AA, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-114; Tarnutzer AA, 2012, J NEUROPHYSIOL, V107, P3095, DOI 10.1152/jn.00724.2010; Tesio L, 2011, INT J REHABIL RES, V34, P307, DOI 10.1097/MRR.0b013e32834c45bc; Trainor LJ, 2009, CORTEX, V45, P35, DOI 10.1016/j.cortex.2007.10.014; VAINA LM, 1994, CEREB CORTEX, V4, P555, DOI 10.1093/cercor/4.5.555; van Beuzekom AD, 2000, J NEUROPHYSIOL, V84, P11, DOI 10.1152/jn.2000.84.1.11; Vibert D, 1999, J VESTIBUL RES-EQUIL, V9, P145; WADE NJ, 1968, PERCEPT PSYCHOPHYS, V3, P215, DOI 10.3758/BF03212730; WADE NJ, 1969, AUST J PSYCHOL, V21, P177, DOI 10.1080/00049536908257782; Wade SW, 1997, VISION RES, V37, P1071, DOI 10.1016/S0042-6989(96)00252-0; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828	56	25	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145528	10.1371/journal.pone.0145528	http://dx.doi.org/10.1371/journal.pone.0145528			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716835	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500041
J	Karki, A; Humphrey, SE; Steele, RE; Hess, DA; Taparowsky, EJ; Konieczny, SF				Karki, Anju; Humphrey, Sean E.; Steele, Rebecca E.; Hess, David A.; Taparowsky, Elizabeth J.; Konieczny, Stephen F.			Silencing Mist1 Gene Expression Is Essential for Recovery from Acute Pancreatitis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MIST1; SEROUS EXOCRINE CELLS; ACINAR-CELL; ONCOGENIC KRAS; INTRAEPITHELIAL NEOPLASIA; ZYMOGENIC CELLS; MICE LACKING; MOUSE; METAPLASIA; DIFFERENTIATION	Acinar cells of the exocrine pancreas are tasked with synthesizing, packaging and secreting vast quantities of pro-digestive enzymes to maintain proper metabolic homeostasis for the organism. Because the synthesis of high levels of hydrolases is potentially dangerous, the pancreas is prone to acute pancreatitis (AP), a disease that targets acinar cells, leading to acinar-ductal metaplasia (ADM), inflammation and fibrosis-events that can transition into the earliest stages of pancreatic ductal adenocarcinoma. Despite a wealth of information concerning the broad phenotype associated with pancreatitis, little is understood regarding specific transcriptional regulatory networks that are susceptible to AP and the role these networks play in acinar cell and exocrine pancreas responses. In this study, we examined the importance of the acinar-specific maturation transcription factor MIST1 to AP damage and organ recovery. Analysis of wild-type and Mist1 conditional null mice revealed that Mist1 gene transcription and protein accumulation were dramatically reduced as acinar cells underwent ADM alterations during AP episodes. To test if loss of MIST1 function was primarily responsible for the damaged status of the organ, mice harboring a Cre-inducible Mist1 transgene (iMist1) were utilized to determine if sustained MIST1 activity could alleviate AP damage responses. Unexpectedly, constitutive iMist1 expression during AP led to a dramatic increase in organ damage followed by acinar cell death. We conclude that the transient silencing of Mist1 expression is critical for acinar cells to survive an AP episode, providing cells an opportunity to suppress their secretory function and regenerate damaged cells. The importance of MIST1 to these events suggests that modulating key pancreas transcription networks could ease clinical symptoms in patients diagnosed with pancreatitis and pancreatic cancer.	[Konieczny, Stephen F.] Purdue Univ, Dept Biol Sci, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA; Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Konieczny, SF (corresponding author), Purdue Univ, Dept Biol Sci, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA.	sfk@purdue.edu		Hess, David/0000-0003-3578-8195	NIH [DK55489, CA124586];  [P30 CA023168]; NATIONAL CANCER INSTITUTE [P30CA023168, R01CA124586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055489] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants to SFK (NIH DK55489, NIH CA124586).; We thank the Purdue Center for Cancer Research Transgenic Mouse Core Facility (supported by P30 CA023168) for producing the genetically engineered mouse strains used in this study, Barbara Damsz for excellence in generating tissue sections, Nirajan Mandal for suggestions on the model and members of the Konieczny lab for advice on all aspects of the study.	Alahari S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028863; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Aure MH, 2015, DEV CELL, V33, P231, DOI 10.1016/j.devcel.2015.02.013; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Bredemeyer AJ, 2009, DEV BIOL, V325, P211, DOI 10.1016/j.ydbio.2008.10.025; Capoccia BJ, 2011, PHYSIOL GENOMICS, V43, P174, DOI 10.1152/physiolgenomics.00084.2010; Carriere C, 2009, BIOCH BIOPHYSICAL RE; Carriere C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027725; Chevet E, 2015, CANCER DISCOV, V5, P586, DOI 10.1158/2159-8290.CD-14-1490; Collins MA, 2014, GASTROENTEROLOGY, V146, P822, DOI 10.1053/j.gastro.2013.11.052; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; di Magliano MP, 2013, GASTROENTEROLOGY, V144, P1220, DOI 10.1053/j.gastro.2013.01.071; di Magliano MP, 2013, GASTROENTEROLOGY, V144, pE1, DOI 10.1053/j.gastro.2012.11.018; Direnzo D, 2012, GASTROENTEROLOGY, V143, P469, DOI 10.1053/j.gastro.2012.04.011; Flandez M, 2014, GUT, V63, P647, DOI 10.1136/gutjnl-2012-304381; Garside VC, 2010, EXP CELL RES, V316, P2859, DOI 10.1016/j.yexcr.2010.06.014; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Glimcher LH, 2010, ANN RHEUM DIS, V69, P67, DOI 10.1136/ard.2009.119388; Grady T, 1998, AM J PHYSIOL-GASTR L, V275, pG1010, DOI 10.1152/ajpgi.1998.275.5.G1010; Greer RL, 2013, GASTROENTEROLOGY, V145, P1088, DOI 10.1053/j.gastro.2013.07.027; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hale MA, 2014, DEVELOPMENT, V141, P3123, DOI 10.1242/dev.109405; Hess DA, 2011, GASTROENTEROLOGY, V141, P1463, DOI 10.1053/j.gastro.2011.06.045; Holmstrom SR, 2011, GENE DEV, V25, P1674, DOI 10.1101/gad.16860911; Houbracken I, 2011, GASTROENTEROLOGY, V141, P731, DOI 10.1053/j.gastro.2011.04.050; Huang H, 2013, ONCOGENE, DOI [10.1038/onc.2012.819, DOI 10.1038/ONC.2012.819]; Huh WJ, 2010, GASTROENTEROLOGY, V139, P2038, DOI 10.1053/j.gastro.2010.08.050; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Jia D, 2008, GASTROENTEROLOGY, V135, P1687, DOI 10.1053/j.gastro.2008.07.026; Johnson CL, 2014, AM J PHYSIOL-ENDOC M, V306, pE916, DOI 10.1152/ajpendo.00559.2013; Johnson CL, 2004, MECH DEVELOP, V121, P261, DOI 10.1016/j.mod.2004.01.003; Kim S, 2015, PANCREAS, V44, P718, DOI 10.1097/MPA.0000000000000328; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Kowalik AS, 2007, AM J PHYSIOL-GASTR L, V292, pG1123, DOI 10.1152/ajpgi.00512.2006; Krah NM, 2015, ELIFE, V4, DOI 10.7554/eLife.07125; Lennerz JKM, 2010, AM J PATHOL, V177, P1514, DOI 10.2353/ajpath.2010.100328; Lerch MM, 2013, GASTROENTEROLOGY, V144, P1180, DOI 10.1053/j.gastro.2012.12.043; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Luo X, 2005, J BIOL CHEM, V280, P12668, DOI 10.1074/jbc.M411973200; MacDonald RJ, 2010, PROG MOL BIOL TRANSL, V97, P1, DOI 10.1016/B978-0-12-385233-5.00001-5; Malka D, 2002, GUT, V51, P849, DOI 10.1136/gut.51.6.849; Martinelli P, 2016, GUT, V65, P476, DOI 10.1136/gutjnl-2014-308042; Masui T, 2007, GENE DEV, V21, P2629, DOI 10.1101/gad.1575207; Masui T, 2010, GASTROENTEROLOGY, V139, P270, DOI 10.1053/j.gastro.2010.04.003; Mehmood R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084182; Mills JC, 2012, BIOESSAYS, V34, P10, DOI 10.1002/bies.201100089; Molero X, 2012, GUT, V61, P1187, DOI 10.1136/gutjnl-2011-300360; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Nam KT, 2010, GASTROENTEROLOGY, V139, P2028, DOI 10.1053/j.gastro.2010.09.005; Nozaki K, 2008, GASTROENTEROLOGY, V134, P511, DOI 10.1053/j.gastro.2007.11.058; Pin CL, 2015, EPIGENOMICS-UK, V7, P267, DOI [10.2217/EPI.14.83, 10.2217/epi.14.83]; Pin CL, 2000, ANAT REC, V259, P157, DOI 10.1002/(SICI)1097-0185(20000601)259:2<157::AID-AR6>3.0.CO;2-0; Pin CL, 2001, J CELL BIOL, V155, P519, DOI 10.1083/jcb.200105060; Pin CL, 1999, CYTOGENET CELL GENET, V86, P219, DOI 10.1159/000015342; Pinho AV, 2014, CANCER LETT, V345, P203, DOI 10.1016/j.canlet.2013.08.015; Pinho AV, 2011, GUT, V60, P958, DOI 10.1136/gut.2010.225920; Prevot PP, 2013, GASTROENTEROLOGY, V145, P668, DOI 10.1053/j.gastro.2013.05.016; Prevot PP, 2012, GUT, V61, P1723, DOI 10.1136/gutjnl-2011-300266; Puri S, 2010, DEV CELL, V18, P342, DOI 10.1016/j.devcel.2010.02.005; Ramsey VG, 2007, DEVELOPMENT, V134, P211, DOI 10.1242/dev.02700; Rodolosse A, 2004, GASTROENTEROLOGY, V127, P937, DOI 10.1053/j.gastro.2004.06.058; Rukstalis JM, 2003, J CELL SCI, V116, P3315, DOI 10.1242/jcs.00631; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shi G, 2013, ONCOGENE, V32, P1950, DOI 10.1038/onc.2012.210; Shi GL, 2009, GASTROENTEROLOGY, V136, P1368, DOI 10.1053/j.gastro.2008.12.066; Sivere JT, 2008, GASTROENTEROLOGY, V134, P544, DOI 10.1053/j.gastro.2007.11.003; Stanger BZ, 2013, GASTROENTEROLOGY, V144, P1170, DOI 10.1053/j.gastro.2013.01.074; Tian XL, 2010, MOL CELL BIOL, V30, P1269, DOI 10.1128/MCB.01328-09; von Figura G, 2014, GUT, V63, P656, DOI 10.1136/gutjnl-2012-304287; Xuan SH, 2012, J CLIN INVEST, V122, P3516, DOI 10.1172/JCI63352; Zhao Y, 2006, MOL ENDOCRINOL, V20, P2187, DOI 10.1210/me.2005-0214; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176; Zhu LQ, 2004, MOL CELL BIOL, V24, P2673, DOI 10.1128/MCB.24.7.2673-2681.2004	78	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145724	10.1371/journal.pone.0145724	http://dx.doi.org/10.1371/journal.pone.0145724			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717480	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500061
J	Lopez, G; Pallas, B; Martinez, S; Lauri, PE; Regnard, JL; Durel, CE; Costes, E				Lopez, Gerardo; Pallas, Benoit; Martinez, Sebastien; Lauri, Pierre-Eric; Regnard, Jean-Luc; Durel, Charles-Eric; Costes, Evelyne			Genetic Variation of Morphological Traits and Transpiration in an Apple Core Collection under Well-Watered Conditions: Towards the Identification of Morphotypes with High Water Use Efficiency	PLOS ONE			English	Article							COMPLEX ARCHITECTURAL TRAITS; PLANT; DETERMINISM; PROGENY; LEAVES	Water use efficiency (WUE) is a quantitative measurement which improvement is a major issue in the context of global warming and restrictions in water availability for agriculture. In this study, we aimed at studying the variation and genetic control of WUE and the respective role of its components (plant biomass and transpiration) in a perennial fruit crop. We explored an INRA apple core collection grown in a phenotyping platform to screen one-year-old scions for their accumulated biomass, transpiration and WUE under optimal growing conditions. Plant biomass was decompose into morphological components related to either growth or organ expansion. For each trait, nine mixed models were evaluated to account for the genetic effect and spatial heterogeneity inside the platform. The Best Linear Unbiased Predictors of genetic values were estimated after model selection. Mean broad-sense heritabilities were calculated from variance estimates. Heritability values indicated that biomass (0.76) and WUE (0.73) were under genetic control. This genetic control was lower in plant transpiration with an heritability of 0.54. Across the collection, biomass accounted for 70% of the WUE variability. A Hierarchical Ascendant Classification of the core collection indicated the existence of six groups of genotypes with contrasting morphology and WUE. Differences between morphotypes were interpreted as resulting from differences in the main processes responsible for plant growth: cell division leading to the generation of new organs and cell elongation leading to organ dimension. Although further studies will be necessary on mature trees with more complex architecture and multiple sinks such as fruits, this study is a first step for improving apple plant material for the use of water.	[Lopez, Gerardo; Pallas, Benoit; Martinez, Sebastien; Lauri, Pierre-Eric; Costes, Evelyne] INRA, UMR Ameliorat Genet & Adaptat Plantes Mediterrane, Montpellier, France; [Regnard, Jean-Luc] Montpellier SupAgro, UMR Ameliorat Genet & Adaptat Plantes Mediterrane, Montpellier, France; [Durel, Charles-Eric] INRA, UMR Inst Rech Hort & Semences, Beaucouze, France	INRAE; Institut Agro; Montpellier SupAgro; INRAE	Lopez, G (corresponding author), INRA, UMR Ameliorat Genet & Adaptat Plantes Mediterrane, Montpellier, France.	gerardo.lopez.velasco@gmail.com	Lopez, Gerardo/C-5636-2011; lauri, pierre-eric/B-5724-2008	lauri, pierre-eric/0000-0002-7549-0484	European Union [265582, 267196]; BAP-INRA department	European Union(European Commission); BAP-INRA department	This work was supported by the European Union seventh Framework Programme project FruitBreedomics, grant number: 265582. GL received the support of the BAP-INRA department and the European Union, in the framework of the Marie-Curie FP7 COFUND People Programme, through the award of an AgreenSkills' fellowship, grant number: 267196.	Adiredjo AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101218; AVERY DJ, 1977, NEW PHYTOL, V78, P55, DOI 10.1111/j.1469-8137.1977.tb01542.x; Bassett CL, 2011, HORTSCIENCE, V46, P1079, DOI 10.21273/HORTSCI.46.8.1079; Ben Sadok I, 2013, TREE GENET GENOMES, V9, P205, DOI 10.1007/s11295-012-0548-x; Ben Sadok I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127539; BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144; Brown Susan K., 2003, P31, DOI 10.1079/9780851995922.0031; Condon AG, 2004, J EXP BOT, V55, P2447, DOI 10.1093/jxb/erh277; Coupel-Ledru A, 2014, J EXP BOT, V65, P6205, DOI 10.1093/jxb/eru228; Durel CE, 1998, THEOR APPL GENET, V96, P1077, DOI 10.1007/s001220050842; Eveland AL, 2012, J EXP BOT, V63, P3367, DOI 10.1093/jxb/err379; Gilmour AR, 2009, ASREML USER GUIDE RE; Glenn DM, 2000, HORTSCIENCE, V35, P1241, DOI 10.21273/HORTSCI.35.7.1241; Hamdy A, 2003, IRRIG DRAIN, V52, P3, DOI 10.1002/ird.73; Honsdorf N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097047; Johnson K, 2011, NEW PHYTOL, V191, P319, DOI 10.1111/j.1469-8137.2011.03737.x; Lassois L, 2016, PLANT MOL BIOL REP, V34, P827, DOI 10.1007/s11105-015-0966-7; Lauri PE, 2011, PLANT CELL ENVIRON, V34, P1276, DOI 10.1111/j.1365-3040.2011.02328.x; Lespinasse Y., 1992, Proceedings of the Joint Conference of the EAPR Breeding & Varietal Assessment Section and the EUCARPIA Potato Section, Landerneau, France, 12-17 January 1992., P103; Liebhard R, 2003, PLANT MOL BIOL, V52, P511, DOI 10.1023/A:1024886500979; Liu BH, 2012, AGROFOREST SYST, V84, P117, DOI 10.1007/s10457-011-9427-y; MANLY BFJ, 1991, RANDOMIZATION BOOTST; Marguerit E, 2014, J EXP BOT, V65, P4757, DOI 10.1093/jxb/eru226; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; Massonnet C, 2007, ANN BOT-LONDON, V100, P1347, DOI 10.1093/aob/mcm222; MCBRATNEY AB, 1986, J SOIL SCI, V37, P617, DOI 10.1111/j.1365-2389.1986.tb00392.x; Neilson EH, 2015, J EXP BOT, V66, P1817, DOI 10.1093/jxb/eru526; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rebolledo MC, 2013, FUNCT PLANT BIOL, V40, P582, DOI 10.1071/FP12312; Regnard JL, 2008, ACTA HORTIC, P151, DOI 10.17660/ActaHortic.2008.772.18; Segura V, 2007, GENOME, V50, P159, DOI 10.1139/G07-002; Segura V, 2006, TREE GENET GENOMES, V2, P140, DOI 10.1007/s11295-006-0037-1; Slafer GA, 2005, ANN APPL BIOL, V146, P61, DOI 10.1111/j.1744-7348.2005.04048.x; Sun XP, 2013, PHOTOSYNTHETICA, V51, P404, DOI 10.1007/s11099-013-0040-3; Tardieu F, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00017; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Tsukaya H, 2003, CURR OPIN PLANT BIOL, V6, P57, DOI 10.1016/S1369526602000055; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Yang WN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6087	40	13	13	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145540	10.1371/journal.pone.0145540	http://dx.doi.org/10.1371/journal.pone.0145540			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717192	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500043
J	Shrotriya, S; Walsh, D; Bennani-Baiti, N; Thomas, S; Lorton, C				Shrotriya, Shiva; Walsh, Declan; Bennani-Baiti, Nabila; Thomas, Shirley; Lorton, Cliona			C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; POTENTIALLY CURATIVE RESECTION; COLORECTAL-CANCER PATIENTS; ACUTE-PHASE PROTEINS; PREOPERATIVE SERUM INTERLEUKIN-6; INFLAMMATORY RESPONSE; CLINICAL-SIGNIFICANCE; LUNG-CANCER; CRP LEVELS; POOR-PROGNOSIS	Purpose A systematic literature review was done to determine the relationship between elevated CRP and prognosis in people with solid tumors. C-reactive protein (CRP) is a serum acute phase reactant and a well-established inflammatory marker. We also examined the role of CRP to predict treatment response and tumor recurrence. Methods MeSH (Medical Subject Heading) terms were used to search multiple electronic databases (PubMed, EMBASE, Web of Science, SCOPUS, EBM-Cochrane). Two independent reviewers selected research papers. We also included a quality Assessment (QA) score. Reports with QA scores <50% were excluded. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) methodology was utilized for this review (S1 PRISMA Checklist). Results 271 articles were identified for final review. There were 45% prospective studies and 52% retrospective. 264 had intermediate QA score (>= 50% but <80%); Seven were adequate (80% - 100%); A high CRP was predictive of prognosis in 90% (245/271) of studies-80% of the 245 studies by multivariate analysis, 20% by univariate analysis. Many (52%) of the articles were about gastrointestinal malignancies (GI) or kidney malignancies. A high CRP was prognostic in 90% (127 of 141) of the reports in those groups of tumors. CRP was also prognostic in most reports in other solid tumors primary sites. Conclusions A high CRP was associated with higher mortality in 90% of reports in people with solid tumors primary sites. This was particularly notable in GI malignancies and kidney malignancies. In other solid tumors (lung, pancreas, hepatocellular cancer, and bladder) an elevated CRP also predicted prognosis. In addition there is also evidence to support the use of CRP to help decide treatment response and identify tumor recurrence. Better designed large scale studies should be conducted to examine these issues more comprehensively.	[Shrotriya, Shiva; Walsh, Declan; Bennani-Baiti, Nabila; Thomas, Shirley] Cleveland Clin, Taussig Canc Inst, Dept Solid Tumor Oncol, Cleveland, OH 44106 USA; [Shrotriya, Shiva; Walsh, Declan; Bennani-Baiti, Nabila; Thomas, Shirley] Cleveland Clin, Taussig Canc Inst, Harry R Horvitz Ctr Palliat Med, Cleveland, OH 44106 USA; [Lorton, Cliona] Our Ladys Hosp & Care Serv, Dublin, Ireland	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Walsh, D (corresponding author), Cleveland Clin, Taussig Canc Inst, Dept Solid Tumor Oncol, Cleveland, OH 44106 USA.	walsht@ccf.org						Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Allin KH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2891; Allin KH, 2009, J CLIN ONCOL, V27, P2217, DOI 10.1200/JCO.2008.19.8440; American Cancer Society, 2012, CANC FACTS FIG 2012; Atzpodien J, 2003, BRIT J CANCER, V88, P348, DOI 10.1038/sj.bjc.6600768; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barber MD, 1999, CLIN SCI, V96, P83, DOI 10.1042/CS19980185; Bedke J, 2012, BJU INT, V110, pE771, DOI 10.1111/j.1464-410X.2012.11642.x; Beer TM, 2008, CANCER, V112, P2377, DOI 10.1002/cncr.23461; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Bland M, 2002, INTRO MED STAT; BLAY JY, 1992, CANCER RES, V52, P3317; Bromwich E, 2004, BRIT J CANCER, V91, P1236, DOI 10.1038/sj.bjc.6602152; BROOM J, 1992, BRIT J CANCER, V66, P1185, DOI 10.1038/bjc.1992.433; Bystrom P, 2012, ACTA ONCOL, V51, P849, DOI 10.3109/0284186X.2012.705020; Canna K, 2008, COLORECTAL DIS, V10, P663, DOI 10.1111/j.1463-1318.2007.01416.x; Canna K, 2005, BRIT J CANCER, V92, P651, DOI 10.1038/sj.bjc.6602419; Canna K, 2004, BRIT J CANCER, V90, P1707, DOI 10.1038/sj.bjc.6601757; Casamassima A, 2005, J UROLOGY, V173, P52, DOI 10.1097/01.ju.0000146713.50673.e5; Chang Cheng-Chih, 2010, Chang Gung Med J, V33, P301; Cho DS, 2011, KOREAN J UROL, V52, P104, DOI 10.4111/kju.2011.52.2.104; Cho KS, 2008, YONSEI MED J, V49, P451, DOI 10.3349/ymj.2008.49.3.451; Christakis NA, 2000, WESTERN J MED, V172, P310, DOI 10.1136/ewjm.172.5.310; Chua TC, 2012, ANN SURG, V256, P342, DOI 10.1097/SLA.0b013e3182602ad2; Chua W, 2012, SUPPORT CARE CANCER, V20, P1869, DOI 10.1007/s00520-011-1289-3; Chung YC, 2003, HEPATO-GASTROENTEROL, V50, P1910; Chung YC, 2003, EUR J GASTROEN HEPAT, V15, P369, DOI 10.1097/00042737-200304000-00006; Cleeland CS, 2003, CANCER-AM CANCER SOC, V97, P2919, DOI 10.1002/cncr.11382; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crozier JEM, 2007, BRIT J SURG, V94, P1028, DOI 10.1002/bjs.5706; Crozier J, 2006, BRIT J CANCER, V94, P1833, DOI 10.1038/sj.bjc.6603185; Crozier JEM, 2009, AM J SURG, V197, P544, DOI 10.1016/j.amjsurg.2007.12.052; Crozier JE, 2007, J GASTROEN HEPATOL, V22, P2288, DOI 10.1111/j.1440-1746.2006.04792.x; Crumley ABC, 2006, BRIT J CANCER, V94, P1568, DOI 10.1038/sj.bjc.6603150; Crumley ABC, 2008, J GASTROEN HEPATOL, V23, pE325, DOI 10.1111/j.1440-1746.2007.05105.x; Crumley ABC, 2011, ANN SURG ONCOL, V18, P2604, DOI 10.1245/s10434-011-1658-7; Crumley ABC, 2010, WORLD J SURG, V34, P2393, DOI 10.1007/s00268-010-0641-y; Crumley ABC, 2010, J GASTROINTEST SURG, V14, P781, DOI 10.1007/s11605-010-1162-6; de Jong KP, 2004, SCAND J GASTROENTERO, V39, P1141, DOI 10.1080/00365520410009609; Deans DAC, 2007, BRIT J SURG, V94, P1501, DOI 10.1002/bjs.5849; Deans DAC, 2006, BRIT J CANCER, V95, P1568, DOI 10.1038/sj.bjc.6603446; Deichmann M, 2000, J EXP CLIN CANC RES, V19, P301; Deichmann M, 2004, BRIT J CANCER, V91, P699, DOI 10.1038/sj.bjc.6602043; Del Fabbro E, 2010, J PAIN SYMPTOM MANAG, V39, P1016, DOI 10.1016/j.jpainsymman.2009.09.021; DEMELLO J, 1983, BRIT J CANCER, V48, P341, DOI 10.1038/bjc.1983.198; Dutta S, 2012, BRIT J CANCER, V106, P702, DOI 10.1038/bjc.2011.610; Dutta S, 2012, AM J SURG, V204, P294, DOI 10.1016/j.amjsurg.2011.10.015; Dutta S, 2011, WORLD J SURG, V35, P1861, DOI 10.1007/s00268-011-1130-7; EKMAN P, 1991, ACTA ONCOL, V30, P173, DOI 10.3109/02841869109092345; Elahi MM, 2004, NUTR CANCER, V48, P171, DOI 10.1207/s15327914nc4802_6; Elsberger B, 2011, PROSTATE CANCER P D, V14, P122, DOI 10.1038/pcan.2011.5; Emery P, 2007, RHEUMATOL INT, V27, P793, DOI 10.1007/s00296-007-0357-y; Ernstoff MS, 2007, CLIN CANCER RES, V13, p733S, DOI 10.1158/1078-0432.CCR-06-2064; Falkensammer CE, 2011, BJU INT, V107, P1893, DOI 10.1111/j.1464-410X.2010.09817.x; Fantini MC, 2008, CURR DRUG TARGETS, V9, P375, DOI 10.2174/138945008784221206; Fearon KC, 2006, AM J CLIN NUTR, V83, P1345, DOI 10.1093/ajcn/83.6.1345; Frigeri M, 2013, SUPPORT CARE CANCER, V21, P157, DOI 10.1007/s00520-012-1505-9; Fujikawa K, 1999, J UROLOGY, V162, P1934, DOI 10.1016/S0022-5347(05)68072-X; Fujita T, 2012, INT J UROL, V19, P908, DOI 10.1111/j.1442-2042.2012.03071.x; Fujiwara H, 2011, J SURG ONCOL, V103, P62, DOI 10.1002/jso.21751; Furukawa K, 2012, ANTICANCER RES, V32, P5121; Furukawa K, 2012, ONCOL LETT, V4, P324, DOI 10.3892/ol.2012.722; Garcea G, 2011, WORLD J SURG, V35, P868, DOI 10.1007/s00268-011-0984-z; Gioulbasanis I, 2012, LUNG CANCER, V77, P383, DOI 10.1016/j.lungcan.2012.04.008; Gioulbasanis I, 2011, LUNG CANCER, V74, P516, DOI 10.1016/j.lungcan.2011.05.009; Glare Paul, 2005, J Support Oncol, V3, P331; Glare PA, 2008, J PALLIAT MED, V11, P84, DOI 10.1089/jpm.2008.9992; Gockel I, 2006, WORLD J GASTROENTERO, V12, P3746, DOI 10.3748/wjg.v12.i23.3746; Gondo T, 2012, UROLOGY, V79, P1085, DOI 10.1016/j.urology.2011.11.070; Grimm M, 2012, MED ONCOL, V29, P1435, DOI 10.1007/s12032-011-0045-3; Groblewska M, 2008, CLIN CHEM LAB MED, V46, P1423, DOI 10.1515/CCLM.2008.278; Guida M, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-51; Guillem P, 2005, DIS ESOPHAGUS, V18, P146, DOI 10.1111/j.1442-2050.2005.00474.x; Haas M, 2012, PANCREAS, V41, P738, DOI 10.1097/MPA.0b013e31823bcc7b; Haas M, 2010, TUMOR BIOL, V31, P351, DOI 10.1007/s13277-010-0044-6; HANNISDAL E, 1994, ACTA ONCOL, V33, P415, DOI 10.3109/02841869409098438; Hara M, 2010, ANN THORAC CARDIOVAS, V16, P85; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hayes DF, 1996, JNCI-J NATL CANCER I, V88, P1456, DOI 10.1093/jnci/88.20.1456; Hefler LA, 2008, CLIN CANCER RES, V14, P710, DOI 10.1158/1078-0432.CCR-07-1044; Hefler-Frischmuth K, 2010, EUR J OBSTET GYN R B, V149, P102, DOI 10.1016/j.ejogrb.2009.12.027; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Heys SD, 1998, INT J ONCOL, V13, P589; Hoffmann R, 1999, BRIT J CANCER, V79, P1742, DOI 10.1038/sj.bjc.6690277; Hotta K, 2011, BRIT J CANCER, V105, P1191, DOI 10.1038/bjc.2011.368; Hwang EC, 2012, JPN J CLIN ONCOL, V42, P955, DOI 10.1093/jjco/hys124; Hwang JE, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-489; Iimura Y, 2009, J UROLOGY, V181, P1004, DOI 10.1016/j.juro.2008.10.156; Ikeda M, 2003, ANN SURG, V238, P197, DOI 10.1097/01.sla.0000080822.22415.cb; Ikeguchi M, 2009, GASTRIC CANCER, V12, P95, DOI 10.1007/s10120-009-0509-8; Inoue A, 2001, INT J RADIAT ONCOL, V49, P649, DOI 10.1016/S0360-3016(00)00783-5; Inoue T, 2000, Hinyokika Kiyo, V46, P229; Ishizuka M, 2007, ANN SURG, V246, P1047, DOI 10.1097/SLA.0b013e3181454171; Ishizuka M, 2012, J SURG ONCOL, V106, P887, DOI 10.1002/jso.23163; Ishizuka M, 2012, ANN SURG ONCOL, V19, P3422, DOI 10.1245/s10434-012-2384-5; Ishizuka M, 2012, ANTICANCER RES, V32, P3291; Ishizuka M, 2012, AM J SURG, V203, P101, DOI 10.1016/j.amjsurg.2010.09.030; Ishizuka M, 2009, J SURG ONCOL, V100, P38, DOI 10.1002/jso.21294; Ishizuka M, 2009, ANN SURG, V250, P268, DOI 10.1097/SLA.0b013e3181b16e24; Ito K, 2006, INT J UROL, V13, P1365, DOI 10.1111/j.1442-2042.2006.01563.x; Ito K, 2011, J UROLOGY, V186, P430, DOI 10.1016/j.juro.2011.03.113; Ito K, 2009, JPN J CLIN ONCOL, V39, P588, DOI 10.1093/jjco/hyp068; Ito M, 2011, UROLOGY, V78, P1131, DOI 10.1016/j.urology.2011.07.1416; Iwasa S, 2011, INT J CLIN ONCOL, V16, P57, DOI 10.1007/s10147-010-0135-9; Jagdev SPK, 2010, BRIT J CANCER, V103, P1649, DOI 10.1038/sj.bjc.6605973; Jeong JH, 2012, ONCOLOGY-BASEL, V83, P292, DOI 10.1159/000342376; Jiang X, 2012, BRIT J CANCER, V107, P275, DOI 10.1038/bjc.2012.262; Johnson TV, 2011, J UROLOGY, V186, P1213, DOI 10.1016/j.juro.2011.06.014; Johnson TV, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.01.052; Johnson TV, 2010, J UROLOGY, V183, P480, DOI 10.1016/j.juro.2009.10.014; Jones JM, 2006, LUNG CANCER, V53, P97, DOI 10.1016/j.lungcan.2006.03.012; Kanz R, 2011, J THROMB HAEMOST, V9, P57, DOI 10.1111/j.1538-7836.2010.04069.x; Kara EK, 2001, JOURNAL OF B U ON, V6, P91; Karakiewicz PI, 2007, CANCER-AM CANCER SOC, V110, P1241, DOI 10.1002/cncr.22896; Kawashima A, 2012, INT J UROL, V19, P1050, DOI 10.1111/j.1442-2042.2012.03115.x; Kawata N, 2008, INT J UROL, V15, P299, DOI 10.1111/j.1442-2042.2008.01990.x; Kelly L, 2007, ANN ONCOL, V18, P1395, DOI 10.1093/annonc/mdm138; Khan K, 2001, 4 CRD, P5; Kim DK, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-155; Kinoshita A, 2012, MED ONCOL, V29, P2800, DOI 10.1007/s12032-012-0220-1; Ko YJ, 2012, CANCER EPIDEM BIOMAR, V21, P2076, DOI 10.1158/1055-9965.EPI-12-0611; Kobayashi T, 2008, SURGERY, V144, P729, DOI 10.1016/j.surg.2008.08.015; Kobayashi T, 2010, DIGEST SURG, V27, P285, DOI 10.1159/000280021; Kobayashi T, 2010, DIGEST SURG, V27, P232, DOI 10.1159/000276910; Koc M, 2003, BIOL PHARM BULL, V26, P1494, DOI 10.1248/bpb.26.1494; Kocsis J, 2011, CELL STRESS CHAPERON, V16, P49, DOI 10.1007/s12192-010-0220-z; Kodama J, 1999, EUR J OBSTET GYN R B, V82, P107, DOI 10.1016/S0301-2115(98)00227-9; Koenig W, 2004, CIRCULATION, V109, P1349, DOI 10.1161/01.CIR.0000120707.98922.E3; Kohles N, 2012, TUMOR BIOL, V33, P33, DOI 10.1007/s13277-011-0237-7; Koike Y, 2008, J SURG ONCOL, V98, P540, DOI 10.1002/jso.21154; Komai Y, 2007, BJU INT, V99, P77, DOI 10.1111/j.1464-410X.2006.06497.x; Komura K, 2011, NUTR CANCER, V63, P908, DOI 10.1080/01635581.2011.594207; Kruse AL, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-21; Kume H, 2011, J UROLOGY, V185, P1611, DOI 10.1016/j.juro.2010.12.037; Kunisaki C, 2012, ONCOLOGY-BASEL, V83, P183, DOI 10.1159/000341346; Kushner I, 2002, ARCH INTERN MED, V162, P867, DOI 10.1001/archinte.162.8.867; Kwon HC, 2012, WORLD J GASTROENTERO, V18, P4744, DOI 10.3748/wjg.v18.i34.4744; Kwon KA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-203; La Torre M, 2012, ANN SURG ONCOL, V19, P2917, DOI 10.1245/s10434-012-2348-9; Lamb GWA, 2012, BRIT J CANCER, V106, P279, DOI 10.1038/bjc.2011.556; Lamb GWA, 2008, BJU INT, V102, P756, DOI 10.1111/j.1464-410X.2008.07666.x; Lamb GWA, 2006, BRIT J CANCER, V94, P781, DOI 10.1038/sj.bjc.6603034; Lau F, 2007, J PALLIAT CARE, V23, P93, DOI 10.1177/082585970702300205; Lee WS, 2013, J SURG RES, V182, P49, DOI 10.1016/j.jss.2012.08.051; Leitch EF, 2007, BRIT J CANCER, V97, P1266, DOI 10.1038/sj.bjc.6604027; Leung EYL, 2012, J THORAC ONCOL, V7, P655, DOI 10.1097/JTO.0b013e318244ffe1; LEWENHAUPT A, 1990, BRIT J UROL, V66, P182, DOI 10.1111/j.1464-410X.1990.tb14900.x; LJUNGBERG B, 1995, CANCER, V76, P1435, DOI 10.1002/1097-0142(19951015)76:8<1435::AID-CNCR2820760821>3.0.CO;2-Y; Lukaszewicz-Zajac M, 2012, J CLIN LAB ANAL, V26, P73, DOI 10.1002/jcla.21486; Lukaszewicz-Zajac M, 2011, CLIN EXP MED, V11, P89, DOI 10.1007/s10238-010-0114-5; Mahmoud Fade Aziz, 2002, Curr Oncol Rep, V4, P250, DOI 10.1007/s11912-002-0023-1; Malik HZ, 2007, ANN SURG, V246, P806, DOI 10.1097/SLA.0b013e318142d964; Marsik C, 2008, CLIN CHEM, V54, P343, DOI 10.1373/clinchem.2007.091959; Masago K, 2010, ONCOLOGY-BASEL, V79, P355, DOI 10.1159/000323486; Masuda H, 1998, Int J Urol, V5, P418, DOI 10.1111/j.1442-2042.1998.tb00380.x; Masuda H, 1997, Int J Urol, V4, P247, DOI 10.1111/j.1442-2042.1997.tb00181.x; MCMILLAN DC, 1995, AM J SURG, V170, P319, DOI 10.1016/S0002-9610(99)80296-7; McMillan DC, 2003, BRIT J SURG, V90, P215, DOI 10.1002/bjs.4038; McMillan DC, 2003, BRIT J CANCER, V89, P612, DOI 10.1038/sj.bjc.6601156; McMillan DC, 2007, INT J COLORECTAL DIS, V22, P881, DOI 10.1007/s00384-006-0259-6; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1023, DOI 10.1093/jnci/dji193; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Melichar B, 2010, J NUTR SCI VITAMINOL, V56, P222, DOI 10.3177/jnsv.56.222; Michigan A, 2011, MOL DIAGN THER, V15, P229, DOI 10.2165/11534900-000000000-00000; Miki C, 2004, DIGEST DIS SCI, V49, P970, DOI 10.1023/B:DDAS.0000034556.48527.6e; Miyake H, 2009, INT J UROL, V16, P465, DOI [10.1111/j.1442-2042.2009.02289.x, 10.1111/j.1442-2042.2009.02262.x]; Miyata H, 2011, EXP THER MED, V2, P879, DOI 10.3892/etm.2011.308; Miyata Y, 2001, UROLOGY, V58, P161, DOI 10.1016/S0090-4295(01)01165-7; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mohri Y, 2012, ANTICANCER RES, V32, P4581; Morizane S, 2012, CENT EUR J UROL, V65, P62, DOI 10.5173/ceju.2012.02.art1; MORLEY JJ, 1982, ANN NY ACAD SCI, V389, P406, DOI 10.1111/j.1749-6632.1982.tb22153.x; MORTENSEN RF, 1982, ONCOLOGY, V39, P129, DOI 10.1159/000225621; Muller MW, 2008, AM J SURG, V195, P221, DOI 10.1016/j.amjsurg.2007.02.026; MULLER T, 1985, EUR J CANCER CLIN ON, V21, P1461, DOI 10.1016/0277-5379(85)90238-X; Naglieri E, 2002, ANTICANCER RES, V22, P3045; Nakamura T, 2012, CANCER-AM CANCER SOC, V118, P1055, DOI 10.1002/cncr.26353; Nakanishi H, 2002, INT J CANCER, V99, P167, DOI 10.1002/ijc.10343; Nakatsu T, 2012, SURG TODAY, V42, P652, DOI 10.1007/s00595-012-0147-3; Nielsen HJ, 2000, ANN SURG ONCOL, V7, P617, DOI 10.1007/BF02725342; Nikiteas NI, 2005, WORLD J GASTROENTERO, V11, P1639; Nozoe T, 1998, AM J SURG, V176, P335, DOI 10.1016/S0002-9610(98)00204-9; Nozoe T, 2008, SURG TODAY, V38, P597, DOI 10.1007/s00595-007-3680-8; Nozoe T, 2011, SURG TODAY, V41, P510, DOI 10.1007/s00595-009-4297-x; Nozoe T, 2011, AM J SURG, V201, P186, DOI 10.1016/j.amjsurg.2010.01.030; O'Gorman P, 2000, NUTR CANCER, V37, P36, DOI 10.1207/S15327914NC3701_4; Obata J, 2012, UROL ONCOL; Ohno Y, 2010, J UROLOGY, V184, P873, DOI 10.1016/j.juro.2010.05.028; Park YH, 2012, BJU INT, V110, pE553, DOI 10.1111/j.1464-410X.2012.11246.x; Peccatori J, 2005, CANCER-AM CANCER SOC, V104, P2099, DOI 10.1002/cncr.21477; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pinato DJ, 2012, J HEPATOL, V57, P1013, DOI 10.1016/j.jhep.2012.06.022; Polterauer S, 2007, GYNECOL ONCOL, V107, P114, DOI 10.1016/j.ygyno.2007.06.001; Proctor MJ, 2011, BRIT J CANCER, V104, P726, DOI 10.1038/sj.bjc.6606087; Qayyum T, 2012, UROL INT, V88, P277, DOI 10.1159/000334971; Ramsey S, 2008, BJU INT, V101, P959, DOI 10.1111/j.1464-410X.2007.07363.x; Ramsey S, 2007, CANCER, V109, P205, DOI 10.1002/cncr.22400; RASHID SA, 1982, BRIT J CANCER, V45, P390, DOI 10.1038/bjc.1982.66; Ravishankaran P, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-18; Read JA, 2006, NUTR CANCER, V55, P78, DOI 10.1207/s15327914nc5501_10; Richards CH, 2010, BRIT J CANCER, V103, P1356, DOI 10.1038/sj.bjc.6605919; Ridwelski K, 2001, DIGEST DIS, V19, P85, DOI 10.1159/000050657; Riley RD, 2009, BRIT J CANCER, V100, P1219, DOI 10.1038/sj.bjc.6604999; Roxburgh CSD, 2011, ANN SURG ONCOL, V18, P997, DOI 10.1245/s10434-010-1410-8; Roxburgh CSD, 2009, J GASTROINTEST SURG, V13, P2011, DOI 10.1007/s11605-009-1034-0; Royston P, 2006, BRIT J CANCER, V94, P1785, DOI 10.1038/sj.bjc.6603192; Saito K, 2009, EUR UROL, V55, P1145, DOI 10.1016/j.eururo.2008.10.012; Samols D., 2006, AM J MED, V119, p166., DOI [DOI 10.1016/J.AMJMED.2005.06.057, 10.1016/j.amjmed.2005.06.057]; Sawaki A, 2008, J GASTROEN HEPATOL, V23, P1292, DOI 10.1111/j.1440-1746.2006.04734.x; Schilsky RL, 2002, SEMIN ONCOL, V29, P211, DOI 10.1053/sonc.2002.32890; Shafique K, 2012, PROSTATE CANCER P D, V15, P195, DOI 10.1038/pcan.2011.60; Sharma R, 2008, CLIN COLORECTAL CANC, V7, P331, DOI 10.3816/CCC.2008.n.044; Shimada H, 2003, J SURG ONCOL, V83, P248, DOI 10.1002/jso.10275; Shimada H, 2003, SURGERY, V133, P24, DOI 10.1067/msy.2003.31; Shimura T, 2012, ANTICANCER RES, V32, P491; Shinohara N, 2011, UROL ONCOL; Shishehbor MH, 2003, CLEV CLIN J MED, V70, P634, DOI 10.3949/ccjm.70.7.634; Shiu YC, 2008, DIS COLON RECTUM, V51, P443, DOI 10.1007/s10350-007-9133-z; Sim SH, 2012, BRIT J CANCER, V107, P1131, DOI 10.1038/bjc.2012.360; SIMPSON WG, 1995, CLIN EXP IMMUNOL, V99, P143; Six L, 2008, EUR J OBSTET GYN R B, V137, P217, DOI 10.1016/j.ejogrb.2007.02.020; Skipworth RJE, 2011, SUPPORT CARE CANCER, V19, P391, DOI 10.1007/s00520-010-0832-y; Slattery ML, 2011, INT J CANCER, V128, P2726, DOI 10.1002/ijc.25721; Soga N, 2011, CURR UROL, V5, P190; Steffens S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-399; Sugimoto K, 2012, DIGEST SURG, V29, P503, DOI 10.1159/000346002; Suh SY, 2010, SUPPORT CARE CANCER, V18, P151, DOI 10.1007/s00520-009-0639-x; Takagawa R, 2009, DIS ESOPHAGUS, V22, P482, DOI 10.1111/j.1442-2050.2008.00935.x; Takayama T, 2011, J CANCER RES CLIN, V137, P1653, DOI 10.1007/s00432-011-1040-y; Tanaka M, 2008, INT J UROL, V15, P394, DOI 10.1111/j.1442-2042.2008.02017.x; Tanaka T, 2008, JPN J CLIN ONCOL, V38, P755, DOI 10.1093/jjco/hyn098; Tartour E, 1996, J CLIN ONCOL, V14, P1697, DOI 10.1200/JCO.1996.14.5.1697; Tas F, 2005, MED ONCOL, V22, P353, DOI 10.1385/MO:22:4:353; Tatokoro M, 2008, J UROLOGY, V180, P515, DOI 10.1016/j.juro.2008.04.025; Toiyama Y, 2011, EXP THER MED, V2, P95, DOI 10.3892/etm.2010.175; van de Poll MCG, 2011, INT J COLORECTAL DIS, V26, P1067, DOI 10.1007/s00384-011-1187-7; Van Hemelrijck M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-895; Vashist YK, 2011, ANN SURG ONCOL, V18, P1130, DOI 10.1245/s10434-010-1383-7; Vogl U, 2006, BRIT J CANCER, V95, P691, DOI 10.1038/sj.bjc.6603327; Volkova E, 2011, BRIT J CANCER, V104, P51, DOI 10.1038/sj.bjc.6606005; Walsh D, 2003, SUPPORT CARE CANCER, V11, P60, DOI [10.1007/s00520-002-0390-z, 10.1007/s00520-003-0530-0]; Wang CY, 2009, RADIOTHER ONCOL, V92, P270, DOI 10.1016/j.radonc.2009.01.002; Wang CY, 2012, IEEE T INF TECHNOL B; Wang DS, 2012, MED ONCOL, V29, P3092, DOI 10.1007/s12032-012-0226-8; Whiteside T, 2007, CYTOKINES HUMAN HLTH; Wigmore SJ, 2001, BRIT J SURG, V88, P255, DOI 10.1046/j.1365-2168.2001.01669.x; Wilop S, 2008, ONKOLOGIE, V31, P665, DOI 10.1159/000165054; Wood SL, 2010, BRIT J CANCER, V103, P101, DOI 10.1038/sj.bjc.6605720; Yang SH, 2011, ANN SURG ONCOL, V18, P1907, DOI 10.1245/s10434-011-1575-9; Yasuda Y, 2012, INT J CLIN ONCOL; Yoshida S, 2008, BJU INT, V101, P978, DOI 10.1111/j.1464-410X.2007.07408.x; Yuceyar S, 1996, INT SURG, V81, P136; Yudoh K, 1996, JPN J CANCER RES, V87, P1288, DOI 10.1111/j.1349-7006.1996.tb03145.x; Zacharakis M, 2010, ANTICANCER RES, V30, P653; Zingg U, 2010, J GASTROINTEST SURG, V14, P462, DOI 10.1007/s11605-009-1113-2	255	157	160	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0143080	10.1371/journal.pone.0143080	http://dx.doi.org/10.1371/journal.pone.0143080			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717416	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500004
J	Zhang, XF; Li, Q; Zhang, M; Lam, S; Sham, PC; Bu, BT; Chua, SE; Wang, W; McAlonan, GM				Zhang, Xiaofan; Li, Qi; Zhang, Min; Lam, Sylvia; Sham, Pak Chung; Bu, Bitao; Chua, Siew Eng; Wang, Wei; McAlonan, Grainne Mary			The Effect of Oxytocin on Social and Non-Social Behaviour and Striatal Protein Expression in C57BL/6N Mice	PLOS ONE			English	Article							PRENATAL IMMUNE CHALLENGE; PREPULSE INHIBITION; SEX-DIFFERENCES; STARTLE REFLEX; MESSENGER-RNA; RAT-BRAIN; SCHIZOPHRENIA; DEFICITS; CELL; STIMULATION	Oxytocin has been suggested as a promising new treatment for neurodevelopmental disorders. However, important gaps remain in our understanding of its mode of action, in particular, to what extent oxytocin modulates social and non-social behaviours and whether its effects are generalizable across both sexes. Here we investigated the effects of a range of oxytocin doses on social and non-social behaviours in C57BL/6N mice of both sexes. As the striatum modulates social and non-social behaviours, and is implicated in neurodevelopmental disorders, we also conducted a pilot exploration of changes in striatal protein expression elicited by oxytocin. Oxytocin increased prepulse inhibition of startle but attenuated the recognition memory in male C57BL/6N mice. It increased social interaction time and suppressed the amphetamine locomotor response in both sexes. The striatum proteome following oxytocin exposure could be clearly discriminated from saline controls. With the caveat that these results are preliminary, oxytocin appeared to alter individual protein expression in directions similar to conventional anti-psychotics. The proteins affected by oxytocin could be broadly categorized as those that modulate glutamatergic, GABAergic or dopaminergic signalling and those that mediate cytoskeleton dynamics. Our results here encourage further research into the clinical application of this peptide hormone, which may potentially extend treatment options across a spectrum of neurodevelopmental conditions.	[Zhang, Xiaofan; Zhang, Min; Bu, Bitao; Wang, Wei] HUST, Tongji Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430030, Peoples R China; [Zhang, Xiaofan; Li, Qi; Lam, Sylvia; Sham, Pak Chung; Chua, Siew Eng] Univ Hong Kong, Dept Psychiat, Pokfulam, Hong Kong, Peoples R China; [McAlonan, Grainne Mary] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Forens & Neurodev Sci, London WC2R 2LS, England	Huazhong University of Science & Technology; University of Hong Kong; University of London; King's College London	Wang, W (corresponding author), HUST, Tongji Hosp, Tongji Med Coll, Dept Neurol, 1095 Jiefang Ave, Wuhan 430030, Peoples R China.	wwang@vip.126.com; grainne.mcalonan@kcl.ac.uk			Hong Kong Universities General Research Fund Award [HKU 774710]; National Natural Science Foundation of China [61327902, 81030021, 81271406]	Hong Kong Universities General Research Fund Award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by research funding from the Hong Kong Universities General Research Fund Award to Dr Grainne McAlonan (HKU 774710) and research funding from National Natural Science Foundation of China to Professor Wang (61327902 and 81030021) and Professor Zhang (81271406). Dr Grainne McAlonan is a member of the EU-AIMS consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, J NEUROCHEM, V62, P1375; Bai O, 2003, J NEUROSCI RES, V71, P127, DOI 10.1002/jnr.10440; Bales KL, 2013, BIOL PSYCHIAT, V74, P180, DOI 10.1016/j.biopsych.2012.08.025; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; BRAFF D, 1978, PSYCHOPHYSIOLOGY, V15, P339, DOI 10.1111/j.1469-8986.1978.tb01390.x; Brenes JC, 2008, PHARMACOL BIOCHEM BE, V89, P85, DOI 10.1016/j.pbb.2007.11.004; CABOCHE J, 1991, J NEUROCHEM, V56, P428, DOI 10.1111/j.1471-4159.1991.tb08168.x; Caldwell HK, 2009, MOL PSYCHIATR, V14, P190, DOI 10.1038/sj.mp.4002150; Carter CS, 2007, BEHAV BRAIN RES, V176, P170, DOI 10.1016/j.bbr.2006.08.025; CASTELLANO C, 1989, BEHAV NEURAL BIOL, V52, P170, DOI 10.1016/S0163-1047(89)90285-9; CASTNER SA, 1993, BRAIN RES, V610, P127, DOI 10.1016/0006-8993(93)91225-H; Castner SA, 1996, BRAIN RES, V712, P245, DOI 10.1016/0006-8993(95)01429-2; Charrier E, 2003, MOL NEUROBIOL, V28, P51, DOI 10.1385/MN:28:1:51; Cheung C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012233; Clark D, 2007, PROTEOM CLIN APPL, V1, P157, DOI 10.1002/prca.200600541; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Csomor PA, 2008, BEHAV NEUROSCI, V122, P885, DOI 10.1037/0735-7044.122.4.885; Dawood M, 1983, ENDOCRINOLOGY PREGNA, P204; Deng MY, 2009, PSYCHOPHARMACOLOGY, V206, P437, DOI 10.1007/s00213-009-1619-z; Feifel D, 1999, PSYCHOPHARMACOLOGY, V141, P93, DOI 10.1007/s002130050811; Feifel D, 2012, EUR NEUROPSYCHOPHARM, V22, P374, DOI 10.1016/j.euroneuro.2011.09.004; Feifel D, 2010, BIOL PSYCHIAT, V68, P678, DOI 10.1016/j.biopsych.2010.04.039; Ferguson JN, 2001, J NEUROSCI, V21, P8278; FILLINGAME RH, 1990, BACTERIA TREATISE ST, V12, P345; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Jo YH, 1998, J NEUROSCI, V18, P2377; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; JONES PM, 1982, NEUROENDOCRINOLOGY, V34, P297, DOI 10.1159/000123316; Kantor L, 1998, J PHARMACOL EXP THER, V284, P592; Karp NA, 2005, PROTEOMICS, V5, P81, DOI 10.1002/pmic.200400881; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Klomp LWJ, 2000, AM J HUM GENET, V67, P1389, DOI 10.1086/316886; Konradi C, 2001, BIOL PSYCHIAT, V50, P729, DOI 10.1016/S0006-3223(01)01267-7; Kumari V, 2004, SCHIZOPHR RES, V69, P219, DOI 10.1016/j.schres.2003.09.010; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Lee PR, 2005, NEUROPSYCHOPHARMACOL, V30, P1883, DOI 10.1038/sj.npp.1300722; Leung M, 2011, SCHIZOPHRENIA BULL, V37, P199, DOI 10.1093/schbul/sbp099; Li Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006354; Loth E, 2013, BIOL PSYCHIAT; Matsuo N, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00029; Meyer U, 2008, BRAIN BEHAV IMMUN, V22, P469, DOI 10.1016/j.bbi.2007.09.012; Meziane H, 2007, GENES BRAIN BEHAV, V6, P192, DOI 10.1111/j.1601-183X.2006.00249.x; Nesvaderani M, 2009, AUST NZ J PSYCHIAT, V43, P310, DOI 10.1080/00048670902721103; NIELSEN EB, 1978, PSYCHOPHARMACOLOGY, V59, P85, DOI 10.1007/BF00428036; PAKKENBERG H, 1973, PSYCHOPHARMACOLOGIA, V29, P329, DOI 10.1007/BF00429280; PEEKE HVS, 1971, SCIENCE, V173, P80, DOI 10.1126/science.173.3991.80; Pennington K, 2008, MOL PSYCHIATR, V13, P1102, DOI 10.1038/sj.mp.4002098; Pennington K, 2009, J PSYCHOPHARMACOL, V23, P520, DOI 10.1177/0269881108091075; Roberts E., 1986, BENZODIAZEPINES GABA, P1; Rushlow WJ, 2005, J NEUROCHEM, V94, P587, DOI 10.1111/j.1471-4159.2005.03092.x; Scheel-Kruger J, 1986, ACTA NEUROLOGICA SCA; SCOTT JP, 1966, AM ZOOL, V6, P683; SHEKHAR A, 1995, PHARMACOL BIOCHEM BE, V50, P253, DOI 10.1016/0091-3057(94)00307-5; SPRUIJT BM, 1994, J NEUROSCI, V14, P3225; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Swonger JM, 2011, PREPULSE INHIBITION; SZECHTMAN H, 1988, ARCH GEN PSYCHIAT, V45, P523; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2007, BIOL PSYCHIAT, V62, P148, DOI 10.1016/j.biopsych.2006.06.035; Takao K, 2013, NEUROPSYCHOPHARMACOL, V38, P1409, DOI 10.1038/npp.2013.38; TAKEICHI M, 1985, FOLIA PSYCHIAT NEU J, V39, P185; Tomizawa K, 2003, NAT NEUROSCI, V6, P384, DOI 10.1038/nn1023; Tricomi E, 2010, NATURE, V463, P1089, DOI 10.1038/nature08785; Vollenweider FX, 2006, BIOL PSYCHIAT, V60, P597, DOI 10.1016/j.biopsych.2006.03.058; Vuillermot S, 2010, J NEUROSCI, V30, P1270, DOI 10.1523/JNEUROSCI.5408-09.2010; Wang Y, 2007, MOL ENDOCRINOL, V21, P972, DOI 10.1210/me.2006-0249; Wheal HV, 1998, PROG NEUROBIOL, V55, P611, DOI 10.1016/S0301-0082(98)00026-4; WheelerJones CPD, 1996, BIOCHEM J, V315, P41, DOI 10.1042/bj3150041; WROBLEWSKI JT, 1985, BRAIN RES, V329, P161, DOI 10.1016/0006-8993(85)90521-9; WYERS EJ, 1968, EXP NEUROL, V22, P350, DOI 10.1016/0014-4886(68)90002-2; Yu K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00189; Yu KK, 2011, J PSYCHIATR NEUROSCI, V36, P412, DOI 10.1503/jpn.100138; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhang X, 2015, BRAIN RES B	78	0	0	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145638	10.1371/journal.pone.0145638	http://dx.doi.org/10.1371/journal.pone.0145638			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716999	gold, Green Published			2022-12-27	WOS:000367510500050
J	Masoud, R; Bizouarn, T; Trepout, S; Wien, F; Baciou, L; Marco, S; Levin, CH				Masoud, Rawand; Bizouarn, Tania; Trepout, Sylvain; Wien, Frank; Baciou, Laura; Marco, Sergio; Levin, Chantal Houee			Titanium Dioxide Nanoparticles Increase Superoxide Anion Production by Acting on NADPH Oxidase	PLOS ONE			English	Article							HUMAN NEUTROPHILS; CONFORMATIONAL-CHANGES; OXIDATIVE STRESS; ARACHIDONIC-ACID; NOX-FAMILY; ACTIVATION; TOXICITY; PHOSPHORYLATION; PARTICLES; P47(PHOX)	Titanium dioxide (TiO2) anatase nanoparticles (NPs) are metal oxide NPs commercialized for several uses of everyday life. However their toxicity has been poorly investigated. Cellular internalization of NPs has been shown to activate macrophages and neutrophils that contribute to superoxide anion production by the NADPH oxidase complex. Transmission electron micrososcopy images showed that the membrane fractions were close to the NPs while fluorescence indicated an interaction between NPs and cytosolic proteins. Using a cell-free system, we have investigated the influence of TiO2 NPs on the behavior of the NADPH oxidase. In the absence of the classical activator molecules of the enzyme (arachidonic acid) but in the presence of TiO2 NPs, no production of superoxide ions could be detected indicating that TiO2 NPs were unable to activate by themselves the complex. However once the NADPH oxidase was activated (i.e., by arachidonic acid), the rate of superoxide anion production went up to 140% of its value without NPs, this effect being dependent on their concentration. In the presence of TiO2 nanoparticles, the NADPH oxidase produces more superoxide ions, hence induces higher oxidative stress. This hyper-activation and the subsequent increase in ROS production by TiO2 NPs could participate to the oxidative stress development.	[Masoud, Rawand; Bizouarn, Tania; Baciou, Laura; Levin, Chantal Houee] Univ Paris 11, Lab Chim Phys, UMR 8000, Orsay, France; [Masoud, Rawand; Bizouarn, Tania; Baciou, Laura; Levin, Chantal Houee] CNRS, UMR 8000, F-91405 Orsay, France; [Trepout, Sylvain; Marco, Sergio] Inst Curie, Ctr Rech, Ctr Univ, F-91405 Orsay, France; [Trepout, Sylvain; Marco, Sergio] Ctr Univ, INSERM, U1196, Orsay, France; [Trepout, Sylvain; Marco, Sergio] Ctr Univ, CNRS, UMR9187, Orsay, France; [Wien, Frank] LOrme Merisiers, Synchrotron SOLEIL, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; SOLEIL Synchrotron	Levin, CH (corresponding author), Univ Paris 11, Lab Chim Phys, UMR 8000, Orsay, France.	Chantal.houee@u-psud.fr	bizouarn, tania/W-6782-2019; marco, SERGIO/E-4875-2017; Wien, Frank/B-7846-2012	Wien, Frank/0000-0002-0752-8735; Trepout, Sylvain/0000-0002-5822-407X; Houee Levin, Chantal/0000-0001-8089-796X	ANR [2010-blan-1536-01]	ANR(French National Research Agency (ANR))	The financial support of ANR 2010-blan-1536-01 is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr H. Remita for a generous gift of nanoparticles, to Prof. E. Pick for the trimera plasmids and to Dr F. Lederer for the preparation of neutrophils. The financial support of ANR 2010-blan-1536-01 is acknowledged. We thank the COST Action CM1201 (Biomimetic Radical Chemistry) for very fruitful discussions.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; Alarifi S, 2013, INT J NANOMED, V8, P3937, DOI 10.2147/IJN.S47174; Allouni ZE, 2015, INT J NANOMED, V10, P687, DOI 10.2147/IJN.S72726; Babin K, 2015, BBA-GEN SUBJECTS, V1850, P2276, DOI 10.1016/j.bbagen.2015.08.006; Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; BABIOR BM, 1984, BLOOD, V64, P959; Baciou L, 2009, FEBS LETT, V583, P3225, DOI 10.1016/j.febslet.2009.09.011; Barnard AS, 2010, NAT NANOTECHNOL, V5, P271, DOI [10.1038/nnano.2010.25, 10.1038/NNANO.2010.25]; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Berdichevsky Y, 2007, J BIOL CHEM, V282, P22122, DOI 10.1074/jbc.M701497200; Bermudez E, 2004, TOXICOL SCI, V77, P347, DOI 10.1093/toxsci/kfh019; Buzea C, 2007, BIOINTERPHASES, V2, pMR17, DOI 10.1116/1.2815690; Dransfield GP, 2000, RADIAT PROT DOSIM, V91, P271, DOI 10.1093/oxfordjournals.rpd.a033216; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Gheshlaghi ZN, 2008, ACTA BIOCH BIOPH SIN, V40, P777, DOI 10.1111/j.1745-7270.2008.00458.x; Goncalves DM, 2010, TOXICOL IN VITRO, V24, P1002, DOI 10.1016/j.tiv.2009.12.007; Goncalves DM, 2011, THESCIENTIFICWORLDJO, V11, P1877, DOI 10.1100/2011/768350; Gurr JR, 2005, TOXICOLOGY, V213, P66, DOI 10.1016/j.tox.2005.05.007; HEDENBORG M, 1988, INT ARCH OCC ENV HEA, V61, P1, DOI 10.1007/BF00381600; Huang CC, 2010, TOXICOL IN VITRO, V24, P45, DOI 10.1016/j.tiv.2009.09.007; Jovanovic B, 2015, ENVIRON TOXICOL CHEM, V34, P1070, DOI 10.1002/etc.2891; Jovanovic B, 2011, ECOTOX ENVIRON SAFE, V74, P675, DOI 10.1016/j.ecoenv.2010.10.017; Karimi G, 2014, BBA-GEN SUBJECTS, V1840, P3277, DOI 10.1016/j.bbagen.2014.07.022; Knaapen AM, 2004, INT J CANCER, V109, P799, DOI 10.1002/ijc.11708; Lagopati N, 2010, J PHOTOCH PHOTOBIO A, V214, P215, DOI 10.1016/j.jphotochem.2010.06.031; Lucky SS, 2015, ACS NANO, V9, P191, DOI 10.1021/nn503450t; Manke A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/942916; Marucco A, 2015, CHEM RES TOXICOL; Masoud R, 2014, REDOX BIOL, V3, P16, DOI 10.1016/j.redox.2014.10.001; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Niederberger M, 2009, ENG MATER PROCESS, P1, DOI 10.1007/978-1-84882-671-7; Niska K, 2015, INT J NANOMED, V10, P1095, DOI 10.2147/IJN.S73557; Ostuni MA, 2010, FREE RADICAL BIO MED, V49, P900, DOI 10.1016/j.freeradbiomed.2010.06.021; Papakostas D, 2011, ARCH DERMATOL RES, V303, P533, DOI 10.1007/s00403-011-1163-7; PICK E, 1987, J BIOL CHEM, V262, P16476; Raad H, 2009, FASEB J, V23, P1011, DOI 10.1096/fj.08-114553; da Rosa ELS, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-11; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Sharma V, 2012, APOPTOSIS, V17, P852, DOI 10.1007/s10495-012-0705-6; Sharma V, 2012, MUTAT RES-GEN TOX EN, V745, P84, DOI 10.1016/j.mrgentox.2011.12.009; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Shi HB, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-15; Shiose A, 2000, J BIOL CHEM, V275, P13793, DOI 10.1074/jbc.275.18.13793; Simon-Vazquez R, 2014, COLLOID SURFACE B, V113, P198, DOI 10.1016/j.colsurfb.2013.08.047; Skocaj M, 2011, RADIOL ONCOL, V45, P227, DOI 10.2478/v10019-011-0037-0; Souabni H, 2012, BBA-BIOMEMBRANES, V1818, P2314, DOI 10.1016/j.bbamem.2012.04.018; Souabni H, BIOCHIMIE; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Swain SD, 1997, J BIOL CHEM, V272, P29502, DOI 10.1074/jbc.272.47.29502; Thomas T, 2006, TOXICOL SCI, V91, P14, DOI 10.1093/toxsci/kfj129; Valencia A, 2008, J INVEST DERMATOL, V128, P214, DOI 10.1038/sj.jid.5700960; Voet D., 2011, BIOCHEMISTRY; Wang C, 2012, SCI TOTAL ENVIRON, V429, P156, DOI 10.1016/j.scitotenv.2012.03.048; Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001; Wiesenthal A, 2011, INT J DERMATOL, V50, P247, DOI 10.1111/j.1365-4632.2010.04815.x; Wilhelmi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065704; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k; Yuan YL, 2010, J NANOSCI NANOTECHNO, V10, P4868, DOI 10.1166/jnn.2010.2225; Zeisser-Labouebe M, 2007, NANOTECHNOLOGIES LIF	62	27	31	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144829	10.1371/journal.pone.0144829	http://dx.doi.org/10.1371/journal.pone.0144829			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714308	Green Published, gold, Green Submitted			2022-12-27	WOS:000367481900020
J	Previtera, ML; Sengupta, A				Previtera, Michelle L.; Sengupta, Amitabha			Substrate Stiffness Regulates Proinflammatory Mediator Production through TLR4 Activity in Macrophages	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; MONONUCLEAR PHAGOCYTE SYSTEM; NF-KAPPA-B; MATRIX; ELASTICITY; ATHEROSCLEROSIS; PHOSPHORYLATION; DIFFERENTIATION; ACTIVATION; EXPRESSION	Clinical data show that disease adversely affects tissue elasticity or stiffness. While macrophage activity plays a critical role in driving disease pathology, there are limited data available on the effects of tissue stiffness on macrophage activity. In this study, the effects of substrate stiffness on inflammatory mediator production by macrophages were investigated. Bone marrow-derived macrophages were grown on polyacrylamide gels that mimicked the stiffness of a variety of soft biological tissues. Overall, macrophages grown on soft substrates produced less proinflammatory mediators than macrophages grown on stiff substrates when the endotoxin LPS was added to media. In addition, the pathways involved in stiffness-regulated proinflammation were investigated. The TLR4 signaling pathway was examined by evaluating TLR4, p-NF-kappa B p65, MyD88, and p-I kappa B alpha expression as well as p-NF-kappa B p65 translocation. Expression and translocation of the various signaling molecules were higher in macrophages grown on stiff substrates than on soft substrates. Furthermore, TLR4 knockout experiments showed that TLR4 activity enhanced proinflammation on stiff substrates. In conclusion, these results suggest that proinflammatory mediator production initiated by TLR4 is mechanically regulated in macrophages.	[Previtera, Michelle L.; Sengupta, Amitabha] JFK Neurosci Inst, JFK Med Ctr, Edison, NJ 08820 USA; [Previtera, Michelle L.] Seton Hall Univ, Dept Neurosci, S Orange, NJ 07079 USA	Seton Hall University	Previtera, ML (corresponding author), JFK Neurosci Inst, JFK Med Ctr, 65 James St, Edison, NJ 08820 USA.	mprevitera@jfkhealth.org			JFK Neuroscience Institute; JFK Foundation	JFK Neuroscience Institute; JFK Foundation	Funding provided by JFK Neuroscience Institute and JFK Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Kimberly Peterman, Rajat Patel, Poonit Mehta, Brian Healy, Tariq Mirza, and Juan Luzuriaga for preparing PA gels and counting cells. Further acknowledgment goes to Kimberly Peterman, Smit Shah, and Norell Hadzimichalis for editing this manuscript. The JFK Neuroscience Institute and JFK Foundation funded this work. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript. The authors have nothing to disclose.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Blacher J, 1998, HYPERTENSION, V32, P570, DOI 10.1161/01.HYP.32.3.570; Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Gotschy A, 2013, CIRC-CARDIOVASC IMAG, V6, P916, DOI 10.1161/CIRCIMAGING.113.000611; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hu J, 2004, CARCINOGENESIS, V25, P1991, DOI 10.1093/carcin/bgh198; Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621; Irwin EF, 2008, J BIOMAT SCI-POLYM E, V19, P1363, DOI 10.1163/156856208786052407; Ishihara S, 2013, EXP CELL RES, V319, P2916, DOI 10.1016/j.yexcr.2013.09.018; Kazemi F, 2006, J HEPATOL, V45, P230, DOI 10.1016/j.jhep.2006.04.006; Khan KMF, 2004, J BIOL CHEM, V279, P22039, DOI 10.1074/jbc.M312735200; Kocgozlu L, 2010, J CELL SCI, V123, P29, DOI 10.1242/jcs.053520; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Nahon P, 2006, AM J GASTROENTEROL, V101, P2744, DOI 10.1111/j.1572-0241.2006.00816.x; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Patel NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041024; Previtera ML, 2013, ANN BIOMED ENG, V41, P1193, DOI 10.1007/s10439-013-0765-y; Previtera ML, 2010, ANN BIOMED ENG, V38, P3733, DOI 10.1007/s10439-010-0112-5; Previtera ML, 2010, J BIOSCI BIOENG, V110, P459, DOI 10.1016/j.jbiosc.2010.04.004; Previtera ML, 2014, ANN BIOMED ENG; Rauch U, 2011, HISTOL HISTOPATHOL, V26, P711, DOI 10.14670/HH-26.711; Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009; Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6; Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Teng ZZ, 2014, ACTA BIOMATER, V10, P5055, DOI 10.1016/j.actbio.2014.09.001; Trotta T, 2014, J NEUROIMMUNOL, V268, P1, DOI 10.1016/j.jneuroim.2014.01.014; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wuerfel J, 2010, NEUROIMAGE, V49, P2520, DOI 10.1016/j.neuroimage.2009.06.018; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	43	97	98	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145813	10.1371/journal.pone.0145813	http://dx.doi.org/10.1371/journal.pone.0145813			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710072	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400081
J	Zhang, WJ; Hou, T; Niu, CH; Song, LB; Zhang, YN				Zhang, Weijing; Hou, Teng; Niu, Chunhao; Song, Libing; Zhang, Yanna			B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PRACTICE GUIDELINES; HUMAN-PAPILLOMAVIRUS; IDENTIFICATION; RISK; PROGNOSIS; BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE; RADIOTHERAPY; MANAGEMENT; RECEPTORS	Background The beta 1,3-N-acetylglucosaminyltransferase-3 gene (B3GNT3) encodes a member of the B3GNT family that functions as the backbone structure of dimeric sialyl-Lewis A and is involved in L-selectin ligand biosynthesis, lymphocyte homing and lymphocyte trafficking. B3GNT3 has been implicated as an important element in the development of certain cancers. However, the characteristics of B3GNT3 in the development and progression of cancer remain largely unknown. Thus, our study aimed to investigate the expression pattern and the prognostic value of B3GNT3 in patients with early-stage cervical cancer. Methods The mRNA and protein levels of B3GNT3 expression were examined in eight cervical cancer cell lines and ten paired cervical cancer tumors, using real-time PCR and western blotting, respectively. Immunohistochemistry (IHC) was used to analyze B3GNT3 protein expression in paraffin-embedded tissues from 196 early-stage cervical cancer patients. Statistical analyses were applied to evaluate the association between B3GNT3 expression scores and clinical parameters, as well as patient survival. Results B3GNT3 expression was significantly upregulated in cervical cancer cell lines and lesions compared with normal cells and adjacent noncancerous cervical tissues. In the 196 cases of tested early-stage cervical cancer samples, the B3GNT3 protein level was positively correlated with high risk TYPES of human papillomavirus (HPV) infection (P = 0.026), FIGO stage (P < 0.001), tumor size (P = 0.025), tumor recurrence (P = 0.004), vital status (P < 0.001), concurrent chemotherapy and radiotherapy (P = 0.016), lymphovascular space involvement (P = 0.003) and most importantly, lymph node metastasis (P = 0.003). Patients with high B3GNT3 expression had a shorter overall survival (OS) and disease-free survival (DFS) compared with those with low expression of this protein. Multivariate analysis suggested that B3GNT3 expression is an independent prognostic indicator for cervical cancer patients. Conclusions Our study demonstrated that elevated B3GNT3 expression is associated with pelvic lymph node metastasis and poor outcome in early-stage cervical cancer patients. B3GNT3 may be a novel prognostic marker and therapeutic target for the treatment of cervical cancer.	[Zhang, Weijing; Niu, Chunhao; Song, Libing; Zhang, Yanna] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Hou, Teng] Huazhong Univ Sci & Technol, Wuhan Union Hosp, Dept Urol, Wuhan 430074, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Huazhong University of Science & Technology	Song, LB (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	songlb@sysucc.org.cn; zhangyn@sysucc.org.cn	Song, LB/AAL-1968-2020; Zhang, Weijing/GQA-9455-2022					Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Cerhan JR, 2007, BLOOD, V110, P4455, DOI 10.1182/blood-2007-05-088682; Dallas MR, 2012, AM J PHYSIOL-CELL PH, V303, pC616, DOI 10.1152/ajpcell.00149.2012; Duenas-Gonzalez A, 2003, CANCER TREAT REV, V29, P389, DOI 10.1016/S0305-7372(03)00068-9; Etcheverry A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-701; Fan CF, 2011, TUMOR BIOL, V32, P873, DOI 10.1007/s13277-011-0188-z; Fleming ND, 2015, GYNECOL ONCOL, V136, P48, DOI 10.1016/j.ygyno.2014.11.010; Grigsby PW, 2001, CANCER J, V7, pS47; Haider S, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0105-3; Haie-Meder C, 2010, ANN ONCOL, V21, pv37, DOI 10.1093/annonc/mdq162; He MA, 2014, GUT, V63, P143, DOI 10.1136/gutjnl-2012-303434; Ho WL, 2013, CANCER SCI, V104, P1600, DOI 10.1111/cas.12294; Hofler D, 2015, GYNECOL ONCOL, V138, P676, DOI 10.1016/j.ygyno.2015.06.039; Hu Z, 2015, J CLIN INVEST, V125, P425, DOI 10.1172/JCI78206; Hua D, 2012, ASIAN PAC J CANCER P, V13, P2087, DOI 10.7314/APJCP.2012.13.5.2087; Iida M, 2014, MOL CLIN ONCOL, V2, P647, DOI 10.3892/mco.2014.324; Ishida H, 2005, FEBS LETT, V579, P71, DOI 10.1016/j.febslet.2004.11.037; Koh WJ, 2013, J NATL COMPR CANC NE, V11, P320, DOI 10.6004/jnccn.2013.0043; Li S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073837; Li Y, 2015, APOPTOSIS; Li Z, 2012, ANN ONCOL, V23, P638, DOI 10.1093/annonc/mdr290; Lin HS, 2004, ARCH OTOLARYNGOL, V130, P311, DOI 10.1001/archotol.130.3.311; Liu LX, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0183-5; Liu XK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-59; Llor X, 1999, CLIN CANCER RES, V5, P1767; Ludyga N, 2011, MOL BIOSYST, V7, P1603, DOI 10.1039/c0mb00286k; Ma S, 2012, GASTROENTEROLOGY, V143, P675, DOI 10.1053/j.gastro.2012.06.007; Mitoma J, 2003, J BIOL CHEM, V278, P9953, DOI 10.1074/jbc.M212756200; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Okazawa M, 2013, INT J GYNECOL CANCER, V23, P567, DOI 10.1097/IGC.0b013e31828703fd; Onal C, 2015, GYNECOL ONCOL; Paiva I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116868; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Schmandt RE, 2006, CANCER BIOL THER, V5, P1136, DOI 10.4161/cbt.5.9.2953; Shen H, 2014, CANCER BIOL THER, V15, P342, DOI 10.4161/cbt.27328; Shen L, 2011, MOL BIOL REP, V38, P1541, DOI 10.1007/s11033-010-0262-4; Shibata TK, 2012, J BIOL CHEM, V287, P6592, DOI 10.1074/jbc.M111.305334; Shiraishi N, 2001, J BIOL CHEM, V276, P3498, DOI 10.1074/jbc.M004800200; Tong YQ, 2012, ASIA-PAC J CLIN ONCO, V8, pE55, DOI 10.1111/j.1743-7563.2012.01564.x; Wheeler CM, 2009, JNCI-J NATL CANCER I, V101, P475, DOI 10.1093/jnci/djn510; Yamashita H, 2010, AM J CLIN ONCOL-CANC, V33, P583, DOI 10.1097/COC.0b013e3181cae5b7; Yang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075849; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Zhang LF, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-4; Zhang W., 2015, TUMOUR BIOL; Zhang ZH, 2012, INT J BIOCHEM CELL B, V44, P1244, DOI 10.1016/j.biocel.2012.04.026	47	20	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144360	10.1371/journal.pone.0144360	http://dx.doi.org/10.1371/journal.pone.0144360			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709519	Green Submitted, Green Published, gold			2022-12-27	WOS:000367451400005
J	Dechavanne, C; Cottrell, G; Garcia, A; Migot-Nabias, F				Dechavanne, Celia; Cottrell, Gilles; Garcia, Andre; Migot-Nabias, Florence			Placental Malaria: Decreased Transfer of Maternal Antibodies Directed to Plasmodium falciparum and Impact on the Incidence of Febrile Infections in Infants	PLOS ONE			English	Article							NEONATAL FC-RECEPTOR; TETANUS ANTIBODIES; MUMPS VACCINATION; MEASLES; RESPONSES; IMMUNITY; SUSCEPTIBILITY; TRANSMISSION; ASSOCIATION; PROTECTION	The efficacy of mother-to-child placental transfer of antibodies specific to malaria blood stage antigens was investigated in the context of placental malaria infection, taking into account IgG specificity and maternal hypergammaglobulinemia. The impact of the resulting maternal antibody transfer on infections in infants up to the age of 6 months was also explored. This study showed that i) placental malaria was associated with a reduced placental transfer of total and specific IgG, ii) antibody placental transfer varied according to IgG specificity and iii) cord blood malaria IgG levels were similar in infants born to mothers with or without placental malaria. The number of malaria infections was negatively associated with maternal age, whereas it was not associated with the transfer of any malaria-specific IgG from the mother to the fetus. These results suggest that i) malaria-specific IgG may serve as a marker of maternal exposure but not as a useful marker of infant protection from malaria and ii) increasing maternal age contributes to diminishing febrile infections diagnosed in infants, perhaps by means of the transmission of an effective antibody response.	[Dechavanne, Celia; Cottrell, Gilles; Garcia, Andre; Migot-Nabias, Florence] Univ Paris 05, IRD, UMR Mere & Enfant Face Infect Trop 216, Paris, France; [Dechavanne, Celia; Cottrell, Gilles; Garcia, Andre; Migot-Nabias, Florence] Univ Paris 05, COMUE Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite	Dechavanne, C (corresponding author), Case Western Reserve Univ, Ctr Global Hlth & Dis, Biomed Res Bldg, Cleveland, OH 44106 USA.	celia.dechavanne@gmail.com	Garcia, Andre/S-2959-2016; Garcia, Andre/ABA-1820-2020	Garcia, Andre/0000-0002-1808-472X; Garcia, Andre/0000-0002-1808-472X; Migot-Nabias, Florence/0000-0001-9982-594X; Cottrell, Gilles/0000-0002-7964-8963; Dechavanne, Celia/0000-0001-8439-9976	Agence Nationale de la Recherche (ANR) Sante Environnement Sante Travail (SEST) [040 01]; Treilles Foundation	Agence Nationale de la Recherche (ANR) Sante Environnement Sante Travail (SEST)(French National Research Agency (ANR)); Treilles Foundation	The funding for this study was received from Agence Nationale de la Recherche (ANR) Sante Environnement Sante Travail (SEST 2006; 040 01). Celia Dechavanne benefited from the financial support of the Treilles Foundation.; We thank all the women and infants of Tori Bossito who agreed to participate in the study as well as the CERPAGE (Centre d'Etude et de Recherche sur le Paludisme Assoecie a la Grossesse et l'Enfance) team at Cotonou and the Tori Bossito medical health center staff (F. Loumedjinon and M Daoudou) for performing fieldwork. We are grateful to R. Anders (La Trobe University, Melbourne, Australia), S. Longacre (Pasteur Institute, Paris, France), E. Remarque (Biomedical Primate Research Centre, Rijswijk, The Netherlands) and M. Theisen (Statens Serum Institute, Copenhagen, Denmark) for their gift of P. falciparum recombinant proteins and G. Tavera and I. Malhotra for critical reading of the manuscript. We thank the Faculte des Sciences de la Sante, the Institut des Sciences Biomedicales Appliquees de Cotonou (ISBA) and the Programme National de Lutte contre le Paludisme (PNLP) for their institutional support. C. Dechavanne benefited from the financial support of the Treilles Foundation. This study was funded by the Agence Nationale de la Recherche (ANR) Sante Environnement Sante Travail (SEST 2006; 040 01).	BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; BRAIR ME, 1994, LANCET, V343, P208, DOI 10.1016/S0140-6736(94)90991-1; Brambell F. W. Rogers, 1970, PEDIATRICS, V18; Cot M, 2003, AM J EPIDEMIOL, V157, P203, DOI 10.1093/aje/kwf192; de Moraes-Pinto MI, 1998, ARCH DIS CHILD-FETAL, V79, pF202, DOI 10.1136/fn.79.3.F202; Dechavanne S, 2015, INFECT IMMUN, V83, P2466, DOI 10.1128/IAI.03116-14; Deloron P, 1997, CLIN EXP IMMUNOL, V110, P212; Dieboit J, 1986, RSA, V34, P35; Fievet N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-251; Fowkes FJI, 2012, J INFECT DIS, V206, P1612, DOI 10.1093/infdis/jis566; Gans H, 2003, VACCINE, V21, P3398, DOI 10.1016/S0264-410X(03)00341-4; Gans H, 2001, J INFECT DIS, V184, P817, DOI 10.1086/323346; Ghetie V, 2002, IMMUNOL RES, V25, P97, DOI 10.1385/IR:25:2:097; Hartter HK, 2000, PEDIATR INFECT DIS J, V19, P635, DOI 10.1097/00006454-200007000-00010; JONES EA, 1972, J CLIN INVEST, V51, P2916, DOI 10.1172/JCI107116; Le Port A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027516; Le Port A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000342; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; LOGIE DE, 1973, B WORLD HEALTH ORGAN, V49, P547; Lusingu JPA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-48; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; Megnekou R, 2015, SCAND J IMMUNOL, V81, P508, DOI 10.1111/sji.12286; Mora L, 2014, J INFECT DIS; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Moulton LH, 1995, BIOMETRICS, V51, P1570, DOI 10.2307/2533289; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; Okoko BJ, 2001, J HEALTH POPUL NUTR, V19, P59; Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646; Rachas A, 2012, CLIN INFECT DIS, V55, P672, DOI 10.1093/cid/cis490; Riley EM, 2000, INFECT IMMUN, V68, P5856, DOI 10.1128/IAI.68.10.5856-5863.2000; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sachs UJH, 2006, IMMUNOLOGY, V119, P83, DOI 10.1111/j.1365-2567.2006.02408.x; SAJI F, 1994, PLACENTA, V15, P453, DOI 10.1016/S0143-4004(05)80415-1; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Santner-Nanan B, 2013, J IMMUNOL, V191, P145, DOI 10.4049/jimmunol.1203165; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; Scott S, 2005, J INFECT DIS, V191, P1854, DOI 10.1086/429963; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; WALDMANN TA, 1969, PROG ALLERGY, V13, P1, DOI 10.1159/000287491; Wilson PT, 2013, ACTA TROP, V128, P149, DOI 10.1016/j.actatropica.2013.07.018	41	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145464	10.1371/journal.pone.0145464	http://dx.doi.org/10.1371/journal.pone.0145464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698578	gold, Green Published			2022-12-27	WOS:000367092600083
J	Dedeine, F; Weinert, LA; Bigot, D; Josse, T; Ballenghien, M; Cahais, V; Galtier, N; Gayral, P				Dedeine, Franck; Weinert, Lucy A.; Bigot, Diane; Josse, Thibaut; Ballenghien, Marion; Cahais, Vincent; Galtier, Nicolas; Gayral, Philippe			Comparative Analysis of Transcriptomes from Secondary Reproductives of Three Reticulitermes Termite Species	PLOS ONE			English	Article							CARBOHYDRATE-ACTIVE ENZYMES; GENE-EXPRESSION; COPTOTERMES-FORMOSANUS; PHYLOGENETIC ANALYSIS; POPULATION GENOMICS; ISOPTERA; GUT; CASTES; HOST; METATRANSCRIPTOME	Termites are eusocial insects related to cockroaches that feed on lignocellulose. These insects are key species in ecosystems since they recycle a large amount of nutrients but also are pests, exerting major economic impacts. Knowledge on the molecular pathways underlying reproduction, caste differentiation or lignocellulose digestion would largely benefit from additional transcriptomic data. This study focused on transcriptomes of secondary reproductive females (nymphoid neotenics). Thirteen transcriptomes were used: 10 of Reticulitermes flavipes and R. grassei sequenced from a previous study, and two transcriptomes of R. lucifugus sequenced for the present study. After transcriptome assembly and read mapping, we examined interspecific variations of genes expressed by termites or gut microorganisms. A total of 18,323 orthologous gene clusters were detected. Functional annotation and taxonomic assignment were performed on a total of 41,287 predicted contigs in the three termite species. Between the termite species studied, functional categories of genes were comparable. Gene ontology (GO) terms analysis allowed the discovery of 9 cellulases and a total of 79 contigs potentially involved in 11 enzymatic activities used in wood metabolism. Altogether, results of this study illustrate the strong potential for the use of comparative interspecific transcriptomes, representing a complete resource for future studies including differentially expressed genes between castes or SNP analysis for population genetics.	[Dedeine, Franck; Bigot, Diane; Josse, Thibaut; Gayral, Philippe] Univ Tours, Inst Rech Biol Insecte, UMR 7261, CNRS, F-37200 Tours, France; [Weinert, Lucy A.; Ballenghien, Marion; Cahais, Vincent; Galtier, Nicolas] Univ Montpellier, Inst Sci Evolut, UMR 5554, CNRS,IRD,EPHE, F-34059 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Gayral, P (corresponding author), Univ Tours, Inst Rech Biol Insecte, UMR 7261, CNRS, F-37200 Tours, France.	philippe.gayral@univ-tours.fr	Josse, Thibaut/F-5606-2016	Josse, Thibaut/0000-0002-6607-506X; Dedeine, Franck/0000-0002-0646-4725	French ANR grant [EvoSymTer 08-JCJC-007601]; European Research Council (ERC) grant [ERC PopPhyl 232971]	French ANR grant(French National Research Agency (ANR)); European Research Council (ERC) grant(European Research Council (ERC))	Termite collection was supported by a a French ANR grant to FD (EvoSymTer 08-JCJC-007601). Transcriptome sequencing was supported by a European Research Council (ERC) grant to NG (ERC PopPhyl 232971).	Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bastien G, 2013, BIOTECHNOL BIOFUELS, V6; Bignell DE, 2011, BIOL TERMITES MODEM; Brune A, 2014, NAT REV MICROBIOL; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Clement JL, 2001, INSECT SOC, V48, P202, DOI 10.1007/PL00001768; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Dietrich C, 2014, APPL ENVIRON MICROB, V80, P2261, DOI 10.1128/AEM.04206-13; Gayral P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003457; Gayral P, 2011, MOL ECOL RESOUR, V11, P650, DOI 10.1111/j.1755-0998.2011.03010.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hayashi Y, 2013, PLOS ONE, V8; He SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061126; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hojo M, 2012, INSECT MOL BIOL, V21, P545, DOI 10.1111/j.1365-2583.2012.01162.x; Howard KJ, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P97, DOI 10.1007/978-90-481-3977-4_5; Huang QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050383; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Husseneder C, 2012, COMP BIOCHEM PHYS D, V7, P14, DOI 10.1016/j.cbd.2011.10.002; Hyatt D, 2012, BIOINFORMATICS, V28, P2223, DOI 10.1093/bioinformatics/bts429; Inward DJG, 2007, MOL PHYLOGENET EVOL, V44, P953, DOI 10.1016/j.ympev.2007.05.014; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Korb J, 2008, BIOL REV, V83, P295, DOI 10.1111/j.1469-185X.2008.00044.x; Korb J, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00009; Lewis JL, 2004, ANN ENTOMOL SOC AM, V97, P1242, DOI 10.1603/0013-8746(2004)097[1242:PCFFCA]2.0.CO;2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lo N, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P51, DOI 10.1007/978-90-481-3977-4_3; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Ni JF, 2013, BIOTECHNOL ADV, V31, P838, DOI 10.1016/j.biotechadv.2013.04.005; Ohkuma M, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P413, DOI 10.1007/978-90-481-3977-4_15; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Perdereau E, 2015, MOL ECOL, V24, P2125, DOI 10.1111/mec.13094; Perdereau E, 2013, MOL ECOL, V22, P1105, DOI 10.1111/mec.12140; Raychoudhury R, 2013, INSECT MOL BIOL, V22, P155, DOI 10.1111/imb.12011; Romiguier J, 2014, NATURE, V515, P261, DOI 10.1038/nature13685; Romiguier J, 2014, J EVOLUTION BIOL, V27, P593, DOI 10.1111/jeb.12331; Sabree ZL, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-138; Scharf ME, 2005, INSECT MOL BIOL, V14, P31, DOI 10.1111/j.1365-2583.2004.00527.x; Scharf ME, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00076; Sen R, 2013, BMC GENOMICS, V14; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Steller MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-463; SU NY, 1987, INSECT SOC, V34, P229, DOI 10.1007/BF02224355; Su NY, 2002, SOCIOBIOLOGY, V40, P95; Tadmor AD, 2011, SCIENCE, V333, P58, DOI 10.1126/science.1200758; Tai V, 2015, APPL ENVIRON MICROB, V81, P1059, DOI 10.1128/AEM.02945-14; Tartar A, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-25; Terrapon N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4636; Todaka N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008636; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vargo EL, 2009, ANNU REV ENTOMOL, V54, P379, DOI 10.1146/annurev.ento.54.110807.090443; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Weil T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-198; Weil T, 2009, MOL BIOL EVOL, V26, P1841, DOI 10.1093/molbev/msp095; Xie L, 2012, GENOMICS, V99, P246, DOI 10.1016/j.ygeno.2012.01.009; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang D, 2012, INSECT MOL BIOL, V21, P235, DOI 10.1111/j.1365-2583.2011.01130.x	62	12	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145596	10.1371/journal.pone.0145596	http://dx.doi.org/10.1371/journal.pone.0145596			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698123	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600101
J	Gourni, E; Canovas, C; Goncalves, V; Denat, F; Meyer, PT; Maecke, HR				Gourni, Eleni; Canovas, Coline; Goncalves, Victor; Denat, Franck; Meyer, Philipp T.; Maecke, Helmut R.			(R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors	PLOS ONE			English	Article							MEMBRANE ANTIGEN-EXPRESSION; PRECLINICAL EVALUATION; INHIBITORS; ANTIBODIES; ENDORADIOTHERAPY; PROBES; GA-68; J591	Purpose The present study aims at developing and evaluating an urea-based prostate specific membrane antigen (PSMA) inhibitor suitable for labeling with In-111 for SPECT and intraoperative applications as well as Ga-68 and Cu-64 for PET imaging. Methods The PSMA-based inhibitor-lysine-urea-glutamate-coupled to the spacer Phe-Phe-D-Lys (suberoyl) and functionalized with the enantiomerically pure prochelator (R)-1-(1-carboxy-3-carbotertbutoxypropyl)-4,7-carbotartbutoxymethyl)-1,4,7-triazacyclononane ((R)-NODAGA(tBu)(3)), to obtain (R)-NODAGA-Phe-Phe-D-Lys(suberoyl)-Lys-urea-Glu (CC34). CC34 was labeled with In-111, Ga-68 and Cu-64. The radioconjugates were further evaluated in vitro and in vivo in LNCaP xenografts by biodistribution and PET studies. Biodistribution studies were also performed with Ga-68-HBED-CC-PSMA (HBED-CC: N,N'-bis[2-hydroxy5-( carboxyethyl)benzyl]ethylenediamine-N,N'-diacetic acid) and In-111-PSMA-617 for comparison. Results Ga-68-CC34, Cu-64-CC34, and In-111-CC34 were prepared in radiochemical purity >95%. Ga-68/nat-CC34, Cu-64/nat-CC34, In-111/nat-CC34, Ga-68/nat-HBED-CC-PSMA, and In-111/nat-PSMA- 617 exhibited high affinity for the LNCaP cells, with K-d values of 19.3 +/- 2.5 nM, 27.5 +/- 2.7 nM, 5.5 +/- 0.9 nM, 2.9 +/- 0.6 nM and 5.4 +/- 0.8 nM, respectively. They revealed comparable internalization profiles with approximately 75% of the total cell associated activity internalized after 3 h of incubation. Ga-68-CC34 showed very high stability after its administration in mice. Tumor uptake of Ga-68-CC34 (14.5 +/- 2.9% IA/g) in LNCaP xenografts at 1 h p.i. was comparable to Ga-68-HBED-CC-PSMA (15.8 +/- 1.4% IA/g) (P = 0.67). The tumor-to-normal tissue ratios at 1 and 2 h p.i of Ga-68-CC34 were also comparable to Ga-68-HBED-CC-PSMA (P>0.05). Tumor uptake of In-111-CC34 (28.5 +/- 2.6%IA/g) at 1 h p.i. was lower than In-111-PSMA-617 (52.1 +/- 6.5% IA/g) (P = 0.02). The acquisition of PET-images with Cu-64-CC34 at later time points showed wash-out from the kidneys, while tumor uptake still remained relatively high. This resulted in an increased tumor-to-kidney ratio over time. Conclusions Ga-68-CC34 is comparable to Ga-68-HBED-CC-PSMA in terms of tumor uptake and tumor to normal tissue ratios. Cu-64-CC34 could enable high contrast imaging of PSMA positive tissues characterized by elevated expression of PSMA or when delayed imaging is required. Cu-64-CC34 is currently being prepared for clinical translation.	[Gourni, Eleni] German Canc Consortium DKTK, Heidelberg, Germany; [Gourni, Eleni; Meyer, Philipp T.; Maecke, Helmut R.] Univ Hosp Freiburg, Dept Nucl Med, Freiburg, Germany; [Gourni, Eleni] German Canc Res Ctr, Heidelberg, Germany; [Canovas, Coline; Goncalves, Victor; Denat, Franck] Univ Bourgogne Franche Comte, Inst Chim Mol, Univ Bourgogne, UMR6302,CNRS, Dijon, France	Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Bourgogne	Gourni, E (corresponding author), Univ Oslo, Inst Basic Med Sci, Fac Med, Oslo, Norway.	eleni.gourni@medisin.uio.no	Gourni, Eleni/ABA-8305-2020; Goncalves, Victor/O-1099-2019	Goncalves, Victor/0000-0001-9854-4409	German Consortium for Translational Cancer Research (DKTK); Conseil Regional de Bourgogne (FABER and 3MIM programs), France	German Consortium for Translational Cancer Research (DKTK); Conseil Regional de Bourgogne (FABER and 3MIM programs), France(Region Bourgogne-Franche-Comte)	This work was supported by the German Consortium for Translational Cancer Research (DKTK) and the Conseil Regional de Bourgogne (FABER and 3MIM programs), France.	Afshar-Oromieh A, 2014, EUR J NUCL MED MOL I, V41, P11, DOI 10.1007/s00259-013-2525-5; Alt K, 2010, PROSTATE, V70, P1413, DOI 10.1002/pros.21176; Anderson CJ, 2009, CANCER BIOTHER RADIO, V24, P379, DOI 10.1089/cbr.2009.0674; Banerjee SR, 2008, J MED CHEM, V51, P4504, DOI 10.1021/jm800111u; Banerjee SR, 2015, J NUCL MED, V56, P628, DOI 10.2967/jnumed.114.149062; Banerjee SR, 2014, J MED CHEM, V57, P2657, DOI 10.1021/jm401921j; Banerjee SR, 2010, J MED CHEM, V53, P5333, DOI 10.1021/jm100623e; Beer AJ, 2011, LANCET ONCOL, V12, P181, DOI 10.1016/S1470-2045(10)70103-0; Benesova M, 2015, J NUCL MED, V56, P914, DOI 10.2967/jnumed.114.147413; Chang Sam S, 2004, Rev Urol, V6 Suppl 10, pS13; Chang SS, 2001, UROLOGY, V57, P1179, DOI 10.1016/S0090-4295(01)00983-9; Chen Y, 2008, J MED CHEM, V51, P7933, DOI 10.1021/jm801055h; CRAIG AS, 1989, POLYHEDRON, V8, P2481, DOI 10.1016/S0277-5387(89)80014-2; Eder M, 2012, BIOCONJUGATE CHEM, V23, P688, DOI 10.1021/bc200279b; Elsasser-Beile U, 2006, PROSTATE, V66, P1359, DOI 10.1002/pros.20367; Hillier SM, 2009, CANCER RES, V69, P6932, DOI 10.1158/0008-5472.CAN-09-1682; Holland JP, 2010, J NUCL MED, V51, P1293, DOI 10.2967/jnumed.110.076174; HOROSZEWICZ JS, 1987, ANTICANCER RES, V7, P927; Kozikowski AP, 2004, J MED CHEM, V47, P1729, DOI 10.1021/jm0306226; Kularatne SA, 2009, MOL PHARMACEUT, V6, P790, DOI 10.1021/mp9000712; Liu TC, 2008, BIOCHEMISTRY-US, V47, P12658, DOI 10.1021/bi801883v; Maresca KP, 2009, J MED CHEM, V52, P347, DOI 10.1021/jm800994j; Milowsky MI, 2007, J CLIN ONCOL, V25, P540, DOI 10.1200/JCO.2006.07.8097; Perner S, 2007, HUM PATHOL, V38, P696, DOI 10.1016/j.humpath.2006.11.012; Roesch F, 2010, CURR TOP MED CHEM, V10, P1633, DOI 10.2174/156802610793176738; Ruggiero A, 2011, J NUCL MED, V52, P1608, DOI 10.2967/jnumed.111.092098; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Silver DA, 1997, CLIN CANCER RES, V3, P81; Troyer JK, 1997, PROSTATE, V30, P232, DOI 10.1002/(SICI)1097-0045(19970301)30:4<232::AID-PROS2>3.0.CO;2-N; Vallabhajosula S, 2005, CLIN CANCER RES, V11, p7195S, DOI 10.1158/1078-0432.CCR-1004-0023; Vallabhajosula S, 2005, J NUCL MED, V46, P634; Vallabhajosula S, 2015, J NUCL MED, V55, P1791; Weineisen M, 2015, J NUCL MED, V56, P1169, DOI 10.2967/jnumed.115.158550; Weineisen M, 2014, EJNMMI RES, V4, DOI 10.1186/s13550-014-0063-1; Wright GL, 1996, UROLOGY, V48, P326, DOI 10.1016/S0090-4295(96)00184-7	35	43	44	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145755	10.1371/journal.pone.0145755	http://dx.doi.org/10.1371/journal.pone.0145755			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700033	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600130
J	Kasperska-Zajac, A; Grzanka, A; Damasiewicz-Bodzek, A				Kasperska-Zajac, Alicja; Grzanka, Alicja; Damasiewicz-Bodzek, Aleksandra			IL-6 Transsignaling in Patients with Chronic Spontaneous Urticaria	PLOS ONE			English	Article							CHRONIC IDIOPATHIC URTICARIA; SOLUBLE RECEPTORS; SKIN-TEST; INTERLEUKIN-6; INFLAMMATION; DISEASE; PLASMA	Background IL-6 trans-signaling is critically involved in the initiation and promotion of inflammatory and autoimmune diseases. Therefore, we investigated the clinical relevance of soluble members of IL-6 trans-signaling system in chronic spontaneous urticaria (CSU). Methods IL-6, interleukin 6 soluble receptor (IL-6 sR) and soluble gp130 (sgp130) were measured by ELISA method in plasma from CSU patients and the healthy subjects. The data were related to activation of the acute phase response as indicated by serum C-reactive protein (CRP) concentration and compared between patients stratified by the disease activity. Results Concentrations of IL-6, IL-6 sR, sgp130 in plasma and CRP in serum were significantly elevated in CSU patients compared with the healthy controls. CRP correlated significantly with IL-6 and sgp130, similarly IL-6 correlated significantly with sgp130. By contrast, CRP and IL-6 did not correlate significantly with IL-6 sR. However, significant correlation was noted between IL-6 sR and sgp130. Conclusions Concentrations of IL-6 and its soluble receptors were significantly elevated in patients with CSU, suggesting upregulation of the IL-6 trans-signaling in the disease. In addition, our results support the concept that the system may be involved in pathogenesis of the systemic inflammatory activation in CSU patients.	[Kasperska-Zajac, Alicja; Grzanka, Alicja] Med Univ Silesia, Dept Internal Dis Dermatol & Allergol Zabrze, SMDZ Zabrze, Katowice, Poland; [Damasiewicz-Bodzek, Aleksandra] Med Univ Silesia, Dept Chem Zabrze, SMDZ Zabrze, Katowice, Poland	Medical University Silesia; Medical University Silesia	Kasperska-Zajac, A (corresponding author), Med Univ Silesia, Dept Internal Dis Dermatol & Allergol Zabrze, SMDZ Zabrze, Katowice, Poland.	alakasperska@gmail.com		Damasiewicz-Bodzek, Aleksandra/0000-0002-4400-1502; Kasperska-Zajac, Alicja/0000-0002-2000-0070; Grzanka, Alicja/0000-0003-0537-5090	Committee for Scientific Research [KNW-640-2-1-004/15]	Committee for Scientific Research(Polish State Committee for Scientific Research)	This research was supported by the Committee for Scientific Research (KNW-640-2-1-004/15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasandagutti ML, 2014, GENET TEST MOL BIOMA, V18, P804, DOI 10.1089/gtmb.2014.0193; Altrichter S, 2009, ALLERGY, V64, P652, DOI 10.1111/j.1398-9995.2008.01799.x; Asero R, 2011, J EUR ACAD DERMATOL, V25, P201, DOI 10.1111/j.1468-3083.2010.03752.x; Chalaris A, 2011, EUR J CELL BIOL, V90, P484, DOI 10.1016/j.ejcb.2010.10.007; Dimitrov S, 2006, FASEB J, V20, P2174, DOI 10.1096/fj.06-5754fje; Gray SR, 2008, CELL STRESS CHAPERON, V13, P247, DOI 10.1007/s12192-008-0019-3; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Kasperska-Zajac A, 2015, CYTOKINE, V76, P566, DOI 10.1016/j.cyto.2015.04.016; Kasperska-Zajac A, 2013, J EUR ACAD DERMATOL, V27, P1048, DOI 10.1111/j.1468-3083.2012.04486.x; Kasperska-Zajac A, 2011, CLIN EXP ALLERGY, V41, P1386, DOI 10.1111/j.1365-2222.2011.03789.x; Kasperska-Zajac A, 2011, INFLAMMATION, V34, P362, DOI 10.1007/s10753-010-9242-z; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Sabroe RA, 1999, BRIT J DERMATOL, V140, P446; Wolf J, 2014, CYTOKINE, V70, P11, DOI 10.1016/j.cyto.2014.05.024	15	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145751	10.1371/journal.pone.0145751	http://dx.doi.org/10.1371/journal.pone.0145751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699882	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600129
J	Mooney, C; Raoof, R; El-Naggar, H; Sanz-Rodriguez, A; Jimenez-Mateos, EM; Henshall, DC				Mooney, Catherine; Raoof, Rana; El-Naggar, Hany; Sanz-Rodriguez, Amaya; Jimenez-Mateos, Eva M.; Henshall, David C.			High Throughput qPCR Expression Profiling of Circulating MicroRNAs Reveals Minimal Sex-and Sample Timing-Related Variation in Plasma of Healthy Volunteers	PLOS ONE			English	Article							PCR DATA; NORMALIZATION; SERUM; QUALITY; CANCER; BIOMARKERS; VARIANCE; MIRNAS	MicroRNAs are a class of small non-coding RNA that regulate gene expression at a post-transcriptional level. MicroRNAs have been identified in various body fluids under normal conditions and their stability as well as their dysregulation in disease opens up a new field for biomarker study. However, diurnal and day-to-day variation in plasma microRNA levels, and differential regulation between males and females, may affect biomarker stability. A QuantStudio 12K Flex Real-Time PCR System was used to profile plasma microRNA levels using OpenArray in male and female healthy volunteers, in the morning and afternoon, and at four time points over a one month period. Using this system we were able to run four OpenArray plates in a single run, the equivalent of 32 traditional 384-well qPCR plates or 12,000 data points. Up to 754 microRNAs can be identified in a single plasma sample in under two hours. 108 individual microRNAs were identified in at least 80% of all our samples which compares favourably with other reports of microRNA profiles in serum or plasma in healthy adults. Many of these microRNAs, including miR-16-5p, miR-17-5p, miR-19a-3p, miR-24-3p, miR-30c-5p, miR-191-5p, miR-223-3p and miR-451a are highly expressed and consistent with previous studies using other platforms. Overall, microRNA levels were very consistent between individuals, males and females, and time points and we did not detect significant differences in levels of microRNAs. These results suggest the suitability of this platform for microRNA profiling and biomarker discovery and suggest minimal confounding influence of sex or sample timing. However, the platform has not been subjected to rigorous validation which must be demonstrated in future biomarker studies where large differences may exist between disease and control samples.	[Mooney, Catherine; Raoof, Rana; Sanz-Rodriguez, Amaya; Jimenez-Mateos, Eva M.; Henshall, David C.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Raoof, Rana] Mosul Med Coll, Dept Anat, Mosul, Iraq; [El-Naggar, Hany] Beaumont Hosp, Dept Neurol, Dublin 9, Ireland	Royal College of Surgeons - Ireland	Mooney, C (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland.	catherinemooney@rcsi.ie	Raoof, Rana/F-8562-2019; Raoof, Rana Mumtaz/J-9316-2019; Jimenez-Mateos, Eva/AAG-8072-2019	Raoof, Rana/0000-0001-5418-1407; Raoof, Rana Mumtaz/0000-0001-5418-1407; El-Naggar, Hany/0000-0001-6500-5273; Mooney, Catherine/0000-0002-7696-1364; Jimenez-Mateos, Eva/0000-0001-6417-6580; Henshall, David/0000-0001-6237-9632	European Union [602130]; Science Foundation Ireland (SFI) [13/SIRG/2114, SFI/13/IA/1891, SFI/12/COEN/18, SFI/12/RC/2272, SFI/14/ADV/RC2721]; Iraqi Ministry of Higher Education and Scientific Research	European Union(European Commission); Science Foundation Ireland (SFI)(Science Foundation Ireland); Iraqi Ministry of Higher Education and Scientific Research	This publication has emanated from research conducted with the financial support of the European Union's 'Seventh Framework' Programme (FP7) under Grant Agreement no 602130, Science Foundation Ireland (SFI) under Grant Numbers 13/SIRG/2114, SFI/13/IA/1891, SFI/12/COEN/18, SFI/12/RC/2272 and SFI/14/ADV/RC2721 and a fellowship from the Iraqi Ministry of Higher Education and Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bovell LC, 2013, CLIN CANCER RES, V19, P3955, DOI 10.1158/1078-0432.CCR-12-3302; Chen RM, 2013, CURR BIOL, V23, P1959, DOI 10.1016/j.cub.2013.08.005; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Drummond MJ, 2011, PHYSIOL GENOMICS, V43, P595, DOI 10.1152/physiolgenomics.00148.2010; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Haider BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089565; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Kinoshita C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4823; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLellan SA, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-27; McCall MN, 2014, BIOINFORMATICS, V30, P2310, DOI 10.1093/bioinformatics/btu239; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moldovan L, 2014, J CELL MOL MED, V18, P371, DOI 10.1111/jcmm.12236; Morgan CP, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-22; Na YJ, 2009, EXP MOL MED, V41, P638, DOI 10.3858/emm.2009.41.9.070; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; R Core Team, 2013, R LANG ENV STAT COMP; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Rekker K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081166; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Ward J, 2014, P NATL ACAD SCI USA, V111, P12169, DOI 10.1073/pnas.1412608111; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wylie Dennis, 2011, BMC Res Notes, V4, P555, DOI 10.1186/1756-0500-4-555	49	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145316	10.1371/journal.pone.0145316	http://dx.doi.org/10.1371/journal.pone.0145316			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699132	gold, Green Submitted, Green Published			2022-12-27	WOS:000367092600065
J	Nagy, VK; Szeplaki, G; Apor, A; Kutyifa, V; Kovacs, A; Kosztin, A; Becker, D; Boros, AM; Geller, L; Merkely, B				Nagy, Vivien Klaudia; Szeplaki, Gabor; Apor, Astrid; Kutyifa, Valentina; Kovacs, Attila; Kosztin, Annamaria; Becker, David; Boros, Andras Mihaly; Geller, Laszlo; Merkely, Bela			Role of Right Ventricular Global Longitudinal Strain in Predicting Early and Long-Term Mortality in Cardiac Resynchronization Therapy Patients	PLOS ONE			English	Article							ADVANCED HEART-FAILURE; EUROPEAN-SOCIETY; ESC GUIDELINES; EJECTION FRACTION; TASK-FORCE; SURVIVAL; ASSOCIATION; COLLABORATION; DYSFUNCTION; CARDIOLOGY	Background Right ventricular (RV) dysfunction has been associated with poor prognosis in chronic heart failure (HF). However, less data is available about the role of RV dysfunction in patients with cardiac resynchronization therapy (CRT). We aimed to investigate if RV dysfunction would predict outcome in CRT. Design We enrolled prospectively ninety-three consecutive HF patients in this single center observational study. All patients underwent clinical evaluation and echocardiography before CRT and 6 months after implantation. We assessed RV geometry and function by using speckle tracking imaging and calculated strain parameters. We performed multivariable Cox regression models to test mortality at 6 months and at 24 months. Results RV dysfunction, characterized by decreased RVGLS (RV global longitudinal strain) [10.2 (7.0-12.8) vs. 19.5 (15.0-23.9) %, p<0.0001] and RVFWS (RV free wall strain) [15.6 (10.0-19.3) vs. 17.4 (10.5-22.2) %, p = 0.04], improved 6 months after CRT implantation. Increasing baseline RVGLS and RVFWS predicted survival independent of other parameters at 6 months [hazard ratio (HR) = 0.37 (0.15-0.90), p = 0.02 and HR = 0.42 (0.19-0.89), p = 0.02; per 1 standard deviation increase, respectively]. RVGLS proved to be a significant independent predictor of mortality at 24 months [HR = 0.53 (0.32-0.86), p = 0.01], and RVFWS showed a strong tendency [HR = 0.64 (0.40-1.00), p = 0.05]. The 24-month survival was significantly impaired in patients with RVGLS below 10.04% before CRT implantation [area under the curve = 0.72 (0.60-0.84), p = 0.002, log-rank p = 0.0008; HR = 5.23 (1.76-15.48), p = 0.003]. Conclusions Our findings indicate that baseline RV dysfunction is associated with poor short-term and long-term prognosis after CRT implantation.	[Nagy, Vivien Klaudia; Szeplaki, Gabor; Apor, Astrid; Kutyifa, Valentina; Kovacs, Attila; Kosztin, Annamaria; Becker, David; Boros, Andras Mihaly; Geller, Laszlo; Merkely, Bela] Semmelweis Univ, Heart & Vasc Ctr, H-1085 Budapest, Hungary	Semmelweis University	Merkely, B (corresponding author), Semmelweis Univ, Heart & Vasc Ctr, H-1085 Budapest, Hungary.	merkely.bela@gmail.com	Kovács, Attila/AAE-7467-2019	Kovács, Attila/0000-0003-2320-6434; Kosztin MD, PhD, Annamaria/0000-0001-6647-2623; Szeplaki, Gabor/0000-0003-3795-1240	Hungarian Foundation Programs: Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; Hungarian Scientific Research Foundation [OTKA 105555]	Hungarian Foundation Programs: Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; Hungarian Scientific Research Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by Hungarian Foundation Programs: Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (GSZ, LG) and the Hungarian Scientific Research Foundation (OTKA 105555). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all the patients who participated in our study. We are thankful to Semmelweis University for the professional assistance background. This work was supported by Hungarian Foundation Programs: Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (GSZ, LG) and the Hungarian Scientific Research Foundation (OTKA 105555).	Alpendurada F, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-68; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Cameli M, 2012, J CARD FAIL, V18, P208, DOI 10.1016/j.cardfail.2011.12.002; Campbell P, 2013, CIRC-HEART FAIL, V6, P435, DOI 10.1161/CIRCHEARTFAILURE.112.000127; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Damy T, 2013, J AM COLL CARDIOL, V61, P2153, DOI 10.1016/j.jacc.2013.02.049; de Groote P, 1998, J AM COLL CARDIOL, V32, P948, DOI 10.1016/S0735-1097(98)00337-4; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; DISALVO TG, 1995, J AM COLL CARDIOL, V25, P1143, DOI 10.1016/0735-1097(94)00511-N; Field ME, 2006, J CARD FAIL, V12, P616, DOI 10.1016/j.cardfail.2006.06.472; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Leong DP, 2013, HEART, V99, P722, DOI 10.1136/heartjnl-2012-303076; Linde C, 2002, J AM COLL CARDIOL, V40, P111, DOI 10.1016/S0735-1097(02)01932-0; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Padeletti L, 2012, HEART FAIL REV, V17, P97, DOI 10.1007/s10741-011-9250-6; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sade LE, 2013, J AM SOC ECHOCARDIOG, V26, P706, DOI 10.1016/j.echo.2013.03.013; Sutherland GR, 2004, J AM SOC ECHOCARDIOG, V17, P788, DOI 10.1016/j.echo.2004.03.027; Taylor J, 2010, EUR HEART J, V31, P2559, DOI 10.1093/eurheartj/ehq358; Vardas PE, 2007, EUR HEART J, V28, P2256, DOI 10.1093/eurheartj/ehm305; Vizzardi E, 2012, ECHOCARDIOGR-J CARD, V29, P773, DOI 10.1111/j.1540-8175.2012.01703.x	22	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0143907	10.1371/journal.pone.0143907	http://dx.doi.org/10.1371/journal.pone.0143907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700308	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600012
J	Yang, SM; Huang, CY; Shiue, HS; Huang, SP; Pu, YS; Chen, WJ; Lin, YC; Hsueh, YM				Yang, Shu-Mei; Huang, Chao-Yuan; Shiue, Horng-Sheng; Huang, Shu-Pin; Pu, Yeong-Shiau; Chen, Wei-Jen; Lin, Ying-Chin; Hsueh, Yu-Mei			Joint Effect of Urinary Total Arsenic Level and VEGF-A Genetic Polymorphisms on the Recurrence of Renal Cell Carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SINGLE NUCLEOTIDE POLYMORPHISMS; DRINKING-WATER; BREAST-CANCER; CHINESE POPULATION; PROSTATE-CANCER; BLADDER-CANCER; TOBACCO-SMOKE; KIDNEY CANCER; LUNG-CANCER	The results of our previous study suggested that high urinary total arsenic levels were associated with an increased risk of renal cell carcinoma (RCC). Germline genetic polymorphisms might also affect cancer risk and clinical outcomes. Vascular endothelial growth factor (VEGF) plays an important role in vasculogenesis and angiogenesis, but the combined effect of these factors on RCC remains unclear. In this study, we explored the association between the VEGFA -2578C> A, -1498T> C, -1154G> A, -634G> C, and +936C> T gene polymorphisms and RCC. We also evaluated the combined effects of the VEGF-A haplotypes and urinary total arsenic levels on the prognosis of RCC. This case-control study was conducted with 191 RCC patients who were diagnosed with renal tumors on the basis of image-guided biopsy or surgical resections. An additional 376 age-and gender-matched controls were recruited. Concentrations of urinary arsenic species were determined by a high performance liquid chromatography-linked hydride generator and atomic absorption spectrometry. Genotyping was investigated using fluorescent-based TaqMan allelic discrimination. We observed no significant associations between VEGF-A haplotypes and RCC risk. However, the VEGF-A ACGG haplotype from VEGF-A -2578, -1498, -1154, and -634 was significantly associated with an increased recurrence of RCC (OR = 3.34, 95% CI = 1.03-10.91). Urinary total arsenic level was significantly associated with the risk of RCC in a dose-response manner, but it was not related to the recurrence of RCC. The combination of high urinary total arsenic level and VEGF-A risk haplotypes affected the OR of RCC recurrence in a dose-response manner. This is the first study to show that joint effect of high urinary total arsenic and VEGF-A risk haplotypes may influence the risk of RCC recurrence in humans who live in an area without obvious arsenic exposure.	[Yang, Shu-Mei; Chen, Wei-Jen; Hsueh, Yu-Mei] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Huang, Chao-Yuan; Pu, Yeong-Shiau] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Urol, Taipei 10764, Taiwan; [Shiue, Horng-Sheng] Chang Gung Univ, Chang Gung Mem Hosp, Dept Chinese Med, Taoyuan, Taiwan; [Shiue, Horng-Sheng] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Huang, Shu-Pin] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Huang, Shu-Pin] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Urol, Kaohsiung, Taiwan; [Lin, Ying-Chin] Taipei Med Univ, Shung Ho Hosp, Dept Family Med, Taipei, Taiwan; [Lin, Ying-Chin] Taipei Med Univ, Wan Fang Hosp, Dept Hlth Examinat, Taipei, Taiwan; [Lin, Ying-Chin] Taipei Med Univ, Sch Med, Div Family Med, Taipei, Taiwan; [Hsueh, Yu-Mei] Taipei Med Univ, Sch Med, Dept Publ Hlth, Coll Med, Taipei, Taiwan	Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University	Hsueh, YM (corresponding author), Taipei Med Univ, Sch Med, Dept Publ Hlth, Coll Med, Taipei, Taiwan.	ymhsueh@tmu.edu.tw	Chen, Wei-Jen/AAF-1739-2019	Chen, Wei-Jen/0000-0003-0683-7904; HUANG, CHAO-YUAN/0000-0002-9322-6062; PU, YEONG-SHIAU/0000-0002-2859-3966	National Science Council of the ROC [NSC 86-2314-B-038-038, NSC 87-2314-B-038-029, NSC-88-2314-B-038-112, NSC-89-2314-B038-049, SC-89-2320-B038-013, NSC-90-2320-B-038-021, NSC-91-3112-B-038-0019, NSC-92-3112-B-038-001];  [NSC-93-3112-B-038-001];  [NSC-94-2314-B-038-023];  [NSC-95-2314-B-038-007];  [NSC-96-2314-B038-003];  [NSC-97-2314-B-038-015-MY3 (1-3)];  [NSC-97-2314-B-038-015-MY3 (2-3)];  [NSC-97-2314-B-038-015-MY3 (3-3)];  [NSC 100-2314-B-038 -026];  [NSC 101-2314-B-038 -051-MY3 (1-3)];  [NSC 101-2314-B-038 -051-MY3 (2-3)];  [NSC 101-2314-B-038 -051-MY3 (3-3)];  [MOST 103-2314-B-038-021-MY2 (1-2)];  [MOST 103-2314-B-038-021-MY2 (2-2)]	National Science Council of the ROC(Ministry of Science and Technology, Taiwan); ; ; ; ; ; ; ; ; ; ; ; ; 	This study was supported by grants from the National Science Council of the ROC (NSC 86-2314-B-038-038, NSC 87-2314-B-038-029, NSC-88-2314-B-038-112, NSC-89-2314-B038-049, SC-89-2320-B038-013, NSC-90-2320-B-038-021, NSC-91-3112-B-038-0019, NSC-92-3112-B-038-001, NSC-93-3112-B-038-001, NSC-94-2314-B-038-023, NSC-95-2314-B-038-007, NSC-96-2314-B038-003, NSC-97-2314-B-038-015-MY3 (1-3), NSC-97-2314-B-038-015-MY3 (2-3), NSC-97-2314-B-038-015-MY3 (3-3), NSC 100-2314-B-038 -026, NSC 101-2314-B-038 -051-MY3 (1-3), NSC 101-2314-B-038 -051-MY3 (2-3), NSC 101-2314-B-038 -051-MY3 (3-3), MOST 103-2314-B-038-021-MY2 (1-2), and MOST 103-2314-B-038-021-MY2 (2-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajaz S, 2011, GENET TEST MOL BIOMA, V15, P653, DOI 10.1089/gtmb.2011.0029; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Bao LZ, 2010, CHEM RES TOXICOL, V23, P1726, DOI 10.1021/tx100191t; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Brogan IJ, 1999, HUM IMMUNOL, V60, P1245, DOI 10.1016/S0198-8859(99)00132-9; Bruyere F, 2010, J UROLOGY, V184, P1273, DOI 10.1016/j.juro.2010.06.009; Bureau of Health Promotion, 2006, CANC REG ANN REP 200; Cao Y, 2012, CANCER RES, V72, P3912, DOI 10.1158/0008-5472.CAN-11-4058; Chae EJ, 2005, RADIOLOGY, V234, P189, DOI 10.1148/radiol.2341031733; Chae YS, 2006, ONCOLOGY-BASEL, V71, P266, DOI 10.1159/000106788; Chen CL, 2010, ENVIRON RES, V110, P455, DOI 10.1016/j.envres.2009.08.010; Chen JY, 2012, GUILTY OF INDIGENCE: THE URBAN POOR IN CHINA, 1900-1953, P13; Crew JP, 1997, CANCER RES, V57, P5281; Ferreccio C, 2013, AM J EPIDEMIOL, V178, P813, DOI 10.1093/aje/kwt059; Fujita Naoyuki, 2014, BMC Res Notes, V7, P369, DOI 10.1186/1756-0500-7-369; GREENBERG RA, 1984, NEW ENGL J MED, V310, P1075, DOI 10.1056/NEJM198404263101703; Howell WM, 2002, GENES IMMUN, V3, P229, DOI 10.1038/sj.gene.6363851; Hsueh YM, 1997, CANCER EPIDEM BIOMAR, V6, P589; Hsueh YM, 1998, J TOXICOL ENV HEAL A, V54, P431, DOI 10.1080/009841098158728; Huang CY, 2012, TOXICOL APPL PHARM, V262, P349, DOI 10.1016/j.taap.2012.05.013; Huang CY, 2011, J UROLOGY, V185, P2040, DOI 10.1016/j.juro.2011.01.079; Huang D, 2008, CANCER RES, V68, P81, DOI 10.1158/0008-5472.CAN-07-5311; Huang YC, 2011, TOXICOL LETT, V201, P62, DOI 10.1016/j.toxlet.2010.12.006; Jacobs EJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1400; JAMES GD, 1988, AM J HYPERTENS, V1, P124, DOI 10.1093/ajh/1.2.124; Jang MJ, 2013, MOL CARCINOGEN, V52, P60, DOI 10.1002/mc.21980; JONGEN WMF, 1985, FOOD CHEM TOXICOL, V23, P669, DOI 10.1016/0278-6915(85)90155-3; Kawai Y, 2007, EUR UROL, V52, P1147, DOI 10.1016/j.eururo.2007.01.073; Kim DH, 2010, ANN ONCOL, V21, P1179, DOI 10.1093/annonc/mdp452; Kim JJ, 2012, CANCER-AM CANCER SOC, V118, P1946, DOI 10.1002/cncr.26491; Kjaer-Frifeldt S, 2012, PHARMACOGENOMICS, V13, P763, DOI [10.2217/PGS.12.38, 10.2217/pgs.12.38]; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Koukourakis MI, 2004, LUNG CANCER, V46, P293, DOI 10.1016/j.lungcan.2004.04.037; Langsenlehner T, 2014, STRAHLENTHER ONKOL, V190, P364, DOI 10.1007/s00066-013-0503-2; LE XC, 1993, TALANTA, V40, P185, DOI 10.1016/0039-9140(93)80320-Q; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Lu GJ, 2015, TUMOR BIOL, V36, P8645, DOI 10.1007/s13277-015-3431-1; Lu H, 2005, CANCER RES, V65, P5015, DOI 10.1158/0008-5472.CAN-04-2786; Luo T, 2013, ASIAN PAC J CANCER P, V14, P2433, DOI 10.7314/APJCP.2013.14.4.2433; Martinez-Fierro ML, 2013, CANCER BIOMARK, V13, P235, DOI 10.3233/CBM-130348; Mostafa MG, 2013, OCCUP ENVIRON MED, V70, P768, DOI 10.1136/oemed-2013-101443; Navas-Acien A, 2009, ENVIRON HEALTH PERSP, V117, P1428, DOI 10.1289/ehp.0800509; Ollerenshaw M, 2004, CANCER GENET CYTOGEN, V153, P122, DOI 10.1016/j.cancergencyto.2004.01.014; Otrock ZK, 2007, BLOOD CELL MOL DIS, V38, P258, DOI 10.1016/j.bcmd.2006.12.003; Pu YS, 2007, TOXICOL APPL PHARM, V218, P99, DOI 10.1016/j.taap.2006.09.021; Rahman M, 2015, CHEMOSPHERE, V120, P336, DOI 10.1016/j.chemosphere.2014.08.003; Renner W, 2000, J VASC RES, V37, P443, DOI 10.1159/000054076; Saenz-Lopez P, 2013, HUM IMMUNOL, V74, P98, DOI 10.1016/j.humimm.2012.10.014; Santos L, 2003, ANN ONCOL, V14, P1419, DOI 10.1093/annonc/mdg377; Sasaki A, 2007, EXP HEMATOL, V35, P252, DOI 10.1016/j.exphem.2006.10.004; Scartozzi M, 2013, BRIT J CANCER, V108, P1126, DOI 10.1038/bjc.2012.501; Shahbazi M, 2002, J AM SOC NEPHROL, V13, P260, DOI 10.1681/ASN.V131260; Stevens A, 2003, CANCER RES, V63, P812; Sun SF, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0410-x; Szarvas T, 2008, CLIN CANCER RES, V14, P8253, DOI 10.1158/1078-0432.CCR-08-0677; Theis RP, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-387; Tsai ML, 2016, ENVIRON TOXICOL, V31, P1121, DOI 10.1002/tox.22121; Tynkevich E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111949; Vincenti V, 1996, CIRCULATION, V93, P1493, DOI 10.1161/01.CIR.93.8.1493; Wang F, 2014, OCCUP ENVIRON MED, V71, P675, DOI 10.1136/oemed-2014-102173; Wang F, 2013, TOXICOL LETT, V222, P303, DOI 10.1016/j.toxlet.2013.08.008; Wang YH, 2013, J HAZARD MATER, V262, P1139, DOI 10.1016/j.jhazmat.2012.08.056; Wang ZM, 1996, AM J CLIN NUTR, V63, P863, DOI 10.1093/ajcn/63.6.863; WANNAMETHEE G, 1988, INT J EPIDEMIOL, V17, P307, DOI 10.1093/ije/17.2.307; Watson CJ, 2000, CYTOKINE, V12, P1232, DOI 10.1006/cyto.2000.0692; World Health Organization, 2008, GUIDELINES FOR DRINK, V1; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yang CY, 2004, ARCH ENVIRON HEALTH, V59, P484, DOI 10.1080/00039890409603430; Zhang Y, 2013, ONCOL LETT, V6, P1068, DOI 10.3892/ol.2013.1499; Zhong WF, 2014, TUMOR BIOL, V35, P9839, DOI 10.1007/s13277-014-2194-4	70	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145410	10.1371/journal.pone.0145410	http://dx.doi.org/10.1371/journal.pone.0145410			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701102	gold, Green Submitted, Green Published			2022-12-27	WOS:000367092600076
J	Zheng, XZ; Mao, XH; Xu, K; Lu, LS; Peng, XZ; Wang, M; Xu, GS; Hua, ZL; Wang, JP; Xue, HC; Wang, JM; Lu, C				Zheng, Xianzhi; Mao, Xuhua; Xu, Kun; Lu, Lingshuang; Peng, Xianzhen; Wang, Min; Xu, Guisheng; Hua, Zhaolai; Wang, Jianping; Xue, Hengchuan; Wang, Jianming; Lu, Cheng			Massive Endoscopic Screening for Esophageal and Gastric Cancers in a High-Risk Area of China	PLOS ONE			English	Article							PROGRAM; TRENDS; SURVEILLANCE; MORTALITY; PROVINCE; STOMACH; IMPACT	Objective This study aims to describe the findings from a massive endoscopic screening program in a high-risk area of China and to evaluate the prognosis of patients diagnosed through endoscopic screening compared with those diagnosed at usual hospital visits because of illness. Methods In 2006, an early detection and treatment program was initiated in Yangzhong county, China. Local residents aged 40-69 years were eligible for free endoscopic screening. Endoscopic examination was performed with Lugol's iodine staining, followed by biopsies. Patients diagnosed with esophageal or gastric cancer were referred for treatment and followed to assess their long-term survival status. Results From 2006 through 2012, we screened 12453 participants, including 5334 (42.8%) men and 7119 (57.2%) women. The average age was 52.8 +/- 8.0 years. We detected 166 patients with upper digestive tract cancers, including 106 cancers in the esophagus (detection rate: 0.85%) and 60 cancers in the stomach (detection rate: 0.48%). Of these patients, 98.11% with esophageal cancer and 100% with gastric cancer were defined as at the early stage. In the process of follow-up, 17 patients died from cancer-related causes, and the median survival time was greater than 85 months. The overall survival rates for 1, 3 and 5 years were 98.0%, 90.0% and 89.0%, respectively. A significant positive effect was observed for the long-term survival of patients diagnosed through massive endoscopic screening. Conclusions In a high-risk population, massive endoscopic screening can identify early stage carcinoma of esophageal and gastric cancers and improve patients' prognosis through early detection and treatment.	[Zheng, Xianzhi; Lu, Lingshuang; Peng, Xianzhen; Wang, Min; Xu, Guisheng; Wang, Jianming] Nanjing Med Univ, Dept Epidemiol, Sch Publ Hlth, Nanjing 211166, Jiangsu, Peoples R China; [Mao, Xuhua] Yixing Peoples Hosp, Dept Clin Lab, Wuxi 214200, Peoples R China; [Xu, Kun; Wang, Jianming] Nanjing Med Univ, Dept Social Med & Hlth Educ, Sch Publ Hlth, Nanjing 211166, Jiangsu, Peoples R China; [Hua, Zhaolai; Wang, Jianping; Xue, Hengchuan] Yangzhong Peoples Hosp, Yangzhong Canc Res Inst, Yangzhong 212200, Peoples R China; [Wang, Jianming] Nanjing Med Univ, Innovat Ctr Social Risk Governance Hlth, Sch Publ Hlth, Nanjing 211166, Jiangsu, Peoples R China; [Lu, Cheng] Nanjing Med Univ, Nanjing Matern & Child Hlth Hosp, Dept Breast, Nanjing 210004, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wang, JM (corresponding author), Nanjing Med Univ, Dept Epidemiol, Sch Publ Hlth, Nanjing 211166, Jiangsu, Peoples R China.	jmwang@njmu.edu.cn; lucheng66@126.com	lu, lu/HII-7530-2022	Wang, Jianming/0000-0002-9151-284X	National Natural Science Foundation of China [81172268]; Key University Science Research Project of Jiangsu Province [12KJA330001]; Qing Lan Project; Six Talent Peaks Project in Jiangsu Province [2014-YY-023]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Medical Science and Technology Development Foundation, Jiangsu Province Department of Health [YZ01313]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key University Science Research Project of Jiangsu Province; Qing Lan Project(Jiangsu Polytech Institute); Six Talent Peaks Project in Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Medical Science and Technology Development Foundation, Jiangsu Province Department of Health	This study is supported by the National Natural Science Foundation of China (81172268), Key University Science Research Project of Jiangsu Province (12KJA330001), Qing Lan Project (2014), Six Talent Peaks Project in Jiangsu Province (2014-YY-023), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and Medical Science and Technology Development Foundation, Jiangsu Province Department of Health (YZ01313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WF, 2010, JAMA-J AM MED ASSOC, V303, P1723, DOI 10.1001/jama.2010.496; Cho E, 2013, ASIAN PAC J CANCER P, V14, P2533, DOI 10.7314/APJCP.2013.14.5.2533; Choi KS, 2011, CANCER SCI, V102, P1559, DOI 10.1111/j.1349-7006.2011.01982.x; Dong ZW, 2002, JPN J CLIN ONCOL, V32, pS10, DOI 10.1093/jjco/hye122; Gallagher LG, 2015, AM J IND MED, V58, P267, DOI 10.1002/ajim.22412; Hamashima C, 2015, WORLD J GASTROENTERO, V21, P2460, DOI 10.3748/wjg.v21.i8.2460; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Keen JD, 2015, J WOMENS HEALTH, V24, P867, DOI 10.1089/jwh.2015.5220; Kim GH, 2015, KOREAN J INTERN MED, V30, P747, DOI 10.3904/kjim.2015.30.6.747; Kong SH, 2004, JPN J CLIN ONCOL, V34, P1, DOI 10.1093/jjco/hyh009; Lambert R, 2012, WORLD J GASTRO ENDOS, V4, P518, DOI 10.4253/wjge.v4.i12.518; Lee SJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8441; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Lu YF, 2014, ASIAN PAC J CANCER P, V15, P1419, DOI 10.7314/APJCP.2014.15.3.1419; Mansour-Ghanaei F, 2012, ASIAN PAC J CANCER P, V13, P1407, DOI 10.7314/APJCP.2012.13.4.1407; Niu X, 2014, WORLD J GASTROENTERO, V20, P5074, DOI 10.3748/wjg.v20.i17.5074; ORGOGOZO JM, 1994, REV NEUROL, V150, P813; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pourhoseingholi Mohamad Amin, 2015, Gastroenterol Hepatol Bed Bench, V8, P19; Riecken B, 2002, PREV MED, V34, P22, DOI 10.1006/pmed.2001.0925; Roshandel G, 2013, ARCH IRAN MED, V16, P351, DOI 013166/AIM.009; Roth MJ, 1997, CANCER-AM CANCER SOC, V80, P2047, DOI 10.1002/(SICI)1097-0142(19971201)80:11<2047::AID-CNCR3>3.0.CO;2-U; Shah PM, 2015, J GASTROINTEST ONCOL, V6, P20, DOI 10.3978/j.issn.2078-6891.2014.096; Wang JP, 2015, ANN SURG ONCOL, V22, P2965, DOI 10.1245/s10434-015-4388-4; Wang JM, 2005, EUR J GASTROEN HEPAT, V17, P1339, DOI 10.1097/00042737-200512000-00012; Wei Wen-Qiang, 2011, Chin J Cancer, V30, P213; Yada Tomoyuki, 2013, Diagn Ther Endosc, V2013, P241320, DOI 10.1155/2013/241320; Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187	28	29	30	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145097	10.1371/journal.pone.0145097	http://dx.doi.org/10.1371/journal.pone.0145097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699332	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600046
J	Garcia-Souto, D; Troncoso, T; Perez, M; Pasantes, JJ				Garcia-Souto, Daniel; Troncoso, Tomas; Perez, Montse; Pasantes, Juan Jose			Molecular Cytogenetic Analysis of the European Hake Merluccius merluccius (Merlucciidae, Gadiformes): U1 and U2 snRNA Gene Clusters Map to the Same Location	PLOS ONE			English	Article							RIBOSOMAL-RNA; 5S RDNA; MULTIGENE FAMILIES; FISH; EVOLUTION; GENOME; MITOCHONDRIAL; ORGANIZATION; PHYLOGENY; DYNAMISM	The European hake (Merluccius merluccius) is a highly valuable and intensely fished species in which a long-term alive stock has been established in captivity for aquaculture purposes. Due to their huge economic importance, genetic studies on hakes were mostly focused on phylogenetic and phylogeographic aspects; however chromosome numbers are still not described for any of the fifteen species in the genus Merluccius. In this work we report a chromosome number of 2n = 42 and a karyotype composed of three meta/submetacentric and 18 subtelo/telocentric chromosome pairs. Telomeric sequences appear exclusively at both ends of every single chromosome. Concerning rRNA genes, this species show a single 45S rDNA cluster at an intercalary location on the long arm of subtelocentric chromosome pair 12; the single 5S rDNA cluster is also intercalary to the long arm of chromosome pair 4. While U2 snRNA gene clusters map to a single subcentromeric position on chromosome pair 13, U1 snRNA gene clusters seem to appear on almost all chromosome pairs, but showing bigger clusters on pairs 5, 13, 16, 17 and 19. The brightest signals on pair 13 are coincident with the single U2 snRNA gene cluster signals. Therefore, the use of these probes allows the unequivocal identification of at least 7 of the chromosome pairs that compose the karyotype of Merluccius merluccius thus opening the way to integrate molecular genetics and cytological data on the study of the genome of this important species.	[Garcia-Souto, Daniel; Troncoso, Tomas; Pasantes, Juan Jose] Univ Vigo, Dept Bioquim Xenet & Inmunol, Vigo 36310, Spain; [Troncoso, Tomas; Perez, Montse] Inst Espanol Oceanog, Ctr Oceanog Vigo, Grp Acuicultura Marina, Vigo, Spain	Universidade de Vigo; Spanish Institute of Oceanography	Pasantes, JJ (corresponding author), Univ Vigo, Dept Bioquim Xenet & Inmunol, Vigo 36310, Spain.	pasantes@uvigo.es	Souto, Daniel García/H-2213-2015; Pérez, Montse/E-6741-2013	Souto, Daniel García/0000-0002-0997-8799; Pérez, Montse/0000-0002-1772-8984; Pasantes, Juan J/0000-0001-6515-3946	Xunta de Galicia; Fondos FEDER [2010/80, GPC2013-011]; Ministerio de Economia y Competitividad (project LETSHAKE); FEDER [AGL2013-48468-R]; FPU fellowship from Ministerio de Educacion (Spain)	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fondos FEDER(European Commission); Ministerio de Economia y Competitividad (project LETSHAKE); FEDER(European Commission); FPU fellowship from Ministerio de Educacion (Spain)	This work was partly funded by grants from Xunta de Galicia and Fondos FEDER: "Unha maneira de facer Europe" (Grupos de Referencia Competitiva, 2010/80; Grupos con Potencial Crecimiento, GPC2013-011) and Ministerio de Economia y Competitividad (project LETSHAKE co-funded by FEDER, AGL2013-48468-R). DGS was supported in part by a FPU fellowship from Ministerio de Educacion (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Merlo MA, 2013, AQUAC RES, V44, P974, DOI 10.1111/j.1365-2109.2012.03103.x; Merlo MA, 2010, GENES GENET SYST, V85, P341, DOI 10.1266/ggs.85.341; Anjos A, 2015, HEREDITY, V114, P207, DOI 10.1038/hdy.2014.87; [Anonymous], 2011, FISH KARYOTYPES CHEC; Bernardi G, 2012, MAR GENOM, V7, P3, DOI 10.1016/j.margen.2012.02.002; Bjelland RM, 2006, AQUAC RES, V37, P1117, DOI 10.1111/j.1365-2109.2006.01536.x; Bueno D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066532; Bueno Vanessa, 2014, ScientificWorldJournal, V2014, P943825, DOI 10.1155/2014/943825; BUSCH H, 1982, ANNU REV BIOCHEM, V51, P617, DOI 10.1146/annurev.bi.51.070182.003153; Cabral-de-Mello DC, 2012, CHROMOSOME RES, V20, P279, DOI 10.1007/s10577-011-9271-y; Campo D, 2007, GENE, V406, P171, DOI 10.1016/j.gene.2007.09.008; Campo D, 2009, J MOL EVOL, V68, P208, DOI 10.1007/s00239-009-9207-8; Casey J, 1995, FISH AND FISHERIES S, V15, P142; Cioffi MB, 2012, GENOME DYNAM, V7, P197, DOI 10.1159/000337950; de Sene VF, 2014, COMP CYTOGENET, V8, P301, DOI 10.3897/CompCytogen.v8i4.8396; Ghigliotti L, 2012, ANIM GENET, V43, P746, DOI 10.1111/j.1365-2052.2012.02343.x; Ghigliotti L, 2008, GENET MOL BIOL, V31, P180, DOI 10.1590/S1415-47572008000200003; Ghigliotti L, 2015, HYDROBIOLOGIA, V761, P373, DOI 10.1007/s10750-015-2355-5; Ghigliotti L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/243938; Gornung E, 2013, CYTOGENET GENOME RES, V141, P90, DOI 10.1159/000354832; GRANT WS, 1988, HEREDITY, V61, P13, DOI 10.1038/hdy.1988.86; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Iglesias J, 2010, AQUAC RES, V41, P607, DOI 10.1111/j.1365-2109.2009.02365.x; Sanchez FJ, 2012, AQUAC RES, V43, P1729, DOI 10.1111/j.1365-2109.2011.02966.x; Kirtiklis L, 2014, GENETICA, V142, P141, DOI 10.1007/s10709-014-9761-x; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lewin HA, 2009, GENOME RES, V19, P1925, DOI 10.1101/gr.094557.109; Lima PA, 2014, CYTOGENET GENOME RES, V142, P197, DOI 10.1159/000360492; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Manchado M, 2006, GENOME, V49, P79, DOI 10.1139/G05-068; Martins C., 2004, FOCUS GENOME RES, P289; Martins Cesar, 2007, P421; Marz M, 2008, J MOL EVOL, V67, P594, DOI 10.1007/s00239-008-9149-6; Merlo MA, 2013, J MOL EVOL, V76, P83, DOI 10.1007/s00239-013-9541-8; Merlo MA, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-33; Murua H, 2010, ADV MAR BIOL, V58, P97, DOI 10.1016/S0065.2881(10)58002.7; Nakajima RT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-198; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Ocalewicz K, 2013, CYTOGENET GENOME RES, V141, P114, DOI 10.1159/000354278; PENDAS AM, 1995, MOL ECOL, V4, P275, DOI 10.1111/j.1365-294X.1995.tb00220.x; Perez M., 2004, Journal of Food Product Technology, V13, P59, DOI 10.1300/J030v13n02_06; Perez M., 2004, Journal of Food Product Technology, V13, P49, DOI 10.1300/J030v13n02_05; Perez M, 2005, J AGR FOOD CHEM, V53, P5239, DOI 10.1021/jf048012h; Perez M., 2011, METODOS TECNICAS INV, P79; Perez M, 2008, J AGR FOOD CHEM, V56, P10865, DOI 10.1021/jf801700x; Perez-Garcia C, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-84; Perez-Garcia C, 2011, GENOME, V54, P771, DOI [10.1139/G11-040, 10.1139/g11-040]; Pinhal D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-151; Quinteiro J, 2000, MAR BIOL, V136, P163, DOI 10.1007/s002270050019; Rebordinos L, 2013, CYTOGENET GENOME RES, V141, P103, DOI 10.1159/000354871; Reeves A, 2000, MICROMEASURE FOR WIN; Ribeiro LB, 2014, GENET MOL BIOL, V37, P46, DOI 10.1590/S1415-47572014000100009; Silva DMZA, 2015, CYTOGENET GENOME RES; Supiwong W, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-51; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ubeda-Manzanaro M, 2010, GENETICA, V138, P787, DOI 10.1007/s10709-010-9460-1; Utsunomia R, 2014, CYTOGENET GENOME RES, V142, P286, DOI 10.1159/000362258; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	58	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146150	10.1371/journal.pone.0146150	http://dx.doi.org/10.1371/journal.pone.0146150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716701	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500136
J	Jensen, R				Jensen, Ralph			Effects of Dopamine D2-Like Receptor Antagonists on Light Responses of Ganglion Cells in Wild-Type and P23H Rat Retinas	PLOS ONE			English	Article							GABA(C) RECEPTORS; IMMUNOCYTOCHEMICAL LOCALIZATION; D-1 RECEPTORS; RHO-SUBUNITS; MUTANT MOUSE; RELEASE; NEURONS; DEGENERATION; PATHWAYS; MODEL	In animal models of retinitis pigmentosa the dopaminergic system in the retina appears to be dysfunctional, which may contribute to the debilitated sight experienced by retinitis pigmentosa patients. Since dopamine D2-like receptors are known to modulate the activity of dopaminergic neurons, I examined the effects of dopamine D2-like receptor antagonists on the light responses of retinal ganglion cells (RGCs) in the P23H rat model of retinitis pigmentosa. Extracellular electrical recordings were made from RGCs in isolated transgenic P23H rat retinas and wild-type Sprague-Dawley rat retinas. Intensity-response curves to flashes of light were evaluated prior to and during bath application of a dopamine D2-like receptor antagonist. The dopamine D2/D3 receptor antagonists sulpiride and eticlopride and the D4 receptor antagonist L-745,870 increased light sensitivity of P23H rat RGCs but decreased light sensitivity in Sprague-Dawley rat RGCs. In addition, L-745,870, but not sulpiride or eticlopride, reduced the maximum peak responses of Sprague-Dawley rat RGCs. I describe for the first time ON-center RGCs in P23H rats that exhibit an abnormally long-latency (> 200 ms) response to the onset of a small spot of light. Both sulpiride and eticlopride, but not L-745,870, reduced this ON response and brought out a short-latency OFF response, suggesting that these cells are in actuality OFF-center cells. Overall, the results show that the altered dopaminergic system in degenerate retinas contributes to the deteriorated light responses of RGCs.	[Jensen, Ralph] VA Boston Healthcare Syst, Boston, MA 02130 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Jensen, R (corresponding author), VA Boston Healthcare Syst, Mail Stop 151E,150 South Huntington Ave, Boston, MA 02130 USA.	ralph.jensen@va.gov			Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service [1I01RX000341-01]; Veterans Affairs [I01RX001299] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service (1I01RX000341-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson CL, 2013, J NEUROPHYSIOL, V109, P1589, DOI 10.1152/jn.00786.2012; Aung MH, 2014, J NEUROSCI, V34, P726, DOI 10.1523/JNEUROSCI.3483-13.2014; Barhoum R, 2008, NEUROSCIENCE, V155, P698, DOI 10.1016/j.neuroscience.2008.06.042; Chua J, 2009, J COMP NEUROL, V514, P473, DOI 10.1002/cne.22029; COHEN AI, 1992, P NATL ACAD SCI USA, V89, P12093, DOI 10.1073/pnas.89.24.12093; Cuenca N, 2004, NEUROSCIENCE, V127, P301, DOI 10.1016/j.neuroscience.2004.04.042; Cuenca N, 2005, EUR J NEUROSCI, V22, P1057, DOI 10.1111/j.1460-9568.2005.04300.x; Dagar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090250; Derouiche A, 1999, EUR J NEUROSCI, V11, P1391, DOI 10.1046/j.1460-9568.1999.00557.x; DUBOCOVICH ML, 1985, J PHARMACOL EXP THER, V233, P747; Enz R, 1996, J NEUROSCI, V16, P4479; Farajian R, 2011, J PHYSIOL-LONDON, V589, P4473, DOI 10.1113/jphysiol.2011.213371; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Grunder T, 2001, VISUAL NEUROSCI, V18, P781, DOI 10.1017/S0952523801185111; HANKINS M, 1994, DOC OPHTHALMOL, V86, P325, DOI 10.1007/BF01203555; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Jackson CR, 2009, J NEUROCHEM, V109, P148, DOI 10.1111/j.1471-4159.2009.05920.x; Jensen RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079126; Jensen RJ, 2012, EXP EYE RES, V105, P21, DOI 10.1016/j.exer.2012.10.005; Jensen RJ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/035002; Klitten LL, 2008, EXP EYE RES, V87, P471, DOI 10.1016/j.exer.2008.08.004; Koulen P, 1998, EUR J NEUROSCI, V10, P115, DOI 10.1046/j.1460-9568.1998.00005.x; Li HY, 2013, J NEUROSCI, V33, P3135, DOI 10.1523/JNEUROSCI.2807-12.2013; Lukasiewicz PD, 1997, VISUAL NEUROSCI, V14, P989, DOI 10.1017/S095252380001169X; Marc RE, 2007, INVEST OPHTH VIS SCI, V48, P3364, DOI 10.1167/iovs.07-0032; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; NguyenLegros J, 1997, VISUAL NEUROSCI, V14, P545, DOI 10.1017/S0952523800012207; NIR I, 1994, BRAIN RES, V649, P85, DOI 10.1016/0006-8993(94)91051-0; Patel S, 1997, J PHARMACOL EXP THER, V283, P636; Patel S, 2003, NEUROPHARMACOLOGY, V44, P1038, DOI 10.1016/S0028-3908(03)00112-6; Puopolo M, 2001, NEURON, V30, P211, DOI 10.1016/S0896-6273(01)00274-4; RASHID K, 1993, J NEUROCHEM, V61, P2025, DOI 10.1111/j.1471-4159.1993.tb07438.x; Renteria RC, 2006, J NEUROSCI, V26, P11857, DOI 10.1523/JNEUROSCI.1718-06.2006; Sekirnjak C, 2011, J NEUROPHYSIOL, V105, P2560, DOI 10.1152/jn.01061.2010; Srivastava P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123896; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; Veruki ML, 1996, EUR J NEUROSCI, V8, P2286, DOI 10.1111/j.1460-9568.1996.tb01192.x; Veruki ML, 1997, EUR J NEUROSCI, V9, P1096, DOI 10.1111/j.1460-9568.1997.tb01461.x; Wang Y, 1997, J NEUROPHYSIOL, V78, P439, DOI 10.1152/jn.1997.78.1.439; Weber B, 2001, BRIT J PHARMACOL, V133, P1243, DOI 10.1038/sj.bjp.0704192; WELLIS DP, 1995, J NEUROSCI, V15, P4748; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a	42	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146154	10.1371/journal.pone.0146154	http://dx.doi.org/10.1371/journal.pone.0146154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717015	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500138
J	Nowicki, MW; Blackburn, EA; McNae, IW; Wear, MA				Nowicki, Matthew W.; Blackburn, Elizabeth A.; McNae, Iain W.; Wear, Martin A.			A Streamlined, Automated Protocol for the Production of Milligram Quantities of Untagged Recombinant Rat Lactate Dehydrogenase A Using AKTAxpress (TM)	PLOS ONE			English	Article							PROTEIN EXPRESSION; ESCHERICHIA-COLI; CANCER; PURIFICATION; SYSTEM; INHIBITORS; IDENTIFICATION; GLYCOLYSIS; METABOLISM; FORMS	We developed an efficient, automated 2-step purification protocol for the production of milligram quantities of untagged recombinant rat lactate dehydrogenase A (rLDHA) from E. coli, using the AKTAxpress (TM) chromatography system. Cation exchange followed by size exclusion results in average final purity in excess of 93% and yields similar to 14 milligrams per 50 ml of original cell culture in EnPresso B media, in under 8 hrs, including all primary sample processing and column equilibration steps. The protein is highly active and coherent biophysically and a viable alternative to the more problematic human homolog for structural and ligand-binding studies; an apo structure of untagged rLDHA was solved to a resolution 2.29 angstrom (PDB ID 5ES3). Our automated methodology uses generic commercially available pre-packed columns and simple buffers, and represents a robust standard method for the production of milligram amounts of untagged rLDHA, facilitating a novel fragment screening approach for new inhibitors.	[Nowicki, Matthew W.; Blackburn, Elizabeth A.; McNae, Iain W.; Wear, Martin A.] Univ Edinburgh, WTCCB, EPPF, Edinburgh, Midlothian, Scotland	University of Edinburgh	Wear, MA (corresponding author), Univ Edinburgh, WTCCB, EPPF, Kings Bldg,Mayfield Rd, Edinburgh, Midlothian, Scotland.	martin.wear@ed.ac.uk		Blackburn, Elizabeth A/0000-0003-1325-9575; McNae, Iain/0000-0002-6312-7936	Wellcome Trust [081287/Z/06/Z, 101527/Z/13/Z]; Wellcome-UoE ISSF award	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome-UoE ISSF award	This work was supported by Wellcome Trust Multi-User Equipment grants 081287/Z/06/Z and 101527/Z/13/Z, the Wellcome-UoE ISSF award (SEC-MALS equipment for the EPPF); http://www.welcome.ac.uk The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alzari PM, 2006, ACTA CRYSTALLOGR D, V62, P1103, DOI 10.1107/S0907444906029775; Au K, 2006, ACTA CRYSTALLOGR D, V62, P1267, DOI 10.1107/S0907444906033555; Auerbach G, 1998, STRUCTURE, V6, P769, DOI 10.1016/S0969-2126(98)00078-1; Bensinger SJ, 2012, SEMIN CELL DEV BIOL, V23, P352, DOI 10.1016/j.semcdb.2012.02.003; Berrow NS, 2006, ACTA CRYSTALLOGR D, V62, P1218, DOI 10.1107/S0907444906031337; Bhikhabhai R, 2005, J CHROMATOGR A, V1080, P83, DOI 10.1016/j.chroma.2005.05.026; Boock JT, 2015, J MOL BIOL, V427, P1451, DOI 10.1016/j.jmb.2015.01.003; Bussow K, 2015, CURR OPIN STRUC BIOL, V32, P81, DOI 10.1016/j.sbi.2015.03.002; Camper DV, 2009, ANAL BIOCHEM, V393, P176, DOI 10.1016/j.ab.2009.07.009; Chambers Stephen P., 2009, V498, P143, DOI 10.1007/978-1-59745-196-3_10; Dragovich PS, 2013, BIOORG MED CHEM LETT, V23, P3186, DOI 10.1016/j.bmcl.2013.04.001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Granja S, 2015, CURR DRUG METAB, V16, P221, DOI 10.2174/1389200216666150602145145; Hamanaka RB, 2011, SCIENCE, V334, P1219, DOI 10.1126/science.1215637; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hiraki M, 2006, ACTA CRYSTALLOGR D, V62, P1058, DOI 10.1107/S0907444906023821; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Jones NP, 2012, DRUG DISCOV TODAY, V17, P232, DOI 10.1016/j.drudis.2011.12.017; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaelin WG, 2010, NATURE, V465, P562, DOI 10.1038/465562a; Kolev Y, 2008, ANN SURG ONCOL, V15, P2336, DOI 10.1245/s10434-008-9955-5; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li XB, 2015, THORAC CANCER, V6, P17, DOI 10.1111/1759-7714.12148; Lin ZL, 2015, METHODS MOL BIOL, V1258, P65, DOI 10.1007/978-1-4939-2205-5_4; Liu HT, 2009, PROTEIN EXPRES PURIF, V63, P102, DOI 10.1016/j.pep.2008.09.008; Ludwig C, 2010, PROTEIN EXPRES PURIF, V71, P54, DOI 10.1016/j.pep.2009.12.001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NOVOA WB, 1959, J BIOL CHEM, V234, P1143; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; PETTIT SM, 1981, CLIN CHEM, V27, P88; Read JA, 2001, PROTEINS, V43, P175, DOI 10.1002/1097-0134(20010501)43:2<175::AID-PROT1029>3.0.CO;2-#; Riek Uwe, 2009, Biotechniques, V46, pix, DOI 10.2144/000113130; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00341; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Seth P, 2011, NEOPLASIA, V13, P60, DOI 10.1593/neo.101020; Sigrell Jill A., 2003, Journal of Structural and Functional Genomics, V4, P109, DOI 10.1023/A:1026202319763; Stromberg P, 2005, J CHROMATOGR B, V818, P11, DOI 10.1016/j.jchromb.2004.09.035; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Ullrich KK, 2015, CURR OPIN BIOTECH, V32, P61, DOI 10.1016/j.copbio.2014.11.011; Valvona CJ, 2016, BRAIN PATHOL, V26, P3, DOI 10.1111/bpa.12299; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vander Heiden MG, 2010, BIOCHEM PHARMACOL, V79, P1118, DOI 10.1016/j.bcp.2009.12.003; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Ward RA, 2012, J MED CHEM, V55, P3285, DOI 10.1021/jm201734r; Waugh DS, 2005, TRENDS BIOTECHNOL, V23, P316, DOI 10.1016/j.tibtech.2005.03.012; Wear MA, 2007, PROTEIN EXPRES PURIF, V51, P80, DOI 10.1016/j.pep.2006.06.019; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wood DW, 2014, CURR OPIN STRUC BIOL, V26, P54, DOI 10.1016/j.sbi.2014.04.006; Wood DW, 2014, J BIOL CHEM, V289, P14512, DOI 10.1074/jbc.R114.552653; Wu JW, 1999, ACTA BIOCHIM POL, V46, P591, DOI 10.18388/abp.1999_4131; Xing YZ, 2015, FEBS J, V282, P3892, DOI 10.1111/febs.13402; Yoo D, 2014, J CHROMATOGR A, V1344, P23, DOI 10.1016/j.chroma.2014.04.014	56	6	6	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146164	10.1371/journal.pone.0146164	http://dx.doi.org/10.1371/journal.pone.0146164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717415	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500140
J	Okuyama, K; Kaida, A; Hayashi, Y; Hayashi, Y; Harada, K; Miura, M				Okuyama, Kohei; Kaida, Atsushi; Hayashi, Yoshiki; Hayashi, Yoshio; Harada, Kiyoshi; Miura, Masahiko			KPU-300, a Novel Benzophenone Diketopiperazine-Type Anti-Microtubule Agent with a 2-Pyridyl Structure, Is a Potent Radiosensitizer That Synchronizes the Cell Cycle in Early M Phase	PLOS ONE			English	Article							VASCULAR-DISRUPTING AGENT; TUMOR BLOOD-FLOW; HELA-CELLS; CANCER-CELLS; MITOTIC CATASTROPHE; COLON-CANCER; RADIATION SENSITIZER; INDUCED APOPTOSIS; INDICATOR FUCCI; SOLID TUMORS	KPU-300 is a novel colchicine-type anti-microtubule agent derived from plinabulin (NPI-2358). We characterized the effects of KPU-300 on cell cycle kinetics and radiosensitization using HeLa cells expressing the fluorescent ubiquitination-based cell cycle indicator (Fucci). Cells treated with 30 nM KPU-300 for 24 h were efficiently synchronized in M phase and contained clearly detectable abnormal Fucci fluorescence. Two-dimensional flow-cytometric analysis revealed a fraction of cells distinct from the normal Fucci fluorescence pattern. Most of these cells were positive for an M phase marker, the phosphorylated form of histone H3. Cells growing in spheroids responded similarly to the drug, and the inner quiescent fraction also responded after recruitment to the growth fraction. When such drug-treated cells were irradiated in monolayer, a remarkable radiosensitization was observed. To determine whether this radiosensitization was truly due to the synchronization in M phase, we compared the radiosensitivity of cells synchronized by KPU-300 treatment and cells in early M phase isolated by a combined method that took advantage of shake-off and the properties of the Fucci system. Following normalization against the surviving fraction of cells treated with KPU-300 alone, the surviving fractions of cells irradiated in early M phase coincided. Taken together with potential vascular disrupting function in vivo, we propose a novel radiosensitizing strategy using KPU-300.	[Okuyama, Kohei; Kaida, Atsushi; Miura, Masahiko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Oral Radiat Oncol, Dept Oral Hlth Sci,Bunkyo Ku, Tokyo 1138549, Japan; [Okuyama, Kohei; Harada, Kiyoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Maxillofacial Surg, Dept Maxillofacial & Neck Reconstruct,Bunkyo Ku, Tokyo, Japan; [Hayashi, Yoshiki; Hayashi, Yoshio] Tokyo Univ Pharm & Life Sci, Dept Med Chem, Hachioji, Tokyo 1920392, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo University of Pharmacy & Life Sciences	Miura, M (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Oral Radiat Oncol, Dept Oral Hlth Sci,Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	masa.mdth@tmd.ac.jp	Okuyama, Kohei/AAO-7647-2021	Okuyama, Kohei/0000-0002-5616-902X	Ministry of Education, Culture, Sports, Science, and Technology, Japan [26861569, 26293399, 25670796]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grants-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science, and Technology, Japan, 26861569 to KK, and 26293399 and 25670796 to MM.	Acharya BR, 2014, BIOCHIMIE, V97, P78, DOI 10.1016/j.biochi.2013.09.025; Crielaard BJ, 2011, INT J NANOMED, V6, P2697, DOI 10.2147/IJN.S24450; Daenen LGM, 2010, CURR CLIN PHARMACOL, V5, P178, DOI 10.2174/157488410791498815; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Dunne AL, 2004, ONCOL RES, V14, P447, DOI 10.3727/0965040041791455; Foley KP, 2012, J PHARMACOL EXP THER, V343, P529, DOI 10.1124/jpet.112.196873; Fujie Y, 2005, JPN J CLIN ONCOL, V35, P453, DOI 10.1093/jjco/hyi130; Geng CX, 2005, WORLD J GASTROENTERO, V11, P2990, DOI 10.3748/wjg.v11.i19.2990; Gigant B, 2009, TOP CURR CHEM, V286, P259, DOI 10.1007/128_2008_11; Giunta S, 2011, CELL CYCLE, V10, P1215, DOI 10.4161/cc.10.8.15334; Golden EB, 2014, ANTI-CANCER DRUG, V25, P502, DOI 10.1097/CAD.0000000000000055; Hayashi Y, 2014, ACS MED CHEM LETT, V5, P1094, DOI 10.1021/ml5001883; Hiro J, 2010, ONCOL REP, V24, P1029, DOI 10.3892/or_0000095; Honda-Uezono A, 2012, BIOCHEM BIOPH RES CO, V428, P224, DOI 10.1016/j.bbrc.2012.10.014; Hori K, 2003, BRIT J CANCER, V89, P1334, DOI 10.1038/sj.bjc.6601261; Hori K, 2002, BRIT J CANCER, V86, P1604, DOI 10.1038/sj.bjc.6600296; Islam MN, 2004, MINI-REV MED CHEM, V4, P1077, DOI 10.2174/1389557043402946; Kaida A, 2013, BIOCHEM BIOPH RES CO, V439, P453, DOI 10.1016/j.bbrc.2013.08.093; Kingston DGI, 2014, ACCOUNTS CHEM RES, V47, P2682, DOI 10.1021/ar500203h; Kumar P, 2003, REV UROL, V3, pS71; Kunos CA, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00226; LIN CM, 1989, BIOCHEMISTRY-US, V28, P6984, DOI 10.1021/bi00443a031; Nguyen L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-522; Magalska A, 2006, INT J CANCER, V119, P1811, DOI 10.1002/ijc.22055; Masunaga S, 2001, INT J RADIAT ONCOL, V50, P1063, DOI 10.1016/S0360-3016(01)01553-X; MILAS L, 1995, CANCER RES, V55, P3564; Millward M, 2012, INVEST NEW DRUG, V30, P1065, DOI 10.1007/s10637-011-9642-4; Mita MM, 2010, CLIN CANCER RES, V16, P5892, DOI 10.1158/1078-0432.CCR-10-1096; Morse DL, 2005, MOL CANCER THER, V4, P1495, DOI 10.1158/1535-7163.MCT-05-0130; Nabell L, 2003, SEMIN ONCOL, V30, P89, DOI 10.1053/j.seminoncol.2003.11.017; Nakayama M, 2011, RADIAT RES, V176, P407, DOI 10.1667/RR2608.1; Nicholson B, 2006, ANTI-CANCER DRUG, V17, P25, DOI 10.1097/01.cad.0000182745.01612.8a; Nielsen T, 2012, CLIN CANCER RES, V18, P6469, DOI 10.1158/1078-0432.CCR-12-2014; Niero A, 1999, CLIN CANCER RES, V5, P2213; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Poruchynsky MS, 2015, P NATL ACAD SCI USA, V112, P1571, DOI 10.1073/pnas.1416418112; Risinger AL, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-41; Rutkauskiene Giedre, 2005, Medicina (Kaunas), V41, P1026; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Salmon BA, 2007, EUR J CANCER, V43, P1622, DOI 10.1016/j.ejca.2007.03.018; SINCLAIR WK, 1965, BIOPHYS J, V5, P1, DOI 10.1016/S0006-3495(65)86700-5; STEREN A, 1993, GYNECOL ONCOL, V50, P89, DOI 10.1006/gyno.1993.1169; Stobbe CC, 2002, INT J RADIAT BIOL, V78, P1149, DOI 10.1080/09553000210166570; TERASIMA T, 1963, EXP CELL RES, V30, P344, DOI 10.1016/0014-4827(63)90306-9; TERASIMA T, 1961, NATURE, V190, P1210, DOI 10.1038/1901210a0; TERASIMA T, 1963, BIOPHYS J, V3, P11, DOI 10.1016/S0006-3495(63)86801-0; TISHLER RB, 1992, INT J RADIAT ONCOL, V22, P613, DOI 10.1016/0360-3016(92)90888-O; Tsuchida E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128090; Werner ME, 2011, ACS NANO, V5, P8990, DOI 10.1021/nn203165z; Yamazaki Y, 2012, J MED CHEM, V55, P1056, DOI 10.1021/jm2009088; Yano S, 2014, CELL CYCLE, V13, P3958, DOI 10.4161/15384101.2014.964115; Yano S, 2014, ONCOTARGET, V5, P8729, DOI 10.18632/oncotarget.2369; Zanelli GD, 1997, EUR J CANCER, V33, P486, DOI 10.1016/S0959-8049(96)00478-9; Zhang F, 2010, ONCOL REP, V24, P1297, DOI 10.3892/or_00000986; Zhou Jun, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P65, DOI 10.2174/1568011053352569	55	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145995	10.1371/journal.pone.0145995	http://dx.doi.org/10.1371/journal.pone.0145995			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716455	gold, Green Submitted, Green Published			2022-12-27	WOS:000367510500111
J	Chen, YJ; Lan, T; Duan, LC; Wang, FH; Zhao, B; Zhang, ST; Wei, W				Chen, Yajun; Lan, Tao; Duan, Lunchao; Wang, Fenghe; Zhao, Bin; Zhang, Shengtian; Wei, Wei			Adsorptive Removal and Adsorption Kinetics of Fluoroquinolone by Nano-Hydroxyapatite	PLOS ONE			English	Article							RICE HUSK ASH; WASTE-WATER; METAL-IONS; ANTIBACTERIAL AGENTS; AQUEOUS-SOLUTION; DRINKING-WATER; ANTIBIOTICS; DEGRADATION; CIPROFLOXACIN; PH	Various kinds of antibiotics, especially fluoroquinolone antibiotics (FQs) have been widely used for the therapy of infectious diseases in human and livestock. For their poorly absorbed by living organisms, large-scale misuse or abuse of FQs will foster drug resistance among pathogenic bacteria, as well as a variety of environmental problems when they were released in the environment. In this work, the adsorption properties of two FQs, namely norfloxacin (NOR) and ciprofloxacin (CIP), by nano-hydroxyapatite (n-HAP) were studied by batch adsorption experiments. The adsorption curves of FQs by n-HAP were simulated by Langmuir and Freundlich isotherms. The results shown that NOR and CIP can be adsorbed effectively by the adsorbent of n-HAP, and the adsorption capacity of FQs increase with increasing dosage of n-HAP. The optimum dosage of n-HAP for FQs removal was 20 g.L-1, in which the removal efficiencies is 51.6% and 47.3%, and an adsorption equilibrium time is 20 min. The maximum removal efficiency occurred when pH is 6 for both FQs. The adsorption isotherm of FQs fits well for both Langmuir and Freundlich equations. The adsorption of both FQs by n-HAP follows second-order kinetics.	[Chen, Yajun; Lan, Tao; Duan, Lunchao; Wang, Fenghe; Zhao, Bin; Wei, Wei] Nanjing Normal Univ, Sch Geog Sci, Jiangsu Prov Key Lab Mat Cycling & Pollut Control, Nanjing 210023, Jiangsu, Peoples R China; [Chen, Yajun; Lan, Tao; Duan, Lunchao; Wang, Fenghe; Zhao, Bin; Wei, Wei] Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing 210023, Jiangsu, Peoples R China; [Zhao, Bin; Zhang, Shengtian] Minist Environm Protect China, Nanjing Inst Environm Sci, Nanjing 210042, Jiangsu, Peoples R China	Nanjing Normal University	Wang, FH (corresponding author), Nanjing Normal Univ, Sch Geog Sci, Jiangsu Prov Key Lab Mat Cycling & Pollut Control, Nanjing 210023, Jiangsu, Peoples R China.	wangfenghe@njnu.edu.cn; zhangshengtian163@163.com	Wei, Wei/AAH-4521-2020		Natural Science Foundation of China [41473071, 41101287]; Science and Technology Project of Construction System of Jiangsu Province [JS2011JH25]; National-Local Joint Engineering Research Center for Biomedical Functional Materials; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [164320H116]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Construction System of Jiangsu Province; National-Local Joint Engineering Research Center for Biomedical Functional Materials; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The authors acknowledge the financial support of the Natural Science Foundation of China (41473071, 41101287), the Science and Technology Project of Construction System of Jiangsu Province (JS2011JH25), National-Local Joint Engineering Research Center for Biomedical Functional Materials, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD, 164320H116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the financial support of the Natural Science Foundation of China (41473071, 41101287), the Science and Technology Project of Construction System of Jiangsu Province (JS2011JH25), National-Local Joint Engineering Research Center for Biomedical Functional Materials, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD, 164320H116).	Adams C, 2002, J ENVIRON ENG-ASCE, V128, P253, DOI 10.1061/(ASCE)0733-9372(2002)128:3(253); [Anonymous], 2009, ENVIRON HEALTH PERSP, V117, pA244, DOI 10.1289/ehp.117-a244; Arikan OA, 2008, J HAZARD MATER, V158, P485, DOI 10.1016/j.jhazmat.2008.01.096; Babic S, 2013, CHEMOSPHERE, V91, P1635, DOI 10.1016/j.chemosphere.2012.12.072; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Bautitz IR, 2007, J PHOTOCH PHOTOBIO A, V187, P33, DOI 10.1016/j.jphotochem.2006.09.009; Beauvais RA, 1998, REACT FUNCT POLYM, V36, P113, DOI 10.1016/S1381-5148(98)00016-9; Carabineiro SAC, 2011, WATER RES, V45, P4583, DOI 10.1016/j.watres.2011.06.008; Chai F, 2007, BIOMOL ENG, V24, P510, DOI 10.1016/j.bioeng.2007.08.001; Chen L, 2013, J MATER SCI-MATER M, V24, P1843, DOI 10.1007/s10856-013-4954-x; Corami A, 2007, J HAZARD MATER, V146, P164, DOI 10.1016/j.jhazmat.2006.12.003; Dolar D, 2011, J ENVIRON SCI-CHINA, V23, P1299, DOI 10.1016/S1001-0742(10)60545-1; El Najjar NH, 2013, CHEMOSPHERE, V93, P604, DOI 10.1016/j.chemosphere.2013.05.086; Elayaraja K, 2012, MATER CHEM PHYS, V134, P464, DOI 10.1016/j.matchemphys.2012.03.018; Fan JJ, 2012, J MATER SCI-MATER M, V23, P399, DOI 10.1007/s10856-011-4491-4; FOWLER BO, 1974, INORG CHEM, V13, P194, DOI 10.1021/ic50131a039; Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385; Gobel A, 2007, SCI TOTAL ENVIRON, V372, P361, DOI 10.1016/j.scitotenv.2006.07.039; Gu C, 2005, ENVIRON SCI TECHNOL, V39, P9166, DOI 10.1021/es051109f; Hasegawa M, 2004, J BIOMED MATER RES B, V70B, P332, DOI 10.1002/jbm.b.30047; Homem V, 2011, J ENVIRON MANAGE, V92, P2304, DOI 10.1016/j.jenvman.2011.05.023; Ji Ying-xue, 2013, Huanjing Kexue, V34, P3912; Ji YX, 2013, APPL SURF SCI, V285, P403, DOI 10.1016/j.apsusc.2013.08.067; Kumar SENK, 2009, INT J DRUG DEV RES, V1, P47; Kumar YP, 2006, J HAZARD MATER, V137, P1211, DOI 10.1016/j.jhazmat.2006.04.006; Langmuir I, 1915, J AM CHEM SOC, V37, P1139, DOI 10.1021/ja02170a017; Larsson DGJ, 2007, J HAZARD MATER, V148, P751, DOI 10.1016/j.jhazmat.2007.07.008; Li HB, 2014, CHEMOSPHERE, V95, P150, DOI 10.1016/j.chemosphere.2013.08.053; Li ZH, 2011, COLLOID SURFACE B, V88, P339, DOI 10.1016/j.colsurfb.2011.07.011; Lindberg RH, 2005, ENVIRON SCI TECHNOL, V39, P3421, DOI 10.1021/es048143z; Medellin-Castillo NA, 2014, J IND ENG CHEM, V20, P4014, DOI 10.1016/j.jiec.2013.12.105; Mittal A, 2010, J COLLOID INTERF SCI, V344, P497, DOI 10.1016/j.jcis.2010.01.007; Mittal A, 2009, J COLLOID INTERF SCI, V340, P16, DOI 10.1016/j.jcis.2009.08.019; Mobasherpour I, 2007, J ALLOY COMPD, V430, P330, DOI 10.1016/j.jallcom.2006.05.018; Naiya TK, 2009, J HAZARD MATER, V163, P1254, DOI 10.1016/j.jhazmat.2008.07.119; Oladoja N. A., 2008, Turkish Journal of Engineering and Environmental Sciences, V32, P143; Orfao JJM, 2006, J COLLOID INTERF SCI, V296, P480, DOI 10.1016/j.jcis.2005.09.063; Otker HM, 2005, J HAZARD MATER, V122, P251, DOI 10.1016/j.jhazmat.2005.03.005; Paul T, 2007, ENVIRON SCI TECHNOL, V41, P4720, DOI 10.1021/es070097q; Quoc HP, 2014, SCI WORLD J, DOI [10.1155/2014/273082, DOI 10.1155/2014/273082]; Ramesh ST, 2013, APPL WATER SCI, V3, P105, DOI 10.1007/s13201-012-0064-z; Ramesh ST, 2012, APPL WATER SCI, V2, P187, DOI 10.1007/s13201-012-0036-3; Renew JE, 2004, J CHROMATOGR A, V1042, P113, DOI 10.1016/j.chroma.2004.05.056; Schlusener MP, 2006, ENVIRON POLLUT, V143, P565, DOI 10.1016/j.envpol.2005.10.049; Srivastava VC, 2006, J HAZARD MATER, V134, P257, DOI 10.1016/j.jhazmat.2005.11.052; Stackelberg PE, 2007, SCI TOTAL ENVIRON, V377, P255, DOI 10.1016/j.scitotenv.2007.01.095; Sukul P, 2006, REV ENVIRON CONTAM T, V187, P67, DOI 10.1007/0-387-32885-8_2; Sukul P, 2009, ENVIRON RES, V109, P225, DOI 10.1016/j.envres.2008.12.007; Tang WenQing, 2013, China Environmental Science, V33, P1017; Velasquez M, 2014, J ENVIRON SCI HEAL A, V49, P661, DOI 10.1080/10934529.2014.865447; Verlicchi P, 2010, J HYDROL, V389, P416, DOI 10.1016/j.jhydrol.2010.06.005; Vieno NM, 2007, ENVIRON SCI TECHNOL, V41, P5077, DOI 10.1021/es062720x; Vila M, 2012, J EUR CERAM SOC, V32, P2121, DOI 10.1016/j.jeurceramsoc.2012.01.034; Wammer KH, 2013, WATER RES, V47, P439, DOI 10.1016/j.watres.2012.10.025; Watkinson AJ, 2009, SCI TOTAL ENVIRON, V407, P2711, DOI 10.1016/j.scitotenv.2008.11.059; Wei W, 2014, CHEMOSPHERE, V105, P14, DOI 10.1016/j.chemosphere.2013.09.121; Wu QF, 2010, APPL CLAY SCI, V50, P204, DOI 10.1016/j.clay.2010.08.001; Xing ZP, 2014, ENVIRON PROG SUSTAIN, V33, P170, DOI 10.1002/ep.11775; Xu WH, 2009, WATER ENVIRON RES, V81, P248, DOI 10.2175/106143008X325719; Yang K, 2010, CHEM REV, V110, P5989, DOI 10.1021/cr100059s; Yin A, 2003, ARCH ORAL BIOL, V48, P361, DOI 10.1016/S0003-9969(03)00012-8; YU XQ, 1994, PHARMACEUT RES, V11, P522, DOI 10.1023/A:1018910431216; [曾荣英 Zeng Rongying], 2013, [过程工程学报, The Chinese Journal of Process Engineering], V13, P817; Zhang D, 2010, ENVIRON SCI TECHNOL, V44, P3806, DOI 10.1021/es903851q; Zhang HC, 2005, ENVIRON SCI TECHNOL, V39, P4474, DOI 10.1021/es048166d; Zhang PC, 1998, ENVIRON SCI TECHNOL, V32, P3318, DOI 10.1021/es980232m; Zhao XY, 2014, J COLLOID INTERF SCI, V416, P11, DOI 10.1016/j.jcis.2013.10.034; Zhao YP, 2011, J COLLOID INTERF SCI, V361, P247, DOI 10.1016/j.jcis.2011.05.051	68	25	26	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145025	10.1371/journal.pone.0145025	http://dx.doi.org/10.1371/journal.pone.0145025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698573	gold, Green Published			2022-12-27	WOS:000367092600043
J	Koyanagi, A; Stickley, A; Haro, JM				Koyanagi, Ai; Stickley, Andrew; Maria Haro, Josep			Psychotic-Like Experiences and Nonsuidical Self-Injury in England: Results from a National Survey	PLOS ONE			English	Article							SYMPTOMS; DISORDERS; VICTIMIZATION; IMPULSIVITY; PERSPECTIVE; POPULATION; PREVALENCE; VALIDITY; HARM	Background Little is known about the association between psychotic-like experiences (PLEs) and non-suicidal self-injury (NSSI) in the general adult population. Thus, the aim of this study was to examine the association using nationally-representative data from England. Methods Data from the 2007 Adult Psychiatric Morbidity Survey was analyzed. The sample consisted of 7403 adults aged >= 16 years. Five forms of PLEs (mania/hypomania, thought control, paranoia, strange experience, auditory hallucination) were assessed with the Psychosis Screening Questionnaire. The association between PLEs and NSSI was assessed by multivariable logistic regression. Hierarchical models were constructed to evaluate the influence of alcohol and drug dependence, common mental disorders, and borderline personality disorder symptoms on this association. Results The prevalence of NSSI was 4.7%(female 5.2% and male 4.2%), while the figures among those with and without any PLEs were 19.2% and 3.9% respectively. In a regression model adjusted for sociodemographic factors and stressful life events, most types of PLE were significantly associated with NSSI: paranoia (OR 3.57; 95% CI 1.96-6.52), thought control (OR 2.45; 95% CI 1.05-5.74), strange experience (OR 3.13; 95% CI 1.99-4.93), auditory hallucination (OR 4.03; 95% CI 1.56-10.42), and any PLE (OR 2.78; 95% CI 1.88-4.11). The inclusion of borderline personality disorder symptoms in the models had a strong influence on the association between PLEs and NSSI as evidenced by a large attenuation in the ORs for PLEs, with only paranoia continuing to be significantly associated with NSSI. Substance dependence and common mental disorders had little influence on the association between PLEs and NSSI. Conclusions Borderline personality disorder symptoms may be an important factor in the link between PLEs and NSSI. Future studies on PLEs and NSSI should take these symptoms into account.	[Koyanagi, Ai; Maria Haro, Josep] Univ Barcelona, Fundac St Joan de Deu, Barcelona, Spain; [Koyanagi, Ai; Maria Haro, Josep] Ctr Invest Biomed Red Salud Mental CIBERSAM, Inst Salud Carlos III, Madrid, Spain; [Stickley, Andrew] Sodertorn Univ, Stockholm Ctr Hlth & Social Change SCOHOST, Huddinge, Sweden; [Stickley, Andrew] Univ Tokyo, Dept Human Ecol, Grad Sch Med, Tokyo, Japan	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Sodertorn University; University of Tokyo	Koyanagi, A (corresponding author), Univ Barcelona, Fundac St Joan de Deu, Parc Sanitari St Joan de Deu, Barcelona, Spain.	a.koyanagi@pssjd.org	Koyanagi, Ai/D-3833-2018; Haro, Josep Maria/D-1423-2011	Koyanagi, Ai/0000-0002-9565-5004; Haro, Josep Maria/0000-0002-3984-277X	Miguel Servet contract - CP13 / 00150 project; ISCIII-General Branch Evaluation and Promotion of Health Research-and the European Regional Development Fund (ERDF-FEDER)	Miguel Servet contract - CP13 / 00150 project; ISCIII-General Branch Evaluation and Promotion of Health Research-and the European Regional Development Fund (ERDF-FEDER)	Ai Koyanagi's work was supported by the Miguel Servet contract financed by the CP13 / 00150 project, integrated into the National R + D + I and funded by the ISCIII-General Branch Evaluation and Promotion of Health Research-and the European Regional Development Fund (ERDF-FEDER). These organizations had no role in the study design, collection, analysis and interpretation; in the writing of the manuscript; and in the decision to submit the paper for publication.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Andover MS, 2014, CAN J PSYCHIAT, V59, P569, DOI 10.1177/070674371405901102; Angelotta C, 2015, J NERV MENT DIS, V203, P75, DOI 10.1097/NMD.0000000000000243; BEBBINGTON P, 1995, INT J METHOD PSYCH, V5, P11; Bentley KH, 2015, CLIN PSYCHOL REV, V37, P72, DOI 10.1016/j.cpr.2015.02.006; Boyda D, 2015, PSYCHIAT RES, V226, P376, DOI 10.1016/j.psychres.2015.01.023; Bragazzi NL, 2014, PSYCHOL RES BEHAV MA, V7, P1, DOI 10.2147/PRBM.S44084; Cerutti R, 2011, J ADOLESCENCE, V34, P337, DOI 10.1016/j.adolescence.2010.04.004; Claes L, 2015, J SEX MED, V12, P168, DOI 10.1111/jsm.12711; Claes L, 2010, J ADOLESCENCE, V33, P775, DOI 10.1016/j.adolescence.2009.10.012; Clifton A, 2005, PSYCHOL ASSESSMENT, V17, P123, DOI 10.1037/1040-3590.17.2.123; Compton MT, 2005, PSYCHIAT RES, V135, P35, DOI 10.1016/j.psychres.2005.03.004; DeVylder JE, 2015, EARLY INTERV PSYCHIA, V9, P331, DOI 10.1111/eip.12161; DeVylder JE, 2014, PSYCHIAT SERV, V65, P774, DOI 10.1176/appi.ps.201300254; Dhingra K, 2015, J INTERPERS IN PRESS; First M. B., 1997, STRUCTURED CLIN INTE; Fisher HL, 2013, SCHIZOPHRENIA BULL, V39, P1045, DOI 10.1093/schbul/sbs088; Freeman D, 2011, PSYCHOL MED, V41, P923, DOI 10.1017/S0033291710001546; Glaser JP, 2010, ACTA PSYCHIAT SCAND, V121, P125, DOI 10.1111/j.1600-0447.2009.01427.x; Guerry JD, 2010, J CLIN CHILD ADOLESC, V39, P77, DOI 10.1080/15374410903401195; Hamza CA, 2015, CLIN PSYCHOL REV, V38, P13, DOI 10.1016/j.cpr.2015.02.010; Jenkins R, 2009, SOC PSYCH PSYCH EPID, V44, P899, DOI 10.1007/s00127-009-0112-7; Johns LC, 2004, BRIT J PSYCHIAT, V185, P298, DOI 10.1192/bjp.185.4.298; Jonas S, 2014, EPIDEMIOL PSYCH SCI, V23, P189, DOI 10.1017/S2045796013000292; Klonsky ED, 2011, PSYCHOL MED, V41, P1981, DOI 10.1017/S0033291710002497; Klonsky ED, 2013, J ABNORM PSYCHOL, V122, P231, DOI 10.1037/a0030278; Klonsky ED, 2003, AM J PSYCHIAT, V160, P1501, DOI 10.1176/appi.ajp.160.8.1501; MALGADY RG, 1992, J PSYCHIAT RES, V26, P59, DOI 10.1016/0022-3956(92)90016-H; Marti GMHI, 2014, CULTURA COMO TRINCHERA: LA POLITICA CULTURAL EN EL PAIS VALENCIANO (1975-2013), P1; McManus S, 2009, ADULT PSYCHIAT MORIB; Murphy J, 2012, SCHIZOPHRENIA BULL, V38, P360, DOI 10.1093/schbul/sbq092; Nock MK, 2010, ANNU REV CLIN PSYCHO, V6, P339, DOI 10.1146/annurev.clinpsy.121208.131258; Nuevo R, 2012, SCHIZOPHRENIA BULL, V38, P475, DOI 10.1093/schbul/sbq099; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Oliva F, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0239-2; Peralta V, 1999, SCHIZOPHR RES, V38, P13, DOI 10.1016/S0920-9964(99)00003-1; Rossler W, 2015, SCHIZOPHR RES, V161, P194, DOI 10.1016/j.schres.2014.11.033; Ryan J, 2015, EARLY INTER IN PRESS; Saha S, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001001; Saha S, 2011, SCHIZOPHR RES, V127, P246, DOI 10.1016/j.schres.2010.12.012; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Selby EA, 2015, CLIN PSYCHOL REV, V38, P79, DOI 10.1016/j.cpr.2015.03.003; STOCKWELL T, 1994, ADDICTION, V89, P167, DOI 10.1111/j.1360-0443.1994.tb00875.x; Tsuang MT, 2013, SCHIZOPHR RES, V150, P31, DOI 10.1016/j.schres.2013.05.004; VazquezBarquero JL, 1996, BRIT J PSYCHIAT, V168, P693, DOI 10.1192/bjp.168.6.693; Whitlock J., 2014, OXFORD HDB SUICIDE S, P133, DOI DOI 10.1093/OXFORDHB/9780195388565.013.0010; Wigman JTW, 2011, SCHIZOPHRENIA BULL, V37, P850, DOI 10.1093/schbul/sbp154; World Health Organization, 1992, SCAN SCHEDULES FOR C	48	18	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145533	10.1371/journal.pone.0145533	http://dx.doi.org/10.1371/journal.pone.0145533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26700475	Green Submitted, Green Published, gold			2022-12-27	WOS:000367092600093
J	Li, X; Kong, LJ; Li, FL; Chen, C; Xu, R; Wang, HS; Peng, SG; Zhou, M; Li, B				Li, Xin; Kong, Lingjun; Li, Fulun; Chen, Chen; Xu, Rong; Wang, Hongshen; Peng, Shiguang; Zhou, Min; Li, Bin			Association between Psoriasis and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis	PLOS ONE			English	Article							MEDIATED INFLAMMATORY DISORDERS; MONOCLONAL-ANTIBODY; COPD; PATHOGENESIS; POPULATION; COMORBIDITIES; MECHANISMS; EXPRESSION; SMOKING; IL-22	Psoriasis is considered a systemic inflammatory disorder. Previous studies have reported conflicting positive or negative correlations between psoriasis and chronic obstructive pulmonary disease. We performed a meta-analysis to determine whether there is an associated risk between psoriasis and chronic obstructive pulmonary disease. We performed a complete 30-year literature search of MEDLINE, Embase, and Cochrane Central Register databases on this topic. Four observational studies with a total of 13,418 subjects were identified. The odds ratios of chronic obstructive pulmonary disease in subjects with psoriasis/mild-to-moderate psoriasis were analyzed using the random-effects model, while the odds ratios of chronic obstructive pulmonary disease in subjects with severe psoriasis and current smoking in subjects with psoriasis were analyzed using the fixed-effect model. We found that psoriasis patients were at a greater risk of developing chronic obstructive pulmonary disease than the general population (odds ratio, 1.90; 95% confidence interval, 1.36-2.65) and that the association between of psoriasis and with chronic obstructive pulmonary disease was stronger among patients with severe psoriasis ( odds ratio, 2.15; 95% confidence interval, 1.26-3.67). Psoriasis patients should be advised to cease smoking to reduce their risk of COPD. Moreover, identification of this potential risk may enable earlier implementation of preventive measures for reduction comorbidity and mortality rates.	[Li, Xin; Li, Fulun; Xu, Rong; Zhou, Min; Li, Bin] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Dept Dermatol, Shanghai 200437, Peoples R China; [Li, Xin; Chen, Chen; Wang, Hongshen; Peng, Shiguang] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Kong, Lingjun] Shanghai Acad Tradit Chinese Med, Res Inst Tuina, Shanghai 201203, Peoples R China	Shanghai University of Traditional Chinese Medicine; Boston University	Li, B (corresponding author), Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Dept Dermatol, Shanghai 200437, Peoples R China.	18930568129@163.com		Kong, Lingjun/0000-0002-6854-4202; Li, Xin/0000-0003-2525-9679	NSFC of China [81302971, 81273764, 81473682]; Shanghai Municipal Health Bureau Project [2010Y133, 2011XY004, XYQ2013073, ZY3-CCCX-3-3033]	NSFC of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Health Bureau Project	This work was supported by NSFC of China (nos. 81302971, 81273764 and 81473682); Shanghai Municipal Health Bureau Project (nos. 2010Y133, 2011XY004, XYQ2013073 and ZY3-CCCX-3-3033).	Al-Mutairi N, 2010, J DERMATOL, V37, P146, DOI 10.1111/j.1346-8138.2009.00777.x; Armstrong AW, 2014, BRIT J DERMATOL, V170, P304, DOI 10.1111/bjd.12670; Chiang YY, 2012, J EUR ACAD DERMATOL, V26, P59, DOI 10.1111/j.1468-3083.2011.04009.x; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Dowlatshahi EA, 2013, BRIT J DERMATOL, V169, P266, DOI 10.1111/bjd.12355; Dreiher J, 2008, BRIT J DERMATOL, V159, P956, DOI 10.1111/j.1365-2133.2008.08749.x; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Eurlings IMJ, 2014, AM J PHYSIOL-LUNG C, V307, pL557, DOI 10.1152/ajplung.00116.2014; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Flisiak I, 2008, BIOMARKERS, V13, P549, DOI 10.1080/13547500802033300; Globe D, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-62; Hijnen D, 2013, J INVEST DERMATOL, V133, P973, DOI 10.1038/jid.2012.456; Huang N, 2008, DNA CELL BIOL, V27, P527, DOI 10.1089/dna.2007.0715; Huang Z, 2006, CURR MED CHEM, V13, P3253, DOI 10.2174/092986706778773040; Jin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111044; Kondo S, 2000, J CELL PHYSIOL, V182, P366, DOI 10.1002/(SICI)1097-4652(200003)182:3<366::AID-JCP7>3.0.CO;2-8; Kristensen SL, 2015, ANN RHEUM DIS, V74, P321, DOI 10.1136/annrheumdis-2014-206617; Kurd SK, 2009, J AM ACAD DERMATOL, V60, P218, DOI 10.1016/j.jaad.2008.09.022; Lapperre TS, 2006, THORAX, V61, P115, DOI 10.1136/thx.2005.040519; Liu Y, 2007, GENES IMMUN, V8, P1, DOI 10.1038/sj.gene.6364351; Ludolph-Hauser D, 1999, EXP DERMATOL, V8, P46, DOI 10.1111/j.1600-0625.1999.tb00347.x; MacNee W, 2001, NOVART FDN SYMP, V234, P169; Martin A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X625120; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Pearce DJ, 2005, J DERMATOL TREAT, V16, P319, DOI 10.1080/09546630500335977; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Robinson D, 2006, CURR MED RES OPIN, V22, P989, DOI 10.1185/030079906X104641; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Singh K, 2013, J IMMUNOL, V190, P2544, DOI 10.4049/jimmunol.1202399; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Starodubtseva N L, 2011, Genetika, V47, P1254; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tabrizi Mohammad, 2010, Inflammation & Allergy Drug Targets, V9, P229; Terricabras E, 2004, AUTOIMMUN REV, V3, P550, DOI 10.1016/j.autrev.2004.07.037; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; Wakkee M, 2011, J AM ACAD DERMATOL, V65, P1135, DOI 10.1016/j.jaad.2010.08.036; Wiczling P, 2010, J CLIN PHARMACOL, V50, P494, DOI 10.1177/0091270009349376; Williams JP, 2002, AM J MANAG CARE, V8, pS664; Williams JP, 2002, AM J MANAG CARE, V8, pS82; Wittmann M, 2013, DERMATOLOGY THER, V3, P1, DOI 10.1007/s13555-013-0023-0; Zhang L, 2013, COPD, V10, P459, DOI 10.3109/15412555.2013.770456	42	64	65	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145221	10.1371/journal.pone.0145221	http://dx.doi.org/10.1371/journal.pone.0145221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700640	Green Submitted, gold, Green Published			2022-12-27	WOS:000367092600054
J	Lin, YJ; Ho, TJ; Yeh, YC; Cheng, CF; Shiao, YT; Wang, CB; Chien, WK; Chen, JH; Liu, X; Tsang, H; Lin, TH; Liao, CC; Huang, SM; Li, JP; Lin, CW; Pang, HY; Lin, JG; Lan, YC; Liu, YH; Chen, SY; Tsai, FJ; Liang, WM				Lin, Ying-Ju; Ho, Tsung-Jung; Yeh, Yi-Chun; Cheng, Chi-Fung; Shiao, Yi-Tzone; Wang, Chang-Bi; Chien, Wen-Kuei; Chen, Jin-Hua; Liu, Xiang; Tsang, Hsinyi; Lin, Ting-Hsu; Liao, Chiu-Chu; Huang, Shao-Mei; Li, Ju-Pi; Lin, Cheng-Wen; Pang, Hao-Yu; Lin, Jaung-Geng; Lan, Yu-Ching; Liu, Yu-Huei; Chen, Shih-Yin; Tsai, Fuu-Jen; Liang, Wen-Miin			Chinese Herbal Medicine Treatment Improves the Overall Survival Rate of Individuals with Hypertension among Type 2 Diabetes Patients and Modulates In Vitro Smooth Muscle Cell Contractility	PLOS ONE			English	Article							TANSHINONE IIA SULFONATE; BLOOD-PRESSURE CONTROL; SALVIANOLIC ACID B; CARDIOVASCULAR EVENTS; DOUBLE-BLIND; BREAST-CANCER; RISK; MELLITUS; THERAPY; COMPLICATIONS	Type 2 diabetes (T2D) is a chronic, multifactorial, and metabolic disorder accounting for 90% diabetes cases worldwide. Among them, almost half of T2D have hypertension, which is responsible for cardiovascular disease, morbidity, and mortality in these patients. The Chinese herbal medicine (CHM) prescription patterns of hypertension individuals among T2D patients have yet to be characterized. This study, therefore, aimed to determine their prescription patterns and evaluate the CHM effect. A cohort of one million randomly sampled cases from the National Health Insurance Research Database (NHIRD) was used to investigate the overall survival rate of CHM users, and prescription patterns. After matching CHM and non-CHM users for age, gender and date of diagnosis of hypertension, 980 subjects for each group were selected. The CHM users were characterized with slightly longer duration time from diabetes to hypertension, and more cases for hyperlipidaemia. The cumulative survival probabilities were higher in CHM users than in non-CHM users. Among these top 12 herbs, Liu-Wei-Di-Huang-Wan, Jia-Wei-Xiao-Yao-San, Dan-Shen, and Ge-Gen were the most common herbs and inhibited in vitro smooth muscle cell contractility. Our study also provides a CHM comprehensive list that may be useful in future investigation of the safety and efficacy for individuals with hypertension among type 2 diabetes patients.	[Lin, Ying-Ju; Ho, Tsung-Jung; Li, Ju-Pi; Lin, Jaung-Geng; Chen, Shih-Yin; Tsai, Fuu-Jen] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Lin, Ying-Ju; Lin, Ting-Hsu; Liao, Chiu-Chu; Huang, Shao-Mei; Liu, Yu-Huei; Chen, Shih-Yin; Tsai, Fuu-Jen] China Med Univ Hosp, Genet Ctr, Dept Med Res, Taichung, Taiwan; [Ho, Tsung-Jung] China Med Univ, Beigang Hosp, Div Chinese Med, Peikang, Yunlin, Taiwan; [Ho, Tsung-Jung] China Med Univ, Tainan Municipal An Nan Hosp, Div Chinese Med, Tainan, Taiwan; [Yeh, Yi-Chun; Cheng, Chi-Fung; Wang, Chang-Bi; Liang, Wen-Miin] China Med Univ, Grad Inst Biostat, Sch Publ Hlth, Taichung, Taiwan; [Shiao, Yi-Tzone] China Med Univ Hosp, Ctr Heart, Taichung, Taiwan; [Chien, Wen-Kuei; Chen, Jin-Hua] Taipei Med Univ, Biostat Ctr, Coll Management, Taipei, Taiwan; [Chen, Jin-Hua] Taipei Med Univ, Sch Hlth Care Adm, Coll Management, Taipei, Taiwan; [Liu, Xiang; Tsang, Hsinyi] NIAID, NIH, Bethesda, MD 20892 USA; [Li, Ju-Pi] China Med Univ Hosp, Rheumatism Res Ctr, Taichung, Taiwan; [Lin, Cheng-Wen; Pang, Hao-Yu] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Lan, Yu-Ching] China Med Univ, Dept Hlth Risk Management, Taichung, Taiwan; [Liu, Yu-Huei] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Tsai, Fuu-Jen] Asia Univ, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Medical University; Taipei Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Tsai, FJ (corresponding author), China Med Univ, Sch Chinese Med, Taichung, Taiwan.	d0704@mail.cmuh.org.tw; wmliang.cmu@gmail.com	Lan, Yu-Ching/F-2449-2017; Liu, Yu-Huei/D-2539-2014; Li, Ju-Pi/AAS-8866-2021	Lan, Yu-Ching/0000-0003-4781-6405; Liu, Yu-Huei/0000-0002-3603-868X; Li, Ju-Pi/0000-0003-3406-4865	Ministry of Science and Technology [MOST 103-2320-B-039 -006 -MY3]; China Medical University [CMU102-PH-01]; China Medical University Hospital [DMR-104-029, DMR-104-089]; China Medical University Beigang Hospital [CMUBH R103-008, CMUBH R104-007]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); China Medical University(China Medical University); China Medical University Hospital; China Medical University Beigang Hospital(China Medical University)	This study was funded by Ministry of Science and Technology (MOST 103-2320-B-039 -006 -MY3; YJL), China Medical University (CMU102-PH-01; YJL and FJT), China Medical University Hospital (DMR-104-029; FJT; DMR-104-089; YJL), and China Medical University Beigang Hospital (CMUBH R103-008; TJH; CMUBH R104-007; TJH).	Bhadriraju K, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-43; Cai HB, 2014, EXP THER MED, V8, P1127, DOI 10.3892/etm.2014.1919; Ceylan-Isik AF, 2008, CURR DIABETES REV, V4, P320, DOI 10.2174/157339908786241142; Chang CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135417; Chao TH, 2014, J ETHNOPHARMACOL, V155, P702, DOI 10.1016/j.jep.2014.06.012; Chen FP, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-26; Chen LC, 2003, MATURITAS, V44, P55, DOI 10.1016/S0378-5122(02)00314-6; Chen MJ, 2016, INT J CANCER, V138, P594, DOI 10.1002/ijc.29813; Chen YC, 2015, THER CLIN RISK MANAG, V11, P1315, DOI 10.2147/TCRM.S91513; Chien SC, 2014, SCI WORLD J, DOI 10.1155/2014/217525; Estacio RO, 2000, DIABETES CARE, V23, pB54; Fang RC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/591391; Geneva WHO, 1999, WHONCDNCS992; Grant SJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006690.pub2; Hsieh CM, 2014, ANN RHEUM DIS, V73, P495, DOI 10.1136/annrheumdis-2014-eular.4676; Hu F, 2012, PHYTOMEDICINE, V19, P1051, DOI 10.1016/j.phymed.2012.07.007; Huang CY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/201329; Huang MA, 2015, PHARM BIOL, V53, P1058, DOI 10.3109/13880209.2014.959611; Huang TP, 2013, ALLERGY, V68, P1610, DOI 10.1111/all.12273; Hui Hongxiang, 2009, Chin Med, V4, P11, DOI 10.1186/1749-8546-4-11; Jiang BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059621; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Koo M, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0220-3; Lai JN, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/891893; LEBOVITZ HE, 1984, PEDIATR CLIN N AM, V31, P521; Lee YC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-225; Li GQ, 2013, ADV EXP MED BIOL, V771, P396; Li SY, 2003, PHARMACOL RES, V48, P127, DOI 10.1016/S1043-6618(03)00099-9; Li WL, 2004, J ETHNOPHARMACOL, V92, P1, DOI 10.1016/j.jep.2003.12.031; Lian FM, 2015, J ETHNOPHARMACOL, V164, P71, DOI 10.1016/j.jep.2015.01.048; Lian FM, 2014, J CLIN ENDOCR METAB, V99, P648, DOI 10.1210/jc.2013-3276; Lin CH, 2013, J INTERN MED, V273, P102, DOI 10.1111/joim.12000; Lin HC, 2008, COMPLEMENT THER MED, V16, P336, DOI 10.1016/j.ctim.2007.11.001; Lin K, 2014, J DIABETES COMPLICAT, V28, P234, DOI 10.1016/j.jdiacomp.2013.09.008; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Liu XA, 2010, ACTA BIOCH BIOPH SIN, V42, P496, DOI 10.1093/abbs/gmq043; Liu XA, 2010, FEBS LETT, V584, P3185, DOI 10.1016/j.febslet.2010.06.002; Loke YK, 2009, CAN MED ASSOC J, V180, P32, DOI 10.1503/cmaj.080486; Mehler PS, 2003, CIRCULATION, V107, P753, DOI 10.1161/01.CIR.0000049640.46039.52; Pan JC, 2014, J ETHNOPHARMACOL, V152, P314, DOI 10.1016/j.jep.2014.01.002; Qian Yi, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P21; Qian Yi, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P34; QICHENG F, 1980, J ETHNOPHARMACOL, V2, P57, DOI 10.1016/0378-8741(80)90031-8; Qu Y, 2010, PHYTOTHER RES, V24, P245, DOI 10.1002/ptr.2920; Rao AD, 2008, DIABETES CARE, V31, P1672, DOI 10.2337/dc08-0167; Raoufi S, 2015, PHARM BIOL, V53, P1803, DOI 10.3109/13880209.2015.1008148; Roumie CL, 2012, ANN INTERN MED, V157, P601, DOI 10.7326/0003-4819-157-9-201211060-00003; Saquib N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-434; Shera AS, 1999, DIABETES RES CLIN PR, V44, P49, DOI 10.1016/S0168-8227(99)00017-0; Singh S, 2011, THORAX, V66, P383, DOI 10.1136/thx.2010.152777; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Teng Y, 2009, MOL BIOL REP, V36, P1129, DOI 10.1007/s11033-008-9288-2; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Turner RM, 2014, BRIT J CLIN PHARMACO, V78, P258, DOI 10.1111/bcp.12306; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; van Wietmarschen HA, 2013, J ETHNOPHARMACOL, V150, P851, DOI 10.1016/j.jep.2013.09.041; Wang BR, 2014, PATIENT PREFER ADHER, V8, P671, DOI 10.2147/PPA.S61280; Wang B, 2012, J DIABETES, V4, P22, DOI 10.1111/j.1753-0407.2011.00167.x; Wang J, 2013, J THORAC DIS, V5, P169, DOI 10.3978/j.issn.2072-1439.2013.02.04; Wang J, 2013, AM J RESP CELL MOL, V48, P125, DOI 10.1165/rcmb.2012-0071OC; Wang J, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/714805; Wang SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131122; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Woo KS, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/132912; Xue YM, 2006, NAN FANG YI KE DA XU, V26, P1446; Yang TY, 2012, PHYTOTHER RES, V26, P291, DOI 10.1002/ptr.3548; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yu MC, 2014, J ETHNOPHARMACOL, V155, P435, DOI 10.1016/j.jep.2014.05.049; Zhang TT, 2014, PHYTOMEDICINE, V21, P1137, DOI 10.1016/j.phymed.2014.05.003	70	14	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145109	10.1371/journal.pone.0145109	http://dx.doi.org/10.1371/journal.pone.0145109			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699542	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600047
J	Miller, SM; Harper, CK; Bloomer, P; Hofmeyr, J; Funston, PJ				Miller, Susan M.; Harper, Cindy K.; Bloomer, Paulette; Hofmeyr, Jennifer; Funston, Paul J.			Fenced and Fragmented: Conservation Value of Managed Metapopulations	PLOS ONE			English	Article							PANTHERA-LEO POPULATIONS; SOUTH-AFRICA; LIONS; DYNAMICS; PROGRAM; RELATEDNESS; SOFTWARE; RESERVES; HISTORY	Population fragmentation is threatening biodiversity worldwide. Species that once roamed vast areas are increasingly being conserved in small, isolated areas. Modern management approaches must adapt to ensure the continued survival and conservation value of these populations. In South Africa, a managed metapopulation approach has been adopted for several large carnivore species, all protected in isolated, relatively small, reserves that are fenced. As far as possible these approaches are based on natural metapopulation structures. In this network, over the past 25 years, African lions (Panthera leo) were reintroduced into 44 fenced reserves with little attention given to maintaining genetic diversity. To examine the situation, we investigated the current genetic provenance and diversity of these lions. We found that overall genetic diversity was similar to that in a large national park, and included a mixture of four different southern African evolutionarily significant units (ESUs). This mixing of ESUs, while not ideal, provides a unique opportunity to study the impact of mixing ESUs over the long term. We propose a strategic managed metapopulation plan to ensure the maintenance of genetic diversity and improve the long-term conservation value of these lions. This managed metapopulation approach could be applied to other species under similar ecological constraints around the globe.	[Miller, Susan M.; Funston, Paul J.] Tshwane Univ Technol, Nat Conservat Dept, Pretoria, Gauteng, South Africa; [Miller, Susan M.; Harper, Cindy K.] Univ Pretoria, Fac Vet Sci, Vet Genet Lab, ZA-0110 Onderstepoort, Gauteng, South Africa; [Bloomer, Paulette] Univ Pretoria, Dept Genet, Mol Ecol & Evolut Programme, ZA-0002 Pretoria, Gauteng, South Africa; [Hofmeyr, Jennifer] South African Natl Pk, Vet Wildlife Serv, Skukuza, Mpumalanga, South Africa; [Funston, Paul J.] Panthera, Lion Program, New York, NY USA	Tshwane University of Technology; University of Pretoria; University of Pretoria	Miller, SM (corresponding author), Tshwane Univ Technol, Nat Conservat Dept, Pretoria, Gauteng, South Africa.	dangerousfrizbee@gmail.com	Bloomer, Paulette/F-5501-2010; Miller, Susan M/Q-5837-2017	Bloomer, Paulette/0000-0002-6357-0153; Miller, Susan M/0000-0002-5976-2742	Boras Zoo, Sweden; Ree Park, Denmark; Tshwane University of Technology Doctoral Scholarship	Boras Zoo, Sweden; Ree Park, Denmark; Tshwane University of Technology Doctoral Scholarship	Funding was provided, in part, by Boras Zoo, Sweden, and Ree Park, Denmark (with assistance from Frank Oberwemmer and Jesper Stagegaard). SMM was supported by a Tshwane University of Technology Doctoral Scholarship. SMM was a registered graduate student at Tshwane University of Technology and thus the study design and decision to publish were approved by members of the Department of Nature Conservation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	African Parks in Conservation, 2012, AFR PARK LAT NEWS; African Parks in Conservation, 2015, AFRICA GEOGRAPH 0728; Akcakaya H. Resit, 2006, P64; Aycrigg JL, 2014, J MAMMAL, V95, P597, DOI 10.1644/12-MAMM-A-300; Barnett R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-70; Bauer H, 2015, IUCN RED LIST THREAT, DOI [http://dx.doi.org/10.2305/IUCN.UK.2015-2.RLTS.T15951A50658092en, DOI 10.2305/IUCN.UK.2015-2.RLTS.T15951A50658092.EN]; Bauer H, 2015, P NATL ACAD SCI USA, V112, P14894, DOI 10.1073/pnas.1500664112; Bertola LD, 2012, GENETIC DIVERSITY NE, P61; Bjorklund M, 2003, CONSERV GENET, V4, P515, DOI 10.1023/A:1024737317695; Davies-Mostert Harriet T., 2009, P10, DOI 10.1002/9781444312034.ch2; DAVIESMOSTERT HT, 2015, S AFR J WILDL RES, V45, P258; Department of Environmental Affairs, 2015, BIOD MAN PLAN AFR LI; Dolrenry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088081; Driscoll CA, 2002, GENOME RES, V12, P414, DOI 10.1101/gr.185702; Dubach JM, 2013, CONSERV GENET, V14, P741, DOI 10.1007/s10592-013-0453-3; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ferreira SM, 2014, S AFR J WILDL RES, V44, P32, DOI 10.3957/056.044.0102; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Funston, 2008, MANAGEMENT CONSERVAT, P109; Gusset M, 2008, J APPL ECOL, V45, P100, DOI 10.1111/j.1365-2664.2007.01357.x; Gusset M, 2010, J NAT CONSERV, V18, P230, DOI 10.1016/j.jnc.2009.11.001; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; HARRISON S, 1991, BIOL J LINN SOC, V42, P73, DOI 10.1111/j.1095-8312.1991.tb00552.x; Hunter LTB, 2007, ORYX, V41, P196, DOI 10.1017/S003060530700172X; IUCN/SSC, 2013, GUID REINTR OTH CONS; IUCN/SSC Cat Specialist, 2006, REG LION CONS STRAT; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Levins R., 1970, SOME MATH PROBLEMS B, P77; Lindsey P, 2011, ORYX, V45, P587, DOI 10.1017/S003060531000150X; Miller SM, 2013, S AFR J WILDL RES, V43, P138, DOI 10.3957/056.043.0202; Miller SM, 2014, J HERED, V105, P762, DOI 10.1093/jhered/esu054; Miller SM, 2014, S AFR J WILDL RES, V44, P43, DOI 10.3957/056.044.0107; Mills MGL, 1997, POPULATION HABIT VIA; Nowell K, 1996, STATUS SURVEY CONSER; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Slotow R., 2009, REINTRODUCTION TOP O, P41; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Trinkel M, 2008, ANIM CONSERV, V11, P138, DOI 10.1111/j.1469-1795.2008.00163.x; Wahlberg N, 2002, OECOLOGIA, V130, P33, DOI 10.1007/s004420100775; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; WILDT DE, 1987, NATURE, V329, P328, DOI 10.1038/329328a0	47	30	31	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144605	10.1371/journal.pone.0144605	http://dx.doi.org/10.1371/journal.pone.0144605			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699333	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600026
J	Prather, RB; Shuster, SM				Prather, Robert B., Jr.; Shuster, Stephen M.			The Opportunity for Post-Copulatory Sexual Selection in the Ectoparasitic Pea Crab, Dissodactylus primitivus (Brachyura: Pinnotheridae)	PLOS ONE			English	Article							MULTIPLE PATERNITY; SPERM COMPETITION; FEMALE CHOICE; VARIANCE; FIELD	Pea crabs, Dissodactylus primitivus, inhabit multiple echinoid (heart urchin) hosts. Male and female crabs move among hosts in search for mates, and both sexes mate multiple times, creating opportunities for post-copulatory sexual selection. For such selection to occur, only a fraction of the males who succeed in mating can also succeed in siring progeny. Jossart et al. 2014 used 4 microsatellite loci to document parentage and mating frequencies of both sexes in D. primitivus. From these data we identified the mean and variance in female offspring numbers, as well as the proportions of the female population that were gravid and not bearing offspring. We next identified the proportions of the male population who had (1) mated and sired offspring, (2) mated but failed to sire offspring, and (3) failed to mate altogether. We used these results to estimate the opportunity for selection on males and females in terms of mate numbers and offspring numbers, and estimated the sex difference in the opportunity for selection (i.e., the opportunity for sexual selection) using both forms of data. We then partitioned the total variance in male fitness into pre- and post-copulatory components and identified the fraction of the total opportunity for selection occurring in each context. Our results show that the opportunity for selection on each sex was of similar magnitude (0.69-0.98), consistent with this polyandrogynous mating system. We also found that 37% of the total opportunity for sexual selection on males occurred within the context of post-copulatory sexual selection. However, the fraction of the total opportunity for selection that was due to sexual selection, estimated using both mate numbers and offspring numbers, was 9% and 23% respectively. Thus, we further reduced our estimate of the opportunity for post-copulatory sexual selection in D. primitivus to less than 10% of the total opportunity for selection (0.37 of 0.09 and 0.23 = 0.03 and 0.09). Our results provide the first estimate of the maximum possible strength of post-copulatory sexual selection in crustaceans using this approach.	[Prather, Robert B., Jr.; Shuster, Stephen M.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA	Northern Arizona University	Shuster, SM (corresponding author), No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA.	Stephen.Shuster@nau.edu						Carling MD, 2003, J MAMMAL, V84, P1237, DOI 10.1644/BRB-116; CLARK AG, 1995, GENETICS, V139, P189; Crow J. F., 1962, METHODOLOGY HUMAN GE, P53; CROW JF, 1958, AM ANTHROPOL, V60, P1; EBERHARD WG, 1991, BIOL REV, V66, P1, DOI 10.1111/j.1469-185X.1991.tb01133.x; Fisher RA, 1930, GENETICAL THEORY NAT; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Hersch EI, 2004, EVOLUTION, V58, P479, DOI 10.1111/j.0014-3820.2004.tb01671.x; Jossart Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090680; KELLOGG KA, 1995, P ROY SOC B-BIOL SCI, V260, P79, DOI 10.1098/rspb.1995.0062; KOGA T, 1993, J CRUSTACEAN BIOL, V13, P134, DOI 10.2307/1549128; Krakauer AH, 2011, J EVOLUTION BIOL, V24, P2064, DOI 10.1111/j.1420-9101.2011.02317.x; LEWIS SM, 1994, BEHAV ECOL, V5, P219; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pischedda A, 2012, P NATL ACAD SCI USA, V109, P2049, DOI 10.1073/pnas.1110841109; SHUSTER SM, 2003, MG BEH ECOL, pR7; Shuster SM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0046; Shuster Stephen M., 2007, P29; Shuster SM, 2009, P NATL ACAD SCI USA, V106, P10009, DOI 10.1073/pnas.0901132106; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; van Camp LM, 2004, MAR FRESHWATER RES, V55, P819, DOI 10.1071/MF03179; Wade MJ, 2010, HEREDITY, V105, P507, DOI 10.1038/hdy.2010.8; WADE MJ, 1979, AM NAT, V114, P742, DOI 10.1086/283520; WADE MJ, 1980, ANIM BEHAV, V28, P446, DOI 10.1016/S0003-3472(80)80052-2; Wade MJ, 2004, AM NAT, V164, pE83, DOI 10.1086/424531	25	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145681	10.1371/journal.pone.0145681	http://dx.doi.org/10.1371/journal.pone.0145681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701316	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600117
J	Williams, AJ; Wyatt, KM; Williams, CA; Logan, S; Henley, WE				Williams, Andrew James; Wyatt, Katrina M.; Williams, Craig A.; Logan, Stuart; Henley, William E.			Exploring the Potential of a School Impact on Pupil Weight Status: Exploratory Factor Analysis and Repeat Cross-Sectional Study of the National Child Measurement Programme	PLOS ONE			English	Article							OBESITY PREVENTION PROGRAMS; BODY-MASS INDEX; MULTILEVEL ANALYSIS; PHYSICAL-ACTIVITY; BUILT ENVIRONMENT; INTERVENTIONS; OVERWEIGHT; RISK; METAANALYSIS; ASSOCIATION	Schools are common sites for obesity prevention interventions. Although many theories suggest that the school context influences weight status, there has been little empirical research. The objective of this study was to explore whether features of the school context were consistently and meaningfully associated with pupil weight status (overweight or obese). Exploratory factor analysis of routinely collected data on 319 primary schools in Devon, England, was used to identify possible school-based contextual factors. Repeated cross-sectional multilevel analysis of five years (2006/07-2010/11) of data from the National Child Measurement Programme was then used to test for consistent and meaningful associations. Four school-based contextual factors were derived which ranked schools according to deprivation, location, resource and prioritisation of physical activity. None of which were meaningfully and consistently associated with pupil weight status, across the five years. The lack of consistent associations between the factors and pupil weight status suggests that the school context is not inherently obesogenic. In contrast, incorporating findings from education research indicates that schools may be equalising weight status, and obesity prevention research, policy and practice might need to address what is happening outside schools and particularly during the school holidays.	[Williams, Andrew James] Univ Edinburgh, Farr Inst Scotland & Scottish Collaborat Publ Hlt, Usher Inst Populat Hlth Sci & Informat, Edinburgh EH8 9DX, Midlothian, Scotland; [Williams, Andrew James; Wyatt, Katrina M.; Logan, Stuart; Henley, William E.] Univ Exeter, Sch Med, Inst Hlth Serv Res, Exeter EX1 2LU, Devon, England; [Williams, Andrew James; Williams, Craig A.] Univ Exeter, Childrens Hlth & Exercise Res Ctr, Sport & Hlth Sci, Exeter EX1 2LU, Devon, England	University of Edinburgh; University of Exeter; University of Exeter	Williams, AJ (corresponding author), Univ Edinburgh, Farr Inst Scotland & Scottish Collaborat Publ Hlt, Usher Inst Populat Hlth Sci & Informat, 20 West Richmond St, Edinburgh EH8 9DX, Midlothian, Scotland.	a.j.williams@ed.ac.uk	Williams, Craig Anthony/AAQ-8954-2020	Williams, Craig Anthony/0000-0002-1740-6248; Williams, Andrew James/0000-0002-2175-8836; Logan, Stuart/0000-0002-9279-261X	Medical Research Council Doctoral Training Grant [MRC DTG PCMD/GS002]; Sport and Health Sciences, University of Exeter; Farr Institute @ Scotland; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Engineering and Physical Sciences Research Council; Medical Research Council; National Institute of Health Research; National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientist Office (Scottish Government Health Directorates); MRC Grant [MR/K007017/1]; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula at the Royal Devon; Exeter NHS Foundation Trust; Medical Research Council [MR/K023209/1, MR/K007017/1] Funding Source: researchfish; MRC [MR/K007017/1, MR/K023209/1] Funding Source: UKRI	Medical Research Council Doctoral Training Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sport and Health Sciences, University of Exeter; Farr Institute @ Scotland; Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientist Office (Scottish Government Health Directorates); MRC Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula at the Royal Devon; Exeter NHS Foundation Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project began as part of AJW's doctoral studies which were funded by a Medical Research Council Doctoral Training Grant (MRC DTG PCMD/GS002) and Sport and Health Sciences, University of Exeter. AJW is now supported by the Farr Institute @ Scotland, which is supported by a 10-funder consortium: Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the Medical Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientist Office (Scottish Government Health Directorates), (MRC Grant No: MR/K007017/1). SL, KMW, and WEH were also partially supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula at the Royal Devon and Exeter NHS Foundation Trust. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KL, 2007, AM SOCIOL REV, V72, P167, DOI 10.1177/000312240707200202; Anderson PM, 2011, J HEALTH ECON, V30, P977, DOI 10.1016/j.jhealeco.2011.06.002; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bonell C., 2013, PUBLIC HLTH RES, V1, P1, DOI [10.3310/phr01010, DOI 10.3310/PHR01010]; Borman GD, 2006, EDUC EVAL POLICY AN, V28, P25, DOI 10.3102/01623737028001025; Brown T, 2009, OBES REV, V10, P110, DOI 10.1111/j.1467-789X.2008.00515.x; Burkam DT, 2004, SOCIOL EDUC, V77, P1, DOI 10.1177/003804070407700101; Butland B, 2007, FORESIGHT TACKLING O; Chen TA, 2015, PEDIAT OBES, DOI [10.1111/ijpo.12025, DOI 10.1111/IJP0.12025]; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Clarke J, 2013, OBES REV, V14, P975, DOI 10.1111/obr.12058; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Conrad D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000463; Department for Communities and Local Government, 2009, LOC IND CHILD WELL B; Department for Communities and Local Government, 2011, ENGLISH INDICES DEPR; Department of Health, 2009, NHS INF CTR VAL PROC; Department of Health, 2007, LEG CHANG NAT CHILD; Department of Health and Department for Education and Skills (n.d), NAT HLTH SCH PROGR G; Downey DB, 2004, AM SOCIOL REV, V69, P613, DOI 10.1177/000312240406900501; Durand CP, 2011, OBES REV, V12, pe173, DOI 10.1111/j.1467-789X.2010.00826.x; Economos CD, 2013, PREV MED, V57, P322, DOI 10.1016/j.ypmed.2013.06.001; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gershenson S, 2013, AM EDUC RES J, V50, P1219, DOI 10.3102/0002831213502516; GOLDSTEIN H, 1995, J ROY STAT SOC A STA, V158, P175, DOI 10.2307/2983411; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Health and Social Care Information Centre, 2013, NATIONAL CHILD MEASU; Johnson BA, 2012, INT J OBESITY, V36, P901, DOI 10.1038/ijo.2012.23; Khambalia AZ, 2012, OBES REV, V13, P214, DOI 10.1111/j.1467-789X.2011.00947.x; Kropski JA, 2008, OBESITY, V16, P1009, DOI 10.1038/oby.2008.29; Lhachimi SK, 2013, OBES REV, V14, P523, DOI 10.1111/obr.12029; Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Miller DP, 2011, SOC SCI MED, V72, P677, DOI 10.1016/j.socscimed.2010.12.003; Miyazaki Y, 2015, SOC SCI MED, V128, P57, DOI 10.1016/j.socscimed.2014.12.032; Moreno JP, 2015, OBESITY, V23, P422, DOI 10.1002/oby.20977; National Obesity Observatory, 2010, NAT CHILD MEAS PROGR; O'Malley PM, 2007, AM J PREV MED, V33, pS187, DOI 10.1016/j.amepre.2007.07.001; Office for National Statistics, 2014, SUP OUTP AR SOAS; Pallan MJ, 2014, ARCH DIS CHILD, V99, P135, DOI 10.1136/archdischild-2013-303987; Procter KL, 2008, SOC SCI MED, V67, P341, DOI 10.1016/j.socscimed.2008.02.029; R Core Team, 2013, R A LANGUAGE AND ENV; Richmond TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083254; School Food Plan, 2014, THE PLAN OFST; Sellstrom E, 2006, J EPIDEMIOL COMMUN H, V60, P149, DOI 10.1136/jech.2005.036707; Sharma M, 2007, OBES REV, V8, P155, DOI 10.1111/j.1467-789X.2006.00268.x; Sharma M, 2006, OBES REV, V7, P261, DOI 10.1111/j.1467-789X.2006.00227.x; South East England Public Health Observatory, 2005, CHOOS HLTH S E OB; South West Healthy Schools Plus, 2009, HDB FOR SCH; StataCorp, 2021, STATA STAT SOFTWARE; Statistical Consulting Group, 2014, STAT FAQ PERF FACT A; Swinburn B, 2002, Obes Rev, V3, P289; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; The NHS Information Centre, 2011, NAT CHILD MEAS PROGR; The NHS Information Centre, 2009, NAT CHILD MEAS PROGR; The NHS Information Centre, 2008, NAT CHILD MEAS PROGR; The NHS Information Centre, 2010, NAT CHILD MEAS PROGR; Townsend N, 2012, INT J OBESITY, V36, P45, DOI 10.1038/ijo.2011.191; von Hippel PT, 2007, AM J PUBLIC HEALTH, V97, P696, DOI 10.2105/AJPH.2005.080754; West P, 2004, RES PAP EDUC, V19, P261, DOI DOI 10.1080/02671522.2004.10058645; Williams AJ, 2013, DETERMINATION SCH BA; Williams AJ, 2014, PREV MED, V64, P103, DOI 10.1016/j.ypmed.2014.04.003; Williams AJ, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-101; Williams AJ, 2012, HEALTH PLACE, V18, P504, DOI 10.1016/j.healthplace.2012.02.004; World Health Organization, 2013, SCH YOUTH HLTH WHAT; Zenzen W, 2009, J PEDIATR HEALTH CAR, V23, P242, DOI 10.1016/j.pedhc.2008.04.008	68	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145128	10.1371/journal.pone.0145128	http://dx.doi.org/10.1371/journal.pone.0145128			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26700027	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092600050
J	Conte, A; Candeloro, L; Ippoliti, C; Monaco, F; De Massis, F; Bruno, R; Di Sabatino, D; Danzetta, ML; Benjelloun, A; Belkadi, B; El Harrak, M; Declich, S; Rizzo, C; Hammami, S; Ben Hassine, T; Calistri, P; Savini, G				Conte, Annamaria; Candeloro, Luca; Ippoliti, Carla; Monaco, Federica; De Massis, Fabrizio; Bruno, Rossana; Di Sabatino, Daria; Luisa Danzetta, Maria; Benjelloun, Abdennasser; Belkadi, Bouchra; El Harrak, Mehdi; Declich, Silvia; Rizzo, Caterina; Hammami, Salah; Ben Hassine, Thameur; Calistri, Paolo; Savini, Giovanni			Spatio-Temporal Identification of Areas Suitable for West Nile Disease in the Mediterranean Basin and Central Europe	PLOS ONE			English	Article							NEW-YORK; EXPERIMENTAL-INFECTION; ARBOVIRUS ACTIVITY; VECTOR COMPETENCE; VIRUS-INFECTION; FEVER; EPIDEMIOLOGY; HORSES; SURVEILLANCE; OUTBREAK	West Nile virus (WNV) is a mosquito-transmitted Flavivirus belonging to the Japanese encephalitis antigenic complex of the Flaviviridae family. Its spread in the Mediterranean basin and the Balkans poses a significant risk to human health and forces public health officials to constantly monitor the virus transmission to ensure prompt application of preventive measures. In this context, predictive tools indicating the areas and periods at major risk of WNV transmission are of paramount importance. Spatial analysis approaches, which use environmental and climatic variables to find suitable habitats for WNV spread, can enhance predictive techniques. Using the Mahalanobis Distance statistic, areas ecologically most suitable for sustaining WNV transmission were identified in the Mediterranean basin and Central Europe. About 270 human and equine clinical cases notified in Italy, Greece, Portugal, Morocco, and Tunisia, between 2008 and 2012, have been considered. The environmental variables included in the model were altitude, slope, night time Land Surface Temperature, Normalized Difference Vegetation Index, Enhanced Vegetation Index, and daily temperature range. Seasonality of mosquito population has been modelled and included in the analyses to produce monthly maps of suitable areas for West Nile Disease. Between May and July, the most suitable areas are located in Tunisia, Libya, Egypt, and North Cyprus. Summer/Autumn months, particularly between August and October, characterize the suitability in Italy, France, Spain, the Balkan countries, Morocco, North Tunisia, the Mediterranean coast of Africa, and the Middle East. The persistence of suitable conditions in December is confined to the coastal areas of Morocco, Tunisia, Libya, Egypt, and Israel.	[Conte, Annamaria; Candeloro, Luca; Ippoliti, Carla; Monaco, Federica; De Massis, Fabrizio; Bruno, Rossana; Di Sabatino, Daria; Luisa Danzetta, Maria; Calistri, Paolo; Savini, Giovanni] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Teramo, Italy; [Benjelloun, Abdennasser; El Harrak, Mehdi] Soc Prod Biol & Pharmaceut Vet Biopharma, Rabat, Morocco; [Benjelloun, Abdennasser; Belkadi, Bouchra] Univ Mohammed 5, Fac Sci, Lab Microbiol & Mol Biol, Rabat, Morocco; [Declich, Silvia; Rizzo, Caterina] Ist Super Sanita, Ctr Nazl Epidemiol Sorveglianza & Promoz Salute, Reparto Epidemiol Malattie Infett, I-00161 Rome, Italy; [Hammami, Salah; Ben Hassine, Thameur] Ecole Natl Med Vet Sidi Thabet ENMV, Sidi Thabet, Tunisia	IZS Dell'abruzzo E Del Molise Giuseppe Caporale; Mohammed V University in Rabat; Istituto Superiore di Sanita (ISS)	Conte, A (corresponding author), Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Teramo, Italy.	a.conte@izs.it	Calistri, Paolo/E-4157-2015; Savini, Giovanni/D-8416-2016; belkadi, bouchra/GWV-2208-2022; HAMMAMI, Salah/AAY-9587-2020; Monaco, Federica/G-9282-2016; Di Sabatino, Daria/I-2868-2016; De Massis, Fabrizio/P-9099-2016; Rizzo, Caterina/H-4092-2012; Danzetta, Maria Luisa/I-8886-2016; Conte, Annamaria/H-5869-2016; Ippoliti, Carla/AAD-8008-2019; Savini, Giovanni/AAT-7897-2020; De Massis, Fabrizio/ABG-8949-2021; Danzetta, Maria Luisa/ABE-1908-2020; Candeloro, Luca/ABA-6009-2021; Ippoliti, Carla/N-1823-2017; Monaco, Federica/ABC-9526-2021	Calistri, Paolo/0000-0001-6004-9373; Savini, Giovanni/0000-0001-7933-7367; belkadi, bouchra/0000-0002-1709-3042; HAMMAMI, Salah/0000-0002-5646-6083; Monaco, Federica/0000-0002-7827-2642; Di Sabatino, Daria/0000-0003-0348-3709; De Massis, Fabrizio/0000-0001-9811-699X; Rizzo, Caterina/0000-0002-5583-7508; Danzetta, Maria Luisa/0000-0002-2128-0780; Conte, Annamaria/0000-0001-6975-2698; Ippoliti, Carla/0000-0001-9030-7329; Savini, Giovanni/0000-0001-7933-7367; De Massis, Fabrizio/0000-0001-9811-699X; Danzetta, Maria Luisa/0000-0002-2128-0780; Candeloro, Luca/0000-0001-8475-3787; Ippoliti, Carla/0000-0001-9030-7329; Monaco, Federica/0000-0002-7827-2642; Declich, Silvia/0000-0002-5916-3889; Bruno, Rossana/0000-0002-6990-517X	Ministry of Agriculture; Societe de Produits Biologiques et Pharmaceutiques veterinaires (Biopharma)	Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Societe de Produits Biologiques et Pharmaceutiques veterinaires (Biopharma)	The authors received no specific funding for this work. Abdennasser Benjelloun performed laboratory tests at the laboratories of Societe de Produits Biologiques et Pharmaceutiques veterinaires (Biopharma), during his period of PhD. Mehdi El Harrak is employed by Societe de Produits Biologiques et Pharmaceutiques veterinaires (Biopharma), which is a semi-public company financed in large part by Ministry of Agriculture. Societe de Produits Biologiques et Pharmaceutiques veterinaires (Biopharma) provided support in the form of a salary for author MEH and for research materials. Societe de Produits Biologiques et Pharmaceutiques veterinaires (Biopharma) did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of these authors is articulated in the 'author contributions section.	Abdelhaq A. T., 1996, Bulletin - Office International des Epizooties, V108, P867; Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; Anis E, 2014, J INFECTION, V68, P170, DOI 10.1016/j.jinf.2013.10.009; Tran A, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-26; Becking LE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075996, 10.1371/journal.pone.0079276]; Ben Hassine T, 2017, TRANSBOUND EMERG DIS, V64, P449, DOI 10.1111/tbed.12384; Brownstein JS, 2004, EMERG INFECT DIS, V10, P1129, DOI 10.3201/eid1006.030457; Bunning ML, 2001, ANN NY ACAD SCI, V951, P338; Bunning ML, 2002, EMERG INFECT DIS, V8, P380; Calistri P, 2013, PREV VET MED, V110, P549, DOI 10.1016/j.prevetmed.2013.02.011; Calistri Paolo, 2010, Open Virol J, V4, P29, DOI 10.2174/1874357901004020029; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; Cantile C, 2000, EQUINE VET J, V32, P31, DOI 10.2746/042516400777612080; Centers for Disease Control and Prevention (CDC), 2013, CLIN EV DIS; Chevalier V, 2014, INT J ENV RES PUB HE, V11, P67, DOI 10.3390/ijerph110100067; Childs JE, 2009, MT SINAI J MED, V76, P421, DOI 10.1002/msj.20133; Cito F, 2013, TRANSBOUND EMERG DIS, V60, P40, DOI 10.1111/tbed.12124; CORNEL AJ, 1993, J MED ENTOMOL, V30, P449, DOI 10.1093/jmedent/30.2.449; Di Sabatino D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/907852; Dohm DJ, 2001, J MED ENTOMOL, V38, P462, DOI 10.1603/0022-2585-38.3.462; ECDC, 2010, EUR CTR DIS PREV CON; Ergunay K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003028; European Center for Disease Prevention and Control ( ECDC), 2014, HIST DAT; FILIPE AR, 1990, ACTA VIROL, V34, P582; Garcia-Bocanegra I, 2012, TRANSBOUND EMERG DIS, V59, P448, DOI 10.1111/j.1865-1682.2011.01298.x; Garcia-Bocanegra I, 2011, EMERG INFECT DIS, V17, P2397, DOI 10.3201/eid1712.110651; Giese C., W NILE VIRUS CIRCULA; Giladi M, 2001, EMERG INFECT DIS, V7, P659; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Hahn MB, 2015, AM J TROP MED HYG, V92, P1013, DOI 10.4269/ajtmh.14-0737; HANNOUN C, 1964, CR HEBD ACAD SCI, V259, P4170; Hannoun C, 1969, EPIDEMIOLOGY W NILE, P379; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; JOUBERT L, 1970, ANN I PASTEUR PARIS, V118, P239; Jupp PG, 2001, ANN NY ACAD SCI, V951, P143, DOI 10.1111/j.1749-6632.2001.tb02692.x; Kalaycioglu H, 2012, EUROSURVEILLANCE, V17, P12; Karabatsos N., 1985, INT CATALOGUE ARBOVI; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; Komar N, 2000, REV SCI TECH OIE, V19, P166, DOI 10.20506/rst.19.1.1201; Kulasekera VL, 2001, EMERG INFECT DIS, V7, P722, DOI 10.3201/eid0704.010421; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Laperriere V, 2011, PREV VET MED, V98, P99, DOI 10.1016/j.prevetmed.2010.10.013; LeGuenno B, 1996, LANCET, V348, P1315, DOI 10.1016/S0140-6736(05)65799-6; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Malkinson M, 2002, EMERG INFECT DIS, V8, P392, DOI 10.3201/eid0804.010217; Manenti C, 2003, MIGRAZIONE UCCELLI; MARBERG K, 1956, AM J HYG, V64, P259, DOI 10.1093/oxfordjournals.aje.a119838; Marcantonio M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121158; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Murgue B, 2001, EMERG INFECT DIS, V7, P692; Murgue B, 2001, ANN NY ACAD SCI, V951, P117; Murgue B, 2002, CURR TOP MICROBIOL, V267, P195; Ocal M, 2013, MIKROBIYOL BUL, V47, P164; OIE, WORLD AN HLTH INF DA; Ozdenerol E, 2013, INT J ENV RES PUB HE, V10, P5399, DOI 10.3390/ijerph10115399; Ozkul A, 2013, INT J INFECT DIS, V17, pE546, DOI 10.1016/j.ijid.2013.02.005; Papa A, 2010, EUROSURVEILLANCE, P15; Paz S, 2013, INT J ENV RES PUB HE, V10, P3543, DOI 10.3390/ijerph10083543; Paz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056398; Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118; Platonov AE, 2014, INT J ENV RES PUB HE, V11, P1211, DOI 10.3390/ijerph110201211; Popovici F, 2008, Euro Surveill, V13; REEVES W. C., 1948, MOSQUITO NEWS, V8, P61; Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2; Richards SL, 2007, VECTOR-BORNE ZOONOT, V7, P629, DOI 10.1089/vbz.2007.0101; Rizzo C, 2012, EUROSURVEILLANCE, V17, P7; Rizzo C, 2009, EUROSURVEILLANCE, P14; ROLLIN PE, 1982, MED MALADIES INFECT, V12, P77, DOI 10.1016/S0399-077X(82)80052-8; Rubel F, 2008, PREV VET MED, V85, P166, DOI 10.1016/j.prevetmed.2008.01.006; Sambri V, 2013, CLIN MICROBIOL INFEC, V19, P699, DOI 10.1111/1469-0691.12211; Schuster G, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-8; Shaman J, 2005, J MED ENTOMOL, V42, P134, DOI 10.1603/0022-2585(2005)042[0134:DAAETO]2.0.CO;2; Sirbu A, 2011, EUROSURVEILLANCE, V16, P2; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; Soliman Atef, 2010, J Infect Public Health, V3, P54, DOI 10.1016/j.jiph.2009.11.002; Soverow JE, 2009, ENVIRON HEALTH PERSP, V117, P1049, DOI 10.1289/ehp.0800487; Sugumaran R, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-43; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; TAYLOR RM, 1956, AM J TROP MED HYG, V5, P579, DOI 10.4269/ajtmh.1956.5.579; Triki H, 2001, Med Trop (Mars), V61, P487; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Valiakos G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096935; Valiakos George, 2012, Virol J, V9, P266, DOI 10.1186/1743-422X-9-266; Ward MP, 2009, PREV VET MED, V88, P205, DOI 10.1016/j.prevetmed.2008.10.003; Ward MP, 2005, VECTOR-BORNE ZOONOT, V5, P181, DOI 10.1089/vbz.2005.5.181	86	38	38	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146024	10.1371/journal.pone.0146024	http://dx.doi.org/10.1371/journal.pone.0146024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717483	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500117
J	Wang, S; Song, JY; Yang, YD; Zhang, YN; Wang, HJ; Ma, J				Wang, Shuo; Song, Jieyun; Yang, Yide; Zhang, Yining; Wang, Haijun; Ma, Jun			HIF3A DNA Methylation Is Associated with Childhood Obesity and ALT	PLOS ONE			English	Article							BASE-SPECIFIC CLEAVAGE; WIDE ASSOCIATION; GENE; METAANALYSIS; VARIANTS; INTRON; HIF-1	Gene polymorphisms associated so far with body mass index (BMI) can explain only 1.18-1.45% of observed variation in BMI. Recent studies suggest that epigenetic modifications, especially DNA methylation, could contribute to explain part of the missing heritability, and two epigenetic genome-wide analysis studies (EWAS) have reported that Hypoxia Inducible Factor 3 Alpha Subunit (HIF3A) methylation was associated with BMI or BMI change. We therefore assessed whether the HIF3A methylation is associated with obesity and other obesity-related phenotypes in Chinese children. The subjects included 110 severe obese cases aged 7-17y and 110 normal-weight controls matched by age and gender for measurement of blood DNA methylation levels at the HIF3A gene locus using the Sequenom's MassARRAY system. We observed significantly higher methylation levels in obese children than in controls at positions 46801642 and 46801699 in HIF3A gene (P<0.05), and found positive associations between methylation and alanine aminotransferase (ALT) levels adjusted by gender, age and BMI at the position 46801699 (r = 0.226, P = 0.007). These results suggest that HIF3A DNA methylation is associated with childhood obesity, and has a BMI-independent association with ALT. The results provide evidence for identifying epigenetic factors of elivated ALT and may be useful for risk assessment and personalized medicine of liver diseases such as non-alcoholic fatty liver disease (NAFLD).	[Wang, Shuo; Song, Jieyun; Yang, Yide; Zhang, Yining; Wang, Haijun; Ma, Jun] Peking Univ, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing 100871, Peoples R China	Peking University	Wang, HJ (corresponding author), Peking Univ, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing 100871, Peoples R China.	whjun1@bjmu.edu.cn; majunt@bjmu.edu.cn	Wang, Haijun/AAD-1302-2021	Wang, Haijun/0000-0003-0849-2903; Wang, Shuo/0000-0002-3146-5818; Yang, Yide/0000-0003-3297-1306	National Natural Science Foundation of China [81172683]; Major State Basic Research and Development Program of China (973 Program) [2012CB517501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research and Development Program of China (973 Program)(National Basic Research Program of China)	The study was supported by Grants from National Natural Science Foundation of China (81172683, HW, http://www.nsfc.gov.cn/) and the Major State Basic Research and Development Program of China (973 Program) (2012CB517501, JM, http://www.973.gov.cn/Default_3.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almen MS, 2014, GENE, V548, P61, DOI 10.1016/j.gene.2014.07.009; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Claude Bouckard, 2010, GENES AND OBESITY, P197; Demerath EW, 2015, HUM MOL GENET, V24, P4464, DOI 10.1093/hmg/ddv161; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Falck-Ytter Y, 2001, SEMIN LIVER DIS, V21, P17, DOI 10.1055/s-2001-12926; Gelfman S, 2013, GENOME RES, V23, P789, DOI 10.1101/gr.143503.112; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Guay SP, 2014, EPIGENETICS-US, V9, P718, DOI 10.4161/epi.27981; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hatanaka M, 2009, BIOL PHARM BULL, V32, P1166, DOI 10.1248/bpb.32.1166; He J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-472; Heidbreder M, 2007, BIOCHEM BIOPH RES CO, V352, P437, DOI 10.1016/j.bbrc.2006.11.027; Heikkila M, 2011, CELL MOL LIFE SCI, V68, P3885, DOI 10.1007/s00018-011-0679-5; Huang RC, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-21; Huang T, 2015, DIABETES, V64, P3146, DOI 10.2337/db15-0264; Lin QC, 2015, SLEEP BREATH, V19, P273, DOI 10.1007/s11325-014-1008-7; Liu ZT, 2014, INT J MED SCI, V11, P925, DOI 10.7150/ijms.8951; Meng XR, 2014, PEDIATR RES, V76, P310, DOI 10.1038/pr.2014.88; Pasanen A, 2010, INT J BIOCHEM CELL B, V42, P1189, DOI 10.1016/j.biocel.2010.04.008; Rigal M, 2012, EMBO J, V31, P2981, DOI 10.1038/emboj.2012.141; Sang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088013; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tamaki Y, 2013, J GASTROENTEROL, V48, P491, DOI 10.1007/s00535-012-0651-7; van den Boom Dirk, 2009, V507, P207, DOI 10.1007/978-1-59745-522-0_16; Wang D, 2010, OBESITY, V18, P573, DOI 10.1038/oby.2009.268; Wang HJ, 2008, BIOMED ENVIRON SCI, V21, P528, DOI 10.1016/S0895-3988(09)60013-1; Wang XL, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-87; Wen WQ, 2014, HUM MOL GENET, V23, P5492, DOI 10.1093/hmg/ddu248; Xia QH, 2013, ANN NY ACAD SCI, V1281, P178, DOI 10.1111/nyas.12020; Xu XJ, 2013, EPIGENETICS-US, V8, P522, DOI 10.4161/epi.24506; Zhao J, 2013, INT J OBESITY, V37, P140, DOI 10.1038/ijo.2012.8	36	35	35	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145944	10.1371/journal.pone.0145944	http://dx.doi.org/10.1371/journal.pone.0145944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717317	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500100
J	Corleto, JA; Bravo-Hernandez, M; Kamizato, K; Kakinohana, O; Santucci, C; Navarro, MR; Platoshyn, O; Cizkova, D; Lukacova, N; Taylor, J; Marsala, M				Corleto, Jose A.; Bravo-Hernandez, Mariana; Kamizato, Kota; Kakinohana, Osamu; Santucci, Camila; Navarro, Michael R.; Platoshyn, Oleksandr; Cizkova, Dasa; Lukacova, Nadezda; Taylor, Julian; Marsala, Martin			Thoracic 9 Spinal Transection-Induced Model of Muscle Spasticity in the Rat: A Systematic Electrophysiological and Histopathological Characterization	PLOS ONE			English	Article							STRETCH REFLEX ACTIVITY; LEVEL NEUROPATHIC PAIN; CORD-INJURY; NEURONAL HYPEREXCITABILITY; INTRATHECAL BACLOFEN; PASSIVE EXERCISE; AMPA RECEPTOR; ACTIVATION; HYPERREFLEXIA; TIZANIDINE	The development of spinal hyper-reflexia as part of the spasticity syndrome represents one of the major complications associated with chronic spinal traumatic injury (SCI). The primary mechanism leading to progressive appearance of muscle spasticity is multimodal and may include loss of descending inhibitory tone, alteration of segmental interneuron-mediated inhibition and/or increased reflex activity to sensory input. Here, we characterized a chronic thoracic (Th 9) complete transection model of muscle spasticity in Sprague-Dawley (SD) rats. Isoflurane-anesthetized rats received a Th9 laminectomy and the spinal cord was transected using a scalpel blade. After the transection the presence of muscle spasticity quantified as stretch and cutaneous hyper-reflexia was identified and quantified as time-dependent changes in: i) ankle-rotation-evoked peripheral muscle resistance (PMR) and corresponding electromyography (EMG) activity, ii) Hoffmann reflex, and iii) EMG responses in gastrocnemius muscle after paw tactile stimulation for up to 8 months after injury. To validate the clinical relevance of this model, the treatment potency after systemic treatment with the clinically established anti-spastic agents baclofen (GABA(B) receptor agonist), tizanidine (alpha(2)-adrenergic agonist) and NGX424 (AMPA receptor antagonist) was also tested. During the first 3 months post spinal transection, a progressive increase in ankle rotation-evoked muscle resistance, Hoffmann reflex amplitude and increased EMG responses to peripherally applied tactile stimuli were consistently measured. These changes, indicative of the spasticity syndrome, then remained relatively stable for up to 8 months post injury. Systemic treatment with baclofen, tizanidine and NGX424 led to a significant but transient suppression of spinal hyper-reflexia. These data demonstrate that a chronic Th9 spinal transection model in adult SD rat represents a reliable experimental platform to be used in studying the pathophysiology of chronic spinal injury-induced spasticity. In addition a consistent anti-spastic effect measured after treatment with clinically effective anti-spastic agents indicate that this model can effectively be used in screening new anti-spasticity compounds or procedures aimed at modulating chronic spinal trauma-associated muscle spasticity.	[Corleto, Jose A.; Bravo-Hernandez, Mariana; Kamizato, Kota; Kakinohana, Osamu; Santucci, Camila; Navarro, Michael R.; Platoshyn, Oleksandr; Marsala, Martin] Univ Calif San Diego, Dept Anesthesiol, Neuroregenerat Lab, La Jolla, CA 92093 USA; [Corleto, Jose A.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Bravo-Hernandez, Mariana] Ctr Invest & Estudios Avanzados Cinvestav Sede Su, Dept Pharmacobiol, Mexico City, DF, Mexico; [Taylor, Julian] Hosp Nacl Paraplejicos, SESCAM, Toledo, Spain; [Cizkova, Dasa; Lukacova, Nadezda; Marsala, Martin] Slovak Acad Sci, Inst Neurobiol, Kosice 04001, Slovakia	University of California System; University of California San Diego; University of California System; University of California San Diego; Hospital Nacional de Paraplejicos; Slovak Academy of Sciences	Marsala, M (corresponding author), Univ Calif San Diego, Dept Anesthesiol, Neuroregenerat Lab, La Jolla, CA 92093 USA.	mmarsala@ucsd.edu	Lukáčová, Nadežda/F-5090-2018; Taylor, Julian/AAC-2802-2021; Cizkova, Dasa/AAF-8976-2019	Lukáčová, Nadežda/0000-0002-8834-6852; Taylor, Julian/0000-0003-2553-2348; cizkova, dasa/0000-0002-2504-3993; Bravo-Hernandez, Mariana/0000-0001-8762-0357	National Institute of Health [NS 40386, NS 51644]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051644, R01NS040386] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Health, grant # NS 40386 and NS 51644 to MM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azouvi P, 1996, ARCH PHYS MED REHAB, V77, P35, DOI 10.1016/S0003-9993(96)90217-8; Bennett DJ, 1999, J NEUROTRAUM, V16, P69, DOI 10.1089/neu.1999.16.69; Bose P, 2002, J NEUROTRAUM, V19, P1231, DOI 10.1089/08977150260338029; Bravo-Esteban E, 2013, NEUROREHABILITATION, V33, P531, DOI 10.3233/NRE-131000; Bravo-Esteban E, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-23; BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; Detloff MR, 2008, EXP NEUROL, V212, P337, DOI 10.1016/j.expneurol.2008.04.009; Feldmann RG, 1980, SPASTICITY DISORDERE, P485; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fuchigami T, 2011, NEUROSCIENCE, V194, P160, DOI 10.1016/j.neuroscience.2011.08.022; Fujimoto Y, 2006, EUR SPINE J, V15, P223, DOI 10.1007/s00586-005-0933-3; Garrison MK, 2011, EXP NEUROL, V227, P104, DOI 10.1016/j.expneurol.2010.09.019; Gomez-Soriano J, 2015, FRONTIER HU IN PRESS; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Gordon GRJ, 2005, NAT NEUROSCI, V8, P1078, DOI 10.1038/nn1498; Gwak YS, 2009, NEUROSCIENCE, V161, P895, DOI 10.1016/j.neuroscience.2009.03.055; Hains BC, 2003, J NEUROSCI, V23, P8881; Hefferan MP, 2007, J NEUROSCI, V27, P11179, DOI 10.1523/JNEUROSCI.0989-07.2007; Hefferan MP, 2006, NEUROSCI LETT, V403, P195, DOI 10.1016/j.neulet.2006.04.048; Ikeda H, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-43; Kakinohana O, 2006, NEUROSCIENCE, V141, P1569, DOI 10.1016/j.neuroscience.2006.04.083; Kakinohana O, 2012, EXP NEUROL, V237, P26, DOI 10.1016/j.expneurol.2012.06.004; Kakinohana O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030561; Kamen L, 2008, CURR MED RES OPIN, V24, P425, DOI [10.1185/030079908X261113, 10.1185/030079908X261113 ]; Kamizato K, 2014, SOC NEUR ABSTR, V422; Kapitza S, 2012, EXP NEUROL, V236, P179, DOI 10.1016/j.expneurol.2012.04.023; Leem JW, 2010, EXP NEUROL, V224, P321, DOI 10.1016/j.expneurol.2010.02.012; Li Y, 2004, J NEUROPHYSIOL, V92, P2694, DOI 10.1152/jn.00164.2004; Lichtman A H, 1990, NIDA Res Monogr, V105, P422; M'Dahoma S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102027; Marsala M, 2005, J NEUROTRAUM, V22, P1348, DOI 10.1089/neu.2005.22.1348; Meisner JG, 2010, J NEUROTRAUM, V27, P729, DOI 10.1089/neu.2009.1166; Mirbagheri MM, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-29; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; NEWMAN PM, 1982, EUR J CLIN PHARMACOL, V23, P31, DOI 10.1007/BF01061374; Oshiro M, 2010, BRIT J PHARMACOL, V161, P976, DOI 10.1111/j.1476-5381.2010.00954.x; PENN RD, 1989, NEW ENGL J MED, V320, P1517, DOI 10.1056/NEJM198906083202303; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Reese NB, 2006, SPINAL CORD, V44, P28, DOI 10.1038/sj.sc.3101810; Schindler-Ivens S, 2000, EXP BRAIN RES, V133, P233, DOI 10.1007/s002210000377; Skalnikova HK, 2013, J PROTEOMICS, V91, P41, DOI 10.1016/j.jprot.2013.06.028; Skold C, 1999, ARCH PHYS MED REHAB, V80, P1548, DOI 10.1016/S0003-9993(99)90329-5; Taylor J, 1999, EUR J NEUROSCI, V11, P363, DOI 10.1046/j.1460-9568.1999.00468.x; Taylor JS, 1997, J NEUROSCI, V17, P5004; Teixeira-Salmela LF, 1999, ARCH PHYS MED REHAB, V80, P1211, DOI 10.1016/S0003-9993(99)90018-7; Thompson FJ, 1998, J NEUROTRAUM, V15, P495, DOI 10.1089/neu.1998.15.495; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; van Gorp S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt209; Watson C, 2009, SPINAL CORD CHRISTOP, P408; Weng HR, 2003, PAIN, V103, P131, DOI 10.1016/S0304-3959(02)00445-1; Xia MS, 2013, J MOL NEUROSCI, V51, P792, DOI 10.1007/s12031-013-0067-8; Yang L, 2004, J NEUROSCI, V24, P10846, DOI 10.1523/JNEUROSCI.2496-04.2004; Yates C, 2011, PROG BRAIN RES, V188, P167, DOI 10.1016/B978-0-444-53825-3.00016-4; Yates C, 2008, SPINAL CORD, V46, P798, DOI 10.1038/sc.2008.49; Yu D, 2013, P NATL ACAD SCI USA, V110, pE746, DOI 10.1073/pnas.1300083110	56	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144642	10.1371/journal.pone.0144642	http://dx.doi.org/10.1371/journal.pone.0144642			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713446	Green Submitted, Green Published, gold			2022-12-27	WOS:000367481900013
J	Lee, YS; An, J; Kim, B; Park, H; Kim, J; Chang, IS				Lee, Yoo Seok; An, Junyeong; Kim, Bongkyu; Park, HyunJun; Kim, Jisu; Chang, In Seop			Increased Power in Sediment Microbial Fuel Cell: Facilitated Mass Transfer via a Water-Layer Anode Embedded in Sediment	PLOS ONE			English	Article							ELECTRICITY-GENERATION; HARVESTING ENERGY; MARINE-SEDIMENTS; REDUCTION; BACTERIA; SULFATE; SYSTEM	We report a methodology for enhancing the mass transfer at the anode electrode of sediment microbial fuel cells (SMFCs), by employing a fabric baffle to create a separate water-layer for installing the anode electrode in sediment. The maximum power in an SMFC with the anode installed in the separate water-layer (SMFC-wFB) was improved by factor of 6.6 compared to an SMFC having the anode embedded in the sediment (SMFC-woFB). The maximum current density in the SMFC-wFB was also 3.9 times higher ( 220.46 mA/m(2)) than for the SMFC-woFB. We found that the increased performance in the SMFC-wFB was due to the improved mass transfer rate of organic matter obtained by employing the water-layer during anode installation in the sediment layer. Acetate injection tests revealed that the SMFC-wFB could be applied to natural water bodies in which there is frequent organic contamination, based on the acetate flux from the cathode to the anode.	[Lee, Yoo Seok; An, Junyeong; Kim, Bongkyu; Park, HyunJun; Kim, Jisu; Chang, In Seop] Gwangju Inst Sci & Technol, Sch Environm Sci & Engn, Gwangju 500712, South Korea	Gwangju Institute of Science & Technology (GIST)	Chang, IS (corresponding author), Gwangju Inst Sci & Technol, Sch Environm Sci & Engn, 261 Cheomdan Gwagiro, Gwangju 500712, South Korea.	ischang@gist.ac.kr		Chang, In Seop/0000-0001-5064-7951; Lee, Yoo Seok/0000-0002-8840-0206	National Research Foundation (NRF) - Korean government (MSIP) [NRF-2013R1A2A2A0314551]	National Research Foundation (NRF) - Korean government (MSIP)	This work was supported by a National Research Foundation (NRF) grant (NRF-2013R1A2A2A0314551) funded by the Korean government (MSIP) (URL: http://www.nrf.re.kr) (author who received the funding: ISC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Research Foundation (NRF) grant (NRF-2013R1A2A2A0314551) funded by the Korean government (MSIP).	Ahn Changwoo, 2013, Environmental Engineering Research, V18, P151, DOI 10.4491/eer.2013.18.3.151; An J, 2013, BIORESOURCE TECHNOL, V127, P138, DOI 10.1016/j.biortech.2012.09.095; An J, 2010, ENVIRON SCI TECHNOL, V44, P7145, DOI 10.1021/es100498g; Berner R A, 1980, EARLY DIAGENESIS THE; Bond DR, 2002, SCIENCE, V295, P483, DOI 10.1126/science.1066771; Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; Boudreau BP, 1996, GEOCHIM COSMOCHIM AC, V60, P3139, DOI 10.1016/0016-7037(96)00158-5; Chang IS, 2006, J MICROBIOL BIOTECHN, V16, P163; Chiou C.T., 2000, CONTAMINANT SORPTION; Donovan C, 2008, ENVIRON SCI TECHNOL, V42, P8591, DOI 10.1021/es801763g; Donovan C, 2011, J POWER SOURCES, V196, P1171, DOI 10.1016/j.jpowsour.2010.08.099; Holmes DE, 2002, APPL ENVIRON MICROB, V68, P2300, DOI 10.1128/AEM.68.5.2300-2306.2002; Hong SW, 2009, BIORESOURCE TECHNOL, V100, P3029, DOI 10.1016/j.biortech.2009.01.030; Hong S, 2009, BIOPROC BIOSYST ENG, V32, P389, DOI 10.1007/s00449-008-0258-9; IVERSEN N, 1993, GEOCHIM COSMOCHIM AC, V57, P571, DOI 10.1016/0016-7037(93)90368-7; Kim BH, 1999, BIOTECHNOL TECH, V13, P475, DOI 10.1023/A:1008993029309; Lewandowski Z, 2013, FUNDAMENTALS BIOFILM; Logan BE, 2005, WATER RES, V39, P942, DOI 10.1016/j.watres.2004.11.019; Lowy DA, 2008, J POWER SOURCES, V185, P70, DOI 10.1016/j.jpowsour.2008.06.079; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; NEALSON KH, 1992, APPL ENVIRON MICROB, V58, P439, DOI 10.1128/AEM.58.2.439-443.1992; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; O'Connor BL, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR007160; Rabaey K, 2006, ENVIRON SCI TECHNOL, V40, P5218, DOI 10.1021/es060382u; Reimers CE, 2001, ENVIRON SCI TECHNOL, V35, P192, DOI 10.1021/es001223s; Rezaei F, 2007, ENVIRON SCI TECHNOL, V41, P4053, DOI 10.1021/es070426e; RICHARDSON CP, 1988, J ENVIRON ENG-ASCE, V114, P792, DOI 10.1061/(ASCE)0733-9372(1988)114:4(792); Rutherford J., 1994, RIVER MIXING 1994; Scott K, 2008, J CHEM TECHNOL BIOT, V83, P1244, DOI 10.1002/jctb.1937; Shantaram A, 2005, ENVIRON SCI TECHNOL, V39, P5037, DOI 10.1021/es0480668; Tender LM, 2008, J POWER SOURCES, V179, P571, DOI 10.1016/j.jpowsour.2007.12.123; WIDDEL F, 1983, ARCH MICROBIOL, V134, P286, DOI 10.1007/BF00407804	32	9	10	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145430	10.1371/journal.pone.0145430	http://dx.doi.org/10.1371/journal.pone.0145430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714176	Green Submitted, Green Published, gold			2022-12-27	WOS:000367481900042
J	Lu, FM; Zhou, JS; Zhang, J; Xiang, YT; Zhang, J; Liu, Q; Wang, XP; Yuan, Z				Lu, Feng-Mei; Zhou, Jian-Song; Zhang, Jiang; Xiang, Yu-Tao; Zhang, Jian; Liu, Qi; Wang, Xiao-Ping; Yuan, Zhen			Functional Connectivity Estimated from Resting-State fMRI Reveals Selective Alterations in Male Adolescents with Pure Conduct Disorder	PLOS ONE			English	Article							MODE NETWORK ACTIVITY; DEFAULT-MODE; BRAIN ACTIVITY; MRI DATA; BOYS; ABNORMALITIES; FLUCTUATIONS; DYSFUNCTION; DEPRESSION; RESPONSES	Conduct disorder (CD) is characterized by a persistent pattern of antisocial behavior and aggression in childhood and adolescence. Previous task-based and resting-state functional magnetic resonance imaging (fMRI) studies have revealed widespread brain regional abnormalities in adolescents with CD. However, whether the resting-state networks (RSNs) are altered in adolescents with CD remains unknown. In this study, resting-state fMRI data were first acquired from eighteen male adolescents with pure CD and eighteen age-and gender-matched typically developing (TD) individuals. Independent component analysis (ICA) was implemented to extract nine representative RSNs, and the generated RSNs were then compared to show the differences between the CD and TD groups. Interestingly, it was observed from the brain mapping results that compared with the TD group, the CD group manifested decreased functional connectivity in four representative RSNs: the anterior default mode network (left middle frontal gyrus), which is considered to be correlated with impaired social cognition, the somatosensory network (bilateral supplementary motor area and right postcentral gyrus), the lateral visual network (left superior occipital gyrus), and the medial visual network (right fusiform, left lingual gyrus and right calcarine), which are expected to be relevant to the perceptual systems responsible for perceptual dysfunction in male adolescents with CD. Importantly, the novel findings suggested that male adolescents with pure CD were identified to have dysfunctions in both low-level perceptual networks (the somatosensory network and visual network) and a high-order cognitive network (the default mode network). Revealing the changes in the functional connectivity of these RSNs enhances our understanding of the neural mechanisms underlying the modulation of emotion and social cognition and the regulation of perception in adolescents with CD.	[Lu, Feng-Mei; Xiang, Yu-Tao; Zhang, Jian; Yuan, Zhen] Univ Macau, Fac Hlth Sci, Bioimaging Core, Taipa, Macau, Peoples R China; [Zhou, Jian-Song; Wang, Xiao-Ping] Cent S Univ, Mental Hlth Inst, Hunan Prov Technol Inst Psychiat, Xiangya Hosp 2,Key Lab Psychiat & Mental Hlth Hun, Changsha 410011, Hunan, Peoples R China; [Zhang, Jiang; Liu, Qi] Sichuan Univ, Sch Elect Engn & Informat, Dept Med Informat Engn, Chengdu 610065, Peoples R China	University of Macau; Central South University; Sichuan University	Zhou, JS (corresponding author), Cent S Univ, Mental Hlth Inst, Hunan Prov Technol Inst Psychiat, Xiangya Hosp 2,Key Lab Psychiat & Mental Hlth Hun, Changsha 410011, Hunan, Peoples R China.	zhoujs2003@126.com; zhenyuan@umac.mo	, 镜海真人（袁振）/ABG-2380-2020; Yuan, zhen/ABG-3111-2020; wang, xiao/HGB-7081-2022	Yuan, zhen/0000-0003-3061-6263; wang, xiao/0000-0002-4088-3341	University of Macau in Macau [SRG2013-00035-FHS, MYRG2014-00093-FHS, MYRG2015-00036-FHS]; MOE (Ministry of Education in China) Project of Humanities and Social Sciences [13YJC190033]; National Natural Science Foundation of China (NSFC) [81571341, 81371500, 61273361]; FDCT grant [026/2014/A1]; FDCT grant from the Macao government [025/2015/A1]	University of Macau in Macau; MOE (Ministry of Education in China) Project of Humanities and Social Sciences; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); FDCT grant; FDCT grant from the Macao government	The study was supported by the SRG2013-00035-FHS Grant and MYRG2014-00093-FHS and MYRG2015-00036-FHS Grants from University of Macau in Macau; the FDCT grant 026/2014/A1 and the FDCT grant 025/2015/A1 from the Macao government; the MOE (Ministry of Education in China) Project of Humanities and Social Sciences (Project No. 13YJC190033); and the National Natural Science Foundation of China (NSFC, 81571341, 81371500 and 61273361).; We sincerely thank the two reviewers for their constructive suggestions. The study was supported by the SRG2013-00035-FHS Grant and MYRG2014-00093-FHS and MYRG2015-00036-FHS Grants from University of Macau in Macau; the FDCT grant 026/2014/A1 and the FDCT grant 025/2015/A1 from the Macao government; the MOE (Ministry of Education in China) Project of Humanities and Social Sciences (Project No. 13YJC190033); and the National Natural Science Foundation of China (NSFC, 81571341, 81371500 and 61273361).	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005; Bartels A, 2005, NEUROIMAGE, V24, P339, DOI 10.1016/j.neuroimage.2004.08.044; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Biswal BB, FUNCTIONAL CONNECTIV; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Colman I, 2009, BMJ, V338; Dalwani MS, 2014, DRUG ALCOHOL DEPEN, V134, P242, DOI 10.1016/j.drugalcdep.2013.10.009; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2005, EXP BRAIN RES, V167, P587, DOI 10.1007/s00221-005-0059-1; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Decety J, 2009, BIOL PSYCHOL, V80, P203, DOI 10.1016/j.biopsycho.2008.09.004; Delfos M.F., 2004, CHILDREN BEHAV PROBL; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Fairchild G, 2011, BRAIN, V168; Fairchild G, 2011, AM J PSYCHIAT, V168, P624, DOI 10.1176/appi.ajp.2010.10081184; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Finger EC, 2011, AM J PSYCHIAT, V168, P152, DOI 10.1176/appi.ajp.2010.10010129; Finger EC, 2012, PSYCHIAT RES-NEUROIM, V202, P239, DOI 10.1016/j.pscychresns.2011.11.002; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Guo WB, 2013, PROG NEURO-PSYCHOPH, V44, P51, DOI 10.1016/j.pnpbp.2013.01.010; Guo WB, 2013, PROG NEURO-PSYCHOPH, V41, P24, DOI 10.1016/j.pnpbp.2012.11.003; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Huebner T, 2008, J AM ACAD CHILD PSY, V47, P540, DOI 10.1097/CHI.0b013e3181676545; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jones AP, 2009, AM J PSYCHIAT, V166, P95, DOI 10.1176/appi.ajp.2008.07071050; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Li Y-O, 2006, BIOM IM NAN MACR 200; Liu Feng, 2015, Brain Struct Funct, V220, P101, DOI 10.1007/s00429-013-0641-4; Lowe MJ, 2000, NEUROIMAGE, V12, P582, DOI 10.1006/nimg.2000.0654; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mantini D, 2009, NEUROIMAGE, V44, P265, DOI 10.1016/j.neuroimage.2008.08.019; McKeown MJ, 1998, P NATL ACAD SCI USA, V95, P803, DOI 10.1073/pnas.95.3.803; Mishra AM, 2013, EPILEPSIA, V54, P1214, DOI 10.1111/epi.12227; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; Rubia K, 2008, AM J PSYCHIAT, V165, P889, DOI 10.1176/appi.ajp.2008.07071084; Rubia K, 2010, HUM BRAIN MAPP, V31, P1823, DOI 10.1002/hbm.20975; Rubia K, 2009, J CHILD PSYCHOL PSYC, V50, P669, DOI 10.1111/j.1469-7610.2008.02022.x; Rubia K, 2009, AM J PSYCHIAT, V166, P83, DOI 10.1176/appi.ajp.2008.08020212; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Sebastian CL, 2012, ARCH GEN PSYCHIAT, V69, P814, DOI 10.1001/archgenpsychiatry.2011.2070; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shanee N, 1997, ISRAEL J PSYCHIAT RE; Shang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096834; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stevens MC, 2012, J PSYCHIATR NEUROSCI, V37, P389, DOI 10.1503/jpn.110148; Tiet QQ, 2001, J CHILD FAMILY STUDI, V10, P181; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; van de Ven V, 2008, HUM BRAIN MAPP, V29, P1450, DOI 10.1002/hbm.20479; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhou J, 2015, PLOS ONE, V10; Zhou JS, 2012, J FORENSIC PSYCHI PS, V23, P664, DOI 10.1080/14789949.2012.727452; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	72	24	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145668	10.1371/journal.pone.0145668	http://dx.doi.org/10.1371/journal.pone.0145668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713867	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900064
J	Lan, TY; Zeng, YF; Tang, GJ; Kao, HC; Chiu, HJ; Lan, TH; Ho, HF				Lan, Tzuo-Yun; Zeng, Ya-Fang; Tang, Gau-Jun; Kao, Hui-Chuan; Chiu, Hsien-Jane; Lan, Tsuo-Hung; Ho, Hsiao-Feng			The Use of Hypnotics and Mortality - A Population-Based Retrospective Cohort Study	PLOS ONE			English	Article							SLEEP DURATION; ALAMEDA-COUNTY; FOLLOW-UP; RISK-FACTOR; HEALTH; ZOLPIDEM; INSOMNIA; BENZODIAZEPINES; HYPERTENSION; PRESCRIPTION	Background Sleep disorders, especially chronic insomnia, have become major health problem worldwide and, as a result, the use of hypnotics is steadily increasing. However, few studies with a large sample size and long-term observation have been conducted to investigate the relationship between specific hypnotics and mortality. Methods We conducted this retrospective cohort study using data from the National Health Insurance Research Database in Taiwan. Information from claims data including basic characteristics, the use of hypnotics, and survival from 2000 to 2009 for 1,320,322 individuals were included. The use of hypnotics was divided into groups using the defined daily dose and the cumulative length of use. Hazard ratios (HRs) were calculated from a Cox proportional hazards model, with two different matching techniques to examine the associations. Results Compared to the non-users, both users of benzodiazepines (HR = 1.81; 95% confidence interval [CI] = 1.78-1.85) and mixed users (HR = 1.44; 95% CI = 1.42-1.47) had a higher risk of death, whereas the users of other non-benzodiazepines users showed no differences. Zolpidem users (HR = 0.73; 95% CI = 0.71-0.75) exhibited a lower risk of mortality in the adjusted models. This pattern remained similar in both matching techniques. Secondary analysis indicated that zolpidem users had a reduced risk of major cause-specific mortality except cancer, and that this protective effect was dose-responsive, with those using for more than 1 year having the lowest risk. Conclusions The effects of different types of hypnotics on mortality were diverse in this large cohort with long-term follow-up based on representative claims data in Taiwan. The use of zolpidem was associated with a reduced risk of mortality.	[Lan, Tzuo-Yun; Zeng, Ya-Fang; Tang, Gau-Jun] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan; [Kao, Hui-Chuan] Tzu Chi Univ, Dept Publ Hlth, Hualien, Taiwan; [Chiu, Hsien-Jane] Min Sheng Gen Hosp, Taoyuan, Taiwan; [Lan, Tsuo-Hung] Taichung Vet Gen Hosp, Dept Psychiat, Taichung, Taiwan; [Ho, Hsiao-Feng] Minist Hlth & Welf, Natl Hlth Insurance Adm, Taipei, Taiwan	National Yang Ming Chiao Tung University; Tzu Chi University; Taichung Veterans General Hospital	Lan, TY (corresponding author), Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan.	tylan@ym.edu.tw		Lan, Tsuo-Hung/0000-0002-2796-1026	National Science Council in Taiwan [NSC 101-2410-H-010 -010 -MY2, NSC 101-2410-H-010-010 -MY2]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This project was supported by National Science Council in Taiwan (NSC 101-2410-H-010 -010 -MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the National Science Council in Taiwan (NSC 101-2410-H-010-010 -MY2). The authors thank the National Health Research Institute in Taiwan for making available insurance claims data for analyses.	Ahmad R, 2005, J GERONTOL A-BIOL, V60, P1052, DOI 10.1093/gerona/60.8.1052; [Anonymous], 2000, PRESCR DRUG RANK EXP; [Anonymous], 2011, SLEEP QUAL REP TAIW; Belleville G, 2010, CAN J PSYCHIAT, V55, P558, DOI 10.1177/070674371005500904; BNHI, 2012, 2011 NAT HLTH INS AN; BRESLOW L, 1980, PREV MED, V9, P469, DOI 10.1016/0091-7435(80)90042-0; BROCK BM, 1988, PREV MED, V17, P483, DOI 10.1016/0091-7435(88)90047-3; Buysse DJ, 2014, SLEEP, V37, P9, DOI 10.5665/sleep.3298; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Colten HR, 2006, SLEEP DISORDERS SLEE; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dockhorn RJ, 1996, CLIN NEUROPHARMACOL, V19, P333, DOI 10.1097/00002826-199619040-00006; Doi Y, 2000, J Epidemiol, V10, P79; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fukuhara S, 2006, KIDNEY INT, V70, P1866, DOI 10.1038/sj.ki.5001832; Gangwisch JE, 2007, SLEEP, V30, P1667, DOI 10.1093/sleep/30.12.1667; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Hausken AM, 2007, PHARMACOEPIDEM DR S, V16, P913, DOI 10.1002/pds.1417; Huang YL, 2012, SLEEP MED, V13, P263, DOI 10.1016/j.sleep.2011.07.016; Hublin C, 2007, SLEEP, V30, P1245, DOI 10.1093/sleep/30.10.1245; ISACSON D, 1992, J CLIN EPIDEMIOL, V45, P429, DOI 10.1016/0895-4356(92)90044-N; Kao CH, 2012, MAYO CLIN PROC, V87, P430, DOI 10.1016/j.mayocp.2012.02.012; Kojima M, 2000, J Epidemiol, V10, P87; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Leger D, 2002, SLEEP, V25, P625; Mallon L, 2009, SLEEP MED, V10, P279, DOI 10.1016/j.sleep.2008.12.004; Neutel CI, 2015, EUR J CLIN PHARMACOL, V71, P637, DOI 10.1007/s00228-015-1841-z; QUERASALVA MA, 1994, BRIT J CLIN PHARMACO, V37, P539, DOI 10.1111/j.1365-2125.1994.tb04301.x; Rod NH, 2011, AM J EPIDEMIOL, V173, P300, DOI 10.1093/aje/kwq371; Roehrs T, 2004, SLEEP MED, V5, P463, DOI 10.1016/j.sleep.2004.03.007; Sabanayagam C, 2010, SLEEP, V33, P1037, DOI 10.1093/sleep/33.8.1037; Schuckit MA, 2002, AM J DRUG ALCOHOL AB, V28, P73, DOI 10.1081/ADA-120001282; Shen M, 2013, FORENSIC SCI INT, V227, P77, DOI 10.1016/j.forsciint.2012.08.035; THOROGOOD M, 1992, LANCET, V340, P1067, DOI 10.1016/0140-6736(92)93081-W; WHO, 2009, ATC DDD METH; WILEY JA, 1980, PREV MED, V9, P1, DOI 10.1016/0091-7435(80)90056-0; WINGARD DL, 1982, AM J EPIDEMIOL, V116, P765, DOI 10.1093/oxfordjournals.aje.a113466; Winkelmayer WC, 2007, KIDNEY INT, V72, P1388, DOI 10.1038/sj.ki.5002548	39	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145271	10.1371/journal.pone.0145271	http://dx.doi.org/10.1371/journal.pone.0145271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709926	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400032
J	Bogels, S; Kendrick, KH; Levinson, SC				Bogels, Sara; Kendrick, Kobin H.; Levinson, Stephen C.			Never Say No ... How the Brain Interprets the Pregnant Pause in Conversation	PLOS ONE			English	Article							SEMANTIC INTEGRATION; WORD RECOGNITION; TURN SILENCE; ERP EVIDENCE; COMPREHENSION; SENTENCES; CUES; ANTICIPATION; ORGANIZATION; SPEECH	In conversation, negative responses to invitations, requests, offers, and the like are more likely to occur with a delay-conversation analysts talk of them as dispreferred. Here we examine the contrastive cognitive load 'yes' and 'no' responses make, either when relatively fast (300 ms after question offset) or delayed (1000 ms). Participants heard short dialogues contrasting in speed and valence of response while having their EEG recorded. We found that a fast 'no' evokes an N400-effect relative to a fast 'yes'; however, this contrast disappeared in the delayed responses. 'No' responses, however, elicited a late frontal positivity both if they were fast and if they were delayed. We interpret these results as follows: a fast 'no' evoked an N400 because an immediate response is expected to be positive-this effect disappears as the response time lengthens because now in ordinary conversation the probability of a 'no' has increased. However, regardless of the latency of response, a 'no' response is associated with a late positivity, since a negative response is always dispreferred. Together these results show that negative responses to social actions exact a higher cognitive load, but especially when least expected, in immediate response.	[Bogels, Sara; Kendrick, Kobin H.; Levinson, Stephen C.] Max Planck Inst Psycholinguist, Language & Cognit Dept, Nijmegen, Netherlands; [Levinson, Stephen C.] Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	Max Planck Society; Radboud University Nijmegen	Bogels, S (corresponding author), Max Planck Inst Psycholinguist, Language & Cognit Dept, Nijmegen, Netherlands.	sara.bogels@mpi.nl		Bogels, Sara/0000-0002-4945-5765	Language and Cognition Department at the Max Planck Institute for Psycholinguistics; European Research Counsel [269484 INTERACT]	Language and Cognition Department at the Max Planck Institute for Psycholinguistics; European Research Counsel	This research was made possible by the financial support of the Language and Cognition Department at the Max Planck Institute for Psycholinguistics and European Research Counsel's Advanced Grant 269484 INTERACT to Stephen C. Levinson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, TORONTOS ROB FORD SA; [Anonymous], 2013, THEGUARDIAN; Bogels S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12881; BRENNAN SE, 1995, J MEM LANG, V34, P383, DOI 10.1006/jmla.1995.1017; Brouwer H, 2012, BRAIN RES, V1446, P127, DOI 10.1016/j.brainres.2012.01.055; CLARK HH, 1972, COGNITIVE PSYCHOL, V3, P472, DOI 10.1016/0010-0285(72)90019-9; Clayman Steven E., 2002, ADV GROUP PROCESSES, P229; CONNOLLY JF, 1994, J COGNITIVE NEUROSCI, V6, P256, DOI 10.1162/jocn.1994.6.3.256; Coulson S, 2001, NEUROSCI LETT, V316, P71, DOI 10.1016/S0304-3940(01)02387-4; Coulson S, 2002, MEM COGNITION, V30, P958, DOI 10.3758/BF03195780; Coulson S, 2010, ITAL J LINGUIST, V22, P107; Couper-Kuhlen E, 2014, PRAGMATICS, V24, P623, DOI 10.1075/prag.24.3.08cou; D'Arcy RCN, 2004, HUM BRAIN MAPP, V22, P40, DOI 10.1002/hbm.20008; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; Ford Cecilia E., 1996, INTERACTION GRAMMAR, P135; Gisladottir RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120068; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1518, DOI 10.1016/S0028-3932(00)00052-X; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hagoort P., 2009, COGNITIVE NEUROSCIEN, V4th, P819, DOI [10.1002/int.4550070108, DOI 10.1002/INT.4550070108]; Hagoort P., 1999, NEUROCOGNITION LANGU, P273, DOI DOI 10.1093/ACPROF:OSO/9780198507932.001.0001; Hayano Kaoru, 2013, HDB CONVERSATION ANA, P395, DOI DOI 10.1002/9781118325001.CH19; Heldner M, 2010, J PHONETICS, V38, P555, DOI 10.1016/j.wocn.2010.08.002; Heritage J., 1984, GARFINKEL ETHNOMETHO; Kendrick KH, 2015, DISCOURSE PROCESS, V52, P255, DOI 10.1080/0163853X.2014.955997; Kitzinger C, 1999, DISCOURSE SOC, V10, P293, DOI 10.1177/0957926599010003002; KRAUT RE, 1978, J PERS SOC PSYCHOL, V36, P380, DOI 10.1037/0022-3514.36.4.380; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Leuthold H, 2015, SOC COGN AFFECT NEUR, V10, P1021, DOI 10.1093/scan/nsu151; Levinson S. C., 1983, PRAGMATICS; Levinson SC, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00731; Magyari L, 2014, J COGNITIVE NEUROSCI, V26, P2530, DOI 10.1162/jocn_a_00673; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; New J, 2015, MORE COLL CAMPUSES S; Nieuwland MS, 2008, PSYCHOL SCI, V19, P1213, DOI 10.1111/j.1467-9280.2008.02226.x; Nordmeyer A.E., 2014, P ANN M COGN SCI SOC, V36; Oostdijk Nelleke, 2000, NEDERLANDSE TAALKUND, V5, P280; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; POLICH J, 1988, ELECTROEN CLIN NEURO, V70, P33, DOI 10.1016/0013-4694(88)90192-7; Pomerantz Anita, 2013, HDB CONVERSATION ANA, P210; Pomerantz Anita M., 1984, STUDIES CONVERSATION, P57, DOI DOI 10.1017/CBO9780511665868.008; Regel S, 2011, J COGNITIVE NEUROSCI, V23, P277, DOI 10.1162/jocn.2010.21411; Regel S, 2010, BRAIN RES, V1311, P121, DOI 10.1016/j.brainres.2009.10.077; Roberts F, 2006, SPEECH COMMUN, V48, P1079, DOI 10.1016/j.specom.2006.02.001; Roberts F, 2013, J ACOUST SOC AM, V133, pEL471, DOI 10.1121/1.4802900; Roberts F, 2011, DISCOURSE PROCESS, V48, P331, DOI 10.1080/0163853X.2011.558002; Roberts SG, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00509; Rockwell P., 1997, COMMUNICATION RES RE, V14, P451, DOI [10.1080/08824099709388688, DOI 10.1080/08824099709388688]; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Sacks H., 1987, TALK SOCIAL ORG, P54; Schegloff E. A., 2007, SEQUENCE ORG INTERAC, V1; Schilbach L, 2013, BEHAV BRAIN SCI, V36, P393, DOI 10.1017/S0140525X12000660; Sereno SC, 1998, NEUROREPORT, V9, P2195, DOI 10.1097/00001756-199807130-00009; SMITH VL, 1993, J MEM LANG, V32, P25, DOI 10.1006/jmla.1993.1002; Stivers T, 2006, LANG SOC, V35, P367, DOI 10.1017/S0047404506060179; Stivers T, 2009, P NATL ACAD SCI USA, V106, P10587, DOI 10.1073/pnas.0903616106; Strijkers K, 2010, CEREB CORTEX, V20, P912, DOI 10.1093/cercor/bhp153; Thornhill DE, 2012, INT J PSYCHOPHYSIOL, V83, P382, DOI 10.1016/j.ijpsycho.2011.12.007; van Berkum JJA, 1999, J COGNITIVE NEUROSCI, V11, P657, DOI 10.1162/089892999563724; Van Berkum JJA, 2009, PSYCHOL SCI, V20, P1092, DOI 10.1111/j.1467-9280.2009.02411.x; de Meerendonk N, 2009, LANG LINGUIST COMPAS, V3, DOI 10.1111/j.1749-818x.2009.00163.x; van den Brink D, 2001, J COGNITIVE NEUROSCI, V13, P967, DOI 10.1162/089892901753165872; Van Petten C, 1999, J EXP PSYCHOL LEARN, V25, P394, DOI 10.1037/0278-7393.25.2.394; Van Petten C, 2012, INT J PSYCHOPHYSIOL, V83, P176, DOI 10.1016/j.ijpsycho.2011.09.015	63	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145474	10.1371/journal.pone.0145474	http://dx.doi.org/10.1371/journal.pone.0145474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26699335	Green Published, gold, Green Accepted			2022-12-27	WOS:000367092600086
J	Ji, FM; Liu, LY; Tien, YH; Peng, YH; Lee, HC				Ji, Fengmin; Liu, Lianyun; Tien, Ya-Hsin; Peng, Yi-Hsien; Lee, Hoong-Chien			Non-Catalytic RISCs and Kinetics Determine Mammalian siRNA Sub-Cellular Localization	PLOS ONE			English	Article							HUMAN-CELLS; RNA; DEADENYLATION; INTERFERENCE; POTENT	Small interfering RNAs (siRNAs) are fundamental to the regulation of cell function. Much is known about its gene interfering mechanism, but a kinetic description of it is still lacking. Here, we derived a set of reaction-diffusion equations for multiple RNA-induced silencing complex (RISC) pathways that give quantitative temporal and spatial descriptions of the siRNA process in mammalian cell, and are able to correctly describe all salient experimentally observed patterns of sub-cellular siRNA localization, including those that, at first glance, appear irreconcilable. These results suggest siRNA sub-cellular localization mainly concerns the non-catalytic RISC-target complex, and is caused by the selectiveness of RISC-target interaction and the permeability of the nuclear membrane to siRNA strands but not to RISC-target complexes. Our method is expected to be useful in devising RNAi based cell regulation strategies.	[Ji, Fengmin] Beijing Jiaotong Univ, Inst Biol Sci & Biotechnol, Beijing 100044, Peoples R China; [Liu, Lianyun] Beijing Jiaotong Univ, Dept Chem, Beijing 100044, Peoples R China; [Tien, Ya-Hsin; Peng, Yi-Hsien; Lee, Hoong-Chien] Natl Cent Univ, Dept Biomed Sci & Engn, Taoyuan 32001, Taiwan; [Lee, Hoong-Chien] Chung Yuan Christian Univ, Dept Phys, Taoyuan 32023, Taiwan; [Lee, Hoong-Chien] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Taoyuan 32001, Taiwan	Beijing Jiaotong University; Beijing Jiaotong University; National Central University; Chung Yuan Christian University; National Central University	Lee, HC (corresponding author), Natl Cent Univ, Dept Biomed Sci & Engn, Taoyuan 32001, Taiwan.	hclee12345@gmail.com			Beijing Jiaotong University; Ministry of Science and Technology through the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan [MOST 102-2911-I-008-001, 103-2911-I-008-001]	Beijing Jiaotong University; Ministry of Science and Technology through the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan	FMJ and LYL were supported by grants from the Beijing Jiaotong University. HCL was supported by Ministry of Science and Technology through the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan, (MOST 102-2911-I-008-001, and 103-2911-I-008-001).; FMJ and LYL were supported by grants from the Beijing Jiaotong University. HCL was supported by Ministry of Science and Technology through the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan, (MOST 102-2911-I-008-001 and 103-2911-I-008-001).	Bartlett DW, 2006, NUCLEIC ACIDS RES, V34, P322, DOI 10.1093/nar/gkj439; Berezhna SY, 2006, P NATL ACAD SCI USA, V103, P7682, DOI 10.1073/pnas.0600148103; Bergstrom CT, 2003, P NATL ACAD SCI USA, V100, P11511, DOI 10.1073/pnas.1931639100; Denti MA, 2004, PLANT J, V37, P762, DOI 10.1111/j.1365-313X.2004.02001.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Papp I, 2003, PLANT PHYSIOL, V132, P1382, DOI 10.1104/pp.103.021980; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Wang X, 2010, BIOSYSTEMS, V100, P31, DOI 10.1016/j.biosystems.2009.12.005; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Zeng Y, 2002, RNA, V8, P855, DOI 10.1017/S1355838202020071	18	0	0	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0143182	10.1371/journal.pone.0143182	http://dx.doi.org/10.1371/journal.pone.0143182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699128	gold, Green Published			2022-12-27	WOS:000367092600005
J	Marzbanrad, F; Kimura, Y; Palaniswami, M; Khandoker, AH				Marzbanrad, Faezeh; Kimura, Yoshitaka; Palaniswami, Marimuthu; Khandoker, Ahsan H.			Quantifying the Interactions between Maternal and Fetal Heart Rates by Transfer Entropy	PLOS ONE			English	Article							PHASE SYNCHRONIZATION; BEHAVIORAL STATES; NORMAL-PREGNANCY; RATE-VARIABILITY; RESPONSES; ELECTROCARDIOGRAM; STIMULATION; EXTRACTION; MATURATION; GESTATION	Evidence of the short term relationship between maternal and fetal heart rates has been found in previous studies. However there is still limited knowledge about underlying mechanisms and patterns of the coupling throughout gestation. In this study, Transfer Entropy (TE) was used to quantify directed interactions between maternal and fetal heart rates at various time delays and gestational ages. Experimental results using maternal and fetal electrocardiograms showed significant coupling for 63 out of 65 fetuses, by statistically validating against surrogate pairs. Analysis of TE showed a decrease in transfer of information from fetus to the mother with gestational age, alongside the maturation of the fetus. On the other hand, maternal to fetal TE was significantly greater in mid (26-31 weeks) and late (32-41 weeks) gestation compared to early (16-25 weeks) gestation (Mann Whitney Wilcoxon (MWW) p<0.05). TE further increased from mid to late, for the fetuses with RMSSD of fetal heart rate being larger than 4 msec in the late gestation. This difference was not observed for the fetuses with smaller RMSSD, which could be associated with the quiet sleep state. Delay in the information transfer from mother to fetus significantly decreased (p = 0.03) from mid to late gestation, implying a decrease in fetal response time. These changes occur concomitant with the maturation of the fetal sensory and autonomic nervous systems with advancing gestational age. The effect of maternal respiratory rate derived from maternal ECG was also investigated and no significant relationship was found between breathing rate and TE at any lag. In conclusion, the application of TE with delays revealed detailed information on the fetal-maternal heart rate coupling strength and latency throughout gestation, which could provide novel clinical markers of fetal development and well-being.	[Marzbanrad, Faezeh; Palaniswami, Marimuthu; Khandoker, Ahsan H.] Univ Melbourne, Elect & Elect Engn Dept, Melbourne, Vic 3010, Australia; [Kimura, Yoshitaka] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Khandoker, Ahsan H.] Khalifa Univ Sci Technol & Res, Dept Biomed Engn, Abu Dhabi, U Arab Emirates	University of Melbourne; Tohoku University; Khalifa University of Science & Technology	Khandoker, AH (corresponding author), Univ Melbourne, Elect & Elect Engn Dept, Melbourne, Vic 3010, Australia.	ahsan.khandoker@kustar.ac.ae	Khandoker, Ahsan Habib/B-3754-2013; Marzbanrad, Faezeh/O-9998-2017; Palaniswami, Marimuthu/AAE-2179-2022	Khandoker, Ahsan Habib/0000-0002-0636-1646; Marzbanrad, Faezeh/0000-0003-0551-1611; 	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council.	Behar J, 2013, COMPUT CARDIOL CONF, V40, P297, DOI 10.1049/iet-tv.41.18108; Copper RL, 1996, AM J OBSTET GYNECOL, V175, P1286, DOI 10.1016/S0002-9378(96)70042-X; Cysarz D, 2008, ANN BIOMED ENG, V36, P2085, DOI 10.1007/s10439-008-9580-2; DiPietro JA, 2008, BIOL PSYCHOL, V77, P11, DOI 10.1016/j.biopsycho.2007.08.008; Faes L, 2015, PHYSIOL MEAS, V36, P683, DOI 10.1088/0967-3334/36/4/683; Faes L, 2014, LAG SPECIFIC TRANSFE; Ivanov PC, 2009, P NATL ACAD SCI USA, V106, P13641, DOI 10.1073/pnas.0906987106; Jezewski J, 2003, PROCEEDINGS SEVENTH, V2, P9; Jezewski J, 2012, BIOMED ENG-BIOMED TE, V57, P383, DOI 10.1515/bmt-2011-0130; Kimura Y., 2012, OPEN MED DEVICES J, V4, P7, DOI [10.2174/1875181401204010007, DOI 10.2174/1875181401204010007]; Kisilevsky BS, 2011, DEVELOPMENTAL SCI, V14, P214, DOI 10.1111/j.1467-7687.2010.00970.x; KISILEVSKY BS, 1992, CHILD DEV, V63, P1497; Lange S, 2009, EARLY HUM DEV, V85, P131, DOI 10.1016/j.earlhumdev.2008.07.004; Lecanuet JP, 2002, DEV PSYCHOBIOL, V40, P57, DOI 10.1002/dev.10013; Lee J, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-19; Leontitsis A, 2002, CHAOTIC SYSTEMS TOOL; Lunshof S, 1998, AM J OBSTET GYNECOL, V178, P247, DOI 10.1016/S0002-9378(98)80008-2; Marzbanrad F, 2015, IEEE ENG MED BIO, P7865, DOI 10.1109/EMBC.2015.7320215; Monk C, 2000, DEV PSYCHOBIOL, V36, P67, DOI 10.1002/(SICI)1098-2302(200001)36:1<67::AID-DEV7>3.3.CO;2-3; Montalto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109462; NIJHUIS JG, 1982, EARLY HUM DEV, V6, P177, DOI 10.1016/0378-3782(82)90106-2; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; PAPP JG, 1988, BASIC RES CARDIOL, V83, P2, DOI 10.1007/BF01907099; PILLAI M, 1990, OBSTET GYNECOL, V76, P812, DOI 10.1097/00006250-199011000-00017; Porta A, 1998, BIOL CYBERN, V78, P71, DOI 10.1007/s004220050414; Porta A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00071; Riedl M, 2009, PHILOS T R SOC A, V367, P1407, DOI 10.1098/rsta.2008.0277; Sameni Reza, 2010, Open Pacing Electrophysiol Ther J, V3, P4; Sato M, 2007, IEEE T BIO-MED ENG, V54, P49, DOI 10.1109/TBME.2006.883791; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; Suykens J. A, 2002, LEAST SQUARES SUPPOR, V4; Van Leeuwen P, 2009, P NATL ACAD SCI USA, V106, P13661, DOI 10.1073/pnas.0901049106; Van Leeuwen P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106036; Van Leeuwen Peter, 2003, BMC Physiol, V3, P2, DOI 10.1186/1472-6793-3-2; Van Leeuwen P, 2010, IFMBE PROC, V28, P262; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Wang QQ, 2013, IEEE ENG MED BIO, P3821, DOI 10.1109/EMBC.2013.6610377; Wibral M, 2011, PROG BIOPHYS MOL BIO, V105, P80, DOI 10.1016/j.pbiomolbio.2010.11.006; Widjaja D, 2012, IEEE T BIO-MED ENG, V59, P1169, DOI 10.1109/TBME.2012.2186448	40	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145672	10.1371/journal.pone.0145672	http://dx.doi.org/10.1371/journal.pone.0145672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701122	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600116
J	Saino, H; Sugiyabu, T; Ueno, G; Yamamoto, M; Ishii, Y; Miyano, M				Saino, Hiromichi; Sugiyabu, Tomohiro; Ueno, Go; Yamamoto, Masaki; Ishii, Yoshikazu; Miyano, Masashi			Crystal Structure of OXA-58 with the Substrate-Binding Cleft in a Closed State: Insights into the Mobility and Stability of the OXA-58 Structure	PLOS ONE			English	Article							D BETA-LACTAMASE; CLASS-A; CRYSTALLOGRAPHIC STRUCTURE; CARBAPENEMASE OXA-24; OMEGA-LOOP; SPECIFICITY; MECHANISM; AVIBACTAM; INHIBITION; REFINEMENT	OXA-58 is a class D beta-lactamase from the multi-drug resistant Acinetobacter baumannii. We determined the crystal structure of OXA-58 in a novel crystal, and revealed the structure of the substrate-binding cleft in a closed state, distinct from a previously reported OXA-58 crystal structure with the binding cleft in an open state. In the closed state, the movement of three loops (alpha 3-alpha 4, beta 6-beta 7, and beta 8-alpha 10) forms an arch-like architecture over the binding cleft through interaction between the Phe113 residues of alpha 3-alpha 4 and Met225 of beta 6-beta 7. This structure suggests the involvement of these flexible loops in OXA-58 substrate binding. In contrast to the mobile loops, the Omega-loop appeared static, including the conserved loop residues and their hydrogen bonds; the pivotal residue Trp169 within the Omega-loop, zeta-carbamic acid of the modified base catalyst residue Lys86, and nucleophilic residue Ser83. The stability of OXA-58 was enhanced concomitant with an increase in the hydrolytic activity catalyzed by NaHCO3-dependent zeta-carbamic acid formation, with an EC50 of 0.34 mM. The W169A mutant enzyme was significantly thermally unstable even in the presence of 100 mM NaHCO3, whereas the S83A mutant was stabilized with NaHCO3-dependent activation. The zeta-carbamic acid was shown to increase not only OXA-58 hydrolytic activity but also OXA-58 stability through the formation of a hydrogen bond network connected to the Omega-loop with Ser83 and Trp169. Thus, the static Omega-loop is important for OXA-58 stability, whereas the mobile loops of the substrate-binding cleft form the basis for accommodation of the various substituents of beta-lactam backbone.	[Saino, Hiromichi; Sugiyabu, Tomohiro; Miyano, Masashi] Aoyama Gakuin Univ, Coll Sci & Engn, Dept Chem & Biol Sci, Sagamihara, Kanagawa, Japan; [Ueno, Go; Yamamoto, Masaki] RIKEN, SPring Ctr 8, Adv Photon Technol Div, Sayo, Hyogo, Japan; [Ishii, Yoshikazu] Toho Univ, Fac Med, Dept Microbiol & Infect Dis, Tokyo, Japan	Aoyama Gakuin University; RIKEN; Toho University	Saino, H (corresponding author), Aoyama Gakuin Univ, Coll Sci & Engn, Dept Chem & Biol Sci, Sagamihara, Kanagawa, Japan.	saino@chem.aoyama.ac.jp	Yamamoto, Masaki/B-7844-2015; Miyano, Masashi/R-2785-2016	Yamamoto, Masaki/0000-0002-1311-1768; Miyano, Masashi/0000-0003-2253-6175	Japan Society for the Promotion of Science KAKENHI [15K21356]; Ministry of Education, Culture, Sports, Science and Technology Supported Program for the Strategic Research Foundation at Private Universities [S1311005]; Grants-in-Aid for Scientific Research [25461524] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology Supported Program for the Strategic Research Foundation at Private Universities; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	HS received a grant from Japan Society for the Promotion of Science KAKENHI, Grant-in-Aid for Young Scientists (B) 15K21356, which had roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder's website: https://www.jsps.go.jp/english/index.html. MM received a grant from Ministry of Education, Culture, Sports, Science and Technology Supported Program for the Strategic Research Foundation at Private Universities (2013-2017) S1311005, which had roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder's website: http://www.mext.go.jp/english/.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2013, ACTA CRYSTALLOGR D, V69, P625, DOI 10.1107/S0907444913000462; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Afonine PV, 2009, J APPL CRYSTALLOGR, V42, P607, DOI 10.1107/S0021889809023528; [Anonymous], 2014, PYM MOL GRAPH SYST V; Antunes NT, 2014, ANTIMICROB AGENTS CH, V58, P2119, DOI 10.1128/AAC.02522-13; Banerjee S, 1998, BIOCHEMISTRY-US, V37, P3286, DOI 10.1021/bi972127f; Baurin S, 2009, BIOCHEMISTRY-US, V48, P11252, DOI 10.1021/bi901548c; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Buchman JS, 2012, BIOCHEMISTRY-US, V51, P3143, DOI 10.1021/bi201896k; DeLano W. L, 2002, CCP4 NEWSLETTER PROT, P40; Docquier JD, 2010, ANTIMICROB AGENTS CH, V54, P2167, DOI 10.1128/AAC.01517-09; Docquier JD, 2009, CHEM BIOL, V16, P540, DOI 10.1016/j.chembiol.2009.04.010; Ehmann DE, 2013, J BIOL CHEM, V288, P27960, DOI 10.1074/jbc.M113.485979; Ehmann DE, 2012, P NATL ACAD SCI USA, V109, P11663, DOI 10.1073/pnas.1205073109; El Garch F, 2011, ANTIMICROB AGENTS CH, V55, P4828, DOI 10.1128/AAC.00522-11; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Ibuka AS, 2003, BIOCHEMISTRY-US, V42, P10634, DOI 10.1021/bi0342822; June CM, 2014, ANTIMICROB AGENTS CH, V58, P333, DOI 10.1128/AAC.01483-13; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nitanai Y, 2010, BBA-PROTEINS PROTEOM, V1804, P684, DOI 10.1016/j.bbapap.2009.10.023; Nukaga M, 1998, BIOCHEMISTRY-US, V37, P10461, DOI 10.1021/bi980184i; Okazaki N, 2008, J SYNCHROTRON RADIAT, V15, P288, DOI 10.1107/S0909049507064679; Paetzel M, 2000, NAT STRUCT BIOL, V7, P918; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P202, DOI 10.1128/AAC.49.1.202-208.2005; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Santillana E, 2007, P NATL ACAD SCI USA, V104, P5354, DOI 10.1073/pnas.0607557104; Schneider KD, 2011, J MOL BIOL, V406, P583, DOI 10.1016/j.jmb.2010.12.042; Shimamura T, 2002, J BIOL CHEM, V277, P46601, DOI 10.1074/jbc.M207884200; Smith CA, 2014, ANTIMICROB AGENTS CH, V58, P2135, DOI 10.1128/AAC.01983-13; Smith CA, 2013, CHEM BIOL, V20, P1107, DOI 10.1016/j.chembiol.2013.07.015; Sun T, 2003, PROTEIN SCI, V12, P82, DOI 10.1110/ps.0224303; Thomas VL, 2010, J MOL BIOL, V396, P47, DOI 10.1016/j.jmb.2009.11.005; Thomas W, 2015, GNUPLOT 5 0 INTERACT; Verma V, 2011, J BIOL CHEM, V286, P37292, DOI 10.1074/jbc.M111.280115; Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Yoshizumi A, 2015, J INFECT CHEMOTHER, V21, P148, DOI 10.1016/j.jiac.2014.08.028	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145869	10.1371/journal.pone.0145869	http://dx.doi.org/10.1371/journal.pone.0145869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701320	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600137
J	Tin, STW; Iro, G; Gadabu, E; Colagiuri, R				Tin, Si Thu Win; Iro, George; Gadabu, Eva; Colagiuri, Ruth			Counting the Cost of Diabetes in the Solomon Islands and Nauru	PLOS ONE			English	Article							CARE; PREVALENCE; PEOPLE; BURDEN	Aim To determine the costs associated with diabetes to governments, people with diabetes and their carers, and its impact on quality of life in two Pacific Island countries-the Solomon Islands and Nauru. Materials and Methods This cross-sectional cost of illness study was conducted on 330 people with type 2 diabetes (197 from the Solomon Islands and 133 from Nauru) using a structured cost of illness survey questionnaire adapted from the Australian DiabCo$t study. Quality of life was measured by the EQ-5D Visual Analogue Scale. Results There were 330 respondents (50% female; mean duration of diabetes 10.9 years; mean age 52.6 years). The estimated annual national cost of diabetes incurred by the Solomon Islands government was AUD12.8 million (AUD281 per person/year) and by Nauru government was AUD1.2 million (AUD747 per person/year). The major contribution to the government costs was inpatient services cost (71% in the Solomon Islands and 83% in Nauru). Annual expenditure for diabetes was approximately 20% of the governments' annual health care expenditure. Considerable absenteeism and retirement from work due to diabetes was found. Conclusions This study found substantial public and personal costs associated with diabetes. The findings provide objective data on which health policy, funding and planning decisions about the prevention and control of diabetes in the Solomon Islands and Nauru can be reliably based and subsequently evaluated.	[Tin, Si Thu Win] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia; [Iro, George] Minist Hlth & Med Serv, Natl Diabet Ctr, Honiara, Solomon Islands; [Gadabu, Eva] Minist Hlth & Med Serv, Natl Diabet Ctr, Yaren, Nauru; [Tin, Si Thu Win; Colagiuri, Ruth] Univ Sydney, Menzies Ctr Hlth Policy, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Tin, STW (corresponding author), Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia.	si.wintin@sydney.edu.au			World Diabetes Foundation; Solomon Islands MHMS; Nauru MHMS; International Centre for Eyecare Education at the University of New South Wales and the Australia; New Zealand Society of Nephrologists	World Diabetes Foundation; Solomon Islands MHMS; Nauru MHMS; International Centre for Eyecare Education at the University of New South Wales and the Australia; New Zealand Society of Nephrologists	This study was conducted as part of a broader diabetes capacity building project in the Solomon Islands and Nauru funded by the World Diabetes Foundation (http://www.worlddiabetesfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was conducted as part of a broader World Diabetes Foundation funded project in partnership with the Solomon Islands MHMS, Nauru MHMS, the International Centre for Eyecare Education at the University of New South Wales and the Australia and New Zealand Society of Nephrologists.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; [Anonymous], 2009, REP 2009 POP HOUS CE; [Anonymous], 2011, DIAB ATL; [Anonymous], 2011, SOL ISL GOV 2011 201; [Anonymous], 2011, NAT REP POP HOUS REP; [Anonymous], 2013, SOL ISL BUDG BUDG ST; [Anonymous], EUROQOL EQ 5D US GUI; Barcelo A, 2003, B WORLD HEALTH ORGAN, V81, P19; Bruno G, 2008, DIABETOLOGIA, V51, P795, DOI 10.1007/s00125-008-0957-4; Central Intelligence Agency, WORLD FACTBOOK; Clarke P, 2006, J DIABETES COMPLICAT, V20, P349, DOI 10.1016/j.jdiacomp.2005.08.004; Colagiuri R, 2006, PRACT DIAB INT, V23, P343; Colagiuri SCR, 2003, DIABCOST AUSTR ASSES; COLLINS VR, 1995, DIABETES CARE, V18, P1140, DOI 10.2337/diacare.18.8.1140; Dall TM, 2010, HEALTH AFFAIR, V29, DOI 10.1377/hlthaff.2009.0155; Doran C, 2003, EC ASS INP NCD COSTS; Falconer DG, 2010, DIABETES RES CLIN PR, V87, P92, DOI 10.1016/j.diabres.2009.09.022; Fu AZ, 2009, DIABETES CARE, V32, P2187, DOI 10.2337/dc09-1128; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; *INT DIAB FED, 2006, DIAB ATL; International diabetes federation, 2010, CALL ACT DIAB; International Diabetes Federation IDF, 2013, DIAB ATL; Javanbakht M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026864; Jonsson B, 2002, DIABETOLOGIA, V45, pS5, DOI 10.1007/s00125-002-0858-x; Khowaja LA, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-189; Koster I, 2006, DIABETOLOGIA, V49, P1498, DOI 10.1007/s00125-006-0277-5; Lee CMY, 2013, DIABETES RES CLIN PR, V99, P385, DOI 10.1016/j.diabres.2012.12.002; McBrien KA, 2013, DIABETES CARE, V36, P1172, DOI 10.2337/dc12-0862; Ministry of Health and Medical Services, 2010, STRAT PLAN REP NAUR; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Shemilt I, 2010, EVID POLICY, V6, P51, DOI 10.1332/174426410X482999; Tin STW, 2014, DIABETES RES CLIN PR, V103, P114, DOI 10.1016/j.diabres.2013.09.017; Tin STW, 2013, DIABETES RES CLIN PR, V100, P230, DOI 10.1016/j.diabres.2013.03.012; *WHO, 2005, PREV CHR DIS VIT INV; World Bank, 2014, SKILLS SOL ISL OP NE; Yang WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039513; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	37	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145603	10.1371/journal.pone.0145603	http://dx.doi.org/10.1371/journal.pone.0145603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698575	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600103
J	Zhang, T; Li, SY; Sun, XY; Zhang, Y; Gong, XQ; Fu, Y; Jia, LM				Zhang, Tao; Li, Suyan; Sun, Xiangyang; Zhang, Yang; Gong, Xiaoqiang; Fu, Ying; Jia, Liming			The Earthworm Eisenia fetida Can Help Desalinate a Coastal Saline Soil in Tianjin, North China	PLOS ONE			English	Article							PLANT; RESTORATION	A laboratory microcosm experiment was conducted to determine whether the earthworm Eisenia fetida could survive in a saline soil from a field site in North China, and an experiment using response surface methodology was conducted at that field site to quantify the effects of E. fetida and green waste compost (GWC) on the salt content of the soil. The microcosm results showed that E. fetida survived in GWC-amended saline soil and increased the contents of humic acid, available N, and available P in the GWC-amended soil. The data from the field experiment were described by the following second-order model: y = -1.76+0.091x(1)+0: 48x(2)-0.00083x(1)x(2)-0.00078x(1)(2)-0.022x(2)(2), where y is the decrease in soil salinity (g of salt per kg of dry soil) relative to the untreated control, x(1) is the number of E. fetida added per m(2), and x(2) is the quantity of GWC added in kg per m(2). The model predicted that the total salt content of the saline soil would decrease by >2 g kg(-1) (p<0.05) when 29-90 individuals m(-2) of E. fetida and 6.1-15.0 kg m(-2) of GWC were applied. We conclude that the use of E. fetida for soil desalination is promising and warrants additional investigation.	[Zhang, Tao; Li, Suyan; Sun, Xiangyang; Zhang, Yang; Gong, Xiaoqiang] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Fu, Ying] Shandong ShengWei Gardening Technol Co Ltd, Weifang, Shandong, Peoples R China; [Jia, Liming] Tianjin JiaLiMing Biol Technol Co Ltd, Tianjin, Peoples R China	Beijing Forestry University	Li, SY (corresponding author), Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China.	lisuyan@bjfu.edu.cn			Special Fund for Forest Scientific Research in the Public Welfare "Development and Application of Technology of Converting Forestry Waste into Growing Media" [201504205]; Graduate Training and Development Program of Beijing Municipal Commission of Education "Application of Earthworms and Green Waste Compost in Saline Soil Amelioration of Beijing-Tianjin-Hebei Coastal Area" [BLCXY201604]; Shandong ShengWei Gardening Technology Co., Ltd.; Tianjin JiaLiMing Biological Technology Co., Ltd.	Special Fund for Forest Scientific Research in the Public Welfare "Development and Application of Technology of Converting Forestry Waste into Growing Media"; Graduate Training and Development Program of Beijing Municipal Commission of Education "Application of Earthworms and Green Waste Compost in Saline Soil Amelioration of Beijing-Tianjin-Hebei Coastal Area"; Shandong ShengWei Gardening Technology Co., Ltd.; Tianjin JiaLiMing Biological Technology Co., Ltd.	This research was supported by the Special Fund for Forest Scientific Research in the Public Welfare "Development and Application of Technology of Converting Forestry Waste into Growing Media" (201504205), and the Graduate Training and Development Program of Beijing Municipal Commission of Education "Application of Earthworms and Green Waste Compost in Saline Soil Amelioration of Beijing-Tianjin-Hebei Coastal Area" (BLCXY201604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shandong ShengWei Gardening Technology Co., Ltd. and Tianjin JiaLiMing Biological Technology Co., Ltd. provided support in the form of salaries for authors [YF] [LJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; BROWN GG, 1995, PLANT SOIL, V170, P209, DOI 10.1007/BF02183068; [仓龙 Cang Long], 2002, [农村生态环境, Rural Eco-Environment], V18, P38; Cortez J, 2000, BIOL FERT SOILS, V30, P318, DOI 10.1007/s003740050010; Daniel Voss, 1999, DESIGN ANAL EXPT; Frund HC, 2010, PEDOBIOLOGIA, V53, P119, DOI 10.1016/j.pedobi.2009.07.002; Guo JS, 1981, CHINESE J ZOOLOGY, P47; Holdsworth AR, 2007, CONSERV BIOL, V21, P997, DOI 10.1111/j.1523-1739.2007.00740.x; Huang Jian, 2006, Zhongguo Nongye Daxue Xuebao, V11, P9; Huang ZH, 1995, FORESTRY EXPT DESIGN; Institute of soil science, 1978, SOIL PHYS CHEM AN; Kursakova VS, 2006, EURASIAN SOIL SCI+, V39, P748, DOI 10.1134/S1064229306070088; Le Bayon RC, 2006, SOIL BIOL BIOCHEM, V38, P235, DOI 10.1016/j.soilbio.2005.05.013; [李素艳 Li Suyan], 2014, [应用基础与工程科学学报, Journal of Basic Science and Engineering], V22, P1069; Liu MS, 2005, EARTHWORM CULTIVATIO; Lowe CN, 2005, PEDOBIOLOGIA, V49, P401, DOI 10.1016/j.pedobi.2005.04.005; Lu R.K., 2000, METHOD SOIL AGR CHEM; Mao S., 2012, EXPT DESIGN, V2; Pan HP, FARMING PROCESSING M; [庞军柱 PANG Jun-Zhu], 2009, [生态学报, Acta Ecologica Sinica], V29, P1017; Qin P, 2002, AGROECOLOGICAL PROJE; Roca-Perez L, 2009, CHEMOSPHERE, V75, P781, DOI 10.1016/j.chemosphere.2008.12.058; Singh K, 2012, CATENA, V96, P57, DOI 10.1016/j.catena.2012.04.007; Singh K, 2012, ECOL ENG, V43, P70, DOI 10.1016/j.ecoleng.2012.02.029; Snyder BA, 2008, RESTOR ECOL, V16, P629, DOI 10.1111/j.1526-100X.2008.00484.x; Sun X.Y., 2004, SOIL SCI; Sun ZJ, 2004, EARTHWORM REACTOR WA; [陶军 TAO Jun], 2010, [资源科学, Resources Science], V32, P466; van der Werff P.A., 1995, Acta Zoologica Fennica, V196, P41; [王琳琳 Wang Linlin], 2015, [生态学报, Acta Ecologica Sinica], V35, P1388; Wang LS, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084485, 10.1371/journal.pone.0109465, 10.1371/journal.pone.0107044, 10.1371/journal.pone.0089185]; [王悦 Wang Yue], 2008, [环境污染与防治, Environmental Pollution & Control], V30, P28; Wolfarth Friederike, 2011, Mycotoxin Res, V27, P215, DOI 10.1007/s12550-011-0098-3; Wu WL, 2001, ACTA ECOLOGICA SINIC, V21, P1109; [伍玉鹏 Wu Yupeng], 2013, [中国农业大学学报, Journal of China Agricultural University], V18, P45; Wurst S, 2004, NEW PHYTOL, V163, P169, DOI 10.1111/j.1469-8137.2004.01106.x; Wurst S, 2003, OECOLOGIA, V137, P90, DOI 10.1007/s00442-003-1329-x; Xie CT, 1993, PRINCIPLES SOIL AMEL; Xu HG, 2004, HALOPHYTIC VEGETATIO; [徐玉坤 Xu Yukun], 2014, [土壤通报, Chinese Journal of Soil Science], V45, P1071; Zeng YM, 2010, J W CHINA FORESTRY S, V39, P50; Zeng YuMin, 2010, Journal of Northeast Forestry University, V38, P47; [翟鹏辉 Zhai Penghui], 2012, [中国水土保持科学, Science of Soil and Water Conservation], V10, P80; Zhang B G, 2000, ACTA ECOLOGICA SINIC, V20, P168; Zhang L, 2013, BIORESOURCE TECHNOL, V131, P68, DOI 10.1016/j.biortech.2012.10.059	45	6	9	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144709	10.1371/journal.pone.0144709	http://dx.doi.org/10.1371/journal.pone.0144709			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699869	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600029
J	Arcari, L; Cimino, S; De Luca, L; Francone, M; Galea, N; Reali, M; Carbone, I; Iacoboni, C; Agati, L				Arcari, Luca; Cimino, Sara; De Luca, Laura; Francone, Marco; Galea, Nicola; Reali, Manuela; Carbone, Iacopo; Iacoboni, Carlo; Agati, Luciano			Impact of Heart Rate on Myocardial Salvage in Timely Reperfused Patients with ST-Segment Elevation Myocardial Infarction: New Insights from Cardiovascular Magnetic Resonance	PLOS ONE			English	Article							PRIMARY CORONARY ANGIOPLASTY; MICROVASCULAR DAMAGE; DELAYED-ENHANCEMENT; ISCHEMIC MYOCARDIUM; DOUBLE-BLIND; BLOOD-FLOW; SIZE; RISK; IVABRADINE; AREA	Background Previous studies evaluating the progression of the necrotic wave in relation to heart rate were carried out only in animal models of ST-elevated myocardial infarction (STEMI). Aim of the study was to investigate changes of myocardial salvage in relation to different heart rates at hospital admission in timely reperfused patients with STEMI by using cardiovascular magnetic resonance (CMR). Methods One hundred-eighty-seven patients with STEMI successfully and timely treated with primary coronary angioplasty underwent CMR five days after hospital admission. According to the heart rate at presentation, patients were subcategorized into 5 quintiles: <55 bpm (group I, n = 44), 55-64 bpm (group II, n = 35), 65-74 bpm (group III, n = 35), 75-84 bpm (group IV, n = 37), >= 85 bpm (group V, n = 36). Area at risk, infarct size, microvascular obstruction (MVO) and myocardium salvaged index (MSI) were assessed by CMR using standard sequences. Results Lower heart rates at presentation were associated with a bigger amount of myocardial salvage after reperfusion. MSI progressively decreased as the heart rates increased (0.54 group I, 0.46 group II, 0.38 group III, 0.34 group IV, 0.32 group V, p<0.001). Stepwise multivariable analysis showed heart rate, peak troponin and the presence of MVO were independent predictor of myocardial salvage. No changes related to heart rate were observed in relation to area at risk and infarct size. Conclusions High heart rates registered before performing coronary angioplasty in timely reperfused patients with STEMI are associated with a reduction in salvaged myocardium. In particular, salvaged myocardium significantly reduced when heart rate at presentation is >= 85 bpm.	[Arcari, Luca; Cimino, Sara; De Luca, Laura; Reali, Manuela; Iacoboni, Carlo; Agati, Luciano] Univ Roma La Sapienza, Dept Cardiol, I-00185 Rome, Italy; [Francone, Marco; Galea, Nicola; Carbone, Iacopo] Univ Roma La Sapienza, Dept Radiol, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome	Agati, L (corresponding author), Univ Roma La Sapienza, Dept Cardiol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	luciano.agati@uniroma1.it	Agati, Luciano/AFQ-4559-2022; Galea, Nicola/AAQ-6612-2020; Francone, Marco/AAQ-5434-2020; Arcari, Luca/Y-6534-2019	Agati, Luciano/0000-0003-3186-1797; Galea, Nicola/0000-0003-4708-5120; Arcari, Luca/0000-0003-1410-6845; CIMINO, SARA/0000-0002-8948-4122; carbone, iacopo/0000-0003-3108-7527				Abdel-Aty H, 2004, CIRCULATION, V109, P2411, DOI 10.1161/01.CIR.0000127428.10985.C6; Abdel-Aty H, 2007, J MAGN RESON IMAGING, V26, P452, DOI 10.1002/jmri.21028; AGATI L, 1994, J AM COLL CARDIOL, V24, P336, DOI 10.1016/0735-1097(94)90285-2; Aletras AH, 2006, CIRCULATION, V113, P1865, DOI 10.1161/CIRCULATIONAHA.105.576025; Antoni ML, 2012, EUR HEART J, V33, P96, DOI 10.1093/eurheartj/ehr293; Berry C, 2010, CIRC-CARDIOVASC IMAG, V3, P527, DOI 10.1161/CIRCIMAGING.109.900761; Bondarenko O, 2005, J CARDIOV MAGN RESON, V7, P481, DOI 10.1081/JCMR-200053623; Botker HE, 2012, CARDIOVASC RES, V94, P266, DOI 10.1093/cvr/cvs081; Canali E, 2012, EUR HEART J-CARD IMG, V13, P948, DOI 10.1093/ehjci/jes087; Dymarkowski S, 2002, INVEST RADIOL, V37, P77, DOI 10.1097/00004424-200202000-00005; Eitel I, 2011, HEART, V97, P2038, DOI 10.1136/heartjnl-2011-300098; Eitel I, 2010, J AM COLL CARDIOL, V55, P2470, DOI 10.1016/j.jacc.2010.01.049; Fernandez-Jimenez R, 2015, J AM COLL CARDIOL, V65, P315, DOI 10.1016/j.jacc.2014.11.004; Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8; Francone M, 2009, J AM COLL CARDIOL, V54, P2145, DOI 10.1016/j.jacc.2009.08.024; Friedrich MG, 2008, J AM COLL CARDIOL, V51, P1581, DOI 10.1016/j.jacc.2008.01.019; Galiuto L, 2008, J AM COLL CARDIOL, V51, P552, DOI 10.1016/j.jacc.2007.09.051; Gerber BL, 2007, EUR HEART J, V28, P1670, DOI 10.1093/eurheartj/ehm213; Heusch G, 2008, EUR HEART J, V29, P2265, DOI 10.1093/eurheartj/ehn337; KANNEL WB, 1987, AM HEART J, V113, P1489, DOI 10.1016/0002-8703(87)90666-1; Larsen JR, 2012, ACTA ANAESTH SCAND, V56, P57, DOI 10.1111/j.1399-6576.2011.02580.x; MAROKO PR, 1971, CIRCULATION, V43, P67, DOI 10.1161/01.CIR.43.1.67; Masci PG, 2013, EUR HEART J-CARD IMG, V14, P1041, DOI 10.1093/ehjci/jet063; Masci PG, 2011, EUR HEART J, V32, P1640, DOI 10.1093/eurheartj/ehr064; Masci PG, 2010, JACC-CARDIOVASC IMAG, V3, P45, DOI 10.1016/j.jcmg.2009.06.016; Ortiz-Perez JT, 2010, JACC-CARDIOVASC IMAG, V3, P491, DOI 10.1016/j.jcmg.2010.02.004; Parodi G, 2010, ATHEROSCLEROSIS, V211, P255, DOI 10.1016/j.atherosclerosis.2010.02.017; PRZYKLENK K, 1986, CARDIOVASC RES, V20, P403, DOI 10.1093/cvr/20.6.403; RASMUSSEN MM, 1977, CIRCULATION, V56, P794, DOI 10.1161/01.CIR.56.5.794; REIMER KA, 1977, CIRCULATION, V56, P786, DOI 10.1161/01.CIR.56.5.786; REIMER KA, 1985, CIRC RES, V56, P651, DOI 10.1161/01.RES.56.5.651; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; Simonetti OP, 1996, RADIOLOGY, V199, P49, DOI 10.1148/radiology.199.1.8633172; Steg PG, 2013, EUR HEART J-ACUTE CA, V2, P270, DOI 10.1177/2048872613489305; Stork A, 2006, EUR RADIOL, V16, P2350, DOI 10.1007/s00330-006-0232-3; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Traupe T, 2013, HEART, V0, P1; Zuanetti G, 1998, EUR HEART J, V19, pF19	38	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145495	10.1371/journal.pone.0145495	http://dx.doi.org/10.1371/journal.pone.0145495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716452	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500039
J	Chen, PC; Shih, CH; Chu, TJ; Wang, D; Lee, YC; Tzeng, TD				Chen, Po-Cheng; Shih, Chun-Han; Chu, Ta-Jen; Wang, Daryi; Lee, Ying-Chou; Tzeng, Tzong-Der			Population Structure and Historical Demography of the Oriental River Prawn (Macrobrachium nipponense) in Taiwan	PLOS ONE			English	Article							FRESH-WATER FISHES; MOLECULAR SYSTEMATICS; GENETIC-EVIDENCE; PHYLOGEOGRAPHY; DECAPODA; SEA; CRUSTACEA; PATTERNS; CARIDEA; MTDNA	The oriental river prawn (Macrobrachium nipponense) is a non-obligatory amphidromous prawn, and it has a wide distribution covering almost the entire Taiwan. Mitochondrial DNA fragment sequences of the cytochrome oxidase subunit I (COI) and 16S rRNA were combined and used to elucidate the population structure and historical demography of oriental river prawn in Taiwan. A total of 202 individuals from six reservoirs and three estuaries were separately collected. Nucleotide diversity (pi) of all populations was 0.01217, with values ranging from 0.00188 (Shihmen Reservoir, SMR, northern Taiwan) to 0.01425 (Mingte Reservoir, MTR, west-central Taiwan). All 76 haplotypes were divided into 2 lineages: lineage A included individuals from all sampling areas except SMR, and lineage B included specimens from all sampling locations except Chengching Lake Reservoir (CLR) and Liyu Lake Reservoir (LLR). All F-ST values among nine populations were significantly different except the one between Jhonggang River Estuary (JGE, west-central Taiwan) and Kaoping River Estuary (KPE, southern Taiwan). UPGMA tree of nine populations showed two main groups: the first group included the SMR and Tamsui River Estuary (TSE) (both located northern Taiwan), and the second one included the other seven populations (west-central, southern and eastern Taiwan). Demographic analyses implied a population expansion occurred during the recent history of the species. The dispersal route of this species might be from China to west-central and west-southern Taiwan, and then the part individuals belonging to lineage A and B dispersed southerly and northerly, respectively. And then part individuals in west-central Taiwan fell back to and stay at estuaries as the sea level rose about 18,000 years ago.	[Chen, Po-Cheng; Lee, Ying-Chou] Natl Taiwan Univ, Inst Fisheries Sci, Coll Life Sci, Taipei 106, Taiwan; [Shih, Chun-Han] Tungnan Univ, Dept Leisure Management, New Taipei 222, Taiwan; [Chu, Ta-Jen] Chung Hua Univ, Dept Leisure & Recreat Management, Hsinchu 300, Taiwan; [Wang, Daryi] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Tzeng, Tzong-Der] Shu Te Univ, Dept Leisure Recreat & Tourism Management, Kaohsiung 824, Taiwan	National Taiwan University; Chung Hua University; Academia Sinica - Taiwan; Shu-Te University	Lee, YC (corresponding author), Natl Taiwan Univ, Inst Fisheries Sci, Coll Life Sci, Taipei 106, Taiwan.	i812@ntu.edu.tw; tdtzeng@stu.edu.tw	Francisco, Sara/K-8239-2013; Vieira, Natividade R/B-5683-2009; , 朱達仁/AGA-5114-2022	Francisco, Sara/0000-0003-0907-7453; Vieira, Natividade R/0000-0003-1297-6046; 	Ministry of Science and Technology [MOST 104-2611-M-366-001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by the Ministry of Science and Technology grant number MOST 104-2611-M-366-001. The funders had role in study design, data collection and analysis, and preparation of the manuscript.	Avise JC, 2000, PHYLOGEOGRAPHY HIST, P301; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bermingham E, 1998, MOL ECOL, V7, P499, DOI 10.1046/j.1365-294x.1998.00358.x; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; Cai YX, 2006, RAFFLES B ZOOL, V54, P245; Cai YX, 2002, HYDROBIOLOGIA, V487, P59, DOI 10.1023/A:1022991224381; Chen PC, 2015, LIMNOLOGICA, V52, P51, DOI 10.1016/j.limno.2015.03.002; Chen RT, 2009, J CRUSTACEAN BIOL, V29, P232, DOI 10.1651/08-3072.1; Chiang TY, 2010, J FISH BIOL, V76, P1173, DOI 10.1111/j.1095-8649.2010.02589.x; Chiang TY, 1999, MOL ECOL, V8, P1037, DOI 10.1046/j.1365-294x.1999.00668.x; CLARK JA, 1979, QUATERNARY RES, V11, P279, DOI 10.1016/0033-5894(79)90076-0; Crandall KA, 1996, SYST BIOL, V45, P1; CRANDALL KA, 1993, GENETICS, V134, P959; Craw D, 2007, GEOMORPHOLOGY, V84, P98, DOI 10.1016/j.geomorph.2006.07.008; Creer S, 2001, MOL ECOL, V10, P1967, DOI 10.1046/j.0962-1083.2001.01332.x; de Grave Sammy, 2006, Aquatic Invasions, V1, P204; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fu YX, 1997, GENETICS, V147, P915; GASCOYNE M, 1979, SCIENCE, V205, P806, DOI 10.1126/science.205.4408.806; GOLDING GB, 1987, GENET RES, V49, P71, DOI 10.1017/S0016672300026768; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; HOELZEL AR, 1991, MOL BIOL EVOL, V8, P475; HUANG CY, 1995, TECTONICS, V14, P19, DOI 10.1029/94TC02452; Li TJ, 1986, DYNAMIC ANAL CONDITI, P81; Liao TY, 2008, ZOOL STUD, V47, P383; Liu CH, 1986, INVESTIGATION MULLET, P56; Liu J, 2003, J LAKE SCI, V15, P177; Liu MY, 2007, ZOOL STUD, V46, P272; Liu MY, 2011, HYDROBIOLOGIA, V671, P1, DOI 10.1007/s10750-011-0699-z; LUNDBERG JG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P156; MASHIKO K, 1990, J CRUSTACEAN BIOL, V10, P306, DOI 10.2307/1548489; MASHIKO K, 1993, ZOOL SCI, V10, P161; Mashiko K, 2000, J CRUSTACEAN BIOL, V20, P118, DOI 10.1651/0278-0372(2000)020[0118:DOPWDS]2.0.CO;2; Mashiko K, 2008, J CRUSTACEAN BIOL, V28, P370, DOI 10.1651/0278-0372(2008)028[0370:DOFMAS]2.0.CO;2; Mirabdullaev IM, 2005, 2 INT S INV AL SPEC, P106; NEI M, 1987, MOL EVOLUTIONARY GEN, P1, DOI DOI 10.7312/NEI-92038; Ota H, 1998, RES POPUL ECOL, V40, P189, DOI 10.1007/BF02763404; PEPIN P, 1993, CAN J FISH AQUAT SCI, V50, P1924, DOI 10.1139/f93-215; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Salman Salman D., 2006, Aquatic Invasions, V1, P109, DOI 10.3391/ai.2006.1.3.2; Sambrook J, 2001, MOL CLONING LAB MANU, P66; Shih CH, 2011, CHINA OCEAN ENG, V25, P215, DOI 10.1007/s13344-011-0019-4; Shih HT, 2006, J BIOGEOGR, V33, P980, DOI 10.1111/j.1365-2699.2006.01472.x; Shy JY, 1987, J FISH SOC TAIWAN, V14, P14; Stanley HF, 1996, MOL BIOL EVOL, V13, P368, DOI 10.1093/oxfordjournals.molbev.a025596; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TZENG C-S, 1986, Journal of Taiwan Museum, V39, P127; Tzeng CS, 2006, ZOOL STUD, V45, P285; Wang HY, 1999, MOL ECOL, V8, P1879, DOI 10.1046/j.1365-294x.1999.00787.x; Wang JP, 2004, MOL PHYLOGENET EVOL, V31, P1143, DOI 10.1016/j.ympev.2003.10.001; Wang JP, 2000, MOL ECOL, V9, P1483, DOI 10.1046/j.1365-294x.2000.01023.x; Wang TY, 2007, ZOOL STUD, V46, P569; Wu B, 1982, TAIWAN STRAIT, V1, P1; Wu S.-C., 1990, Bulletin of Taiwan Fisheries Research Institute, P121; Xiao SB, 2004, J COASTAL RES, V20, P599, DOI 10.2112/1551-5036(2004)020[0599:THOTYR]2.0.CO;2; Yang Pin, 2007, Zoological Research, V28, P113; Yu H-P, 1972, OHMU, V3, P45; Yu HP, 1984, ACTA MARIMA AQUAC, V19, P117	64	9	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145927	10.1371/journal.pone.0145927	http://dx.doi.org/10.1371/journal.pone.0145927			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716687	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500096
J	Franco, A; Leekitcharoenphon, P; Feltrin, F; Alba, P; Cordaro, G; Iurescia, M; Tolli, R; D'Incau, M; Staffolani, M; Di Giannatale, E; Hendriksen, RS; Battisti, A				Franco, Alessia; Leekitcharoenphon, Pimlapas; Feltrin, Fabiola; Alba, Patricia; Cordaro, Gessica; Iurescia, Manuela; Tolli, Rita; D'Incau, Mario; Staffolani, Monica; Di Giannatale, Elisabetta; Hendriksen, Rene S.; Battisti, Antonio			Emergence of a Clonal Lineage of Multidrug-Resistant ESBL-Producing Salmonella Infantis Transmitted from Broilers and Broiler Meat to Humans in Italy between 2011 and 2014	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; FOOD ANIMALS; PLASMIDS; DISSEMINATION; CONSEQUENCES; INFECTIONS; BURDEN; GENES	We report the spread of a clone of multidrug-resistant (MDR), ESBL-producing (bla(CTX-M-1)) Salmonella enterica subsp. enterica serovar Infantis, in the Italian broiler chicken industry and along the food-chain. This was first detected in Italy in 2011 and led to human infection in Italy in 2013-2014. A set (n = 49) of extended-spectrum cephalosporin (ESC)-resistant (R) isolates of S. Infantis (2011-2014) from humans, food-producing animals and meat thereof, were studied along with a selected set of earlier and more recent ESC-susceptible (ESC-S) isolates (n = 42, 2001-2014). They were characterized by macrorestriction-PFGE analysis and genetic environment of ESC-resistance. Isolates representative of PFGE-patterns and origin were submitted to Whole Genome Sequencing. The emerging ESC-R clone, detected mainly from broiler chickens, broiler meat and humans, showed a minimum pattern of clinical resistance to cefotaxime, tetracycline, sulfonamides, and trimethoprim, beside ciprofloxacin microbiological resistance (MIC 0.25 mg/L). All isolates of this clone harbored a conjugative megaplasmid (similar to 280-320 Kb), similar to that described in ESC-susceptible S. Infantis in Israel (pESI-like) in 2014. This megaplasmid carried the ESBL gene bla(CTX-M-1), and additional genes [tet(A), sul1, dfrA1 and dfrA14] mediating cefotaxime, tetracycline, sulfonamide, and trimethoprim resistance. It also contained genes conferring enhanced colonization capability, virulence (fimbriae, yersiniabactin), resistance and fitness (qacE1, mer) in the intensive-farming environment. This emerging clone of S. Infantis has been causing infections in humans, most likely through the broiler industry. Since S. Infantis is among major serovars causing human infections in Europe and is an emerging non-typhoidal Salmonella globally, further spread of this lineage in primary productions deserves quick and thorough risk-management strategies.	[Franco, Alessia; Feltrin, Fabiola; Alba, Patricia; Cordaro, Gessica; Iurescia, Manuela; Tolli, Rita; Battisti, Antonio] Ist Zooprofilatt Sperimentale Lazio & Toscana M A, Natl Reference Lab Antimicrobial Resistance, I-00178 Rome, Italy; [Leekitcharoenphon, Pimlapas; Hendriksen, Rene S.] Tech Univ Denmark, Natl Food Inst, WHO Collaborating Ctr Antimicrobial Resistance Fo, DK-2800 Lyngby, Denmark; [Leekitcharoenphon, Pimlapas; Hendriksen, Rene S.] European Union Reference Lab Antimicrobial Resist, Lyngby, Denmark; [D'Incau, Mario] Ist Zooprofilatt Sperimentale Lombardia & Emilia, I-25124 Brescia, Italy; [Staffolani, Monica] Ist Zooprofilatt Sperimentale Umbria & Marche, Sez Macerata, I-62100 Macerata, Italy; [Di Giannatale, Elisabetta] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, I-64100 Teramo, Italy	IZS Lazio e Toscana; Technical University of Denmark; IZS Lombardia e Emilia; IZS Umbria e Marche; IZS Dell'abruzzo E Del Molise Giuseppe Caporale	Battisti, A (corresponding author), Ist Zooprofilatt Sperimentale Lazio & Toscana M A, Natl Reference Lab Antimicrobial Resistance, Via Appia Nuova 1411, I-00178 Rome, Italy.	antonio.battisti@izslt.it	Leekitcharoenphon, Pimlapas/AAB-5487-2021; Di Giannatale, Elisabetta/J-9010-2016; Iurescia, Manuela/AAE-9267-2021; Alba, Patricia/T-3593-2018; Battisti, Antonio/AAQ-9243-2021; D'Incau, Mario/W-8784-2018	Di Giannatale, Elisabetta/0000-0001-8874-5856; Iurescia, Manuela/0000-0001-9527-8600; Alba, Patricia/0000-0002-9621-0955; Battisti, Antonio/0000-0003-1308-199X; D'Incau, Mario/0000-0001-9918-2497; Hendriksen, Rene S./0000-0003-2934-8214; Franco, Alessia/0000-0001-6968-973X; Leekitcharoenphon, Pimlapas/0000-0002-5674-0142	European Union [643476]	European Union(European Commission)	This work was supported by the COMPARE project under the European Union's Horizon 2020 research and innovation programme (grant agreement No 643476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AD, 2003, MICROB DRUG RESIST, V9, P373, DOI 10.1089/107662903322762815; Aviv G, 2014, ENVIRON MICROBIOL, V16, P977, DOI 10.1111/1462-2920.12351; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Boelaert F, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.3991; Burke L, 2014, J ANTIMICROB CHEMOTH, V69, P977, DOI 10.1093/jac/dkt469; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Chen PL, 2007, J INTERN MED, V261, P91, DOI 10.1111/j.1365-2796.2006.01748.x; Clinical Laboratory Standard Institute, 2010, M100S23 CLSI, P50; Cloeckaert A, 2007, ANTIMICROB AGENTS CH, V51, P1872, DOI 10.1128/AAC.01514-06; Collignon P, 2009, CLIN INFECT DIS, V49, P132, DOI 10.1086/599374; Deng YT, 2011, ANTIMICROB AGENTS CH, V55, P4926, DOI 10.1128/AAC.00133-11; Desenclos JC, 2004, EMERG INFECT DIS, V10, P759, DOI 10.3201/eid1004.030754; Dionisi AM, 2011, INT J ANTIMICROB AG, V38, P384, DOI 10.1016/j.ijantimicag.2011.07.001; Donati V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090564; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4036; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3590; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Garcia-Migura L, 2012, MICROB DRUG RESIST, V18, P88, DOI 10.1089/mdr.2011.0064; Helms M, 2002, EMERG INFECT DIS, V8, P490, DOI 10.3201/eid0805.010267; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Jones TF, 2008, J INFECT DIS, V198, P109, DOI 10.1086/588823; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Leekitcharoenphon P, 2014, PLOS ONE, V4, DOI [10.1371/journal.pone.0087991, DOI 10.1371/J0URNAL.P0NE.0087991]; Leekitcharoenphon P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S6; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Martin LJ, 2004, J INFECT DIS, V189, P377, DOI 10.1086/381270; Parry CM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001163; Sirichote P, 2010, J CLIN MICROBIOL, V48, P883, DOI 10.1128/JCM.01792-09; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vasallo FJ, 1998, CLIN INFECT DIS, V26, P535, DOI 10.1086/517087; Zheng HQ, 2012, INT J ANTIMICROB AG, V39, P305, DOI 10.1016/j.ijantimicag.2011.12.001	35	97	101	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0144802	10.1371/journal.pone.0144802	http://dx.doi.org/10.1371/journal.pone.0144802			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716443	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500015
J	Kennedy, JA; Syed, S; Schmidt, KH				Kennedy, Jessica A.; Syed, Salahuddin; Schmidt, Kristina H.			Structural Motifs Critical for In Vivo Function and Stability of the RecQ-Mediated Genome Instability Protein Rmi1	PLOS ONE			English	Article							TOPOISOMERASE-III-ALPHA; SACCHAROMYCES-CEREVISIAE; FOLDING PROBLEM; SGS1 HELICASE; COMPLEX; BLM; BINDING; YEAST; RECOMBINATION; DISSOLVASOME	Rmi1 is a member of the Sgs1/Top3/Rmi1 (STR) complex of Saccharomyces cerevisiae and has been implicated in binding and catalytic enhancement of Top3 in the dissolution of double Holliday junctions. Deletion of RMI1 results in a severe growth defect resembling that of top3.. Despite the importance of Rmi1 for cell viability, little is known about its functional domains, particularly in Rmi1 of S. cerevisiae, which does not have a resolved crystal structure and the primary sequence is poorly conserved. Here, we rationally designed point mutations based on bioinformatics analysis of order/disorder and helical propensity to define three functionally important motifs in yeast Rmi1 outside of the proposed OB-fold core. Replacing residues F63, Y218 and E220 with proline, designed to break predicted N-terminal and C-terminal a-helices, or with lysine, designed to eliminate hydrophobic residues at positions 63 and 218, while maintaining a-helical structure, caused hypersensitivity to hydroxyurea. Further, Y218P and E220P mutations, but not F63P and F63K mutations, led to reduced Rmi1 levels compared to wild type Rmi1, suggesting a role of the C-terminal a-helix in Rmi1 stabilization, most likely by protecting the integrity of the OB-fold core. Our bioinformatics analysis also suggests the presence of a disordered linker between the Nterminal a-helix and the OB fold core; a P88A mutation, designed to increase helicity in this linker, also impaired Rmi1 function in vivo. In conclusion, we propose a model that maps all functionally important structural features for yeast Rmi1 based on biological findings in yeast and structure-prediction-based alignment with the recently established crystal structure of the N-terminus of human Rmi1.	[Kennedy, Jessica A.; Syed, Salahuddin; Schmidt, Kristina H.] Univ S Florida, Dept Cell Biol Mol Biol & Microbiol, Tampa, FL 33620 USA; [Kennedy, Jessica A.; Syed, Salahuddin] H Lee Moffitt Canc Ctr & Res Inst, Grad Program Cell & Mol Biol, Tampa, FL 33612 USA; [Schmidt, Kristina H.] H Lee Moffitt Canc Ctr & Res Inst, Canc Biol & Evolut Program, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Schmidt, KH (corresponding author), Univ S Florida, Dept Cell Biol Mol Biol & Microbiol, Tampa, FL 33620 USA.	kschmidt@usf.edu	Syed, Salahuddin/B-4809-2017	Syed, Salahuddin/0000-0003-0851-9678	National Institutes of Health [R01GM081425]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the National Institutes of Health grant R01GM081425 to KHS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton TM, 2011, MOL CELL BIOL, V31, P1921, DOI 10.1128/MCB.01130-10; Bennett RJ, 1999, J MOL BIOL, V289, P235, DOI 10.1006/jmbi.1999.2739; Bocquet N, 2014, NAT STRUCT MOL BIOL, V21, P261, DOI 10.1038/nsmb.2775; Bonnet S, 2013, NUCLEIC ACIDS RES, V41, P9349, DOI 10.1093/nar/gkt730; Cejka P, 2010, NAT STRUCT MOL BIOL, V17, P1377, DOI 10.1038/nsmb.1919; Chang M, 2005, EMBO J, V24, P2024, DOI 10.1038/sj.emboj.7600684; Chen CF, 2007, J BIOL CHEM, V282, P28971, DOI 10.1074/jbc.M705427200; Chen H, 2011, MOL CARCINOGEN, V50, P80, DOI 10.1002/mc.20694; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Daley JM, 2014, NUCLEIC ACIDS RES, V42, P11083, DOI 10.1093/nar/gku803; Fasching CL, 2015, MOL CELL, V57, P595, DOI 10.1016/j.molcel.2015.01.022; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Guiraldelli MF, 2013, DNA REPAIR, V12, P835, DOI 10.1016/j.dnarep.2013.07.004; Hoadley KA, 2010, STRUCTURE, V18, P1149, DOI 10.1016/j.str.2010.06.009; Huerta-Cepas J, 2014, NUCLEIC ACIDS RES, V42, pD897, DOI 10.1093/nar/gkt1177; Hyre DE, 1998, J MOL BIOL, V279, P929, DOI 10.1006/jmbi.1998.1811; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Kennedy JA, 2013, NUCLEIC ACIDS RES, V41, P10215, DOI 10.1093/nar/gkt817; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lo YC, 2006, MOL CELL BIOL, V26, P4086, DOI 10.1128/MCB.00136-06; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mitchel K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003340; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Wang F, 2010, STRUCTURE, V18, P1159, DOI 10.1016/j.str.2010.06.008; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Yang J, 2012, MOL CELL BIOL, V32, P3054, DOI 10.1128/MCB.00255-12; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	38	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145466	10.1371/journal.pone.0145466	http://dx.doi.org/10.1371/journal.pone.0145466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717309	Green Submitted, gold, Green Published			2022-12-27	WOS:000367510500036
J	Li, XY; Guo, YQ; Yan, WB; Snyder, MP; Li, X				Li, Xiyan; Guo, Yuqi; Yan, Wenbo; Snyder, Michael P.; Li, Xin			Metformin Improves Diabetic Bone Health by Re-Balancing Catabolism and Nitrogen Disposal	PLOS ONE			English	Article							NF-KAPPA-B; SUCCINATE RECEPTOR GPR91; ANTIDIABETIC DRUG METFORMIN; OSTEOCLAST FORMATION; ACID CYCLE; IN-VIVO; DIFFERENTIATION; ACTIVATION; GLUTAMATE; CELL	Objective Metformin, a leading drug used to treat diabetic patients, is reported to benefit bone homeostasis under hyperglycemia in animal models. However, both the molecular targets and the biological pathways affected by metformin in bone are not well identified or characterized. The objective of this study is to investigate the bioengergeric pathways affected by metformin in bone marrow cells of mice. Materials and Methods Metabolite levels were examined in bone marrow samples extracted from metformin or PBS -treated healthy (Wild type) and hyperglycemic (diabetic) mice using liquid chromatography-mass spectrometry (LC-MS)-based metabolomics. We applied an untargeted high performance LC-MS approach which combined multimode chromatography (ion exchange, reversed phase and hydrophilic interaction (HILIC)) and Orbitrap-based ultra-high accuracy mass spectrometry to achieve a wide coverage. A multivariate clustering was applied to reveal the global trends and major metabolite players. Results A total of 346 unique metabolites were identified, and they are grouped into distinctive clusters that reflected general and diabetes-specific responses to metformin. As evidenced by changes in the TCA and urea cycles, increased catabolism and nitrogen waste that are commonly associated with diabetes were rebalanced upon treatment with metformin. In particular, we found glutamate and succinate whose levels were drastically elevated in diabetic animals were brought back to normal levels by metformin. These two metabolites were further validated as the major targets of metformin in bone marrow stromal cells. Conclusion Overall using limited sample size, our study revealed the metabolic pathways modulated by metformin in bones which have broad implication in our understanding of bone remodeling under hyperglycemia and in finding therapeutic interventions in mammals.	[Li, Xiyan; Snyder, Michael P.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Guo, Yuqi; Li, Xin] NYU, Coll Dent, Basic Sci & Craniofacial Biol, New York, NY 10010 USA; [Yan, Wenbo] Nyack Coll, Dept Biol & Chem, New York, NY 10013 USA	Stanford University; New York University	Li, X (corresponding author), NYU, Coll Dent, Basic Sci & Craniofacial Biol, New York, NY 10010 USA.	xl15@nyu.edu	yan, wenbo/GXV-2795-2022	Li, Xin/0000-0002-7414-5734; Li, Xiyan/0000-0002-1959-2160; Snyder, Michael/0000-0003-0784-7987	NIH [R01CA180277, R03 CA172894, 5R01GM06248012-12, 3U54DK10255602S2]; California Institute for Regenerative Medicine [RB4-06087]; NATIONAL CANCER INSTITUTE [R03CA172894, R01CA180277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants R01CA180277 and R03 CA172894 to Xin Li, 5R01GM06248012-12, 3U54DK10255602S2 grant and California Institute for Regenerative Medicine grant (RB4-06087) to MPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrzejewski S, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-12; Ang ESM, 2007, J CELL PHYSIOL, V212, P787, DOI 10.1002/jcp.21076; Cheema AK, 2011, J PROTEOME RES, V10, P2651, DOI 10.1021/pr101243j; Chung YH, 2014, INT J BIOCHEM CELL B, V54, P198, DOI 10.1016/j.biocel.2014.07.018; Corominas-Faja B, 2012, AGING-US, V4, P480, DOI 10.18632/aging.100472; Cowan Robert W, 2012, Front Endocrinol (Lausanne), V3, P89, DOI 10.3389/fendo.2012.00089; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Favret S, 2013, AGING-US, V5, P427, DOI 10.18632/aging.100563; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Gao Y, 2010, EUR J PHARMACOL, V635, P231, DOI 10.1016/j.ejphar.2010.02.051; Gao Y, 2008, J PHARM PHARMACOL, V60, P1695, DOI 10.1211/jpp.60/12.0017; Gnana-Prakasam JP, 2011, INVEST OPHTH VIS SCI, V52, P3751, DOI 10.1167/iovs.10-6722; Gore DC, 2005, ANN SURG, V241, P334, DOI 10.1097/01.sla.0000152013.23032.d1; Gravel SP, 2014, CANCER RES, V74, P7521, DOI 10.1158/0008-5472.CAN-14-2643-T; Guan SH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010728; Hakak Y, 2009, J LEUKOCYTE BIOL, V85, P837, DOI 10.1189/jlb.1008618; Hamann C, 2012, NAT REV ENDOCRINOL, V8, P297, DOI 10.1038/nrendo.2011.233; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165; Hundal RS, 2003, DRUGS, V63, P1879, DOI 10.2165/00003495-200363180-00001; Janzer A, 2014, P NATL ACAD SCI USA, V111, P10574, DOI 10.1073/pnas.1409844111; Jeyabalan J, 2013, OSTEOPOROSIS INT, V24, P2659, DOI 10.1007/s00198-013-2371-0; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Kajiya H, 2012, ADV EXP MED BIOL, V740, P917, DOI 10.1007/978-94-007-2888-2_41; Kamburov A, 2011, BIOINFORMATICS, V27, P2917, DOI 10.1093/bioinformatics/btr499; Kawashima Y, 2009, BONE, V44, P648, DOI 10.1016/j.bone.2008.12.012; Koenig W, 2008, CLIN CHEM, V54, P231, DOI 10.1373/clinchem.2007.099705; Kos E, 2012, ENDOCR PRACT, V18, P179, DOI 10.4158/EP11009.OR; KRAKAUER JC, 1995, DIABETES, V44, P775, DOI 10.2337/diabetes.44.7.775; L Newton Anna, 2013, Bonekey Rep, V2, P315, DOI 10.1038/bonekey.2013.49; Large V, 1999, DIABETES, V48, P1251, DOI 10.2337/diabetes.48.6.1251; Levasseur R, 2003, ENDOCRINOLOGY, V144, P2761, DOI 10.1210/en.2002-0071; Li HW, 2013, BIOCHEM BIOPH RES CO, V430, P951, DOI 10.1016/j.bbrc.2012.12.051; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Mai QG, 2011, J CELL BIOCHEM, V112, P2902, DOI 10.1002/jcb.23206; Mediero A, 2013, BRIT J PHARMACOL, V169, P1372, DOI 10.1111/bph.12227; Merle B, 2003, J CELL BIOCHEM, V90, P424, DOI 10.1002/jcb.10625; Miller RA, 2010, J CLIN INVEST, V120, P2267, DOI 10.1172/JCI43661; Miranda VC, 2014, DRUG TODAY, V50, P623, DOI 10.1358/dot.2014.50.9.2229920; Miyauchi A, 1996, ENDOCRINOLOGY, V137, P3544, DOI 10.1210/en.137.8.3544; Newsholme P, 2005, CLIN SCI, V108, P185, DOI 10.1042/CS20040290; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Shah M, 2010, BONE, V47, P309, DOI 10.1016/j.bone.2010.04.596; SHAMBAUGH GE, 1977, AM J CLIN NUTR, V30, P2083, DOI 10.1093/ajcn/30.12.2083; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; SULAIMAN WR, 1977, ACTA DIABETOL LAT, V14, P129, DOI 10.1007/BF02581400; Sundstrom L, 2013, FEBS LETT, V587, P2399, DOI 10.1016/j.febslet.2013.05.067; Suzuki K, 2005, DIABETES RES CLIN PR, V68, P117, DOI 10.1016/j.diabres.2004.08.006; Tagliaferri C, 2015, EUR J NUTR, V54, P1139, DOI 10.1007/s00394-014-0790-0; Tai ES, 2010, DIABETOLOGIA, V53, P757, DOI 10.1007/s00125-009-1637-8; Takarada T, 2008, J PHARMACOL SCI, V106, P536, DOI 10.1254/jphs.FM0070243; Takarada-Iemata M, 2011, J CELL PHYSIOL, V226, P652, DOI 10.1002/jcp.22390; Takizawa M, 2008, DIABETES RES CLIN PR, V82, P119, DOI 10.1016/j.diabres.2008.07.008; Tsubaki M, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-10; Tsubaki M, 2010, J CELL BIOCHEM, V111, P1661, DOI 10.1002/jcb.22907; Uno K, 2007, J CELL PHYSIOL, V213, P105, DOI 10.1002/jcp.21095; Vestergaard P, 2005, DIABETOLOGIA, V48, P1292, DOI 10.1007/s00125-005-1786-3; Vinaixa M, 2012, METABOLITES, V2, P775, DOI 10.3390/metabo2040775; Wu CL, 2013, INT J OBESITY, V37, P1079, DOI 10.1038/ijo.2012.171; Yan WB, 2013, FRONT MED-PRC, V7, P81, DOI 10.1007/s11684-013-0243-9; Zinman B, 2010, J CLIN ENDOCR METAB, V95, P134, DOI 10.1210/jc.2009-0572	67	11	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146152	10.1371/journal.pone.0146152	http://dx.doi.org/10.1371/journal.pone.0146152			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716870	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500137
J	Tang, YJ; Ho, SY; Chu, FY; Chen, HA; Yin, YJ; Lee, HC; Chu, WCC; Yeh, HW; Chiang, WS; Yeh, CL; Huang, HL; Tzeng, NS				Tang, Yih-Jing; Ho, Shinn-Ying; Chu, Fang-Ying; Chen, Hung-An; Yin, Yun-Ju; Lee, Hua-Chin; Chu, William Cheng-Chung; Yeh, Hui-Wen; Chiang, Wei-Shan; Yeh, Chia-Lun; Huang, Hui-Ling; Tzeng, Nian-Sheng			Is Zolpidem Associated with Increased Risk of Fractures in the Elderly with Sleep Disorders? A Nationwide Case Cross-Over Study in Taiwan	PLOS ONE			English	Article							HIP-FRACTURES; OLDER-PEOPLE; BENZODIAZEPINE USE; PELVIC FRACTURES; ECONOMIC BURDEN; INSOMNIA; FALLS; ADULTS; POPULATION; OSTEOPOROSIS	Background We conducted a study using a case-crossover design to clarify the risk of acute effects of zolpidem and benzodiazepine on all-sites of fractures in the elderly. Design of study Case-crossover design. Methods and Materials Elderly enrollees (n = 6010) in Taiwan's National Health Insurance Research Database with zolpidem or benzodiazepine use were analyzed for the risk of developing fractures. Results After adjusting for medications such as antipsychotics, antidepressants, and diuretics, or comorbidities such as hypertension, osteoarthritis, osteoporosis, rheumatoid arthritis and depression, neither zolpidem nor benzodiazepine was found to be associated with increased risk in all-sites fractures. Subjects without depression were found to have an increased risk of fractures. Diazepam is the only benzodiazepine with increased risk of fractures after adjusting for medications and comorbidities. Hip and spine were particular sites for increased fracture risk, but following adjustment for comorbidities, the associations were found to be insignificant. Conclusion Neither zolpidem nor benzodiazepine was associated with increased risk of all-site fractures in this case cross-over study after adjusting for medications or comorbidities in elderly individuals with insomnia. Clinicians should balance the benefits and risks for prescribing zolpidem or benzodiazepine in the elderly accordingly.	[Tang, Yih-Jing] Taichung Vet Gen Hosp, Ctr Geriatr & Gerontol, Dept Family Med, Taichung, Taiwan; [Tang, Yih-Jing] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Ho, Shinn-Ying; Huang, Hui-Ling] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Ho, Shinn-Ying; Chu, Fang-Ying; Chen, Hung-An; Yin, Yun-Ju; Lee, Hua-Chin; Yeh, Hui-Wen; Yeh, Chia-Lun; Huang, Hui-Ling] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Chu, William Cheng-Chung] Tunghai Univ, Dept Comp Sci, Taichung 40704, Taiwan; [Yeh, Hui-Wen] Natl Def Med Ctr, Sch Nursing, Dept Nursing, Triserv Gen Hosp, Taipei, Taiwan; [Yeh, Hui-Wen; Chiang, Wei-Shan] Natl Tamkang Univ, Inst & Dept Math, New Taipei, Taiwan; [Chiang, Wei-Shan; Tzeng, Nian-Sheng] Natl Def Med Ctr, Sch Med, Triserv Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Tzeng, Nian-Sheng] Natl Def Med Ctr, Student Counseling Ctr, Taipei, Taiwan	Taichung Veterans General Hospital; Chung Shan Medical University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Tunghai University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Huang, HL (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.	hlhuang@mail.nctu.edu.tw; pierrens@mail.ndmctsgh.edu.tw	Ho, Shinn-Ying/AFD-8402-2022; Ho, Shinn-Ying/AAE-9394-2022; Tzeng, Nian-Sheng/AAU-4945-2021	Ho, Shinn-Ying/0000-0002-1901-8353; Ho, Shinn-Ying/0000-0002-1901-8353; 	Ministry of Science and Technology of Taiwan [MOST-103-2221-E-009-117-, MOST -103-2221-E-009-141-]; "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University; Ministry of Education, Taiwan, R.O.C. [103W962]; UST-UCSD International Center of Excellence in Advanced Bioengineering - Taiwan Ministry of Science and Technology I-RiCE Program [MOST-103-2911-1-009-101-];  [Tri-Service-General-Hospital (TSGH)-C103-019]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University; Ministry of Education, Taiwan, R.O.C.(Ministry of Education, Taiwan); UST-UCSD International Center of Excellence in Advanced Bioengineering - Taiwan Ministry of Science and Technology I-RiCE Program; 	This work was supported by grant number Tri-Service-General-Hospital (TSGH)-C103-019. This work was also funded by Ministry of Science and Technology of Taiwan under the contract number MOST-103-2221-E-009-117- and MOST -103-2221-E-009-141-, and "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C. for the project 103W962. This work was also supported in part by the UST-UCSD International Center of Excellence in Advanced Bioengineering sponsored by the Taiwan Ministry of Science and Technology I-RiCE Program under Grant Number: MOST-103-2911-1-009-101-. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AL, 2013, OSTEOPOROSIS INT, V24, P373, DOI 10.1007/s00198-012-1938-5; Antai- D, 2006, PERSPECT PSYCHIATR C, V42, P196, DOI 10.1111/j.1744-6163.2006.00070.x; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bakken MS, 2014, EUR J CLIN PHARMACOL, V70, P873, DOI 10.1007/s00228-014-1684-z; Berry SD, 2013, JAMA INTERN MED, V173, P754, DOI 10.1001/jamainternmed.2013.3795; Brassington GS, 2000, J AM GERIATR SOC, V48, P1234, DOI 10.1111/j.1532-5415.2000.tb02596.x; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Castano-Betancourt MC, 2013, ARTHRITIS RHEUM-US, V65, P693, DOI 10.1002/art.37792; Chan WSH, 2010, EPMA J, V1, P563, DOI 10.1007/s13167-010-0056-8; Chang CM, 2008, AM J GERIAT PSYCHIAT, V16, P686, DOI 10.1097/JGP.0b013e31817c6a99; Chen HL, 2015, PHARMACOEPIDEM DR S, V24, P841, DOI 10.1002/pds.3814; Chen IJ, 2015, OSTEOPOROSIS INT, V26, P681, DOI 10.1007/s00198-014-2930-z; Chen LF, 2013, NEUROPSYCH DIS TREAT, V9, P1159, DOI 10.2147/NDT.S48152; Chiang YY, 2012, J EUR ACAD DERMATOL, V26, P59, DOI 10.1111/j.1468-3083.2011.04009.x; Chinese Hospital Association, 2000, ICD 9 CM ENGL CHIN D; Chung SD, 2011, J ANDROL, V32, P159, DOI 10.2164/jandrol.110.011163; Cizza Giovanni, 2011, Dialogues Clin Neurosci, V13, P73; Cizza G, 2009, TRENDS ENDOCRIN MET, V20, P367, DOI 10.1016/j.tem.2009.05.003; Cummings-Vaughn LA, 2011, MED CLIN N AM, V95, P495, DOI 10.1016/j.mcna.2011.03.003; Dolder CR, 2008, CNS DRUGS, V22, P1021, DOI 10.2165/0023210-200822120-00005; Fang JF, 2008, INJURY, V39, P881, DOI 10.1016/j.injury.2008.03.012; Finkle WD, 2011, J AM GERIATR SOC, V59, P1883, DOI 10.1111/j.1532-5415.2011.03591.x; Gale Catharine R, 2012, Arch Osteoporos, V7, P59, DOI 10.1007/s11657-012-0080-5; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Harboun M, 2008, INT J GERIATR PSYCH, V23, P1245, DOI 10.1002/gps.2058; Heffner KL, 2012, AM J GERIAT PSYCHIAT, V20, P744, DOI 10.1097/JGP.0b013e31824361de; Hill EL, 2007, J GERONTOL A-BIOL, V62, P62, DOI 10.1093/gerona/62.1.62; Huang WF, 2005, DRUG AGING, V22, P957, DOI 10.2165/00002512-200522110-00005; Hwang TJ, 2010, J CLIN PSYCHIAT, V71, P1331, DOI 10.4088/JCP.09m05083bro; Jaussent I, 2011, SLEEP, V34, P1103, DOI 10.5665/SLEEP.1170; Johnston SS, 2012, DIABETES OBES METAB, V14, P634, DOI 10.1111/j.1463-1326.2012.01583.x; Kang Dong-Yoon, 2012, J Prev Med Public Health, V45, P219, DOI 10.3961/jpmph.2012.45.4.219; Khawaja Muhammad Rizwamillah, 2005, JPMA Journal of the Pakistan Medical Association, V55, P259; Khazai NB, 2009, CURR OPIN ENDOCRINOL, V16, P435, DOI 10.1097/MED.0b013e328331c7eb; Lecrubier Y, 2006, J CLIN PSYCHIAT, V67, P23; Lehrer S, 2013, SLEEP BREATH, V17, P1117, DOI 10.1007/s11325-013-0811-x; Lin HY, 2011, UPSALA J MED SCI, V116, P155, DOI 10.3109/03009734.2010.547636; Lin LY, 2011, ATHEROSCLEROSIS, V217, P292, DOI 10.1016/j.atherosclerosis.2011.03.033; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; MANDELLI M, 1978, CLIN PHARMACOKINET, V3, P72, DOI 10.2165/00003088-197803010-00005; MELTON LJ, 1981, CLIN ORTHOP RELAT R, P43; Parthasarathy S, 2015, AM J MED, V128, P268, DOI 10.1016/j.amjmed.2014.10.015; Pigeon Wilfred R, 2012, J Clin Psychiatry, V73, pe1160, DOI 10.4088/JCP.11r07586; Pigeon WR, 2011, J WOMENS HEALTH, V20, P1923, DOI 10.1089/jwh.2011.2781; Pike C, 2011, OSTEOPOROSIS INT, V22, P47, DOI 10.1007/s00198-010-1267-5; Poceta JS, 2011, J CLIN SLEEP MED, V7, P632, DOI 10.5664/jcsm.1468; Stenbacka M, 2002, ALCOHOL, V28, P9, DOI 10.1016/S0741-8329(02)00223-9; Stone KL, 2008, SLEEP MED, V9, pS18, DOI 10.1016/S1389-9457(08)70012-1; Stone KL, 2006, J AM GERIATR SOC, V54, P1177, DOI 10.1111/j.1532-5415.2006.00818.x; Strand LB, 2013, SLEEP, V36, P99, DOI 10.5665/sleep.2310; Susanszky Eva, 2011, Psychiatr Hung, V26, P250; U.S. Food and Drug Administration, AMBIEN ZOLP TARTR FU; Vermeeren A, 2004, CNS DRUGS, V18, P297, DOI 10.2165/00023210-200418050-00003; Wagner AK, 2004, ARCH INTERN MED, V164, P1567, DOI 10.1001/archinte.164.14.1567; Wang CB, 2013, BONE, V56, P147, DOI 10.1016/j.bone.2013.05.015; Wang PS, 2001, J AM GERIATR SOC, V49, P1685, DOI 10.1111/j.1532-5415.2001.49280.x; Wang PS, 2001, AM J PSYCHIAT, V158, P892, DOI 10.1176/appi.ajp.158.6.892; Yang NP, 2008, INJURY, V39, P443, DOI 10.1016/j.injury.2007.12.007; Yang S, 2014, OSTEOPOROSIS INT, V25, P97, DOI 10.1007/s00198-013-2457-8; Yang YH, 2011, J EPIDEMIOL, V21, P37, DOI 10.2188/jea.JE20090195; Ziade N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-344; Zint K, 2010, PHARMACOEPIDEM DR S, V19, P1248, DOI 10.1002/pds.2031	63	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146030	10.1371/journal.pone.0146030	http://dx.doi.org/10.1371/journal.pone.0146030			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716836	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500121
J	Beltran, AR; Carraro-Lacroix, LR; Bezerra, CNA; Cornejo, M; Norambuena, K; Toledo, F; Araos, J; Pardo, F; Leiva, A; Sanhueza, C; Malnic, G; Sobrevia, L; Ramirez, MA				Beltran, Ana R.; Carraro-Lacroix, Luciene R.; Bezerra, Camila N. A.; Cornejo, Marcelo; Norambuena, Katrina; Toledo, Fernando; Araos, Joaquin; Pardo, Fabian; Leiva, Andrea; Sanhueza, Carlos; Malnic, Gerhard; Sobrevia, Luis; Ramirez, Marco A.			Escherichia coli Heat-Stable Enterotoxin Mediates Na+/H+ Exchanger 4 Inhibition Involving cAMP in T-84 Human Intestinal Epithelial Cells	PLOS ONE			English	Article							T84 CELLS; FLUID SECRETION; CL-SECRETION; DIARRHEA; RAT; PH; LINE; NHE4; REGULATOR; CANCER	The enterotoxigenic Escherichia coli strains lead to diarrhoea in humans due to heat-labile and heat-stable (STa) enterotoxins. STa increases Cl-release in intestinal cells, including the human colonic carcinoma T-84 cell line, involving increased cGMP and membrane alkalization due to reduced Na+/H+ exchangers (NHEs) activity. Since NHEs modulate intracellular pH (pH(i)), and NHE1, NHE2, and NHE4 are expressed in T-84 cells, we characterized the STa role as modulator of these exchangers. pHi was assayed by the NH4Cl pulse technique and measured by fluorescence microscopy in BCECF-preloaded cells. pHi recovery rate (dpHi/dt) was determined in the absence or presence of 0.25 mu mol/L STa (30 minutes), 25 mu mol/L HOE-694 (concentration inhibiting NHE1 and NHE2), 500 mu mol/L sodium nitroprusside (SNP, spontaneous nitric oxide donor), 100 mu mol/L dibutyryl cyclic GMP (db-cGMP), 100 nmol/L H89 (protein kinase A inhibitor), or 10 mu mol/L forskolin (adenylyl cyclase activator). cGMP and cAMP were measured in cell extracts by radioimmunoassay, and buffering capacity (Bi) and H+ efflux (J(H)(+)) was determined. NHE4 protein abundance was determined by western blotting. STa and HOE-694 caused comparable reduction in dpHi/dt and J(H)(+) (similar to 63%), without altering basal pHi (range 7.144-7.172). STa did not alter Bi value in a range of 1.6 pHi units. The dpHi/dt and J(H)(+) was almost abolished (similar to 94% inhibition) by STa + HOE-694. STa effect was unaltered by db-cGMP or SNP. However, STa and forskolin increased cAMP level. STa-decreased dpHi/dt and J(H)(+) was mimicked by forskolin, and STa + HOE-694 effect was abolished by H89. Thus, incubation of T-84 cells with STa results in reduced NHE4 activity leading to a lower capacity of pH(i) recovery requiring cAMP, but not cGMP. STa effect results in a causal phenomenon (STa/increased cAMP/increased PKA activity/reduced NHE4 activity) ending with intracellular acidification that could have consequences in the gastrointestinal cells function promoting human diarrhoea.	[Beltran, Ana R.; Cornejo, Marcelo; Norambuena, Katrina; Ramirez, Marco A.] Univ Antofagasta, Biomed Dept, Cellular Physiol Lab, Fac Hlth Sci, Antofagasta 1270300, Chile; [Beltran, Ana R.] Univ Antofagasta, Dept Educ, Fac Educ, Antofagasta 1270300, Chile; [Carraro-Lacroix, Luciene R.; Bezerra, Camila N. A.; Malnic, Gerhard] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, BR-35503081 Sao Paulo, Brazil; [Toledo, Fernando] Univ Bio Bio, Dept Basic Sci, Fac Sci, Chillan 3780000, Chile; [Sobrevia, Luis] Univ Seville, Dept Physiol, Fac Pharm, E-41012 Seville, Spain; [Sobrevia, Luis] Univ Queensland, Clin Res Ctr, Fac Med & Biomed Sci, Herston, Qld 4029, Australia; [Araos, Joaquin; Pardo, Fabian; Leiva, Andrea; Sanhueza, Carlos; Sobrevia, Luis; Ramirez, Marco A.] Pontificia Univ Catolica Chile, Sch Med, Div Obstet & Gynecol, CMPL,Fac Med, Santiago 8330024, Chile	Universidad de Antofagasta; Universidad de Antofagasta; Universidade de Sao Paulo; Universidad del Bio-Bio; University of Sevilla; University of Queensland; Pontificia Universidad Catolica de Chile	Sobrevia, L (corresponding author), Univ Seville, Dept Physiol, Fac Pharm, E-41012 Seville, Spain.	sobrevia@med.puc.cl; marco.ramirez@uantof.cl	Cornejo Alaniz, Marcelo Alejandro/AGD-4851-2022; Sobrevia, Luis/H-9608-2016	Cornejo Alaniz, Marcelo Alejandro/0000-0002-1377-0149; TOLEDO-MONTIEL, FERNANDO/0000-0001-9435-0973; Beltran Gonzalez, Ana Rosa/0000-0001-5068-2132; Sobrevia, Luis/0000-0001-5802-2243	Semillero Direccion de Investigacion Universidad de Antofagasta, Chile [5309, 5313]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, Brazil; Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile [FONDECYT 1150377, 1150344, 3140516, 11150083]	Semillero Direccion de Investigacion Universidad de Antofagasta, Chile; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Semillero Direccion de Investigacion Universidad de Antofagasta (5309, 5313), Chile, http://www.uantof.cl. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, Brazil, http://www.fapesp.br. Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 1150377, 1150344, 3140516, 11150083), Chile, http://www.conicyt.cl/fondecyt/.	Abu-Elyazeed R, 1999, J INFECT DIS, V179, P382, DOI 10.1086/314593; Ao M, 2013, AM J PHYSIOL-CELL PH, V305, pC447, DOI 10.1152/ajpcell.00416.2012; Aravena C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051451; Arena EA, 2012, AM J PHYSIOL-CELL PH, V302, pC412, DOI 10.1152/ajpcell.00163.2011; Bachmann O, 2011, ACTA PHYSIOL, V201, P33, DOI 10.1111/j.1748-1716.2010.02153.x; Beltran AR, 2008, PFLUG ARCH EUR J PHY, V455, P799, DOI 10.1007/s00424-007-0333-0; Bijvelds MJC, 2015, J INFECT DIS, V212, P1806, DOI 10.1093/infdis/jiv300; Carrithers SL, 2003, P NATL ACAD SCI USA, V100, P3018, DOI 10.1073/pnas.0730484100; CARTWRIGHT CA, 1985, J CLIN INVEST, V76, P1837, DOI 10.1172/JCI112176; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CRAVIOTO A, 1988, EPIDEMIOL INFECT, V101, P123, DOI 10.1017/S0950268800029289; Fawcus K, 1997, COMP BIOCHEM PHYS A, V118, P291, DOI 10.1016/S0300-9629(96)00307-6; Fernandez R, 1998, J MEMBRANE BIOL, V163, P137, DOI 10.1007/s002329900378; FIELD M, 1978, P NATL ACAD SCI USA, V75, P2800, DOI 10.1073/pnas.75.6.2800; FORTE LR, 1989, AM J PHYSIOL, V257, pF874, DOI 10.1152/ajprenal.1989.257.5.F874; Fuster DG, 2014, PFLUG ARCH EUR J PHY, V466, P61, DOI 10.1007/s00424-013-1408-8; Gawenis LR, 2005, J BIOL CHEM, V280, P12781, DOI 10.1074/jbc.M414118200; GIANNELLA RA, 1979, INFECT IMMUN, V24, P19, DOI 10.1128/IAI.24.1.19-23.1979; Gillies RJ, 2004, IEEE ENG MED BIOL, V23, P57, DOI 10.1109/MEMB.2004.1360409; Golin-Bisello F, 2005, AM J PHYSIOL-CELL PH, V289, pC708, DOI 10.1152/ajpcell.00544.2004; GROSS RJ, 1983, J INFECTION, V7, P177, DOI 10.1016/S0163-4453(83)96953-0; HUOTT PA, 1988, J CLIN INVEST, V82, P514, DOI 10.1172/JCI113626; Ikuma M, 1999, AM J PHYSIOL-GASTR L, V276, pG539, DOI 10.1152/ajpgi.1999.276.2.G539; Kots AY, 2008, P NATL ACAD SCI USA, V105, P8440, DOI 10.1073/pnas.0803096105; Lucas ML, 2001, J APPL MICROBIOL, V90, P7, DOI 10.1046/j.1365-2672.2001.01225.x; Moon C, 2015, PHARMACOL RES, V102, P107, DOI 10.1016/j.phrs.2015.08.024; Morel E, 2003, RADIAT RES, V160, P263, DOI 10.1667/RR3041; Musa-Aziz R, 2005, J MEMBRANE BIOL, V205, P49, DOI 10.1007/s00232-005-0762-7; Nakashima R, 2013, VET IMMUNOL IMMUNOP, V152, P78, DOI 10.1016/j.vetimm.2012.09.026; Nichols JM, 2015, AM J PHYSIOL-GASTR L, V309, pG670, DOI 10.1152/ajpgi.00214.2015; Orlowski J, 2011, COMPR PHYSIOL, V1, P2083, DOI 10.1002/cphy.c110020; Pardo F, 2015, INT J OBESITY, V39, P1264, DOI 10.1038/ijo.2015.57; Pizzonia JH, 2013, AM J PHYSIOL, V275, pF510; Provost JJ, 2013, CHEM BIOL DRUG DES, V81, P85, DOI 10.1111/cbdd.12035; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Ramirez MA, 2000, J MEMBRANE BIOL, V177, P149, DOI 10.1007/s002320001108; Rossmann H, 2001, AM J PHYSIOL-GASTR L, V281, pG447, DOI 10.1152/ajpgi.2001.281.2.G447; Salsoso R, 2015, PLACENTA, V36, P287, DOI 10.1016/j.placenta.2014.12.007; SCHULZ S, 1990, CELL, V63, P941, DOI 10.1016/0092-8674(90)90497-3; Sellers ZM, 2005, AM J PHYSIOL-GASTR L, V288, pG654, DOI 10.1152/ajpgi.00386.2004; Selvaraj NG, 2000, BBA-MOL CELL RES, V1498, P32, DOI 10.1016/S0167-4889(00)00075-6; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Toriano R, 2001, AM J PHYSIOL-GASTR L, V281, pG816, DOI 10.1152/ajpgi.2001.281.3.G816; Toriano R, 2011, CELL PHYSIOL BIOCHEM, V28, P733, DOI 10.1159/000335767; WASSERMAN SI, 1988, AM J PHYSIOL, V254, pC53, DOI 10.1152/ajpcell.1988.254.1.C53	45	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0146042	10.1371/journal.pone.0146042	http://dx.doi.org/10.1371/journal.pone.0146042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713849	gold, Green Published, Green Submitted			2022-12-27	WOS:000367481900112
J	Saito-Hakoda, A; Uruno, A; Yokoyama, A; Shimizu, K; Parvin, R; Kudo, M; Saito-Ito, T; Sato, I; Kogure, N; Suzuki, D; Shimada, H; Yoshikawa, T; Fujiwara, I; Kagechika, H; Iwasaki, Y; Kure, S; Ito, S; Sugawara, A				Saito-Hakoda, Akiko; Uruno, Akira; Yokoyama, Atsushi; Shimizu, Kyoko; Parvin, Rehana; Kudo, Masataka; Saito-Ito, Takako; Sato, Ikuko; Kogure, Naotaka; Suzuki, Dai; Shimada, Hiroki; Yoshikawa, Takeo; Fujiwara, Ikuma; Kagechika, Hiroyuki; Iwasaki, Yasumasa; Kure, Shigeo; Ito, Sadayoshi; Sugawara, Akira			Effects of RXR Agonists on Cell Proliferation/Apoptosis and ACTH Secretion/Pomc Expression	PLOS ONE			English	Article							PROOPIOMELANOCORTIN GENE-EXPRESSION; RETINOID-X-RECEPTORS; CUSHINGS-DISEASE; PITUITARY-ADENOMAS; THERAPEUTIC TARGET; CANCER PREVENTION; MEDICAL THERAPY; CLINICAL-TRIAL; ACID; TRANSCRIPTION	Various retinoid X receptor (RXR) agonists have recently been developed, and some of them have shown anti-tumor effects both in vivo and in vitro. However, there has been no report showing the effects of RXR agonists on Cushing's disease, which is caused by excessive ACTH secretion in a corticotroph tumor of the pituitary gland. Therefore, we examined the effects of synthetic RXR pan-agonists HX630 and PA024 on the proliferation, apoptosis, ACTH secretion, and pro-opiomelanocortin (Pomc) gene expression of murine pituitary corticotroph tumor AtT20 cells. We demonstrated that both RXR agonists induced apoptosis dose-dependently in AtT20 cells, and inhibited their proliferation at their higher doses. Microarray analysis identified a significant gene network associated with caspase 3 induced by high dose HX630. On the other hand, HX630, but not PA024, inhibited Pomc transcription, Pomc mRNA expression, and ACTH secretion dose-dependently. Furthermore, we provide new evidence that HX630 negatively regulates the Pomc promoter activity at the transcriptional level due to the suppression of the transcription factor Nur77 and Nurr1 mRNA expression and the reduction of Nur77/Nurr1 heterodimer recruiting to the Pomc promoter region. We also demonstrated that the HX630-mediated suppression of the Pomc gene expression was exerted via RXR alpha. Furthermore, HX630 inhibited tumor growth and decreased Pomc mRNA expression in corticotroph tumor cells in female nude mice in vivo. Thus, these results indicate that RXR agonists, especially HX630, could be a new therapeutic candidate for Cushing's disease.	[Saito-Hakoda, Akiko; Yokoyama, Atsushi; Shimizu, Kyoko; Parvin, Rehana; Saito-Ito, Takako; Sato, Ikuko; Kogure, Naotaka; Shimada, Hiroki; Sugawara, Akira] Tohoku Univ, Grad Sch Med, Dept Mol Endocrinol, Sendai, Miyagi 980, Japan; [Uruno, Akira] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 980, Japan; [Kudo, Masataka; Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 980, Japan; [Suzuki, Dai; Fujiwara, Ikuma; Kure, Shigeo] Tohoku Univ, Grad Sch Med, Dept Pediat, Sendai, Miyagi 980, Japan; [Yoshikawa, Takeo] Tohoku Univ, Grad Sch Med, Dept Pharmacol, Sendai, Miyagi 980, Japan; [Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo, Japan; [Iwasaki, Yasumasa] Kochi Univ, Hlth Serv Ctr, Kochi 780, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tokyo Medical & Dental University (TMDU); Kochi University	Sugawara, A (corresponding author), Tohoku Univ, Grad Sch Med, Dept Mol Endocrinol, Sendai, Miyagi 980, Japan.	akiras2i@med.tohoku.ac.jp	Uruno, Akira/U-1812-2019; Yokoyama, Atsushi/W-3519-2019; Ito, Sadayoshi/A-3933-2015; Yoshikawa, Takeo/F-9599-2019; Yoshikawa, Takeo/U-1823-2019; Uruno, Akira/ABF-3988-2020	Yoshikawa, Takeo/0000-0002-7056-6021; Kagechika, Hiroyuki/0000-0002-6747-1013; Ito, Sadayoshi/0000-0002-5092-3626; Yokoyama, Atsushi/0000-0003-2842-4334; Sugawara, Akira/0000-0003-4511-8101	Ministry of Health, Labor and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by Grants-in-Aid for Scientific Research (Research on Hypothalamo-hypophyseal Disorders) from the Ministry of Health, Labor and Welfare, Japan and Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Alexandraki KI, 2008, EXPERT OPIN INV DRUG, V17, P669, DOI [10.1517/13543784.17.5.669, 10.1517/13543784.17.5.669 ]; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003; Castillo V, 2006, ENDOCRINOLOGY, V147, P4438, DOI 10.1210/en.2006-0414; Crowe DL, 2004, BREAST CANCER RES, V6, pR546, DOI 10.1186/bcr913; CWIKEL BJ, 1987, J BIOL CHEM, V262, P14235; Dai AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039950; Duvic M, 2001, ARCH DERMATOL, V137, P581; Feng Q, 2008, MOL CANCER THER, V7, P3780, DOI 10.1158/1535-7163.MCT-08-0753; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Giacomini D, 2006, ENDOCRINOLOGY, V147, P247, DOI 10.1210/en.2005-0958; Giraldi FP, 2012, J CLIN ENDOCR METAB, V97, P3577, DOI 10.1210/jc.2012-2328; Hashimoto K, 2011, NEUROSCI LETT, V494, P34, DOI 10.1016/j.neulet.2011.02.048; Heaney Anthony P, 2003, Pituitary, V6, P153, DOI 10.1023/B:PITU.0000011176.05771.46; Heaney AP, 2002, NAT MED, V8, P1281, DOI 10.1038/nm784; Howe LR, 2007, CLIN CANCER RES, V13, P5983, DOI 10.1158/1078-0432.CCR-07-1065; Ishida S, 2003, MOL CANCER THER, V2, P49; Jenks BG, 2009, ANN NY ACAD SCI, V1163, P17, DOI 10.1111/j.1749-6632.2008.03620.x; Kagechika H, 2005, J MED CHEM, V48, P5875, DOI 10.1021/jm0581821; Karalis KP, 2004, J BIOL CHEM, V279, P10837, DOI 10.1074/jbc.M313063200; Kudo M, 2014, WORLD J HYPERTENS, V4, P7; Labeur M, 2009, REV ENDOCR METAB DIS, V10, P103, DOI 10.1007/s11154-008-9080-6; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Maira M, 1999, MOL CELL BIOL, V19, P7549; Matsumoto S, 2009, MOL ENDOCRINOL, V23, P47, DOI 10.1210/me.2007-0533; Miller VA, 1997, J CLIN ONCOL, V15, P790, DOI 10.1200/JCO.1997.15.2.790; Nishimaki-Mogami T, 2008, BIOCHEM PHARMACOL, V76, P1006, DOI 10.1016/j.bcp.2008.08.005; Paez-Pereda M, 2001, J CLIN INVEST, V108, P1123, DOI 10.1172/JCI11098; Perez E, 2012, BBA-MOL CELL BIOL L, V1821, P57, DOI 10.1016/j.bbalip.2011.04.003; Philips A, 1997, MOL CELL BIOL, V17, P5946; Poulin G, 1997, MOL CELL BIOL, V17, P6673, DOI 10.1128/MCB.17.11.6673; Qu LY, 2010, CANCER CHEMOTH PHARM, V65, P201, DOI 10.1007/s00280-009-1140-4; Spyroglou A, 2009, J MOL ENDOCRINOL, V42, P407, DOI 10.1677/JME-08-0167; SUGAWARA A, 1995, ENDOCRINOLOGY, V136, P1766, DOI 10.1210/en.136.4.1766; Sugawara A, 2002, J BIOL CHEM, V277, P9676, DOI 10.1074/jbc.M104560200; Takahashi B, 2002, J MED CHEM, V45, P3327, DOI 10.1021/jm0255320; Tanaka T, 2007, J BIOL CHEM, V282, P29987, DOI 10.1074/jbc.M701700200; Tanaka T, 2009, CANCER RES, V69, P4945, DOI 10.1158/0008-5472.CAN-08-4407; THERRIEN M, 1993, MOL CELL BIOL, V13, P2342, DOI 10.1128/MCB.13.4.2342; Tritos NA, 2011, NAT REV ENDOCRINOL, V7, P279, DOI 10.1038/nrendo.2011.12; Umemiya H, 1997, BIOCHEM BIOPH RES CO, V233, P121, DOI 10.1006/bbrc.1997.6414; Umemiya H, 1997, J MED CHEM, V40, P4222, DOI 10.1021/jm9704309; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Uruno A, 2014, ENDOCR J, V61, P1105, DOI 10.1507/endocrj.EJ14-0115; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Yen PM, 1996, J BIOL CHEM, V271, P10910, DOI 10.1074/jbc.271.18.10910; Zhang CL, 2002, CLIN CANCER RES, V8, P1234; ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0	50	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0141960	10.1371/journal.pone.0141960	http://dx.doi.org/10.1371/journal.pone.0141960			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714014	Green Published, Green Submitted, gold			2022-12-27	WOS:000367481900001
J	Foditsch, C; Pereira, RV; Ganda, EK; Gomez, MS; Marques, EC; Santin, T; Bicalho, RC				Foditsch, Carla; Pereira, Richard Van Vleck; Ganda, Erika Korzune; Gomez, Marilia Souza; Marques, Eduardo Carvalho; Santin, Thiago; Bicalho, Rodrigo Carvalho			Oral Administration of Faecalibacterium prausnitzii Decreased the Incidence of Severe Diarrhea and Related Mortality Rate and Increased Weight Gain in Preweaned Dairy Heifers	PLOS ONE			English	Article							BUTYRATE-PRODUCING BACTERIA; MILK REPLACER; RUMEN DEVELOPMENT; SODIUM-BUTYRATE; NEWBORN CALVES; WASTE MILK; GUT; INTESTINE; COMMUNITY; DISEASE	Probiotics are a promising alternative to improve food animal productivity and health. However, scientific evidence that specific microbes can be used to benefit animal health and performance is limited. The objective of this study was to evaluate the effects of administering a live culture of Faecalibacterium prausnitzii to newborn dairy calves on subsequent growth, health, and fecal microbiome. Initially, a safety trial was conducted using 30 newborn bull calves to assess potential adverse effects of the oral and rectal administration of F. prausnitzii to neonatal calves. No adverse reactions, such as increased body temperature or heart and respiratory rates, were observed after the administration of the treatments. All calves survived the experimental period, and there was no difference in fecal consistency score, attitude, appetite or dehydration between the treatment groups. The rectal route was not an efficient practice while the oral route ensures that the full dose is administered to the treated calves. Subsequently, a randomized field trial was completed in a commercial farm with preweaned calves. A total of 554 Holstein heifers were assigned to one of two treatment groups: treated calves (FPTRT) and non-treated calves (control). Treated calves received two oral doses of F. prausnitzii, one at treatment assignment (1st week) and another one week later. The FPTRT group presented significantly lower incidence of severe diarrhea (3.1%) compared with the control group (6.8%). Treated calves also had lower mortality rate associated with severe diarrhea (1.5%) compared to control calves (4.4%). Furthermore, FPTRT calves gained significantly more weight, 4.4 kg over the preweaning period, than controls calves. The relative abundance of F. prausnitzii in the fecal microbiota was significantly higher in the 3rd and 5th weeks of life of FPTRT calves than of the control calves, as revealed by sequencing of the 16S rRNA gene. Our findings showed that oral administration of F. prausnitzii improves gastrointestinal health and growth of preweaned calves, supporting its use as a potential probiotic.	[Foditsch, Carla; Pereira, Richard Van Vleck; Ganda, Erika Korzune; Gomez, Marilia Souza; Bicalho, Rodrigo Carvalho] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Marques, Eduardo Carvalho; Santin, Thiago] Univ Sao Paulo, Coll Vet Med & Anim Sci, Dept Clin Sci, Sao Paulo, SP, Brazil	Cornell University; Universidade de Sao Paulo	Bicalho, RC (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rcb28@cornell.edu	Ganda, Erika/AAD-6286-2020; Pereira, Richard/L-2684-2019	Ganda, Erika/0000-0002-8735-0753; Pereira, Richard/0000-0003-2028-8761	Merck Animal Health	Merck Animal Health(Merck & Company)	This study was funded by Merck Animal Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by Merck Animal Health. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ahmed AF, 2002, J DAIRY SCI, V85, P1502, DOI 10.3168/jds.S0022-0302(02)74219-7; [Anonymous], 2015, VET REC, V176, P666, DOI 10.1136/vr.h3339; Balamurugan R, 2010, BRIT J NUTR, V103, P335, DOI 10.1017/S0007114509992182; Baldwin R L, 2004, J DAIRY SCI, V87, pE55, DOI [10.3168/jds.2012-5970, DOI 10.3168/JDS.S0022-0302(04)70061-2]; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Beharka AA, 1998, J DAIRY SCI, V81, P1946, DOI 10.3168/jds.S0022-0302(98)75768-6; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bruss M. L., 1997, Clinical biochemistry of domestic animals., P83, DOI 10.1016/B978-012396305-5/50005-1; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edrington TS, 2012, J DAIRY SCI, V95, P4519, DOI 10.3168/jds.2011-5119; Foditsch C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116465; Galvao KN, 2005, REPROD NUTR DEV, V45, P427, DOI 10.1051/rnd:2005040; Geurts L, 2014, BENEF MICROBES, V5, P3, DOI 10.3920/BM2012.0065; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI [10.4056/aigs.1443528, 10.4056/sigs.1433550]; Gorka P, 2011, J DAIRY SCI, V94, P5578, DOI 10.3168/jds.2011-4166; Gorka P, 2011, J DAIRY SCI, V94, P3002, DOI 10.3168/jds.2010-3499; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Hill TM, 2010, J DAIRY SCI, V93, P1105, DOI 10.3168/jds.2009-2458; Hold GL, 2003, APPL ENVIRON MICROB, V69, P4320, DOI 10.1128/AEM.69.7.4320-4324.2003; Hollander D, 1999, Curr Gastroenterol Rep, V1, P410, DOI 10.1007/s11894-999-0023-5; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; KEITH EA, 1983, J DAIRY SCI, V66, P833, DOI 10.3168/jds.S0022-0302(83)81864-5; Klein-Jobstl D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00622; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lund M, 2010, POULTRY SCI, V89, P1217, DOI 10.3382/ps.2010-00653; Machiels K., 2013, GUT; Malmuthuge N, 2014, APPL ENVIRON MICROB, V80, P2021, DOI 10.1128/AEM.03864-13; Martin R, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0400-1; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mentschel J, 2001, ARCH ANIM NUTR, V55, P85, DOI 10.1080/17450390109386185; MINATO H, 1992, J GEN APPL MICROBIOL, V38, P447, DOI 10.2323/jgam.38.447; Miquel S, 2015, MBIO, V6, DOI 10.1128/mBio.00300-15; Nava GM, 2011, GUT MICROBES, V2, P99, DOI 10.4161/gmic.2.2.15416; Oikonomou G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063157; Ploger S, 2012, ANN NY ACAD SCI, V1258, P52, DOI 10.1111/j.1749-6632.2012.06553.x; Qiu XY, 2013, J CROHNS COLITIS, V7, pE558, DOI 10.1016/j.crohns.2013.04.002; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Slusarczyk K, 2010, J ANIM FEED SCI, V19, P348; Soberon F, 2013, J ANIM SCI, V91, P706, DOI 10.2527/jas.2012-5834; Soberon F, 2012, J DAIRY SCI, V95, P783, DOI 10.3168/jds.2011-4391; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Steele MA, 2011, PHYSIOL GENOMICS, V43, P308, DOI 10.1152/physiolgenomics.00117.2010; Suau A, 2001, SYST APPL MICROBIOL, V24, P139, DOI 10.1078/0723-2020-00015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; USDA, 2012, DAIR HEIF RAIS 2011; USDA, 2010, HEIF CALF HLTH MAN P; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wang W, 2013, J CLIN MICROBIOL; World Health Organization, 2014, ANT RES GLOB REP SUR	53	56	62	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145485	10.1371/journal.pone.0145485	http://dx.doi.org/10.1371/journal.pone.0145485			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710101	gold, Green Published, Green Submitted			2022-12-27	WOS:000367451400050
J	Gofton, AW; Doggett, S; Ratchford, A; Oskam, CL; Paparini, A; Ryan, U; Irwin, P				Gofton, Alexander W.; Doggett, Stephen; Ratchford, Andrew; Oskam, Charlotte L.; Paparini, Andrea; Ryan, Una; Irwin, Peter			Bacterial Profiling Reveals Novel "Ca. Neoehrlichia", Ehrlichia, and Anaplasma Species in Australian Human-Biting Ticks	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; IXODES-RICINUS TICKS; LYME-DISEASE; SPOTTED-FEVER; FAMILY ANAPLASMATACEAE; PHYLOGENETIC ANALYSIS; AMBLYOMMA-AMERICANUM; BORRELIA-AFZELII; GENE SEQUENCE; MIKURENSIS	In Australia, a conclusive aetiology of Lyme disease-like illness in human patients remains elusive, despite growing numbers of people presenting with symptoms attributed to tick bites. In the present study, we surveyed the microbial communities harboured by human-biting ticks from across Australia to identify bacteria that may contribute to this syndrome. Universal PCR primers were used to amplify the V1-2 hyper-variable region of bacterial 16S rRNA genes in DNA samples from individual Ixodes holocyclus (n = 279), Amblyomma triguttatum (n = 167), Haemaphysalis bancrofti (n = 7), and H. longicornis (n = 7) ticks. The 16S amplicons were sequenced on the Illumina MiSeq platform and analysed in USEARCH, QIIME, and BLAST to assign genus and species-level taxonomies. Nested PCR and Sanger sequencing were used to confirm the NGS data and further analyse novel findings. All 460 ticks were negative for Borrelia spp. by both NGS and nested PCR analysis. Two novel "Candidatus Neoehrlichia" spp. were identified in 12.9% of I. holocyclus ticks. A novel Anaplasma sp. was identified in 1.8% of A. triguttatum ticks, and a novel Ehrlichia sp. was identified in both A. triguttatum (1.2%) ticks and a single I. holocyclus (0.6%) tick. Further phylogenetic analysis of novel "Ca. Neoehrlichia", Anaplasma and Ehrlichia based on 1,265 bp 16S rRNA gene sequences suggests that these are new species. Determining whether these newly discovered organisms cause disease in humans and animals, like closely related bacteria do abroad, is of public health importance and requires further investigation.	[Gofton, Alexander W.; Oskam, Charlotte L.; Paparini, Andrea; Ryan, Una; Irwin, Peter] Murdoch Univ, Sch Vet & Life Sci, Vector & Water Borne Pathogen Res Grp, Perth, WA, Australia; [Doggett, Stephen] Westmead Hosp, Dept Med Entomol, Pathol West, Westmead, NSW 2145, Australia; [Doggett, Stephen] Westmead Hosp, Inst Clin Pathol & Med Res, Westmead, NSW 2145, Australia; [Ratchford, Andrew] Mona Vale Hosp, Emergency Dept, Sydney, NSW, Australia	Murdoch University; University of Sydney; University of Sydney	Gofton, AW (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Vector & Water Borne Pathogen Res Grp, Perth, WA, Australia.	a.gofton@murdoch.edu.au; p.irwin@murdoch.edu.au	Gofton, Alexander W/GOJ-8010-2022; Oskam, Charlotte/N-4097-2018; Paparini, Andrea/T-8057-2019	Gofton, Alexander W/0000-0002-5039-6117; Oskam, Charlotte/0000-0001-8886-2120; Irwin, Peter/0000-0002-0006-8262; Ryan, Una/0000-0003-2710-9324; Paparini, Andrea/0000-0002-1105-5184	Australian Research Council [LP13010050]; Bayer Healthcare; Bayer Australia Ltd.	Australian Research Council(Australian Research Council); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Bayer Australia Ltd.	This study was part-funded by the Australian Research Council (LP13010050), www.arc.gov.au, Bayer Healthcare, www.healthcare.bayer.com, and Bayer Australia Ltd., www.bayer.com.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON BE, 1991, J CLIN MICROBIOL, V29, P2838, DOI 10.1128/JCM.29.12.2838-2842.1991; Andersson M, 2014, TICKS TICK-BORNE DIS, V5, P706, DOI 10.1016/j.ttbdis.2014.05.013; Andersson M, 2013, VECTOR-BORNE ZOONOT, V13, P438, DOI 10.1089/vbz.2012.1118; Andreasson K, 2015, RHEUMATOLOGY, V54, P369, DOI 10.1093/rheumatology/keu441; Barbour AG, 1996, J INFECT DIS, V173, P403, DOI 10.1093/infdis/173.2.403; Barker SC, 2014, INT J PARASITOL, V44, P941, DOI 10.1016/j.ijpara.2014.08.008; Barker SC, 2014, ZOOTAXA, V3816, P1, DOI 10.11646/zootaxa.3816.1.1; Brouqui P, 2003, ANN NY ACAD SCI, V990, P134, DOI 10.1111/j.1749-6632.2003.tb07352.x; CAMPBELL RW, 1974, T ROY SOC TROP MED H, V68, P397, DOI 10.1016/0035-9203(74)90156-4; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728; Clark KL, 2013, INT J MED SCI, V10, P915, DOI 10.7150/ijms.6273; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Derdakova M, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-160; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Donohoe H, 2015, TOURISM MANAGE, V46, P408, DOI 10.1016/j.tourman.2014.07.006; DUMLER JS, 1995, CLIN INFECT DIS, V20, P1102, DOI 10.1093/clinids/20.5.1102; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fehr JS, 2010, EMERG INFECT DIS, V16, P1127, DOI 10.3201/eid1607.091907; Ferla MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083383; Foldvari G, 2014, EMERG INFECT DIS, V20, P496, DOI 10.3201/eid2003.130935; Glatz M, 2014, TICKS TICK-BORNE DIS, V5, P139, DOI 10.1016/j.ttbdis.2013.10.006; Gofton AW, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0958-3; Grankvist A, 2015, J CLIN MICROBIOL, V53, P3126, DOI 10.1128/JCM.00880-15; Grankvist A, 2015, EMERG INFECT DIS, V21, P1462, DOI 10.3201/eid2108.150060; Grankvist A, 2014, CLIN INFECT DIS, V58, P1716, DOI 10.1093/cid/ciu189; Gray J, 2002, LYME BORRELIOSIS BIO; Halperin JJ, 2015, INFECT DRUG RESIST, V8, DOI 10.2147/IDR.S66739; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Hodzic A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0692-x; Inokuma H, 2001, J CLIN MICROBIOL, V39, P3031, DOI 10.1128/JCM.39.9.3031-3039.2001; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawahara M, 2004, INT J SYST EVOL MICR, V54, P1837, DOI 10.1099/ijs.0.63260-0; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kurilshikov A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131413; Li AY, 2010, VET MICROBIOL, V146, P59, DOI 10.1016/j.vetmic.2010.04.018; Li H, 2013, APPL ENVIRON MICROB, V79, P1024, DOI 10.1128/AEM.02917-12; Mayne P, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu133; Mayne PJ, 2015, INT J GEN MED, V8, P15, DOI 10.2147/IJGM.S75825; Mc Pherson MJ MS., 2005, PCR BASICS BACKGROUN; McDiarmid L, 2000, INT J PARASITOL, V30, P791, DOI 10.1016/S0020-7519(00)00062-X; Mignard S, 2006, J MICROBIOL METH, V67, P574, DOI 10.1016/j.mimet.2006.05.009; Naitou H, 2006, MICROBIOL IMMUNOL, V50, P45, DOI 10.1111/j.1348-0421.2006.tb03769.x; Obiegala A, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0563-x; Paddock CD, 1997, J CLIN MICROBIOL, V35, P2496, DOI 10.1128/JCM.35.10.2496-2502.1997; Palomar AM, 2014, PARASITES VECTORS, V7; Pekova S, 2011, DIAGN MICR INFEC DIS, V69, P266, DOI 10.1016/j.diagmicrobio.2010.10.004; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Rar V A, 2011, Mol Gen Mikrobiol Virusol, P17; Rar V, 2011, INFECT GENET EVOL, V11, P1842, DOI 10.1016/j.meegid.2011.09.019; Richter D, 2011, J CLIN MICROBIOL; Richter D, 2012, J CLIN MICROBIOL, V50, P943, DOI 10.1128/JCM.05802-11; Roberts F.H.S., 1970, AUSTR TICKS; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RUSSELL RC, 1994, EPIDEMIOL INFECT, V112, P375, DOI 10.1017/S0950268800057782; Silaghi C, 2015, EXP APPL ACAROL; Silaghi C, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-191; Song S, 2011, INT J PARASITOL, V41, P871, DOI 10.1016/j.ijpara.2011.03.008; Stenos J, 2005, AM J TROP MED HYG, V73, P1083, DOI 10.4269/ajtmh.2005.73.1083; STEWART A, 1982, MED J AUSTRALIA, V1, P139, DOI 10.5694/j.1326-5377.1982.tb132207.x; STOTHARD DR, 1994, INT J SYST BACTERIOL, V44, P798, DOI 10.1099/00207713-44-4-798; Stuen S, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00031; Su ZQ, 2011, EXPERT REV MOL DIAGN, V11, P333, DOI [10.1586/ERM.11.3, 10.1586/erm.11.3]; Sumner JW, 1997, J CLIN MICROBIOL, V35, P2087, DOI 10.1128/JCM.35.8.2087-2092.1997; Szekeres S, 2015, TICKS TICK-BORNE DIS, V6, P111, DOI 10.1016/j.ttbdis.2014.10.004; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Unsworth NB, 2007, EMERG INFECT DIS, V13, P566; van Nunen S, 2015, ASIA PAC ALLERGY, V5, P3, DOI 10.5415/apallergy.2015.5.1.3; Vayssier-Taussat M, 2012, EMERG INFECT DIS, V18, P2063, DOI 10.3201/eid1812.120846; von Loewenich FD, 2010, J CLIN MICROBIOL, V48, P2630, DOI 10.1128/JCM.00588-10; Welc-Faleciak R, 2014, J CLIN MICROBIOL, V52, P3072, DOI 10.1128/JCM.00741-14; Welinder-Olsson C, 2010, J CLIN MICROBIOL, V48, P1956, DOI 10.1128/JCM.02423-09; WILLS MC, 1991, MED J AUSTRALIA, V155, P275, DOI 10.5694/j.1326-5377.1991.tb142253.x; Wojcik-Fatla A, 2015, TICKS TICK-BORNE DIS, V6, P253, DOI 10.1016/j.ttbdis.2015.01.005; Yabsley MJ, 2008, VET MICROBIOL, V131, P301, DOI 10.1016/j.vetmic.2008.04.004; Yabsley MJ, 2008, INT J SYST EVOL MICR, V58, P2794, DOI 10.1099/ijs.0.65836-0	79	46	46	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145449	10.1371/journal.pone.0145449	http://dx.doi.org/10.1371/journal.pone.0145449			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709826	Green Published, Green Submitted, gold			2022-12-27	WOS:000367451400047
J	Pavluvcik, P; Poprach, K; Machar, I; Losik, J; Gouveia, A; Tkadlec, E				Pavluvcik, Petr; Poprach, Karel; Machar, Ivo; Losik, Jan; Gouveia, Ana; Tkadlec, Emil			Barn Owl Productivity Response to Variability of Vole Populations	PLOS ONE			English	Article							TYTO-ALBA; ANTICIPATORY REPRODUCTION; NUMERICAL RESPONSE; MICROTUS-ARVALIS; PREY; DYNAMICS; PREDATOR; DENSITY; SIZE; FOOD	We studied the response of the barn owl annual productivity to the common vole population numbers and variability to test the effects of environmental stochasticity on their life histories. Current theory predicts that temporal environmental variability can affect long-term nonlinear responses (e.g., production of young) both positively and negatively, depending on the shape of the relationship between the response and environmental variables. At the level of the Czech Republic, we examined the shape of the relationship between the annual sum of fledglings (annual productivity) and vole numbers in both non-detrended and detrended data. At the districts' level, we explored whether the degree of synchrony (measured by the correlation coefficient) and the strength of the productivity response increase (measured by the regression coefficient) in areas with higher vole population variability measured by the s-index. We found that the owls' annual productivity increased linearly with vole numbers in the Czech Republic. Furthermore, based on district data, we also found that synchrony between dynamics in owls' reproductive output and vole numbers increased with vole population variability. However, the strength of the response was not affected by the vole population variability. Additionally, we have shown that detrending remarkably increases the Taylor's exponent b relating variance to mean in vole time series, thereby reversing the relationship between the coefficient of variation and the mean. This shift was not responsible for the increased synchrony with vole population variability. Instead, we suggest that higher synchrony could result from high food specialization of owls on the common vole in areas with highly fluctuating vole populations.	[Pavluvcik, Petr; Losik, Jan; Gouveia, Ana; Tkadlec, Emil] Palacky Univ, Fac Sci, Dept Ecol & Environm Sci, CR-77147 Olomouc, Czech Republic; [Poprach, Karel] TYTO Obcanske Sdruzeni, Nenakonice, Verovany, Czech Republic; [Machar, Ivo] Palacky Univ, Fac Sci, Dept Dev Studies, CR-77147 Olomouc, Czech Republic; [Tkadlec, Emil] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences	Tkadlec, E (corresponding author), Palacky Univ, Fac Sci, Dept Ecol & Environm Sci, CR-77147 Olomouc, Czech Republic.	emil.tkadlec@upol.cz	Tkadlec, Emil/A-6230-2014; Gouveia, Ana/AAQ-6166-2020	Gouveia, Ana/0000-0002-9711-4367; Tkadlec, Emil/0000-0003-3782-8867	POSTUP I project [CZ.1.07/2.3.00/30.0004]; Ministry of the Environment, Landscape Management Fund; Ministry of the Environment; County of Pardubice; County of Olomouc; County of Zlin; DEFRA Environment Assistance Fund [EF/33/02]; Iceland, Liechtenstein and Norway through the EEA Financial Mechanism; Iceland, Liechtenstein and Norway through the Norwegian Financial Mechanism; Usti Community Foundation; VIA Foundation [TMHK 008/2010];  [IGA_PrF_2015_008];  [N-2036]	POSTUP I project; Ministry of the Environment, Landscape Management Fund; Ministry of the Environment(Ministry of the Environment, Japan); County of Pardubice; County of Olomouc; County of Zlin; DEFRA Environment Assistance Fund; Iceland, Liechtenstein and Norway through the EEA Financial Mechanism; Iceland, Liechtenstein and Norway through the Norwegian Financial Mechanism; Usti Community Foundation; VIA Foundation; ; 	The work was funded by grant IGA_PrF_2015_008 to E.T.; POSTUP I project CZ.1.07/2.3.00/30.0004 to E.T; Ministry of the Environment, Landscape Management Fund to I.M. and K.P.; Ministry of the Environment to I.M.; County of Pardubice to I.M.; County of Olomouc to I.M.; County of Zlin to I.M.; DEFRA Environment Assistance Fund EF/33/02 to I.M.; Iceland, Liechtenstein and Norway through the EEA Financial Mechanism and the Norwegian Financial Mechanism intermediated by the Civil Society Development to I.M.; the Partnership Foundation, N-2036, to I.M.; the Usti Community Foundation to I.M.; and VIA Foundation TMHK 008/2010 to I.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGERBJORN A, 1991, J ANIM ECOL, V60, P705, DOI 10.2307/5307; Angerbjorn A, 1999, J ANIM ECOL, V68, P34, DOI 10.1046/j.1365-2656.1999.00258.x; [Anonymous], 2014, R LANG ENV STAT COMP; Baines D, 2013, J APPL ECOL, V50, P1397, DOI 10.1111/1365-2664.12154; Barraquand F, 2014, POPUL ECOL, V56, P551, DOI 10.1007/s10144-014-0440-7; Barraquand F, 2014, J ANIM ECOL, V83, P375, DOI 10.1111/1365-2656.12140; Bernard N, 2010, CAN J ZOOL, V88, P416, DOI 10.1139/Z10-011; Bond G, 2005, LANDSCAPE ECOL, V20, P555, DOI 10.1007/s10980-004-5037-7; Boutin S, 2006, SCIENCE, V314, P1928, DOI 10.1126/science.1135520; Brommer JE, 2002, AUK, V119, P544, DOI 10.1642/0004-8038(2002)119[0544:RASIAV]2.0.CO;2; Bryja J, 2005, CAN J ZOOL, V83, P1391, DOI 10.1139/Z05-133; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Charter M, 2015, J ARID ENVIRON, V122, P59, DOI 10.1016/j.jaridenv.2015.06.011; Cohen Dan, 1993, Lecture Notes in Biomathematics, V98, P8; DEBRUIJN O, 1994, ARDEA, V82, P1; GASTON KJ, 1994, PHILOS T R SOC B, V345, P335, DOI 10.1098/rstb.1994.0114; Gouveia A, 2015, POPUL ECOL, V57, P581, DOI 10.1007/s10144-015-0504-3; Granger CW., 1974, J ECONOMETRICS, V2, P111, DOI [DOI 10.1016/0304-4076(74)90034-7, 10.1016/0304-4076(74)90034-7]; Honer M. R., 1963, Ardea, V51, P158; Husek J, 2013, POPUL ECOL, V55, P363, DOI 10.1007/s10144-013-0366-5; JAKSIC FM, 1992, OECOLOGIA, V89, P90, DOI 10.1007/BF00319020; Kontiainen P, 2009, BEHAV ECOL, V20, P789, DOI 10.1093/beheco/arp062; Lande R., 2003, OXFORD SERIES ECOLOG; LINDSTROM E, 1988, OIKOS, V52, P115, DOI 10.2307/3565990; Linnerud M, 2013, OIKOS, V122, P1207, DOI 10.1111/j.1600-0706.2012.20517.x; Lisicka L, 2007, FOLIA ZOOL, V56, P169; MARTI CD, 1994, CONDOR, V96, P468, DOI 10.2307/1369329; MCARDLE BH, 1990, J ANIM ECOL, V59, P439, DOI 10.2307/4873; Millon A, 2008, OIKOS, V117, P1500, DOI 10.1111/j.0030-1299.2008.16458.x; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Otis DL., 1982, CAPTURE RECAPTURE RE; Pertoldi C, 2014, THEOR BIOSCI, V133, P165, DOI 10.1007/s12064-014-0201-3; Royama T., 1992, ANAL POPULATION ECOL; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Salamolard M, 2000, ECOLOGY, V81, P2428, DOI 10.1890/0012-9658(2000)081[2428:ROAAPT]2.0.CO;2; Schonfeld M., 1975, Hercynia N F, V12, P257; Sundell J, 2003, ACTA THERIOL, V48, P59, DOI 10.1007/BF03194266; Taylor I. R, 1994, BARN OWLS PREDATOR P; Tkadlec E, 2001, P ROY SOC B-BIOL SCI, V268, P1547, DOI 10.1098/rspb.2001.1694; Tkadlec E, 2006, CLIM RES, V32, P99, DOI 10.3354/cr032099; Toms MP, 1994, RAPTOR, V21, P57; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Valkama J, 2002, J AVIAN BIOL, V33, P426, DOI 10.1034/j.1600-048X.2002.02875.x; White TCR, 2013, NEW ZEAL J ZOOL, V40, P332, DOI 10.1080/03014223.2013.798336; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; Yang LH, 2010, ECOL MONOGR, V80, P125, DOI 10.1890/08-1996.1; Yoccoz NG, 2009, ENVIRON INT, V35, P107, DOI 10.1016/j.envint.2008.08.014	47	10	12	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145851	10.1371/journal.pone.0145851	http://dx.doi.org/10.1371/journal.pone.0145851			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709518	Green Published, gold, Green Submitted			2022-12-27	WOS:000367451400085
J	Chen, CQ; Lu, ML; Pan, QH; Fichna, J; Zheng, LJ; Wang, KS; Yu, Z; Li, YY; Li, K; Song, AH; Liu, ZC; Song, ZS; Kreis, M				Chen, Chunqiu; Lu, Meiling; Pan, Qiuhui; Fichna, Jakub; Zheng, Lijun; Wang, Kesheng; Yu, Zhen; Li, Yongyu; Li, Kun; Song, Aihong; Liu, Zhongchen; Song, Zhenshun; Kreis, Martin			Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner	PLOS ONE			English	Article							QUALITY-OF-LIFE; ABDOMINAL-PAIN; DELTA; MICE; RATS; MU; FACILITATION; DISORDERS; EFFICACY; BEHAVIOR	Background and Aims Berberine and its derivatives display potent analgesic, anti-inflammatory and anticancer activity. Here we aimed at characterizing the mechanism of action of berberine in the gastrointestinal (GI) tract and cortical neurons using animal models and in vitro tests. Methods The effect of berberine was characterized in murine models mimicking diarrhea-predominant irritable bowel syndrome (IBS-D) symptoms. Then the opioidantagonists were used to identify the receptors involved. Furthermore, the effect of berberineon opioid receptors expression was established in the mouse intestine and rat fetal cortical neurons. Results In mouse models, berberine prolonged GI transit and time to diarrhea in a dose-dependent manner, and significantly reduced visceral pain. In physiological conditions the effects of berberine were mediated by mu-(MOR) and delta-(DOR) opioidreceptors; hypermotility, excessive secretion and nociception were reversed by berberine through MOR and DOR-dependent action. We also found that berberine increased the expression of MOR and DOR in the mouse bowel and rat fetal cortical neurons. Conclusion Berberine significantly improved IBS-D symptoms in animal models, possibly through mu-and delta-opioid receptors. Berberine may become a new drug candidate for the successful treatment of IBS-D in clinical conditions.	[Chen, Chunqiu; Lu, Meiling; Pan, Qiuhui; Zheng, Lijun; Wang, Kesheng; Yu, Zhen; Song, Aihong; Liu, Zhongchen; Song, Zhenshun] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China; [Fichna, Jakub] Med Univ Lodz, Dept Biochem, Lodz, Poland; [Li, Yongyu; Li, Kun] Tongji Univ, Dept Pathophysiol, Inst Digest Dis, Sch Med, Shanghai 200092, Peoples R China; [Kreis, Martin] Charite, Dept Gen Visceral & Vasc Surg, D-13353 Berlin, Germany	Tongji University; Medical University Lodz; Tongji University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Fichna, J (corresponding author), Med Univ Lodz, Dept Biochem, Lodz, Poland.	jakub.fichna@umed.lodz.pl	Fichna, Jakub/S-6641-2016	Fichna, Jakub/0000-0002-8443-4417; Kreis, Martin E./0000-0002-9312-4840	National Science Foundation of China [81170345, 31571181]; bilateral cooperation project between China and Poland from the Ministry of Science and technology [36-25]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); bilateral cooperation project between China and Poland from the Ministry of Science and technology	This work was supported by grants awarded to Dr. Chunqiu Chen and Dr. Yongyu Li from the National Science Foundation of China (No. 81170345 and No. 31571181), and by bilateral cooperation project between China and Poland from the Ministry of Science and technology (Chunqiu Chen and Jakub Fichna No. 36-25, 2015).	Altarifi AA, 2015, J PHARMACOL EXP THER, V352, P208, DOI 10.1124/jpet.114.219873; Bhutada P, 2011, BEHAV BRAIN RES, V220, P30, DOI 10.1016/j.bbr.2011.01.022; Bodnar RJ, 2013, PEPTIDES, V50, P55, DOI 10.1016/j.peptides.2013.10.001; Bray BD, 2006, BRIT J GEN PRACT, V56, P122; Brocardo PS, 2009, BEHAV BRAIN RES, V200, P122, DOI 10.1016/j.bbr.2009.01.004; Chen CQ, 2014, AM J CHINESE MED, V42, P1053, DOI 10.1142/S0192415X14500669; Chen DP, 2013, J PHARM PHARMACOL, V65, P734, DOI 10.1111/jphp.12026; CORAZZIARI E, 1999, CAN J GASTROENTEROL, V13, P71; Dahan A, 2015, PAIN, V156, pS119, DOI [10.1097/01.j.pain.0000460340.62094.3e, 10.1016/j.pain.0000000000000023]; Derosa G, 2012, EXPERT OPIN BIOL TH, V12, P1113, DOI 10.1517/14712598.2012.704014; Dong H, 2013, PLANTA MED, V79, P437, DOI 10.1055/s-0032-1328321; Feng YJ, 2013, PHYTOTHER RES, V27, P1564, DOI 10.1002/ptr.4926; Fichna J, 2012, PHARMACOL REP, V64, P1146, DOI 10.1016/S1734-1140(12)70911-8; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; He SQ, 2011, NEURON, V69, P120, DOI 10.1016/j.neuron.2010.12.001; Hsu YY, 2013, TOXICOL APPL PHARM, V272, P787, DOI 10.1016/j.taap.2013.08.008; Ide S, 2010, NEUROPHARMACOLOGY, V58, P241, DOI 10.1016/j.neuropharm.2009.07.005; Ito D, 2013, BRAIN RES, V1534, P22, DOI 10.1016/j.brainres.2013.08.004; Jerndal P, 2010, NEUROGASTROENT MOTIL, V22, P646, DOI 10.1111/j.1365-2982.2010.01493.x; Kabli N, 2014, MOL PSYCHIATR, V19, P986, DOI 10.1038/mp.2013.115; Kulkarni SK, 2010, PHYTOTHER RES, V24, P317, DOI 10.1002/ptr.2968; Martini C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128997; Matsumoto K, 2014, J PHARMACOL EXP THER, V348, P383, DOI 10.1124/jpet.113.208108; Mo CF, 2014, ANTIOXID REDOX SIGN, V20, P574, DOI 10.1089/ars.2012.5116; Normandin A, 2013, J NEUROSCI, V33, P11703, DOI 10.1523/JNEUROSCI.1631-13.2013; Nozaki C, 2014, BRIT J PHARMACOL, V171, P5376, DOI 10.1111/bph.12852; Ong Edmund W, 2014, Cells, V3, P152, DOI 10.3390/cells3010152; Peng WH, 2007, LIFE SCI, V81, P933, DOI 10.1016/j.lfs.2007.08.003; Pradhan AA, 2011, TRENDS PHARMACOL SCI, V32, P581, DOI 10.1016/j.tips.2011.06.008; Saitoh A, 2012, CURR NEUROPHARMACOL, V10, P231, DOI 10.2174/157015912803217314; Sauriyal DS, 2011, NEUROPEPTIDES, V45, P175, DOI 10.1016/j.npep.2010.12.004; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Sobczak M, 2014, PEPTIDES, V60, P102, DOI 10.1016/j.peptides.2014.08.005; Tan Wen, 2011, Int J Nanomedicine, V6, P1773, DOI 10.2147/IJN.S22683; Tang QL, 2013, WORLD J GASTROENTERO, V19, P4582, DOI 10.3748/wjg.v19.i28.4582; Wagner JJ, 2001, J PHARMACOL EXP THER, V296, P776; Werner MU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125887; Xu SY, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/803930; Zhang X, 2015, BRIT J PHARMACOL, V172, P364, DOI 10.1111/bph.12653; Zielinska M, 2015, J PHARM PHARMACOL, V67, P244, DOI 10.1111/jphp.12335	40	32	36	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145556	10.1371/journal.pone.0145556	http://dx.doi.org/10.1371/journal.pone.0145556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700862	gold, Green Published, Green Submitted			2022-12-27	WOS:000367092600095
J	Gonella-Diaza, AM; Andrade, SCD; Sponchiado, M; Pugliesi, G; Mesquita, FS; Van Hoeck, V; Strefezzi, RD; Gasparin, GR; Coutinho, LL; Binelli, M				Gonella-Diaza, Angela Maria; da Silva Andrade, Sonia Cristina; Sponchiado, Mariana; Pugliesi, Guilherme; Mesquita, Fernando Silveira; Van Hoeck, Veerle; Strefezzi, Ricardo de Francisco; Gasparin, Gustavo R.; Coutinho, Luiz L.; Binelli, Mario			Size of the Ovulatory Follicle Dictates Spatial Differences in the Oviductal Transcriptome in Cattle	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX COMPONENTS; RETINOL-BINDING-PROTEIN; BOVINE OVIDUCT; EMBRYO DEVELOPMENT; ESTROUS-CYCLE; PROGESTERONE-RECEPTOR; MORPHOLOGICAL-CHANGES; EXPRESSION ANALYSIS; GENE-EXPRESSION; EARLY DIESTRUS	In cattle, molecular control of oviduct receptivity to the embryo is poorly understood. Here, we used a bovine model for receptivity based on size of the pre-ovulatory follicle to compare oviductal global and candidate gene transcript abundance on day 4 of the estrous cycle. Growth of the pre-ovulatory follicle (POF) of Nelore (Bos indicus) cows was manipulated to produce two groups: large POF large corpus luteum (CL) group (LF-LCL; greater receptivity) and small POF-small CL group (SF-SCL). Oviductal samples were collected four days after GnRH-induced ovulation. Ampulla and isthmus transcriptome was obtained by RNA-seq, regional gene expression was assessed by qPCR, and PGR and ERa protein distribution was evaluated by immunohistochemistry. There was a greater abundance of PGR and ERa in the oviduct of LF-LCL animals thus indicating a greater availability of receptors and possibly sex steroids stimulated signaling in both regions. Transcriptomic profiles indicated a series of genes associated with functional characteristics of the oviduct that are regulated by the periovulatory sex steroid milieu and that potentially affect oviductal receptivity and early embryo development. They include tissue morphology changes (extra cellular matrix remodeling), cellular changes (proliferation), and secretion changes (growth factors, ions and metal transporters), and were enriched for the genes with increased expression in the LF-LCL group. In conclusion, differences in the periovulatory sex steroid milieu lead to different oviductal gene expression profiles that could modify the oviductal environment to affect embryo survival and development.	[Gonella-Diaza, Angela Maria; Sponchiado, Mariana; Pugliesi, Guilherme; Van Hoeck, Veerle; Binelli, Mario] Univ Sao Paulo, Fac Med Vet & Zootecnia, Sao Paulo, Brazil; [da Silva Andrade, Sonia Cristina; Gasparin, Gustavo R.; Coutinho, Luiz L.] Univ Sao Paulo, Lab Biotecnol Anim, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [Mesquita, Fernando Silveira] Univ Fed Pampa, Fac Med Vet, Uruguaiana, Brazil; [Strefezzi, Ricardo de Francisco] Univ Sao Paulo, Fac Zootecnia & Engn Alimentos, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Pampa; Universidade de Sao Paulo	Binelli, M (corresponding author), Univ Sao Paulo, Fac Med Vet & Zootecnia, Sao Paulo, Brazil.	binelli@usp.br	Coutinho, Luiz L/C-8455-2012; MESQUITA, FERNANDO SILVEIRA/J-9978-2012; huang, dezhi/ABC-6566-2021; Strefezzi, Ricardo F/B-8754-2010; Pugliesi, Guilherme/AAK-9557-2020; pugliesi, Guilherme/A-9149-2013; Coutinho, Luiz/P-5233-2019; Andrade, Sonia/GLS-1234-2022	Coutinho, Luiz L/0000-0002-7266-8881; MESQUITA, FERNANDO SILVEIRA/0000-0002-4433-0832; Strefezzi, Ricardo F/0000-0002-8810-2815; Pugliesi, Guilherme/0000-0001-5739-0677; Coutinho, Luiz/0000-0002-7266-8881; Andrade, Sonia/0000-0002-1302-5261	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); PEC-PG program [15068-12-9]; National Counsel of Technological and Scientific Development (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/03226-4]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PEC-PG program; National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); PEC-PG program: AMGD grant number 15068-12-9; National Counsel of Technological and Scientific Development (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP): MB grant number 2011/03226-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1996, HISTOL HISTOPATHOL, V11, P743; Ahumada CJ, 2013, ANIMAL, V7, P455, DOI 10.1017/S1751731112001991; Alminana C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-293; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Araujo ER, 2014, REPROD FERTIL DEV, V87; Aviles M, 2010, MOL HUM REPROD, V16, P896, DOI 10.1093/molehr/gaq056; Ayen E, 2012, IRAN J VET RES, V13, P42; Batzios SP, 2013, FEBS LETT, V587, P1258, DOI 10.1016/j.febslet.2013.02.035; Bauersachs S, 2005, J MOL ENDOCRINOL, V34, P889, DOI 10.1677/jme.1.01799; Bauersachs S, 2003, BIOL REPROD, V68, P1170, DOI 10.1095/biolreprod.102.010660; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binelli M, 1999, BIOL REPROD, V61, P127, DOI 10.1095/biolreprod61.1.127; Block J, 2003, J ANIM SCI, V81, P1590; Bridges GA, 2012, ANIM REPROD SCI, V133, P16, DOI 10.1016/j.anireprosci.2012.06.013; Bridges GA, 2010, ANIM REPROD SCI, V117, P208, DOI 10.1016/j.anireprosci.2009.05.002; Brower L. K., 1969, Biology of Reproduction, V1, P130, DOI 10.1095/biolreprod1.2.130; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Buhi WC, 2000, CELLS TISSUES ORGANS, V166, P165, DOI 10.1159/000016731; Capiod T, 2013, RECENT PAT ANTI-CANC, V8, P4; Cerny KL, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0077-1; Cigankova V, 1996, VET MED-CZECH, V41, P339; Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Daley WP, 2013, CURR OPIN GENET DEV, V23, P408, DOI 10.1016/j.gde.2013.05.005; Dennis G, 2003, GENOME BIOL, V4; ERIKSEN T, 1994, ANAT EMBRYOL, V190, P583; Forde N, 2011, BIOL REPROD, V84, P266, DOI 10.1095/biolreprod.110.085910; Forde N, 2013, BMC GENOMICS, P14; Gabler C, 2001, REPRODUCTION, V122, P121, DOI 10.1530/rep.0.1220121; GANDOLFI F, 1989, DEVELOPMENT, V106, P303; Garbarino EJ, 2004, J DAIRY SCI, V87, P4123, DOI 10.3168/jds.S0022-0302(04)73555-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; George F, 2008, THERIOGENOLOGY, V69, P612, DOI 10.1016/j.theriogenology.2007.11.008; Hugentobler SA, 2010, REPROD FERT DEVELOP, V22, P684, DOI 10.1071/RD09129; Hunter RHF, 2012, BIOL REV, V87, P244, DOI 10.1111/j.1469-185X.2011.00196.x; Hunter RHF, 1998, ACTA OBSTET GYN SCAN, V77, P475, DOI 10.1034/j.1600-0412.1998.770501.x; HUNTER RHF, 1991, TISSUE CELL, V23, P641, DOI 10.1016/0040-8166(91)90020-T; KASTELIC JP, 1990, THERIOGENOLOGY, V34, P487, DOI 10.1016/0093-691X(90)90006-F; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kolle S, 2009, BIOL REPROD, V81, P267, DOI 10.1095/biolreprod.108.073874; Kurzawa Rafal, 2002, Reprod Biol, V2, P143; Kutys ML, 2013, EXP CELL RES, V319, P2434, DOI 10.1016/j.yexcr.2013.05.030; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee Y, 1996, P NATL ACAD SCI USA, V93, P15180, DOI 10.1073/pnas.93.26.15180; Lee YJ, 1998, MOL CELL ENDOCRINOL, V137, P85, DOI 10.1016/S0303-7207(97)00235-9; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RF, 2007, MOL REPROD DEV, V74, P1228, DOI 10.1002/mrd.20682; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Maillo V, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.127969; Mesquita FS, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.129031; Mesquita FS, 2014, THERIOGENOLOGY, V81, P861, DOI 10.1016/j.theriogenology.2013.12.022; Mondejar I, 2012, REPROD DOMEST ANIM, V47, P22, DOI 10.1111/j.1439-0531.2012.02027.x; MURRAY MK, 1995, BIOL REPROD, V53, P653, DOI 10.1095/biolreprod53.3.653; Neve A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/756078; Peres RFG, 2009, THERIOGENOLOGY, V72, P681, DOI 10.1016/j.theriogenology.2009.04.026; Pugliesi G, 2014, REPROD DOMEST ANIM, V49, P85, DOI 10.1111/rda.12231; Ramos RS, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0036-x; ROTELLO RJ, 1991, P NATL ACAD SCI USA, V88, P3412, DOI 10.1073/pnas.88.8.3412; Shimizu T, 2010, PHYSIOL GENOMICS, V42A, P290, DOI 10.1152/physiolgenomics.00107.2010; Siddiqui MAR, 2009, REPRODUCTION, V137, P689, DOI 10.1530/REP-08-0403; Smit A., REPEATMASKER OPEN 3; Takahashi M, 2012, J REPROD DEVELOP, V58, P1, DOI 10.1262/jrd.11-138N; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Ulbrich SE, 2003, J STEROID BIOCHEM, V84, P279, DOI 10.1016/S0960-0760(03)00039-6; VALLET JL, 1995, BIOL REPROD, V53, P1436, DOI 10.1095/biolreprod53.6.1436; Vallet JL, 1996, BIOL REPROD, V55, P1172, DOI 10.1095/biolreprod55.5.1172; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walsh B, 2009, REDOX REP, V14, P275, DOI 10.1179/135100009X12525712409652; Wijayagunawardane MPB, 1998, THERIOGENOLOGY, V49, P607, DOI 10.1016/S0093-691X(98)00011-9; Zervomanolakis I, 2009, EUR J OBSTET GYN R B, V144, pS45, DOI 10.1016/j.ejogrb.2009.02.012	70	27	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145321	10.1371/journal.pone.0145321	http://dx.doi.org/10.1371/journal.pone.0145321			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699362	Green Published, Green Submitted, gold			2022-12-27	WOS:000367092600066
J	Hagiwara, K; Ishii, H; Murakami, T; Takeshima, SN; Chutiwitoonchai, N; Kodama, EN; Kawaji, K; Kondoh, Y; Honda, K; Osada, H; Tsunetsugu-Yokota, Y; Suzuki, M; Aida, Y				Hagiwara, Kyoji; Ishii, Hideki; Murakami, Tomoyuki; Takeshima, Shin-nosuke; Chutiwitoonchai, Nopporn; Kodama, Eiichi N.; Kawaji, Kumi; Kondoh, Yasumitsu; Honda, Kaori; Osada, Hiroyuki; Tsunetsugu-Yokota, Yasuko; Suzuki, Masaaki; Aida, Yoko			Synthesis of a Vpr-Binding Derivative for Use as a Novel HIV-1 Inhibitor	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TERMINALLY TRUNCATED FORM; VIRAL PROTEIN R; NUCLEAR IMPORT; CELL-CYCLE; ALPHA; APOPTOSIS; REPLICATION; MACROPHAGES; ACTIVATION	The emergence of multidrug-resistant viruses compromises the efficacy of anti-human immunodeficiency virus type 1 (HIV-1) therapy and limits treatment options. Therefore, new targets that can be used to develop novel antiviral agents need to be identified. We previously identified a potential parent compound, hematoxylin, which suppresses the nuclear import of HIV-1 via the Vpr-importin a interaction and inhibits HIV-1 replication in a Vpr-dependent manner by blocking nuclear import of the pre-integration complex. However, it was unstable. Here, we synthesized a stable derivative of hematoxylin that bound specifically and stably to Vpr and inhibited HIV-1 replication in macrophages. Furthermore, like hematoxylin, the derivative inhibited nuclear import of Vpr in an in vitro nuclear import assay, but had no effect on Vpr-induced G2/M phase cell cycle arrest or caspase activity. Interestingly, this derivative bound strongly to amino acid residues 54-74 within the C-terminal a-helical domain (alpha H3) of Vpr. These residues are highly conserved among different HIV strains, indicating that this region is a potential target for drug-resistant HIV-1 infection. Thus, we succeeded in developing a stable hematoxylin derivative that bound directly to Vpr, suggesting that specific inhibitors of the interaction between cells and viral accessory proteins may provide a new strategy for the treatment of HIV-1 infection.	[Hagiwara, Kyoji; Murakami, Tomoyuki; Takeshima, Shin-nosuke; Chutiwitoonchai, Nopporn; Aida, Yoko] RIKEN, Viral Infect Dis Unit, Wako, Saitama 3510198, Japan; [Ishii, Hideki; Suzuki, Masaaki] RIKEN, Mol Imaging Med Chem Lab, Ctr Mol Imaging Sci, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kodama, Eiichi N.; Kawaji, Kumi] Tohoku Univ, Grad Sch Med, Div Miyagi Community Hlth Promot, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kondoh, Yasumitsu; Honda, Kaori; Osada, Hiroyuki] RIKEN, CSRS, Chem Biol Res Grp, Wako, Saitama 3510198, Japan; [Tsunetsugu-Yokota, Yasuko] Natl Inst Infect Dis, Dept Frontier Biosci, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan	RIKEN; RIKEN; Tohoku University; RIKEN; National Institute of Infectious Diseases (NIID)	Aida, Y (corresponding author), RIKEN, Viral Infect Dis Unit, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	aida@riken.jp	Kodama, Eiichi N/C-4032-2009; Osada, Hiroyuki/N-4305-2014; KONDOH, Yasumitsu/C-7461-2017; Osada, Hiroyuki/AAY-6254-2020; Takeshima, Shinnosuke/E-1246-2011	Kodama, Eiichi N/0000-0002-6622-2752; KONDOH, Yasumitsu/0000-0002-3481-5481; Takeshima, Shinnosuke/0000-0001-9648-0480; Ishii, Hideki/0000-0003-4348-0123; ISHII, HIDEKI/0000-0003-2408-4897	Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan, Research on HIV/AIDS [H25-AIDS-003, 15fk0410010h0002]; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan [06-01]; Grants-in-Aid for Scientific Research [26350976] Funding Source: KAKEN	Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan, Research on HIV/AIDS; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan, Research on HIV/AIDS (ID: H25-AIDS-003 and ID: 15fk0410010h0002, http://www.jhsf.or.jp/English/index_e.html), and by the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan (ID 06-01, http://www.nibio.go.jp/english/index.html).; We are grateful to Drs. Norio Yamamoto, Naoki Yamamoto, Yuetsu Tanaka, and Kazu Okuma for help with the viral infection experiments. We are also grateful to the RIKEN BSI Research Resources Center for help with sequence analysis. This work was supported in part by a Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan, Research on HIV/AIDS: (ID: H25-AIDS-003 and ID: 15fk0410010h0002, http://www.jhsf.or.jp/English/index_e.html), and by the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan (ID 06-01: http://www.nibio.go.jp/english/index.html).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Aida Y, 2010, CURR CHEM BIOL, V4, P188; Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; Barbaro G, 2005, CURR PHARM DESIGN, V11, P1805, DOI 10.2174/1381612053764869; Bukrinsky M, 1999, REV MED VIROL, V9, P39, DOI 10.1002/(SICI)1099-1654(199901/03)9:1<39::AID-RMV235>3.0.CO;2-3; Felzien LK, 1998, P NATL ACAD SCI USA, V95, P5281, DOI 10.1073/pnas.95.9.5281; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Hagiwara K, 2010, BIOCHEM BIOPH RES CO, V403, P40, DOI 10.1016/j.bbrc.2010.10.107; Hagiwara K, 2010, BIOCHEM BIOPH RES CO, V394, P721, DOI 10.1016/j.bbrc.2010.03.058; Hashizume C, 2007, MICROBES INFECT, V9, P490, DOI 10.1016/j.micinf.2007.01.013; Iijima S, 2004, VIROLOGY, V327, P249, DOI 10.1016/j.virol.2004.06.024; Ishii H, 2012, BIOORG MED CHEM LETT, V22, P1469, DOI 10.1016/j.bmcl.2011.06.066; Kamata M, 2005, J VIROL, V79, P3557, DOI 10.1128/JVI.79.6.3557-3564.2005; Kamiyama T, 2013, BIOPHYS CHEM, V173, P8, DOI 10.1016/j.bpc.2013.01.004; Kanoh N, 2006, ANAL CHEM, V78, P2226, DOI 10.1021/ac051777j; Kanoh N, 2005, ANGEW CHEM INT EDIT, V44, P3559, DOI 10.1002/anie.200462370; KAWAMURA M, 1994, J GEN VIROL, V75, P2427, DOI 10.1099/0022-1317-75-9-2427; Kuramitsu M, 2005, MICROBES INFECT, V7, P1150, DOI 10.1016/j.micinf.2005.03.022; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Murakami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086840; Nishizawa M, 2000, J VIROL, V74, P6058, DOI 10.1128/JVI.74.13.6058-6067.2000; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Nonaka M, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-20; Orenstein JM, 1999, AIDS, V13, P2219, DOI 10.1097/00002030-199911120-00004; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; Saito A, 2008, CHEM-ASIAN J, V3, P1607, DOI 10.1002/asia.200800099; Sawaya BE, 2000, J VIROL, V74, P4877, DOI 10.1128/JVI.74.10.4877-4881.2000; Suzuki T, 2009, BIOCHEM BIOPH RES CO, V380, P838, DOI 10.1016/j.bbrc.2009.01.180; Takeda E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027815; TRISTEM M, 1992, EMBO J, V11, P3405, DOI 10.1002/j.1460-2075.1992.tb05419.x; TSUNETSUGUYOKOTA Y, 1995, J VIROL, V69, P4544, DOI 10.1128/JVI.69.7.4544-4547.1995; Vodicka MA, 1998, GENE DEV, V12, P175, DOI 10.1101/gad.12.2.175; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211	34	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145573	10.1371/journal.pone.0145573	http://dx.doi.org/10.1371/journal.pone.0145573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701275	gold, Green Submitted, Green Published			2022-12-27	WOS:000367092600097
J	Wang, Z; Yang, Y; Yuan, LJ; Liu, J; Duan, YY; Cao, TS				Wang, Zhen; Yang, Yong; Yuan, Li-jun; Liu, Jie; Duan, Yun-you; Cao, Tie-sheng			Noninvasive Method for Measuring Local Pulse Wave Velocity by Dual Pulse Wave Doppler: In Vitro and In Vivo Studies	PLOS ONE			English	Article							ARTERIAL STIFFNESS; AORTIC STIFFNESS; 17.6 TESLA; ALL-CAUSE; MORTALITY; MICE; POPULATION; ULTRASOUND; INDEX; AGE	Objectives To evaluate the validity and reproducibility of a noninvasive dual pulse wave Doppler (DPWD) method, which involves simultaneous recording of flow velocity of two independent sample volumes with a measurable distance, for measuring the local arterial pulse wave velocity (PWV) through in vitro and in vivo studies. Methods The DPWD mode of Hitachi HI Vision Preirus ultrasound system with a 5-13MHz transducer was used. An in vitro model was designed to compare the PWV of a homogeneous rubber tubing with the local PWV of its middle part measured by DPWD method. In the in vivo study, local PWV of 45 hypertensive patients (25 male, 49.8 +/- 3.1 years) and 45 matched healthy subjects (25 male, 49.3 +/- 3.0 years) were investigated at the left common carotid artery (LCCA) by DPWD method. Results In the in vitro study, the local PWV measured by DPWP method and the PWV of the homogeneous rubber tubing did not show statistical difference (5.16 +/- 0.28 m/s vs 5.03 +/- 0.15 m/s, p = 0.075). The coefficient of variation (CV) of the intra-and inter-measurements for local PWV were 3.46% and 4.96%, for the PWV of the homogeneous rubber tubing were 0.99% and 1.98%. In the in vivo study, a significantly higher local PWV of LCCA was found in the hypertensive patients as compared to that in healthy subjects (6.29 +/- 1.04m/s vs. 5.31 +/- 0.72m/s, P = 0.019). The CV of the intra-and inter-measurements in hypertensive patients were 2.22% and 3.94%, in healthy subjects were 2.07% and 4.14%. Conclusions This study demonstrated the feasibility of the noninvasive DPWD method to determine the local PWV, which was accurate and reproducible not only in vitro but also in vivo studies. This noninvasive echocardiographic method may be illuminating to clinical use.	[Wang, Zhen; Yang, Yong; Yuan, Li-jun; Liu, Jie; Duan, Yun-you; Cao, Tie-sheng] Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Diagnost, Xian 710032, Peoples R China	Air Force Military Medical University	Yuan, LJ (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Diagnost, Xian 710032, Peoples R China.	yuanlj@fmmu.edu.cn; caots4335@126.com	Ghosh, Amit/AAA-3490-2021; Liang, Yan/K-8199-2016; Stefanadis, Christodoulos/ABH-2232-2020; Ghosh, Amit/AAB-3140-2019; Liu, Jie/E-5484-2016	Ghosh, Amit/0000-0003-3514-885X; Liang, Yan/0000-0002-2144-1388; Stefanadis, Christodoulos/0000-0001-5974-6454; Liu, Jie/0000-0002-7441-2417; Tang, Ming/0000-0002-8158-6300	National Natural Science Foundation of China (NSFC) [81171348]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by Grant 81171348 from the National Natural Science Foundation of China (NSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutouyrie P, 2009, ARTERY RES, V3, P3, DOI 10.1016/j.artres.2008.11.002; Calabia J, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-13; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; DeLoach SS, 2008, CLIN J AM SOC NEPHRO, V3, P184, DOI 10.2215/CJN.03340807; Gosse P, 2008, J HYPERTENS, V26, P1138, DOI 10.1097/HJH.0b013e3282fa142b; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Hermeling E, 2007, ULTRASOUND MED BIOL, V33, P774, DOI 10.1016/j.ultrasmedbio.2006.11.018; Herold V, 2009, MAGN RESON MED, V61, P1293, DOI 10.1002/mrm.21957; Hickson SS, 2010, JACC-CARDIOVASC IMAG, V3, P1247, DOI 10.1016/j.jcmg.2010.09.016; Hoeks APG, 1997, ULTRASOUND MED BIOL, V23, P1017, DOI 10.1016/S0301-5629(97)00119-1; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Laurent S, 2007, J NEPHROL, V20, pS45; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Liu J, 2011, ARTHRIT CARE RES, V63, P579, DOI 10.1002/acr.20306; Nichols WW, 1990, MCDONALDS BLOOD FLOW; Parczyk M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-72; Reneman RS, 2005, EUR HEART J, V26, P960, DOI 10.1093/eurheartj/ehi177; Rogers WJ, 2001, J AM COLL CARDIOL, V38, P1123, DOI 10.1016/S0735-1097(01)01504-2; Safar ME, 2004, HYPERTENSION, V43, P163, DOI 10.1161/01.HYP.0000114571.75762.b0; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053917; Wang Z, 2012, ULTRASOUND MED BIOL, V38, P1778, DOI 10.1016/j.ultrasmedbio.2012.05.016; Williams R, 2007, ULTRASOUND MED BIOL, V33, P1368, DOI 10.1016/j.ultrasmedbio.2007.03.012; Yu HY, 2006, MAGN RESON MED, V56, P876, DOI 10.1002/mrm.21034	24	163	176	12	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120482	10.1371/journal.pone.0120482	http://dx.doi.org/10.1371/journal.pone.0120482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786124	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500175
J	Yang, YR; Han, XZ; Liang, Y; Ghosh, A; Chen, J; Tang, M				Yang, Yurong; Han, Xiaozhen; Liang, Yan; Ghosh, Amit; Chen, Jie; Tang, Ming			The Combined Effects of Arbuscular Mycorrhizal Fungi (AMF) and Lead (Pb) Stress on Pb Accumulation, Plant Growth Parameters, Photosynthesis, and Antioxidant Enzymes in Robinia pseudoacacia L.	PLOS ONE			English	Article							HEAVY-METAL UPTAKE; CHLOROPHYLL FLUORESCENCE; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; WATER STATUS; GLUTATHIONE; TOXICITY; DAMAGE; MAIZE; SOIL	Arbuscular mycorrhizal fungi (AMF) are considered as a potential biotechnological tool for improving phytostabilization efficiency and plant tolerance to heavy metal-contaminated soils. However, the mechanisms through which AMF help to alleviate metal toxicity in plants are still poorly understood. A greenhouse experiment was conducted to evaluate the effects of two AMF species (Funneliformis mosseae and Rhizophagus intraradices) on the growth, Pb accumulation, photosynthesis and antioxidant enzyme activities of a leguminous tree (Robinia pseudoacacia L.) at Pb addition levels of 0, 500, 1000 and 2000 mg kg(-1) soil. AMF symbiosis decreased Pb concentrations in the leaves and promoted the accumulation of biomass as well as photosynthetic pigment contents. Mycorrhizal plants had higher gas exchange capacity, non-photochemistry efficiency, and photochemistry efficiency compared with non-mycorrhizal plants. The enzymatic activities of superoxide dismutase (SOD), ascorbate peroxidases (APX) and glutathione peroxidase (GPX) were enhanced, and hydrogen peroxide (H2O2) and malondialdehyde (MDA) contents were reduced in mycorrhizal plants. These findings suggested that AMF symbiosis could protect plants by alleviating cellular oxidative damage in response to Pb stress. Furthermore, mycorrhizal dependency on plants increased with increasing Pb stress levels, indicating that AMF inoculation likely played a more important role in plant Pb tolerance in heavily contaminated soils. Overall, both F. mosseae and R. intraradices were able to maintain efficient symbiosis with R. pseudoacacia in Pb polluted soils. AMF symbiosis can improve photosynthesis and reactive oxygen species (ROS) scavenging capabilities and decrease Pb concentrations in leaves to alleviate Pb toxicity in R. pseudoacacia. Our results suggest that the application of the two AMF species associated with R. pseudoacacia could be a promising strategy for enhancing the phytostabilization efficiency of Pb contaminated soils.	[Yang, Yurong] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China; [Yang, Yurong; Chen, Jie; Tang, Ming] Northwest A&F Univ, Coll Forestry, Yangling 712100, Shaanxi, Peoples R China; [Han, Xiaozhen] Natl Univ Ireland, Sch Nat Sci, Plant Syst Biol Lab, Bot & Plant Sci, Galway, Ireland; [Liang, Yan] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Liang, Yan] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Ghosh, Amit] Indian Inst Technol Kharagpur, Sch Energy Sci & Engn, PK Sinha Ctr Bioenergy, Kharagpur 721302, W Bengal, India	Northwest A&F University - China; Northwest A&F University - China; Ollscoil na Gaillimhe-University of Galway; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Tang, M (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling 712100, Shaanxi, Peoples R China.	tangm@nwsuaf.edu.cn	Ghosh, Amit/AAA-3490-2021; Liang, Yan/K-8199-2016; Stefanadis, Christodoulos/ABH-2232-2020; Ghosh, Amit/AAB-3140-2019; Liu, Jie/E-5484-2016	Ghosh, Amit/0000-0003-3514-885X; Liang, Yan/0000-0002-2144-1388; Stefanadis, Christodoulos/0000-0001-5974-6454; Liu, Jie/0000-0002-7441-2417; Tang, Ming/0000-0002-8158-6300	National Natural Science Foundation of China [31270639, 31170607, 31170567]; Program for Changjiang Scholars and Innovative Research Team in University of China [IRT1035]; PhD Programs Foundation of Education Ministry of China [20100204110033, 20110204130001]; China Scholarship Council [201306300018]; DOE Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); PhD Programs Foundation of Education Ministry of China; China Scholarship Council(China Scholarship Council); DOE Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	Yurong Yang, Jie Chen and Ming Tang were financially supported by the National Natural Science Foundation of China (31270639, 31170607, 31170567), the Program for Changjiang Scholars and Innovative Research Team in University of China (IRT1035) and the PhD Programs Foundation of Education Ministry of China (20100204110033, 20110204130001). Xiaozhen Han was supported by the China Scholarship Council (201306300018). Yan Liang was funded by the DOE Joint BioEnergy Institute (http://www.jbei.org) which is supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SAL, 2009, CHEMOSPHERE, V75, P1363, DOI 10.1016/j.chemosphere.2009.02.008; Azcon R, 2009, APPL SOIL ECOL, V41, P168, DOI 10.1016/j.apsoil.2008.10.008; Bago B, 2000, PLANT PHYSIOL, V124, P949, DOI 10.1104/pp.124.3.949; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Chen X, 2005, CHEMOSPHERE, V60, P665, DOI 10.1016/j.chemosphere.2005.01.029; Deng CN, 2014, BIOL TRACE ELEM RES, V160, P268, DOI 10.1007/s12011-014-0039-z; Diaz G, 1996, PLANT SOIL, V180, P241, DOI 10.1007/BF00015307; Durnford DG, 2003, PHYSIOL PLANTARUM, V118, P193, DOI 10.1034/j.1399-3054.2003.00078.x; Eichler A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400196; Fatima RA, 2005, SCI TOTAL ENVIRON, V346, P256, DOI 10.1016/j.scitotenv.2004.12.004; Foyer CH, 2002, ADV PHOTO RESPIRAT, V12, P1; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Gajewska E, 2006, BIOL PLANTARUM, V50, P653, DOI 10.1007/s10535-006-0102-5; Gao J, 2000, EXPT TECHNIQUES PLAN; Garg N, 2015, PLANT GROWTH REGUL, V75, P521, DOI 10.1007/s10725-014-0016-8; Garrido I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046137; Giannakoula A, 2010, ENVIRON EXP BOT, V67, P487, DOI 10.1016/j.envexpbot.2009.07.010; Gohre V, 2006, PLANTA, V223, P1115, DOI 10.1007/s00425-006-0225-0; Hadi F., 2015, J BIOL LIFE SCI, V6, P91, DOI 10.5296/jbls.v6i2.7152; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; HEGGO A, 1990, SOIL BIOL BIOCHEM, V22, P865, DOI 10.1016/0038-0717(90)90169-Z; HEMEDA HM, 1990, J FOOD SCI, V55, P184, DOI 10.1111/j.1365-2621.1990.tb06048.x; Hildebrandt U, 1999, J PLANT PHYSIOL, V154, P709, DOI 10.1016/S0176-1617(99)80249-1; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hohnjec N, 2005, PLANT PHYSIOL, V137, P1283, DOI 10.1104/pp.104.056572; Islam E, 2008, J HAZARD MATER, V154, P914, DOI 10.1016/j.jhazmat.2007.10.121; Iturbe-Ormaetxe I, 2001, MOL PLANT MICROBE IN, V14, P1189, DOI 10.1094/MPMI.2001.14.10.1189; Jimenez A, 1997, PLANT PHYSIOL, V114, P275, DOI 10.1104/pp.114.1.275; Joner EJ, 2001, BIOL FERT SOILS, V33, P351, DOI 10.1007/s003740000331; Kosobrukhov A, 2004, PLANT GROWTH REGUL, V42, P145, DOI 10.1023/B:GROW.0000017490.59607.6b; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Kupper H, 2017, METAL IONS LIFE SCI, V17, P491, DOI [10.1590/S1677-04202005000100004, 10.1515/9783110434330-015]; Latef AAHA, 2011, SCI HORTIC-AMSTERDAM, V127, P228, DOI 10.1016/j.scienta.2010.09.020; Li X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124304; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Lingua G, 2008, ENVIRON POLLUT, V153, P137, DOI 10.1016/j.envpol.2007.07.012; Mateos-Naranjo E, 2008, MAR ENVIRON RES, V66, P459, DOI 10.1016/j.marenvres.2008.07.007; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MIDDLETON EM, 1993, PLANT PHYSIOL, V103, P741, DOI 10.1104/pp.103.3.741; Milla MAR, 2003, PLANT J, V36, P602, DOI 10.1046/j.1365-313X.2003.01901.x; Miransari M, 2011, BIOTECHNOL ADV, V29, P645, DOI 10.1016/j.biotechadv.2011.04.006; Mishra S, 2006, CHEMOSPHERE, V65, P1027, DOI 10.1016/j.chemosphere.2006.03.033; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Ouziad F, 2006, ENVIRON EXP BOT, V57, P177, DOI 10.1016/j.envexpbot.2005.05.011; Padmavathiamma PK, 2007, WATER AIR SOIL POLL, V184, P105, DOI 10.1007/s11270-007-9401-5; Pande M, 2004, APPL SOIL ECOL, V26, P233, DOI 10.1016/j.apsoil.2003.12.009; PATTERSON BD, 1984, ANAL BIOCHEM, V139, P487, DOI 10.1016/0003-2697(84)90039-3; Pawlowska TE, 2004, APPL ENVIRON MICROB, V70, P6643, DOI 10.1128/AEM.70.11.6643-6649.2004; PLENCHETTE C, 1983, PLANT SOIL, V70, P211, DOI 10.1007/BF02374781; Pourrut B, 2011, REV ENVIRON CONTAM T, V213, P113, DOI 10.1007/978-1-4419-9860-6_4; Rahantaniaina MS, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00477; Ralph PJ, 1998, ENVIRON POLLUT, V103, P91, DOI 10.1016/S0269-7491(98)00121-3; Reddy AM, 2005, CHEMOSPHERE, V60, P97, DOI 10.1016/j.chemosphere.2004.11.092; Ruley AT, 2006, ENVIRON POLLUT, V144, P11, DOI 10.1016/j.envpol.2006.01.016; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Sheng M, 2008, MYCORRHIZA, V18, P287, DOI 10.1007/s00572-008-0180-7; Shi GR, 2010, B ENVIRON CONTAM TOX, V85, P256, DOI 10.1007/s00128-010-0067-0; Singh S, 2006, CHEMOSPHERE, V62, P233, DOI 10.1016/j.chemosphere.2005.05.017; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI, V3rd, DOI DOI 10.1097/00010694-198403000-00011; Sousa RHV, 2015, PLANT CELL ENVIRON, V38, P499, DOI 10.1111/pce.12409; Sudova R, 2007, PLANT SOIL, V296, P77, DOI 10.1007/s11104-007-9291-8; Sun SQ, 2010, ENVIRON MONIT ASSESS, V163, P303, DOI 10.1007/s10661-009-0835-7; Toussaint JP, 2007, MYCORRHIZA, V17, P349, DOI 10.1007/s00572-007-0133-6; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; Varadi G, 2003, PHYSIOL PLANTARUM, V118, P47, DOI 10.1034/j.1399-3054.2003.00089.x; Verma S, 2003, PLANT SCI, V164, P645, DOI 10.1016/S0168-9452(03)00022-0; Vogel-Mikus K, 2006, ENVIRON POLLUT, V139, P362, DOI 10.1016/j.envpol.2005.05.005; Wang PF, 2012, ECOTOX ENVIRON SAFE, V78, P28, DOI 10.1016/j.ecoenv.2011.11.008; Wang YS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030635, 10.1371/journal.pone.0047302, 10.1371/journal.pone.0048669]; Wioleta W, 2015, BIOMETALS, V28, P151, DOI 10.1007/s10534-014-9811-y; Wu QS, 2006, J PLANT PHYSIOL, V163, P417, DOI 10.1016/j.jplph.2005.04.024; Xu ZY, 2014, ENVIRON SCI POLLUT R, V21, P12671, DOI 10.1007/s11356-014-3209-9; Yang YR, 2015, ENVIRON SCI POLLUT R, V22, P13179, DOI 10.1007/s11356-015-4521-8; Yang YR, 2015, SOIL BIOL BIOCHEM, V86, P146, DOI 10.1016/j.soilbio.2015.03.018; Yang YR, 2014, J PLANT GROWTH REGUL, V33, P612, DOI 10.1007/s00344-013-9410-0; Yemets O, 2015, ECOL INDIC, V55, P59, DOI 10.1016/j.ecolind.2015.03.015; Zhang HH, 2010, EUR J SOIL BIOL, V46, P306, DOI 10.1016/j.ejsobi.2010.05.006; Zhu XQ, 2014, PHOTOSYNTHETICA, V52, P247, DOI 10.1007/s11099-014-0031-z	80	163	176	12	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145726	10.1371/journal.pone.0145726	http://dx.doi.org/10.1371/journal.pone.0145726			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	25786124	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600123
